PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Savage, N				Savage, Neil			BIOINFORMATICS Big data versus the big C	NATURE			English	Editorial Material																		Davoli T, 2013, CELL, V155, P948, DOI 10.1016/j.cell.2013.10.011; McNerney ME, 2013, BLOOD, V121, P975, DOI 10.1182/blood-2012-04-426965	2	25	28	0	41	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 29	2014	509	7502					S66	S67		10.1038/509S66a	http://dx.doi.org/10.1038/509S66a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AH9JC	24860876	Bronze			2022-12-28	WOS:000336457100009
J	Miller, PS; Aricescu, AR				Miller, Paul S.; Aricescu, A. Radu			Crystal structure of a human GABA(A) receptor	NATURE			English	Article							NICOTINIC ACETYLCHOLINE-RECEPTORS; SIZE-EXCLUSION CHROMATOGRAPHY; LIGAND-BINDING DOMAIN; X-RAY-STRUCTURE; EXTRACELLULAR DOMAIN; ALPHA-BUNGAROTOXIN; ION SELECTIVITY; CHANNEL; MUTATION; EXPRESSION	Type-A gamma-aminobutyric acid receptors (GABA(A)Rs) are the principal mediators of rapid inhibitory synaptic transmission in the human brain. A decline in GABA(A)R signalling triggers hyperactive neurological disorders such as insomnia, anxiety and epilepsy. Here we present the first three-dimensional structure of a GABA(A)R, the human beta 3homopentamer, at 3 angstrom resolution. This structure reveals architectural elements unique to eukaryotic Cys-loop receptors, explains the mechanistic consequences of multiple human disease mutations and shows an unexpected structural role for a conserved N-linked glycan. The receptor was crystallized bound to a previously unknown agonist, benzamidine, opening a new avenue for the rational design of GABA(A)R modulators. The channel region forms a closed gate at the base of the pore, representative of a desensitized state. These results offer new insights into the signalling mechanisms of pentameric ligand-gated ion channels and enhance current understanding of GABAergic neurotransmission.	[Miller, Paul S.; Aricescu, A. Radu] Univ Oxford, Div Struct Biol, Wellcome Trust Ctr Human Genet, Oxford OX3 7BN, England	University of Oxford; Wellcome Centre for Human Genetics	Aricescu, AR (corresponding author), Univ Oxford, Div Struct Biol, Wellcome Trust Ctr Human Genet, Roosevelt Dr, Oxford OX3 7BN, England.	paul@strubi.ox.ac.uk; radu@strubi.ox.ac.uk		Aricescu, Alexandru ARadu/0000-0003-3783-1388; Miller, Paul/0000-0002-6512-9441	Wellcome Trust (OXION: Ion channels and Disease Initiative) [084655]; UK Medical Research Council ((MRC)) [G0700232]; Royal Society [RG090810]; Wellcome Trust [090532/Z/09/Z]; Medical Research Council [G0700232, MR/L009609/1] Funding Source: researchfish; MRC [G0700232, MR/L009609/1] Funding Source: UKRI	Wellcome Trust (OXION: Ion channels and Disease Initiative); UK Medical Research Council ((MRC))(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Royal Society(Royal Society of London); Wellcome Trust(Wellcome Trust); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	We thank T. Malinauskas, Y. Kong and staff at Diamond Light Source beamlines I03 and I24 for synchrotron assistance; K. Harlos and T. Walter for technical support with crystallization; G. Schertler and J. Standfuss for advice concerning the Rho-1D4 affinity purification method; T. Nakagawa for electron microscopy sample examination; F. Ashcroft, S. Tucker, M. Clausen and P. Proks for access to electrophysiology equipment and assistance with electrophysiological recordings; J. McIlhinney, M. Sansom, L. Carpenter, S. Newstead, I. de Moraes and members of the Aricescu laboratory for discussions; E. Y. Jones, D. I. Stuart and C. Siebold for reading the manuscript. This work was supported by grants from the Wellcome Trust (OXION: Ion channels and Disease Initiative, 084655), the UK Medical Research Council ((MRC) G0700232) and the Royal Society (RG090810). Further support from the Wellcome Trust Core Award Grant Number 090532/Z/09/Z is acknowledged. P. S. M. was a Wellcome Trust OXION Training Fellow. A. R. A. is an MRC Senior Research Fellow.	Akabas MH, 2013, P NATL ACAD SCI USA, V110, P16700, DOI 10.1073/pnas.1316157110; Allen AS, 2013, NATURE, V501, P217, DOI 10.1038/nature12439; Aricescu AR, 2006, ACTA CRYSTALLOGR D, V62, P1243, DOI 10.1107/S0907444906029799; Aricescu AR, 2013, CURR OPIN STRUC BIOL, V23, P345, DOI 10.1016/j.sbi.2013.04.003; Baker NA, 2001, P NATL ACAD SCI USA, V98, P10037, DOI 10.1073/pnas.181342398; Baulac S, 2001, NAT GENET, V28, P46, DOI 10.1038/88254; Belelli D, 2005, NAT REV NEUROSCI, V6, P565, DOI 10.1038/nrn1703; Bergmann R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0052323; Blanc E., 2011, BUSTER VERSION 2 11; Bocquet N, 2009, NATURE, V457, P111, DOI 10.1038/nature07462; Brejc K, 2001, NATURE, V411, P269, DOI 10.1038/35077011; Buhr A, 2002, HUM GENET, V111, P154, DOI 10.1007/s00439-002-0766-7; Butts CA, 2009, P NATL ACAD SCI USA, V106, P6501, DOI 10.1073/pnas.0810590106; Celie PHN, 2004, NEURON, V41, P907, DOI 10.1016/S0896-6273(04)00115-1; Chang VT, 2007, STRUCTURE, V15, P267, DOI 10.1016/j.str.2007.01.011; Chaudhary S, 2012, NAT PROTOC, V7, P453, DOI 10.1038/nprot.2011.453; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Chovancova E, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002708; Cymes GD, 2005, NATURE, V438, P975, DOI 10.1038/nature04293; daCosta CJB, 2011, J NEUROSCI, V31, P13870, DOI 10.1523/JNEUROSCI.2652-11.2011; Dellisanti CD, 2007, NAT NEUROSCI, V10, P953, DOI 10.1038/nn1942; Deprez C, 2005, J MOL BIOL, V346, P1047, DOI 10.1016/j.jmb.2004.12.028; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Farre C, 2009, COMB CHEM HIGH T SCR, V12, P24, DOI 10.2174/138620709787047966; GRENNINGLOH G, 1987, NATURE, V330, P25, DOI 10.1038/330025b0; Gurba KN, 2012, J BIOL CHEM, V287, P12083, DOI 10.1074/jbc.M111.332528; Hansen SB, 2005, EMBO J, V24, P3635, DOI 10.1038/sj.emboj.7600828; Hansen SB, 2008, J BIOL CHEM, V283, P36066, DOI 10.1074/jbc.C800194200; Hattori M, 2012, STRUCTURE, V20, P1293, DOI 10.1016/j.str.2012.06.009; Hibbs RE, 2011, NATURE, V474, P54, DOI 10.1038/nature10139; Hilf RJC, 2008, NATURE, V452, P375, DOI 10.1038/nature06717; Horenstein J, 1998, MOL PHARMACOL, V53, P870; Huang S, 2013, BIOCHEM J, V454, P303, DOI 10.1042/BJ20130636; Jansen M, 2008, J GEN PHYSIOL, V131, P137, DOI 10.1085/jgp.200709896; Jensen ML, 2002, J BIOL CHEM, V277, P41438, DOI 10.1074/jbc.M205645200; Karlin A, 1995, NEURON, V15, P1231, DOI 10.1016/0896-6273(95)90004-7; Kawate T, 2006, STRUCTURE, V14, P673, DOI 10.1016/j.str.2006.01.013; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Lape R, 2012, J NEUROSCI, V32, P1336, DOI 10.1523/JNEUROSCI.4346-11.2012; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Lee WY, 2005, NATURE, V438, P243, DOI 10.1038/nature04156; Li GD, 2006, J NEUROSCI, V26, P11599, DOI 10.1523/JNEUROSCI.3467-06.2006; Lo WY, 2010, J BIOL CHEM, V285, P31348, DOI 10.1074/jbc.M110.151449; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Miller PS, 2010, TRENDS PHARMACOL SCI, V31, P161, DOI 10.1016/j.tips.2009.12.005; Miller PS, 2005, J BIOL CHEM, V280, P37877, DOI 10.1074/jbc.M508303200; Miyazawa A, 2003, NATURE, V423, P949, DOI 10.1038/nature01748; MOLDAY RS, 1983, BIOCHEMISTRY-US, V22, P653, DOI 10.1021/bi00272a020; Mukhtasimova N, 2005, J GEN PHYSIOL, V126, P23, DOI 10.1085/jgp.200509283; Nagai T, 2002, NAT BIOTECHNOL, V20, P87, DOI 10.1038/nbt0102-87; Newell JG, 2004, J NEUROSCI, V24, P11226, DOI 10.1523/JNEUROSCI.3746-04.2004; Nury H, 2011, NATURE, V469, P428, DOI 10.1038/nature09647; OPRIAN DD, 1987, P NATL ACAD SCI USA, V84, P8874, DOI 10.1073/pnas.84.24.8874; Parker JL, 2012, PROTEIN SCI, V21, P1358, DOI 10.1002/pro.2122; RABOW LE, 1995, SYNAPSE, V21, P189, DOI 10.1002/syn.890210302; RAJENDRA S, 1995, NEURON, V14, P169, DOI 10.1016/0896-6273(95)90251-1; Rees DC, 2004, NAT REV DRUG DISCOV, V3, P660, DOI 10.1038/nrd1467; Reeves PJ, 2002, P NATL ACAD SCI USA, V99, P13419, DOI 10.1073/pnas.212519299; Rudolph U, 2011, NAT REV DRUG DISCOV, V10, P685, DOI 10.1038/nrd3502; Sancar F, 2004, J BIOL CHEM, V279, P47034, DOI 10.1074/jbc.M403388200; Saras A, 2008, J BIOL CHEM, V283, P10470, DOI 10.1074/jbc.M709993200; Sauguet L, 2013, EMBO J, V32, P728, DOI 10.1038/emboj.2013.17; Shan Q, 2001, J BIOL CHEM, V276, P12556, DOI 10.1074/jbc.M011264200; Sigel E, 2012, J BIOL CHEM, V287, P40224, DOI 10.1074/jbc.R112.386664; Simon J, 2004, J BIOL CHEM, V279, P41422, DOI 10.1074/jbc.M401354200; Smart OS, 2012, ACTA CRYSTALLOGR D, V68, P368, DOI 10.1107/S0907444911056058; STUART DI, 1979, J MOL BIOL, V134, P109, DOI 10.1016/0022-2836(79)90416-9; Tasneem A, 2005, GENOME BIOL, V6; Terwilliger TC, 2008, ACTA CRYSTALLOGR D, V64, P61, DOI 10.1107/S090744490705024X; Unwin N, 2005, J MOL BIOL, V346, P967, DOI 10.1016/j.jmb.2004.12.031; Unwin N, 2012, J MOL BIOL, V422, P617, DOI 10.1016/j.jmb.2012.07.010; Venkatachalan SP, 2008, P NATL ACAD SCI USA, V105, P13604, DOI 10.1073/pnas.0801854105; Wagner DA, 2004, J NEUROSCI, V24, P2733, DOI 10.1523/JNEUROSCI.4316-03.2004; Wallner M, 2003, P NATL ACAD SCI USA, V100, P15218, DOI 10.1073/pnas.2435171100; Walter TS, 2005, ACTA CRYSTALLOGR D, V61, P651, DOI 10.1107/S0907444905007808; Winter G, 2010, J APPL CRYSTALLOGR, V43, P186, DOI 10.1107/S0021889809045701; Xu M, 1996, J GEN PHYSIOL, V107, P195, DOI 10.1085/jgp.107.2.195; Yip GMS, 2013, NAT CHEM BIOL, V9, P715, DOI [10.1038/NCHEMBIO.1340, 10.1038/nchembio.1340]; Young GT, 2008, P NATL ACAD SCI USA, V105, P14686, DOI 10.1073/pnas.0804372105; Zacharias DA, 2002, SCIENCE, V296, P913, DOI 10.1126/science.1068539	80	499	513	10	200	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 21	2014	512	7514					270	+		10.1038/nature13293	http://dx.doi.org/10.1038/nature13293			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN3SF	24909990	Green Accepted			2022-12-28	WOS:000340508200026
J	Zuo, ZW; Ahneman, DT; Chu, LL; Terrett, JA; Doyle, AG; MacMillan, DWC				Zuo, Zhiwei; Ahneman, Derek T.; Chu, Lingling; Terrett, Jack A.; Doyle, Abigail G.; MacMillan, David W. C.			Merging photoredox with nickel catalysis: Coupling of alpha-carboxyl sp(3)-carbons with aryl halides	SCIENCE			English	Article							VISIBLE-LIGHT PHOTOCATALYSIS; ALKYL-HALIDES; ARYLATION; ACTIVATION; COMPLEXES; ALDEHYDES; GOLD	Over the past 40 years, transition metal catalysis has enabled bond formation between aryl and olefinic (sp(2)) carbons in a selective and predictable manner with high functional group tolerance. Couplings involving alkyl (sp(3)) carbons have proven more challenging. Here, we demonstrate that the synergistic combination of photoredox catalysis and nickel catalysis provides an alternative cross-coupling paradigm, in which simple and readily available organic molecules can be systematically used as coupling partners. By using this photoredox-metal catalysis approach, we have achieved a direct decarboxylative sp(3)-sp(2) cross-coupling of amino acids, as well as alpha-O- or phenyl-substituted carboxylic acids, with aryl halides. Moreover, this mode of catalysis can be applied to direct cross-coupling of C-sp3-H in dimethylaniline with aryl halides via C-H functionalization.	[Zuo, Zhiwei; Ahneman, Derek T.; Chu, Lingling; Terrett, Jack A.; Doyle, Abigail G.; MacMillan, David W. C.] Princeton Univ, Merck Ctr Catalysis, Princeton, NJ 08544 USA	Princeton University	Doyle, AG (corresponding author), Princeton Univ, Merck Ctr Catalysis, Princeton, NJ 08544 USA.	agdoyle@princeton.edu; dmacmill@princeton.edu	Zuo, Zhiwei/HDL-8353-2022; CHU, Lingling/GYJ-0028-2022; Zuo, Zhiwei/I-5092-2016	Chu, Lingling/0000-0001-7969-0531; Doyle, Abigail/0000-0002-6641-0833; Zuo, Zhiwei/0000-0002-3361-3220	NIH [NIHGMS R01 GM103558-01, R01 GM100985-01]; Shanghai Institute of Organic Chemistry; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM103558, R01GM100985] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Shanghai Institute of Organic Chemistry; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The authors are grateful for financial support provided by the NIH General Medical Sciences (grants NIHGMS R01 GM103558-01 and R01 GM100985-01) and gifts from Merck, Amgen, Eli Lilly, and Roche. Z.Z. and L. C. are grateful for postdoctoral fellowships from the Shanghai Institute of Organic Chemistry. The authors thank G. Molander and co-workers for graciously offering to concurrently publish a related study that was submitted slightly ahead of our own.	AMATORE C, 1988, ORGANOMETALLICS, V7, P2203, DOI 10.1021/om00100a019; Biswas S, 2013, J AM CHEM SOC, V135, P16192, DOI 10.1021/ja407589e; Budnikova YH, 2001, J ORGANOMET CHEM, V630, P185, DOI 10.1016/S0022-328X(01)00813-0; Durandetti M, 1996, NEW J CHEM, V20, P659; Graham TJA, 2011, CHEM SCI, V2, P980, DOI 10.1039/c1sc00026h; Hamilton DS, 2012, J AM CHEM SOC, V134, P18577, DOI 10.1021/ja309635w; Ischay MA, 2008, J AM CHEM SOC, V130, P12886, DOI 10.1021/ja805387f; Kalyani D, 2011, J AM CHEM SOC, V133, P18566, DOI 10.1021/ja208068w; Lowry MS, 2005, CHEM MATER, V17, P5712, DOI 10.1021/cm051312+; McNally A, 2011, SCIENCE, V334, P1114, DOI 10.1126/science.1213920; Narayanam JMR, 2009, J AM CHEM SOC, V131, P8756, DOI 10.1021/ja9033582; Netherton MR, 2004, ADV SYNTH CATAL, V346, P1525, DOI 10.1002/adsc.200404223; Nicewicz DA, 2008, SCIENCE, V322, P77, DOI 10.1126/science.1161976; Osawa M, 2007, DALTON T, P827, DOI 10.1039/b618007h; Pirnot MT, 2013, SCIENCE, V339, P1593, DOI 10.1126/science.1232993; Rudolph A, 2009, ANGEW CHEM INT EDIT, V48, P2656, DOI 10.1002/anie.200803611; Rueping M, 2012, CHEM-EUR J, V18, P5170, DOI 10.1002/chem.201200050; Sahoo B, 2013, J AM CHEM SOC, V135, P5505, DOI 10.1021/ja400311h; Shields JD, 2014, ORG LETT, V16, P142, DOI 10.1021/ol4031364; Shu XZ, 2014, J AM CHEM SOC, V136, P5844, DOI 10.1021/ja500716j; Sylvester KT, 2012, J AM CHEM SOC, V134, P16967, DOI 10.1021/ja3079362; Ye YD, 2012, J AM CHEM SOC, V134, P9034, DOI 10.1021/ja301553c; Zultanski SL, 2013, J AM CHEM SOC, V135, P624, DOI 10.1021/ja311669p; Zuo ZW, 2014, J AM CHEM SOC, V136, P5257, DOI 10.1021/ja501621q	24	1028	1032	31	906	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 25	2014	345	6195					437	440		10.1126/science.1255525	http://dx.doi.org/10.1126/science.1255525			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM2CB	24903563	Green Accepted			2022-12-28	WOS:000339655100039
J	Dev, SP; Stefan, RA; Saun, T; Lee, S				Dev, Shelly P.; Stefan, Raluca A.; Saun, Tomas; Lee, Shirley			Insertion of an Intraosseous Needle in Adults	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							CARDIOPULMONARY-RESUSCITATION; VASCULAR ACCESS; DRUG; INFUSION		[Dev, Shelly P.; Stefan, Raluca A.; Saun, Tomas; Lee, Shirley] Univ Toronto, Sunnybrook Hlth Sci Ctr, Toronto, ON, Canada	University of Toronto; Sunnybrook Research Institute; University Toronto Affiliates; Sunnybrook Health Science Center	Dev, SP (corresponding author), Sunnybrook Hlth Sci Ctr, Dept Crit Care Med, 2075 Bayview Ave,D112, Toronto, ON M4N 3M5, Canada.	shelly.dev@sunnybrook.ca	Saun, Tomas J./ABF-1630-2021	Saun, Tomas J./0000-0002-1053-0895				Blumberg SM, 2008, PEDIATR EMERG CARE, V24, P50, DOI 10.1097/pec.0b013e31815f727b; Buck ML, 2007, ANN PHARMACOTHER, V41, P1679, DOI 10.1345/aph.1K168; Davidoff Jack, 2005, JEMS, V30, P20; Fowler R, 2007, PREHOSP EMERG CARE, V11, P63, DOI 10.1080/10903120601021036; Horton MA, 2008, PEDIATR EMERG CARE, V24, P347, DOI 10.1097/PEC.0b013e318177a6fe; Johnson L, 1999, CRIT CARE MED, V27, P1147, DOI 10.1097/00003246-199906000-00039; Leidel BA, 2010, RESUSCITATION, V81, P994, DOI 10.1016/j.resuscitation.2010.03.038; Neumar RW, 2010, CIRCULATION, V122, pS729, DOI 10.1161/CIRCULATIONAHA.110.970988; Olaussen A, 2012, PREHOSP DISASTER MED, V27, P468, DOI 10.1017/S1049023X12001124; ORLOWSKI JP, 1989, ANN EMERG MED, V18, P1348, DOI 10.1016/S0196-0644(89)80274-4; ORLOWSKI JP, 1994, PEDIATR CLIN N AM, V41, P1183; ROSETTI VA, 1985, ANN EMERG MED, V14, P885, DOI 10.1016/S0196-0644(85)80639-9; Schwartz D, 2008, J TRAUMA, V64, P650, DOI 10.1097/TA.0b013e31814db2a6; Stanley R, 2004, CLIN PROCEDURES EMER, P475	14	12	14	1	12	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUN 12	2014	370	24							e35	10.1056/NEJMvcm1211371	http://dx.doi.org/10.1056/NEJMvcm1211371			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AI7BB	24918394				2022-12-28	WOS:000337033700001
J	Cole, TB				Cole, Thomas B.			Maudell Sleet's Magic Garden	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material																			0	0	0	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUN 11	2014	311	22					2256	2257		10.1001/jama.2013.279544	http://dx.doi.org/10.1001/jama.2013.279544			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AI6HL	24915241				2022-12-28	WOS:000336972600001
J	Rueda-Clausen, CF; Padwal, RS				Rueda-Clausen, Christian F.; Padwal, Raj S.			THERAPEUTICS Pharmacotherapy for weight loss	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							LORCASERIN; TOPIRAMATE; TRIAL; OBESE; OVERWEIGHT; ADULTS		[Rueda-Clausen, Christian F.; Padwal, Raj S.] Univ Alberta, Dept Med, Edmonton, AB T6G 2G3, Canada	University of Alberta	Padwal, RS (corresponding author), Univ Alberta, Dept Med, Edmonton, AB T6G 2G3, Canada.	rpadwal@ualberta.ca	Rueda-Clausen, Christian/S-2428-2019; Padwal, Raj/G-6903-2016	Rueda-Clausen, Christian/0000-0002-4077-6159; Padwal, Raj/0000-0003-3541-2817				Allison DB, 2012, OBESITY, V20, P330, DOI 10.1038/oby.2011.330; Bays HE, 2011, EXPERT REV CARDIOVAS, V9, P265, DOI [10.1586/erc.10.22, 10.1586/ERC.10.22]; Bray GA, 2000, NATURE, V404, P672, DOI 10.1038/35007544; Connolly HM, 1997, NEW ENGL J MED, V337, P581, DOI 10.1056/NEJM199708283370901; Fidler MC, 2011, J CLIN ENDOCR METAB, V96, P3067, DOI 10.1210/jc.2011-1256; Gadde KM, 2011, LANCET, V377, P1341, DOI 10.1016/S0140-6736(11)60205-5; Garvey WT, 2014, DIABETES CARE, V37, P912, DOI 10.2337/dc13-1518; Hendricks EJ, 2014, INT J OBESITY, V38, P292, DOI 10.1038/ijo.2013.74; Hunt S, 2008, NEUROLOGY, V71, P272, DOI 10.1212/01.wnl.0000318293.28278.33; Mirza N, 2009, BRIT J CLIN PHARMACO, V68, P655, DOI 10.1111/j.1365-2125.2009.03521.x; National Institute for HealthandClinical Excellence, 2006, OB PREV ID ASS MAN O; O'Neil PM, 2012, OBESITY, V20, P1426, DOI 10.1038/oby.2012.66; Padwal R, 2007, INT J OBESITY, V31, P1567, DOI 10.1038/sj.ijo.0803631; Rucker D, 2007, BMJ-BRIT MED J, V335, P1194, DOI 10.1136/bmj.39385.413113.25; Shram MJ, 2011, CLIN PHARMACOL THER, V89, P683, DOI 10.1038/clpt.2011.20; SILVERSTONE T, 1992, DRUGS, V43, P820, DOI 10.2165/00003495-199243060-00003; Smith SR, 2010, NEW ENGL J MED, V363, P245, DOI 10.1056/NEJMoa0909809; Torgerson JS, 2004, DIABETES CARE, V27, P155, DOI 10.2337/diacare.27.1.155; Verrotti A, 2011, EPILEPSY RES, V95, P189, DOI 10.1016/j.eplepsyres.2011.05.014; Wolfe SM, 2013, BMJ-BRIT MED J, V347, DOI 10.1136/bmj.f5140	21	4	4	0	5	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JUN 6	2014	348								g3526	10.1136/bmj.g3526	http://dx.doi.org/10.1136/bmj.g3526			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AI7CE	24907124				2022-12-28	WOS:000337038000009
J	Friend, SH; Schadt, EE				Friend, Stephen H.; Schadt, Eric E.			Clues from the resilient	SCIENCE			English	Editorial Material							GENETIC-VARIATION; CYSTIC-FIBROSIS; DISEASE		[Friend, Stephen H.] Sage Bionetworks, Seattle, WA 98109 USA; [Friend, Stephen H.; Schadt, Eric E.] Icahn Sch Med Mt Sinai, Dept Genet & Genom Sci, New York, NY 10029 USA; [Friend, Stephen H.; Schadt, Eric E.] Icahn Inst Genom & Multiscale Biol, New York, NY 10029 USA	Icahn School of Medicine at Mount Sinai	Friend, SH (corresponding author), Sage Bionetworks, Seattle, WA 98109 USA.	friend@sagebase.org; eric.schadt@exchange.mssm.edu						Cooper DN, 2013, HUM GENET, V132, P1077, DOI 10.1007/s00439-013-1331-2; Flannick J, 2014, NAT GENET, V46, P357, DOI 10.1038/ng.2915; Galarneau G, 2010, NAT GENET, V42, P1049, DOI 10.1038/ng.707; Gorry PR, 2002, LANCET, V359, P1832, DOI 10.1016/S0140-6736(02)08681-6; Hartman JL, 2001, SCIENCE, V291, P1001, DOI 10.1126/science.291.5506.1001; Hartman JL, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-7-r49; Hartman JL, 2007, P NATL ACAD SCI USA, V104, P11700, DOI 10.1073/pnas.0705212104; Hood L, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3008665; Iyer G, 2012, SCIENCE, V338, P221, DOI 10.1126/science.1226344; Jonathan C, 2005, NAT GENET, V37, P161, DOI 10.1038/ng1509; Kaiser J, 2014, SCIENCE, V344, P687, DOI 10.1126/science.344.6185.687; Louie RJ, 2012, GENOME MED, V4, DOI 10.1186/gm404; Ramsey BW, 2011, NEW ENGL J MED, V365, P1663, DOI 10.1056/NEJMoa1105185; Sosnay PR, 2013, NAT GENET, V45, P1160, DOI 10.1038/ng.2745; Stenson Peter D, 2012, Curr Protoc Bioinformatics, VChapter 1, DOI 10.1002/0471250953.bi0113s39; Welter D, 2014, NUCLEIC ACIDS RES, V42, pD1001, DOI 10.1093/nar/gkt1229	16	32	32	1	14	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 30	2014	344	6187					970	972		10.1126/science.1255648	http://dx.doi.org/10.1126/science.1255648			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AH9WM	24876479				2022-12-28	WOS:000336495800020
J	Luquero, FJ; Grout, L; Ciglenecki, I; Sakoba, K; Traore, B; Heile, M; Diallo, AA; Itama, C; Page, AL; Quilici, ML; Mengel, MA; Eiros, JM; Serafini, M; Legros, D; Grais, RF				Luquero, Francisco J.; Grout, Lise; Ciglenecki, Iza; Sakoba, Keita; Traore, Bala; Heile, Melat; Diallo, Alpha Amadou; Itama, Christian; Page, Anne-Laure; Quilici, Marie-Laure; Mengel, Martin A.; Maria Eiros, Jose; Serafini, Micaela; Legros, Dominique; Grais, Rebecca F.			Use of Vibrio cholerae Vaccine in an Outbreak in Guinea	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							MASS VACCINATION; CONTROLLED-TRIAL; BANGLADESH; CAMPAIGN; EPIDEMIC; EFFICACY; KOLKATA; BURDEN; INDIA	BACKGROUND The use of vaccines to prevent and control cholera is currently under debate. Shanchol is one of the two oral cholera vaccines prequalified by the World Health Organization; however, its effectiveness under field conditions and the protection it confers in the first months after administration remain unknown. The main objective of this study was to estimate the short-term effectiveness of two doses of Shanchol used as a part of the integrated response to a cholera outbreak in Africa. METHODS We conducted a matched case-control study in Guinea between May 20 and October 19, 2012. Suspected cholera cases were confirmed by means of a rapid test, and controls were selected among neighbors of the same age and sex as the case patients. The odds of vaccination were compared between case patients and controls in bivariate and adjusted conditional logistic-regression models. Vaccine effectiveness was calculated as (1-odds ratio) x 100. RESULTS Between June 8 and October 19, 2012, we enrolled 40 case patients and 160 controls in the study for the primary analysis. After adjustment for potentially confounding variables, vaccination with two complete doses was associated with significant protection against cholera (effectiveness, 86.6%; 95% confidence interval, 56.7 to 95.8; P=0.001). CONCLUSIONS In this study, Shanchol was effective when used in response to a cholera outbreak in Guinea. This study provides evidence supporting the addition of vaccination as part of the response to an outbreak. It also supports the ongoing efforts to establish a cholera vaccine stockpile for emergency use, which would enhance outbreak prevention and control strategies. (Funded by Medecins sans Frontieres.)	[Luquero, Francisco J.; Grout, Lise; Page, Anne-Laure; Grais, Rebecca F.] Epictr, F-75011 Paris, France; [Sakoba, Keita; Mengel, Martin A.] Agence Med Prevent, African Cholera Surveillance Network, Paris, France; [Quilici, Marie-Laure] Inst Pasteur, Natl Reference Ctr Vibrios & Cholera, Enter Bacterial Pathogens Res & Expertise Unit, Paris, France; [Grout, Lise; Ciglenecki, Iza; Serafini, Micaela; Legros, Dominique] Med Sans Frontieres, Geneva, Switzerland; [Sakoba, Keita] Minist Hlth, Conakry, Guinea; [Traore, Bala] Minist Hlth, Direct Prefectorale Sante, Conakry, Guinea; [Diallo, Alpha Amadou] Minist Hlth, Res & Documentat Serv, Conakry, Guinea; [Heile, Melat] Med Sans Frontieres, Conakry, Guinea; [Itama, Christian] WHO, Conakry, Guinea; [Maria Eiros, Jose] Univ Valladolid, Dept Microbiol, Valladolid, Spain	Agence de Medecine Preventive; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Doctors Without Borders; World Health Organization; Universidad de Valladolid	Luquero, FJ (corresponding author), Epictr, 8 Rue St Sabin, F-75011 Paris, France.	francisco.luquero@epicentre.msf.org		Eiros, Jose M/0000-0002-5357-6340; Freeman Grais, Rebecca/0000-0002-5037-8218	Medecins sans Frontieres; Division of Disease Prevention and Control of the Ministry of Health of Guinea, Africhol; Institut Pasteur; French Institute for Public Health Surveillance	Medecins sans Frontieres; Division of Disease Prevention and Control of the Ministry of Health of Guinea, Africhol; Institut Pasteur(European Commission); French Institute for Public Health Surveillance	Supported by Medecins sans Frontieres.; We thank the people of Guinea for their support and participation in the conduct of this survey; the Division of Disease Prevention and Control of the Ministry of Health of Guinea, Africhol, and all the district health and medical officers involved in the study for their support; Jean Rauzier for the work performed at the French National Reference Center for Vibrios and Cholera, which is funded by the Institut Pasteur and the French Institute for Public Health Surveillance; Charles Gaudry, head of mission for Medecins sans Frontieres in Guinea, and the emergency coordinators, logisticians, and administrative staff of the Medecins sans Frontieres Geneva operational center for their patience and enthusiastic support; the study teams and the Medecins sans Frontieres teams in Boffa and Forecariah, especially the research assistants Drs. Soumah Abubacar and Oumar Toure; and Dr. Pedro Pablo Palma, medical director of the Medecins sans Frontieres Barcelona-Athens operational center, for his comments and insight into this project and his continuing support.	AHMED ZU, 1994, MICROBIOL IMMUNOL, V38, P837, DOI 10.1111/j.1348-0421.1994.tb02135.x; Ali M, 2005, LANCET, V366, P44, DOI 10.1016/S0140-6736(05)66550-6; Ali M, 2013, CLIN INFECT DIS, V56, P1123, DOI 10.1093/cid/cit009; Ali M, 2012, B WORLD HEALTH ORGAN, V90, P209, DOI 10.2471/BLT.11.093427; [Anonymous], 2010, Wkly Epidemiol Rec, V85, P117; Armah GE, 2010, LANCET, V376, P606, DOI 10.1016/S0140-6736(10)60889-6; Bhattacharya SK, 2013, LANCET INFECT DIS, V13, P1011, DOI 10.1016/S1473-3099(13)70347-5; Bhattacharya S, 2013, LANCET INFECT DIS, V13, P1050, DOI 10.1016/S1473-3099(13)70273-1; Ciglenecki I, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001512; CLEMENS JD, 1986, LANCET, V2, P124; Dorlencourt F, 1999, B WORLD HEALTH ORGAN, V77, P949; Fournier J. M., 1992, LAB METHODS DIAGNOSI, P59; Harris JB, 2012, LANCET, V379, P2466, DOI 10.1016/S0140-6736(12)60436-X; Holmgren J, 2012, CURR OPIN IMMUNOL, V24, P343, DOI 10.1016/j.coi.2012.03.014; Hoshino K, 1998, FEMS IMMUNOL MED MIC, V20, P201, DOI 10.1111/j.1574-695X.1998.tb01128.x; Khatib AM, 2012, LANCET INFECT DIS, V12, P837, DOI 10.1016/S1473-3099(12)70196-2; Lucas MES, 2005, NEW ENGL J MED, V352, P757, DOI 10.1056/NEJMoa043323; Luquero FJ, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002465; Madhi SA, 2010, NEW ENGL J MED, V362, P289, DOI 10.1056/NEJMoa0904797; Martin S, 2012, B WORLD HEALTH ORGAN, V90, P714, DOI 10.2471/BLT.12.112433; Martinez-Pino I, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002366; Medecins Sans Frontieres, 2004, CHOL GUID, V2nd; Page AL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037360; Pastor M, 2013, VACCINE, V31, P4069, DOI 10.1016/j.vaccine.2013.06.096; Shin S, 2011, CLIN INFECT DIS, V52, P1343, DOI 10.1093/cid/cir141; Sur D, 2010, LANCET, V376, P1392; Sur D, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001289; World Health Organisation, 2010, CHOL OUTBR ASS OUTBR, pWorld health organisation; World Health Organization, 2010, 1 STEPS MAN OUTBR AC; Zuckerman JN, 2007, LANCET INFECT DIS, V7, P521, DOI 10.1016/S1473-3099(07)70138-X	30	105	106	0	12	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAY 29	2014	370	22					2111	2120		10.1056/NEJMoa1312680	http://dx.doi.org/10.1056/NEJMoa1312680			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AH9BM	24869721	Bronze, Green Published, Green Submitted			2022-12-28	WOS:000336434000009
J	Chin, G; Culotta, E				Chin, Gilbert; Culotta, Elizabeth			the science of Inequality What the numbers tell us	SCIENCE			English	Editorial Material																			0	26	27	1	11	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 23	2014	344	6186					818	821		10.1126/science.344.6186.818	http://dx.doi.org/10.1126/science.344.6186.818			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AH6IL	24855249				2022-12-28	WOS:000336233800027
J	Mitchell, KJ; Llamas, B; Soubrier, J; Rawlence, NJ; Worthy, TH; Wood, J; Lee, MSY; Cooper, A				Mitchell, Kieren J.; Llamas, Bastien; Soubrier, Julien; Rawlence, Nicolas J.; Worthy, Trevor H.; Wood, Jamie; Lee, Michael S. Y.; Cooper, Alan			Ancient DNA reveals elephant birds and kiwi are sister taxa and clarifies ratite bird evolution	SCIENCE			English	Article							MOA; VICARIANCE; LOSSES; FLIGHT	The evolution of the ratite birds has been widely attributed to vicariant speciation, driven by the Cretaceous breakup of the supercontinent Gondwana. The early isolation of Africa and Madagascar implies that the ostrich and extinct Madagascan elephant birds (Aepyornithidae) should be the oldest ratite lineages. We sequenced the mitochondrial genomes of two elephant birds and performed phylogenetic analyses, which revealed that these birds are the closest relatives of the New Zealand kiwi and are distant from the basal ratite lineage of ostriches. This unexpected result strongly contradicts continental vicariance and instead supports flighted dispersal in all major ratite lineages. We suggest that convergence toward gigantism and flightlessness was facilitated by early Tertiary expansion into the diurnal herbivory niche after the extinction of the dinosaurs.	[Mitchell, Kieren J.; Llamas, Bastien; Soubrier, Julien; Rawlence, Nicolas J.; Lee, Michael S. Y.; Cooper, Alan] Univ Adelaide, Sch Earth & Environm Sci, Australian Ctr Ancient DNA, Adelaide, SA 5005, Australia; [Worthy, Trevor H.] Flinders Univ S Australia, Sch Biol Sci, Adelaide, SA 5001, Australia; [Wood, Jamie] Landcare Res, Lincoln 7640, New Zealand; [Lee, Michael S. Y.] S Australian Museum, Adelaide, SA 5000, Australia	University of Adelaide; Flinders University South Australia; Landcare Research - New Zealand	Cooper, A (corresponding author), Univ Adelaide, Sch Earth & Environm Sci, Australian Ctr Ancient DNA, North Terrace Campus, Adelaide, SA 5005, Australia.	alan.cooper@adelaide.edu.au	Llamas, Bastien/Y-2781-2018; Worthy, Trevor/B-3781-2012; Soubrier, Julien/AAX-9560-2021; Llamas, Bastien/AAK-1693-2021; Wood, Jamie/AAU-5530-2021; Mitchell, Kieren/AAF-5837-2019; Wood, Jamie/A-9393-2008	Llamas, Bastien/0000-0002-5550-9176; Worthy, Trevor/0000-0001-7047-4680; Soubrier, Julien/0000-0001-9350-7369; Llamas, Bastien/0000-0002-5550-9176; Mitchell, Kieren/0000-0002-3921-0262; Wood, Jamie/0000-0001-8008-6083; Cooper, Alan/0000-0002-7738-7851	New Zealand Marsden Fund; Australian Research Council	New Zealand Marsden Fund(Royal Society of New ZealandMarsden Fund (NZ)); Australian Research Council(Australian Research Council)	This study was funded by the New Zealand Marsden Fund and the Australian Research Council. Grid computing facilities were provided by eRSA (e-research South Australia) and CIPRES (Cyberinfrastructure for Phylogenetic Research). We thank the Museum of New Zealand Te Papa Tongarewa (P. Millener, S. Bartle, A. Tennyson), Natural History Museum Oslo (N. Heintz), and National Museum of Natural History Paris (C. Lefevre) for samples. We acknowledge D. Penny, M. Phillips, D. Burney and R. Ward for valuable advice and assistance. All data associated with this study are available on GenBank (accession nos. KJ749824 and KJ749825) and DRYAD (doi:10.5061/dryad.2727k).	Ali JR, 2011, J BIOGEOGR, V38, P1855, DOI 10.1111/j.1365-2699.2011.02546.x; Black KH, 2012, EARTH LIFE GLOBAL BI, P983, DOI DOI 10.1007/978-90-481-3428-1_35; BLEDSOE A H, 1988, Annals of Carnegie Museum, V57, P73; Bunce M, 2009, P NATL ACAD SCI USA, V106, P20646, DOI 10.1073/pnas.0906660106; COOPER A, 1992, P NATL ACAD SCI USA, V89, P8741, DOI 10.1073/pnas.89.18.8741; Cooper A, 2001, NATURE, V409, P704, DOI 10.1038/35055536; CRACRAFT J, 1974, IBIS, V116, P494, DOI 10.1111/j.1474-919X.1974.tb07648.x; CRACRAFT J, 1973, J ZOOL, V169, P455; Haddrath O, 2012, P ROY SOC B-BIOL SCI, V279, P4617, DOI 10.1098/rspb.2012.1630; Harshman J, 2008, P NATL ACAD SCI USA, V105, P13462, DOI 10.1073/pnas.0803242105; Hume J.P., 2012, EXTINCT BIRDS; Johnston P, 2011, ZOOL J LINN SOC-LOND, V163, P959, DOI 10.1111/j.1096-3642.2011.00730.x; Lee Krista, 1997, P173, DOI 10.1016/B978-012498315-1/50011-X; Mayr G., 2009, PALEOGENE FOSSIL BIR, P25; Parker TJ, 1895, T ZOOLOGICAL SOC LON, V13, P373, DOI [10.1111/j.1096-3642.1895.tb00044.x, DOI 10.1111/J.1096-3642.1895.TB00044.X]; Phillips MJ, 2010, SYST BIOL, V59, P90, DOI 10.1093/sysbio/syp079; Schellart WP, 2006, EARTH-SCI REV, V76, P191, DOI 10.1016/j.earscirev.2006.01.002; Smith JV, 2013, SYST BIOL, V62, P35, DOI 10.1093/sysbio/sys067; Worthy TH, 2012, NEW ZEAL J ZOOL, V39, P87, DOI 10.1080/03014223.2012.665060; WORTHY TH, 2002, LOST WORLD MOA; Worthy Trevor H., 2013, P63	21	177	181	8	305	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 23	2014	344	6186					898	900		10.1126/science.1251981	http://dx.doi.org/10.1126/science.1251981			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AH6IL	24855267				2022-12-28	WOS:000336233800047
J	Alushin, GM; Lander, GC; Kellogg, EH; Zhang, R; Baker, D; Nogales, E				Alushin, Gregory M.; Lander, Gabriel C.; Kellogg, Elizabeth H.; Zhang, Rui; Baker, David; Nogales, Eva			High-Resolution Microtubule Structures Reveal the Structural Transitions in alpha beta-Tubulin upon GTP Hydrolysis	CELL			English	Article							SLOWLY HYDROLYZABLE ANALOG; NDC80 KINETOCHORE COMPLEX; STATHMIN-LIKE DOMAIN; ELECTRON CRYSTALLOGRAPHY; CRYOELECTRON MICROSCOPY; DYNAMIC INSTABILITY; GAMMA-TUBULIN; DENSITY MAPS; UCSF CHIMERA; BINDING	Dynamic instability, the stochastic switching between growth and shrinkage, is essential for microtubule function. This behavior is driven by GTP hydrolysis in the microtubule lattice and is inhibited by anticancer agents like Taxol. We provide insight into the mechanism of dynamic instability, based on high-resolution cryo-EM structures (4.7-5.6 angstrom) of dynamic microtubules and microtubules stabilized by GMPCPP or Taxol. We infer that hydrolysis leads to a compaction around the E-site nucleotide at longitudinal interfaces, as well as movement of the alpha-tubulin intermediate domain and H7 helix. Displacement of the C-terminal helices in both alpha- and beta-tubulin subunits suggests an effect on interactions with binding partners that contact this region. Taxol inhibits most of these conformational changes, allosterically inducing a GMPCPP-like state. Lateral interactions are similar in all conditions we examined, suggesting that microtubule lattice stability is primarily modulated at longitudinal interfaces.	[Alushin, Gregory M.] Univ Calif Berkeley, Biophys Grad Program, Berkeley, CA 94720 USA; [Lander, Gabriel C.; Zhang, Rui; Nogales, Eva] Univ Calif Berkeley, Lawrence Berkeley Natl Lab, Div Life Sci, Berkeley, CA 94720 USA; [Kellogg, Elizabeth H.; Baker, David] Univ Washington, Dept Biochem, Howard Hughes Med Inst, Seattle, WA 98105 USA; [Nogales, Eva] Univ Calif Berkeley, Dept Mol & Cell Biol, Howard Hughes Med Inst, Berkeley, CA 94720 USA	University of California System; University of California Berkeley; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley; Howard Hughes Medical Institute; University of Washington; University of Washington Seattle; Howard Hughes Medical Institute; University of California System; University of California Berkeley	Nogales, E (corresponding author), Univ Calif Berkeley, Lawrence Berkeley Natl Lab, Div Life Sci, Berkeley, CA 94720 USA.	enogales@lbl.gov	Baker, David/K-8941-2012	Baker, David/0000-0001-7896-6217; Lander, Gabriel C./0000-0003-4921-1135; Alushin, Gregory/0000-0001-7250-4484	National Institute of General Medical Sciences [GM051487]; Damon Runyon Cancer Research Foundation [DRG 2055-10]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P01GM051487] Funding Source: NIH RePORTER	National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Damon Runyon Cancer Research Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank Patricia Grob and Tom Houweling for electron microscopy and computer support, respectively, Tom Goddard for help with UCSF Chimera, Yifan Song and Frank DiMaio for making code available for use prior to publication, and Stuart Howes for assistance with kinesin purification. We are grateful to Robert Glaeser for assistance with data collection and many discussions. The kinesin expression construct was the gift of Erik Jonsson and Ron Vale. This work was funded by the National Institute of General Medical Sciences (GM051487) (to E.N.) and a Damon Runyon Cancer Research Foundation fellowship (DRG 2055-10) (to G. C. L.). E.N. and D. B. are Howard Hughes Medical Institute Investigators.	Al-Bassam J, 2002, J CELL BIOL, V157, P1187, DOI 10.1083/jcb.200201048; Aldaz H, 2005, NATURE, V435, P523, DOI 10.1038/nature03586; Alushin GM, 2012, NAT STRUCT MOL BIOL, V19, P1161, DOI 10.1038/nsmb.2411; Alushin GM, 2010, NATURE, V467, P805, DOI 10.1038/nature09423; Amos LA, 1999, CHEM BIOL, V6, pR65, DOI 10.1016/S1074-5521(99)89002-4; ARNAL I, 1995, CURR BIOL, V5, P900, DOI 10.1016/S0960-9822(95)00180-1; Ayaz P, 2012, SCIENCE, V337, P857, DOI 10.1126/science.1221698; Aylett CHS, 2011, INT REV CEL MOL BIO, V292, P1, DOI 10.1016/B978-0-12-386033-0.00001-3; Barbier P, 2010, J BIOL CHEM, V285, P31672, DOI 10.1074/jbc.M110.141929; CAPLOW M, 1994, J CELL BIOL, V127, P779, DOI 10.1083/jcb.127.3.779; CHRETIEN D, 1995, J CELL BIOL, V129, P1311, DOI 10.1083/jcb.129.5.1311; Desai A, 1997, ANNU REV CELL DEV BI, V13, P83, DOI 10.1146/annurev.cellbio.13.1.83; DiMaio F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020450; DiMaio F, 2009, J MOL BIOL, V392, P181, DOI 10.1016/j.jmb.2009.07.008; Dumontet C, 2010, NAT REV DRUG DISCOV, V9, P790, DOI 10.1038/nrd3253; Egelman EH, 2007, J STRUCT BIOL, V157, P83, DOI 10.1016/j.jsb.2006.05.015; Gigant B, 2000, CELL, V102, P809, DOI 10.1016/S0092-8674(00)00069-6; Gigant B, 2005, NATURE, V435, P519, DOI 10.1038/nature03566; Goddard TD, 2007, J STRUCT BIOL, V157, P281, DOI 10.1016/j.jsb.2006.06.010; Grafmuller A, 2013, J MOL BIOL, V425, P2232, DOI 10.1016/j.jmb.2013.03.029; Grigorieff N, 2007, J STRUCT BIOL, V157, P117, DOI 10.1016/j.jsb.2006.05.004; Hyams J. S, 1993, MICROTUBULES; HYMAN AA, 1992, MOL BIOL CELL, V3, P1155, DOI 10.1091/mbc.3.10.1155; HYMAN AA, 1995, J CELL BIOL, V128, P117, DOI 10.1083/jcb.128.1.117; Lander GC, 2009, J STRUCT BIOL, V166, P95, DOI 10.1016/j.jsb.2009.01.002; Li HL, 2002, STRUCTURE, V10, P1317, DOI 10.1016/S0969-2126(02)00827-4; Lowe J, 2001, J MOL BIOL, V313, P1045, DOI 10.1006/jmbi.2001.5077; MANDELKOW EM, 1991, J CELL BIOL, V114, P977, DOI 10.1083/jcb.114.5.977; Maurer SP, 2012, CELL, V149, P371, DOI 10.1016/j.cell.2012.02.049; Maurer SP, 2011, P NATL ACAD SCI USA, V108, P3988, DOI 10.1073/pnas.1014758108; McIntosh JR, 2010, J CELL SCI, V123, P3425, DOI 10.1242/jcs.067611; Menendez M, 1998, J BIOL CHEM, V273, P167, DOI 10.1074/jbc.273.1.167; MITCHISON T, 1984, NATURE, V312, P237, DOI 10.1038/312237a0; MITCHISON TJ, 1993, SCIENCE, V261, P1044, DOI 10.1126/science.8102497; Muller-Reichert T, 1998, P NATL ACAD SCI USA, V95, P3661, DOI 10.1073/pnas.95.7.3661; Nakata T, 2011, J CELL BIOL, V194, P245, DOI 10.1083/jcb.201104034; Nawrotek A, 2011, J MOL BIOL, V412, P35, DOI 10.1016/j.jmb.2011.07.029; Nettles JH, 2004, SCIENCE, V305, P866, DOI 10.1126/science.1099190; Nogales E, 2000, ANNU REV BIOCHEM, V69, P277, DOI 10.1146/annurev.biochem.69.1.277; Nogales E, 1999, CELL, V96, P79, DOI 10.1016/S0092-8674(00)80961-7; Nogales E, 1998, NATURE, V391, P199, DOI 10.1038/34465; Nogales E, 2006, CURR OPIN STRUC BIOL, V16, P221, DOI 10.1016/j.sbi.2006.03.005; NOGALES E, 1995, J STRUCT BIOL, V115, P199, DOI 10.1006/jsbi.1995.1044; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Prota AE, 2013, SCIENCE, V339, P587, DOI 10.1126/science.1230582; Ravelli RBG, 2004, NATURE, V428, P198, DOI 10.1038/nature02393; Redwine WB, 2012, SCIENCE, V337, P1532, DOI 10.1126/science.1224151; Rice LM, 2008, P NATL ACAD SCI USA, V105, P5378, DOI 10.1073/pnas.0801155105; SIMON JR, 1990, J CELL SCI, V96, P571; Sindelar CV, 2010, P NATL ACAD SCI USA, V107, P4111, DOI 10.1073/pnas.0911208107; Song YF, 2013, STRUCTURE, V21, P1735, DOI 10.1016/j.str.2013.08.005; Sui HX, 2010, STRUCTURE, V18, P1022, DOI 10.1016/j.str.2010.05.010; Suloway C, 2005, J STRUCT BIOL, V151, P41, DOI 10.1016/j.jsb.2005.03.010; VALE RD, 1994, J BIOL CHEM, V269, P23769; Wang HW, 2005, NATURE, V435, P911, DOI 10.1038/nature03606; Yajima H, 2012, J CELL BIOL, V198, P315, DOI 10.1083/jcb.201201161	56	391	396	2	142	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAY 22	2014	157	5					1117	1129		10.1016/j.cell.2014.03.053	http://dx.doi.org/10.1016/j.cell.2014.03.053			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	AH9CG	24855948	Green Accepted, Bronze			2022-12-28	WOS:000336437200014
J	Arnegard, ME; McGee, MD; Matthews, B; Marchinko, KB; Conte, GL; Kabir, S; Bedford, N; Bergek, S; Chan, YF; Jones, FC; Kingsley, DM; Peichel, CL; Schluter, D				Arnegard, Matthew E.; McGee, Matthew D.; Matthews, Blake; Marchinko, Kerry B.; Conte, Gina L.; Kabir, Sahriar; Bedford, Nicole; Bergek, Sara; Chan, Yingguang Frank; Jones, Felicity C.; Kingsley, David M.; Peichel, Catherine L.; Schluter, Dolph			Genetics of ecological divergence during speciation	NATURE			English	Article							DEPENDENT POSTMATING ISOLATION; ADAPTIVE RADIATION; NATURAL-SELECTION; 3-SPINED STICKLEBACKS; TROPHIC POSITION; SPECIES-PAIR; HABITAT USE; EVOLUTION; ADAPTATION; SIZE	Ecological differences often evolve early in speciation as divergent natural selection drives adaptation to distinct ecological niches, leading ultimately to reproductive isolation. Although this process is a major generator of biodiversity, its genetic basis is still poorly understood. Here we investigate the genetic architecture of niche differentiation in a sympatric species pair of threespine stickleback fish by mapping the environment-dependent effects of phenotypic traits on hybrid feeding and performance under semi-natural conditions. We show that multiple, unlinked loci act largely additively to determine position along the major niche axis separating these recently diverged species. We also find that functional mismatch between phenotypic traits reduces the growth of some stickleback hybrids beyond that expected from an intermediate phenotype, suggesting a role for epistasis between the underlying genes. This functional mismatch might lead to hybrid incompatibilities that are analogous to those underlying intrinsic reproductive isolation but depend on the ecological context.	[Arnegard, Matthew E.; Peichel, Catherine L.] Fred Hutchinson Canc Res Ctr, Human Biol Div, Seattle, WA 98109 USA; [Arnegard, Matthew E.; Peichel, Catherine L.] Fred Hutchinson Canc Res Ctr, Div Basic Sci, Seattle, WA 98109 USA; [Arnegard, Matthew E.; Marchinko, Kerry B.; Conte, Gina L.; Kabir, Sahriar; Bedford, Nicole; Schluter, Dolph] Univ British Columbia, Biodivers Res Ctr, Vancouver, BC V6T 1Z4, Canada; [Arnegard, Matthew E.; Marchinko, Kerry B.; Conte, Gina L.; Kabir, Sahriar; Bedford, Nicole; Schluter, Dolph] Univ British Columbia, Dept Zool, Vancouver, BC V6T 1Z4, Canada; [McGee, Matthew D.] Univ Calif Davis, Dept Ecol & Evolut, Davis, CA 95616 USA; [Matthews, Blake] EAWAG, Ctr Ecol Evolut & Biogeochem, Dept Aquat Ecol, CH-6047 Kastanienbaum, Switzerland; [Bergek, Sara] Uppsala Univ, Dept Anim Ecol, Evolutionary Biol Ctr, SE-75236 Uppsala, Sweden; [Chan, Yingguang Frank; Jones, Felicity C.; Kingsley, David M.] Stanford Univ, Dept Dev Biol, Sch Med, Stanford, CA 94305 USA; [Chan, Yingguang Frank; Jones, Felicity C.; Kingsley, David M.] Howard Hughes Med Inst, Stanford, CA 94305 USA	Fred Hutchinson Cancer Center; Fred Hutchinson Cancer Center; University of British Columbia; University of British Columbia; University of California System; University of California Davis; Swiss Federal Institutes of Technology Domain; Swiss Federal Institute of Aquatic Science & Technology (EAWAG); Uppsala University; Stanford University; Howard Hughes Medical Institute	Arnegard, ME (corresponding author), Fred Hutchinson Canc Res Ctr, Human Biol Div, 1100 Fairview Ave North, Seattle, WA 98109 USA.	marnegar@fhcrc.org	Chan, Yingguang Frank/ABG-9852-2020; Jones, Felicity C/AAY-3523-2021; Matthews, Blake/B-5608-2009	Chan, Yingguang Frank/0000-0001-6292-9681; Jones, Felicity C/0000-0002-5027-1031; Matthews, Blake/0000-0001-9089-704X; Peichel, Catherine/0000-0002-7731-8944; Schluter, Dolph/0000-0003-1683-7836; Bedford, Nicole/0000-0001-5700-1774	US National Institutes of Health [F32GM086125, R01 GM089733, P50 HG002568]; Natural Sciences and Engineering Research Council of Canada; Canada Foundation for Innovation; NATIONAL CANCER INSTITUTE [P30CA015704] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [P50HG002568] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM089733, F32GM086125] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Canada Foundation for Innovation(Canada Foundation for InnovationCGIAR); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank J. Perez for counting gill rakers; C. Sather for performing lab work for SNP genotyping; and K. Broman, G. Coop, I. Goodliffe, A. Greenwood, P. Wainwright, M. White and M. Wund for constructive comments. Stable isotopes were analysed at the University of California, Davis, Stable Isotope Facility. Funding was provided by grants from the US National Institutes of Health (F32GM086125 to M. E. A., R01 GM089733 to C. L. P. and D. S., and P50 HG002568 to C. L. P. and D. M. K.), the Natural Sciences and Engineering Research Council of Canada (to D. S.) and the Canada Foundation for Innovation (to D.S.).	AKAIKE H, 1974, IEEE T AUTOMAT CONTR, VAC19, P716, DOI 10.1109/TAC.1974.1100705; Albert AYK, 2008, EVOLUTION, V62, P76, DOI 10.1111/j.1558-5646.2007.00259.x; [Anonymous], 1861, ORIGIN SPECIES MEANS; Arnegard ME, 2010, AM NAT, V176, P335, DOI 10.1086/655221; Barrett RDH, 2011, NAT REV GENET, V12, P767, DOI 10.1038/nrg3015; Behm JE, 2010, AM NAT, V175, P11, DOI 10.1086/648559; Bolnick D. I., 2011, INT J ECOL, V2011, DOI [10.1155/2011/942847, DOI 10.1155/2011/942847)]; Bolnick DI, 2003, AM NAT, V161, P1, DOI 10.1086/343878; Broman KW, 2009, STAT BIOL HEALTH, P1, DOI 10.1007/978-0-387-92125-9_1; Burnham K.P., 2002, MODEL SELECTION MULT, VSecond edition; Candolin U, 2001, OIKOS, V95, P225, DOI 10.1034/j.1600-0706.2001.950204.x; Carlson SM, 2010, ECOLOGY, V91, P1016, DOI 10.1890/09-0252.1; Chase J.M., 2009, ECOLOGICAL NICHES LI; Coyne J.A., 2004, SPECIATION; Dryden I. L., 2009, PACKAGE SHAPES STAT; Egan SP, 2009, P NATL ACAD SCI USA, V106, P19426, DOI 10.1073/pnas.0909424106; ENGLE RF, 1986, APPL MATH COMPUT, V20, P313, DOI 10.1016/0096-3003(86)90009-3; Erickson DL, 2004, MOL ECOL, V13, P2505, DOI 10.1111/j.1365-294X.2004.02254.x; Feder JL, 2012, TRENDS GENET, V28, P342, DOI 10.1016/j.tig.2012.03.009; Fisher R.A., 1930, GENETICAL THEORY NAT; FRY B., 2006, STABLE ISOTOPE ECOLO; GAVRILETS S, 2004, MONOGRAPHS POPULATIO, V41; Gow JL, 2007, J EVOLUTION BIOL, V20, P2173, DOI 10.1111/j.1420-9101.2007.01427.x; Gow JL, 2006, MOL ECOL, V15, P739, DOI 10.1111/j.1365-294X.2006.02825.x; Hadfield J., 2012, PACKAGE MASTERBAYES; Hadfield JD, 2006, MOL ECOL, V15, P3715, DOI 10.1111/j.1365-294X.2006.03050.x; Harmon LJ, 2009, NATURE, V458, P1167, DOI 10.1038/nature07974; HARTIGAN JA, 1985, ANN STAT, V13, P70, DOI 10.1214/aos/1176346577; Hatfield T, 1999, EVOLUTION, V53, P866, DOI 10.1111/j.1558-5646.1999.tb05380.x; Hohenlohe PA, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000862; Hothorn T, 2012, PACKAGE IMTEST TESTI; Jones FC, 2012, NATURE, V484, P55, DOI 10.1038/nature10944; Jones FC, 2012, CURR BIOL, V22, P83, DOI 10.1016/j.cub.2011.11.045; Kosambi DD, 1943, ANN EUGENIC, V12, P172, DOI 10.1111/j.1469-1809.1943.tb02321.x; Lumley T, 2009, PACKAGE LEAPS REGRES; MacColl ADC, 2009, BIOL J LINN SOC, V96, P425, DOI 10.1111/j.1095-8312.2008.01123.x; Mackay TFC, 2014, NAT REV GENET, V15, P22, DOI 10.1038/nrg3627; Mackay TFC, 2009, NAT REV GENET, V10, P565, DOI 10.1038/nrg2612; Maechler M., 2011, PACKAGE DIPTEST HART; MALLOWS CL, 1973, TECHNOMETRICS, V15, P661, DOI 10.2307/1267380; Manichaikul A, 2006, GENETICS, V174, P481, DOI 10.1534/genetics.106.061549; Marchinko KB, 2009, EVOLUTION, V63, P127, DOI 10.1111/j.1558-5646.2008.00529.x; Matthews B, 2010, ECOLOGY, V91, P1025, DOI 10.1890/09-0235.1; McBride CS, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000529; McGee MD, 2013, BMC EVOL BIOL, V13, DOI 10.1186/1471-2148-13-277; McGee MD, 2013, EVOLUTION, V67, P1204, DOI 10.1111/j.1558-5646.2012.01839.x; McIntyre PB, 2006, OECOLOGIA, V148, P12, DOI 10.1007/s00442-005-0354-3; MCPHAIL JD, 1992, CAN J ZOOL, V70, P361, DOI 10.1139/z92-054; Miller A., 2002, MG STAT PRO, V95; Nosil P, 2012, OX ECOL EV, P1, DOI 10.1093/acprof:osobl/9780199587100.001.0001; Orr HA, 2005, NAT REV GENET, V6, P119, DOI 10.1038/nrg1523; Peichel CL, 2001, NATURE, V414, P901, DOI 10.1038/414901a; Phillips PC, 2008, NAT REV GENET, V9, P855, DOI 10.1038/nrg2452; Post DM, 2002, ECOLOGY, V83, P703, DOI 10.2307/3071875; Presgraves DC, 2010, NAT REV GENET, V11, P175, DOI 10.1038/nrg2718; R DEVELOPMENT CORE TEAM, 2011, R LANG ENV STAT COMP; RICE WR, 1993, EVOLUTION, V47, P1637, DOI [10.2307/2410209, 10.1111/j.1558-5646.1993.tb01257.x]; Rogers SM, 2012, EVOLUTION, V66, P2439, DOI 10.1111/j.1558-5646.2012.01622.x; Rohlf F.J., 2006, TPSDIG2; ROHLF FJ, 1990, SYST ZOOL, V39, P40, DOI 10.2307/2992207; Rundle HD, 2000, SCIENCE, V287, P306, DOI 10.1126/science.287.5451.306; Rundle HD, 2005, ECOL LETT, V8, P336, DOI 10.1111/j.1461-0248.2004.00715.x; Rundle HD, 2002, EVOLUTION, V56, P322, DOI 10.1111/j.0014-3820.2002.tb01342.x; Sambrook J., 2001, MOL CLONING LAB MANU; SCHLUTER D, 1988, EVOLUTION, V42, P849, DOI [10.2307/2408904, 10.1111/j.1558-5646.1988.tb02507.x]; SCHLUTER D, 1994, SCIENCE, V266, P798, DOI 10.1126/science.266.5186.798; SCHLUTER D, 1993, ECOLOGY, V74, P699, DOI 10.2307/1940797; SCHLUTER D, 1995, ECOLOGY, V76, P82, DOI 10.2307/1940633; Schluter D., 2000, ECOLOGY ADAPTIVE RAD; Schluter D, 2009, P NATL ACAD SCI USA, V106, P9955, DOI 10.1073/pnas.0901264106; Seehausen O, 2014, NAT REV GENET, V15, P176, DOI 10.1038/nrg3644; Smith RJ, 2009, AM J PHYS ANTHROPOL, V140, P476, DOI 10.1002/ajpa.21090; Strasburg JL, 2012, PHILOS T R SOC B, V367, P364, DOI 10.1098/rstb.2011.0199; Taylor EB, 2000, P ROY SOC B-BIOL SCI, V267, P2375, DOI 10.1098/rspb.2000.1294; van Ooijen J.W., 2001, JOINMAP 3 0 SOFTWARE; Vander Zanden MJ, 2002, ECOLOGY, V83, P2152, DOI 10.1890/0012-9658(2002)083[2152:FAIOBA]2.0.CO;2; Via S, 2009, P NATL ACAD SCI USA, V106, P9939, DOI 10.1073/pnas.0901397106; Warton DI, 2012, METHODS ECOL EVOL, V3, P257, DOI 10.1111/j.2041-210X.2011.00153.x; WHITLOCK MC, 1995, ANNU REV ECOL SYST, V26, P601, DOI 10.1146/annurev.es.26.110195.003125; Wootton R. J., 1984, FUNCTIONAL BIOL STIC; Yeaman S, 2011, EVOLUTION, V65, P1897, DOI 10.1111/j.1558-5646.2011.01269.x	82	186	187	13	451	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 17	2014	511	7509					307	+		10.1038/nature13301	http://dx.doi.org/10.1038/nature13301			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AL2YR	24909991	Green Accepted			2022-12-28	WOS:000338992200027
J	Koh, HK; Blakey, CR; Roper, AY				Koh, Howard K.; Blakey, Carter R.; Roper, Allison Y.			Healthy People 2020: A Report Card on the Health of the Nation	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Koh, Howard K.; Blakey, Carter R.; Roper, Allison Y.] US Dept HHS, Washington, DC 20201 USA		Koh, HK (corresponding author), US Dept HHS, 200 Independence Ave SW,Ste 716-G, Washington, DC 20201 USA.	howard.koh@hhs.gov						Carman KG, 2013, CHANGES IN HEALTH IN; Centers for Disease Control and Prevention, 2014, SECONDHAND SMOKE FAC; Koh HK, 2011, HEALTH EDUC BEHAV, V38, P551, DOI 10.1177/1090198111428646; Matthews T J, 2013, Natl Vital Stat Rep, V62, P1; Murphy Sherry L, 2013, Natl Vital Stat Rep, V61, P1; Skopec L, AFFORDABLE CARE ACT; US Department of Health and Human Services, HEALTHY PEOPLE 2020	7	54	54	1	9	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUN 25	2014	311	24					2475	2476		10.1001/jama.2014.6446	http://dx.doi.org/10.1001/jama.2014.6446			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AJ5VE	24870206				2022-12-28	WOS:000337757000015
J	Hossain, M; Zimmerman, C; Watts, C				Hossain, Mazeda; Zimmerman, Cathy; Watts, Charlotte			Preventing violence against women and girls in conflict	LANCET			English	Editorial Material							SEXUAL VIOLENCE		[Hossain, Mazeda; Zimmerman, Cathy; Watts, Charlotte] London Sch Hyg & Trop Med, Dept Global Hlth & Dev, Gender Violence & Hlth Ctr, London WC1H 9SH, England	University of London; London School of Hygiene & Tropical Medicine	Hossain, M (corresponding author), London Sch Hyg & Trop Med, Dept Global Hlth & Dev, Gender Violence & Hlth Ctr, London WC1H 9SH, England.	mazeda.hossain@lshtm.ac.uk	Hossain, Mazeda/AAL-3202-2020	Hossain, Mazeda/0000-0002-1878-8145	Economic and Social Research Council [ES/J021032/1] Funding Source: researchfish; ESRC [ES/J021032/1] Funding Source: UKRI	Economic and Social Research Council(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); ESRC(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC))		Casey SE, 2011, AM J PUBLIC HEALTH, V101, P1054, DOI 10.2105/AJPH.2010.300045; Cohen Dara Kay, 2013, WARTIME SEXUAL VIOLE; D'Costa B, 2010, CRIMINAL LAW FORUM, V21, P331, DOI DOI 10.1007/S10609-010-9120-2; Duroch F, 2011, BMC INT HEALTH HUM R, V11, DOI 10.1186/1472-698X-11-5; Heise L, 2013, WHAT WORKS PREVENT P; Hossain M., 2013, EVIDENCE REV RES HLT, P50; Hossain M, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-339; Hossain M, 2014, BMJ OPEN, V4, DOI 10.1136/bmjopen-2013-003644; Human Security Report Project, 2012, HUM SEC REP 2012 SEX; IRC, 2014, 3 YEARS CONFL DISPL; Johnson K, 2010, JAMA-J AM MED ASSOC, V304, P553, DOI 10.1001/jama.2010.1086; Ministere du Plan Macro International Inc., 2008, ENQ DEM SANT REP DEM; Peterman A, 2011, AM J PUBLIC HEALTH, V101, P1060, DOI 10.2105/AJPH.2010.300070; Sharlach Lisa, 2000, NEW POLIT SCI, V22, P94, DOI [DOI 10.1080/713687893, 10.1080/713687893]; Siddiqi S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113258; Spangaro J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062600	16	32	33	0	11	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JUN 14	2014	383	9934					2021	2022		10.1016/S0140-6736(14)60964-8	http://dx.doi.org/10.1016/S0140-6736(14)60964-8			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	AI9VZ	24923526				2022-12-28	WOS:000337292400005
J	Jorgensen, T; Jacobsen, RK; Toft, U; Aadahl, M; Glumer, C; Pisinger, C				Jorgensen, Torben; Jacobsen, Rikke Kart; Toft, Ulla; Aadahl, Mette; Glumer, Charlotte; Pisinger, Charlotta			Effect of screening and lifestyle counselling on incidence of ischaemic heart disease in general population: Inter99 randomised trial	BMJ-BRITISH MEDICAL JOURNAL			English	Article							FAT DIETARY PATTERN; CARDIOVASCULAR-DISEASE; GLOSTRUP POPULATION; PRIMARY PREVENTION; COLORECTAL-CANCER; PHYSICAL-ACTIVITY; RISK-SCORES; HEALTH; INTERVENTION; MORTALITY	Objective To investigate the effect of systematic screening for risk factors for ischaemic heart disease followed by repeated lifestyle counselling on the 10 year development of ischaemic heart disease at a population level. Design Randomised controlled community based trial. Setting Suburbs of Copenhagen, Denmark Participants 59 616 people aged 30-60 years randomised with different age and sex randomisation ratios to an intervention group (n=11 629) and a control group (n=47 987). Intervention The intervention group was invited for screening, risk assessment, and lifestyle counselling up to four times over a five year period. All participants with an unhealthy lifestyle had individually tailored lifestyle counselling at all visits (at baseline and after one and three years); those at high risk of ischaemic heart disease, according to predefined criteria, were furthermore offered six sessions of group based lifestyle counselling on smoking cessation, diet, and physical activity. After five years all were invited for a final counselling session. Participants were referred to their general practitioner for medical treatment, if relevant. The control group was not invited for screening. Main outcome measures The primary outcome measure was incidence of ischaemic heart disease in the intervention group compared with the control group. Secondary outcome measures were stroke, combined events (ischaemic heart disease, stroke, or both), and mortality. Results 6091 (52.4%) people in the intervention group participated at baseline. Among 5978 people eligible at five year follow-up (59 died and 54 emigrated), 4028 (67.4%) attended. A total of 3163 people died in the 10 year follow-up period. Among 58 308 without a history of ischaemic heart disease at baseline, 2782 developed ischaemic heart disease. Among 58 940 without a history of stroke at baseline, 1726 developed stroke. No significant difference was seen between the intervention and control groups in the primary end point (hazard ratio for ischaemic heart disease 1.03, 95% confidence interval 0.94 to 1.13) or in the secondary endpoints (stroke 0.98, 0.87 to 1.11; combined endpoint 1.01, 0.93 to 1.09; total mortality 1.00, 0.91 to 1.09). Conclusion A community based, individually tailored intervention programme with screening for risk of ischaemic heart disease and repeated lifestyle intervention over five years had no effect on ischaemic heart disease, stroke, or mortality at the population level after 10 years.	[Jorgensen, Torben; Jacobsen, Rikke Kart; Toft, Ulla; Aadahl, Mette; Glumer, Charlotte; Pisinger, Charlotta] Glostrup Cty Hosp, Res Ctr Prevent & Hlth, DK-2600 Glostrup, Denmark; [Jorgensen, Torben; Pisinger, Charlotta] Univ Copenhagen, Fac Hlth Sci, DK-1168 Copenhagen, Denmark; [Jorgensen, Torben; Glumer, Charlotte] Aalborg Univ, Fac Med, Aalborg, Denmark	University of Copenhagen; University of Copenhagen; Aalborg University	Jorgensen, T (corresponding author), Glostrup Cty Hosp, Res Ctr Prevent & Hlth, Bldg 84-85, DK-2600 Glostrup, Denmark.	torben.joergensen@regionh.dk	H, V/M-5550-2014; Jørgensen, Torben/Z-1335-2018; Toft, Ulla/AAH-2589-2020	Toft, Ulla/0000-0001-7770-8419; Pisinger, Charlotta/0000-0002-7970-3168; Jacobsen, Rikke Kart/0000-0003-4677-2973; Aadahl, Mette/0000-0001-5904-9747; Jorgensen, Torben/0000-0001-9453-2830	Danish Research Councils; Health Foundation; Danish Centre for Evaluation and Health Technology Assessment; Copenhagen County; Danish Heart Foundation; Ministry of Health and Prevention; Association of Danish Pharmacies; Augustinus Foundation; Novo Nordisk; Velux Foundation; Becket Foundation; Ib Henriksens Foundation	Danish Research Councils(Det Frie Forskningsrad (DFF)); Health Foundation; Danish Centre for Evaluation and Health Technology Assessment; Copenhagen County; Danish Heart Foundation; Ministry of Health and Prevention; Association of Danish Pharmacies; Augustinus Foundation; Novo Nordisk(Novo Nordisk); Velux Foundation(Velux Fonden); Becket Foundation; Ib Henriksens Foundation	The Inter99 study was funded by the Danish Research Councils, Health Foundation, Danish Centre for Evaluation and Health Technology Assessment, Copenhagen County, Danish Heart Foundation, Ministry of Health and Prevention, Association of Danish Pharmacies, Augustinus Foundation, Novo Nordisk, Velux Foundation, Becket Foundation, and Ib Henriksens Foundation. The researchers are independent of the founders, who had no influence on study design or conduct, analyses, or interpretation of results.	Aadahl M, 2011, BRIT J SPORT MED, V45, P209, DOI 10.1136/bjsm.2009.064840; Andersen PK, 2012, INT J EPIDEMIOL, V41, P861, DOI 10.1093/ije/dyr213; Bandura A, 1986, SOCIAL FDN THOUGHTS; Bender AM, 2012, EUR J PREV CARDIOL; Beresford SAA, 2006, JAMA-J AM MED ASSOC, V295, P643, DOI 10.1001/jama.295.6.643; Burke BL, 2003, J CONSULT CLIN PSYCH, V71, P843, DOI 10.1037/0022-006X.71.5.843; Chan M., 2013, WHO DIR GEN ADDR HLT; COLLINS R, 1990, LANCET, V335, P827, DOI 10.1016/0140-6736(90)90944-Z; Cooney MT, 2009, EUR J CARDIOV PREV R, V16, P541, DOI 10.1097/HJR.0b013e32832b38a1; Ding Alexander, 2005, Yale Journal of Biology and Medicine, V78, P37; Ebrahim S, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001561.pub3; Ebrahim S, 1997, BMJ-BRIT MED J, V314, P1666, DOI 10.1136/bmj.314.7095.1666; Estruch R, 2013, NEW ENGL J MED, V368, P1279, DOI 10.1056/NEJMoa1200303; Franco M, 2007, AM J EPIDEMIOL, V166, P1374, DOI 10.1093/aje/kwm226; Frederiksen BL, 2010, BRIT J CANCER, V103, P1496, DOI 10.1038/sj.bjc.6605962; Grace SL, 2002, GEN HOSP PSYCHIAT, V24, P127, DOI 10.1016/S0163-8343(02)00179-2; GRAY RJ, 1988, ANN STAT, V16, P1141, DOI 10.1214/aos/1176350951; He FJ, 2009, J HUM HYPERTENS, V23, P363, DOI 10.1038/jhh.2008.144; HJERMANN I, 1986, AM J MED, V80, P7, DOI 10.1016/0002-9343(86)90154-3; HOLME I, 1985, PREV MED, V14, P279, DOI 10.1016/0091-7435(85)90057-X; Jahiel RI, 2007, ADDICTION, V102, P1335, DOI 10.1111/j.1360-0443.2007.01900.x; JANZ NK, 1984, HEALTH EDUC QUART, V11, P1, DOI 10.1177/109019818401100101; Jorgensen T, 2013, EUR J PREV CARDIOL, V20, P409, DOI 10.1177/2047487312441726; Jorgensen Torben, 2003, Eur J Cardiovasc Prev Rehabil, V10, P377; Jorgensen T, 2009, PREV MED, V48, P242, DOI 10.1016/j.ypmed.2008.12.010; Justice AC, 1999, ANN INTERN MED, V130, P515, DOI 10.7326/0003-4819-130-6-199903160-00016; KJELSBERG MO, 1990, JAMA-J AM MED ASSOC, V263, P1795; Kramer BS, 1999, CANC SCREENING THEOR; Krogsboll LT, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD009009.pub2; Lightwood JM, 2009, CIRCULATION, V120, P1373, DOI 10.1161/CIRCULATIONAHA.109.870691; Lynge E, 2011, SCAND J PUBLIC HEALT, V39, P30, DOI 10.1177/1403494811401482; McCartney M, 2013, BMJ-BRIT MED J, V347, DOI 10.1136/bmj.f5834; Pisinger C, 2008, PREV MED, V46, P579, DOI 10.1016/j.ypmed.2008.02.026; Pisinger C, 2009, PREV MED, V49, P418, DOI 10.1016/j.ypmed.2009.08.011; Prentice RL, 2006, JAMA-J AM MED ASSOC, V295, P629, DOI 10.1001/jama.295.6.629; Proctor RN, 2011, GOLDEN HOLOCAUST: ORIGINS OF THE CIGARETTE CATASTROPHE AND THE CASE FOR ABOLITION, P1; Rees K, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD002128.pub4; Rose G., 1992, STRATEGY PREVENTIVE; Saidj M, 2013, DAN MED J, V60; SCHROLL M, 1981, DAN MED BULL, V28, P236; Smith LVH, 2008, SCAND J PUBLIC HEALT, V36, P380, DOI 10.1177/1403494807085313; Stamler J, 1999, JAMA-J AM MED ASSOC, V282, P2012, DOI 10.1001/jama.282.21.2012; Stuckler D, 2011, BMJ-BRIT MED J, V343, DOI 10.1136/bmj.d5336; Thomsen TF, 2001, J CARDIOVASC RISK, V8, P291, DOI 10.1097/00043798-200110000-00008; Thomsen TF, 2002, INT J EPIDEMIOL, V31, P817, DOI 10.1093/ije/31.4.817; Thomsen T, 2005, EUR J CARDIOV PREV R, V12, P424, DOI 10.1097/01.hjr.0000186617.29992.11; Toft U, 2008, PREV MED, V47, P378, DOI 10.1016/j.ypmed.2008.05.013; Toft U, 2009, PREV MED, V49, P115, DOI 10.1016/j.ypmed.2009.06.007; TRUELSEN T, 1994, STROKE, V25, P802, DOI 10.1161/01.STR.25.4.802; Wagenaar AC, 2009, ADDICTION, V104, P179, DOI 10.1111/j.1360-0443.2008.02438.x; WHO, 2009, EUROPEAN HEALTH REPORT 2009: HEALTH AND HEALTH SYSTEMS, P1; WILHELMSEN L, 1986, EUR HEART J, V7, P279, DOI 10.1093/oxfordjournals.eurheartj.a062065; Wilson JMG, 1968, PRINCIPLES PRACTICE; Wood D, 1998, ATHEROSCLEROSIS, V140, P199, DOI 10.1016/S0021-9150(98)90209-X; Zatonski WA, 1998, BMJ-BRIT MED J, V316, P1047	57	158	158	0	12	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JUN 9	2014	348								g3617	10.1136/bmj.g3617	http://dx.doi.org/10.1136/bmj.g3617			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	AJ1DS	24912589	Green Published, hybrid			2022-12-28	WOS:000337396600004
J	Weiss, S; Ellis, LB				Weiss, Soma; Ellis, Laurence B.			The Rational Treatment of Arterial Hypertension (Reprinted from vol 95, pg 846, 1930)	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Reprint																		Fahr G, 1928, AM J MED SCI, V175, P453, DOI 10.1097/00000441-192804000-00002; Riseman JEF, 1930, AM J MED SCI, V180, P47, DOI 10.1097/00000441-193007000-00007; Weiss S, 1930, J AMER MED ASSOC, V95, P846, DOI 10.1001/jama.1930.02720120014005	3	0	1	0	1	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUN 4	2014	311	21					2238	2238		10.1001/jama.2013.279537	http://dx.doi.org/10.1001/jama.2013.279537			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AI2DU	24893102				2022-12-28	WOS:000336668400035
J	Autor, DH				Autor, David H.			Skills, education, and the rise of earnings inequality among the "other 99 percent"	SCIENCE			English	Review							TOP 1 PERCENT; INCOME INEQUALITY; COLLEGE; COMPETITION; UNIONS; MARKET; TRENDS; RETURN	The singular focus of public debate on the "top 1 percent" of households overlooks the component of earnings inequality that is arguably most consequential for the "other 99 percent" of citizens: the dramatic growth in the wage premium associated with higher education and cognitive ability. This Review documents the central role of both the supply and demand for skills in shaping inequality, discusses why skill demands have persistently risen in industrialized countries, and considers the economic value of inequality alongside its potential social costs. I conclude by highlighting the constructive role for public policy in fostering skills formation and preserving economic mobility.	[Autor, David H.] MIT, Dept Econ, Cambridge, MA 02142 USA; [Autor, David H.] MIT, Natl Bur Econ Res, Cambridge, MA 02142 USA	Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); National Bureau of Economic Research	Autor, DH (corresponding author), MIT, Dept Econ, 40 Ames St,E17-216, Cambridge, MA 02142 USA.	dautor@mit.edu			NSF [SES-1227334]; Russell Sage Foundation [85-12-07]; Alfred P. Sloan Foundation [2011-10-12]	NSF(National Science Foundation (NSF)); Russell Sage Foundation; Alfred P. Sloan Foundation(Alfred P. Sloan Foundation)	I thank D. Acemoglu, L. Katz, J. Van Reenen, M. Tatsutani, and two anonymous referees for valuable comments and advice, and C. Patterson and B. Price for expert research assistance. Supported by NSF grant SES-1227334, Russell Sage Foundation grant 85-12-07, and Alfred P. Sloan Foundation grant 2011-10-12. All data and code that are unique to this article (Figs. 1, 3, and 6; fig. S2) are available from the author. All other figures (Figs. 2, 4, and 5; figs. S1 and S3) are reproduced from other publications, as noted, with permission of the authors.	Acemoglu D., 2012, WHY NATIONS FAIL; Acemoglu D, 2011, HBK ECON, V4, P1043, DOI 10.1016/S0169-7218(11)02410-5; Alvaredo F, 2013, J ECON PERSPECT, V27, P3, DOI 10.1257/jep.27.3.3; Autor DH, 2008, REV ECON STAT, V90, P300, DOI 10.1162/rest.90.2.300; Autor DH, 2013, AM ECON REV, V103, P2121, DOI 10.1257/aer.103.6.2121; Autor DH, 2013, AM ECON REV, V103, P1553, DOI 10.1257/aer.103.5.1553; Autor DH, 2003, Q J ECON, V118, P1279, DOI 10.1162/003355303322552801; Avery C, 2012, J ECON PERSPECT, V26, P165, DOI 10.1257/jep.26.1.165; Bivens J, 2013, J ECON PERSPECT, V27, P57, DOI 10.1257/jep.27.3.57; Bonica A, 2013, J ECON PERSPECT, V27, P103, DOI 10.1257/jep.27.3.103; Card D, 2004, J LABOR RES, V25, P519, DOI 10.1007/s12122-004-1011-z; Card D, 2001, AM ECON REV, V91, P97, DOI 10.1257/aer.91.2.97; Card D, 2001, Q J ECON, V116, P705, DOI 10.1162/00335530151144140; Chetty Raj Nathaniel, 2014, 19844 NBER; Corak M, 2013, J ECON PERSPECT, V27, P79, DOI 10.1257/jep.27.3.79; Crivellaro Elena, 2014, DEP EC RES PAPER SER; GOLDBERGER AS, 1979, ECONOMICA, V46, P327, DOI 10.2307/2553675; Goldin C, 2007, BROOKINGS PAP ECO AC, P135; Goldin Claudia, 2008, RACE ED TECHNOLOGY; Hanushek Eric A, 2013, 19762 NBER; Harper M., 2010, LABOR NEW EC; Hirsch BT, 2008, J ECON PERSPECT, V22, P153, DOI 10.1257/jep.22.1.153; Johnston L.D., 2012, MINNPOST 0222; Kaplan SN, 2013, J ECON PERSPECT, V27, P35, DOI 10.1257/jep.27.3.35; Katz L.F., 1999, HDB LABOR EC, V3, P1463, DOI DOI 10.1016/S1573-4463(99)03007-2; KATZ LF, 1992, Q J ECON, V107, P35, DOI 10.2307/2118323; Klenow P.J., 2013, NATL BUREAU EC RES; Lee CI, 2009, REV ECON STAT, V91, P766, DOI 10.1162/rest.91.4.766; Lemieux T., 2006, 12077 NAT BUR EC RES; Murnane RJ, 2013, J ECON LIT, V51, P370, DOI 10.1257/jel.51.2.370; Piketty T, 2003, Q J ECON, V118, P1, DOI 10.1162/00335530360535135; Reardon SF, 2011, WHITHER OPPORTUNITY?: RISING INEQUALITY, SCHOOLS, AND CHILDREN'S LIFE CHANCES, P91; Smith Christopher, 2010, 16533 NBER; Snyder T. D., 1993, 120 YEARS AM ED STAT; Stanley M, 2003, Q J ECON, V118, P671, DOI 10.1162/003355303321675482; TINBERGEN J, 1974, KYKLOS, V27, P217, DOI 10.1111/j.1467-6435.1974.tb01903.x; Wijzer in Geldzaken, 2013, PENSIOENMONITOR	38	369	372	26	272	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 23	2014	344	6186					843	851		10.1126/science.1251868	http://dx.doi.org/10.1126/science.1251868			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AH6IL	24855259	Green Submitted			2022-12-28	WOS:000336233800036
J	McNutt, M				McNutt, Marcia			A new look	SCIENCE			English	Editorial Material														McNutt, Marcia/0000-0003-0117-7716					0	1	1	1	38	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 23	2014	344	6186					781	781		10.1126/science.1255999	http://dx.doi.org/10.1126/science.1255999			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AH6IL	24855226				2022-12-28	WOS:000336233800001
J	Ravallion, M				Ravallion, Martin			Income inequality in the developing world	SCIENCE			English	Review								Should income inequality be of concern in developing countries? New data reveal less income inequality in the developing world than 30 years ago. However, this is due to falling inequality between countries. Average inequality within developing countries has been slowly rising, though staying fairly flat since 2000. As a rule, higher rates of growth in average incomes have not put upward pressure on inequality within countries. Growth has generally helped reduce the incidence of absolute poverty, but less so in more unequal countries. High inequality also threatens to stall future progress against poverty by attenuating growth prospects. Perceptions of rising absolute gaps in living standards between the rich and the poor in growing economies are also consistent with the evidence.	[Ravallion, Martin] Georgetown Univ, Dept Econ, Washington, DC 20057 USA; [Ravallion, Martin] Natl Bur Econ Res, Cambridge, MA 02138 USA	Georgetown University; National Bureau of Economic Research	Ravallion, M (corresponding author), Georgetown Univ, Dept Econ, Washington, DC 20057 USA.	mr1185@georgetown.edu						[Anonymous], 1999, THINKING INEQUALITY; [Anonymous], 2000, ECONOMIST, V27, P94; Benabou R., 1996, NBER MACROECON ANNU, V11, P11, DOI [10.1086/654291, DOI 10.1086/654291]; Berg A, 2012, J DEV ECON, V98, P149, DOI 10.1016/j.jdeveco.2011.08.002; Chen SH, 2013, REV INCOME WEALTH, V59, P1, DOI 10.1111/j.1475-4991.2012.00520.x; Chen SH, 2010, Q J ECON, V125, P1577, DOI 10.1162/qjec.2010.125.4.1577; HARRISON E, 1994, PUBLIC CHOICE, V79, P61, DOI 10.1007/BF01047919; Herzer D, 2012, J ECON INEQUAL, V10, P489, DOI 10.1007/s10888-011-9171-6; Korinek A., 2006, J ENDOCRINOL INVEST, V4, P33, DOI [10.1007/s10888-005-1089-4, DOI 10.1007/S10888-005-1089-4]; Martin Ravallion, 2007, INEQUALITY POVERTY R, P37; Ravallion M, 2003, ECON LETT, V80, P351, DOI 10.1016/S0165-1765(03)00141-1; Ravallion M., 2005, J ECON INEQUAL, V3, P169; Ravallion M, 2004, BROOKINGS TRADE FORU, V2004, P1; Ravallion M, 2012, AM ECON REV, V102, P504, DOI 10.1257/aer.102.1.504; Ravallion Martin, 2014, HDB INCOME DISTRIBUT, V2; Ravallion Martin, 2009, OXFORD HDB EC INEQUA, P599; Rawls J., 1971, THEORY JUSTICE; Voitchovsky Sarah, 2009, OXFORD HDB EC INEQUA, P559	18	99	102	7	55	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 23	2014	344	6186					851	855		10.1126/science.1251875	http://dx.doi.org/10.1126/science.1251875			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AH6IL	24855260				2022-12-28	WOS:000336233800037
J	Cunningham, JT; Moreno, MV; Lodi, A; Ronen, SM; Ruggero, D				Cunningham, John T.; Moreno, Melissa V.; Lodi, Alessia; Ronen, Sabrina M.; Ruggero, Davide			Protein and Nucleotide Biosynthesis Are Coupled by a Single Rate-Limiting Enzyme, PRPS2, to Drive Cancer	CELL			English	Article							INITIATION-FACTOR 4E; C-MYC; METABOLISM; MTOR; TRANSLATION; ACTIVATION; MOUSE; SUPPRESSION; INHIBITION; EXPRESSION	Cancer cells must integrate multiple biosynthetic demands to drive indefinite proliferation. How these key cellular processes, such as metabolism and protein synthesis, crosstalk to fuel cancer cell growth is unknown. Here, we uncover the mechanism by which the Myc oncogene coordinates the production of the two most abundant classes of cellular macromolecules, proteins, and nucleic acids in cancer cells. We find that a single rate-limiting enzyme, phosphoribosyl- pyrophosphate synthetase 2 (PRPS2), promotes increased nucleotide biosynthesis in Myc-transformed cells. Remarkably, Prps2 couples protein and nucleotide biosynthesis through a specialized cis-regulatory element within the Prps2 50 UTR, which is controlled by the oncogene and translation initiation factor eIF4E downstream Myc activation. We demonstrate with a Prps2 knockout mouse that the nexus between protein and nucleotide biosynthesis controlled by PRPS2 is crucial for Myc-driven tumorigenesis. Together, these studies identify a translationally anchored anabolic circuit critical for cancer cell survival and an unexpected vulnerability for ``undruggable'' oncogenes, such as Myc.	[Cunningham, John T.; Moreno, Melissa V.; Ruggero, Davide] Univ Calif San Francisco, Helen Diller Family Comprehens Canc Ctr, Sch Med, San Francisco, CA 94158 USA; [Cunningham, John T.; Moreno, Melissa V.; Ruggero, Davide] Univ Calif San Francisco, Helen Diller Family Comprehens Canc Ctr, Dept Urol, San Francisco, CA 94158 USA; [Lodi, Alessia; Ronen, Sabrina M.] Univ Calif San Francisco, Dept Radiol & Biomed Imaging, San Francisco, CA 94158 USA	University of California System; University of California San Francisco; UCSF Medical Center; UCSF Helen Diller Family Comprehensive Cancer Center; University of California System; University of California San Francisco; UCSF Medical Center; UCSF Helen Diller Family Comprehensive Cancer Center; University of California System; University of California San Francisco	Ruggero, D (corresponding author), Univ Calif San Francisco, Helen Diller Family Comprehens Canc Ctr, Sch Med, San Francisco, CA 94158 USA.	davide.ruggero@ucsf.edu	Cunningham, John T./AAS-5008-2021	Cunningham, John T./0000-0001-6490-4533	NIH [R01 CA130812, R01 CA154915, R01CA140456, R01CA154916, U01HG004085]; American Cancer Society [121364-PF-11-184-01-TBG]; Children's Hospital Oakland Research Institute (CHORI)/Sanger/UC Davis Consortium [U01HG004080]; KOMP Repository at UC Davis and CHORI [U42RR024244]; NATIONAL CANCER INSTITUTE [R01CA154916, R01CA154915, R01CA140456] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [U42RR024244] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U01HG004085, U01HG004080] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Cancer Society(American Cancer Society); Children's Hospital Oakland Research Institute (CHORI)/Sanger/UC Davis Consortium; KOMP Repository at UC Davis and CHORI; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	We thank Maria Barna and Kevan Shokat for helpful discussions and their critical reading of the manuscript. D. R. is a Leukemia and Lymphoma Society Scholar. This work was supported by NIH (R01 CA130812 and R01 CA154915 to S. M. R. and R01CA140456 and R01CA154916 to D. R.) and the American Cancer Society (121364-PF-11-184-01-TBG to J.T.C.). NIH grants to Velocigene at Regeneron (U01HG004085) and the Children's Hospital Oakland Research Institute (CHORI)/Sanger/UC Davis Consortium (U01HG004080) funded the generation of gene-targeted ES cells for 8,500 genes in the KOMP Program and archived and distributed by the KOMP Repository at UC Davis and CHORI (U42RR024244). J.T.C. and D.R. are joint inventors on a UC Regents-owned patent application covering these molecules that has been licensed to eFFECTOR Therapeutics. D.R. is a shareholder of eFFECTOR Therapeutics and a member of its scientific advisory board.	ADAMS JM, 1985, NATURE, V318, P533, DOI 10.1038/318533a0; Aird KM, 2013, CELL REP, V3, P1252, DOI 10.1016/j.celrep.2013.03.004; Barna M, 2008, NATURE, V456, P971, DOI 10.1038/nature07449; BECKER MA, 1990, GENOMICS, V8, P555, DOI 10.1016/0888-7543(90)90043-T; Belteki G, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni051; Ben-Sahra I, 2013, SCIENCE, V339, P1323, DOI 10.1126/science.1228792; Bester AC, 2011, CELL, V145, P435, DOI 10.1016/j.cell.2011.03.044; BOSS GR, 1982, J BIOL CHEM, V257, P4242; Bywater MJ, 2013, NAT REV CANCER, V13, P299, DOI 10.1038/nrc3496; Bywater MJ, 2012, CANCER CELL, V22, P51, DOI 10.1016/j.ccr.2012.05.019; Cairns RA, 2011, NAT REV CANCER, V11, P85, DOI 10.1038/nrc2981; Dang Chi V, 2010, Genes Cancer, V1, P526; Dieterle F, 2006, ANAL CHEM, V78, P4281, DOI 10.1021/ac051632c; Doherty JR, 2014, CANCER RES, V74, P908, DOI 10.1158/0008-5472.CAN-13-2034; EILERS M, 1989, NATURE, V340, P66, DOI 10.1038/340066a0; Faubert B, 2013, CELL METAB, V17, P113, DOI 10.1016/j.cmet.2012.12.001; Ferraro P, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkp1141; Gerhart-Hines Z, 2007, EMBO J, V26, P1913, DOI 10.1038/sj.emboj.7601633; GEYER PK, 1982, MOL CELL BIOL, V2, P685, DOI 10.1128/MCB.2.6.685; Gordan JD, 2007, CANCER CELL, V12, P108, DOI 10.1016/j.ccr.2007.07.006; Granneman S, 2004, EXP CELL RES, V296, P43, DOI 10.1016/j.yexcr.2004.03.016; Graves JA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013717; Gunther UL, 2000, J MAGN RESON, V145, P201, DOI 10.1006/jmre.2000.2071; HARRIS AW, 1988, J EXP MED, V167, P353, DOI 10.1084/jem.167.2.353; Hemann MT, 2005, NATURE, V436, P807, DOI 10.1038/nature03845; Hochedlinger K, 2005, CELL, V121, P465, DOI 10.1016/j.cell.2005.02.018; Hopkins AL, 2002, NAT REV DRUG DISCOV, V1, P727, DOI 10.1038/nrd892; Hsieh AC, 2012, NATURE, V485, P55, DOI 10.1038/nature10912; Hsieh AC, 2010, CLIN CANCER RES, V16, P4914, DOI 10.1158/1078-0432.CCR-10-0433; Hsieh AC, 2010, CANCER CELL, V17, P249, DOI 10.1016/j.ccr.2010.01.021; HWANG TL, 1995, J MAGN RESON SER A, V112, P275, DOI 10.1006/jmra.1995.1047; Iritani BM, 1999, P NATL ACAD SCI USA, V96, P13180, DOI 10.1073/pnas.96.23.13180; Jones RM, 1996, MOL CELL BIOL, V16, P4754; Lempiainen H, 2009, CURR OPIN CELL BIOL, V21, P855, DOI 10.1016/j.ceb.2009.09.002; Liu YC, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002722; Ludwig C, 2012, METABOLOMICS, V8, P8, DOI 10.1007/s11306-011-0347-7; Mannava S, 2008, CELL CYCLE, V7, P2392, DOI 10.4161/cc.6390; Morrish F, 2008, CELL CYCLE, V7, P1054, DOI 10.4161/cc.7.8.5739; NOSAL JM, 1993, J BIOL CHEM, V268, P10168; Oliver ER, 2004, DEVELOPMENT, V131, P3907, DOI 10.1242/dev.01268; Pourdehnada M, 2013, P NATL ACAD SCI USA, V110, P11988, DOI 10.1073/pnas.1310230110; Rickert RC, 1997, NUCLEIC ACIDS RES, V25, P1317, DOI 10.1093/nar/25.6.1317; Ronen SM, 2001, BRIT J CANCER, V84, P691, DOI 10.1054/bjoc.2000.1663; Ruggero D, 2004, NAT MED, V10, P484, DOI 10.1038/nm1042; Schmitt CA, 2000, NAT MED, V6, P1029, DOI 10.1038/79542; Shim H, 1998, P NATL ACAD SCI USA, V95, P1511, DOI 10.1073/pnas.95.4.1511; SMOLENSKI RT, 1990, J CHROMATOGR-BIOMED, V527, P414, DOI 10.1016/S0378-4347(00)82125-8	47	147	156	0	36	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAY 22	2014	157	5					1088	1103		10.1016/j.cell.2014.03.052	http://dx.doi.org/10.1016/j.cell.2014.03.052			16	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	AH9CG	24855946	Bronze, Green Accepted			2022-12-28	WOS:000336437200012
J	Morris, SC; Caron, JB				Morris, Simon Conway; Caron, Jean-Bernard			A primitive fish from the Cambrian of North America	NATURE			English	Article							PIKAIA-GRACILENS WALCOTT; BURGESS SHALE; VERTEBRATE JAW; EVOLUTION; CHORDATE; LAMPREY; ANATOMY	Knowledge of the early evolution of fish largely depends on soft-bodied material from the Lower (Series 2) Cambrian period of South China(1,2). Owing to the rarity of some of these forms and a general lack of comparative material from other deposits, interpretations of various features remain controversial(3,4), as do their wider relationships amongst post-Cambrian early un-skeletonized jawless vertebrates. Here we redescribe Metaspriggina(5) on the basis of new material from the Burgess Shale and exceptionally preserved material collected near Marble Canyon, British Columbia(6), and three other Cambrian Burgess Shale-type deposits from Laurentia. This primitive fish displays unambiguous vertebrate features: a notochord, a pair of prominent camera-type eyes, paired nasal sacs, possible cranium and arcualia, W-shaped myomeres, and a post-anal tail. A striking feature is the branchial area with an array of bipartite bars. Apart from the anterior most bar, which appears to be slightly thicker, each is associated with externally located gills, possibly housed in pouches. Phylogenetic analysis places Metaspriggina as a basal vertebrate, apparently close to the Chengjiang taxa Haikouichthys(1-4) and Myllokunmingia(1), demonstrating also that this primitive group of fish was cosmopolitan during Lower-Middle Cambrian times (Series 2-3). However, the arrangement of the branchial region in Metaspriggina has wider implications for reconstructing the morphology of the primitive vertebrate. Each bipartite bar is identified as being respectively equivalent to an epibranchial and ceratobranchial. This configuration suggests that a bipartite arrangement is primitive and reinforces the view that the branchial basket of lampreys(7) is probably derived. Other features of Metaspriggina, including the external position of the gills and possible absence of a gill opposite the more robust anterior-most bar, are characteristic of gnathostomes(8) and so may be primitive within vertebrates.	[Morris, Simon Conway] Univ Cambridge, Dept Earth Sci, Cambridge CB2 3EQ, England; [Caron, Jean-Bernard] Royal Ontario Museum, Dept Nat Hist Palaeobiol, Toronto, ON M5S 2C6, Canada; [Caron, Jean-Bernard] Univ Toronto, Dept Ecol & Evolutionary Biol, Toronto, ON M5S 3B2, Canada	University of Cambridge; Royal Ontario Museum; University of Toronto	Morris, SC (corresponding author), Univ Cambridge, Dept Earth Sci, Downing St, Cambridge CB2 3EQ, England.	sc113@cam.ac.uk; jcaron@rom.on.ca		Caron, Jean-Bernard/0000-0002-1670-5502	Department of Earth Sciences and St John's College, Cambridge; Natural Sciences and Engineering Research Council [341944]; Royal Ontario Museum [53]	Department of Earth Sciences and St John's College, Cambridge; Natural Sciences and Engineering Research Council(Natural Sciences and Engineering Research Council of Canada (NSERC)); Royal Ontario Museum	We thank T. Lacalli for comments on an earlier draft of the manuscript,J. Mallatt for an extensive series of critiques, and J. Hoyal-Cuthill and C. Aria for assistance with phylogenetic analyses. We also thank M. Collins for technical drawings and reconstructions, and R. Thomas and M. Webster for information on the Kinzers and Parker formations, respectively. S.C.M. thanks V. Brown for manuscript preparation, and the Department of Earth Sciences and St John's College, Cambridge for support. We thank Parks Canada for granting a collection and research permit to J.-B.C. (YNP-2012-12054). Fieldwork support for the 2012 expedition comes from the Royal Ontario Museum (DMV Research and Acquisition Fund and DNH Fieldwork Fund), M. Streng (Uppsala University and the Swedish Research Council), R. Gaines (Pomona College), G. Mangano (University of Saskatchewan) and a Natural Sciences and Engineering Research Council Discovery Grant (to J.-B.C., #341944). This is Royal Ontario Museum Burgess Shale project number 53.	Caron JB, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4210; Depew MJ, 2008, J EXP ZOOL PART B, V310B, P315, DOI 10.1002/jez.b.21205; Gai ZK, 2011, NATURE, V476, P324, DOI 10.1038/nature10276; Gess RW, 2006, NATURE, V443, P981, DOI 10.1038/nature05150; Gillis JA, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2429; Hou XG, 2002, P ROY SOC B-BIOL SCI, V269, P1865, DOI 10.1098/rspb.2002.2104; Janvier P, 2006, NATURE, V440, P1183, DOI 10.1038/nature04471; Janvier P, 1996, OXFORD MONOGRAPHS GE, V33; Janvier P, 2007, GEODIVERSITAS, V29, P143; Johnston KJ, 2009, PALAEOGEOGR PALAEOCL, V277, P106, DOI 10.1016/j.palaeo.2009.02.015; Kuratani S, 2005, J ANAT, V207, P489, DOI 10.1111/j.1469-7580.2005.00483.x; Kuratani S, 2012, EVOL DEV, V14, P76, DOI 10.1111/j.1525-142X.2011.00523.x; Lacalli T, 2012, EVODEVO, V3, DOI 10.1186/2041-9139-3-12; MALLATT J, 1984, J ZOOL, V204, P169; Mallatt J, 2013, J EXP ZOOL PART B, V320B, P247, DOI 10.1002/jez.b.22500; Martin WM, 2009, DEV DYNAM, V238, P3126, DOI 10.1002/dvdy.22164; Medeiros DM, 2012, DEV BIOL, V371, P121, DOI 10.1016/j.ydbio.2012.08.026; MORRIS SC, 1993, PALAEONTOLOGY, V36, P593; Morris SC, 2008, J PALEONTOL, V82, P424, DOI 10.1666/06-130.1; Morris SC, 2012, BIOL REV, V87, P480, DOI 10.1111/j.1469-185X.2012.00220.x; Nichols JT, 2013, DEVELOPMENT, V140, P2765, DOI 10.1242/dev.090639; Sansom RS, 2013, PALAEONTOLOGY, V56, P457, DOI 10.1111/pala.12037; Shu DG, 2003, NATURE, V421, P526, DOI 10.1038/nature01264; Shu DG, 1999, NATURE, V402, P42, DOI 10.1038/46965; Van Leeuwen JL, 1999, J EXP BIOL, V202, P3405; Webster M, 2009, MEM ASSOC AUSTRALAS, V37, P369; Zhang XG, 2004, J EVOLUTION BIOL, V17, P1162, DOI 10.1111/j.1420-9101.2004.00741.x	27	94	94	2	120	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 28	2014	512	7515					419	U413		10.1038/nature13414	http://dx.doi.org/10.1038/nature13414			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN8GC	24919146				2022-12-28	WOS:000340840600031
J	Nabavi, S; Fox, R; Proulx, CD; Lin, JY; Tsien, RY; Malinow, R				Nabavi, Sadegh; Fox, Rocky; Proulx, Christophe D.; Lin, John Y.; Tsien, Roger Y.; Malinow, Roberto			Engineering a memory with LTD and LTP	NATURE			English	Article							LONG-TERM POTENTIATION; FEAR; AMYGDALA; EXPRESSION; NEURONS; ACQUISITION; RECEPTORS; INDUCTION; NETWORKS; CIRCUITS	It has been proposed that memories are encoded by modification of synaptic strengths through cellular mechanisms such as long-term potentiation (LTP) and long-term depression (LTD)(1). However, the causal link between these synaptic processes and memory has been difficult to demonstrate(2). Here we show that fear conditioning(3-8), a type of associative memory, can be inactivated and reactivated by LTD and LTP, respectively. We began by conditioning an animal to associate a foot shock with optogenetic stimulation of auditory inputs targeting the amygdala, a brain region known to be essential for fear conditioning(3-8). Subsequent optogenetic delivery of LTD conditioning to the auditory input inactivates memory of the shock. Then subsequent optogenetic delivery of LTP conditioning to the auditory input reactivates memory of the shock. Thus, we have engineered inactivation and reactivation of a memory using LTD and LTP, supporting a causal link between these synaptic processes and memory.	[Nabavi, Sadegh; Fox, Rocky; Proulx, Christophe D.; Malinow, Roberto] Univ Calif San Diego, Dept Neurosci, Ctr Neural Circuits & Behav, La Jolla, CA 92093 USA; [Nabavi, Sadegh; Fox, Rocky; Proulx, Christophe D.; Malinow, Roberto] Univ Calif San Diego, Neurobiol Sect, La Jolla, CA 92093 USA; [Lin, John Y.; Tsien, Roger Y.] Univ Calif San Diego, Dept Pharmacol, La Jolla, CA 92093 USA; [Tsien, Roger Y.] Univ Calif San Diego, Howard Hughes Med Inst, La Jolla, CA 92093 USA	University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego; Howard Hughes Medical Institute; University of California System; University of California San Diego	Malinow, R (corresponding author), Univ Calif San Diego, Dept Neurosci, Ctr Neural Circuits & Behav, La Jolla, CA 92093 USA.	rmalinow@ucsd.edu		Lin, John/0000-0002-1723-4597; Proulx, Christophe/0000-0001-6484-9677; Nabavi, Sadegh/0000-0002-3940-1210	NIH [MH049159, NS27177]; Cure Alzheimer's Foundation; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH091119, R29MH049159, R01MH049159, R37MH049159] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R37NS027177, R01NS027177] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG032132] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Cure Alzheimer's Foundation; NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	We thank J. Isaacson, L. Squire and members of the Malinow laboratory for suggestions. This study was supported by NIH MH049159 and Cure Alzheimer's Foundation grants to R. M. and NIH grant NS27177 to R. T.; R. T. is an Investigator of the HHMI.	Chen BT, 2008, NEURON, V59, P288, DOI 10.1016/j.neuron.2008.05.024; Ciocchi S, 2010, NATURE, V468, P277, DOI 10.1038/nature09559; DAVIS M, 1992, ANNU REV NEUROSCI, V15, P353, DOI 10.1146/annurev.neuro.15.1.353; Fanselow MS, 2005, ANNU REV PSYCHOL, V56, P207, DOI 10.1146/annurev.psych.56.091103.070213; Garner AR, 2012, SCIENCE, V335, P1513, DOI 10.1126/science.1214985; Herry C, 2010, EUR J NEUROSCI, V31, P599, DOI 10.1111/j.1460-9568.2010.07101.x; Hoffman DA, 1998, J NEUROSCI, V18, P3521; KAUER JA, 1988, NEURON, V1, P911, DOI 10.1016/0896-6273(88)90148-1; Kirby ED, 2012, JOVE-J VIS EXP, DOI 10.3791/4079; LeDoux JE, 2000, ANNU REV NEUROSCI, V23, P155, DOI 10.1146/annurev.neuro.23.1.155; Li B, 2011, NATURE, V470, P535, DOI 10.1038/nature09742; Li HH, 2013, NAT NEUROSCI, V16, P332, DOI 10.1038/nn.3322; Li XF, 1996, LEARN MEMORY, V3, P229, DOI 10.1101/lm.3.2-3.229; Lin JY, 2013, NAT NEUROSCI, V16, P1499, DOI 10.1038/nn.3502; Lin JY, 2009, BIOPHYS J, V96, P1803, DOI 10.1016/j.bpj.2008.11.034; Liu X, 2012, NATURE, V484, P381, DOI 10.1038/nature11028; Maren S, 2004, NAT REV NEUROSCI, V5, P844, DOI 10.1038/nrn1535; Martin SJ, 2002, HIPPOCAMPUS, V12, P609, DOI 10.1002/hipo.10107; McKernan MG, 1997, NATURE, V390, P607, DOI 10.1038/37605; MORRIS RGM, 1986, NATURE, V319, P774, DOI 10.1038/319774a0; MULKEY RM, 1992, NEURON, V9, P967, DOI 10.1016/0896-6273(92)90248-C; MULLER D, 1988, SCIENCE, V242, P1694, DOI 10.1126/science.2904701; Pape HC, 2010, PHYSIOL REV, V90, P419, DOI 10.1152/physrev.00037.2009; Pare D, 2004, J NEUROPHYSIOL, V92, P1, DOI 10.1152/jn.00153.2004; Ramirez S, 2013, SCIENCE, V341, P387, DOI 10.1126/science.1239073; Repa JC, 2001, NAT NEUROSCI, V4, P724, DOI 10.1038/89512; ROGAN MT, 1995, NEURON, V15, P127, DOI 10.1016/0896-6273(95)90070-5; Rogan MT, 1997, NATURE, V390, P604, DOI 10.1038/37601; Rumpel S, 2005, SCIENCE, V308, P83, DOI 10.1126/science.1103944; Sah P, 2008, ANN NY ACAD SCI, V1129, P88, DOI 10.1196/annals.1417.020; SILVA AJ, 1992, SCIENCE, V257, P206, DOI 10.1126/science.1321493; SILVA AJ, 1992, SCIENCE, V257, P201, DOI 10.1126/science.1378648; Squire L.R., 2009, MEMORY MIND MOL; Stevens CF, 1998, NEURON, V20, P1, DOI 10.1016/S0896-6273(00)80426-2; Whitlock JR, 2006, SCIENCE, V313, P1093, DOI 10.1126/science.1128134; Wilensky AE, 2006, J NEUROSCI, V26, P12387, DOI 10.1523/JNEUROSCI.4316-06.2006	36	567	577	6	248	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 17	2014	511	7509					348	+		10.1038/nature13294	http://dx.doi.org/10.1038/nature13294			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AL2YR	24896183	Green Accepted, Green Submitted			2022-12-28	WOS:000338992200036
J	Wang, LH; Yamaguchi, S; Burstein, MD; Terashima, K; Chang, K; Ng, HK; Nakamura, H; He, ZX; Doddapaneni, H; Lewis, L; Wang, M; Suzuki, T; Nishikawa, R; Natsume, A; Terasaka, S; Dauser, R; Whitehead, W; Adekunle, A; Sun, JY; Qiao, Y; Marth, G; Muzny, DM; Gibbs, RA; Leal, SM; Wheeler, DA; Lau, CC				Wang, Linghua; Yamaguchi, Shigeru; Burstein, Matthew D.; Terashima, Keita; Chang, Kyle; Ng, Ho-Keung; Nakamura, Hideo; He, Zongxiao; Doddapaneni, Harshavardhan; Lewis, Lora; Wang, Mark; Suzuki, Tomonari; Nishikawa, Ryo; Natsume, Atsushi; Terasaka, Shunsuke; Dauser, Robert; Whitehead, William; Adekunle, Adesina; Sun, Jiayi; Qiao, Yi; Marth, Gabor; Muzny, Donna M.; Gibbs, Richard A.; Leal, Suzanne M.; Wheeler, David A.; Lau, Ching C.			Novel somatic and germline mutations in intracranial germ cell tumours	NATURE			English	Article							COMPARATIVE GENOMIC HYBRIDIZATION; SEQUENCING DATA; CANCER-CELLS; LUNG-CANCER; SNP ARRAYS; GENE; RESISTANCE; VARIANTS; COMMON; JMJD1C	Intracranial germ cell tumours (IGCTs) are a group of rare heterogeneous brain tumours that are clinically and histologically similar to the more common gonadal GCTs. IGCTs show great variation in their geographical and gender distribution, histological composition and treatment outcomes. The incidence of IGCTs is historically five- to eightfold greater in Japan and other East Asian countries than in Western countries(1), with peak incidence near the time of puberty(2). About half of the tumours are located in the pineal region. The male to-female incidence ratio is approximately 3-4:1 overall, but is even higher for tumours located in the pineal region(3). Owing to the scarcity of tumour specimens available for research, little is currently known about this rare disease. Here we report the analysis of 62 cases by next-generation sequencing, single nucleotide polymorphism array and expression array. We find the KIT/RAS signalling pathway frequently mutated in more than 50% of IGCTs, including novel recurrent somatic mutations in KIT, its downstream mediators KRAS and NRAS, and its negative regulator CBL. Novel somatic alterations in the AKT/mTOR pathway included copy number gains of the AKT1 locus at 14q32.33 in 19% of patients, with corresponding upregulation of AKT1 expression. We identified loss-of-function mutations in BCORL1, a transcriptional co-repressor and tumour suppressor. We report significant enrichment of novel and rare germline variants in JMJD1C, which codes for a histone demethylase and is a coactivator of the androgen receptor, among Japanese IGCT patients. This study establishes a molecular foundation for understanding the biology of IGCTs and suggests potentially promising therapeutic strategies focusing on the inhibition of KIT/RAS activation and the AKT1/mTOR pathway.	[Wang, Linghua; Chang, Kyle; Doddapaneni, Harshavardhan; Lewis, Lora; Wang, Mark; Muzny, Donna M.; Gibbs, Richard A.; Wheeler, David A.] Baylor Coll Med, Human Genome Sequencing Ctr, Houston, TX 77030 USA; [Yamaguchi, Shigeru; Terashima, Keita; Lau, Ching C.] Baylor Coll Med, Texas Childrens Canc Ctr, Houston, TX 77030 USA; [Yamaguchi, Shigeru; Terashima, Keita; Lau, Ching C.] Baylor Coll Med, Texas Childrens Hematol Ctr, Houston, TX 77030 USA; [Burstein, Matthew D.] Baylor Coll Med, Struct & Computat Biol & Mol Biophys Program, Houston, TX 77030 USA; [Burstein, Matthew D.; Sun, Jiayi; Lau, Ching C.] Baylor Coll Med, Med Scientist Training Program, Houston, TX 77030 USA; [Terashima, Keita] Natl Ctr Child Hlth & Dev, Tokyo 1578535, Japan; [Ng, Ho-Keung] Chinese Univ Hong Kong, Prince Wales Hosp, Dept Anat & Cellular Pathol, Shatin, Hong Kong, Peoples R China; [Nakamura, Hideo] Kumamoto Univ, Dept Neurosurg, Kumamoto 8600862, Japan; [He, Zongxiao; Leal, Suzanne M.] Baylor Coll Med, Dept Mol & Human Genet, Ctr Stat Genet, Houston, TX 77030 USA; [Suzuki, Tomonari; Nishikawa, Ryo] Saitama Med Univ, Dept Neurosurg, Saitama 3500495, Japan; [Natsume, Atsushi] Nagoya Univ, Dept Neurosurg, Nagoya, Aichi 4668550, Japan; [Terasaka, Shunsuke] Hokkaido Univ, Dept Neurosurg, Sapporo, Hokkaido 0600808, Japan; [Dauser, Robert; Whitehead, William] Baylor Coll Med, Dept Neurosurg, Houston, TX 77030 USA; [Adekunle, Adesina] Baylor Coll Med, Dept Pathol, Houston, TX 77030 USA; [Qiao, Yi; Marth, Gabor] Boston Coll, Dept Biol, Chestnut Hill, MA 02467 USA; [Lau, Ching C.] Baylor Coll Med, Dan L Duncan Canc Ctr, Houston, TX 77030 USA	Baylor College of Medicine; Baylor College of Medicine; Texas Children's Cancer Center; Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; National Center for Child Health & Development - Japan; Chinese University of Hong Kong; Prince of Wales Hospital; Kumamoto University; Baylor College of Medicine; Saitama Medical University; Nagoya University; Hokkaido University; Baylor College of Medicine; Baylor College of Medicine; Boston College; Baylor College of Medicine	Wheeler, DA (corresponding author), Baylor Coll Med, Human Genome Sequencing Ctr, Houston, TX 77030 USA.	wheeler@bcm.edu; cclau@txch.org	Burstein, Matthew/GWZ-8436-2022; Yamaguchi, Shigeru/G-5419-2012; Ng, Ho Keung/I-3952-2015; Wheeler, David A/M-9740-2018; Dauser, Thomas/AAU-1209-2020; Natsume, Atsushi/I-7364-2014	Yamaguchi, Shigeru/0000-0003-3710-5888; Wheeler, David A/0000-0002-9056-6299; Dauser, Thomas/0000-0003-4583-9048; Natsume, Atsushi/0000-0002-9113-0470; doddapaneni, harshavardhan/0000-0002-2433-633X; Wang, Linghua/0000-0001-9380-0266; Chang, Kyle/0000-0001-5295-9676	National Human Genome Research Institute (NHGRI) [5U54HG003273]; Children Brain Tumor Foundation; Gillson Longenbaugh Foundation; Anderson Charitable Foundation; CCBTP Fellowship from the Cancer Prevention & Research Institute of Texas (CPRIT) [RP101489]; St Baldrick's Foundation; NLM predoctoral fellowships [5T15 LM07093-18, 5T15 LM07093-19]; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U54HG003273] Funding Source: NIH RePORTER; NATIONAL LIBRARY OF MEDICINE [T15LM007093] Funding Source: NIH RePORTER	National Human Genome Research Institute (NHGRI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); Children Brain Tumor Foundation; Gillson Longenbaugh Foundation; Anderson Charitable Foundation; CCBTP Fellowship from the Cancer Prevention & Research Institute of Texas (CPRIT); St Baldrick's Foundation; NLM predoctoral fellowships; NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL LIBRARY OF MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM))	This work was supported by research funding from the National Human Genome Research Institute (NHGRI, grant number 5U54HG003273) to D. A. W., the Children Brain Tumor Foundation, the Gillson Longenbaugh Foundation and Anderson Charitable Foundation to C. C. L., the CCBTP Fellowship from the Cancer Prevention & Research Institute of Texas (CPRIT grant RP101489) to S.Y., the St Baldrick's Foundation to K. T. and the NLM predoctoral fellowships to M. D. B. (5T15 LM07093-18) and J.S. (5T15 LM07093-19). We thank H. H. Dinh and Y. Han for their technical support, J. G. Reid for Illumina sequence mapping.	Adzhubei IA, 2010, NAT METHODS, V7, P248, DOI 10.1038/nmeth0410-248; Choi Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046688; Corless CL, 2011, NAT REV CANCER, V11, P865, DOI 10.1038/nrc3143; DePristo MA, 2011, NAT GENET, V43, P491, DOI 10.1038/ng.806; Gajiwala KS, 2009, P NATL ACAD SCI USA, V106, P1542, DOI 10.1073/pnas.0812413106; Hatzivassiliou G, 2012, MOL CANCER THER, V11, P1143, DOI 10.1158/1535-7163.MCT-11-1010; Heery DM, 1997, NATURE, V387, P733, DOI 10.1038/42750; Janne PA, 2013, LANCET ONCOL, V14, P38, DOI 10.1016/S1470-2045(12)70489-8; JENNINGS MT, 1985, J NEUROSURG, V63, P155, DOI 10.3171/jns.1985.63.2.0155; Jin GF, 2012, HUM MOL GENET, V21, P5222, DOI 10.1093/hmg/dds361; Kamakura Y, 2006, J NEUROSURG, V104, P173, DOI 10.3171/ped.2006.104.3.173; Katoh M, 2003, INT J MOL MED, V12, P817; Kemmer K, 2004, AM J PATHOL, V164, P305, DOI 10.1016/S0002-9440(10)63120-3; Kim SM, 2010, NUCLEIC ACIDS RES, V38, P6389, DOI 10.1093/nar/gkq491; Kumar P, 2009, NAT PROTOC, V4, P1073, DOI 10.1038/nprot.2009.86; Kuroki S, 2013, BIOL REPROD, V89, DOI 10.1095/biolreprod.113.108597; Li BS, 2008, AM J HUM GENET, V83, P311, DOI 10.1016/j.ajhg.2008.06.024; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Li M, 2011, BLOOD, V118, P5914, DOI 10.1182/blood-2011-05-356204; Liu LZ, 2007, CANCER RES, V67, P6325, DOI 10.1158/0008-5472.CAN-06-4261; Madsen BE, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000384; Makishima H, 2012, LEUKEMIA, V26, P1547, DOI 10.1038/leu.2012.7; Makishima H, 2009, J CLIN ONCOL, V27, P6109, DOI 10.1200/JCO.2009.23.7503; Matsutani M, 1997, J NEUROSURG, V86, P446, DOI 10.3171/jns.1997.86.3.0446; McCarthy BJ, 2012, NEURO-ONCOLOGY, V14, P1194, DOI 10.1093/neuonc/nos155; Muzny DM, 2012, NATURE, V487, P330, DOI 10.1038/nature11252; Okada Y, 2002, J NEUROPATH EXP NEUR, V61, P531, DOI 10.1093/jnen/61.6.531; Packer R J, 2000, Oncologist, V5, P312; Pagan JK, 2007, J BIOL CHEM, V282, P15248, DOI 10.1074/jbc.M700246200; Popova T, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-11-r128; Rickert CH, 2000, J NEUROPATH EXP NEUR, V59, P815, DOI 10.1093/jnen/59.9.815; Sakuma Y, 2004, CANCER SCI, V95, P716, DOI 10.1111/j.1349-7006.2004.tb03251.x; Schneider DT, 2006, MODERN PATHOL, V19, P864, DOI 10.1038/modpathol.3800607; Shen YF, 2010, GENOME RES, V20, P273, DOI 10.1101/gr.096388.109; Staaf J, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-9-r136; Terashima K, 2014, PEDIATR BLOOD CANCER, V61, P593, DOI 10.1002/pbc.24833; Thien CBF, 2001, MOL CELL, V7, P355, DOI 10.1016/S1097-2765(01)00183-6; Venkatraman ES, 2007, BIOINFORMATICS, V23, P657, DOI 10.1093/bioinformatics/btl646; Wang K, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq603; Wolf SS, 2007, ARCH BIOCHEM BIOPHYS, V460, P56, DOI 10.1016/j.abb.2007.01.017; Ye K, 2009, BIOINFORMATICS, V25, P2865, DOI 10.1093/bioinformatics/btp394	41	116	121	3	38	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 10	2014	511	7508					241	+		10.1038/nature13296	http://dx.doi.org/10.1038/nature13296			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK8AP	24896186	Green Accepted			2022-12-28	WOS:000338649800048
J	Coresh, J; Turin, TC; Matsushita, K; Sang, Y; Ballew, SH; Appel, LJ; Arima, H; Chadban, SJ; Cirillo, M; Djurdjev, O; Green, JA; Heine, GH; Inker, LA; Irie, F; Ishani, A; Ix, JH; Kovesdy, CP; Marks, A; Ohkubo, T; Shalev, V; Shankar, A; Wen, CP; de Jong, PE; Iseki, K; Stengel, B; Gansevoort, RT; Levey, AS				Coresh, Josef; Turin, Tanvir Chowdhury; Matsushita, Kunihiro; Sang, Yingying; Ballew, Shoshana H.; Appel, Lawrence J.; Arima, Hisatomi; Chadban, Steven J.; Cirillo, Massimo; Djurdjev, Ognjenka; Green, Jamie A.; Heine, Gunnar H.; Inker, Lesley A.; Irie, Fujiko; Ishani, Areef; Ix, Joachim H.; Kovesdy, Csaba P.; Marks, Angharad; Ohkubo, Takayoshi; Shalev, Varda; Shankar, Anoop; Wen, Chi Pang; de Jong, Paul E.; Iseki, Kunitoshi; Stengel, Benedicte; Gansevoort, Ron T.; Levey, Andrew S.		CKD Prognosis Consortium	Decline in Estimated Glomerular Filtration Rate and Subsequent Risk of End-Stage Renal Disease and Mortality	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							KIDNEY-FUNCTION DECLINE; COLLABORATIVE METAANALYSIS; HIGHER ALBUMINURIA; ALL-CAUSE; ESTIMATED GFR; POPULATION; EQUATION	IMPORTANCE The established chronic kidney disease (CKD) progression end point of end-stage renal disease (ESRD) or a doubling of serum creatinine concentration (corresponding to a change in estimated glomerular filtration rate [GFR] of -57% or greater) is a late event. OBJECTIVE To characterize the association of decline in estimated GFR with subsequent progression to ESRD with implications for using lesser declines in estimated GFR as potential alternative end points for CKD progression. Because most people with CKD die before reaching ESRD, mortality risk also was investigated. DATA SOURCES AND STUDY SELECTION Individual meta-analysis of 1.7 million participants with 12 344 ESRD events and 223 944 deaths from 35 cohorts in the CKD Prognosis Consortium with a repeated measure of serum creatinine concentration over 1 to 3 years and outcome data. DATA EXTRACTION AND SYNTHESIS Transfer of individual participant data or standardized analysis of outputs for random-effects meta-analysis conducted between July 2012 and September 2013, with baseline estimated GFR values collected from 1975 through 2012. MAIN OUTCOMES AND MEASURES End-stage renal disease (initiation of dialysis or transplantation) or all-cause mortality risk related to percentage change in estimated GFR over 2 years, adjusted for potential confounders and first estimated GFR. RESULTS The adjusted hazard ratios (HRs) of ESRD and mortality were higher with larger estimated GFR decline. Among participants with baseline estimated GFR of less than 60 mL/min/1.73m(2), the adjusted HRs for ESRD were 32.1 (95% CI, 22.3-46.3) for changes of -57% in estimated GFR and 5.4 (95% CI, 4.5-6.4) for changes of -30%. However, changes of -30% or greater (6.9%[95% CI, 6.4%-7.4%] of the entire consortium) were more common than changes of -57%(0.79% [95% CI, 0.52%-1.06%]). This association was strong and consistent across the length of the baseline period (1 to 3 years), baseline estimated GFR, age, diabetes status, or albuminuria. Average adjusted 10-year risk of ESRD (in patients with a baseline estimated GFR of 35 mL/min/1.73m(2)) was 99%(95% CI, 95%-100%) for estimated GFR change of -57%, was 83%(95% CI, 71%-93%) for estimated GFR change of -40%, and was 64%(95% CI, 52%-77%) for estimated GFR change of -30% vs 18%(95% CI, 15%-22%) for estimated GFR change of 0%. Corresponding mortality risks were 77%(95% CI, 71%-82%), 60%(95% CI, 56%-63%), and 50% (95% CI, 47%-52%) vs 32%(95% CI, 31%-33%), showing a similar but weaker pattern. CONCLUSIONS AND RELEVANCE Declines in estimated GFR smaller than a doubling of serum creatinine concentration occurred more commonly and were strongly and consistently associated with the risk of ESRD and mortality, supporting consideration of lesser declines in estimated GFR (such as a 30% reduction over 2 years) as an alternative end point for CKD progression.	[Coresh, Josef; Matsushita, Kunihiro; Sang, Yingying; Ballew, Shoshana H.] Johns Hopkins Bloomberg, Sch Publ Hlth, Baltimore, MD USA; [Turin, Tanvir Chowdhury] Univ Calgary, Dept Community Hlth Sci, Calgary, AB, Canada; [Appel, Lawrence J.] Johns Hopkins Med Inst, Baltimore, MD 21205 USA; [Arima, Hisatomi] Univ Sydney, George Inst Global Hlth, Sydney, NSW 2006, Australia; [Chadban, Steven J.] Royal Prince Alfred Hosp, Dept Nephrol & Transplantat, Sydney, NSW, Australia; [Chadban, Steven J.] Univ Sydney, Sydney Med Sch, Sydney, NSW 2006, Australia; [Cirillo, Massimo] Univ Salerno, Dept Med, I-84100 Salerno, Italy; [Djurdjev, Ognjenka] BC Prov Renal Agcy, Vancouver, BC, Canada; [Green, Jamie A.] Geisinger Med Ctr, Dept Nephrol, Danville, PA 17822 USA; [Heine, Gunnar H.] Saarland Univ Med Ctr, Dept Internal Med Nephrol & Hypertens 4, Hamburg, Germany; [Inker, Lesley A.; Levey, Andrew S.] Tufts Med Ctr, Div Nephrol, Boston, MA USA; [Irie, Fujiko] Ibaraki Prefectural Off, Dept Hlth & Welf, Mito, Ibaraki, Japan; [Ishani, Areef] Univ Minnesota, Minneapolis VA Hlth Care Syst, Minneapolis, MN USA; [Ishani, Areef] Univ Minnesota, Dept Med, Minneapolis, MN 55455 USA; [Ix, Joachim H.] Univ Calif San Diego, San Diego, CA 92103 USA; [Kovesdy, Csaba P.] Memphis Vet Affairs, Med Ctr, Memphis, TN USA; [Kovesdy, Csaba P.] Univ Tennessee, Ctr Hlth Sci, Memphis, TN 38163 USA; [Marks, Angharad] Univ Aberdeen, Div Appl Hlth Sci, Aberdeen, Scotland; [Marks, Angharad] NHS Grampian, Aberdeen, Scotland; [Ohkubo, Takayoshi] Teikyo Univ, Sch Med, Dept Hyg & Publ Hlth, Tokyo 173, Japan; [Ohkubo, Takayoshi] Tohoku Univ, Grad Sch Pharmaceut Sci, Dept Planning Drug Dev & Clin Evaluat, Sendai, Miyagi 980, Japan; [Ohkubo, Takayoshi] Shiga Univ Med Sci, Dept Hlth Sci, Shiga, Japan; [Shalev, Varda] Tel Aviv Univ, Dept Med Informat, Maccabi Healthcare Serv, IL-69978 Tel Aviv, Israel; [Shalev, Varda] Tel Aviv Univ, Fac Med, IL-69978 Tel Aviv, Israel; [Shankar, Anoop] Virginia Commonwealth Univ, Sch Med, Dept Family Med & Populat Hlth, Richmond, VA 23284 USA; [Wen, Chi Pang] China Med Univ Hosp, Taichung, Taiwan; [Wen, Chi Pang] Inst Populat Hlth Sci, Natl Hlth Res Inst, Zhunan, Taiwan; [de Jong, Paul E.; Gansevoort, Ron T.] Univ Groningen, Univ Med Ctr Groningen, Dept Nephrol, Groningen, Netherlands; [Iseki, Kunitoshi] Univ Hosp Ryukyus, Dialysis Unit, Okinawa, Japan; [Stengel, Benedicte] Univ Paris Sud, Inserm U1018, CESP Ctr Res Epidemiol & Populat Hlth, Villejuif, France; [Stengel, Benedicte] Univ Paris Sud, UMRS 1018, Villejuif, France	Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; University of Calgary; Johns Hopkins University; Johns Hopkins Medicine; George Institute for Global Health; University of Sydney; University of Sydney; University of Sydney; University of Salerno; Geisinger Medical Center; Tufts Medical Center; University of Minnesota System; University of Minnesota Twin Cities; US Department of Veterans Affairs; Veterans Health Administration (VHA); Minneapolis VA Health Care System; University of Minnesota System; University of Minnesota Twin Cities; University of California System; University of California San Diego; US Department of Veterans Affairs; Veterans Health Administration (VHA); Memphis VA Medical Center; University of Tennessee System; University of Tennessee Health Science Center; University of Aberdeen; Teikyo University; Tohoku University; Shiga University of Medical Science; Tel Aviv University; Tel Aviv University; Virginia Commonwealth University; China Medical University Taiwan; China Medical University Hospital - Taiwan; National Health Research Institutes - Taiwan; University of Groningen; University of the Ryukyus; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay; UDICE-French Research Universities; Universite Paris Saclay	Coresh, J (corresponding author), Data Coordinating Ctr, Chron Kidney Dis Prognosis Consortium, 615 N Wolfe St, Baltimore, MD 21205 USA.	ckdpc@jhmi.edu	Matsushita, Kunihiro/AAJ-5817-2020; Marks, Angharad/H-5657-2019; Schöttker, Ben/F-8183-2014; Brenner, Hermann/ABE-6383-2020; Kalantar-Zadeh, Kamyar/Q-4734-2018; Kikuya, Masahiro/X-5662-2018; de Zeeuw, Dick/E-9080-2014; Matsushita, Kunihiro/B-1021-2018; Turin, Tanvir C/L-7617-2016; Stengel, Benedicte/G-5730-2015; Brenner, Hermann/B-4627-2017; Heerspink, Hiddo J Lambers/K-3358-2014; Wetzels, Jack F.M./A-1720-2014; Appel, Larry/GLT-2608-2022; Cirillo, Massimo/G-5480-2018; Froissart, Marc/L-7493-2014; Metzger, Marie/K-9772-2018	Matsushita, Kunihiro/0000-0002-7179-718X; Marks, Angharad/0000-0003-1910-462X; Schöttker, Ben/0000-0002-1217-4521; Brenner, Hermann/0000-0002-6129-1572; Kalantar-Zadeh, Kamyar/0000-0002-8666-0725; Kikuya, Masahiro/0000-0002-3080-6107; de Zeeuw, Dick/0000-0003-3434-7777; Matsushita, Kunihiro/0000-0002-7179-718X; Turin, Tanvir C/0000-0002-7499-5050; Stengel, Benedicte/0000-0001-9469-0804; Brenner, Hermann/0000-0002-6129-1572; Heerspink, Hiddo J Lambers/0000-0002-3126-3730; Wetzels, Jack F.M./0000-0002-0650-6921; Ohkubo, Takayoshi/0000-0002-3283-8196; Heine, Gunnar/0000-0001-8320-5260; Cirillo, Massimo/0000-0002-6409-3504; Rothenbacher, Dietrich/0000-0002-3563-2791; Townend, Jonathan/0000-0002-5881-5806; Emberson, Jonathan/0000-0001-7792-9422; Ballew, Shoshana/0000-0002-7547-3764; /0000-0002-5189-8995; Sairenchi, Toshimi/0000-0001-8896-6501; Woodward, Mark/0000-0001-9800-5296; Kleefstra, Nanne/0000-0003-1473-8519; Froissart, Marc/0000-0002-4010-3173; Metzger, Marie/0000-0003-3597-5409; Chang, Yoosoo/0000-0002-6945-9050; Prescott, Gordon/0000-0002-9156-2361	US National Kidney Foundation; AbbVie; Amgen; National Institute of Diabetes and Digestive and Kidney Diseases [R01DK100446]; national institutes of health and medical research councils; Medical Research Council [MC_PC_13040, MR/K007017/1] Funding Source: researchfish; Chief Scientist Office [CZH/4/656] Funding Source: researchfish; MRC [MR/K007017/1] Funding Source: UKRI; DIVISION OF EPIDEMIOLOGY AND CLINICAL APPLICATIONS [N01HC095159, N01HC025195] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR001079] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR024156, UL1RR025005] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL068140, R01HL043232, R01HL080295, R44HL095169, R43HL095169, R01HL085083] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [U01DK035073, R01DK100446, R01DK031801, K23DK067303, K23DK002904] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG028507, R01AG023629, R01AG007181] Funding Source: NIH RePORTER	US National Kidney Foundation; AbbVie(AbbVie); Amgen(Amgen); National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); national institutes of health and medical research councils(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); Chief Scientist Office; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); DIVISION OF EPIDEMIOLOGY AND CLINICAL APPLICATIONS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	The Chronic Kidney Disease Prognosis Consortium (CKD-PC) data coordinating center is funded in part by a program grant from the US National Kidney Foundation (funding sources include AbbVie and Amgen) and the National Institute of Diabetes and Digestive and Kidney Diseases (grant R01DK100446). A variety of sources have supported enrollment and data collection, including laboratory measurements and follow-up in the collaborating cohorts of the CKD-PC. These funding sources include government agencies such as national institutes of health and medical research councils as well as foundations and industry sponsors listed in eAppendix 3 in the Supplement.	Al-Aly Z, 2010, J AM SOC NEPHROL, V21, P1961, DOI 10.1681/ASN.2009121210; Astor BC, 2011, KIDNEY INT, V79, P1331, DOI 10.1038/ki.2010.550; Cheng TYD, 2008, AM J KIDNEY DIS, V52, P1051, DOI 10.1053/j.ajkd.2008.05.030; Eckardt KU, 2013, LANCET, V382, P158, DOI 10.1016/S0140-6736(13)60439-0; Gansevoort RT, 2011, KIDNEY INT, V80, P93, DOI 10.1038/ki.2010.531; Grams ME, 2013, AM J KIDNEY DIS, V62, P245, DOI 10.1053/j.ajkd.2013.03.009; Grams ME, 2012, CLIN J AM SOC NEPHRO, V7, P1606, DOI 10.2215/CJN.03460412; Greene T, 2013, J AM SOC NEPHROL, V24, p151A; Heerspink HJL, 2014, AM J KIDNEY DIS, V63, P244, DOI 10.1053/j.ajkd.2013.09.016; Inker LA, 2013, J AM SOC NEPHROL, V24, p12A; Kovesdy CP, 2009, AM J CLIN NUTR, V90, P407, DOI 10.3945/ajcn.2008.27390; Levey AS, 2007, CLIN CHEM, V53, P766, DOI 10.1373/clinchem.2006.077180; Levey AS, 2009, ANN INTERN MED, V150, P604, DOI 10.7326/0003-4819-150-9-200905050-00006; Levin A, 2013, KIDNEY INT SUPPL, V3, P5, DOI 10.1038/kisup.2012.77; LEWIS EJ, 1993, NEW ENGL J MED, V329, P1456, DOI 10.1056/NEJM199311113292004; MATSUSHITA K, 2009, CHANGE, V20, P2617, DOI DOI 10.1681/ASN.2009010025; Matsushita K, 2013, INT J EPIDEMIOL, V42, P1660, DOI 10.1093/ije/dys173; Matsushita K, 2012, JAMA-J AM MED ASSOC, V307, P1941, DOI 10.1001/jama.2012.3954; Matsushita K, 2010, LANCET, V375, P2073, DOI 10.1016/S0140-6736(10)60674-5; Miller WG, 2009, CLIN CHEM, V55, P24, DOI 10.1373/clinchem.2008.106567; Myers GL, 2006, CLIN CHEM, V52, P5, DOI 10.1373/clinchem.2005.0525144; National Kidney Foundation, RES GFR DECL ENDP CL; Palmer SC, 2011, AM J KIDNEY DIS, V58, P335, DOI 10.1053/j.ajkd.2011.06.006; Perkins RM, 2011, CLIN J AM SOC NEPHRO, V6, P1879, DOI 10.2215/CJN.00470111; Rifkin DE, 2008, ARCH INTERN MED, V168, P2212, DOI 10.1001/archinte.168.20.2212; Rockhill B, 1998, AM J PUBLIC HEALTH, V88, P15, DOI 10.2105/AJPH.88.1.15; Shlipak MG, 2009, J AM SOC NEPHROL, V20, P2625, DOI 10.1681/ASN.2009050546; Tonelli M, 2011, KIDNEY INT, V80, P1306, DOI 10.1038/ki.2011.280; Turin TC, 2013, KIDNEY INT, V83, P684, DOI 10.1038/ki.2012.443; Turin TC, 2012, NEPHROL DIAL TRANSPL, V27, P3835, DOI 10.1093/ndt/gfs263; Turin TC, 2012, AM J NEPHROL, V36, P41, DOI 10.1159/000339289; van der Velde M, 2011, KIDNEY INT, V79, P1341, DOI 10.1038/ki.2010.536	32	609	632	3	58	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUN 25	2014	311	24					2518	2531		10.1001/jama.2014.6634	http://dx.doi.org/10.1001/jama.2014.6634			14	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AJ5VE	24892770	Green Submitted, Green Accepted			2022-12-28	WOS:000337757000025
J	Genovese, P; Schiroli, G; Escobar, G; Di Tomaso, T; Firrito, C; Calabria, A; Moi, D; Mazzieri, R; Bonini, C; Holmes, MC; Gregory, PD; van der Burg, M; Gentner, B; Montini, E; Lombardo, A; Naldini, L				Genovese, Pietro; Schiroli, Giulia; Escobar, Giulia; Di Tomaso, Tiziano; Firrito, Claudia; Calabria, Andrea; Moi, Davide; Mazzieri, Roberta; Bonini, Chiara; Holmes, Michael C.; Gregory, Philip D.; van der Burg, Mirjam; Gentner, Bernhard; Montini, Eugenio; Lombardo, Angelo; Naldini, Luigi			Targeted genome editing in human repopulating haematopoietic stem cells	NATURE			English	Article							ZINC-FINGER NUCLEASES; GENE-THERAPY; LENTIVIRAL VECTOR; T-CELLS; INTEGRATION; SAFE; CCR5	Targeted genome editing by artificial nucleases has brought the goal of site-specific transgene integration and gene correction within the reach of gene therapy. However, its application to long-term repopulating haematopoietic stem cells (HSCs) has remained elusive. Here we show that poor permissiveness to gene transfer and limited proficiency of the homology-directed DNA repair pathway constrain gene targeting in human HSCs. By tailoring delivery platforms and culture conditions we overcame these barriers and provide stringent evidence of targeted integration in human HSCs by long-term multilineage repopulation of transplanted mice. We demonstrate the therapeutic potential of our strategy by targeting a corrective complementary DNA into the IL2RG gene of HSCs from healthy donors and a subject with X-linked severe combined immunodeficiency (SCID-X1). Gene-edited HSCs sustained normal haematopoiesis and gave rise to functional lymphoid cells that possess a selective growth advantage over those carrying disruptive IL2RG mutations. These results open up new avenues for treating SCID-X1 and other diseases.	[Genovese, Pietro; Schiroli, Giulia; Escobar, Giulia; Di Tomaso, Tiziano; Firrito, Claudia; Calabria, Andrea; Moi, Davide; Mazzieri, Roberta; Gentner, Bernhard; Montini, Eugenio; Lombardo, Angelo; Naldini, Luigi] Ist Sci San Raffaele, San Raffaele Telethon Inst Gene Therapy, TIGET, I-20132 Milan, Italy; [Schiroli, Giulia; Escobar, Giulia; Gentner, Bernhard; Lombardo, Angelo; Naldini, Luigi] Univ Vita Salute San Raffaele, I-20132 Milan, Italy; [Bonini, Chiara] Ist Sci San Raffaele, Expt Hematol Unit, I-20132 Milan, Italy; [Holmes, Michael C.; Gregory, Philip D.] Sangamo BioSci Inc, Richmond, CA 94804 USA; [van der Burg, Mirjam] Univ Med Ctr, Erasmus MC, Dept Immunol, NL-3015 Rotterdam, Netherlands	Fondazione Telethon; San Raffaele Telethon Institute For Gene Therapy (Sr-Tiget); Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele; Vita-Salute San Raffaele University; Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele; Sangamo Therapeutics, Inc.; Erasmus University Rotterdam; Erasmus MC	Naldini, L (corresponding author), Ist Sci San Raffaele, San Raffaele Telethon Inst Gene Therapy, TIGET, I-20132 Milan, Italy.	naldini.luigi@hsr.it	Escobar, Giulia/AFD-7497-2022; Genovese, Pietro/H-3710-2018; lombardo, angelo/J-6241-2016; Mazzieri, Roberta/C-9773-2015; Calabria, Andrea/AAA-3349-2019; bonini, chiara/I-9202-2012; Montini, Eugenio/L-1152-2016	Genovese, Pietro/0000-0001-9507-9003; lombardo, angelo/0000-0001-8262-042X; Mazzieri, Roberta/0000-0002-5172-0927; Calabria, Andrea/0000-0003-3515-3384; Montini, Eugenio/0000-0003-1771-6067; Schiroli, Giulia/0000-0002-9812-8728; NALDINI, Luigi/0000-0002-7835-527X; BONINI, Maria Chiara/0000-0002-0772-1674; Gregory, Philip/0000-0001-9249-2468; Escobar, Giulia/0000-0001-9177-0251; Gentner, Bernhard/0000-0001-6024-4718; Moi, Davide/0000-0002-1198-5146	Telethon (TIGET grant) [D2]; EU [249845]; Italian Ministry of Health	Telethon (TIGET grant)(Fondazione Telethon); EU(European Commission); Italian Ministry of Health(Ministry of Health, Italy)	We thank D. Weissman for advice on mRNA production and the whole Naldini laboratory for discussion, F. Benedicenti for help with MiSeq sequencing, L. Sergi Sergi, T. Plati, V. Valtolina, B. Camisa and A. Ranghetti for technical help. SR1 was provided by T. Boitano and M. Cooke under an MTA with the Genomics Institute of the Novartis Research Foundation. This work was supported by grants to L.N. from Telethon (TIGET grant D2) EU (FP7 222878 PERSIST, FP7 601958 SUPERSIST, ERC Advanced Grant 249845 TARGETINGGENETHERAPY) and the Italian Ministry of Health.	Aiuti A, 2013, SCIENCE, V341, P865, DOI 10.1126/science.1233151; Akatsuka Y, 1999, TISSUE ANTIGENS, V53, P122, DOI 10.1034/j.1399-0039.1999.530202.x; Barnett DW, 2011, BIOINFORMATICS, V27, P1691, DOI 10.1093/bioinformatics/btr174; Biffi A, 2013, SCIENCE, V341, P864, DOI 10.1126/science.1233158; Boitano AE, 2010, SCIENCE, V329, P1345, DOI 10.1126/science.1191536; Braun CJ, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3007280; Cartier N, 2009, SCIENCE, V326, P818, DOI 10.1126/science.1171242; Cavazza A, 2013, HUM GENE THER, V24, P119, DOI 10.1089/hum.2012.203; Cavazzana-Calvo M, 2010, NATURE, V467, P318, DOI 10.1038/nature09328; Ciccia A, 2010, MOL CELL, V40, P179, DOI 10.1016/j.molcel.2010.09.019; Cieri N, 2013, BLOOD, V121, P573, DOI 10.1182/blood-2012-05-431718; Doulatov S, 2012, CELL STEM CELL, V10, P120, DOI 10.1016/j.stem.2012.01.006; Escobar G, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3006353; Gabriel R, 2011, NAT BIOTECHNOL, V29, P816, DOI 10.1038/nbt.1948; Gattinoni L, 2011, NAT MED, V17, P1290, DOI 10.1038/nm.2446; Gentner B, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3001522; Goessling W, 2011, CELL STEM CELL, V8, P445, DOI 10.1016/j.stem.2011.02.003; Harris DT, 2013, CLIN EXP IMMUNOL, V174, P402, DOI 10.1111/cei.12192; Hockemeyer D, 2009, NAT BIOTECHNOL, V27, P851, DOI 10.1038/nbt.1562; Holt N, 2010, NAT BIOTECHNOL, V28, P839, DOI 10.1038/nbt.1663; Joung JK, 2013, NAT REV MOL CELL BIO, V14, P49, DOI 10.1038/nrm3486; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Li HJ, 2011, NATURE, V475, P217, DOI 10.1038/nature10177; Lombardo A, 2007, NAT BIOTECHNOL, V25, P1298, DOI 10.1038/nbt1353; Lombardo A, 2011, NAT METHODS, V8, P861, DOI [10.1038/NMETH.1674, 10.1038/nmeth.1674]; Matrai J, 2011, HEPATOLOGY, V53, P1696, DOI 10.1002/hep.24230; Miller JC, 2007, NAT BIOTECHNOL, V25, P778, DOI 10.1038/nbt1319; Milyavsky M, 2010, CELL STEM CELL, V7, P186, DOI 10.1016/j.stem.2010.05.016; Mohrin M, 2010, CELL STEM CELL, V7, P174, DOI 10.1016/j.stem.2010.06.014; Mukherjee S, 2013, GENE, V525, P174, DOI 10.1016/j.gene.2013.03.098; Mussolino C, 2011, NUCLEIC ACIDS RES, V39, P9283, DOI 10.1093/nar/gkr597; Naldini L, 2011, NAT REV GENET, V12, P301, DOI 10.1038/nrg2985; North TE, 2007, NATURE, V447, P1007, DOI 10.1038/nature05883; Provasi E, 2012, NAT MED, V18, P807, DOI 10.1038/nm.2700; Sander JD, 2014, NAT BIOTECHNOL, V32, P347, DOI 10.1038/nbt.2842; Tebas P, 2014, NEW ENGL J MED, V370, P901, DOI 10.1056/NEJMoa1300662; Urnov FD, 2005, NATURE, V435, P646, DOI 10.1038/nature03556; Urnov FD, 2010, NAT REV GENET, V11, P636, DOI 10.1038/nrg2842; Woods NB, 2006, NATURE, V440, P1123, DOI 10.1038/4401123a; Wu CJ, 2000, BLOOD, V95, P352; Zou JZ, 2011, BLOOD, V117, P5561, DOI 10.1182/blood-2010-12-328161	42	397	424	1	87	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 12	2014	510	7504					235	+		10.1038/nature13420	http://dx.doi.org/10.1038/nature13420			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI7AT	24870228	Green Accepted			2022-12-28	WOS:000337032400043
J	Shi, YK; Hu, FB				Shi, Yuankai; Hu, Frank B.			The global implications of diabetes and cancer	LANCET			English	Editorial Material							PROSTATE-CANCER; MELLITUS; RISK; MORTALITY; ADULTS; TYPE-2; WOMEN		[Shi, Yuankai] Chinese Acad Med Sci, Canc Inst Hosp, Peking Union Med Coll, Dept Med Oncol, Beijing 100730, Peoples R China; [Shi, Yuankai] Natl Ctr Anticanc Drugs Clin Study, Beijing, Peoples R China; [Shi, Yuankai] Beijing Key Lab Clin Study Anticanc Mol Targeted, Beijing, Peoples R China; [Hu, Frank B.] Harvard Univ, Sch Publ Hlth, Dept Nutr, Boston, MA 02115 USA; [Hu, Frank B.] Harvard Univ, Sch Publ Hlth, Dept Epidemiol, Boston, MA 02115 USA; [Hu, Frank B.] Brigham & Womens Hosp, Dept Med, Channing Div Network Med, Boston, MA 02115 USA; [Hu, Frank B.] Harvard Univ, Sch Med, Boston, MA USA	Chinese Academy of Medical Sciences - Peking Union Medical College; Cancer Institute & Hospital - CAMS; Peking Union Medical College; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School	Shi, YK (corresponding author), Chinese Acad Med Sci, Canc Inst Hosp, Peking Union Med Coll, Dept Med Oncol, Beijing 100730, Peoples R China.	syuankai@cicams.ac.cn						Bensimon L, 2014, CANCER CAUSE CONTROL, V25, P329, DOI 10.1007/s10552-013-0334-6; Coughlin SS, 2004, AM J EPIDEMIOL, V159, P1160, DOI 10.1093/aje/kwh161; Gallagher EJ, 2013, DIABETES CARE, V36, pS233, DOI 10.2337/dcS13-2001; Giovannucci E, 2010, DIABETES CARE, V33, P1674, DOI 10.2337/dc10-0666; Goodwin PJ, 2008, CLIN BREAST CANCER, V8, P501, DOI 10.3816/CBC.2008.n.060; Goss PE, 2014, LANCET ONCOL, V15, P489, DOI 10.1016/S1470-2045(14)70029-4; Home P, 2013, DIABETES CARE, V36, pS240, DOI 10.2337/dcS13-2002; Hu FB, 1999, JNCI-J NATL CANCER I, V91, P542, DOI 10.1093/jnci/91.6.542; Kasper JS, 2006, CANCER EPIDEM BIOMAR, V15, P2056, DOI 10.1158/1055-9965.EPI-06-0410; Le TN, 2012, TRENDS ENDOCRIN MET, V23, P32, DOI 10.1016/j.tem.2011.09.005; Seshasai SRK, 2011, NEW ENGL J MED, V364, P829, DOI 10.1056/NEJMoa1008862; Vangoitsenhoven R, 2012, ENDOCR-RELAT CANCER, V19, pF77, DOI 10.1530/ERC-12-0111; Xu Y, 2013, JAMA-J AM MED ASSOC, V310, P948, DOI 10.1001/jama.2013.168118	13	271	292	2	13	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	JUN 7	2014	383	9933					1947	1948		10.1016/S0140-6736(14)60886-2	http://dx.doi.org/10.1016/S0140-6736(14)60886-2			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	AI4PV	24910221				2022-12-28	WOS:000336848200004
J	Remer, LA				Remer, Lorraine A.			ATMOSPHERIC SCIENCE Just add aerosols	SCIENCE			English	Editorial Material									Univ Maryland Baltimore Cty, Joint Ctr Earth Syst Technol, Baltimore, MD 21228 USA	University System of Maryland; University of Maryland Baltimore County	Remer, LA (corresponding author), Univ Maryland Baltimore Cty, Joint Ctr Earth Syst Technol, 5523 Res Pk Dr, Baltimore, MD 21228 USA.	remer@umbc.edu						Chin M, 2014, ATMOS CHEM PHYS, V14, P3657, DOI 10.5194/acp-14-3657-2014; Koren I, 2008, SCIENCE, V321, P946, DOI 10.1126/science.1159185; Koren I, 2014, SCIENCE, V344, P1143, DOI 10.1126/science.1252595; Rosenfeld D, 2014, SCIENCE, V343, P379, DOI 10.1126/science.1247490; Yuan T, 2011, ATMOS CHEM PHYS, V11, P7119, DOI 10.5194/acp-11-7119-2011	5	0	0	1	62	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 6	2014	344	6188					1089	1089		10.1126/science.1255398	http://dx.doi.org/10.1126/science.1255398			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AI3UU	24904141				2022-12-28	WOS:000336791200022
J	Waychunas, GA				Waychunas, Glenn A.			INTERFACIAL CHEMISTRY Disrupting dissolving ions at surfaces with fluid flow	SCIENCE			English	Editorial Material							DISSOLUTION; SCALE		Univ Calif Berkeley, Lawrence Berkeley Natl Lab, Div Earth Sci, Berkeley, CA 94720 USA	United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley	Waychunas, GA (corresponding author), Univ Calif Berkeley, Lawrence Berkeley Natl Lab, Div Earth Sci, Berkeley, CA 94720 USA.	gawaychunas@lbl.gov						DU Q, 1994, SCIENCE, V264, P826, DOI 10.1126/science.264.5160.826; Henderson D, 2009, PHYS CHEM CHEM PHYS, V11, P3822, DOI 10.1039/b815946g; Holmberg N, 2014, PHYS CHEM CHEM PHYS, V16, P17437, DOI 10.1039/c4cp00635f; Lis D, 2014, SCIENCE, V344, P1138, DOI 10.1126/science.1253793; Liu LM, 2011, PHYS CHEM CHEM PHYS, V13, P13162, DOI 10.1039/c1cp21077g; Lutzenkirchen J, 2010, ADV COLLOID INTERFAC, V157, P61, DOI 10.1016/j.cis.2010.03.003; Ohlin CA, 2010, NAT MATER, V9, P11, DOI [10.1038/NMAT2585, 10.1038/nmat2585]; Ostroverkhov V, 2005, PHYS REV LETT, V94, DOI 10.1103/PhysRevLett.94.046102; Ruiz-Agudo E, 2012, GEOLOGY, V40, P947, DOI 10.1130/G33339.1; Urosevic M, 2012, GEOCHIM COSMOCHIM AC, V80, P1, DOI 10.1016/j.gca.2011.11.036; Vlieg E, 2007, FARADAY DISCUSS, V136, P57, DOI 10.1039/b618566p	11	7	7	0	66	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 6	2014	344	6188					1094	1095		10.1126/science.1254906	http://dx.doi.org/10.1126/science.1254906			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AI3UU	24904144				2022-12-28	WOS:000336791200025
J	Blackledge, NP; Farcas, AM; Kondo, T; King, HW; McGouran, JF; Hanssen, LLP; Ito, S; Cooper, S; Kondo, K; Koseki, Y; Ishikura, T; Long, HK; Sheahan, TW; Brockdorff, N; Kessler, BM; Koseki, H; Klose, RJ				Blackledge, Neil P.; Farcas, Anca M.; Kondo, Takashi; King, Hamish W.; McGouran, Joanna F.; Hanssen, Lars L. P.; Ito, Shinsuke; Cooper, Sarah; Kondo, Kaori; Koseki, Yoko; Ishikura, Tomoyuki; Long, Hannah K.; Sheahan, Thomas W. p; Brockdorff, Neil; Kessler, Benedikt M.; Koseki, Haruhiko; Klose, Robert J.			Variant PRC1 Complex-Dependent H2A Ubiquitylation Drives PRC2 Recruitment and Polycomb Domain Formation	CELL			English	Article							HISTONE METHYLTRANSFERASE ACTIVITY; EMBRYONIC STEM-CELLS; UBIQUITIN LIGASE COMPLEX; GROUP PROTEINS RING1A/B; REPRESSIVE COMPLEX; GENOME-WIDE; CPG ISLANDS; DROSOPHILA-MELANOGASTER; X-INACTIVATION; SAM DOMAIN	Chromatin modifying activities inherent to polycomb repressive complexes PRC1 and PRC2 play an essential role in gene regulation, cellular differentiation, and development. However, the mechanisms by which these complexes recognize their target sites and function together to form repressive chromatin domains remain poorly understood. Recruitment of PRC1 to target sites has been proposed to occur through a hierarchical process, dependent on prior nucleation of PRC2 and placement of H3K27me3. Here, using a de novo targeting assay in mouse embryonic stem cells we unexpectedly discover that PRC1-dependent H2AK119ub1 leads to recruitment of PRC2 and H3K27me3 to effectively initiate a polycomb domain. This activity is restricted to variant PRC1 complexes, and genetic ablation experiments reveal that targeting of the variant PCGF1/PRC1 complex by KDM2B to CpG islands is required for normal polycomb domain formation and mouse development. These observations provide a surprising PRC1-dependent logic for PRC2 occupancy at target sites in vivo.	[Blackledge, Neil P.; Farcas, Anca M.; King, Hamish W.; Hanssen, Lars L. P.; Long, Hannah K.; Sheahan, Thomas W. p; Klose, Robert J.] Univ Oxford, Dept Biochem, Lab Chromatin Biol & Transcript, Oxford OX1 3QU, England; [Kondo, Takashi; Ito, Shinsuke; Kondo, Kaori; Koseki, Yoko; Ishikura, Tomoyuki; Koseki, Haruhiko] RIKEN, Ctr Integrat Med Sci, Lab Dev Genet, Yokohama, Kanagawa 2300045, Japan; [McGouran, Joanna F.; Kessler, Benedikt M.] Univ Oxford, Target Discovery Inst, Nuffield Dept Med, Cent Prote Facil,Ubiquitin Proteolysis Grp, Oxford OX3 7BN, England; [Cooper, Sarah; Brockdorff, Neil] Univ Oxford, Dept Biochem, Lab Dev Epigenet, Oxford OX1 3QU, England	University of Oxford; RIKEN; University of Oxford; University of Oxford	Klose, RJ (corresponding author), Univ Oxford, Dept Biochem, Lab Chromatin Biol & Transcript, S Parks Rd, Oxford OX1 3QU, England.	rob.klose@bioch.ox.ac.uk	Long, Hannah/X-9731-2019; McGouran, Joanna/A-1545-2019; Kessler, Benedikt/AAY-8614-2021; Koseki, Haruhiko/I-3825-2014; Long, Hannah/A-6301-2013; King, Hamish/U-9808-2019	Long, Hannah/0000-0002-5694-0398; McGouran, Joanna/0000-0002-9349-2141; Kessler, Benedikt/0000-0002-8160-2446; Koseki, Haruhiko/0000-0001-8424-5854; Long, Hannah/0000-0002-5694-0398; King, Hamish/0000-0001-5972-8926; Brockdorff, Neil/0000-0003-4838-2653; Farcas, Anca Madalina/0000-0002-6467-494X; Sheahan, Thomas/0000-0002-9457-4691; jin teng, long/0000-0002-1948-9331; Hanssen, Lars/0000-0002-2551-2278	Wellcome Trust [WT0834922, WT081385]; CRUK [C28585/A10839]; NIHR; EMBO; Lister Institute of Preventative Medicine; RIKEN; MEXT; JST CREST; Medical Research Council [G0501068] Funding Source: researchfish; MRC [G0501068] Funding Source: UKRI	Wellcome Trust(Wellcome TrustEuropean Commission); CRUK(Cancer Research UK); NIHR(National Institute for Health Research (NIHR)); EMBO(European Molecular Biology Organization (EMBO)); Lister Institute of Preventative Medicine; RIKEN; MEXT(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); JST CREST(Japan Science & Technology Agency (JST)Core Research for Evolutional Science and Technology (CREST)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	We thank Dr. Tom Milne for comments and suggestions, Marie-Laetitia Thezenas and Dr. Rebecca Konietzny for mass spectrometry expertise. This study was funded by the Wellcome Trust (WT0834922 and WT081385), CRUK (C28585/A10839), NIHR, EMBO, Lister Institute of Preventative Medicine, RIKEN, MEXT, and JST CREST. The WTCHG Genomics Facility carried out massively parallel sequencing.	Akasaka T, 1996, DEVELOPMENT, V122, P1513; Arnold P, 2013, GENOME RES, V23, P60, DOI 10.1101/gr.142661.112; Bentley ML, 2011, EMBO J, V30, P3285, DOI 10.1038/emboj.2011.243; Blackledge NP, 2010, MOL CELL, V38, P179, DOI 10.1016/j.molcel.2010.04.009; Boyer LA, 2006, NATURE, V441, P349, DOI 10.1038/nature04733; Bracken AP, 2009, NAT REV CANCER, V9, P773, DOI 10.1038/nrc2736; Bracken AP, 2006, GENE DEV, V20, P1123, DOI 10.1101/gad.381706; Brookes E, 2012, CELL STEM CELL, V10, P157, DOI 10.1016/j.stem.2011.12.017; Buchwald G, 2006, EMBO J, V25, P2465, DOI 10.1038/sj.emboj.7601144; Cao R, 2004, MOL CELL, V15, P57, DOI 10.1016/j.molcel.2004.06.020; Cao R, 2002, SCIENCE, V298, P1039, DOI 10.1126/science.1076997; Chamberlain SJ, 2008, STEM CELLS, V26, P1496, DOI 10.1634/stemcells.2008-0102; Cooper S, 2014, CELL REP, V7, P1456, DOI 10.1016/j.celrep.2014.04.012; Czermin B, 2002, CELL, V111, P185, DOI 10.1016/S0092-8674(02)00975-3; de Napoles M, 2004, DEV CELL, V7, P663, DOI 10.1016/j.devcel.2004.10.005; Dietrich N, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002494; Endoh M, 2008, DEVELOPMENT, V135, P1513, DOI 10.1242/dev.014340; Eskeland R, 2010, MOL CELL, V38, P452, DOI 10.1016/j.molcel.2010.02.032; Farcas AM, 2012, ELIFE, V1, DOI 10.7554/eLife.00205; Fukuda T, 2011, MOL CELL NEUROSCI, V46, P614, DOI 10.1016/j.mcn.2011.01.001; Gao ZH, 2012, MOL CELL, V45, P344, DOI 10.1016/j.molcel.2012.01.002; Gearhart MD, 2006, MOL CELL BIOL, V26, P6880, DOI 10.1128/MCB.00630-06; Grossmann V, 2011, BLOOD, V118, P6153, DOI 10.1182/blood-2011-07-365320; Hansen KH, 2008, NAT CELL BIOL, V10, P1291, DOI 10.1038/ncb1787; He J, 2013, NAT CELL BIOL, V15, P373, DOI 10.1038/ncb2702; Hosogane M, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003698; Isono K, 2013, DEV CELL, V26, P565, DOI 10.1016/j.devcel.2013.08.016; Kaneko S, 2014, MOL CELL, V53, P290, DOI 10.1016/j.molcel.2013.11.012; Ketel CS, 2005, MOL CELL BIOL, V25, P6857, DOI 10.1128/MCB.25.16.6857-6868.2005; Kim CA, 2002, NAT STRUCT BIOL, V9, P453, DOI 10.1038/nsb802; Klose RJ, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003717; Kondo T, 1999, CELL, V97, P407, DOI 10.1016/S0092-8674(00)80749-7; Ku M, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000242; Kuzmichev A, 2002, GENE DEV, V16, P2893, DOI 10.1101/gad.1035902; Lagarou A, 2008, GENE DEV, V22, P2799, DOI 10.1101/gad.484208; Leeb M, 2010, GENE DEV, V24, P265, DOI 10.1101/gad.544410; Levine SS, 2002, MOL CELL BIOL, V22, P6070, DOI 10.1128/MCB.22.17.6070-6078.2002; Li ZZ, 2006, J BIOL CHEM, V281, P20643, DOI 10.1074/jbc.M602461200; Long HK, 2013, BIOCHEM SOC T, V41, P727, DOI 10.1042/BST20130028; Lorente MD, 2000, DEVELOPMENT, V127, P5093; Lynch MD, 2012, EMBO J, V31, P317, DOI 10.1038/emboj.2011.399; Margueron R, 2009, NATURE, V461, P762, DOI 10.1038/nature08398; Min JR, 2003, GENE DEV, V17, P1823, DOI 10.1101/gad.269603; Muller J, 2002, CELL, V111, P197, DOI 10.1016/S0092-8674(02)00976-5; Ogawa H, 2002, SCIENCE, V296, P1132, DOI 10.1126/science.1069861; Papp B, 2006, GENE DEV, V20, P2041, DOI 10.1101/gad.388706; Pasini D, 2004, EMBO J, V23, P4061, DOI 10.1038/sj.emboj.7600402; Pasini D, 2007, MOL CELL BIOL, V27, P3769, DOI 10.1128/MCB.01432-06; Pasqualucci L, 2011, NAT GENET, V43, P830, DOI 10.1038/ng.892; Posfai E, 2012, GENE DEV, V26, P920, DOI 10.1101/gad.188094.112; Sanchez C, 2007, MOL CELL PROTEOMICS, V6, P820, DOI 10.1074/mcp.M600275-MCP200; Schoeftner S, 2006, EMBO J, V25, P3110, DOI 10.1038/sj.emboj.7601187; Schwartz YB, 2006, NAT GENET, V38, P700, DOI 10.1038/ng1817; Schwartz YB, 2013, NAT REV GENET, V14, P853, DOI 10.1038/nrg3603; Simon JA, 2013, MOL CELL, V49, P808, DOI 10.1016/j.molcel.2013.02.013; Suzuki M, 2002, DEVELOPMENT, V129, P4171; Tavares L, 2012, CELL, V148, P664, DOI 10.1016/j.cell.2011.12.029; Tolhuis B, 2006, NAT GENET, V38, P694, DOI 10.1038/ng1792; van der Stoop P, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002235; VANDERLUGT NMT, 1994, GENE DEV, V8, P757, DOI 10.1101/gad.8.7.757; Voigt P, 2013, GENE DEV, V27, P1318, DOI 10.1101/gad.219626.113; Voncken JW, 2003, P NATL ACAD SCI USA, V100, P2468, DOI 10.1073/pnas.0434312100; Wang HB, 2004, NATURE, V431, P873, DOI 10.1038/nature02985; Wang L, 2004, MOL CELL, V14, P637, DOI 10.1016/j.molcel.2004.05.009; Wang RJ, 2010, STRUCTURE, V18, P966, DOI 10.1016/j.str.2010.04.013; Wu XD, 2013, MOL CELL, V49, P1134, DOI 10.1016/j.molcel.2013.01.016; Yuan W, 2012, SCIENCE, V337, P971, DOI 10.1126/science.1225237; Zhang JH, 2012, NATURE, V481, P329, DOI 10.1038/nature10733	68	474	486	1	56	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUN 5	2014	157	6					1445	1459		10.1016/j.cell.2014.05.004	http://dx.doi.org/10.1016/j.cell.2014.05.004			15	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	AN8UV	24856970	Green Published, hybrid			2022-12-28	WOS:000340881400019
J	Tsai, KL; Tomomori-Sato, C; Sato, S; Conaway, RC; Conaway, JW; Asturias, FJ				Tsai, Kuang-Lei; Tomomori-Sato, Chieri; Sato, Shigeo; Conaway, Ronald C.; Conaway, Joan W.; Asturias, Francisco J.			Subunit Architecture and Functional Modular Rearrangements of the Transcriptional Mediator Complex	CELL			English	Article							RNA-POLYMERASE-II; HEAD MODULE; YEAST MEDIATOR; MIDDLE MODULE; TAIL MODULE; IN-VIVO; ACTIVATOR; DOMAIN; BINDING; CRSP	The multisubunit Mediator, comprising similar to 30 distinct proteins, plays an essential role in gene expression regulation by acting as a bridge between DNA-binding transcription factors and the RNA polymerase II (RNAPII) transcription machinery. Efforts to uncover the Mediator mechanism have been hindered by a poor understanding of its structure, subunit organization, and conformational rearrangements. By overcoming biochemical and image analysis hurdles, we obtained accurate EM structures of yeast and human Mediators. Subunit localization experiments, docking of partial X-ray structures, and biochemical analyses resulted in comprehensive mapping of yeast Mediator subunits and a complete reinterpretation of our previous Mediator organization model. Large-scale Mediator rearrangements depend on changes at the interfaces between previously described Mediator modules, which appear to be facilitated by factors conducive to transcription initiation. Conservation across eukaryotes of Mediator structure, subunit organization, and RNA polymerase II interaction suggest conservation of fundamental aspects of the Mediator mechanism.	[Tsai, Kuang-Lei; Asturias, Francisco J.] Scripps Res Inst, Dept Integrat Struct & Computat Biol, La Jolla, CA 92037 USA; [Tomomori-Sato, Chieri; Sato, Shigeo; Conaway, Ronald C.; Conaway, Joan W.] Stowers Inst Med Res, Kansas City, MO 64110 USA; [Conaway, Ronald C.; Conaway, Joan W.] Univ Kansas, Med Ctr, Dept Biochem & Mol Biol, Kansas City, KS 66160 USA	Scripps Research Institute; Stowers Institute for Medical Research; University of Kansas; University of Kansas Medical Center	Asturias, FJ (corresponding author), Scripps Res Inst, Dept Integrat Struct & Computat Biol, La Jolla, CA 92037 USA.	asturias@scripps.edu		Tomomori-Sato, Chieri/0000-0002-2543-293X; Conaway, Joan/0000-0002-2786-0663	US National Institutes of Health [R01 GM67167, R01 GM41628]; Helen Nelson Medical Research Fund at the Greater Kansas City Community Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM067167, R01GM041628] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Helen Nelson Medical Research Fund at the Greater Kansas City Community Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by US National Institutes of Health grants R01 GM67167 (F.J.A.) and R01 GM41628 (R. C. C. and J.W.C.) and by a grant to the Stowers Institute from the Helen Nelson Medical Research Fund at the Greater Kansas City Community Foundation. We thank Y. Takagi for providing the plasmid for MBP tagging in yeast, G. C. Lander for critical reading of manuscript, and Patrick Cramer for providing a Med19 Delta yeast strain. We thank T. Otomo for providing the plasmid for HA-tagging in yeast. EM data collection was carried out at the National Resource for Automated Macromolecular Microscopy (NRAMM).	Abmayr Susan M, 2006, Curr Protoc Pharmacol, VChapter 12, DOI [10.1002/0471142727.mb1201s75, 10.1002/0471141755.ph1203s35]; Ansari SA, 2012, EMBO J, V31, P44, DOI 10.1038/emboj.2011.362; Asturias FJ, 1999, SCIENCE, V283, P985, DOI 10.1126/science.283.5404.985; Bahler J, 1998, YEAST, V14, P943, DOI 10.1002/(SICI)1097-0061(199807)14:10<943::AID-YEA292>3.0.CO;2-Y; Baidoobonso SM, 2007, J BIOL CHEM, V282, P5551, DOI 10.1074/jbc.M609484200; Baumli S, 2005, J BIOL CHEM, V280, P18171, DOI 10.1074/jbc.M413466200; Bernecky C, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1000603; Beve J, 2005, J BIOL CHEM, V280, P41366, DOI 10.1074/jbc.M511181200; Bourbon HM, 2008, NUCLEIC ACIDS RES, V36, P3993, DOI 10.1093/nar/gkn349; Brzovic PS, 2011, MOL CELL, V44, P942, DOI 10.1016/j.molcel.2011.11.008; Cai G, 2012, STRUCTURE, V20, P899, DOI 10.1016/j.str.2012.02.023; Cai G, 2010, NAT STRUCT MOL BIOL, V17, P273, DOI 10.1038/nsmb.1757; Cai G, 2009, STRUCTURE, V17, P559, DOI 10.1016/j.str.2009.01.016; Conaway RC, 2013, BBA-GENE REGUL MECH, V1829, P69, DOI 10.1016/j.bbagrm.2012.08.017; Davis JA, 2002, MOL CELL, V10, P409, DOI 10.1016/S1097-2765(02)00598-1; Dotson MR, 2000, P NATL ACAD SCI USA, V97, P14307, DOI 10.1073/pnas.260489497; Ebmeier CC, 2010, P NATL ACAD SCI USA, V107, P11283, DOI 10.1073/pnas.0914215107; Ge K, 2008, MOL CELL BIOL, V28, P1081, DOI 10.1128/MCB.00967-07; Hallberg M, 2006, MOL GENET GENOMICS, V276, P197, DOI 10.1007/s00438-006-0135-7; Hoeppner S, 2005, J MOL BIOL, V350, P833, DOI 10.1016/j.jmb.2005.05.041; Hohn M, 2007, J STRUCT BIOL, V157, P47, DOI 10.1016/j.jsb.2006.07.003; Imasaki T, 2011, NATURE, V475, P240, DOI 10.1038/nature10162; Ito M, 2002, EMBO J, V21, P3464, DOI 10.1093/emboj/cdf348; Kim S, 2013, J BIOL CHEM, V288, P12197, DOI 10.1074/jbc.M112.449553; KIM YJ, 1994, CELL, V77, P599, DOI 10.1016/0092-8674(94)90221-6; Koschubs T, 2010, NUCLEIC ACIDS RES, V38, P3186, DOI 10.1093/nar/gkq029; Koschubs T, 2009, EMBO J, V28, P69, DOI 10.1038/emboj.2008.254; Lariviere L, 2006, NAT STRUCT MOL BIOL, V13, P895, DOI 10.1038/nsmb1143; Lariviere L, 2013, NUCLEIC ACIDS RES, V41, P9266, DOI 10.1093/nar/gkt704; Lariviere L, 2012, NATURE, V492, P448, DOI 10.1038/nature11670; LI Y, 1995, P NATL ACAD SCI USA, V92, P10864, DOI 10.1073/pnas.92.24.10864; Linder T, 2006, BIOCHEM BIOPH RES CO, V349, P948, DOI 10.1016/j.bbrc.2006.08.099; Malik S, 2010, NAT REV GENET, V11, P761, DOI 10.1038/nrg2901; Meyer KD, 2010, NAT STRUCT MOL BIOL, V17, P753, DOI 10.1038/nsmb.1816; Mittler G, 2001, EMBO REP, V2, P808, DOI 10.1093/embo-reports/kve186; Mo XM, 2004, MOL CELL, V13, P241, DOI 10.1016/S1097-2765(03)00521-5; Naar AM, 2002, GENE DEV, V16, P1339, DOI 10.1101/gad.987602; Paoletti AC, 2006, P NATL ACAD SCI USA, V103, P18928, DOI 10.1073/pnas.0606379103; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Reeves WM, 2005, MOL CELL BIOL, V25, P9092, DOI 10.1128/MCB.25.20.9092-9102.2005; Robinson PJJ, 2012, P NATL ACAD SCI USA, V109, P17931, DOI 10.1073/pnas.1215241109; Ryu SJ, 1999, NATURE, V397, P446, DOI 10.1038/17141; Sato S, 2004, MOL CELL, V14, P685, DOI 10.1016/j.molcel.2004.05.006; Sato S, 2003, J BIOL CHEM, V278, P49671, DOI 10.1074/jbc.C300444200; Sato S, 2003, J BIOL CHEM, V278, P15123, DOI 10.1074/jbc.C300054200; Soutourina J, 2011, SCIENCE, V331, P1451, DOI 10.1126/science.1200188; Stevens JL, 2002, SCIENCE, V296, P755, DOI 10.1126/science.1068943; Suloway C, 2005, J STRUCT BIOL, V151, P41, DOI 10.1016/j.jsb.2005.03.010; Taatjes DJ, 2002, SCIENCE, V295, P1058, DOI 10.1126/science.1065249; Taatjes DJ, 2004, NAT STRUCT MOL BIOL, V11, P664, DOI 10.1038/nsmb789; Taatjes DJ, 2010, TRENDS BIOCHEM SCI, V35, P315, DOI 10.1016/j.tibs.2010.02.004; Takahashi H, 2011, CELL, V146, P92, DOI 10.1016/j.cell.2011.06.005; Thakur JK, 2009, J BIOL CHEM, V284, P4422, DOI 10.1074/jbc.M808263200; Tsai KL, 2013, NAT STRUCT MOL BIOL, V20, P611, DOI 10.1038/nsmb.2549; Vojnic E, 2011, NAT STRUCT MOL BIOL, V18, P404, DOI 10.1038/nsmb.1997; Zhang F, 2004, MOL CELL BIOL, V24, P6871, DOI 10.1128/mcb.24.15.6871-6886.2004	56	142	146	0	32	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUN 5	2014	157	6					1430	1444		10.1016/j.cell.2014.05.015	http://dx.doi.org/10.1016/j.cell.2014.05.015			15	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	AN8UV	24882805	Green Accepted, Bronze			2022-12-28	WOS:000340881400018
J	Weber, ME; Clark, PU; Kuhn, G; Timmermann, A; Sprenk, D; Gladstone, R; Zhang, X; Lohmann, G; Menviel, L; Chikamoto, MO; Friedrich, T; Ohlwein, C				Weber, M. E.; Clark, P. U.; Kuhn, G.; Timmermann, A.; Sprenk, D.; Gladstone, R.; Zhang, X.; Lohmann, G.; Menviel, L.; Chikamoto, M. O.; Friedrich, T.; Ohlwein, C.			Millennial-scale variability in Antarctic ice-sheet discharge during the last deglaciation	NATURE			English	Article							PINE ISLAND GLACIER; SOUTHERN-OCEAN; WEDDELL SEA; SCOTIA SEA; RADIOCARBON CONSTRAINTS; CIRCUMPOLAR CURRENT; RETREAT; CORE; CHRONOLOGY; MAXIMUM	Our understanding of the deglacial evolution of the Antarctic Ice Sheet (AIS) following the Last Glacial Maximum(26,000-19,000 years ago)(1) is based largely on a few well-dated but temporally and geographically restricted terrestrial and shallow-marine sequences(2-4). This sparseness limits our understanding of the dominant feedbacks between the AIS, Southern Hemisphere climate and global sea level. Marine records of iceberg-rafted debris (IBRD) provide a nearly continuous signal of ice-sheet dynamics and variability. IBRD records from the North Atlantic Ocean have been widely used to reconstruct variability in Northern Hemisphere ice sheets(5), but comparable records from the Southern Ocean of the AIS are lacking because of the low resolution and large dating uncertainties in existing sediment cores. Here we present two well-dated, high-resolution IBRD records that capture a spatially integrated signal of AIS variability during the last deglaciation. We document eight events of increased iceberg flux from various parts of the AIS between 20,000 and 9,000 years ago, in marked contrast to previous scenarios which identified the main AIS retreat as occurring after meltwater pulse 1A(3,6-8) and continuing into the late Holocene epoch. The highest IBRD flux occurred 14,600 years ago, providing the first direct evidence for an Antarctic contribution to meltwater pulse 1A. Climate model simulations with AIS freshwater forcing identify a positive feedback between poleward transport of Circumpolar Deep Water, subsurface warming and AIS melt, suggesting that small perturbations to the ice sheet can be substantially enhanced, providing a possible mechanism for rapid sea-level rise.	[Weber, M. E.; Sprenk, D.] Univ Cologne, Inst Geol & Mineral, D-50935 Cologne, Germany; [Clark, P. U.] Oregon State Univ, Coll Earth Ocean & Atmospher Sci, Corvallis, OR 97331 USA; [Kuhn, G.; Zhang, X.; Lohmann, G.] Alfred Wegener Inst Helmholtz Zentrum Polar & Mee, D-27568 Bremerhaven, Germany; [Timmermann, A.; Chikamoto, M. O.; Friedrich, T.] Univ Hawaii Manoa, Int Pacific Res Ctr, Sch Ocean & Earth Sci & Technol, Honolulu, HI 96822 USA; [Gladstone, R.] Univ Lapland, Arctic Ctr, Rovaniemi 96101, Finland; [Menviel, L.] Univ New S Wales, Climate Change Res Ctr, Sydney, NSW 2052, Australia; [Menviel, L.] Univ New S Wales, ARC Ctr Excellence Climate Syst Sci, Sydney, NSW 2052, Australia; [Ohlwein, C.] Univ Bonn, Hans Ertel Ctr Weather Res, Climate Monitoring Branch, Inst Meteorol, D-53121 Bonn, Germany	University of Cologne; Oregon State University; Helmholtz Association; Alfred Wegener Institute, Helmholtz Centre for Polar & Marine Research; University of Hawaii System; University of Hawaii Manoa; University of Lapland; University of New South Wales Sydney; ARC Centre of Excellence for Climate System Science; University of New South Wales Sydney; University of Bonn	Weber, ME (corresponding author), Univ Cologne, Inst Geol & Mineral, Zuelpicher Str 49a, D-50935 Cologne, Germany.	michael.weber@uni-koeln.de	Menviel, Laurie/O-7833-2019; Gladstone, Rupert/C-1086-2013; Friedrich, Tobias/D-1053-2013; Zhang, Xu/AFX-8847-2022; Lohmann, Gerrit/M-7453-2016; Timmermann, Axel/F-4977-2011; Timmermann, Axel/Y-2799-2019; Menviel, Laurie/D-6902-2013	Gladstone, Rupert/0000-0002-1582-3857; Friedrich, Tobias/0000-0001-7324-4100; Zhang, Xu/0000-0003-1833-9689; Lohmann, Gerrit/0000-0003-2089-733X; Timmermann, Axel/0000-0003-0657-2969; Timmermann, Axel/0000-0003-0657-2969; Menviel, Laurie/0000-0002-5068-1591; Kuhn, Gerhard/0000-0001-6069-7485; Weber, Michael E/0000-0003-2175-8980	Deutsche Forschungsgemeinschaft (DFG) [We2039/7-1, Ri525/17-1, Ku683/9-1]; University of Cologne; US NSF Antarctic Glaciology Program [ANT-1043517, ANT-1341311]; US NSF Paleoclimatology Program; Japan Agency for Marine-Earth Science and Technology; Helmholtz funding through the Polar Regions and Coasts in the changing Earth System (PACES) programme; Div Atmospheric & Geospace Sciences [1010869] Funding Source: National Science Foundation	Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); University of Cologne; US NSF Antarctic Glaciology Program(National Science Foundation (NSF)NSF - Directorate for Geosciences (GEO)); US NSF Paleoclimatology Program; Japan Agency for Marine-Earth Science and Technology; Helmholtz funding through the Polar Regions and Coasts in the changing Earth System (PACES) programme; Div Atmospheric & Geospace Sciences(National Science Foundation (NSF)NSF - Directorate for Geosciences (GEO))	We acknowledge support from the Deutsche Forschungsgemeinschaft (DFG grant numbers We2039/7-1, Ri525/17-1 and Ku683/9-1 to M. E. W. and G. K.), the University of Cologne (to M. E. W.), the US NSF Antarctic Glaciology Program (grant numbers ANT-1043517 to P. U. C. and ANT-1341311 to A. T.), the US NSF Paleoclimatology Program and the Japan Agency for Marine-Earth Science and Technology (to A. T.), and Helmholtz funding through the Polar Regions and Coasts in the changing Earth System (PACES) programme (to X.Z., G. L. and G. K.). Our study was also part of the Southern Ocean Initiative of the International Marine Past Global Change Study (IMAGES) program. We thank W. F. Budd for comments on Antarctic ice-sheet dynamics, and M. Winstrup and S. Rasmussen for advice on comparing ice-core chronologies. Experiments with the Bern3D were performed in the Department of Climate and Environmental Physics, University of Bern, and with funding through the Oeschger Center for Climate Change.	Andersen KK, 2004, NATURE, V431, P147, DOI 10.1038/nature02805; Anderson JB, 1999, GEOLOGY, V27, P179, DOI 10.1130/0091-7613(1999)027<0179:RCOISA>2.3.CO;2; Anderson RF, 2009, SCIENCE, V323, P1443, DOI 10.1126/science.1167441; Barbante C, 2006, NATURE, V444, P195, DOI 10.1038/nature05301; Bard E, 2010, SCIENCE, V327, P1235, DOI 10.1126/science.1180557; Bentley MJ, 2010, GEOLOGY, V38, P411, DOI 10.1130/G30754.1; Bintanja R, 2013, NAT GEOSCI, V6, P376, DOI [10.1038/NGEO1767, 10.1038/ngeo1767]; BOND GC, 1995, SCIENCE, V267, P1005, DOI 10.1126/science.267.5200.1005; Clark PU, 2009, SCIENCE, V325, P710, DOI 10.1126/science.1172873; Clark PU, 2002, SCIENCE, V295, P2438; Conway H, 1999, SCIENCE, V286, P280, DOI 10.1126/science.286.5438.280; Deschamps P, 2012, NATURE, V483, P559, DOI 10.1038/nature10902; Diekmann B, 2000, PALAEOGEOGR PALAEOCL, V162, P357, DOI 10.1016/S0031-0182(00)00138-3; Fischer H, 2007, EARTH PLANET SC LETT, V260, P340, DOI 10.1016/j.epsl.2007.06.014; Galton-Fenzi BK, 2012, J GEOPHYS RES-OCEANS, V117, DOI 10.1029/2012JC008214; Gladstone RM, 2001, J GEOPHYS RES-OCEANS, V106, P19903, DOI 10.1029/2000JC000347; Gladstone RM, 2012, EARTH PLANET SC LETT, V333, P191, DOI 10.1016/j.epsl.2012.04.022; Golledge NR, 2012, P NATL ACAD SCI USA, V109, P16052, DOI 10.1073/pnas.1205385109; Grobe H., 1987, POLARFORSCHUNG, V57, P123, DOI DOI 10.2312/P0LARF0RSCHUNG.57.3.123; Hall BL, 2000, GEOGR ANN A, V82A, P305, DOI 10.1111/j.0435-3676.2000.00127.x; Hellmer HH, 2012, NATURE, V485, P225, DOI 10.1038/nature11064; Heroy DC, 2007, QUATERNARY SCI REV, V26, P3286, DOI 10.1016/j.quascirev.2007.07.012; Hofmann A., 1999, THESIS U BREMEN; Jacka TH, 2007, J GLACIOL, V53, P341, DOI 10.3189/002214307783258521; Jansen JHF, 1998, MAR GEOL, V151, P143, DOI 10.1016/S0025-3227(98)00074-7; Jenkins A, 2010, NAT GEOSCI, V3, P468, DOI 10.1038/NGEO890; Kanfoush SL, 2000, SCIENCE, V288, P1815, DOI 10.1126/science.288.5472.1815; Kirshner AE, 2012, QUATERNARY SCI REV, V38, P11, DOI 10.1016/j.quascirev.2012.01.017; Knorr G, 2011, GEOPHYS RES LETT, V38, DOI 10.1029/2011GL048873; Lamy F, 2014, SCIENCE, V343, P403, DOI 10.1126/science.1245424; Lemieux-Dudon B, 2010, QUATERNARY SCI REV, V29, P8, DOI 10.1016/j.quascirev.2009.11.010; Leventer A., 2006, GSA TODAY GEOL SOC A, V16, P4, DOI [10.1130/GSAT01612A.1, DOI 10.1130/GSAT01612A.1]; LISIECKI LE, 2005, PALEOCEANOGRAPHY, V0020; Lourantou A, 2010, GLOBAL BIOGEOCHEM CY, V24, DOI 10.1029/2009GB003545; Mackintosh A, 2011, NAT GEOSCI, V4, P195, DOI 10.1038/NGEO1061; Marshall SJ, 2006, PALEOCEANOGRAPHY, V21, DOI 10.1029/2005PA001247; Martinez-Garcia A, 2011, NATURE, V476, P312, DOI 10.1038/nature10310; Mckay RM, 2008, PALAEOGEOGR PALAEOCL, V260, P245, DOI 10.1016/j.palaeo.2007.08.015; Menviel L, 2012, PALEOCEANOGRAPHY, V27, DOI 10.1029/2011PA002224; Menviel L, 2010, PALEOCEANOGRAPHY, V25, DOI 10.1029/2009PA001892; Menviel L, 2008, PALEOCEANOGRAPHY, V23, DOI 10.1029/2008PA001604; MULLER PJ, 1993, DEEP-SEA RES PT I, V40, P425, DOI 10.1016/0967-0637(93)90140-X; Nakada M, 2000, MAR GEOL, V167, P85, DOI 10.1016/S0025-3227(00)00018-9; Nielsen SHH, 2007, GEOCHEM GEOPHY GEOSY, V8, DOI 10.1029/2007GC001618; Parrenin F, 2007, CLIM PAST, V3, P485, DOI 10.5194/cp-3-485-2007; Peltier WR, 2006, QUATERNARY SCI REV, V25, P3322, DOI 10.1016/j.quascirev.2006.04.010; Peltier WR, 2004, ANNU REV EARTH PL SC, V32, P111, DOI 10.1146/annurev.earth.32.082503.144359; Pierce EL, 2011, PALEOCEANOGRAPHY, V26, DOI 10.1029/2011PA002127; Price SF, 2007, J GEOPHYS RES-EARTH, V112, DOI 10.1029/2006JF000725; Pritchard HD, 2012, NATURE, V484, P502, DOI 10.1038/nature10968; Pudsey CJ, 1998, MAR GEOL, V148, P83, DOI 10.1016/S0025-3227(98)00014-0; Pugh RS, 2009, EARTH PLANET SC LETT, V284, P113, DOI 10.1016/j.epsl.2009.04.016; Rasmussen SO, 2006, J GEOPHYS RES-ATMOS, V111, DOI 10.1029/2005JD006079; Richter TO, 2006, GEOL SOC SPEC PUBL, V267, P39, DOI 10.1144/GSL.SP.2006.267.01.03; Ritz SP, 2011, J CLIMATE, V24, P349, DOI 10.1175/2010JCLI3351.1; Rosen P, 2010, J PALEOLIMNOL, V43, P247, DOI 10.1007/s10933-009-9329-4; Roy M, 2007, CHEM GEOL, V244, P507, DOI 10.1016/j.chemgeo.2007.07.017; Ruth U, 2007, CLIM PAST, V3, P475, DOI 10.5194/cp-3-475-2007; Schmitt J, 2012, SCIENCE, V336, P711, DOI 10.1126/science.1217161; Schodlok MP, 2006, J GEOPHYS RES-OCEANS, V111, DOI 10.1029/2004JC002661; Silva TAM, 2006, J GEOPHYS RES-OCEANS, V111, DOI 10.1029/2004JC002843; Simms AR, 2011, QUATERNARY SCI REV, V30, P1583, DOI 10.1016/j.quascirev.2011.03.018; Smith JA, 2010, EARTH PLANET SC LETT, V296, P287, DOI 10.1016/j.epsl.2010.05.008; Sprenk D, 2013, GEOL SOC SPEC PUBL, V381, P245, DOI 10.1144/SP381.17; Stuart KM, 2011, DEEP-SEA RES PT II, V58, P1285, DOI 10.1016/j.dsr2.2010.11.004; Timm O, 2008, PALEOCEANOGRAPHY, V23, DOI 10.1029/2007PA001461; Timmermann A, 2009, J CLIMATE, V22, P1626, DOI 10.1175/2008JCLI2161.1; Toggweiler JR, 2008, NATURE, V451, P286, DOI 10.1038/nature06590; Toggweiler JR, 2010, PALEOCEANOGRAPHY, V25, DOI 10.1029/2009PA001758; Veres D, 2013, CLIM PAST, V9, P1733, DOI 10.5194/cp-9-1733-2013; Veres D., 2012, CLIM PAST DISCUSS, V8, P6011, DOI DOI 10.5194/CPD-8-6011-2012; Weber ME, 2012, QUATERNARY SCI REV, V36, P177, DOI 10.1016/j.quascirev.2012.01.016; Weber ME, 2010, GEOCHEM GEOPHY GEOSY, V11, DOI 10.1029/2009GC002611; Weber ME, 1998, DEEP-SEA RES PT I, V45, P1955, DOI 10.1016/S0967-0637(98)00028-4; Weber ME, 1997, MAR GEOL, V136, P151, DOI 10.1016/S0025-3227(96)00071-0; Weber ME, 2011, SCIENCE, V334, P1265, DOI 10.1126/science.1209299; Wei W, 2012, J PHYS OCEANOGR, V42, P785, DOI 10.1175/JPO-D-11-038.1; White DA, 2011, GEOLOGY, V39, P23, DOI 10.1130/G31591.1; Williams T, 2010, EARTH PLANET SC LETT, V290, P351, DOI 10.1016/j.epsl.2009.12.031; Yoon HI, 2007, DEEP-SEA RES PT II, V54, P2367, DOI 10.1016/j.dsr2.2007.07.019; Zhang X, 2013, CLIM PAST, V9, P2319, DOI 10.5194/cp-9-2319-2013	81	137	145	3	139	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 5	2014	510	7503					134	+		10.1038/nature13397	http://dx.doi.org/10.1038/nature13397			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI3NR	24870232				2022-12-28	WOS:000336768900043
J	Feltner, C; Jones, CD; Cene, CW; Zheng, ZJ; Sueta, CA; Coker-Schwimmer, EJL; Arvanitis, M; Lohr, KN; Middleton, JC; Jonas, DE				Feltner, Cynthia; Jones, Christine D.; Cene, Crystal W.; Zheng, Zhi-Jie; Sueta, Carla A.; Coker-Schwimmer, Emmanuel J. L.; Arvanitis, Marina; Lohr, Kathleen N.; Middleton, Jennifer C.; Jonas, Daniel E.			Transitional Care Interventions to Prevent Readmissions for Persons With Heart Failure A Systematic Review and Meta-analysis	ANNALS OF INTERNAL MEDICINE			English	Review							RANDOMIZED CONTROLLED-TRIAL; HOME-BASED INTERVENTION; ACUTE MYOCARDIAL-INFARCTION; DISEASE MANAGEMENT PROGRAM; MULTIDISCIPLINARY CARE; SELF-CARE; ELDERLY-PATIENTS; HIGH-RISK; HOSPITAL DISCHARGE; CLINICAL-OUTCOMES	Background: Nearly 25% of patients hospitalized with heart failure (HF) are readmitted within 30 days. Purpose: To assess the efficacy, comparative effectiveness, and harms of transitional care interventions to reduce readmission and mortality rates for adults hospitalized with HF. Data Sources: MEDLINE, Cochrane Library, CINAHL, ClinicalTrials.gov, and World Health Organization International Clinical Trials Registry Platform (1 January 1990 to late October 2013). Study Selection: Two reviewers independently selected randomized, controlled trials published in English reporting a readmission or mortality rate within 6 months of an index hospitalization. Data Extraction: One reviewer extracted data, and another checked accuracy. Two reviewers assessed risk of bias and graded strength of evidence (SOE). Data Synthesis: Forty-seven trials were included. Most enrolled adults with moderate to severe HF and a mean age of 70 years. Few trials reported 30-day readmission rates. At 30 days, a high-intensity home-visiting program reduced all-cause readmission and the composite end point (all-cause readmission or death; low SOE). Over 3 to 6 months, home-visiting programs and multidisciplinary heart failure (MDS-HF) clinic interventions reduced all-cause readmission (high SOE). Home-visiting programs reduced HF-specific readmission and the composite end point (moderate SOE). Structured telephone support (STS) interventions reduced HF-specific readmission (high SOE) but not all-cause readmissions (moderate SOE). Home-visiting programs, MDS-HF clinics, and STS interventions produced a mortality benefit. Neither telemonitoring nor primarily educational interventions reduced readmission or mortality rates. Limitations: Few trials reported 30-day readmission rates. Usual care was heterogeneous and sometimes not adequately described. Conclusion: Home-visiting programs and MDS-HF clinics reduced all-cause readmission and mortality; STS reduced HF-specific readmission and mortality. These interventions should receive the greatest consideration by systems or providers seeking to implement transitional care interventions for persons with HF.	Univ N Carolina, Chapel Hill, NC 27599 USA; Cecil G Sheps Ctr Hlth Serv Res, Chapel Hill, NC USA; Univ Colorado, Aurora, CO USA; [Lohr, Kathleen N.] RTI Int, Res Triangle Pk, NC 27709 USA; [Zheng, Zhi-Jie] RTI Int, Rockville, MD 20852 USA	University of North Carolina; University of North Carolina Chapel Hill; University of Colorado System; University of Colorado Anschutz Medical Campus; Research Triangle Institute; Research Triangle Institute	Feltner, C (corresponding author), Univ N Carolina, Dept Med, 5034 Old Clin Bldg,CB 7110, Chapel Hill, NC 27599 USA.	cindy_feltner@med.unc.edu	Sueta, Carla/AAH-8100-2021	Arvanitis, Marina/0000-0002-2186-5164; Lohr, Kathleen/0000-0002-3825-0713	AHRQ [HHSA290201200008I]; U.S. Department of Health and Human Services [HHSA29032003T]	AHRQ(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); U.S. Department of Health and Human Services	In part by AHRQ (grant HHSA290201200008I) and the U.S. Department of Health and Human Services (contract HHSA29032003T).	Alberta NM, 2007, PATIENT EDUC COUNS, V69, P129, DOI 10.1016/j.pec.2007.08.007; Allen LA, 2012, CIRC-HEART FAIL, V5, P672, DOI 10.1161/CIRCHEARTFAILURE.112.967356; Angermann CE, 2012, CIRC-HEART FAIL, V5, P25, DOI 10.1161/CIRCHEARTFAILURE.111.962969; Barth V, 2001, HOME HLTH CARE MAN P, V13, P436; Benatar D, 2003, ARCH INTERN MED, V163, P347, DOI 10.1001/archinte.163.3.347; Bernheim SM, 2010, CIRC-CARDIOVASC QUAL, V3, P459, DOI 10.1161/CIRCOUTCOMES.110.957613; Bueno H, 2010, JAMA-J AM MED ASSOC, V303, P2141, DOI 10.1001/jama.2010.748; Centers for Medicaid and Medicare Services, 2013, READM RED PROGR; Centers for Medicare & Medicaid Services Office of Information Services, 2006, MED RANK ALL SHORT S; Coleman EA, 2003, J AM GERIATR SOC, V51, P556, DOI 10.1046/j.1532-5415.2003.51186.x; Dar O, 2009, EUR J HEART FAIL, V11, P319, DOI 10.1093/eurjhf/hfn050; Davis KK, 2012, EUR J HEART FAIL, V14, P1041, DOI 10.1093/eurjhf/hfs096; Dendale P, 2012, EUR J HEART FAIL, V14, P333, DOI 10.1093/eurjhf/hfr144; Dharmarajan K, 2013, JAMA-J AM MED ASSOC, V309, P355, DOI 10.1001/jama.2012.216476; Domingues FB, 2011, ARQ BRAS CARDIOL, V96, P233, DOI 10.1590/S0066-782X2011005000014; Ducharme A, 2005, CAN MED ASSOC J, V173, P40, DOI 10.1503/cmaj.1041137; Duffy JR, 2010, J NURS CARE QUAL, V25, P56, DOI 10.1097/NCQ.0b013e3181ad0fbd; Dunagan WC, 2005, J CARD FAIL, V11, P358, DOI 10.1016/j.cardfail.2004.12.004; Ekman I, 1998, EUR HEART J, V19, P1254, DOI 10.1053/euhj.1998.1095; Feltner C, 2014, TRANSITIONA IN PRESS; Goldberg LR, 2003, AM HEART J, V146, P705, DOI 10.1016/S0002-8703(03)00393-4; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; Holland R, 2007, BRIT MED J, V334, P1098, DOI 10.1136/bmj.39164.568183.AE; Inglis SC, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD007228.pub2; Irabrgui BAE, 2007, REV ESP CARDIOL, V60, P914, DOI 10.1157/13109644; Jaarsma T, 1999, EUR HEART J, V20, P673, DOI 10.1053/euhj.1998.1341; Jencks SF, 2009, NEW ENGL J MED, V360, P1418, DOI 10.1056/NEJMsa0803563; Jerant AF, 2001, MED CARE, V39, P1234, DOI 10.1097/00005650-200111000-00010; Jerant Anthony F, 2003, Home Health Care Serv Q, V22, P1, DOI 10.1300/J027v22n01_01; Kasper EK, 2002, J AM COLL CARDIOL, V39, P471, DOI 10.1016/S0735-1097(01)01761-2; Kimmelstiel C, 2004, CIRCULATION, V110, P1450, DOI 10.1161/01.CIR.0000141562.22216.00; Kociol RD, 2012, CIRC-HEART FAIL, V5, P680, DOI 10.1161/CIRCHEARTFAILURE.112.967406; Koelling TM, 2005, CIRCULATION, V111, P179, DOI 10.1161/01.CIR.0000151811.53450.B8; Kwok T, 2008, J CLIN NURS, V17, P109, DOI 10.1111/j.1365-2702.2007.01978.x; Laramee AS, 2003, ARCH INTERN MED, V163, P809, DOI 10.1001/archinte.163.7.809; Ledwidge M, 2003, EUR J HEART FAIL, V5, P381, DOI 10.1016/S1388-9842(02)00235-0; Linne Agneta Bjorck, 2006, BMC Cardiovasc Disord, V6, P30, DOI 10.1186/1471-2261-6-30; Liu MH, 2012, INT HEART J, V53, P11, DOI 10.1536/ihj.53.11; Lopez Cabezas C, 2006, Farm Hosp, V30, P328; McDonald K, 2002, J CARD FAIL, V8, P142, DOI 10.1054/jcaf.2002.124340; McDonald K, 2001, EUR J HEART FAIL, V3, P209, DOI 10.1016/S1388-9842(00)00134-3; Naylor MD, 2011, HEALTH AFFAIR, V30, P746, DOI 10.1377/hlthaff.2011.0041; Naylor MD, 2004, J AM GERIATR SOC, V52, P675, DOI 10.1111/j.1532-5415.2004.52202.x; Nucifora G, 2006, J CARDIOVASC MED, V7, P614, DOI 10.2459/01.JCM.0000237910.34000.58; Oddone E Z, 1999, Eff Clin Pract, V2, P201; Owens DK, 2010, J CLIN EPIDEMIOL, V63, P513, DOI 10.1016/j.jclinepi.2009.03.009; Pandor A, 2013, HEART, V99, P1717, DOI 10.1136/heartjnl-2013-303811; Pekmezaris R, 2012, TELEMED E-HEALTH, V18, P101, DOI 10.1089/tmj.2011.0095; Pugh LC., 2001, MEDSURG NURS, V10, P71; Rainville EC, 1999, AM J HEALTH-SYST PH, V56, P1339, DOI 10.1093/ajhp/56.13.1339; Raman G, 2008, NONPHARMACOLOGIC INT; RICH MW, 1993, J GEN INTERN MED, V8, P585, DOI 10.1007/BF02599709; RICH MW, 1995, NEW ENGL J MED, V333, P1190, DOI 10.1056/NEJM199511023331806; Riegel B, 2006, J CARD FAIL, V12, P211, DOI 10.1016/j.cardfail.2006.01.005; Riegel B, 2002, ARCH INTERN MED, V162, P705, DOI 10.1001/archinte.162.6.705; Riegel Barbara, 2004, J Cardiovasc Nurs, V19, P174; Schu nemann HJ, 2011, COCHRANE HDB SYSTEMA; Schwarz Karen A, 2008, Prog Cardiovasc Nurs, V23, P18, DOI 10.1111/j.1751-7117.2008.tb00527.x; Sethares KA, 2004, HEART LUNG, V33, P249, DOI 10.1016/j.hrtlng.2004.03.005; Stauffer BD, 2011, ARCH INTERN MED, V171, P1238, DOI 10.1001/archinternmed.2011.274; Stewart S, 1999, LANCET, V354, P1077, DOI 10.1016/S0140-6736(99)03428-5; Stewart S, 1998, ARCH INTERN MED, V158, P1067, DOI 10.1001/archinte.158.10.1067; Stromberg A, 2003, EUR HEART J, V24, P1014, DOI 10.1016/S0195-668X(03)00112-X; Sutton AJ, 2002, STAT MED, V21, P1539; Takeda A, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD002752.pub3; Thompson DR, 2005, EUR J HEART FAIL, V7, P377, DOI 10.1016/j.ejheart.2004.10.008; Triller DM, 2007, AM J HEALTH-SYST PH, V64, P2244, DOI 10.2146/ajhp050492; Tsuyuki RT, 2004, J CARD FAIL, V10, P473, DOI 10.1016/j.cardfail.2004.02.005; Viswanathan M AM, 2012, METHODS GUIDE EFFECT; Wakefield BJ, 2008, TELEMED J E-HEALTH, V14, P753, DOI 10.1089/tmj.2007.0131; Wakefield BJ, 2009, J TELEMED TELECARE, V15, P46, DOI 10.1258/jtt.2008.080701; Woodend AK, 2008, HEART LUNG, V37, P36, DOI 10.1016/j.hrtlng.2007.04.004	72	427	441	7	122	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JUN 3	2014	160	11					774	+		10.7326/M14-0083	http://dx.doi.org/10.7326/M14-0083			19	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	AJ0MT	24862840	Green Submitted			2022-12-28	WOS:000337348700004
J	Garza, U; Gayer, C				Garza, Ulises; Gayer, Christopher			Gastric Emphysema	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Garza, Ulises; Gayer, Christopher] Childrens Hosp Los Angeles, Los Angeles, CA 90027 USA	Children's Hospital Los Angeles	Garza, U (corresponding author), Childrens Hosp Los Angeles, Los Angeles, CA 90027 USA.	cgayer@chla.usc.edu	Serna, Ulises Garza/AAB-5927-2019						0	0	0	0	2	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAY 29	2014	370	22					E33	E33		10.1056/NEJMicm1310201	http://dx.doi.org/10.1056/NEJMicm1310201			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	AH9BM	24869741				2022-12-28	WOS:000336434000001
J	Tallis, R				Tallis, Ray			Assisted dying is not the same as euthanasia	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												raymond@rtallis.wanadoo.co.uk						Hartropp P., 2014, BMJ; YouGov, 2013, YOU GOV DIGN DYING S	2	2	2	0	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	MAY 28	2014	348								g3532	10.1136/bmj.g3532	http://dx.doi.org/10.1136/bmj.g3532			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AI3EH	24871316				2022-12-28	WOS:000336742000009
J	Manns, M; Marcellin, P; Poordad, F; de Araujo, ESA; Buti, M; Horsmans, Y; Janczewska, E; Villamil, F; Scott, J; Peeters, M; Lenz, O; Ouwerkerk-Mahadevan, S; De La Rosa, G; Kalmeijer, R; Sinha, R; Beumont-Mauviel, M				Manns, Michael; Marcellin, Patrick; Poordad, Fred; Affonso de Araujo, Evaldo Stanislau; Buti, Maria; Horsmans, Yves; Janczewska, Ewa; Villamil, Federico; Scott, Jane; Peeters, Monika; Lenz, Oliver; Ouwerkerk-Mahadevan, Sivi; De La Rosa, Guy; Kalmeijer, Ronald; Sinha, Rekha; Beumont-Mauviel, Maria			Simeprevir with pegylated interferon alfa 2a or 2b plus ribavirin in treatment-naive patients with chronic hepatitis C virus genotype 1 infection (QUEST-2): a randomised, double-blind, placebo-controlled phase 3 trial	LANCET			English	Article							SUSTAINED VIROLOGICAL RESPONSE; ONCE-DAILY TMC435; PEGINTERFERON ALPHA-2B; TRIPLE THERAPY; IN-VITRO; ONE PILL; TELAPREVIR; BOCEPREVIR; ASSOCIATION; MANAGEMENT	Background Pegylated interferon (peginterferon) alfa 2a or 2b plus ribavirin regimens were the standard of care in patients with hepatitis C virus (HCV) infection, but the sustained virological response can be suboptimum in patients with HCV genotype 1 infection. The efficacy, safety, and tolerability of the combination of simeprevir, a one-pill, once-daily, oral HCV NS3/4A protease inhibitor versus placebo, plus peginterferon alfa 2a or 2b plus ribavirin was assessed in treatment-naive patients with HCV genotype 1 infection. Methods In the QUEST-2, phase 3 study, done at 76 sites in 14 countries (Europe, and North and South Americas), patients with confirmed chronic HCV genotype 1 infection and no history of HCV treatment were randomly assigned with a computer-generated allocation sequence in a ratio of 2: 1 and stratified by HCV genotype 1 subtype and host IL28B genotype to receive simeprevir (150 mg once daily, orally), peginterferon alfa 2a (180 mu g once weekly, subcutaneous injection) or 2b (according to bodyweight; 50 mu g, 80 mu g, 100 mu g, 120 mu g, or 150 mu g once weekly, subcutaneous injection), plus ribavirin (1000-1200 mg/day or 800-1400 mg/day, orally; simeprevir group) or placebo (once daily, orally), peginterferon alfa 2a or 2b, plus ribavirin (placebo group) for 12 weeks, followed by just peginterferon alfa 2a or 2b plus ribavirin. Total treatment duration was 24 weeks or 48 weeks (simeprevir group) based on criteria for response-guided therapy (ie, HCV RNA <25 IU/mL undetectable or detectable at week 4 and undetectable week 12) or 48 weeks (placebo). Patients, study personnel, and the sponsor were masked to treatment assignment. The primary efficacy endpoint was sustained virological response at 12 weeks after the planned end of treatment (SVR12). Analyses were by intention to treat. The trial is registered with ClinicalTrials.gov, number NCT01290679. Results from the primary (SVR12, week 60) analysis are presented. Findings 209 (81%) of 257 patients in the simeprevir group and 67 (50%) of 134 in the placebo group had SVR12 (adjusted difference 32.2%, 95% CI 23.3-41.2; p<0.0001). The incidences of adverse events were similar in the simeprevir and placebo groups at 12 weeks (246 [96%] vs 130 [97%]) and for the entire treatment (249 [97%] vs 132 [99%]), irrespective of the peginterferon alfa used. The most common adverse events were headache, fatigue, pyrexia, and influenza-like illness at 12 weeks (95 [37%) vs 45 [34%], 89 [35%] vs 52 [39%], 78 [30%] vs 48 [36%], and 66 [26%] vs 34 [25%], respectively) and for the entire treatment (100 [39%] vs 49 [37%], 94 [37%] vs 56 [42%], 79 [31%] vs 53 [40%], and 66 [26%] vs 35 [26%], respectively). Rash and photosensitivity frequencies were higher in the simeprevir group than in the placebo group (61 [24%] vs 15 [11%] and ten [4%] vs one [<1%], respectively). There was no difference in the prevalence of anaemia between the simeprevir and placebo groups (35 [14%] vs 21 [16%], respectively, at 12 weeks, and 53 [21%] vs 37 [28%], respectively, during the entire treatment). Interpretation Addition of simeprevir to either peginterferon alfa 2a or peginterferon alfa 2b plus ribavirin improved SVR in treatment-naive patients with HCV genotype 1 infection, without worsening the known adverse events associated with peginterferon alfa plus ribavirin.	[Manns, Michael] Hannover Med Sch, Dept Gastroenterol Hepatol & Endocrinol, D-30625 Hannover, Germany; [Marcellin, Patrick] Univ Paris Diderot, Hop Beaujon, Serv Hepatol, Clichy, France; [Marcellin, Patrick] Hop Beaujon, INSERM, CRB3, Clichy, France; [Poordad, Fred] Univ Texas Hlth Sci Ctr San Antonio, Texas Liver Inst, San Antonio, TX 78229 USA; [Affonso de Araujo, Evaldo Stanislau] Univ Sao Paulo, Hosp Clin, Fac Med, Sch Med,LIM 47, Sao Paulo, Brazil; [Buti, Maria] Hosp Valle De Hebron, Barcelona, Spain; [Buti, Maria] Ciberhed Inst Carlos III, Barcelona, Spain; [Horsmans, Yves] Univ Catholique Louvain St Luc, Brussels, Belgium; [Janczewska, Ewa] ID Clin, Myslowice, Poland; [Villamil, Federico] CIPREC, Buenos Aires, DF, Argentina; [Scott, Jane] Janssen Global Serv, High Wycombe, Bucks, England; [Peeters, Monika; Lenz, Oliver; Sinha, Rekha; Beumont-Mauviel, Maria] Janssen Infect Dis, Beerse, Belgium; [Ouwerkerk-Mahadevan, Sivi] Janssen Res & Dev, Beerse, Belgium; [De La Rosa, Guy; Sinha, Rekha] Janssen Global Serv, Titusville, NJ USA	Hannover Medical School; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Beaujon - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Beaujon - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; University of Texas System; University of Texas Health San Antonio; Universidade de Sao Paulo; Hospital Universitari Vall d'Hebron; Universite Catholique Louvain; Cliniques Universitaires Saint-Luc; Johnson & Johnson; Janssen Pharmaceuticals	Manns, M (corresponding author), Hannover Med Sch, Dept Gastroenterol Hepatol & Endocrinol, Carl Neuberg Str 1, D-30625 Hannover, Germany.	manns.michael@mh-hannover.de	Janczewska, Ewa/J-7231-2015	Janczewska, Ewa/0000-0002-5406-4603; Buti Ferret, Maria/0000-0002-0732-3078	Janssen Infectious Diseases-Diagnostics	Janssen Infectious Diseases-Diagnostics	Janssen Infectious Diseases-Diagnostics.	Asselah T, 2012, LIVER INT, V32, P88, DOI 10.1111/j.1478-3231.2011.02699.x; Awad T, 2010, HEPATOLOGY, V51, P1176, DOI 10.1002/hep.23504; Bacon BR, 2011, NEW ENGL J MED, V364, P1207, DOI 10.1056/NEJMoa1009482; Barritt AS, 2012, GASTROENTEROLOGY, V142, P1314, DOI 10.1053/j.gastro.2012.02.013; Bedossa P, 1996, HEPATOLOGY, V24, P289, DOI 10.1002/hep.510240201; Bota S, 2013, CLIN DRUG INVEST, V33, P325, DOI 10.1007/s40261-013-0074-0; Buti M, 2012, HEPATOLOGY, V56, p191A; Craxi A, 2011, J HEPATOL, V55, P245, DOI 10.1016/j.jhep.2011.02.023; Fried M, 2002, AM POETRY REV, V31, P36; Fried MW, 2013, HEPATOLOGY, V58, P1918, DOI 10.1002/hep.26641; Fried MW, 2002, NEW ENGL J MED, V347, P975, DOI 10.1056/NEJMoa020047; Gao X, 2012, EXPERT REV PHARM OUT, V12, P335, DOI [10.1586/ERP.12.10, 10.1586/erp.12.10]; Ge DL, 2009, NATURE, V461, P399, DOI 10.1038/nature08309; Ghany MG, 2011, HEPATOLOGY, V54, P1433, DOI 10.1002/hep.24641; Ghany MG, 2009, HEPATOLOGY, V49, P1335, DOI 10.1002/hep.22759; Hezode C, 2012, LIVER INT, V32, P32, DOI 10.1111/j.1478-3231.2011.02707.x; Hezode C, 2009, NEW ENGL J MED, V360, P1839, DOI 10.1056/NEJMoa0807650; Huisman MT, 2010, HEPATOLOGY, V52, p461A; Jacobson IM, 2014, LANCET; Jacobson IM, 2013, HEPATOLOGY, V58, p1379A; Jacobson IM, 2011, NEW ENGL J MED, V364, P2405, DOI 10.1056/NEJMoa1012912; Legrand-Abravanel F, 2009, J MED VIROL, V81, P2029, DOI 10.1002/jmv.21583; Lenz O, 2010, ANTIMICROB AGENTS CH, V54, P1878, DOI 10.1128/AAC.01452-09; Leroy V, 2012, LIVER INT, V32, P1477, DOI 10.1111/j.1478-3231.2012.02856.x; Lewis JH, 2006, PHARMACOEPIDEM DR S, V15, P221, DOI 10.1002/pds.1209; Manns M, 2011, ANTIVIR THER, V16, P1021, DOI 10.3851/IMP1894; Manns MP, 2013, NAT REV DRUG DISCOV, V12, P595, DOI 10.1038/nrd4050; Manns MP, 2001, LANCET, V358, P958, DOI 10.1016/S0140-6736(01)06102-5; McHutchison JG, 2010, NEW ENGL J MED, V362, P1292, DOI 10.1056/NEJMoa0908014; McHutchison JG, 2009, NEW ENGL J MED, V361, P580, DOI 10.1056/NEJMoa0808010; Moreno C, 2012, J HEPATOL, V56, P1247, DOI 10.1016/j.jhep.2011.12.033; Pawlotsky JM, 2014, GASTROENTEROLOGY, V146, P1176, DOI 10.1053/j.gastro.2014.03.003; Poordad F, 2011, NEW ENGL J MED, V364, P1195, DOI 10.1056/NEJMoa1010494; Qin HM, 2012, CLIN DRUG INVEST, V32, P665, DOI [10.1007/BF03261920, 10.2165/11633240-000000000-00000]; Reesink HW, 2010, GASTROENTEROLOGY, V138, P913, DOI 10.1053/j.gastro.2009.10.033; Sarkar S, 2012, J HEPATOL, V57, P946, DOI 10.1016/j.jhep.2012.06.030; Scott J, 2013, 18 ANN M INT SOC PHA; Sherman KE, 2011, NEW ENGL J MED, V365, P1014, DOI 10.1056/NEJMoa1014463; Stattermayer AF, 2011, CLIN GASTROENTEROL H, V9, P344, DOI 10.1016/j.cgh.2010.07.019; U.S. Department of Health and Human Services, 2009, GUID IND DRUG IND LI; Zeuzem S, 2013, GASTROENTEROLOGY, V146; Zeuzem S, 2011, NEW ENGL J MED, V364, P2417, DOI 10.1056/NEJMoa1013086	42	283	304	0	26	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	AUG 2	2014	384	9941					414	426		10.1016/S0140-6736(14)60538-9	http://dx.doi.org/10.1016/S0140-6736(14)60538-9			13	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AM9IV	24907224				2022-12-28	WOS:000340195800025
J	Zherebetskyy, D; Scheele, M; Zhang, YJ; Bronstein, N; Thompson, C; Britt, D; Salmeron, M; Alivisatos, P; Wang, LW				Zherebetskyy, Danylo; Scheele, Marcus; Zhang, Yingjie; Bronstein, Noah; Thompson, Christopher; Britt, David; Salmeron, Miquel; Alivisatos, Paul; Wang, Lin-Wang			Hydroxylation of the surface of PbS nanocrystals passivated with oleic acid	SCIENCE			English	Article							COLLOIDAL NANOCRYSTALS; SHAPE; WATER; DISSOCIATION; CHEMISTRY; EVOLUTION; FACETS; GROWTH; POLAR	Controlling the structure of colloidal nanocrystals (NCs) is key to the generation of their complex functionality. This requires an understanding of the NC surface at the atomic level. The structure of colloidal PbS NCs passivated with oleic acid has been studied theoretically and experimentally. We show the existence of surface OH-groups, which play a key role in stabilizing the PbS(111) facets, consistent with x-ray photoelectron spectroscopy as well as other spectroscopic and chemical experiments. The role of water in the synthesis process is also revealed. Our model, along with existing observations of NC surface termination and passivation by ligands, helps to explain and predict the properties of NCs and their assemblies.	[Zherebetskyy, Danylo; Scheele, Marcus; Zhang, Yingjie; Thompson, Christopher; Salmeron, Miquel; Alivisatos, Paul; Wang, Lin-Wang] Univ Calif Berkeley, Lawrence Berkeley Natl Lab, Div Mat Sci, Berkeley, CA 94720 USA; [Scheele, Marcus; Bronstein, Noah; Thompson, Christopher; Alivisatos, Paul] Univ Calif Berkeley, Dept Chem, Berkeley, CA 94720 USA; [Zhang, Yingjie] Univ Calif Berkeley, Appl Sci & Technol Grad Program, Berkeley, CA 94720 USA; [Britt, David] Univ Calif Berkeley, Lawrence Berkeley Natl Lab, Mol Foundry, Berkeley, CA 94720 USA	United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley; University of California System; University of California Berkeley; University of California System; University of California Berkeley; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley	Wang, LW (corresponding author), Univ Calif Berkeley, Lawrence Berkeley Natl Lab, Div Mat Sci, Berkeley, CA 94720 USA.	lwwang@lbl.gov	wang, lin/HHM-2225-2022; wang, lin/GSE-3040-2022; Alivisatos, Paul/N-8863-2015; Zherebetskyy, Danylo/B-3404-2015; wang, lili/HDL-7210-2022; Britt, David/D-4675-2009	Alivisatos, Paul/0000-0001-6895-9048; Britt, David/0000-0001-8241-8731; Scheele, Marcus/0000-0002-2704-3591	Office of Science, the Office of Basic Energy Sciences, Materials Sciences and Engineering Division of the U.S. Department of Energy (DOE) through the organic/inorganic nanocomposite program [DE-AC02-05CH11231]; Office of Science of the DOE [DE-AC05-00OR22725]; Alexander von Humboldt-Foundation	Office of Science, the Office of Basic Energy Sciences, Materials Sciences and Engineering Division of the U.S. Department of Energy (DOE) through the organic/inorganic nanocomposite program(United States Department of Energy (DOE)); Office of Science of the DOE(United States Department of Energy (DOE)); Alexander von Humboldt-Foundation(Alexander von Humboldt Foundation)	We thank R. Cai and Z. Zhu for helpful discussions and J. Engel for help in the XPS experiments. This work was supported by the Director, Office of Science, the Office of Basic Energy Sciences, Materials Sciences and Engineering Division of the U.S. Department of Energy (DOE) through the organic/inorganic nanocomposite program under contract DE-AC02-05CH11231. It used resources of the National Energy Research Scientific Computing Center, the Molecular Foundry, and the Advanced Light Source, which are supported by the Office of Science of the DOE. Computations also used resources of the Oak Ridge Leadership Computing Facility at the Oak Ridge National Laboratory, which is supported by the Office of Science of the DOE under contract no. DE-AC05-00OR22725, with computational time allocated by the Innovative and Novel Computational Impact on Theory and Experiment project. M. S. thanks the Alexander von Humboldt-Foundation for a Feodor Lynen-Fellowship. Materials and methods, supporting information, and the coordinates of NC models are included in the supplementary materials.	Alivisatos AP, 1996, SCIENCE, V271, P933, DOI 10.1126/science.271.5251.933; Andersson K, 2004, PHYS REV LETT, V93, DOI 10.1103/PhysRevLett.93.196101; Bealing CR, 2012, ACS NANO, V6, P2118, DOI 10.1021/nn3000466; Britt DK, 2013, CHEM MATER, V25, P2544, DOI 10.1021/cm401083g; Deng XY, 2008, LANGMUIR, V24, P9474, DOI 10.1021/la8011052; Eng PJ, 2000, SCIENCE, V288, P1029, DOI 10.1126/science.288.5468.1029; Fang CM, 2010, ACS NANO, V4, P211, DOI 10.1021/nn9013406; Feibelman PJ, 2002, SCIENCE, V295, P99, DOI 10.1126/science.1065483; Gai YQ, 2009, J PHYS CHEM C, V113, P21506, DOI 10.1021/jp905868f; Houtepen AJ, 2006, J AM CHEM SOC, V128, P6792, DOI 10.1021/ja061644v; Ip AH, 2012, NAT NANOTECHNOL, V7, P577, DOI [10.1038/nnano.2012.127, 10.1038/NNANO.2012.127]; Jun YW, 2005, J PHYS CHEM B, V109, P14795, DOI 10.1021/jp052257v; Khan SUM, 2002, SCIENCE, V297, P2243, DOI 10.1126/science.1075035; KIMURA K, 1994, SURF SCI, V318, P363, DOI 10.1016/0039-6028(94)90110-4; Klein DL, 1997, NATURE, V389, P699, DOI 10.1038/39535; Lee SM, 2002, J AM CHEM SOC, V124, P11244, DOI 10.1021/ja026805j; Li JB, 2003, NANO LETT, V3, P1357, DOI 10.1021/nl034488o; Liu HT, 2007, J AM CHEM SOC, V129, P305, DOI 10.1021/ja0656696; Manna L, 2005, J PHYS CHEM B, V109, P6183, DOI 10.1021/jp0445573; Moreels I, 2008, J AM CHEM SOC, V130, P15081, DOI 10.1021/ja803994m; Moreels I, 2007, CHEM MATER, V19, P6101, DOI 10.1021/cm071410q; Moreels I, 2011, ACS NANO, V5, P2004, DOI 10.1021/nn103050w; Murray CB, 2001, IBM J RES DEV, V45, P47, DOI 10.1147/rd.451.0047; Petkov V, 2010, PHYS REV B, V81, DOI 10.1103/PhysRevB.81.241304; Polarz S, 2011, ADV FUNCT MATER, V21, P3214, DOI 10.1002/adfm.201101205; Pong WT, 2005, J PHYS D APPL PHYS, V38, pR329, DOI 10.1088/0022-3727/38/21/R01; Ringe E, 2011, NANO LETT, V11, P3399, DOI 10.1021/nl2018146; Schrier J, 2008, J PHYS CHEM C, V112, P11158, DOI 10.1021/jp800489m; Shin HJ, 2010, NAT MATER, V9, P442, DOI [10.1038/NMAT2740, 10.1038/nmat2740]; SHIRAISHI K, 1990, J PHYS SOC JPN, V59, P3455, DOI 10.1143/JPSJ.59.3455; Srivastava GP, 1997, REP PROG PHYS, V60, P561, DOI 10.1088/0034-4885/60/5/002; Steckel JS, 2006, J AM CHEM SOC, V128, P13032, DOI 10.1021/ja062626g; Talapin DV, 2010, CHEM REV, V110, P389, DOI 10.1021/cr900137k; Wu S, 2012, NANOSCALE, V4, P2005, DOI 10.1039/c2nr11707j; Wulff G, 1901, Z KRYSTALLOGR MINERA, V34, P449, DOI 10.1524/zkri.1901.34.1.449; Yin Y, 2005, NATURE, V437, P664, DOI 10.1038/nature04165	36	344	345	12	402	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 20	2014	344	6190					1380	1384		10.1126/science.1252727	http://dx.doi.org/10.1126/science.1252727			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AJ2YQ	24876347	Green Submitted			2022-12-28	WOS:000337531700036
J	Schmandt, B; Jacobsen, SD; Becker, TW; Liu, ZX; Dueker, KG				Schmandt, Brandon; Jacobsen, Steven D.; Becker, Thorsten W.; Liu, Zhenxian; Dueker, Kenneth G.			EARTH'S INTERIOR Dehydration melting at the top of the lower mantle	SCIENCE			English	Article							STORAGE CAPACITY; WATER SOLUBILITY; TRANSITION; CONSTRAINTS; LAYER	The high water storage capacity of minerals in Earth's mantle transition zone (410- to 660-kilometer depth) implies the possibility of a deep H2O reservoir, which could cause dehydration melting of vertically flowing mantle. We examined the effects of downwelling from the transition zone into the lower mantle with high-pressure laboratory experiments, numerical modeling, and seismic P-to-S conversions recorded by a dense seismic array in North America. In experiments, the transition of hydrous ringwoodite to perovskite and (Mg, Fe) O produces intergranular melt. Detections of abrupt decreases in seismic velocity where downwelling mantle is inferred are consistent with partial melt below 660 kilometers. These results suggest hydration of a large region of the transition zone and that dehydration melting may act to trap H2O in the transition zone.	[Schmandt, Brandon] Univ New Mexico, Dept Earth & Planetary Sci, Albuquerque, NM 87131 USA; [Jacobsen, Steven D.] Northwestern Univ, Dept Earth & Planetary Sci, Evanston, IL USA; [Becker, Thorsten W.] Univ So Calif, Dept Earth Sci, Los Angeles, CA USA; [Liu, Zhenxian] Carnegie Inst Sci, Geophys Lab, Washington, DC USA; [Dueker, Kenneth G.] Univ Wyoming, Dept Geol & Geophys, Laramie, WY 82071 USA	University of New Mexico; Northwestern University; University of Southern California; Carnegie Institution for Science; University of Wyoming	Schmandt, B (corresponding author), Univ New Mexico, Dept Earth & Planetary Sci, Albuquerque, NM 87131 USA.	bschmandt@unm.edu; steven@earth.northwestern.edu	Becker, Thorsten W/ABF-7643-2021; Jacobsen, Steven/F-3443-2013	Becker, Thorsten W/0000-0002-5656-4564; Jacobsen, Steven/0000-0002-9746-958X; Liu, Zhenxian/0000-0003-2617-7077; Dueker, Ken G/0000-0002-7601-675X	NSF [EAR-0748707, EAR-1215720, EAR-1128799]; David and Lucile Packard Foundation; Carnegie/DOE Alliance Center (CDAC); U.S. Department of Energy (DOE) [DE-FG02-94ER14466]; COMPRES (Consortium for Materials Properties Research in Earth Sciences) under NSF [EAR 11-57758]; DOE-NNSA (National Nuclear Security Administration) [DE-FC-52-O8NA28554, CDAC]; Division Of Earth Sciences [1045810] Funding Source: National Science Foundation	NSF(National Science Foundation (NSF)); David and Lucile Packard Foundation(The David & Lucile Packard Foundation); Carnegie/DOE Alliance Center (CDAC)(United States Department of Energy (DOE)); U.S. Department of Energy (DOE)(United States Department of Energy (DOE)); COMPRES (Consortium for Materials Properties Research in Earth Sciences) under NSF(National Science Foundation (NSF)); DOE-NNSA (National Nuclear Security Administration); Division Of Earth Sciences(National Science Foundation (NSF)NSF - Directorate for Geosciences (GEO))	Seismic data were acquired from the IRIS Data Management Center. This work was supported by NSF grants EAR-0748707 to S.D.J. and EAR-1215720 to T.W.B., and by the David and Lucile Packard Foundation and Carnegie/DOE Alliance Center (CDAC) to S.D.J. Portions of this work were performed at GSECARS (Sector 13), Advanced Photon Source (APS), Argonne National Laboratory. GSECARS is supported by the NSF (EAR-1128799) and U.S. Department of Energy (DOE) (DE-FG02-94ER14466). Use of the APS was supported by the DOE-BES (Basic Energy Sciences) (DE-AC02-06CH11357). Portions of this work were performed at beamline U2A of the National Synchrotron Light Source (NSLS), Brookhaven National Laboratory. U2A is supported by COMPRES (Consortium for Materials Properties Research in Earth Sciences) under NSF Cooperative Agreement EAR 11-57758 and DOE-NNSA (National Nuclear Security Administration) (DE-FC-52-O8NA28554, CDAC). Use of the NSLS was supported by the DOE-BES (DE-AC02-98CH10886). We thank S. Demouchy, D. J. Frost, E. H. Hauri, M. M. Hirschmann, F. Langenhorst, J. F. Lin, G. Shen, V. B. Prakapenka, and J. R. Smyth for discussions and help with experiments. B. S. and S. D. J. designed the research and wrote the paper. B. S. conducted the seismological research, and S. D. J. performed the experiments. T.W.B. produced the mantle circulation models, Z.L. contributed to the FTIR experiments, and K.G.D. contributed to seismic imaging. All authors participated in data interpretation and contributed to the manuscript.	Becker T.W., 2014, EARTH PLANET SCI LET; Bercovici D, 2003, NATURE, V425, P39, DOI 10.1038/nature01918; Bolfan-Casanova N, 2003, GEOPHYS RES LETT, V30, DOI 10.1029/2003GL017182; Forte AM, 2010, TECTONOPHYSICS, V481, P3, DOI 10.1016/j.tecto.2009.06.010; Hier-Majumder S, 2011, EARTH PLANET SC LETT, V308, P334, DOI 10.1016/j.epsl.2011.05.055; Hirschmann MM, 2009, PHYS EARTH PLANET IN, V176, P54, DOI 10.1016/j.pepi.2009.04.001; Inoue T, 2010, PHYS EARTH PLANET IN, V183, P245, DOI 10.1016/j.pepi.2010.08.003; Jacobsen SD, 2004, PHYS EARTH PLANET IN, V143, P47, DOI 10.1016/j.pepi.2003.07.019; Kelbert A, 2009, NATURE, V460, P1003, DOI 10.1038/nature08257; Kerr RA, 2013, SCIENCE, V340, P1283, DOI 10.1126/science.340.6138.1283; Kohlstedt DL, 1996, CONTRIB MINERAL PETR, V123, P345, DOI 10.1007/s004100050161; Lee CTA, 2007, EARTH PLANET SC LETT, V255, P357, DOI 10.1016/j.epsl.2006.12.022; Litasov K, 2003, EARTH PLANET SC LETT, V211, P189, DOI 10.1016/S0012-821X(03)00200-0; Mercier JP, 2006, GEOPHYSICS, V71, pSI95, DOI 10.1190/1.2213951; Murakami M, 2002, SCIENCE, V295, P1885, DOI 10.1126/science.1065998; Pearson DG, 2014, NATURE, V507, P221, DOI 10.1038/nature13080; Ritsema J, 2011, GEOPHYS J INT, V184, P1223, DOI 10.1111/j.1365-246X.2010.04884.x; Saal AE, 2002, NATURE, V419, P451, DOI 10.1038/nature01073; Sakamaki T, 2006, NATURE, V439, P192, DOI 10.1038/nature04352; Schmandt B, 2011, GEOCHEM GEOPHY GEOSY, V12, DOI 10.1029/2011GC003668; Schmandt B, 2012, EARTH PLANET SC LETT, V331, P224, DOI 10.1016/j.epsl.2012.03.025; Simmons NA, 2009, GEOPHYS J INT, V177, P1284, DOI 10.1111/j.1365-246X.2009.04133.x; SMYTH JR, 1987, AM MINERAL, V72, P1051; Steinberger B, 2000, PHYS EARTH PLANET IN, V118, P241, DOI 10.1016/S0031-9201(99)00172-7; Tauzin B, 2013, J GEOPHYS RES-SOL EA, V118, P2307, DOI 10.1002/jgrb.50182; Tauzin B, 2010, NAT GEOSCI, V3, P718, DOI 10.1038/NGEO969; Tenner TJ, 2012, CONTRIB MINERAL PETR, V163, P297, DOI 10.1007/s00410-011-0675-7; Xu WB, 2008, EARTH PLANET SC LETT, V275, P70, DOI 10.1016/j.epsl.2008.08.012; Zhu HJ, 2013, EARTH PLANET SC LETT, V381, P1, DOI 10.1016/j.epsl.2013.08.030	29	217	231	8	188	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 13	2014	344	6189					1265	1268		10.1126/science.1253358	http://dx.doi.org/10.1126/science.1253358			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI7ND	24926016				2022-12-28	WOS:000337077500036
J	Andrews, MA; O'Malley, PG				Andrews, Mary A.; O'Malley, Patrick G.			Diabetes Overtreatment in Elderly Individuals Risky Business in Need of Better Management	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							GLUCOSE CONTROL	IMPORTANCE Although serious hypoglycemia is a common adverse drug event in ambulatory care, current performance measures do not assess potential over-treatment. OBJECTIVE To identify high-risk patients who had evidence of intensive glycemic management and thus were at risk for serious hypoglycemia. PARTICIPANTS Cross-sectional study of patients in the Veterans Health Administration receiving insulin and/or sulfonylureas in 2009. MAIN OUTCOMES AND MEASURES Intensive control was defined as the last hemoglobin A(1c) (HbA(1c)) measured in 2009 that was less than 6.0%, less than 6.5%, or less than 7.0%. The primary outcome measure was an HbA(1c) less than 7.0% in patients who were aged 75 years or older who had a serum creatinine value greater than 2.0 mg/dL or had a diagnosis of cognitive impairment or dementia. We also assessed the rates in patients with other significant medical, neurologic, or mental comorbid illness. Variation in rates of possible glycemic overtreatment was evaluated among 139 Veterans Health Administration facilities grouped within 21 Veteran Integrated Service Networks. RESULTS There were 652 378 patients who received insulin and/or a sulfonylurea with an HbA(1c) test result. Fifty percent received sulfonylurea therapy without insulin; the remainder received insulin therapy. We identified 205 857 patients (31.5%) as the denominator for the primary outcome measure; 11.3% had a last HbA(1c) value less than 6.0%, 28.6% less than 6.5%, and 50.0% less than 7.0%. Variation in rates by Veterans Integrated Service Network facility ranged 8.5% to 14.3%, 24.7% to 32.7%, and 46.2% to 53.4% for HbAic less than 6.0%, less than 6.5%, and less than 7.0%, respectively. The magnitude of variation by facility was larger, with overtreatment rates ranging from 6.1% to 23.0%, 20.4% to 45.9%, and 39.7% to 65.0% for HbAic less than 6.0%, less than 6.5%, and less than 7.0%, respectively. The maximum rate was nearly 4-fold compared with the minimum rates for HbAic less than 6.0%, followed by 2.25-fold for HbAic less than 6.5% and less than 2-fold for HbAic less than 7.0%. When comorbid conditions were included, 430 178 patients (65.9%) were identified as high risk. Rates of overtreatment were 10.1% for HbAic less than 6.0%, 25.2% for less than 6.5%, and 44.3% for less than 7.0%. CONCLUSIONS AND RELEVANCE Patients with risk factors for serious hypoglycemia represent a large subset of individuals receiving hypoglycemic agents; approximately one-half had evidence of intensive treatment. A patient safety indicator derived from administrative data can identify high-risk patients for whom reevaluation of glycemic management may be appropriate, consistent with meaningful use criteria for electronic medical records.	[Andrews, Mary A.; O'Malley, Patrick G.] Walter Reed Natl Mil Med Ctr, Bethesda, MD USA; [Andrews, Mary A.; O'Malley, Patrick G.] Uniformed Serv Univ Hlth Sci, 4301 Jones Bridge Rd, Bethesda, MD 20814 USA	Walter Reed National Military Medical Center; Uniformed Services University of the Health Sciences - USA	O'Malley, PG (corresponding author), Uniformed Serv Univ Hlth Sci, 4301 Jones Bridge Rd, Bethesda, MD 20814 USA.	patrick.omalley@usuhs.edu						Duckworth W, 2009, NEW ENGL J MED, V360, P129, DOI 10.1056/NEJMoa0808431; Gerstein HC, 2005, DIABETOLOGIA, V48, P1749, DOI 10.1007/s00125-005-1858-4; Gerstein HC, 2008, NEW ENGL J MED, V358, P2545, DOI 10.1056/NEJMoa0802743; Harle CA, 2013, J CLIN HYPERTENS, V15, P820, DOI 10.1111/jch.12179; Patel A, 2008, NEW ENGL J MED, V358, P2560, DOI 10.1056/NEJMoa0802987; Prasad V, 2012, JAMA-J AM MED ASSOC, V307, P37, DOI 10.1001/jama.2011.1960; Tseng CL, 2014, JAMA INTERN MED, V174, P259, DOI 10.1001/jamainternmed.2013.12963; Turner RC, 1998, LANCET, V352, P837, DOI 10.1016/s0140-6736(98)07019-6	8	12	12	1	11	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUN 11	2014	311	22					2326	+		10.1001/jama.2014.4563	http://dx.doi.org/10.1001/jama.2014.4563			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AI6HL	24915264				2022-12-28	WOS:000336972600024
J	McNally, A; Haffemayer, B; Collins, BSL; Gaunt, MJ				McNally, Andrew; Haffemayer, Benjamin; Collins, Beatrice S. L.; Gaunt, Matthew J.			Palladium-catalysed C-H activation of aliphatic amines to give strained nitrogen heterocycles	NATURE			English	Article							C(SP(3))-H BONDS; DIRECT ARYLATION; FUNCTIONALIZATION; SP(2); AMINATION; ACIDS	The development of new chemical transformations based on catalytic functionalization of unactivated C-H bonds has the potential to simplify the synthesis of complex molecules dramatically. Transition metal catalysis has emerged as a powerful tool with which to convert these unreactive bonds into carbon-carbon and carbon-heteroatom bonds(1-6), but the selective transformation of aliphatic C-H bonds is still a challenge. The most successful approaches involve a 'directing group', which positions the metal catalyst near a particular C-H bond, so that the C-H functionalization step occurs via cyclometallation(7). Most directed aliphatic C-H activation processes proceed through a five-membered-ring cyclometallated intermediate(8-10). Considering the number of new reactions that have arisen from such intermediates, it seems likely that identification of distinct cyclometallation pathways would lead to the development of other useful chemical transformations(11). Here we report a palladium-catalysed C-H bond activation mode that proceeds through a four-membered-ring cyclopalladation pathway. The chemistry described here leads to the selective transformation of a methyl group that is adjacent to an unprotected secondary amine into a synthetically versatile nitrogen heterocycle. The scope of this previously unknown bond disconnection is highlighted through the development of C-H amination and carbonylation processes, leading to the synthesis of aziridines and beta-lactams (respectively), and is suggestive of a generic C-H functionalization platform that could simplify the synthesis of aliphatic secondary amines, a class of small molecules that are particularly important features of many pharmaceutical agents.	[McNally, Andrew; Haffemayer, Benjamin; Collins, Beatrice S. L.; Gaunt, Matthew J.] Univ Cambridge, Dept Chem, Cambridge CB2 1EW, England	University of Cambridge	Gaunt, MJ (corresponding author), Univ Cambridge, Dept Chem, Lensfield Rd, Cambridge CB2 1EW, England.	mjg32@cam.ac.uk		Collins, Beatrice/0000-0002-2545-3458; Gaunt, Matthew/0000-0002-7214-608X	EPSRC; GSK; University of Cambridge; ERC; EPSRC [EP/I00548X/1] Funding Source: UKRI; Engineering and Physical Sciences Research Council [EP/I00548X/1] Funding Source: researchfish	EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); GSK(GlaxoSmithKline); University of Cambridge(University of Cambridge); ERC(European Research Council (ERC)European Commission); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))	We thank the EPSRC (A. M.), GSK (for a Case Award to B. H.) and the University of Cambridge (B. S. L. C.) for financial support, and the ERC and EPSRC for Fellowships (M.J.G.). Mass spectrometry data were acquired at the EPSRC UK National Mass Spectrometry Facility at Swansea University.	Ackermann L, 2011, CHEM REV, V111, P1315, DOI 10.1021/cr100412j; AGNUS Y, 1994, J CHEM SOC CHEM COMM, P939, DOI 10.1039/c39940000939; Campeau LC, 2008, J AM CHEM SOC, V130, P3266, DOI 10.1021/ja710451s; Chan KSL, 2014, NAT CHEM, V6, P146, DOI [10.1038/NCHEM.1836, 10.1038/nchem.1836]; Colby DA, 2010, CHEM REV, V110, P624, DOI 10.1021/cr900005n; Davies HML, 2008, NATURE, V451, P417, DOI 10.1038/nature06485; Davies HML, 2011, CHEM SOC REV, V40, P1855, DOI 10.1039/c1cs90010b; Desai LV, 2004, J AM CHEM SOC, V126, P9542, DOI 10.1021/ja046831c; Dupont J, 2005, CHEM REV, V105, P2527, DOI 10.1021/cr030681r; Engle KM, 2012, ACCOUNTS CHEM RES, V45, P788, DOI 10.1021/ar200185g; Giri R, 2005, ANGEW CHEM INT EDIT, V44, P2112, DOI 10.1002/anie.200462884; Giri R, 2007, J AM CHEM SOC, V129, P3510, DOI 10.1021/ja0701614; Godula K, 2006, SCIENCE, V312, P67, DOI 10.1126/science.1114731; He G, 2012, J AM CHEM SOC, V134, P3, DOI 10.1021/ja210660g; Hickman AJ, 2012, NATURE, V484, P177, DOI 10.1038/nature11008; Hu XE, 2004, TETRAHEDRON, V60, P2701, DOI 10.1016/j.tet.2004.01.042; Jia CG, 2001, ACCOUNTS CHEM RES, V34, P633, DOI 10.1021/ar000209h; Leow D, 2012, NATURE, V486, P518, DOI 10.1038/nature11158; Lyons TW, 2010, CHEM REV, V110, P1147, DOI 10.1021/cr900184e; Mkhalid IAI, 2010, CHEM REV, V110, P890, DOI 10.1021/cr900206p; RYABOV AD, 1990, CHEM REV, V90, P403, DOI 10.1021/cr00100a004; Simmons EM, 2012, NATURE, V483, P70, DOI 10.1038/nature10785; Tan YC, 2012, J AM CHEM SOC, V134, P3683, DOI 10.1021/ja2122156; Wang DH, 2008, J AM CHEM SOC, V130, P7190, DOI 10.1021/ja801355s; Wehn PM, 2003, ORG LETT, V5, P4823, DOI 10.1021/ol035776u; Yamaguchi J, 2012, ANGEW CHEM INT EDIT, V51, P8960, DOI 10.1002/anie.201201666; Yoo EJ, 2010, J AM CHEM SOC, V132, P17378, DOI 10.1021/ja108754f; Zaitsev VG, 2005, J AM CHEM SOC, V127, P13154, DOI 10.1021/ja054549f; Zhang SY, 2013, J AM CHEM SOC, V135, P2124, DOI 10.1021/ja312277g	29	401	402	6	332	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 5	2014	510	7503					129	133		10.1038/nature13389	http://dx.doi.org/10.1038/nature13389			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI3NR	24870240				2022-12-28	WOS:000336768900042
J	Sapetschnig, A; Miska, EA				Sapetschnig, Alexandra; Miska, Eric A.			Getting a Grip on piRNA Cluster Transcription	CELL			English	Editorial Material							DROSOPHILA	The generation of piRNAs from long primary transcripts requires specialized factors that distinguish these precursors from canonical RNA polymerase II transcripts. Mohn et al. and Zhang et al. provide evidence that in Drosophila melanogaster noncanonical transcription coupled with splicing inhibition differentiates piRNA precursors from mRNAs and ensures their correct processing.	[Sapetschnig, Alexandra] Univ Cambridge, Wellcome Trust Canc Res Gurdon Inst, Cambridge CB2 1QN, England; Univ Cambridge, Dept Genet, Cambridge CB2 1QN, England	University of Cambridge; University of Cambridge	Miska, EA (corresponding author), Univ Cambridge, Wellcome Trust Canc Res Gurdon Inst, Tennis Court Rd, Cambridge CB2 1QN, England.	eam29@cam.ac.uk		Miska, Eric/0000-0002-4450-576X	Cancer Research UK [11832] Funding Source: Medline	Cancer Research UK(Cancer Research UK)		Brennecke J, 2007, CELL, V128, P1089, DOI 10.1016/j.cell.2007.01.043; Jiao XF, 2013, MOL CELL, V50, P104, DOI 10.1016/j.molcel.2013.02.017; Klattenhoff C, 2009, CELL, V138, P1137, DOI 10.1016/j.cell.2009.07.014; Li XZG, 2013, MOL CELL, V50, P67, DOI 10.1016/j.molcel.2013.02.016; Mohn F, 2014, CELL, V157, P1364, DOI 10.1016/j.cell.2014.04.031; Pane A, 2011, EMBO J, V30, P4601, DOI 10.1038/emboj.2011.334; Rangan P, 2011, CURR BIOL, V21, P1373, DOI 10.1016/j.cub.2011.06.057; Siomi MC, 2011, NAT REV MOL CELL BIO, V12, P246, DOI 10.1038/nrm3089; Zhang F, 2012, CELL, V151, P871, DOI 10.1016/j.cell.2012.09.040; Zhang Z, 2014, CELL, V157, P1353, DOI 10.1016/j.cell.2014.04.030	10	6	7	0	8	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUN 5	2014	157	6					1253	1254		10.1016/j.cell.2014.05.022	http://dx.doi.org/10.1016/j.cell.2014.05.022			2	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	AN8UV	24906143	Green Published, hybrid			2022-12-28	WOS:000340881400003
J	Szyk, A; Deaconescu, AM; Spector, J; Goodman, B; Valenstein, ML; Ziolkowska, NE; Kormendi, V; Grigorieff, N; Roll-Mecak, A				Szyk, Agnieszka; Deaconescu, Alexandra M.; Spector, Jeffrey; Goodman, Benjamin; Valenstein, Max L.; Ziolkowska, Natasza E.; Kormendi, Vasilisa; Grigorieff, Nikolaus; Roll-Mecak, Antonina			Molecular Basis for Age-Dependent Microtubule Acetylation by Tubulin Acetyltransferase	CELL			English	Article							CHLAMYDOMONAS ALPHA-TUBULIN; STRUCTURAL BASIS; POSTTRANSLATIONAL MODIFICATION; CRYOELECTRON TOMOGRAPHY; CELLULAR MICROTUBULES; BINDING; MEC-17; RESOLUTION; LATTICE; NEURONS	Acetylation of alpha-tubulin Lys40 by tubulin acetyltransferase (TAT) is the only known posttranslational modification in the microtubule lumen. It marks stable microtubules and is required for polarity establishment and directional migration. Here, we elucidate the mechanistic underpinnings for TAT activity and its preference for microtubules with slow turnover. 1.35 angstrom TAT cocrystal structures with bisubstrate analogs constrain TAT action to the microtubule lumen and reveal Lys40 engaged in a suboptimal active site. Assays with diverse tubulin polymers show that TAT is stimulated by microtubule interprotofilament contacts. Unexpectedly, despite the confined intraluminal location of Lys40, TAT efficiently scans the microtubule bidirectionally and acetylates stochastically without preference for ends. First-principles modeling and single-molecule measurements demonstrate that TAT catalytic activity, not constrained luminal diffusion, is rate limiting for acetylation. Thus, because of its preference for microtubules over free tubulin and its modest catalytic rate, TAT can function as a slow clock for microtubule lifetimes.	[Szyk, Agnieszka; Spector, Jeffrey; Goodman, Benjamin; Valenstein, Max L.; Ziolkowska, Natasza E.; Kormendi, Vasilisa; Roll-Mecak, Antonina] Porter Neurosci Res Ctr, Natl Inst Neurol Disorders & Stroke, Cell Biol & Biophys Unit, Bethesda, MD 20892 USA; [Deaconescu, Alexandra M.; Grigorieff, Nikolaus] Howard Hughes Med Inst, Ashburn, VA 20147 USA; [Roll-Mecak, Antonina] NHLBI, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Neurological Disorders & Stroke (NINDS); Howard Hughes Medical Institute; National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI)	Roll-Mecak, A (corresponding author), Porter Neurosci Res Ctr, Natl Inst Neurol Disorders & Stroke, Cell Biol & Biophys Unit, Bethesda, MD 20892 USA.	antonina@mail.nih.gov	Deaconescu, Alexandra/AAW-8139-2021	Grigorieff, Nikolaus/0000-0002-1506-909X; Roll-Mecak, Antonina/0000-0003-2621-7307; Valenstein, Max/0000-0001-7616-0148; Deaconescu, Alexandra/0000-0002-2742-5493	NIH [P01 GM62580]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P01GM062580] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [ZIANS003122] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank G. Piszczek (National Heart, Lung and Blood Institute Biophysics core) for AUC help, B. Castle and D. Odde (University of Minnesota) for modifying the TipTracker program, and G. Brouhard (McGill University) for the doublecortin expression plasmid. A.R.-M. thanks A. Szabo for discussions on diffusion and A. Ferre-D'Amare, E. Giniger, S. Gottesman, K. Swartz, and R. Vale for critical reading of the manuscript. We are grateful to Chen Xu for training at the Brandeis University EM facility where the EM data was collected (supported by NIH grant P01 GM62580 awarded to N.G.). A.R.-M. is a Searle Scholar and supported by the intramural program of the NIH.	Akella JS, 2010, NATURE, V467, P218, DOI 10.1038/nature09324; Bechstedt S, 2012, DEV CELL, V23, P181, DOI 10.1016/j.devcel.2012.05.006; BLACK MM, 1989, J NEUROSCI, V9, P358; Bungay P. M., 1973, INT J MULTIPHAS FLOW, V1, P25, DOI DOI 10.1016/0301-9322(73)90003-7; BURTON PR, 1984, J CELL BIOL, V99, P520, DOI 10.1083/jcb.99.2.520; Cai DW, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000216; CHRETIEN D, 1992, J CELL BIOL, V117, P1031, DOI 10.1083/jcb.117.5.1031; Cooper JR, 2009, CURR OPIN CELL BIOL, V21, P68, DOI 10.1016/j.ceb.2009.01.005; CUEVA JG, 2012, CURR BIOL, V22, P1066, DOI [DOI 10.1016/j.cub.2012.05.012, DOI 10.1016/J.CUB.2012.05.012]; Dompierre JP, 2007, J NEUROSCI, V27, P3571, DOI 10.1523/JNEUROSCI.0037-07.2007; Fourniol FJ, 2010, J CELL BIOL, V191, P463, DOI 10.1083/jcb.201007081; Friedmann DR, 2012, P NATL ACAD SCI USA, V109, P19655, DOI 10.1073/pnas.1209357109; Garnham CP, 2012, CYTOSKELETON, V69, P442, DOI 10.1002/cm.21027; Garvalov BK, 2006, J CELL BIOL, V174, P759, DOI 10.1083/jcb.200606074; Gigant B, 2005, NATURE, V435, P519, DOI 10.1038/nature03566; GREER K, 1985, J CELL BIOL, V101, P2081, DOI 10.1083/jcb.101.6.2081; Hammond JW, 2010, MOL BIOL CELL, V21, P572, DOI 10.1091/mbc.E09-01-0044; Helenius J, 2006, NATURE, V441, P115, DOI 10.1038/nature04736; Hinrichs MH, 2012, J BIOL CHEM, V287, P38559, DOI 10.1074/jbc.M112.369785; Howes SC, 2014, MOL BIOL CELL, V25, P257, DOI 10.1091/mbc.E13-07-0387; Hubbert C, 2002, NATURE, V417, P455, DOI 10.1038/417455a; Kalebic N, 2013, MOL CELL BIOL, V33, P1114, DOI 10.1128/MCB.01044-12; Kim GW, 2013, J BIOL CHEM, V288, P20334, DOI 10.1074/jbc.M113.464792; Kormendi V, 2012, J BIOL CHEM, V287, P41569, DOI 10.1074/jbc.C112.421222; LEDIZET M, 1987, P NATL ACAD SCI USA, V84, P5720, DOI 10.1073/pnas.84.16.5720; LHERNAULT SW, 1985, BIOCHEMISTRY-US, V24, P473, DOI 10.1021/bi00323a034; Li L, 2012, J NEUROSCI, V32, P12673, DOI 10.1523/JNEUROSCI.0016-12.2012; Liu X, 2008, NATURE, V451, P846, DOI 10.1038/nature06546; MARUTA H, 1986, J CELL BIOL, V103, P571, DOI 10.1083/jcb.103.2.571; Maurer SP, 2012, CELL, V149, P371, DOI 10.1016/j.cell.2012.02.049; Meijering E, 2012, METHOD ENZYMOL, V504, P183, DOI 10.1016/B978-0-12-391857-4.00009-4; Mulder AM, 2009, J CELL BIOL, V185, P51, DOI 10.1083/jcb.200812052; Neumann B, 2014, CELL REP, V6, P93, DOI 10.1016/j.celrep.2013.12.004; Nicastro D, 2006, SCIENCE, V313, P944, DOI 10.1126/science.1128618; Nogales E, 1999, CELL, V96, P79, DOI 10.1016/S0092-8674(00)80961-7; Nogales E, 1998, NATURE, V391, P199, DOI 10.1038/34465; North BJ, 2003, MOL CELL, V11, P437, DOI 10.1016/S1097-2765(03)00038-8; Odde D, 1998, EUR BIOPHYS J BIOPHY, V27, P514, DOI 10.1007/s002490050161; PIPERNO G, 1987, J CELL BIOL, V104, P289, DOI 10.1083/jcb.104.2.289; Poux AN, 2002, P NATL ACAD SCI USA, V99, P14065, DOI 10.1073/pnas.222373899; Reed NA, 2006, CURR BIOL, V16, P2166, DOI 10.1016/j.cub.2006.09.014; Roll-Mecak A, 2008, NATURE, V451, P363, DOI 10.1038/nature06482; SCHULZE E, 1987, J CELL BIOL, V105, P2167, DOI 10.1083/jcb.105.5.2167; SCHULZE E, 1987, J CELL BIOL, V104, P277, DOI 10.1083/jcb.104.2.277; Shida T, 2010, P NATL ACAD SCI USA, V107, P21517, DOI 10.1073/pnas.1013728107; Soppina V, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048204; Subramanian R, 2013, CELL, V154, P377, DOI 10.1016/j.cell.2013.06.021; Sui HX, 2006, NATURE, V442, P475, DOI 10.1038/nature04816; TAKEMURA R, 1992, J CELL SCI, V103, P953; Taschner M, 2012, P NATL ACAD SCI USA, V109, P19649, DOI 10.1073/pnas.1209343109; Topalidou I, 2012, CURR BIOL, V22, P1057, DOI 10.1016/j.cub.2012.03.066; Varga V, 2009, CELL, V138, P1174, DOI 10.1016/j.cell.2009.07.032; VONHIPPEL PH, 1989, J BIOL CHEM, V264, P675; WEBSTER DR, 1989, J CELL SCI, V92, P57; Wloga D, 2010, J CELL SCI, V123, P3447, DOI 10.1242/jcs.063727; Xiao H, 2006, P NATL ACAD SCI USA, V103, P10166, DOI 10.1073/pnas.0603704103; Yajima H, 2012, J CELL BIOL, V198, P315, DOI 10.1083/jcb.201201161; Zhang Y, 2002, NATURE, V418, P331, DOI 10.1038/nature00891; Ziolkowska NE, 2013, METHODS MOL BIOL, V1046, P323, DOI 10.1007/978-1-62703-538-5_19	59	130	137	0	25	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUN 5	2014	157	6					1405	1415		10.1016/j.cell.2014.03.061	http://dx.doi.org/10.1016/j.cell.2014.03.061			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	AN8UV	24906155	Green Accepted, Bronze			2022-12-28	WOS:000340881400016
J	Waeber, B; Feihl, F				Waeber, Bernard; Feihl, Francois			Nebivolol and valsartan: useful treatment for hypertension?	LANCET			English	Editorial Material							DOSE COMBINATION; BETA-BLOCKERS		[Waeber, Bernard] CHU Vaudois, Div Clin Pathophysiol, CH-1011 Lausanne, Switzerland; Univ Lausanne, CH-1011 Lausanne, Switzerland	University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV); University of Lausanne	Waeber, B (corresponding author), CHU Vaudois, Div Clin Pathophysiol, MP14, CH-1011 Lausanne, Switzerland.	bernard.waeber@chuv.ch						Chrysant SG, 2012, DRUG TODAY, V48, P353, DOI 10.1358/dot.2012.48.5.1782932; FENICHEL RR, 1994, ARCH INTERN MED, V154, P1429, DOI 10.1001/archinte.154.13.1429; Giles TD, 2014, LANCET, V383, P1889, DOI 10.1016/S0140-6736(14)60614-0; Gorre F, 2010, ACTA CARDIOL, V65, P565, DOI 10.1080/AC.65.5.2056244; Jamerson K, 2008, NEW ENGL J MED, V359, P2417, DOI 10.1056/NEJMoa0806182; James PA, 2014, JAMA-J AM MED ASSOC, V311, P1809, DOI 10.1001/jama.2013.284427; Law MR, 2003, BRIT MED J, V326, P1427, DOI 10.1136/bmj.326.7404.1427; Mancia G, 2013, J HYPERTENS, V31, P1281, DOI 10.1097/01.hjh.0000431740.32696.cc; Markham A, 1997, DRUGS, V54, P299, DOI 10.2165/00003495-199754020-00009; National Institute for Health and Care Excellence, 2011, HYP CLIN MAN PRIM HY; O'Brien E, 2013, J HYPERTENS, V31, P1731, DOI 10.1097/HJH.0b013e328363e964; TRAYNOR K, 2008, AM J HEALTH SYST PH, V65, P190	12	4	4	0	9	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAY 31	2014	383	9932					1864	1866		10.1016/S0140-6736(14)60836-9	http://dx.doi.org/10.1016/S0140-6736(14)60836-9			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	AI4PR	24881977				2022-12-28	WOS:000336847800008
J	Hwang, TJ; Carpenter, D; Kesselheim, AS				Hwang, Thomas J.; Carpenter, Daniel; Kesselheim, Aaron S.			Target small firms for antibiotic innovation	SCIENCE			English	Editorial Material							DRUGS		[Hwang, Thomas J.; Carpenter, Daniel] Harvard Univ, Fac Arts & Sci, Cambridge, MA 02138 USA; [Carpenter, Daniel] Harvard Univ, Radclif Inst Adv Study, Cambridge, MA 02138 USA; [Hwang, Thomas J.; Kesselheim, Aaron S.] Brigham & Womens Hosp, Dept Med, Div Pharmacoepidemiol & Pharmacoecon, PORTAL, Boston, MA 02115 USA; [Hwang, Thomas J.; Kesselheim, Aaron S.] Harvard Univ, Sch Med, Boston, MA 02115 USA	Harvard University; Harvard University; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School	Hwang, TJ (corresponding author), Blackstone Grp, London W1J5AL, England.	tjhwang@post.harvard.edu; akesselheim@partners.org	Kesselheim, Aaron/R-6793-2017	Kesselheim, Aaron/0000-0002-8867-2666; Hwang, Thomas/0000-0003-0717-1497				Blume-Kohout ME, 2012, J POLICY ANAL MANAG, V31, P641, DOI 10.1002/pam.21640; Boucher HW, 2013, CLIN INFECT DIS, V56, P1685, DOI 10.1093/cid/cit152; Coates A, 2002, NAT REV DRUG DISCOV, V1, P895, DOI 10.1038/nrd940; DiMasi JA, 2010, CLIN PHARMACOL THER, V87, P272, DOI 10.1038/clpt.2009.295; Downing NS, 2014, JAMA-J AM MED ASSOC, V311, P368, DOI 10.1001/jama.2013.282034; Holmes D, 2014, NAT MED, V20, P320, DOI 10.1038/nm0414-320; Hwang TJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071966; Projan SJ, 2003, CURR OPIN MICROBIOL, V6, P427, DOI 10.1016/j.mib.2003.08.003; Rex JH, 2013, LANCET INFECT DIS, V13, P269, DOI 10.1016/S1473-3099(12)70293-1	9	11	11	0	17	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 30	2014	344	6187					967	969		10.1126/science.1251419	http://dx.doi.org/10.1126/science.1251419			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AH9WM	24876477				2022-12-28	WOS:000336495800018
J	Pimm, SL; Jenkins, CN; Abell, R; Brooks, TM; Gittleman, JL; Joppa, LN; Raven, PH; Roberts, CM; Sexton, JO				Pimm, S. L.; Jenkins, C. N.; Abell, R.; Brooks, T. M.; Gittleman, J. L.; Joppa, L. N.; Raven, P. H.; Roberts, C. M.; Sexton, J. O.			The biodiversity of species and their rates of extinction, distribution, and protection	SCIENCE			English	Review							IUCN RED LIST; CLIMATE-CHANGE; FRESH-WATER; MARINE BIODIVERSITY; GLOBAL PATTERNS; HABITAT LOSS; RANGE-SIZE; CONSERVATION; FUTURE; BIRD	Recent studies clarify where the most vulnerable species live, where and how humanity changes the planet, and how this drives extinctions. We assess key statistics about species, their distribution, and their status. Most are undescribed. Those we know best have large geographical ranges and are often common within them. Most known species have small ranges. The numbers of small-ranged species are increasing quickly, even in well-known taxa. They are geographically concentrated and are disproportionately likely to be threatened or already extinct. Current rates of extinction are about 1000 times the likely background rate of extinction. Future rates depend on many factors and are poised to increase. Although there has been rapid progress in developing protected areas, such efforts are not ecologically representative, nor do they optimally protect biodiversity.	[Pimm, S. L.] Duke Univ, Nicholas Sch Environm, Durham, NC 27708 USA; [Jenkins, C. N.] Inst Pesquisas Ecol, BR-12960000 Nazare Paulista, SP, Brazil; [Brooks, T. M.] IUCN, CH-1196 Gland, Switzerland; [Gittleman, J. L.] Univ Georgia, Odum Sch Ecol, Athens, GA 30602 USA; [Joppa, L. N.] Microsoft Res, Cambridge CB1 2FB, England; [Raven, P. H.] Missouri Bot Garden, St Louis, MO 63166 USA; [Roberts, C. M.] Univ York, Dept Environm, York YO10 5DD, N Yorkshire, England; [Sexton, J. O.] Univ Maryland, Dept Geog Sci, Global Land Cover Facil, College Pk, MD 20742 USA	Duke University; Instituto de Pesquisas Ecologicas; University System of Georgia; University of Georgia; Microsoft; Missouri Botanical Gardens; University of York - UK; University System of Maryland; University of Maryland College Park	Pimm, SL (corresponding author), Duke Univ, Nicholas Sch Environm, Box 90328, Durham, NC 27708 USA.	stuartpimm@me.com	Jenkins, Clinton/D-6134-2011; pimm, stuart/ABF-1082-2020	Jenkins, Clinton/0000-0003-2198-0637; Brooks, Thomas/0000-0001-8159-3116	NASA's Making Earth System Data Records for Use in Research Environments (MEaSUREs) [NNH06ZDA001N]; Land Cover and Land Use Change [NNH07ZDA001N-LCLUC]; CAPES, through the Ciencia Sem Fronteiras program	NASA's Making Earth System Data Records for Use in Research Environments (MEaSUREs); Land Cover and Land Use Change; CAPES, through the Ciencia Sem Fronteiras program(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES))	We thank A. Arino, J. A. Drake, M. A. Fisher, S. Loarie, E. Norse, and P. R. Stephens for comments. The original data for this paper are in public archives from BirdLife International (37), IUCN (13), WCSPF (43), and the World Conservation Monitoring Centre (94). We thank those responsible for access to them and especially the many professionals and amateurs who collected them. NASA's Making Earth System Data Records for Use in Research Environments (MEaSUREs) (NNH06ZDA001N) and Land Cover and Land Use Change (NNH07ZDA001N-LCLUC) programs provided forest cover data. We thank the World Checklist of Selected Plant Families. The Brazilian agency CAPES, through the Ciencia Sem Fronteiras program, supports C.N.J. M. Thieme, P. Petry, and C. Revenga co-led the synthesis of the freshwater fish data. Additional biodiversity maps are at www.biodiversitymapping.org.	Abell R, 2008, BIOSCIENCE, V58, P403, DOI 10.1641/B580507; Abell R, 2011, CONSERV LETT, V4, P127, DOI 10.1111/j.1755-263X.2010.00153.x; Adeney JM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005014; Almeida-Gomes M, 2014, CONSERV BIOL, V28, P616, DOI 10.1111/cobi.12196; Alroy J, 1996, PALAEOGEOGR PALAEOCL, V127, P285, DOI 10.1016/S0031-0182(96)00100-9; [Anonymous], 2014, TREE LIFE; [Anonymous], 2014, WORLD CHECKLIST SELE; [Anonymous], 2014, STRATEGIC PLAN BIODI; Appeltans W, 2012, CURR BIOL, V22, P2189, DOI 10.1016/j.cub.2012.09.036; Araujo MB, 2006, SCIENCE, V313, P1396, DOI 10.1126/science.1131758; Barnosky AD, 2011, NATURE, V471, P51, DOI 10.1038/nature09678; Bomhard B, 2005, GLOBAL CHANGE BIOL, V11, P1452, DOI 10.1111/j.1365-2486.2005.00997.x; Brook BW, 2000, NATURE, V404, P385, DOI 10.1038/35006050; Brooke MD, 2008, CONSERV BIOL, V22, P417, DOI 10.1111/j.1523-1739.2008.00905.x; Brooks T, 1996, NATURE, V380, P115, DOI 10.1038/380115a0; Brooks TM, 2011, NATURE, V474, P284, DOI 10.1038/474284b; Brooks TM, 2002, CONSERV BIOL, V16, P909, DOI 10.1046/j.1523-1739.2002.00530.x; Brooks TM, 1997, CONSERV BIOL, V11, P382, DOI 10.1046/j.1523-1739.1997.95493.x; Brummitt Neil, 2008, Endangered Species Research, V6, P127, DOI 10.3354/esr00135; Burkhead NM, 2012, BIOSCIENCE, V62, P798, DOI 10.1525/bio.2012.62.9.5; Butchart SHM, 2004, PLOS BIOL, V2, P2294, DOI 10.1371/journal.pbio.0020383; Butchart Stuart H M, 2012, PLoS One, V7, pe32529, DOI 10.1371/journal.pone.0032529; Cantu-Salazar L, 2013, BIODIVERS CONSERV, V22, P1033, DOI 10.1007/s10531-013-0467-7; Cardillo M, 2006, P NATL ACAD SCI USA, V103, P4157, DOI 10.1073/pnas.0510541103; Cardillo M, 2008, P ROY SOC B-BIOL SCI, V275, P1441, DOI 10.1098/rspb.2008.0179; Carpenter KE, 2008, SCIENCE, V321, P560, DOI 10.1126/science.1159196; Ceballos G, 2002, SCIENCE, V296, P904, DOI 10.1126/science.1069349; Chao A, 2005, ECOL LETT, V8, P148, DOI 10.1111/j.1461-0248.2004.00707.x; Chapman A, 2009, NUMBERS LIVING SPECI, P1; Chen IC, 2009, P NATL ACAD SCI USA, V106, P1479, DOI 10.1073/pnas.0809320106; Chessman BC, 2013, J APPL ECOL, V50, P969, DOI 10.1111/1365-2664.12104; Cheung WWL, 2009, FISH FISH, V10, P235, DOI 10.1111/j.1467-2979.2008.00315.x; Collen B, 2004, GLOBAL ECOL BIOGEOGR, V13, P459, DOI 10.1111/j.1466-822X.2004.00121.x; Collen B, 2014, GLOBAL ECOL BIOGEOGR, V23, P40, DOI 10.1111/geb.12096; Costello MJ, 2013, SCIENCE, V339, P413, DOI 10.1126/science.1230318; Dulvy NK, 2014, ELIFE, V3, DOI 10.7554/eLife.00590; Edgar GJ, 2014, NATURE, V506, P216, DOI 10.1038/nature13022; Feeley KJ, 2011, J BIOGEOGR, V38, P783, DOI 10.1111/j.1365-2699.2010.02444.x; Ferrer MM, 2012, ANN BOT-LONDON, V110, P535, DOI 10.1093/aob/mcs124; Forero-Medina G, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028535; Gaiji S., 2013, BIODIVERS INFORM, V8, P94; Gaston KJ, 1996, TRENDS ECOL EVOL, V11, P197, DOI 10.1016/0169-5347(96)10027-6; Gibson L, 2013, SCIENCE, V341, P1508, DOI 10.1126/science.1240495; Global Marine Species Assessment, 2014, GLOBAL MARINE SPECIE; Hanski I, 2013, P NATL ACAD SCI USA, V110, P12715, DOI 10.1073/pnas.1311491110; Harnik PG, 2012, TRENDS ECOL EVOL, V27, P608, DOI 10.1016/j.tree.2012.07.010; Harris G, 2008, CONSERV BIOL, V22, P163, DOI 10.1111/j.1523-1739.2007.00798.x; Harrison Ian J., 1999, P271; Hebert PDN, 2004, P NATL ACAD SCI USA, V101, P14812, DOI 10.1073/pnas.0406166101; Hebert PDN, 2003, P ROY SOC B-BIOL SCI, V270, pS96, DOI 10.1098/rsbl.2003.0025; Hoffmann M, 2010, SCIENCE, V330, P1503, DOI 10.1126/science.1194442; IUCN UNEP-WCMC, 2014, WORLD DAT PROT AR; Jenkins CN, 2009, BIOL CONSERV, V142, P2166, DOI 10.1016/j.biocon.2009.04.016; Jetz W, 2007, PLOS BIOL, V5, P1211, DOI 10.1371/journal.pbio.0050157; Johnson PD, 2013, FISHERIES, V38, P247, DOI 10.1080/03632415.2013.785396; Joppa LN, 2013, SCIENCE, V341, P1100, DOI 10.1126/science.1241706; Joppa LN, 2008, P NATL ACAD SCI USA, V105, P6673, DOI 10.1073/pnas.0802471105; Joppa LN, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004279; Joppa LN, 2011, P NATL ACAD SCI USA, V108, P13171, DOI 10.1073/pnas.1109389108; Joppa LN, 2011, P ROY SOC B-BIOL SCI, V278, P554, DOI 10.1098/rspb.2010.1004; Joppa LN, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008273; La Sorte FA, 2010, J EXP BIOL, V213, P862, DOI 10.1242/jeb.038356; Lasram FB, 2010, GLOBAL CHANGE BIOL, V16, P3233, DOI 10.1111/j.1365-2486.2010.02224.x; Maclean IMD, 2011, P NATL ACAD SCI USA, V108, P12337, DOI 10.1073/pnas.1017352108; Malcolm JR, 2006, CONSERV BIOL, V20, P538, DOI 10.1111/j.1523-1739.2006.00364.x; Manne LL, 1999, NATURE, V399, P258, DOI 10.1038/20436; MAY RM, 1988, SCIENCE, V241, P1441, DOI 10.1126/science.241.4872.1441; McPeek MA, 2008, AM NAT, V172, pE270, DOI 10.1086/593137; Mora C, 2006, SCIENCE, V312, P1750, DOI 10.1126/science.1125295; Mora C, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001127; Myers N, 2000, NATURE, V403, P853, DOI 10.1038/35002501; Myers RA, 2003, NATURE, V423, P280, DOI 10.1038/nature01610; NEE S, 1994, PHILOS T ROY SOC B, V344, P77, DOI 10.1098/rstb.1994.0054; Nilsson C, 2005, SCIENCE, V308, P405, DOI 10.1126/science.1107887; Norse EA, 1986, CONSERVING BIOL DIVE; Parker Laura M., 2013, Biology - Basel, V2, P651, DOI 10.3390/biology2020651; Paton AJ, 2013, ANN MO BOT GARD, V99, P206, DOI 10.3417/2011115; Pereira HM, 2010, SCIENCE, V330, P1496, DOI 10.1126/science.1196624; Peters H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083353; Phillimore AB, 2008, PLOS BIOL, V6, P483, DOI 10.1371/journal.pbio.0060071; PIMM SL, 1995, SCIENCE, V269, P347, DOI 10.1126/science.269.5222.347; Pimm SL, 2000, NATURE, V403, P843, DOI 10.1038/35002708; PIMM SL, 1995, P NATL ACAD SCI USA, V92, P9343, DOI 10.1073/pnas.92.20.9343; Pimm S, 2006, P NATL ACAD SCI USA, V103, P10941, DOI 10.1073/pnas.0604181103; Pimm SL, 2008, CURR BIOL, V18, pR117, DOI 10.1016/j.cub.2007.11.055; Pimm SL, 2013, CURR BIOL, V23, pR1098, DOI 10.1016/j.cub.2013.10.024; Pimm SL, 2010, NAT CONSERVACAO, V8, P71, DOI 10.4322/natcon.00801011; Pimm SL, 2010, CONSERVATION BIOLOGY FOR ALL, P181; Pino-Del-Carpio A, 2014, BIOL CONSERV, V173, P74, DOI 10.1016/j.biocon.2013.11.020; Rabosky DL, 2010, EVOLUTION, V64, P1816, DOI 10.1111/j.1558-5646.2009.00926.x; Ratnasingham S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066213; Raven PH, 2007, AUST J ENTOMOL, V46, P177, DOI 10.1111/j.1440-6055.2007.00601.x; Ricketts TH, 2005, P NATL ACAD SCI USA, V102, P18497, DOI 10.1073/pnas.0509060102; Riggio J, 2013, BIODIVERS CONSERV, V22, P17, DOI 10.1007/s10531-012-0381-4; Roberts CM, 2002, SCIENCE, V295, P1280, DOI 10.1126/science.1067728; Rodrigues ASL, 2004, NATURE, V428, P640, DOI 10.1038/nature02422; Rondinini C, 2006, ECOL LETT, V9, P1136, DOI 10.1111/j.1461-0248.2006.00970.x; Russell GJ, 1998, CONSERV BIOL, V12, P1365, DOI 10.1046/j.1523-1739.1998.96332.x; SAVIDGE JA, 1987, ECOLOGY, V68, P660, DOI 10.2307/1938471; Scheffers BR, 2012, TRENDS ECOL EVOL, V27, P501, DOI 10.1016/j.tree.2012.05.008; Schipper J, 2008, SCIENCE, V322, P225, DOI 10.1126/science.1165115; Schnell JK, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065357; Sekercioglu CH, 2008, CONSERV BIOL, V22, P140, DOI 10.1111/j.1523-1739.2007.00852.x; Sexton JO, 2013, INT J DIGIT EARTH, V6, P427, DOI 10.1080/17538947.2013.786146; Sexton JO, 2013, REMOTE SENS ENVIRON, V128, P246, DOI 10.1016/j.rse.2012.10.010; Spalding MD, 2013, OCEAN YEARB, V27, P213, DOI 10.1163/22116001-90000160; Strayer DL, 2010, J N AM BENTHOL SOC, V29, P344, DOI 10.1899/08-171.1; Stuart SN, 2010, SCIENCE, V328, P177, DOI 10.1126/science.1188606; Stuart SN, 2004, SCIENCE, V306, P1783, DOI 10.1126/science.1103538; ter Steege H, 2013, SCIENCE, V342, P325, DOI 10.1126/science.1243092; Thomas CD, 2004, NATURE, V427, P145, DOI 10.1038/nature02121; Tittensor DP, 2010, NATURE, V466, P1098, DOI 10.1038/nature09329; Toonen RJ, 2013, MAR POLLUT BULL, V77, P7, DOI 10.1016/j.marpolbul.2013.10.039; Townshend JR, 2012, INT J DIGIT EARTH, V5, P373, DOI 10.1080/17538947.2012.713190; Valente LM, 2010, P ROY SOC B-BIOL SCI, V277, P1489, DOI 10.1098/rspb.2009.2163; van Vuuren DP, 2006, ECOL SOC, V11; Waldron A, 2013, P NATL ACAD SCI USA, V110, P12144, DOI 10.1073/pnas.1221370110; Wilkie DS, 2011, ANN NY ACAD SCI, V1223, P120, DOI 10.1111/j.1749-6632.2010.05908.x; WITTE F, 1992, ENVIRON BIOL FISH, V34, P1, DOI 10.1007/BF00004782	119	1629	1709	131	1290	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 30	2014	344	6187					987	+	1246752	10.1126/science.1246752	http://dx.doi.org/10.1126/science.1246752			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AH9WM	24876501				2022-12-28	WOS:000336495800034
J	Yang, H				Yang, Hong			China must continue the momentum of green law	NATURE			English	Editorial Material									Univ Oslo, Dept Biosci, Ctr Ecol & Evolutionary Synth, N-0316 Oslo, Norway	University of Oslo	Yang, H (corresponding author), Univ Oslo, Dept Biosci, Ctr Ecol & Evolutionary Synth, N-0316 Oslo, Norway.	hongyanghy@gmail.com	Hong, YANG/C-1739-2008	Hong, YANG/0000-0001-9940-8273					0	73	75	0	44	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 29	2014	509	7502					535	535		10.1038/509535a	http://dx.doi.org/10.1038/509535a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AH9JC	24870508	Bronze			2022-12-28	WOS:000336457100014
J	Kirschner, LS				Kirschner, Lawrence S.			A unified cause for adrenal Cushing's syndrome	SCIENCE			English	Editorial Material							MUTATIONS; SUBUNIT; ACTIVATION; PRKAR1A; PKA		[Kirschner, Lawrence S.] Ohio State Univ, Div Endocrinol Diabet & Metab, Dept Internal Med, Columbus, OH 43210 USA; [Kirschner, Lawrence S.] Ohio State Univ, Dept Mol Virol Immunol & Med Genet, Columbus, OH 43210 USA	Ohio State University; Ohio State University	Kirschner, LS (corresponding author), Ohio State Univ, Div Endocrinol Diabet & Metab, Dept Internal Med, Columbus, OH 43210 USA.	lawrence.kirschner@osumc.edu						Allolio B, 2006, J CLIN ENDOCR METAB, V91, P2027, DOI 10.1210/jc.2005-2639; Assie G, 2013, NEW ENGL J MED, V369, P2105, DOI 10.1056/NEJMoa1304603; Azevedo MF, 2014, ENDOCR REV, V35, P195, DOI 10.1210/er.2013-1053; Beuschlein F, 2014, NEW ENGL J MED, V370, P1019, DOI 10.1056/NEJMoa1310359; Cao YN, 2014, SCIENCE, V344, P913, DOI 10.1126/science.1249480; de Fraipont F, 2005, J CLIN ENDOCR METAB, V90, P1819, DOI 10.1210/jc.2004-1075; Goh G, 2014, NAT GENET, V46, P613, DOI 10.1038/ng.2956; Kim C, 2005, SCIENCE, V307, P690, DOI 10.1126/science.1104607; Kirschner LS, 2000, NAT GENET, V26, P89, DOI 10.1038/79238; Lacroix A, 2001, ENDOCR REV, V22, P75, DOI 10.1210/er.22.1.75; Molyneux SD, 2010, J CLIN INVEST, V120, P3310, DOI 10.1172/JCI42391; Pringle DR, 2014, J CLIN ENDOCR METAB, V99, pE804, DOI 10.1210/jc.2013-3101; Sato Y, 2014, SCIENCE, V344, P917, DOI 10.1126/science.1252328; Vogelstein B, 2013, SCIENCE, V339, P1546, DOI 10.1126/science.1235122; Weinstein LS, 2001, ENDOCR REV, V22, P675, DOI 10.1210/er.22.5.675	15	11	11	0	6	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 23	2014	344	6186					804	805		10.1126/science.1254901	http://dx.doi.org/10.1126/science.1254901			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AH6IL	24855241				2022-12-28	WOS:000336233800013
J	Bertazzo, S; Steele, JAM; Chester, AH; Yacoub, MH; Stevens, MM				Bertazzo, Sergio; Steele, Joseph A. M.; Chester, Adrian H.; Yacoub, Magdi H.; Stevens, Molly M.			Cardiovascular calcification violet pearl	LANCET			English	Editorial Material									[Bertazzo, Sergio; Stevens, Molly M.] Univ London Imperial Coll Sci Technol & Med, Dept Mat, Dept Bioengn, London SW7 2AZ, England; [Chester, Adrian H.; Yacoub, Magdi H.] Univ London Imperial Coll Sci Technol & Med, Natl Heart & Lung Inst, Harefield Heart Sci Ctr, London SW7 2AZ, England; [Steele, Joseph A. M.; Stevens, Molly M.] Univ London Imperial Coll Sci Technol & Med, Inst Biomed Engn, London SW7 2AZ, England	Imperial College London; Imperial College London; Imperial College London	Bertazzo, S (corresponding author), Univ London Imperial Coll Sci Technol & Med, Dept Mat, London SW7 2AZ, England.	s.bertazzo@imperial.ac.uk; m.stevens@imperial.ac.uk	Bertazzo, Sergio/J-7357-2016	Bertazzo, Sergio/0000-0003-4889-8190; Steele, Joseph/0000-0002-7913-0531					0	4	4	1	22	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	OCT 4	2014	384	9950					1294	1294		10.1016/S0140-6736(13)62369-7	http://dx.doi.org/10.1016/S0140-6736(13)62369-7			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AQ7NB	24857203				2022-12-28	WOS:000343003400032
J	Chokshi, DA				Chokshi, Dave A.			Improving Health Care for Veterans - A Watershed Moment for the VA	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							TRANSFORMATION; SYSTEM		[Chokshi, Dave A.] NYU, Dept Populat Hlth, Langone Med Ctr, New York, NY 10012 USA; [Chokshi, Dave A.] NYU, Dept Med, Langone Med Ctr, New York, NY 10016 USA	New York University; NYU Langone Medical Center; New York University; NYU Langone Medical Center	Chokshi, DA (corresponding author), NYU, Dept Populat Hlth, Langone Med Ctr, New York, NY 10012 USA.			Chokshi, Dave/0000-0001-7467-4591				Department of Veterans Affairs Office of Public and Intergovernmental Affairs, 2014, IND 2013 SURV SHOWS; Government Accountability Office, 2012, GAO13130; Jha AK, 2003, NEW ENGL J MED, V348, P2218, DOI 10.1056/NEJMsa021899; Kizer KW, 2012, J GEN INTERN MED, V27, P395, DOI 10.1007/s11606-011-1981-5; Kizer KW, 2009, ANNU REV PUBL HEALTH, V30, P313, DOI 10.1146/annurev.publhealth.29.020907.090940; Trivedi AN, 2011, MED CARE, V49, P76, DOI 10.1097/MLR.0b013e3181f53575	6	28	28	0	2	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUL 24	2014	371	4					297	299		10.1056/NEJMp1406868	http://dx.doi.org/10.1056/NEJMp1406868			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	AL7TY	24896820	Bronze			2022-12-28	WOS:000339339800005
J	Costello, EK; Relman, DA				Costello, Elizabeth K.; Relman, David A.			POPULATION HEALTH Immaturity in the gut microbial community	NATURE			English	Editorial Material									[Costello, Elizabeth K.; Relman, David A.] Stanford Univ, Dept Med, Stanford, CA 94305 USA; [Costello, Elizabeth K.; Relman, David A.] Stanford Univ, Dept Microbiol & Immunol, Stanford, CA 94305 USA; [Costello, Elizabeth K.; Relman, David A.] Vet Affairs Palo Alto Hlth Care Syst, Palo Alto, CA USA	Stanford University; Stanford University; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Palo Alto Health Care System	Costello, EK (corresponding author), Stanford Univ, Dept Med, Stanford, CA 94305 USA.	costelle@stanford.edu; relman@stanford.edu		Relman, David A./0000-0001-8331-1354				Black RE, 2013, LANCET, V382, P427, DOI 10.1016/S0140-6736(13)60937-X; Costello EK, 2012, SCIENCE, V336, P1255, DOI 10.1126/science.1224203; De Filippo C, 2010, P NATL ACAD SCI USA, V107, P14691, DOI 10.1073/pnas.1005963107; Fukami Tadashi, 2010, P45; Gordon JI, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3004347; Mondal D, 2012, CLIN INFECT DIS, V54, P185, DOI 10.1093/cid/cir807; Smith MI, 2013, SCIENCE, V339, P548, DOI 10.1126/science.1229000; Subramanian S, 2014, NATURE, V510, P417, DOI 10.1038/nature13421; Suding KN, 2004, TRENDS ECOL EVOL, V19, P46, DOI 10.1016/j.tree.2003.10.005; Yatsunenko T, 2012, NATURE, V486, P222, DOI 10.1038/nature11053	10	5	5	0	15	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 19	2014	510	7505					344	345		10.1038/nature13347	http://dx.doi.org/10.1038/nature13347			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AJ0NG	24896185				2022-12-28	WOS:000337350200022
J	Bouwmeester, D				Bouwmeester, Dirk			QUANTUM MECHANICS The quantum nondemolition derby	SCIENCE			English	Editorial Material							GROUND-STATE; MOTION; OSCILLATOR		[Bouwmeester, Dirk] Univ Calif Santa Barbara, Dept Phys, Santa Barbara, CA 93106 USA; [Bouwmeester, Dirk] Leiden Univ, Huygens Kamerlingh Onnes Lab, NL-2300 RA Leiden, Netherlands	University of California System; University of California Santa Barbara; Leiden University; Leiden University - Excl LUMC	Bouwmeester, D (corresponding author), Univ Calif Santa Barbara, Dept Phys, Santa Barbara, CA 93106 USA.	bouwmeester@physics.ucsb.edu						Abadie J, 2011, NAT PHYS, V7, P962, DOI [10.1038/NPHYS2083, 10.1038/nphys2083]; Braginskii V. B., 1975, Soviet Physics - Uspekhi, V17, P644, DOI 10.1070/PU1975v017n05ABEH004362; Braginsky V. B., 1974, GRAVITATIONAL RAD GR, P28; BRAGINSKY VB, 1980, SCIENCE, V209, P547, DOI 10.1126/science.209.4456.547; CAVES CM, 1980, REV MOD PHYS, V52, P341, DOI 10.1103/RevModPhys.52.341; CAVES CM, 1980, PHYS REV LETT, V45, P75, DOI 10.1103/PhysRevLett.45.75; Clerk AA, 2008, NEW J PHYS, V10, DOI 10.1088/1367-2630/10/9/095010; Guerlin C, 2007, NATURE, V448, P889, DOI 10.1038/nature06057; O'Connell AD, 2010, NATURE, V464, P697, DOI 10.1038/nature08967; Palomaki TA, 2013, SCIENCE, V342, P710, DOI 10.1126/science.1244563; Suh J, 2014, SCIENCE, V344, P1262, DOI 10.1126/science.1253258; Teufel JD, 2011, NATURE, V475, P359, DOI 10.1038/nature10261; Teufel JD, 2009, NAT NANOTECHNOL, V4, P820, DOI [10.1038/NNANO.2009.343, 10.1038/nnano.2009.343]; THORNE KS, 1978, PHYS REV LETT, V40, P667, DOI 10.1103/PhysRevLett.40.667; Verhagen E, 2012, NATURE, V482, P63, DOI 10.1038/nature10787	15	0	0	0	17	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 13	2014	344	6189					1224	1226		10.1126/science.1255313	http://dx.doi.org/10.1126/science.1255313			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI7ND	24926001				2022-12-28	WOS:000337077500017
J	King, NP; Bale, JB; Sheffler, W; McNamara, DE; Gonen, S; Gonen, T; Yeates, TO; Baker, D				King, Neil P.; Bale, Jacob B.; Sheffler, William; McNamara, Dan E.; Gonen, Shane; Gonen, Tamir; Yeates, Todd O.; Baker, David			Accurate design of co-assembling multi-component protein nanomaterials	NATURE			English	Article							COMPUTATIONAL DESIGN; DIRECTED EVOLUTION; DNA; SYMMETRY; NANOSTRUCTURES; INTERFACES; HOMODIMER; CONTAINER; ARRAYS; CAGES	The self-assembly of proteins into highly ordered nanoscale architectures is a hallmark of biological systems. The sophisticated functions of these molecular machines have inspired the development of methods to engineer self-assembling protein nanostructures; however, the design of multi-component protein nanomaterials with high accuracy remains an outstanding challenge. Here we report a computational method for designing protein nanomaterials in which multiple copies of two distinct subunits co-assemble into a specific architecture. We use the method to design five 24-subunit cage-like protein nanomaterials in two distinct symmetric architectures and experimentally demonstrate that their structures are in close agreement with the computational design models. The accuracy of the method and the number and variety of two-component materials that it makes accessible suggest a route to the construction of functional protein nanomaterials tailored to specific applications.	[King, Neil P.; Bale, Jacob B.; Sheffler, William; Gonen, Shane; Baker, David] Univ Washington, Dept Biochem, Seattle, WA 98195 USA; [King, Neil P.; Baker, David] Univ Washington, Inst Prot Design, Seattle, WA 98195 USA; [Bale, Jacob B.] Univ Washington, Grad Program Mol & Cellular Biol, Seattle, WA 98195 USA; [McNamara, Dan E.; Yeates, Todd O.] UCLA Dept Chem & Biochem, Los Angeles, CA 90095 USA; [Gonen, Shane; Gonen, Tamir] Howard Hughes Med Inst, Ashburn, VA 20147 USA; [Yeates, Todd O.] UCLA DOE Inst Genom & Prote, Los Angeles, CA 90095 USA; [Yeates, Todd O.] UCLA Mol Biol Inst, Los Angeles, CA 90095 USA; [Baker, David] Univ Washington, Howard Hughes Med Inst, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; Howard Hughes Medical Institute; United States Department of Energy (DOE); University of California System; University of California Los Angeles; Howard Hughes Medical Institute; University of Washington; University of Washington Seattle	Baker, D (corresponding author), Univ Washington, Dept Biochem, Seattle, WA 98195 USA.	dabaker@u.washington.edu	Baker, David/K-8941-2012	Baker, David/0000-0001-7896-6217; Gonen, Shane/0000-0002-4829-3151; Yeates, Todd/0000-0001-5709-9839; McNamara, Dan/0000-0003-0600-7847; Bale, Jacob/0000-0003-2444-5875	Howard Hughes Medical Institute; JFRC; National Science Foundation [CHE-1332907]; International AIDS Vaccine Initiative, DTRA [N00024-10-D-6318/0024]; AFOSR [FA950-12-10112]; DOE [DE-SC0005155]; NIH [T32GM067555]; NSF [DGE-0718124]; BER programme of the DOE Office of Science; Division Of Chemistry [1332907] Funding Source: National Science Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM067555] Funding Source: NIH RePORTER	Howard Hughes Medical Institute(Howard Hughes Medical Institute); JFRC; National Science Foundation(National Science Foundation (NSF)); International AIDS Vaccine Initiative, DTRA; AFOSR(United States Department of DefenseAir Force Office of Scientific Research (AFOSR)); DOE(United States Department of Energy (DOE)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NSF(National Science Foundation (NSF)); BER programme of the DOE Office of Science(United States Department of Energy (DOE)); Division Of Chemistry(National Science Foundation (NSF)NSF - Directorate for Mathematical & Physical Sciences (MPS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank D. Shi and B. Nannenga (JFRC) for help with electron microscopy, F. DiMaio and R. Moretti for assistance with software development, P. Greisen for scripts used to compare side-chain conformations, J. Gallaher for technical assistance, M. Collazo for help with preliminary crystallization screening, D. Cascio and M. Sawaya for help with crystallographic experiments, and M. Capel, J. Schuermann and I. Kourinov at NE-CAT beamline 24-ID-C for help with data collection. This work was supported by the Howard Hughes Medical Institute (T. G. and D. B.) and the JFRC visitor program (S. G.), the National Science Foundation under CHE-1332907 (D. B. and T.O.Y.), grants from the International AIDS Vaccine Initiative, DTRA (N00024-10-D-6318/0024), AFOSR (FA950-12-10112) and DOE (DE-SC0005155) to D. B., an NIH Biotechnology Training Program award to D. E. M. (T32GM067555) and an NSF graduate research fellowship to J. B. B. (DGE-0718124). T.O.Y. and D.E.M. also acknowledge support from the BER programme of the DOE Office of Science. The content is solely the responsibility of the authors and does not necessarily represent the official views of the funding bodies.	Arnold FH, 1999, CURR OPIN CHEM BIOL, V3, P54, DOI 10.1016/S1367-5931(99)80010-6; Boyle AL, 2012, J AM CHEM SOC, V134, P15457, DOI 10.1021/ja3053943; Bradley P, 2006, PROTEINS, V65, P922, DOI 10.1002/prot.21133; Brodin JD, 2012, NAT CHEM, V4, P375, DOI [10.1038/NCHEM.1290, 10.1038/nchem.1290]; Der BS, 2012, J AM CHEM SOC, V134, P375, DOI 10.1021/ja208015j; DiMaio F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020450; Douglas T, 2006, SCIENCE, V312, P873, DOI 10.1126/science.1123223; Fleishman SJ, 2011, SCIENCE, V332, P816, DOI 10.1126/science.1202617; Fletcher JM, 2013, SCIENCE, V340, P595, DOI 10.1126/science.1233936; Goodsell DS, 2000, ANNU REV BIOPH BIOM, V29, P105, DOI 10.1146/annurev.biophys.29.1.105; Grigoryan G, 2011, SCIENCE, V332, P1071, DOI 10.1126/science.1198841; Han DR, 2013, SCIENCE, V339, P1412, DOI 10.1126/science.1232252; Howorka S, 2011, CURR OPIN BIOTECH, V22, P485, DOI 10.1016/j.copbio.2011.05.003; Huang PS, 2007, PROTEIN SCI, V16, P2770, DOI 10.1110/ps.073125207; Jackel C, 2008, ANNU REV BIOPHYS, V37, P153, DOI 10.1146/annurev.biophys.37.032807.125832; Janin J, 2008, Q REV BIOPHYS, V41, P133, DOI 10.1017/S0033583508004708; Jha RK, 2010, J MOL BIOL, V400, P257, DOI 10.1016/j.jmb.2010.05.006; Karanicolas J, 2011, MOL CELL, V42, P250, DOI 10.1016/j.molcel.2011.03.010; Ke YG, 2012, SCIENCE, V338, P1177, DOI 10.1126/science.1227268; Khare SD, 2013, FEBS LETT, V587, P1147, DOI 10.1016/j.febslet.2012.12.009; King NP, 2013, CURR OPIN STRUC BIOL, V23, P632, DOI 10.1016/j.sbi.2013.06.002; King NP, 2012, SCIENCE, V336, P1171, DOI 10.1126/science.1219364; Kuhlman B, 2000, P NATL ACAD SCI USA, V97, P10383, DOI 10.1073/pnas.97.19.10383; Lai YT, 2012, TRENDS CELL BIOL, V22, P653, DOI 10.1016/j.tcb.2012.08.004; Lai YT, 2012, SCIENCE, V336, P1129, DOI 10.1126/science.1219351; Lanci CJ, 2012, P NATL ACAD SCI USA, V109, P7304, DOI [10.1073/pnas.1112595109, 10.1073/pnas.111259510]; LAWRENCE MC, 1993, J MOL BIOL, V234, P946, DOI 10.1006/jmbi.1993.1648; Leaver-Fay A, 2011, METHOD ENZYMOL, P545, DOI [10.1016/S0076-6879(11)87019-9, 10.1016/B978-0-12-381270-4.00019-6]; Padilla JE, 2001, P NATL ACAD SCI USA, V98, P2217, DOI 10.1073/pnas.041614998; Rothemund PWK, 2006, NATURE, V440, P297, DOI 10.1038/nature04586; Salgado EN, 2010, ACCOUNTS CHEM RES, V43, P661, DOI 10.1021/ar900273t; Seeman NC, 2010, ANNU REV BIOCHEM, V79, P65, DOI 10.1146/annurev-biochem-060308-102244; Sinclair JC, 2013, CURR OPIN CHEM BIOL, V17, P946, DOI 10.1016/j.cbpa.2013.10.004; Sinclair JC, 2011, NAT NANOTECHNOL, V6, P558, DOI [10.1038/nnano.2011.122, 10.1038/NNANO.2011.122]; Stranges PB, 2011, P NATL ACAD SCI USA, V108, P20562, DOI 10.1073/pnas.1115124108; Usui K, 2009, PROTEIN SCI, V18, P960, DOI 10.1002/pro.106; Worsdorfer B, 2012, J AM CHEM SOC, V134, P909, DOI 10.1021/ja211011k; Worsdorfer B, 2011, SCIENCE, V331, P589, DOI 10.1126/science.1199081	38	383	393	13	402	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 5	2014	510	7503					103	+		10.1038/nature13404	http://dx.doi.org/10.1038/nature13404			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI3NR	24870237	Green Accepted			2022-12-28	WOS:000336768900037
J	Walch, M; Dotiwala, F; Mulik, S; Thiery, J; Kirchhausen, T; Clayberger, C; Krensky, AM; Martinvalet, D; Lieberman, J				Walch, Michael; Dotiwala, Farokh; Mulik, Sachin; Thiery, Jerome; Kirchhausen, Tomas; Clayberger, Carol; Krensky, Alan M.; Martinvalet, Denis; Lieberman, Judy			Cytotoxic Cells Kill Intracellular Bacteria through Granulysin-Mediated Delivery of Granzymes	CELL			English	Article							ESCHERICHIA-COLI; COMPLEX-I; HYDROGEN-PEROXIDE; T-CELLS; SUPEROXIDE; DEATH; ANTIBIOTICS; SCAVENGER; APOPTOSIS; OXIDOREDUCTASE	When killer lymphocytes recognize infected cells, perforin delivers cytotoxic proteases (granzymes) into the target cell to trigger apoptosis. What happens to intracellular bacteria during this process is unclear. Human, but not rodent, cytotoxic granules also contain granulysin, an antimicrobial peptide. Here, we show that granulysin delivers granzymes into bacteria to kill diverse bacterial strains. In Escherichia coli, granzymes cleave electron transport chain complex I and oxidative stress defense proteins, generating reactive oxygen species (ROS) that rapidly kill bacteria. ROS scavengers and bacterial antioxidant protein overexpression inhibit bacterial death. Bacteria overexpressing a GzmB-uncleavable mutant of the complex I subunit nuoF or strains that lack complex I still die, but more slowly, suggesting that granzymes disrupt multiple vital bacterial pathways. Mice expressing transgenic granulysin are better able to clear Listeria monocytogenes. Thus killer cells play an unexpected role in bacterial defense.	[Walch, Michael; Dotiwala, Farokh; Mulik, Sachin; Thiery, Jerome; Kirchhausen, Tomas; Martinvalet, Denis; Lieberman, Judy] Harvard Univ, Sch Med, Boston Childrens Hosp, Cellular & Mol Med Program, Boston, MA 02115 USA; [Clayberger, Carol; Krensky, Alan M.] Northwestern Univ, Feinberg Sch Med, Chicago, IL 60611 USA	Harvard University; Boston Children's Hospital; Harvard Medical School; Northwestern University; Feinberg School of Medicine	Walch, M (corresponding author), Harvard Univ, Sch Med, Boston Childrens Hosp, Cellular & Mol Med Program, 200 Longwood Ave, Boston, MA 02115 USA.	michael.walch@unifr.ch; judy.lieberman@childrens.harvard.edu	Dotiwala, Farokh/S-5367-2019; Lieberman, Judy/A-2717-2015; THIERY, Jerome/N-2469-2018	Dotiwala, Farokh/0000-0002-7387-2219; THIERY, Jerome/0000-0002-0998-3627; Walch, Michael/0000-0001-7284-3291; MULIK, SACHIN/0000-0003-2568-3402	NIH [AI-045587, GM-075252]; Stiefel-Zangger Foundation; Kurt and Senta Herrmann Foundation; PCMM-Glaxo Smith Kline Alliance; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R56AI045587, R01AI045587] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM075252] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Stiefel-Zangger Foundation; Kurt and Senta Herrmann Foundation; PCMM-Glaxo Smith Kline Alliance; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by NIH AI-045587 (to J.L.), the Stiefel-Zangger and the Kurt and Senta Herrmann Foundations (to M. W.), and PCMM-Glaxo Smith Kline Alliance (to F. D.), and by NIH grant GM-075252 (to T. K.). We thank Zhan Xu and Solange Kharoubi Hess for technical support, Luis Filgueira for helpful discussions, Marshall Thomas for HeLa-BCL2 cells, James Imlay (University of Illinois) for valuable suggestions and for the L106 E. coli strain, Susan Lovett (Brandeis) for the recA strain, Thorsten Friedrich (Albert-Ludwigs-University, Freiburg, Germany) for E. coli strain ANN0221/pBADnuo/His-nuoF, and Darren Higgins (Harvard Medical School) for the Lm expression plasmid pLIV1 and Eric Marino for maintaining the Imaging Resource used in this study.	Chiang SM, 2012, ARCH BIOCHEM BIOPHYS, V525, P161, DOI 10.1016/j.abb.2012.02.007; Chowdhury D, 2008, ANNU REV IMMUNOL, V26, P389, DOI 10.1146/annurev.immunol.26.021607.090404; Efremov RG, 2010, NATURE, V465, P441, DOI 10.1038/nature09066; Ernst WA, 2000, J IMMUNOL, V165, P7102, DOI 10.4049/jimmunol.165.12.7102; Friedrich T, 1997, J THEOR BIOL, V187, P529, DOI 10.1006/jtbi.1996.0387; Gallo RL, 2003, CURR ALLERGY ASTHM R, V3, P402, DOI 10.1007/s11882-003-0074-x; GARDNER PR, 1991, J BIOL CHEM, V266, P19328; Gray MW, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a011403; Hampton MB, 1998, BLOOD, V92, P3007, DOI 10.1182/blood.V92.9.3007.421k47_3007_3017; Hirche TO, 2008, J IMMUNOL, V181, P4945, DOI 10.4049/jimmunol.181.7.4945; Huang LP, 2007, J IMMUNOL, V178, P77, DOI 10.4049/jimmunol.178.1.77; KAGI D, 1994, EUR J IMMUNOL, V24, P3068, DOI 10.1002/eji.1830241223; Keren I, 2013, SCIENCE, V339, P1213, DOI 10.1126/science.1232688; Kohanski MA, 2007, CELL, V130, P797, DOI 10.1016/j.cell.2007.06.049; Konola JT, 2000, MUTAT RES-DNA REPAIR, V459, P187, DOI 10.1016/S0921-8777(99)00073-7; Krensky AM, 2009, TISSUE ANTIGENS, V73, P193, DOI 10.1111/j.1399-0039.2008.01218.x; LEDENEV AN, 1986, BIOCHEM INT, V13, P391; Liu YY, 2013, SCIENCE, V339, P1210, DOI 10.1126/science.1232751; Martinvalet D, 2005, IMMUNITY, V22, P355, DOI 10.1016/j.immuni.2005.02.004; Martinvalet D, 2008, CELL, V133, P681, DOI 10.1016/j.cell.2008.03.032; Pitabut N, 2011, MICROBIOL IMMUNOL, V55, P565, DOI 10.1111/j.1348-0421.2011.00348.x; Ricci JE, 2004, CELL, V117, P773, DOI 10.1016/j.cell.2004.05.008; Seaver LC, 2001, J BACTERIOL, V183, P7173, DOI 10.1128/JB.183.24.7173-7181.2001; Spaeny-Dekking EHA, 1998, J IMMUNOL, V160, P3610; Spehr V, 1999, BIOCHEMISTRY-US, V38, P16261, DOI 10.1021/bi9919605; Steinwede K, 2012, J IMMUNOL, V188, P4476, DOI 10.4049/jimmunol.1103346; Stenger S, 1998, SCIENCE, V282, P121, DOI 10.1126/science.282.5386.121; Taiwo FA, 2008, SPECTROSC-INT J, V22, P491, DOI 10.1155/2008/953692; Thiery J., 2010, CURR PROTOC CELL BIO; Thoma-Uszynski S, 2000, J IMMUNOL, V165, P5773, DOI 10.4049/jimmunol.165.10.5773; Walch M, 2009, J IMMUNOL, V182, P7569, DOI 10.4049/jimmunol.0800296; Zhao HT, 2003, FREE RADICAL BIO MED, V34, P1359, DOI 10.1016/S0891-5849(03)00142-4	32	115	119	0	36	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUN 5	2014	157	6					1309	1323		10.1016/j.cell.2014.03.062	http://dx.doi.org/10.1016/j.cell.2014.03.062			15	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	AN8UV	24906149	Green Accepted, Bronze			2022-12-28	WOS:000340881400009
J	Brody, H				Brody, Herb			Cancer	NATURE			English	Editorial Material																			0	2	2	1	16	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 29	2014	509	7502					S49	S49		10.1038/509S49a	http://dx.doi.org/10.1038/509S49a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AH9JC	24870818	Bronze			2022-12-28	WOS:000336457100001
J	Peacock, S				Peacock, Sharon			Bring microbial sequencing to hospitals	NATURE			English	Editorial Material									[Peacock, Sharon] Univ Cambridge, Cambridge CB2 1TN, England; [Peacock, Sharon] Publ Hlth England, London, England; [Peacock, Sharon] Cambridge Univ Hosp NHS Fdn Trust, Cambridge, England	University of Cambridge; Public Health England; University of Cambridge	Peacock, S (corresponding author), Univ Cambridge, Cambridge CB2 1TN, England.	sjp97@medschl.cam.ac.uk	Peacock, Sharon J/ABE-6331-2020					Bernard EJ, 2007, HIV MED, V8, P382, DOI 10.1111/j.1468-1293.2007.00486.x; Koser CU, 2013, NEW ENGL J MED, V369, P290, DOI 10.1056/NEJMc1215305; Reuter S, 2013, JAMA INTERN MED, V173, P1397, DOI 10.1001/jamainternmed.2013.7734; Snitkin ES, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3004129; WHO, 2012, EVOLVING THREAT OF ANTIMICROBIAL RESISTANCE: OPTIONS FOR ACTION, P1	5	13	13	0	6	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 29	2014	509	7502					557	559		10.1038/509557a	http://dx.doi.org/10.1038/509557a			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AH9JC	24877182	Bronze			2022-12-28	WOS:000336457100024
J	Wright, J				Wright, Jessica			NANOTECHNOLOGY Deliver on a promise	NATURE			English	Editorial Material																		Davis ME, 2010, NATURE, V464, P1067, DOI 10.1038/nature08956; Hrkach J, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003651; Verma S, 2012, NEW ENGL J MED, V367, P1783, DOI 10.1056/NEJMoa1209124	3	27	27	0	58	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 29	2014	509	7502					S58	S59		10.1038/509S58a	http://dx.doi.org/10.1038/509S58a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AH9JC	24870822				2022-12-28	WOS:000336457100005
J	Haushofer, J; Fehr, E				Haushofer, Johannes; Fehr, Ernst			On the psychology of poverty	SCIENCE			English	Review							SOCIOECONOMIC-STATUS; TIME-PREFERENCES; RISK-TAKING; STRESS; HEALTH; INCOME; DEPRESSION; CHILDREN; LOTTERY; ANXIETY	Poverty remains one of the most pressing problems facing the world; the mechanisms through which poverty arises and perpetuates itself, however, are not well understood. Here, we examine the evidence for the hypothesis that poverty may have particular psychological consequences that can lead to economic behaviors that make it difficult to escape poverty. The evidence indicates that poverty causes stress and negative affective states which in turn may lead to short-sighted and risk-averse decision-making, possibly by limiting attention and favoring habitual behaviors at the expense of goal-directed ones. Together, these relationships may constitute a feedback loop that contributes to the perpetuation of poverty. We conclude by pointing toward specific gaps in our knowledge and outlining poverty alleviation programs that this mechanism suggests.	[Haushofer, Johannes] MIT, Abdul Latif Jameel Poverty Act Lab, Cambridge, MA 02142 USA; [Haushofer, Johannes] Harvard Univ, Program Econ Hist & Polit, Cambridge, MA 02138 USA; [Haushofer, Johannes; Fehr, Ernst] Univ Zurich, Dept Econ, CH-8006 Zurich, Switzerland; [Haushofer, Johannes] Princeton Univ, Dept Psychol, Princeton, NJ 08544 USA; [Haushofer, Johannes] Princeton Univ, Woodrow Wilson Sch Publ & Int Affairs, Princeton, NJ 08544 USA	Massachusetts Institute of Technology (MIT); Harvard University; University of Zurich; Princeton University; Princeton University	Haushofer, J (corresponding author), MIT, Abdul Latif Jameel Poverty Act Lab, 30 Wadsworth St, Cambridge, MA 02142 USA.	joha@mit.edu; ernst.fehr@econ.uzh.ch			Cogito Foundation; NIH grant [R01AG039297]; Abdul Latif Jameel Poverty Action Lab; Harvard Program in Economics, History, and Politics; NATIONAL INSTITUTE ON AGING [R01AG039297] Funding Source: NIH RePORTER	Cogito Foundation; NIH grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Abdul Latif Jameel Poverty Action Lab; Harvard Program in Economics, History, and Politics; NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	We thank M. Alsan, V. Baranov, L. I. O. Berge, S. Bowles, A. D. Almenberg, C. Fry, H. Gintis, J. Elster, U. Karmarkar, I. Krajbich, J. Lerner, S. Mullainathan, D. Prelec, E. Rothschild, B. Tungodden, and T. Williams for comments. We gratefully acknowledge support from the Cogito Foundation, NIH grant R01AG039297, the Abdul Latif Jameel Poverty Action Lab, and the Harvard Program in Economics, History, and Politics.	[Anonymous], [No title captured]; Apouey B. H., J HLTH EC; ARNETZ BB, 1991, PSYCHOTHER PSYCHOSOM, V55, P76, DOI 10.1159/000288412; Arnsten AFT, 1998, TRENDS COGN SCI, V2, P436, DOI 10.1016/S1364-6613(98)01240-6; Ashraf N, 2006, Q J ECON, V121, P635, DOI 10.1162/qjec.2006.121.2.635; Baird S, 2013, J HUM RESOUR, V48, P370, DOI 10.1353/jhr.2013.0014; Banerjee A., REV EC STUD; Banerjee AV, 2008, J ECON PERSPECT, V22, P3, DOI 10.1257/jep.22.2.3; Banerjee AbhijitV., 2003, ECONOMETRIC SOC MONO, V37, P1; Blattman C., 2013, 2268552 SSRN ID; Bolton P, 2003, JAMA-J AM MED ASSOC, V289, P3117, DOI 10.1001/jama.289.23.3117; Bowles S, 2006, POVERTY TRAPS, DOI 10.1515/9781400841295; BROADHURST PL, 1959, ACTA PSYCHOL, V15, P603, DOI 10.1016/S0001-6918(59)80332-2; CARVALHO L. S, 2014, POVERTY EC DECISION; Cesarini D., 2013, ESTIMATING CAUSAL IM; Chemin M., 2013, POVERTY STRESS RAINF; Chen E, 2010, PSYCHOL SCI, V21, P31, DOI 10.1177/0956797609355566; Cingl L., 2013, 172013 IES; Cohen S, 2006, PSYCHOSOM MED, V68, P41, DOI 10.1097/01.psy.0000195967.51768.ea; Cohen S, 2006, PSYCHOSOM MED, V68, P414, DOI 10.1097/01.psy.0000221236.37158.b9; Cohn A., 2013, 004 UBS INT CTR EC S; Conte A., 2013, JENA EC RES PAPERS, V2013-046; Cornelisse S., 2013, SSRN WORKING PAPER S; Costello EJ, 2003, JAMA-J AM MED ASSOC, V290, P2023, DOI 10.1001/jama.290.15.2023; de Mel S, 2008, Q J ECON, V123, P1329, DOI 10.1162/qjec.2008.123.4.1329; Devoto F., 2011, W16933 NBER; Dohmen T, 2011, J EUR ECON ASSOC, V9, P522, DOI 10.1111/j.1542-4774.2011.01015.x; Drichoutis AC, 2013, J SOCIO-ECON, V45, P18, DOI 10.1016/j.socec.2013.04.008; Dupas P, 2013, AM ECON REV, V103, P1138, DOI 10.1257/aer.103.4.1138; Easterlin R. A., 1974, NATIONS HOUSEHOLDS E, P89, DOI [DOI 10.1016/B978-0-12-205050-3.50008-7, 10.1016/b978-0-12-205050-3.50008-7]; Evans GW, 2002, CHILD DEV, V73, P1238, DOI 10.1111/1467-8624.00469; Fernald LCH, 2008, LANCET, V371, P828, DOI 10.1016/S0140-6736(08)60382-7; Fernald LCH, 2008, BMC PUBLIC HEALTH, V8, DOI 10.1186/1471-2458-8-409; Finkelstein A, 2012, Q J ECON, V127, P1057, DOI 10.1093/qje/qjs020; Gardner J, 2007, J HEALTH ECON, V26, P49, DOI 10.1016/j.jhealeco.2006.08.004; Gollier C., 2001, HOUSEHOLD PORTFOLIOS; Guiso L., 2013, W19284 NBER; Guiso L, 2008, J EUR ECON ASSOC, V6, P1109, DOI 10.1162/JEEA.2008.6.6.1109; Haushofer J., 2013, HOUSEHOLD RESPONSE I; Haushofer J., 2013, NEGATIVE INCOME SHOC; Haushofer J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078597; Heilman RM, 2010, EMOTION, V10, P257, DOI 10.1037/a0018489; Ifcher J, 2011, AM ECON REV, V101, P3109, DOI 10.1257/aer.101.7.3109; Kandasamy N, 2014, P NATL ACAD SCI USA, V111, P3608, DOI 10.1073/pnas.1317908111; Karlan D., 2010, W16205 NBER; Kugler T, 2012, J BEHAV DECIS MAKING, V25, P123, DOI 10.1002/bdm.724; Kuhn P, 2011, AM ECON REV, V101, P2226, DOI 10.1257/aer.101.5.2226; LAWRANCE EC, 1991, J POLIT ECON, V99, P54, DOI 10.1086/261740; Lerner JS, 2013, PSYCHOL SCI, V24, P72, DOI 10.1177/0956797612450302; Li L, 2007, PSYCHONEUROENDOCRINO, V32, P824, DOI 10.1016/j.psyneuen.2007.05.014; Lighthall NR, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006002; Ludwig J., 2013, W18772 NBER; Lund C, 2010, SOC SCI MED, V71, P517, DOI 10.1016/j.socscimed.2010.04.027; Lupien SJ, 2001, DEV PSYCHOPATHOL, V13, P653, DOI 10.1017/S0954579401003133; Lupien SJ, 2000, BIOL PSYCHIAT, V48, P976, DOI 10.1016/S0006-3223(00)00965-3; Mani A, 2013, SCIENCE, V341, P976, DOI 10.1126/science.1238041; Mather M, 2009, PSYCHOL SCI, V20, P174, DOI 10.1111/j.1467-9280.2009.02275.x; Mendolia S., 2013, IMPACT JOB LOSS FAMI; Muraven M, 2000, PSYCHOL BULL, V126, P247, DOI 10.1037/0033-2909.126.2.247; Ozer EJ, 2011, INT J EPIDEMIOL, V40, P1565, DOI 10.1093/ije/dyr103; Paxson C, 2010, ECON DEV CULT CHANGE, V59, P187, DOI 10.1086/655458; Pender JL, 1996, J DEV ECON, V50, P257, DOI 10.1016/S0304-3878(96)00400-2; Porcelli AJ, 2009, PSYCHOL SCI, V20, P278, DOI 10.1111/j.1467-9280.2009.02288.x; PRATT JW, 1987, ECONOMETRICA, V55, P143, DOI 10.2307/1911160; Raghunathan R, 1999, ORGAN BEHAV HUM DEC, V79, P56, DOI 10.1006/obhd.1999.2838; Sacks D. W., 2012, DEV CHALLENGES POSTC, P283; Sacks DW, 2012, EMOTION, V12, P1181, DOI 10.1037/a0029873; Saridjan NS, 2010, HORM BEHAV, V57, P247, DOI 10.1016/j.yhbeh.2009.12.001; Schmitz A, 2012, NAT PROTOC, V7, P527, DOI 10.1038/nprot.2012.001; Schwabe L, 2012, J NEUROSCI, V32, P10146, DOI 10.1523/JNEUROSCI.1304-12.2012; Schwabe L, 2009, J NEUROSCI, V29, P7191, DOI 10.1523/JNEUROSCI.0979-09.2009; Seligman MEP, 2005, AM PSYCHOL, V60, P410, DOI 10.1037/0003-066X.60.5.410; Shah AK, 2012, SCIENCE, V338, P682, DOI 10.1126/science.1222426; Spears D, 2011, BE J ECON ANAL POLI, V11, DOI 10.2202/1935-1682.2973; Ssewamala FM, 2012, J ADOLESCENT HEALTH, V50, P346, DOI 10.1016/j.jadohealth.2011.08.008; Ssewamala FM, 2009, SOC SCI MED, V69, P191, DOI 10.1016/j.socscimed.2009.05.019; Stevenson B, 2008, BROOKINGS PAP ECO AC, P1; Tanaka T, 2010, AM ECON REV, V100, P557, DOI 10.1257/aer.100.1.557; Thaler RH, 2004, J POLIT ECON, V112, pS164, DOI 10.1086/380085; Tseng F. M., 2012, DUNDEE DISCUSSION PA, P263; UNICEF, 2012, STAT WORLDS CHILDR; WHO, 2001, WORLD HLTH REPORT 20; World health organization, 2013, WORLD HLTH STAT 2013; Yerkes RM, 1908, J COMP NEUROL PSYCHO, V18, P459, DOI 10.1002/cne.920180503; Yesuf M., 2008, 0816 EFD DP	85	616	638	41	490	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 23	2014	344	6186					862	867		10.1126/science.1232491	http://dx.doi.org/10.1126/science.1232491			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AH6IL	24855262				2022-12-28	WOS:000336233800039
J	Sedgwick, P				Sedgwick, Philip			STATISTICAL QUESTION What is an open label trial?	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							ALLOCATION		Univ London, Ctr Med & Healthcare Educ, London, England	St Georges University London; University of London	Sedgwick, P (corresponding author), Univ London, Ctr Med & Healthcare Educ, London, England.	p.sedgwick@sgul.ac.uk	Sedgwick, Philip/C-6997-2019	Sedgwick, Philip/0000-0001-8859-2175				Bawaskar HS, 2010, BMJ-BRIT MED J, V341, pc7136; Sedgwick P, 2013, BMJ-BRIT MED J, V347, DOI 10.1136/bmj.f5518; Sedgwick P, 2014, BMJ-BRIT MED J, V348, DOI 10.1136/bmj.g2409; Sedgwick P, 2013, BMJ BRIT MED J, V346, DOI 10.1136/bmj.f3345; Sedgwick P, 2011, BRIT MED J, V343, DOI 10.1136/bmj.d6068	5	6	6	0	7	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	MAY 23	2014	348								g3434	10.1136/bmj.g3434	http://dx.doi.org/10.1136/bmj.g3434			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AH9AC	24859904				2022-12-28	WOS:000336429700012
J	Spiegel, I; Mardinly, AR; Gabel, HW; Bazinet, JE; Couch, CH; Tzeng, CP; Harmin, DA; Greenberg, ME				Spiegel, Ivo; Mardinly, Alan R.; Gabel, Harrison W.; Bazinet, Jeremy E.; Couch, Cameron H.; Tzeng, Christopher P.; Harmin, David A.; Greenberg, Michael E.			Npas4 Regulates Excitatory-Inhibitory Balance within Neural Circuits through Cell-Type-Specific Gene Programs	CELL			English	Article							NEURONAL-ACTIVITY; CRITICAL PERIOD; VISUAL-CORTEX; INTERNEURONS; PLASTICITY; TRANSCRIPTION; EXPRESSION; MECHANISMS; MATURATION; EXPERIENCE	The nervous system adapts to experience by inducing a transcriptional program that controls important aspects of synaptic plasticity. Although the molecular mechanisms of experience-dependent plasticity are well characterized in excitatory neurons, the mechanisms that regulate this process in inhibitory neurons are only poorly understood. Here, we describe a transcriptional program that is induced by neuronal activity in inhibitory neurons. We find that, while neuronal activity induces expression of early-response transcription factors such as Npas4 in both excitatory and inhibitory neurons, Npas4 activates distinct programs of late-response genes in inhibitory and excitatory neurons. These late-response genes differentially regulate synaptic input to these two types of neurons, promoting inhibition onto excitatory neurons while inducing excitation onto inhibitory neurons. These findings suggest that the functional outcomes of activity-induced transcriptional responses are adapted in a cell-type-specific manner to achieve a circuit-wide homeostatic response.	[Spiegel, Ivo; Mardinly, Alan R.; Gabel, Harrison W.; Bazinet, Jeremy E.; Couch, Cameron H.; Tzeng, Christopher P.; Harmin, David A.; Greenberg, Michael E.] Harvard Univ, Sch Med, Dept Neurobiol, Boston, MA 02115 USA; [Mardinly, Alan R.; Tzeng, Christopher P.] Harvard Univ, Sch Med, Program Neurosci, Boston, MA 02115 USA	Harvard University; Harvard Medical School; Harvard University; Harvard Medical School	Greenberg, ME (corresponding author), Harvard Univ, Sch Med, Dept Neurobiol, 220 Longwood Ave, Boston, MA 02115 USA.	meg@hms.harvard.edu	Spiegel, Ivo/O-4025-2014	Tzeng, Christopher/0000-0003-4734-6298; Mardinly, Alan/0000-0001-9891-6719; Spiegel, Ivo/0000-0003-0979-1358	Human Frontiers Science Program; Swiss National Science Foundation; National Institutes of Health [NS048276]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P30HD018655] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [T32MH020017] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R37NS028829, R01NS048276] Funding Source: NIH RePORTER	Human Frontiers Science Program(Human Frontier Science Program); Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank F. Polleux and J. De Marchena for help with establishing the MGE cultures, C. Mandel-Brehm and C. Chen for help with electrophysiology experiments, J. M. Gray and A. M. Costa for help with preparing RNA-seq libraries, B. L. Bloodgood for preliminary recordings from MGE cultures, N. Sharma for the lentiviral expression construct of Npas4, E. Griffith and T. Cherry for critical reading of the manuscript, and P. Zhang for managing the mouse colony. This work was funded by fellowships by the Human Frontiers Science Program and the Swiss National Science Foundation (I. S.) and the National Institutes of Health grant NS048276 (M.E.G.).	Batista-Brito R, 2008, CEREB CORTEX, V18, P2306, DOI 10.1093/cercor/bhm258; Bloodgood BL, 2013, NATURE, V503, P121, DOI 10.1038/nature12743; Chang MC, 2010, NAT NEUROSCI, V13, P1090, DOI 10.1038/nn.2621; Chattopadhyaya B, 2004, J NEUROSCI, V24, P9598, DOI 10.1523/JNEUROSCI.1851-04.2004; Chen JL, 2011, NAT NEUROSCI, V14, P587, DOI 10.1038/nn.2799; Coutellier L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046604; Creyghton MP, 2010, P NATL ACAD SCI USA, V107, P21931, DOI 10.1073/pnas.1016071107; Fazzari P, 2010, NATURE, V464, P1376, DOI 10.1038/nature08928; Fino E, 2011, NEURON, V69, P1188, DOI 10.1016/j.neuron.2011.02.025; Flavell SW, 2008, ANNU REV NEUROSCI, V31, P563, DOI 10.1146/annurev.neuro.31.060407.125631; Garaschuk O, 2000, NAT NEUROSCI, V3, P452, DOI 10.1038/74823; Hensch TK, 2005, NAT REV NEUROSCI, V6, P877, DOI 10.1038/nrn1787; Hoffman DA, 1997, NATURE, V387, P869, DOI 10.1038/43119; Hong EJ, 2008, NEURON, V60, P610, DOI 10.1016/j.neuron.2008.09.024; Isaacson JS, 2011, NEURON, V72, P231, DOI 10.1016/j.neuron.2011.09.027; Kim TK, 2010, NATURE, V465, P182, DOI 10.1038/nature09033; Lee HW, 2008, J NEUROSCI, V28, P14546, DOI 10.1523/JNEUROSCI.3112-08.2008; Lewis DA, 2005, NAT REV NEUROSCI, V6, P312, DOI 10.1038/nrn1648; Lin YX, 2008, NATURE, V455, P1198, DOI 10.1038/nature07319; Markram H, 2004, NAT REV NEUROSCI, V5, P793, DOI 10.1038/nrn1519; Maya-Vetencourt JF, 2012, J PHYSIOL-LONDON, V590, P4777, DOI 10.1113/jphysiol.2012.234237; Okaty BW, 2009, J NEUROSCI, V29, P7040, DOI 10.1523/JNEUROSCI.0105-09.2009; Ploski JE, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023760; Ramamoorthi K, 2011, SCIENCE, V334, P1669, DOI 10.1126/science.1208049; Rudy B, 2011, DEV NEUROBIOL, V71, P45, DOI 10.1002/dneu.20853; Sanz E, 2009, P NATL ACAD SCI USA, V106, P13939, DOI 10.1073/pnas.0907143106; Silberberg G, 2007, NEURON, V53, P735, DOI 10.1016/j.neuron.2007.02.012; Somogyi P, 2005, J PHYSIOL-LONDON, V562, P9, DOI 10.1113/jphysiol.2004.078915; Turrigiano G, 2011, ANNU REV NEUROSCI, V34, P89, DOI 10.1146/annurev-neuro-060909-153238; WIESEL TN, 1963, J NEUROPHYSIOL, V26, P1003, DOI 10.1152/jn.1963.26.6.1003; Wonders CP, 2006, NAT REV NEUROSCI, V7, P687, DOI 10.1038/nrn1954	31	212	216	3	33	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAY 22	2014	157	5					1216	1229		10.1016/j.cell.2014.03.058	http://dx.doi.org/10.1016/j.cell.2014.03.058			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	AH9CG	24855953	Green Accepted, Bronze			2022-12-28	WOS:000336437200021
J	Brenner, H; Stock, C; Hoffmeister, M				Brenner, Hermann; Stock, Christian; Hoffmeister, Michael			Effect of screening sigmoidoscopy and screening colonoscopy on colorectal cancer incidence and mortality: systematic review and meta-analysis of randomised controlled trials and observational studies	BMJ-BRITISH MEDICAL JOURNAL			English	Review							SIDED COLON-CANCER; OCCULT BLOOD-TEST; FLEXIBLE SIGMOIDOSCOPY; UNITED-STATES; FOLLOW-UP; TELEMARK POLYP; RISK; PREVENTION; ENDOSCOPY; RATES	Objectives To review, summarise, and compare the evidence for effectiveness of screening sigmoidoscopy and screening colonoscopy in the prevention of colorectal cancer occurrence and deaths. Design Systematic review and meta-analysis of randomised controlled trials and observational studies. Data sources PubMed, Embase, and Web of Science. Two investigators independently extracted characteristics and results of identified studies and performed standardised quality ratings. Eligibility criteria Randomised controlled trials and observational studies in English on the impact of screening sigmoidoscopy and screening colonoscopy on colorectal cancer incidence and mortality in the general population at average risk. Results For screening sigmoidoscopy, four randomised controlled trials and 10 observational studies were identified that consistently found a major reduction in distal but not proximal colorectal cancer incidence and mortality. Summary estimates of reduction in distal colorectal cancer incidence and mortality were 31% (95% confidence intervals 26% to 37%) and 46% (33% to 57%) in intention to screen analysis, 42% (29% to 53%) and 61% (27% to 79%) in per protocol analysis of randomised controlled trials, and 64% (50% to 74%) and 66% (38% to 81%) in observational studies. For screening colonoscopy, evidence was restricted to six observational studies, the results of which suggest tentatively an even stronger reduction in distal colorectal cancer incidence and mortality, along with a significant reduction in mortality from cancer of the proximal colon. Indirect comparisons of results of observational studies on screening sigmoidoscopy and colonoscopy suggest a 40% to 60% lower risk of incident colorectal cancer and death from colorectal cancer after screening colonoscopy even though this incremental risk reduction was statistically significant for deaths from cancer of the proximal colon only. Conclusions Compelling and consistent evidence from randomised controlled trials and observational studies suggests that screening sigmoidoscopy and screening colonoscopy prevent most deaths from distal colorectal cancer. Observational studies suggest that colonoscopy compared with flexible sigmoidoscopy decreases mortality from cancer of the proximal colon. This added value should be examined in further research and weighed against the higher costs, discomfort, complication rates, capacities needed, and possible differences in compliance.	[Brenner, Hermann; Stock, Christian; Hoffmeister, Michael] German Canc Res Ctr, Div Clin Epidemiol & Aging Res, D-69120 Heidelberg, Germany; [Brenner, Hermann] German Canc Consortium, Heidelberg, Germany; [Stock, Christian] Heidelberg Univ, Inst Med Biometry & Informat, Heidelberg, Germany	Helmholtz Association; German Cancer Research Center (DKFZ); Helmholtz Association; German Cancer Research Center (DKFZ); Ruprecht Karls University Heidelberg	Brenner, H (corresponding author), German Canc Res Ctr, Div Clin Epidemiol & Aging Res, INF 581, D-69120 Heidelberg, Germany.	h.brenner@dkfz.de	Hoffmeister, Michael/AAB-2321-2022; Stock, Christian/F-6180-2015; Hoffmeister, Michael/T-7187-2019; Brenner, Hermann/B-4627-2017; Brenner, Hermann/ABE-6383-2020; Hoffmeister, Michael/B-5745-2012	Hoffmeister, Michael/0000-0002-8307-3197; Stock, Christian/0000-0002-3493-3234; Hoffmeister, Michael/0000-0002-8307-3197; Brenner, Hermann/0000-0002-6129-1572; Brenner, Hermann/0000-0002-6129-1572; Hoffmeister, Michael/0000-0002-8307-3197	German Research Council (Deutsche Forschungsgemeinschaft) [BR 1704/6-4]; German Federal Ministry of Education and Research [01ER0814]	German Research Council (Deutsche Forschungsgemeinschaft)(German Research Foundation (DFG)); German Federal Ministry of Education and Research(Federal Ministry of Education & Research (BMBF))	This work was supported in part by grants from the German Research Council (Deutsche Forschungsgemeinschaft, grant BR 1704/6-4) and the German Federal Ministry of Education and Research (grant No 01ER0814). The sponsors had no role in the study design; collection, analysis, and interpretation of data; writing of the report; and decision to submit the article for publication.	Arain MA, 2010, AM J GASTROENTEROL, V105, P1189, DOI 10.1038/ajg.2009.699; Atkin WS, 2010, LANCET, V375, P1624, DOI 10.1016/S0140-6736(10)60551-X; Baxter NN, 2012, J CLIN ONCOL, V30, P2664, DOI 10.1200/JCO.2011.40.4772; Baxter NN, 2009, ANN INTERN MED, V150, P1, DOI 10.7326/0003-4819-150-1-200901060-00306; Blom J, 2008, CANCER EPIDEM BIOMAR, V17, P1163, DOI 10.1158/1055-9965.EPI-07-2764; Brenner H, 2001, BRIT J CANCER, V85, P972, DOI 10.1038/sj.bjc.6692023; Brenner H, 2007, CANCER EPIDEM BIOMAR, V16, P494, DOI 10.1158/1055-9965.EPI-06-0460; Brenner H, 2014, GASTROENTEROLOGY, V146, P709, DOI 10.1053/j.gastro.2013.09.001; Brenner H, 2013, J CLIN EPIDEMIOL, V66, P1144, DOI 10.1016/j.jclinepi.2013.05.008; Brenner H, 2011, ANN INTERN MED, V154, P22, DOI 10.7326/0003-4819-154-1-201101040-00004; Bressler B, 2004, GASTROENTEROLOGY, V127, P452, DOI 10.1053/j.gastro.2004.05.032; Bressler B, 2007, GASTROENTEROLOGY, V132, P96, DOI 10.1053/j.gastro.2006.10.027; Bucher HC, 1997, J CLIN EPIDEMIOL, V50, P683, DOI 10.1016/S0895-4356(97)00049-8; Castro G, 2013, CANCER-AM CANCER SOC, V119, P2849, DOI 10.1002/cncr.28159; Cooper GS, 2013, JAMA INTERN MED, V173, P551, DOI 10.1001/jamainternmed.2013.2908; Cotterchio M, 2005, CANCER CAUSE CONTROL, V16, P865, DOI 10.1007/s10552-005-2370-3; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; Doubeni CA, 2013, ANN INTERN MED, V158, P312, DOI 10.7326/0003-4819-158-5-201303050-00003; Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629; Elmunzer BJ, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001352; GILBERTSEN VA, 1978, CANCER, V41, P1137, DOI 10.1002/1097-0142(197803)41:3<1137::AID-CNCR2820410350>3.0.CO;2-G; Higgins JPT, 2002, STAT MED, V21, P1539, DOI 10.1002/sim.1186; Hoff G, 1996, SCAND J GASTROENTERO, V31, P1006, DOI 10.3109/00365529609003121; Hoff G, 2009, BMJ-BRIT MED J, V338, DOI 10.1136/bmj.b1846; Iacopetta B, 2002, INT J CANCER, V101, P403, DOI 10.1002/ijc.10635; Jacob BJ, 2012, GASTROINTEST ENDOSC, V76, P355, DOI 10.1016/j.gie.2012.03.247; Kahi CJ, 2009, CLIN GASTROENTEROL H, V7, P770, DOI 10.1016/j.cgh.2008.12.030; Kaminski MF, 2012, ENDOSCOPY, V44, P695, DOI 10.1055/s-0032-1306895; Kavanagh AM, 1998, CANCER CAUSE CONTROL, V9, P455; Liberati A, 2009, BMJ-BRIT MED J, V339, DOI [10.1371/journal.pmed.1000100, 10.1136/bmj.b2700, 10.7326/0003-4819-151-4-200908180-00136]; Littlejohn C, 2012, BRIT J SURG, V99, P1488, DOI 10.1002/bjs.8882; Manser CN, 2012, GASTROINTEST ENDOSC, V76, P110, DOI 10.1016/j.gie.2012.02.040; Mulder SA, 2010, EUR J GASTROEN HEPAT, V22, P437, DOI 10.1097/MEG.0b013e328333fc6a; MULLER AD, 1995, ARCH INTERN MED, V155, P1741, DOI 10.1001/archinte.155.16.1741; MULLER AD, 1995, ANN INTERN MED, V123, P904, DOI 10.7326/0003-4819-123-12-199512150-00002; Nawa T, 2008, J GASTROEN HEPATOL, V23, P418, DOI 10.1111/j.1440-1746.2007.04923.x; NEWCOMB PA, 1992, JNCI-J NATL CANCER I, V84, P1572, DOI 10.1093/jnci/84.20.1572; Newcomb PA, 2003, J NATL CANCER I, V95, P622, DOI 10.1093/jnci/95.8.622; Nishihara R, 2013, NEW ENGL J MED, V369, P1095, DOI 10.1056/NEJMoa1301969; Rabeneck L, 2008, AM J GASTROENTEROL, V103, P2075, DOI 10.1111/j.1572-0241.2008.01932.x; Rabeneck L, 2010, AM J GASTROENTEROL, V105, P1627, DOI 10.1038/ajg.2010.83; Rex DK, 2000, AM J GASTROENTEROL, V95, P868, DOI 10.1111/j.1572-0241.2000.02059.x; Scheitel SM, 1999, MAYO CLIN PROC, V74, P1207, DOI 10.4065/74.12.1207; Schmiegel W, 2004, Z GASTROENTEROL, V42, P1129, DOI 10.1055/s-2004-813699; Schoen RE, 2012, NEW ENGL J MED, V366, P2345, DOI 10.1056/NEJMoa1114635; Schwarzer G, 2013, META METAANALYSIS R; Segnan N, 2011, J NATL CANCER I, V103, P1310, DOI 10.1093/jnci/djr284; SELBY JV, 1992, NEW ENGL J MED, V326, P653, DOI 10.1056/NEJM199203053261001; Shapiro JA, 2012, CANCER EPIDEM BIOMAR, V21, P895, DOI 10.1158/1055-9965.EPI-12-0192; Sharaf RN, 2013, AM J GASTROENTEROL, V108, P120, DOI 10.1038/ajg.2012.380; Siegel RL, 2012, CANCER EPIDEM BIOMAR, V21, P411, DOI 10.1158/1055-9965.EPI-11-1020; Singh H, 2006, JAMA-J AM MED ASSOC, V295, P2366, DOI 10.1001/jama.295.20.2366; Singh H, 2010, GASTROENTEROLOGY, V139, P1128, DOI 10.1053/j.gastro.2010.06.052; Slattery ML, 2000, CANCER CAUSE CONTROL, V11, P555, DOI 10.1023/A:1008924115604; Smith RA, 2005, CA-CANCER J CLIN, V55, P31, DOI 10.3322/canjclin.55.1.31; Stock C, 2011, ENDOSCOPY, V43, P771, DOI 10.1055/s-0030-1256504; Stock C, 2010, ENDOSCOPY, V42, P546, DOI 10.1055/s-0029-1244127; Stock C, 2013, GASTROINTEST ENDOSC, V77, P419, DOI 10.1016/j.gie.2012.10.028; Stock C, 2012, GASTROINTEST ENDOSC, V75, P621, DOI 10.1016/j.gie.2011.10.025; Stock C, 2010, GASTROINTEST ENDOSC, V71, P366, DOI 10.1016/j.gie.2009.06.018; Strock P, 2011, DIGEST LIVER DIS, V43, P899, DOI 10.1016/j.dld.2011.05.020; Stroup DF, 2000, JAMA-J AM MED ASSOC, V283, P2008, DOI 10.1001/jama.283.15.2008; Thiis-Evensen E, 1999, SCAND J GASTROENTERO, V34, P414; Wang YZR, 2013, MAYO CLIN PROC, V88, P464, DOI 10.1016/j.mayocp.2012.12.012; Weiss NS, 2004, EPIDEMIOLOGY, V15, P409, DOI 10.1097/01.ede.0000129518.99816.e1; Winawer S, 2003, GASTROENTEROLOGY, V124, P544, DOI 10.1053/gast.2003.50044; WINAWER SJ, 1993, NEW ENGL J MED, V329, P1977, DOI 10.1056/NEJM199312303292701	67	465	486	3	11	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	APR 9	2014	348								g2467	10.1136/bmj.g2467	http://dx.doi.org/10.1136/bmj.g2467			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AE9SE	24922745	Green Published, hybrid			2022-12-28	WOS:000334348700001
J	Ioannidis, JPA; Khoury, MJ				Ioannidis, John P. A.; Khoury, Muin J.			Assessing Value in Biomedical Research The PQRST of Appraisal and Reward	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Ioannidis, John P. A.] Stanford Univ, Sch Med, Dept Med, Palo Alto, CA 94304 USA; [Ioannidis, John P. A.] Stanford Univ, Sch Med, Dept Hlth Res & Policy, Palo Alto, CA 94304 USA; [Ioannidis, John P. A.] Stanford Univ, Sch Humanities & Sci, Dept Stat, Palo Alto, CA 94304 USA; [Ioannidis, John P. A.] Stanford Univ, Meta Res Innovat Ctr Stanford METRICS, Palo Alto, CA 94304 USA; [Khoury, Muin J.] Ctr Dis Control & Prevent, Off Publ Hlth Genom, Atlanta, GA USA; [Khoury, Muin J.] NCI, NIH, Bethesda, MD 20892 USA	Stanford University; Stanford University; Stanford University; Stanford University; Centers for Disease Control & Prevention - USA; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Ioannidis, JPA (corresponding author), Stanford Univ, Stanford Prevent Res Ctr, Stanford, CA 94305 USA.	jioannid@stanford.edu	Ioannidis, John P. A./G-9836-2011		Intramural CDC HHS [CC999999] Funding Source: Medline	Intramural CDC HHS		Aziz NA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059814; Bohannon J, 2013, SCIENCE, V342, P60, DOI 10.1126/science.342.6154.60; Collins FS, 2014, NATURE, V505, P612, DOI 10.1038/505612a; Dal-Re R, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3007513; Gordon D, 2013, NEW ENGL J MED, V369, P1926, DOI 10.1056/NEJMsa1300237; Macleod M, 2011, NATURE, V477, P511, DOI 10.1038/477511a; Macleod MR, 2014, LANCET, V383, P101, DOI 10.1016/S0140-6736(13)62329-6; Simera I, 2010, EUR J CLIN INVEST, V40, P35, DOI 10.1111/j.1365-2362.2009.02234.x	8	61	63	0	22	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	AUG 6	2014	312	5					483	484		10.1001/jama.2014.6932	http://dx.doi.org/10.1001/jama.2014.6932			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AM4FL	24911291	Green Accepted			2022-12-28	WOS:000339808600013
J	Kizer, KW; Jha, AK				Kizer, Kenneth W.; Jha, Ashish K.			Restoring Trust in VA Health Care	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							TRANSFORMATION; SYSTEM		[Kizer, Kenneth W.] UC Davis Hlth Syst, Inst Populat Hlth Improvement, Sacramento, CA 95817 USA; [Kizer, Kenneth W.] Univ Calif Davis, Sch Med, Dept Emergency Med, Sacramento, CA 95817 USA; [Kizer, Kenneth W.] Betty Irene Moore Sch Nursing, Sacramento, CA USA; [Jha, Ashish K.] Harvard Univ, Sch Publ Hlth, Dept Hlth Policy & Management, Boston, MA 02115 USA; [Jha, Ashish K.] Brigham & Womens Hosp, Div Gen Med, Boston, MA 02115 USA	University of California System; University of California Davis; University of California System; University of California Davis; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Brigham & Women's Hospital	Kizer, KW (corresponding author), UC Davis Hlth Syst, Inst Populat Hlth Improvement, Sacramento, CA 95817 USA.							Institute of Medicine, 2001, CROSSING QUALITY CHA, DOI [10.17226/10027, DOI 10.17226/10027]; Jha AK, 2003, NEW ENGL J MED, V348, P2218, DOI 10.1056/NEJMsa021899; Kizer KW, 2012, J GEN INTERN MED, V27, P395, DOI 10.1007/s11606-011-1981-5; Kizer KW, 2009, ANNU REV PUBL HEALTH, V30, P313, DOI 10.1146/annurev.publhealth.29.020907.090940; Trivedi AN, 2011, MED CARE, V49, P76, DOI 10.1097/MLR.0b013e3181f53575	5	50	50	0	8	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUL 24	2014	371	4					295	297		10.1056/NEJMp1406852	http://dx.doi.org/10.1056/NEJMp1406852			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	AL7TY	24896816				2022-12-28	WOS:000339339800004
J	Patel, AP; Tirosh, I; Trombetta, JJ; Shalek, AK; Gillespie, SM; Wakimoto, H; Cahill, DP; Nahed, BV; Curry, WT; Martuza, RL; Louis, DN; Rozenblatt-Rosen, O; Suva, ML; Regev, A; Bernstein, BE				Patel, Anoop P.; Tirosh, Itay; Trombetta, John J.; Shalek, Alex K.; Gillespie, Shawn M.; Wakimoto, Hiroaki; Cahill, Daniel P.; Nahed, Brian V.; Curry, William T.; Martuza, Robert L.; Louis, David N.; Rozenblatt-Rosen, Orit; Suva, Mario L.; Regev, Aviv; Bernstein, Bradley E.			Single-cell RNA-seq highlights intratumoral heterogeneity in primary glioblastoma	SCIENCE			English	Article							STEM-LIKE CELLS; INTEGRATED GENOMIC ANALYSIS; TUMOR HETEROGENEITY; GROWTH; EXPRESSION; EVOLUTION; RECEPTOR; GENOTYPE; REVEALS; CANCER	Human cancers are complex ecosystems composed of cells with distinct phenotypes, genotypes, and epigenetic states, but current models do not adequately reflect tumor composition in patients. We used single-cell RNA sequencing (RNA-seq) to profile 430 cells from five primary glioblastomas, which we found to be inherently variable in their expression of diverse transcriptional programs related to oncogenic signaling, proliferation, complement/immune response, and hypoxia. We also observed a continuum of stemness-related expression states that enabled us to identify putative regulators of stemness in vivo. Finally, we show that established glioblastoma subtype classifiers are variably expressed across individual cells within a tumor and demonstrate the potential prognostic implications of such intratumoral heterogeneity. Thus, we reveal previously unappreciated heterogeneity in diverse regulatory programs central to glioblastoma biology, prognosis, and therapy.	[Patel, Anoop P.; Wakimoto, Hiroaki; Cahill, Daniel P.; Nahed, Brian V.; Curry, William T.; Martuza, Robert L.] Massachusetts Gen Hosp, Dept Neurosurg, Boston, MA 02114 USA; [Patel, Anoop P.; Gillespie, Shawn M.; Wakimoto, Hiroaki; Cahill, Daniel P.; Nahed, Brian V.; Curry, William T.; Martuza, Robert L.; Louis, David N.; Suva, Mario L.; Bernstein, Bradley E.] Harvard Univ, Sch Med, Boston, MA 02114 USA; [Patel, Anoop P.; Gillespie, Shawn M.; Louis, David N.; Suva, Mario L.; Bernstein, Bradley E.] Massachusetts Gen Hosp, Dept Pathol, Boston, MA 02114 USA; [Patel, Anoop P.; Tirosh, Itay; Trombetta, John J.; Shalek, Alex K.; Gillespie, Shawn M.; Rozenblatt-Rosen, Orit; Suva, Mario L.; Regev, Aviv; Bernstein, Bradley E.] Broad Inst Harvard & Massachusetts Inst Techonol, Cambridge, MA 02142 USA; [Patel, Anoop P.; Gillespie, Shawn M.; Regev, Aviv; Bernstein, Bradley E.] Howard Hughes Med Inst Chevy Chase, Chevy Chase, MD 20815 USA; [Regev, Aviv] MIT, Dept Biol, Cambridge, MA 02139 USA	Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Massachusetts Institute of Technology (MIT)	Suva, ML (corresponding author), Massachusetts Gen Hosp, Dept Pathol, Boston, MA 02114 USA.	suva.mario@mgh.harvard.edu; aregev@broadinstitute.org; bernstein.bradley@mgh.harvard.edu	Wakimoto, Hiroaki/H-4533-2019; Rozenblatt-Rosen, Orit/HDN-4182-2022; wang, edwin/G-5372-2010; Shalek, Alex/Y-2434-2019; Suva, Mario/AAY-7798-2020; Nahed, Brian/E-4239-2014	Wakimoto, Hiroaki/0000-0001-8225-241X; Shalek, Alex/0000-0001-5670-8778; Suva, Mario/0000-0001-9898-5351; Gillespie, Shawn/0000-0003-1913-0860; Cahill, Daniel/0000-0003-2552-6546; Nahed, Brian/0000-0001-8537-106X	NIH- National Institute of Neurological Disorders and Stroke [R25NS065743]; Human Frontier Science Program fellowship; Rothschild fellowship; Medic Foundation; Howard Hughes Medical Institute; Burroughs Wellcome Fund; Harvard Stem Cell Institute; NIH [R01 NS032677, U24 CA180922]; National Brain Tumor Society; Klarman Family Foundation; NATIONAL CANCER INSTITUTE [U24CA180922, P50CA165962] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U54HG006991] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R25NS065743, R01NS032677] Funding Source: NIH RePORTER	NIH- National Institute of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Human Frontier Science Program fellowship(Human Frontier Science Program); Rothschild fellowship; Medic Foundation; Howard Hughes Medical Institute(Howard Hughes Medical Institute); Burroughs Wellcome Fund(Burroughs Wellcome Fund); Harvard Stem Cell Institute; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Brain Tumor Society; Klarman Family Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank E. Shefler for project management, E. Rheinbay for graphical contributions, J. Kim and P. Santos for histology, and P. Bautista and Y. Yagi for slide scanning. A. P. P was supported by NIH- National Institute of Neurological Disorders and Stroke R25NS065743. I. T. was supported by a Human Frontier Science Program fellowship and a Rothschild fellowship. M. L. S was supported by a grant from Medic Foundation. This research was supported by funds from Howard Hughes Medical Institute, Burroughs Wellcome Fund, Harvard Stem Cell Institute, NIH (R01 NS032677 to R. L. M. and U24 CA180922 to A. R.), National Brain Tumor Society, and Klarman Family Foundation. A. R. is a scientific advisory board member for Syros Pharmaceuticals and a consultant for Cancer Therapeutics Innovation Group. B. E. B. is a scientific advisory board member for Syros Pharmaceuticals and a founder and scientific advisor for HiFiBio SAS. RNA-seq data are deposited in Gene Expression Omnibus with accession no. GSE57872.	Bao SD, 2006, NATURE, V444, P756, DOI 10.1038/nature05236; Bedard PL, 2013, NATURE, V501, P355, DOI 10.1038/nature12627; Bhat KPL, 2013, CANCER CELL, V24, P331, DOI 10.1016/j.ccr.2013.08.001; Brennan CW, 2013, CELL, V155, P462, DOI 10.1016/j.cell.2013.09.034; Chen J, 2012, NATURE, V488, P522, DOI 10.1038/nature11287; Cho MS, 2014, CELL REP, V6, P1085, DOI 10.1016/j.celrep.2014.02.014; Choi BD, 2013, P NATL ACAD SCI USA, V110, P270, DOI 10.1073/pnas.1219817110; Cloughesy TF, 2014, ANNU REV PATHOL-MECH, V9, P1, DOI 10.1146/annurev-pathol-011110-130324; Driessens G, 2012, NATURE, V488, P527, DOI 10.1038/nature11344; Eppert K, 2011, NAT MED, V17, P1086, DOI 10.1038/nm.2415; Gerlinger M, 2012, NEW ENGL J MED, V366, P883, DOI 10.1056/NEJMoa1113205; Gilbert MR, 2014, NEW ENGL J MED, V370, P699, DOI 10.1056/NEJMoa1308573; Lee J, 2006, CANCER CELL, V9, P391, DOI 10.1016/j.ccr.2006.03.030; Li Z, 2009, CANCER CELL, V15, P501, DOI 10.1016/j.ccr.2009.03.018; Lonsdale J, 2013, NAT GENET, V45, P580, DOI 10.1038/ng.2653; Martynoga B, 2013, GENE DEV, V27, P1769, DOI 10.1101/gad.216804.113; Meacham CE, 2013, NATURE, V501, P328, DOI 10.1038/nature12624; Nathanson DA, 2014, SCIENCE, V343, P72, DOI 10.1126/science.1241328; Navin N, 2011, NATURE, V472, P90, DOI 10.1038/nature09807; Noushmehr H, 2010, CANCER CELL, V17, P510, DOI 10.1016/j.ccr.2010.03.017; Novershtern N, 2011, CELL, V144, P296, DOI 10.1016/j.cell.2011.01.004; Parsons DW, 2008, SCIENCE, V321, P1807, DOI 10.1126/science.1164382; Ramskold D, 2012, NAT BIOTECHNOL, V30, P777, DOI 10.1038/nbt.2282; Ricci-Vitiani L, 2010, NATURE, V468, P824, DOI 10.1038/nature09557; Roesch A, 2010, CELL, V141, P583, DOI 10.1016/j.cell.2010.04.020; Sang LY, 2008, SCIENCE, V321, P1095, DOI 10.1126/science.1155998; Schepers AG, 2012, SCIENCE, V337, P730, DOI 10.1126/science.1224676; Shalek AK, 2013, NATURE, V498, P236, DOI 10.1038/nature12172; Shostak KO, 2003, J SURG ONCOL, V82, P57, DOI 10.1002/jso.10180; Singh SK, 2004, NATURE, V432, P396, DOI 10.1038/nature03128; Snuderl M, 2011, CANCER CELL, V20, P810, DOI 10.1016/j.ccr.2011.11.005; Soda Y, 2011, P NATL ACAD SCI USA, V108, P4274, DOI 10.1073/pnas.1016030108; Sottoriva A, 2013, P NATL ACAD SCI USA, V110, P4009, DOI 10.1073/pnas.1219747110; Stommel JM, 2007, SCIENCE, V318, P287, DOI 10.1126/science.1142946; Stupp R, 2005, NEW ENGL J MED, V352, P987, DOI 10.1056/NEJMoa043330; Suva ML, 2014, CELL, V157, P580, DOI 10.1016/j.cell.2014.02.030; Verhaak RGW, 2010, CANCER CELL, V17, P98, DOI 10.1016/j.ccr.2009.12.020; Wakimoto H, 2012, NEURO-ONCOLOGY, V14, P132, DOI 10.1093/neuonc/nor195; Wang H, 2011, NEOPLASIA, V13, P461, DOI 10.1593/neo.101744; Wang R, 2010, NATURE, V468, P829, DOI 10.1038/nature09624; Xu J, 2014, SCI REP-UK, V4, DOI 10.1038/srep04223; Yachida S, 2010, NATURE, V467, P1114, DOI 10.1038/nature09515	42	2347	2432	33	493	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 20	2014	344	6190					1396	1401		10.1126/science.1254257	http://dx.doi.org/10.1126/science.1254257			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AJ2YQ	24925914	Green Accepted, Green Submitted			2022-12-28	WOS:000337531700040
J	Bartlett, SD				Bartlett, Stephen D.			QUANTUM COMPUTING Powered by magic	NATURE			English	Editorial Material									[Bartlett, Stephen D.] Univ Sydney, Ctr Engn Quantum Syst, Sydney, NSW 2006, Australia; [Bartlett, Stephen D.] Univ Sydney, Sch Phys, Sydney, NSW 2006, Australia	University of Sydney; University of Sydney	Bartlett, SD (corresponding author), Univ Sydney, Ctr Engn Quantum Syst, Sydney, NSW 2006, Australia.	stephen.bartlett@sydney.edu.au	Bartlett, Stephen D/A-4163-2008	Bartlett, Stephen D/0000-0003-4387-670X				Aaronson S, 2004, PHYS REV A, V70, DOI 10.1103/PhysRevA.70.052328; Bravyi S, 2005, PHYS REV A, V71, DOI 10.1103/PhysRevA.71.022316; Gibbons KS, 2004, PHYS REV A, V70, DOI 10.1103/PhysRevA.70.062101; Gottesman D, 1996, PHYS REV A, V54, P1862, DOI 10.1103/PhysRevA.54.1862; Howard M, 2014, NATURE, V510, P351, DOI 10.1038/nature13460; Raussendorf R, 2013, PHYS REV A, V88, DOI 10.1103/PhysRevA.88.022322; Spekkens RW, 2007, PHYS REV A, V75, DOI 10.1103/PhysRevA.75.032110; Veitch V, 2012, NEW J PHYS, V14, DOI 10.1088/1367-2630/14/11/113011	8	6	6	0	23	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 19	2014	510	7505					345	347		10.1038/nature13504	http://dx.doi.org/10.1038/nature13504			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AJ0NG	24919151				2022-12-28	WOS:000337350200023
J	Tura, J; Augusiak, R; Sainz, AB; Vertesi, T; Lewenstein, M; Acin, A				Tura, J.; Augusiak, R.; Sainz, A. B.; Vertesi, T.; Lewenstein, M.; Acin, A.			QUANTUM NONLOCALITY Detecting nonlocality in many-body quantum states	SCIENCE			English	Article							BELLS THEOREM; ENTANGLEMENT	Intensive studies of entanglement properties have proven essential for our understanding of quantum many-body systems. In contrast, much less is known about the role of quantum nonlocality in these systems because the available multipartite Bell inequalities involve correlations among many particles, which are difficult to access experimentally. We constructed multipartite Bell inequalities that involve only two-body correlations and show how they reveal the nonlocality in many-body systems relevant for nuclear and atomic physics. Our inequalities are violated by any number of parties and can be tested by measuring total spin components, opening the way to the experimental detection of many-body nonlocality, for instance with atomic ensembles.	[Tura, J.; Augusiak, R.; Sainz, A. B.; Lewenstein, M.; Acin, A.] ICFO Inst Ciencies Foton, Barcelona 08860, Spain; [Vertesi, T.] Hungarian Acad Sci, Inst Nucl Res, H-4001 Debrecen, Hungary; [Lewenstein, M.; Acin, A.] ICREA Inst Catalana Recerca & Estudis Avancats, Barcelona 08010, Spain	Barcelona Institute of Science & Technology; Universitat Politecnica de Catalunya; Institut de Ciencies Fotoniques (ICFO); Eotvos Lorand Research Network; Hungarian Academy of Sciences; Hungarian Institute for Nuclear Research; ICREA	Augusiak, R (corresponding author), ICFO Inst Ciencies Foton, Ave Carl Friedrich Gauss 3, Barcelona 08860, Spain.	remigiusz.augusiak@icfo.es	Tura, Jordi/G-4172-2016; Lewenstein, Maciej/I-1337-2014; Tura, Jordi/AAA-2816-2020; Augusiak, Remigiusz/J-9759-2015; Vértesi, Tamás/B-3416-2017; Sainz, Ana Belen/AAW-8136-2020	Tura, Jordi/0000-0002-6123-1422; Lewenstein, Maciej/0000-0002-0210-7800; Tura, Jordi/0000-0002-6123-1422; Augusiak, Remigiusz/0000-0003-1154-6132; Vértesi, Tamás/0000-0003-4437-9414; Sainz, Ana Belen/0000-0003-3123-8436	Hungarian Scientific Research Fund [PD101461]; Spanish Device-Independent Quantum Information Processing (DIQIP) CHIST-ERA project; Juan de la Cierva Fellowship; FPU PhD grant [AP2009-1174]; European Union (EU) Integrated Projects Simulators and Interfaces with Quantum Systems (EU IP SIQS); EU Specific Targeted Research Projects Emulators of Quantum Frustrated Magnetism (EU STREP EQUAM); European Research Council Advanced Grants Quantum Gauge Theories and Ultracold Atoms (ERC AdG QUAGATUA); Open SYstems RevISited (OSYRIS); Consolidator Grant Quantum Information Theory with black BOXes (CoG QITBOX); ICREA Funding Source: Custom	Hungarian Scientific Research Fund(Orszagos Tudomanyos Kutatasi Alapprogramok (OTKA)); Spanish Device-Independent Quantum Information Processing (DIQIP) CHIST-ERA project; Juan de la Cierva Fellowship; FPU PhD grant(German Research Foundation (DFG)); European Union (EU) Integrated Projects Simulators and Interfaces with Quantum Systems (EU IP SIQS); EU Specific Targeted Research Projects Emulators of Quantum Frustrated Magnetism (EU STREP EQUAM); European Research Council Advanced Grants Quantum Gauge Theories and Ultracold Atoms (ERC AdG QUAGATUA); Open SYstems RevISited (OSYRIS); Consolidator Grant Quantum Information Theory with black BOXes (CoG QITBOX); ICREA(ICREA)	Discussions with J. Stasinska are greatly acknowledged. This work is supported by the Hungarian Scientific Research Fund (PD101461), the Spanish Device-Independent Quantum Information Processing (DIQIP) CHIST-ERA project, a Juan de la Cierva Fellowship and AP2009-1174 FPU PhD grant, European Union (EU) Integrated Projects Simulators and Interfaces with Quantum Systems (EU IP SIQS); EU Specific Targeted Research Projects Emulators of Quantum Frustrated Magnetism (EU STREP EQUAM); European Research Council Advanced Grants Quantum Gauge Theories and Ultracold Atoms (ERC AdG QUAGATUA) and Open SYstems RevISited (OSYRIS), and Consolidator Grant Quantum Information Theory with black BOXes (CoG QITBOX). This publication was made possible through the support of a grant from the John Templeton Foundation.	Acin A, 2007, PHYS REV LETT, V98, DOI 10.1103/PhysRevLett.98.230501; Aolita L, 2012, PHYS REV LETT, V108, DOI 10.1103/PhysRevLett.108.100401; Augusiak R, 2012, PHYS REV A, V86, DOI 10.1103/PhysRevA.86.042316; Bancal JD, 2010, J PHYS A-MATH THEOR, V43, DOI 10.1088/1751-8113/43/38/385303; Barrett J, 2005, PHYS REV LETT, V95, DOI 10.1103/PhysRevLett.95.010503; Bell JS., 1964, PHYS, V1, P195, DOI [10.1103/PhysicsPhysiqueFizika.1.195, 10.1103/Physics-PhysiqueFizika.1.195, DOI 10.1103/PHYSICSPHYSIQUEFIZIKA.1.195]; Brunner N, 2014, REV MOD PHYS, V86, DOI 10.1103/RevModPhys.86.419; Brunner N, 2012, PHYS REV LETT, V108, DOI 10.1103/PhysRevLett.108.110501; Chang DE, 2013, PHYS REV LETT, V110, DOI 10.1103/PhysRevLett.110.113606; Colbeck R., 2007, THESIS U CAMBRIDGE; Colbeck R, 2011, J PHYS A-MATH THEOR, V44, DOI 10.1088/1751-8113/44/9/095305; DICKE RH, 1954, PHYS REV, V93, P99, DOI 10.1103/PhysRev.93.99; Eckert K, 2008, NAT PHYS, V4, P50, DOI 10.1038/nphys776; EKERT AK, 1991, PHYS REV LETT, V67, P661, DOI 10.1103/PhysRevLett.67.661; Wurflinger LE, 2012, PHYS REV A, V86, DOI 10.1103/PhysRevA.86.032117; Grass T, 2013, PHYS REV LETT, V111, DOI 10.1103/PhysRevLett.111.090404; Hammerer K, 2010, REV MOD PHYS, V82, P1041, DOI 10.1103/RevModPhys.82.1041; Li H, 2008, PHYS REV LETT, V101, DOI 10.1103/PhysRevLett.101.010504; LIPKIN HJ, 1965, NUCL PHYS, V62, P188, DOI 10.1016/0029-5582(65)90862-X; Osborne TJ, 2002, PHYS REV A, V66, DOI 10.1103/PhysRevA.66.032110; Osterloh A, 2002, NATURE, V416, P608, DOI 10.1038/416608a; Pironio S, 2010, NATURE, V464, P1021, DOI 10.1038/nature09008; POPESCU S, 1992, PHYS LETT A, V166, P293, DOI 10.1016/0375-9601(92)90711-T; Prevedel R, 2009, PHYS REV LETT, V103, DOI 10.1103/PhysRevLett.103.020503; Sachdev S., 1999, QUANTUM PHASE TRANSI; Sliwa C, 2003, PHYS LETT A, V317, P165, DOI 10.1016/S0375-9601(03)01115-0; Sorensen A, 2001, NATURE, V409, P63, DOI 10.1038/35051038; Verstraete F, 2006, PHYS REV LETT, V96, DOI 10.1103/PhysRevLett.96.220601; Vidal G, 2003, PHYS REV LETT, V90, DOI 10.1103/PhysRevLett.90.227902; Werner RF, 2001, PHYS REV A, V64, DOI 10.1103/PhysRevA.64.032112; Wiesniak M, 2012, PHYS REV A, V86, DOI 10.1103/PhysRevA.86.042339; Zukowski M, 2002, PHYS REV LETT, V88, DOI 10.1103/PhysRevLett.88.210401	36	98	98	1	45	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 13	2014	344	6189					1256	1258		10.1126/science.1247715	http://dx.doi.org/10.1126/science.1247715			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI7ND	24926014	Green Submitted			2022-12-28	WOS:000337077500033
J	Boland, J				Boland, James			MATERIALS SCIENCE Diamond gets harder	NATURE			English	Editorial Material									Commonwealth Sci & Ind Res Org CSIRO, Div Earth Sci & Resource Engn, Pullenvale, Qld 4069, Australia	Commonwealth Scientific & Industrial Research Organisation (CSIRO)	Boland, J (corresponding author), Commonwealth Sci & Ind Res Org CSIRO, Div Earth Sci & Resource Engn, Pullenvale, Qld 4069, Australia.	jim.boland@csiro.au						HALL EO, 1951, P PHYS SOC LOND B, V64, P747, DOI 10.1088/0370-1301/64/9/303; Huang Q, 2014, NATURE, V510, P250, DOI 10.1038/nature13381; Irifune T., 2014, COMPREHENSIVE HARD M, V3, P173, DOI DOI 10.1016/B978-0-08-096527-7.00045-3; Ivanov M, 2014, NANOSYST-PHYS CHEM M, V5, P160; Mochalin VN, 2012, NAT NANOTECHNOL, V7, P11, DOI [10.1038/nnano.2011.209, 10.1038/NNANO.2011.209]; PETCH NJ, 1953, J IRON STEEL I, V174, P25; Suryanarayana C, 2013, PROG MATER SCI, V58, P383, DOI 10.1016/j.pmatsci.2012.10.001; Tian YJ, 2013, NATURE, V493, P385, DOI 10.1038/nature11728; Tolansky S., 1967, SCI TECHNOLOGY IND D, V2, P341; WILKS E, 1991, PROPERTIES APPL DIAM; Zhao YS, 2004, APPL PHYS LETT, V84, P1356, DOI 10.1063/1.1650556	11	4	4	2	47	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 12	2014	510	7504					220	221		10.1038/510220a	http://dx.doi.org/10.1038/510220a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI7AT	24919916				2022-12-28	WOS:000337032400036
J	Burgin, S; Stone, JH; Shenoy-Bhangle, AS; McGuone, D				Burgin, Susan; Stone, John H.; Shenoy-Bhangle, Anuradha S.; McGuone, Declan			Case 18-2014: A 32-Year-Old Man with a Rash, Myalgia, and Weakness Dermatomyositis. Malignant atrophic papulosis (Degos's disease), involving the skin and gastrointestinal tract.	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							COMPLEMENT		[Burgin, Susan] Beth Israel Deaconess Med Ctr, Dept Dermatol, Boston, MA 02215 USA; [Stone, John H.] Massachusetts Gen Hosp, Dept Med, Boston, MA 02114 USA; [Shenoy-Bhangle, Anuradha S.] Massachusetts Gen Hosp, Dept Radiol, Boston, MA 02114 USA; [McGuone, Declan] Massachusetts Gen Hosp, Dept Pathol, Boston, MA 02114 USA; [Burgin, Susan] Harvard Univ, Sch Med, Dept Dermatol, Boston, MA 02115 USA; [Stone, John H.] Harvard Univ, Sch Med, Dept Med, Boston, MA USA; [Shenoy-Bhangle, Anuradha S.] Harvard Univ, Sch Med, Dept Radiol, Boston, MA 02115 USA; [McGuone, Declan] Harvard Univ, Sch Med, Dept Pathol, Boston, MA 02115 USA	Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School	Burgin, S (corresponding author), Beth Israel Deaconess Med Ctr, Dept Dermatol, Boston, MA 02215 USA.							Amaravadi RR, 2008, ABDOM IMAGING, V33, P196, DOI 10.1007/s00261-007-9225-1; Ball E, 2003, AM J DERMATOPATH, V25, P308, DOI 10.1097/00000372-200308000-00005; DRUCKER CR, 1990, DERMATOLOGICA, V180, P90, DOI 10.1159/000247999; Gupta S, 2011, J CUTAN MED SURG, V15, P162, DOI 10.2310/7750.2011.10035; Hillmen P, 2004, NEW ENGL J MED, V350, P552, DOI 10.1056/NEJMoa031688; Katz SK, 1997, J AM ACAD DERMATOL, V37, P480, DOI 10.1016/S0190-9622(97)70151-8; Kocheril SV, 2004, ARTHRIT RHEUM-ARTHR, V51, P498, DOI 10.1002/art.20393; KOLB WP, 1975, P NATL ACAD SCI USA, V72, P1687, DOI 10.1073/pnas.72.5.1687; Macari M, 2001, AM J ROENTGENOL, V176, P1105, DOI 10.2214/ajr.176.5.1761105; Magro CM, 2011, AM J CLIN PATHOL, V135, P599, DOI 10.1309/AJCP66QIMFARLZKI; Mutizwa Misha M, 2010, Dermatol Online J, V16, P5; Parker C, 2009, LANCET, V373, P759, DOI 10.1016/S0140-6736(09)60001-5; Scheinfeld N, 2011, DERMATOL ONLINE J, V17, P6; STAHL D, 1978, ARCH DERMATOL, V114, P1687, DOI 10.1001/archderm.114.11.1687; STEPHANSSON EA, 1991, ACTA DERM-VENEREOL, V71, P416; Wang S, 2011, INT J DERMATOL, V50, P370, DOI 10.1111/j.1365-4632.2009.04339.x; Wilson J, 2007, PEDIATR DERMATOL, V24, P18, DOI 10.1111/j.1525-1470.2007.00326.x; YOUNG JDE, 1986, SCIENCE, V233, P184, DOI 10.1126/science.2425429	18	12	12	0	2	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUN 12	2014	370	24					2327	2337		10.1056/NEJMcpc1304161	http://dx.doi.org/10.1056/NEJMcpc1304161			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AI7BB	24918376				2022-12-28	WOS:000337033700013
J	Wolfe, SM				Wolfe, Sidney M.			A morphine-oxycodone combo pill: toward the "holy grail" for opioids or a justifiably rejected drug?	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									Publ Citizen, Hlth Res Grp, Washington, DC 20009 USA		Wolfe, SM (corresponding author), Publ Citizen, Hlth Res Grp, Washington, DC 20009 USA.	Swolfe@citizen.org						Corbett AD, 2006, BRIT J PHARMACOL, V147, pS153, DOI 10.1038/sj.bjp.0706435; FDA, 4 22 14 ADV COMM M, P122; FDA, 4 22 14 ADV COMM M, P5; Food and Drug Administration, 2014, AN AN DRUG PROD ADV; QRx Pharma, 2012, NONC OV DUAL OP TECH	5	1	1	0	3	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JUN 9	2014	348								g3620	10.1136/bmj.g3620	http://dx.doi.org/10.1136/bmj.g3620			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AJ1DS	24912942	Bronze, Green Published			2022-12-28	WOS:000337396600005
J	Gabuzda, D				Gabuzda, Denise			The MAD world of black holes	NATURE			English	Editorial Material							ACCRETION; SIZE; M87; JET		Natl Univ Ireland Univ Coll Cork, Dept Phys, Cork, Ireland	University College Cork	Gabuzda, D (corresponding author), Natl Univ Ireland Univ Coll Cork, Dept Phys, Cork, Ireland.	d.gabuzda@ucc.ie						BLANDFORD RD, 1977, MON NOT R ASTRON SOC, V179, P433, DOI 10.1093/mnras/179.3.433; Dexter J, 2013, MON NOT R ASTRON SOC, V432, P2252, DOI 10.1093/mnras/stt583; Doeleman SS, 2012, SCIENCE, V338, P355, DOI 10.1126/science.1224768; Gabuzda DC, 2014, MON NOT R ASTRON SOC, V438, pL1, DOI 10.1093/mnrasl/slt129; Johannsen T, 2012, ASTROPHYS J, V758, DOI 10.1088/0004-637X/758/1/30; Kardashev NS, 2013, ASTRON REP+, V57, P153, DOI 10.1134/S1063772913030025; McKinney JC, 2012, MON NOT R ASTRON SOC, V423, P3083, DOI 10.1111/j.1365-2966.2012.21074.x; Molina S. N., 2014, ASTRON ASTR IN PRESS; Takahashi R, 2011, ASTROPHYS J, V729, DOI 10.1088/0004-637X/729/2/86; Tchekhovskoy A, 2011, MON NOT R ASTRON SOC, V418, pL79, DOI 10.1111/j.1745-3933.2011.01147.x; Zamaninasab M, 2014, NATURE, V510, P126, DOI 10.1038/nature13399	11	2	2	0	9	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 5	2014	510	7503					42	43		10.1038/510042a	http://dx.doi.org/10.1038/510042a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AI3NR	24899300				2022-12-28	WOS:000336768900027
J	Hsu, PD; Lander, ES; Zhang, F				Hsu, Patrick D.; Lander, Eric S.; Zhang, Feng			Development and Applications of CRISPR-Cas9 for Genome Engineering	CELL			English	Review							ZINC-FINGER NUCLEASES; RNA-GUIDED ENDONUCLEASE; DOUBLE-STRAND BREAKS; ONE-STEP GENERATION; CAS SYSTEMS; HUMAN-CELLS; STREPTOCOCCUS-THERMOPHILUS; HOMOLOGOUS RECOMBINATION; TRANSCRIPTION FACTORS; SACCHAROMYCES-CEREVISIAE	Recent advances in genome engineering technologies based on the CRISPR-associated RNA-guided endonuclease Cas9 are enabling the systematic interrogation of mammalian genome function. Analogous to the search function in modern word processors, Cas9 can be guided to specific locations within complex genomes by a short RNA search string. Using this system, DNA sequences within the endogenous genome and their functional outputs are now easily edited or modulated in virtually any organism of choice. Cas9-mediated genetic perturbation is simple and scalable, empowering researchers to elucidate the functional organization of the genome at the systems level and establish causal linkages between genetic variations and biological phenotypes. In this Review, we describe the development and applications of Cas9 for a variety of research or translational applications while highlighting challenges as well as future directions. Derived from a remarkable microbial defense system, Cas9 is driving innovative applications from basic biology to biotechnology and medicine.	[Hsu, Patrick D.; Lander, Eric S.; Zhang, Feng] Broad Inst & Harvard, Cambridge, MA 02141 USA; [Hsu, Patrick D.; Zhang, Feng] MIT, Dept Brain & Cognit Sci, McGovern Inst Brain Res, Dept Biol Engn, Cambridge, MA 02139 USA; [Hsu, Patrick D.] Harvard Univ, Dept Mol & Cellular Biol, Cambridge, MA 02138 USA	Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Massachusetts Institute of Technology (MIT); Harvard University	Zhang, F (corresponding author), Broad Inst & Harvard, 7 Cambridge Ctr, Cambridge, MA 02141 USA.	zhang@broadinstitute.org	Macrae, Rhiannon/AAX-1536-2020; Hsu, Patrick/ABD-5749-2021	Hsu, Patrick/0000-0002-9380-2648	NIMH through a NIH Director's Pioneer Award [DP1-MH100706]; NINDS through a NIH Transformative R01 grant [R01-NS 07312401]; NSF; Keck Foundation; McKnight Foundation; Damon Runyon Foundation; Searle Scholars Foundation; Klingenstein Foundation; Vallee Foundation; Merkin Foundation; Simons Foundation; Bob Metcalfe; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK097768] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [DP1MH100706] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS073124] Funding Source: NIH RePORTER	NIMH through a NIH Director's Pioneer Award; NINDS through a NIH Transformative R01 grant; NSF(National Science Foundation (NSF)); Keck Foundation(W.M. Keck Foundation); McKnight Foundation; Damon Runyon Foundation; Searle Scholars Foundation; Klingenstein Foundation(Klingenstein Philanthropies); Vallee Foundation; Merkin Foundation; Simons Foundation; Bob Metcalfe; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We gratefully acknowledge Sigrid Knemeyer for help with illustration; Ian Slaymaker for structural guidance; Chengwei Luo for expertise in phylogenetic analysis; Emmanuelle Charpentier, Philippe Horvath, Charles Jennings, Ellen Law, Luciano Marraffini, Francisco Mojica, Hiroshi Nishimasu, Virginijus Siksnys, and Alexandro Trevino for discussion and comments; and the CRISPR community for this beautiful story. P. D. H. is a James Mills Pierce Fellow. This work is supported by the NIMH through a NIH Director's Pioneer Award (DP1-MH100706), the NINDS through a NIH Transformative R01 grant (R01-NS 07312401), NSF, the Keck, McKnight, Damon Runyon, Searle Scholars, Klingenstein, Vallee, Merkin, and Simons Foundations, and Bob Metcalfe. CRISPR reagents are available to the academic community through Addgene, and associated protocols, support forum, and computational tools are available via the Zhang lab website (http://www.genome-engineering.org).	Barrangou R., 2013, CRISPR CAS SYSTEMS R; Barrangou R, 2007, SCIENCE, V315, P1709, DOI 10.1126/science.1138140; Beerli RR, 2000, J BIOL CHEM, V275, P32617, DOI 10.1074/jbc.M005108200; Beerli RR, 2000, P NATL ACAD SCI USA, V97, P1495, DOI 10.1073/pnas.040552697; Bibikova M, 2001, MOL CELL BIOL, V21, P289, DOI 10.1128/MCB.21.1.289-297.2001; Bibikova M, 2003, SCIENCE, V300, P764, DOI 10.1126/science.1079512; Bibikova M, 2002, GENETICS, V161, P1169; Boch J, 2009, SCIENCE, V326, P1509, DOI 10.1126/science.1178811; Bolotin A, 2005, MICROBIOL-SGM, V151, P2551, DOI 10.1099/mic.0.28048-0; Brouns SJJ, 2008, SCIENCE, V321, P960, DOI 10.1126/science.1159689; CAPECCHI MR, 1989, SCIENCE, V244, P1288, DOI 10.1126/science.2660260; Chen BH, 2013, CELL, V155, P1479, DOI 10.1016/j.cell.2013.12.001; Cho SW, 2013, NAT BIOTECHNOL, V31, P230, DOI 10.1038/nbt.2507; CHOULIKA A, 1995, MOL CELL BIOL, V15, P1968; Christian M, 2010, GENETICS, V186, P757, DOI 10.1534/genetics.110.120717; Chylinski K, 2014, NUCLEIC ACIDS RES, V42, P6091, DOI 10.1093/nar/gku241; Chylinski K, 2013, RNA BIOL, V10, P726, DOI 10.4161/rna.24321; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; Couzin-Frankel J, 2013, SCIENCE, V342, P1432, DOI 10.1126/science.342.6165.1432; Crosetto N, 2013, NAT METHODS, V10, P361, DOI 10.1038/nmeth.2408; Deltcheva E, 2011, NATURE, V471, P602, DOI 10.1038/nature09886; Deveau H, 2008, J BACTERIOL, V190, P1390, DOI 10.1128/JB.01412-07; Dianov GL, 2013, NUCLEIC ACIDS RES, V41, P3483, DOI 10.1093/nar/gkt076; Esvelt KM, 2013, NAT METHODS, V10, P1116, DOI [10.1038/NMETH.2681, 10.1038/nmeth.2681]; Fonfara I, 2014, NUCLEIC ACIDS RES, V42, P2577, DOI 10.1093/nar/gkt1074; Fu YF, 2014, NAT BIOTECHNOL, V32, P279, DOI 10.1038/nbt.2808; Fu YF, 2013, NAT BIOTECHNOL, V31, P822, DOI 10.1038/nbt.2623; Gabriel R, 2011, NAT BIOTECHNOL, V29, P816, DOI 10.1038/nbt.1948; Garneau JE, 2010, NATURE, V468, P67, DOI 10.1038/nature09523; Gasiunas G, 2012, P NATL ACAD SCI USA, V109, pE2579, DOI 10.1073/pnas.1208507109; Gilbert LA, 2013, CELL, V154, P442, DOI 10.1016/j.cell.2013.06.044; Gonzalez B, 2010, NAT PROTOC, V5, P791, DOI 10.1038/nprot.2010.34; Haft DH, 2005, PLOS COMPUT BIOL, V1, P474, DOI 10.1371/journal.pcbi.0010060; Hale CR, 2012, MOL CELL, V45, P292, DOI 10.1016/j.molcel.2011.10.023; Hale CR, 2009, CELL, V139, P945, DOI 10.1016/j.cell.2009.07.040; Horvath P, 2008, J BACTERIOL, V190, P1401, DOI 10.1128/JB.01415-07; Horvath P, 2009, INT J FOOD MICROBIOL, V131, P62, DOI 10.1016/j.ijfoodmicro.2008.05.030; Hou ZG, 2013, P NATL ACAD SCI USA, V110, P15644, DOI 10.1073/pnas.1313587110; Hsu PD, 2013, NAT BIOTECHNOL, V31, P827, DOI 10.1038/nbt.2647; ISHINO Y, 1987, J BACTERIOL, V169, P5429, DOI 10.1128/jb.169.12.5429-5433.1987; Jansen R, 2002, MOL MICROBIOL, V43, P1565, DOI 10.1046/j.1365-2958.2002.02839.x; Jiang WY, 2013, NAT BIOTECHNOL, V31, P233, DOI 10.1038/nbt.2508; Jinek M, 2014, SCIENCE, V343, P1215, DOI 10.1126/science.1247997; Jinek M, 2013, ELIFE, V2, DOI 10.7554/eLife.00471; Jinek M, 2012, SCIENCE, V337, P816, DOI 10.1126/science.1225829; Jonathan C, 2005, NAT GENET, V37, P161, DOI 10.1038/ng1509; Juillerat A, 2014, NUCLEIC ACIDS RES, V42, P5390, DOI 10.1093/nar/gku155; Konermann S, 2013, NATURE, V500, P472, DOI 10.1038/nature12466; Li W, 2013, NAT BIOTECHNOL, V31, P684, DOI 10.1038/nbt.2652; Lombardo A, 2007, NAT BIOTECHNOL, V25, P1298, DOI 10.1038/nbt1353; Maeder ML, 2008, MOL CELL, V31, P294, DOI 10.1016/j.molcel.2008.06.016; Maeder ML, 2013, NAT METHODS, V10, P977, DOI [10.1038/NMETH.2598, 10.1038/nmeth.2598]; Makarova KS, 2006, BIOL DIRECT, V1, DOI 10.1186/1745-6150-1-7; Makarova KS, 2011, BIOL DIRECT, V6, DOI 10.1186/1745-6150-6-38; Makarova KS, 2011, NAT REV MICROBIOL, V9, P467, DOI 10.1038/nrmicro2577; Mali P, 2013, NAT BIOTECHNOL, V31, P833, DOI 10.1038/nbt.2675; Mali P, 2013, SCIENCE, V339, P823, DOI 10.1126/science.1232033; Marraffini LA, 2010, NATURE, V463, P568, DOI 10.1038/nature08703; Marraffini LA, 2008, SCIENCE, V322, P1843, DOI 10.1126/science.1165771; Mendenhall EM, 2013, NAT BIOTECHNOL, V31, P1133, DOI 10.1038/nbt.2701; Miller JC, 2007, NAT BIOTECHNOL, V25, P778, DOI 10.1038/nbt1319; Miller JC, 2011, NAT BIOTECHNOL, V29, P143, DOI 10.1038/nbt.1755; Mojica FJM, 2005, J MOL EVOL, V60, P174, DOI 10.1007/s00239-004-0046-3; Mojica FJM, 2000, MOL MICROBIOL, V36, P244, DOI 10.1046/j.1365-2958.2000.01838.x; Moscou MJ, 2009, SCIENCE, V326, P1501, DOI 10.1126/science.1178817; Musunuru K, 2010, NEW ENGL J MED, V363, P2220, DOI 10.1056/NEJMoa1002926; Niewoehner J, 2014, NEURON, V81, P49, DOI 10.1016/j.neuron.2013.10.061; Nishimasu H, 2014, CELL, V156, P935, DOI 10.1016/j.cell.2014.02.001; Niu YY, 2014, CELL, V156, P836, DOI 10.1016/j.cell.2014.01.027; Pattanayak V, 2013, NAT BIOTECHNOL, V31, P839, DOI 10.1038/nbt.2673; Perez-Pinera P, 2013, NAT METHODS, V10, P973, DOI [10.1038/NMETH.2600, 10.1038/nmeth.2600]; PLESSIS A, 1992, GENETICS, V130, P451; Pourcel C, 2005, MICROBIOL-SGM, V151, P653, DOI 10.1099/mic.0.27437-0; Qi LS, 2013, CELL, V152, P1173, DOI 10.1016/j.cell.2013.02.022; Quiberoni A, 2010, INT DAIRY J, V20, P657, DOI 10.1016/j.idairyj.2010.03.012; Ran FA, 2013, CELL, V154, P1380, DOI 10.1016/j.cell.2013.08.021; ROUET P, 1994, MOL CELL BIOL, V14, P8096, DOI 10.1128/MCB.14.12.8096; RUDIN N, 1989, GENETICS, V122, P519; Sander JD, 2014, NAT BIOTECHNOL, V32, P347, DOI 10.1038/nbt.2842; Sander JD, 2011, NAT METHODS, V8, P67, DOI 10.1038/NMETH.1542; Sapranauskas R, 2011, NUCLEIC ACIDS RES, V39, P9275, DOI 10.1093/nar/gkr606; Schwank G, 2013, CELL STEM CELL, V13, P653, DOI 10.1016/j.stem.2013.11.002; Shah SA, 2013, RNA BIOL, V10, P891, DOI 10.4161/rna.23764; Shalem O, 2014, SCIENCE, V343, P84, DOI 10.1126/science.1247005; Smith J, 2006, NUCLEIC ACIDS RES, V34, DOI 10.1093/nar/gkl720; Sternberg SH, 2014, NATURE, V507, P62, DOI 10.1038/nature13011; Tang TH, 2002, P NATL ACAD SCI USA, V99, P7536, DOI 10.1073/pnas.112047299; Tebas P, 2014, NEW ENGL J MED, V370, P901, DOI 10.1056/NEJMoa1300662; Urnov FD, 2005, NATURE, V435, P646, DOI 10.1038/nature03556; Wang HY, 2013, CELL, V153, P910, DOI 10.1016/j.cell.2013.04.025; Wang T, 2014, SCIENCE, V343, P80, DOI 10.1126/science.1246981; Wu XB, 2014, NAT BIOTECHNOL, V32, P670, DOI 10.1038/nbt.2889; Wu YX, 2013, CELL STEM CELL, V13, P659, DOI 10.1016/j.stem.2013.10.016; Xu GL, 1997, NAT GENET, V17, P376, DOI 10.1038/ng1297-376; Yang H, 2013, CELL, V154, P1370, DOI 10.1016/j.cell.2013.08.022; Yin H, 2014, NAT BIOTECHNOL, V32, P551, DOI 10.1038/nbt.2884; Zahradka K, 2006, NATURE, V443, P569, DOI 10.1038/nature05160; Zhang Y, 2013, MOL CELL, V50, P488, DOI 10.1016/j.molcel.2013.05.001	98	3348	3831	220	4177	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUN 5	2014	157	6					1262	1278		10.1016/j.cell.2014.05.010	http://dx.doi.org/10.1016/j.cell.2014.05.010			17	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	AN8UV	24906146	Green Published, Green Accepted, Bronze			2022-12-28	WOS:000340881400006
J	Kull, FJ; Sloboda, RD				Kull, F. Jon; Sloboda, Roger D.			A Slow Dance for Microtubule Acetylation	CELL			English	Editorial Material							ALPHA-TUBULIN; ACETYLTRANSFERASE; FLAGELLA; BINDING	Microtubules contribute to diverse cellular processes through balancing dynamic, short-lived and stable, long-lived populations. One way in which long-lived microtubules are marked is by post-translational acetylation of alpha-tubulin by tubulin acetyltransferase (TAT). Szyk et al. now provide insight into TAT's mechanism of action and its unique time-stamping ability.	[Kull, F. Jon] Dartmouth Coll, Dept Chem, Hanover, NH 03755 USA; [Sloboda, Roger D.] Dartmouth Coll, Dept Biol Sci, Hanover, NH 03755 USA	Dartmouth College; Dartmouth College	Kull, FJ (corresponding author), Dartmouth Coll, Dept Chem, Hanover, NH 03755 USA.	f.jon.kull@dartmouth.edu						Akella JS, 2010, NATURE, V467, P218, DOI 10.1038/nature09324; CUEVA JG, 2012, CURR BIOL, V22, P1066, DOI [DOI 10.1016/j.cub.2012.05.012, DOI 10.1016/J.CUB.2012.05.012]; GREER K, 1985, J CELL BIOL, V101, P2081, DOI 10.1083/jcb.101.6.2081; Howes SC, 2014, MOL BIOL CELL, V25, P257, DOI 10.1091/mbc.E13-07-0387; Kormendi V, 2012, J BIOL CHEM, V287, P41569, DOI 10.1074/jbc.C112.421222; LHERNAULT SW, 1983, J CELL BIOL, V97, P258, DOI 10.1083/jcb.97.1.258; Nogales E, 1999, CELL, V96, P79, DOI 10.1016/S0092-8674(00)80961-7; Reed NA, 2006, CURR BIOL, V16, P2166, DOI 10.1016/j.cub.2006.09.014; Szyk A, 2014, CELL, V157, P1405, DOI 10.1016/j.cell.2014.03.061	9	15	15	0	13	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUN 5	2014	157	6					1255	1256		10.1016/j.cell.2014.05.021	http://dx.doi.org/10.1016/j.cell.2014.05.021			2	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	AN8UV	24906144	Bronze			2022-12-28	WOS:000340881400004
J	Sanchez, I; Dynlacht, BD				Sanchez, Irma; Dynlacht, Brian D.			Short RNAs and shortness of breath	NATURE			English	Editorial Material							CP110; MICRORNA; CELLS		[Sanchez, Irma; Dynlacht, Brian D.] NYU, Sch Med, New York, NY 10016 USA	New York University	Sanchez, I (corresponding author), NYU, Sch Med, New York, NY 10016 USA.	irma.sanchez@med.nyu.edu; brian.dynlacht@med.nyu.edu			NICHD NIH HHS [R01 HD069647] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD069647] Funding Source: NIH RePORTER	NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		Cao JL, 2012, NAT CELL BIOL, V14, P697, DOI 10.1038/ncb2512; Chen ZH, 2002, DEV CELL, V3, P339, DOI 10.1016/S1534-5807(02)00258-7; D'Angiolella V, 2010, NATURE, V466, P138, DOI 10.1038/nature09140; Flynt AS, 2008, NAT REV GENET, V9, P831, DOI 10.1038/nrg2455; Lai YY, 2011, J ALLERGY CLIN IMMUN, V128, P1207, DOI 10.1016/j.jaci.2011.09.001; Li J, 2013, NATURE, V495, P255, DOI 10.1038/nature11941; Lize M, 2010, CELL CYCLE, V9, P4579, DOI 10.4161/cc.9.22.13870; Marcet B, 2011, NAT CELL BIOL, V13, P693, DOI 10.1038/ncb2241; Martinez-Anton A, 2013, AM J RESP CELL MOL, V49, P384, DOI 10.1165/rcmb.2012-0368OC; Song R, 2014, NATURE, V510, P115, DOI 10.1038/nature13413; Spektor A, 2007, CELL, V130, P678, DOI 10.1016/j.cell.2007.06.027; Tsang William Y, 2013, Cilia, V2, P9, DOI 10.1186/2046-2530-2-9	12	1	2	0	16	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 5	2014	510	7503					40	42		10.1038/510040a	http://dx.doi.org/10.1038/510040a			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AI3NR	24899299	Green Accepted			2022-12-28	WOS:000336768900026
J	Rothberg, MB				Rothberg, Michael B.			The $50 000 Physical	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									Cleveland Clin, Ctr Value Based Care Res, Inst Med, Cleveland, OH 44106 USA	Cleveland Clinic Foundation	Rothberg, MB (corresponding author), Cleveland Clin, Ctr Value Based Care Res, Inst Med, Cleveland, OH 44106 USA.	rothbem@ccf.org						American Medical Association, 2002, CPT ASS; [Anonymous], 2013, 5 THINGS PHYS PAT SH; Bloomfield HE, 2011, EVIDENCE BRIEF ROLE; Calonge N, 2005, ANN INTERN MED, V142, P198, DOI 10.7326/0003-4819-142-3-200502010-00011; Centers for Medicare & Medicaid Services Medicare Learning Network, ABCS PROV ANN WELLN; Krogsboll LT, 2012, BMJ-BRIT MED J, V345, DOI 10.1136/bmj.e7191; MOLD JW, 1986, NEW ENGL J MED, V314, P512, DOI 10.1056/NEJM198602203140809; Sox HC, 2013, JAMA-J AM MED ASSOC, V309, P2496, DOI 10.1001/jama.2013.5040; Welch HG, 2010, J NATL CANCER I, V102, P605, DOI 10.1093/jnci/djq099	9	13	13	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUN 4	2014	311	21					2175	2176		10.1001/jama.2014.3415	http://dx.doi.org/10.1001/jama.2014.3415			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AI2DU	24893085				2022-12-28	WOS:000336668400016
J	Falaschetti, E; Mindell, J; Knott, C; Poulter, N				Falaschetti, Emanuela; Mindell, Jennifer; Knott, Craig; Poulter, Neil			Hypertension management in England: a serial cross-sectional study from 1994 to 2011	LANCET			English	Article							HEALTH SURVEY; BLOOD-PRESSURE; UNITED-KINGDOM; GLOBAL BURDEN; CANADA; IMPROVEMENT; GUIDELINES; OUTCOMES; SOCIETY; DISEASE	Background Hypertension is the leading risk factor contributing to the global burden of disease. We aimed to assess the change in blood pressure management between 1994 and 2011 in England with a series of annual surveys. Methods We did a serial cross-sectional study of five Health Survey for England surveys based on nationally representative samples of non-institutionalised adults (aged >= 16 years). Mean blood pressure levels and rates of awareness, treatment, and control of hypertension were assessed. Hypertension was defined as systolic blood pressure 140 mm Hg or higher, diastolic blood pressure 90 mm Hg or higher, or receiving treatment for high blood pressure. Findings The mean blood pressure levels of men and women in the general population and among patients with treated hypertension progressively improved between 1994 and 2011. In patients with treated hypertension, blood pressure improved from 150.0 (SE 0.59)/80.2 (0.27) mm Hg to 135.4 (0.58)/73.5 (0.41) mm Hg. Awareness, treatment, and control rates among men and women combined also improved significantly across each stage of this 17-year period, with the prevalence of control among treated patients almost doubling from 33% (SE 1.4) in 1994 to 63% (1.7) in 2011. Nevertheless, of all adults with survey-defined hypertension in 2011, hypertension was controlled in only 37%. Interpretation If the same systematic improvement in all aspects of hypertension management continues until 2022, 80% of patients with treated hypertension will have controlled blood pressure levels with a potential annual saving of about 50 000 major cardiovascular events.	[Falaschetti, Emanuela] Univ London Imperial Coll Sci Technol & Med, Imperial Clin Trials Unit, Sch Publ Hlth, London W2 1PG, England; [Poulter, Neil] Univ London Imperial Coll Sci Technol & Med, Int Ctr Circulatory Hlth, Natl Heart & Lung Inst, London W2 1PG, England; [Mindell, Jennifer; Knott, Craig] UCL, Dept Epidemiol & Publ Hlth, London, England	Imperial College London; Imperial College London; University of London; University College London	Falaschetti, E (corresponding author), Univ London Imperial Coll Sci Technol & Med, Imperial Clin Trials Unit, Sch Publ Hlth, London W2 1PG, England.	e.falaschetti@imperial.ac.uk	Mindell, Jennifer S/G-2241-2011	Mindell, Jennifer S/0000-0002-7604-6131; Falaschetti, Emanuela/0000-0001-6964-2042	HSCIC; National Institute for Health Research [NF-SI-0510-10055] Funding Source: researchfish	HSCIC; National Institute for Health Research(National Institute for Health Research (NIHR))	JM is and EF and CK were funded by the HSCIC to work on the HSE, but the study reported in this paper was not funded.	Campbell NRC, 2013, CAN J CARDIOL, V29, P564, DOI 10.1016/j.cjca.2012.05.006; Colhoun HM, 1998, J HYPERTENS, V16, P747, DOI 10.1097/00004872-199816060-00005; Craig R, 2012, HLTH SURVY ENGLAND 2, V2; Department of Health, 2003, DEL INV GEN PRACT IM; Elliott William J, 2003, J Clin Hypertens (Greenwich), V5, P3, DOI 10.1111/j.1524-6175.2003.02463.x; Falaschetti E, 2009, HYPERTENSION, V53, P480, DOI 10.1161/HYPERTENSIONAHA.108.125617; Go AS, 2014, CIRCULATION, V129, pE28, DOI 10.1161/01.cir.0000441139.02102.80; Hippisley-Cox J, 2007, BMJ-BRIT MED J, V335, P136, DOI 10.1136/bmj.39261.471806.55; Jamerson K, 2008, NEW ENGL J MED, V359, P2417, DOI 10.1056/NEJMoa0806182; James PA, 2014, JAMA-J AM MED ASSOC, V311, P1809, DOI 10.1001/jama.2013.284427; Joffres M, 2013, BMJ OPEN, V3, DOI 10.1136/bmjopen-2013-003423; Kearney PM, 2005, LANCET, V365, P217, DOI 10.1016/S0140-6736(05)70151-3; Lim SS, 2012, LANCET, V380, P2224, DOI 10.1016/S0140-6736(12)61766-8; Mancia G, 2007, EUR HEART J, V28, P1462, DOI [10.1093/eurheartj/ehm236, 10.1093/eurheartj/eht151]; McAlister FA, 2011, CAN MED ASSOC J, V183, P1007, DOI 10.1503/cmaj.101767; Mindell J, 2012, INT J EPIDEMIOL, V41, P1585, DOI 10.1093/ije/dyr199; National Collaborating Centre for Chronic Conditions, 2006, HYP MAN HYP AD PRIM; ONS, 20 CENT MORT FIL 199; Primatesta P, 2001, HYPERTENSION, V38, P827, DOI 10.1161/hyp.38.4.827; Primatesta P, 2006, J HYPERTENS, V24, P1187, DOI 10.1097/01.hjh.0000226210.95936.bc; Ryan AM, 2012, MED CARE, V50, P191, DOI 10.1097/MLR.0b013e318244e6b5; Sadler K, 2013, NAT DIET NUTR SURV A; Serumaga Brian, 2011, BMJ, V342, pd108, DOI 10.1136/bmj.d108; SMITH WCS, 1990, BRIT MED J, V300, P981, DOI 10.1136/bmj.300.6730.981; Turnbull F, 2003, LANCET, V362, P1527; Volpe M, 2007, J HYPERTENS, V25, P1491, DOI 10.1097/HJH.0b013e3280fa83a6; Williams B, 2004, J HUM HYPERTENS, V18, P139, DOI 10.1038/sj.jhh.1001683; Wolf-Maier K, 2004, HYPERTENSION, V43, P10, DOI 10.1161/01.HYP.0000103630.72812.10	28	170	176	0	26	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAY 31	2014	383	9932					1912	1919		10.1016/S0140-6736(14)60688-7	http://dx.doi.org/10.1016/S0140-6736(14)60688-7			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AI4PR	24881995				2022-12-28	WOS:000336847800031
J	van Roosmalen, J; Meguid, T				van Roosmalen, Jos; Meguid, Tarek			The dilemma of vaginal breech delivery worldwide	LANCET			English	Editorial Material							CESAREAN-SECTION; TERM; DISAGREEMENT; TRIAL; ROOM		[van Roosmalen, Jos] Vrije Univ Amsterdam, Med Ctr, Amsterdam, Netherlands; [van Roosmalen, Jos] Leiden Univ, Med Ctr, NL-2300 RC Leiden, Netherlands; [Meguid, Tarek] Mnazi Mmoja Hosp, Zanzibar, Tanzania; [Meguid, Tarek] State Univ Zanzibar, Sch Hlth & Med Sci, Zanzibar, Tanzania; [Meguid, Tarek] Haukeland Hosp, Helse Bergen, N-5021 Bergen, Norway	Vrije Universiteit Amsterdam; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; University of Bergen; Haukeland University Hospital	van Roosmalen, J (corresponding author), Vrije Univ Amsterdam, Med Ctr, Amsterdam, Netherlands.	j.j.m.van_roosmalen@lumc.nl						Grivell RM., 2011, EXPERT REV OBSTET GY, V6, P205, DOI [10.1586/eog.11.5, DOI 10.1586/eog.11.5]; Hannah ME, 2000, LANCET, V356, P1375, DOI 10.1016/S0140-6736(00)02840-3; Hendriks J, 2013, VOX SANG, V104, P234, DOI 10.1111/j.1423-0410.2012.01654.x; Kotaska AR, 2004, BRIT MED J, V329, P1039, DOI 10.1136/bmj.329.7473.1039; Lawson GW, 2012, BIRTH-ISS PERINAT C, V39, P3, DOI 10.1111/j.1523-536X.2011.00507.x; Lumley J, 2000, LANCET, V356, P1368, DOI 10.1016/S0140-6736(00)02833-6; Maaloe N, 2012, BJOG-INT J OBSTET GY, V119, P605, DOI 10.1111/j.1471-0528.2012.03284.x; Naicker Saraladevi, 2009, Ethn Dis, V19, pS1; Onah HE, 2002, INT J GYNECOL OBSTET, V76, P321, DOI 10.1016/S0020-7292(01)00578-1; Rietberg CCT, 2005, BJOG-INT J OBSTET GY, V112, P205, DOI 10.1111/j.1471-0528.2004.00317.x; Schutte JM, 2007, ACTA OBSTET GYN SCAN, V86, P240, DOI 10.1080/00016340601104054; van Roosmalen J, 2002, BJOG-INT J OBSTET GY, V109, P967, DOI 10.1016/S1470-0328(02)01705-6; Vlemmix F, 2013, AM J OBSTET GYNECOL, V208, pS321, DOI 10.1016/j.ajog.2012.10.102	13	33	33	0	7	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	MAY 31	2014	383	9932					1863	1864		10.1016/S0140-6736(14)60618-8	http://dx.doi.org/10.1016/S0140-6736(14)60618-8			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	AI4PR	24881976				2022-12-28	WOS:000336847800007
J	Lampert, A; Hastings, A; Grosholz, ED; Jardine, SL; Sanchirico, JN				Lampert, Adam; Hastings, Alan; Grosholz, Edwin D.; Jardine, Sunny L.; Sanchirico, James N.			Optimal approaches for balancing invasive species eradication and endangered species management	SCIENCE			English	Article							BIRDS; CONSERVATION; FISHERIES; IMPACTS	Resolving conflicting ecosystem management goals-such as maintaining fisheries while conserving marine species or harvesting timber while preserving habitat-is a widely recognized challenge. Even more challenging may be conflicts between two conservation goals that are typically considered complementary. Here, we model a case where eradication of an invasive plant, hybrid Spartina, threatens the recovery of an endangered bird that uses Spartina for nesting. Achieving both goals requires restoration of native Spartina. We show that the optimal management entails less intensive treatment over longer time scales to fit with the time scale of natural processes. In contrast, both eradication and restoration, when considered separately, would optimally proceed as fast as possible. Thus, managers should simultaneously consider multiple, potentially conflicting goals, which may require flexibility in the timing of expenditures.	[Lampert, Adam; Hastings, Alan; Grosholz, Edwin D.; Sanchirico, James N.] Univ Calif Davis, Davis, CA 95616 USA; [Jardine, Sunny L.] Univ Delaware, Newark, DE 19716 USA; [Sanchirico, James N.] Resources Future Inc, Washington, DC 20036 USA	University of California System; University of California Davis; University of Delaware; Resources for the Future	Lampert, A (corresponding author), Univ Calif Davis, One Shield Ave, Davis, CA 95616 USA.	alampert@ucdavis.edu	Hastings, Alan/O-6864-2019	Hastings, Alan/0000-0002-0717-8026	NSF [DEB 1009957]; Division Of Environmental Biology [1009957] Funding Source: National Science Foundation	NSF(National Science Foundation (NSF)); Division Of Environmental Biology(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	We thank the personnel of the Invasive Spartina Project, including P. Olofson, E. Grijalva, D. Kerr, I. Hogle, W. Thornton, M. Latta, and others, who provided data on Spartina distributions, clapper rail populations, and costs of eradication and restoration efforts. We thank D. Kling for research assistance and P. Reynolds for comments on the manuscript. We thank the California State Coastal Conservancy and the California State Wildlife Conservation Board for use of their data. The data used for this paper are summarized in table S1 (24) and are given in more detail in (24). This research was supported by NSF grant no. DEB 1009957 to A. H., E. D. G., J.N.S., A. L., and S.L.J.	Ando A, 1998, SCIENCE, V279, P2126, DOI 10.1126/science.279.5359.2126; Ayres DR, 2004, BIOL INVASIONS, V6, P221, DOI 10.1023/B:BINV.0000022140.07404.b7; Buckley YM, 2008, J APPL ECOL, V45, P397, DOI 10.1111/j.1365-2664.2008.01471.x; Clark C.W., 1990, MATH BIOECONOMICS OP, V2nd; Crowder LB, 1998, FISHERIES, V23, P8, DOI 10.1577/1548-8446(1998)023&lt;0008:FBIFM&gt;2.0.CO;2; Faber P, 2000, COAST OCEAN, V16, P14; Folke C, 2005, ANNU REV ENV RESOUR, V30, P441, DOI 10.1146/annurev.energy.30.050504.144511; Groom M.J., 2006, PRINCIPLES CONSERVAT; Grosholz E.D., 2009, HUMAN IMPACTS SALT M, P23; Hambright KD, 2000, AQUAT CONSERV, V10, P393, DOI 10.1002/1099-0755(200011/12)10:6<393::AID-AQC419>3.0.CO;2-O; Hastings A, 2003, ECOL APPL, V13, pS65; Hastings A, 2006, THEOR POPUL BIOL, V70, P431, DOI 10.1016/j.tpb.2006.05.003; Hoegh-Guldberg O, 2008, SCIENCE, V321, P345, DOI 10.1126/science.1157897; Holge I., 2012, SAN FRANCISCO ESTUAR; Hughes TP, 2005, TRENDS ECOL EVOL, V20, P380, DOI 10.1016/j.tree.2005.03.022; Leslie HM, 2007, FRONT ECOL ENVIRON, V5, P540, DOI 10.1890/060093; Levin LA, 2006, ECOLOGY, V87, P419, DOI 10.1890/04-1752; Mack RN, 2000, ECOL APPL, V10, P689, DOI 10.1890/1051-0761(2000)010[0689:BICEGC]2.0.CO;2; Mark Freeberg J.G.Pope, 1994, GLOBAL ASSESSMENT FI; Martin TG, 2006, BIOL CONSERV, V127, P201, DOI 10.1016/j.biocon.2005.08.014; McBroom J., 2011, 2010 CALIFORNIA CLAP; Nalle D. J., 2004, Journal of Environmental Economics and Management, V48, P997, DOI 10.1016/j.jeem.2004.01.001; Neilan W, 2006, BIOL CONSERV, V129, P393, DOI 10.1016/j.biocon.2005.11.007; Simberloff D, 2013, TRENDS ECOL EVOL, V28, P58, DOI 10.1016/j.tree.2012.07.013; Sogge MK, 2008, RESTOR ECOL, V16, P146, DOI 10.1111/j.1526-100X.2008.00357.x; Soule M. E., 1980, CONSERVATION BIOL EV; Strong DR, 2013, ANNU REV ECOL EVOL S, V44, P389, DOI 10.1146/annurev-ecolsys-110512-135803; SWANSON FJ, 1992, ECOL APPL, V2, P262, DOI 10.2307/1941860; Taylor CM, 2004, J APPL ECOL, V41, P1049, DOI 10.1111/j.0021-8901.2004.00979.x; Worm B, 2006, SCIENCE, V314, P787, DOI 10.1126/science.1132294; Yokomizo H, 2012, BIOL INVASIONS, V14, P839, DOI 10.1007/s10530-011-0120-x	31	80	83	6	214	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 30	2014	344	6187					1028	1031		10.1126/science.1250763	http://dx.doi.org/10.1126/science.1250763			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AH9WM	24876497				2022-12-28	WOS:000336495800045
J	Stocchetti, N; Maas, AIR				Stocchetti, Nino; Maas, Andrew I. R.			Traumatic Intracranial Hypertension	NEW ENGLAND JOURNAL OF MEDICINE			English	Review							SEVERE HEAD-INJURY; BRAIN-INJURY; DECOMPRESSIVE CRANIECTOMY; PRESSURE; IMPACT; ADULTS; COMPLICATIONS; EPIDEMIOLOGY; HYPOTHERMIA; MANAGEMENT		[Stocchetti, Nino] Univ Milan, Dept Pathophysiol & Transplantat, Milan, Italy; [Stocchetti, Nino] Fdn Ist Ricovero & Cura Carattere Sci IRCCS Ca Gr, Milan, Italy; [Maas, Andrew I. R.] Univ Antwerp, Univ Antwerp Hosp, Dept Neurosurg, B-2650 Edegem, Belgium	University of Milan; University of Antwerp	Stocchetti, N (corresponding author), IRCCS Ca Granda Osped Maggiore Policlin, Via F Sforza 35, I-20122 Milan, Italy.	stocchet@policlinico.mi.it; andrew.maas@uza.be	Stocchetti, Nino/O-7444-2017	Stocchetti, Nino/0000-0003-3250-6834	Orsan Medical Technologies; BHR Pharma; NeuroVive; Sanofi Aventis; Shire	Orsan Medical Technologies; BHR Pharma; NeuroVive; Sanofi Aventis(Sanofi-Aventis); Shire	Dr. Stocchetti reports receiving consulting fees from Orsan Medical Technologies and lecture fees from BHR Pharma; and Dr. Maas, receiving consulting fees through his institution from NeuroVive, Sanofi Aventis, and Shire. No other potential conflict of interest relevant to this article was reported.	Bauer DF, 2011, NEUROSURGERY, V69, P255, DOI 10.1227/NEU.0b013e31821a45ba; Brain Trauma F, 2007, J NEUROTRAUM, V24, pS87; Brain Trauma Foundation, 2007, J Neurotrauma, V24 Suppl 1, pS37; Brain Trauma Foundation, 2007, J Neurotrauma, V24 Suppl 1, pS26; Brain Trauma Foundation American Association of Neurological Surgeons (AANS) Congress of Neurological Surgeons (CNS), 2007, J NEUROTRAUMA S1, V24, pS3; Bratton S L, 2007, J NEUROTRAUMA S1, V24, pS71, DOI DOI 10.1089/NEU.2007.9985; Bratton S. L., 2007, J NEUROTRAUMA S1, V24, pS45; Bullock M Ross, 2006, Neurosurgery, V58, pS7; Chesnut RM, 2012, NEW ENGL J MED, V367, P2471, DOI 10.1056/NEJMoa1207363; Clifton GL, 2001, NEW ENGL J MED, V344, P556, DOI 10.1056/NEJM200102223440803; Clifton GL, 2011, LANCET NEUROL, V10, P131, DOI 10.1016/S1474-4422(10)70300-8; Cooper DJ, 2011, NEW ENGL J MED, V364, P1493, DOI 10.1056/NEJMoa1102077; Cremer OL, 2005, CRIT CARE MED, V33, P2207, DOI 10.1097/01.CCM.0000181300.99078.B5; Farahvar A, 2012, J NEUROSURG, V117, P729, DOI 10.3171/2012.7.JNS111816; GOPINATH SP, 1994, J NEUROL NEUROSUR PS, V57, P717, DOI 10.1136/jnnp.57.6.717; Grady MS, 2009, J NEUROSURG, V110, P1198, DOI 10.3171/2008.11.JNS081336; GUILLAUME J, 1951, REV NEUROL, V84, P131; Kawamata T, 2006, ACTA NEUROCHIR SUPPL, V96, P3; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; LUNDBERG N, 1960, Acta Psychiatr Scand Suppl, V36, P1; Maas AIR, 1997, ACTA NEUROCHIR, V139, P286, DOI 10.1007/BF01808823; Maas AIR, 2008, LANCET NEUROL, V7, P728, DOI 10.1016/S1474-4422(08)70164-9; MARMAROU A, 1991, J NEUROSURG, V75, pS59, DOI 10.3171/sup.1991.75.1s.0s59; Miller J D, 1993, Acta Neurochir Suppl (Wien), V57, P152; Mushkudiani NA, 2007, J NEUROTRAUM, V24, P259, DOI 10.1089/neu.2006.0028; National Research Council Committee on a Framework for Developing a New Taxonomy of Disease, 2011, PREC MED; Nordstrom CH, 2003, ANESTHESIOLOGY, V98, P809, DOI 10.1097/00000542-200304000-00004; Olivecrona M, 2009, J NEUROSURG, V110, P300, DOI 10.3171/2008.4.17538; Poca MA, 2002, J NEUROTRAUM, V19, P439, DOI 10.1089/08977150252932398; Polderman KH, 2008, LANCET, V371, P1955, DOI 10.1016/S0140-6736(08)60837-5; Rebuck JA, 2000, J NEUROL NEUROSUR PS, V69, P381, DOI 10.1136/jnnp.69.3.381; Roberts I, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD000033.pub2; Roozenbeek B, 2013, NAT REV NEUROL, V9, P231, DOI 10.1038/nrneurol.2013.22; Ropper AH, 2012, NEW ENGL J MED, V367, P746, DOI 10.1056/NEJMct1206321; SAUL TG, 1982, J NEUROSURG, V56, P498, DOI 10.3171/jns.1982.56.4.0498; Shafi S, 2008, J TRAUMA, V64, P335, DOI 10.1097/TA.0b013e31815dd017; Slichter Sherrill J, 2007, Hematology Am Soc Hematol Educ Program, P172, DOI 10.1182/asheducation-2007.1.172; Stiver SI, 2009, NEUROSURG FOCUS, V26, DOI 10.3171/2009.4.FOCUS0965; Stocchetti N, 2005, CHEST, V127, P1812, DOI 10.1378/chest.127.5.1812; Stocchetti N, 2008, INTENS CARE MED, V34, P461, DOI 10.1007/s00134-007-0948-9; Stocchetti N, 2012, J NEUROTRAUM, V29, P1119, DOI 10.1089/neu.2011.1995; TANAKA H, 1994, ACTA NEUROCHIR, P524; TEASDALE G, 1976, ACTA NEUROCHIR, V34, P45, DOI 10.1007/BF01405862; Thompson HJ, 2006, J AM GERIATR SOC, V54, P1590, DOI 10.1111/j.1532-5415.2006.00894.x; Vespa PM, 1999, J NEUROSURG, V91, P750, DOI 10.3171/jns.1999.91.5.0750; Vik A, 2008, J NEUROSURG, V109, P678, DOI 10.3171/JNS/2008/109/10/0678; WILKINSON HA, 1989, NEUROSURGERY, V24, P348, DOI 10.1227/00006123-198903000-00007; Zumkeller M, 1996, NEUROSURGERY, V39, P708, DOI 10.1097/00006123-199610000-00011	48	180	189	2	24	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAY 29	2014	370	22					2121	2130		10.1056/NEJMra1208708	http://dx.doi.org/10.1056/NEJMra1208708			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AH9BM	24869722				2022-12-28	WOS:000336434000010
J	McCartney, M				McCartney, Margaret			NO HOLDS BARRED What should we die from?	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												margaret@margaretmccartney.com	mccartney, margaret/AAR-4727-2020	McCartney, Margaret/0000-0002-7238-6358					0	1	1	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	MAY 27	2014	348								g3380	10.1136/bmj.g3380	http://dx.doi.org/10.1136/bmj.g3380			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AI3EB	24868097				2022-12-28	WOS:000336741400009
J	Munz, M; Gobert, D; Schohl, A; Poquerusse, J; Podgorski, K; Spratt, P; Ruthazer, ES				Munz, Martin; Gobert, Delphine; Schohl, Anne; Poquerusse, Jessie; Podgorski, Kaspar; Spratt, Perry; Ruthazer, Edward S.			Rapid Hebbian axonal remodeling mediated by visual stimulation	SCIENCE			English	Article							RECEPTOR ANTAGONISTS DISRUPT; NMDA RECEPTOR; MAP FORMATION; IN-VIVO; RETINOTECTAL SYSTEM; TOPOGRAPHIC MAP; EXPERIENCE; INFUSION; ARBORS; MICE	We examined how correlated firing controls axon remodeling, using in vivo time-lapse imaging and electrophysiological analysis of individual retinal ganglion cell (RGC) axons that were visually stimulated either synchronously or asynchronously relative to neighboring inputs in the Xenopus laevis optic tectum. RGCs stimulated out of synchrony rapidly lost the ability to drive tectal postsynaptic partners while their axons grew and added many new branches. In contrast, synchronously activated RGCs produced fewer new branches, but these were more stable. The effects of synchronous activation were prevented by the inhibition of neurotransmitter release and N-methyl-D-aspartate receptor (NMDAR) blockade, which is consistent with a role for synaptic NMDAR activation in the stabilization of axonal branches and suppression of further exploratory branch addition.	[Munz, Martin; Gobert, Delphine; Schohl, Anne; Poquerusse, Jessie; Spratt, Perry; Ruthazer, Edward S.] McGill Univ, Montreal Neurol Inst, Dept Neurol & Neurosurg, Montreal, PQ H3A 2B4, Canada; [Poquerusse, Jessie] Dartmouth Coll, Geisel Sch Med, Hanover, NH 03755 USA; [Podgorski, Kaspar] Univ British Columbia, Brain Res Ctr, Vancouver, BC V6T 2B5, Canada	McGill University; Dartmouth College; University of British Columbia	Ruthazer, ES (corresponding author), McGill Univ, Montreal Neurol Inst, Dept Neurol & Neurosurg, 3801 Rue Univ, Montreal, PQ H3A 2B4, Canada.	edward.ruthazer@mcgill.ca	Ruthazer, Edward/H-4782-2019; Ruthazer, Edward S/P-5935-2014	Ruthazer, Edward/0000-0003-0452-3151; Ruthazer, Edward S/0000-0003-0452-3151; Podgorski, Kaspar/0000-0002-0374-2005	Canadian Institutes for Health Research; Natural Sciences and Engineering Research Council (NSERC) of Canada; Deutscher Akademischer Austausch Dienst; NSERC CREATE Neuroengineering Training Program; Fonds de la recherche en sante du Quebec; NSERC	Canadian Institutes for Health Research(Canadian Institutes of Health Research (CIHR)); Natural Sciences and Engineering Research Council (NSERC) of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)); Deutscher Akademischer Austausch Dienst(Deutscher Akademischer Austausch Dienst (DAAD)); NSERC CREATE Neuroengineering Training Program; Fonds de la recherche en sante du Quebec(Fonds de la Recherche en Sante du Quebec); NSERC(Natural Sciences and Engineering Research Council of Canada (NSERC))	We thank the laboratory of K. Haas (UBC) for assistance with the MATLAB analysis tool Dynamo for dynamic morphometric analysis. We also thank M. Meyer for providing us with the tetanus toxin light chain plasmid (5UAS-TeNT-EGFP) and D. Freiheit for photography of tadpoles. We are grateful to S. Glasgow for advice on statistical analysis and to H. Cline and W. Sossin for useful comments on our manuscript. This work was supported by grants from the Canadian Institutes for Health Research and the Natural Sciences and Engineering Research Council (NSERC) of Canada to E. S. R. and by fellowships from the Deutscher Akademischer Austausch Dienst and the NSERC CREATE Neuroengineering Training Program to M.M., the Fonds de la recherche en sante du Quebec to D.G., and NSERC to P.S. The authors declare that they have no conflicts of interest.	BEAR MF, 1990, J NEUROSCI, V10, P909; Benjumeda I, 2013, J NEUROSCI, V33, P18208, DOI 10.1523/JNEUROSCI.1931-13.2013; Cang JH, 2013, ANNU REV NEUROSCI, V36, P51, DOI 10.1146/annurev-neuro-062012-170341; CHANGEUX JP, 1976, NATURE, V264, P705, DOI 10.1038/264705a0; CLINE HT, 1989, NEURON, V3, P413, DOI 10.1016/0896-6273(89)90201-8; CLINE HT, 1987, P NATL ACAD SCI USA, V84, P4342, DOI 10.1073/pnas.84.12.4342; DEBSKI EA, 1990, J NEUROBIOL, V21, P18, DOI 10.1002/neu.480210103; Dhande OS, 2011, J NEUROSCI, V31, P3384, DOI 10.1523/JNEUROSCI.4899-10.2011; FREDJ NB, 2010, J NEUROSCI, V30, P10939, DOI DOI 10.1523/JNEUR0SCI.1556-10.2010; Hebb Donald O., 1949, ORG BEHAV; Hua JY, 2005, NATURE, V434, P1022, DOI 10.1038/nature03409; Kirkby LA, 2013, NEURON, V80, P1129, DOI 10.1016/j.neuron.2013.10.030; Larsen RS, 2011, NAT NEUROSCI, V14, P338, DOI 10.1038/nn.2750; LIU H, 1994, P NATL ACAD SCI USA, V91, P8383, DOI 10.1073/pnas.91.18.8383; Patterson GH, 2002, SCIENCE, V297, P1873, DOI 10.1126/science.1074952; Peter M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062132; Rajan I, 1999, J NEUROBIOL, V38, P357, DOI 10.1002/(SICI)1097-4695(19990215)38:3<357::AID-NEU5>3.0.CO;2-#; Ruthazer ES, 2003, SCIENCE, V301, P66, DOI 10.1126/science.1082545; Ruthazer ES, 2004, J NEUROBIOL, V59, P134, DOI 10.1002/neu.10344; SAKAGUCHI DS, 1985, J NEUROSCI, V5, P3228; SIMON DK, 1992, P NATL ACAD SCI USA, V89, P10593, DOI 10.1073/pnas.89.22.10593; SRETAVAN DW, 1988, NATURE, V336, P468, DOI 10.1038/336468a0; Tremblay M, 2009, J NEUROSCI, V29, P14066, DOI 10.1523/JNEUROSCI.3542-09.2009; UDIN SB, 1983, NATURE, V301, P336, DOI 10.1038/301336a0; Zhang JY, 2012, NAT NEUROSCI, V15, P298, DOI 10.1038/nn.3007; Zou DJ, 1999, J NEUROSCI, V19, P8909, DOI 10.1523/JNEUROSCI.19-20-08909.1999	26	51	51	0	17	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 23	2014	344	6186					904	909		10.1126/science.1251593	http://dx.doi.org/10.1126/science.1251593			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AH6IL	24855269				2022-12-28	WOS:000336233800049
J	Ravi, B; Jenkinson, R; Austin, PC; Croxford, R; Wasserstein, D; Escott, B; Paterson, JM; Kreder, H; Hawker, GA				Ravi, Bheeshma; Jenkinson, Richard; Austin, Peter C.; Croxford, Ruth; Wasserstein, David; Escott, Benjamin; Paterson, J. Michael; Kreder, Hans; Hawker, Gillian A.			Relation between surgeon volume and risk of complications after total hip arthroplasty: propensity score matched cohort study	BMJ-BRITISH MEDICAL JOURNAL			English	Article							TOTAL KNEE REPLACEMENT; BODY-MASS INDEX; UNITED-STATES; PANCREATIC RESECTION; JOINT ARTHROPLASTY; SMOKING-CESSATION; DIABETES-MELLITUS; HOSPITAL VOLUME; SURGICAL VOLUME; OUTCOMES	Objectives To identify a cut point in annual surgeon volume associated with increased risk of complications after primary elective total hip arthroplasty and to quantify any risk identified. Design Propensity score matched cohort study. Setting Ontario, Canada Participants 37 881 people who received their first primary total hip arthroplasty during 2002-09 and were followed for at least two years after their surgery. Main outcome measure The rates of various surgical complications within 90 days (venous thromboembolism, death) and within two years (infection, dislocation, periprosthetic fracture, revision) of surgery. Results Multivariate splines were developed to visualize the relation between surgeon volume and the risk for various complications. A threshold of 35 cases a year was identified, under which there was an increased risk of dislocation and revision. 6716 patients whose total hip arthroplasty was carried out by surgeons who had done <= 35 such procedure in the previous year were successfully matched to patients whose surgeon had carried out more than 35 procedures. Patients in the former group had higher rates of dislocation (1.9% v 1.3%, P=0.006; NNH 172) and revision (1.5% v 1.0%, P=0.03; NNH 204). Conclusions In a cohort of first time recipients of total hip arthroplasty, patients whose operation was carried by surgeons who had performed 35 or fewer such procedures in the year before the index procedure were at increased risk for dislocation and early revision. Surgeons should consider performing 35 cases or more a year to minimize the risk for complications. Furthermore, the methods used to visualize the relationship between surgeon volume and the occurrence of complications can be easily applied in any jurisdiction, to help inform and optimize local healthcare delivery.	[Ravi, Bheeshma; Jenkinson, Richard; Wasserstein, David; Escott, Benjamin; Kreder, Hans] Univ Toronto, Dept Surg, Div Orthopaed Surg, Toronto, ON, Canada; [Austin, Peter C.; Croxford, Ruth; Paterson, J. Michael; Kreder, Hans; Hawker, Gillian A.] Inst Clin Evaluat Sci, Toronto, ON, Canada; [Austin, Peter C.; Paterson, J. Michael; Kreder, Hans; Hawker, Gillian A.] Univ Toronto, Inst Hlth Policy Management & Evaluat, Toronto, ON, Canada; [Hawker, Gillian A.] Womens Coll Hosp, Dept Med, Div Rheumatol, Toronto, ON, Canada	University of Toronto; University of Toronto; University of Toronto; University of Toronto; University Toronto Affiliates; Womens College Hospital	Ravi, B (corresponding author), Univ Toronto, Dept Surg, Div Orthopaed Surg, Toronto, ON, Canada.	bheeshma.ravi@mail.utoronto.ca		Austin, Peter/0000-0003-3337-233X	Canadian Institutes of Health Research; Institute for Clinical Evaluative Sciences - Ontario Ministry of Health and Long-Term Care; FM Hill Chair in Academic Women's Medicine; Ministry of Health and Long-Term Care; CIHR [MOP-15468]	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Institute for Clinical Evaluative Sciences - Ontario Ministry of Health and Long-Term Care(Ministry of Health and Long-Term Care, Ontario); FM Hill Chair in Academic Women's Medicine; Ministry of Health and Long-Term Care(Ministry of Health and Long-Term Care, Ontario); CIHR(Canadian Institutes of Health Research (CIHR))	This study was supported by a grant from the Canadian Institutes of Health Research and by the Institute for Clinical Evaluative Sciences, a non-profit research institute funded by the Ontario Ministry of Health and Long-Term Care. The opinions, results and conclusions reported in this paper are those of the authors and are independent from the funding sources. No endorsement by the Institute for Clinical Evaluative Sciences or the Ontario Ministry of Health and Long-Term Care is intended or should be inferred. GAH is supported in part by the FM Hill Chair in Academic Women's Medicine. ICES received support from the Ministry of Health and Long-Term Care. CIHR Grant number: MOP-15468.	Agabiti N, 2007, INT J QUAL HEALTH C, V19, P37, DOI 10.1093/intqhc/mzl065; Alberton GM, 2002, J BONE JOINT SURG AM, V84A, P1788, DOI 10.2106/00004623-200210000-00008; Austin PC, 2011, STAT MED, V30, P1292, DOI 10.1002/sim.4200; Austin PC, 2011, MULTIVAR BEHAV RES, V46, P119, DOI 10.1080/00273171.2011.540480; Austin PC, 2011, PHARM STAT, V10, P150, DOI 10.1002/pst.433; Austin PC, 2009, STAT MED, V28, P3083, DOI 10.1002/sim.3697; Baker P, 2011, SURG-J R COLL SURG E, V9, P13, DOI 10.1016/j.surge.2010.08.011; Bakhshi E, 2012, COMPUT MATH METHOD M, V2012, DOI 10.1155/2012/639124; BARLOW WE, 1994, BIOMETRICS, V50, P1064, DOI 10.2307/2533444; Bini S, 2013, J BONE JOINT SURG AM, V95A, P2195, DOI 10.2106/JBJS.L.01006; Birkmeyer JD, 2003, NEW ENGL J MED, V349, P2117, DOI 10.1056/NEJMsa035205; Block EFJ, 2010, J TRAUMA, V69, P640, DOI 10.1097/TA.0b013e3181efbed9; Bourne RB, 2010, CLIN ORTHOP RELAT R, V468, P57, DOI 10.1007/s11999-009-1119-9; Burns AWR, 2006, CLIN ORTHOP RELAT R, P29, DOI 10.1097/01.blo.0000214420.14088.76; Clyburn TA, 2013, J AM ACAD ORTHOP SUR; Collier R, 2010, CAN MED ASSOC J, V182, P331, DOI 10.1503/cmaj.109-3167; Colosia AD, 2013, DIABETES METAB SYNDR, V6, P327, DOI 10.2147/DMSO.S51325; Cook RE, 2008, CLIN ORTHOP RELAT R, V466, P1652, DOI 10.1007/s11999-008-0289-1; Courcoulas A, 2003, SURGERY, V134, P613, DOI 10.1016/S0039-6060(03)00306-4; Cowan JA, 2003, J VASC SURG, V37, P1169, DOI 10.1016/S0741-5214(03)00085-5; Dawson NV, 2012, MED DECIS MAKING, V32, P225, DOI 10.1177/0272989X12437605; de Palma L, 2012, HIP INT, V22, P62, DOI 10.5301/HIP.2012.9059; DEYO RA, 1992, J CLIN EPIDEMIOL, V45, P613, DOI 10.1016/0895-4356(92)90133-8; Dobzyniak M, 2006, CLIN ORTHOP RELAT R, P76, DOI 10.1097/01.blo.0000203484.90711.52; FitzGerald JD, 2012, ARTHRIT CARE RES, V64, P890, DOI 10.1002/acr.21611; Franklin J, 2007, INJURY, V38, P655, DOI 10.1016/j.injury.2007.02.049; Gershon AS, 2009, COPD, V6, P388, DOI 10.1080/15412550903140865; Glazier RH, 2000, CAN J PUBLIC HEALTH, V91, P268, DOI 10.1007/BF03404286; Grossman E, 2008, ADV CARDIOL, V45, P82, DOI 10.1159/000115189; Gustafson P, 2002, BIOMETRICS, V58, P878, DOI 10.1111/j.0006-341X.2002.00878.x; Halimi JM, 2000, KIDNEY INT, V58, P1285, DOI 10.1046/j.1523-1755.2000.00284.x; HASTINGS DE, 1975, CLIN ORTHOP RELAT R, P76; Haverkamp D, 2011, ACTA ORTHOP, V82, P417, DOI 10.3109/17453674.2011.588859; Hu FB, 2003, LIPIDS, V38, P103, DOI 10.1007/s11745-003-1038-4; Hu JC, 2003, J CLIN ONCOL, V21, P401, DOI 10.1200/JCO.2003.05.169; Hubbard RE, 2009, J NUTR HEALTH AGING, V13, P468, DOI 10.1007/s12603-009-0085-y; Hubbard RE, 2010, J GERONTOL A-BIOL, V65, P377, DOI 10.1093/gerona/glp186; Hux JE, 2002, DIABETES CARE, V25, P512, DOI 10.2337/diacare.25.3.512; Information CIfH, 2008, RED GAPS HLTH FOC SO; Information CIfH, 2006, ASS THEIR HLTH STAT; Kapadia BH, 2014, J ARTHROPLASTY, V29, P777, DOI 10.1016/j.arth.2013.08.023; Katz JN, 2007, ARTHRITIS RHEUM, V56, P568, DOI 10.1002/art.22333; Katz JN, 2001, J BONE JOINT SURG AM, V83A, P1622, DOI 10.2106/00004623-200111000-00002; Katz JN, 2003, ARTHRITIS RHEUM, V48, P560, DOI 10.1002/art.10754; Kenchaiah S, 2002, NEW ENGL J MED, V347, P305, DOI 10.1056/NEJMoa020245; KIRK PG, 1993, CAN J SURG, V36, P229; Kluess D, 2007, MED ENG PHYS, V29, P465, DOI 10.1016/j.medengphy.2006.07.001; Ko DT, 2004, JAMA-J AM MED ASSOC, V291, P1864, DOI 10.1001/jama.291.15.1864; Kralj B, 2000, ONTARIO MED REV, P37; Kralj B., 2005, MEASURING RURALITY P; Lau RL, 2012, BMC MUSCULOSKEL DIS, V13, DOI 10.1186/1471-2474-13-250; LAVERNIA CJ, 1995, J ARTHROPLASTY, V10, P133, DOI 10.1016/S0883-5403(05)80119-6; Lewis Steven, 2004, Healthc Pap, V5, P12; LIEBERMAN MD, 1995, ANN SURG, V222, P638, DOI 10.1097/00000658-199511000-00006; Lingard EA, 2004, J BONE JOINT SURG AM, V86A, P2179, DOI 10.2106/00004623-200410000-00008; Losina E, 2004, ARTHRITIS RHEUM-US, V50, P1338, DOI 10.1002/art.20148; Losina E, 2007, ARCH INTERN MED, V167, P182, DOI 10.1001/archinte.167.2.182; Marrie RA, 2009, J CLIN EPIDEMIOL, V62, P511, DOI 10.1016/j.jclinepi.2008.05.015; Masonis JL, 2002, CLIN ORTHOP RELAT R, P46, DOI 10.1097/01.blo.0000038476.05771.6c; Matheson F., 2011, ONTARIO MARGINALIZAT; Matheson FI, 2008, SOC SCI MED, V66, P675, DOI 10.1016/j.socscimed.2007.10.008; Matheson FI, 2006, SOC SCI MED, V63, P2604, DOI 10.1016/j.socscimed.2006.07.001; Matheson FI, 2012, J EPIDEMIOL COMMUN H, V66, DOI 10.1136/jech.2010.112441; McMinn D, 2006, P I MECH ENG H, V220, P239, DOI 10.1243/095441105X68944; Morrey B F, 1992, J Arthroplasty, V7, P71, DOI 10.1016/0883-5403(92)90035-O; Morris AH, 2001, J BONE JOINT SURG AM, V83A, P1754, DOI 10.2106/00004623-200111000-00022; Moser BK, 2004, STAT MED, V23, P1843, DOI 10.1002/sim.1776; Nilsdotter AK, 2003, ANN RHEUM DIS, V62, P923, DOI 10.1136/ard.62.10.923; O'Donnell DE, 2012, PULM MED, V2012, DOI 10.1155/2012/818925; Papakostidou I, 2012, BMC MUSCULOSKEL DIS, V13, DOI 10.1186/1471-2474-13-116; Paterson JM, 2010, CAN J SURG, V53, P175; Perkins NJ, 2006, AM J EPIDEMIOL, V163, P670, DOI 10.1093/aje/kwj063; RAGLAND DR, 1992, EPIDEMIOLOGY, V3, P434, DOI 10.1097/00001648-199209000-00009; Ravi B, 2014, ARTHRITIS RHEUMATOL, V66, P254, DOI 10.1002/art.38231; Royston P, 2006, STAT MED, V25, P127, DOI 10.1002/sim.2331; Rutkowski P, 2006, J RENAL NUTR, V16, P216, DOI 10.1053/j.jrn.2006.04.017; Saleh K, 2002, J ORTHOP RES, V20, P506, DOI 10.1016/S0736-0266(01)00153-X; Santaguida PL, 2008, CAN J SURG, V51, P428; Schneeweiss S, 2006, PHARMACOEPIDEM DR S, V15, P291, DOI 10.1002/pds.1200; SHAH PK, 1988, CHEST, V94, P449, DOI 10.1378/chest.94.3.449; Simunovic M, 1999, CAN MED ASSOC J, V160, P643; Stavrakis AI, 2007, SURGERY, V142, P887, DOI 10.1016/j.surg.2007.09.003; Tashkin DP, 2009, RESP MED, V103, P963, DOI 10.1016/j.rmed.2009.02.013; Tu Karen, 2007, Open Med, V1, pe18; Urquhart DM, 2010, J ARTHROPLASTY, V25, P1216, DOI 10.1016/j.arth.2009.08.011; Weiner J., 2011, J HOPKINS ACG SYSTEM; White HL, 2011, HEALTH PLACE, V17, P361, DOI 10.1016/j.healthplace.2010.11.016; Will JC, 2001, INT J EPIDEMIOL, V30, P540, DOI 10.1093/ije/30.3.540	88	150	151	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	MAY 23	2014	348								g3284	10.1136/bmj.g3284	http://dx.doi.org/10.1136/bmj.g3284			14	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	AH9AC	24859902	Green Published, hybrid			2022-12-28	WOS:000336429700004
J	Mitchison, TJ				Mitchison, T. J.			The Engine of Microtubule Dynamics Comes into Focus	CELL			English	Editorial Material							SLOWLY HYDROLYZABLE ANALOG; TUBULIN POLYMERIZATION; GTP HYDROLYSIS; INFORMATION	In this issue, Alushin et al. report high-resolution structures of three states of the microtubule lattice: GTP-bound, which is stable to depolymerization; unstable GDP-bound; and stable Taxol and GDP-bound. By comparing these structures at near-atomic resolution, they are able to propose a detailed model for how GTP hydrolysis destabilizes the microtubule and thus powers dynamic instability and chromosome movement. Destabilization of cytoskeleton filaments by nucleotide hydrolysis is an important general principle in cell dynamics, and this work represents a major step forward on a problem with a long history.	Harvard Univ, Sch Med, Dept Syst Biol, Boston, MA 02115 USA	Harvard University; Harvard Medical School	Mitchison, TJ (corresponding author), Harvard Univ, Sch Med, Dept Syst Biol, Boston, MA 02115 USA.	timothy_mitchison@hms.harvard.edu			NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P01GM051487] Funding Source: NIH RePORTER; NIGMS NIH HHS [P01 GM051487] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Alushin GM, 2014, CELL, V157, P1117, DOI 10.1016/j.cell.2014.03.053; CAPLOW M, 1994, J CELL BIOL, V127, P779, DOI 10.1083/jcb.127.3.779; CARLIER MF, 1981, BIOCHEMISTRY-US, V20, P1918, DOI 10.1021/bi00510a030; HYMAN AA, 1992, MOL BIOL CELL, V3, P1155, DOI 10.1091/mbc.3.10.1155; HYMAN AA, 1995, J CELL BIOL, V128, P117, DOI 10.1083/jcb.128.1.117; Inoue S., 1964, PRIMITIVE MOTILE SYS, P549; KIRSCHNER M, 1986, CELL, V45, P329, DOI 10.1016/0092-8674(86)90318-1; MANDELKOW EM, 1991, J CELL BIOL, V114, P977, DOI 10.1083/jcb.114.5.977; Mitchison TJ, 2012, MOL BIOL CELL, V23, P1, DOI 10.1091/mbc.E10-04-0335; SANDOVAL IV, 1977, P NATL ACAD SCI USA, V74, P4881, DOI 10.1073/pnas.74.11.4881	10	4	4	0	22	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAY 22	2014	157	5					1008	1010		10.1016/j.cell.2014.05.001	http://dx.doi.org/10.1016/j.cell.2014.05.001			4	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	AH9CG	24855939	Bronze			2022-12-28	WOS:000336437200004
J	Unlu, C; de Vries, JPPM				Unlu, Cagdas; de Vries, Jean-Paul P. M.			Ischaemic scalp ulceration and hair loss	LANCET			English	Editorial Material									[Unlu, Cagdas; de Vries, Jean-Paul P. M.] St Antonius Hosp, Dept Vasc Surg, NL-3435 CM Nieuwegein, Netherlands	St. Antonius Hospital Utrecht	Unlu, C (corresponding author), St Antonius Hosp, Koekoekslaan 1, NL-3435 CM Nieuwegein, Netherlands.	cagdas.unlu@gmail.com							0	2	2	0	5	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	OCT 11	2014	384	9951					1375	1375		10.1016/S0140-6736(14)60929-6	http://dx.doi.org/10.1016/S0140-6736(14)60929-6			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AQ7NH	24910386	Bronze			2022-12-28	WOS:000343004000027
J	Xu, H; Yang, JL; Gao, WQ; Li, L; Li, P; Zhang, L; Gong, YN; Peng, XL; Xi, JZJ; Chen, S; Wang, FC; Shao, F				Xu, Hao; Yang, Jieling; Gao, Wenqing; Li, Lin; Li, Peng; Zhang, Li; Gong, Yi-Nan; Peng, Xiaolan; Xi, Jianzhong Jeff; Chen, She; Wang, Fengchao; Shao, Feng			Innate immune sensing of bacterial modifications of Rho GTPases by the Pyrin inflammasome	NATURE			English	Article							FAMILIAL MEDITERRANEAN FEVER; GTP-BINDING PROTEINS; CLOSTRIDIUM-DIFFICILE; BURKHOLDERIA-CENOCEPACIA; TOXIN-B; ACTIN CYTOSKELETON; VIBRIO-CHOLERAE; RTX TOXIN; ACTIVATION; SYSTEM	Cytosolic inflammasome complexes mediated by a pattern recognition receptor (PRR) defend against pathogen infection by activating caspase 1. Pyrin, a candidate PRR, can bind to the inflammasome adaptor ASC to form a caspase 1-activating complex(1,2). Mutations in the Pyrin-encoding gene, MEFV, cause a human autoinflammatory disease known as familial Mediterranean fever(3-5). Despite important roles in immunity and disease, the physiological function of Pyrin remains unknown. Here we show that Pyrin mediates caspase 1 inflammasome activation in response to Rho-glucosylation activity of cytotoxin TcdB(6-8), a major virulence factor of Clostridium difficile, which causes most cases of nosocomial diarrhoea. The glucosyltransferase-inactive TcdB mutant loses the inflammasome-stimulating activity. Other Rho-inactivating toxins, including FIC-domain adenylyltransferases (Vibrioparahaemolyticus VopS and Histophilus somnilbpA) and Clostridium botulinum ADP-ribosylating C3 toxin, can also biochemically activate the Pyrin inflammasome in their enzymatic activitydependent manner. These toxins all target the Rho subfamily and modify a switch-I residue. We further demonstrate that Burkholderia cenocepacia inactivates RHOA by deamidating Asn 41, also in the switch-I region, and thereby triggers Pyrin inflammasome activation, both of which require the bacterial type VI secretion system (T6SS). Loss of the Pyrin inflammasome causes elevated intra-macrophage growth of B. cenocepacia and diminished lung inflammation in mice. Thus, Pyrin functions to sense pathogen modification and inactivation of Rho GTPases, representing a new paradigm in mammalian innate immunity.	[Xu, Hao; Yang, Jieling; Gao, Wenqing; Li, Lin; Li, Peng; Zhang, Li; Gong, Yi-Nan; Peng, Xiaolan; Chen, She; Wang, Fengchao; Shao, Feng] Natl Inst Biol Sci, Beijing 102206, Peoples R China; [Yang, Jieling; Shao, Feng] Chinese Acad Sci, Inst Biophys, Natl Lab Biomacromol, Beijing 100101, Peoples R China; [Xi, Jianzhong Jeff] Peking Univ, Coll Engn, Dept Biomed Engn, Beijing 100871, Peoples R China; [Shao, Feng] Collaborat Innovat Ctr Canc Med, Beijing 102206, Peoples R China	National Institute of Biological Sciences, Beijing; Chinese Academy of Sciences; Institute of Biophysics, CAS; Peking University	Shao, F (corresponding author), Natl Inst Biol Sci, Beijing 102206, Peoples R China.	shaofeng@nibs.ac.cn	Xi, Jianzhong/J-1420-2014	Xu, Hao/0000-0003-3286-0710	International Early Career Scientist grant from the Howard Hughes Medical Institute; National Basic Research Program of China 973 Program [2012CB518700]; Strategic Priority Research Program of the Chinese Academy of Sciences [XDB08020202]; China National Science Foundation Program for Distinguished Young Scholars [31225002]	International Early Career Scientist grant from the Howard Hughes Medical Institute(Howard Hughes Medical Institute); National Basic Research Program of China 973 Program(National Basic Research Program of China); Strategic Priority Research Program of the Chinese Academy of Sciences(Chinese Academy of Sciences); China National Science Foundation Program for Distinguished Young Scholars(National Natural Science Foundation of China (NSFC))	We thank V. Dixit for providing knockout mice and anti-ASC antibody, D. Lyras for C. sordellii genomic DNA, J. Xiao for IbpA-Fic constructs, T. Iida for V. parahaemolyticus strain, M. Valvano for pDAI-Scel vector and H. Feng for TcdB B. megaterium expression system. We thank members of the Shao laboratory for discussions. The research was supported in part by an International Early Career Scientist grant from the Howard Hughes Medical Institute to F.S. This work was also supported by the National Basic Research Program of China 973 Program (2012CB518700), the Strategic Priority Research Program of the Chinese Academy of Sciences (XDB08020202) and China National Science Foundation Program for Distinguished Young Scholars (31225002) to F.S.	AKTORIES K, 1989, TRENDS PHARMACOL SCI, V10, P415, DOI 10.1016/0165-6147(89)90191-0; Aktories K, 2011, NAT REV MICROBIOL, V9, P487, DOI 10.1038/nrmicro2592; [Anonymous], 1997, CELL, V90, P797; Benard V, 1999, J BIOL CHEM, V274, P13198, DOI 10.1074/jbc.274.19.13198; Boyer L, 2011, IMMUNITY, V35, P536, DOI 10.1016/j.immuni.2011.08.015; Bruno VM, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000538; Cermak T, 2011, NUCLEIC ACIDS RES, V39, DOI 10.1093/nar/gkr218; Chae JJ, 2011, IMMUNITY, V34, P755, DOI 10.1016/j.immuni.2011.02.020; Cordero CL, 2006, J BIOL CHEM, V281, P32366, DOI 10.1074/jbc.M605275200; Flannagan RS, 2008, ENVIRON MICROBIOL, V10, P1652, DOI 10.1111/j.1462-2920.2008.01576.x; Flannagan RS, 2012, CELL MICROBIOL, V14, P239, DOI 10.1111/j.1462-5822.2011.01715.x; French FMF Consortium, 1997, NATURE GENET, V17, P25; Fukazawa A, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000228; Gavrilin MA, 2012, J IMMUNOL, V188, P3469, DOI 10.4049/jimmunol.1102272; Gong YN, 2010, CELL RES, V20, P1289, DOI 10.1038/cr.2010.135; Higa N, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003142; Jank T, 2008, TRENDS MICROBIOL, V16, P222, DOI 10.1016/j.tim.2008.01.011; Jank T, 2007, J BIOL CHEM, V282, P35222, DOI 10.1074/jbc.M703138200; Jones JDG, 2006, NATURE, V444, P323, DOI 10.1038/nature05286; Just I, 1996, J BIOL CHEM, V271, P10149, DOI 10.1074/jbc.271.17.10149; Kayagaki N, 2011, NATURE, V479, P117, DOI 10.1038/nature10558; Keestra AM, 2013, NATURE, V496, P233, DOI 10.1038/nature12025; Kuehne SA, 2010, NATURE, V467, P711, DOI 10.1038/nature09397; Lyras D, 2009, NATURE, V458, P1176, DOI 10.1038/nature07822; Mattoo S, 2011, J BIOL CHEM, V286, P32834, DOI 10.1074/jbc.M111.227603; Ng J., 2010, GASTROENTEROLOGY, V139; Popoff MR, 1996, J BIOL CHEM, V271, P10217, DOI 10.1074/jbc.271.17.10217; Ren XD, 2000, METHOD ENZYMOL, V325, P264; Richards N, 2001, J BIOL CHEM, V276, P39320, DOI 10.1074/jbc.M104730200; Rosales-Reyes R, 2012, CELL MICROBIOL, V14, P255, DOI 10.1111/j.1462-5822.2011.01716.x; Seshadri S, 2007, J IMMUNOL, V179, P1274, DOI 10.4049/jimmunol.179.2.1274; Sheahan KL, 2007, CELL MICROBIOL, V9, P1324, DOI 10.1111/j.1462-5822.2006.00876.x; Waite AL, 2009, EXP BIOL MED, V234, P40, DOI 10.3181/0806-RM-184; Worby CA, 2009, MOL CELL, V34, P93, DOI 10.1016/j.molcel.2009.03.008; Yang GL, 2008, BMC MICROBIOL, V8, DOI 10.1186/1471-2180-8-192; Yang JL, 2013, P NATL ACAD SCI USA, V110, P14408, DOI 10.1073/pnas.1306376110; Yarbrough ML, 2009, SCIENCE, V323, P269, DOI 10.1126/science.1166382; Yu JW, 2006, CELL DEATH DIFFER, V13, P236, DOI 10.1038/sj.cdd.4401734; Zhao Y, 2011, NATURE, V477, P596, DOI 10.1038/nature10510	39	498	516	8	163	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 11	2014	513	7517					237	+		10.1038/nature13449	http://dx.doi.org/10.1038/nature13449			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO5DP	24919149	Bronze			2022-12-28	WOS:000341362800051
J	Hemmes, SNT; de Abreu, MG; Pelosi, P; Schultz, MJ; Severgnini, P; Hollmann, MW; Binnekade, JM; Wrigge, H; Canet, J; Hiesmayr, M; Schmid, W; Jaber, S; Hedenstierna, G; Putensen, C; Sessler, DI; Lachmann, B; Kacmarek, RM; Slutsky, AS; De Baerdemaeker, L; De Hert, S; Heyse, B; Van Limmen, J; Mulier, JP; Velghe, D; Jamaer, L; Vandenbrande, J; Bugedo, G; Florez, J; Goranovic, T; Mazul-Sunko, B; Bluth, T; Guldner, A; Kiss, T; Koch, T; Spieth, PM; Uhlig, C; Yaqub, J; Bastin, B; Geib, J; Schaefer, MS; Weiss, M; Treschan, TA; Reske, AW; Simon, P; Ferner, ABM; Hartmann, E; Laufenberg-Feldmann, R; Strys, L; De Robertis, E; Perilli, V; Proietti, R; Amantea, B; Caroleo, S; Tropea, F; Bacuzzi, A; Vanoni, M; Cinnella, G; Caggianelli, G; D'Antini, D; La Bella, D; Mollica, G; Cortegiani, A; Giarratano, A; Montalto, F; Raineri, SM; Barberis, B; Celentano, C; Grio, M; Spagnolo, L; Gratarola, A; Molin, A; Pellerano, G; Pezzato, S; Rusca, R; Della Rocca, G; Bos, LD; Brunelli, A; Marti, A; Cegarra, V; Merten, A; Moral, MV; Parera, A; Unzueta, MC; Sabate, S; Sierra, P; Mayoral, JF; Prieto, M; Gil, MG; Marin, CM; Mills, GH; Bodger, P; Melo, MFV; Sulemanji, D; Sprung, J; De Bruyne, A; Ongena, P; Bleyl, JU; Koch, M; Muller, M; Rossel, T; Saeger, HD; Weitz, J; Babian, R; Rathmann, AM; Pochert, J; Dathe, M; Chiaravalloti, F; Madia, D; Pezzoli, I; Caruso, A; Bianco, MF; Picicco, F; Mirabella, L; Rauseo, M; Anguilano, R; Palmeri, C; Strano, MT; Federico, A; Pompei, L; Buttera, S; Everingham, K; Han, R; Hewson, R; Januszewska, M; Mohr, O; Pearse, R; Raj, A; Oto, J; Kacmarek, RM; Weingarten, TN				Hemmes, Sabrine N. T.; de Abreu, Marcelo Gama; Pelosi, Paolo; Schultz, Marcus J.; Severgnini, Paolo; Hollmann, Markus W.; Binnekade, Jan M.; Wrigge, Hermann; Canet, Jaume; Hiesmayr, Michael; Schmid, Werner; Jaber, Samir; Hedenstierna, Goran; Putensen, Christian; Sessler, Daniel I.; Lachmann, Burkhard; Kacmarek, Robert M.; Slutsky, Arthur S.; De Baerdemaeker, Luc; De Hert, Stefan; Heyse, Bjorn; Van Limmen, Jurgen; Mulier, Jan-Paul; Velghe, David; Jamaer, Luc; Vandenbrande, Jeroen; Bugedo, Guillermo; Florez, Jorge; Goranovic, Tatjana; Mazul-Sunko, Branka; Bluth, Thomas; Guldner, Andreas; Kiss, Thomas; Koch, Thea; Spieth, Peter Markus; Uhlig, Christopher; Yaqub, Jonathan; Bastin, Bea; Geib, Johann; Schaefer, Maximilian S.; Weiss, Martin; Treschan, Tanja A.; Reske, Andreas W.; Simon, Philipp; Ferner, Alexander Brodhun Marion; Hartmann, Eric; Laufenberg-Feldmann, Rita; Strys, Lydia; De Robertis, Edoardo; Perilli, Valter; Proietti, Rodolfo; Amantea, Bruno; Caroleo, Santo; Tropea, Francesco; Bacuzzi, Alessandro; Vanoni, Massimo; Cinnella, Gilda; Caggianelli, Girolamo; D'Antini, Davide; La Bella, Daniela; Mollica, Giuseppina; Cortegiani, Andrea; Giarratano, Antonino; Montalto, Francesca; Raineri, Santi Maurizio; Barberis, Bruno; Celentano, Cristian; Grio, Michele; Spagnolo, Luigi; Gratarola, Angelo; Molin, Alexandre; Pellerano, Giulia; Pezzato, Stefano; Rusca, Roberta; Della Rocca, Giorgio; Bos, Lieuwe D. J.; Brunelli, Andrea; Marti, Agnes; Cegarra, Virginia; Merten, Alfred; Victoria Moral, Maria; Parera, Ana; Carmen Unzueta, Maria; Sabate, Sergi; Sierra, Pilar; Mayoral, Juan F.; Prieto, Merce; Granell Gil, Manuel; Minguez Marin, Conrado; Mills, Gary H.; Bodger, Phoebe; Melo, Marcos F. Vidal; Sulemanji, Demet; Sprung, Juraj; De Bruyne, Ann; Ongena, Patricia; Bleyl, Jorg-Uwe; Koch, Moritz; Muller, Michael; Rossel, Thomas; Saeger, Hans-Detlef; Weitz, Jurgen; Babian, Renate; Rathmann, Anna Malina; Pochert, Julia; Dathe, Mandy; Chiaravalloti, Fernando; Madia, Daniela; Pezzoli, Ivana; Caruso, Andrea; Bianco, Maria Francesca; Picicco, Francesco; Mirabella, Lucia; Rauseo, Michela; Anguilano, Romina; Palmeri, Cesira; Strano, Maria Teresa; Federico, Antonino; Pompei, Livia; Buttera, Stefania; Everingham, Kirsty; Han, Ruth; Hewson, Russell; Januszewska, Marta; Mohr, Otto; Pearse, Rupert; Raj, Ashok; Oto, Jun; Kacmarek, Robert M.; Weingarten, Toby N.		PROVE Network Investigators Clinic; European Soc Anaesthesiology	High versus low positive end-expiratory pressure during general anaesthesia for open abdominal surgery (PROVHILO trial): a multicentre randomised controlled trial	LANCET			English	Article							POSTOPERATIVE PULMONARY COMPLICATIONS; MECHANICALLY VENTILATED PATIENTS; RESPIRATORY-DISTRESS-SYNDROME; MULTIFACTORIAL RISK INDEX; ATELECTASIS; STRATEGIES; PREVENTS; VOLUME	Background The role of positive end-expiratory pressure in mechanical ventilation during general anaesthesia for surgery remains uncertain. Levels of pressure higher than 0 cm H2O might protect against postoperative pulmonary complications but could also cause intraoperative circulatory depression and lung injury from overdistension. We tested the hypothesis that a high level of positive end-expiratory pressure with recruitment manoeuvres protects against postoperative pulmonary complications in patients at risk of complications who are receiving mechanical ventilation with low tidal volumes during general anaesthesia for open abdominal surgery. Methods In this randomised controlled trial at 30 centres in Europe and North and South America, we recruited 900 patients at risk for postoperative pulmonary complications who were planned for open abdominal surgery under general anaesthesia and ventilation at tidal volumes of 8 mL/kg. We randomly allocated patients to either a high level of positive end-expiratory pressure (12 cm H2O) with recruitment manoeuvres (higher PEEP group) or a low level of pressure (<= 2 cm H2O) without recruitment manoeuvres (lower PEEP group). We used a centralised computer-generated randomisation system. Patients and outcome assessors were masked to the intervention. Primary endpoint was a composite of postoperative pulmonary complications by postoperative day 5. Analysis was by intention-to-treat. The study is registered at Controlled-Trials. com, number ISRCTN70332574. Findings From February, 2011, to January, 2013, 447 patients were randomly allocated to the higher PEEP group and 453 to the lower PEEP group. Six patients were excluded from the analysis, four because they withdrew consent and two for violation of inclusion criteria. Median levels of positive end-expiratory pressure were 12 cm H2O (IQR 12-12) in the higher PEEP group and 2 cm H2O (0-2) in the lower PEEP group. Postoperative pulmonary complications were reported in 174 (40%) of 445 patients in the higher PEEP group versus 172 (39%) of 449 patients in the lower PEEP group (relative risk 1.01; 95% CI 0.86-1.20; p = 0.86). Compared with patients in the lower PEEP group, those in the higher PEEP group developed intraoperative hypotension and needed more vasoactive drugs. Interpretation A strategy with a high level of positive end-expiratory pressure and recruitment manoeuvres during open abdominal surgery does not protect against postoperative pulmonary complications. An intraoperative protective ventilation strategy should include a low tidal volume and low positive end-expiratory pressure, without recruitment manoeuvres.	[Hemmes, Sabrine N. T.; Schultz, Marcus J.; Hollmann, Markus W.; Binnekade, Jan M.; Bos, Lieuwe D. J.] Univ Amsterdam, Acad Med Ctr, NL-1105 AZ Amsterdam, Netherlands; [de Abreu, Marcelo Gama; Bluth, Thomas; Guldner, Andreas; Kiss, Thomas; Koch, Thea; Spieth, Peter Markus; Uhlig, Christopher; Yaqub, Jonathan] Tech Univ Dresden, Univ Hosp Dresden, D-01062 Dresden, Germany; [Pelosi, Paolo; Gratarola, Angelo; Molin, Alexandre; Pellerano, Giulia; Pezzato, Stefano; Rusca, Roberta] Univ Genoa, IRCCS San Martino IST, Genoa, Italy; [Severgnini, Paolo] Univ Insubria, Varese, Italy; [Wrigge, Hermann; Reske, Andreas W.; Simon, Philipp] Univ Leipzig, Leipzig, Germany; [Canet, Jaume] Hosp Badalona Germans Trias & Pujol, Barcelona, Spain; [Hiesmayr, Michael; Schmid, Werner] Med Univ, Vienna, Austria; [Jaber, Samir] St Eloi Univ Hosp, Montpellier, France; [Hedenstierna, Goran] Univ Uppsala Hosp, Uppsala, Sweden; [Putensen, Christian] Univ Hosp, Bonn, Germany; [Sessler, Daniel I.] Cleveland Clin, Dept Outcomes Res, Cleveland, OH USA; [Lachmann, Burkhard] Univ Med Berlin, Dept Anaesthesia & Intens Care Med, Charite Campus Virchow Klinkum, Berlin, Germany; [Kacmarek, Robert M.] Massachusetts Gen Hosp, Harvard Med Sch & Director Resp Care, Boston, MA USA; [Slutsky, Arthur S.] Univ Toronto, St Michaels Hosp, Toronto, ON, Canada; [Slutsky, Arthur S.] Li Ka Shing Inst St Michaels Hosp, Keenan Res Ctr, Toronto, ON, Canada; [de Abreu, Marcelo Gama; De Baerdemaeker, Luc; De Hert, Stefan; Heyse, Bjorn; Van Limmen, Jurgen] Ghent Univ Hosp, Ghent, Belgium; [Mulier, Jan-Paul] Acad Hosp St Jan, Brugge, Belgium; [Velghe, David; Ongena, Patricia] ZNA Middelheim, Antwerp, Belgium; [Jamaer, Luc; Vandenbrande, Jeroen] Virga Jesse Ziekenhuis, Hasselt, Belgium; [Bugedo, Guillermo; Florez, Jorge] Hosp Clin, Pontificia Univ Catol Chile, Santiago, Chile; [Goranovic, Tatjana; Mazul-Sunko, Branka] Univ Hosp Sveti Duh, Zagreb, Croatia; [Bastin, Bea; Geib, Johann; Schaefer, Maximilian S.; Weiss, Martin; Treschan, Tanja A.] Dusseldorf Univ Hosp, Heinrich Heine Univ Dusseldorf, Dusseldorf, Germany; [Ferner, Alexander Brodhun Marion; Hartmann, Eric; Laufenberg-Feldmann, Rita; Strys, Lydia] Johannes Gutenberg Univ Mainz, Mainz, Germany; [Putensen, Christian] Univ Hosp, Bonn Med Sch, Bonn, Germany; [De Robertis, Edoardo] Univ Napoli Federico II, Naples, Italy; [Perilli, Valter; Proietti, Rodolfo] Univ Studi Roma Cattolica, Rome, Italy; [Amantea, Bruno; Caroleo, Santo; Tropea, Francesco; Chiaravalloti, Fernando; Madia, Daniela; Pezzoli, Ivana; Caruso, Andrea; Bianco, Maria Francesca; Picicco, Francesco] Magna Graecia Univ Catanzaro, Catanzaro, Italy; [Bacuzzi, Alessandro; Vanoni, Massimo] Univ Insubria, Azienda Osped Fdn Macchi, Osped Circolo, Varese, Italy; [Cinnella, Gilda; Caggianelli, Girolamo; D'Antini, Davide; La Bella, Daniela; Mollica, Giuseppina; Mirabella, Lucia; Rauseo, Michela; Anguilano, Romina] Univ Foggia, Foggia, Italy; [Cortegiani, Andrea; Giarratano, Antonino; Montalto, Francesca; Raineri, Santi Maurizio; Palmeri, Cesira; Strano, Maria Teresa; Federico, Antonino] Univ Studi Palermo, Palermo, Italy; [Barberis, Bruno; Celentano, Cristian; Grio, Michele; Spagnolo, Luigi] Osped Rivoli, Azienda Sanitaria Locale TO3, Turin, Italy; [Della Rocca, Giorgio; Pompei, Livia; Buttera, Stefania] Univ Studi Udine, Udine, Italy; [Brunelli, Andrea; Marti, Agnes] Hosp Univ Germans Trias I Pujol, Barcelona, Spain; [Cegarra, Virginia; Merten, Alfred; Victoria Moral, Maria; Parera, Ana; Carmen Unzueta, Maria] Hosp Sant Pau, Barcelona, Spain; [Sabate, Sergi; Sierra, Pilar; Mayoral, Juan F.; Prieto, Merce] Fdn Puigvert, Barcelona, Spain; [Granell Gil, Manuel; Minguez Marin, Conrado] Consorcio Hosp Gen Univ Valencia, Valencia, Spain; [Mills, Gary H.] Sheffield Teaching Hosp, Sheffield, S Yorkshire, England; [Bodger, Phoebe; Everingham, Kirsty; Han, Ruth; Hewson, Russell; Januszewska, Marta; Mohr, Otto; Pearse, Rupert; Raj, Ashok] Barts Hlth NHS Trust, London, England; [Kacmarek, Robert M.; Melo, Marcos F. Vidal; Sulemanji, Demet; Oto, Jun] Massachusetts Gen Hosp, Boston, MA USA; [Sprung, Juraj; Weingarten, Toby N.] Mayo Clin, Rochester, MN USA; [Bleyl, Jorg-Uwe; Koch, Moritz; Muller, Michael; Rossel, Thomas; Saeger, Hans-Detlef; Weitz, Jurgen] Univ Hosp Dresden, Dresden, Germany; [Babian, Renate; Rathmann, Anna Malina] Heinrich Heine Univ Dusseldorf, Dusseldorf, Germany; [Pochert, Julia; Dathe, Mandy] Univ Leipzig, Leipzig, Germany	University of Amsterdam; Academic Medical Center Amsterdam; Technische Universitat Dresden; Carl Gustav Carus University Hospital; University of Genoa; IRCCS AOU San Martino IST; University of Insubria; Leipzig University; Hospital Germans Trias i Pujol; Universite de Montpellier; CHU de Montpellier; Uppsala University; Uppsala University Hospital; University of Bonn; Cleveland Clinic Foundation; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Harvard University; Massachusetts General Hospital; University of Toronto; University Toronto Affiliates; Saint Michaels Hospital Toronto; Ghent University; Ghent University Hospital; ZNA Middelheim Hospital; Pontificia Universidad Catolica de Chile; Heinrich Heine University Dusseldorf; Heinrich Heine University Dusseldorf Hospital; Johannes Gutenberg University of Mainz; University of Bonn; University of Naples Federico II; Magna Graecia University of Catanzaro; Ospedale Circolo & Fondazione Macchi; University of Insubria; University of Foggia; University of Palermo; University of Udine; Hospital Germans Trias i Pujol; Hospital of Santa Creu i Sant Pau; Fundacio Puigvert; University of Sheffield; Barts Health NHS Trust; Harvard University; Massachusetts General Hospital; Mayo Clinic; Technische Universitat Dresden; Carl Gustav Carus University Hospital; Heinrich Heine University Dusseldorf; Leipzig University	Schultz, MJ (corresponding author), Univ Amsterdam, Acad Med Ctr, Dept Intens Care, NL-1105 AZ Amsterdam, Netherlands.	marcus.j.schultz@gmail.com	Schaefer, Maximilian Sebastian/R-1230-2018; Meyer-Treschan, Tanja A./S-6624-2017; Schäfer, Maximilian/F-2964-2013; Reske, Andreas W/E-8141-2010; Spieth, Peter/C-2928-2011; Wrigge, Hermann/AAJ-8985-2021; Bacuzzi, Alessandro/K-3120-2016; Cinnella, Gilda/O-2987-2016; Bos, Lieuwe/H-2578-2018; Schultz, Marcus/AAB-6379-2021; Cortegiani, Andrea/H-4902-2016; Rauseo, Michela/GQZ-1907-2022; Simon, Philipp/AAL-5318-2021; Hiesmayr, Michael Joerg/AAR-1969-2020; mirabella, lucia/I-7897-2018; Rocco, Patricia/I-7460-2012; mulier, jan/A-7370-2018	Schaefer, Maximilian Sebastian/0000-0001-8186-4748; Meyer-Treschan, Tanja A./0000-0001-9363-1028; Schäfer, Maximilian/0000-0001-8186-4748; Reske, Andreas W/0000-0002-2759-0245; Wrigge, Hermann/0000-0002-9035-6822; Bacuzzi, Alessandro/0000-0002-4108-156X; Cinnella, Gilda/0000-0001-9864-2893; Bos, Lieuwe/0000-0003-2911-4549; Schultz, Marcus/0000-0003-3969-7792; Cortegiani, Andrea/0000-0003-1416-9993; Rauseo, Michela/0000-0001-9718-7454; mirabella, lucia/0000-0001-6441-7372; Rocco, Patricia/0000-0003-1412-7136; Raineri, Santi Maurizio/0000-0002-0675-2399; Spieth, Peter/0000-0003-3953-3253; Mills, Gary/0000-0002-3929-2149; Sabate, Sergi/0000-0001-7582-2832; Severgnini, Paolo/0000-0001-8027-0059; mulier, jan/0000-0001-6664-8270; D'Antini, Davide/0000-0002-2346-9720; GIARRATANO, Antonino/0000-0001-9344-8311; Pelosi, Paolo/0000-0001-5055-3023	Academic Medical Center (Amsterdam, Netherlands); European Society of Anaesthesiology; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R34HL123438] Funding Source: NIH RePORTER	Academic Medical Center (Amsterdam, Netherlands)(Netherlands Government); European Society of Anaesthesiology; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	Academic Medical Center (Amsterdam, Netherlands), European Society of Anaesthesiology.	Arozullah AM, 2001, ANN INTERN MED, V135, P847, DOI 10.7326/0003-4819-135-10-200111200-00005; Arozullah AM, 2000, ANN SURG, V232, P242, DOI 10.1097/00000658-200008000-00015; Briel M, 2010, JAMA-J AM MED ASSOC, V303, P865, DOI 10.1001/jama.2010.218; BRISMAR B, 1985, ANESTHESIOLOGY, V62, P422, DOI 10.1097/00000542-198504000-00009; Brown D, 2009, MILLERS ANESTHESIA, P1611; Canet J, 2010, ANESTHESIOLOGY, V113, P1338, DOI 10.1097/ALN.0b013e3181fc6e0a; Carvalho AR, 2013, ANESTH ANALG, V116, P677, DOI 10.1213/ANE.0b013e318254230b; Duggan M, 2005, ANESTHESIOLOGY, V102, P838, DOI 10.1097/00000542-200504000-00021; Futier E, 2013, NEW ENGL J MED, V369, P428, DOI 10.1056/NEJMoa1301082; HACHENBERG T, 1993, ACTA ANAESTH SCAND, V37, P549, DOI 10.1111/j.1399-6576.1993.tb03763.x; Halter JM, 2003, AM J RESP CRIT CARE, V167, P1620, DOI 10.1164/rccm.200205-435OC; Hemmes SNT, 2011, TRIALS, V12, DOI 10.1186/1745-6215-12-111; Hemmes SNT, 2013, CURR OPIN ANESTHESIO, V26, P126, DOI 10.1097/ACO.0b013e32835e1242; Lellouche F, 2012, ANESTHESIOLOGY, V116, P1072, DOI 10.1097/ALN.0b013e3182522df5; LINDBERG P, 1992, ACTA ANAESTH SCAND, V36, P546, DOI 10.1111/j.1399-6576.1992.tb03516.x; Luecke T, 2005, CRIT CARE, V9, P607, DOI 10.1186/cc3877; Melo MFV, 2013, ANESTHESIOLOGY, V118, P1254, DOI 10.1097/ALN.0b013e3182910309; Neto AS, 2012, JAMA-J AM MED ASSOC, V308, P1651, DOI 10.1001/jama.2012.13730; Neumann P, 1999, ACTA ANAESTH SCAND, V43, P295, DOI 10.1034/j.1399-6576.1999.430309.x; Nielsen J, 2005, INTENS CARE MED, V31, P1189, DOI 10.1007/s00134-005-2732-z; Pagel P, 2009, MILLERS ANESTHESIA, P595; Pearse RM, 2012, LANCET, V380, P1059, DOI 10.1016/S0140-6736(12)61148-9; Putensen C, 2009, ANN INTERN MED, V151, P566, DOI 10.7326/0003-4819-151-8-200910200-00011; Reves J, 2009, MILLERS ANESTHESIA, P719; Severgnini P, 2013, ANESTHESIOLOGY, V118, P1307, DOI 10.1097/ALN.0b013e31829102de; Smetana GW, 2006, ANN INTERN MED, V144, P581, DOI 10.7326/0003-4819-144-8-200604180-00009; Tusman G, 1999, BRIT J ANAESTH, V82, P8, DOI 10.1093/bja/82.1.8; Tusman G, 2010, CURR ANAESTH CRIT CA, V21, P244, DOI [DOI 10.1016/j.cacc.2010.07.007, DOI 10.1016/J.CACC.2010.07.007]; Weiser TG, 2008, LANCET, V372, P139, DOI 10.1016/S0140-6736(08)60878-8	29	391	409	7	83	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	AUG 9	2014	384	9942					495	503		10.1016/S0140-6736(14)60416-5	http://dx.doi.org/10.1016/S0140-6736(14)60416-5			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AM9JR	24894577	Green Accepted, Green Published			2022-12-28	WOS:000340198300028
J	Weber, GM; Mandl, KD; Kohane, IS				Weber, Griffin M.; Mandl, Kenneth D.; Kohane, Isaac S.			Finding the Missing Link for Big Biomedical Data	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							MEDICINE		[Weber, Griffin M.; Mandl, Kenneth D.; Kohane, Isaac S.] Harvard Univ, Sch Med, Ctr Biomed Informat, Boston, MA 02115 USA; [Weber, Griffin M.] Beth Israel Deaconess Med Ctr, Dept Med, Boston, MA 02215 USA; [Mandl, Kenneth D.; Kohane, Isaac S.] Boston Childrens Hosp, Dept Pediat, Boston, MA USA	Harvard University; Harvard Medical School; Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Boston Children's Hospital	Weber, GM (corresponding author), Harvard Univ, Sch Med, Ctr Biomed Informat, 10 Shattuck St,Room 316A, Boston, MA 02115 USA.	weber@hms.harvard.edu		Weber, Griffin/0000-0002-2597-881X	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM104303] Funding Source: NIH RePORTER; NIGMS NIH HHS [R01 GM104303] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Ayers JW, 2014, JAMA-J AM MED ASSOC, V311, P1399, DOI 10.1001/jama.2014.1505; Grannis SJ, 2002, AMIA 2002 SYMPOSIUM, PROCEEDINGS, P305; Gymrek M, 2013, SCIENCE, V339, P321, DOI 10.1126/science.1229566; Institute of Medicine Committee on Health Research and the Privacy of Health Information, BEYOND THE HIPAA PRI; Kayyali B, 2013, THE BIG DATA REVOLUT; Kohane IS, 2006, JAMA-J AM MED ASSOC, V296, P212, DOI 10.1001/jama.296.2.212; Kohane IS, 2005, NEW ENGL J MED, V353, P2074, DOI 10.1056/NEJMsb051220; Sweeney Latanya, 2000, SIMPLE DEMOGRAPHICS	8	218	221	0	47	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUN 25	2014	311	24					2479	2480		10.1001/jama.2014.4228	http://dx.doi.org/10.1001/jama.2014.4228			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AJ5VE	24854141				2022-12-28	WOS:000337757000017
J	Bingol, B; Tea, JS; Phu, L; Reichelt, M; Bakalarski, CE; Song, QH; Foreman, O; Kirkpatrick, DS; Sheng, MG				Bingol, Baris; Tea, Joy S.; Phu, Lilian; Reichelt, Mike; Bakalarski, Corey E.; Song, Qinghua; Foreman, Oded; Kirkpatrick, Donald S.; Sheng, Morgan			The mitochondrial deubiquitinase USP30 opposes parkin-mediated mitophagy	NATURE			English	Article							DOPAMINERGIC NEURON DEGENERATION; DROSOPHILA MODEL; DISEASE; UBIQUITINATION; MUTATIONS; PINK1; PHOSPHORYLATION; DEPOLARIZATION; DYSFUNCTION; P62/SQSTM1	Cells maintain healthy mitochondria by degrading damaged mitochondria through mitophagy; defective mitophagy is linked to Parkinson's disease. Here we report that USP30, a deubiquitinase localized to mitochondria, antagonizes mitophagy driven by the ubiquitin ligase parkin (also known as PARK2) and protein kinase PINK1, which are encoded by two genes associated with Parkinson's disease. Parkin ubiquitinates and tags damaged mitochondria for clearance. Overexpression of USP 30 removes ubiquitin attached by parkin onto damaged mitochondria and blocks parkin's ability to drive mitophagy, whereas reducing USP30 activity enhances mitochondrial degradation in neurons. Global ubiquitination site profiling identified multiple mitochondrial substrates oppositely regulated by parkin and USP30. Knockdown of USP30 rescues the defective mitophagy caused by pathogenic mutations in parkin and improves mitochondrial integrity in parkin-or PINK1-deficient flies. Knockdown of USP30 in dopaminergic neurons protects flies against paraquat toxicity in vivo, ameliorating defects in dopamine levels, motor function and organismal survival. Thus USP30 inhibition is potentially beneficial for Parkinson's disease by promoting mitochondrial clearance and quality control.	[Bingol, Baris; Tea, Joy S.; Sheng, Morgan] Genentech Inc, Dept Neurosci, San Francisco, CA 94080 USA; [Phu, Lilian; Kirkpatrick, Donald S.] Genentech Inc, Dept Prot Chem, San Francisco, CA 94080 USA; [Reichelt, Mike; Foreman, Oded] Genentech Inc, Dept Pathol, San Francisco, CA 94080 USA; [Bakalarski, Corey E.] Genentech Inc, Dept Bioinformat & Computat Biol, San Francisco, CA 94080 USA; [Song, Qinghua] Genentech Inc, Dept Nonclin Biostat, San Francisco, CA 94080 USA	Roche Holding; Genentech; Roche Holding; Genentech; Roche Holding; Genentech; Roche Holding; Genentech; Roche Holding; Genentech	Bingol, B (corresponding author), Genentech Inc, Dept Neurosci, San Francisco, CA 94080 USA.	bingol.baris@gene.com	liu, wen/HGE-3071-2022; Liu, Zhanqiang/HGC-0565-2022	Sheng, Morgan/0000-0002-8703-5366; Kirkpatrick, Donald/0000-0003-3091-2804; Tea, Joy/0000-0002-3395-149X; Bakalarski, Corey/0000-0003-1085-7828				Beausoleil SA, 2006, NAT BIOTECHNOL, V24, P1285, DOI 10.1038/nbt1240; BRAND AH, 1993, DEVELOPMENT, V118, P401; Burchell VS, 2013, NAT NEUROSCI, V16, P1257, DOI 10.1038/nn.3489; Bustos D, 2012, MOL CELL PROTEOMICS, V11, P1529, DOI 10.1074/mcp.R112.019117; Cha GH, 2005, P NATL ACAD SCI USA, V102, P10345, DOI 10.1073/pnas.0500346102; Chan NC, 2011, HUM MOL GENET, V20, P1726, DOI 10.1093/hmg/ddr048; Clark IE, 2006, NATURE, V441, P1162, DOI 10.1038/nature04779; Cocheme HM, 2008, J BIOL CHEM, V283, P1786, DOI 10.1074/jbc.M708597200; Dooley CT, 2004, J BIOL CHEM, V279, P22284, DOI 10.1074/jbc.M312847200; Geisler S, 2010, NAT CELL BIOL, V12, P119, DOI 10.1038/ncb2012; Greene JC, 2003, P NATL ACAD SCI USA, V100, P4078, DOI 10.1073/pnas.0737556100; Guo M, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a009944; Guzman JN, 2010, NATURE, V468, P696, DOI 10.1038/nature09536; Hauser DN, 2013, NEUROBIOL DIS, V51, P35, DOI 10.1016/j.nbd.2012.10.011; Katayama H, 2011, CHEM BIOL, V18, P1042, DOI 10.1016/j.chembiol.2011.05.013; Kim W, 2011, MOL CELL, V44, P325, DOI 10.1016/j.molcel.2011.08.025; Kitada T, 1998, NATURE, V392, P605, DOI 10.1038/33416; Lee JY, 2010, J CELL BIOL, V189, P671, DOI 10.1083/jcb.201001039; Matsuda N, 2010, J CELL BIOL, V189, P211, DOI 10.1083/jcb.200910140; Nakamura N, 2008, MOL BIOL CELL, V19, P1903, DOI 10.1091/mbc.E07-11-1103; Narendra D, 2008, J CELL BIOL, V183, P795, DOI 10.1083/jcb.200809125; Narendra DP, 2011, ANTIOXID REDOX SIGN, V14, P1929, DOI 10.1089/ars.2010.3799; Narendra DP, 2010, AUTOPHAGY, V6, P1090, DOI 10.4161/auto.6.8.13426; Narendra DP, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000298; Park J, 2006, NATURE, V441, P1157, DOI 10.1038/nature04788; Pinheiro J., 2011, NLME LINEAR NONLINEA; Rappsilber J, 2003, ANAL CHEM, V75, P663, DOI 10.1021/ac026117i; Sang TK, 2007, J NEUROSCI, V27, P981, DOI 10.1523/JNEUROSCI.4810-06.2007; Sarraf SA, 2013, NATURE, V496, P372, DOI 10.1038/nature12043; Seeburg DP, 2008, J NEUROSCI, V28, P6583, DOI 10.1523/JNEUROSCI.1853-08.2008; Seyfried NT, 2008, ANAL CHEM, V80, P4161, DOI 10.1021/ac702516a; Shiba-Fukushima K, 2012, SCI REP-UK, V2, DOI 10.1038/srep01002; Tanner CM, 2011, ENVIRON HEALTH PERSP, V119, P866, DOI 10.1289/ehp.1002839; Valente EM, 2004, SCIENCE, V304, P1158, DOI 10.1126/science.1096284; Vives-Bauza C, 2010, P NATL ACAD SCI USA, V107, P378, DOI 10.1073/pnas.0911187107; Wang C, 2007, J NEUROSCI, V27, P8563, DOI 10.1523/JNEUROSCI.0218-07.2007; Whitworth AJ, 2005, P NATL ACAD SCI USA, V102, P8024, DOI 10.1073/pnas.0501078102; Wu JS, 2006, NAT PROTOC, V1, P2110, DOI 10.1038/nprot.2006.336; Xu GQ, 2010, NAT BIOTECHNOL, V28, P868, DOI 10.1038/nbt.1654; Yang YF, 2006, P NATL ACAD SCI USA, V103, P10793, DOI 10.1073/pnas.0602493103; Yoshii SR, 2011, J BIOL CHEM, V286, P19630, DOI 10.1074/jbc.M110.209338	41	515	547	7	150	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 19	2014	510	7505					370	+		10.1038/nature13418	http://dx.doi.org/10.1038/nature13418			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AJ0NG	24896179				2022-12-28	WOS:000337350200029
J	Myburg, AA; Grattapaglia, D; Tuskan, GA; Hellsten, U; Hayes, RD; Grimwood, J; Jenkins, J; Lindquist, E; Tice, H; Bauer, D; Goodstein, DM; Dubchak, I; Poliakov, A; Mizrachi, E; Kullan, ARK; Hussey, SG; Pinard, D; Van der Merwe, K; Singh, P; Van Jaarsveld, I; Silva, OB; Togawa, RC; Pappas, MR; Faria, DA; Sansaloni, CP; Petroli, CD; Yang, XH; Ranjan, P; Tschaplinski, TJ; Ye, CY; Li, T; Sterck, L; Vanneste, K; Murat, F; Soler, M; Clemente, HS; Saidi, N; Cassan-Wang, H; Dunand, C; Hefer, CA; Bornberg-Bauer, E; Kersting, AR; Vining, K; Amarasinghe, V; Ranik, M; Naithani, S; Elser, J; Boyd, AE; Liston, A; Spatafora, JW; Dharmwardhana, P; Raja, R; Sullivan, C; Romanel, E; Alves-Ferreira, M; Lheim, CK; Foley, W; Carocha, V; Paiva, J; Kudrna, D; Brommonschenkel, SH; Pasquali, G; Byrne, M; Rigault, P; Tibbits, J; Spokevicius, A; Jones, RC; Steane, DA; Vaillancourt, RE; Potts, BM; Joubert, F; Barry, K; Pappas, GJ; Strauss, SH; Jaiswal, P; Grima-Pettenati, J; Salse, J; Van de Peer, Y; Rokhsar, DS; Schmutz, J				Myburg, Alexander A.; Grattapaglia, Dario; Tuskan, Gerald A.; Hellsten, Uffe; Hayes, Richard D.; Grimwood, Jane; Jenkins, Jerry; Lindquist, Erika; Tice, Hope; Bauer, Diane; Goodstein, David M.; Dubchak, Inna; Poliakov, Alexandre; Mizrachi, Eshchar; Kullan, Anand R. K.; Hussey, Steven G.; Pinard, Desre; Van der Merwe, Karen; Singh, Pooja; Van Jaarsveld, Ida; Silva-Junior, Orzenil B.; Togawa, Roberto C.; Pappas, Marilia R.; Faria, Danielle A.; Sansaloni, Carolina P.; Petroli, Cesar D.; Yang, Xiaohan; Ranjan, Priya; Tschaplinski, Timothy J.; Ye, Chu-Yu; Li, Ting; Sterck, Lieven; Vanneste, Kevin; Murat, Florent; Soler, Maral; Clemente, Helene San; Saidi, Naijib; Cassan-Wang, Hua; Dunand, Christophe; Hefer, Charles A.; Bornberg-Bauer, Erich; Kersting, Anna R.; Vining, Kelly; Amarasinghe, Vindhya; Ranik, Martin; Naithani, Sushma; Elser, Justin; Boyd, Alexander E.; Liston, Aaron; Spatafora, Joseph W.; Dharmwardhana, Palitha; Raja, Rajani; Sullivan, Christopher; Romanel, Elisson; Alves-Ferreira, Marcio; Lheim, Carsten Ku; Foley, William; Carocha, Victor; Paiva, Jorge; Kudrna, David; Brommonschenkel, Sergio H.; Pasquali, Giancarlo; Byrne, Margaret; Rigault, Philippe; Tibbits, Josquin; Spokevicius, Antanas; Jones, Rebecca C.; Steane, Dorothy A.; Vaillancourt, Rene E.; Potts, Brad M.; Joubert, Fourie; Barry, Kerrie; Pappas, Georgios J., Jr.; Strauss, Steven H.; Jaiswal, Pankaj; Grima-Pettenati, Jacqueline; Salse, Jerome; Van de Peer, Yves; Rokhsar, Daniel S.; Schmutz, Jeremy			The genome of Eucalyptus grandis	NATURE			English	Article							WHOLE-GENOME; NUCLEAR-DNA; PLANT; ALIGNMENT; TOOLS; GENE; DIVERSITY; EVOLUTION; DATABASE; TANDEM	Eucalypts are the world's most widely planted hardwood trees. Their outstanding diversity, adaptability and growth have made them a global renewable resource of fibre and energy. We sequenced and assembled >94% of the 640-megabase genome of Eucalyptus grandis. Of 36,376 predicted protein-coding genes, 34% occur in tandem duplications, the largest proportion thus far in plant genomes. Eucalyptus also shows the highest diversity of genes for specialized metabolites such as terpenes that act as chemical defence and provide unique pharmaceutical oils. Genome sequencing of the E. grandis sister species E. globulus and a set of inbred E. grandis tree genomes reveals dynamic genome evolution and hotspots of inbreeding depression. The E. grandis genome is the first reference for the eudicot order Myrtales and is placed here sister to the eurosids. This resource expands our understanding of the unique biology of large woody perennials and provides a powerful tool to accelerate comparative biology, breeding and biotechnology.	[Myburg, Alexander A.; Mizrachi, Eshchar; Kullan, Anand R. K.; Hussey, Steven G.; Pinard, Desre; Van der Merwe, Karen; Singh, Pooja] Univ Pretoria, Dept Genet, Forestry & Agr Biotechnol Inst FABI, ZA-0028 Pretoria, South Africa; [Myburg, Alexander A.; Mizrachi, Eshchar; Kullan, Anand R. K.; Hussey, Steven G.; Pinard, Desre; Van der Merwe, Karen; Singh, Pooja; Joubert, Fourie; Van de Peer, Yves] Univ Pretoria, Genom Res Inst GRI, ZA-0028 Pretoria, South Africa; [Grattapaglia, Dario; Pappas, Marilia R.; Faria, Danielle A.; Sansaloni, Carolina P.; Petroli, Cesar D.] EPQB Final W5 Norte, EMBRAPA Recursos Genet & Biotecnol, Lab Genet Vegetal, BR-70770917 Brasilia, DF, Brazil; [Grattapaglia, Dario] Univ Catolica Brasilia SGAN 916, Programa Ciencias Genom & Biotecnol, BR-70790160 Brasilia, DF, Brazil; [Tuskan, Gerald A.; Hellsten, Uffe; Hayes, Richard D.; Lindquist, Erika; Tice, Hope; Bauer, Diane; Goodstein, David M.; Dubchak, Inna; Poliakov, Alexandre; Barry, Kerrie; Rokhsar, Daniel S.; Schmutz, Jeremy] US DOE, Joint Genome Inst, Walnut Creek, CA 94598 USA; [Tuskan, Gerald A.; Yang, Xiaohan; Ranjan, Priya; Tschaplinski, Timothy J.; Ye, Chu-Yu; Li, Ting] Oak Ridge Natl Lab, Biosci Div, Oak Ridge, TN 37831 USA; [Grimwood, Jane; Jenkins, Jerry; Schmutz, Jeremy] HudsonAlpha Inst Biotechnol, Huntsville, AL 35801 USA; [Van Jaarsveld, Ida; Hefer, Charles A.; Joubert, Fourie] Univ Pretoria, Dept Biochem, Bioinformat & Computat Biol Unit, ZA-0028 Pretoria, South Africa; [Silva-Junior, Orzenil B.; Togawa, Roberto C.] EPQB Final W5 Norte, EMBRAPA Recursos Genet & Biotecnol, Lab Bioinformat, BR-70770917 Brasilia, DF, Brazil; [Sterck, Lieven; Vanneste, Kevin; Van de Peer, Yves] Univ Ghent VIB, Dept Plant Biotechnol & Bioinformat, B-9000 Ghent, Belgium; [Murat, Florent; Salse, Jerome] INRA UBP UMR 1095, F-63100 Clermont Ferrand, France; [Soler, Maral; Clemente, Helene San; Saidi, Naijib; Cassan-Wang, Hua; Dunand, Christophe; Carocha, Victor; Grima-Pettenati, Jacqueline] Univ Toulouse 3, Lab Rech Sci Vegetales, UMR 5546, CNRS, F-31326 Castanet Tolosan, France; [Hefer, Charles A.] Univ British Columbia, Dept Bot, Vancouver, BC V6T 1Z4, Canada; [Bornberg-Bauer, Erich; Kersting, Anna R.] Univ Munster, Inst Evolut & Biodivers, D-48149 Munster, Germany; [Kersting, Anna R.] Univ Dusseldorf, Inst Comp Sci, Dept Bioinformat, D-40225 Dusseldorf, Germany; [Vining, Kelly; Amarasinghe, Vindhya; Ranik, Martin; Strauss, Steven H.] Oregon State Univ, Dept Forest Ecosyst & Soc, Corvallis, OR 97331 USA; [Naithani, Sushma; Elser, Justin; Liston, Aaron; Spatafora, Joseph W.; Dharmwardhana, Palitha; Raja, Rajani; Jaiswal, Pankaj] Oregon State Univ, Dept Bot & Plant Pathol, Corvallis, OR 97331 USA; [Naithani, Sushma; Boyd, Alexander E.; Liston, Aaron; Spatafora, Joseph W.; Sullivan, Christopher; Jaiswal, Pankaj] Oregon State Univ, Ctr Genome Res & Biocomp, Corvallis, OR 97331 USA; [Romanel, Elisson] Univ Fed Rio de Janeiro, Dept Genet, Lab Biol Evolut Teor & Aplicada, BR-21949900 Rio de Janeiro, Brazil; [Romanel, Elisson] EEL USP, Dept Biotecnol, BR-12602810 Lorena, SP, Brazil; [Romanel, Elisson; Alves-Ferreira, Marcio] Univ Fed Rio de Janeiro, Dept Genet, LGMV, BR-21949900 Rio de Janeiro, Brazil; [Lheim, Carsten Ku; Foley, William] Australian Natl Univ, Res Sch Biol, Canberra, ACT 0200, Australia; [Carocha, Victor; Paiva, Jorge] IICT MNE, P-1349007 Lisbon, Portugal; [Carocha, Victor; Paiva, Jorge] IBET ITQB, P-2781901 Oeiras, Portugal; [Kudrna, David] Univ Arizona, Arizona Genom Inst, Tucson, AZ 85721 USA; [Brommonschenkel, Sergio H.] Univ Fed Vicosa, Dep Fitopatol, BR-36570000 Vicosa, MG, Brazil; [Pasquali, Giancarlo] Univ Fed Rio Grande do Sul, Ctr Biotecnol, BR-91501970 Porto Alegre, RS, Brazil; [Byrne, Margaret] Dept Parks & Wildlife, Sci & Conservat Div, Bentley, WA 6983, Australia; [Rigault, Philippe] GYDLE, Quebec City, PQ G1T 1Z2, Canada; [Tibbits, Josquin] Victorian Govt, Dept Environm & Primary Ind, Yallambie, Vic 3085, Australia; [Spokevicius, Antanas] Univ Melbourne, Melbourne Sch Land & Environm, Melbourne, Vic 3010, Australia; [Jones, Rebecca C.; Steane, Dorothy A.; Vaillancourt, Rene E.; Potts, Brad M.] Univ Tasmania, Sch Biol Sci, Hobart, Tas 7001, Australia; [Jones, Rebecca C.; Steane, Dorothy A.; Vaillancourt, Rene E.; Potts, Brad M.] Univ Tasmania, Natl Ctr Future Forest Ind, Hobart, Tas 7001, Australia; [Steane, Dorothy A.] Univ Sunshine Coast, Fac Sci Hlth Educ & Engn, Sippy Downs, Qld 4558, Australia; [Pappas, Georgios J., Jr.] Univ Brasilia, Dept Biol Celular, BR-70910900 Brasilia, DF, Brazil	University of Pretoria; University of Pretoria; Empresa Brasileira de Pesquisa Agropecuaria (EMBRAPA); United States Department of Energy (DOE); Joint BioEnergy Institute - JBEI; Joint Genome Institute - JGI; United States Department of Energy (DOE); Oak Ridge National Laboratory; HudsonAlpha Institute for Biotechnology; University of Pretoria; Empresa Brasileira de Pesquisa Agropecuaria (EMBRAPA); Flanders Institute for Biotechnology (VIB); Ghent University; INRAE; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Universite de Toulouse; Universite Toulouse III - Paul Sabatier; University of British Columbia; University of Munster; Heinrich Heine University Dusseldorf; Oregon State University; Oregon State University; Oregon State University; Universidade Federal do Rio de Janeiro; Universidade Federal do Rio de Janeiro; Australian National University; University of Arizona; Universidade Federal de Vicosa; Universidade Federal do Rio Grande do Sul; University of Melbourne; University of Tasmania; University of Tasmania; University of the Sunshine Coast; Universidade de Brasilia	Myburg, AA (corresponding author), Univ Pretoria, Dept Genet, Forestry & Agr Biotechnol Inst FABI, Private Bag X20, ZA-0028 Pretoria, South Africa.	zander.myburg@up.ac.za	Tschaplinski, Timothy/D-6382-2018; Grattapaglia, Dario/AAB-6805-2020; Byrne, Margaret/H-8198-2015; Grimwood, Jane/ABD-5737-2021; Grattapaglia, Dario/B-5864-2014; Jenkins, Jerry/ABE-6479-2020; Jones, Rebecca C/J-7901-2014; Foley, William J/C-8069-2009; Naithani, Sushma/AAU-1450-2021; Pasquali, Giancarlo/L-6421-2013; Hussey, Steven/AAM-6245-2021; Pappas, Georgios J/D-5933-2016; Romanel, Elisson AC/E-5888-2019; Vaillancourt, Rene E/C-6123-2013; Pappas, Georgios J./N-8071-2019; Van de Peer, Yves/D-4388-2009; Hefer, Charles/A-6093-2011; Potts, Brad M/C-6489-2013; Soler, Marçal/G-3522-2016; Schmutz, Jeremy/N-3173-2013; Mizrachi, Eshchar/N-3179-2014; Alves-Ferreira, Marcio/C-5849-2009; Barry, Kerrie Whitelaw/AAA-5500-2020; Yang, Xiaohan/A-6975-2011; Tuskan, Gerald/A-6225-2011; Kulheim, Carsten/AAR-2734-2021; Wang, Hua Cassan/AAF-5966-2021; Dunand, Christophe/I-6424-2012; Steane, Dorothy/N-9940-2013; Silva-Junior, Orzenil/B-3488-2013; Myburg, Alexander A/C-5426-2008; Jaiswal, Pankaj/H-7599-2016; Romanel, Elisson AC/F-1933-2013; Bornberg-Bauer, Erich/A-1563-2013; Van de Peer, Yves/AAE-7666-2019; Sterck, Lieven/A-9439-2016; Jaiswal, Pankaj/R-4214-2019; Vaillancourt, Rene E/J-7456-2014; Yang, Xiaohan/AAM-2449-2020; Kulheim, Carsten/F-4720-2010; Paiva, Jorge A P/C-2858-2008	Tschaplinski, Timothy/0000-0002-9540-6622; Grattapaglia, Dario/0000-0002-0050-970X; Byrne, Margaret/0000-0002-7197-5409; Grattapaglia, Dario/0000-0002-0050-970X; Jenkins, Jerry/0000-0002-7943-3997; Jones, Rebecca C/0000-0002-6491-1423; Foley, William J/0000-0001-8587-1814; Naithani, Sushma/0000-0001-7819-4552; Pasquali, Giancarlo/0000-0003-1256-544X; Hussey, Steven/0000-0002-1079-8373; Pappas, Georgios J/0000-0002-1100-976X; Romanel, Elisson AC/0000-0002-4794-4215; Vaillancourt, Rene E/0000-0002-1159-9149; Pappas, Georgios J./0000-0002-1100-976X; Van de Peer, Yves/0000-0003-4327-3730; Hefer, Charles/0000-0001-7527-5461; Potts, Brad M/0000-0001-6244-289X; Soler, Marçal/0000-0002-9138-9394; Schmutz, Jeremy/0000-0001-8062-9172; Alves-Ferreira, Marcio/0000-0002-6107-3700; Barry, Kerrie Whitelaw/0000-0002-8999-6785; Yang, Xiaohan/0000-0001-5207-4210; Tuskan, Gerald/0000-0003-0106-1289; Wang, Hua Cassan/0000-0002-7395-9285; Dunand, Christophe/0000-0003-1637-4042; Silva-Junior, Orzenil/0000-0002-2104-2010; Myburg, Alexander A/0000-0003-0644-5003; Jaiswal, Pankaj/0000-0002-1005-8383; Romanel, Elisson AC/0000-0002-4794-4215; Bornberg-Bauer, Erich/0000-0002-1826-3576; Van de Peer, Yves/0000-0003-4327-3730; Sterck, Lieven/0000-0001-7116-4000; Jaiswal, Pankaj/0000-0002-1005-8383; Vaillancourt, Rene E/0000-0002-1159-9149; Yang, Xiaohan/0000-0001-5207-4210; Paiva, Jorge A P/0000-0003-3162-4396; Spokevicius, Antanas/0000-0003-3507-9583; Ranjan, Priya/0000-0002-0357-1939; Pinard, Desre/0000-0001-5600-0139; Goodstein, David/0000-0001-6287-2697; Togawa, Roberto/0000-0001-7179-3210; Saidi, Mohamed Najib/0000-0002-7692-4643; Kulheim, Carsten/0000-0002-0798-3324; Murat, Florent/0000-0003-2116-2511; Hayes, Richard/0000-0002-5236-7918; Rokhsar, Daniel/0000-0002-8704-2224; Mizrachi, Eshchar/0000-0002-3126-9593; Singh, Pooja/0000-0001-6576-400X; Steane, Dorothy/0000-0002-8061-8454; Pappas, Marilia/0000-0002-4680-0199	Office of Science of the US Department of Energy [DE-AC02-05CH11231]; Office of Biological and Environmental Research in the US Department of Energy Office of Science, US DOE Bioenergy Center [DE-AC05-00OR22725]; Brazilian Ministry of Science, Technology and Innovation (MCTI) through (CNPq); Brazilian Ministry of Science, Technology and Innovation (MCTI) through (FINEP); Brazilian Federal District Research Foundation (FAP-DF); Technology and Human Resources for Industry Programme (THRIP) [UID 80118]; South African Department of Science and Technology (DST); National Research Foundation (NRF) [UID 18312, 86936]; Laboratoire d'Excellence [LABEX TULIP ANR-10-LABX-41]; Agence Nationale pour la Recherche (Project Tree For Joules) [ANR-2010-KBBE-007-01]; Fundacao para a Ciencia e Tecnologia (FCT) [P-KBBE/AGR_GPL/0001/2010]; Centre National pour la Recherche Scientifique (CNRS); University Paul Sabatier Toulouse III (UPS); Ghent University; Hercules Foundation; Flemish Government-department EWI; Div Of Industrial Innovation & Partnersh [1238305] Funding Source: National Science Foundation	Office of Science of the US Department of Energy(United States Department of Energy (DOE)); Office of Biological and Environmental Research in the US Department of Energy Office of Science, US DOE Bioenergy Center(United States Department of Energy (DOE)); Brazilian Ministry of Science, Technology and Innovation (MCTI) through (CNPq); Brazilian Ministry of Science, Technology and Innovation (MCTI) through (FINEP); Brazilian Federal District Research Foundation (FAP-DF); Technology and Human Resources for Industry Programme (THRIP); South African Department of Science and Technology (DST); National Research Foundation (NRF); Laboratoire d'Excellence; Agence Nationale pour la Recherche (Project Tree For Joules)(French National Research Agency (ANR)); Fundacao para a Ciencia e Tecnologia (FCT)(Portuguese Foundation for Science and TechnologyEuropean Commission); Centre National pour la Recherche Scientifique (CNRS)(Centre National de la Recherche Scientifique (CNRS)); University Paul Sabatier Toulouse III (UPS); Ghent University(Ghent University); Hercules Foundation; Flemish Government-department EWI; Div Of Industrial Innovation & Partnersh(National Science Foundation (NSF)NSF - Directorate for Engineering (ENG))	The work conducted by the US Department of Energy Joint Genome Institute is supported by the Office of Science of the US Department of Energy under Contract No. DE-AC02-05CH11231. The research and writing of the manuscript was supported, in part, by the Office of Biological and Environmental Research in the US Department of Energy Office of Science under contract DE-AC05-00OR22725 as part of the US DOE Bioenergy Center. Funding for additional components of the study was provided by the Brazilian Ministry of Science, Technology and Innovation (MCTI) through its research funding agencies (CNPq and FINEP), the Brazilian Federal District Research Foundation (FAP-DF), the public-private Genolyptus network of Brazilian forestry companies, the Tree Biosafety and Genomics Research Cooperative (TBGRC, Oregon State University), South African forestry companies Sappi and Mondi, the Technology and Human Resources for Industry Programme (THRIP, UID 80118), the South African Department of Science and Technology (DST) and National Research Foundation (NRF, UID 18312 and 86936), the Laboratoire d'Excellence (LABEX TULIP ANR-10-LABX-41), the Agence Nationale pour la Recherche (Project Tree For Joules ANR-2010-KBBE-007-01; Fundacao para a Ciencia e Tecnologia (FCT, P-KBBE/AGR_GPL/0001/2010), the Centre National pour la Recherche Scientifique (CNRS), the University Paul Sabatier Toulouse III (UPS). Part of this work was carried out using the Stevin Supercomputer Infrastructure at Ghent University, funded by Ghent University, the Hercules Foundation, and the Flemish Government-department EWI. We also acknowledge S. Oda and E. Gonzalez of Suzano Paper and Pulp for providing genetic material of E. grandis genotypes BRASUZ1, G7J1, M35D2 and their progeny used for genome sequencing and resequencing, Forestal Mininco (Chile) for genetic material of X46, the E. globulus genotype used for genome resequencing, M. Hinchee and W. Rottmann of ArborGen for EST sequences used to support gene annotation, Sappi (South Africa) for genetic material of the population used for genetic linkage mapping, and Sappi and Mondi (South Africa) for E. grandis tissues used for RNA sequencing. We acknowledge M. O'Neill of the University of Pretoria for technical assistance with E. grandis RNA sequencing.	Agren JA, 2011, CHROMOSOME RES, V19, P777, DOI 10.1007/s10577-011-9229-0; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Bauhus J., 2010, ECOSYSTEM GOODS SERV; Bell CD, 2010, AM J BOT, V97, P1296, DOI 10.3732/ajb.0900346; Bendtsen JD, 2004, J MOL BIOL, V340, P783, DOI 10.1016/j.jmb.2004.05.028; Boerjan W, 2003, ANNU REV PLANT BIOL, V54, P519, DOI 10.1146/annurev.arplant.54.031902.134938; Brooker MIH, 2000, AUST SYST BOT, V13, P79, DOI 10.1071/SB98008; Brudno M, 2003, GENOME RES, V13, P721, DOI 10.1101/gr.926603; Buljan M, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-7-r74; Byrne M., 2008, PLANT GENOME BIODI E, V1, P303; Silva JCE, 2011, HEREDITY, V107, P50, DOI 10.1038/hdy.2010.154; Crisp MD, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1191; D'Hont A, 2012, NATURE, V488, P213, DOI 10.1038/nature11241; Dubchak I, 2009, GENOME RES, V19, P682, DOI 10.1101/gr.081778.108; Ekman D, 2005, J MOL BIOL, V348, P231, DOI 10.1016/j.jmb.2005.02.007; Eschler BM, 2000, BIOCHEM SYST ECOL, V28, P813, DOI 10.1016/S0305-1978(99)00123-4; Fawcett JA, 2009, P NATL ACAD SCI USA, V106, P5737, DOI 10.1073/pnas.0900906106; Finn RD, 2011, NUCLEIC ACIDS RES, V39, pW29, DOI 10.1093/nar/gkr367; Forslund K, 2008, MOL BIOL EVOL, V25, P254, DOI 10.1093/molbev/msm254; Frazer KA, 2004, NUCLEIC ACIDS RES, V32, pW273, DOI 10.1093/nar/gkh458; Freeling M, 2009, ANNU REV PLANT BIOL, V60, P433, DOI 10.1146/annurev.arplant.043008.092122; Gardner Paul P, 2011, Nucleic Acids Res, V39, pD141, DOI 10.1093/nar/gkq1129; Goodger JQD, 2011, PHYTOCHEMISTRY, V72, P2259, DOI 10.1016/j.phytochem.2011.08.026; GRATTAPAGLIA D, 1994, CAN J FOREST RES, V24, P1074, DOI 10.1139/x94-142; Grattapaglia D, 2012, TREE GENET GENOMES, V8, P463, DOI 10.1007/s11295-012-0491-x; Griffiths-Jones S, 2003, NUCLEIC ACIDS RES, V31, P439, DOI 10.1093/nar/gkg006; Groover AT, 2005, TRENDS PLANT SCI, V10, P210, DOI 10.1016/j.tplants.2005.03.001; Haas BJ, 2003, NUCLEIC ACIDS RES, V31, P5654, DOI 10.1093/nar/gkg770; Hanada K, 2008, PLANT PHYSIOL, V148, P993, DOI 10.1104/pp.108.122457; House Susan M., 1997, P30; Hudson CJ, 2012, TREE GENET GENOMES, V8, P339, DOI 10.1007/s11295-011-0444-9; Hunter S, 2009, NUCLEIC ACIDS RES, V37, pD211, DOI 10.1093/nar/gkn785; Iglesias I., EUCALYPTOLOGICS INFO; Jaffe DB, 2003, GENOME RES, V13, P91, DOI 10.1101/gr.828403; Jaillon O, 2007, NATURE, V449, P463, DOI 10.1038/nature06148; Jaiswal P, 2011, METHODS MOL BIOL, V678, P247, DOI 10.1007/978-1-60761-682-5_18; Jeffroy O, 2006, TRENDS GENET, V22, P225, DOI 10.1016/j.tig.2006.02.003; Katoh K, 2002, NUCLEIC ACIDS RES, V30, P3059, DOI 10.1093/nar/gkf436; Kent WJ, 2002, GENOME RES, V12, P656, DOI [10.1101/gr.229202, 10.1101/gr.229202. Article published online before March 2002]; Kulheim C, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-452; Kullan ARK, 2012, TREE GENET GENOMES, V8, P163, DOI 10.1007/s11295-011-0430-2; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Lee J, 2010, J EXP BOT, V61, P2247, DOI 10.1093/jxb/erq098; Martin W, 2005, TRENDS PLANT SCI, V10, P203, DOI 10.1016/j.tplants.2005.03.007; Mizrachi E, 2012, NEW PHYTOL, V194, P54, DOI 10.1111/j.1469-8137.2011.03971.x; Nawrocki EP, 2009, BIOINFORMATICS, V25, P1335, DOI 10.1093/bioinformatics/btp157; Novaes E, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-312; Ostlund G, 2010, NUCLEIC ACIDS RES, V38, pD196, DOI 10.1093/nar/gkp931; Peterson DG, 1997, PLANT MOL BIOL REP, V15, P148, DOI 10.1007/BF02812265; Petit RJ, 2006, ANNU REV ECOL EVOL S, V37, P187, DOI 10.1146/annurev.ecolsys.37.091305.110215; Petroli CD, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044684; Remm M, 2001, J MOL BIOL, V314, P1041, DOI 10.1006/jmbi.2000.5197; Resende MDV, 2012, NEW PHYTOL, V194, P116, DOI 10.1111/j.1469-8137.2011.04038.x; Robbertse B, 2011, PLOS CURR-TREE LIFE, DOI 10.1371/currents.RRN1213; Salse J, 2012, CURR OPIN PLANT BIOL, V15, P122, DOI 10.1016/j.pbi.2012.01.001; Salse J, 2009, BRIEF BIOINFORM, V10, P619, DOI 10.1093/bib/bbp037; Salse J, 2009, P NATL ACAD SCI USA, V106, P14908, DOI 10.1073/pnas.0902350106; Scheller HV, 2010, ANNU REV PLANT BIOL, V61, P263, DOI 10.1146/annurev-arplant-042809-112315; Shulaev V, 2011, NAT GENET, V43, P109, DOI 10.1038/ng.740; Small I, 2004, PROTEOMICS, V4, P1581, DOI 10.1002/pmic.200300776; Sonnhammer E L, 1998, Proc Int Conf Intell Syst Mol Biol, V6, P175; Stamatakis A, 2006, BIOINFORMATICS, V22, P2688, DOI 10.1093/bioinformatics/btl446; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Tibbits JFG, 2006, PLANT MOL BIOL REP, V24, P81, DOI 10.1007/BF02914048; Trapnell C, 2010, NAT BIOTECHNOL, V28, P511, DOI 10.1038/nbt.1621; Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120; Tuskan GA, 2006, SCIENCE, V313, P1596, DOI 10.1126/science.1128691; Wang HC, 2009, P NATL ACAD SCI USA, V106, P3853, DOI 10.1073/pnas.0813376106; Youens-Clark K, 2011, NUCLEIC ACIDS RES, V39, pD1085, DOI 10.1093/nar/gkq1148	70	527	561	17	312	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	JUN 19	2014	510	7505					356	+		10.1038/nature13308	http://dx.doi.org/10.1038/nature13308			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AJ0NG	24919147	Green Published, hybrid			2022-12-28	WOS:000337350200027
J	Das, P				Das, Pamela			Ziad Memish: father of mass gatherings medicine	LANCET			English	Biographical-Item																			0	2	2	0	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	JUN 14	2014	383	9934					E21	E21		10.1016/S0140-6736(14)60851-5	http://dx.doi.org/10.1016/S0140-6736(14)60851-5			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AI9VZ	24857702	Green Published, Bronze			2022-12-28	WOS:000337292400001
J	Churcher, TS; Cohen, JM; Novotny, J; Ntshalintshali, N; Kunene, S; Cauchemez, S				Churcher, Thomas S.; Cohen, Justin M.; Novotny, Joseph; Ntshalintshali, Nyasatu; Kunene, Simon; Cauchemez, Simon			PUBLIC HEALTH Measuring the path toward malaria elimination	SCIENCE			English	Editorial Material									[Churcher, Thomas S.; Cauchemez, Simon] Univ London Imperial Coll Sci Technol & Med, Dept Infect Dis Epidemiol, London, England; [Cohen, Justin M.; Novotny, Joseph; Ntshalintshali, Nyasatu] Clinton Hlth Access Initiat, Boston, MA 02127 USA; [Novotny, Joseph; Ntshalintshali, Nyasatu] Univ Calif San Francisco, Global Hlth Grp, San Francisco, CA 94143 USA; [Kunene, Simon] Natl Malaria Control Program, Manzini, Swaziland; [Cauchemez, Simon] Inst Pasteur, Math Modelling Infect Dis Unit, Paris, France	Imperial College London; University of California System; University of California San Francisco; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris	Cauchemez, S (corresponding author), Univ London Imperial Coll Sci Technol & Med, Dept Infect Dis Epidemiol, London, England.	simon.cauchemez@pasteur.fr		Churcher, Thomas/0000-0002-8442-0525; Cohen, Justin/0000-0003-4481-6784	MRC [MR/K010174/1] Funding Source: UKRI; Medical Research Council [MR/K010174/1B] Funding Source: researchfish; Medical Research Council [MR/K010174/1] Funding Source: Medline; NIGMS NIH HHS [U54 GM088491] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U54GM088491] Funding Source: NIH RePORTER	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Cauchemez S, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001399; Cohen JM, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-213; Dureau J, 2013, BIOSTATISTICS, V14, P541, DOI 10.1093/biostatistics/kxs052; Hay SI, 2008, LANCET INFECT DIS, V8, P369, DOI 10.1016/S1473-3099(08)70069-0; Hsiang MS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029550; Kunene S, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-313; Smith DL, 2009, TRENDS PARASITOL, V25, P511, DOI 10.1016/j.pt.2009.08.002; WHO, 2013, WORLD MALARIA REPORT 2013, P1; WHO, 2012, DIS SURV MAL EL OP M	9	53	53	0	13	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 13	2014	344	6189					1230	1232		10.1126/science.1251449	http://dx.doi.org/10.1126/science.1251449			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AI7ND	24926005	Green Accepted, Green Submitted			2022-12-28	WOS:000337077500021
J	Martin, E; Palmic, N; Sanquer, S; Lenoir, C; Hauck, F; Mongellaz, C; Fabrega, S; Nitschke, P; Degli Esposti, M; Schwartzentruber, J; Taylor, N; Majewski, J; Jabado, N; Wynn, RF; Picard, C; Fischer, A; Arkwright, PD; Latour, S				Martin, Emmanuel; Palmic, Noe; Sanquer, Sylvia; Lenoir, Christelle; Hauck, Fabian; Mongellaz, Cedric; Fabrega, Sylvie; Nitschke, Patrick; Degli Esposti, Mauro; Schwartzentruber, Jeremy; Taylor, Naomi; Majewski, Jacek; Jabado, Nada; Wynn, Robert F.; Picard, Capucine; Fischer, Alain; Arkwright, Peter D.; Latour, Sylvain			CTP synthase 1 deficiency in humans reveals its central role in lymphocyte proliferation	NATURE			English	Article							NOVO PYRIMIDINE SYNTHESIS; EPSTEIN-BARR-VIRUS; KILLER T-CELLS; DE-NOVO; SACCHAROMYCES-CEREVISIAE; SIGNAL-TRANSDUCTION; VIRAL-INFECTION; SYNTHETASE; ACTIVATION; PATHWAY	Lymphocyte functions triggered by antigen recognition and costimulation signals are associated with a rapid and intense cell division, and hence with metabolism adaptation(1). The nucleotide cytidine 5' triphosphate (CTP) is a precursor required for the metabolism of DNA, RNA and phospholipids(2-4). CTP originates from two sources: a salvage pathway and a de novo synthesis pathway that depends on two enzymes, the CTP synthases (or synthetases) 1 and 2 (CTPS1 with CTPS2); the respective roles of these two enzymes are not known(5-7). CTP synthase activity is a potentially important step for DNA synthesis in lymphocytes(8,9). Here we report the identification of a loss-of- function homozygous mutation (rs145092287) in CTPS1 in humans that causes a novel and life-threatening immunodeficiency, characterized by an impaired capacity of activated T and B cells to proliferate in response to antigen receptor-mediated activation. In contrast, proximal and distal T-cell receptor (TCR) signalling events and responses were only weakly affected by the absence of CTPS1. Activated CTPS1-deficient cells had decreased levels of CTP. Normal T-cell proliferation was restored in CTPS1-deficient cells by expressing wild-type CTPS1 or by addition of exogenous CTP or its nucleoside precursor, cytidine. CTPS1 expression was found to be low in resting T cells, but rapidly upregulated following TCR activation. These results highlight a key and specific role of CTPS1 in the immune system by its capacity to sustain the proliferation of activated lymphocytes during the immune response. CTPS1 may therefore represent a therapeutic target of immunosuppressive drugs that could specifically dampen lymphocyte activation.	[Martin, Emmanuel; Palmic, Noe; Lenoir, Christelle; Hauck, Fabian; Fischer, Alain; Latour, Sylvain] Hop Necker Enfants Malad, Lab Activat Lymphocytaire & Susceptibilite EBV, INSERM, UMR 1163, F-75015 Paris, France; [Martin, Emmanuel; Palmic, Noe; Lenoir, Christelle; Hauck, Fabian; Fabrega, Sylvie; Nitschke, Patrick; Picard, Capucine; Fischer, Alain; Latour, Sylvain] Univ Paris 05, Sorbonne Paris Cite, Inst Imagine, F-75015 Paris, France; [Sanquer, Sylvia; Latour, Sylvain] Hop Necker Enfants Malad, Lab Biochim Metabol & Proteom, F-75015 Paris, France; [Mongellaz, Cedric; Taylor, Naomi] Inst Genet Mol Montpellier, CNRS, UMR 5535, F-34293 Montpellier, France; [Fabrega, Sylvie] Hop Necker Enfants Malad, Plateforme Vecteurs Viraux & Transfert Genes, IFR94, F-75015 Paris, France; [Nitschke, Patrick] Hop Necker Enfants Malad, Serv Bioinformat, F-75015 Paris, France; [Degli Esposti, Mauro; Wynn, Robert F.; Arkwright, Peter D.] Univ Manchester, Royal Manchester Childrens Hosp, Manchester M13 0WL, Lancs, England; [Degli Esposti, Mauro] Italian Inst Technol, I-16163 Genoa, Italy; [Schwartzentruber, Jeremy; Majewski, Jacek; Jabado, Nada] McGill Univ, Montreal, PQ H3A 0G1, Canada; [Schwartzentruber, Jeremy; Majewski, Jacek; Jabado, Nada] Genome Quebec Innovat Ctr, Montreal, PQ H3A 0G1, Canada; [Jabado, Nada] McGill Univ, Hlth Ctr Res Inst, Dept Pediat, Montreal, PQ H3H 1P3, Canada; [Picard, Capucine] Hop Necker Enfants Malad, AP HP, Ctr Etude Deficits Immunitaires, F-75015 Paris, France; [Picard, Capucine] Hop Necker Enfants Malad, INSERM, Lab Genet Humaine Malad Infect, UMR 1163, F-75015 Paris, France; [Fischer, Alain] Hop Necker Enfants Malad, AP HP, Unite Immunol & Hematol Pediat, F-75015 Paris, France; [Fischer, Alain] Coll France, F-75005 Paris, France	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Universite de Montpellier; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite; Royal Manchester Children's Hospital; University of Manchester; Istituto Italiano di Tecnologia - IIT; McGill University; McGill University; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; PSL Research University Paris; College de France	Latour, S (corresponding author), Hop Necker Enfants Malad, Lab Activat Lymphocytaire & Susceptibilite EBV, INSERM, UMR 1163, F-75015 Paris, France.	sylvain.latour@inserm.fr	Taylor, Naomi/H-4016-2014; Hauck, Fabian/H-5556-2016; Martin, Emmanuel/F-9743-2016; Picard, Capucine/H-3914-2017; Jabado, Nada/AAN-4026-2020; Latour, Sylvain/H-3652-2017	Martin, Emmanuel/0000-0003-4211-7373; Picard, Capucine/0000-0001-8788-5056; Wynn, robert/0000-0002-6046-8428; Arkwright, Peter/0000-0002-7411-5375; Latour, Sylvain/0000-0001-8238-4391; Hauck, Fabian/0000-0001-9644-2003; Schwartzentruber, Jeremy/0000-0002-6183-2092; Degli Esposti, Mauro/0000-0002-0977-119X	INSERM; ANR [ANR-08-MIEN-012-01, ANR-2010-MIDI-005-02, ANR-10-IAHU-01]; Fondation ARC (France); European Research Council [ERC-2009-AdG_20090506, FP7-249816]; Rare Diseases Fondation (France); ANR (France); Ligue contre le cancer (France); Wellcome Trust; Medical Research Council [WT095219MA, G1001799]; MRC [G1001799] Funding Source: UKRI	INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); ANR(French National Research Agency (ANR)); Fondation ARC (France); European Research Council(European Research Council (ERC)European Commission); Rare Diseases Fondation (France); ANR (France)(French National Research Agency (ANR)); Ligue contre le cancer (France); Wellcome Trust(Wellcome Trust); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	The authors thank the patients, their families and the healthy donors for cooperation. We thank S. Rigaud, S. Gerart, C. Synaeve and R. Rodriguez for help with experiments and P. Revy for discussion. This work was supported by grants from INSERM, ANR (ANR-08-MIEN-012-01, ANR-2010-MIDI-005-02 and ANR-10-IAHU-01), Fondation ARC (France), the European Research Council (ERC-2009-AdG_20090506 noFP7-249816) and the Rare Diseases Fondation (France). S. L. is a senior scientist of CNRS (France). E. M. is supported by ANR (France) and Ligue contre le cancer (France). We are also grateful to the UK 1958 Birth Cohort (http://www2.le.ac.uk/projects/birthcohort) for providing DNA from 752 individuals born in the northwest of England. Access to these resources was enabled via the 58READIE Project funded by the Wellcome Trust and Medical Research Council (grant numbers WT095219MA and G1001799). A full list of the financial, institutional and personal contributions to the development of the 1958 Birth Cohort Biomedical resource is available at (http://www2.le.ac.uk/projects/birthcohort).	Austin WR, 2012, J EXP MED, V209, P2215, DOI 10.1084/jem.20121061; Ben-Sahra I, 2013, SCIENCE, V339, P1323, DOI 10.1126/science.1228792; Brennan PJ, 2013, NAT REV IMMUNOL, V13, P101, DOI 10.1038/nri3369; Chung BK, 2013, BLOOD, V122, P2600, DOI 10.1182/blood-2013-01-480665; Evans DR, 2004, J BIOL CHEM, V279, P33035, DOI 10.1074/jbc.R400007200; FAIRBANKS LD, 1995, J BIOL CHEM, V270, P29682; Gulow K, 2005, J IMMUNOL, V174, P5249, DOI 10.4049/jimmunol.174.9.5249; Higgins MJ, 2007, J BIOL CHEM, V282, P29493, DOI 10.1074/jbc.M703948200; Hislop AD, 2007, ANNU REV IMMUNOL, V25, P587, DOI 10.1146/annurev.immunol.25.022106.141553; Huang M, 2003, CELL MOL LIFE SCI, V60, P321, DOI 10.1007/s000180300027; Kassel KM, 2010, J BIOL CHEM, V285, P33727, DOI 10.1074/jbc.M110.178566; Kursula P, 2006, ACTA CRYSTALLOGR F, V62, P613, DOI 10.1107/S1744309106018136; Latour S, 2001, NAT IMMUNOL, V2, P681, DOI 10.1038/90615; Le Bourhis L, 2013, CURR OPIN IMMUNOL, V25, P174, DOI 10.1016/j.coi.2013.01.005; Luo B, 2007, J CHROMATOGR A, V1147, P153, DOI 10.1016/j.chroma.2007.02.034; MacIver NJ, 2013, ANNU REV IMMUNOL, V31, P259, DOI 10.1146/annurev-immunol-032712-095956; MARIJNEN YMT, 1989, BIOCHIM BIOPHYS ACTA, V1012, P148, DOI 10.1016/0167-4889(89)90088-8; MCPARTLAND RP, 1974, CANCER RES, V34, P3107; Murali-Krishna K, 1998, IMMUNITY, V8, P177, DOI 10.1016/S1074-7613(00)80470-7; NADKARNI AK, 1995, J BIOL CHEM, V270, P24982, DOI 10.1074/jbc.270.42.24982; Notarangelo LD, 2013, ANNU REV IMMUNOL, V31, P195, DOI 10.1146/annurev-immunol-032712-095927; Ostrander DB, 1998, J BIOL CHEM, V273, P18992, DOI 10.1074/jbc.273.30.18992; Picard C, 2009, EUR J IMMUNOL, V39, P1966, DOI 10.1002/eji.200939385; Qiu Y, 2000, TRANSPLANTATION, V69, P890; Robitaille AM, 2013, SCIENCE, V339, P1320, DOI 10.1126/science.1228771; SCAVENNEC J, 1982, CANCER RES, V42, P1326; Toy G, 2010, P NATL ACAD SCI USA, V107, P5551, DOI 10.1073/pnas.0913900107; TRAUT TW, 1994, MOL CELL BIOCHEM, V140, P1, DOI 10.1007/BF00928361; van Kuilenburg ABP, 2000, BBA-GENE STRUCT EXPR, V1492, P548, DOI 10.1016/S0167-4781(00)00141-X; VANDENBERG AA, 1994, LEUKEMIA, V8, P1375; VANDENBERG AA, 1995, EUR J CANCER, V31A, P108, DOI 10.1016/0959-8049(94)00442-8; Vivier E, 2008, NAT IMMUNOL, V9, P503, DOI 10.1038/ni1582; Wynn RF, 2005, LANCET ONCOL, V6, P344, DOI 10.1016/S1470-2045(05)70171-6	33	126	138	1	43	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 12	2014	510	7504					288	+		10.1038/nature13386	http://dx.doi.org/10.1038/nature13386			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI7AT	24870241	Green Accepted			2022-12-28	WOS:000337032400054
J	Lee, YS; Kim, JW; Osborne, O; Oh, DY; Sasik, R; Schenk, S; Chen, A; Chung, H; Murphy, A; Watkins, SM; Quehenberger, O; Johnson, RS; Olefsky, JM				Lee, Yun Sok; Kim, Jung-whan; Osborne, Olivia; Oh, Da Young; Sasik, Roman; Schenk, Simon; Chen, Ai; Chung, Heekyung; Murphy, Anne; Watkins, Steven M.; Quehenberger, Oswald; Johnson, Randall S.; Olefsky, Jerrold M.			Increased Adipocyte O-2 Consumption Triggers HIF-1 alpha, Causing Inflammation and Insulin Resistance in Obesity	CELL			English	Article							ADENINE-NUCLEOTIDE TRANSLOCASE; WHITE ADIPOSE-TISSUE; NITRIC-OXIDE; MITOCHONDRIAL RESPIRATION; ENERGY-EXPENDITURE; HYPOXIA; MICE; FAT; MACROPHAGES; INHIBITION	Adipose tissue hypoxia and inflammation have been causally implicated in obesity-induced insulin resistance. Here, we report that, early in the course of high-fat diet (HFD) feeding and obesity, adipocyte respiration becomes uncoupled, leading to increased oxygen consumption and a state of relative adipocyte hypoxia. These events are sufficient to trigger HIF-1 alpha induction, setting off the chronic adipose tissue inflammatory response characteristic of obesity. At the molecular level, these events involve saturated fatty acid stimulation of the adenine nucleotide translocase 2 (ANT2), an inner mitochondrial membrane protein, which leads to the uncoupled respiratory state. Genetic or pharmacologic inhibition of either ANT2 or HIF-1 alpha can prevent or reverse these pathophysiologic events, restoring a state of insulin sensitivity and glucose tolerance. These results reveal the sequential series of events in obesity-induced inflammation and insulin resistance.	[Lee, Yun Sok; Osborne, Olivia; Oh, Da Young; Sasik, Roman; Chen, Ai; Chung, Heekyung; Quehenberger, Oswald; Olefsky, Jerrold M.] Univ Calif San Diego, Dept Med, Div Endocrinol & Metab, La Jolla, CA 92093 USA; [Kim, Jung-whan; Johnson, Randall S.] Univ Calif San Diego, Div Biol Sci, Mol Biol Sect, La Jolla, CA 92093 USA; [Schenk, Simon] Univ Calif San Diego, Dept Orthopaed Surg, La Jolla, CA 92093 USA; [Murphy, Anne] Univ Calif San Diego, Dept Pharmacol, La Jolla, CA 92093 USA; [Watkins, Steven M.] Lipomics Technol Inc, West Sacramento, CA 95691 USA; [Johnson, Randall S.] Karolinska Inst, Dept Cell & Mol Biol, S-17177 Stockholm, Sweden; [Johnson, Randall S.] Univ Cambridge, Dept Physiol Dev & Neurosci, Cambridge CB2 3EG, England	University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego; Karolinska Institutet; University of Cambridge	Johnson, RS (corresponding author), Univ Calif San Diego, Div Biol Sci, Mol Biol Sect, La Jolla, CA 92093 USA.	rsj33@cam.ac.uk; jolefsky@ucsd.edu	Lee, Yun Sok/ABC-9195-2021; Lee, Yun Sok/B-3265-2015; Johnson, Randall/AAM-1189-2021; Murphy, Anne N/H-3217-2016	Lee, Yun Sok/0000-0001-7967-4734; Lee, Yun Sok/0000-0001-7967-4734; Johnson, Randall/0000-0002-4084-6639; Murphy, Anne N/0000-0002-5222-9902; Kim, Jung-whan/0000-0002-7829-1480; Schenk, Simon/0000-0002-8224-3203	National Institutes of Health (NIH) [DK-033651, DK-074868, DK-063491, P01-DK054441]; American Diabetes Association; National Institute of Aging; National Institute of Child Health and Human Development of the NIH [R01AG043120, R24HD050837]; Wellcome Trust; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P50HD012303, U54HD012303, R24HD050837] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK033651, P01DK054441, T32DK007494, R37DK033651, P01DK074868, P30DK063491, R01DK101395] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG043120] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Diabetes Association(American Diabetes Association); National Institute of Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); National Institute of Child Health and Human Development of the NIH; Wellcome Trust(Wellcome TrustEuropean Commission); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by the National Institutes of Health (NIH) grants DK-033651, DK-074868, DK-063491, and P01-DK054441. Y.S.L. was supported by a Mentor-Based Postdoctoral Fellowship Award from the American Diabetes Association. S. S. is supported by the National Institute of Aging and National Institute of Child Health and Human Development of the NIH under award numbers R01AG043120 and R24HD050837. R.S.J. is supported by a Principal Research Fellowship from the Wellcome Trust.	Ahmadian M, 2011, CELL METAB, V13, P739, DOI 10.1016/j.cmet.2011.05.002; ANDREYEV AY, 1988, FEBS LETT, V226, P265, DOI 10.1016/0014-5793(88)81436-4; Barak Y, 2002, P NATL ACAD SCI USA, V99, P303, DOI 10.1073/pnas.012610299; Branco-Price C, 2012, CANCER CELL, V21, P52, DOI 10.1016/j.ccr.2011.11.017; Brand MD, 2005, BIOCHEM J, V392, P353, DOI 10.1042/BJ20050890; Chalkiadaki A, 2012, CELL METAB, V16, P180, DOI 10.1016/j.cmet.2012.07.003; Deng T, 2013, CELL METAB, V17, P411, DOI 10.1016/j.cmet.2013.02.009; DIGIROLAMO M, 1992, FASEB J, V6, P2405, DOI 10.1096/fasebj.6.7.1563593; Doege K, 2005, BLOOD, V106, P2311, DOI 10.1182/blood-2005-03-1138; Garcia-Arcos I, 2013, J BIOL CHEM, V288, P14046, DOI 10.1074/jbc.M113.469270; Glass CK, 2012, CELL METAB, V15, P635, DOI 10.1016/j.cmet.2012.04.001; Gonsalves CS, 2010, J IMMUNOL, V184, P3878, DOI 10.4049/jimmunol.0902594; Hagen T, 2003, SCIENCE, V302, P1975, DOI 10.1126/science.1088805; Halberg N, 2009, MOL CELL BIOL, V29, P4467, DOI 10.1128/MCB.00192-09; He WM, 2003, P NATL ACAD SCI USA, V100, P15712, DOI 10.1073/pnas.2536828100; Hosogai N, 2007, DIABETES, V56, P901, DOI 10.2337/db06-0911; Jiang CT, 2011, DIABETES, V60, P2484, DOI 10.2337/db11-0174; Keith B, 2012, NAT REV CANCER, V12, P9, DOI 10.1038/nrc3183; Krishnan J, 2012, GENE DEV, V26, P259, DOI 10.1101/gad.180406.111; Lee KY, 2011, CELL METAB, V14, P491, DOI 10.1016/j.cmet.2011.08.006; Lee YS, 2008, MOL ENDOCRINOL, V22, P2176, DOI 10.1210/me.2008-0023; Lee YS, 2013, CELL, V153, P413, DOI 10.1016/j.cell.2013.03.001; Lee YS, 2011, DIABETES, V60, P2474, DOI 10.2337/db11-0194; Lee YS, 2010, J BIOL CHEM, V285, P22174, DOI 10.1074/jbc.M109.085464; LEIBEL RL, 1985, AM J CLIN NUTR, V42, P198, DOI 10.1093/ajcn/42.2.198; Li PP, 2011, CELL, V147, P815, DOI 10.1016/j.cell.2011.09.050; Melillo G, 1996, J IMMUNOL, V157, P2638; Nielsen S, 2004, J CLIN INVEST, V113, P1582, DOI [10.1172/JCI200421047, 10.1172/JCI21047]; Oh DY, 2012, DIABETES, V61, P346, DOI 10.2337/db11-0860; Pasarica M, 2009, DIABETES, V58, P718, DOI 10.2337/db08-1098; Paschos GK, 2012, NAT MED, V18, P1768, DOI 10.1038/nm.2979; Perreault M, 2001, NAT MED, V7, P1138, DOI 10.1038/nm1001-1138; Polak P, 2008, CELL METAB, V8, P399, DOI 10.1016/j.cmet.2008.09.003; Qvisth V, 2007, AM J PHYSIOL-ENDOC M, V292, pE709, DOI 10.1152/ajpendo.00104.2006; Rohm M, 2013, CELL METAB, V17, P575, DOI 10.1016/j.cmet.2013.02.010; Sabio G, 2008, SCIENCE, V322, P1539, DOI 10.1126/science.1160794; Sato Y, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M110.194738; Shu CJ, 2012, SEMIN IMMUNOL, V24, P436, DOI 10.1016/j.smim.2012.12.001; Sims K, 2010, J BIOL CHEM, V285, P38568, DOI 10.1074/jbc.M110.170621; Spite M, 2011, J IMMUNOL, V187, P1942, DOI 10.4049/jimmunol.1100196; Sridharan V, 2008, AM J PHYSIOL-CELL PH, V295, pC29, DOI 10.1152/ajpcell.00466.2007; Sun K, 2013, MOL CELL BIOL, V33, P904, DOI 10.1128/MCB.00951-12; Takeda N, 2010, GENE DEV, V24, P491, DOI 10.1101/gad.1881410; Yasukawa T, 2005, J BIOL CHEM, V280, P7511, DOI 10.1074/jbc.M411871200; Zhang XM, 2010, J BIOL CHEM, V285, P32869, DOI 10.1074/jbc.M110.135509; Zhivotovsky B, 2009, CELL DEATH DIFFER, V16, P1419, DOI 10.1038/cdd.2009.118	46	314	318	2	47	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUN 5	2014	157	6					1339	1352		10.1016/j.cell.2014.05.012	http://dx.doi.org/10.1016/j.cell.2014.05.012			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	AN8UV	24906151	Green Accepted, Bronze			2022-12-28	WOS:000340881400011
J	Liberali, P; Snijder, B; Pelkmans, L				Liberali, Prisca; Snijder, Berend; Pelkmans, Lucas			A Hierarchical Map of Regulatory Genetic Interactions in Membrane Trafficking	CELL			English	Article							ORGANIZATION; ENDOCYTOSIS; RNAI; ENDOSOME; KINASES; PATHWAY; SCREEN; YEAST	Endocytosis is critical for cellular physiology and thus is highly regulated. To identify regulatory interactions controlling the endocytic membrane system, we conducted 13 RNAi screens on multiple endocytic activities and their downstream organelles. Combined with image analysis of thousands of single cells per perturbation and their cell-to-cell variability, this created a high-quality and cross-comparable quantitative data set. Unbiased analysis revealed emergent properties of the endocytic membrane system and how its complexity evolved and distinct programs of regulatory control that coregulate specific subsets of endocytic uptake routes and organelle abundances. We show that these subset effects allow the mapping of functional regulatory interactions and their interaction motifs between kinases, membrane-trafficking machinery, and the cytoskeleton at a large scale, some of which we further characterize. Our work presents a powerful approach to identify regulatory interactions in complex cellular systems from parallel single-gene or double-gene perturbation screens in human cells and yeast.	[Liberali, Prisca; Snijder, Berend; Pelkmans, Lucas] Univ Zurich, Inst Mol Life Sci, CH-8057 Zurich, Switzerland	University of Zurich	Liberali, P (corresponding author), Univ Zurich, Inst Mol Life Sci, Winterthurerstr 190, CH-8057 Zurich, Switzerland.	prisca.liberali@uzh.ch; lucas.pelkmans@imls.uzh.ch	Snijder, Berend/O-9206-2019; Snijder, Berend/M-2998-2017	Snijder, Berend/0000-0003-3386-6583; Liberali, Prisca/0000-0003-0695-6081; Pelkmans, Lucas/0000-0002-6754-9730	FEBS; SystemsX.ch Research, Technology, and Development project PhosphoNetX; SystemsX.ch Research, Technology, and Development project LipidX; University of Zurich	FEBS; SystemsX.ch Research, Technology, and Development project PhosphoNetX; SystemsX.ch Research, Technology, and Development project LipidX; University of Zurich	We thank Y. Heer, N. Battich, B. Thijssen, M. Stark, C. von Meering, and K. Mench for help with experiments and computation, Y. Yakimovich for IT support, and lab members for comments on the manuscript. P. L. is supported by a FEBS. L. P. acknowledges financial support from the SystemsX.ch Research, Technology, and Development projects PhosphoNetX and LipidX and the University of Zurich.	Alon U, 2007, NAT REV GENET, V8, P450, DOI 10.1038/nrg2102; Altschuler SJ, 2010, CELL, V141, P559, DOI 10.1016/j.cell.2010.04.033; Bassik MC, 2013, CELL, V152, P909, DOI 10.1016/j.cell.2013.01.030; Boutros M, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-7-r66; Brunner Y, 2007, MOL CELL PROTEOMICS, V6, P1007, DOI 10.1074/mcp.M600443-MCP200; Carpenter AE, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-10-r100; Ciccarelli FD, 2006, SCIENCE, V311, P1283, DOI 10.1126/science.1123061; Clevers H, 2006, CELL, V127, P469, DOI 10.1016/j.cell.2006.10.018; Collinet C, 2010, NATURE, V464, P243, DOI 10.1038/nature08779; Conner SD, 2003, NATURE, V422, P37, DOI 10.1038/nature01451; Costanzo M, 2010, SCIENCE, V327, P425, DOI 10.1126/science.1180823; Doherty GJ, 2009, ANNU REV BIOCHEM, V78, P857, DOI 10.1146/annurev.biochem.78.081307.110540; Fiedler D, 2009, CELL, V136, P952, DOI 10.1016/j.cell.2008.12.039; Galvez T, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-7-r142; Hillenmeyer ME, 2008, SCIENCE, V320, P362, DOI 10.1126/science.1150021; Kozik P, 2013, NAT CELL BIOL, V15, P50, DOI 10.1038/ncb2652; Laufer C, 2013, NAT METHODS, V10, P427, DOI [10.1038/NMETH.2436, 10.1038/nmeth.2436]; Liberali P, 2008, ANNU REV CELL DEV BI, V24, P501, DOI 10.1146/annurev.cellbio.041008.145637; Loerke D, 2009, PLOS BIOL, V7, P628, DOI 10.1371/journal.pbio.1000057; Mali P, 2013, SCIENCE, V339, P823, DOI 10.1126/science.1232033; Maxfield FR, 2004, NAT REV MOL CELL BIO, V5, P121, DOI 10.1038/nrm1315; Moustakas A, 1999, J CELL SCI, V112, P1169; Nichols RJ, 2011, CELL, V144, P143, DOI 10.1016/j.cell.2010.11.052; Pelkmans L, 2005, NATURE, V436, P78, DOI 10.1038/nature03571; Ramo P, 2009, BIOINFORMATICS, V25, P3028, DOI 10.1093/bioinformatics/btp524; Richardson SCW, 2004, MOL BIOL CELL, V15, P1197, DOI 10.1091/mbc.E03-06-0358; Roguev A, 2013, NAT METHODS, V10, P432, DOI [10.1038/nmeth.2398, 10.1038/NMETH.2398]; Rutherford AC, 2006, J CELL SCI, V119, P3944, DOI 10.1242/jcs.03153; Schuldiner M, 2005, CELL, V123, P507, DOI 10.1016/j.cell.2005.08.031; Scita G, 2010, NATURE, V463, P464, DOI 10.1038/nature08910; Shalem O, 2014, SCIENCE, V343, P84, DOI 10.1126/science.1247005; Snijder B, 2013, NAT METHODS, V10, P1089, DOI [10.1038/NMETH.2655, 10.1038/nmeth.2655]; Snijder B, 2012, MOL SYST BIOL, V8, DOI 10.1038/msb.2012.9; Snijder B, 2009, NATURE, V461, P520, DOI 10.1038/nature08282; STEINMAN RM, 1983, J CELL BIOL, V96, P1, DOI 10.1083/jcb.96.1.1; Steinmetz LM, 2002, NAT GENET, V31, P400, DOI 10.1038/ng929; Tsujita K, 2004, J BIOL CHEM, V279, P13817, DOI 10.1074/jbc.M312294200; Walz HA, 2010, J BIOL CHEM, V285, P14101, DOI 10.1074/jbc.M110.110536	38	66	66	1	25	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUN 5	2014	157	6					1473	1487		10.1016/j.cell.2014.04.029	http://dx.doi.org/10.1016/j.cell.2014.04.029			15	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	AN8UV	24906158	Bronze			2022-12-28	WOS:000340881400021
J	McCall, AS; Cummings, CF; Bhave, G; Vanacore, R; Page-McCaw, A; Hudson, BG				McCall, A. Scott; Cummings, Christopher F.; Bhave, Gautam; Vanacore, Roberto; Page-McCaw, Andrea; Hudson, Billy G.			Bromine Is an Essential Trace Element for Assembly of Collagen IV Scaffolds in Tissue Development and Architecture	CELL			English	Article							BASEMENT-MEMBRANE; EXTRACELLULAR-MATRIX; DROSOPHILA; THIOCYANATE; MUTATIONS; ACIDS; INTERMEDIATE; REACTIVITY; OXIDATION; ELEGANS	Bromine is ubiquitously present in animals as ionic bromide (Br-) yet has no known essential function. Herein, we demonstrate that Br- is a required cofactor for peroxidasin-catalyzed formation of sulfilimine crosslinks, a posttranslational modification essential for tissue development and architecture found within the collagen IV scaffold of basement membranes (BMs). Bromide, converted to hypobromous acid, forms a bromosulfonium-ion intermediate that energetically selects for sulfilimine formation. Dietary Br deficiency is lethal in Drosophila, whereas Br replenishment restores viability, demonstrating its physiologic requirement. Importantly, Br-deficient flies phenocopy the developmental and BM defects observed in peroxidasin mutants and indicate a functional connection between Br-, collagen IV, and peroxidasin. We establish that Br- is required for sulfilimine formation within collagen IV, an event critical for BM assembly and tissue development. Thus, bromine is an essential trace element for all animals, and its deficiency may be relevant to BM alterations observed in nutritional and smoking-related disease.	[McCall, A. Scott] Vanderbilt Univ, Sch Med, Dept Pharmacol, Nashville, TN 37232 USA; [Cummings, Christopher F.; Hudson, Billy G.] Vanderbilt Univ, Sch Med, Dept Biochem, Nashville, TN 37232 USA; [Cummings, Christopher F.; Bhave, Gautam; Vanacore, Roberto; Hudson, Billy G.] Vanderbilt Univ, Sch Med, Dept Med, Div Nephrol & Hypertens, Nashville, TN 37232 USA; [Vanacore, Roberto; Hudson, Billy G.] Vanderbilt Univ, Sch Med, Ctr Matrix Biol, Nashville, TN 37232 USA; [Page-McCaw, Andrea] Vanderbilt Univ, Sch Med, Dept Cell & Dev Biol, Nashville, TN 37232 USA; [Page-McCaw, Andrea] Vanderbilt Univ, Sch Med, Dept Canc Biol, Nashville, TN 37232 USA; [Page-McCaw, Andrea; Hudson, Billy G.] Vanderbilt Univ, Sch Med, Vanderbilt Ingram Canc3, Nashville, TN 37232 USA; [Hudson, Billy G.] Vanderbilt Univ, Sch Med, Dept Pathol Microbiol & Immunol, Nashville, TN 37232 USA; [Hudson, Billy G.] Vanderbilt Univ, Sch Med, Vanderbilt Inst Chem Biol, Nashville, TN 37232 USA	Vanderbilt University; Vanderbilt University; Vanderbilt University; Vanderbilt University; Vanderbilt University; Vanderbilt University; Vanderbilt University; Vanderbilt University; Vanderbilt University	Hudson, BG (corresponding author), Vanderbilt Univ, Sch Med, Dept Biochem, 607 Light Hall, Nashville, TN 37232 USA.	billy.hudson@vanderbilt.edu	Vanacore, Roberto/AAD-6399-2020	Vanacore, Roberto/0000-0002-2886-0606; Hudson, Billy/0000-0002-5420-4100	NIH [R01 DK18381, F30 DK100094-01, KO8 DK097306, R01 GM073883]; NIGMS [T32 GM07347]; Canby Robinson Society; Vanderbilt Physician Scientist Development Award; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL069765] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [K08DK097306, R01DK018381, F30DK100094] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM073883, T32GM007347] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Canby Robinson Society; Vanderbilt Physician Scientist Development Award; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by the following: NIH R01 DK18381 to B. G. H.; NIH F30 DK100094-01 to A. S. M.; NIGMS T32 GM07347 to the Vanderbilt Medical-Scientist Training Program and the Canby Robinson Society in support of A. S. M.; NIH KO8 DK097306 and the Vanderbilt Physician Scientist Development Award to G. B.; and NIH R01 GM073883 to A.P.-M. We are grateful to K. L. Rose at Vanderbilt Mass Spectrometry Resource Center; J. Clanton, X. Wang, and E. Shannon for assistance with Drosophila; J. Williams and W. G. Jerome for assistance with Electron Microscopy and sample preparation, performed with use of the VUMC Cell Imaging Shared Resource; and the Bloomington Drosophila Stock Center, Yale FlyTrap, and the VDRC for fly stocks. The technical assistance of P. Todd and M. Rafi is appreciated. We acknowledge S. Kraft for helpful chemistry discussions. C. F. C. and B. G. H. are cofounders of SULFILATEC, INC. C. F. C. is a director and officer without salary of SULFILATEC, INC.	ANKE M, 1990, Acta Agronomica Hungarica, V39, P297; Armesto XL, 2000, TETRAHEDRON, V56, P1103, DOI 10.1016/S0040-4020(99)01066-2; ASMUSSEN I, 1979, Clinical Cardiology, V2, P246; BARRATT TM, 1969, J CLIN INVEST, V48, P56, DOI 10.1172/JCI105974; Bhave G, 2012, NAT CHEM BIOL, V8, P784, DOI [10.1038/NCHEMBIO.1038, 10.1038/nchembio.1038]; Borchiellini C, 1996, MECH DEVELOP, V58, P179, DOI 10.1016/S0925-4773(96)00574-6; BOZEMAN PM, 1990, J IMMUNOL METHODS, V126, P125, DOI 10.1016/0022-1759(90)90020-V; Brodie BB, 1939, J BIOL CHEM, V130, P555; Chmutova G., 1999, RUSS J ORG CHEM+, V35, P56; DAHLSTROM KA, 1986, J PEDIATR-US, V109, P625, DOI 10.1016/S0022-3476(86)80225-6; Daley WP, 2013, CURR OPIN GENET DEV, V23, P408, DOI 10.1016/j.gde.2013.05.005; Gotenstein JR, 2010, DEVELOPMENT, V137, P3603, DOI 10.1242/dev.049189; Gould DB, 2005, SCIENCE, V308, P1167, DOI 10.1126/science.1109418; Groos S, 2003, J SURG RES, V109, P74, DOI 10.1016/S0022-4804(02)00094-X; Gupta MC, 1997, J CELL BIOL, V137, P1185, DOI 10.1083/jcb.137.5.1185; Haigo SL, 2011, SCIENCE, V331, P1071, DOI 10.1126/science.1199424; Hudson BG, 2003, NEW ENGL J MED, V348, P2543, DOI 10.1056/NEJMra022296; Hynes RO, 2009, SCIENCE, V326, P1216, DOI 10.1126/science.1176009; KLOPMAN G, 1968, J AM CHEM SOC, V90, P223, DOI 10.1021/ja01004a002; LANGEVELD JPM, 1988, J BIOL CHEM, V263, P10481; LIN CQ, 1993, FASEB J, V7, P737, DOI 10.1096/fasebj.7.9.8330681; MAYENO AN, 1989, J BIOL CHEM, V264, P5660; MERTZ W, 1981, SCIENCE, V213, P1332, DOI 10.1126/science.7022654; Miura Y, 2002, NUCL INSTRUM METH B, V189, P443, DOI 10.1016/S0168-583X(01)01122-3; Nagy P, 2006, CHEM RES TOXICOL, V19, P587, DOI 10.1021/tx050338c; Nielsen FH, 1998, J TRACE ELEM EXP MED, V11, P251, DOI 10.1002/(SICI)1520-670X(1998)11:2/3&lt;251::AID-JTRA15&gt;3.0.CO;2-Q; Oe P., 1981, TRACE ELEMENT METABO, P526; Olszowy HA, 1998, J ANAL TOXICOL, V22, P225, DOI 10.1093/jat/22.3.225; Pastor-Pareja JC, 2011, DEV CELL, V21, P245, DOI 10.1016/j.devcel.2011.06.026; Pavelka S, 2005, PHYSIOL RES, V54, P639, DOI 10.33549/physiolres.930691; PEARSON RG, 1968, J CHEM EDUC, V45, P581, DOI 10.1021/ed045p581; Peskin AV, 2009, BIOCHEMISTRY-US, V48, P10175, DOI 10.1021/bi901266w; PIEDADEGUERREIRO J, 1987, J RADIOAN NUCL CH AR, V110, P531, DOI 10.1007/BF02035542; Poschl E, 2004, DEVELOPMENT, V131, P1619, DOI 10.1242/dev.01037; Rodriguez A, 1996, GENETICS, V143, P929; SEEMAN JI, 1983, CHEM REV, V83, P83, DOI 10.1021/cr00054a001; Shanbhag S, 2009, J EXP BIOL, V212, P1731, DOI 10.1242/jeb.029306; Soltani A, 2012, HISTOPATHOLOGY, V60, P964, DOI 10.1111/j.1365-2559.2011.04147.x; Song JJ, 2011, TRENDS MOL MED, V17, P424, DOI 10.1016/j.molmed.2011.03.005; TRAUTNER M, 1968, ACTA PHYSIOL SCAND, V74, P606, DOI 10.1111/j.1748-1716.1968.tb04271.x; Tsuge K, 2000, J HEALTH SCI, V46, P343; Vanacore R, 2009, SCIENCE, V325, P1230, DOI 10.1126/science.1176811; VANLEEUWEN FXR, 1987, CRIT REV TOXICOL, V18, P189, DOI 10.3109/10408448709089861; VANLOGTEN MJ, 1974, TOXICOLOGY, V2, P257, DOI 10.1016/0300-483X(74)90017-1; VRACKO R, 1974, AM J PATHOL, V77, P314; WALLAEYS B, 1986, KIDNEY INT, V30, P599, DOI 10.1038/ki.1986.227; Wang XM, 2008, NATURE, V455, P72, DOI 10.1038/nature07214; WEISS SJ, 1986, SCIENCE, V234, P200, DOI 10.1126/science.3018933; Werb Z, 1997, CELL, V91, P439, DOI 10.1016/S0092-8674(00)80429-8; WOLF RL, 1950, AM J PHYSIOL, V163, P436, DOI 10.1152/ajplegacy.1950.163.2.436; WOODS AE, 1979, B ENVIRON CONTAM TOX, V23, P179, DOI 10.1007/BF01769938; YOUNG PR, 1978, J AM CHEM SOC, V100, P7121, DOI 10.1021/ja00490a082; Yurchenco PD, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a004911	53	224	226	8	59	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUN 5	2014	157	6					1380	1392		10.1016/j.cell.2014.05.009	http://dx.doi.org/10.1016/j.cell.2014.05.009			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	AN8UV	24906154	Green Accepted, Bronze			2022-12-28	WOS:000340881400014
J	Williams, T				Williams, Trevor			CLIMATE SCIENCE How Antarctic ice retreats	NATURE			English	Editorial Material							LAST GLACIAL MAXIMUM; SEA-LEVEL; VOLUME		Columbia Univ, Lamont Doherty Earth Observ, Palisades, NY 10964 USA	Columbia University	Williams, T (corresponding author), Columbia Univ, Lamont Doherty Earth Observ, Palisades, NY 10964 USA.	trevor@ldeo.columbia.edu			Directorate For Geosciences [0944489] Funding Source: National Science Foundation	Directorate For Geosciences(National Science Foundation (NSF)NSF - Directorate for Geosciences (GEO))		Austermann J, 2013, NAT GEOSCI, V6, P553, DOI 10.1038/NGEO1859; Clark PU, 2009, SCIENCE, V325, P710, DOI 10.1126/science.1172873; Deschamps P, 2012, NATURE, V483, P559, DOI 10.1038/nature10902; Dutton A, 2012, SCIENCE, V337, P216, DOI 10.1126/science.1205749; Heroy DC, 2007, QUATERNARY SCI REV, V26, P3286, DOI 10.1016/j.quascirev.2007.07.012; Hillenbrand C.-D., 2013, QUAT SCI REV; Kopp RE, 2009, NATURE, V462, P863, DOI 10.1038/nature08686; Medley B., 2014, SCIENCE; Pierce EL, 2011, PALEOCEANOGRAPHY, V26, DOI 10.1029/2011PA002127; Rignot E., 2014, GEOPHYS RES LETT; Weber ME, 2014, NATURE, V510, P134, DOI 10.1038/nature13397; Whitehouse PL, 2012, QUATERNARY SCI REV, V32, P1, DOI 10.1016/j.quascirev.2011.11.016	12	2	2	0	20	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 5	2014	510	7503					39	40		10.1038/nature13345	http://dx.doi.org/10.1038/nature13345			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AI3NR	24870233				2022-12-28	WOS:000336768900025
J	Vize, R				Vize, Richard			INTEGRATED CARE Financial benefits of integration: a case of wishful thinking?	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												richard.vize@gmail.com						Ashton CM, 2003, NEW ENGL J MED, V349, P1637, DOI 10.1056/NEJMsa003299; Black N, 2009, BRIT MED J, V339, DOI 10.1136/bmj.b2495; Coulter A, 2014, BMJ-BRIT MED J, V348, DOI 10.1136/bmj.g2225; Curry N, 2010, CLIN SERVICE INTEGRA; Mason A., 2014, FINANCIAL MECH INTEG	5	2	2	0	4	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JUN 3	2014	348								g3661	10.1136/bmj.g3661	http://dx.doi.org/10.1136/bmj.g3661			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AI7CB	24895204				2022-12-28	WOS:000337037600008
J	Zumla, A; Hui, DS				Zumla, Alimuddin; Hui, David S.			Infection control and MERS-CoV in health-care workers	LANCET			English	Editorial Material							ACUTE RESPIRATORY SYNDROME; HONG-KONG; CORONAVIRUS; SARS; OUTBREAK		[Zumla, Alimuddin] UCL, Dept Infect, Div Infect & Immun, Ctr Clin Microbiol, London, England; [Zumla, Alimuddin] Univ Coll London Hosp, NIHR Biomed Res Ctr, London, England; [Hui, David S.] Chinese Univ Hong Kong, Dept Med & Therapeut, Shatin, Hong Kong, Peoples R China; [Hui, David S.] Chinese Univ Hong Kong, Stanley Ho Ctr Emerging Infect Dis, Shatin, Hong Kong, Peoples R China	University of London; University College London; University College London Hospitals NHS Foundation Trust; University of London; University College London; Chinese University of Hong Kong; Chinese University of Hong Kong	Hui, DS (corresponding author), Chinese Univ Hong Kong, Dept Med & Therapeut, Shatin, Hong Kong, Peoples R China.	dschui@cuhk.edu.hk	Hui, David Shu-Cheong/O-2754-2015; ZUMLA, Alimuddin/ABA-8208-2020	Hui, David Shu-Cheong/0000-0003-4382-2445; ZUMLA, Alimuddin/0000-0002-5111-5735				Assiri A, 2013, NEW ENGL J MED, V369, P407, DOI 10.1056/NEJMoa1306742; Booth TF, 2005, J INFECT DIS, V191, P1472, DOI 10.1086/429634; CDC, 2014, INT INF PREV CONTR R; Hijawi B, 2013, E MEDITERR HEALTH J, V19, pS12; Hui DS, 2014, CURR OPIN PULM MED, V20, P233, DOI 10.1097/MCP.0000000000000046; Tran K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035797; Lee N, 2003, NEW ENGL J MED, V348, P1986, DOI 10.1056/NEJMoa030685; Riley S, 2003, SCIENCE, V300, P1961, DOI 10.1126/science.1086478; Sehulster Lynne, 2003, MMWR Recomm Rep, V52, P1; Seto WH, 2013, E MEDITERR HEALTH J, V19, pS39; SIEGEL JD, 2007, 2007 GUID IS PREC PR; Tomlinson B, 2003, LANCET, V361, P1486, DOI 10.1016/S0140-6736(03)13218-7; WHO, 2014, GLOB AL RESP MIDD E; WHO (World Health Organization), 2016, ASS RISK ASS INFL A; World Health Organization, 2014, WHO STAT 5 M IHR EM; Yu IT, 2007, CLIN INFECT DIS, V44, P1017, DOI 10.1086/512819; Zaki AM, 2012, NEW ENGL J MED, V367, P1814, DOI 10.1056/NEJMoa1211721	17	58	59	2	14	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	MAY 31	2014	383	9932					1869	1871		10.1016/S0140-6736(14)60852-7	http://dx.doi.org/10.1016/S0140-6736(14)60852-7			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	AI4PR	24857701	Bronze, Green Published			2022-12-28	WOS:000336847800011
J	Maldacena, J				Maldacena, Juan			Testing gauge/gravity duality on a quantum black hole	SCIENCE			English	Editorial Material									Inst Adv Study, Sch Nat Sci, Princeton, NJ 08540 USA	Institute for Advanced Study - USA	Maldacena, J (corresponding author), Inst Adv Study, Sch Nat Sci, Olden Lane, Princeton, NJ 08540 USA.	malda@ias.edu						Banks T, 1997, PHYS REV D, V55, P5112, DOI 10.1103/PhysRevD.55.5112; Green MB, 1997, PHYS LETT B, V409, P177, DOI 10.1016/S0370-2693(97)00931-3; Hanada M, 2014, SCIENCE, V344, P882, DOI 10.1126/science.1250122; Hanada M, 2009, PHYS REV LETT, V102, DOI 10.1103/PhysRevLett.102.191602; Itzhaki N, 1998, PHYS REV D, V58, DOI 10.1103/PhysRevD.58.046004; Polchinski J, 1995, PHYS REV LETT, V75, P4724, DOI 10.1103/PhysRevLett.75.4724	6	2	2	0	16	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 23	2014	344	6186					806	807		10.1126/science.1254597	http://dx.doi.org/10.1126/science.1254597			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AH6IL	24855242				2022-12-28	WOS:000336233800014
J	Birnbaum, ME; Mendoza, JL; Sethi, DK; Dong, S; Glanville, J; Dobbins, J; Ozkan, E; Davis, MM; Wucherpfennig, KW; Garcia, KC				Birnbaum, Michael E.; Mendoza, Juan L.; Sethi, Dhruv K.; Dong, Shen; Glanville, Jacob; Dobbins, Jessica; Oezkan, Engin; Davis, Mark M.; Wucherpfennig, Kai W.; Garcia, K. Christopher			Deconstructing the Peptide-MHC Specificity of T Cell Recognition	CELL			English	Article							CROSS-REACTIVITY; RECEPTOR RECOGNITION; DIRECTED EVOLUTION; SURFACE DISPLAY; ANTIGEN; BINDING; TCR; DEGENERACY; SELF; IDENTIFICATION	In order to survey a universe of major histocompatibility complex (MHC)-presented peptide antigens whose numbers greatly exceed the diversity of the T cell repertoire, T cell receptors (TCRs) are thought to be cross- reactive. However, the nature and extent of TCR cross- reactivity has not been conclusively measured experimentally. We developed a system to identify MHC-presented peptide ligands by combining TCR selection of highly diverse yeast-displayed peptide-MHC libraries with deep sequencing. Although we identified hundreds of peptides reactive with each of five different mouse and human TCRs, the selected peptides possessed TCR recognition motifs that bore a close resemblance to their known antigens. This structural conservation of the TCR interaction surface allowed us to exploit deep-sequencing information to computationally identify activating microbial and self-ligands for human autoimmune TCRs. The mechanistic basis of TCR cross- reactivity described here enables effective surveillance of diverse self and foreign antigens without necessitating degenerate recognition of nonhomologous peptides.	[Birnbaum, Michael E.; Mendoza, Juan L.; Dong, Shen; Oezkan, Engin; Garcia, K. Christopher] Stanford Univ, Sch Med, Dept Mol & Cellular Physiol, Stanford, CA 94305 USA; [Birnbaum, Michael E.; Mendoza, Juan L.; Dong, Shen; Oezkan, Engin; Garcia, K. Christopher] Stanford Univ, Sch Med, Dept Struct Biol, Stanford, CA 94305 USA; [Glanville, Jacob; Davis, Mark M.] Stanford Univ, Sch Med, Dept Microbiol & Immunol, Stanford, CA 94305 USA; [Birnbaum, Michael E.; Glanville, Jacob; Davis, Mark M.; Garcia, K. Christopher] Stanford Univ, Sch Med, Program Immunol, Stanford, CA 94305 USA; [Oezkan, Engin; Davis, Mark M.; Garcia, K. Christopher] Stanford Univ, Sch Med, Howard Hughes Med Inst, Stanford, CA 94305 USA; [Sethi, Dhruv K.; Dobbins, Jessica; Wucherpfennig, Kai W.] Dana Farber Canc Inst, Dept Canc Immunol & AIDS, Boston, MA 02115 USA; [Dobbins, Jessica; Wucherpfennig, Kai W.] Harvard Univ, Sch Med, Program Immunol, Boston, MA 02115 USA	Stanford University; Stanford University; Stanford University; Stanford University; Howard Hughes Medical Institute; Stanford University; Harvard University; Dana-Farber Cancer Institute; Harvard University; Harvard Medical School	Garcia, KC (corresponding author), Stanford Univ, Sch Med, Dept Mol & Cellular Physiol, Stanford, CA 94305 USA.	kcgarcia@stanford.edu	Dong, Shen/ABC-2875-2020	Ozkan, Engin/0000-0002-0263-6729; Davis, Mark/0000-0001-6868-657X; Birnbaum, Michael/0000-0002-2281-3518; Mendoza, Juan/0000-0001-6972-7476; Kohler, Jessica/0000-0002-6074-5595; dong, Shen/0000-0001-8839-7046	Regina Casper Stanford Graduate Fellowship; Gerald J. Lieberman Fellowship; National Science Foundation; Helen Hay Whitney Foundation; NIH [PO1 AI045757, R01 AI03867, R01 AI022511, U19 4100041120, P41GM103393]; HHMI; U.S. Department of Energy [DE-AC02-76SF00515]; DOE Office of Biological and Environmental Research; NCI-K01CA175127; NATIONAL CANCER INSTITUTE [K01CA175127] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P01AI045757, R01AI103867, R01AI022511, R01AI048540, U19AI057229] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [DP3DK097681] Funding Source: NIH RePORTER	Regina Casper Stanford Graduate Fellowship; Gerald J. Lieberman Fellowship; National Science Foundation(National Science Foundation (NSF)); Helen Hay Whitney Foundation; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); HHMI(Howard Hughes Medical Institute); U.S. Department of Energy(United States Department of Energy (DOE)); DOE Office of Biological and Environmental Research(United States Department of Energy (DOE)); NCI-K01CA175127; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We thank Suzanne Fischer, Gary Mantalas, and Nelida Prado for technical assistance and Jarrett Adams, Lauren Ely, and Evan Newell for helpful discussions. M.E.B. was supported by a Regina Casper Stanford Graduate Fellowship, a Gerald J. Lieberman Fellowship, and a National Science Foundation Graduate Fellowship. J.L.M. was supported by NCI-K01CA175127 and a Helen Hay Whitney Foundation postdoctoral fellowship. This work was supported by the NIH (PO1 AI045757 to K.W.W., R01 AI03867 to K. C. G., R01 AI022511 to M. M. D., and U19 4100041120 to M. M. D. and K. C. G.) and HHMI (to M. M. D. and K. C. G.). Use of the Stanford Synchrotron Radiation Lightsource, SLAC National Accelerator Laboratory, is supported by the U.S. Department of Energy under Contract No. DE-AC02-76SF00515. The SSRL Structural Molecular Biology Program is supported by the DOE Office of Biological and Environmental Research and by the National Institutes of Health (including P41GM103393).	Adams JJ, 2011, IMMUNITY, V35, P681, DOI 10.1016/j.immuni.2011.09.013; Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Basu D, 2000, J IMMUNOL, V164, P5788, DOI 10.4049/jimmunol.164.11.5788; Benoist C, 2001, NAT IMMUNOL, V2, P797, DOI 10.1038/ni0901-797; Birnbaum ME, 2012, IMMUNOL REV, V250, P82, DOI 10.1111/imr.12006; Boder ET, 2005, BIOTECHNOL BIOENG, V92, P485, DOI 10.1002/bit.20616; Borbulevych OY, 2011, J IMMUNOL, V186, P2950, DOI 10.4049/jimmunol.1003150; Borbulevych OY, 2009, IMMUNITY, V31, P885, DOI 10.1016/j.immuni.2009.11.003; Chao G, 2006, NAT PROTOC, V1, P755, DOI 10.1038/nprot.2006.94; COCKCROFT VB, 1991, FEBS LETT, V293, P149, DOI 10.1016/0014-5793(91)81173-6; Colf LA, 2007, CELL, V129, P135, DOI 10.1016/j.cell.2007.01.048; Crawford F, 2006, IMMUNOL REV, V210, P156, DOI 10.1111/j.0105-2896.2006.00365.x; Crawford F, 2004, PLOS BIOL, V2, P523, DOI 10.1371/journal.pbio.0020090; DAVIS MM, 1988, NATURE, V334, P395, DOI 10.1038/334395a0; De la Herran-Arita AK, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3007762; Ebert PJR, 2009, NAT IMMUNOL, V10, P1162, DOI 10.1038/ni.1797; EHRICH EW, 1993, J EXP MED, V178, P713, DOI 10.1084/jem.178.2.713; Esteban O, 2004, J MOL BIOL, V340, P81, DOI 10.1016/j.jmb.2004.04.054; EVAVOLD BD, 1995, IMMUNITY, V2, P655, DOI 10.1016/1074-7613(95)90010-1; Garcia KC, 2005, CELL, V122, P333, DOI 10.1016/j.cell.2005.07.015; Hafler DA, 2007, NEW ENGL J MED, V357, P851, DOI 10.1056/NEJMoa073493; Hahn M, 2005, NAT IMMUNOL, V6, P490, DOI 10.1038/ni1187; Harkiolaki M, 2009, IMMUNITY, V30, P348, DOI 10.1016/j.immuni.2009.01.009; Hausmann S, 1999, J IMMUNOL, V162, P338; Hemmer B, 1997, J EXP MED, V185, P1651, DOI 10.1084/jem.185.9.1651; Hemmer B, 1998, J IMMUNOL, V160, P3631; Hemmer B, 1998, IMMUNOL TODAY, V19, P163, DOI 10.1016/S0167-5699(97)01217-6; HENIKOFF S, 1992, P NATL ACAD SCI USA, V89, P10915, DOI 10.1073/pnas.89.22.10915; Jiang W, 2010, P NATL ACAD SCI USA, V107, P13258, DOI 10.1073/pnas.1006344107; Kersh GJ, 1996, NATURE, V380, P495, DOI 10.1038/380495a0; Krishnamoorthy G, 2009, NAT MED, V15, P626, DOI 10.1038/nm.1975; Krogsgaard M, 2003, MOL CELL, V12, P1367, DOI 10.1016/S1097-2765(03)00474-X; Lo WL, 2009, NAT IMMUNOL, V10, P1155, DOI 10.1038/ni.1796; Macdonald WA, 2009, IMMUNITY, V31, P897, DOI 10.1016/j.immuni.2009.09.025; Madsen LS, 1999, NAT GENET, V23, P343, DOI 10.1038/15525; Mason D, 1998, IMMUNOL TODAY, V19, P395, DOI 10.1016/S0167-5699(98)01299-7; MATSUI K, 1991, SCIENCE, V254, P1788, DOI 10.1126/science.1763329; Maynard J, 2005, IMMUNITY, V22, P81, DOI 10.1016/j.immuni.2004.11.015; Mazza C, 2007, EMBO J, V26, P1972, DOI 10.1038/sj.emboj.7601605; McCoy AJ, 2007, ACTA CRYSTALLOGR D, V63, P32, DOI 10.1107/S0907444906045975; Morris GP, 2012, NAT IMMUNOL, V13, P121, DOI 10.1038/ni.2190; Morris GP, 2011, P NATL ACAD SCI USA, V108, P3695, DOI 10.1073/pnas.1017015108; Newell EW, 2011, J IMMUNOL, V186, P5823, DOI 10.4049/jimmunol.1100197; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Patsopoulos NA, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003926; REAY PA, 1994, J IMMUNOL, V152, P3946; Reiser JB, 2003, NAT IMMUNOL, V4, P241, DOI 10.1038/ni891; Rudolph MG, 2006, ANNU REV IMMUNOL, V24, P419, DOI 10.1146/annurev.immunol.23.021704.115658; Sewell AK, 2012, NAT REV IMMUNOL, V12, P668, DOI 10.1038/nri3279; Shann F, 2010, PEDIATR INFECT DIS J, V29, P457, DOI 10.1097/INF.0b013e3181c91361; Shih FF, 2004, MOL IMMUNOL, V40, P1041, DOI 10.1016/j.molimm.2003.11.008; Starwalt SE, 2003, PROTEIN ENG, V16, P147, DOI 10.1093/proeng/gzg018; Tynan FE, 2005, NAT IMMUNOL, V6, P1114, DOI 10.1038/ni1257; Wang YB, 2005, P NATL ACAD SCI USA, V102, P2476, DOI 10.1073/pnas.0409798102; Welsh RM, 2010, IMMUNOL REV, V235, P244, DOI 10.1111/j.0105-2896.2010.00897.x; Wen F, 2008, J IMMUNOL METHODS, V336, P37, DOI 10.1016/j.jim.2008.03.008; Wen F, 2011, PROTEIN ENG DES SEL, V24, P701, DOI 10.1093/protein/gzr035; Wilson DB, 1999, J IMMUNOL, V163, P6424; Wilson DB, 2004, MOL IMMUNOL, V40, P1047, DOI 10.1016/j.molimm.2003.11.022; Wooldridge L, 2012, J BIOL CHEM, V287, P1168, DOI 10.1074/jbc.M111.289488; Wu LC, 2002, NATURE, V418, P552, DOI 10.1038/nature00920; Wucherpfennig KW, 2007, SEMIN IMMUNOL, V19, P216, DOI 10.1016/j.smim.2007.02.012; WUCHERPFENNIG KW, 1994, J IMMUNOL, V152, P5581; WUCHERPFENNIG KW, 1995, CELL, V80, P695, DOI 10.1016/0092-8674(95)90348-8; WUCHERPFENNIG KW, 1994, J EXP MED, V179, P279, DOI 10.1084/jem.179.1.279; Yin YY, 2009, IMMUNITY, V31, P849, DOI 10.1016/j.immuni.2009.12.002; Zhao R, 1999, J EXP MED, V189, P359, DOI 10.1084/jem.189.2.359; Zhao YD, 2001, J IMMUNOL, V167, P2130, DOI 10.4049/jimmunol.167.4.2130	68	332	342	2	86	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAY 22	2014	157	5					1073	1087		10.1016/j.cell.2014.03.047	http://dx.doi.org/10.1016/j.cell.2014.03.047			15	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	AH9CG	24855945	Green Accepted, Bronze			2022-12-28	WOS:000336437200011
J	Lu, M; Zak, J; Chen, SO; Sanchez-Pulido, L; Severson, DT; Endicott, J; Ponting, CP; Schofield, CJ; Lu, X				Lu, Min; Zak, Jaroslav; Chen, Shuo; Sanchez-Pulido, Luis; Severson, David T.; Endicott, Jane; Ponting, Chris P.; Schofield, Christopher J.; Lu, Xin			A Code for RanGDP Binding in Ankyrin Repeats Defines a Nuclear Import Pathway	CELL			English	Article							CRYSTAL-STRUCTURE; TUMOR-SUPPRESSOR; TRANSPORT FACTOR; PROTEIN IMPORT; LOCALIZATION; P53; CELLS; ASPP1; INHIBITOR; APOPTOSIS	Regulation of nuclear import is fundamental to eukaryotic biology. The majority of nuclear import pathways are mediated by importin-cargo interactions. Yet not all nuclear proteins interact with importins, necessitating the identification of a general importin-independent nuclear import pathway. Here, we identify a code that determines importin-independent nuclear import of ankyrin repeats (ARs), a structural motif found in over 250 human proteins with diverse functions. AR-containing proteins (ARPs) with a hydrophobic residue at the 13th position of two consecutive ARs bind RanGDP efficiently, and consequently enter the nucleus. This code, experimentally tested in 17 ARPs, predicts the nuclear-cytoplasmic localization of over 150 annotated human ARPs with high accuracy and is acquired by the most common familial melanoma-associated CDKN2A mutation, leading to nuclear accumulation of mutant p16ink4a. The RaDAR (RanGDP/AR) pathway represents a general importin-independent nuclear import pathway and is frequently used by AR-containing transcriptional regulators, especially those regulating NF-kappa B/p53.	[Lu, Min; Zak, Jaroslav; Chen, Shuo; Severson, David T.; Lu, Xin] Univ Oxford, Nuffield Dept Clin Med, Ludwig Inst Canc Res, Oxford OX3 7DQ, England; [Sanchez-Pulido, Luis; Ponting, Chris P.] Univ Oxford, Dept Physiol Anat & Genet, MRC Funct Genom Unit, Oxford OX1 3PT, England; [Endicott, Jane] Univ Newcastle, Northern Inst Canc Res, Newcastle NE2 4HH, Tyne & Wear, England; [Schofield, Christopher J.] Univ Oxford, Dept Chem, Chem Res Lab, Oxford OX1 3TA, England	Ludwig Institute for Cancer Research; University of Oxford; University of Oxford; Newcastle University - UK; University of Oxford	Lu, X (corresponding author), Univ Oxford, Nuffield Dept Clin Med, Ludwig Inst Canc Res, Oxford OX3 7DQ, England.	xin.lu@ludwig.ox.ac.uk	lu, min/E-5407-2014; Ponting, Chris/AAV-2621-2021	Ponting, Chris/0000-0003-0202-7816; Zak, Jaroslav/0000-0002-8135-856X; Schofield, Christopher/0000-0002-0290-6565; lu, min/0000-0001-6902-3751; Sanchez Pulido, Luis/0000-0002-2300-8502; Endicott, Jane/0000-0003-4868-0116; Severson, David T/0000-0002-1750-8332; Lu, Xin/0000-0002-6587-1152	Ludwig Institute for Cancer Research Ltd.; Biotechnology and Biological Sciences Research Council [BB/L009846/1] Funding Source: researchfish; Medical Research Council [G0901526, MC_UU_12021/1, MC_U137761446] Funding Source: researchfish; BBSRC [BB/L009846/1] Funding Source: UKRI; MRC [MC_UU_12021/1, G0901526, MC_U137761446] Funding Source: UKRI	Ludwig Institute for Cancer Research Ltd.; Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was funded by the Ludwig Institute for Cancer Research Ltd. We thank Andrew Wilde, Katrien Van Impe, Paul Clarke, Svitlana Korolchuk, Ming Yang, Vann Bennett, Matthew Cockman, and Mark Hannink for the generous gift of plasmids or proteins. We thank Yvonne Jones for generous access to facilities for protein production. We thank Claire Beveridge and Kimberley Bryon-Dodd for critical reading of the manuscript.	Adams RL, 2013, CELL, V152, P1218, DOI 10.1016/j.cell.2013.02.042; Agrawal N, 2011, SCIENCE, V333, P1154, DOI 10.1126/science.1206923; Aylon Y, 2010, GENE DEV, V24, P2420, DOI 10.1101/gad.1954410; Bennett V, 2001, PHYSIOL REV, V81, P1353, DOI 10.1152/physrev.2001.81.3.1353; Bergamaschi D, 2004, MOL CELL BIOL, V24, P1341, DOI 10.1128/MCB.24.3.1341-1350.2004; Brameier M, 2007, BIOINFORMATICS, V23, P1159, DOI 10.1093/bioinformatics/btm066; Brooks CL, 2006, MOL CELL, V21, P307, DOI 10.1016/j.molcel.2006.01.020; Catimel B, 2001, J BIOL CHEM, V276, P34189, DOI 10.1074/jbc.M103531200; Chaillan-Huntington C, 2000, J BIOL CHEM, V275, P5874, DOI 10.1074/jbc.275.8.5874; Chen S, 2011, DEV CELL, V21, P848, DOI 10.1016/j.devcel.2011.09.007; Chook YM, 2011, BBA-MOL CELL RES, V1813, P1593, DOI 10.1016/j.bbamcr.2010.10.014; Cook A, 2007, ANNU REV BIOCHEM, V76, P647, DOI 10.1146/annurev.biochem.76.052705.161529; Deng L, 2000, CELL, V103, P351, DOI 10.1016/S0092-8674(00)00126-4; Dreier B, 2013, P NATL ACAD SCI USA, V110, pE869, DOI 10.1073/pnas.1213653110; Eber SW, 1996, NAT GENET, V13, P214, DOI 10.1038/ng0696-214; Fagotto F, 1998, CURR BIOL, V8, P181, DOI 10.1016/S0960-9822(98)70082-X; Ghiorzo P, 2004, HUM PATHOL, V35, P25, DOI 10.1016/j.humpath.2003.08.017; Goldstein AM, 2006, CANCER RES, V66, P9818, DOI 10.1158/0008-5472.CAN-06-0494; Gorlich D, 1999, ANNU REV CELL DEV BI, V15, P607, DOI 10.1146/annurev.cellbio.15.1.607; Kim S, 2013, BIOPHYS J, V105, P565, DOI 10.1016/j.bpj.2013.04.025; Kohl A, 2003, P NATL ACAD SCI USA, V100, P1700, DOI 10.1073/pnas.0337680100; Kose S, 2012, CELL, V149, P578, DOI 10.1016/j.cell.2012.02.058; Kutay U, 1997, CELL, V90, P1061, DOI 10.1016/S0092-8674(00)80372-4; Lee BJ, 2006, CELL, V126, P543, DOI 10.1016/j.cell.2006.05.049; Lu M, 2013, CANCER CELL, V23, P618, DOI 10.1016/j.ccr.2013.03.013; McConnell BB, 1999, MOL CELL BIOL, V19, P1981; MELCHIOR F, 1993, J CELL BIOL, V123, P1649, DOI 10.1083/jcb.123.6.1649; Michaely P, 2002, EMBO J, V21, P6387, DOI 10.1093/emboj/cdf651; Mohler PJ, 2003, NATURE, V421, P634, DOI 10.1038/nature01335; Mohr D, 2009, EMBO J, V28, P2541, DOI 10.1038/emboj.2009.200; Morrison J, 2003, J MOL BIOL, V333, P587, DOI 10.1016/j.jmb.2003.08.050; Notari M, 2011, P NATL ACAD SCI USA, V108, P16645, DOI 10.1073/pnas.1102292108; Ranganathan P, 2011, NAT REV CANCER, V11, P338, DOI 10.1038/nrc3035; Ribbeck K, 1998, EMBO J, V17, P6587, DOI 10.1093/emboj/17.22.6587; Rouleau M, 2010, NAT REV CANCER, V10, P293, DOI 10.1038/nrc2812; Sachdev S, 1998, MOL CELL BIOL, V18, P2524, DOI 10.1128/MCB.18.5.2524; Samuels-Lev Y, 2001, MOL CELL, V8, P781, DOI 10.1016/S1097-2765(01)00367-7; Sedgwick SG, 1999, TRENDS BIOCHEM SCI, V24, P311, DOI 10.1016/S0968-0004(99)01426-7; Slee EA, 2004, ONCOGENE, V23, P9007, DOI 10.1038/sj.onc.1208088; Sottocornola R, 2010, DEV CELL, V19, P126, DOI 10.1016/j.devcel.2010.06.003; Stewart M, 2007, NAT REV MOL CELL BIO, V8, P195, DOI 10.1038/nrm2114; Van Impe K, 2008, TRAFFIC, V9, P695, DOI 10.1111/j.1600-0854.2008.00720.x; Vigneron AM, 2010, GENE DEV, V24, P2430, DOI 10.1101/gad.1954310; Vives V, 2006, GENE DEV, V20, P1262, DOI 10.1101/gad.374006; Wang Y, 2013, CELL DEATH DIFFER, V20, P525, DOI 10.1038/cdd.2013.3; Yang JP, 1999, J BIOL CHEM, V274, P15662, DOI 10.1074/jbc.274.22.15662	46	50	51	2	35	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAY 22	2014	157	5					1130	1145		10.1016/j.cell.2014.05.006	http://dx.doi.org/10.1016/j.cell.2014.05.006			16	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	AH9CG	24855949	Bronze			2022-12-28	WOS:000336437200015
J	Shimizu, H; Woodcock, SA; Wilkin, MB; Trubenova, B; Monk, NAM; Baron, M				Shimizu, Hideyuki; Woodcock, Simon A.; Wilkin, Marian B.; Trubenova, Barbora; Monk, Nicholas A. M.; Baron, Martin			Compensatory Flux Changes within an Endocytic Trafficking Network Maintain Thermal Robustness of Notch Signaling	CELL			English	Article							OF-DELTEX GENE; DROSOPHILA-MELANOGASTER; ACTIVATION; RECEPTOR; PATHWAY; SUPPRESSOR; REGULATOR; REQUIRES; COMPLEX	Developmental signaling is remarkably robust to environmental variation, including temperature. For example, in ectothermic animals such as Drosophila, Notch signaling is maintained within functional limits across a wide temperature range. We combine experimental and computational approaches to show that temperature compensation of Notch signaling is achieved by an unexpected variety of endocytic-dependent routes to Notch activation which, when superimposed on ligand-induced activation, act as a robustness module. Thermal compensation arises through an altered balance of fluxes within competing trafficking routes, coupled with temperature-dependent ubiquitination of Notch. This flexible ensemble of trafficking routes supports Notch signaling at low temperature but can be switched to restrain Notch signaling at high temperature and thus compensates for the inherent temperature sensitivity of ligand-induced activation. The outcome is to extend the physiological range over which normal development can occur. Similar mechanisms may provide thermal robustness for other developmental signals.	[Shimizu, Hideyuki; Woodcock, Simon A.; Wilkin, Marian B.; Trubenova, Barbora; Baron, Martin] Univ Manchester, Fac Life Sci, Manchester M13 9PT, Lancs, England; [Monk, Nicholas A. M.] Univ Sheffield, Sch Math & Stat, Sheffield S3 7RH, S Yorkshire, England	University of Manchester; University of Sheffield	Baron, M (corresponding author), Univ Manchester, Fac Life Sci, Michael Smith Bldg,Oxford Rd, Manchester M13 9PT, Lancs, England.	mbaron@manchester.ac.uk	Trubenova, Barbora/GQB-4224-2022	Trubenova, Barbora/0000-0002-6873-2967; Love, Marian/0000-0003-2203-3551; Monk, Nick/0000-0002-5465-4857	Manchester Fly Facility; Biotechnology and Biological Sciences Research Council [H000976]; Wellcome Trust [087928]; BBSRC [BB/H000976/1, BB/E002285/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/H000976/1, BB/C503162/1, BB/E002285/1] Funding Source: researchfish	Manchester Fly Facility; Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Wellcome Trust(Wellcome TrustEuropean Commission); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	We thank Sarah Bray, Gunter Merdes, Spyros Artavanis-Tsakonas, Matthew Scott, Helmut Kramer, Suzanne Eaton, Stephen Brown, Michael Cornell, Bezhad Rowshanravan, David Hughes, the Bloomington Drosophila Stock Center (University of Indiana), and the Developmental Studies Hybridoma Bank (University of Iowa) for reagents, constructs, and fly lines, and the University of Sheffield RNAi Screening Facility, (Wellcome Trust-084757) for RNAi. We also acknowledge technical support from Deborah Ashworth, Sanjai Patel and the Manchester Fly Facility, and the Biotechnology and Biological Sciences Research Council (H000976) and Wellcome Trust (087928) for funding. We thank Shane Herbert for critical discussion. Research materials generated in this work are available on request.	Allgood AG, 2011, J MOL BIOL, V414, P243, DOI 10.1016/j.jmb.2011.09.050; Baron M, 2012, SEMIN CELL DEV BIOL, V23, P437, DOI 10.1016/j.semcdb.2012.01.008; Bishop SA, 1999, DEVELOPMENT, V126, P2993; Christian AE, 1997, J LIPID RES, V38, P2264; Cornell M, 1999, GENETICS, V152, P567; Di Guglielmo GM, 2003, NAT CELL BIOL, V5, P410, DOI 10.1038/ncb975; FEHON RG, 1990, CELL, V61, P523, DOI 10.1016/0092-8674(90)90534-L; Fortini ME, 2009, CURR OPIN GENET DEV, V19, P323, DOI 10.1016/j.gde.2009.04.005; Fostier M, 1998, GENETICS, V150, P1477; Frankel N, 2010, NATURE, V466, P490, DOI 10.1038/nature09158; Hori K, 2011, J CELL BIOL, V195, P1005, DOI 10.1083/jcb.201104146; Hortsch R, 2010, MOL BIOL CELL, V21, P778, DOI 10.1091/mbc.E09-01-0005; Katkere B, 2010, J IMMUNOL, V185, P5032, DOI 10.4049/jimmunol.1001653; Kitano H, 2004, NAT REV GENET, V5, P826, DOI 10.1038/nrg1471; Kopan R, 2009, CELL, V137, P216, DOI 10.1016/j.cell.2009.03.045; Levental I, 2010, BIOCHEMISTRY-US, V49, P6305, DOI 10.1021/bi100882y; Li X, 2009, CELL, V137, P273, DOI 10.1016/j.cell.2009.01.058; Lucchetta EM, 2005, NATURE, V434, P1134, DOI 10.1038/nature03509; Mazaleyrat SL, 2003, DEV BIOL, V255, P363, DOI 10.1016/S0012-1606(02)00086-6; Saj A, 2010, DEV CELL, V18, P862, DOI 10.1016/j.devcel.2010.03.013; Salvat C, 2004, J BIOL CHEM, V279, P18935, DOI 10.1074/jbc.M312201200; Schmid SL, 2013, NATURE, V499, P161, DOI 10.1038/nature12408; Schneider M, 2013, J CELL SCI, V126, P645, DOI 10.1242/jcs.116590; Sigismund S, 2008, DEV CELL, V15, P209, DOI 10.1016/j.devcel.2008.06.012; Venkatachalam K, 2013, AUTOPHAGY, V9, P98, DOI 10.4161/auto.22260; WADDINGTON CH, 1959, NATURE, V183, P1654, DOI 10.1038/1831654a0; Whiteman P, 2013, J BIOL CHEM, V288, P7305, DOI 10.1074/jbc.M112.428854; Wilkin M, 2008, DEV CELL, V15, P762, DOI 10.1016/j.devcel.2008.09.002; XU T, 1990, GENETICS, V126, P665; Zheng L, 2013, MOL BIOL CELL, V24, P297, DOI 10.1091/mbc.E12-02-0081	30	44	46	0	14	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAY 22	2014	157	5					1160	1174		10.1016/j.cell.2014.03.050	http://dx.doi.org/10.1016/j.cell.2014.03.050			15	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	AH9CG	24855951	hybrid, Green Published			2022-12-28	WOS:000336437200017
J	Dora, C; Haines, A; Balbus, J; Fletcher, E; Adair-Rohani, H; Alabaster, G; Hossain, R; de Onis, M; Branca, F; Neira, M				Dora, Carlos; Haines, Andy; Balbus, John; Fletcher, Elaine; Adair-Rohani, Heather; Alabaster, Graham; Hossain, Rifat; de Onis, Mercedes; Branca, Francesco; Neira, Maria			Indicators linking health and sustainability in the post-2015 development agenda	LANCET			English	Review							RED MEAT CONSUMPTION; CLIMATE-CHANGE; URBAN SPRAWL; RISK-FACTOR; BENEFITS; UNDERNUTRITION; EMISSIONS; DISEASE; TRAVEL	The UN-led discussion about the post-2015 sustainable development agenda provides an opportunity to develop indicators and targets that show the importance of health as a precondition for and an outcome of policies to promote sustainable development. Health as a precondition for development has received considerable attention in terms of achievement of health-related Millennium Development Goals (MDGs), addressing growing challenges of non-communicable diseases, and ensuring universal health coverage. Much less attention has been devoted to health as an outcome of sustainable development and to indicators that show both changes in exposure to health-related risks and progress towards environmental sustainability. We present a rationale and methods for the selection of health-related indicators to measure progress of post-2015 development goals in non-health sectors. The proposed indicators show the ancillary benefits to health and health equity (co-benefits) of sustainable development policies, particularly those to reduce greenhouse gas emissions and increase resilience to environmental change. We use illustrative examples from four thematic areas: cities, food and agriculture, energy, and water and sanitation. Embedding of a range of health-related indicators in the post-2015 goals can help to raise awareness of the probable health gains from sustainable development policies, thus making them more attractive to decision makers and more likely to be implemented than before.	[Dora, Carlos; Fletcher, Elaine; Adair-Rohani, Heather; Hossain, Rifat; Neira, Maria] WHO, Dept Publ Hlth & Environm, CH-1211 Geneva 27, Switzerland; [de Onis, Mercedes; Branca, Francesco] WHO, Dept Nutr Hlth & Dev, CH-1211 Geneva 27, Switzerland; [Haines, Andy] London Sch Hyg & Trop Med, Dept Social & Environm Hlth Res, London WC1, England; [Haines, Andy] London Sch Hyg & Trop Med, Dept Populat Hlth, London WC1, England; [Balbus, John] NIEHS, NIH, Durham, NC USA; [Alabaster, Graham] UN Human Settlements Programme, Urban Basic Serv Branch, Nairobi, Kenya	World Health Organization; World Health Organization; University of London; London School of Hygiene & Tropical Medicine; University of London; London School of Hygiene & Tropical Medicine; National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS)	Dora, C (corresponding author), WHO, Dept Publ Hlth & Environm, 20 Ave Appia, CH-1211 Geneva 27, Switzerland.	dorac@who.int	Adair-Rohani, Heather/GXN-2766-2022	Haines, Andy/0000-0002-8053-4605	USA National Institute of Environmental Health Sciences (NIEHS)	USA National Institute of Environmental Health Sciences (NIEHS)	For contributions to the discussions that informed this paper, we thank participants of the June, 2012, workshop Health Indicators of Sustainable Development, hosted by the WHO and funded partly by the USA National Institute of Environmental Health Sciences (NIEHS). We also thank contributors to the scoping reviews of the WHO's Health in a Green Economy series, funded partly by a contribution from the UK of UK's Department for International Development (DFID). We also thankfully acknowledge the work of Jamie Hosking and Nathalie Roebbel, as lead authors of reports on transport and on housing respectively, part of the WHO Health in Green Economy series that outline linkages between health and climate change mitigation policies proposed by the Intergovernmental Panel on Climate Change (IPCC) in their fourth assessment report in certain sectors of the economy. We thank Nana L Wenz for technical assistance with the preparation of this paper. We thank Tara Garnett for advice and comment on the food and agriculture section.	AbouZahr C, 2005, B WORLD HEALTH ORGAN, V83, P578; Adair-Rohani H, 2013, GLOB HEALTH-SCI PRAC, V1, P249, DOI 10.9745/GHSP-D-13-00037; [Anonymous], 2012, Wkly Epidemiol Rec, V87, P1; [Anonymous], AIR POLL EST SUMM RE; [Anonymous], 2013, SUPP POL PROC HELP S; [Anonymous], EXP GROUP M SLUM ID; [Anonymous], 2011, NEAR TERM CLIMATE PR; [Anonymous], 2009, ENERGY ACCESS SITUAT; [Anonymous], 2013, GLOB DAT CHILD GROWT; [Anonymous], 2012, UN C SUST DEV; [Anonymous], STANDARD TESTING 201; [Anonymous], HLTH IMP ASS HLTH IN; [Anonymous], CLIM CLEAN AIR COAL; [Anonymous], ACT AG SUST DEV; [Anonymous], STAT FOOD AGR; [Anonymous], INP POST 2015 UN DEV; [Anonymous], NONC DIS MENT HLTH; [Anonymous], HLTH POST 2015 AG; [Anonymous], 2011, MILL DEV GOALS REP; [Anonymous], 2011, HLTH GREEN EC HLTH C; [Anonymous], WHO IND AIR IN PRESS; [Anonymous], TST ISS BRIEF FOOD S; [Anonymous], STEPWISE APPR SURV S; [Anonymous], LIF LONG SHAD ENV IS; [Anonymous], 2012, REPORT SECRETARY GEN; [Anonymous], HLTH EFFECTS BLACK C; [Anonymous], CME INF; [Anonymous], IND 7 10 PROP URB PO; [Anonymous], 2011, HLTH GREEN EC HLTH C; [Anonymous], MDG1 ER EXTR POV HUN; [Anonymous], GLOB HOUS EN DAT; [Anonymous], EXPL HLTH CAN BEN LO; [Anonymous], 2009, STAT FOOD AGR LIV BA; [Anonymous], 2003, DIET NUTR PREV CHRON; [Anonymous], 3 SESS OP WORK GROUP; [Anonymous], TURN DOWN THE HEAT; [Anonymous], OFF UN SIT MDG IND; [Anonymous], 2001, MILLENNIUM CITIES DA; [Anonymous], 2011, BETTER STREETS BETTE; [Anonymous], GREEN LOGISTICS IMPR; [Anonymous], PRIV VOL FOOD SEC RE; [Anonymous], SECR GEN ZER HUNG CH; [Anonymous], 2011, INTEGRATED ASSESSMEN; [Anonymous], 2012, WORK TIME ANAL ANM A; [Anonymous], REP 2 CONS POST 2015; [Anonymous], HLTH ENV MANAGING LI; [Anonymous], TRACK PROGR; [Anonymous], IWA 11 2012 GUID EV; [Anonymous], 2014, POST 2015 GLOB GOAL; [Anonymous], AMB AIR POLL; [Anonymous], GLOBAL REPORT HUMAN; [Anonymous], 2011, BIOD FOOD AGR CONTR; [Anonymous], IND MON IMPL COMPR I; [Anonymous], WAT QUAL MON; [Anonymous], REP SECR GEN HIGH LE; [Anonymous], GLOB AN ASS SAN DRIN; [Anonymous], 2010, GLAAS 2010 UN WAT GL; [Anonymous], 2012, RENEWABLE ENERGY SOU; [Anonymous], HUM RIGHT WAT SAN RE; Black RE, 2008, LANCET, V371, P243, DOI 10.1016/S0140-6736(07)61690-0; Campbell-Lendrum D, 2007, J URBAN HEALTH, V84, pI109, DOI 10.1007/s11524-007-9170-x; Child Trends, 2018, IMMIGRANT CHILDREN; Corvalan C, 2005, ECOSYSTEMS HUMAN WEL; de Onis M, 2013, MATERN CHILD NUTR, V9, P6, DOI 10.1111/mcn.12075; Edwards P, 2009, INT J EPIDEMIOL, V38, P1137, DOI 10.1093/ije/dyp172; Ewing R, 2003, AM J PUBLIC HEALTH, V93, P1541, DOI 10.2105/AJPH.93.9.1541; Ewing R, 2003, AM J HEALTH PROMOT, V18, P47, DOI 10.4278/0890-1171-18.1.47; Finucane MM, 2011, LANCET, V377, P557, DOI 10.1016/S0140-6736(10)62037-5; Friel S, 2009, LANCET, V374, P2016, DOI 10.1016/S0140-6736(09)61753-0; Grabow ML, 2012, ENVIRON HEALTH PERSP, V120, P68, DOI 10.1289/ehp.1103440; Haines A, 2013, J URBAN HEALTH, V90, P810, DOI 10.1007/s11524-012-9773-8; Haines A, 2012, LANCET, V379, P2189, DOI 10.1016/S0140-6736(12)60779-X; Haines A, 2009, LANCET, V374, P2104, DOI 10.1016/S0140-6736(09)61759-1; Hooper L, 2011, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD011834, 10.1002/14651858.CD002137.pub2]; Howard G, 2010, VISION 2030 RESILIEN; Hu FB, 2001, J AM COLL NUTR, V20, P5, DOI 10.1080/07315724.2001.10719008; Jarrett J, 2012, LANCET, V379, P2198, DOI 10.1016/S0140-6736(12)60766-1; Jensen HT, 2013, CLIMATIC CHANGE, V121, P223, DOI 10.1007/s10584-013-0881-6; Jones AD, 2014, FOOD POLICY, V46, P1, DOI 10.1016/j.foodpol.2014.02.001; Lam NL, 2012, ENVIRON SCI TECHNOL, V46, P13531, DOI 10.1021/es302697h; Lim SS, 2012, LANCET, V380, P2224, DOI 10.1016/S0140-6736(12)61766-8; Lloyd SJ, 2011, ENVIRON HEALTH PERSP, V119, P1817, DOI 10.1289/ehp.1003311; Markandya A, 2009, LANCET, V374, P2006, DOI 10.1016/S0140-6736(09)61715-3; Mila i Canals L, 2007, ENVIRON SCI POLLUT R, V14, P338, DOI 10.1065/espr2007.04.412; Norat T, 2002, INT J CANCER, V98, P241, DOI 10.1002/ijc.10126; Organization WH, 2009, GLOB HLTH RISKS MORT; Pan A, 2013, JAMA INTERN MED, V173, P1328, DOI 10.1001/jamainternmed.2013.6633; Pan A, 2012, ARCH INTERN MED, V172, P555, DOI 10.1001/archinternmed.2011.2287; Pruss-Ustun A., 2006, WORLD HEALTH; Rockstrom J, 2009, NATURE, V461, P472, DOI 10.1038/461472a; Ruel MT, 2013, LANCET, V382, P536, DOI 10.1016/S0140-6736(13)60843-0; Sims REH, 2007, AR4 CLIMATE CHANGE 2007: MITIGATION OF CLIMATE CHANGE, P251; Sinha R, 2009, ARCH INTERN MED, V169, P562, DOI 10.1001/archinternmed.2009.6; Stone B, 2010, ENVIRON HEALTH PERSP, V118, P1425, DOI 10.1289/ehp.0901879; Straif K., 2013, IARC SCI PUBLICATION, V161; Unger N, 2010, P NATL ACAD SCI USA, V107, P3382, DOI 10.1073/pnas.0906548107; United Nations, 2013, MILL DEV GOALS REP; United Nations, 2013, NEW GLOB PARTN ER PO; Victora CG, 2008, LANCET, V371, P340, DOI 10.1016/S0140-6736(07)61692-4; WHO, 2012, GLOBAL TUBERCULOSIS REPORT 2012, P1; WHO, 2011, P WORLD C SOC DET HL; WHO, 2011, GUID DRINK WAT QUAL; WHO/UNICEF, 2014, PROGR DRINK WAT SAN; Wilkinson P, 2009, LANCET, V374, P1917, DOI 10.1016/S0140-6736(09)61713-X; Woodcock J, 2009, LANCET, V374, P1930, DOI 10.1016/S0140-6736(09)61714-1; World Cancer Research Fund & American Institute for Cancer Research, 2007, FOOD NUTR PHYS ACT P; World Health Organisation, 2010, HIDD CIT UNM OV HLTH; World Health Organization, 2008, The global burden of disease: 2004 update; World Health Organization, 2021, OB OV FACT SHEETS; World Health Organization, 2013, GLOB STAT REP ROAD S; World Health Organization, 2006, GLOB STRAT DIET PHYS; World Health Organization, 2006, AIR QUAL GUID GLOB U; World Health Organization and World Meteorological Organization, 2012, ATL HLTH CLIM; World Health Organization (WHO), 2013, REV EV HLTH ASP AIR	114	74	79	2	74	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JAN 24	2015	385	9965					380	391		10.1016/S0140-6736(14)60605-X	http://dx.doi.org/10.1016/S0140-6736(14)60605-X			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AZ9CN	24923529				2022-12-28	WOS:000348509000031
J	McAllister, L; Anderson, J; Werth, K; Cho, I; Copeland, K; Bouveret, NL; Plant, D; Mendelman, PM; Cobb, DK				McAllister, Linda; Anderson, Jonathan; Werth, Kristen; Cho, Iksung; Copeland, Karen; Bouveret, Nancy Le Cam; Plant, David; Mendelman, Paul M.; Cobb, David K.			Needle-free jet injection for administration of influenza vaccine: a randomised non-inferiority trial	LANCET			English	Article							IMMUNOGENICITY; SAFETY; PREVALENCE; SYRINGE; ADULTS; YOUNG; FEAR	Background Administration of vaccines by needle-free technology such as jet injection might off er an alternative to needles and syringes that avoids the issue of needle phobia and the risk of needle-stick injury. We aimed to assess the immunogenicity and safety of trivalent influenza vaccine given by needle-free jet injector compared with needle and syringe. Methods For this randomised, comparator-controlled trial, we randomly assigned (1:1) healthy adults (aged 18-64 years) who attended one of four employee health clinics in the University of Colorado health system, with stratification by site, to receive one dose of the trivalent inactivated influenza vaccine Afluria given either intramuscularly with a needle-free jet injector (Stratis; PharmaJet, Golden, CO, USA) or with needle and syringe. Randomisation was done with a computer-generated randomisation schedule with a block size of 100. Because of the nature of the study, masking of participants was not possible. Immunogenicity was assessed by measurement of the hemagglutination inhibition antibody titres in serum for the three viral strains included in the vaccine. We included six coprimary endpoints: three strain-specific geometric mean titre ratios and the absolute differences in three strain-specific seroconversion rates. The immune response of the jet injector group was regarded as non-inferior to that of the needle and syringe group if both the upper bound of each of the three 95% CIs for the strain-specific geometric mean titre ratios was 1.5 or less, and the upper bound of the three 95% CIs for the strain-specific seroconversion rate differences was less than 10 percentage points. We used t test for group comparison. This study is registered with ClinicalTrials.gov, number NCT01688921. Findings During the 2012-13 influenza season of the northern hemisphere, we allocated 1250 participants to receive vaccination by needle-free jet injector (n=627) or needle and syringe (n=623). In the intention-to-treat immunogenicity population, all participants with two serum samples were included (575 in the jet injector group and 574 in the needle and syringe group). The immune response to Afluria when given by needle-free jet injector met the criteria for non-inferiority for all six coprimary endpoints. The jet injector group met the geometric mean titre criterion for non-inferiority for the A/H1N1, A/H3N2, and B strains (upper bound of the 95% CI for the geometric mean titre ratios were 1.10 for A/H1N1, 1.17 for A/H3N2, and 1.04 for B strains). The jet injector group met the seroconversion rate criterion for non-inferiority for the A/H1N1, A/H3N2, and B strains (upper bound of the 95% CI of the seroconversion rate differences were 6.0% for A/H1N1, 7.0% for A/H3N2, and 5.7% for B strains). We recorded serious adverse events in three participants, none of which were study related. Interpretation The immune response to influenza vaccine given with the jet injector device was non-inferior to the immune response to influenza vaccine given with needle and syringe. The device had a clinically acceptable safety profile, but was associated with a higher frequency of local injection site reactions than was the use of needle and syringe. The Stratis needle-free jet injector device could be used as an alternative method of administration of Afluria trivalent influenza vaccine.	[McAllister, Linda; Werth, Kristen; Cho, Iksung] PharmaJet, Golden, CO 80401 USA; [Anderson, Jonathan; Bouveret, Nancy Le Cam; Plant, David] BioCSL, Parkville, Vic, Australia; [Copeland, Karen] Boulder Stat, Boulder, CO USA; [Cobb, David K.] Med Ctr Rockies, Loveland, CO USA		McAllister, L (corresponding author), PharmaJet, Golden, CO 80401 USA.	linda.mcallister@pharmajet.com		Anderson, Jonathan/0000-0002-7316-428X	Biomedical Advanced Research and Development Authority (BARDA); PATH; bioCSL; PharmaJet	Biomedical Advanced Research and Development Authority (BARDA); PATH; bioCSL; PharmaJet	Funding Biomedical Advanced Research and Development Authority (BARDA), PATH, bioCSL, and PharmaJet.	American Nurses Association, 2002, AM NURS ASS NEEDL PR; Atkinson William L, 2002, MMWR Recomm Rep, V51, P1; Beyer WEP, 2004, VIRUS RES, V103, P125, DOI 10.1016/j.virusres.2004.02.024; Beyer WEP, 1996, VACCINE, V14, P1331, DOI 10.1016/S0264-410X(96)00058-8; BioCSL, 2013, AFL INFL VACC STN BL; CANTER J, 1990, ARCH INTERN MED, V150, P1923, DOI 10.1001/archinte.150.9.1923; Committee for Proprietary MedicinalProducts, 1997, CPMPBWP21496; duChatelet IP, 1997, VACCINE, V15, P449, DOI 10.1016/S0264-410X(96)00173-9; FDA, 2011, FDA UPD COMM US JET; FDA, 2007, GUID IND CLIN DAT NE; Giudice EL, 2006, ADV DRUG DELIVER REV, V58, P68, DOI 10.1016/j.addr.2005.12.003; Kroger Andrew T., 2011, Morbidity and Mortality Weekly Report, V60, P3; HINGSON RA, 1963, MIL MED, V128, P525, DOI 10.1093/milmed/128.6.525; Jackson LA, 2001, VACCINE, V19, P4703, DOI 10.1016/S0264-410X(01)00225-0; Kennedy ED, 2013, INFLUENZA VACCINATIO; Kieninger D, 2013, BMC INFECT DIS, V13, DOI 10.1186/1471-2334-13-343; Konietschke F, 2010, CRC BIOSTATISTICS SE; Levine MM, 2003, NAT MED, V9, P99, DOI 10.1038/nm0103-99; Lloyd J., 2000, TECHNOLOGIES VACCINE; Mazurek Gerald H., 2010, Morbidity and Mortality Weekly Report, V59, P1; Newcombe RG, 1998, STAT MED, V17, P873, DOI 10.1002/(SICI)1097-0258(19980430)17:8<873::AID-SIM779>3.0.CO;2-I; Nir Y, 2003, AM J TROP MED HYG, V68, P341, DOI 10.4269/ajtmh.2003.68.341; Pruss-Ustun A, 2005, AM J IND MED, V48, P482, DOI 10.1002/ajim.20230; Sasaki S, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002975; Simon JK, 2011, VACCINE, V29, P9544, DOI 10.1016/j.vaccine.2011.09.097; STEINGLASS R, 1995, B WORLD HEALTH ORGAN, V73, P57; Taddio A, 2012, VACCINE, V30, P4807, DOI 10.1016/j.vaccine.2012.05.011; Weniger B.G., 2012, VACCINES, P1200; Weniger BG, 2006, NEEDLE FREE INJECTIO; Wright S, 2009, AUST FAM PHYSICIAN, V38, P172	30	48	49	0	39	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	AUG 23	2014	384	9944					674	681		10.1016/S0140-6736(14)60524-9	http://dx.doi.org/10.1016/S0140-6736(14)60524-9			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AO5CJ	24881803				2022-12-28	WOS:000341359100025
J	Hovenden, MJ; Newton, PCD; Wills, KE				Hovenden, Mark J.; Newton, Paul C. D.; Wills, Karen E.			Seasonal not annual rainfall determines grassland biomass response to carbon dioxide	NATURE			English	Article							ELEVATED CO2; CLIMATE-CHANGE; NITROGEN INTERACTIONS; WATER RELATIONS; ECOSYSTEMS; PRODUCTIVITY; LIMITATION; RANGELANDS; LESSONS; TRENDS	The rising atmospheric concentration of carbon dioxide (CO2) should stimulate ecosystem productivity, but to what extent is highly uncertain, particularly when combined with changing temperature and precipitation(1). Ecosystem response to CO2 is complicated by biogeochemical feedbacks(2) but must be understood if carbon storage and associated dampening of climate warming are to be predicted(3). Feedbacks through the hydrological cycle are particularly important(4) and the physiology is well known; elevated CO2 reduces stomatal conductance and increases plant water use efficiency (the amount of water required to produce a unit of plant dry matter)(5). The CO2 response should consequently be strongest when water is limiting(6); although this has been shown in some experiments(7), it is absent frommany(8-11). Here we show that large annual variation in the stimulation of above-ground biomass by elevated CO2 in a mixed C-3/C-4 temperate grassland can be predicted accurately using seasonal rainfall totals; summer rainfall had a positive effect but autumn and spring rainfall had negative effects on the CO2 response. Thus, the elevated CO2 effect mainly depended upon the balance between summer and autumn/spring rainfall. This is partly because high rainfall during cool, moist seasons leads to nitrogen limitation, reducing or even preventing biomass stimulation by elevated CO2. Importantly, the prediction held whether plots were warmed by 2 degrees C or left unwarmed, and was similar for C-3 plants and total biomass, allowing us to make a powerful generalization about ecosystem responses to elevated CO2. This new insight is particularly valuable because climate projections predict large changes in the timing of rainfall, even where annual totals remain static(12). Our findings will help resolve apparent differences in the outcomes of CO2 experiments and improve the formulation and interpretation of models that are insensitive to differences in the seasonal effects of rainfall on the CO2 response(7,13,14).	[Hovenden, Mark J.; Wills, Karen E.] Univ Tasmania, Sch Biol Sci, Hobart, Tas 7001, Australia; [Newton, Paul C. D.] AgResearch, Land & Environm Management, Palmerston North 4474, New Zealand	University of Tasmania; AgResearch - New Zealand	Hovenden, MJ (corresponding author), Univ Tasmania, Sch Biol Sci, Hobart, Tas 7001, Australia.	Mark.Hovenden@utas.edu.au	Wills, Karen/M-2652-2019; Wills, Karen E/H-4390-2012; Hovenden, Mark/A-1323-2008	Wills, Karen/0000-0003-3897-2908; Wills, Karen E/0000-0003-3897-2908; Hovenden, Mark/0000-0001-7208-9700	Australian Research Council	Australian Research Council(Australian Research Council)	This work was supported by grants from the Australian Research Council Discovery Projects scheme. We thank the Australian Department of Defence for access to the Pontville Small Arms Range Complex. J. Vander Schoor, A. Williams, J. Janes, J. Buettel and M. Porter provided technical assistance. R. Mallett assisted with statistical analyses and L. Barmuta provided advice on multimodel inference.	Borken W, 2009, GLOBAL CHANGE BIOL, V15, P808, DOI 10.1111/j.1365-2486.2008.01681.x; Burnham K.P., 2002, MODEL SELECTION MULT, VSecond edition; De Kauwe MG, 2013, GLOBAL CHANGE BIOL, V19, P1759, DOI 10.1111/gcb.12164; Derner JD, 2003, GLOBAL CHANGE BIOL, V9, P452, DOI 10.1046/j.1365-2486.2003.00579.x; Dukes JS, 2005, PLOS BIOL, V3, P1829, DOI 10.1371/journal.pbio.0030319; Grunzweig JM, 2001, OECOLOGIA, V128, P251, DOI 10.1007/s004420100657; Hovenden MJ, 2006, AUST J BOT, V54, P1, DOI 10.1071/BT04194; K/rner C., 2007, TERRESTRIAL ECOSYSTE, P9, DOI [10.1007/978-3-540-32730-1_2, DOI 10.1007/978-3-540-32730-1_2]; Knapp AK, 2001, ECOSYSTEMS, V4, P19, DOI 10.1007/s100210000057; Le Quere C, 2009, NAT GEOSCI, V2, P831, DOI 10.1038/ngeo689; Leakey ADB, 2009, J EXP BOT, V60, P2859, DOI 10.1093/jxb/erp096; Leuzinger S, 2010, GLOBAL CHANGE BIOL, V16, P246, DOI 10.1111/j.1365-2486.2009.01937.x; Marissink M, 2002, AGR ECOSYST ENVIRON, V93, P107, DOI 10.1016/S0167-8809(01)00356-5; Matthews HD, 2007, GLOBAL CHANGE BIOL, V13, P1068, DOI 10.1111/j.1365-2486.2007.01343.x; McMurtrie RE, 2008, FUNCT PLANT BIOL, V35, P521, DOI 10.1071/FP08128; Morgan JA, 2004, OECOLOGIA, V140, P11, DOI 10.1007/s00442-004-1550-2; Morgan JA, 2004, ECOL APPL, V14, P208, DOI 10.1890/02-5213; Morgan JA, 2011, NATURE, V476, P202, DOI 10.1038/nature10274; Norby RJ, 2011, ANNU REV ECOL EVOL S, V42, P181, DOI 10.1146/annurev-ecolsys-102209-144647; Nowak RS, 2004, NEW PHYTOL, V162, P253, DOI 10.1111/j.1469-8137.2004.01033.x; Osanai Y, 2012, PLANT SOIL, V350, P365, DOI 10.1007/s11104-011-0920-x; Peters GP, 2013, NAT CLIM CHANGE, V3, P4, DOI 10.1038/nclimate1783; Piao SL, 2013, GLOBAL CHANGE BIOL, V19, P2117, DOI 10.1111/gcb.12187; Polley HW, 2013, RANGELAND ECOL MANAG, V66, P493, DOI 10.2111/REM-D-12-00068.1; Quinn GP, 2003, EXPT DESIGN DATA ANA; R DEVELOPMENT CORE TEAM, 2011, R LANG ENV STAT COMP; Reich PB, 2006, NATURE, V440, P922, DOI 10.1038/nature04486; Reich PB, 2006, ANNU REV ECOL EVOL S, V37, P611, DOI 10.1146/annurev.ecolsys.37.091305.110039; Reich PB, 2013, NAT CLIM CHANGE, V3, P278, DOI [10.1038/nclimate1694, 10.1038/NCLIMATE1694]; Singh D, 2013, J GEOPHYS RES-ATMOS, V118, P7063, DOI 10.1002/jgrd.50543; Sokolov AP, 2008, J CLIMATE, V21, P3776, DOI 10.1175/2008JCLI2038.1; Solomon S., 2007, PHYS SCI BASIS WORKI; Soussana JF, 2007, GRASS FORAGE SCI, V62, P127, DOI 10.1111/j.1365-2494.2007.00577.x; Webb NP, 2012, CLIMATIC CHANGE, V112, P925, DOI 10.1007/s10584-011-0236-0	34	107	115	8	226	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 30	2014	511	7511					583	+		10.1038/nature13281	http://dx.doi.org/10.1038/nature13281			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM0VT	24870242				2022-12-28	WOS:000339566300033
J	Vachieri, SG; Xiong, XL; Collins, PJ; Walker, PA; Martin, SR; Haire, LF; Zhang, Y; McCauley, JW; Gamblin, SJ; Skehel, JJ				Vachieri, Sebastien G.; Xiong, Xiaoli; Collins, Patrick J.; Walker, Philip A.; Martin, Stephen R.; Haire, Lesley F.; Zhang, Ying; McCauley, John W.; Gamblin, Steven J.; Skehel, John J.			Receptor binding by H10 influenza viruses	NATURE			English	Article							A VIRUS; HEMAGGLUTININ; H5; SPECIFICITY; COMPLEXES; EPITHELIUM; EVOLUTION; SELECTION; CELL; H7	H10N8 follows H7N9 and H5N1 as the latest in a line of avian influenza viruses that cause serious disease in humans and have become a threat to public health(1). Since December 2013, three human cases of H10N8 infection have been reported, two of whom are known to have died. To gather evidence relating to the epidemic potential of H10 we have determined the structure of the haemagglutinin of a previously isolated avian H10 virus and we present here results relating especially to its receptor-binding properties, as these are likely to be major determinants of virus transmissibility. Our results show, first, that the H10 virus possesses high avidity for human receptors and second, from the crystal structure of the complex formed by avian H10 haemagglutinin with human receptor, it is clear that the conformation of the bound receptor has characteristics of both the 1918 H1N1 pandemic virus(2) and the human H7 viruses isolated from patients in 2013 (ref. 3). We conclude that avian H10N8 virus has sufficient avidity for human receptors to account for its infection of humans but that its preference for avian receptors should make avian receptor-rich human airway mucins(4) an effective block to widespread infection. In terms of surveillance, particular attention will be paid to the detection of mutations in the receptor-binding site of the H10 haemagglutinin that decrease its avidity for avian receptor, and could enable it to be more readily transmitted between humans.	[Vachieri, Sebastien G.; Xiong, Xiaoli; Collins, Patrick J.; Walker, Philip A.; Martin, Stephen R.; Haire, Lesley F.; Zhang, Ying; McCauley, John W.; Gamblin, Steven J.; Skehel, John J.] MRC Natl Inst Med Res, London NW7 1AA, England	MRC National Institute for Medical Research	Gamblin, SJ (corresponding author), MRC Natl Inst Med Res, Mill Hill, London NW7 1AA, England.	sgambli@nimr.mrc.ac.uk; skeheljj@nimr.mrc.ac.uk		Gamblin, Steve/0000-0001-5331-639X; Xiong, Xiaoli/0000-0002-4632-9122	Medical Research Council [U117584222, U117570592, U117585868]; Medical Research Council [MC_U117512723, G0600522, MC_U117585868] Funding Source: researchfish; MRC [MC_U117585868, MC_U117512723, G0600522] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	We thank N. Bovin for gifts of sulphated sialoside. We greatly acknowledge Diamond Light Source for access to synchrotron time under proposal 7707. This work was funded by the Medical Research Council through programmes U117584222, U117570592 and U117585868.	Chen H., 2014, LANCET; Eisen MB, 1997, VIROLOGY, V232, P19, DOI 10.1006/viro.1997.8526; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Gambaryan AS, 2008, VIROL J, V5, DOI 10.1186/1743-422X-5-85; Gamblin SJ, 2004, SCIENCE, V303, P1838, DOI 10.1126/science.1093155; Ha Y, 2003, VIROLOGY, V309, P209, DOI 10.1016/S0042-6822(03)00068-0; Ha Y, 2001, P NATL ACAD SCI USA, V98, P11181, DOI 10.1073/pnas.201401198; Keawcharoen J, 2010, VACCINE, V28, P5803, DOI 10.1016/j.vaccine.2010.06.072; Lin YP, 2012, P NATL ACAD SCI USA, V109, P21474, DOI 10.1073/pnas.1218841110; Liu JF, 2009, P NATL ACAD SCI USA, V106, P17175, DOI 10.1073/pnas.0906849106; Matrosovich M, 2000, J VIROL, V74, P8502, DOI 10.1128/JVI.74.18.8502-8512.2000; Matrosovich M, 2007, VIROLOGY, V361, P384, DOI 10.1016/j.virol.2006.11.030; McCoy AJ, 2007, ACTA CRYSTALLOGR D, V63, P32, DOI 10.1107/S0907444906045975; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; NELSON J, 1993, VIRUS RES, V29, P155, DOI 10.1016/0168-1702(93)90056-S; Otwinowski Z., 1993, P CCP4 STUDY WEEKEND, P556; Reid AH, 1999, P NATL ACAD SCI USA, V96, P1651, DOI 10.1073/pnas.96.4.1651; ROGERS GN, 1985, J BIOL CHEM, V260, P7362; Russell RJ, 2004, VIROLOGY, V325, P287, DOI 10.1016/j.virol.2004.04.040; Shi Y, 2013, SCIENCE, V342, P243, DOI 10.1126/science.1242917; SKEHEL JJ, 1971, VIROLOGY, V44, P396, DOI 10.1016/0042-6822(71)90270-4; Xiong X, 2013, VIRUS RES, V178, P12, DOI 10.1016/j.virusres.2013.08.007; Xiong XL, 2013, NATURE, V499, P496, DOI 10.1038/nature12372; Xiong XL, 2013, NATURE, V497, P392, DOI 10.1038/nature12144; Xu R, 2012, J VIROL, V86, P982, DOI 10.1128/JVI.06322-11; Xu R, 2011, J VIROL, V85, P5172, DOI 10.1128/JVI.02430-10; Zhang W, 2013, SCIENCE, V340, P1463, DOI 10.1126/science.1236787	27	62	65	0	35	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 24	2014	511	7510					475	+		10.1038/nature13443	http://dx.doi.org/10.1038/nature13443			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AL7SO	24870229				2022-12-28	WOS:000339335700048
J	Memish, ZA; Zumla, A; Alhakeem, RF; Assiri, A; Turkestani, A; Al Harby, KD; Alyemni, M; Dhafar, K; Gautret, P; Barbeschi, M; McCloskey, B; Heymann, D; Al Rabeeah, AA; Al-Tawfiq, JA				Memish, Ziad A.; Zumla, Alimuddin; Alhakeem, Rafat F.; Assiri, Abdullah; Turkestani, Abdulhafeez; Al Harby, Khalid D.; Alyemni, Mohamed; Dhafar, Khalid; Gautret, Philippe; Barbeschi, Maurizio; McCloskey, Brian; Heymann, David; Al Rabeeah, Abdullah A.; Al-Tawfiq, Jaffar A.			Hajj: infectious disease surveillance and control	LANCET			English	Article							RESPIRATORY SYNDROME CORONAVIRUS; MASS GATHERINGS; SAUDI-ARABIA; TUBERCULOSIS INFECTION; MENINGOCOCCAL DISEASE; IRANIAN PILGRIMS; SEROGROUP W135; PANDEMIC H1N1; OUTBREAK; PREVENTION	Religious festivals attract a large number of pilgrims from worldwide and are a potential risk for the transmission of infectious diseases between pilgrims, and to the indigenous population. The gathering of a large number of pilgrims could compromise the health system of the host country. The threat to global health security posed by infectious diseases with epidemic potential shows the importance of advanced planning of public health surveillance and response at these religious events. Saudi Arabia has extensive experience of providing health care at mass gatherings acquired through decades of managing millions of pilgrims at the Hajj. In this report, we describe the extensive public health planning, surveillance systems used to monitor public health risks, and health services provided and accessed during Hajj 2012 and Hajj 2013 that together attracted more than 5 million pilgrims from 184 countries. We also describe the recent establishment of the Global Center for Mass Gathering Medicine, a Saudi Government partnership with the WHO Collaborating Centre for Mass Gatherings Medicine, Gulf Co-operation Council states, UK universities, and public health institutions globally.	[Memish, Ziad A.; Zumla, Alimuddin; Alhakeem, Rafat F.; Barbeschi, Maurizio; McCloskey, Brian; Heymann, David; Al-Tawfiq, Jaffar A.] Minist Hlth, Global Ctr Mass Gathering Med, Riyadh 11176, Saudi Arabia; [Memish, Ziad A.] WHO Collaborating Ctr Mass Gatherings Med, Riyadh, Saudi Arabia; [Memish, Ziad A.] Al Faisal Univ, Riyadh, Saudi Arabia; [Memish, Ziad A.; Alhakeem, Rafat F.; Assiri, Abdullah; Turkestani, Abdulhafeez; Al Harby, Khalid D.; Alyemni, Mohamed; Dhafar, Khalid; Al Rabeeah, Abdullah A.] Minist Hlth, Riyadh 11176, Saudi Arabia; [Zumla, Alimuddin] UCL, Div Infect & Immun, London, England; [Zumla, Alimuddin] Univ Coll London Hosp NHS Fdn Trust, London, England; [Gautret, Philippe] Aix Marseille Univ, Unite Rech Malad Infect & Trop Emergentes, INSERM, Marseille, France; [Gautret, Philippe] Inst Hosp Univ Mediterranee Infect, Marseille, France; [Barbeschi, Maurizio] WHO, CH-1211 Geneva, Switzerland; [McCloskey, Brian] WHO Collaborating Ctr Mass Gatherings & High Visi, Geneva, Switzerland; [Heymann, David] Chatham House, London, England; [Heymann, David] London Sch Hyg & Trop Med, London WC1, England; [Al-Tawfiq, Jaffar A.] Saudi Aramco Med Serv Org, Dhahran, Saudi Arabia; [Al-Tawfiq, Jaffar A.] Indiana Univ Sch Med, Indianapolis, IN 46202 USA	Alfaisal University; Ministry of Health - Saudi Arabia; University of London; University College London; University College London Hospitals NHS Foundation Trust; University of London; University College London; UDICE-French Research Universities; Aix-Marseille Universite; Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); Institut de Recherche pour le Developpement (IRD); UDICE-French Research Universities; Aix-Marseille Universite; World Health Organization; University of London; London School of Hygiene & Tropical Medicine; Saudi Aramco; Indiana University System; Indiana University Bloomington	Memish, ZA (corresponding author), Minist Hlth, Global Ctr Mass Gathering Med, Riyadh 11176, Saudi Arabia.	zmemish@yahoo.com	Gautret, Philippe/AAY-5126-2021; Assiri, Abdullah M./GQP-2239-2022; ZUMLA, Alimuddin/ABA-8208-2020; assiri, abdullah/AAF-5665-2021; Memish, Ziad Ahmed/AEJ-9424-2022	Gautret, Philippe/0000-0002-1664-958X; ZUMLA, Alimuddin/0000-0002-5111-5735; assiri, abdullah/0000-0002-5605-2876; Memish, Ziad Ahmed/0000-0002-5099-0714	European and Developing Countries Clinical Trials Partnership TB NEAT; European and Developing Countries Clinical Trials Partnership, PANACEA; European and Developing Countries Clinical Trials Partnership, REMox; UBS Optimus Foundation, Switzerland; National Institute for Health Research Biomedical Research Centre, University College London Hospitals	European and Developing Countries Clinical Trials Partnership TB NEAT; European and Developing Countries Clinical Trials Partnership, PANACEA; European and Developing Countries Clinical Trials Partnership, REMox; UBS Optimus Foundation, Switzerland; National Institute for Health Research Biomedical Research Centre, University College London Hospitals	We thank the staff at the Ministry of Health for their support; Adam Zumla, University College London School of Pharmacy, London, UK, for technical and administrative assistance. AZ acknowledges support from the European and Developing Countries Clinical Trials Partnership TB NEAT, PANACEA, and REMox grants; UBS Optimus Foundation, Switzerland; and National Institute for Health Research Biomedical Research Centre, University College London Hospitals.	Abouzeid MS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039478; Abubakar I, 2012, LANCET INFECT DIS, V12, P66, DOI 10.1016/S1473-3099(11)70246-8; Aguilera JF, 2002, EMERG INFECT DIS, V8, P761, DOI 10.3201/eid0808.010422; Ahmed QA, 2009, TRAVEL MED INFECT DI, V7, P226, DOI 10.1016/j.tmaid.2009.01.005; Al Rabeeah A, 2012, LANCET, V380, P3, DOI 10.1016/S0140-6736(12)61073-3; Al-Ghamdi AS, 2011, SAUDI MED J, V32, P1161; Al-Ghamdi SM, 2003, SAUDI MED J, V24, P1073; Al-Hajoj S, 2013, ANTIMICROB AGENTS CH, V57, P2161, DOI 10.1128/AAC.02403-12; Al-Joudi AS, 2007, J FAM COMMUNITY MED, V14, P29; Al-Mazrou YY, 2004, SAUDI MED J, V25, P11; Al-Orainey IO, 2013, SAUDI MED J, V34, P676; Al-Tawfiq JA, 2013, E MEDITERR HEALTH J, V19, pS48; Al-Tawfiq JA, 2012, EURO SURVEILL, V17, P20295; Al-Tawfiq JA, 2013, CURR OPIN PULM MED, V19, P192, DOI 10.1097/MCP.0b013e32835f1ae8; Al-Tawfiq JA, 2012, INFECT DIS CLIN N AM, V26, P725, DOI 10.1016/j.idc.2012.05.005; AlGahtani YM, 1995, EPIDEMIOL INFECT, V115, P399, DOI 10.1017/S0950268800058556; Alherabi AZ, 2011, SAUDI MED J, V32, P933; Alzeer A, 1998, J INFECTION, V36, P303, DOI 10.1016/S0163-4453(98)94315-8; Assiri A, 2013, LANCET INFECT DIS, V13, P752, DOI 10.1016/S1473-3099(13)70204-4; Balkhy HH, 2004, J TRAVEL MED, V11, P82, DOI 10.2310/7060.2004.17027; Benkouiten S, 2013, CLIN INFECT DIS, V57, P992, DOI 10.1093/cid/cit446; Botelho-Nevers E, 2013, EURO SURVEILL, V18, P20426; Buchholz U, 2013, EUROSURVEILLANCE, V18; Cotten M, 2013, LANCET, V382, P1993, DOI 10.1016/S0140-6736(13)61887-5; D'Alessandro Kenneth, 2013, JEMS, V38, P52; Ebrahim SH, 2009, SCIENCE, V326, P938, DOI 10.1126/science.1183210; Emamian MH, 2013, IRAN RED CRESCENT ME, V15, P317, DOI 10.5812/ircmj.3681; Farid M.A., 1956, WHO EMRO INT C MAL E; Gatrad AR, 2005, BRIT MED J, V330, P133, DOI 10.1136/bmj.330.7483.133; Gautret P, 2013, CLIN MICROBIOL INFEC, V19, pE315, DOI 10.1111/1469-0691.12174; Gautret P, 2009, J TRAVEL MED, V16, P377, DOI 10.1111/j.1708-8305.2009.00358.x; Hymavathi P, 1993, Bull Indian Inst Hist Med Hyderabad, V23, P113; Johansson A, 2012, LANCET INFECT DIS, V12, P150, DOI 10.1016/S1473-3099(11)70287-0; Kandeel A, 2011, EMERG INFECT DIS, V17, P1266, DOI 10.3201/eid1707.101484; Khan K, 2012, LANCET INFECT DIS, V12, P222, DOI 10.1016/S1473-3099(11)70313-9; Khan K, 2010, CAN MED ASSOC J, V182, P579, DOI 10.1503/cmaj.100093; Kraemer JL, 2000, HIST RELIGIONS, V40, P198, DOI 10.1086/463631; Langley G, 2013, MMWR-MORBID MORTAL W, V62, P793; Loncarevic G, 2009, EUROSURVEILLANCE, V14, P14; Madani TA, 2007, ANN SAUDI MED, V27, P101, DOI 10.4103/0256-4947.51528; Madani TA, 2006, ANN SAUDI MED, V26, P346, DOI 10.5144/0256-4947.2006.346; Mailles A, 2013, EURO SURVEILL, V18; Mandourah Y, 2012, BMC INFECT DIS, V12, DOI 10.1186/1471-2334-12-117; Mazroa Mohammed A A I, 2012, PLoS One, V7, pe45919, DOI 10.1371/journal.pone.0045919; Memish Z, 2013, EURO SURVEILL, V18, P20581; Memish ZA, 2010, EURO SURVEILL, V15; Memish ZA, 2013, NEW ENGL J MED, V369, P884, DOI 10.1056/NEJMc1308698; Memish ZA, 2013, J EPIDEMIOL GLOB HEA, V3, P59, DOI 10.1016/j.jegh.2013.03.001; Memish ZA, 2013, NEW ENGL J MED, V368, P2487, DOI 10.1056/NEJMoa1303729; Memish Ziad A, 2012, J Infect Public Health, V5, P113, DOI 10.1016/j.jiph.2012.03.001; Memish ZA, 2012, LANCET INFECT DIS, V12, P56, DOI 10.1016/S1473-3099(11)70337-1; Memish ZA, 2011, TRAVEL MED INFECT DI, V9, P60, DOI 10.1016/j.tmaid.2011.01.004; Meysamie A, 2006, SAUDI MED J, V27, P1049; Momattin H, 2013, INT J INFECT DIS, V17, pE792, DOI 10.1016/j.ijid.2013.07.002; Puzelli S., 2013, EURO SURVEILL, V18; Rashid H, 2013, TRAVEL MED INFECT DI, V11, P288, DOI 10.1016/j.tmaid.2013.06.001; Shafi Shuja, 2008, J Infect Public Health, V1, P27, DOI 10.1016/j.jiph.2008.08.008; Shibl A, 2013, E MEDITERR HEALTH J, V19, P389, DOI 10.26719/2013.19.4.389; Shibl A, 2012, CLIN MICROBIOL INFEC, V18, P1068, DOI 10.1111/1469-0691.12010; Snow RW, 2013, ADV PARASIT, V82, P205, DOI 10.1016/B978-0-12-407706-5.00003-4; Tahir M, 2013, EURO SURVEILL; Tewari S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047291; Thackway S, 2009, BMC PUBLIC HEALTH, V9, DOI 10.1186/1471-2458-9-324; WHO, 2012, GLOBAL TUBERCULOSIS REPORT 2012, P1; WHO MERSCoV Research Group, 2013, PLOS CURR, DOI [10.1371/currents.outbreaks.0bf719e352e7478f8ad85fa30127ddb8, DOI 10.1371/CURRENTS.OUTBREAKS.0BF719E352E7478F8AD85FA30127DDB8]; Wilder-Smith A, 2005, TROP MED INT HEALTH, V10, P336, DOI 10.1111/j.1365-3156.2005.01395.x; Wilder-Smith A, 2003, CLIN INFECT DIS, V36, P679, DOI 10.1086/367858; World Health Organisation (WHO), 2008, COMM DIS AL RESP MAS; Zaki AM, 2012, NEW ENGL J MED, V367, P1814, DOI 10.1056/NEJMoa1211721; Ziyaeyan M, 2012, INFLUENZA OTHER RESP, V6, pe80, DOI 10.1111/j.1750-2659.2012.00381.x	70	201	204	1	32	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JUN 14	2014	383	9934					2073	2082		10.1016/S0140-6736(14)60381-0	http://dx.doi.org/10.1016/S0140-6736(14)60381-0			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AI9VZ	24857703	Green Published, Bronze			2022-12-28	WOS:000337292400027
J	Goldacre, B; Godlee, F; Heneghan, C; Tovey, D; Lehman, R; Chalmers, I; Barbour, V; Brown, T				Goldacre, Ben; Godlee, Fiona; Heneghan, Carl; Tovey, David; Lehman, Richard; Chalmers, Iain; Barbour, Virginia; Brown, Tracey			OPEN DATA CAMPAIGN Open letter: European Medicines Agency should remove barriers to access clinical trial data	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									[Goldacre, Ben] London Sch Hyg & Trop Med, London, England; [Heneghan, Carl] Ctr Evidence based Med, Oxford, England	University of London; London School of Hygiene & Tropical Medicine; University of Oxford	Goldacre, B (corresponding author), London Sch Hyg & Trop Med, London, England.			Goldacre, Ben/0000-0002-5127-4728; Barbour, Virginia/0000-0002-2358-2440; Brown, Tracey/0000-0002-8112-6873					0	7	7	0	6	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JUN 6	2014	348								g3768	10.1136/bmj.g3768	http://dx.doi.org/10.1136/bmj.g3768			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AI7CE	24906718	Green Published, Bronze			2022-12-28	WOS:000337038000010
J	Segawa, K; Kurata, S; Yanagihashi, Y; Brummelkamp, TR; Matsuda, F; Nagata, S				Segawa, Katsumori; Kurata, Sachiko; Yanagihashi, Yuichi; Brummelkamp, Thijn R.; Matsuda, Fumihiko; Nagata, Shigekazu			Caspase-mediated cleavage of phospholipid flippase for apoptotic phosphatidylserine exposure	SCIENCE			English	Article							AMINOPHOSPHOLIPID TRANSLOCASE; CELL-DEATH; LYMPHOCYTES; PROTEIN; IDENTIFICATION; P-4-ATPASES; CLEARANCE; P4-ATPASE; TRANSPORT; MEMBRANES	Phospholipids are asymmetrically distributed in the plasma membrane. This asymmetrical distribution is disrupted during apoptosis, exposing phosphatidylserine (PtdSer) on the cell surface. Using a haploid genetic screen in human cells, we found that ATP11C (adenosine triphosphatase type 11C) and CDC50A (cell division cycle protein 50A) are required for aminophospholipid translocation from the outer to the inner plasma membrane leaflet; that is, they display flippase activity. ATP11C contained caspase recognition sites, and mutations at these sites generated caspase-resistant ATP11C without affecting its flippase activity. Cells expressing caspase-resistant ATP11C did not expose PtdSer during apoptosis and were not engulfed by macrophages, which suggests that inactivation of the flippase activity is required for apoptotic PtdSer exposure. CDC50A-deficient cells displayed PtdSer on their surface and were engulfed by macrophages, indicating that PtdSer is sufficient as an "eat me" signal.	[Segawa, Katsumori; Kurata, Sachiko; Yanagihashi, Yuichi; Nagata, Shigekazu] Kyoto Univ, Grad Sch Med, Dept Med Chem, Kyoto 6068501, Japan; [Brummelkamp, Thijn R.] Netherlands Canc Inst, NL-1066 CX Amsterdam, Netherlands; [Matsuda, Fumihiko] Kyoto Univ, Grad Sch Med, Ctr Genom Med, Kyoto 6068501, Japan; [Nagata, Shigekazu] Japan Sci & Technol Corp, Core Res Evolut Sci & Technol, Kyoto 6068501, Japan	Kyoto University; Netherlands Cancer Institute; Kyoto University; Japan Science & Technology Agency (JST)	Nagata, S (corresponding author), Kyoto Univ, Grad Sch Med, Dept Med Chem, Kyoto 6068501, Japan.	snagata@mfour.med.kyoto-u.ac.jp	Nagata, Shigekazu/AAG-3203-2019	Nagata, Shigekazu/0000-0001-9758-8426	Ministry of Education, Science, Sports, and Culture, Japan; Grants-in-Aid for Scientific Research [22000013] Funding Source: KAKEN	Ministry of Education, Science, Sports, and Culture, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	We thank B. H. Cochran for KBM7 cells, K. Higasa and M. Shimizu for help in next-generation sequencing, K. Okamoto-Furuta and H. Kohda for support in electron microscope analysis, and M. Fujii for secretarial assistance. This work was supported in part by grants-in-aid from the Ministry of Education, Science, Sports, and Culture, Japan. Kyoto University has filed a patent entitled "Method of screening agents for the treatment or prevention of cancer or apoptosis-related diseases" (inventors, Shigekazu Nagata, Katsumori Segawa; reference number: 61/978415). Plasmids encoding human ATP11C or CDC50A, human KBM7 cells lacking ATP11C or CDC50A, and mouse W3 cell lines lacking ATP11C or CDC50A are all available under material transfer agreements. T. R. B. is a co-founder, shareholder, and member of the scientific advisory board of Haplogen, an early-phase biotech company based on haploid genetics.	Bratton DL, 1997, J BIOL CHEM, V272, P26159, DOI 10.1074/jbc.272.42.26159; Brown GC, 2012, TRENDS BIOCHEM SCI, V37, P325, DOI 10.1016/j.tibs.2012.05.002; Carette JE, 2011, NAT BIOTECHNOL, V29, P542, DOI 10.1038/nbt.1857; Chen BH, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001235; Chen R, 2011, J IMMUNOL, V186, P3215, DOI 10.4049/jimmunol.1002710; Coleman JA, 2013, BBA-MOL CELL BIOL L, V1831, P555, DOI 10.1016/j.bbalip.2012.10.006; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; Daleke DL, 2000, BBA-MOL CELL BIOL L, V1486, P108, DOI 10.1016/S1388-1981(00)00052-4; Darland-Ransom M, 2008, SCIENCE, V320, P528, DOI 10.1126/science.1155847; Elliott JI, 2005, NAT CELL BIOL, V7, P808, DOI 10.1038/ncb1279; Hanayama R, 2002, NATURE, V417, P182, DOI 10.1038/417182a; Kotecki M, 1999, EXP CELL RES, V252, P273, DOI 10.1006/excr.1999.4656; Leventis PA, 2010, ANNU REV BIOPHYS, V39, P407, DOI 10.1146/annurev.biophys.093008.131234; Nagata S, 2010, CELL, V140, P619, DOI 10.1016/j.cell.2010.02.014; Oldenborg PA, 2000, SCIENCE, V288, P2051, DOI 10.1126/science.288.5473.2051; Overholtzer M, 2007, CELL, V131, P966, DOI 10.1016/j.cell.2007.10.040; Sakahira H, 1998, NATURE, V391, P96, DOI 10.1038/34214; Sebastian TT, 2012, BBA-MOL CELL BIOL L, V1821, P1068, DOI 10.1016/j.bbalip.2011.12.007; Segawa K, 2011, P NATL ACAD SCI USA, V108, P19246, DOI 10.1073/pnas.1114799108; Seitz HM, 2007, J IMMUNOL, V178, P5635, DOI 10.4049/jimmunol.178.9.5635; Siggs OM, 2011, P NATL ACAD SCI USA, V108, P7890, DOI 10.1073/pnas.1104631108; Suzuki J, 2013, SCIENCE, V341, P403, DOI 10.1126/science.1236758; Suzuki J, 2010, NATURE, V468, P834, DOI 10.1038/nature09583; Takatsu H, 2011, J BIOL CHEM, V286, P38159, DOI 10.1074/jbc.M111.281006; Tanaka K, 2011, J BIOCHEM, V149, P131, DOI 10.1093/jb/mvq140; Tanaka M, 1997, J IMMUNOL, V158, P2303; Tang XJ, 1996, SCIENCE, V272, P1495, DOI 10.1126/science.272.5267.1495; van der Velden LM, 2010, J BIOL CHEM, V285, P40088, DOI 10.1074/jbc.M110.139006; VERHOVEN B, 1995, J EXP MED, V182, P1597, DOI 10.1084/jem.182.5.1597; Yabas M, 2011, NAT IMMUNOL, V12, P441, DOI 10.1038/ni.2011	30	320	321	1	85	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 6	2014	344	6188					1164	1168		10.1126/science.1252809	http://dx.doi.org/10.1126/science.1252809			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI3UU	24904167	Green Published			2022-12-28	WOS:000336791200049
J	Bauer, BW; Shemesh, T; Chen, Y; Rapoport, TA				Bauer, Benedikt W.; Shemesh, Tom; Chen, Yu; Rapoport, Tom A.			A "Push and Slide" Mechanism Allows Sequence-Insensitive Translocation of Secretory Proteins by the SecA ATPase	CELL			English	Article							POLYPEPTIDE TRANSLOCATION; SECYEG COMPLEX; CHANNEL; MEMBRANE; MACHINE; BINDING; MEDIATE; PORE; MOTIONS; REVEAL	In bacteria, most secretory proteins are translocated across the plasma membrane by the interplay of the SecA ATPase and the SecY channel. How SecA moves a broad range of polypeptide substrates is only poorly understood. Here we show that SecA moves polypeptides through the SecY channel by a "push and slide" mechanism. In its ATP-bound state, SecA interacts through a two-helix finger with a subset of amino acids in a substrate, pushing them into the channel. A polypeptide can also passively slide back and forth when SecA is in the predominant ADP-bound state or when SecA encounters a poorly interacting amino acid in its ATP-bound state. SecA performs multiple rounds of ATP hydrolysis before dissociating from SecY. The proposed push and slide mechanism is supported by a mathematical model and explains how SecA allows translocation of a wide range of polypeptides. This mechanism may also apply to hexameric polypeptide-translocating ATPases.	[Bauer, Benedikt W.; Shemesh, Tom; Chen, Yu; Rapoport, Tom A.] Harvard Med Sch, Howard Hughes Med Inst, Boston, MA 02115 USA; [Bauer, Benedikt W.; Shemesh, Tom; Chen, Yu; Rapoport, Tom A.] Harvard Med Sch, Dept Cell Biol, Boston, MA 02115 USA	Harvard University; Harvard Medical School; Howard Hughes Medical Institute; Harvard University; Harvard Medical School	Rapoport, TA (corresponding author), Harvard Med Sch, Howard Hughes Med Inst, 240 Longwood Ave, Boston, MA 02115 USA.	tom_rapoport@hms.harvard.edu			Boehringer Ingelheim Fonds; NIH [GM052586]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM052586] Funding Source: NIH RePORTER	Boehringer Ingelheim Fonds(Boehringer Ingelheim); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank Karl Erlandson and Stephanie Miller for providing preliminary data, the Institute of Chemistry and Cell Biology for providing access to the plate reader, Alexander Stein for helpful suggestions, and Thomas Guttler, Alexander Stein, and Long Li for critical reading of the manuscript. B. W. B. is the recipient of a fellowship from the Boehringer Ingelheim Fonds. T. A. R. is supported by NIH grant GM052586 and is a Howard Hughes Medical Institute Investigator.	Alami M, 2007, EMBO J, V26, P1995, DOI 10.1038/sj.emboj.7601661; Barkow SR, 2009, CHEM BIOL, V16, P605, DOI 10.1016/j.chembiol.2009.05.007; DeLaBarre B, 2006, MOL CELL, V22, P451, DOI 10.1016/j.molcel.2006.03.036; Economou A, 1995, CELL, V83, P1171, DOI 10.1016/0092-8674(95)90143-4; Erlandson KJ, 2008, NATURE, V455, P984, DOI 10.1038/nature07439; Erlandson KJ, 2008, J BIOL CHEM, V283, P15709, DOI 10.1074/jbc.M710356200; Glynn SE, 2009, CELL, V139, P744, DOI 10.1016/j.cell.2009.09.034; HENDRICK JP, 1991, J BIOL CHEM, V266, P24596; Hinnerwisch J, 2005, CELL, V121, P1029, DOI 10.1016/j.cell.2005.04.012; Hunt JF, 2002, SCIENCE, V297, P2018, DOI 10.1126/science.1074424; Kraut DA, 2013, J BIOL CHEM, V288, P34729, DOI 10.1074/jbc.M113.512533; Kusters I, 2010, METHODS MOL BIOL, V619, P131, DOI 10.1007/978-1-60327-412-8_8; Liebermeister W, 2001, J MOL BIOL, V305, P643, DOI 10.1006/jmbi.2000.4302; Martin A, 2008, MOL CELL, V29, P441, DOI 10.1016/j.molcel.2008.02.002; Park E, 2012, ANNU REV BIOPHYS, V41, P21, DOI [10.1146/annurev-biophys-050511-102312, 10.1146/annurev-biophys-050511-402312]; PESKIN CS, 1993, BIOPHYS J, V65, P316, DOI 10.1016/S0006-3495(93)81035-X; Pyle AM, 2008, ANNU REV BIOPHYS, V37, P317, DOI 10.1146/annurev.biophys.37.032807.125908; Robson A, 2009, P NATL ACAD SCI USA, V106, P5111, DOI 10.1073/pnas.0809592106; Tian L, 2005, NAT STRUCT MOL BIOL, V12, P1045, DOI 10.1038/nsmb1018; Too PHM, 2013, J BIOL CHEM, V288, P13243, DOI 10.1074/jbc.M113.452524; Tsukazaki T, 2011, NATURE, V474, P235, DOI 10.1038/nature09980; van den Berg B, 2004, NATURE, V427, P36, DOI 10.1038/nature02218; Wang J, 2001, STRUCTURE, V9, P177, DOI 10.1016/S0969-2126(01)00570-6; Whitehouse S, 2012, J CELL BIOL, V199, P919, DOI 10.1083/jcb.201205191; Zimmer J, 2008, NATURE, V455, P936, DOI 10.1038/nature07335; Zimmer J, 2009, J MOL BIOL, V394, P606, DOI 10.1016/j.jmb.2009.10.024	26	77	77	0	13	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUN 5	2014	157	6					1416	1429		10.1016/j.cell.2014.03.063	http://dx.doi.org/10.1016/j.cell.2014.03.063			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	AN8UV	24906156	Bronze, Green Accepted			2022-12-28	WOS:000340881400017
J	Peirce, V; Carobbio, S; Vidal-Puig, A				Peirce, Vivian; Carobbio, Stefania; Vidal-Puig, Antonio			The different shades of fat	NATURE			English	Review							BROWN ADIPOSE-TISSUE; DIET-INDUCED THERMOGENESIS; PLURIPOTENT STEM-CELLS; NATRIURETIC PEPTIDES; WHITE ADIPOCYTES; COLD-EXPOSURE; THERMOGENICALLY COMPETENT; SUPRACLAVICULAR REGION; GLUCOSE-HOMEOSTASIS; ENERGY-EXPENDITURE	Our understanding of adipose tissue biology has progressed rapidly since the turn of the century. White adipose tissue has emerged as a key determinant of healthy metabolism and metabolic dysfunction. This realization is paralleled only by the confirmation that adult humans have heat-dissipating brown adipose tissue, an important contributor to energy balance and a possible therapeutic target for the treatment of metabolic disease. We propose that the development of successful strategies to target brown and white adipose tissues will depend on investigations that elucidate their developmental origins and cell-type-specific functional regulators.	[Peirce, Vivian; Carobbio, Stefania; Vidal-Puig, Antonio] Univ Cambridge, Metab Res Labs, Wellcome Trust MRC Inst Metab Sci, Addenbrookes Hosp, Cambridge CB2 OQQ, England; [Carobbio, Stefania; Vidal-Puig, Antonio] Wellcome Trust Sanger Inst, Cambridge CB10 1SA, England	Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge; Wellcome Trust Sanger Institute	Peirce, V (corresponding author), Univ Cambridge, Metab Res Labs, Wellcome Trust MRC Inst Metab Sci, Addenbrookes Hosp, Level 4,Box 289, Cambridge CB2 OQQ, England.	vm272@medschl.cam.ac.uk; ajv22@medschl.cam.ac.uk	carobbio, stefania/E-7095-2018	Vidal-Puig, Antonio/0000-0003-4220-9577	FP7 BetaBAT; BBSRC; BHF; MRC; Wellcome Trust; Cambridge Overseas Trust; Biotechnology and Biological Sciences Research Council [BB/H002731/1, BB/J009865/1] Funding Source: researchfish; British Heart Foundation [PG/12/53/29714] Funding Source: researchfish; Medical Research Council [MC_UU_12012/2, MC_UU_12012/5/B, G0802051] Funding Source: researchfish; BBSRC [BB/H002731/1, BB/J009865/1] Funding Source: UKRI; MRC [MC_UU_12012/2, G0802051] Funding Source: UKRI	FP7 BetaBAT; BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BHF(British Heart Foundation); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome TrustEuropean Commission); Cambridge Overseas Trust; Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); British Heart Foundation(British Heart Foundation); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	We apologize to those whose work was not directly cited because of space constraints. The authors are supported by FP7 BetaBAT, BBSRC, BHF and MRC programme grants, Wellcome Trust, and Cambridge Overseas Trust.	Ahfeldt T, 2012, NAT CELL BIOL, V14, P209, DOI 10.1038/ncb2411; ARBEENY CM, 1995, AM J PHYSIOL-ENDOC M, V268, pE678, DOI 10.1152/ajpendo.1995.268.4.E678; Arch JRS, 2002, EUR J PHARMACOL, V440, P99, DOI 10.1016/S0014-2999(02)01421-8; Bartelt A, 2011, NAT MED, V17, P200, DOI 10.1038/nm.2297; Berry R, 2013, NAT CELL BIOL, V15, P302, DOI 10.1038/ncb2696; Boon MR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074083; Bordicchia M, 2012, J CLIN INVEST, V122, P1022, DOI 10.1172/JCI59701; Bostrom P, 2012, NATURE, V481, P463, DOI 10.1038/nature10777; Cannon B, 2004, PHYSIOL REV, V84, P277, DOI 10.1152/physrev.00015.2003; Cannon B, 2009, P NUTR SOC, V68, P401, DOI 10.1017/S0029665109990255; Carobbio S, 2013, J MOL ENDOCRINOL, V51, pT75, DOI 10.1530/JME-13-0158; Cederberg A, 2001, CELL, V106, P563, DOI 10.1016/S0092-8674(01)00474-3; Chen Y, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2742; Cinti S, 1997, ENDOCRINOLOGY, V138, P797, DOI 10.1210/en.138.2.797; Cohen P, 2014, CELL, V156, P304, DOI 10.1016/j.cell.2013.12.021; Collins S, 2001, RECENT PROG HORM RES, V56, P309, DOI 10.1210/rp.56.1.309; Cypess AM, 2013, NAT MED, V19, P635, DOI 10.1038/nm.3112; Cypess AM, 2009, NEW ENGL J MED, V360, P1509, DOI 10.1056/NEJMoa0810780; de Souza CJ, 2001, DIABETES, V50, P1863, DOI 10.2337/diabetes.50.8.1863; Digby JE, 1998, DIABETES, V47, P138, DOI 10.2337/diabetes.47.1.138; Elias I, 2012, DIABETES, V61, P1801, DOI 10.2337/db11-0832; Feldmann HM, 2009, CELL METAB, V9, P203, DOI 10.1016/j.cmet.2008.12.014; Fisher FM, 2012, GENE DEV, V26, P271, DOI 10.1101/gad.177857.111; Frescas D, 2005, J BIOL CHEM, V280, P20589, DOI 10.1074/jbc.M412357200; Fulco M, 2003, MOL CELL, V12, P51, DOI 10.1016/S1097-2765(03)00226-0; Geerling JJ, 2014, J LIPID RES, V55, P180, DOI 10.1194/jlr.R045013; Gronning LM, 2006, FEBS LETT, V580, P4126, DOI 10.1016/j.febslet.2006.06.058; Gunawardana SC, 2012, DIABETES, V61, P674, DOI 10.2337/db11-0510; Gupta RK, 2012, CELL METAB, V15, P230, DOI 10.1016/j.cmet.2012.01.010; Hansen JB, 2006, BIOCHEM J, V398, P153, DOI 10.1042/BJ20060402; Hany TF, 2002, EUR J NUCL MED MOL I, V29, P1393, DOI 10.1007/s00259-002-0902-6; Hondares E, 2011, J BIOL CHEM, V286, P12983, DOI 10.1074/jbc.M110.215889; Jespersen NZ, 2013, CELL METAB, V17, P798, DOI 10.1016/j.cmet.2013.04.011; Jones SA, 2011, J CLIN INVEST, V121, P3375, DOI 10.1172/JCI57158; Khan T, 2009, MOL CELL BIOL, V29, P1575, DOI 10.1128/MCB.01300-08; Tran KV, 2012, CELL METAB, V15, P222, DOI 10.1016/j.cmet.2012.01.008; Kim JY, 2007, J CLIN INVEST, V117, P2621, DOI 10.1172/JCI31021; Kolonin MG, 2004, NAT MED, V10, P625, DOI 10.1038/nm1048; Kusminski CM, 2012, NAT MED, V18, P1539, DOI 10.1038/nm.2899; Lafontan M, 2008, TRENDS ENDOCRIN MET, V19, P130, DOI 10.1016/j.tem.2007.11.006; Lagouge M, 2006, CELL, V127, P1109, DOI 10.1016/j.cell.2006.11.013; Lee P, 2014, INT J OBESITY, V38, P170, DOI 10.1038/ijo.2013.82; Lee P, 2014, CELL METAB, V19, P302, DOI 10.1016/j.cmet.2013.12.017; Lee P, 2013, J CLIN ENDOCR METAB, V98, pE98, DOI 10.1210/jc.2012-3107; Lee P, 2011, J CLIN ENDOCR METAB, V96, P2450, DOI 10.1210/jc.2011-0487; Lee YH, 2012, CELL METAB, V15, P480, DOI 10.1016/j.cmet.2012.03.009; Lelliott C, 2004, INT J OBESITY, V28, pS22, DOI 10.1038/sj.ijo.0802854; Lepper C, 2010, GENESIS, V48, P424, DOI 10.1002/dvg.20630; Lichtenbelt WDV, 2009, NEW ENGL J MED, V360, P1500, DOI 10.1056/NEJMoa0808718; Lidell ME, 2013, NAT MED, V19, P631, DOI 10.1038/nm.3017; Lidell ME, 2011, DIABETES, V60, P427, DOI 10.2337/db10-0409; Liu WY, 2013, J CELL SCI, V126, P3527, DOI 10.1242/jcs.124321; Liu WY, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003626; LONCAR D, 1988, J ULTRA MOL STRUCT R, V101, P109, DOI 10.1016/0889-1605(88)90001-8; LOWELL BB, 1993, NATURE, V366, P740, DOI 10.1038/366740a0; Moreno-Aliaga MJ, 2011, CELL METAB, V14, P242, DOI 10.1016/j.cmet.2011.05.013; Mori M, 2012, PLOS BIOL, V10, DOI 10.1371/journal.pbio.1001314; Muzik O, 2013, J NUCL MED, V54, P523, DOI 10.2967/jnumed.112.111336; Nedergaard J, 2007, AM J PHYSIOL-ENDOC M, V293, pE444, DOI 10.1152/ajpendo.00691.2006; Nguyen KD, 2011, NATURE, V480, P104, DOI 10.1038/nature10653; Nishio M, 2012, CELL METAB, V16, P394, DOI 10.1016/j.cmet.2012.08.001; Ohno H, 2013, NATURE, V504, P163, DOI 10.1038/nature12652; Okuno A, 1998, J CLIN INVEST, V101, P1354, DOI 10.1172/JCI1235; Ouchi N, 2011, NAT REV IMMUNOL, V11, P85, DOI 10.1038/nri2921; Ouellet V, 2012, J CLIN INVEST, V122, P545, DOI 10.1172/JCI60433; Ouellet V, 2011, J CLIN ENDOCR METAB, V96, P192, DOI 10.1210/jc.2010-0989; Petrovic N, 2008, AM J PHYSIOL-ENDOC M, V295, pE287, DOI 10.1152/ajpendo.00035.2008; Petrovic N, 2010, J BIOL CHEM, V285, P7153, DOI 10.1074/jbc.M109.053942; Pfannenberg C, 2010, DIABETES, V59, P1789, DOI 10.2337/db10-0004; Puigserver P, 2005, INT J OBESITY, V29, pS5, DOI 10.1038/sj.ijo.0802905; Qiang L, 2012, CELL, V150, P620, DOI 10.1016/j.cell.2012.06.027; Roca-Rivada A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060563; Rodeheffer MS, 2008, CELL, V135, P240, DOI 10.1016/j.cell.2008.09.036; Rodgers JT, 2005, NATURE, V434, P113, DOI 10.1038/nature03354; Rosenwald M, 2013, NAT CELL BIOL, V15, P659, DOI 10.1038/ncb2740; ROTHWELL NJ, 1983, CLIN SCI, V64, P19, DOI 10.1042/cs0640019; Rupnick MA, 2002, P NATL ACAD SCI USA, V99, P10730, DOI 10.1073/pnas.162349799; Saito M, 2009, DIABETES, V58, P1526, DOI 10.2337/db09-0530; Sanchez-Gurmaches J, 2012, CELL METAB, V16, P348, DOI 10.1016/j.cmet.2012.08.003; Scherer PE, 2006, DIABETES, V55, P1537, DOI 10.2337/db06-0263; Schulz TJ, 2013, BIOCHEM J, V453, P167, DOI 10.1042/BJ20130457; Schulz TJ, 2013, NATURE, V495, P379, DOI 10.1038/nature11943; Seale P, 2000, CELL, V102, P777, DOI 10.1016/S0092-8674(00)00066-0; Seale P, 2008, NATURE, V454, P961, DOI 10.1038/nature07182; Seale P, 2007, CELL METAB, V6, P38, DOI 10.1016/j.cmet.2007.06.001; Seale P, 2011, J CLIN INVEST, V121, P96, DOI 10.1172/JCI44271; Sengenes C, 2000, FASEB J, V14, P1345, DOI 10.1096/fj.14.10.1345; Shabalina IG, 2013, CELL REP, V5, P1196, DOI 10.1016/j.celrep.2013.10.044; Shan TZ, 2013, J LIPID RES, V54, P2214, DOI 10.1194/jlr.M038711; Sharp LZ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049452; Stanford KI, 2013, J CLIN INVEST, V123, P215, DOI 10.1172/JCI62308; Sun K, 2012, P NATL ACAD SCI USA, V109, P5874, DOI 10.1073/pnas.1200447109; Sun L, 2014, METABOLISM, V63, P272, DOI 10.1016/j.metabol.2013.10.004; Sun L, 2011, NAT CELL BIOL, V13, P958, DOI 10.1038/ncb2286; Symonds ME, 2012, J PEDIATR-US, V161, P892, DOI 10.1016/j.jpeds.2012.04.056; Tang W, 2008, SCIENCE, V322, P583, DOI 10.1126/science.1156232; Timmons JA, 2007, P NATL ACAD SCI USA, V104, P4401, DOI 10.1073/pnas.0610615104; Torp-Pedersen C, 2007, EUR HEART J, V28, P2915, DOI 10.1093/eurheartj/ehm217; Trajkovski M, 2013, TRENDS ENDOCRIN MET, V24, P442, DOI 10.1016/j.tem.2013.05.002; Trajkovski M, 2012, NAT CELL BIOL, V14, P1330, DOI 10.1038/ncb2612; Trayhurn Paul, 2008, Archives of Physiology and Biochemistry, V114, P267, DOI [10.1080/13813450802306602, 10.1080/13813450802306602 ]; Tseng YH, 2008, NATURE, V454, P1000, DOI 10.1038/nature07221; van der Lans AAJJ, 2013, J CLIN INVEST, V123, P3395, DOI 10.1172/JCI68993; Vijgen GHEJ, 2013, J CLIN ENDOCR METAB, V98, pE1230, DOI 10.1210/jc.2013-1348; Villarroya F, 2013, CELL METAB, V17, P638, DOI 10.1016/j.cmet.2013.02.020; Virtanen KA, 2009, NEW ENGL J MED, V360, P1518, DOI 10.1056/NEJMoa0808949; Virtue S, 2010, BBA-MOL CELL BIOL L, V1801, P338, DOI 10.1016/j.bbalip.2009.12.006; Vitali A, 2012, J LIPID RES, V53, P619, DOI 10.1194/jlr.M018846; Walden TB, 2012, AM J PHYSIOL-ENDOC M, V302, pE19, DOI 10.1152/ajpendo.00249.2011; Walden TB, 2009, J CELL PHYSIOL, V218, P444, DOI 10.1002/jcp.21621; Wang QA, 2013, NAT MED, V19, P1338, DOI 10.1038/nm.3324; Whittle AJ, 2012, CELL, V149, P871, DOI 10.1016/j.cell.2012.02.066; Wikstrom JD, 2014, EMBO J, V33, P418, DOI 10.1002/embj.201385014; Wilcox Gisela, 2005, Clin Biochem Rev, V26, P19; Wu J, 2012, CELL, V150, P366, DOI 10.1016/j.cell.2012.05.016; Xue Y, 2008, P NATL ACAD SCI USA, V105, P10167, DOI 10.1073/pnas.0802486105; Xue Y, 2009, CELL METAB, V9, P99, DOI 10.1016/j.cmet.2008.11.009; Yamauchi T, 2001, NAT MED, V7, P941, DOI 10.1038/90984; Yin H, 2013, CELL METAB, V17, P210, DOI 10.1016/j.cmet.2013.01.004; Yoneshiro T, 2013, J CLIN INVEST, V123, P3404, DOI 10.1172/JCI67803; Yoneshiro T, 2011, OBESITY, V19, P1755, DOI 10.1038/oby.2011.125; Yoneshiro T, 2011, OBESITY, V19, P13, DOI 10.1038/oby.2010.105; YOUNG P, 1984, FEBS LETT, V167, P10, DOI 10.1016/0014-5793(84)80822-4; Zhang Y, 2014, DIABETES, V63, P514, DOI 10.2337/db13-1106	124	293	308	2	94	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	JUN 5	2014	510	7503					76	83		10.1038/nature13477	http://dx.doi.org/10.1038/nature13477			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI3NR	24899307				2022-12-28	WOS:000336768900034
J	Appleby, J; Mitchell, PD; Robinson, C; Brough, A; Rutty, G; Harris, RA; Thompson, D; Morgan, B				Appleby, Jo; Mitchell, Piers D.; Robinson, Claire; Brough, Alison; Rutty, Guy; Harris, Russell A.; Thompson, David; Morgan, Bruno			The scoliosis of Richard III, last Plantagenet King of England: diagnosis and clinical significance	LANCET			English	Editorial Material									[Appleby, Jo] Univ Leicester, Sch Archaeol & Ancient Hist, Leicester LE1 7RH, Leics, England; [Brough, Alison; Rutty, Guy] Univ Leicester, East Midlands Forens Pathol Unit, Leicester LE1 7RH, Leics, England; [Morgan, Bruno] Univ Leicester, Dept Radiol, Leicester LE1 7RH, Leics, England; [Mitchell, Piers D.] Univ Cambridge, Div Biol Anthropol, Cambridge CB2 1TN, England; [Robinson, Claire] Univ Hosp Leicester, Dept Imaging, Leicester, Leics, England; [Harris, Russell A.; Thompson, David] Univ Loughborough, Wolfson Sch Mech & Mfg Engn, Loughborough, Leics, England	University of Leicester; University of Leicester; University of Leicester; University of Cambridge; University Hospitals of Leicester NHS Trust; University of Leicester; Loughborough University	Appleby, J (corresponding author), Univ Leicester, Sch Archaeol & Ancient Hist, Leicester LE1 7RH, Leics, England.	ja253@leicester.ac.uk		Morgan, Bruno/0000-0001-9708-675X; Robinson, Claire/0000-0002-8759-7457; Mitchell, Piers/0000-0002-1009-697X	Richard III Society; Leicester City Council; University of Leicester	Richard III Society; Leicester City Council; University of Leicester	The original search for Richard III project which led to the discovery was jointly funded by the Richard III Society (especial thanks to Philippa Langley), Leicester City Council, and University of Leicester. The research for this paper was funded by the University of Leicester. The authors would like to thank Loughborough University for 3D models and the University Hospitals Leicester imaging department for use of the CT scanner. Photographs were taken by Carl Vivian of the University of Leicester.	[Anonymous], 2013, ANTIQUITY, V87, P519; King HA, 1983, J BONE JOINT SURG AM, V66, P1061; Rous J., 1745, J ROSSI ANTIQUARII W; Weinstein SL, 2003, JAMA-J AM MED ASSOC, V289, P559, DOI 10.1001/jama.289.5.559	4	22	23	0	25	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	MAY 31	2014	383	9932					1944	1944		10.1016/S0140-6736(14)60762-5	http://dx.doi.org/10.1016/S0140-6736(14)60762-5			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AI4PR	24881996				2022-12-28	WOS:000336847800035
J	Tropek, R; Sedlacek, O; Beck, J; Keil, P; Musilova, Z; Simova, I; Storch, D				Tropek, Robert; Sedlacek, Ondrej; Beck, Jan; Keil, Petr; Musilova, Zuzana; Simova, Irena; Storch, David			Comment on "High-resolution global maps of 21st-century forest cover change"	SCIENCE			English	Editorial Material							BIODIVERSITY; AGRICULTURE	Hansen et al. (Reports, 15 November 2013, p. 850) published a high-resolution global forest map with detailed information on local forest loss and gain. We show that their product does not distinguish tropical forests from plantations and even herbaceous crops, which leads to a substantial underestimate of forest loss and compromises its value for local policy decisions.	[Tropek, Robert; Beck, Jan] Univ Basel, Dept Environm Sci Biogeog, CH-4056 Basel, Switzerland; [Tropek, Robert] Acad Sci Czech Republ, Inst Entomol, Ctr Biol, CZ-37005 Ceske Budejovice, Czech Republic; [Sedlacek, Ondrej; Simova, Irena; Storch, David] Charles Univ Prague, Fac Sci, Dept Ecol, CZ-12844 Prague 2, Czech Republic; [Keil, Petr] Yale Univ, Dept Ecol & Evolutionary Biol, New Haven, CT 06520 USA; [Keil, Petr; Simova, Irena; Storch, David] Charles Univ Prague, Ctr Theoret Study, CZ-11000 Prague 1, Czech Republic; [Keil, Petr; Simova, Irena; Storch, David] Acad Sci Czech Republ, CZ-11000 Prague 1, Czech Republic; [Musilova, Zuzana] Univ Basel, Inst Zool, CH-4051 Basel, Switzerland	University of Basel; Czech Academy of Sciences; Biology Centre of the Czech Academy of Sciences; Charles University Prague; Yale University; Charles University Prague; Czech Academy of Sciences; University of Basel	Tropek, R (corresponding author), Univ Basel, Dept Environm Sci Biogeog, St Johanns Vorstadt 10, CH-4056 Basel, Switzerland.	robert.tropek@gmail.com	Simova, Irena/C-1334-2017; Storch, David/C-3339-2017; Tropek, Robert/AAD-4638-2022; Tropek, Robert/G-6564-2014; Keil, Petr/A-9875-2014; Beck, Jan/L-5659-2015; Sedláček, Ondřej/A-1667-2009	Simova, Irena/0000-0002-9474-569X; Storch, David/0000-0001-5967-1544; Tropek, Robert/0000-0001-7499-6259; Tropek, Robert/0000-0001-7499-6259; Beck, Jan/0000-0003-1170-4751				Barlow J, 2007, P NATL ACAD SCI USA, V104, P18555, DOI 10.1073/pnas.0703333104; Brockerhoff EG, 2008, BIODIVERS CONSERV, V17, P925, DOI 10.1007/s10531-008-9380-x; Fitzherbert EB, 2008, TRENDS ECOL EVOL, V23, P538, DOI 10.1016/j.tree.2008.06.012; Gibson L, 2011, NATURE, V478, P378, DOI 10.1038/nature10425; Guo LB, 2002, GLOBAL CHANGE BIOL, V8, P345, DOI 10.1046/j.1354-1013.2002.00486.x; Hanson MA, 2012, SCIENCE, V335, P851, DOI [10.1126/science.1244693, 10.1126/science.1215904]; Koenig R, 2008, SCIENCE, V320, P1439, DOI 10.1126/science.320.5882.1439; Koh LP, 2008, CONSERV LETT, V1, P60, DOI 10.1111/j.1755-263X.2008.00011.x; Maestre FT, 2004, FOREST ECOL MANAG, V198, P303, DOI 10.1016/j.foreco.2004.05.040; Pereira HM, 2006, ECOLOGY, V87, P1877, DOI 10.1890/0012-9658(2006)87[1877:MBDICL]2.0.CO;2; Wilcove DS, 2013, TRENDS ECOL EVOL, V28, P531, DOI 10.1016/j.tree.2013.04.005; Ziegler AD, 2012, GLOBAL CHANGE BIOL, V18, P3087, DOI 10.1111/j.1365-2486.2012.02747.x	12	168	168	17	223	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 30	2014	344	6187								10.1126/science.1248753	http://dx.doi.org/10.1126/science.1248753			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AH9WM	24876487				2022-12-28	WOS:000336495800030
J	Vogel, J				Vogel, Joerg			A bacterial seek-and-destroy system for foreign DNA	SCIENCE			English	Editorial Material							ARGONAUTE PROTEINS; RNA; INSIGHTS; CLEAVAGE; DEFENSE; GENOME; HFQ		Univ Wurzburg, Inst Mol Infect Biol, RNA Biol Grp, D-97080 Wurzburg, Germany	University of Wurzburg	Vogel, J (corresponding author), Univ Wurzburg, Inst Mol Infect Biol, RNA Biol Grp, D-97080 Wurzburg, Germany.	joerg.vogel@uni-wuerzburg.de	Vogel, Jörg/D-5574-2011	Vogel, Jörg/0000-0003-2220-1404				Charpentier E, 2013, NATURE, V495, P50, DOI 10.1038/495050a; Gregory ST, 2008, FEMS MICROBIOL LETT, V289, P187, DOI 10.1111/j.1574-6968.2008.01389.x; Kuhn CD, 2013, TRENDS BIOCHEM SCI, V38, P263, DOI 10.1016/j.tibs.2013.02.008; Makarova KS, 2009, BIOL DIRECT, V4, DOI 10.1186/1745-6150-4-29; Meister G, 2013, NAT REV GENET, V14, P447, DOI 10.1038/nrg3462; Navarre WW, 2007, GENE DEV, V21, P1456, DOI 10.1101/gad.1543107; Olovnikov I, 2013, MOL CELL, V51, P594, DOI 10.1016/j.molcel.2013.08.014; Pandey SP, 2011, NUCLEIC ACIDS RES, V39, P4691, DOI 10.1093/nar/gkr060; Sampson TR, 2013, NATURE, V497, P254, DOI 10.1038/nature12048; Sheng G, 2014, P NATL ACAD SCI USA, V111, P652, DOI 10.1073/pnas.1321032111; Swarts DC, 2014, NATURE, V507, P258, DOI 10.1038/nature12971; Vogel J, 2011, NAT REV MICROBIOL, V9, P578, DOI 10.1038/nrmicro2615; Yuan YR, 2005, MOL CELL, V19, P405, DOI 10.1016/j.molcel.2005.07.011	13	8	27	0	28	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 30	2014	344	6187					972	973		10.1126/science.1252962	http://dx.doi.org/10.1126/science.1252962			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AH9WM	24876480				2022-12-28	WOS:000336495800021
J	Kohout, AL; Williams, MJM; Dean, SM; Meylan, MH				Kohout, A. L.; Williams, M. J. M.; Dean, S. M.; Meylan, M. H.			Storm-induced sea-ice breakup and the implications for ice extent	NATURE			English	Article							OCEAN WAVES; ATTENUATION; TRENDS; ZONE; CLIMATE	The propagation of large, storm-generated waves through sea ice has so far not been measured, limiting our understanding of how ocean waves break sea ice. Without improved knowledge of ice breakup, we are unable to understand recent changes, or predict future changes, in Arctic and Antarctic sea ice. Here we show that storm-generated ocean waves propagating through Antarctic sea ice are able to transport enough energy to break sea ice hundreds of kilometres from the ice edge. Our results, which are based on concurrent observations at multiple locations, establish that large waves break sea ice much farther from the ice edge than would be predicted by the commonly assumed exponential decay(1-3). We observed the wave height decay to be almost linear for large waves-those with a significant wave height greater than three metres-and to be exponential only for small waves. This implies a more prominent role for large ocean waves in sea-ice breakup and retreat than previously thought. We examine the wider relevance of this by comparing observed Antarctic sea-ice edge positions with changes in modelled significant wave heights for the Southern Ocean between 1997 and 2009, and find that the retreat and expansion of the sea-ice edge correlate with mean significant wave height increases and decreases, respectively. This includes capturing the spatial variability in sea-ice trends found in the Ross and Amundsen-Bellingshausen seas. Climate models fail to capture recent changes in sea ice in both polar regions(4,5). Our results suggest that the incorporation of explicit or parameterized interactions between ocean waves and sea ice may resolve this problem.	[Kohout, A. L.] Natl Inst Water & Atmospher Res, Christchurch 8011, New Zealand; [Williams, M. J. M.; Dean, S. M.] Natl Inst Water & Atmospher Res, Wellington 6021, New Zealand; [Meylan, M. H.] Univ Newcastle, Newcastle, NSW 2308, Australia	National Institute of Water & Atmospheric Research (NIWA) - New Zealand; National Institute of Water & Atmospheric Research (NIWA) - New Zealand; University of Newcastle	Kohout, AL (corresponding author), Natl Inst Water & Atmospher Res, Christchurch 8011, New Zealand.	alison.kohout@niwa.co.nz	Dean, Sam/F-7711-2011; Williams, Michael/H-9674-2014; Meylan, Michael/A-7341-2010	Dean, Sam/0000-0001-6338-4601; Meylan, Michael/0000-0002-3164-1367	New Zealand Foundation of Research Science and Technology; Marsden Fund Council; NIWA, under National Climate Centre Climate Systems programme; Antarctic Climate and Ecosystems Cooperative Research Centre; Australian Antarctic Science project [4073]	New Zealand Foundation of Research Science and Technology(New Zealand Foundation for Research, Science and Technology); Marsden Fund Council(Royal Society of New ZealandMarsden Fund (NZ)); NIWA, under National Climate Centre Climate Systems programme; Antarctic Climate and Ecosystems Cooperative Research Centre(Australian GovernmentDepartment of Industry, Innovation and ScienceCooperative Research Centres (CRC) Programme); Australian Antarctic Science project	We thank Inprod Pty Ltd for instrument design and construction; M. Doble, V. Squire and T. Haskell for contributions toward instrument design; T. Toyota for the provision of ice floe size and ice thickness data; the captain and crew of RSV Aurora Australis and the second Sea Ice Physics and Ecosystem Experiment (SIPEX II) for their assistance in deploying the waves-in-ice instruments; and V. Squire, T. Toyota, L. Bennetts and T. Williams for contributions toward interpretation and editing. The work was funded by a New Zealand Foundation of Research Science and Technology Postdoctoral award to A. L. K.; the Marsden Fund Council, administered by the Royal Society of New Zealand; NIWA, through core funding under the National Climate Centre Climate Systems programme; the Antarctic Climate and Ecosystems Cooperative Research Centre; and Australian Antarctic Science project 4073.	[Anonymous], GEOPHYS RES LETT, DOI [10.1029/2007/GL029703, DOI 10.1029/2007GL029703]; Chawla A, 2013, OCEAN MODEL, V70, P189, DOI 10.1016/j.ocemod.2012.07.005; Dee DP, 2011, Q J ROY METEOR SOC, V137, P553, DOI 10.1002/qj.828; Dobrynin M, 2012, GEOPHYS RES LETT, V39, DOI 10.1029/2012GL052843; Downer J, 2001, ANN GLACIOL, V33, P345, DOI 10.3189/172756401781818923; Dumont D, 2011, J GEOPHYS RES-OCEANS, V116, DOI 10.1029/2010JC006682; Earle M. D., 1996, 9601 NDBC US DEP COM; Hartmann DL, 2014, CLIMATE CHANGE 2013: THE PHYSICAL SCIENCE BASIS, P159; Holland PR, 2012, NAT GEOSCI, V5, P872, DOI [10.1038/ngeo1627, 10.1038/NGEO1627]; Kaleschke L, 2001, CAN J REMOTE SENS, V27, P526, DOI 10.1080/07038992.2001.10854892; Kaleschke L., 2006, SEA ICE CONCENTRATIO; Kohout AL, 2008, J GEOPHYS RES-OCEANS, V113, DOI 10.1029/2007JC004434; Kohout A. L., 2013, WAVES IN ICE OBSERVA; Komen G. J., 1994, DYNAMICS MODELLING O, P232; LIU AK, 1992, ATMOS OCEAN, V30, P192, DOI 10.1080/07055900.1992.9649437; LONGUETHIGGINS MS, 1952, J MAR RES, V11, P245; Marko J. R., 2003, J GEOPHYS RES, V108, pC9; Meier W., 2013, NOAANSIDC CLIMATE DA; Parkinson CL, 2012, CRYOSPHERE, V6, P871, DOI 10.5194/tc-6-871-2012; Peng G, 2013, EARTH SYST SCI DATA, V5, P311, DOI 10.5194/essd-5-311-2013; Prinsenberg SJ, 2011, ANN GLACIOL, V52, P35, DOI 10.3189/172756411795931688; Shackleton E. H., 1982, S STORY SHACKLETONS, V103; Spreen G, 2008, J GEOPHYS RES-OCEANS, V113, DOI 10.1029/2005JC003384; Squire VA, 2007, COLD REG SCI TECHNOL, V49, P110, DOI 10.1016/j.coldregions.2007.04.007; SQUIRE VA, 1980, NATURE, V283, P365, DOI 10.1038/283365a0; SQUIRE VA, 1995, ANNU REV FLUID MECH, V27, P115, DOI 10.1146/annurev.fl.27.010195.000555; Toyota T, 2006, GEOPHYS RES LETT, V33, DOI 10.1029/2005GL024556; Tucker M.J., 2001, WAVES OCEAN ENG; Turner J, 2013, J CLIMATE, V26, P1473, DOI 10.1175/JCLI-D-12-00068.1; WADHAMS P, 1988, J GEOPHYS RES-OCEANS, V93, P6799, DOI 10.1029/JC093iC06p06799; Wadhams P., 2002, ICE OCEAN, P202; Williams TD, 2013, OCEAN MODEL, V71, P92, DOI 10.1016/j.ocemod.2013.05.011; Young IR, 2011, SCIENCE, V332, P451, DOI 10.1126/science.1197219	34	192	198	2	78	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 29	2014	509	7502					604	+		10.1038/nature13262	http://dx.doi.org/10.1038/nature13262			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AH9JC	24870546				2022-12-28	WOS:000336457100046
J	Power, A; Berger, AC; Ginsburg, GS				Power, Aidan; Berger, Adam C.; Ginsburg, Geoffrey S.			Genomics-Enabled Drug Repositioning and Repurposing Insights From an IOM Roundtable Activity	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Power, Aidan] Pfizer Worldwide Res & Dev, Groton, CT USA; [Berger, Adam C.] Natl Acad Sci, Inst Med, Washington, DC 20418 USA; [Ginsburg, Geoffrey S.] Duke Univ, Inst Genome Sci & Policy, Durham, NC 27708 USA	Pfizer; National Academies of Sciences, Engineering & Medicine; Duke University	Ginsburg, GS (corresponding author), Duke Univ, Inst Genome Sci & Policy, 101 Sci Dr, Durham, NC 27708 USA.	geoffrey.ginsburg@duke.edu						Denny JC, 2013, NAT BIOTECHNOL, V31, P1102, DOI 10.1038/nbt.2749; Institute of Medicine, DRUG REP REP; Medical Research Council, ALZH CANC RAR DIS RE; National Center for Advancing Translational Sciences, NEW THER US 2013 PRO; Novac N, 2013, TRENDS PHARMACOL SCI, V34, P267, DOI 10.1016/j.tips.2013.03.004; Plenge RM, 2013, NAT REV DRUG DISCOV, V12, P581, DOI 10.1038/nrd4051; US Food and Drug Administration, VAL RES DRUG DEV RAR; US Food and Drug Administration, NOV NEW DRUGS 2013 S	8	21	22	0	5	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAY 28	2014	311	20					2063	2064		10.1001/jama.2014.3002	http://dx.doi.org/10.1001/jama.2014.3002			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AH8MQ	24867009				2022-12-28	WOS:000336392400017
J	Capewell, S				Capewell, Simon			PERSONAL VIEW Sugar sweetened drinks should carry obesity warnings	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							CONSUMPTION; TOBACCO; ADULTS; FOOD		Univ Liverpool, Liverpool L69 3BX, Merseyside, England	University of Liverpool	Capewell, S (corresponding author), Univ Liverpool, Liverpool L69 3BX, Merseyside, England.	Capewell@liverpool.ac.uk						Academy of Medical Royal Colleges, 2013, MEAS MED PROF PRESCR; [Anonymous], BBC NEWS; Capewell S, 2011, BRIT MED J, V342, DOI 10.1136/bmj.d287; Chantler C, 2014, INDEPENDENT REV STAN; Cochrane Library, 2011, TREATM OB; Credit Suisse Research Institute, 2013, SUG CONS CROSSR; DiMeglio DP, 2000, INT J OBESITY, V24, P794, DOI 10.1038/sj.ijo.0801229; Editorial, 2011, LANCET, V378, P741; Finlex, RAD IND MIN REG LAB; Hennessy M., 2014, FOOD NAVIGATOR  0424; Joossens L, 2006, TOB CONTROL, V15, P247, DOI 10.1136/tc.2005.015347; Moodie R, 2013, LANCET, V381, P670, DOI 10.1016/S0140-6736(12)62089-3; National Institute for Health and Care Excellence, 2010, PREV CARD DIS; Ng SW, 2012, BRIT J NUTR, V108, P536, DOI 10.1017/S0007114511006465; Quinn I, 2014, GROCER          0510; Romaguera D, 2013, DIABETOLOGIA, V56, P1520, DOI 10.1007/s00125-013-2899-8; Yang QH, 2014, JAMA INTERN MED, V174, P516, DOI 10.1001/jamainternmed.2013.13563	17	4	4	0	5	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	MAY 27	2014	348								g3428	10.1136/bmj.g3428	http://dx.doi.org/10.1136/bmj.g3428			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AI3EB	24870354				2022-12-28	WOS:000336741400010
J	Ali, O; Narshi, C; Khanna, M; Roncaroli, F; Abraham, S				Ali, Omer; Narshi, Chetan; Khanna, Monica; Roncaroli, Federico; Abraham, Sonya			A painful swollen thigh in a diabetic patient: diabetic myonecrosis	LANCET			English	Editorial Material							MUSCLE INFARCTION		[Ali, Omer; Narshi, Chetan; Abraham, Sonya] Charing Cross Hosp, Imperial Coll Healthcare NHS Trust, Dept Rheumatol, London W6 8RF, England; [Khanna, Monica] Charing Cross Hosp, Imperial Coll Healthcare NHS Trust, Dept Radiol, London W6 8RF, England; [Roncaroli, Federico] Univ London Imperial Coll Sci Technol & Med, Dept Med, London SW7 2AZ, England	Imperial College London; Imperial College London; Imperial College London	Ali, O (corresponding author), Charing Cross Hosp, Imperial Coll Healthcare NHS Trust, Dept Rheumatol, London W6 8RF, England.	omerali@doctors.org.uk						Habib GS, 2003, CLIN RHEUMATOL, V22, P450, DOI 10.1007/s10067-003-0789-z; Mathew A, 2007, EMERG MED J, V24, P513, DOI 10.1136/emj.2006.040071; Trujillo-Santos AJ, 2003, DIABETES CARE, V26, P211, DOI 10.2337/diacare.26.1.211	3	2	2	0	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	MAY 24	2014	383	9931					1860	1860		10.1016/S0140-6736(14)60543-2	http://dx.doi.org/10.1016/S0140-6736(14)60543-2			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AH6US	24856030				2022-12-28	WOS:000336267800032
J	Ronco, C; Garzotto, F; Brendolan, A; Zanella, M; Bellettato, M; Vedovato, S; Chiarenza, F; Ricci, Z; Goldstein, SL				Ronco, Claudio; Garzotto, Francesco; Brendolan, Alessandra; Zanella, Monica; Bellettato, Massimo; Vedovato, Stefania; Chiarenza, Fabio; Ricci, Zaccaria; Goldstein, Stuart L.			Continuous renal replacement therapy in neonates and small infants: development and first-in-human use of a miniaturised machine (CARPEDIEM)	LANCET			English	Article							ACUTE KIDNEY INJURY; PEDIATRIC-PATIENTS; BIOMARKERS; CYTOKINES; CHILDREN; SURGERY	Background Peritoneal dialysis is the renal replacement therapy of choice for acute kidney injury in neonates, but in some cases is not feasible or effective. Continuous renal replacement therapy (CRRT) machines are used off label in infants smaller than 15 kg and are not designed specifically for small infants. We aimed to design and create a CRRT machine specifically for neonates and small infants. Methods We prospectively planned a 5-year project to conceive, design, and create a miniaturised Cardio-Renal Pediatric Dialysis Emergency Machine (CARPEDIEM), specifically for neonates and small infants. We created the new device and assessed it with in-vitro laboratory tests, completed its development to meet regulatory requirements, and obtained a licence for human use. Once approved, we used the machine to treat a critically ill neonate Findings The main characteristics of CARPEDIEM are the low priming volume of the circuit (less than 30 mL), miniaturised roller pumps, and accurate ultrafiltration control via calibrated scales with a precision of 1 g. In-vitro tests confirmed that both hardware and software met the specifications. We treated a 2.9 kg neonate with haemorrhagic shock, multiple organ dysfunction, and severe fluid overload for more than 400 h with the CARPEDIEM, using continuous venovenous haemofiltration, single-pass albumin dialysis, blood exchange, and plasma exchange. The patient's 65% fluid overload, raised creatinine and bilirubin concentrations, and severe acidosis were all managed safely and effectively. Despite the severity of the illness, organ function was restored and the neonate survived and was discharged from hospital with only mild renal insufficiency that did not require renal replacement therapy. Interpretation The CARPEDIEM CRRT machine can be used to provide various treatment modalities and support for multiple organ dysfunction in neonates and small infants. The CARPEDIEM could reduce the range of indications for peritoneal dialysis, widen the range of indications for CRRT, make the use of CRRT less traumatic, and expand its use as supportive therapy even when complete renal replacement therapy is not indicated.	[Ronco, Claudio; Garzotto, Francesco; Brendolan, Alessandra; Zanella, Monica] San Bortolo Hosp, Int Renal Res Inst, Dept Nephrol Dialysis & Transplantat, I-36100 Vicenza, Italy; [Bellettato, Massimo; Vedovato, Stefania] San Bortolo Hosp, Dept Paediat, I-36100 Vicenza, Italy; [Chiarenza, Fabio] San Bortolo Hosp, Dept Paediat Surg, I-36100 Vicenza, Italy; [Ricci, Zaccaria] Bambino Gesu Pediat Hosp, Paediat Cardiac Intens Care Unit, Dept Cardiol & Cardiac Surg, Rome, Italy; [Goldstein, Stuart L.] Cincinnati Childrens Hosp Med Ctr, Ctr Acute Care Nephrol, Cincinnati, OH 45229 USA	ULSS 8 Berica; Ospedale San Bortolo di Vicenza; ULSS 8 Berica; Ospedale San Bortolo di Vicenza; ULSS 8 Berica; Ospedale San Bortolo di Vicenza; IRCCS Bambino Gesu; Cincinnati Children's Hospital Medical Center	Ronco, C (corresponding author), San Bortolo Hosp, Int Renal Res Inst, Dept Nephrol Dialysis & Transplantat, I-36100 Vicenza, Italy.	cronco@goldnet.it	Ricci, Zaccaria/J-2944-2012; garzotto, francesco/K-3552-2018	garzotto, francesco/0000-0002-0233-3752; ricci, zaccaria/0000-0001-8916-0569; Ronco, Claudio/0000-0002-6697-4065	Associazione Amici del Rene di Vicenza	Associazione Amici del Rene di Vicenza	Funding Associazione Amici del Rene di Vicenza.	Akcan-Arikan A, 2007, KIDNEY INT, V71, P1028, DOI 10.1038/sj.ki.5002231; American Society of Nephrology, 2005, J Am Soc Nephrol, V16, P1886; Askenazi DJ, 2012, J PEDIATR-US, V161, P270, DOI 10.1016/j.jpeds.2012.02.007; Askenazi DJ, 2009, PEDIATR NEPHROL, V24, P265, DOI 10.1007/s00467-008-1060-2; Askenazi DJ, 2006, KIDNEY INT, V69, P184, DOI 10.1038/sj.ki.5000032; Bellomo R, 2004, CRIT CARE, V8, pR204, DOI 10.1186/cc2872; Berdat PA, 2004, J THORAC CARDIOV SUR, V127, P1688, DOI 10.1016/j.jtcvs.2004.01.030; Blinder JJ, 2012, J THORAC CARDIOV SUR, V143, P368, DOI 10.1016/j.jtcvs.2011.06.021; Bokesch PM, 2000, ANN THORAC SURG, V70, P639, DOI 10.1016/S0003-4975(00)01453-3; BUNCHMAN TE, 1994, PEDIATR NEPHROL, V8, P96, DOI 10.1007/BF00868282; Chawla LS, 2011, KIDNEY INT, V79, P1361, DOI 10.1038/ki.2011.42; Devarajan P, 2007, CONTRIB NEPHROL, V156, P203; Eckardt KU, 2012, KIDNEY INT SUPPL, V2, P7, DOI 10.1038/kisup.2012.8; Goldstein SL, 2005, KIDNEY INT, V67, P653, DOI 10.1111/j.1523-1755.2005.67121.x; Goldstein SL, 2001, PEDIATRICS, V107, P1309, DOI 10.1542/peds.107.6.1309; Goldstein SL, 2013, CLIN J AM SOC NEPHRO, V8, P476, DOI 10.2215/CJN.12101112; Hackbarth R, 2007, INT J ARTIF ORGANS, V30, P1116, DOI 10.1177/039139880703001212; Hsu CW, 2010, PEDIATR NEPHROL, V25, P2401, DOI 10.1007/s00467-010-1508-z; Mehta RL, 2007, CRIT CARE, V11, DOI 10.1186/cc5713; Pisoni R, 2008, NEPHRON CLIN PRACT, V109, pC188, DOI 10.1159/000142927; Ronco C, 2012, PEDIATR NEPHROL, V27, P1203, DOI 10.1007/s00467-012-2179-8; SADOWSKI RH, 1994, KIDNEY INT, V45, P903, DOI 10.1038/ki.1994.119; Sutherland SM, 2010, AM J KIDNEY DIS, V55, P316, DOI 10.1053/j.ajkd.2009.10.048; Waikar SS, 2008, NEPHRON CLIN PRACT, V109, pC192, DOI 10.1159/000142928; Walters S, 2009, PEDIATR NEPHROL, V24, P37, DOI 10.1007/s00467-008-0826-x	25	100	105	0	9	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAY 24	2014	383	9931					1807	1813		10.1016/S0140-6736(14)60799-6	http://dx.doi.org/10.1016/S0140-6736(14)60799-6			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AH6US	24856026				2022-12-28	WOS:000336267800027
J	Strasburger, VC; Brown, SS				Strasburger, Victor C.; Brown, Sarah S.			Sex Education in the 21st Century	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Strasburger, Victor C.] Univ New Mexico, Sch Med, Dept Pediat, Albuquerque, NM 87131 USA; [Brown, Sarah S.] Natl Campaign Prevent Teen & Unplanned Pregnancy, Washington, DC USA	University of New Mexico	Strasburger, VC (corresponding author), Univ New Mexico, Sch Med, MSC 10 5590,1 Univ New Mexico, Albuquerque, NM 87131 USA.	vstrasburger@salud.unm.edu						[Anonymous], 2012, FACTS AM TEENS SOURC; [Anonymous], 2013, STAT POL BRIEF SEX H; Giordano M., 2012, LETS TALK SEX YOUNG; Office of Adolescent Health, TEEN PREGN PREV RES; Nguyen P, 2013, J ADOLESCENT HEALTH, V53, P98, DOI 10.1016/j.jadohealth.2013.02.007; Strasburger Victor C, 2012, Adolesc Med State Art Rev, V23, P15	6	30	30	1	5	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUL 9	2014	312	2					125	126		10.1001/jama.2014.4789	http://dx.doi.org/10.1001/jama.2014.4789			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AK6BB	24921683				2022-12-28	WOS:000338511200013
J	Chey, WD; Webster, L; Sostek, M; Lappalainen, J; Barker, PN; Tack, J				Chey, William D.; Webster, Lynn; Sostek, Mark; Lappalainen, Jaakko; Barker, Peter N.; Tack, Jan			Naloxegol for Opioid-Induced Constipation in Patients with Noncancer Pain	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							INDUCED BOWEL DYSFUNCTION; PREVALENCE; CHALLENGES; MANAGEMENT; EFFICACY	Background Opioid-induced constipation is common and debilitating. We investigated the efficacy and safety of naloxegol, an oral, peripherally acting, mu-opioid receptor antagonist, for the treatment of opioid-induced constipation. Methods In two identical phase 3, double-blind studies (study 04, 652 participants; study 05, 700 participants), outpatients with noncancer pain and opioid-induced constipation were randomly assigned to receive a daily dose of 12.5 or 25 mg of naloxegol or placebo. The primary end point was the 12-week response rate (>= 3 spontaneous bowel movements per week and an increase from baseline of >= 1 spontaneous bowel movements for >= 9 of 12 weeks and for >= 3 of the final 4 weeks) in the intention-to-treat population. The key secondary end points were the response rate in the sub-population of patients with an inadequate response to laxatives before enrollment, time to first postdose spontaneous bowel movement, and mean number of days per week with one or more spontaneous bowel movements. Results Response rates were significantly higher with 25 mg of naloxegol than with placebo (intention-to-treat population: study 04, 44.4% vs. 29.4%, P = 0.001; study 05, 39.7% vs. 29.3%, P = 0.02; patients with an inadequate response to laxatives: study 04, 48.7% vs. 28.8%, P = 0.002; study 05, 46.8% vs. 31.4%, P = 0.01); in study 04, response rates were also higher in the group treated with 12.5 mg of naloxegol (intention-to-treat population, 40.8% vs. 29.4%, P = 0.02; patients with an inadequate response to laxatives, 42.6% vs. 28.8%, P = 0.03). A shorter time to the first postdose spontaneous bowel movement and a higher mean number of days per week with one or more spontaneous bowel movements were observed with 25 mg of naloxegol versus placebo in both studies (P<0.001) and with 12.5 mg of naloxegol in study 04 (P<0.001). Pain scores and daily opioid dose were similar among the three groups. Adverse events (primarily gastrointestinal) occurred most frequently in the groups treated with 25 mg of naloxegol. Conclusions Treatment with naloxegol, as compared with placebo, resulted in a significantly higher rate of treatment response, without reducing opioid-mediated analgesia.	[Chey, William D.] Univ Michigan Hlth Syst, Dept Internal Med, Ann Arbor, MI 48109 USA; [Webster, Lynn] PRA Int, Salt Lake City, UT USA; [Sostek, Mark; Lappalainen, Jaakko; Barker, Peter N.] AstraZeneca, Wilmington, DE USA; [Tack, Jan] Katholieke Univ Leuven, Translat Res Ctr Gastrointestinal Disorder TARGID, Leuven, Belgium	University of Michigan System; University of Michigan; AstraZeneca; KU Leuven	Chey, WD (corresponding author), Univ Michigan Hlth Syst, Div Gastroenterol, Taubman Ctr 3912, SPC 5362, Ann Arbor, MI 48109 USA.	wchey@umich.edu	Chey, William/AAY-7766-2021	Tack, Jan/0000-0002-3206-6704	AstraZeneca; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK034933] Funding Source: NIH RePORTER	AstraZeneca(AstraZeneca); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	Funded by AstraZeneca; KODIAC-04 and KODIAC-05 ClinicalTrials.gov numbers, NCT01309841 and NCT01323790, respectively.	Bell TJ, 2009, PAIN MED, V10, P35, DOI 10.1111/j.1526-4637.2008.00495.x; Bream-Rouwenhorst HR, 2009, AM J HEALTH-SYST PH, V66, P1267, DOI 10.2146/ajhp080445; Camilleri M, 2011, AM J GASTROENTEROL, V106, P835, DOI 10.1038/ajg.2011.30; Chenard BL, 2005, ANNU REP MED CHEM, V40, P373, DOI 10.1016/S0065-7743(05)40024-X; CULPEPPERMORGAN JA, 1992, CLIN PHARMACOL THER, V52, P90, DOI 10.1038/clpt.1992.106; Diego L, 2011, EXPERT OPIN INV DRUG, V20, P1047, DOI 10.1517/13543784.2011.592830; Eldon MA, 2007, 18 ANN CLIN M AM AC; Faasen F, 2003, INT J PHARMACEUT, V263, P113, DOI 10.1016/S0378-5173(03)00372-7; Farrar JT, 2001, PAIN, V94, P149, DOI 10.1016/S0304-3959(01)00349-9; Himmelsbach CK, 1941, ANN INTERN MED, V15, P829, DOI 10.7326/0003-4819-15-5-829; Holzer P, 2008, EUR REV MED PHARMACO, V12, P119; Holzer P, 2008, THERAPY, V5, P531; IMS Institute for Healthcare Informatics, 2011, US MED US REV 2010; Kalso E, 2004, PAIN, V112, P372, DOI 10.1016/j.pain.2004.09.019; Panchal SJ, 2007, INT J CLIN PRACT, V61, P1181, DOI 10.1111/j.1742-1241.2007.01415.x; Pappagallo M, 2001, AM J SURG, V182, p11S, DOI 10.1016/S0002-9610(01)00782-6; Rachinger-Adam B, 2011, CURR OPIN ANESTHESIO, V24, P408, DOI 10.1097/ACO.0b013e32834873e5; Reimer K, 2009, PHARMACOLOGY, V83, P10, DOI 10.1159/000165778; Tuteja AK, 2010, NEUROGASTROENT MOTIL, V22, P424, DOI 10.1111/j.1365-2982.2009.01458.x; Webster L, 2013, PAIN, V154, P1542, DOI 10.1016/j.pain.2013.04.024	20	224	240	1	22	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUN 19	2014	370	25					2387	2396		10.1056/NEJMoa1310246	http://dx.doi.org/10.1056/NEJMoa1310246			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AJ0OA	24896818	Bronze			2022-12-28	WOS:000337353000007
J	Grady, JM; Enquist, BJ; Dettweiler-Robinson, E; Wright, NA; Smith, FA				Grady, John M.; Enquist, Brian J.; Dettweiler-Robinson, Eva; Wright, Natalie A.; Smith, Felisa A.			DINOSAUR PHYSIOLOGY Evidence for mesothermy in dinosaurs	SCIENCE			English	Article							BODY TEMPERATURES; GROWTH-RATES; THERMOREGULATION; EVOLUTION; PATTERNS	Were dinosaurs ectotherms or fast-metabolizing endotherms whose activities were unconstrained by temperature? To date, some of the strongest evidence for endothermy comes from the rapid growth rates derived from the analysis of fossil bones. However, these studies are constrained by a lack of comparative data and an appropriate energetic framework. Here we compile data on ontogenetic growth for extant and fossil vertebrates, including all major dinosaur clades. Using a metabolic scaling approach, we find that growth and metabolic rates follow theoretical predictions across clades, although some groups deviate. Moreover, when the effects of size and temperature are considered, dinosaur metabolic rates were intermediate to those of endotherms and ectotherms and closest to those of extant mesotherms. Our results suggest that the modern dichotomy of endothermic versus ectothermic is overly simplistic.	[Grady, John M.; Dettweiler-Robinson, Eva; Wright, Natalie A.; Smith, Felisa A.] Univ New Mexico, Dept Biol, Albuquerque, NM 87131 USA; [Enquist, Brian J.] Univ Arizona, Dept Ecol & Evolutionary Biol, Tucson, AZ 85721 USA; [Enquist, Brian J.] Santa Fe Inst, Santa Fe, NM 87501 USA	University of New Mexico; University of Arizona; The Santa Fe Institute	Grady, JM (corresponding author), Univ New Mexico, Dept Biol, Albuquerque, NM 87131 USA.	jgrady@unm.edu	Enquist, Brian J/B-6436-2008; Smith, Felisa/ABE-6160-2021	Enquist, Brian J/0000-0002-6124-7096; Smith, Felisa/0000-0001-6262-436X; Dettweiler-Robinson, Eva/0000-0002-9742-3434; Grady, John/0000-0001-6444-3300	Program in Interdisciplinary Biological and Biomedical Sciences at the University of New Mexico (grant from the National Institute of Biomedical Imaging and Bioengineering) [T32EB009414]; NSF CAREER; NSF ATB [EF 0742800]; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [T32EB009414] Funding Source: NIH RePORTER	Program in Interdisciplinary Biological and Biomedical Sciences at the University of New Mexico (grant from the National Institute of Biomedical Imaging and Bioengineering); NSF CAREER(National Science Foundation (NSF)NSF - Office of the Director (OD)); NSF ATB; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB))	This work was supported by a fellowship from the Program in Interdisciplinary Biological and Biomedical Sciences at the University of New Mexico (grant no. T32EB009414 from the National Institute of Biomedical Imaging and Bioengineering to F.A.S. and J. H. Brown). B.J.E. was supported by an NSF CAREER and ATB Award (EF 0742800). We thank C. White and two anonymous reviewers for valuable feedback on our manuscript and N. Milan for assistance with the figures. Data are available in the supplementary materials.	Bernal D, 2001, COMP BIOCHEM PHYS A, V129, P695, DOI 10.1016/S1095-6433(01)00333-6; Brice PH, 2002, AUST J ZOOL, V50, P461, DOI 10.1071/ZO01080; Brown JH, 2004, ECOLOGY, V85, P1771, DOI 10.1890/03-9000; CASE TJ, 1978, Q REV BIOL, V53, P243, DOI 10.1086/410622; Charnov Eric L., 1993, Evolutionary Anthropology, V1, P191, DOI 10.1002/evan.1360010604; Chinsamy Anusuya, 2002, P421; Eagle RA, 2011, SCIENCE, V333, P443, DOI 10.1126/science.1206196; ELSE PL, 1981, AM J PHYSIOL, V240, pR3, DOI 10.1152/ajpregu.1981.240.1.R3; Erickson GM, 2001, NATURE, V412, P429, DOI 10.1038/35086558; Erickson GM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007390; Gillooly JF, 2001, SCIENCE, V293, P2248, DOI 10.1126/science.1061967; Hou C, 2008, SCIENCE, V322, P736, DOI 10.1126/science.1162302; Isler K, 2009, J HUM EVOL, V57, P392, DOI 10.1016/j.jhevol.2009.04.009; Lee AH, 2008, P NATL ACAD SCI USA, V105, P582, DOI 10.1073/pnas.0708903105; Padian K, 2001, NATURE, V412, P405, DOI 10.1038/35086500; PALADINO FV, 1990, NATURE, V344, P858, DOI 10.1038/344858a0; Portner HO, 2008, SCIENCE, V322, P690, DOI 10.1126/science.1163156; Reid R., 2012, COMPLETE DINOSAUR, P873; Sander PM, 2011, BIOL REV, V86, P117, DOI 10.1111/j.1469-185X.2010.00137.x; Seebacher F, 1999, J EXP BIOL, V202, P77; Seebacher F, 2003, PALEOBIOLOGY, V29, P105, DOI 10.1666/0094-8373(2003)029<0105:DBTTOO>2.0.CO;2; West GB, 2001, NATURE, V413, P628, DOI 10.1038/35098076; White CR, 2006, BIOL LETTERS, V2, P125, DOI 10.1098/rsbl.2005.0378	23	104	105	6	250	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 13	2014	344	6189					1268	1272		10.1126/science.1253143	http://dx.doi.org/10.1126/science.1253143			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI7ND	24926017				2022-12-28	WOS:000337077500037
J	Albert, JB; Auty, DJ; Barbeau, PS; Beauchamp, E; Beck, D; Belov, V; Benitez-Medina, C; Bonatt, J; Breidenbach, M; Brunner, T; Burenkov, A; Cao, GF; Chambers, C; Chaves, J; Cleveland, B; Coon, M; Craycraft, A; Daniels, T; Danilov, M; Daugherty, SJ; Davis, CG; Davis, J; Devoe, R; Delaquis, S; Didberidze, T; Dolgolenko, A; Dolinski, MJ; Dunford, M; Fairbank, W; Farine, J; Feldmeier, W; Fierlinger, P; Fudenberg, D; Giroux, G; Gornea, R; Graham, K; Gratta, G; Hall, C; Herrin, S; Hughes, M; Jewell, MJ; Jiang, XS; Johnson, A; Johnson, TN; Johnston, S; Karelin, A; Kaufman, LJ; Killick, R; Koffas, T; Kravitz, S; Kuchenkov, A; Kumar, KS; Leonard, DS; Leonard, F; Licciardi, C; Lin, YH; MacLellan, R; Marino, MG; Mong, B; Moore, D; Nelson, R; Odian, A; Ostrovskiy, I; Ouellet, C; Piepke, A; Pocar, A; Prescott, CY; Rivas, A; Rowson, PC; Rozo, MP; Russell, JJ; Schubert, A; Sinclair, D; Slutsky, S; Smith, E; Stekhanov, V; Tarka, M; Tolba, T; Tosi, D; Twelker, K; Vogel, P; Vuilleumier, JL; Waite, A; Walton, J; Walton, T; Weber, M; Wen, LJ; Wichoski, U; Wright, JD; Yang, L; Yen, YR; Zeldovich, OY; Zhao, YB				Albert, J. B.; Auty, D. J.; Barbeau, P. S.; Beauchamp, E.; Beck, D.; Belov, V.; Benitez-Medina, C.; Bonatt, J.; Breidenbach, M.; Brunner, T.; Burenkov, A.; Cao, G. F.; Chambers, C.; Chaves, J.; Cleveland, B.; Coon, M.; Craycraft, A.; Daniels, T.; Danilov, M.; Daugherty, S. J.; Davis, C. G.; Davis, J.; Devoe, R.; Delaquis, S.; Didberidze, T.; Dolgolenko, A.; Dolinski, M. J.; Dunford, M.; Fairbank, W., Jr.; Farine, J.; Feldmeier, W.; Fierlinger, P.; Fudenberg, D.; Giroux, G.; Gornea, R.; Graham, K.; Gratta, G.; Hall, C.; Herrin, S.; Hughes, M.; Jewell, M. J.; Jiang, X. S.; Johnson, A.; Johnson, T. N.; Johnston, S.; Karelin, A.; Kaufman, L. J.; Killick, R.; Koffas, T.; Kravitz, S.; Kuchenkov, A.; Kumar, K. S.; Leonard, D. S.; Leonard, F.; Licciardi, C.; Lin, Y. H.; MacLellan, R.; Marino, M. G.; Mong, B.; Moore, D.; Nelson, R.; Odian, A.; Ostrovskiy, I.; Ouellet, C.; Piepke, A.; Pocar, A.; Prescott, C. Y.; Rivas, A.; Rowson, P. C.; Rozo, M. P.; Russell, J. J.; Schubert, A.; Sinclair, D.; Slutsky, S.; Smith, E.; Stekhanov, V.; Tarka, M.; Tolba, T.; Tosi, D.; Twelker, K.; Vogel, P.; Vuilleumier, J. -L.; Waite, A.; Walton, J.; Walton, T.; Weber, M.; Wen, L. J.; Wichoski, U.; Wright, J. D.; Yang, L.; Yen, Y. -R.; Zeldovich, O. Ya.; Zhao, Y. B.		EXO-200 Collaboration	Search for Majorana neutrinos with the first two years of EXO-200 data	NATURE			English	Article							DECAY	Many extensions of the standard model of particle physics suggest that neutrinos should be Majorana-type fermions-that is, that neutrinos are their own anti-particles-but this assumption is difficult to confirm. Observation of neutrinoless double-beta decay (0 nu beta beta), a spontaneous transition that may occur in several candidate nuclei, would verify the Majorana nature of the neutrino and constrain the absolute scale of the neutrino mass spectrum. Recent searches carried out with Ge-76 (the GERDA experiment) and Xe-136 (the KamLAND-Zen and EXO (Enriched Xenon Observatory)-200 experiments) have established the lifetime of this decay to be longer than 10(25) years, corresponding to a limit on the neutrino mass of 0.2-0.4 electronvolts. Here we report new results from EXO-200 based on a large Xe-136 exposure that represents an almost fourfold increase from our earlier published data sets. We have improved the detector resolution and revised the data analysis. The half-life sensitivity we obtain is 1.9x10(25) years, an improvement by a factor of 2.7 on previous EXO-200 results. We find no statistically significant evidence for 0 nu beta beta decay and set a half-life limit of 1.1x10(25) years at the 90 per cent confidence level. The high sensitivity holds promise for further running of the EXO-200 detector and future 0 nu beta beta decay searches with an improved Xe-based experiment, nEXO.	[Albert, J. B.; Daugherty, S. J.; Johnson, T. N.; Kaufman, L. J.] Indiana Univ, Dept Phys, Bloomington, IN 47405 USA; [Albert, J. B.; Daugherty, S. J.; Johnson, T. N.; Kaufman, L. J.] Indiana Univ, CEEM, Bloomington, IN 47405 USA; [Auty, D. J.; Didberidze, T.; Hughes, M.; Piepke, A.] Univ Alabama, Dept Phys & Astron, Tuscaloosa, AL 35487 USA; [Barbeau, P. S.] Duke Univ, Dept Phys, Durham, NC 27708 USA; [Barbeau, P. S.] Triangle Univ Nucl Lab, Durham, NC 27708 USA; [Beauchamp, E.; Cleveland, B.; Farine, J.; Mong, B.; Wichoski, U.] Laurentian Univ, Dept Phys, Sudbury, ON P3E 2C6, Canada; [Beck, D.; Coon, M.; Tarka, M.; Walton, J.; Yang, L.] Univ Illinois, Dept Phys, Urbana, IL 61801 USA; [Belov, V.; Burenkov, A.; Danilov, M.; Dolgolenko, A.; Karelin, A.; Kuchenkov, A.; Stekhanov, V.; Zeldovich, O. Ya.] Inst Theoret & Expt Phys, Moscow 117218, Russia; [Benitez-Medina, C.; Chambers, C.; Craycraft, A.; Fairbank, W., Jr.; Walton, T.] Colorado State Univ, Dept Phys, Ft Collins, CO 80523 USA; [Bonatt, J.; Daniels, T.; Johnston, S.; Kumar, K. S.; Pocar, A.; Wright, J. D.] Univ Massachusetts, Dept Phys, Amherst, MA 01003 USA; [Bonatt, J.; Brunner, T.; Chaves, J.; Davis, J.; Devoe, R.; Fudenberg, D.; Gratta, G.; Kravitz, S.; Moore, D.; Ostrovskiy, I.; Rivas, A.; Schubert, A.; Tosi, D.; Twelker, K.; Weber, M.] Stanford Univ, Dept Phys, Stanford, CA 94305 USA; [Breidenbach, M.; Herrin, S.; Johnson, A.; MacLellan, R.; Odian, A.; Prescott, C. Y.; Rowson, P. C.; Russell, J. J.; Waite, A.] SLAC Natl Accelerator Lab, Menlo Pk, CA 94025 USA; [Cao, G. F.; Jiang, X. S.; Wen, L. J.; Zhao, Y. B.] Inst High Energy Phys, Beijing 100049, Peoples R China; [Cleveland, B.] SNOLAB, Sudbury, ON P3Y 1N2, Canada; [Davis, C. G.; Hall, C.; Slutsky, S.; Yen, Y. -R.] Univ Maryland, Dept Phys, College Pk, MD 20742 USA; [Delaquis, S.; Giroux, G.; Gornea, R.; Tolba, T.; Vuilleumier, J. -L.] Univ Bern, Albert Einstein Ctr, LHEP, CH-3012 Bern, Switzerland; [Dolinski, M. J.; Jewell, M. J.; Lin, Y. H.; Smith, E.; Yen, Y. -R.] Drexel Univ, Dept Phys, Philadelphia, PA 19104 USA; [Dunford, M.; Graham, K.; Killick, R.; Koffas, T.; Leonard, F.; Licciardi, C.; Ouellet, C.; Rozo, M. P.; Sinclair, D.] Carleton Univ, Dept Phys, Ottawa, ON K1S 5B6, Canada; [Feldmeier, W.; Fierlinger, P.; Marino, M. G.] Tech Univ Munich, Dept Phys, D-85748 Garching, Germany; [Feldmeier, W.; Fierlinger, P.; Marino, M. G.] Excellence Cluster Universe, D-85748 Garching, Germany; [Leonard, D. S.] Univ Seoul, Dept Phys, Seoul 130743, South Korea; [Nelson, R.] Waste Isolat Pilot Plant, Carlsbad, NM 88220 USA; [Sinclair, D.] TRIUMF, Vancouver, BC V6T 2A3, Canada; [Vogel, P.] CALTECH, Kellogg Lab, Pasadena, CA 91125 USA; [Giroux, G.] Queens Univ, Kingston, ON K7L 3N6, Canada; [Slutsky, S.] CALTECH, Pasadena, CA 91125 USA; [Tosi, D.] Univ Wisconsin, Madison, WI 53706 USA	Indiana University System; Indiana University Bloomington; Indiana University System; Indiana University Bloomington; University of Alabama System; University of Alabama Tuscaloosa; Duke University; University of North Carolina; North Carolina State University; University of North Carolina Chapel Hill; Duke University; Laurentian University; University of Illinois System; University of Illinois Urbana-Champaign; National Research Centre - Kurchatov Institute; Alikhanov Institute for Theoretical & Experimental Physics; Colorado State University; University of Massachusetts System; University of Massachusetts Amherst; Stanford University; Stanford University; United States Department of Energy (DOE); SLAC National Accelerator Laboratory; Chinese Academy of Sciences; Institute of High Energy Physics, CAS; University System of Maryland; University of Maryland College Park; University of Bern; Drexel University; Carleton University; Technical University of Munich; University of Munich; University of Seoul; University of British Columbia; California Institute of Technology; Queens University - Canada; California Institute of Technology; University of Wisconsin System; University of Wisconsin Madison	Albert, JB (corresponding author), Indiana Univ, Dept Phys, Bloomington, IN 47405 USA.		Moore, David C/Q-2208-2017; Danilov, Mikhail/C-5380-2014; Yang, Liang/AAT-9994-2020; Brunner, Thomas/CAF-7872-2022; Burenkov, Alexander A/I-4323-2014; Wen, Liangjian/C-5113-2015	Moore, David C/0000-0002-2358-4761; Danilov, Mikhail/0000-0001-9227-5164; Yang, Liang/0000-0001-5272-050X; Burenkov, Alexander A/0000-0002-8390-4667; Vogel, Petr/0000-0003-0587-5466; Marino, Michael/0000-0003-1226-6036; Wen, Liangjian/0000-0003-4541-9422; Barbeau, Phillip/0000-0002-8891-8988; Koffas, Thomas/0000-0001-9612-4988; Breidenbach, Martin/0000-0001-5022-0835; Mong, Brian/0000-0001-5670-9535; Tarka, Michal/0000-0002-7099-2119; Jewell, Michael/0000-0002-5260-7416; Dolinski, Michelle/0000-0002-7716-2126; Hughes, Mitchell/0000-0001-5217-1758; Brunner, Thomas/0000-0002-3131-8148; MacLellan, Ryan/0000-0003-2479-5277; Hall, Carter/0000-0003-4243-8265; Ostrovskiy, Igor/0000-0003-4939-0225	DOE; NSF in the United States; NSERC in Canada; SNF in Switzerland; NRF in Korea; RFBR in Russia [12-02-12145]; DFG Cluster of Excellence 'Universe' in Germany; Office of Science of the US DOE [DE-AC02-05CH11231]; Direct For Mathematical & Physical Scien [1307362, 1205977] Funding Source: National Science Foundation	DOE(United States Department of Energy (DOE)); NSF in the United States(National Science Foundation (NSF)); NSERC in Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)); SNF in Switzerland; NRF in Korea(National Research Foundation of Korea); RFBR in Russia(Russian Foundation for Basic Research (RFBR)); DFG Cluster of Excellence 'Universe' in Germany; Office of Science of the US DOE(United States Department of Energy (DOE)); Direct For Mathematical & Physical Scien(National Science Foundation (NSF)NSF - Directorate for Mathematical & Physical Sciences (MPS))	EXO-200 is supported by the DOE and NSF in the United States, NSERC in Canada, SNF in Switzerland, NRF in Korea, RFBR (12-02-12145) in Russia and the DFG Cluster of Excellence 'Universe' in Germany. EXO-200 data analysis and simulation used resources of the National Energy Research Scientific Computing Center (NERSC), which is supported by the Office of Science of the US DOE under contract no. DE-AC02-05CH11231. The EXO-200 collaboration acknowledges the WIPP for their hospitality.	Ackerman N, 2011, PHYS REV LETT, V107, DOI 10.1103/PhysRevLett.107.212501; Agostini M, 2013, PHYS REV LETT, V111, DOI 10.1103/PhysRevLett.111.122503; Albert JB, 2014, PHYS REV C, V89, DOI 10.1103/PhysRevC.89.015502; Allison J, 2006, IEEE T NUCL SCI, V53, P270, DOI 10.1109/TNS.2006.869826; [Anonymous], 2014, 3M HFE 7000; Auger M, 2012, PHYS REV LETT, V109, DOI 10.1103/PhysRevLett.109.032505; Auger M, 2012, J INSTRUM, V7, DOI 10.1088/1748-0221/7/05/P05010; Barabash AS, 2010, PHYS REV C, V81, DOI 10.1103/PhysRevC.81.035501; Barea J, 2013, PHYS REV C, V87, DOI 10.1103/PhysRevC.87.014315; Battistoni G, 2007, AIP CONF PROC, V896, P31, DOI 10.1063/1.2720455; Bhat M., 1992, RES REPORTS PHYS, P817; Camilleri L, 2008, ANNU REV NUCL PART S, V58, P343, DOI 10.1146/annurev.nucl.57.090506.123038; Cowan G., 1998, STAT DATA ANAL; Esch EI, 2005, NUCL INSTRUM METH A, V538, P516, DOI 10.1016/j.nima.2004.09.005; Ferrari A, 2005, CERN2005010; Forero DV, 2012, PHYS REV D, V86, DOI 10.1103/PhysRevD.86.073012; Gando A, 2013, PHYS REV LETT, V110, DOI 10.1103/PhysRevLett.110.062502; Gell-Mann M., 1979, Supergravity, P315; Leonard DS, 2008, NUCL INSTRUM METH A, V591, P490, DOI 10.1016/j.nima.2008.03.001; Majorana E., 1937, NUOVO CIMENTO, V5, P171, DOI [10.1007/BF02961314, DOI 10.1007/BF02961314]; Menendez J, 2009, NUCL PHYS A, V818, P139, DOI 10.1016/j.nuclphysa.2008.12.005; MOHAPATRA RN, 1980, PHYS REV LETT, V44, P912, DOI 10.1103/PhysRevLett.44.912; Mourik V, 2012, SCIENCE, V336, P1003, DOI 10.1126/science.1222360; Racah G., 1937, NUOVO CIM, V14, P322, DOI [10.1007/BF02961321, DOI 10.1007/BF02961321]; Redshaw M, 2007, PHYS REV LETT, V98, DOI 10.1103/PhysRevLett.98.053003; Rodriguez TR, 2010, PHYS REV LETT, V105, DOI 10.1103/PhysRevLett.105.252503; SCHECHTER J, 1982, PHYS REV D, V25, P2951, DOI 10.1103/PhysRevD.25.2951; Simkovic F, 2013, PHYS REV C, V87, DOI 10.1103/PhysRevC.87.045501; Vogel P, 2012, J PHYS G NUCL PARTIC, V39, DOI 10.1088/0954-3899/39/12/124002; Wilks SS, 1938, ANN MATH STAT, V9, P60, DOI 10.1214/aoms/1177732360; Wilson W. B., 1999, LA13639MS LOS AL NAT	33	331	333	0	53	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 12	2014	510	7504					229	234		10.1038/nature13432	http://dx.doi.org/10.1038/nature13432			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI7AT	24896189	Green Submitted, Green Accepted			2022-12-28	WOS:000337032400042
J	Lazar, JD; Willis, LK				Lazar, Jeffrey D.; Willis, Lucy K.			A Blinking Knee	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Lazar, Jeffrey D.; Willis, Lucy K.] New York Presbyterian Lower Manhattan Hosp, New York, NY 10038 USA	NewYork-Presbyterian Hospital	Lazar, JD (corresponding author), New York Presbyterian Lower Manhattan Hosp, New York, NY 10038 USA.	jdl9002@med.cornell.edu							0	4	4	0	0	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUN 12	2014	370	24					E36	E36		10.1056/NEJMicm1311581	http://dx.doi.org/10.1056/NEJMicm1311581			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AI7BB	24918395				2022-12-28	WOS:000337033700002
J	Sukhija, J; Kaur, S				Sukhija, Jaspreet; Kaur, Savleen			Morgagnian Cataract	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Sukhija, Jaspreet; Kaur, Savleen] Postgrad Inst Med Educ & Res, Chandigarh 160012, India	Post Graduate Institute of Medical Education & Research (PGIMER), Chandigarh	Sukhija, J (corresponding author), Postgrad Inst Med Educ & Res, Chandigarh 160012, India.	jaspreetsukhija@rediffmail.com	Gupta, Gaurav/AAA-6134-2020; Kaur, Savleen/AAH-6415-2020	Gupta, Gaurav/0000-0002-7080-5635; Kaur, Savleen/0000-0003-1929-4451					0	1	2	0	3	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUN 12	2014	370	24					2326	2326		10.1056/NEJMicm1312140	http://dx.doi.org/10.1056/NEJMicm1312140			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AI7BB	24918375				2022-12-28	WOS:000337033700012
J	Woyach, JA; Furman, RR; Liu, TM; Ozer, HG; Zapatka, M; Ruppert, AS; Xue, L; Li, DHH; Steggerda, SM; Versele, M; Dave, SS; Zhang, J; Yilmaz, AS; Jaglowski, SM; Blum, KA; Lozanski, A; Lozanski, G; James, DF; Barrientos, JC; Lichter, P; Stilgenbauer, S; Buggy, JJ; Chang, BY; Johnson, AJ; Byrd, JC				Woyach, Jennifer A.; Furman, Richard R.; Liu, Ta-Ming; Ozer, Hatice Gulcin; Zapatka, Marc; Ruppert, Amy S.; Xue, Ling; Li, Daniel Hsieh-Hsin; Steggerda, Susanne M.; Versele, Matthias; Dave, Sandeep S.; Zhang, Jenny; Yilmaz, Ayse Selen; Jaglowski, Samantha M.; Blum, Kristie A.; Lozanski, Arletta; Lozanski, Gerard; James, Danelle F.; Barrientos, Jacqueline C.; Lichter, Peter; Stilgenbauer, Stephan; Buggy, Joseph J.; Chang, Betty Y.; Johnson, Amy J.; Byrd, John C.			Resistance Mechanisms for the Bruton's Tyrosine Kinase Inhibitor Ibrutinib	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							CHRONIC LYMPHOCYTIC-LEUKEMIA; ACQUIRED-RESISTANCE; CLINICAL RESISTANCE; THERAPEUTIC TARGET; MYELOID-LEUKEMIA; MUTATION; CANCER; SURVIVAL; IMATINIB; GENOME	BACKGROUND Ibrutinib is an irreversible inhibitor of Bruton's tyrosine kinase (BTK) and is effective in chronic lymphocytic leukemia (CLL). Resistance to irreversible kinase inhibitors and resistance associated with BTK inhibition have not been characterized. Although only a small proportion of patients have had a relapse during ibrutinib therapy, an understanding of resistance mechanisms is important. We evaluated patients with relapsed disease to identify mutations that may mediate ibrutinib resistance. METHODS We performed whole-exome sequencing at baseline and the time of relapse on samples from six patients with acquired resistance to ibrutinib therapy. We then performed functional analysis of identified mutations. In addition, we performed Ion Torrent sequencing for identified resistance mutations on samples from nine patients with prolonged lymphocytosis. RESULTS We identified a cysteine-to-serine mutation in BTK at the binding site of ibrutinib in five patients and identified three distinct mutations in PLC gamma 2 in two patients. Functional analysis showed that the C481S mutation of BTK results in a protein that is only reversibly inhibited by ibrutinib. The R665W and L845F mutations in PLC gamma 2 are both potentially gain-of-function mutations that lead to autonomous B-cell-receptor activity. These mutations were not found in any of the patients with prolonged lymphocytosis who were taking ibrutinib. CONCLUSIONS Resistance to the irreversible BTK inhibitor ibrutinib often involves mutation of a cysteine residue where ibrutinib binding occurs. This finding, combined with two additional mutations in PLC gamma 2 that are immediately downstream of BTK, underscores the importance of the B-cell-receptor pathway in the mechanism of action of ibrutinib in CLL.	[Woyach, Jennifer A.; Liu, Ta-Ming; Ruppert, Amy S.; Jaglowski, Samantha M.; Blum, Kristie A.; Lozanski, Arletta; Johnson, Amy J.; Byrd, John C.] Ohio State Univ, Div Hematol, Dept Internal Med, Columbus, OH 43210 USA; [Ozer, Hatice Gulcin; Yilmaz, Ayse Selen] Ohio State Univ, Dept Biomed Informat, Columbus, OH 43210 USA; [Lozanski, Gerard] Ohio State Univ, Dept Pathol, Columbus, OH 43210 USA; [Furman, Richard R.] Weill Cornell Med Coll, Dept Med, Div Hematol Oncol, New York, NY USA; [Zapatka, Marc; Lichter, Peter] German Canc Res Ctr, Div Mol Genet, Heidelberg, Germany; [Stilgenbauer, Stephan] Univ Ulm, Dept Internal Med 3, D-89069 Ulm, Germany; [Xue, Ling; Li, Daniel Hsieh-Hsin; Steggerda, Susanne M.; James, Danelle F.; Buggy, Joseph J.; Chang, Betty Y.] Pharmacycl Sunnyvale, Sunnyvale, CA USA; [Dave, Sandeep S.; Zhang, Jenny] Duke Univ, Duke Canc Inst, Durham, NC USA; [Barrientos, Jacqueline C.] Hofstra North Shore LIJ Sch Med, Div Hematol Oncol, Dept Med, New Hyde Pk, NY USA; [Versele, Matthias] Janssen Res & Dev, Beerse, Belgium	University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; Cornell University; Helmholtz Association; German Cancer Research Center (DKFZ); Ulm University; Duke University; Hofstra University; Northwell Health; Johnson & Johnson; Janssen Pharmaceuticals	Byrd, JC (corresponding author), Ohio State Univ, Div Hematol, Dept Internal Med, Columbus, OH 43210 USA.	john.byrd@osumc.edu	Barrientos, Jacqueline/AAE-6683-2022; Zapatka, Marc/G-9896-2013; Stilgenbauer, Stephan/ABE-6609-2020; Zhang, Jenny/GXV-4980-2022; Woyach, Jennifer Ann/F-1087-2015	Zapatka, Marc/0000-0001-8287-5967; Barrientos, Jacqueline Claudia/0000-0001-6018-5535	National Cancer Institute [P50 CA140158, R01 CA177292, K23 CA178183]; Four Winds Foundation; D. Warren Brown Foundation; Harry T. Mangurian Jr. Foundation; Leukemia and Lymphoma Society; Pharmacyclics; Conquer Cancer Foundation; American Society of Hematology Scholar Award; Else Kroner-Fresenius-Stiftung [2010_Kolleg24, 2012_A146]; Helmholtz Virtual Institute [VH-VI-404, TP2]; German Research Foundation (SFB) [1074, B2]; NATIONAL CANCER INSTITUTE [P30CA016058, P50CA140158, K12CA133250, R01CA177292, P01CA095426, K23CA178183, R01CA183444, P30CA014236, P01CA081534] Funding Source: NIH RePORTER	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Four Winds Foundation; D. Warren Brown Foundation; Harry T. Mangurian Jr. Foundation; Leukemia and Lymphoma Society(Leukemia and Lymphoma Society); Pharmacyclics; Conquer Cancer Foundation; American Society of Hematology Scholar Award; Else Kroner-Fresenius-Stiftung; Helmholtz Virtual Institute; German Research Foundation (SFB)(German Research Foundation (DFG)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	Supported by the National Cancer Institute (P50 CA140158, R01 CA177292, and K23 CA178183), the Four Winds Foundation, the D. Warren Brown Foundation, Mr. and Mrs. Michael Thomas, Mr. and Mrs. Al Lipkin, the Harry T. Mangurian Jr. Foundation, the Leukemia and Lymphoma Society, Pharmacyclics, the Conquer Cancer Foundation, an American Society of Hematology Scholar Award, Else Kroner-Fresenius-Stiftung (2010_Kolleg24, Project 2012_A146), Helmholtz Virtual Institute (VH-VI-404, TP2), and the German Research Foundation (SFB 1074 Project B2).	Antonescu CR, 2005, CLIN CANCER RES, V11, P4182, DOI 10.1158/1078-0432.CCR-04-2245; Awad MM, 2013, NEW ENGL J MED, V368, P2395, DOI 10.1056/NEJMoa1215530; Bernal A, 2001, BLOOD, V98, P3050, DOI 10.1182/blood.V98.10.3050; Burger JA, 2013, BLOOD, V122, DOI 10.1182/blood.V122.21.866.866; Byrd JC, 2014, NEW ENGL J MED, V370, P786, DOI 10.1056/NEJMx130049; Byrd JC, 2013, NEW ENGL J MED, V369, P32, DOI 10.1056/NEJMoa1215637; Cibulskis K, 2013, NAT BIOTECHNOL, V31, P213, DOI 10.1038/nbt.2514; Cingolani P, 2012, FLY, V6, P80, DOI 10.4161/fly.19695; Cortes J, 2007, BLOOD, V110, P4005, DOI 10.1182/blood-2007-03-080838; Dal Porto JM, 2004, MOL IMMUNOL, V41, P599, DOI 10.1016/j.molimm.2004.04.008; Deglesne PA, 2006, CANCER RES, V66, P7158, DOI 10.1158/0008-5472.CAN-06-0085; Dubovsky JA, 2013, BLOOD, V122, P2539, DOI 10.1182/blood-2013-06-507947; Furman RR, 2014, NEW ENGL J MED, V370, P2352, DOI 10.1056/NEJMc1402716; Gorre ME, 2001, SCIENCE, V293, P876, DOI 10.1126/science.1062538; Hantschel O, 2007, P NATL ACAD SCI USA, V104, P13283, DOI 10.1073/pnas.0702654104; Heidel F, 2006, BLOOD, V107, P293, DOI 10.1182/blood-2005-06-2469; Herman SEM, 2011, BLOOD, V117, P6287, DOI 10.1182/blood-2011-01-328484; Honigberg LA, 2010, P NATL ACAD SCI USA, V107, P13075, DOI 10.1073/pnas.1004594107; Kobayashi S, 2005, NEW ENGL J MED, V352, P786, DOI 10.1056/NEJMoa044238; Landau DA, 2013, CELL, V152, P714, DOI 10.1016/j.cell.2013.01.019; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; McKenna A, 2010, GENOME RES, V20, P1297, DOI 10.1101/gr.107524.110; O'Brien SG, 2003, NEW ENGL J MED, V348, P994, DOI 10.1056/NEJMoa022457; Pao W, 2005, PLOS MED, V2, P225, DOI 10.1371/journal.pmed.0020073; Ponader S, 2012, BLOOD, V119, P1182, DOI 10.1182/blood-2011-10-386417; Puente XS, 2011, NATURE, V475, P101, DOI 10.1038/nature10113; Quintes-Cardama A, 2009, CANCER CONTROL, V16, P122, DOI 10.1177/107327480901600204; Smith CC, 2012, NATURE, V485, P260, DOI 10.1038/nature11016; Stoklosa T, 2008, CANCER RES, V68, P2576, DOI 10.1158/0008-5472.CAN-07-6858; Valiaho J, 2006, HUM MUTAT, V27, P1209, DOI 10.1002/humu.20410; Wang LL, 2011, NEW ENGL J MED, V365, P2497, DOI 10.1056/NEJMoa1109016; Woyach JA, 2014, BLOOD, V123, P1810, DOI 10.1182/blood-2013-09-527853; Zhou Q, 2012, AM J HUM GENET, V91, P713, DOI 10.1016/j.ajhg.2012.08.006	33	831	901	10	138	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUN 12	2014	370	24					2286	2294		10.1056/NEJMoa1400029	http://dx.doi.org/10.1056/NEJMoa1400029			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AI7BB	24869598	Green Accepted, Bronze			2022-12-28	WOS:000337033700008
J	Ni, WM; Xu, SL; Tepperman, JM; Stanley, DJ; Maltby, DA; Gross, JD; Burlingame, AL; Wang, ZY; Quail, PH				Ni, Weimin; Xu, Shou-Ling; Tepperman, James M.; Stanley, David J.; Maltby, Dave A.; Gross, John D.; Burlingame, Alma L.; Wang, Zhi-Yong; Quail, Peter H.			A mutually assured destruction mechanism attenuates light signaling in Arabidopsis	SCIENCE			English	Article							BHLH TRANSCRIPTION FACTORS; PHYTOCHROME B; INDUCED PHOSPHORYLATION; UBIQUITIN LIGASES; DEGRADATION; PIF3; PROTEINS; ACTS; LOOP	After light-induced nuclear translocation, phytochrome photoreceptors interact with and induce rapid phosphorylation and degradation of basic helix-loop-helix transcription factors, such as PHYTOCHROME-INTERACTING FACTOR 3 (PIF3), to regulate gene expression. Concomitantly, this interaction triggers feedback reduction of phytochrome B (phyB) levels. Light-induced phosphorylation of PIF3 is necessary for the degradation of both proteins. We report that this PIF3 phosphorylation induces, and is necessary for, recruitment of LRB [Light-Response Bric-a-Brack/Tramtrack/Broad (BTB)] E3 ubiquitin ligases to the PIF3-phyB complex. The recruited LRBs promote concurrent polyubiqutination and degradation of both PIF3 and phyB in vivo. These data reveal a linked signal-transmission and attenuation mechanism involving mutually assured destruction of the receptor and its immediate signaling partner.	[Ni, Weimin; Tepperman, James M.; Quail, Peter H.] Univ Calif Berkeley, Dept Plant & Microbial Biol, Berkeley, CA 94720 USA; [Ni, Weimin; Tepperman, James M.; Quail, Peter H.] ARS, Plant Gene Express Ctr, USDA, Albany, CA 94710 USA; [Xu, Shou-Ling; Stanley, David J.; Maltby, Dave A.; Gross, John D.; Burlingame, Alma L.] Univ Calif San Francisco, Dept Pharmaceut Chem, San Francisco, CA 94143 USA; [Xu, Shou-Ling; Wang, Zhi-Yong] Carnegie Inst Sci, Dept Plant Biol, Stanford, CA 94305 USA	University of California System; University of California Berkeley; United States Department of Agriculture (USDA); University of California System; University of California San Francisco; Carnegie Institution for Science	Quail, PH (corresponding author), Univ Calif Berkeley, Dept Plant & Microbial Biol, Berkeley, CA 94720 USA.	quail@berkeley.edu	Wang, Zhi-Yong/E-3810-2012	Wang, Zhi-Yong/0000-0003-4602-3390; xu, shouling/0000-0002-6741-9506	National Institutes of Health (NIH) [2R01 GM-047475]; U.S. Department of Energy (DOE) [DEFG03-87ER13742]; USDA ARS Current Research Information System [5335-21000-032-00D]; NIH [5R01GM066258, 8P41GM103481, P50 GM082250]; DOE [DEFG02-08ER15973]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P41GM103481, P50GM082250, R01GM047475, R01GM066258, T32GM008284] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); U.S. Department of Energy (DOE)(United States Department of Energy (DOE)); USDA ARS Current Research Information System(United States Department of Agriculture (USDA)USDA Agricultural Research Service); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); DOE(United States Department of Energy (DOE)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank R. J. Chalkley, A. Pfeiffer, M. Zhuang, and B. A. Schulman for materials and technical assistance and S. McCormick for comments on the manuscript. We also thank the Salk Institute and Arabidopsis Biological Resource Center for the Arabidopsis T-DNA insertion lines. The plasmid pGEX-CUL3 (split 'n' coexpress)-Rbx1 used in the in vitro ubiquitination assays was provided by B. A. Schulman under a materials transfer agreement with St. Jude Children's Research Hospital. For access to this reagent, contact B. A. Schulman. The supplementary materials contain additional data. This work was supported by the National Institutes of Health (NIH) (2R01 GM-047475), the U.S. Department of Energy (DOE) (DEFG03-87ER13742), and USDA ARS Current Research Information System (5335-21000-032-00D) to P. H. Q; by NIH (5R01GM066258) and DOE (DEFG02-08ER15973) to Z.Y.W.; by NIH (8P41GM103481) to A. L. B; and by NIH (P50 GM082250) to J.D.G.	Al-Sady B, 2006, MOL CELL, V23, P439, DOI 10.1016/j.molcel.2006.06.011; Al-Sady B, 2008, P NATL ACAD SCI USA, V105, P2232, DOI 10.1073/pnas.0711675105; Amit I, 2007, NAT GENET, V39, P503, DOI 10.1038/ng1987; Avraham R, 2011, NAT REV MOL CELL BIO, V12, P104, DOI 10.1038/nrm3048; Bae G, 2008, ANNU REV PLANT BIOL, V59, P281, DOI 10.1146/annurev.arplant.59.032607.092859; Bauer D, 2004, PLANT CELL, V16, P1433, DOI 10.1105/tpc.021568; Christians MJ, 2012, PLANT PHYSIOL, V160, P118, DOI 10.1104/pp.112.199109; Deshaies RJ, 2009, ANNU REV BIOCHEM, V78, P399, DOI 10.1146/annurev.biochem.78.101807.093809; Hua ZH, 2011, ANNU REV PLANT BIOL, V62, P299, DOI 10.1146/annurev-arplant-042809-112256; Jang IC, 2010, PLANT CELL, V22, P2370, DOI 10.1105/tpc.109.072520; Jiao YL, 2007, NAT REV GENET, V8, P217, DOI 10.1038/nrg2049; Khanna R, 2007, PLANT CELL, V19, P3915, DOI 10.1105/tpc.107.051508; Leivar P, 2008, CURR BIOL, V18, P1815, DOI 10.1016/j.cub.2008.10.058; Leivar P, 2012, MOL PLANT, V5, P734, DOI 10.1093/mp/sss031; Leivar P, 2011, TRENDS PLANT SCI, V16, P19, DOI 10.1016/j.tplants.2010.08.003; Lorrain S, 2008, PLANT J, V53, P312, DOI 10.1111/j.1365-313X.2007.03341.x; Monte E, 2004, P NATL ACAD SCI USA, V101, P16091, DOI 10.1073/pnas.0407107101; Ni M, 1999, NATURE, V400, P781, DOI 10.1038/23500; Ni WM, 2013, PLANT CELL, V25, P2679, DOI 10.1105/tpc.113.112342; Rockwell NC, 2006, ANNU REV PLANT BIOL, V57, P837, DOI 10.1146/annurev.arplant.56.032604.144208; Shen H, 2008, PLANT CELL, V20, P1586, DOI 10.1105/tpc.108.060020; Shen Y, 2007, PLANT PHYSIOL, V145, P1043, DOI 10.1104/pp.107.105601; Tang XJ, 2012, P NATL ACAD SCI USA, V109, P3287, DOI 10.1073/pnas.1116455109; Yarden Y, 2010, ONCOLOGIST, V15, P1, DOI 10.1634/theoncologist.2010-S5-01; Zhang Y, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003244	25	182	192	4	90	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 6	2014	344	6188					1160	1164		10.1126/science.1250778	http://dx.doi.org/10.1126/science.1250778			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI3UU	24904166	Green Accepted			2022-12-28	WOS:000336791200048
J	Stark, Z; Campbell, LJ; Mitchell, C; James, PA; Heath, JA; Boussioutas, A; Lynch, C; Trainer, AH				Stark, Zornitza; Campbell, Lynda J.; Mitchell, Catherine; James, Paul A.; Heath, John A.; Boussioutas, Alex; Lynch, Craig; Trainer, Alison H.			Spot Diagnosis	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							TEMOZOLOMIDE; MUTATIONS; GLIOMAS		[Stark, Zornitza] Murdoch Childrens Res Inst, Victorian Clin Genet Serv, Parkville, Vic 3052, Australia; [Campbell, Lynda J.; James, Paul A.; Heath, John A.; Boussioutas, Alex; Lynch, Craig; Trainer, Alison H.] Univ Melbourne, Parkville, Vic 3052, Australia; [Heath, John A.] Royal Childrens Hosp, Childrens Canc Ctr, Parkville, Vic 3052, Australia; [Campbell, Lynda J.] St Vincents Hosp, Victorian Canc Cytogenet Serv, Fitzroy, Vic 3065, Australia; [Mitchell, Catherine] Peter MacCallum Canc Ctr, Dept Pathol, East Melbourne, Vic, Australia; [Boussioutas, Alex; Lynch, Craig] Peter MacCallum Canc Ctr, Dept Surg, East Melbourne, Vic, Australia; [James, Paul A.; Trainer, Alison H.] Peter MacCallum Canc Ctr, Familial Canc Serv, East Melbourne, Vic, Australia	Murdoch Children's Research Institute; University of Melbourne; Royal Children's Hospital Melbourne; St Vincent's Hospital Melbourne; Peter Maccallum Cancer Center; Peter Maccallum Cancer Center; Peter Maccallum Cancer Center	Stark, Z (corresponding author), Murdoch Childrens Res Inst, Victorian Clin Genet Serv, 4th Fl,Flemington Rd, Parkville, Vic 3052, Australia.	zornitza.stark@vcgs.org.au		James, Paul/0000-0002-4361-4657; Boussioutas, Alex/0000-0002-8109-6897				Barrow E, 2013, FAM CANC; Cohen KJ, 2011, NEURO-ONCOLOGY, V13, P317, DOI 10.1093/neuonc/noq191; Hackman P, 1997, NAT GENET, V17, P135, DOI 10.1038/ng1097-135; Hunter C, 2006, CANCER RES, V66, P3987, DOI 10.1158/0008-5472.CAN-06-0127; Jarvinen HJ, 2000, GASTROENTEROLOGY, V118, P829, DOI 10.1016/S0016-5085(00)70168-5; Liu LL, 1996, CANCER RES, V56, P5375; Lodish MB, 2011, FAM CANCER, V10, P481, DOI 10.1007/s10689-011-9446-x; Martin-Lopez J.V., 2013, FAM CANC; Schmeler KM, 2006, NEW ENGL J MED, V354, P261, DOI 10.1056/NEJMoa052627; Scott RH, 2007, NAT CLIN PRACT ONCOL, V4, P130, DOI 10.1038/ncponc0719; Vasen HFA, 2014, J MED GENET, V51, P283, DOI 10.1136/jmedgenet-2013-102238; Vasen HFA, 2013, GUT, V62, P812, DOI 10.1136/gutjnl-2012-304356; Wimmer K, 2008, HUM GENET, V124, P105, DOI 10.1007/s00439-008-0542-4; Winship IM, 2008, LANCET ONCOL, V9, P462, DOI 10.1016/S1470-2045(08)70126-8	14	7	7	0	4	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUN 5	2014	370	23					2229	2236		10.1056/NEJMcps1302661	http://dx.doi.org/10.1056/NEJMcps1302661			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AI3AF	24897087				2022-12-28	WOS:000336729900012
J	Yimlamai, D; Christodoulou, C; Galli, GG; Yanger, K; Pepe-Mooney, B; Gurung, B; Shrestha, K; Cahan, P; Stanger, BZ; Camargo, FD				Yimlamai, Dean; Christodoulou, Constantina; Galli, Giorgio G.; Yanger, Kilangsungla; Pepe-Mooney, Brian; Gurung, Basanta; Shrestha, Kriti; Cahan, Patrick; Stanger, Ben Z.; Camargo, Fernando D.			Hippo Pathway Activity Influences Liver Cell Fate	CELL			English	Article							BILE-DUCT DEVELOPMENT; EPITHELIAL-CELLS; TEAD/TEF FAMILY; YAP ONCOPROTEIN; ORGAN SIZE; STEM-CELLS; HEPATOCYTES; PROTEIN; GROWTH; INACTIVATION	The Hippo-signaling pathway is an important regulator of cellular proliferation and organ size. However, little is known about the role of this cascade in the control of cell fate. Employing a combination of lineage tracing, clonal analysis, and organoid culture approaches, we demonstrate that Hippo pathway activity is essential for the maintenance of the differentiated hepatocyte state. Remarkably, acute inactivation of Hippo pathway signaling in vivo is sufficient to dedifferentiate, at very high efficiencies, adult hepatocytes into cells bearing progenitor characteristics. These hepatocyte-derived progenitor cells demonstrate self-renewal and engraftment capacity at the single-cell level. We also identify the NOTCH-signaling pathway as a functional important effector downstream of the Hippo transducer YAP. Our findings uncover a potent role for Hippo/YAP signaling in controlling liver cell fate and reveal an unprecedented level of phenotypic plasticity in mature hepatocytes, which has implications for the understanding and manipulation of liver regeneration.	[Yimlamai, Dean; Christodoulou, Constantina; Galli, Giorgio G.; Pepe-Mooney, Brian; Gurung, Basanta; Shrestha, Kriti; Cahan, Patrick; Camargo, Fernando D.] Boston Childrens Hosp, Stem Cell Program, Boston, MA 02115 USA; [Yimlamai, Dean] Boston Childrens Hosp, Dept Med, Div Gastroenterol & Nutr, Boston, MA 02115 USA; [Christodoulou, Constantina; Galli, Giorgio G.; Pepe-Mooney, Brian; Gurung, Basanta; Camargo, Fernando D.] Harvard Stem Cell Inst, Cambridge, MA 02138 USA; [Christodoulou, Constantina; Galli, Giorgio G.; Pepe-Mooney, Brian; Gurung, Basanta; Camargo, Fernando D.] Harvard Univ, Dept Stem Cell & Regenerat Biol, Cambridge, MA 02138 USA; [Yanger, Kilangsungla; Stanger, Ben Z.] Univ Penn, Perelman Sch Med, Dept Med, Div Gastroenterol, Philadelphia, PA 19104 USA; [Stanger, Ben Z.] Univ Penn, Perelman Sch Med, Abramson Family Canc Res Inst, Philadelphia, PA 19104 USA; [Stanger, Ben Z.] Univ Penn, Perelman Sch Med, Dept Cell & Dev Biol, Philadelphia, PA 19104 USA	Harvard University; Boston Children's Hospital; Harvard University; Boston Children's Hospital; Harvard University; Harvard University; University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine	Camargo, FD (corresponding author), Boston Childrens Hosp, Stem Cell Program, Boston, MA 02115 USA.	fernando.camargo@childrens.harvard.edu	Yanger, Kilang/N-2888-2015; Yimlamai, Dean/AAA-6607-2020	Yanger, Kilang/0000-0002-1710-5306; Yimlamai, Dean/0000-0002-7936-7168; Cahan, Patrick/0000-0003-3652-2540; Galli, Giorgio/0000-0002-9401-060X; Christodoulou, Constantina/0000-0001-5371-2210; Gurung, Basanta/0000-0003-3196-7495; camargo, fernando/0000-0002-5630-5909	Stand Up to Cancer-AACR initiative; National Institutes of Health [AR064036, DK099559, DK083355]; Department of Defense [W81XWH-9]; Harvard Stem Cell Institute; National Institute of Diabetes and Digestive and Kidney Diseases [5T32 DK007477-27]; Boston Children's Hospital Career Development Award; American-Italian Cancer Foundation postdoctoral research fellowship; National Science Foundation Graduate Research Fellowship Program [DGE1144152]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR064036] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [T32DK007477, R01DK099559, R01DK083355, K08DK105351, P30DK034854] Funding Source: NIH RePORTER	Stand Up to Cancer-AACR initiative; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Defense(United States Department of Defense); Harvard Stem Cell Institute; National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Boston Children's Hospital Career Development Award; American-Italian Cancer Foundation postdoctoral research fellowship; National Science Foundation Graduate Research Fellowship Program(National Science Foundation (NSF)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We are grateful for stimulating discussions with the Camargo lab members, Barbara Trejo for help with IHC, Roderick Bronson for reviewing mouse liver pathology, and Ron Mathieu of the Stem Cell Program FACS facility. We thank G. Gu, T. Honjo, and M. Giovannini for use of Ck19-CreERT, RPBJ, and Nf2 mice, respectively. V. Factor generously donated A6 antibody for our use. This study was supported by awards from the Stand Up to Cancer-AACR initiative (FDC), grants from the National Institutes of Health (AR064036 and DK099559 to F. D. C.; DK083355 to B.Z.S.), a Department of Defense award (W81XWH-9) (to F. D. C.), and Junior Investigator funds from the Harvard Stem Cell Institute (to F. D. C.). D.Y. is supported by the National Institute of Diabetes and Digestive and Kidney Diseases (5T32 DK007477-27) and a Boston Children's Hospital Career Development Award and is a George Ferry Young Investigator (NASPGHAN). G. G. G. is supported by an American-Italian Cancer Foundation postdoctoral research fellowship. B.P.-M. is supported by the National Science Foundation Graduate Research Fellowship Program (DGE1144152). F. D. C. is a Pew Scholar in the Biomedical Sciences.	Benhamouche S, 2010, GENE DEV, V24, P1718, DOI 10.1101/gad.1938710; Camargo FD, 2007, CURR BIOL, V17, P2054, DOI 10.1016/j.cub.2007.10.039; Demetris AJ, 1996, AM J PATHOL, V149, P439; Dong JX, 2007, CELL, V130, P1120, DOI 10.1016/j.cell.2007.07.019; Dorrell C, 2011, GENE DEV, V25, P1193, DOI 10.1101/gad.2029411; ENGELHARDT NV, 1993, DIFFERENTIATION, V55, P19, DOI 10.1111/j.1432-0436.1993.tb00029.x; Espanol-Suner R, 2012, GASTROENTEROLOGY, V143, P1564, DOI 10.1053/j.gastro.2012.08.024; Fan B, 2012, J CLIN INVEST, V122, P2911, DOI 10.1172/JCI63212; Furuyama K, 2011, NAT GENET, V43, P34, DOI 10.1038/ng.722; Geisler F, 2008, HEPATOLOGY, V48, P607, DOI 10.1002/hep.22381; Gouw ASH, 2011, HEPATOLOGY, V54, P1853, DOI 10.1002/hep.24613; Greenbaum LE, 2011, GASTROENTEROLOGY, V141, P1152, DOI 10.1053/j.gastro.2011.08.023; GROMPE M, 1995, NAT GENET, V10, P453, DOI 10.1038/ng0895-453; Hamaratoglu F, 2006, NAT CELL BIOL, V8, P27, DOI 10.1038/ncb1339; Han H, 2002, INT IMMUNOL, V14, P637, DOI 10.1093/intimm/dxf030; Hofmann JJ, 2010, DEVELOPMENT, V137, P4061, DOI 10.1242/dev.052118; Home P, 2012, P NATL ACAD SCI USA, V109, P7362, DOI 10.1073/pnas.1201595109; Huch M, 2013, NATURE, V494, P247, DOI 10.1038/nature11826; Kohler C, 2004, HEPATOLOGY, V39, P1056, DOI 10.1002/hep.20156; Komuta M, 2012, HEPATOLOGY, V55, P1876, DOI 10.1002/hep.25595; Lee KP, 2010, P NATL ACAD SCI USA, V107, P8248, DOI 10.1073/pnas.0912203107; Li H, 2012, LIVER INT, V32, P38, DOI 10.1111/j.1478-3231.2011.02646.x; Lu L, 2010, P NATL ACAD SCI USA, V107, P1437, DOI 10.1073/pnas.0911427107; Malato Y, 2011, J CLIN INVEST, V121, P4850, DOI 10.1172/JCI59261; McCright B, 2002, DEVELOPMENT, V129, P1075; Means AL, 2008, GENESIS, V46, P318, DOI 10.1002/dvg.20397; Michalopoulos George K, 2012, Hepatology, V55, P2024, DOI 10.1002/hep.25703; Michalopoulos GK, 2005, HEPATOLOGY, V41, P535, DOI 10.1002/hep.20600; Mohseni M, 2014, NAT CELL BIOL, V16, P108, DOI 10.1038/ncb2884; Oertel M, 2008, BBA-MOL BASIS DIS, V1782, P61, DOI 10.1016/j.bbadis.2007.12.004; Oka T, 2008, J BIOL CHEM, V283, P27534, DOI 10.1074/jbc.M804380200; Ramos A, 2012, TRENDS CELL BIOL, V22, P339, DOI 10.1016/j.tcb.2012.04.006; Sekiya S, 2012, J CLIN INVEST, V122, P3914, DOI 10.1172/JCI63065; Tanigawa H, 2007, CIRCULATION, V116, P1267, DOI 10.1161/CIRCULATIONAHA.107.704254; Tschaharganeh DF, 2013, GASTROENTEROLOGY, V144, P1530, DOI 10.1053/j.gastro.2013.02.009; Turner R, 2011, HEPATOLOGY, V53, P1035, DOI 10.1002/hep.24157; Wu S, 2008, DEV CELL, V14, P388, DOI 10.1016/j.devcel.2008.01.007; Yanger K, 2013, GENE DEV, V27, P719, DOI 10.1101/gad.207803.112; Zender S, 2013, CANCER CELL, V23, P784, DOI 10.1016/j.ccr.2013.04.019; Zhang L, 2008, DEV CELL, V14, P377, DOI 10.1016/j.devcel.2008.01.006; Zhang NL, 2010, DEV CELL, V19, P27, DOI 10.1016/j.devcel.2010.06.015; Zhao B, 2008, GENE DEV, V22, P1962, DOI 10.1101/gad.1664408; Zhao B, 2007, GENE DEV, V21, P2747, DOI 10.1101/gad.1602907; Zhou DW, 2009, CANCER CELL, V16, P425, DOI 10.1016/j.ccr.2009.09.026; Zong YW, 2009, DEVELOPMENT, V136, P1727, DOI 10.1242/dev.029140	45	525	545	7	121	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUN 5	2014	157	6					1324	1338		10.1016/j.cell.2014.03.060	http://dx.doi.org/10.1016/j.cell.2014.03.060			15	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	AN8UV	24906150	Bronze, Green Accepted			2022-12-28	WOS:000340881400010
J	Eisenstein, M				Eisenstein, Michael			CLINICAL TRIALS More trials, fewer tribulations	NATURE			English	Editorial Material							CELL LUNG-CANCER; GEFITINIB											Hoos WA, 2013, J CLIN ONCOL, V31, P3432, DOI 10.1200/JCO.2013.49.4823; Iyer G, 2012, SCIENCE, V338, P221, DOI 10.1126/science.1226344; Maemondo M, 2010, NEW ENGL J MED, V362, P2380, DOI 10.1056/NEJMoa0909530; Mosse YP, 2013, LANCET ONCOL, V14, P472, DOI 10.1016/S1470-2045(13)70095-0; Prowell TM, 2012, NEW ENGL J MED, V366, P2438, DOI 10.1056/NEJMp1205737; Thatcher N, 2005, LANCET, V366, P1527, DOI 10.1016/S0140-6736(05)67625-8	6	1	1	0	7	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 29	2014	509	7502					S55	S57		10.1038/509S55a	http://dx.doi.org/10.1038/509S55a			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AH9JC	24870821	Bronze			2022-12-28	WOS:000336457100004
J	Trotta, F; Da Cas, R; Alegiani, SS; Gramegna, M; Venegoni, M; Zocchetti, C; Traversa, G				Trotta, Francesco; Da Cas, Roberto; Alegiani, Stefania Spila; Gramegna, Maria; Venegoni, Mauro; Zocchetti, Carlo; Traversa, Giuseppe			Evaluation of safety of A/H1N1 pandemic vaccination during pregnancy: cohort study	BMJ-BRITISH MEDICAL JOURNAL			English	Article							H1N1 INFLUENZA; CONGENITAL-ABNORMALITIES; FETAL-DEATH; RISK; OUTCOMES; WOMEN	Objective To assess the risk of maternal, fetal, and neonatal outcomes associated with the administration of an MF59 adjuvanted A/H1N1 vaccine during pregnancy. Design Historical cohort study. Setting Singleton pregnancies of the resident population of the Lombardy region of Italy. Participants All deliveries between 1 October 2009 and 30 September 2010. Data on exposure to A/H1N1 pandemic vaccine, pregnancy, and birth outcomes were retrieved from regional databases. Vaccinated and non-vaccinated women were compared in a propensity score matched analysis to estimate risks of adverse outcomes. Main outcome measures Main maternal outcomes included type of delivery, admission to intensive care unit, eclampsia, and gestational diabetes; fetal and neonatal outcomes included perinatal deaths, small for gestational age births, and congenital malformations. Results Among the 86 171 eligible pregnancies, 6246 women were vaccinated (3615 (57.9%) in the third trimester and 2557 (40.9%) in the second trimester). No difference was observed in terms of spontaneous deliveries (adjusted odds ratio 1.02, 95% confidence interval 0.96 to 1.08) or admissions to intensive care units (0.95, 0.47 to 1.88), whereas a limited increase in the prevalence of gestational diabetes (1.26, 1.04 to 1.53) and eclampsia (1.19, 1.04 to 1.39) was seen in vaccinated women. Rates of fetal and neonatal outcomes were similar in vaccinated and non-vaccinated women. A slight increase in congenital malformations, although not statistically significant, was present in the exposed cohort (1.14, 0.99 to 1.31). Conclusions Our findings add relevant information about the safety of the MF59 adjuvanted A/H1N1 vaccine in pregnancy. Residual confounding may partly explain the increased risk of some maternal outcomes. Meta-analysis of published studies should be conducted to further clarify the risk of infrequent outcomes, such as specific congenital malformations.	[Trotta, Francesco; Da Cas, Roberto; Alegiani, Stefania Spila; Traversa, Giuseppe] Natl Inst Hlth, Natl Ctr Epidemiol, Pharmacoepidemiol Unit, I-00161 Rome, Italy; [Trotta, Francesco] Italian Med Agcy AIFA, Pharmacovigilance Unit, I-00187 Rome, Italy; [Gramegna, Maria] Gen Directorate Hlth, Unit Prevent Med, I-20124 Milan, Italy; [Venegoni, Mauro] Gen Directorate Hlth, Reg Ctr Pharmacovigilance, I-20124 Milan, Italy; [Zocchetti, Carlo] Gen Directorate Hlth, Unit Local Hlth Serv Governance, I-20124 Milan, Italy	Istituto Superiore di Sanita (ISS)	Traversa, G (corresponding author), Natl Inst Hlth, Natl Ctr Epidemiol, Pharmacoepidemiol Unit, Viale Regina Elena 299, I-00161 Rome, Italy.	giuseppe.traversa@iss.it	Venegoni, Mauro/H-3416-2019; Trotta, Francesco/G-8702-2013	Trotta, Francesco/0000-0001-6889-8484; Venegoni, Mauro/0000-0002-5462-5327				Acs N, 2005, BIRTH DEFECTS RES A, V73, P989, DOI 10.1002/bdra.20195; [Anonymous], MALF COD GUID; Chan M., 2009, WORLD NOW START 2009; Chowell G, 2009, NEW ENGL J MED, V361, P674, DOI 10.1056/NEJMoa0904023; Conlin AMS, 2013, OBSTET GYNECOL, V121, P511, DOI 10.1097/AOG.0b013e318280d64e; Czeizel AE, 2008, BIRTH DEFECTS RES A, V82, P139, DOI 10.1002/bdra.20431; European Medicines Agency European Centre for Disease Prevention and Control, 2009, EUR STRAT INFL A H1N; Fell Deshayne B, 2012, Am J Public Health, V102, pe33, DOI 10.2105/AJPH.2011.300606; GRIFFITH GW, 1972, BMJ-BRIT MED J, V3, P553, DOI 10.1136/bmj.3.5826.553; Haberg SE, 2013, NEW ENGL J MED, V368, P333, DOI 10.1056/NEJMoa1207210; Heikkinen T, 2012, AM J OBSTET GYNECOL, V207, DOI 10.1016/j.ajog.2012.07.007; Jamieson DJ, 2012, AM J OBSTET GYNECOL, V207, P145, DOI 10.1016/j.ajog.2012.07.011; Jamieson DJ, 2009, LANCET, V374, P451, DOI 10.1016/S0140-6736(09)61304-0; Kallen B, 2012, BJOG-INT J OBSTET GY, V119, P1583, DOI 10.1111/j.1471-0528.2012.03470.x; Laibl VR, 2005, CLIN PERINATOL, V32, P727, DOI 10.1016/j.clp.2005.04.009; Ludvigsson JF, 2013, EUR J EPIDEMIOL, V28, P579, DOI 10.1007/s10654-013-9813-z; Mak TK, 2008, LANCET INFECT DIS, V8, P44, DOI 10.1016/S1473-3099(07)70311-0; Mereckiene J, 2012, EURO SURVEILL, V17; Ministero del Lavoro della Salute e delle Politiche Sociali, 2009, MIS URG MAT PROT VIR; Nishiura H, 2009, EUR J OBSTET GYN R B, V147, P115, DOI 10.1016/j.ejogrb.2009.07.009; Oppermann M, 2012, VACCINE, V30, P4445, DOI 10.1016/j.vaccine.2012.04.081; Pasternak B, 2012, JAMA-J AM MED ASSOC, V308, P165, DOI 10.1001/jama.2012.6131; Pasternak B, 2012, BMJ-BRIT MED J, V344, DOI 10.1136/bmj.e2794; Richards JL, 2013, CLIN INFECT DIS, V56, P1216, DOI 10.1093/cid/cit045; Rubinstein F, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f393; Sammon CJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051734; Seppelt I, 2010, BMJ-BRIT MED J, V340, DOI 10.1136/bmj.c1279; Steinhoff MC, 2012, JAMA-J AM MED ASSOC, V308, P184, DOI 10.1001/jama.2012.7911; VAILLANT L, 2009, EURO SURVEILL, V14	29	31	31	0	7	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	MAY 29	2014	348								g3361	10.1136/bmj.g3361	http://dx.doi.org/10.1136/bmj.g3361			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AI3EK	24874845	hybrid, Green Published			2022-12-28	WOS:000336742400003
J	Blanc, HW				Blanc, Henry Wm			The Treatment of Acne (Reprinted from vol 15, pg 601, 1890)	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Reprint																		BLANC HW, 1890, JAMA-J AM MED ASSOC, V15, P601	1	0	0	0	2	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAY 28	2014	311	20					2131	2131		10.1001/jama.2013.279523	http://dx.doi.org/10.1001/jama.2013.279523			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AH8MQ	24867023				2022-12-28	WOS:000336392400036
J	Devuyst, O; Knoers, NVAM; Remuzzi, G; Schaefer, F				Devuyst, Olivier; Knoers, Nine V. A. M.; Remuzzi, Giuseppe; Schaefer, Franz		European Renal Assoc; European Dialysis Transplant Assoc	Rare inherited kidney diseases: challenges, opportunities, and perspectives	LANCET			English	Article							PHARMACOLOGICAL CHAPERONES; HYPOKALEMIC ALKALOSIS; NEPHROTIC SYNDROME; BARTTERS-SYNDROME; UMOD GENE; MUTATIONS; PROTEIN; GENERATION; CELL; IDENTIFICATION	At least 10% of adults and nearly all children who receive renal-replacement therapy have an inherited kidney disease. These patients rarely die when their disease progresses and can remain alive for many years because of advances in organ-replacement therapy. However, these disorders substantially decrease their quality of life and have a large effect on health-care systems. Since the kidneys regulate essential homoeostatic processes,inherited kidney disorders have multisystem complications, which add to the usual challenges for rare disorders. In this review, we discuss the nature of rare inherited kidney diseases, the challenges they pose, and opportunities from technological advances, which are well suited to target the kidney. Mechanistic insights from rare disorders are relevant for common disorders such as hypertension, kidney stones, cardiovascular disease, and progression of chronic kidney disease.	[Devuyst, Olivier] Catholic Univ Louvain, Div Nephrol, B-1200 Brussels, Belgium; [Devuyst, Olivier] Univ Zurich, Zurich Ctr Integrat Human Physiol, Inst Physiol, CH-8057 Zurich, Switzerland; [Knoers, Nine V. A. M.] Univ Med Ctr Utrecht, Div Biomed Genet, Dept Med Genet, Utrecht, Netherlands; [Remuzzi, Giuseppe] Azienda Osped Papa Giovanni XXIII, IRCCS Ist Ric Farmacol Mario Negri, Ctr Anna Maria Astori Sci & Technol Pk Kilometro, Bergamo, Italy; [Remuzzi, Giuseppe] Azienda Osped Papa Giovanni XXIII, Unit Nephrol & Dialysis, Bergamo, Italy; [Schaefer, Franz] Univ Heidelberg Hosp, Ctr Pediat & Adolescent Med, Pediat Nephrol Div, Heidelberg, Germany	Universite Catholique Louvain; University of Zurich; Zurich Center Integrative Human Physiology (ZIHP); Utrecht University; Utrecht University Medical Center; ASST Papa Giovanni XXIII; Istituto di Ricerche Farmacologiche Mario Negri IRCCS; ASST Papa Giovanni XXIII; Ruprecht Karls University Heidelberg	Devuyst, O (corresponding author), Univ Zurich, Zurich Ctr Integrat Human Physiol, Inst Physiol, CH-8057 Zurich, Switzerland.	olivier.devuyst@uzh.ch	Maxwell, Patrick H/C-5557-2008; Ong, Albert/AAN-9430-2021; Remuzzi, Giuseppe/V-9766-2017; ANTIGNAC, Corinne/H-8945-2017	Maxwell, Patrick H/0000-0002-0338-2679; Ong, Albert/0000-0002-7211-5400; Remuzzi, Giuseppe/0000-0002-6194-3446; ANTIGNAC, Corinne/0000-0002-9934-4940; Devuyst, Olivier/0000-0003-3744-4767	European Union [305608]; Gebert-Ruf Stiftung [GRS-038/12]; Cystinosis Research Foundation; Swiss National Science Foundation [310030_146490]; Klinischer Forschungsschwerpunkt (KFSP) radiz - Rare Disease Initiative Zurich; National Centre of Competence in Research (NCCR) Kidney.CH; Dutch Kidney Foundation (CP11.18 Project Kouncil); KfH Foundation for Preventive Medicine (4C Study); National Institutes of Health (PediGFR) [5R01DK082394-03]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK082394] Funding Source: NIH RePORTER; Wellcome Trust [096956/Z/11/Z] Funding Source: researchfish	European Union(European Commission); Gebert-Ruf Stiftung; Cystinosis Research Foundation; Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Klinischer Forschungsschwerpunkt (KFSP) radiz - Rare Disease Initiative Zurich; National Centre of Competence in Research (NCCR) Kidney.CH(Swiss National Science Foundation (SNSF)); Dutch Kidney Foundation (CP11.18 Project Kouncil); KfH Foundation for Preventive Medicine (4C Study); National Institutes of Health (PediGFR)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Wellcome Trust(Wellcome TrustEuropean Commission)	The authors' research on rare inherited kidney diseases is supported by the European Union 7th Framework Programme (FP7; 2007-13) under grant agreement number 305608 (EURenOmics, to all authors); the Gebert-Ruf Stiftung (GRS-038/12; to OD), the Cystinosis Research Foundation (to OD), the Swiss National Science Foundation (Project Grant 310030_146490; to OD), the Klinischer Forschungsschwerpunkt (KFSP) radiz - Rare Disease Initiative Zurich (to OD), the National Centre of Competence in Research (NCCR) Kidney.CH (to OD); the Dutch Kidney Foundation (CP11.18 Project Kouncil; to NK); the KfH Foundation for Preventive Medicine (4C Study; to FS), and the National Institutes of Health (5R01DK082394-03, PediGFR; to FS). We declare no competing interests.	Alkhalaf A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013421; [Anonymous], 2013, ORPHANET REPORT SERI; Artuso R, 2012, EUR J HUM GENET, V20, P50, DOI 10.1038/ejhg.2011.164; Ayme S, 2008, LANCET, V371, P2048, DOI 10.1016/S0140-6736(08)60875-2; Baker M, 2013, NATURE, V494, P416, DOI 10.1038/494416a; BARKER DF, 1990, SCIENCE, V248, P1224, DOI 10.1126/science.2349482; Beets I, 2012, SCIENCE, V338, P543, DOI 10.1126/science.1226860; Bernier V, 2006, J AM SOC NEPHROL, V17, P232, DOI 10.1681/ASN.2005080854; Boger CA, 2011, J AM SOC NEPHROL, V22, P555, DOI 10.1681/ASN.2010060598; Bolignano D, 2014, NEPHROL DIAL TRANSPL, V29, P1628, DOI 10.1093/ndt/gft344; Bomback AS, 2012, NAT REV NEPHROL, V8, P634, DOI 10.1038/nrneph.2012.213; Boute N, 2000, NAT GENET, V24, P349, DOI 10.1038/74166; Boyer O, 2011, NEW ENGL J MED, V365, P2377, DOI 10.1056/NEJMoa1109122; Brodin-Sartorius A, 2012, KIDNEY INT, V81, P179, DOI 10.1038/ki.2011.277; Brown AJ, 2013, NAT METHODS, V10, P638, DOI 10.1038/nmeth.2516; Chasman DI, 2012, HUM MOL GENET, V21, P5329, DOI 10.1093/hmg/dds369; COCHAT P, 2013, GLOB PUBLIC HEALTH, V8, P649, DOI DOI 10.1056/NEJMRA1301564; Cravedi P, 2013, AM J TRANSPLANT, V13, P266, DOI 10.1111/ajt.12045; Dai Y, 2009, RHEUMATOL INT, V29, P749, DOI 10.1007/s00296-008-0758-6; Dear JW, 2013, PROTEOMICS, V13, P1572, DOI 10.1002/pmic.201200285; Denamur E, 2010, KIDNEY INT, V77, P350, DOI 10.1038/ki.2009.440; Desai AN, 2012, CLIN GENET, V81, P503, DOI 10.1111/j.1399-0004.2012.01865.x; Devuyst O, 2012, NEPHROL DIAL TRANSPL, V27, P67, DOI 10.1093/ndt/gfr764; Devuyst O, 2010, ORPHANET J RARE DIS, V5, DOI 10.1186/1750-1172-5-28; Devuyst O, 2009, NEPHROL DIAL TRANSPL, V24, P2011, DOI 10.1093/ndt/gfp095; Drube J, 2012, PEDIATRICS, V129, pE356, DOI 10.1542/peds.2010-3467; Drummond IA, 2005, J AM SOC NEPHROL, V16, P299, DOI 10.1681/ASN.2004090754; Drummond I, 2009, METHOD CELL BIOL, V93, P197, DOI 10.1016/S0091-679X(08)93011-9; Eckardt KU, 2013, LANCET, V382, P158, DOI 10.1016/S0140-6736(13)60439-0; Eddy AA, 2012, PEDIATR NEPHROL, V27, P1233, DOI 10.1007/s00467-011-1938-2; Emma F, 2012, PEDIATR NEPHROL, V27, P539, DOI 10.1007/s00467-011-1926-6; Field MJ, 2010, RARE DIS ORPHAN PROU; Forman J, 2012, ACTA PAEDIATR, V101, P805, DOI 10.1111/j.1651-2227.2012.02705.x; Gadegbeku CA, 2013, KIDNEY INT, V83, P749, DOI 10.1038/ki.2012.428; Gbadegesin RA, 2013, NAT REV NEPHROL, V9, P179, DOI 10.1038/nrneph.2012.286; Grubb SC, 2014, NUCLEIC ACIDS RES, V42, pD825, DOI 10.1093/nar/gkt1159; Hart TC, 2002, J MED GENET, V39, P882, DOI 10.1136/jmg.39.12.882; Hayashi S, 2008, LANCET, V372, P889, DOI 10.1016/S0140-6736(08)61393-8; Hildebrandt F, 2010, LANCET, V375, P1287, DOI 10.1016/S0140-6736(10)60236-X; Hoefele J, 2007, J AM SOC NEPHROL, V18, P2789, DOI 10.1681/ASN.2007020243; Hogan MC, 2009, J AM SOC NEPHROL, V20, P278, DOI 10.1681/ASN.2008060564; Ingelfinger JR, 2011, NEW ENGL J MED, V364, P1670, DOI 10.1056/NEJMe1102290; Jezegou A, 2012, P NATL ACAD SCI USA, V109, pE3434, DOI 10.1073/pnas.1211198109; Ji WZ, 2008, NAT GENET, V40, P592, DOI 10.1038/ng.118; Jouret F, 2007, J AM SOC NEPHROL, V18, P707, DOI 10.1681/ASN.2006030269; Jouret F, 2010, AM J PHYSIOL-RENAL, V298, pF454, DOI 10.1152/ajprenal.00413.2009; Kamath-Rayne BD, 2014, REPROD SCI, V21, P6, DOI 10.1177/1933719113485292; Kantarci S, 2007, NAT GENET, V39, P957, DOI 10.1038/ng2063; Koboldt DC, 2013, CELL, V155, P27, DOI 10.1016/j.cell.2013.09.006; Kohler S, 2014, NUCLEIC ACIDS RES, V42, pD966, DOI 10.1093/nar/gkt1026; Lemaire M, 2013, NAT GENET, V45, P531, DOI 10.1038/ng.2590; Ling XB, 2010, J AM SOC NEPHROL, V21, P646, DOI 10.1681/ASN.2009080876; Liu BC, 2010, J PUBLIC HEALTH POL, V31, P407, DOI 10.1057/jphp.2010.30; Lloyd SE, 1996, NATURE, V379, P445, DOI 10.1038/379445a0; Lv LL, 2013, AM J PHYSIOL-RENAL, V305, pF1220, DOI 10.1152/ajprenal.00148.2013; Ly JP, 2011, CURR OPIN NEPHROL HY, V20, P382, DOI 10.1097/MNH.0b013e328347cd4a; Mahmood F, 2013, DIS MODEL MECH, V6, P652, DOI 10.1242/dmm.009480; McCarthy HJ, 2013, CLIN J AM SOC NEPHRO, V8, P637, DOI 10.2215/CJN.07200712; Meneton P, 2000, AM J PHYSIOL-RENAL, V278, pF339, DOI 10.1152/ajprenal.2000.278.3.F339; Morello JP, 2000, J CLIN INVEST, V105, P887, DOI 10.1172/JCI8688; Muller RU, 2011, CURR OPIN NEPHROL HY, V20, P400, DOI 10.1097/MNH.0b013e3283471a22; Noris M, 2012, NAT REV NEPHROL, V8, P622, DOI 10.1038/nrneph.2012.195; Noris M, 2009, NEW ENGL J MED, V361, P1676, DOI 10.1056/NEJMra0902814; Otto EA, 2011, J MED GENET, V48, P105, DOI 10.1136/jmg.2010.082552; Otto EA, 2010, NAT GENET, V42, P840, DOI 10.1038/ng.662; Rampoldi L, 2011, KIDNEY INT, V80, P338, DOI 10.1038/ki.2011.134; REEDERS ST, 1985, NATURE, V317, P542, DOI 10.1038/317542a0; Riveira-Munoz E, 2007, J AM SOC NEPHROL, V18, P1271, DOI 10.1681/ASN.2006101095; Robben JH, 2009, P NATL ACAD SCI USA, V106, P12195, DOI 10.1073/pnas.0900130106; Rogowski WH, 2009, NAT REV GENET, V10, P489, DOI 10.1038/nrg2606; ROSENTHAL W, 1992, NATURE, V359, P233, DOI 10.1038/359233a0; Schieppati A, 2008, LANCET, V371, P2039, DOI 10.1016/S0140-6736(08)60872-7; Schlingmann KP, 2011, NEW ENGL J MED, V365, P410, DOI 10.1056/NEJMoa1103864; Schreiber A, 2012, AM J PHYSIOL-RENAL, V303, pF783, DOI 10.1152/ajprenal.00279.2012; Scott J, 2013, PEDIATRICS, V132, pS231, DOI 10.1542/peds.2013-1032H; Seyberth HW, 2011, PEDIATR NEPHROL, V26, P1789, DOI 10.1007/s00467-011-1871-4; Shapiro E, 2013, NAT REV GENET, V14, P618, DOI 10.1038/nrg3542; SHIMKETS RA, 1994, CELL, V79, P407, DOI 10.1016/0092-8674(94)90250-X; Simon DB, 1996, NAT GENET, V12, P24, DOI 10.1038/ng0196-24; Simon DB, 1996, NAT GENET, V13, P183, DOI 10.1038/ng0696-183; Soliman NA, 2012, NEPHRON CLIN PRACT, V120, pC194, DOI 10.1159/000339785; Stuiver M, 2011, AM J HUM GENET, V88, P333, DOI 10.1016/j.ajhg.2011.02.005; Syres K, 2009, BLOOD, V114, P2542, DOI 10.1182/blood-2009-03-213934; Takahashi K, 2012, J BIOL CHEM; Tong A, 2013, EUR J PEDIATR, V172, P293, DOI 10.1007/s00431-012-1725-5; Tory K, 2007, J AM SOC NEPHROL, V18, P1566, DOI 10.1681/ASN.2006101164; Tory K, 2014, NAT GENET, V46, P299, DOI 10.1038/ng.2898; Town M, 1998, NAT GENET, V18, P319, DOI 10.1038/ng0498-319; Trudu M, 2013, NAT MED, V19, P1655, DOI 10.1038/nm.3384; Vilasi A, 2007, AM J PHYSIOL-RENAL, V293, pF456, DOI 10.1152/ajprenal.00095.2007; WARD CJ, 1994, CELL, V77, P881; Weavers H, 2009, NATURE, V457, P322, DOI 10.1038/nature07526; Yasuda Yoshinari, 2006, Clin Exp Nephrol, V10, P91, DOI 10.1007/s10157-006-0421-z; Yu CC, 2013, NEW ENGL J MED, V369, P2416, DOI 10.1056/NEJMoa1304572; Zhang AH, 2012, CLIN CHIM ACTA, V414, P65, DOI 10.1016/j.cca.2012.08.016; Zhang FJ, 2013, J AM SOC NEPHROL, V24, P209, DOI 10.1681/ASN.2012080795; Zheng SS, 2012, J GENET GENOMICS, V39, P261, DOI 10.1016/j.jgg.2012.05.003; Zhou H, 2013, AM J PHYSIOL-RENAL, V305, pF553, DOI 10.1152/ajprenal.00056.2013; Zhou WB, 2012, J AM SOC NEPHROL, V23, P1039, DOI 10.1681/ASN.2011080776; Zuber J, 2012, NAT REV NEPHROL, V8, P643, DOI 10.1038/nrneph.2012.214	100	131	150	1	39	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAY 24	2014	383	9931					1844	1859		10.1016/S0140-6736(14)60659-0	http://dx.doi.org/10.1016/S0140-6736(14)60659-0			16	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AH6US	24856029	Green Accepted			2022-12-28	WOS:000336267800031
J	Browne, KM; Murphy, O; Clover, AJP				Browne, Katherine M.; Murphy, Olive; Clover, A. James P.			UNCERTAINTIES PAGE Should we advise patients with sutures not to swim?	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							RECREATIONAL WATER; UNITED-STATES; HEALTH EVENTS; SURVEILLANCE; OUTBREAKS; DISEASE		[Browne, Katherine M.; Clover, A. James P.] Cork Univ Hosp, Dept Plast Surg, Cork, Ireland; [Murphy, Olive] Bon Secour Hosp, Dept Pathol, Cork, Ireland	University College Cork	Browne, KM (corresponding author), Cork Univ Hosp, Dept Plast Surg, Cork, Ireland.	katheribrowne@rcsi.ie						AUERBACH PS, 1987, ANN EMERG MED, V16, P643, DOI 10.1016/S0196-0644(87)80061-6; Barna Z, 2012, ANN I SUPER SANITA, V48, P374, DOI 10.4415/ANN_12_04_05; Bross MH, 2007, AM FAM PHYSICIAN, V76, P539; Cappello MA, 2011, J ENVIRON HEALTH, V73, P19; Fernandez R, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003861.pub3; Finkelstein Renato, 2011, Curr Infect Dis Rep, V13, P470, DOI 10.1007/s11908-011-0199-3; GOLD WL, 1993, CLIN INFECT DIS, V16, P69, DOI 10.1093/clinids/16.1.69; Hlavsa Michele C., 2011, Morbidity and Mortality Weekly Report, V60, P1; National Collaborating Centre for Women's and Children's Health, 2008, SURG SIT INF PREV TR; NHS, 2012, SOON CAN I GO SWIMM; NHS, 2013, ADV PAT UND FRAM SUR; Rich L, 2012, WIDE LOCAL EXCISION; SCHLECH WF, 1986, CAN MED ASSOC J, V134, P909; Toon CD, 2013, COCHRANE DB SYST REV, V10; WHO, 2003, GUID SAF RECR WAT EN; Yoder Jonathan S, 2008, MMWR Surveill Summ, V57, P1	16	2	2	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	MAY 23	2014	348								g3171	10.1136/bmj.g3171	http://dx.doi.org/10.1136/bmj.g3171			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AH9AC	24859900				2022-12-28	WOS:000336429700001
J	Aleman, A; Denys, D				Aleman, Andre; Denys, Damiaan			A road map for suicide research and prevention	NATURE			English	Editorial Material									[Aleman, Andre] Univ Groningen, NL-9700 AB Groningen, Netherlands; [Denys, Damiaan] Univ Amsterdam, NL-1012 WX Amsterdam, Netherlands; [Denys, Damiaan] Netherlands Inst Neurosci, Amsterdam, Netherlands	University of Groningen; University of Amsterdam; Royal Netherlands Academy of Arts & Sciences; Netherlands Institute for Neuroscience (NIN-KNAW)	Aleman, A (corresponding author), Univ Groningen, NL-9700 AB Groningen, Netherlands.	a.aleman@umcg.nl; d.denys@amc.uva.nl						Dour HJ, 2011, BEHAV RES THER, V49, P294, DOI 10.1016/j.brat.2011.01.010; Lourey C., 2013, CONTRIBUTING LIFE 20; Matthews S, 2012, PSYCHOSOM MED, V74, P471, DOI 10.1097/PSY.0b013e31824f888f; Nock MK, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000123; Pisani AR, 2013, J YOUTH ADOLESCENCE, V42, P807, DOI 10.1007/s10964-012-9884-2; Research Prioritization Task Force National Action Alliance for Suicide Prevention, 2014, PRIOR RES AG SUIC PR; Ruiz P., 2001, KAPLAN SADOCKS COMPR, P2031; van Heeringen C, 2011, NEUROSCI BIOBEHAV R, V35, P688, DOI 10.1016/j.neubiorev.2010.08.007; WHO, 2012, PUBL HLTH ACT PREV S	9	58	63	1	24	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 22	2014	509	7501					421	423		10.1038/509421a	http://dx.doi.org/10.1038/509421a			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AH4VE	24860882	Green Published, Bronze			2022-12-28	WOS:000336126000013
J	Kvon, EZ; Kazmar, T; Stampfel, G; Yanez-Cuna, JO; Pagani, M; Schernhuber, K; Dickson, BJ; Stark, A				Kvon, Evgeny Z.; Kazmar, Tomas; Stampfel, Gerald; Yanez-Cuna, J. Omar; Pagani, Michaela; Schernhuber, Katharina; Dickson, Barry J.; Stark, Alexander			Genome-scale functional characterization of Drosophila developmental enhancers in vivo	NATURE			English	Article							GENE-EXPRESSION PATTERNS; SITU HYBRIDIZATION; TISSUE; ELEMENTS; SPECIFICITY; RESOURCE; DATABASE; PROTEIN; TOOLS	Transcriptional enhancers are crucial regulators of gene expression and animal development(1) and the characterization of their genomic organization, spatiotemporal activities and sequence properties is a key goal in modern biology(2-8). Here we characterize the in vivo activity of 7,705 Drosophila melanogaster enhancer candidates covering 13.5% of the non-coding non-repetitive genome throughout embryogenesis. 3,557 (46%) candidates are active, suggesting a high density with 50,000 to 100,000 developmental enhancers genome-wide. The vast majority of enhancers display specific spatial patterns that are highly dynamic during development. Most appear to regulate their neighbouring genes, suggesting that the cis-regulatory genome is organized locally into domains, which are supported by chromosomal domains, insulator binding and genome evolution. However, 12 to 21 per cent of enhancers appear to skip non-expressed neighbours and regulate a more distal gene. Finally, we computationally identify cis-regulatory motifs that are predictive and required for enhancer activity, as we validate experimentally. This work provides global insights into the organization of an animal regulatory genome and the make-up of enhancer sequences and confirms and generalizes principles from previous studies(1,9). All enhancer patterns are annotated manually with a controlled vocabulary and all results are available through a web interface (http://enhancers.starklab.org), including the raw images of all microscopy slides for manual inspection at arbitrary zoom levels.	[Kvon, Evgeny Z.; Kazmar, Tomas; Stampfel, Gerald; Yanez-Cuna, J. Omar; Pagani, Michaela; Schernhuber, Katharina; Dickson, Barry J.; Stark, Alexander] Vienna Bioctr VBC, Res Inst Mol Pathol IMP, A-1030 Vienna, Austria	Vienna Biocenter (VBC); Research Institute of Molecular Pathology (IMP)	Stark, A (corresponding author), Vienna Bioctr VBC, Res Inst Mol Pathol IMP, Dr Bohr Gasse 7, A-1030 Vienna, Austria.	stark@starklab.org	Dickson, Barry/AAE-7632-2019; Stark, Alexander/D-1473-2012	Dickson, Barry/0000-0003-0715-892X; Stark, Alexander/0000-0003-2611-0841; Kvon, Evgeny/0000-0002-1562-0945	European Research Council (ERC) from the European Community [242922]; Austrian Science Fund (FWF) [F4303-B09]; ERC; Boehringer Ingelheim GmbH	European Research Council (ERC) from the European Community(European Research Council (ERC)); Austrian Science Fund (FWF)(Austrian Science Fund (FWF)); ERC(European Research Council (ERC)European Commission); Boehringer Ingelheim GmbH(Boehringer Ingelheim)	We thank members of the Dickson laboratory VT project for cloning the candidate regions and generating transgenic flies and the VDRC (http://stockcenter.vdrc.at) for their maintenance and distribution. We are grateful to the IMP/IMBA Scientific Services, in particular BioOptics, Genomics, and IT for help and to C. H. Lampert (IST Austria) for advice. We thank M. Levine (UC Berkeley) and V. Hartenstein (UCLA) for their permission to reproduce figures. The Stark group is supported by a European Research Council (ERC) Starting Grant from the European Community's Seventh Framework Programme (FP7/2007-2013)/ERC grant agreement no. 242922 awarded to A.S. and by the Austrian Science Fund (FWF, F4303-B09). Generation of transgenic lines was supported in part by an ERC Advanced Investigator Grant to B.J.D. Basic research at the IMP is supported by Boehringer Ingelheim GmbH.	Baylies MK, 1996, SCIENCE, V272, P1481, DOI 10.1126/science.272.5267.1481; Bonn S, 2012, NAT GENET, V44, P148, DOI 10.1038/ng.1064; Calhoun VC, 2002, P NATL ACAD SCI USA, V99, P9243, DOI 10.1073/pnas.142291299; Campos-Ortega J, 1997, EMBRYONIC DEV DROSOP; Clark AG, 2007, NATURE, V450, P203, DOI 10.1038/nature06341; Dunham I, 2012, NATURE, V489, P57, DOI 10.1038/nature11247; Erives A, 2004, P NATL ACAD SCI USA, V101, P3851, DOI 10.1073/pnas.0400611101; Fisher WW, 2012, P NATL ACAD SCI USA, V109, P21330, DOI 10.1073/pnas.1209589110; Frise E, 2010, MOL SYST BIOL, V6, DOI 10.1038/msb.2009.102; Gajewski K, 2001, DEV BIOL, V233, P425, DOI 10.1006/dbio.2001.0220; Gallo SM, 2011, NUCLEIC ACIDS RES, V39, pD118, DOI 10.1093/nar/gkq999; Graveley BR, 2011, NATURE, V471, P473, DOI 10.1038/nature09715; Harrison MM, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002266; Hartenstein V., 1993, ATLAS DROSOPHILA DEV; Hong JW, 2008, SCIENCE, V321, P1314, DOI 10.1126/science.1160631; JACK J, 1991, DEVELOPMENT, V113, P735; Jenett A, 2012, CELL REP, V2, P991, DOI 10.1016/j.celrep.2012.09.011; Jory A, 2012, CELL REP, V2, P1014, DOI 10.1016/j.celrep.2012.09.010; Kvon EZ, 2012, GENE DEV, V26, P908, DOI 10.1101/gad.188052.112; Lecuyer Eric, 2008, V420, P289, DOI 10.1007/978-1-59745-583-1_18; Levine M, 2010, CURR BIOL, V20, pR754, DOI 10.1016/j.cub.2010.06.070; Liang HL, 2008, NATURE, V456, P400, DOI 10.1038/nature07388; Maeda RK, 2011, CURR OPIN GENET DEV, V21, P187, DOI 10.1016/j.gde.2011.01.021; Manning L, 2012, CELL REP, V2, P1002, DOI 10.1016/j.celrep.2012.09.009; Marinic M, 2013, DEV CELL, V24, P530, DOI 10.1016/j.devcel.2013.01.025; NAMBU JR, 1991, CELL, V67, P1157, DOI 10.1016/0092-8674(91)90292-7; Negre N, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000814; NGUYEN HT, 1994, P NATL ACAD SCI USA, V91, P7520, DOI 10.1073/pnas.91.16.7520; Nien CY, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002339; Ochoa-Espinosa A, 2005, P NATL ACAD SCI USA, V102, P4960, DOI 10.1073/pnas.0500373102; Pennacchio LA, 2006, NATURE, V444, P499, DOI 10.1038/nature05295; Perry MW, 2011, P NATL ACAD SCI USA, V108, P13570, DOI 10.1073/pnas.1109873108; Pfeiffer BD, 2008, P NATL ACAD SCI USA, V105, P9715, DOI 10.1073/pnas.0803697105; Pfeiffer BD, 2010, GENETICS, V186, P735, DOI 10.1534/genetics.110.119917; Quinlan AR, 2010, BIOINFORMATICS, V26, P841, DOI 10.1093/bioinformatics/btq033; Rubin GM, 2000, SCIENCE, V287, P2216, DOI 10.1126/science.287.5461.2216; Sexton T, 2012, CELL, V148, P458, DOI 10.1016/j.cell.2012.01.010; Shen Y, 2012, NATURE, V488, P116, DOI 10.1038/nature11243; SMALL S, 1992, EMBO J, V11, P4047, DOI 10.1002/j.1460-2075.1992.tb05498.x; St Pierre SE, 2014, NUCLEIC ACIDS RES, V42, pD780, DOI 10.1093/nar/gkt1092; Stark A, 2007, NATURE, V450, P219, DOI 10.1038/nature06340; The modENCODE Consortium, 2010, SCIENCE, V489, P57; Thomas S, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-5-r43; Tomancak P, 2002, GENOME BIOL, V3, P88, DOI 10.1186/gb-2002-3-12-research0088; Visel A, 2007, NUCLEIC ACIDS RES, V35, pD88, DOI 10.1093/nar/gkl822; Visel A, 2009, NATURE, V457, P854, DOI 10.1038/nature07730; Weiszmann R, 2009, NAT PROTOC, V4, P605, DOI 10.1038/nprot.2009.55; Yanez-Cuna JO, 2013, TRENDS GENET, V29, P11, DOI 10.1016/j.tig.2012.09.007; Yanez-Cuna JO, 2012, GENOME RES, V22, P2018, DOI 10.1101/gr.132811.111; Zeitlinger J, 2010, DEV BIOL, V339, P230, DOI 10.1016/j.ydbio.2009.12.039; Zinzen RP, 2009, NATURE, V462, P65, DOI 10.1038/nature08531	51	262	264	1	47	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 7	2014	512	7512					91	+		10.1038/nature13395	http://dx.doi.org/10.1038/nature13395			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM5NX	24896182				2022-12-28	WOS:000339908000038
J	Dar, RD; Hosmane, NN; Arkin, MR; Siliciano, RF; Weinberger, LS				Dar, Roy D.; Hosmane, Nina N.; Arkin, Michelle R.; Siliciano, Robert F.; Weinberger, Leor S.			Screening for noise in gene expression identifies drug synergies	SCIENCE			English	Article							TRANSCRIPTIONAL REGULATION; LATENT INFECTION; HIV-1 LATENCY; STOCHASTICITY; CONSEQUENCES; FREQUENCY; PROMOTER; CELLS; CURE	Stochastic fluctuations are inherent to gene expression and can drive cell-fate specification. We used such fluctuations to modulate reactivation of HIV from latency-a quiescent state that is a major barrier to an HIV cure. By screening a diverse library of bioactive small molecules, we identified more than 80 compounds that modulated HIV gene-expression fluctuations (i.e., "noise"), without changing mean expression. These noise-modulating compounds would be neglected in conventional screens, and yet, they synergized with conventional transcriptional activators. Noise enhancers reactivated latent cells significantly better than existing best-in-class reactivation drug combinations (and with reduced off-target cytotoxicity), whereas noise suppressors stabilized latency. Noise-modulating chemicals may provide novel probes for the physiological consequences of noise and an unexplored axis for drug discovery, allowing enhanced control over diverse cell-fate decisions.	[Dar, Roy D.; Weinberger, Leor S.] Gladstone Inst, San Francisco, CA 94158 USA; [Hosmane, Nina N.; Siliciano, Robert F.] Johns Hopkins Univ, Sch Med, Dept Med, Baltimore, MD 21205 USA; [Arkin, Michelle R.] Univ Calif San Francisco, Small Mol Discovery Ctr, San Francisco, CA 94158 USA; [Arkin, Michelle R.] Univ Calif San Francisco, Dept Pharmaceut Chem, Sch Pharm, San Francisco, CA 94143 USA; [Siliciano, Robert F.] Johns Hopkins Univ, Sch Med, Howard Hughes Med Inst, Baltimore, MD 21205 USA; [Weinberger, Leor S.] Univ Calif San Francisco, Calif Inst Quantitat Biosci QB3, San Francisco, CA 94158 USA; [Weinberger, Leor S.] Univ Calif San Francisco, Dept Biochem & Biophys, San Francisco, CA 94143 USA	University of California System; University of California San Francisco; The J David Gladstone Institutes; Johns Hopkins University; University of California System; University of California San Francisco; University of California System; University of California San Francisco; Howard Hughes Medical Institute; Johns Hopkins University; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Weinberger, LS (corresponding author), Gladstone Inst, 1650 Owens St, San Francisco, CA 94158 USA.	leor.weinberger@gladstone.ucsf.edu	Arkin, Michelle/AAO-2009-2021; arkin, michelle/AAN-4298-2021	arkin, michelle/0000-0002-9366-6770; Dar, Roy/0000-0002-6006-4888	NIH National Research Service Award fellowship [AI104380]; NIH Director's New Innovator Award [DP2-OD006677]; NIH Delaney Collaboratory of AIDS Researchers for a Cure [U19AI096113]; UCSF CTSI-SOS Award; UCSF-GIVI CFAR [P30AI027763]; UCSF-CSSB [P50GM081879]; Pew Scholars in the Biomedical Sciences; Alfred P. Sloan Foundation; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR001079] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI096113, F32AI104380, P30AI027763] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P50GM081879, T32GM008752] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP2OD006677] Funding Source: NIH RePORTER	NIH National Research Service Award fellowship(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH Director's New Innovator Award(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH Delaney Collaboratory of AIDS Researchers for a Cure; UCSF CTSI-SOS Award; UCSF-GIVI CFAR; UCSF-CSSB; Pew Scholars in the Biomedical Sciences; Alfred P. Sloan Foundation(Alfred P. Sloan Foundation); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We thank I. Golding, J. Weissman, O. Weiner, E. Verdin, M. Simpson, C. Lee, A. Pai and the Weinberger lab for thoughtful discussions. We thank C. Wilson, M. Cavrois, M. Gesner, and M. Titus for technical expertise and assistance. R. D. D. was supported by an NIH National Research Service Award fellowship (AI104380). This work was supported by the NIH Director's New Innovator Award DP2-OD006677 (L. S. W.), the NIH Delaney Collaboratory of AIDS Researchers for a Cure (U19AI096113), a UCSF CTSI-SOS Award, UCSF-GIVI CFAR (P30AI027763), UCSF-CSSB (P50GM081879), the Pew Scholars in the Biomedical Sciences, and the Alfred P. Sloan Foundation.	Acar M, 2008, NAT GENET, V40, P471, DOI 10.1038/ng.110; Archin NM, 2012, NATURE, V487, P482, DOI 10.1038/nature11286; Blake WJ, 2006, MOL CELL, V24, P853, DOI 10.1016/j.molcel.2006.11.003; Blake WJ, 2003, NATURE, V422, P633, DOI 10.1038/nature01546; Boehm D, 2013, CELL CYCLE, V12, P452, DOI 10.4161/cc.23309; Dar RD, 2012, P NATL ACAD SCI USA, V109, P17454, DOI 10.1073/pnas.1213530109; Deeks SG, 2012, NATURE, V487, P439, DOI 10.1038/487439a; Elowitz MB, 2002, SCIENCE, V297, P1183, DOI 10.1126/science.1070919; Golding I, 2005, CELL, V123, P1025, DOI 10.1016/j.cell.2005.09.031; Ho YC, 2013, CELL, V155, P540, DOI 10.1016/j.cell.2013.09.020; Jordan A, 2003, EMBO J, V22, P1868, DOI 10.1093/emboj/cdg188; Kaern M, 2005, NAT REV GENET, V6, P451, DOI 10.1038/nrg1615; Kepler TB, 2001, BIOPHYS J, V81, P3116, DOI 10.1016/S0006-3495(01)75949-8; Ozbudak EM, 2002, NAT GENET, V31, P69, DOI 10.1038/ng869; Raj A, 2006, PLOS BIOL, V4, P1707, DOI 10.1371/journal.pbio.0040309; Raser JM, 2004, SCIENCE, V304, P1811, DOI 10.1126/science.1098641; Reuse S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006093; Richman DD, 2009, SCIENCE, V323, P1304, DOI 10.1126/science.1165706; Ruelas DS, 2013, CELL, V155, P519, DOI 10.1016/j.cell.2013.09.044; Simpson ML, 2004, J THEOR BIOL, V229, P383, DOI 10.1016/j.jtbi.2004.04.017; Singh A, 2010, BIOPHYS J, V98, pL32, DOI 10.1016/j.bpj.2010.03.001; Taniguchi Y, 2010, SCIENCE, V329, P533, DOI 10.1126/science.1188308; Vardi N, 2013, CURR BIOL, V23, P2051, DOI 10.1016/j.cub.2013.08.043; Weinberger AD, 2013, CELL, V155, P497, DOI 10.1016/j.cell.2013.09.039; Weinberger LS, 2008, NAT GENET, V40, P466, DOI 10.1038/ng.116; Weinberger LS, 2005, CELL, V122, P169, DOI 10.1016/j.cell.2005.06.006; Yang HC, 2009, J CLIN INVEST, V119, P3473, DOI 10.1172/JCI39199	27	137	140	0	47	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 20	2014	344	6190					1392	1396		10.1126/science.1250220	http://dx.doi.org/10.1126/science.1250220			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AJ2YQ	24903562	Green Accepted			2022-12-28	WOS:000337531700039
J	Subramanian, S; Huq, S; Yatsunenko, T; Haque, R; Mahfuz, M; Alam, MA; Benezra, A; DeStefano, J; Meier, MF; Muegge, BD; Barratt, MJ; VanArendonk, LG; Zhang, QY; Province, MA; Petri, WA; Ahmed, T; Gordon, JI				Subramanian, Sathish; Huq, Sayeeda; Yatsunenko, Tanya; Haque, Rashidul; Mahfuz, Mustafa; Alam, Mohammed A.; Benezra, Amber; DeStefano, Joseph; Meier, Martin F.; Muegge, Brian D.; Barratt, Michael J.; VanArendonk, Laura G.; Zhang, Qunyuan; Province, Michael A.; Petri, William A., Jr.; Ahmed, Tahmeed; Gordon, Jeffrey I.			Persistent gut microbiota immaturity in malnourished Bangladeshi children	NATURE			English	Article							GROWTH; MALNUTRITION; AGE	Therapeutic food interventions have reduced mortality in children with severe acute malnutrition (SAM), but incomplete restoration of healthy growth remains a major problem(1,2). The relationships between the type of nutritional intervention, the gut microbiota, and therapeutic responses are unclear. In the current study, bacterial species whose proportional representation define a healthy gut microbiota as it assembles during the first two postnatal years were identified by applying amachine-learning-based approach to 16S ribosomal RNA data sets generated from monthly faecal samples obtained from birth onwards in a cohort of children living in an urban slum of Dhaka, Bangladesh, who exhibited consistently healthy growth. These age discriminatory bacterial species were incorporated into a model that computes a 'relative microbiota maturity index' and 'microbiotafor- age Z-score' that compare postnatal assembly (defined here as maturation) of a child's faecal microbiota relative to healthy children of similar chronologic age. The model was applied to twins and triplets (to test for associations of these indices with genetic and environmental factors, including diarrhoea), children with SAM enrolled in a randomized trial of two food interventions, and children with moderate acute malnutrition. Our results indicate that SAM is associated with significant relative microbiota immaturity that is only partially ameliorated following two widely used nutritional interventions. Immaturity is also evident in less severe forms of malnutrition and correlates with anthropometric measurements. Microbiota maturity indices provide a microbial measure of human postnatal development, a way of classifying malnourished states, and a parameter for judging therapeutic efficacy. More prolonged interventions with existing or new therapeutic foods and/or addition of gut microbes may be needed to achieve enduring repair of gut microbiota immaturity in childhood malnutrition and improve clinical outcomes.	[Subramanian, Sathish; Yatsunenko, Tanya; Benezra, Amber; DeStefano, Joseph; Meier, Martin F.; Muegge, Brian D.; Barratt, Michael J.; VanArendonk, Laura G.; Gordon, Jeffrey I.] Washington Univ, Ctr Genome Sci & Syst Biol, St Louis, MO 63108 USA; [Huq, Sayeeda; Haque, Rashidul; Mahfuz, Mustafa; Alam, Mohammed A.; Ahmed, Tahmeed] Int Ctr Diarrhoeal Dis Res, Ctr Nutr & Food Secur, Dhaka 1212, Bangladesh; [Benezra, Amber] New Sch Social Res, Dept Anthropol, New York, NY 10003 USA; [Zhang, Qunyuan; Province, Michael A.] Washington Univ, Div Stat Genom, St Louis, MO 63108 USA; [Petri, William A., Jr.] Univ Virginia, Sch Med, Dept Med, Charlottesville, VA 22908 USA; [Petri, William A., Jr.] Univ Virginia, Sch Med, Dept Microbiol & Pathol, Charlottesville, VA 22908 USA	Washington University (WUSTL); International Centre for Diarrhoeal Disease Research (ICDDR); The New School; Washington University (WUSTL); University of Virginia; University of Virginia	Gordon, JI (corresponding author), Washington Univ, Ctr Genome Sci & Syst Biol, St Louis, MO 63108 USA.	jgordon@wustl.edu	Mahfuz, Mustafa/H-5923-2017; alam, mohammed/GXH-3645-2022; Benezra, Amber/ABU-7951-2022; Petri, William/AAL-3642-2020; Petri, William A./D-3639-2019; Alam, Ashraful/AAA-3893-2020	Mahfuz, Mustafa/0000-0002-4090-785X; Benezra, Amber/0000-0002-7092-6808; Petri, William/0000-0002-7268-1218; Alam, Ashraful/0000-0003-1389-8510; Muegge, Brian/0000-0002-0044-3704	Bill & Melinda Gates Foundation; International Atomic Energy Agency; NIH [AI043596]; SBE Doctoral Dissertation Research Improvement Grant (NSF) [SES-1027035]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI043596] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007067] Funding Source: NIH RePORTER	Bill & Melinda Gates Foundation(Bill & Melinda Gates FoundationCGIAR); International Atomic Energy Agency(International Atomic Energy Agency); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); SBE Doctoral Dissertation Research Improvement Grant (NSF); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank the parents and children from Dhaka, Bangladesh for their participation in this study, J. Hoisington-Lopez and S. Deng for technical assistance, and N. Griffin, A. Kau, N. Dey and J. Faith for suggestions during the course of this work. This work was supported by the Bill & Melinda Gates Foundation. The clinical component of the SAM study was funded by the International Atomic Energy Agency. The birth cohort study of singletons was supported in part by the NIH (AI043596). S. S. is a member of the Washington University Medical Scientist Training Program. A. B. is the recipient of an SBE Doctoral Dissertation Research Improvement Grant (NSF Award no. SES-1027035).	Ahmed T, 1999, LANCET, V353, P1919, DOI 10.1016/S0140-6736(98)07499-6; Ahmed T., 2004, J PEDIAT GASTROENTER, V39, pS277; Ahmed Tahmeed, 2001, Indian Journal of Pediatrics, V68, P45, DOI 10.1007/BF02728857; Ashraf H, 2012, J TROP PEDIATRICS, V58, P253, DOI 10.1093/tropej/fmr083; Bates D., 2011, PACKAGE LME4 LINEAR, V1; Bokulich NA, 2013, NAT METHODS, V10, P57, DOI [10.1038/NMETH.2276, 10.1038/nmeth.2276]; Breiman L., 2001, Machine Learning, V45, P5, DOI 10.1023/A:1010933404324; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; David LA, 2014, NATURE, V505, P559, DOI 10.1038/nature12820; Dewey KG, 2005, MATERN CHILD NUTR, V1, P11, DOI 10.1111/j.1740-8709.2004.00004.x; Faith JJ, 2013, SCIENCE, V341, P44, DOI 10.1126/science.1237439; Kuznetsova A., 2013, CHRISTENSEN RHB LMER; Lazzerini M, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD009584.pub2; Lin A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053838; McDonald D, 2012, ISME J, V6, P610, DOI 10.1038/ismej.2011.139; Mondal D, 2012, CLIN INFECT DIS, V54, P185, DOI 10.1093/cid/cir807; Muegge BD, 2011, SCIENCE, V332, P970, DOI 10.1126/science.1198719; Nahar B, 2012, EUR J CLIN NUTR, V66, P701, DOI 10.1038/ejcn.2012.13; National Institute of Population Research and Training (NIPORT) Mitra and Associates and ICF International, 2013, BANGL DEM HLTH SURV; Pathela P, 2006, ACTA PAEDIATR, V95, P430, DOI 10.1080/08035250500444875; Prentice AM, 2013, AM J CLIN NUTR, V97, P911, DOI 10.3945/ajcn.112.052332; Smith MI, 2013, SCIENCE, V339, P548, DOI 10.1126/science.1229000; Tang WHW, 2013, NEW ENGL J MED, V368, P1575, DOI 10.1056/NEJMoa1109400; Victora CG, 2010, PEDIATRICS, V125, pE473, DOI 10.1542/peds.2009-1519; World Health Organization Department of Nutrition for Health and Development, 2009, WHO CHILD GROWTH STA; Wu GD, 2011, SCIENCE, V334, P105, DOI 10.1126/science.1208344; Yatsunenko T, 2012, NATURE, V486, P222, DOI 10.1038/nature11053	27	709	728	13	194	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	JUN 19	2014	510	7505					417	+		10.1038/nature13421	http://dx.doi.org/10.1038/nature13421			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AJ0NG	24896187	Green Accepted			2022-12-28	WOS:000337350200039
J	Wilson, MR; Naccache, SN; Samayoa, E; Biagtan, M; Bashir, H; Yu, GX; Salamat, SM; Somasekar, S; Federman, S; Miller, S; Sokolic, R; Garabedian, E; Candotti, F; Buckley, RH; Reed, KD; Meyer, TL; Seroogy, CM; Galloway, R; Henderson, SL; Gern, JE; DeRisi, JL; Chiu, CY				Wilson, Michael R.; Naccache, Samia N.; Samayoa, Erik; Biagtan, Mark; Bashir, Hiba; Yu, Guixia; Salamat, Shahriar M.; Somasekar, Sneha; Federman, Scot; Miller, Steve; Sokolic, Robert; Garabedian, Elizabeth; Candotti, Fabio; Buckley, Rebecca H.; Reed, Kurt D.; Meyer, Teresa L.; Seroogy, Christine M.; Galloway, Renee; Henderson, Sheryl L.; Gern, James E.; DeRisi, Joseph L.; Chiu, Charles Y.			Actionable Diagnosis of Neuroleptospirosis by Next-Generation Sequencing	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							TRIATHLON PARTICIPANTS; PATHOGEN DISCOVERY; LEPTOSPIROSIS; ENCEPHALITIS; OUTBREAK; GENOME; ETIOLOGIES; EXPERIENCE; CHALLENGE; PCR	A 14-year-old boy with severe combined immunodeficiency presented three times to a medical facility over a period of 4 months with fever and headache that progressed to hydrocephalus and status epilepticus necessitating a medically induced coma. Diagnostic workup including brain biopsy was unrevealing. Unbiased next-generation sequencing of the cerebrospinal fluid identified 475 of 3,063,784 sequence reads (0.016%) corresponding to leptospira infection. Clinical assays for leptospirosis were negative. Targeted antimicrobial agents were administered, and the patient was discharged home 32 days later with a status close to his premorbid condition. Polymerase-chain-reaction (PCR) and serologic testing at the Centers for Disease Control and Prevention (CDC) subsequently confirmed evidence of Leptospira santarosai infection.	[Wilson, Michael R.; DeRisi, Joseph L.] Univ Calif San Francisco, Dept Biochem & Biophys, San Francisco, CA 94107 USA; [Wilson, Michael R.] Univ Calif San Francisco, Dept Neurol, San Francisco, CA 94107 USA; [Naccache, Samia N.; Samayoa, Erik; Yu, Guixia; Somasekar, Sneha; Federman, Scot; Miller, Steve; Chiu, Charles Y.] Univ Calif San Francisco, Dept Lab Med, San Francisco, CA 94107 USA; [Chiu, Charles Y.] Univ Calif San Francisco, Dept Med, Div Infect Dis, San Francisco, CA 94107 USA; [Naccache, Samia N.; Samayoa, Erik; Yu, Guixia; Somasekar, Sneha; Federman, Scot; Miller, Steve; Chiu, Charles Y.] Univ Calif San Francisco, Abbott Viral Diagnost & Discovery Ctr, San Francisco, CA 94107 USA; [Biagtan, Mark; Bashir, Hiba; Gern, James E.] Univ Wisconsin, Dept Med, Div Allergy & Immunol, Madison, WI 53706 USA; [Salamat, Shahriar M.; Reed, Kurt D.] Univ Wisconsin, Dept Pathol & Lab Med, Madison, WI 53706 USA; [Meyer, Teresa L.; Seroogy, Christine M.; Henderson, Sheryl L.; Gern, James E.] Univ Wisconsin, Dept Pediat, Madison, WI 53706 USA; [Sokolic, Robert; Garabedian, Elizabeth; Candotti, Fabio] NCI, Expt Transplantat & Immunol Branch, Ctr Canc Res, NIH, Bethesda, MD 20892 USA; [Buckley, Rebecca H.] Duke Univ, Dept Pediat, Div Allergy & Immunol, Durham, NC 27706 USA; [Buckley, Rebecca H.] Duke Univ, Dept Immunol, Div Allergy & Immunol, Durham, NC USA; [Galloway, Renee] Ctr Dis Control & Prevent, Atlanta, GA USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Duke University; Duke University; Centers for Disease Control & Prevention - USA	Chiu, CY (corresponding author), Univ Calif San Francisco, Dept Lab Med, 185 Berry St,Box 134, San Francisco, CA 94107 USA.	charles.chiu@ucsf.edu	Sokolic, Robert/E-6224-2017	Sokolic, Robert/0000-0002-3399-7893; Chiu, Charles/0000-0003-2915-2094; Wilson, Michael/0000-0002-8705-5084; Candotti, Fabio/0000-0001-6399-6042	American Brain Foundation; National Human Genome Research Institute; Howard Hughes Medical Institute; National Institutes of Health [R01-HL105704]; University of California; Amazon Web Services in Education Research Grant; Abbott Viral Discovery Award; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL105704] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [ZIAHG000121] Funding Source: NIH RePORTER	American Brain Foundation; National Human Genome Research Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); Howard Hughes Medical Institute(Howard Hughes Medical Institute); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of California(University of California System); Amazon Web Services in Education Research Grant; Abbott Viral Discovery Award; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	Supported by the American Brain Foundation Clinical Research Training Fellowship (to Dr. Wilson), a National Human Genome Research Institute Intramural Research Program appointment (to Dr. Sokolic, Ms. Garabedian, and Dr. Candotti), a Howard Hughes Medical Institute appointment (to Dr. DeRisi), a grant from the National Institutes of Health (R01-HL105704, to Dr. Chiu), a University of California Discovery Grant (to Dr. Chiu), an Amazon Web Services in Education Research Grant (to Dr. Chiu), and an Abbott Viral Discovery Award (to Dr. Chiu).	Bourhy P, 2011, J CLIN MICROBIOL, V49, P2154, DOI 10.1128/JCM.02452-10; Briese T, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000455; Brockmann S, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-91; Brownlow T, 2013, EPIDEMIOL INFECT; Bulach DM, 2006, P NATL ACAD SCI USA, V103, P14560, DOI 10.1073/pnas.0603979103; Chius CY, 2013, CURR OPIN MICROBIOL, V16, P468, DOI 10.1016/j.mib.2013.05.001; Chou LF, 2012, GENE, V511, P364, DOI 10.1016/j.gene.2012.09.074; Dunne WM, 2012, EUR J CLIN MICROBIOL, V31, P1719, DOI 10.1007/s10096-012-1641-7; Garcia-Monco JC, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003288; Gaspar HB, 2009, BLOOD, V114, P3524, DOI 10.1182/blood-2009-06-189209; Glaser CA, 2006, CLIN INFECT DIS, V43, P1565, DOI 10.1086/509330; Glaser CA, 2003, CLIN INFECT DIS, V36, P731, DOI 10.1086/367841; Granerod J, 2010, NEUROLOGY, V75, P924, DOI 10.1212/WNL.0b013e3181f11d65; Grard G, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002924; Greninger AL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013381; Haake DA, 2002, CLIN INFECT DIS, V34, pE40, DOI 10.1086/339942; Levett PN, 2001, CLIN DIAGN LAB IMMUN, V8, P349, DOI 10.1128/CDLI.8.2.349-351.2001; Levett PN, 2001, CLIN MICROBIOL REV, V14, P296, DOI 10.1128/CMR.14.2.296-326.2001; LICHTIGER B, 1991, ARCH PATHOL LAB MED, V115, P467; Lin PC, 2008, J MICROBIOL IMMUNOL, V41, P145; Mailles A, 2009, CLIN INFECT DIS, V49, P1838, DOI 10.1086/648419; Mathew T, 2006, INDIAN J MED RES, V124, P155; Morgan J, 2002, CLIN INFECT DIS, V34, P1593, DOI 10.1086/340615; Murgatroyd F, 1937, BRIT MED J, V1937, P7, DOI 10.1136/bmj.1.3965.7; Naccache SN, 2013, J VIROL, V87, P11966, DOI 10.1128/JVI.02323-13; Naccache SN, GENOME RES IN PRESS; Nalam K, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012637; Palacios G, 2008, NEW ENGL J MED, V358, P991, DOI 10.1056/NEJMoa073785; Rathinam S R, 2005, J Postgrad Med, V51, P189; Sakellaridis N, 2009, SOUTH MED J, V102, P549, DOI 10.1097/SMJ.0b013e3181a0ae80; Sejvar J, 2003, EMERG INFECT DIS, V9, P702; Sharma Jayashree, 2007, Asian J Transfus Sci, V1, P52, DOI 10.4103/0973-6247.33447; Stern EJ, 2010, CLIN INFECT DIS, V50, P843, DOI 10.1086/650578; Stoddard RA, 2009, DIAGN MICR INFEC DIS, V64, P247, DOI 10.1016/j.diagmicrobio.2009.03.014; Sunbul M, 2001, SCAND J INFECT DIS, V33, P896, DOI 10.1080/00365540110076796; Swei A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062083; Vinetz JM, 1996, ANN INTERN MED, V125, P794, DOI 10.7326/0003-4819-125-10-199611150-00002; Yu GX, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049449	38	492	554	4	65	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUN 19	2014	370	25					2408	2417		10.1056/NEJMoa1401268	http://dx.doi.org/10.1056/NEJMoa1401268			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AJ0OA	24896819	Green Accepted, Green Published			2022-12-28	WOS:000337353000009
J	Vater, LB; Donohue, JM; Arnold, R; White, DB; Chu, E; Schenker, Y				Vater, Laura B.; Donohue, Julie M.; Arnold, Robert; White, Douglas B.; Chu, Edward; Schenker, Yael			What Are Cancer Centers Advertising to the Public? A Content Analysis	ANNALS OF INTERNAL MEDICINE			English	Article							PALLIATIVE RADIOTHERAPY; PRESCRIPTION DRUGS; LUNG-CANCER; EXPECTATIONS; PATIENT; CARE; PERCEPTIONS; PROGNOSIS; THERAPY; COST	Background: Although critics have expressed concerns about cancer center advertising, analyses of the content of these advertisements are lacking. Objective: To characterize the information and emotional content of direct-to-consumer cancer center advertisements. Design: Content analysis. Setting: Top U. S. consumer magazines (n = 269) and television networks (n = 44) in 2012. Measurements: Types of clinical services promoted; information provided about clinical services, including risks, benefits, costs, and insurance availability; use of emotional advertising appeals; and use of patient testimonials were assessed. Two investigators independently coded advertisements using ATLAS.ti, and kappa values ranged from 0.77 to 1.00. Results: A total of 102 cancer centers placed 409 unique clinical advertisements in top media markets in 2012. Advertisements promoted treatments (88%) more often than screening (18%) or supportive services (13%). Benefits of advertised therapies were described more often than risks (27% vs. 2%) but were rarely quantified (2%). Few advertisements mentioned coverage or costs (5%), and none mentioned specific insurance plans. Emotional appeals were frequent (85%), evoking hope for survival (61%), describing cancer treatment as a fight or battle (41%), and inducing fear (30%). Nearly one half of advertisements included patient testimonials, which were usually focused on survival, rarely included disclaimers (15%), and never described the results that a typical patient may expect. Limitation: Internet advertisements were not included. Conclusion: Clinical advertisements by cancer centers frequently promote cancer therapy with emotional appeals that evoke hope and fear while rarely providing information about risks, benefits, costs, or insurance availability. Further work is needed to understand how these advertisements influence patient understanding and expectations of benefit from cancer treatments.	Univ Pittsburgh, Grad Sch Publ Hlth, Biobehav Oncol Program, Canc Inst,Palliat & Support Inst,Med Ctr, Pittsburgh, PA 15213 USA; Univ Pittsburgh, Clin Res Invest & Syst Modeling Acute Illness Ctr, Pittsburgh, PA 15213 USA; Indiana Univ, Sch Med, South Bend, IN 46615 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Indiana University System; Indiana University South Bend	Schenker, Y (corresponding author), Univ Pittsburgh, Sect Palliat Care & Med Eth, Div Gen Med, 230 McKee Pl,Suite 600, Pittsburgh, PA 15213 USA.	schenkery@upmc.edu		Vater, Laura/0000-0002-5920-9576; Donohue, Julie/0000-0003-2418-6017	National Institutes of Health; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [KL2TR000146] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS))	Primary Funding Source: National Institutes of Health.	Abel GA, 2007, J CLIN ONCOL, V25, P1267, DOI 10.1200/JCO.2006.09.5968; Abel GA, 2009, J CLIN ONCOL, V27, P4182, DOI 10.1200/JCO.2008.20.6599; Algie J, 2010, J PREV INTERV COMMUN, V38, P264, DOI 10.1080/10852352.2010.509019; Ambler T, 1999, J ADVERTISING RES, V39, P25; American College of Surgeons, SEARCH COC HOSP LOC; American College of Surgeons, ACCR; Armstrong J.Scott., 2010, PERSUASIVE ADVERTISI, DOI 10.1057/9780230285804; Bell RA, 2000, J FAM PRACTICE, V49, P329; Burns CM, 2007, SUPPORT CARE CANCER, V15, P187, DOI 10.1007/s00520-006-0116-8; Char SJL, 2010, AM J RESP CRIT CARE, V182, P905, DOI 10.1164/rccm.201002-0262OC; Chen AB, 2013, J CLIN ONCOL, V31, P2730, DOI 10.1200/JCO.2012.48.5748; Chow E, 2001, CLIN ONCOL-UK, V13, P204, DOI 10.1053/clon.2001.9255; Dillard JP, 2006, J COMMUN, V56, pS123, DOI 10.1111/j.1460-2466.2006.00286.x; Donohue JM, 2007, NEW ENGL J MED, V357, P673, DOI 10.1056/NEJMsa070502; Dunlop SM, 2014, J HEALTH COMMUN, V19, P41, DOI 10.1080/10810730.2013.798375; Dunlop SM, 2012, TOB CONTROL; EIDINGER RN, 1984, CANCER, V53, P2736, DOI 10.1002/1097-0142(19840615)53:12<2736::AID-CNCR2820531233>3.0.CO;2-W; Frosch DL, 2007, ANN FAM MED, V5, P6, DOI 10.1370/afm.611; Gattellari M, 2002, J CLIN ONCOL, V20, P503, DOI 10.1200/JCO.20.2.503; Gray SW, 2012, J ONCOL PRACT, V8, P124, DOI 10.1200/JOP.2011.000513; Illes J, 2004, ARCH INTERN MED, V164, P2415, DOI 10.1001/archinte.164.22.2415; Kravitz RL, 2005, JAMA-J AM MED ASSOC, V293, P1995, DOI 10.1001/jama.293.16.1995; Larson RJ, 2005, ARCH INTERN MED, V165, P645, DOI 10.1001/archinte.165.6.645; Lee SJ, 2001, JAMA-J AM MED ASSOC, V285, P1034, DOI 10.1001/jama.285.8.1034; Lovett KM, 2012, J CLIN ONCOL, V30, P1411, DOI 10.1200/JCO.2011.37.8984; MACKILLOP WJ, 1988, BRIT J CANCER, V58, P355, DOI 10.1038/bjc.1988.218; Mariotto AB, 2011, JNCI-J NATL CANCER I, V103, P117, DOI 10.1093/jnci/djq495; Mehrotra A, 2006, HEALTH AFFAIR, V25, P759, DOI 10.1377/hlthaff.25.3.759; Mitera G, 2012, CLIN ONCOL-UK, V24, P134, DOI 10.1016/j.clon.2011.09.001; National Cancer Institute, NCI DES CANC CTR; National Research Council, 2013, DEL HIGH QUAL CANC C; Newman A. A., 2011, NY TIMES; Parrott Roxanne, 2008, Health Mark Q, V25, P8, DOI 10.1080/07359680802126061; PRONZATO P, 1994, SUPPORT CARE CANCER, V2, P242, DOI 10.1007/BF00365729; Ravdin PM, 1998, J CLIN ONCOL, V16, P515, DOI 10.1200/JCO.1998.16.2.515; Sapir R, 2000, SUPPORT CARE CANCER, V8, P458, DOI 10.1007/s005200000163; Schenker Y, 2014, AM J BIOETHICS, V14, P34, DOI 10.1080/15265161.2013.879943; SCHWARTZ IM, 1989, J ADOLESCENT HEALTH, V10, P473, DOI 10.1016/0197-0070(89)90009-0; Singer Natasha, 2009, NY TIMES        0805, pA1; STERN BB, 1994, J CONSUM RES, V20, P601, DOI 10.1086/209373; Tellis GJ, 2004, EFFECTIVE ADVERTISIN; Temel JS, 2011, J CLIN ONCOL, V29, P2319, DOI 10.1200/JCO.2010.32.4459; The AM, 2000, BRIT MED J, V321, P1376, DOI 10.1136/bmj.321.7273.1376; Volpp KG, 2012, JAMA-J AM MED ASSOC, V308, P1635, DOI 10.1001/jama.2012.13616; Warren JL, 2008, J NATL CANCER I, V100, P888, DOI 10.1093/jnci/djn175; Weeks JC, 2012, NEW ENGL J MED, V367, P1616, DOI 10.1056/NEJMoa1204410; Weissman J. S., 2004, HLTH AFF MILLWOOD S	47	39	39	0	19	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JUN 17	2014	160	12					813	U24		10.7326/M14-0500	http://dx.doi.org/10.7326/M14-0500			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	AJ0VR	24863081	Green Accepted			2022-12-28	WOS:000337374900014
J	Chisari, FV; Mason, WS; Seeger, C				Chisari, Francis V.; Mason, William S.; Seeger, Christoph			VIROLOGY Comment on "Specific and nonhepatotoxic degradation of nuclear hepatitis B virus cccDNA"	SCIENCE			English	Editorial Material							INFECTION; LIVER	Lucifora et al. (Research Articles, 14March 2014, p. 1221) report that the hepatitis B virus (HBV) transcriptional template, a long-lived covalently closed circular DNA (cccDNA) molecule, is degraded noncytolytically by agents that up-regulate APOBEC3A and 3B. If these results can be independently confirmed, they would represent a critical first step toward development of a cure for the 400 million patients who are chronically infected by HBV.	[Chisari, Francis V.] Scripps Res Inst, La Jolla, CA 92037 USA; [Mason, William S.; Seeger, Christoph] Fox Chase Canc Ctr, Philadelphia, PA 19111 USA	Scripps Research Institute; Fox Chase Cancer Center	Chisari, FV (corresponding author), Scripps Res Inst, La Jolla, CA 92037 USA.	fchisari@scripps.edu	Chisari, Francis V/A-3086-2008	Chisari, Francis/0000-0002-4832-1044				Baumert TF, 2007, HEPATOLOGY, V46, P682, DOI 10.1002/hep.21733; GUIDOTTI LG, 1994, J VIROL, V68, P5469, DOI 10.1128/JVI.68.9.5469-5475.1994; Guidotti LG, 1996, IMMUNITY, V4, P25, DOI 10.1016/S1074-7613(00)80295-2; Guidotti LG, 1999, SCIENCE, V284, P825, DOI 10.1126/science.284.5415.825; Haybaeck J, 2009, CANCER CELL, V16, P295, DOI 10.1016/j.ccr.2009.08.021; Hu XL, 2013, CARCINOGENESIS, V34, P1105, DOI 10.1093/carcin/bgt014; Lucifora J, 2014, SCIENCE, V343, P1221, DOI 10.1126/science.1243462; Summers J, 2003, P NATL ACAD SCI USA, V100, P11652, DOI 10.1073/pnas.1635109100; Tumanov AV, 2009, GASTROENTEROLOGY, V136, P694, DOI 10.1053/j.gastro.2008.09.015; Wieland SF, 2004, P NATL ACAD SCI USA, V101, P2129, DOI 10.1073/pnas.0308478100; Wolf MJ, 2010, ONCOGENE, V29, P5006, DOI 10.1038/onc.2010.260	11	31	34	0	32	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 13	2014	344	6189								10.1126/science.1254082	http://dx.doi.org/10.1126/science.1254082			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI7ND	24926010				2022-12-28	WOS:000337077500028
J	Fischer, A				Fischer, Alain			GENE THERAPY Repair and replace	NATURE			English	Editorial Material									[Fischer, Alain] Hop Necker Enfants Malad, Imagine Inst, F-75015 Paris, France; [Fischer, Alain] Coll France, F-75231 Paris, France	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; PSL Research University Paris; College de France	Fischer, A (corresponding author), Hop Necker Enfants Malad, Imagine Inst, F-75015 Paris, France.	alain.fischer@inserm.fr						Aiuti A, 2002, SCIENCE, V296, P2410, DOI 10.1126/science.1070104; Aiuti A, 2013, SCIENCE, V341, P865, DOI 10.1126/science.1233151; Biffi A, 2013, SCIENCE, V341, P864, DOI 10.1126/science.1233158; Cartier N, 2009, SCIENCE, V326, P818, DOI 10.1126/science.1171242; Cavazzana-Calvo M, 2000, SCIENCE, V288, P669, DOI 10.1126/science.288.5466.669; Cavazzana-Calvo M, 2010, NATURE, V467, P318, DOI 10.1038/nature09328; FRIEDMANN T, 1972, SCIENCE, V175, P949, DOI 10.1126/science.175.4025.949; Genovese P, 2014, NATURE, V510, P235, DOI 10.1038/nature13420; Hacein-Bey-Abina S, 2003, SCIENCE, V302, P415, DOI 10.1126/science.1088547; Kim H, 2014, NAT REV GENET, V15, P321, DOI 10.1038/nrg3686; Riddell J, 2014, CELL, V157, P549, DOI 10.1016/j.cell.2014.04.006	11	9	9	0	11	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 12	2014	510	7504					226	227		10.1038/nature13344	http://dx.doi.org/10.1038/nature13344			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI7AT	24870243				2022-12-28	WOS:000337032400041
J	Finkelstein, J; Heemels, MT; Shadan, S; Weiss, U				Finkelstein, Joshua; Heemels, Marie-Therese; Shadan, Sadaf; Weiss, Ursula			nature INSIGHT LIPIDS IN HEALTH AND DISEASE	NATURE			English	Editorial Material														Finkelstein, Joshua/0000-0003-2613-9345					0	20	20	0	25	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 5	2014	510	7503					47	47		10.1038/510047a	http://dx.doi.org/10.1038/510047a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AI3NR	24899303	Bronze			2022-12-28	WOS:000336768900030
J	Clery, D				Clery, Daniel			Six handshakes, then silence	SCIENCE			English	Editorial Material														Clery, Daniel/0000-0002-8742-3596					0	2	2	0	4	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 30	2014	344	6187					964	965		10.1126/science.344.6187.964	http://dx.doi.org/10.1126/science.344.6187.964			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AH9WM	24876476				2022-12-28	WOS:000336495800017
J	Kessler, R				Kessler, Rebecca			PREVENTION Air of danger	NATURE			English	Editorial Material							BREAST-CANCER; EXPOSURE; DDT; AGE											Cohn BA, 2007, ENVIRON HEALTH PERSP, V115, P1406, DOI 10.1289/ehp.10260; Cohn BA, 2012, BREAST CANCER RES TR, V136, P267, DOI 10.1007/s10549-012-2257-4; Cohn BA, 2010, ARCH ENVIRON OCCUP H, V65, P127, DOI 10.1080/19338241003730887; DOLL R, 1981, JNCI-J NATL CANCER I, V66, P1191, DOI 10.1093/jnci/66.6.1192; Guerrero-Bosagna C, 2012, REPROD TOXICOL, V34, P694, DOI 10.1016/j.reprotox.2012.09.005; National Toxicology Program, 2011, REP CARC; Prins GS, 2014, ENDOCRINOLOGY, V155, P805, DOI 10.1210/en.2013-1955; Straif K., 2013, AIR POLLUTION CANC; Vandenberg LN, 2012, ENDOCR REV, V33, P378, DOI 10.1210/er.2011-1050; [No title captured]	10	15	16	0	26	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 29	2014	509	7502					S62	S63		10.1038/509S62a	http://dx.doi.org/10.1038/509S62a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AH9JC	24870824	Bronze			2022-12-28	WOS:000336457100007
J	Tarlinton, DM				Tarlinton, David M.			To affinity and beyond	NATURE			English	Editorial Material							GERMINAL-CENTERS; MEMORY		[Tarlinton, David M.] Walter & Eliza Hall Inst Med Res, Parkville, Vic 3052, Australia; [Tarlinton, David M.] Univ Melbourne, Dept Med Biol, Parkville, Vic 3052, Australia	Walter & Eliza Hall Institute; University of Melbourne	Tarlinton, DM (corresponding author), Walter & Eliza Hall Inst Med Res, Parkville, Vic 3052, Australia.	tarlinton@wehi.edu.au		Tarlinton, David/0000-0001-9928-686X				Allen CDC, 2004, NAT IMMUNOL, V5, P943, DOI 10.1038/ni1100; Crotty S, 2011, ANNU REV IMMUNOL, V29, P621, DOI 10.1146/annurev-immunol-031210-101400; Gitlin AD, 2014, NATURE, V509, P637, DOI 10.1038/nature13300; MACLENNAN ICM, 1994, ANNU REV IMMUNOL, V12, P117, DOI 10.1146/annurev.iy.12.040194.001001; Muramatsu M, 2000, CELL, V102, P553, DOI 10.1016/S0092-8674(00)00078-7; Smith KGC, 1997, EMBO J, V16, P2996, DOI 10.1093/emboj/16.11.2996; Tarlinton D, 2013, SCIENCE, V341, P1205, DOI 10.1126/science.1241146; Turner ML, 2008, J IMMUNOL, V181, P374, DOI 10.4049/jimmunol.181.1.374; Victora GD, 2012, ANNU REV IMMUNOL, V30, P429, DOI 10.1146/annurev-immunol-020711-075032	9	6	6	0	10	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 29	2014	509	7502					573	574		10.1038/509573a	http://dx.doi.org/10.1038/509573a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AH9JC	24870540				2022-12-28	WOS:000336457100038
J	Owen, CE				Owen, Cindy England			Treating Acne With High-Dose Isotretinoin	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							VULGARIS	IMPORTANCE Isotretinoin is the most effective treatment for acne. The ideal dosing regimen is unknown. OBJECTIVE To determine the rates of relapse of acne vulgaris and retrial of isotretinoin after high cumulative-dose treatment and the changes to the adverse effect profile. DESIGN, SETTING, AND PARTICIPANTS A prospective, observational, intervention study was conducted from August 1, 2008, to August 31, 2010, in a single academic tertiary care center with multiple providers. A total of 180 patients with acne resistant to other treatments were enrolled. Of these, 116 participated in the 12-month follow-up survey, for a response rate of 64.4%. EXPOSURE Patients received isotretinoin, with dosing based on the providers' judgment. Patients were divided into 2 groups on the basis of cumulative dosing (< 220 mg/kg and >= 220 mg/kg). MAIN OUTCOMES AND MEASURES Relapse (treatment with a prescription topical or oral acne medication after a course of isotretinoin) or retrial (retreatment with isotretinoin) at 12-month follow-up and adverse effects experienced during and after 12 months of treatment. RESULTS The mean age of the participants was 19.3 years, 51.9% were female, and 74.1% were white. At 12 months' follow-up, 97.4% of the patients reported that their acne was improved. Overall, acne in 32.7% of patients in the study relapsed at 12 months, and 1.72% of the patients required a retrial. In the lower-dose treatment group (< 220mg/kg), the relapse rate was 47.4%(95% CI, 32.3%-63.0%) compared with 26.9%(95% CI, 18.3%-37.8%) in the high-dose group (P = .03). Almost 100% of the patients in both treatment groups developed cheilitis and xerosis during treatment. Retinoid dermatitis was significantly more common in the high-dose treatment group (53.8% vs 31.6%; P = .02). None of the other adverse effects was significantly different between the 2 groups. CONCLUSIONS AND RELEVANCE The dosing regimen used in the present study is considerably higher than that used in previous studies of isotretinoin. At 1 year after completion of isotretinoin treatment, we found that patients receiving 220 mg/kg or more had a significantly decreased risk of relapse. Rash was the only adverse effect that was significantly more common in the high-dose group during treatment. This study suggests that significantly higher doses of isotretinoin are effective for treating acne and decreasing relapse rates without increasing adverse effects.	Univ Louisville, 310 E Broadway,Ste 200, Louisville, KY 40204 USA	University of Louisville	Owen, CE (corresponding author), Univ Louisville, 310 E Broadway,Ste 200, Louisville, KY 40204 USA.	ceowen01@louisville.edu						Blasiak RC, 2013, JAMA DERMATOL, V149, P1392, DOI 10.1001/jamadermatol.2013.6746; Dreno B, 2003, DERMATOLOGY, V206, P7, DOI 10.1159/000067817; Goldsmith LA, 2004, J AM ACAD DERMATOL, V51, P348; Goldsmith LA, 2004, J AM ACAD DERMATOL, V50, P900, DOI 10.1016/j.jaad.2004.02.012; Goulden V, 1999, J AM ACAD DERMATOL, V41, P577, DOI 10.1016/S0190-9622(99)70300-2; Knutsen-Larson S, 2012, DERMATOL CLIN, V30, P99, DOI 10.1016/j.det.2011.09.001; Mallon E, 1999, BRIT J DERMATOL, V140, P672	7	9	11	1	8	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAY 28	2014	311	20					2121	+		10.1001/jama.2014.2323	http://dx.doi.org/10.1001/jama.2014.2323			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AH8MQ	24867015				2022-12-28	WOS:000336392400028
J	Brar, SS; Aharonian, V; Mansukhani, P; Moore, N; Shen, AYJ; Jorgensen, M; Dua, A; Short, L; Kane, K				Brar, Somjot S.; Aharonian, Vicken; Mansukhani, Prakash; Moore, Naing; Shen, Albert Y-J; Jorgensen, Michael; Dua, Aman; Short, Lindsay; Kane, Kevin			Haemodynamic-guided fluid administration for the prevention of contrast-induced acute kidney injury: the POSEIDON randomised controlled trial	LANCET			English	Article							PERCUTANEOUS CORONARY INTERVENTION; INDUCED NEPHROPATHY; SODIUM-BICARBONATE; MEDIA; ANGIOGRAPHY; PREDICTION; HYDRATION; RESPONSIVENESS; FAILURE; VOLUME	Background The administration of intravenous fluid remains the cornerstone treatment for the prevention of contrast-induced acute kidney injury. However, no well-defined protocols exist to guide fluid administration in this treatment. We aimed to establish the efficacy of a new fluid protocol to prevent contrast-induced acute kidney injury. Methods In this randomised, parallel-group, comparator-controlled, single-blind phase 3 trial, we assessed the efficacy of a new fluid protocol based on the left ventricular end-diastolic pressure for the prevention of contrast-induced acute kidney injury in patients undergoing cardiac catheterisation. The primary outcome was the occurrence of contrast-induced acute kidney injury, which was defined as a greater than 25% or greater than 0.5 mg/dL increase in serum creatinine concentration. Between Oct 10, 2010, and July 17, 2012, 396 patients aged 18 years or older undergoing cardiac catheterisation with an estimated glomerular filtration rate of 60 mL/min per 1.73 m(2) or less and one or more of several risk factors (diabetes mellitus, history of congestive heart failure, hypertension, or age older than 75 years) were randomly allocated in a 1:1 ratio to left ventricular end-diastolic pressure-guided volume expansion (n=196) or the control group (n=200) who received a standard fluid administration protocol. Four computer-generated concealed randomisation schedules, each with permuted block sizes of 4, were used for randomisation, and participants were allocated to the next sequential randomisation number by sealed opaque envelopes. Patients and laboratory personnel were masked to treatment assignment, but the physicians who did the procedures were not masked. Both groups received intravenous 0.9% sodium chloride at 3 mL/kg for 1 h before cardiac catheterisation. Analyses were by intention to treat. Adverse events were assessed at 30 days and 6 months and all such events were classified by staff who were masked to treatment assignment. This trial is registered with ClinicalTrials.gov, number NCT01218828. Findings Contrast-induced acute kidney injury occurred less frequently in patients in the left ventricular end-diastolic pressure-guided group (6.7% [12/178]) than in the control group (16.3% [28/172]; relative risk 0.41, 95% CI 0.22-0.79; p=0.005). Hydration treatment was terminated prematurely because of shortness of breath in three patients in each group. Interpretation Left ventricular end-diastolic pressure-guided fluid administration seems to be safe and effective in preventing contrast-induced acute kidney injury in patients undergoing cardiac catheterisation.	[Brar, Somjot S.; Shen, Albert Y-J; Jorgensen, Michael; Dua, Aman] Kaiser Permanente, Dept Cardiol, Los Angeles, CA 90027 USA; [Brar, Somjot S.; Aharonian, Vicken; Mansukhani, Prakash; Moore, Naing; Short, Lindsay; Kane, Kevin] Kaiser Permanente, Reg Cardiac Cath Lab, Los Angeles, CA 90027 USA; [Brar, Somjot S.] Kaiser Permanente, Dept Res & Evaluat, Pasadena, CA USA	Kaiser Permanente; Kaiser Permanente; Kaiser Permanente	Brar, SS (corresponding author), Kaiser Permanente, Cardiac Cath Lab, 4867 Sunset Blvd,Room 3755, Los Angeles, CA 90027 USA.	sbrar@cvri.org			Kaiser Permanente Southern California regional research committee grant	Kaiser Permanente Southern California regional research committee grant	Funding Kaiser Permanente Southern California regional research committee grant.	Bader BD, 2004, CLIN NEPHROL, V62, P1, DOI 10.5414/cnp62001; Bartholomew BA, 2004, AM J CARDIOL, V93, P1515, DOI 10.1016/j.amjcard.2004.03.008; Brar SS, 2008, JAMA-J AM MED ASSOC, V300, P1038, DOI 10.1001/jama.300.9.1038; Brar SS, 2009, CLIN J AM SOC NEPHRO, V4, P1584, DOI 10.2215/CJN.03120509; Briguori C, 2007, CIRCULATION, V115, P1211, DOI 10.1161/CIRCULATIONAHA.106.687152; Charron C, 2006, CURR OPIN CRIT CARE, V12, P249, DOI 10.1097/01.ccx.0000224870.24324.cc; Chertow GM, 2005, J AM SOC NEPHROL, V16, P3365, DOI 10.1681/ASN.2004090740; Drazner MH, 2008, CIRC-HEART FAIL, V1, P170, DOI 10.1161/CIRCHEARTFAILURE.108.769778; Eckardt KU, 2012, KIDNEY INT SUPPL, V2, P7, DOI 10.1038/kisup.2012.8; GATTINONI L, 1995, NEW ENGL J MED, V333, P1025, DOI 10.1056/NEJM199510193331601; Gurm HS, 2013, J AM COLL CARDIOL, V61, P2242, DOI 10.1016/j.jacc.2013.03.026; Heyman SN, 2010, INVEST RADIOL, V45, P188, DOI 10.1097/RLI.0b013e3181d2eed8; Hofer CK, 2005, CHEST, V128, P848, DOI 10.1378/chest.128.2.848; James MT, 2011, CIRCULATION, V123, P409, DOI 10.1161/CIRCULATIONAHA.110.970160; James MT, 2010, KIDNEY INT, V78, P803, DOI 10.1038/ki.2010.258; Marenzi G, 2006, NEW ENGL J MED, V354, P2773, DOI 10.1056/NEJMoa054209; Marenzi G, 2012, JACC-CARDIOVASC INTE, V5, P90, DOI 10.1016/j.jcin.2011.08.017; Mehran R, 2004, J AM COLL CARDIOL, V44, P1393, DOI 10.1016/j.jacc.2004.06.068; Merten GJ, 2004, JAMA-J AM MED ASSOC, V291, P2328, DOI 10.1001/jama.291.19.2328; Michard F, 2002, CHEST, V121, P2000, DOI 10.1378/chest.121.6.2000; Mueller C, 2002, ARCH INTERN MED, V162, P329, DOI 10.1001/archinte.162.3.329; Navaneethan SD, 2009, AM J KIDNEY DIS, V53, P617, DOI 10.1053/j.ajkd.2008.08.033; Parikh CR, 2008, ARCH INTERN MED, V168, P987, DOI 10.1001/archinte.168.9.987; Rihal CS, 2002, CIRCULATION, V105, P2259, DOI 10.1161/01.CIR.0000016043.87291.33; Seeliger E, 2012, EUR HEART J, V33, P2007, DOI 10.1093/eurheartj/ehr494; Seeliger E, 2010, RADIOLOGY, V256, P406, DOI 10.1148/radiol.10091485; Seeliger E, 2009, AM J PHYSIOL-RENAL, V296, pF1334, DOI 10.1152/ajprenal.90476.2008; Solomon RJ, 2007, CIRCULATION, V115, P3189, DOI 10.1161/CIRCULATIONAHA.106.671644; Stone GW, 2003, JAMA-J AM MED ASSOC, V290, P2284, DOI 10.1001/jama.290.17.2284; Task Force on Myocardial Revascularization of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS), 2010, Eur Heart J, V31, P2501, DOI 10.1093/eurheartj/ehq277; Thygesen K, 2012, CIRCULATION, V126, P2020, DOI 10.1161/CIR.0b013e31826e1058; Vroon DH, 1990, CLIN METHODS HIST PH; Weisbord SD, 2008, ARCH INTERN MED, V168, P1325, DOI 10.1001/archinte.168.12.1325; Weisbord SD, 2008, CLIN J AM SOC NEPHRO, V3, P273, DOI 10.2215/CJN.02580607	34	226	234	2	22	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAY 24	2014	383	9931					1814	1823		10.1016/S0140-6736(14)60689-9	http://dx.doi.org/10.1016/S0140-6736(14)60689-9			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AH6US	24856027				2022-12-28	WOS:000336267800028
J	Palmer, T				Palmer, Tim			Record-breaking winters and global climate change	SCIENCE			English	Editorial Material							WEST-PACIFIC		Univ Oxford, Oxford Martin Programme Modelling & Predicting Cl, Oxford OX1 3BD, England	University of Oxford	Palmer, T (corresponding author), Univ Oxford, Oxford Martin Programme Modelling & Predicting Cl, Oxford OX1 3BD, England.	t.n.palmer@atm.ox.ac.uk		Palmer, Tim/0000-0002-7121-2196				Balmaseda MA, 2013, GEOPHYS RES LETT, V40, P1754, DOI 10.1002/grl.50382; Clement A, 2014, SCIENCE, V343, P976, DOI 10.1126/science.1248115; Hartmann D. L., 2013, CLIM CHANG 2013 PHYS; Hume T., 2014, CNN             0122; Kintisch E, 2014, SCIENCE, V344, P250, DOI 10.1126/science.344.6181.250; Kosaka Y, 2013, NATURE, V501, P403, DOI 10.1038/nature12534; Met Office, 2014, REC STORMS FLOODS UK; PALMER TN, 1984, NATURE, V310, P483, DOI 10.1038/310483a0; PALMER TN, 1986, MON WEATHER REV, V114, P648, DOI 10.1175/1520-0493(1986)114<0648:APRBSW>2.0.CO;2; SIMMONS AJ, 1983, J ATMOS SCI, V40, P1363, DOI 10.1175/1520-0469(1983)040<1363:BWPAIA>2.0.CO;2; Tang QH, 2014, NAT CLIM CHANGE, V4, P45, DOI [10.1038/nclimate2065, 10.1038/NCLIMATE2065]	11	84	85	2	77	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 23	2014	344	6186					803	804		10.1126/science.1255147	http://dx.doi.org/10.1126/science.1255147			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AH6IL	24855240				2022-12-28	WOS:000336233800012
J	Rifkin, DE				Rifkin, Dena E.			My Hidden VA List	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Rifkin, Dena E.] Vet Affairs Healthcare Syst, San Diego, CA 92161 USA; [Rifkin, Dena E.] Univ Calif San Diego, San Diego, CA 92103 USA	University of California System; University of California San Diego	Rifkin, DE (corresponding author), Vet Affairs Healthcare Syst, San Diego, CA 92161 USA.			Rifkin, Dena/0000-0002-1278-5795				Ross JS, 2008, ARCH INTERN MED, V168, P950, DOI 10.1001/archinte.168.9.950	1	0	0	0	0	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUL 24	2014	371	4					299	301		10.1056/NEJMp1406767	http://dx.doi.org/10.1056/NEJMp1406767			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	AL7TY	24896821				2022-12-28	WOS:000339339800006
J	Sawicki, NN				Sawicki, Nadia N.			Clinicians' Involvement in Capital Punishment - Constitutional Implications	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									Loyola Univ, Chicago Sch Law, Beazley Inst Hlth Law & Policy, Chicago, IL 60611 USA	Loyola University Chicago	Sawicki, NN (corresponding author), Loyola Univ, Chicago Sch Law, Beazley Inst Hlth Law & Policy, Chicago, IL 60611 USA.			Sawicki, Nadia/0000-0002-8307-3867				Denno DW, GEORGETOWN IN PRESS	1	3	3	0	3	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUL 10	2014	371	2					103	105		10.1056/NEJMp1405651	http://dx.doi.org/10.1056/NEJMp1405651			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	AK7YZ	24869595				2022-12-28	WOS:000338645500006
J	Shin, J; Wallingford, MC; Gallant, J; Marcho, C; Jiao, BW; Byron, M; Bossenz, M; Lawrence, JB; Jones, SN; Mager, J; Bach, I				Shin, JongDae; Wallingford, Mary C.; Gallant, Judith; Marcho, Chelsea; Jiao, Baowei; Byron, Meg; Bossenz, Michael; Lawrence, Jeanne B.; Jones, Stephen N.; Mager, Jesse; Bach, Ingolf			RLIM is dispensable for X-chromosome inactivation in the mouse embryonic epiblast	NATURE			English	Article							FUNCTIONAL-ACTIVITY; RNF12; RNA; PLURIPOTENCY; RLIM/RNF12; NANOG; GENE; JPX	In female mice, two forms of X-chromosome inactivation (XCI) ensure the selective silencing of female sex chromosomes during mouse embryogenesis. Beginning at the four-cell stage, imprinted XCI (iXCI) exclusively silences the paternal X chromosome. Later, around implantation, epiblast cells of the inner cell mass that give rise to the embryo reactivate the paternal X chromosome and undergo a random form of XCI (rXCI)(1,2). Xist, a long non-coding RNA crucial for both forms of XCI, is activated by the ubiquitin ligase RLIM (also known as Rnf12)(3-5). Although RLIM is required for triggering iXCI in mice, its importance for rXCI has been controversial. Here we show that RLIM levels are downregulated in embryonic cells undergoing rXCI. Using mouse genetics we demonstrate that female cells lacking RLIM from pre-implantation stages onwards show hallmarks of XCI, including Xist clouds and H3K27me3 foci, and have full embryogenic potential. These results provide evidence that RLIM is dispensable for rXCI, indicating that in mice an RLIM-independent mechanism activates Xist in the embryo proper.	[Shin, JongDae; Jiao, Baowei; Bach, Ingolf] UMMS, Program Gene Funct & Express, Worcester, MA 01605 USA; [Wallingford, Mary C.; Marcho, Chelsea; Mager, Jesse] Univ Massachusetts, Amherst, MA 01003 USA; [Gallant, Judith; Byron, Meg; Lawrence, Jeanne B.; Jones, Stephen N.] UMMS, Dept Cell & Dev Biol, Worcester, MA 01605 USA; [Bossenz, Michael] Ortenau Klinikum Lahr Ettenheim, Inst Pathol, D-77933 Lahr, Germany; [Bach, Ingolf] UMMS, Program Mol Med, Worcester, MA 01605 USA	University of Massachusetts System; University of Massachusetts Amherst	Bach, I (corresponding author), UMMS, Program Gene Funct & Express, Worcester, MA 01605 USA.	Ingolf.bach@umassmed.edu	Marcho, Chelsea/N-8230-2019	Marcho, Chelsea/0000-0003-0932-7416; JIAO, BAOWEI/0000-0001-8559-9160; Lawrence, Jeanne/0000-0001-6572-3128	National Institutes of Health grants [CA131158, CA077735, GM053234]; NATIONAL CANCER INSTITUTE [R01CA131158, R56CA077735, R01CA077735] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK032520] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM053234] Funding Source: NIH RePORTER	National Institutes of Health grants(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We are grateful to H. Ma for help in the mouse facility, M. Keeler for culturing ES cells, T. Fazzio, N. Lawson and Y. Yoon for advice, and T. Fazzio for helpful discussions and reading of the manuscript. I.B. is a member of the University of Massachusetts Diabetes-Endocrinology Research Center (DK32520). This work was supported by National Institutes of Health grants CA131158 to I.B., CA077735 to S.N.J. and GM053234 to J.B.L.	Augui S, 2011, NAT REV GENET, V12, P429, DOI 10.1038/nrg2987; Avilion AA, 2003, GENE DEV, V17, P126, DOI 10.1101/gad.224503; Bach I, 1999, NAT GENET, V22, P394, DOI 10.1038/11970; Barakat TS, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002001; Chambers I, 2007, NATURE, V450, P1230, DOI 10.1038/nature06403; Dupont C, 2013, CURR OPIN CELL BIOL, V25, P314, DOI 10.1016/j.ceb.2013.03.001; Gontan C, 2012, NATURE, V485, P386, DOI 10.1038/nature11070; Griffith GJ, 2011, BIOL REPROD, V84, P654, DOI 10.1095/biolreprod.110.087213; Hadjantonakis AK, 2001, GENESIS, V29, P133, DOI 10.1002/gene.1016; Hall LL, 2002, P NATL ACAD SCI USA, V99, P8677, DOI 10.1073/pnas.132468999; Hayashi S, 2003, GENESIS, V37, P51, DOI 10.1002/gene.10225; Hayashi S, 2002, MECH DEVELOP, V119, pS97, DOI 10.1016/S0925-4773(03)00099-6; Jiao BW, 2013, MOL BIOL CELL, V24, P3085, DOI 10.1091/mbc.E13-05-0239; Jiao BW, 2012, CELL, V149, P630, DOI 10.1016/j.cell.2012.02.056; Jonkers I, 2009, CELL, V139, P999, DOI 10.1016/j.cell.2009.10.034; Lee JT, 2011, NAT REV MOL CELL BIO, V12, P815, DOI 10.1038/nrm3231; Mitsui K, 2003, CELL, V113, P631, DOI 10.1016/S0092-8674(03)00393-3; Nagy A., 2003, MANIPULATING MOUSE E; Ostendorff HP, 2006, DEV DYNAM, V235, P786, DOI 10.1002/dvdy.20669; Ostendorff HP, 2002, NATURE, V416, P99, DOI 10.1038/416099a; Panning B, 2004, METHOD ENZYMOL, V376, P419; Plath K, 2003, SCIENCE, V300, P131, DOI 10.1126/science.1084274; Robertson EJ, 1987, TERATOCARCINOMAS EMB, P71; Schulz EG, 2013, CURR OPIN GENET DEV, V23, P109, DOI 10.1016/j.gde.2013.01.008; Shin J, 2010, NATURE, V467, P977, DOI 10.1038/nature09457; Sun S, 2013, CELL, V153, P1537, DOI 10.1016/j.cell.2013.05.028; Tian D, 2010, CELL, V143, P390, DOI 10.1016/j.cell.2010.09.049; Tursun B, 2005, GENE DEV, V19, P2307, DOI 10.1101/gad.1340605; Zhang L, 2012, MOL CELL, V46, P650, DOI 10.1016/j.molcel.2012.04.003	29	39	39	0	26	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 3	2014	511	7507					86	U443		10.1038/nature13286	http://dx.doi.org/10.1038/nature13286			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK1TN	24870238	Green Accepted			2022-12-28	WOS:000338199400041
J	Chou, R; Dana, T; Bougatsos, C; Blazina, I; Khangura, J; Zakher, B				Chou, Roger; Dana, Tracy; Bougatsos, Christina; Blazina, Ian; Khangura, Jessi; Zakher, Bernadette			Screening for Hepatitis B Virus Infection in Adolescents and Adults: A Systematic Review to Update the US Preventive Services Task Force Recommendation	ANNALS OF INTERNAL MEDICINE			English	Review							TENOFOVIR DISOPROXIL FUMARATE; RANDOMIZED CONTROLLED-TRIAL; SURFACE-ANTIGEN CARRIERS; INTERFERON-ALPHA THERAPY; HBEAG-POSITIVE PATIENTS; TERM-FOLLOW-UP; HEPATOCELLULAR-CARCINOMA; ADEFOVIR DIPIVOXIL; DOUBLE-BLIND; PREDNISONE WITHDRAWAL	Background: In 2004, the U. S. Preventive Services Task Force (USPSTF) recommended against screening for hepatitis B virus (HBV) infection. Purpose: To update the 2004 USPSTF review on screening for HBV infection in adolescents and adults. Data Sources: MEDLINE (through January 2014), the Cochrane Central Register of Controlled Trials, the Cochrane Database of Systematic Reviews, and PsycINFO. Study Selection: Randomized trials of screening and treatment and observational studies of screening or the association between intermediate and clinical outcomes after antiviral therapy. Data Extraction: One investigator abstracted data, and a second investigator checked them; 2 investigators independently assessed study quality. Data Synthesis: No study directly evaluated the effects of screening for HBV infection versus no screening on clinical outcomes. Vaccination against HBV infection was associated with decreased risk in high-risk populations. On the basis of 11 primarily fair-quality trials, antiviral therapy may be more effective than placebo for reducing the risk for clinical outcomes associated with HBV infection. However, differences were not statistically significant. On the basis of 22 primarily fair-quality trials, antiviral therapy was more effective than placebo for various intermediate outcomes, with limited evidence that first-line antiviral agents are superior to lamivudine. Antiviral therapy was associated with a higher risk for withdrawal due to adverse events than placebo, but risk for serious adverse events did not differ. Limitation: Only English-language articles were included, clinical outcome data for antiviral therapies were limited, and several studies were done in countries where the prevalence and natural history of HBV infection differ from those of the United States. Conclusion: Antiviral treatment for chronic HBV infection is associated with improved intermediate outcomes, but more research is needed to understand the effects of screening and subsequent interventions on clinical outcomes and to identify optimal screening strategies.	[Chou, Roger; Dana, Tracy; Bougatsos, Christina; Blazina, Ian; Khangura, Jessi; Zakher, Bernadette] Oregon Hlth & Sci Univ, Pacific Northwest Evidence Based Practice Ctr, Portland, OR 97239 USA	Oregon Health & Science University	Chou, R (corresponding author), Oregon Hlth & Sci Univ, 3181 SW Sam Jackson Pk Rd,Mail Code BICC, Portland, OR 97239 USA.	chour@ohsu.edu		Chou, Roger/0000-0001-9889-8610; Blazina, Ian/0000-0003-0164-6674	Agency for Healthcare Research and Quality	Agency for Healthcare Research and Quality(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality)	Primary Funding Source: Agency for Healthcare Research and Quality.	Ali HY, 2003, SAUDI MED J, V24, P996; Andreone P, 2004, J VIRAL HEPATITIS, V11, P439, DOI 10.1111/j.1365-2893.2004.00564.x; Baltayiannis G, 2006, ALIMENT PHARM THERAP, V24, P525, DOI 10.1111/j.1365-2036.2006.03008.x; BAYRAKTAR Y, 1993, GUT, V34, pS101, DOI 10.1136/gut.34.2_Suppl.S101; Bozkaya H, 2005, ANTIVIR THER, V10, P319; Calonge N, 2009, ANN INTERN MED, V150, P869; Centers for Disease Control and Prevention . Viral Hepatitis Surveillance United States, 2013, VIR HEP STAT SURV; Chan HLY, 2007, ANTIVIR THER, V12, P345; Chang MH, 1997, NEW ENGL J MED, V336, P1855, DOI 10.1056/NEJM199706263362602; Chang TT, 2009, J VIRAL HEPATITIS, V16, P784, DOI 10.1111/j.1365-2893.2009.01142.x; Chang TT, 2006, NEW ENGL J MED, V354, P1001, DOI 10.1056/NEJMoa051285; Chen JG, 2003, J MED SCREEN, V10, P204, DOI 10.1258/096914103771773320; Chen W, 2005, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD000100.pub3; Chou R., 2014, SCREENING HEPATITIS; Chou R, 2013, ANN INTERN MED, V158, P114, DOI 10.7326/0003-4819-158-2-201301150-00576; Cohen MS, 2011, NEW ENGL J MED, V365, P493, DOI [10.1056/NEJMoa1105243, 10.1056/NEJMoa1600693]; COUTINHO RA, 1983, BRIT MED J, V286, P1305, DOI 10.1136/bmj.286.6374.1305; Dakin H, 2010, VALUE HEALTH, V13, P934, DOI 10.1111/j.1524-4733.2010.00777.x; Di Marco V, 2004, HEPATOLOGY, V40, P883, DOI 10.1002/hep.20381; Dienstag JL, 1999, NEW ENGL J MED, V341, P1256, DOI 10.1056/NEJM199910213411702; Fattovich G, 1997, HEPATOLOGY, V26, P1338; Fattovich G, 2008, J HEPATOL, V48, P335, DOI 10.1016/j.jhep.2007.11.011; FRANCIS DP, 1982, ANN INTERN MED, V97, P362, DOI 10.7326/0003-4819-97-3-362; Gish RG, 2007, GASTROENTEROLOGY, V133, P1437, DOI 10.1053/j.gastro.2007.08.025; HADZIYANNIS S, 1990, J HEPATOL, V11, pS133, DOI 10.1016/0168-8278(90)90180-Y; Hadziyannis SJ, 2003, NEW ENGL J MED, V348, P800, DOI 10.1056/NEJMoa021812; Harris RP, 2001, AM J PREV MED, V20, P21, DOI 10.1016/S0749-3797(01)00261-6; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; Hui CK, 2008, J CLIN GASTROENTEROL, V42, P533, DOI 10.1097/MCG.0b013e31804bbdff; Ioannou GN, 2011, ANN INTERN MED, V154, P319, DOI 10.7326/0003-4819-154-5-201103010-00006; Jin H, 2011, HEPATOL RES, V41, P512, DOI 10.1111/j.1872-034X.2011.00801.x; Jonas MM, 2008, HEPATOLOGY, V47, P1863, DOI 10.1002/hep.22250; Kowdley KV, 2012, HEPATOLOGY, V56, P422, DOI 10.1002/hep.24804; Lai CL, 2007, ANN INTERN MED, V147, P58, DOI 10.7326/0003-4819-147-1-200707030-00010; Lai CL, 2013, HEPATOLOGY, V57, P399, DOI 10.1002/hep.25937; Lai CL, 1998, NEW ENGL J MED, V339, P61, DOI 10.1056/NEJM199807093390201; Lai CL, 2002, GASTROENTEROLOGY, V123, P1831, DOI 10.1053/gast.2002.37058; Lai CL, 2006, NEW ENGL J MED, V354, P1011, DOI 10.1056/NEJMoa051287; Lai CL, 2004, HEPATOLOGY, V40, P719, DOI 10.1002/hep.20374; Lai CL, 1997, HEPATOLOGY, V25, P241, DOI 10.1002/hep.510250144; Lampertico P, 1997, HEPATOLOGY, V26, P1621, DOI 10.1002/hep.510260634; Lampertico P, 2003, HEPATOLOGY, V37, P756, DOI 10.1053/jhep.2003.50148; Lau DTY, 1997, GASTROENTEROLOGY, V113, P1660, DOI 10.1053/gast.1997.v113.pm9352870; Lau GKK, 2005, NEW ENGL J MED, V352, P2682, DOI 10.1056/NEJMoa043470; Liang J, 2012, PHARMAZIE, V67, P883, DOI 10.1691/ph.2012.1861; LIAW YF, 1994, J HEPATOL, V20, P175, DOI 10.1016/S0168-8278(05)80055-8; Liaw YF, 2004, NEW ENGL J MED, V351, P1521, DOI 10.1056/NEJMoa033364; Lim SG, 2009, J GASTROEN HEPATOL, V24, P1352, DOI 10.1111/j.1440-1746.2009.05985.x; Lin SM, 1999, HEPATOLOGY, V29, P971, DOI 10.1002/hep.510290312; Lin SY, 2007, HEPATOLOGY, V46, P1034, DOI 10.1002/hep.21784; Lok ASF, 2009, HEPATOLOGY, V50, P661, DOI 10.1002/hep.23190; Marcellin P, 2004, NEW ENGL J MED, V351, P1206, DOI 10.1056/NEJMoa040431; Marcellin P, 2003, NEW ENGL J MED, V348, P808, DOI 10.1056/NEJMoa020681; Marcellin P, 2008, NEW ENGL J MED, V359, P2442, DOI 10.1056/NEJMoa0802878; Mazzella G, 1999, AM J GASTROENTEROL, V94, P2246, DOI 10.1111/j.1572-0241.1999.01300.x; Mitchell T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027717; Miyake Y, 2009, J GASTROENTEROL, V44, P470, DOI 10.1007/s00535-009-0024-z; MULLER R, 1990, J HEPATOL, V11, pS137, DOI 10.1016/0168-8278(90)90181-P; Murray KF, 2012, HEPATOLOGY, V56, P2018, DOI 10.1002/hep.25818; Niederau C, 1996, NEW ENGL J MED, V334, P1422, DOI 10.1056/NEJM199605303342202; Papatheodoridis GV, 2011, GUT, V60, P1109, DOI 10.1136/gut.2010.221846; Papatheodoridis GV, 2010, J HEPATOL, V53, P348, DOI 10.1016/j.jhep.2010.02.035; Papatheodoridis GV, 2001, J HEPATOL, V34, P306, DOI 10.1016/S0168-8278(00)00094-5; PEREZ V, 1990, J HEPATOL, V11, pS113, DOI 10.1016/0168-8278(90)90175-Q; PERRILLO RP, 1990, NEW ENGL J MED, V323, P295, DOI 10.1056/NEJM199008023230503; Ren FY, 2007, WORLD J GASTROENTERO, V13, P4264, DOI 10.3748/wjg.v13.i31.4264; Sarin SK, 1996, J HEPATOL, V24, P391, DOI 10.1016/S0168-8278(96)80158-9; Shamliyan TA, 2011, J GEN INTERN MED, V26, P326, DOI 10.1007/s11606-010-1569-5; Sorrell MF, 2009, ANN INTERN MED, V150, P104, DOI 10.7326/0003-4819-150-2-200901200-00100; Spenatto N, 2013, J HEPATOL, V58, P690, DOI 10.1016/j.jhep.2012.11.044; SZMUNESS W, 1980, NEW ENGL J MED, V303, P833, DOI 10.1056/NEJM198010093031501; Tassopoulos NC, 1999, HEPATOLOGY, V29, P889, DOI 10.1002/hep.510290321; U.S. Preventive Services Task Force, 2004, SCREEN HEP B VIR INF; US Preventive Services Task Force, 2008, AHRQ PUBLICATION, V08-05124-EF-3; WAKED I, 1990, J CHEMOTHERAPY, V2, P310, DOI 10.1080/1120009X.1990.11739035; Weinbaum Cindy M., 2008, Morbidity and Mortality Weekly Report, V57, P1, DOI 10.1002/hep.22882; Wong GLH, 2010, ALIMENT PHARM THER, V32, P1059, DOI 10.1111/j.1365-2036.2010.04447.x; Woo G, 2010, GASTROENTEROLOGY, V139, P1218, DOI 10.1053/j.gastro.2010.06.042; Yalcin Kendal, 2004, Turk J Gastroenterol, V15, P14; Yao GB, 1999, CHINESE MED J-PEKING, V112, P387; Yu HB, 2010, BIOMED PHARMACOTHER, V64, P559, DOI 10.1016/j.biopha.2010.03.004; Zanetti AR, 2008, VACCINE, V26, P6266, DOI 10.1016/j.vaccine.2008.09.056; Zeng MD, 2006, HEPATOLOGY, V44, P108, DOI 10.1002/hep.21225; Zhang BH, 2004, J CANCER RES CLIN, V130, P417, DOI 10.1007/s00432-004-0552-0; Zhang QQ, 2011, VIROL J, V8, DOI 10.1186/1743-422X-8-72; Zhao SH, 2012, BRAZ J INFECT DIS, V16, P366, DOI 10.1016/j.bjid.2012.06.016	86	31	34	0	5	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JUL 1	2014	161	1					31	+		10.7326/M13-2837	http://dx.doi.org/10.7326/M13-2837			24	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AK4UN	24861032				2022-12-28	WOS:000338419700004
J	Lee, YJ; Dominy, JE; Choi, YJ; Jurczak, M; Tolliday, N; Camporez, JP; Chim, H; Lim, JH; Ruan, HB; Yang, XY; Vazquez, F; Sicinski, P; Shulman, GI; Puigserver, P				Lee, Yoonjin; Dominy, John E.; Choi, Yoon Jong; Jurczak, Michael; Tolliday, Nicola; Camporez, Joao Paulo; Chim, Helen; Lim, Ji-Hong; Ruan, Hai-Bin; Yang, Xiaoyong; Vazquez, Francisca; Sicinski, Piotr; Shulman, Gerald I.; Puigserver, Pere			Cyclin D1-Cdk4 controls glucose metabolism independently of cell cycle progression	NATURE			English	Article							HEPATIC GLUCONEOGENESIS; INSULIN-RESISTANCE; MICE LACKING; PHOSPHORYLATION; INHIBITION; EXPRESSION; CDK4; PGC-1-ALPHA; ACTIVATION; RECEPTOR	Insulin constitutes a principal evolutionarily conserved hormonal axis for maintaining glucose homeostasis(1-3); dysregulation of this axis causes diabetes(2,4). PGC-1 alpha(peroxisome-proliferator-activated receptor-gamma coactivator-1 alpha) links insulin signalling to the expression of glucose and lipid metabolic genes(5-7). The histone acetyltransferase GCN5 (general control non-repressed protein 5) acetylates PGC-1 alpha and suppresses its transcriptional activity, whereas sirtuin 1 deacetylates and activates PGC-1 alpha(8,9). Although insulin is a mitogenic signal in proliferative cells(10,11), whether components of the cell cycle machinery contribute to its metabolic action is poorly understood. Here we report that in mice insulin activates cyclin D1-cyclin-dependent kinase 4 (Cdk4), which, in turn, increases GCN5 acetyltransferase activity and suppresses hepatic glucose production independently of cell cycle progression. Through a cell-based high-throughput chemical screen, we identify a Cdk4 inhibitor that potently decreases PGC-1 alpha acetylation. Insulin/GSK-3 beta (glycogen synthase kinase 3-beta) signalling induces cyclin D1 protein stability by sequestering cyclin D1 in the nucleus. In parallel, dietary amino acids increase hepatic cyclin D1 messenger RNA transcripts. Activated cyclin D1-Cdk4 kinase phosphorylates and activates GCN5, which then acetylates and inhibits PGC-1 alpha activity on gluconeogenic genes. Loss of hepatic cyclin D1 results in increased gluconeogenesis and hyperglycaemia. In diabetic models, cyclin D1-Cdk4 is chronically elevated and refractory to fasting/feeding transitions; nevertheless further activation of this kinase normalizes glycaemia. Our findings show that insulin uses components of the cell cycle machinery in post-mitotic cells to control glucose homeostasis independently of cell division.	[Lee, Yoonjin; Dominy, John E.; Choi, Yoon Jong; Chim, Helen; Lim, Ji-Hong; Vazquez, Francisca; Sicinski, Piotr; Puigserver, Pere] Dana Farber Canc Inst, Dept Canc Biol, Boston, MA 02115 USA; [Lee, Yoonjin; Dominy, John E.; Chim, Helen; Lim, Ji-Hong; Vazquez, Francisca; Puigserver, Pere] Harvard Univ, Sch Med, Dept Cell Biol, Boston, MA 02115 USA; [Lee, Yoonjin] Harvard Univ, Dept Chem & Chem Biol, Cambridge, MA 02138 USA; [Choi, Yoon Jong; Sicinski, Piotr] Harvard Univ, Sch Med, Dept Genet, Boston, MA 02115 USA; [Jurczak, Michael; Camporez, Joao Paulo; Ruan, Hai-Bin; Yang, Xiaoyong; Shulman, Gerald I.] Yale Univ, Sch Med, Yales Mouse Metab Phenotyping Ctr, New Haven, CT 06510 USA; [Jurczak, Michael; Camporez, Joao Paulo; Ruan, Hai-Bin; Yang, Xiaoyong; Shulman, Gerald I.] Yale Univ, Sch Med, Dept Internal Med, New Haven, CT 06510 USA; [Jurczak, Michael; Camporez, Joao Paulo; Ruan, Hai-Bin; Yang, Xiaoyong; Shulman, Gerald I.] Yale Univ, Sch Med, Dept Cellular & Mol Physiol, New Haven, CT 06510 USA; [Tolliday, Nicola] Broad Inst Harvard & MIT, Chem Biol Platform, Cambridge Ctr 7, Cambridge, MA 02141 USA	Harvard University; Dana-Farber Cancer Institute; Harvard University; Harvard Medical School; Harvard University; Harvard University; Harvard Medical School; Yale University; Yale University; Yale University; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute	Puigserver, P (corresponding author), Dana Farber Canc Inst, Dept Canc Biol, Boston, MA 02115 USA.	pere_puigserver@dfci.harvard.edu	Vazquez, Francisca/AAA-3751-2020; Camporez, Joao Paulo G/B-9122-2015; Ruan, Hai-Bin/AAN-7777-2021; Vazquez, Francisca/ABC-4620-2020; Shulman, Gerald I./P-7176-2019; Ruan, Hai-Bin/G-9907-2012	Vazquez, Francisca/0000-0002-2857-4685; Ruan, Hai-Bin/0000-0002-3858-1272; Shulman, Gerald I./0000-0003-1529-5668; Ruan, Hai-Bin/0000-0002-3858-1272; Camporez, Joao Paulo/0000-0003-3486-4301; Jurczak, Michael/0000-0002-6335-6915	Ewha Womans University; National Research Service Award Kirschstein Fellowship from the National Institutes of Health (NIH); Dana-Farber Cancer Institute; American Diabetes Association; Department of Defense; NIH/National Institute of Diabetes and Digestive and Kidney Diseases [R01069966, R24DK080261-06]; NIH [R03 MH092174, R01 CA108420, DK059635]; NATIONAL CANCER INSTITUTE [R01CA108420, R01CA083688] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK089098, P30DK034989, R24DK080261, R01DK069966, F32DK083871, U2CDK059635, U24DK059635] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R03DA032468] Funding Source: NIH RePORTER	Ewha Womans University; National Research Service Award Kirschstein Fellowship from the National Institutes of Health (NIH); Dana-Farber Cancer Institute; American Diabetes Association(American Diabetes Association); Department of Defense(United States Department of Defense); NIH/National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	We thank all the members of the Puigserver laboratory for discussions and suggestions about this project. We also appreciate the consultations with and efforts by M. Jedrychowski and S. Gygi for proteomic analysis. Y.L. was supported in part by a 21st Century Leaders scholarship from Ewha Womans University. J.E.D. was supported in part by a National Research Service Award Kirschstein Fellowship from the National Institutes of Health (NIH). The participating researchers were supported with funds from the Dana-Farber Cancer Institute and with grants from the American Diabetes Association, Department of Defense, NIH/National Institute of Diabetes and Digestive and Kidney Diseases (R01069966 and R24DK080261-06), NIH (R03 MH092174) awarded to P.P., NIH (R01 CA108420) awarded to P.S. and NIH (DK059635) awarded to Yale's Mouse Metabolic Phenotyping Center/G.I.S.	Abella A, 2005, CELL METAB, V2, P239, DOI 10.1016/j.cmet.2005.09.003; Anders L, 2011, CANCER CELL, V20, P620, DOI 10.1016/j.ccr.2011.10.001; Blanchet E, 2011, NAT CELL BIOL, V13, P1146, DOI 10.1038/ncb2309; Boyer LA, 2002, MOL CELL, V10, P935, DOI 10.1016/S1097-2765(02)00634-2; Cho H, 2001, SCIENCE, V292, P1728, DOI 10.1126/science.292.5522.1728; Choi YJ, 2012, CANCER CELL, V22, P438, DOI 10.1016/j.ccr.2012.09.015; Dentin R, 2007, NATURE, V449, P366, DOI 10.1038/nature06128; Diehl JA, 1997, GENE DEV, V11, P957, DOI 10.1101/gad.11.8.957; Diehl JA, 1998, GENE DEV, V12, P3499, DOI 10.1101/gad.12.22.3499; Estall JL, 2009, DIABETES, V58, P1499, DOI 10.2337/db08-1571; Fry DW, 2004, MOL CANCER THER, V3, P1427; HINDS PW, 1994, P NATL ACAD SCI USA, V91, P709, DOI 10.1073/pnas.91.2.709; IshShalom D, 1997, DIABETOLOGIA, V40, pS25, DOI 10.1007/s001250051393; Jurczak MJ, 2012, J BIOL CHEM, V287, P2558, DOI 10.1074/jbc.M111.316760; KATO J, 1993, GENE DEV, V7, P331; Lerin C, 2006, CELL METAB, V3, P429, DOI 10.1016/j.cmet.2006.04.013; Li DM, 2009, APPL BIOCHEM BIOTECH, V158, P253, DOI 10.1007/s12010-008-8391-0; Li XH, 2007, NATURE, V447, P1012, DOI 10.1038/nature05861; Macotela Y, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021187; Matsumoto M, 2007, CELL METAB, V6, P208, DOI 10.1016/j.cmet.2007.08.006; MATSUSHIME H, 1992, CELL, V71, P323, DOI 10.1016/0092-8674(92)90360-O; MCKEEHAN WL, 1984, CANCER RES, V44, P1998; Nakae J, 1999, J BIOL CHEM, V274, P15982, DOI 10.1074/jbc.274.23.15982; Ogryzko VV, 1998, CELL, V94, P35, DOI 10.1016/S0092-8674(00)81219-2; PINKERT CA, 1987, GENE DEV, V1, P268, DOI 10.1101/gad.1.3.268; Puigserver P, 2003, NATURE, V423, P550, DOI 10.1038/nature01667; Rane SG, 1999, NAT GENET, V22, P44, DOI 10.1038/8751; Rodgers JT, 2007, P NATL ACAD SCI USA, V104, P12861, DOI 10.1073/pnas.0702509104; Rodgers JT, 2010, CELL METAB, V11, P23, DOI 10.1016/j.cmet.2009.11.006; Rodgers JT, 2005, NATURE, V434, P113, DOI 10.1038/nature03354; Schwartz GK, 2011, BRIT J CANCER, V104, P1862, DOI 10.1038/bjc.2011.177; Soni R, 2000, BIOCHEM BIOPH RES CO, V275, P877, DOI 10.1006/bbrc.2000.3349; Vazquez F, 2013, CANCER CELL, V23, P287, DOI 10.1016/j.ccr.2012.11.020; Wang YG, 2012, NATURE, V485, P128, DOI 10.1038/nature10988; Zeggini E, 2007, SCIENCE, V316, P1336, DOI 10.1126/science.1142364	35	168	175	2	66	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 26	2014	510	7506					547	+		10.1038/nature13267	http://dx.doi.org/10.1038/nature13267			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AJ6LK	24870244	Green Accepted, Green Submitted			2022-12-28	WOS:000337806300049
J	Hernandez-Molina, FJ; Stow, DAV; Alvarez-Zarikian, CA; Acton, G; Bahr, A; Balestra, B; Ducassou, E; Flood, R; Flores, JA; Furota, S; Grunert, P; Hodell, D; Jimenez-Espejo, FJ; Kim, JK; Krissek, L; Kuroda, J; Li, BH; Llave, E; Lofi, J; Lourens, L; Miller, M; Nanayama, F; Nishida, N; Richter, C; Roque, C; Pereira, H; Goni, MFS; Sierro, FJ; Singh, AD; Sloss, C; Takashimizu, Y; Tzanova, A; Voelker, A; Williams, T; Xuan, C				Hernandez-Molina, F. Javier; Stow, Dorrik A. V.; Alvarez-Zarikian, Carlos A.; Acton, Gary; Bahr, Andre; Balestra, Barbara; Ducassou, Emmanuelle; Flood, Roger; Flores, Jose-Abel; Furota, Satoshi; Grunert, Patrick; Hodell, David; Jimenez-Espejo, Francisco J.; Kim, Jin Kyoung; Krissek, Lawrence; Kuroda, Junichiro; Li, Baohua; Llave, Estefania; Lofi, Johanna; Lourens, Lucas; Miller, Madeline; Nanayama, Futoshi; Nishida, Naohisa; Richter, Carl; Roque, Cristina; Pereira, Helder; Goni, Maria Fernanda Sanchez; Sierro, Francisco J.; Singh, Arun Deo; Sloss, Craig; Takashimizu, Yasuhiro; Tzanova, Alexandrina; Voelker, Antje; Williams, Trevor; Xuan, Chuang			Onset of Mediterranean outflow into the North Atlantic	SCIENCE			English	Article							DEEP-WATER CIRCULATION; HEMISPHERE GLACIATION; CONTOURITE DRIFTS; ALGARVE MARGIN; LATE PLIOCENE; ICE VOLUME; SEA-LEVEL; EVOLUTION; CLIMATE; CADIZ	Sediments cored along the southwestern Iberian margin during Integrated Ocean Drilling Program Expedition 339 provide constraints on Mediterranean Outflow Water (MOW) circulation patterns from the Pliocene epoch to the present day. After the Strait of Gibraltar opened (5.33 million years ago), a limited volume of MOW entered the Atlantic. Depositional hiatuses indicate erosion by bottom currents related to higher volumes of MOW circulating into the North Atlantic, beginning in the late Pliocene. The hiatuses coincide with regional tectonic events and changes in global thermohaline circulation (THC). This suggests that MOW influenced Atlantic Meridional Overturning Circulation (AMOC), THC, and climatic shifts by contributing a component of warm, saline water to northern latitudes while in turn being influenced by plate tectonics.	[Hernandez-Molina, F. Javier] Univ London, Dept Earth Sci, Egham TW20 0EX, Surrey, England; [Stow, Dorrik A. V.] Heriot Watt Univ, Inst Petr Engn, Edinburgh EH14 4AS, Midlothian, Scotland; [Alvarez-Zarikian, Carlos A.] Texas A&M Univ, Dept Oceanog, Int Ocean Discovery Program, College Stn, TX 77845 USA; [Acton, Gary] Sam Houston State Univ, Dept Geog & Geol, Huntsville, TX 77341 USA; [Bahr, Andre] Goethe Univ Frankfurt, Inst Geosci, D-60438 Frankfurt, Germany; [Balestra, Barbara] Univ Calif Santa Cruz, Inst Marine Sci, Santa Cruz, CA 95064 USA; [Ducassou, Emmanuelle] Univ Bordeaux, EPOC, F-33615 Pessac, France; [Flood, Roger] SUNY Stony Brook, Sch Marine & Atmospher Sci, Stony Brook, NY 11794 USA; [Flores, Jose-Abel; Sierro, Francisco J.] Univ Salamanca, Dept Geol, Salamanca 3008, Spain; [Furota, Satoshi] Hokkaido Univ, Dept Nat Hist Sci, Kita Ku, Sapporo, Hokkaido 0600810, Japan; [Grunert, Patrick] Graz Univ, Inst Earth Sci, A-8010 Graz, Austria; [Hodell, David] Univ Cambridge, Godwin Lab Palaeoclimate Res, Cambridge CB2 3EQ, England; [Jimenez-Espejo, Francisco J.] JAMSTEC, Dept Biogeochem, Yokosuka, Kanagawa 2370061, Japan; [Kim, Jin Kyoung] Korea Inst Ocean Sci & Technol, Ansan 426744, South Korea; [Krissek, Lawrence] Ohio State Univ, Sch Earth Sci, Columbus, OH 43210 USA; [Kuroda, Junichiro] JAMSTEC, IFREE, Yokosuka, Kanagawa 2370061, Japan; [Li, Baohua] Chinese Acad Sci, Nanjing Inst Geol & Palaeontol, Dept Micropalaeontol, Nanjing 210008, Jiangsu, Peoples R China; [Llave, Estefania] Inst Geol & Minero Espana, Madrid 28003, Spain; [Lofi, Johanna] Univ Montpellier 2, Geosci Montpellier, F-34090 Montpellier, France; [Lofi, Johanna] Univ Leicester, Dept Geol, Leicester LE1 7RH, Leics, England; [Lourens, Lucas] Univ Utrecht, Inst Earth Sci, NL-3584 CD Utrecht, Netherlands; [Miller, Madeline] CALTECH, Dept Mech Engn, Pasadena, CA 91125 USA; [Nanayama, Futoshi; Nishida, Naohisa] Geol Survey Japan AIST, Inst Geol & Geoinformat, Ibaraki 3058567, Japan; [Richter, Carl] Univ Louisiana, Sch Geosci, Lafayette, LA 70504 USA; [Roque, Cristina; Voelker, Antje] IPMA, Div Geol & Georecursos Marinhos, P-1749077 Lisbon, Portugal; [Pereira, Helder] Escola Secundaria Loule, Grp Biol & Geol, P-8100740 Loule, Portugal; [Goni, Maria Fernanda Sanchez] Univ Bordeaux, EPOC, Ecole Prat Hautes Etud, F-33615 Pessac, France; [Singh, Arun Deo] Banaras Hindu Univ, Dept Geol, Varanasi 221005, Uttar Pradesh, India; [Sloss, Craig] Queensland Univ Technol, Sch Earth Environm & Biol Sci, Brisbane, Qld 4001, Australia; [Takashimizu, Yasuhiro] Niigata Univ, Dept Geol, Fac Educ, Niigata 9502181, Japan; [Tzanova, Alexandrina] Brown Univ, Dept Geol Sci, Providence, RI 02912 USA; [Williams, Trevor] Columbia Univ, Lamont Doherty Earth Observ, Palisades, NY 10964 USA; [Xuan, Chuang] Univ Southampton, Natl Oceanog Ctr Southampton, Southampton SO14 3ZH, Hants, England	University of London; Royal Holloway University London; Heriot Watt University; Texas A&M University System; Texas A&M University College Station; Texas State University System; Sam Houston State University; Goethe University Frankfurt; University of California System; University of California Santa Cruz; UDICE-French Research Universities; Universite de Bordeaux; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; University of Salamanca; Hokkaido University; University of Graz; University of Cambridge; Japan Agency for Marine-Earth Science & Technology (JAMSTEC); Korea Institute of Ocean Science & Technology (KIOST); University System of Ohio; Ohio State University; Japan Agency for Marine-Earth Science & Technology (JAMSTEC); Chinese Academy of Sciences; Universite de Montpellier; University of Leicester; Utrecht University; California Institute of Technology; National Institute of Advanced Industrial Science & Technology (AIST); University of Louisiana Lafayette; Instituto Portugues do Mar e da Atmosfera; UDICE-French Research Universities; Universite de Bordeaux; Banaras Hindu University (BHU); Queensland University of Technology (QUT); Niigata University; Brown University; Columbia University; NERC National Oceanography Centre; University of Southampton	Hernandez-Molina, FJ (corresponding author), Univ London, Dept Earth Sci, Egham TW20 0EX, Surrey, England.	javier.hernandez-molina@rhul.ac.uk	Nanayama, Futoshi/K-2190-2019; Sierro, Francisco/A-4714-2008; Acton, Gary/B-6108-2016; Voelker, Antje H L/C-5427-2012; Llave, Estefania/H-2232-2015; Flores, José-Abel/D-4218-2009; Nanayama, Futoshi/L-4453-2018; Roque, Cristina/A-8146-2013; Jimenez-Espejo, Francisco J/F-4486-2016; Xuan, Chuang/E-2039-2011; Jimenez-Espejo, Francisco J./AAR-2318-2020; Nishida, Naohisa/I-7483-2016; Lofi, Johanna/I-5159-2018; Kuroda, Junichiro/A-3007-2016; Goñi, Maria Fernanda Sanchez/R-3699-2019	Nanayama, Futoshi/0000-0001-8693-4784; Sierro, Francisco/0000-0002-8647-456X; Voelker, Antje H L/0000-0001-6465-6023; Llave, Estefania/0000-0001-7873-7211; Flores, José-Abel/0000-0003-1909-293X; Nanayama, Futoshi/0000-0001-8693-4784; Roque, Cristina/0000-0002-2583-594X; Jimenez-Espejo, Francisco J/0000-0002-0335-8580; Xuan, Chuang/0000-0003-4043-3073; Lofi, Johanna/0000-0002-0602-595X; Kuroda, Junichiro/0000-0002-2218-4854; Goñi, Maria Fernanda Sanchez/0000-0001-8238-7488; Alvarez Zarikian, Carlos/0000-0002-3785-3336; Pereira, Helder/0000-0001-7664-7650; Sloss, Craig/0000-0001-8694-6822; Miller, Madeline/0000-0003-2598-6518; Hodell, David/0000-0001-8537-1588; Bahr, Andre/0000-0001-5890-8773; Takashimizu, Yasuhiro/0000-0002-3840-9325; , barbara/0000-0001-7064-3173; Acton, Gary/0000-0002-3285-4022	 [CTM 2008-06399-C04/MAR];  [CTM 2012-39599-C03];  [CGL2011-26493];  [CTM2012-38248];  [IGCP-619];  [INQUA 1204];  [FWF P25831-N29]; NERC [NE/J017922/1] Funding Source: UKRI; Austrian Science Fund (FWF) [P 25831] Funding Source: researchfish; Natural Environment Research Council [NE/J017922/1] Funding Source: researchfish	; ; ; ; ; ; ; NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Austrian Science Fund (FWF)(Austrian Science Fund (FWF)); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	This research used samples and data collected through the Integrated Ocean Drilling Program (IODP). The research was partially supported through the CTM 2008-06399-C04/MAR, CTM 2012-39599-C03, CGL2011-26493, CTM2012-38248, IGCP-619, INQUA 1204, and FWF P25831-N29 Projects. The Continental Margins Research Group at Royal Holloway, University of London, also contributed to the research. We thank REPSOL and TGS-NOPEC (Tomlinson Geophysical Services Inc. and Norwegian Petroleum Exploration Consultants) Geophysical Company ASA for use of an unpublished seismic record. We thank N. Khelifi (Springer, Germany) and M. Rogerson (University of Hull, UK) for discussing the changes in MOW density during the Pliocene and Quaternary, as well as the anonymous reviewers whose suggestions improved the final version of our manuscript. Data available at http://doi.pangaea.de/10.1594/PANGAEA.832885?format=html and at the IODP web page, http://iodp.tamu.edu/scienceops/expeditions/mediterranean_outflow.html.	Bailey I, 2013, QUATERNARY SCI REV, V75, P181, DOI 10.1016/j.quascirev.2013.06.004; Bartoli G, 2005, EARTH PLANET SC LETT, V237, P33, DOI 10.1016/j.epsl.2005.06.020; Billups K, 1998, PALEOCEANOGRAPHY, V13, P84, DOI 10.1029/97PA02995; Brackenridge RE, 2013, MAR PETROL GEOL, V46, P36, DOI 10.1016/j.marpetgeo.2013.05.015; CLOETINGH S, 1990, J GEOL SOC LONDON, V147, P495, DOI 10.1144/gsjgs.147.3.0495; deMenocal PB, 2011, SCIENCE, V331, P540, DOI 10.1126/science.1190683; Duarte JC, 2011, MAR GEOL, V289, P135, DOI 10.1016/j.margeo.2011.09.014; DWYER GS, 1995, SCIENCE, V270, P1347, DOI 10.1126/science.270.5240.1347; Elderfield H, 2012, SCIENCE, V337, P704, DOI 10.1126/science.1221294; Esteras M., 2000, REV SOC GEOL ESPAN, V13, P539; Flinch JF, 1998, SEPM SPECIAL PUBLICA, V60, P199; Gutscher MA, 2002, GEOLOGY, V30, P1071, DOI 10.1130/0091-7613(2002)030<1071:EFASBG>2.0.CO;2; Hay WW, 1996, GEOL RUNDSCH, V85, P409, DOI 10.1007/BF02369000; Hernandez-Molina FJ, 2014, GEOLOGY, V42, P227, DOI 10.1130/G35083.1; Khelifi N, 2009, GEOLOGY, V37, P811, DOI 10.1130/G30058A.1; Knutz PC, 2008, DEVEL SEDIM, V60, P511, DOI 10.1016/S0070-4571(08)00224-0; LEDBETTER MT, 1978, NATURE, V272, P237, DOI 10.1038/272237a0; Llave E, 2007, GEOL SOC SPEC PUBL, V276, P49, DOI 10.1144/GSL.SP.2007.276.01.03; Martinez-Garcia P, 2013, BASIN RES, V25, P361, DOI 10.1111/bre.12005; Maslin MA, 1998, QUATERNARY SCI REV, V17, P411, DOI 10.1016/S0277-3791(97)00047-4; Medialdea T, 2004, MAR GEOL, V209, P173, DOI 10.1016/j.margeo.2004.05.029; Miller KG, 2011, OCEANOGRAPHY, V24, P40, DOI 10.5670/oceanog.2011.26; Nisancioglu KH, 2003, PALEOCEANOGRAPHY, V18, DOI 10.1029/2002PA000767; Potter PE, 2009, EARTH-SCI REV, V96, P279, DOI 10.1016/j.earscirev.2009.07.003; Rogerson M, 2012, CLIM DYNAM, V39, P589, DOI 10.1007/s00382-011-1148-4; Rogerson M, 2012, REV GEOPHYS, V50, DOI 10.1029/2011RG000376; Rohling EJ, 2014, NATURE, V508, P477, DOI 10.1038/nature13230; Roque C, 2012, MAR GEOL, V303, P42, DOI 10.1016/j.margeo.2011.11.001; Roveri M, 2014, MAR GEOL, V352, P25, DOI 10.1016/j.margeo.2014.02.002; Serra N, 2010, OCEAN SCI, V6, P191, DOI 10.5194/os-6-191-2010; Summerhayes C. P., 1986, N ATLANTIC PALEOCEAN, P103; White N, 1997, NATURE, V387, P888, DOI 10.1038/43151; Zachos J, 2001, SCIENCE, V292, P686, DOI 10.1126/science.1059412; Zitellini N, 2009, EARTH PLANET SC LETT, V280, P13, DOI 10.1016/j.epsl.2008.12.005	34	120	123	0	130	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 13	2014	344	6189					1244	1250		10.1126/science.1251306	http://dx.doi.org/10.1126/science.1251306			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI7ND	24926012	Green Submitted, Green Published			2022-12-28	WOS:000337077500031
J	Ingelfinger, JR				Ingelfinger, Julie R.			The Child or Adolescent with Elevated Blood Pressure	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							LEFT-VENTRICULAR HYPERTROPHY; CARDIOVASCULAR RISK; HYPERTENSIVE CHILDREN; WEIGHT-LOSS; OBESITY; EXERCISE; YOUNG; PREHYPERTENSION; RECOMMENDATIONS; INTERVENTION	A 13-year-old boy visits his pediatrician because his school football team requires medical clearance before the start of the season. On physical examination, his weight is 72 kg (above the 99th percentile for age and sex) and his height is 155 cm (the 50th percentile); his body-mass index (the weight in kilograms divided by the square of the height in meters) is 30 (above the 99th percentile). His blood pressure is 134/77 mm Hg (the 99th percentile for systolic blood pressure and the 90th percentile for diastolic blood pressure), and his heart rate is 70 beats per minute. The serum creatinine level is 0.7 mg per deciliter (62 mu mol per liter), and the urinalysis is normal. He is otherwise healthy and does not report any symptoms. His father has hypertension and type 2 diabetes. How should this case be further evaluated and treated?										Adams HR, 2010, PEDIATRICS, V126, pE1425, DOI 10.1542/peds.2010-1899; Appel LJ, 2009, J CLIN HYPERTENS, V11, P358, DOI 10.1111/j.1751-7176.2009.00136.x; BAO WH, 1995, AM J HYPERTENS, V8, P657, DOI 10.1016/0895-7061(95)00116-7; Bibbins-Domingo K, 2009, NEW ENGL J MED, V360, P1179, DOI 10.1056/NEJMoa0807265; Brady TM, 2008, J PEDIATR-US, V152, P73, DOI 10.1016/j.jpeds.2007.05.053; Butani L, 2003, PEDIATR NEPHROL, V18, P313, DOI 10.1007/s00467-003-1075-7; Carrico Robert J, 2013, Open J Pediatr, V3, P116; Chen XL, 2008, CIRCULATION, V117, P3171, DOI 10.1161/CIRCULATIONAHA.107.730366; Chobanian AV, 2003, HYPERTENSION, V42, P1206, DOI 10.1161/01.HYP.0000107251.49515.c2; Chockalingam A, 2006, CAN J CARDIOL, V22, P553, DOI 10.1016/S0828-282X(06)70275-6; Couch SC, 2008, J PEDIATR-US, V152, P494, DOI 10.1016/j.jpeds.2007.09.022; Daniels SR, 2013, JAMA PEDIATR, V167, P302, DOI 10.1001/jamapediatrics.2013.439; Erlingsdottir A, 2010, PEDIATR NEPHROL, V25, P323, DOI 10.1007/s00467-009-1350-3; Feber J, 2010, CLIN SCI, V119, P151, DOI 10.1042/CS20090544; Ferguson MA, 2013, PEDIAT HYPERTENSION, V3th, P539; FIXLER DE, 1985, PEDIATRICS, V75, P1071; Flynn J, 2013, PEDIATR NEPHROL, V28, P1059, DOI 10.1007/s00467-012-2344-0; Flynn JT, 2006, J PEDIATR-US, V149, P746, DOI 10.1016/j.jpeds.2006.08.074; Flynn JT, 2012, J CLIN HYPERTENS, V14, P372, DOI 10.1111/j.1751-7176.2012.00655.x; Flynn JT, 2005, PEDIATR NEPHROL, V20, P961, DOI 10.1007/s00467-005-1855-3; Franks PW, 2010, NEW ENGL J MED, V362, P485, DOI 10.1056/NEJMoa0904130; Gidding SS, 2012, PEDIATRICS, V129, pE1311, DOI 10.1542/peds.2011-2903; Guenther ALB, 2009, HYPERTENSION, V53, P6, DOI 10.1161/HYPERTENSIONAHA.108.116665; Hammerness PG, 2011, J AM ACAD CHILD PSY, V50, P978, DOI 10.1016/j.jaac.2011.07.018; Hansen ML, 2007, JAMA-J AM MED ASSOC, V298, P874, DOI 10.1001/jama.298.8.874; Holm JC, 2012, J HYPERTENS, V30, P368, DOI 10.1097/HJH.0b013e32834e4a87; James PA, 2014, JAMA-J AM MED ASSOC, V311, P507, DOI 10.1001/jama.2013.284427; Kaelber DC, 2009, PEDIATRICS, V123, pE972, DOI 10.1542/peds.2008-2680; Kalarchian MA, 2009, PEDIATRICS, V124, P1060, DOI 10.1542/peds.2008-3727; Lande MB, 2013, J AM SOC HYPERTENS, V7, P353, DOI 10.1016/j.jash.2013.05.003; LAUER RM, 1989, PEDIATRICS, V84, P633; Li SX, 2004, HYPERTENSION, V43, P541, DOI 10.1161/01.HYP.0000115922.98155.23; Litwin M, 2010, PEDIATR NEPHROL, V25, P2489, DOI 10.1007/s00467-010-1626-7; Lo JC, 2013, PEDIATRICS, V131, pE415, DOI 10.1542/peds.2012-1292; Lurbe E, 2009, J HYPERTENS, V27, P1719, DOI 10.1097/HJH.0b013e32832f4f6b; McCambridge Teri M, 2010, Pediatrics, V125, P1287, DOI 10.1542/peds.2010-0658; McLaughlin D, 2010, CLIN PEDIATR, V49, P355, DOI 10.1177/0009922809339844; McNiece KL, 2007, HYPERTENSION, V50, P392, DOI 10.1161/HYPERTENSIONAHA.107.092197; McNiece KL, 2007, J PEDIATR-US, V150, P640, DOI 10.1016/j.jpeds.2007.01.052; Mitchell CK, 2011, J PAEDIATR CHILD H, V47, P22, DOI 10.1111/j.1440-1754.2010.01885.x; Mitchell P, 2007, HYPERTENSION, V49, P1156, DOI 10.1161/HYPERTENSIONAHA.106.085910; Moyer VA, 2013, PEDIATRICS, V132, P907, DOI 10.1542/peds.2013-2864; Natl High Blood Pressure Educ Prog, 2004, PEDIATRICS, V114, P555; Ramos Elisabete, 2005, Rev Port Cardiol, V24, P1075; Robinson Renee F, 2005, Paediatr Drugs, V7, P27, DOI 10.2165/00148581-200507010-00003; Salvadori M, 2008, PEDIATRICS, V122, pE821, DOI 10.1542/peds.2008-0951; Schofield G, 2009, J SCI MED SPORT, V12, P148, DOI 10.1016/j.jsams.2007.10.003; Seeman T, 2007, AM J HYPERTENS, V20, P990, DOI 10.1016/j.amjhyper.2007.03.009; Shalitin S, 2009, HORM RES, V72, P287, DOI 10.1159/000245931; Sorof JM, 2003, PEDIATR NEPHROL, V18, P1020, DOI 10.1007/s00467-003-1187-0; Stabouli S, 2011, EXPERT REV CARDIOVAS, V9, P753, DOI [10.1586/erc.11.63, 10.1586/ERC.11.63]; Stabouli S, 2009, PEDIATR NEPHROL, V24, P1545, DOI 10.1007/s00467-009-1165-2; Thompson M, 2013, PEDIATRICS, V131, P490, DOI 10.1542/peds.2012-3523; Urbina E, 2008, HYPERTENSION, V52, P433, DOI 10.1161/HYPERTENSIONAHA.108.190329; Woroniecki RP, 2005, PEDIATR NEPHROL, V20, P791, DOI 10.1007/s00467-004-1804-6	55	48	54	0	15	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUN 12	2014	370	24					2316	2325		10.1056/NEJMcp1001120	http://dx.doi.org/10.1056/NEJMcp1001120			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AI7BB	24918374				2022-12-28	WOS:000337033700011
J	Dunn, SJ; Martello, G; Yordanov, B; Emmott, S; Smith, AG				Dunn, S. -J.; Martello, G.; Yordanov, B.; Emmott, S.; Smith, A. G.			Defining an essential transcription factor program for naive pluripotency	SCIENCE			English	Article							SELF-RENEWAL; STEM-CELLS; DIFFERENTIATION; EXPRESSION; NETWORK; TARGET; NANOG	The gene regulatory circuitry through which pluripotent embryonic stem (ES) cells choose between self-renewal and differentiation appears vast and has yet to be distilled into an executive molecular program. We developed a data-constrained, computational approach to reduce complexity and to derive a set of functionally validated components and interaction combinations sufficient to explain observed ES cell behavior. This minimal set, the simplest version of which comprises only 16 interactions, 12 components, and three inputs, satisfies all prior specifications for self-renewal and furthermore predicts unknown and nonintuitive responses to compound genetic perturbations with an overall accuracy of 70%. We propose that propagation of ES cell identity is not determined by a vast interactome but rather can be explained by a relatively simple process of molecular computation.	[Dunn, S. -J.; Yordanov, B.; Emmott, S.] Microsoft Res, Computat Sci Lab, Cambridge CB1 2FB, England; [Martello, G.; Smith, A. G.] Univ Cambridge, Wellcome Trust Med Res Council Cambridge Stem Cel, Cambridge CB2 1QR, England; [Smith, A. G.] Univ Cambridge, Dept Biochem, Cambridge CB2 1QW, England	Microsoft; University of Cambridge; University of Cambridge	Martello, G (corresponding author), Univ Cambridge, Wellcome Trust Med Res Council Cambridge Stem Cel, Cambridge CB2 1QR, England.	graziano.martello@unipd.it; austin.smith@cscr.cam.ac.uk	Martello, Graziano/AAM-3325-2021	Smith, Austin/0000-0002-3029-4682; Martello, Graziano/0000-0001-5520-085X	Human Frontier Science Program fellowship; Wellcome Trust; Medical Research Council [G19/38, G1100526, MC_PC_12009] Funding Source: researchfish	Human Frontier Science Program fellowship(Human Frontier Science Program); Wellcome Trust(Wellcome TrustEuropean Commission); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	We thank T. Kalkan, H. Kugler, and S. Dupont for stimulating discussions and comments on this manuscript and B. Simons for reading the manuscript. G. M. was a recipient of a Human Frontier Science Program fellowship. A. G. S. is a Medical Research Council Professor and is also funded by the Wellcome Trust.	Chambers I, 2007, NATURE, V450, P1230, DOI 10.1038/nature06403; Chen X, 2008, CELL, V133, P1106, DOI 10.1016/j.cell.2008.04.043; Enver T, 2009, CELL STEM CELL, V4, P387, DOI 10.1016/j.stem.2009.04.011; Hall J, 2009, CELL STEM CELL, V5, P597, DOI 10.1016/j.stem.2009.11.003; Ivanova N, 2006, NATURE, V442, P533, DOI 10.1038/nature04915; Lanner F, 2010, STEM CELLS, V28, P191, DOI 10.1002/stem.265; Lu R, 2009, NATURE, V462, P358, DOI 10.1038/nature08575; Martello G, 2013, EMBO J, V32, P2561, DOI 10.1038/emboj.2013.177; Martello G, 2012, CELL STEM CELL, V11, P491, DOI 10.1016/j.stem.2012.06.008; Masui S, 2007, NAT CELL BIOL, V9, P625, DOI 10.1038/ncb1589; Nichols J, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a008128; Niwa H, 2000, NAT GENET, V24, P372, DOI 10.1038/74199; Silva J, 2009, CELL, V138, P722, DOI 10.1016/j.cell.2009.07.039; Som A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015165; Tai CI, 2013, J CELL SCI, V126, P1093, DOI 10.1242/jcs.118273; van den Berg DLC, 2010, CELL STEM CELL, V6, P369, DOI 10.1016/j.stem.2010.02.014; Wilczynski B, 2009, BIOINFORMATICS, V25, P286, DOI 10.1093/bioinformatics/btn505; Yeo JC, 2013, CELL RES, V23, P20, DOI 10.1038/cr.2012.172; Ying QL, 2008, NATURE, V453, P519, DOI 10.1038/nature06968; Yordanov Boyan, 2013, NASA Formal Methods. 5th International Symposium, NFM 2013. Proceedings, P78, DOI 10.1007/978-3-642-38088-4_6	20	250	256	2	51	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 6	2014	344	6188					1156	1160		10.1126/science.1248882	http://dx.doi.org/10.1126/science.1248882			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI3UU	24904165	Green Accepted			2022-12-28	WOS:000336791200047
J	Youngs, H; Somerville, C				Youngs, Heather; Somerville, Chris			PLANT SCIENCE Best practices for biofuels	SCIENCE			English	Editorial Material							CROP RESIDUE; IMPACTS		[Youngs, Heather; Somerville, Chris] Univ Calif Berkeley, Energy Biosci Inst, Berkeley, CA 94720 USA; [Somerville, Chris] King Abdulaziz Univ, Fac Meteorol Environm & Arid Land Agr, Dept Arid Land Agr, Jeddah 21413, Saudi Arabia	University of California System; University of California Berkeley; King Abdulaziz University	Youngs, H (corresponding author), Univ Calif Berkeley, Energy Biosci Inst, Berkeley, CA 94720 USA.	crs@berkeley.edu						Anderson-Teixeira K. J., 2013, Ecosystems, V16, P508, DOI 10.1007/s10021-012-9628-x; Barros V, 2014, CLIMATE CHANGE 2014: IMPACTS, ADAPTATION, AND VULNERABILITY, PT A: GLOBAL AND SECTORAL ASPECTS, pIX; Bonner IJ, 2014, BIOENERG RES, V7, P576, DOI 10.1007/s12155-014-9423-y; Edenhofer O., 2011, IPCC SPECIAL REPORT; Hertel TW, 2013, GLOB FOOD SECUR-AGR, V2, P131, DOI 10.1016/j.gfs.2013.05.003; Karlen DL, 2014, BIOENERG RES, V7, P528, DOI [10.1007/s12155-014-9419-7, 10.1007/s12155-014-9407-y]; Liska AJ, 2014, NAT CLIM CHANGE, V4, P398, DOI [10.1038/NCLIMATE2187, 10.1038/nclimate2187]; Robertson GP, 2008, SCIENCE, V322, P49, DOI 10.1126/science.1161525; Scarlat N, 2011, ENERG POLICY, V39, P1630, DOI 10.1016/j.enpol.2010.12.039; Searchinger T, 2008, SCIENCE, V319, P1238, DOI 10.1126/science.1151861; Tilman D, 2009, SCIENCE, V325, P270, DOI 10.1126/science.1177970	11	29	30	0	102	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 6	2014	344	6188					1095	1096		10.1126/science.1255812	http://dx.doi.org/10.1126/science.1255812			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AI3UU	24904145				2022-12-28	WOS:000336791200026
J	Lee, JH; Park, CK; Chen, G; Han, QJ; Xie, RG; Liu, T; Ji, RR; Lee, SY				Lee, Jun-Ho; Park, Chul-Kyu; Chen, Gang; Han, Qingjian; Xie, Rou-Gang; Liu, Tong; Ji, Ru-Rong; Lee, Seok-Yong			RETRACTED: A Monoclonal Antibody that Targets a Na(V)1.7 Channel Voltage Sensor for Pain and Itch Relief (Retracted article. See vol. 181, pg. 1695, 2020)	CELL			English	Article; Retracted Publication							GATED SODIUM-CHANNELS; SYNAPTIC-TRANSMISSION; CHARGE MOVEMENT; NA+ CHANNEL; SPINAL-CORD; MUTATIONS; INTERNEURONS; NOCICEPTORS; ACTIVATION; GENERATION	Voltage-gated sodium (Na-V) channels control the upstroke of the action potentials in excitable cells. Multiple studies have shown distinct roles of Na-V channel subtypes in human physiology and diseases, but subtype-specific therapeutics are lacking and the current efforts have been limited to small molecules. Here, we present a monoclonal antibody that targets the voltage-sensor paddle of Na(V)1.7, the subtype critical for pain sensation. This antibody not only inhibits Na(V)1.7 with high selectivity, but also effectively suppresses inflammatory and neuropathic pain in mice. Interestingly, the antibody inhibits acute and chronic itch despite well-documented differences in pain and itch modulation. Using this antibody, we discovered that Na(V)1.7 plays a key role in spinal cord nociceptive and pruriceptive synaptic transmission. Our studies reveal that Na(V)1.7 is a target for itch management, and the antibody has therapeutic potential for suppressing pain and itch. Our antibody strategy may have broad applications for voltage-gated cation channels.	[Lee, Jun-Ho; Lee, Seok-Yong] Duke Univ, Med Ctr, Dept Biochem, Durham, NC 27710 USA; [Park, Chul-Kyu; Chen, Gang; Han, Qingjian; Xie, Rou-Gang; Liu, Tong; Ji, Ru-Rong] Duke Univ, Med Ctr, Dept Anesthesiol & Neurobiol, Durham, NC 27710 USA	Duke University; Duke University	Ji, RR (corresponding author), Duke Univ, Med Ctr, Dept Anesthesiol & Neurobiol, Durham, NC 27710 USA.	ru-rong.ji@duke.edu; sylee@biochem.duke.edu	Ji, Ru-Rong/L-7070-2017	Ji, Ru-Rong/0000-0002-9355-3688; Xie, Rou-gang/0000-0001-7644-1492	N.I.H. [1 DP2 OD008380-01, R01DE17794, R01DE22743, R01NS67686]; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE022743, R01DE017794] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS067686] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP2OD008380] Funding Source: NIH RePORTER	N.I.H.(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We thank Francis Valiyaveetil and Zachary Johnson for critical reading. We thank Kwan-Ki Hwang and Cheom-Gil Cheong for help with hybridoma culture and ELISA assays, respectively. This work was supported by the N.I.H. Director's New Innovator Award 1 DP2 OD008380-01 (S.-Y.L) and N.I.H. R01DE17794, R01DE22743, and R01NS67686 (R.-R.J.). S.-Y.L. is a McKnight Scholar, Klingenstein fellow, Alfred P. Sloan Research fellow, Mallinckrodt Scholar, Basil O'Connor Starter Scholar, and Whitehead Scholar.	Akiyama T, 2014, PAIN, V155, P80, DOI 10.1016/j.pain.2013.09.011; Akiyama T, 2013, NEUROSCIENCE, V250, P697, DOI 10.1016/j.neuroscience.2013.07.035; Alabi AA, 2007, NATURE, V450, P370, DOI 10.1038/nature06266; ARMSTRONG CM, 1974, J GEN PHYSIOL, V63, P533, DOI 10.1085/jgp.63.5.533; Beck A, 2010, NAT REV IMMUNOL, V10, P345, DOI 10.1038/nri2747; Black JA, 2012, MOL PAIN, V8, DOI 10.1186/1744-8069-8-82; Bolognesi R, 1997, AM J CARDIOL, V79, P242, DOI 10.1016/S0002-9149(96)00727-8; CASADEI JM, 1984, P NATL ACAD SCI-BIOL, V81, P6227, DOI 10.1073/pnas.81.19.6227; Cestele S, 1998, NEURON, V21, P919, DOI 10.1016/S0896-6273(00)80606-6; Cha A, 1999, NEURON, V22, P73, DOI 10.1016/S0896-6273(00)80680-7; Chan AC, 2010, NAT REV IMMUNOL, V10, P301, DOI 10.1038/nri2761; Cox JJ, 2006, NATURE, V444, P894, DOI 10.1038/nature05413; Cronin NB, 2003, J BIOL CHEM, V278, P10675, DOI 10.1074/jbc.M208356200; Drenth JPH, 2001, AM J HUM GENET, V68, P1277, DOI 10.1086/320107; ECHT DS, 1991, NEW ENGL J MED, V324, P781, DOI 10.1056/NEJM199103213241201; Eijkelkamp N, 2012, BRAIN, V135, P2585, DOI 10.1093/brain/aws225; England S, 2009, BRIT J PHARMACOL, V158, P1413, DOI 10.1111/j.1476-5381.2009.00437.x; Escayg A, 2010, EPILEPSIA, V51, P1650, DOI 10.1111/j.1528-1167.2010.02640.x; Fertleman CR, 2006, NEURON, V52, P767, DOI 10.1016/j.neuron.2006.10.006; Han L, 2013, NAT NEUROSCI, V16, P174, DOI 10.1038/nn.3289; HYLDEN JLK, 1980, EUR J PHARMACOL, V67, P313, DOI 10.1016/0014-2999(80)90515-4; Jiang YX, 2003, NATURE, V423, P42, DOI 10.1038/nature01581; Jiang YX, 2003, NATURE, V423, P33, DOI 10.1038/nature01580; Jurkat-Rott K, 2010, PFLUG ARCH EUR J PHY, V460, P239, DOI 10.1007/s00424-010-0814-4; Koga K, 2011, MOL PAIN, V7, DOI 10.1186/1744-8069-7-47; Lee SY, 2004, NATURE, V430, P232, DOI 10.1038/nature02632; Liao YJ, 2008, P NATL ACAD SCI USA, V105, P2705, DOI 10.1073/pnas.0710771105; Liu T, 2013, PFLUG ARCH EUR J PHY, V465, P1671, DOI 10.1007/s00424-013-1284-2; Liu T, 2012, J CLIN INVEST, V122, P2195, DOI 10.1172/JCI45414; Liu Y, 2010, NEURON, V68, P543, DOI 10.1016/j.neuron.2010.09.008; Ma QF, 2010, J CLIN INVEST, V120, P3773, DOI 10.1172/JCI43426; McCormack K, 2013, P NATL ACAD SCI USA, V110, pE2724, DOI 10.1073/pnas.1220844110; Minett MS, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1795; Mishra SK, 2013, SCIENCE, V340, P968, DOI 10.1126/science.1233765; Nardi A, 2012, CHEMMEDCHEM, V7, P1712, DOI 10.1002/cmdc.201200298; Pardridge WM, 2012, METHOD ENZYMOL, V503, P269, DOI 10.1016/B978-0-12-396962-0.00011-2; Payandeh J, 2011, NATURE, V475, P353, DOI 10.1038/nature10238; Ross SE, 2010, NEURON, V65, P886, DOI 10.1016/j.neuron.2010.02.025; Schmalhofer WA, 2008, MOL PHARMACOL, V74, P1476, DOI 10.1124/mol.108.047670; Scott AM, 2012, NAT REV CANCER, V12, P278, DOI 10.1038/nrc3236; Sun H, 2013, ACTA PHARMACOL SIN, V34, P199, DOI 10.1038/aps.2012.202; Sun YG, 2007, NATURE, V448, P700, DOI 10.1038/nature06029; Swartz KJ, 1997, NEURON, V18, P675, DOI 10.1016/S0896-6273(00)80307-4; Swartz KJ, 1997, NEURON, V18, P665, DOI 10.1016/S0896-6273(00)80306-2; Todd AJ, 2010, NAT REV NEUROSCI, V11, P823, DOI 10.1038/nrn2947; Wang XD, 2013, NEURON, V78, P312, DOI 10.1016/j.neuron.2013.03.001; Weiss J, 2011, NATURE, V472, P186, DOI 10.1038/nature09975; Xu SZ, 2005, NAT BIOTECHNOL, V23, P1289, DOI 10.1038/nbt1148; Xu ZZ, 2010, NAT MED, V16, P592, DOI 10.1038/nm.2123; Yang SL, 2013, P NATL ACAD SCI USA, V110, P17534, DOI 10.1073/pnas.1306285110; Zimmer T, 2008, PROG BIOPHYS MOL BIO, V98, P120, DOI 10.1016/j.pbiomolbio.2008.10.005	51	164	185	1	54	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUN 5	2014	157	6					1393	1404		10.1016/j.cell.2014.03.064	http://dx.doi.org/10.1016/j.cell.2014.03.064			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	AN8UV	24856969	Green Accepted, Bronze			2022-12-28	WOS:000340881400015
J	Perry, RJ; Samuel, VT; Petersen, KF; Shulman, GI				Perry, Rachel J.; Samuel, Varman T.; Petersen, Kitt F.; Shulman, Gerald I.			The role of hepatic lipids in hepatic insulin resistance and type 2 diabetes	NATURE			English	Article							NONALCOHOLIC FATTY LIVER; DE-NOVO LIPOGENESIS; C3 GENE VARIANTS; SKELETAL-MUSCLE; PYRUVATE-CARBOXYLASE; CELLULAR MECHANISMS; ENERGY-EXPENDITURE; METABOLIC SYNDROME; CGI-58 KNOCKDOWN; WEIGHT-REDUCTION	Non-alcoholic fatty liver disease and its downstream sequelae, hepatic insulin resistance and type 2 diabetes, are rapidly growing epidemics, which lead to increased morbidity and mortality rates, and soaring health-care costs. Developing interventions requires a comprehensive understanding of the mechanisms by which excess hepatic lipid develops and causes hepatic insulin resistance and type 2 diabetes. Proposed mechanisms implicate various lipid species, inflammatory signalling and other cellular modifications. Studies in mice and humans have elucidated a key role for hepatic diacylglycerol activation of protein kinase C epsilon in triggering hepatic insulin resistance. Therapeutic approaches based on this mechanism could alleviate the related epidemics of non-alcoholic fatty liver disease and type 2 diabetes.	[Perry, Rachel J.; Samuel, Varman T.; Petersen, Kitt F.; Shulman, Gerald I.] Yale Univ, Sch Med, Dept Internal Med, New Haven, CT 06520 USA; [Samuel, Varman T.] VA Connecticut Healthcare Syst, West Haven, CT 06516 USA; [Petersen, Kitt F.; Shulman, Gerald I.] Univ Copenhagen, Novo Nordisk Fdn, Ctr Basic Metab Res, DK-2200 Copenhagen, Denmark; [Shulman, Gerald I.] Yale Univ, Sch Med, Dept Cellular & Mol Physiol, New Haven, CT 06520 USA; [Shulman, Gerald I.] Yale Univ, Sch Med, Howard Hughes Med Inst, New Haven, CT 06535 USA	Yale University; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Connecticut Healthcare System; Novo Nordisk Foundation; University of Copenhagen; Yale University; Howard Hughes Medical Institute; Yale University	Shulman, GI (corresponding author), Yale Univ, Sch Med, Dept Internal Med, 333 Cedar St, New Haven, CT 06520 USA.	gerald.shulman@yale.edu	Shulman, Gerald I./P-7176-2019	Shulman, Gerald I./0000-0003-1529-5668; Perry, Rachel/0000-0003-0748-8064	National Institutes of Health [R01 DK-40936, R01 DK-49230, R24 DK-085836, R01 AG-23686, U24 DK-059635, UL1 RR-024139, P30 DK-45735, T32-DK101019, I01-BX000901]; Novo Nordisk Foundation for Basic Metabolic Research, University of Copenhagen; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR024139] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK034989, P30DK045735, T32DK101019, R13DK085836, R01DK049230, U24DK059635, R01DK040936] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG023686] Funding Source: NIH RePORTER; Veterans Affairs [I01BX000901] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Novo Nordisk Foundation for Basic Metabolic Research, University of Copenhagen; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Veterans Affairs(US Department of Veterans Affairs)	Space limitations preclude this from being a comprehensive review, and this unfortunately limits appropriate recognition of many of our colleagues worldwide who have contributed immeasurably to the development of this field. This work was supported by grants from the National Institutes of Health: R01 DK-40936, R01 DK-49230, R24 DK-085836, R01 AG-23686, U24 DK-059635, UL1 RR-024139, P30 DK-45735, T32-DK101019 and I01-BX000901 (V.T.S.), and the Novo Nordisk Foundation for Basic Metabolic Research, University of Copenhagen.	Adina-Zada A, 2012, BIOCHEM SOC T, V40, P567, DOI 10.1042/BST20120041; Adina-Zada A, 2012, ARCH BIOCHEM BIOPHYS, V519, P118, DOI 10.1016/j.abb.2011.11.015; Amarapurkar DN, 2007, J GASTROEN HEPATOL, V22, P788, DOI 10.1111/j.1440-1746.2007.05042.x; Chavez JA, 2010, BBA-MOL CELL BIOL L, V1801, P252, DOI 10.1016/j.bbalip.2009.09.015; Asai A, 2014, AM J PHYSL GASTROINT; Auinger A, 2010, HORM METAB RES, V42, P854, DOI 10.1055/s-0030-1267186; Befroy DE, 2014, NAT MED, V20, P98, DOI 10.1038/nm.3415; Benhamed F, 2012, J CLIN INVEST, V122, P2176, DOI 10.1172/JCI41636; Bergman BC, 2012, DIABETOLOGIA, V55, P1140, DOI 10.1007/s00125-011-2419-7; Bilz S, 2006, AM J PHYSIOL-ENDOC M, V290, pE716, DOI 10.1152/ajpendo.00355.2005; Birkenfeld AL, 2011, CELL METAB, V14, P184, DOI 10.1016/j.cmet.2011.06.009; Brown JM, 2010, J LIPID RES, V51, P3306, DOI 10.1194/jlr.M010256; Brown MS, 2008, CELL METAB, V7, P95, DOI 10.1016/j.cmet.2007.12.009; Brown WH, 2012, P NATL ACAD SCI USA, V109, P14966, DOI 10.1073/pnas.1212887109; Browning JD, 2004, HEPATOLOGY, V40, P1387, DOI 10.1002/hep.20466; Camporez JPG, 2013, ENDOCRINOLOGY, V154, P3099, DOI 10.1210/en.2013-1191; Camporez JPG, 2013, ENDOCRINOLOGY, V154, P1021, DOI 10.1210/en.2012-1989; Cantley JL, 2013, P NATL ACAD SCI USA, V110, P1869, DOI 10.1073/pnas.1219456110; Cao H, 2006, DIABETES, V55, P1915, DOI 10.2337/db05-1496; Charlton MR, 2011, GASTROENTEROLOGY, V141, P1249, DOI 10.1053/j.gastro.2011.06.061; Cheng ZY, 2010, TRENDS ENDOCRIN MET, V21, P589, DOI 10.1016/j.tem.2010.06.005; Choi CS, 2007, J BIOL CHEM, V282, P22678, DOI 10.1074/jbc.M704213200; Cohen JC, 2011, SCIENCE, V332, P1519, DOI 10.1126/science.1204265; Cortes VA, 2014, J LIPID RES, V55, P276, DOI 10.1194/jlr.M045799; Das K, 2010, HEPATOLOGY, V51, P1593, DOI 10.1002/hep.23567; Delarue J, 1996, INT J OBESITY, V20, P130; Diraison F, 2003, DIABETES METAB, V29, P478, DOI 10.1016/S1262-3636(07)70061-7; Doege H, 2008, J BIOL CHEM, V283, P22186, DOI 10.1074/jbc.M803510200; Donnelly KL, 2005, J CLIN INVEST, V115, P1343, DOI 10.1172/JCI23621; Dries DR, 2007, J BIOL CHEM, V282, P826, DOI 10.1074/jbc.C600268200; Dutchak PA, 2012, CELL, V148, P556, DOI 10.1016/j.cell.2011.11.062; Fabbrini E, 2010, HEPATOLOGY, V51, P679, DOI 10.1002/hep.23280; Fan JG, 2005, J HEPATOL, V43, P508, DOI 10.1016/j.jhep.2005.02.042; Farese RV, 2012, CELL METAB, V15, P570, DOI 10.1016/j.cmet.2012.03.004; Flannery C, 2012, DIABETES, V61, P2711, DOI 10.2337/db12-0206; Franke TF, 1997, SCIENCE, V275, P665, DOI 10.1126/science.275.5300.665; Fullerton MD, 2013, NAT MED, V19, P1649, DOI 10.1038/nm.3372; Funke A, 2014, ATHEROSCLEROSIS, V232, P390, DOI 10.1016/j.atherosclerosis.2013.11.074; Gandotra S, 2011, NEW ENGL J MED, V364, P740, DOI 10.1056/NEJMoa1007487; Hanke S, 2009, MOL CELL PROTEOMICS, V8, P519, DOI 10.1074/mcp.M800407-MCP200; Haufe S, 2013, DIABETES CARE, V36, P3786, DOI 10.2337/dc13-0102; Houten SM, 2013, HUM MOL GENET, V22, P5249, DOI 10.1093/hmg/ddt382; Hui JM, 2003, HEPATOLOGY, V38, P420, DOI 10.1053/jhep.2003.50320; Jacobs RL, 2010, J BIOL CHEM, V285, P22403, DOI 10.1074/jbc.M110.108514; Jaworski K, 2009, NAT MED, V15, P159, DOI 10.1038/nm.1904; Jornayvaz FR, 2012, ENDOCRINOLOGY, V153, P583, DOI 10.1210/en.2011-1793; Jornayvaz FR, 2011, P NATL ACAD SCI USA, V108, P5748, DOI 10.1073/pnas.1103451108; Jornayvaz FR, 2010, AM J PHYSIOL-ENDOC M, V299, pE808, DOI 10.1152/ajpendo.00361.2010; Kantartzis K, 2009, CLIN SCI, V116, P531, DOI 10.1042/CS20080306; Kim JK, 2000, J BIOL CHEM, V275, P8456, DOI 10.1074/jbc.275.12.8456; Kim JK, 2001, P NATL ACAD SCI USA, V98, P7522, DOI 10.1073/pnas.121164498; Kim JK, 2003, DIABETES, V52, P1311, DOI 10.2337/diabetes.52.6.1311; Kim JK, 2001, J CLIN INVEST, V108, P153, DOI 10.1172/JCI10294; Kleiner DE, 2005, HEPATOLOGY, V41, P1313, DOI 10.1002/hep.20701; Kozlitina J, 2011, HEPATOLOGY, V53, P467, DOI 10.1002/hep.24072; Kumari M, 2012, CELL METAB, V15, P691, DOI 10.1016/j.cmet.2012.04.008; Kumashiro N, 2013, HEPATOLOGY, V57, P1763, DOI 10.1002/hep.26170; Kumashiro N, 2011, P NATL ACAD SCI USA, V108, P16381, DOI 10.1073/pnas.1113359108; Lee HY, 2011, HEPATOLOGY, V54, P1650, DOI 10.1002/hep.24571; Lim EL, 2011, DIABETOLOGIA, V54, P2506, DOI 10.1007/s00125-011-2204-7; Lin JD, 2005, CELL, V120, P261, DOI 10.1016/j.cell.2004.11.043; Lin YC, 2014, AM J CLIN NUTR, V99, P869, DOI 10.3945/ajcn.113.079749; Magkos F, 2012, GASTROENTEROLOGY, V142; Mayerson AB, 2002, DIABETES, V51, P797, DOI 10.2337/diabetes.51.3.797; McGuire MT, 1999, INT J OBESITY, V23, P1314, DOI 10.1038/sj.ijo.0801075; Mingrone G, 1999, DIABETES, V48, P1258, DOI 10.2337/diabetes.48.6.1258; Mittendorfer B, 2009, OBESITY, V17, P1872, DOI 10.1038/oby.2009.224; Miyazaki Y, 2003, DIABETES, V52, P1943, DOI 10.2337/diabetes.52.8.1943; Monetti M, 2007, CELL METAB, V6, P69, DOI 10.1016/j.cmet.2007.05.005; Moran-Ramos S, 2012, J NUTR, V142, P1956, DOI 10.3945/jn.112.165563; Nagai Y, 2009, CELL METAB, V9, P252, DOI 10.1016/j.cmet.2009.01.011; Nagle CA, 2007, J BIOL CHEM, V282, P14807, DOI 10.1074/jbc.M611550200; Neschen S, 2005, CELL METAB, V2, P55, DOI 10.1016/j.cmet.2005.06.006; Neschen S, 2007, DIABETES, V56, P1034, DOI 10.2337/db06-1206; Niebergall LJ, 2011, BBA-MOL CELL BIOL L, V1811, P1177, DOI 10.1016/j.bbalip.2011.06.021; Pardina E, 2009, OBES SURG, V19, P894, DOI 10.1007/s11695-008-9739-9; Perry RJ, 2013, CELL METAB, V18, P740, DOI 10.1016/j.cmet.2013.10.004; Peter A, 2012, INT J OBESITY, V36, P774, DOI 10.1038/ijo.2011.154; Petersen KF, 2002, J CLIN INVEST, V109, P1345, DOI [10.1172/JCI0215001, 10.1172/JCI200215001]; Petersen KF, 1998, J CLIN INVEST, V101, P1203, DOI 10.1172/JCI579; Petersen KF, 2005, DIABETES, V54, P603, DOI 10.2337/diabetes.54.3.603; Petersen KF, 2007, P NATL ACAD SCI USA, V104, P12587, DOI 10.1073/pnas.0705408104; Petersen KF, 2006, P NATL ACAD SCI USA, V103, P18273, DOI 10.1073/pnas.0608537103; Petersen KF, 2012, P NATL ACAD SCI USA, V109, P8236, DOI 10.1073/pnas.1205675109; Petersen KF, 2010, NEW ENGL J MED, V362, P1082, DOI 10.1056/NEJMoa0907295; PILKIS SJ, 1990, DIABETES CARE, V13, P582, DOI 10.2337/diacare.13.6.582; Prieur X, 2013, DIABETOLOGIA, V56, P1813, DOI 10.1007/s00125-013-2926-9; Rabol R, 2011, P NATL ACAD SCI USA, V108, P13705, DOI 10.1073/pnas.1110105108; Raddatz K, 2011, DIABETOLOGIA, V54, P1447, DOI 10.1007/s00125-011-2073-0; Ratziu V, 2010, J HEPATOL, V53, P372, DOI 10.1016/j.jhep.2010.04.008; Roden M, 1996, J CLIN INVEST, V97, P2859, DOI 10.1172/JCI118742; Ruiz R, 2014, J BIOL CHEM, V289, P5510, DOI 10.1074/jbc.M113.541110; Samuel VT, 2007, J CLIN INVEST, V117, P739, DOI 10.1172/JCI30400; Samuel VT, 2012, CELL, V148, P852, DOI 10.1016/j.cell.2012.02.017; Samuel VT, 2004, J BIOL CHEM, V279, P32345, DOI 10.1074/jbc.M313478200; Satapati S, 2012, J LIPID RES, V53, P1080, DOI 10.1194/jlr.M023382; Savage DB, 2006, J CLIN INVEST, V116, P817, DOI 10.1172/JCI27300; Savage DB, 2005, J CLIN ENDOCR METAB, V90, P1446, DOI 10.1210/jc.2004-1494; Schmid AI, 2011, DIABETES CARE, V34, P448, DOI 10.2337/dc10-1076; Shindo N, 2010, J HEPATOL, V52, P903, DOI 10.1016/j.jhep.2009.12.033; Shulman GI, 2000, J CLIN INVEST, V106, P171, DOI 10.1172/JCI10583; SILVERMAN JF, 1990, AM J GASTROENTEROL, V85, P1349; Simha V, 2003, DIABETES CARE, V26, P30, DOI 10.2337/diacare.26.1.30; Singhal NS, 2008, AM J PHYSIOL-ENDOC M, V295, pE331, DOI 10.1152/ajpendo.00577.2007; Smits MM, 2013, J GASTROEN HEPATOL, V28, P664, DOI 10.1111/jgh.12106; Speliotes EK, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001324; Sun Z, 2013, TRENDS ENDOCRIN MET, V24, P4, DOI 10.1016/j.tem.2012.09.005; Sun Z, 2012, NAT MED, V18, P934, DOI 10.1038/nm.2744; Sunny NE, 2011, CELL METAB, V14, P804, DOI 10.1016/j.cmet.2011.11.004; Szendroedi J, 2009, HEPATOLOGY, V50, P1079, DOI 10.1002/hep.23093; Tolman KG, 2007, DIABETES CARE, V30, P734, DOI 10.2337/dc06-1539; Verrijken A, 2013, OBESITY, V21, P2138, DOI 10.1002/oby.20366; Wang FF, 2013, P NATL ACAD SCI USA, V110, P18656, DOI 10.1073/pnas.1314863110; Wang HY, 2013, BIOCHEM J, V449, P479, DOI 10.1042/BJ20120702; WANLESS IR, 1990, HEPATOLOGY, V12, P1106, DOI 10.1002/hep.1840120505; Weiss EC, 2007, AM J PREV MED, V33, P34, DOI 10.1016/j.amepre.2007.02.040; Weiss R, 2005, J CLIN ENDOCR METAB, V90, P3731, DOI 10.1210/jc.2004-2305; Xu E, 2014, HEPATOLOGY, V59, P1803, DOI 10.1002/hep.26957; Yu XX, 2005, HEPATOLOGY, V42, P362, DOI 10.1002/hep.20783; Zhang C, 2012, TOXICOL LETT, V212, P229, DOI 10.1016/j.toxlet.2012.06.002; Zhang DY, 2007, P NATL ACAD SCI USA, V104, P17075, DOI 10.1073/pnas.0707060104	121	729	759	18	308	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 5	2014	510	7503					84	91		10.1038/nature13478	http://dx.doi.org/10.1038/nature13478			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI3NR	24899308	Green Accepted			2022-12-28	WOS:000336768900035
J	Qiu, YF; Nguyen, KD; Odegaard, JI; Cui, XJ; Tian, XY; Locksley, RM; Palmiter, RD; Chawla, A				Qiu, Yifu; Nguyen, Khoa D.; Odegaard, Justin I.; Cui, Xiaojin; Tian, Xiaoyu; Locksley, Richard M.; Palmiter, Richard D.; Chawla, Ajay			Eosinophils and Type 2 Cytokine Signaling in Macrophages Orchestrate Development of Functional Beige Fat	CELL			English	Article							BROWN ADIPOSE-TISSUE; NONSHIVERING THERMOGENESIS; ADAPTIVE THERMOGENESIS; GENE-EXPRESSION; IN-VIVO; ADULT HUMANS; WHITE; ACTIVATION; ADIPOCYTES; INFLAMMATION	Beige fat, which expresses the thermogenic protein UCP1, provides a defense against cold and obesity. Although a cold environment is the physiologic stimulus for inducing beige fat in mice and humans, the events that lead from the sensing of cold to the development of beige fat remain poorly understood. Here, we identify the efferent beige fat thermogenic circuit, consisting of eosinophils, type 2 cytokines interleukin (IL)-4/13, and alternatively activated macrophages. Genetic loss of eosinophils or IL-4/13 signaling impairs cold-induced biogenesis of beige fat. Mechanistically, macrophages recruited to cold-stressed subcutaneous white adipose tissue (scWAT) undergo alternative activation to induce tyrosine hydroxylase expression and catecholamine production, factors required for browning of scWAT. Conversely, administration of IL-4 to thermoneutral mice increases beige fat mass and thermogenic capacity to ameliorate pre-established obesity. Together, our findings have uncovered the efferent circuit controlling biogenesis of beige fat and provide support for its targeting to treat obesity.	[Qiu, Yifu; Nguyen, Khoa D.; Odegaard, Justin I.; Cui, Xiaojin; Tian, Xiaoyu; Chawla, Ajay] Univ Calif San Francisco, Inst Cardiovasc Res, San Francisco, CA 94158 USA; [Locksley, Richard M.] Univ Calif San Francisco, Howard Hughes Med Inst, Dept Med, San Francisco, CA 94158 USA; [Locksley, Richard M.] Univ Calif San Francisco, Howard Hughes Med Inst, Dept Microbiol & Immunol, San Francisco, CA 94158 USA; [Locksley, Richard M.; Palmiter, Richard D.] Univ Washington, Howard Hughes Med Inst, Dept Biochem, Seattle, WA 98195 USA; [Chawla, Ajay] Univ Calif San Francisco, Dept Physiol, San Francisco, CA 94158 USA; [Chawla, Ajay] Univ Calif San Francisco, Dept Med, San Francisco, CA 94158 USA	University of California System; University of California San Francisco; Howard Hughes Medical Institute; University of California System; University of California San Francisco; Howard Hughes Medical Institute; University of California System; University of California San Francisco; Howard Hughes Medical Institute; University of Washington; University of Washington Seattle; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Chawla, A (corresponding author), Univ Calif San Francisco, Inst Cardiovasc Res, San Francisco, CA 94158 USA.	ajay.chawla@ucsf.edu	Tian, Xiao Yu/P-1092-2016	Tian, Xiao Yu/0000-0003-3472-9898; Qiu, Yifu/0000-0001-5645-3189; Nguyen, Khoa/0000-0002-6720-2470	NIH [HL076746, DK094641]; American Heart Association Innovative Science Award [12PILT11840038]; NIH Director's Pioneer Award [DP1AR064158]; AHA Postdoctoral Fellowship; AHA Predoctoral Fellowship; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL107202, R01HL076746] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI030663, R37AI026918] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [DP1AR064158] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK026743, R01DK094641] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP1OD006415] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association Innovative Science Award; NIH Director's Pioneer Award(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); AHA Postdoctoral Fellowship(American Heart Association); AHA Predoctoral Fellowship(American Heart Association); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We thank members of the Chawla laboratory, A. Loh for comments on the manuscript, P. Cohen for providing the protocol to measure oxygen consumption in isolated adipose tissues, and S. Kajimura for assistance with use of their Clark electrode. The authors' work was supported by grants from NIH (HL076746, DK094641), American Heart Association Innovative Science Award (12PILT11840038), and an NIH Director's Pioneer Award (DP1AR064158) to A. C. Y.Q was supported by an AHA Postdoctoral Fellowship, and K.D.N. was supported by an AHA Predoctoral Fellowship. All animal care and procedures were performed in accordance with UCSF's IACUC guidelines. The authors declare that they have no competing financial interests.	Cannon B, 2010, INT J OBESITY, V34, pS7, DOI 10.1038/ijo.2010.177; Cannon B, 2011, J EXP BIOL, V214, P242, DOI 10.1242/jeb.050989; Charo IF, 2006, NEW ENGL J MED, V354, P610, DOI 10.1056/NEJMra052723; Cypess AM, 2013, NAT MED, V19, P635, DOI 10.1038/nm.3112; Cypess AM, 2009, NEW ENGL J MED, V360, P1509, DOI 10.1056/NEJMoa0810780; DANIEL H, 1969, CAN J PHYSIOL PHARM, V47, P941, DOI 10.1139/y69-154; Enerback S, 2010, CELL METAB, V11, P248, DOI 10.1016/j.cmet.2010.03.008; Feldmann HM, 2009, CELL METAB, V9, P203, DOI 10.1016/j.cmet.2008.12.014; Finucane MM, 2011, LANCET, V377, P557, DOI 10.1016/S0140-6736(10)62037-5; Geissmann F, 2010, SCIENCE, V327, P656, DOI 10.1126/science.1178331; Goenka S, 2011, IMMUNOL RES, V50, P87, DOI 10.1007/s12026-011-8205-2; Golozoubova V, 2006, AM J PHYSIOL-ENDOC M, V291, pE350, DOI 10.1152/ajpendo.00387.2005; Harms M, 2013, NAT MED, V19, P1252, DOI 10.1038/nm.3361; Heller NM, 2008, SCI SIGNAL, V1, DOI 10.1126/scisignal.1164795; Herbert DR, 2004, IMMUNITY, V20, P623, DOI 10.1016/S1074-7613(04)00107-4; Heredia JE, 2013, CELL, V153, P376, DOI 10.1016/j.cell.2013.02.053; Jackson CR, 2012, J NEUROSCI, V32, P9359, DOI 10.1523/JNEUROSCI.0711-12.2012; Kelly-Welch AE, 2003, SCIENCE, V300, P1527, DOI 10.1126/science.1085458; Lee YH, 2012, CELL METAB, V15, P480, DOI 10.1016/j.cmet.2012.03.009; Lepper C, 2010, GENESIS, V48, P424, DOI 10.1002/dvg.20630; Lichtenbelt WDV, 2009, NEW ENGL J MED, V360, P1500, DOI 10.1056/NEJMoa0808718; Lidell ME, 2013, NAT MED, V19, P631, DOI 10.1038/nm.3017; Liu WY, 2013, J CELL SCI, V126, P3527, DOI 10.1242/jcs.124321; Lowell BB, 2000, NATURE, V404, P652, DOI 10.1038/35007527; Maier E, 2012, EUR J IMMUNOL, V42, P2827, DOI 10.1002/eji.201242433; Martinez FO, 2009, ANNU REV IMMUNOL, V27, P451, DOI 10.1146/annurev.immunol.021908.132532; Mohrs M, 2001, IMMUNITY, V15, P303, DOI 10.1016/S1074-7613(01)00186-8; Morrison Shaun F, 2012, Front Endocrinol (Lausanne), V3; Morrison SF, 2011, FRONT BIOSCI-LANDMRK, V16, P74, DOI 10.2741/3677; Nguyen KD, 2011, NATURE, V480, P104, DOI 10.1038/nature10653; Odegaard JI, 2013, SCIENCE, V339, P172, DOI 10.1126/science.1230721; Odegaard JI, 2011, ANNU REV PATHOL-MECH, V6, P275, DOI 10.1146/annurev-pathol-011110-130138; Ohno H, 2012, CELL METAB, V15, P395, DOI 10.1016/j.cmet.2012.01.019; Ricardo-Gonzalez RR, 2010, P NATL ACAD SCI USA, V107, P22617, DOI 10.1073/pnas.1009152108; Saito M, 2009, DIABETES, V58, P1526, DOI 10.2337/db09-0530; Seale P, 2008, NATURE, V454, P961, DOI 10.1038/nature07182; Seale P, 2011, J CLIN INVEST, V121, P96, DOI 10.1172/JCI44271; Shabalina IG, 2013, CELL REP, V5, P1196, DOI 10.1016/j.celrep.2013.10.044; Sharp LZ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049452; Shi C, 2011, NAT REV IMMUNOL, V11, P762, DOI 10.1038/nri3070; SLAVIN BG, 1978, ANAT REC, V191, P377, DOI 10.1002/ar.1091910310; Thomas SA, 1997, NATURE, V387, P94, DOI 10.1038/387094a0; Timmons JA, 2007, P NATL ACAD SCI USA, V104, P4401, DOI 10.1073/pnas.0610615104; TRAYHURN P, 1987, P NUTR SOC, V46, P135, DOI 10.1079/PNS19870017; van der Lans AAJJ, 2013, J CLIN INVEST, V123, P3395, DOI 10.1172/JCI68993; Virtanen KA, 2009, NEW ENGL J MED, V360, P1518, DOI 10.1056/NEJMoa0808949; Wu D, 2011, SCIENCE, V332, P243, DOI 10.1126/science.1201475; Wu J, 2013, GENE DEV, V27, P234, DOI 10.1101/gad.211649.112; Wu J, 2012, CELL, V150, P366, DOI 10.1016/j.cell.2012.05.016; Yoneshiro T, 2013, J CLIN INVEST, V123, P3404, DOI 10.1172/JCI67803; Yu CN, 2002, J EXP MED, V195, P1387, DOI 10.1084/jem.20020656; ZHOU QY, 1995, NATURE, V374, P640, DOI 10.1038/374640a0	52	575	600	9	86	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUN 5	2014	157	6					1292	1308		10.1016/j.cell.2014.03.066	http://dx.doi.org/10.1016/j.cell.2014.03.066			17	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	AN8UV	24906148	Green Accepted, Bronze			2022-12-28	WOS:000340881400008
J	Lynch, MD; Cliffe, J; Morris-Jones, R				Lynch, Magnus D.; Cliffe, Jane; Morris-Jones, Rachael			Management of cutaneous viral warts	BMJ-BRITISH MEDICAL JOURNAL			English	Review							DIOXIDE LASER THERAPY; PULSED-DYE-LASER; PHOTODYNAMIC THERAPY; PLANTAR WARTS; DUCT TAPE; AMINOLEVULINIC-ACID; VERRUCA-VULGARIS; CONTROLLED-TRIAL; LIQUID-NITROGEN; COMMON WARTS		[Lynch, Magnus D.; Morris-Jones, Rachael] Kings Coll Hosp London, Dept Dermatol, London SE5 9RS, England; [Cliffe, Jane] The Surgery, London, England	King's College Hospital NHS Foundation Trust; King's College Hospital	Lynch, MD (corresponding author), Kings Coll Hosp London, Dept Dermatol, London SE5 9RS, England.	magnus.lynch@nhs.net		Lynch, Magnus/0000-0001-7586-4338				BERTHJONES J, 1992, BRIT J DERMATOL, V127, P262, DOI 10.1111/j.1365-2133.1992.tb00125.x; Beutner KR, 1998, J AM ACAD DERMATOL, V38, P230, DOI 10.1016/S0190-9622(98)70243-9; BOURKE JF, 1995, BRIT J DERMATOL, V132, P433, DOI 10.1111/j.1365-2133.1995.tb08678.x; Buckley DA, 1999, BRIT J DERMATOL, V141, P292; BUNNEY MH, 1976, BRIT J DERMATOL, V94, P667, DOI 10.1111/j.1365-2133.1976.tb05167.x; Burkhart CG, 2007, J AM ACAD DERMATOL, V57, P1019, DOI 10.1016/j.jaad.2007.06.037; Chew A, 2007, BR J DERMATOL SUPPL, V157, P1; Choi YL, 2006, INT J DERMATOL, V45, P480, DOI 10.1111/j.1365-4632.2005.02643.x; de Haen M, 2006, ARCH PEDIAT ADOL MED, V160, P1121, DOI 10.1001/archpedi.160.11.1121; DUTHIE DA, 1951, BMJ-BRIT MED J, V2, P216, DOI 10.1136/bmj.2.4725.216; Fabbrocini G, 2001, J PHOTOCH PHOTOBIO B, V61, P30, DOI 10.1016/S1011-1344(01)00141-5; Focht DR, 2002, ARCH PEDIAT ADOL MED, V156, P971, DOI 10.1001/archpedi.156.10.971; Grussendorf-Conen EI, 2002, PEDIATR DERMATOL, V19, P263, DOI 10.1046/j.1525-1470.2002.00083.x; Hay RJ, 2013, J INVEST DERMATOL; Hengge UR, 2000, BRIT J DERMATOL, V143, P1026, DOI 10.1046/j.1365-2133.2000.03777.x; Horn TD, 2005, ARCH DERMATOL, V141, P589, DOI 10.1001/archderm.141.5.589; Kopera D, 2003, INT J DERMATOL, V42, P905, DOI 10.1046/j.1365-4362.2003.01994.x; Kwok CS, 2013, COCHRANE DB SYST REV, V9; LOGAN RA, 1989, BRIT J DERMATOL, V121, P99, DOI 10.1111/j.1365-2133.1989.tb01405.x; Lu YG, 2010, PHOTOMED LASER SURG, V28, P561, DOI 10.1089/pho.2009.2566; MASSING AM, 1963, ARCH DERMATOL, V87, P306, DOI 10.1001/archderm.1963.01590150022004; Micali G, 2003, J Dermatolog Treat, V14, P233, DOI 10.1080/09546630310016763; Mitsuishi T, 2010, DERMATOL SURG, V36, P1401, DOI 10.1111/j.1524-4725.2010.01648.x; Passeron T, 2007, ANN DERMATOL VENER, V134, P135, DOI 10.1016/S0151-9638(07)91604-X; Recica HAI, 2014, TREATMENT OF SKIN DI, P788; Robson KJ, 2000, J AM ACAD DERMATOL, V43, P275, DOI 10.1067/mjd.2000.106365; Simonart T, 2012, J DERMATOL TREAT, V23, P72, DOI 10.3109/09546634.2010.500324; STEELE K, 1988, J ROY COLL GEN PRACT, V38, P256; Stender IM, 2000, LANCET, V355, P963, DOI 10.1016/S0140-6736(00)90013-8; Wenner R, 2007, ARCH DERMATOL, V143, P309, DOI 10.1001/archderm.143.3.309; Wolff K, 2009, FITZPATRICKS COLOR A, P787	31	13	14	0	19	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	MAY 27	2014	348								g3339	10.1136/bmj.g3339	http://dx.doi.org/10.1136/bmj.g3339			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AI3EB	24865780				2022-12-28	WOS:000336741400008
J	Steculorum, SM; Bruning, JC				Steculorum, Sophie M.; Bruening, Jens C.			Die Another Day: A Painless Path to Longevity	CELL			English	Editorial Material							LIFE-SPAN; RECEPTOR; MICE; NEURONS	Riera et al. identify a neuroendocrine circuit that controls longevity and the age-dependent onset of metabolic decline via the pain-transducing channel TRPV1. Thus, pharmacological inhibition of TRPV1 may provide a new approach to treat not only metabolic disorders but also a broader range of age-related pathologies.	[Steculorum, Sophie M.; Bruening, Jens C.] Max Planck Inst Neurol Res, D-50931 Cologne, Germany; [Steculorum, Sophie M.; Bruening, Jens C.] Univ Cologne, Univ Hosp Cologne, Ctr Endocrinol Diabet & Prevent Med CEDP, Inst Genet,Dept Mouse Genet & Metab, D-50674 Cologne, Germany; [Steculorum, Sophie M.; Bruening, Jens C.] CMMC, D-50674 Cologne, Germany; [Steculorum, Sophie M.; Bruening, Jens C.] Cologne Excellence Cluster Cellular Stress Respo, D-50674 Cologne, Germany	Max Planck Society; University of Cologne; University of Cologne; University of Cologne	Bruning, JC (corresponding author), Max Planck Inst Neurol Res, Gleueler Str 50a, D-50931 Cologne, Germany.	bruening@nf.mpg.de	Steculorum, Sophie/R-2704-2017	Steculorum, Sophie/0000-0002-5665-2732				Alcedo J, 2004, NEURON, V41, P45, DOI 10.1016/S0896-6273(03)00816-X; Caterina MJ, 2000, SCIENCE, V288, P306, DOI 10.1126/science.288.5464.306; Gao H, 2012, DIABETES, V61, P1381, DOI 10.2337/db11-0820; Libert S, 2007, SCIENCE, V315, P1133, DOI 10.1126/science.1136610; Mair W, 2011, NATURE, V470, P404, DOI 10.1038/nature09706; Marsch R, 2007, J NEUROSCI, V27, P832, DOI 10.1523/JNEUROSCI.3303-06.2007; Mezey E, 2000, P NATL ACAD SCI USA, V97, P3655, DOI 10.1073/pnas.060496197; Motter AL, 2008, FEBS LETT, V582, P2257, DOI 10.1016/j.febslet.2008.05.021; Riera CE, 2014, CELL, V157, P1023, DOI 10.1016/j.cell.2014.03.051; Steculorum SM, 2014, ALZHEIMERS DEMENT, V10, pS3, DOI 10.1016/j.jalz.2013.12.008	10	5	5	1	26	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAY 22	2014	157	5					1004	1006		10.1016/j.cell.2014.05.013	http://dx.doi.org/10.1016/j.cell.2014.05.013			3	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	AH9CG	24855937	Bronze			2022-12-28	WOS:000336437200002
J	O'Gara, PT				O'Gara, Patrick T.			Caution Advised: Medicare's Physician-Payment Data Release	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									Brigham & Womens Hosp, Div Cardiovasc, Boston, MA 02115 USA	Harvard University; Brigham & Women's Hospital	O'Gara, PT (corresponding author), Brigham & Womens Hosp, Div Cardiovasc, 75 Francis St, Boston, MA 02115 USA.							Abelson R., 2014, NY TIMES; [Anonymous], MED PROV UT PAY DAT; [Anonymous], 2014, MED FEE SERV PROV UT	3	11	11	0	2	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUL 10	2014	371	2					101	103		10.1056/NEJMp1405322	http://dx.doi.org/10.1056/NEJMp1405322			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	AK7YZ	24869596	Bronze			2022-12-28	WOS:000338645500005
J	Alcorn, T				Alcorn, Ted			Muriel Volpellier: confronting sexual violence with evidence	LANCET			English	Biographical-Item																			0	0	0	0	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	JUN 14	2014	383	9934					2038	2038		10.1016/S0140-6736(14)60968-5	http://dx.doi.org/10.1016/S0140-6736(14)60968-5			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AI9VZ	24923528				2022-12-28	WOS:000337292400013
J	Glaeser, EL; Shleifer, A				Glaeser, Edward L.; Shleifer, Andrei			RETROSPECTIVE Gary Becker (1930-2014)	SCIENCE			English	Biographical-Item									[Glaeser, Edward L.; Shleifer, Andrei] Harvard Univ, Boston, MA 02115 USA	Harvard University	Glaeser, EL (corresponding author), Harvard Univ, Boston, MA 02115 USA.	shleifer@fas.harvard.edu						BECKER GS, PUBLICATION LIST	1	0	0	0	9	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 13	2014	344	6189					1233	1233		10.1126/science.1256540	http://dx.doi.org/10.1126/science.1256540			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI7ND	24926006				2022-12-28	WOS:000337077500022
J	Chirinos, JA; Gurubhagavatula, I; Teff, K; Rader, DJ; Wadden, TA; Townsend, R; Foster, GD; Maislin, G; Saif, H; Broderick, P; Chittams, J; Hanlon, AL; Pack, AI				Chirinos, Julio A.; Gurubhagavatula, Indira; Teff, Karen; Rader, Daniel J.; Wadden, Thomas A.; Townsend, Raymond; Foster, Gary D.; Maislin, Greg; Saif, Hassam; Broderick, Preston; Chittams, Jesse; Hanlon, Alexandra L.; Pack, Allan I.			CPAP, Weight Loss, or Both for Obstructive Sleep Apnea	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							POSITIVE AIRWAY PRESSURE; C-REACTIVE PROTEIN; CARDIOVASCULAR-DISEASE; INSULIN SENSITIVITY; LOW-CARBOHYDRATE; BLOOD-PRESSURE; RISK-FACTORS; ASSOCIATION; OBESITY; DIET	BACKGROUND Obesity and obstructive sleep apnea tend to coexist and are associated with inflammation, insulin resistance, dyslipidemia, and high blood pressure, but their causal relation to these abnormalities is unclear. METHODS We randomly assigned 181 patients with obesity, moderate-to-severe obstructive sleep apnea, and serum levels of C-reactive protein (CRP) greater than 1.0 mg per liter to receive treatment with continuous positive airway pressure (CPAP), a weight-loss intervention, or CPAP plus a weight-loss intervention for 24 weeks. We assessed the incremental effect of the combined interventions over each one alone on the CRP level (the primary end point), insulin sensitivity, lipid levels, and blood pressure. RESULTS Among the 146 participants for whom there were follow-up data, those assigned to weight loss only and those assigned to the combined interventions had reductions in CRP levels, insulin resistance, and serum triglyceride levels. None of these changes were observed in the group receiving CPAP alone. Blood pressure was reduced in all three groups. No significant incremental effect on CRP levels was found for the combined interventions as compared with either weight loss or CPAP alone. Reductions in insulin resistance and serum triglyceride levels were greater in the combined-intervention group than in the group receiving CPAP only, but there were no significant differences in these values between the combined-intervention group and the weight-loss group. In per-protocol analyses, which included 90 participants who met prespecified criteria for adherence, the combined interventions resulted in a larger reduction in systolic blood pressure and mean arterial pressure than did either CPAP or weight loss alone. CONCLUSIONS In adults with obesity and obstructive sleep apnea, CPAP combined with a weight-loss intervention did not reduce CRP levels more than either intervention alone. In secondary analyses, weight loss provided an incremental reduction in insulin resistance and serum triglyceride levels when combined with CPAP. In addition, adherence to a regimen of weight loss and CPAP may result in incremental reductions in blood pressure as compared with either intervention alone.	[Chirinos, Julio A.; Gurubhagavatula, Indira] Philadelphia Vet Affairs Med Ctr, Philadelphia, PA USA; [Chirinos, Julio A.; Gurubhagavatula, Indira; Rader, Daniel J.; Wadden, Thomas A.; Townsend, Raymond; Maislin, Greg; Saif, Hassam; Broderick, Preston; Pack, Allan I.] Univ Penn, Perelman Sch Med, Hosp Univ Penn, Philadelphia, PA 19104 USA; [Teff, Karen] Monell Chem Senses Ctr, Philadelphia, PA USA; [Foster, Gary D.] Temple Univ, Sch Med, Philadelphia, PA 19122 USA; [Chittams, Jesse; Hanlon, Alexandra L.] Univ Penn, Sch Nursing, Philadelphia, PA 19104 USA	University of Pennsylvania; Pennsylvania Medicine; US Department of Veterans Affairs; Veterans Health Administration (VHA); Philadelphia Veterans Affairs Medical Center; University of Pennsylvania; Pennsylvania Medicine; Monell Chemical Senses Center; Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University; University of Pennsylvania	Chirinos, JA (corresponding author), Univ Penn, Div Cardiol, Rm 8B111,Univ & Woodland Aves, Philadelphia, PA 19104 USA.	julio.chirinos@uphs.upenn.edu	Maislin, Greg/S-5322-2019; Hanlon, Alexandra L/J-9585-2013	Pack, Allan/0000-0002-2879-0484	National Heart, Lung, and Blood Institute [HL-R01080076, P01 HL094307]; Novo Nordisk; Nutrisystem; Orexigen; Boehringer Ingelheim; Weight Watchers; ConAgra Foods; Tate and Lyle; UnitedHealth Group; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL094307, R01HL080076] Funding Source: NIH RePORTER	National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Novo Nordisk(Novo Nordisk); Nutrisystem; Orexigen; Boehringer Ingelheim(Boehringer Ingelheim); Weight Watchers; ConAgra Foods; Tate and Lyle; UnitedHealth Group; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	Supported by grants from the National Heart, Lung, and Blood Institute (HL-R01080076, to Dr. Chirinos; and P01 HL094307, to Dr. Pack).; Dr. Wadden reports receiving fees for serving on advisory boards for Novo Nordisk, Nutrisystem, and Orexigen, consulting fees from Boehringer Ingelheim, and grant support from Weight Watchers, Novo Nordisk, and Nutrisystem. Dr. Foster reports receiving fees for serving on advisory boards for ConAgra Foods, Tate and Lyle, and UnitedHealth Group and reports being an employee of Weight Watchers. No other potential conflict of interest relevant to this article was reported.	Akashiba T, 2005, INTERNAL MED, V44, P899, DOI 10.2169/internalmedicine.44.899; Barbe F, 2010, AM J RESP CRIT CARE, V181, P718, DOI 10.1164/rccm.200901-0050OC; Bazzano LA, 2007, HYPERTENSION, V50, P417, DOI 10.1161/HYPERTENSIONAHA.106.085175; Bergman RN, 2007, DIABETES, V56, P1489, DOI 10.2337/db07-9903; BERGMAN RN, 1987, J CLIN INVEST, V79, P790, DOI 10.1172/JCI112886; Brown DL, 2011, J CLIN SLEEP MED, V7, P103; Colish J, 2012, CHEST, V141, P674, DOI 10.1378/chest.11-0615; Coughlin SR, 2007, EUR RESPIR J, V29, P720, DOI 10.1183/09031936.00043306; Craig SE, 2012, THORAX, V67, P1090, DOI 10.1136/thoraxjnl-2012-202178; Dorkova Z, 2008, CHEST, V134, P686, DOI 10.1378/chest.08-0556; Fox CS, 2007, CIRCULATION, V116, P39, DOI 10.1161/CIRCULATIONAHA.106.675355; GRUNSTEIN R, 1993, INT J OBESITY, V17, P533; Haentjens P, 2007, ARCH INTERN MED, V167, P757, DOI 10.1001/archinte.167.8.757; Harsch IA, 2004, AM J RESP CRIT CARE, V169, P156, DOI 10.1164/rccm.200302-206OC; Horvath K, 2008, ARCH INTERN MED, V168, P571, DOI 10.1001/archinte.168.6.571; Ip MSM, 2002, AM J RESP CRIT CARE, V165, P670, DOI 10.1164/ajrccm.165.5.2103001; Ishida K, 2009, CHEST, V136, P125, DOI 10.1378/chest.08-1431; Malhotra A, 2002, LANCET, V360, P237, DOI 10.1016/S0140-6736(02)09464-3; McNicholas WT, 2007, EUR RESPIR J, V29, P614; McNicholas WT, 2007, EUR RESPIR J, V29, P156, DOI 10.1183/09031936.00027406; Nicklas BJ, 2004, AM J CLIN NUTR, V79, P544; Nieto FJ, 2000, JAMA-J AM MED ASSOC, V283, P1829, DOI 10.1001/jama.283.14.1829; Nieto FJ, 2002, JAMA-J AM MED ASSOC, V288, P1985; Pack AI, 2009, PROG CARDIOVASC DIS, V51, P434, DOI 10.1016/j.pcad.2009.01.002; Patruno V, 2007, CHEST, V131, P1393, DOI 10.1378/chest.06-2192; Peppard PE, 2000, JAMA-J AM MED ASSOC, V284, P3015, DOI 10.1001/jama.284.23.3015; Peppard PE, 2000, NEW ENGL J MED, V342, P1378, DOI 10.1056/NEJM200005113421901; Rodway GW, 2010, SLEEP, V33, P260, DOI 10.1093/sleep/33.2.260; Samaha FF, 2003, NEW ENGL J MED, V348, P2074, DOI 10.1056/NEJMoa022637; Seshadri P, 2006, AM J MED, V119, P191, DOI 10.1016/j.amjmed.2005.12.008; Seshadri P, 2004, AM J MED, V117, P398, DOI 10.1016/j.amjmed.2004.04.009; Shamsuzzaman ASM, 2002, CIRCULATION, V105, P2462, DOI 10.1161/01.CIR.0000018948.95175.03; Shamsuzzaman ASM, 2003, JAMA-J AM MED ASSOC, V290, P1906, DOI 10.1001/jama.290.14.1906; Sharma SK, 2008, SLEEP MED, V9, P149, DOI 10.1016/j.sleep.2007.02.004; Shinohara E, 1997, J INTERN MED, V241, P11, DOI 10.1046/j.1365-2796.1997.63889000.x; Singer JD, 1998, J EDUC BEHAV STAT, V23, P323; Tasali Esra, 2008, Proc Am Thorac Soc, V5, P207, DOI 10.1513/pats.200708-139MG; Wadden TA, 2012, CIRCULATION, V125, P1157, DOI 10.1161/CIRCULATIONAHA.111.039453; Wadden TA, 2011, NEW ENGL J MED, V365, P1969, DOI 10.1056/NEJMoa1109220; Yang D, 2013, SLEEP BREATH, V17, P33, DOI 10.1007/s11325-012-0680-8; Yokoe T, 2003, CIRCULATION, V107, P1129, DOI 10.1161/01.CIR.0000052627.99976.18; YOUNG T, 1993, NEW ENGL J MED, V328, P1230, DOI 10.1056/NEJM199304293281704	42	294	298	3	53	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUN 12	2014	370	24					2265	2275		10.1056/NEJMoa1306187	http://dx.doi.org/10.1056/NEJMoa1306187			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AI7BB	24918371	Green Accepted, Green Published			2022-12-28	WOS:000337033700006
J	Mescher, MC; De Moraes, CM				Mescher, Mark C.; De Moraes, Consuelo M.			PLANT BIOLOGY Pass the ammunition	NATURE			English	Editorial Material							COMMUNICATION; HERBIVORY; DEFENSE		[Mescher, Mark C.; De Moraes, Consuelo M.] ETH, Dept Environm Syst Sci, CH-8092 Zurich, Switzerland	ETH Zurich	Mescher, MC (corresponding author), ETH, Dept Environm Syst Sci, CH-8092 Zurich, Switzerland.	mescher@usys.ethz.ch; consuelo.demoraes@usys.ethz.ch						Bushdid C, 2014, SCIENCE, V343, P1370, DOI 10.1126/science.1249168; De Moraes CM, 1998, NATURE, V393, P570, DOI 10.1038/31219; Farmer EE, 2001, NATURE, V411, P854, DOI 10.1038/35081189; FOWLER SV, 1985, AM NAT, V126, P181, DOI 10.1086/284408; Frost CJ, 2007, ECOL LETT, V10, P490, DOI 10.1111/j.1461-0248.2007.01043.x; Gfeller A, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.3109cm3; Heil M, 2007, P NATL ACAD SCI USA, V104, P5467, DOI 10.1073/pnas.0610266104; Helms AM, 2013, P NATL ACAD SCI USA, V110, P199, DOI 10.1073/pnas.1218606110; Karban R, 2000, OECOLOGIA, V125, P66, DOI 10.1007/PL00008892; Karban R, 2014, ECOL LETT, V17, P44, DOI 10.1111/ele.12205; Runyon JB, 2006, SCIENCE, V313, P1964, DOI 10.1126/science.1131371; Sugimoto K, 2014, P NATL ACAD SCI USA, V111, P7144, DOI 10.1073/pnas.1320660111	12	3	3	0	48	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 12	2014	510	7504					221	222		10.1038/510221a	http://dx.doi.org/10.1038/510221a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI7AT	24919917				2022-12-28	WOS:000337032400037
J	Veillette, A; Davidson, D				Veillette, Andre; Davidson, Dominique			IMMUNOLOGY When lymphocytes run out of steam	NATURE			English	Editorial Material							TRIPHOSPHATE SYNTHETASE		[Veillette, Andre; Davidson, Dominique] Inst Rech Clin Montreal, Mol Oncol Lab, Montreal, PQ H2W 1R7, Canada; [Veillette, Andre] Univ Montreal, Dept Med, Montreal, PQ H3C 3J7, Canada; [Veillette, Andre] McGill Univ, Dept Med, Montreal, PQ, Canada	Institut de Recherche Clinique de Montreal (IRCM); Universite de Montreal; Universite de Montreal; McGill University	Veillette, A (corresponding author), Inst Rech Clin Montreal, Mol Oncol Lab, Montreal, PQ H2W 1R7, Canada.	veillea@ircm.qc.ca						Chang YF, 2008, PROG LIPID RES, V47, P333, DOI 10.1016/j.plipres.2008.03.004; Evans DR, 2004, J BIOL CHEM, V279, P33035, DOI 10.1074/jbc.R400007200; Gou KM, 2014, EXP CELL RES, V323, P242, DOI 10.1016/j.yexcr.2014.01.029; Higgins MJ, 2007, J BIOL CHEM, V282, P29493, DOI 10.1074/jbc.M703948200; Kassel KM, 2010, J BIOL CHEM, V285, P33727, DOI 10.1074/jbc.M110.178566; LEVITZKI A, 1972, BIOCHEMISTRY-US, V11, P247, DOI 10.1021/bi00752a016; Liu JL, 2011, BIOESSAYS, V33, P159, DOI 10.1002/bies.201000129; Martin E, 2014, NATURE, V510, P288, DOI 10.1038/nature13386; MCPARTLAND RP, 1974, CANCER RES, V34, P3107; Pearce Erika L, 2013, Science, V342, P1242454, DOI 10.1126/science.1242454	10	2	2	0	7	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 12	2014	510	7504					222	223		10.1038/nature13346	http://dx.doi.org/10.1038/nature13346			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI7AT	24870231				2022-12-28	WOS:000337032400038
J	Roumie, CL; Greevy, RA; Grijalva, CG; Hung, AM; Liu, XL; Murff, HJ; Elasy, TA; Griffin, MR				Roumie, Christianne L.; Greevy, Robert A.; Grijalva, Carlos G.; Hung, Adriana M.; Liu, Xulei; Murff, Harvey J.; Elasy, Tom A.; Griffin, Marie R.			Association Between Intensification of Metformin Treatment With Insulin vs Sulfonylureas and Cardiovascular Events and All-Cause Mortality Among Patients With Diabetes	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							MARGINAL STRUCTURAL MODELS; AFFAIRS HEALTH-CARE; BETA-CELL FUNCTION; SEVERE HYPOGLYCEMIA; GLUCOSE CONTROL; FOLLOW-UP; TYPE-2; RISK; THERAPIES; OUTCOMES	IMPORTANCE Preferred second-line medication for diabetes treatment after metformin failure remains uncertain. OBJECTIVE To compare time to acute myocardial infarction (AMI), stroke, or death in a cohort of metformin initiators who added insulin or a sulfonylurea. DESIGN, SETTING, AND PARTICIPANTS Retrospective cohort constructed with national Veterans Health Administration, Medicare, and National Death Index databases. The study population comprised veterans initially treated with metformin from 2001 through 2008 who subsequently added either insulin or sulfonylurea. Propensity score matching on characteristics was performed, matching each participant who added insulin to 5 who added a sulfonylurea. Patients were followed through September 2011 for primary analyses or September 2009 for cause-of-death analyses. MAIN OUTCOMES AND MEASURES Risk of a composite outcome of AMI, stroke hospitalization, or all-cause death was compared between therapies with marginal structural Cox proportional hazard models adjusting for baseline and time-varying demographics, medications, cholesterol level, hemoglobin A(1c) level, creatinine level, blood pressure, body mass index, and comorbidities. RESULTS Among 178 341 metformin monotherapy patients, 2948 added insulin and 39 990 added a sulfonylurea. Propensity score matching yielded 2436 metformin + insulin and 12 180 metformin + sulfonylurea patients. At intensification, patients had received metformin for a median of 14 months (IQR, 5-30), and hemoglobin A(1c) level was 8.1% (IQR, 7.2%-9.9%). Median follow-up after intensification was 14 months (IQR, 6-29 months). There were 172 vs 634 events for the primary outcome among patients who added insulin vs sulfonylureas, respectively (42.7 vs 32.8 events per 1000 person-years; adjusted hazard ratio [aHR],1.30; 95% Cl, 1.07-1.58; P = .009). Acute myocardial infarction and stroke rates were statistically similar, 41 vs 229 events (10.2 and 11.9 events per 1000 person-years; aHR, 0.88; 95% Cl, 0.59-1.30; P =.52), whereas all-cause death rates were 137 vs 444 events, respectively (33.7 and 22.7 events per 1000 person-years; aHR, 1.44; 95% Cl, 1.15-1.79; P = .001). There were 54 vs 258 secondary outcomes: AMI, stroke hospitalizations, or cardiovascular deaths (22.8 vs 22.5 events per 1000 person-years; aHR, 0.98; 95% Cl, 0.71-1.34; P = .87). CONCLUSIONS AND RELEVANCE Among patients with diabetes who were receiving metformin, the addition of insulin vs a sulfonylurea was associated with an increased risk of a composite of nonfatal cardiovascular outcomes and all-cause mortality. These findings require further investigation to understand risks associated with insulin use in these patients.	[Roumie, Christianne L.; Greevy, Robert A.; Grijalva, Carlos G.; Hung, Adriana M.; Liu, Xulei; Murff, Harvey J.; Elasy, Tom A.; Griffin, Marie R.] Geriatr Res Educ Clin Ctr, Vet Hlth Adm Valley Healthcare Syst, HSR&D Ctr, Nashville, TN USA; [Roumie, Christianne L.; Hung, Adriana M.; Murff, Harvey J.; Elasy, Tom A.; Griffin, Marie R.] Vanderbilt Univ, Dept Med, Nashville, TN USA; [Greevy, Robert A.; Liu, Xulei] Vanderbilt Univ, Dept Biostat, Nashville, TN 37235 USA; [Grijalva, Carlos G.; Griffin, Marie R.] Vanderbilt Univ, Dept Hlth Policy, Nashville, TN 37235 USA	Geriatric Research Education & Clinical Center; US Department of Veterans Affairs; Veterans Health Administration (VHA); Vanderbilt University; Vanderbilt University; Vanderbilt University	Roumie, CL (corresponding author), Geriatr Res Educ Clin Ctr, Nashville VA Med Ctr, 1310 24th Ave S, Nashville, TN 37212 USA.	christianne.roumie@vanderbilt.edu		Grijalva, Carlos/0000-0002-2329-7797	Agency for Healthcare Research and Quality, US Department of Health and Human Services [HHSA2902010000161]; VA Clinical Science Research and Development investigator-initiated grant [I01CX000570-01]; Center for Diabetes Translation Research [P30DK092986]; VA Career Development Award [2-031-09S]; Department of Veterans Affairs, Veterans Affairs Health Services Research and Development Service, Veterans Affairs Information Resource Center [SDR 02-237, 98-004]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK092986] Funding Source: NIH RePORTER; Veterans Affairs [I01CX000570] Funding Source: NIH RePORTER	Agency for Healthcare Research and Quality, US Department of Health and Human Services(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); VA Clinical Science Research and Development investigator-initiated grant; Center for Diabetes Translation Research; VA Career Development Award; Department of Veterans Affairs, Veterans Affairs Health Services Research and Development Service, Veterans Affairs Information Resource Center; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Veterans Affairs(US Department of Veterans Affairs)	This project was funded by the Agency for Healthcare Research and Quality, US Department of Health and Human Services, contract HHSA2902010000161, as part of the Developing Evidence to Inform Decisions About Effectiveness (DEcIDE 2) program. This work was supported in part by VA Clinical Science Research and Development investigator-initiated grant I01CX000570-01 (Dr Roumie) and the Center for Diabetes Translation Research P30DK092986 (Drs Roumie and Elasy). Dr Hung (2-031-09S) was supported by a VA Career Development Award. Support for Veterans Affairs/Centers for Medicare & Medicaid Services data was provided by the Department of Veterans Affairs, Veterans Affairs Health Services Research and Development Service, Veterans Affairs Information Resource Center (project numbers SDR 02-237 and 98-004).	Alvarsson M, 2008, DIABETES OBES METAB, V10, P421, DOI 10.1111/j.1463-1326.2007.00719.x; [Anonymous], 2010, OPTMACH FUNCTIONS FO; [Anonymous], 2010, RITOOLS RANDOMIZATIO; Arnold N, 2006, COMPARISON OF VA OUT; Bonds DE, 2012, BMC ENDOCR DISORD, V12, DOI 10.1186/1472-6823-12-5; Bonds DE, 2010, BMJ-BRIT MED J, V340, DOI 10.1136/bmj.b4909; Centers for Disease Control and Prevention, ADULTS WITH DIABETES; Cohen FJ, 2003, DIABETES CARE, V26, P1847, DOI 10.2337/diacare.26.6.1847; Currie CJ, 2013, J CLIN ENDOCR METAB, V98, P668, DOI 10.1210/jc.2012-3042; D'Agostino RB, 2000, J AM STAT ASSOC, V95, P749, DOI 10.2307/2669455; Gamble JM, 2010, DIABETES OBES METAB, V12, P47, DOI 10.1111/j.1463-1326.2009.01125.x; Gerstein HC, 2008, NEW ENGL J MED, V358, P2545, DOI 10.1056/NEJMoa0802743; Gerstein HC, 2012, NEW ENGL J MED, V367, P319, DOI 10.1056/NEJMoa1203858; Greevy RA, 2011, CLIN PHARMACOL THER, V90, P813, DOI 10.1038/clpt.2011.228; Harrison LB, 2012, DIABETES CARE, V35, P1406, DOI 10.2337/dc11-2170; Hernan MA, 2000, EPIDEMIOLOGY, V11, P561, DOI 10.1097/00001648-200009000-00012; Holden SE, 2011, BMJ OPEN, V1, DOI 10.1136/bmjopen-2011-000258; Holman RR, 2008, NEW ENGL J MED, V359, P1577, DOI 10.1056/NEJMoa0806470; Humensky J, 2012, MEDICARE MEDICAID RE, V2; Hung AM, 2012, KIDNEY INT, V81, P698, DOI 10.1038/ki.2011.444; Hynes DM, 2007, MED CARE, V45, P214, DOI 10.1097/01.mlr.0000244657.90074.b7; Inzucchi SE, 2012, DIABETES CARE, V35, P1364, DOI 10.2337/dc12-0413; Kerr EA, 2004, ANN INTERN MED, V141, P272, DOI 10.7326/0003-4819-141-4-200408170-00007; McCarthy JF, 2009, AM J EPIDEMIOL, V169, P1033, DOI 10.1093/aje/kwp010; National Center for Health Statistics, 1988, INTERNATIONAL CLASSI; Niesner K, 2013, EPIDEMIOLOGY, V24, P334, DOI 10.1097/EDE.0b013e3182821e75; Office of Minority Health Department of Health and Human Services, HEART DISEASE AND AF; Parsons L., REDUCING BIAS IN A P; Peyrot Mark, 2010, Prim Care Diabetes, V4 Suppl 1, pS11, DOI 10.1016/S1751-9918(10)60004-6; Ray WA, 2001, ARCH GEN PSYCHIAT, V58, P1161, DOI 10.1001/archpsyc.58.12.1161; Robins JM, 2000, EPIDEMIOLOGY, V11, P550, DOI 10.1097/00001648-200009000-00011; Roumie CL, 2012, ANN INTERN MED, V157, P601, DOI 10.7326/0003-4819-157-9-201211060-00003; Roumie CL, 2012, PHARMACOEPIDEM DR S, V21, P515, DOI 10.1002/pds.3249; Roumie CL, 2011, PHARMACOEPIDEM DR S, V20, P36, DOI 10.1002/pds.2029; Schneeweiss S, 2005, EPIDEMIOLOGY, V16, P17, DOI 10.1097/01.ede.0000147164.11879.b5; Selbly JV, 2009, MED CARE, V47, P395, DOI 10.1097/MLR.0b013e31818d775c; Sohn Min-Woong, 2006, Popul Health Metr, V4, P2, DOI 10.1186/1478-7954-4-2; Turner RC, 1998, LANCET, V352, P837, DOI 10.1016/s0140-6736(98)07019-6; Weng JP, 2008, LANCET, V371, P1753, DOI 10.1016/S0140-6736(08)60762-X; Yuan Y. C., 2011, MULTIPLE IMPUTATION	40	134	138	1	25	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUN 11	2014	311	22					2288	2296		10.1001/jama.2014.4312	http://dx.doi.org/10.1001/jama.2014.4312			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AI6HL	24915260	Bronze, Green Accepted			2022-12-28	WOS:000336972600020
J	Maceyka, M; Spiegel, S				Maceyka, Michael; Spiegel, Sarah			Sphingolipid metabolites in inflammatory disease	NATURE			English	Review							SPHINGOSINE KINASE 1; INFLUENZA-VIRUS INFECTION; PROTEIN-COUPLED RECEPTOR; INSULIN-RESISTANCE; LYMPHOCYTE EGRESS; APOLIPOPROTEIN M; TNF-ALPHA; INTESTINAL INFLAMMATION; CERAMIDE BIOSYNTHESIS; AIRWAY INFLAMMATION	Sphingolipids are ubiquitous building blocks of eukaryotic cell membranes. Progress in our understanding of sphingolipid metabolism, state-of-the-art sphingolipidomic approaches and animal models have generated a large body of evidence demonstrating that sphingolipid metabolites, particularly ceramide and sphingosine-1-phosphate, are signalling molecules that regulate a diverse range of cellular processes that are important in immunity, inflammation and inflammatory disorders. Recent insights into the molecular mechanisms of action of sphingolipid metabolites and new perspectives on their roles in regulating chronic inflammation have been reported. The knowledge gained in this emerging field will aid in the development of new therapeutic options for inflammatory disorders.	[Maceyka, Michael; Spiegel, Sarah] Virginia Commonwealth Univ, Dept Biochem & Mol Biol, Sch Med, Richmond, VA 23298 USA	Virginia Commonwealth University	Spiegel, S (corresponding author), Virginia Commonwealth Univ, Dept Biochem & Mol Biol, Sch Med, Med Coll Virginia Campus, Richmond, VA 23298 USA.	sspiegel@vcu.edu	Maceyka, Michael/B-9277-2008		US National Institutes of Health [R37GM043880, R01AI500941, R01CA61774]; NATIONAL CANCER INSTITUTE [R01CA061774] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI050094] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM043880, R01GM043880] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank S. Milstien for critically reading the manuscript. This work was supported by grants R37GM043880, R01AI500941 and R01CA61774 from the US National Institutes of Health. We apologize to those whose work was not cited owing to space constraints.	Adada MM, 2013, J BIOL CHEM, V288, P27667, DOI 10.1074/jbc.M113.489443; Ali M, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.451; Alvarez SE, 2010, NATURE, V465, P1084, DOI 10.1038/nature09128; Arnon TI, 2013, NATURE, V493, P684, DOI 10.1038/nature11738; Arnon TI, 2011, SCIENCE, V333, P1898, DOI 10.1126/science.1208248; Bagdanoff JT, 2010, J MED CHEM, V53, P8650, DOI 10.1021/jm101183p; Baker DA, 2010, J IMMUNOL, V185, P2570, DOI 10.4049/jimmunol.1000644; Billich A, 2005, CELL SIGNAL, V17, P1203, DOI 10.1016/j.cellsig.2004.12.005; Blackwell K, 2013, MOL CELL BIOL, V33, P1901, DOI 10.1128/MCB.01416-12; Breslow DK, 2010, NATURE, V463, P1048, DOI 10.1038/nature08787; Brinkmann V, 2010, NAT REV DRUG DISCOV, V9, P883, DOI 10.1038/nrd3248; Caliskan M, 2013, NEW ENGL J MED, V368, P1398, DOI 10.1056/NEJMoa1211592; Camerer E, 2009, J CLIN INVEST, V119, P1871, DOI 10.1172/JCI38575; Canals D, 2012, J BIOL CHEM, V287, P10145, DOI 10.1074/jbc.M111.306456; Chavez JA, 2012, CELL METAB, V15, P585, DOI 10.1016/j.cmet.2012.04.002; Chi HB, 2011, TRENDS PHARMACOL SCI, V32, P16, DOI 10.1016/j.tips.2010.11.002; Choi JW, 2011, P NATL ACAD SCI USA, V108, P751, DOI 10.1073/pnas.1014154108; Christoffersen C, 2011, P NATL ACAD SCI USA, V108, P9613, DOI 10.1073/pnas.1103187108; Clarke CJ, 2007, J BIOL CHEM, V282, P1384, DOI 10.1074/jbc.M609216200; Cui H, 2013, J ALLERGY CLIN IMMUN, V132, P1205, DOI 10.1016/j.jaci.2013.07.026; Cyster JG, 2012, ANNU REV IMMUNOL, V30, P69, DOI 10.1146/annurev-immunol-020711-075011; D'Angelo G, 2012, BBA-MOL CELL BIOL L, V1821, P1089, DOI 10.1016/j.bbalip.2012.01.003; Daniel C, 2007, MOL IMMUNOL, V44, P3305, DOI 10.1016/j.molimm.2007.02.026; Dennis EA, 2010, J BIOL CHEM, V285, P39976, DOI 10.1074/jbc.M110.182915; Di AK, 2010, J BIOL CHEM, V285, P15848, DOI 10.1074/jbc.M109.075549; Dobrosotskaya IY, 2002, SCIENCE, V296, P879, DOI 10.1126/science.1071124; Faroudi M, 2010, BLOOD, V116, P5536, DOI 10.1182/blood-2010-08-299438; Fox TE, 2007, J BIOL CHEM, V282, P12450, DOI 10.1074/jbc.M700082200; Fukuhara S, 2012, J CLIN INVEST, V122, P1416, DOI 10.1172/JCI60746; Garcia JGN, 2001, J CLIN INVEST, V108, P689, DOI 10.1172/JCI12450; Garofalo K, 2011, J CLIN INVEST, V121, P4735, DOI 10.1172/JCI57549; Gergely P, 2012, BRIT J PHARMACOL, V167, P1035, DOI 10.1111/j.1476-5381.2012.02061.x; Granado MH, 2009, CELL SIGNAL, V21, P405, DOI 10.1016/j.cellsig.2008.11.003; Green JA, 2011, NAT IMMUNOL, V12, P672, DOI 10.1038/ni.2047; Grigorova IL, 2010, P NATL ACAD SCI USA, V107, P20447, DOI 10.1073/pnas.1009968107; Grin'kina NM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036475; Ha SG, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3479; Hait NC, 2009, SCIENCE, V325, P1254, DOI 10.1126/science.1176709; Hanada K, 2014, BBA-MOL CELL BIOL L, V1841, P704, DOI 10.1016/j.bbalip.2013.06.006; Hankins JL, 2011, J BIOL CHEM, V286, P44357, DOI 10.1074/jbc.M111.264010; Hannun YA, 2008, NAT REV MOL CELL BIO, V9, P139, DOI 10.1038/nrm2329; Hanson MA, 2012, SCIENCE, V335, P851, DOI [10.1126/science.1244693, 10.1126/science.1215904]; Harikumar KB, 2014, NAT IMMUNOL, V15, P231, DOI 10.1038/ni.2810; Henry B, 2013, HDB EXP PHARM, V215, P77; Herzog BH, 2013, NATURE, V502, P105, DOI 10.1038/nature12501; Hla T, 2012, CELL METAB, V16, P420, DOI 10.1016/j.cmet.2012.06.017; Holland WL, 2013, CELL METAB, V17, P790, DOI 10.1016/j.cmet.2013.03.019; Holland WL, 2011, J CLIN INVEST, V121, P1858, DOI 10.1172/JCI43378; Holland WL, 2011, NAT MED, V17, P55, DOI 10.1038/nm.2277; Hotamisligil GS, 2006, NATURE, V444, P860, DOI 10.1038/nature05485; Ihlefeld K, 2012, BIOCHEM J, V447, P457, DOI 10.1042/BJ20120811; Jenkins RW, 2011, J BIOL CHEM, V286, P13292, DOI 10.1074/jbc.M110.163378; Kawamori T, 2009, FASEB J, V23, P405, DOI 10.1096/fj.08-117572; Kharel Y, 2011, BIOCHEM J, V440, P345, DOI 10.1042/BJ20110817; Khor B, 2011, NATURE, V474, P307, DOI 10.1038/nature10209; Kitano M, 2006, ARTHRITIS RHEUM-US, V54, P742, DOI 10.1002/art.21668; Kitano M., 2006, ARTHRITIS RHEUM, V54, P1704; Kohno M, 2006, MOL CELL BIOL, V26, P7211, DOI 10.1128/MCB.02341-05; Kumaraswamy SB, 2012, CRIT CARE, V16, DOI 10.1186/cc11305; Kurano M, 2013, ATHEROSCLEROSIS, V229, P102, DOI 10.1016/j.atherosclerosis.2013.04.024; Lamour NF, 2011, J BIOL CHEM, V286, P42808, DOI 10.1074/jbc.M111.310169; Lee MJ, 1998, SCIENCE, V279, P1552, DOI 10.1126/science.279.5356.1552; Lee MJ, 1999, CELL, V99, P301, DOI 10.1016/S0092-8674(00)81661-X; Levine B, 2011, NATURE, V469, P323, DOI 10.1038/nature09782; Liang J, 2013, CANCER CELL, V23, P107, DOI 10.1016/j.ccr.2012.11.013; Lin ZF, 2013, CELL METAB, V17, P779, DOI 10.1016/j.cmet.2013.04.005; Liu MX, 2014, J BIOL CHEM, V289, P2801, DOI 10.1074/jbc.M113.499913; Majumdar I, 2012, ENDOCRINE, V41, P442, DOI 10.1007/s12020-011-9589-4; Mandala S, 2002, SCIENCE, V296, P346, DOI 10.1126/science.1070238; Masini E, 2008, J PHARMACOL EXP THER, V324, P548, DOI 10.1124/jpet.107.131565; Mendoza A, 2012, CELL REP, V2, P1104, DOI 10.1016/j.celrep.2012.09.021; Michaud J, 2006, FEBS LETT, V580, P4607, DOI 10.1016/j.febslet.2006.07.035; Mietla JA, 2013, J LIPID RES, V54, P1834, DOI 10.1194/jlr.M035683; Miller M, 2012, P NATL ACAD SCI USA, V109, P16648, DOI 10.1073/pnas.1204151109; Moffatt MF, 2010, NEW ENGL J MED, V363, P1211, DOI 10.1056/NEJMoa0906312; Nakahara K, 2012, MOL CELL, V46, P461, DOI 10.1016/j.molcel.2012.04.033; Natarajan V, 2013, AM J RESP CELL MOL, V49, P6, DOI 10.1165/rcmb.2012-0411TR; Nguyen-Tran DH, 2014, DIS MODEL MECH, V7, P41, DOI 10.1242/dmm.013631; Nishiuma T, 2008, AM J PHYSIOL-LUNG C, V294, pL1085, DOI 10.1152/ajplung.00445.2007; Olivera A, 2013, J LEUKOCYTE BIOL, V94, P1013, DOI 10.1189/jlb.0313163; Oo ML, 2011, J CLIN INVEST, V121, P2290, DOI 10.1172/JCI45403; Pappu R, 2007, SCIENCE, V316, P295, DOI 10.1126/science.1139221; Park JW, 2013, HEPATOLOGY, V57, P525, DOI 10.1002/hep.26015; Petrache Irina, 2011, Proc Am Thorac Soc, V8, P492, DOI 10.1513/pats.201104-034MW; Pettus BJ, 2003, FASEB J, V17, P1411, DOI 10.1096/fj.02-1038com; Pettus BJ, 2004, J BIOL CHEM, V279, P11320, DOI 10.1074/jbc.M309262200; Pham THM, 2010, J EXP MED, V207, P17, DOI 10.1084/jem.20091619; Pitson SM, 2003, EMBO J, V22, P5491, DOI 10.1093/emboj/cdg540; Predescu S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075846; Price MM, 2013, J ALLERGY CLIN IMMUN, V131, P501, DOI 10.1016/j.jaci.2012.07.014; Puneet P, 2013, SCIENCE, V341, P342, DOI 10.1126/science.341.6144.342-a; Quehenberger O, 2010, J LIPID RES, V51, P3299, DOI 10.1194/jlr.M009449; Rivera J, 2008, NAT REV IMMUNOL, V8, P753, DOI 10.1038/nri2400; Saddoughi SA, 2013, EMBO MOL MED, V5, P105, DOI 10.1002/emmm.201201283; Sanada Y, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023933; Schwab SR, 2005, SCIENCE, V309, P1735, DOI 10.1126/science.1113640; Simanshu DK, 2013, NATURE, V500, P463, DOI 10.1038/nature12332; Sims K, 2010, J BIOL CHEM, V285, P38568, DOI 10.1074/jbc.M110.170621; Siow DL, 2012, J BIOL CHEM, V287, P40198, DOI 10.1074/jbc.C112.404012; Skon CN, 2013, NAT IMMUNOL, V14, P1285, DOI 10.1038/ni.2745; Snider AJ, 2009, FASEB J, V23, P143, DOI 10.1096/fj.08-118109; Spiegel S, 2011, NAT REV IMMUNOL, V11, P403, DOI 10.1038/nri2974; Suzuki E, 2004, P NATL ACAD SCI USA, V101, P14788, DOI 10.1073/pnas.0406536101; Takabe K., 2014, J LIPID RES; Takada K, 2011, J IMMUNOL, V186, P775, DOI 10.4049/jimmunol.1000094; Tauzin L, 2007, J LIPID RES, V48, P66, DOI 10.1194/jlr.M600399-JLR200; Teijaro JR, 2014, P NATL ACAD SCI USA, V111, P3799, DOI 10.1073/pnas.1400593111; Teijaro JR, 2011, CELL, V146, P980, DOI 10.1016/j.cell.2011.08.015; Thudichum J.L.W., 1884, TREATISE CHEM CONSTI; Trifilieff A, 2012, J PHARMACOL EXP THER, V342, P399, DOI 10.1124/jpet.112.191585; Tsunemi S, 2010, CLIN IMMUNOL, V136, P197, DOI 10.1016/j.clim.2010.03.428; Ullman TA, 2011, GASTROENTEROLOGY, V140, P1807, DOI 10.1053/j.gastro.2011.01.057; Vandanmagsar B, 2011, NAT MED, V17, P179, DOI 10.1038/nm.2279; Venkataraman K, 2008, CIRC RES, V102, P669, DOI 10.1161/CIRCRESAHA.107.165845; Wang YJ, 2014, CIRC RES, V114, P792, DOI 10.1161/CIRCRESAHA.114.302439; Worgall TS, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3005765; Xia P, 2002, J BIOL CHEM, V277, P7996, DOI 10.1074/jbc.M111423200; Xiong YQ, 2013, J BIOL CHEM, V288, P32563, DOI 10.1074/jbc.M113.483750; Yamauchi T, 2002, NAT MED, V8, P1288, DOI 10.1038/nm788; Youm YH, 2013, CELL METAB, V18, P519, DOI 10.1016/j.cmet.2013.09.010; Youm YH, 2012, CELL REP, V1, P56, DOI 10.1016/j.celrep.2011.11.005; Zemann B, 2007, IMMUNOL LETT, V109, P56, DOI 10.1016/j.imlet.2007.01.001; Zhang GQ, 2013, BLOOD, V122, P443, DOI 10.1182/blood-2012-11-467191; Zhang QJ, 2012, DIABETES, V61, P1848, DOI 10.2337/db11-1399	124	709	727	11	178	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 5	2014	510	7503					58	67		10.1038/nature13475	http://dx.doi.org/10.1038/nature13475			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI3NR	24899305	Green Accepted			2022-12-28	WOS:000336768900032
J	Yutzey, KE				Yutzey, Katherine E.			Switched at birth	NATURE			English	Editorial Material							HEART		Cincinnati Childrens Med Ctr, Div Mol Cardiovasc Biol, Cincinnati, OH 45229 USA	Cincinnati Children's Hospital Medical Center	Yutzey, KE (corresponding author), Cincinnati Childrens Med Ctr, Div Mol Cardiovasc Biol, Cincinnati, OH 45229 USA.	katherine.yutzey@cchmc.org		Yutzey, Katherine/0000-0002-1444-7124				Kikuchi K, 2012, ANNU REV CELL DEV BI, V28, P719, DOI 10.1146/annurev-cellbio-101011-155739; Porrello ER, 2011, SCIENCE, V331, P1078, DOI 10.1126/science.1200708; Puente BN, 2014, CELL, V157, P565, DOI 10.1016/j.cell.2014.03.032; Ritzman TB, 2012, ANAT REC, V295, P1596, DOI 10.1002/ar.22524; Sochman J, 2002, J AM COLL CARDIOL, V39, P1422, DOI 10.1016/S0735-1097(02)01797-7; Xin M, 2013, NAT REV MOL CELL BIO, V14, P529, DOI 10.1038/nrm3619	6	6	6	0	11	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 29	2014	509	7502					572	573		10.1038/509572a	http://dx.doi.org/10.1038/509572a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AH9JC	24870539				2022-12-28	WOS:000336457100037
J	[Anonymous]				[Anonymous]			Seizing the opportunity to rethink renal research	LANCET			English	Editorial Material																			0	1	1	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	MAY 24	2014	383	9931					1782	1782						1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	AH6US	24856010				2022-12-28	WOS:000336267800002
J	Andrault, D; Pesce, G; Bouhifd, MA; Bolfan-Casanova, N; Henot, JM; Mezouar, M				Andrault, Denis; Pesce, Giacomo; Bouhifd, Mohamed Ali; Bolfan-Casanova, Nathalie; Henot, Jean-Marc; Mezouar, Mohamed			Melting of subducted basalt at the core-mantle boundary	SCIENCE			English	Article							OCEANIC-CRUST; HIGH-PRESSURE; PEROVSKITE; PHASE; CONSTRAINTS; SILICATE; SOLIDUS; EARTH	The geological materials in Earth's lowermost mantle control the characteristics and interpretation of seismic ultra-low velocity zones at the base of the core-mantle boundary. Partial melting of the bulk lower mantle is often advocated as the cause, but this does not explain the nonubiquitous character of these regional seismic features. We explored the melting properties of mid-oceanic ridge basalt (MORB), which can reach the lowermost mantle after subduction of oceanic crust. At a pressure representative of the core-mantle boundary (135 gigapascals), the onset of melting occurs at similar to 3800 kelvin, which is similar to 350 kelvin below the mantle solidus. The SiO2-rich liquid generated either remains trapped in the MORB material or solidifies after reacting with the surrounding MgO-rich mantle, remixing subducted MORB with the lowermost mantle.	[Andrault, Denis; Pesce, Giacomo; Bouhifd, Mohamed Ali; Bolfan-Casanova, Nathalie; Henot, Jean-Marc] Univ Blaise Pascal, CNRS, IRD, Lab Magmas & Volcans, Clermont Ferrand, France; [Mezouar, Mohamed] European Synchrotron Radiat Facil, F-38043 Grenoble, France	Centre National de la Recherche Scientifique (CNRS); Institut de Recherche pour le Developpement (IRD); Universite Clermont Auvergne (UCA); European Synchrotron Radiation Facility (ESRF)	Andrault, D (corresponding author), Univ Blaise Pascal, CNRS, IRD, Lab Magmas & Volcans, Clermont Ferrand, France.	denis.andrault@univ-bpclermont.fr	ANDRAULT, Denis/N-8843-2016	ANDRAULT, Denis/0000-0002-9921-4572; Bouhifd, Mohamed Ali/0000-0002-1722-1331	Institut National des Sciences de l'Univers; l'European Synchrotron Radiation Facility; project Oxydeep of the Agence Nationale de la Recherche	Institut National des Sciences de l'Univers; l'European Synchrotron Radiation Facility; project Oxydeep of the Agence Nationale de la Recherche(French National Research Agency (ANR))	We thank M. Benbakkar, J. L. Devidal, A. Fabbrizio, G. Garbarino, P. Parisiadis, V. Svitlyk, and F. van Wyk de Vries for their help and three anonymous reviewers for fruitful comments. The MORB starting material was kindly provided by P. Schiano. This work is supported by Institut National des Sciences de l'Univers, l'European Synchrotron Radiation Facility, and the project Oxydeep of the Agence Nationale de la Recherche. This is Laboratory of Excellence ClerVolc contribution no. 99. All experimental data are presented in the supplementary materials.	Akins JA, 2002, GEOPHYS RES LETT, V29, DOI 10.1029/2001GL014806; Akins JA, 2004, GEOPHYS RES LETT, V31, DOI 10.1029/2004GL020237; Andrault D, 2012, NATURE, V487, P354, DOI 10.1038/nature11294; Andrault D, 2011, EARTH PLANET SC LETT, V304, P251, DOI 10.1016/j.epsl.2011.02.006; Asimow PD, 1997, PHILOS T R SOC A, V355, P255, DOI 10.1098/rsta.1997.0009; Bolfan-Casanova N, 2003, GEOPHYS RES LETT, V30, DOI 10.1029/2003GL017182; Fiquet G, 2010, SCIENCE, V329, P1516, DOI 10.1126/science.1192448; Geballe ZM, 2012, J APPL PHYS, V111, DOI 10.1063/1.4729905; Hirose K, 1999, NATURE, V397, P53, DOI 10.1038/16225; IRIFUNE T, 1993, EARTH PLANET SC LETT, V117, P101, DOI 10.1016/0012-821X(93)90120-X; Katsura T, 2010, PHYS EARTH PLANET IN, V183, P212, DOI 10.1016/j.pepi.2010.07.001; Labrosse S, 2007, NATURE, V450, P866, DOI 10.1038/nature06356; Lay T, 1998, NATURE, V392, P461, DOI 10.1038/33083; Liu ZJ, 2010, SOLID STATE COMMUN, V150, P590, DOI 10.1016/j.ssc.2009.12.038; Miyajima N, 2001, AM MINERAL, V86, P740, DOI 10.2138/am-2001-5-614; Murakami M, 2005, GEOPHYS RES LETT, V32, DOI 10.1029/2004GL021956; Murakami M, 2012, NATURE, V485, P90, DOI 10.1038/nature11004; Nakagawa T, 2010, GEOCHEM GEOPHY GEOSY, V11, DOI 10.1029/2010GC003031; Nishi M, 2014, NAT GEOSCI, V7, P224, DOI [10.1038/NGEO2074, 10.1038/ngeo2074]; Nomura R, 2014, SCIENCE, V343, P522, DOI 10.1126/science.1248186; PAWLEY AR, 1993, SCIENCE, V261, P1024, DOI 10.1126/science.261.5124.1024; Ricolleau A, 2010, J GEOPHYS RES-SOL EA, V115, DOI 10.1029/2009JB006709; Rost S, 2005, NATURE, V435, P666, DOI 10.1038/nature03620; Sano A, 2008, GEOPHYS RES LETT, V35, DOI 10.1029/2007GL031718; Thomas CW, 2013, J GEOPHYS RES-SOL EA, V118, P5738, DOI 10.1002/jgrb.50374; van der Hilst RD, 1999, SCIENCE, V283, P1885, DOI 10.1126/science.283.5409.1885; Wen LX, 1998, SCIENCE, V279, P1701, DOI 10.1126/science.279.5357.1701; White RS, 2001, J PETROL, V42, P1171, DOI 10.1093/petrology/42.6.1171; YASUDA A, 1994, J GEOPHYS RES-SOL EA, V99, P9401, DOI 10.1029/93JB03205	29	96	97	0	98	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 23	2014	344	6186					892	895		10.1126/science.1250466	http://dx.doi.org/10.1126/science.1250466			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AH6IL	24855266				2022-12-28	WOS:000336233800045
J	Ivanova, NN; Schwientek, P; Tripp, HJ; Rinke, C; Pati, A; Huntemann, M; Visel, A; Woyke, T; Kyrpides, NC; Rubin, EM				Ivanova, Natalia N.; Schwientek, Patrick; Tripp, H. James; Rinke, Christian; Pati, Amrita; Huntemann, Marcel; Visel, Axel; Woyke, Tanja; Kyrpides, Nikos C.; Rubin, Edward M.			Stop codon reassignments in the wild	SCIENCE			English	Article							METAGENOME; BACTERIA; EVOLUTION; SEQUENCE; UGA	The canonical genetic code is assumed to be deeply conserved across all domains of life with very few exceptions. By scanning 5.6 trillion base pairs of metagenomic data for stop codon reassignment events, we detected recoding in a substantial fraction of the >1700 environmental samples examined. We observed extensive opal and amber stop codon reassignments in bacteriophages and of opal in bacteria. Our data indicate that bacteriophages can infect hosts with a different genetic code and demonstrate phage-host antagonism based on code differences. The abundance and diversity of genetic codes present in environmental organisms should be considered in the design of engineered organisms with altered genetic codes in order to preclude the exchange of genetic information with naturally occurring species.	[Ivanova, Natalia N.; Schwientek, Patrick; Tripp, H. James; Rinke, Christian; Pati, Amrita; Huntemann, Marcel; Visel, Axel; Woyke, Tanja; Kyrpides, Nikos C.; Rubin, Edward M.] Dept Energy Joint Genome Inst DOE JGI, Walnut Creek, CA 94598 USA; [Visel, Axel; Rubin, Edward M.] Univ Calif Berkeley, Lawrence Berkeley Natl Lab, Genom Div, Berkeley, CA 94720 USA; [Visel, Axel] Univ Calif, Sch Nat Sci, Merced, CA 95343 USA	United States Department of Energy (DOE); United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley; University of California System; University of California Merced	Rubin, EM (corresponding author), Dept Energy Joint Genome Inst DOE JGI, Walnut Creek, CA 94598 USA.	emrubin@lbl.gov	Rinke, Christian/ABA-3139-2021; Rinke, Christian/AAE-8100-2019; Huntemann, Marcel/HCH-8928-2022; Kyrpides, Nikos C./A-6305-2014; Visel, Axel/A-9398-2009	Rinke, Christian/0000-0003-4632-1187; Huntemann, Marcel/0000-0002-1284-3748; Kyrpides, Nikos C./0000-0002-6131-0462; Visel, Axel/0000-0002-4130-7784; Ivanova, Natalia/0000-0002-5802-9485	Office of Science of DOE [DE-AC02-05CH11231]	Office of Science of DOE(United States Department of Energy (DOE))	We thank the DOE JGI production sequencing, IMG, and Genomes OnLine Database teams for their support and J. Kim, A. Tadmor, and A. Nord for reviewing the manuscript. The work conducted by the DOE JGI was supported in part by the Office of Science of DOE under contract DE-AC02-05CH11231. Supporting data can be accessed through www.jgi.doe.gov and can be downloaded from http://portal.nersc.gov/dna/microbial/prokpubs/recoding.	Albertsen M, 2013, NAT BIOTECHNOL, V31, P533, DOI 10.1038/nbt.2579; BOVE JM, 1993, CLIN INFECT DIS, V17, pS10, DOI 10.1093/clinids/17.Supplement_1.S10; Campbell JH, 2013, P NATL ACAD SCI USA, V110, P5540, DOI 10.1073/pnas.1303090110; Dymond JS, 2011, NATURE, V477, P471, DOI 10.1038/nature10403; Hyatt D, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-119; INAGAKI Y, 1993, NUCLEIC ACIDS RES, V21, P1335, DOI 10.1093/nar/21.6.1335; Ivanova N, 2010, ENVIRON MICROBIOL, V12, P1803, DOI 10.1111/j.1462-2920.2010.02270.x; Knight RD, 2001, NAT REV GENET, V2, P49, DOI 10.1038/35047500; Lajoie MJ, 2013, SCIENCE, V342, P361, DOI 10.1126/science.1241460; Lajoie MJ, 2013, SCIENCE, V342, P357, DOI 10.1126/science.1241459; Markowitz VM, 2012, NUCLEIC ACIDS RES, V40, pD123, DOI 10.1093/nar/gkr975; Marraffini LA, 2010, NAT REV GENET, V11, P181, DOI 10.1038/nrg2749; McCutcheon JP, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000565; Methe BA, 2012, NATURE, V486, P215, DOI 10.1038/nature11209; NIRENBERG M, 1965, P NATL ACAD SCI USA, V53, P1161, DOI 10.1073/pnas.53.5.1161; OSAWA S, 1992, MICROBIOL REV, V56, P229, DOI 10.1128/MMBR.56.1.229-264.1992; Rappe MS, 2003, ANNU REV MICROBIOL, V57, P369, DOI 10.1146/annurev.micro.57.030502.090759; Rinke C, 2013, NATURE, V499, P431, DOI 10.1038/nature12352; SCHNEIDER SU, 1989, MOL GEN GENET, V218, P445, DOI 10.1007/BF00332408; Shackelton LA, 2008, J THEOR BIOL, V254, P128, DOI 10.1016/j.jtbi.2008.05.024; Tu AHT, 2001, PLASMID, V45, P122, DOI 10.1006/plas.2000.1501; Voelker LL, 1999, GENE, V233, P101, DOI 10.1016/S0378-1119(99)00150-X; Woyke T, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005299; Wrighton KC, 2012, SCIENCE, V337, P1661, DOI 10.1126/science.1224041	24	72	76	2	47	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 23	2014	344	6186					909	913		10.1126/science.1250691	http://dx.doi.org/10.1126/science.1250691			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AH6IL	24855270				2022-12-28	WOS:000336233800050
J	Xie, Y				Xie, Yu			"Undemocracy": inequalities in science	SCIENCE			English	Editorial Material							TOURNAMENTS		[Xie, Yu] Univ Michigan, Inst Social Res, Ann Arbor, MI 48104 USA; [Xie, Yu] Peking Univ, Ctr Social Res, Beijing 100871, Peoples R China	University of Michigan System; University of Michigan; Peking University	Xie, Y (corresponding author), Univ Michigan, Inst Social Res, Ann Arbor, MI 48104 USA.	yuxie@umich.edu			EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R24HD041028] Funding Source: NIH RePORTER; NICHD NIH HHS [R24HD041028, R24 HD041028] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		ALLISON PD, 1990, AM SOCIOL REV, V55, P469, DOI 10.2307/2095801; Cole J. R., 1973, SOCIAL STRATIFICATIO; Cole Jonathan R., 2009, GREAT AM U ITS RISE; De Solla Price D. J., 1963, LITTLE SCI BIG SCI, DOI 10.7312/pric91844; EHRENBERG RG, 1990, J POLIT ECON, V98, P1307, DOI 10.1086/261736; Ehrenberg RG, 2003, J LABOR ECON, V21, P267, DOI 10.1086/345558; Evans JA, 2008, SCIENCE, V321, P395, DOI 10.1126/science.1150473; Firebaugh G., 2003, NEW GEOGRAPHY GLOBAL; Frank R.H., 1995, WINNER TAKE ALL SOC; Friedman T.L., 2005, WORLD IS FLAT BRIEF; King DA, 2004, NATURE, V430, P311, DOI 10.1038/430311a; LAZEAR EP, 1981, J POLIT ECON, V89, P841, DOI 10.1086/261010; MERTON RK, 1957, AM SOCIOL REV, V22, P635, DOI 10.2307/2089193; MERTON RK, 1968, SCIENCE, V159, P56, DOI 10.1126/science.159.3810.56; Merton RobertK., 1973, SOCIOLOGY SCI, P267; Rodriguez-Ruiz O, 2009, J EDUC ADMIN, V47, P250, DOI 10.1108/09578230910941075; Stephan P., 2012, EC SHAPES SCI, P41; Xie Y., 2014, ISSUES SCI TECHNOL; Xie Y., 2012, IS AM SCI DECLINE; Zuckerman H., 1977, SCI ELITE NOBEL LAUR	20	55	58	2	43	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 23	2014	344	6186					809	810		10.1126/science.1252743	http://dx.doi.org/10.1126/science.1252743			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AH6IL	24855244	Green Accepted			2022-12-28	WOS:000336233800016
J	Xiol, J; Spinelli, P; Laussmann, MA; Homolka, D; Yang, Z; Cora, E; Coute, Y; Conn, S; Kadlec, J; Sachidanandam, R; Kaksonen, M; Cusack, S; Ephrussi, A; Pillai, RS				Xiol, Jordi; Spinelli, Pietro; Laussmann, Maike A.; Homolka, David; Yang, Zhaolin; Cora, Elisa; Coute, Yohann; Conn, Simon; Kadlec, Jan; Sachidanandam, Ravi; Kaksonen, Marko; Cusack, Stephen; Ephrussi, Anne; Pillai, Ramesh S.			RNA Clamping by Vasa Assembles a piRNA Amplifier Complex on Transposon Transcripts	CELL			English	Article							PIWI-INTERACTING RNAS; MESSENGER-RNA; DROSOPHILA; PROTEIN; GERMLINE; HELICASE; ELEMENTS; AMPLIFICATION; MACHINERY; MECHANISM	Germline-specific Piwi-interacting RNAs (piRNAs) protect animal genomes against transposons and are essential for fertility. piRNAs targeting active transposons are amplified by the ping-pong cycle, which couples Piwi endonucleolytic slicing of target RNAs to biogenesis of new piRNAs. Here, we describe the identification of a transient Amplifier complex that mediates biogenesis of secondary piRNAs in insect cells. Amplifier is nucleated by the DEAD box RNA helicase Vasa and contains the two Piwi proteins participating in the ping-pong loop, the Tudor protein Qin/Kumo and antisense piRNA guides. These components assemble on the surface of Vasa's helicase domain, which functions as an RNA clamp to anchor Amplifier onto transposon transcripts. We show that ATP-dependent RNP remodeling by Vasa facilitates transfer of 50 sliced piRNA precursors between ping-pong partners, and loss of this activity causes sterility in Drosophila. Our results reveal the molecular basis for the small RNA amplification that confers adaptive immunity against transposons.	[Xiol, Jordi; Spinelli, Pietro; Laussmann, Maike A.; Homolka, David; Yang, Zhaolin; Cora, Elisa; Conn, Simon; Kadlec, Jan; Cusack, Stephen; Pillai, Ramesh S.] Univ Grenoble Alpes, CNRS, EMBL, Grenoble Outstn, F-38042 Grenoble, France; [Xiol, Jordi; Spinelli, Pietro; Laussmann, Maike A.; Homolka, David; Yang, Zhaolin; Cora, Elisa; Conn, Simon; Kadlec, Jan; Cusack, Stephen; Pillai, Ramesh S.] Univ Grenoble Alpes, CNRS, EMBL, Unit Virus Host Cell Interact, F-38042 Grenoble, France; [Laussmann, Maike A.; Kaksonen, Marko] EMBL, Cell Biol & Biophys Unit, D-69117 Heidelberg, Germany; [Coute, Yohann] CEA, IRTSV, Lab Biol Grande Echelle, F-38054 Grenoble, France; [Sachidanandam, Ravi] Icahn Sch Med Sinai, Dept Oncol Sci, New York, NY 10029 USA; [Ephrussi, Anne] EMBL, Dev Biol Unit, D-69117 Heidelberg, Germany	Centre National de la Recherche Scientifique (CNRS); Communaute Universite Grenoble Alpes; UDICE-French Research Universities; Universite Grenoble Alpes (UGA); European Molecular Biology Laboratory (EMBL); Centre National de la Recherche Scientifique (CNRS); European Molecular Biology Laboratory (EMBL); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); European Molecular Biology Laboratory (EMBL); CEA; UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); Icahn School of Medicine at Mount Sinai; European Molecular Biology Laboratory (EMBL)	Pillai, RS (corresponding author), Univ Grenoble Alpes, CNRS, EMBL, Grenoble Outstn, 71 Ave Martyrs, F-38042 Grenoble, France.	pillai@embl.fr	Couté, Yohann/G-2695-2015; Ephrussi, Anne/ABD-4393-2021; sachidanandam, ravi/Q-6916-2019; Ephrussi, Anne/AAG-4075-2020	Couté, Yohann/0000-0003-3896-6196; Ephrussi, Anne/0000-0002-5061-4620; sachidanandam, ravi/0000-0001-9844-4459; Kaksonen, Marko/0000-0003-3645-7689; Cusack, Stephen/0000-0002-9324-0796; Conn, Simon/0000-0002-1376-4515; Kadlec, Jan/0000-0002-4853-6918	European Union (European Research Council); EMBL Interdisciplinary Postdoc Programme (EIPOD); Region Rhone Alp; EMBL	European Union (European Research Council)(European Research Council (ERC)European Commission); EMBL Interdisciplinary Postdoc Programme (EIPOD); Region Rhone Alp; EMBL	We thank Paul Lasko, Hugo Bellen, and Beat Suter for fly stocks/reagents. We are grateful to Sanjay Ghosh, Andrea Picco, Enrico Zamattia, Sandra Muller, and Anna Cyrklaff for help with data analysis and experiments. We thank the following EMBL core facilities: Advanced Light Microscopy, Genomics, Protein Expression and Purification, and High-Throughput Crystallization. Crystallographic data collection was at European Synchrotron Radiation Facility (ESRF), Grenoble, France. This work was supported by grants from European Union (European Research Council; "pisilence") to R.S.P. We are grateful for fellowships from the EMBL Interdisciplinary Postdoc Programme (EIPOD) under Marie Curie COFUND Actions (M.A.L), EMBO (D.H), and Region Rhone Alp (E.C.). This work was supported by the EMBL.	Anand A, 2012, EMBO J, V31, P870, DOI 10.1038/emboj.2011.449; Andersen CBF, 2006, SCIENCE, V313, P1968, DOI 10.1126/science.1131981; Aravin AA, 2007, SCIENCE, V318, P761, DOI 10.1126/science.1146484; Bagijn MP, 2012, SCIENCE, V337, P574, DOI 10.1126/science.1220952; Bono F, 2006, CELL, V126, P713, DOI 10.1016/j.cell.2006.08.006; Brennecke J, 2008, SCIENCE, V322, P1387, DOI 10.1126/science.1165171; Brennecke J, 2007, CELL, V128, P1089, DOI 10.1016/j.cell.2007.01.043; Caruthers JM, 2002, CURR OPIN STRUC BIOL, V12, P123, DOI 10.1016/S0959-440X(02)00298-1; Chen Y, 2007, CURR BIOL, V17, P637, DOI 10.1016/j.cub.2007.02.027; Czech B, 2013, MOL CELL, V50, P749, DOI 10.1016/j.molcel.2013.04.007; De Fazio S, 2011, NATURE, V480, P259, DOI 10.1038/nature10547; de la Cruz J, 1999, TRENDS BIOCHEM SCI, V24, P192, DOI 10.1016/S0968-0004(99)01376-6; de Vanssay A, 2012, NATURE, V490, P112, DOI 10.1038/nature11416; Ghildiyal M, 2009, NAT REV GENET, V10, P94, DOI 10.1038/nrg2504; Grentzinger T, 2012, GENOME RES, V22, P1877, DOI 10.1101/gr.136614.111; Gunawardane LS, 2007, SCIENCE, V315, P1587, DOI 10.1126/science.1140494; Johnstone O, 2004, DEVELOPMENT, V131, P4167, DOI 10.1242/dev.01286; Kawaoka S, 2013, NUCLEIC ACIDS RES, V41, P1581, DOI 10.1093/nar/gks1275; Kawaoka S, 2011, MOL CELL, V43, P1015, DOI 10.1016/j.molcel.2011.07.029; Kawaoka S, 2009, RNA, V15, P1258, DOI 10.1261/rna.1452209; Kazazian HH, 2004, SCIENCE, V303, P1626, DOI 10.1126/science.1089670; Kirino Y, 2010, J BIOL CHEM, V285, P8148, DOI 10.1074/jbc.M109.089821; Klattenhoff C, 2009, CELL, V138, P1137, DOI 10.1016/j.cell.2009.07.014; Kuramochi-Miyagawa S, 2010, GENE DEV, V24, P887, DOI 10.1101/gad.1902110; LASKO PF, 1988, NATURE, V335, P611, DOI 10.1038/335611a0; Le Hir H, 2000, EMBO J, V19, P6860, DOI 10.1093/emboj/19.24.6860; LEHMANN R, 1991, DEVELOPMENT, V112, P679; Li CJ, 2009, CELL, V137, P509, DOI 10.1016/j.cell.2009.04.027; LIANG L, 1994, DEVELOPMENT, V120, P1201; Lim AK, 2007, P NATL ACAD SCI USA, V104, P6714, DOI 10.1073/pnas.0701920104; Linder P, 2011, NAT REV MOL CELL BIO, V12, P505, DOI 10.1038/nrm3154; Liu F, 2008, P NATL ACAD SCI USA, V105, P20209, DOI 10.1073/pnas.0811115106; Luteijn MJ, 2013, NAT REV GENET, V14, P523, DOI 10.1038/nrg3495; Malone CD, 2009, CELL, V137, P522, DOI 10.1016/j.cell.2009.03.040; Mathioudakis N, 2012, RNA, V18, P2056, DOI 10.1261/rna.034181.112; Meister G, 2013, NAT REV GENET, V14, P447, DOI 10.1038/nrg3462; Pane A, 2007, DEV CELL, V12, P851, DOI 10.1016/j.devcel.2007.03.022; PAUSE A, 1992, EMBO J, V11, P2643, DOI 10.1002/j.1460-2075.1992.tb05330.x; SCHUPBACH T, 1986, DEV BIOL, V113, P443, DOI 10.1016/0012-1606(86)90179-X; Sengoku T, 2006, CELL, V125, P287, DOI 10.1016/j.cell.2006.01.054; Shoji M, 2009, DEV CELL, V17, P775, DOI 10.1016/j.devcel.2009.10.012; Xiol J, 2012, MOL CELL, V47, P970, DOI 10.1016/j.molcel.2012.07.019; Zhang F, 2012, CELL, V151, P871, DOI 10.1016/j.cell.2012.09.040; Zhang Z, 2011, MOL CELL, V44, P572, DOI 10.1016/j.molcel.2011.10.011	44	145	152	0	32	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUN 19	2014	157	7					1698	1711		10.1016/j.cell.2014.05.018	http://dx.doi.org/10.1016/j.cell.2014.05.018			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	AN9QG	24910301	Bronze			2022-12-28	WOS:000340941900022
J	Charles, E; Milroy, C; Goldstraw, NK; Giuliani, S				Charles, E.; Milroy, C.; Goldstraw, N. K.; Giuliani, S.			A 3 month old infant with a "strawberry" red mass on her nose	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							DIFFUSE NEONATAL HEMANGIOMATOSIS; PORT-WINE STAINS; VASCULAR MALFORMATIONS; CONGENITAL HEMANGIOMAS; CLASSIFICATION; PROPRANOLOL; TERMINOLOGY; ASSOCIATION; BIRTHMARKS		[Charles, E.; Giuliani, S.] St Georges Healthcare NHS Trust, Dept Paediat & Neonatal Surg, London SW17 0QT, England; [Charles, E.; Milroy, C.; Goldstraw, N. K.; Giuliani, S.] Univ London, London SW17 0QT, England; [Milroy, C.] St Georges Healthcare NHS Trust, Dept Paediat Plast Surg, London SW17 0QT, England; [Goldstraw, N. K.] St Georges Healthcare NHS Trust, Dept Paediat Dermatol, London SW17 0QT, England	St Georges University London; University of London; St Georges University London; St Georges University London	Giuliani, S (corresponding author), St Georges Healthcare NHS Trust, Dept Paediat & Neonatal Surg, London SW17 0QT, England.	stefano.giuliani@nhs.net		Giuliani, Stefano/0000-0002-4555-3093				BARSKY SH, 1980, J INVEST DERMATOL, V74, P154, DOI 10.1111/1523-1747.ep12535052; Blei F, 1997, J AM ACAD DERMATOL, V37, P1019; Bruckner AL, 2003, J AM ACAD DERMATOL, V48, P477, DOI 10.1067/mjd.2003.200; Drolet BA, 2013, PEDIATRICS, V131, P128, DOI 10.1542/peds.2012-1691; Drolet BA, 2010, J PEDIATR-US, V157, P789, DOI 10.1016/j.jpeds.2010.07.054; Haggstrom AN, 2007, J PEDIATR-US, V150, P291, DOI 10.1016/j.jpeds.2006.12.003; Hand JL, 2002, AM J MED GENET, V108, P257, DOI 10.1002/ajmg.10161; Ho VWG, 2000, J PAEDIATR CHILD H, V36, P286, DOI 10.1046/j.1440-1754.2000.00491.x; Iacobas I, 2010, J PEDIATR-US, V157, P795, DOI 10.1016/j.jpeds.2010.05.027; JACOBS AH, 1976, PEDIATRICS, V58, P218; Kilcline C, 2008, PEDIATR DERMATOL, V25, P168, DOI 10.1111/j.1525-1470.2008.00626.x; Kollipara R, 2013, RADIOL CLIN N AM, V51, P659, DOI 10.1016/j.rcl.2013.04.002; Krol A, 2005, ARCH FACIAL PLAST S, V7, P307, DOI 10.1001/archfaci.7.5.307; Leaute-Labreze C, 2011, J EUR ACAD DERMATOL, V25, P1254, DOI 10.1111/j.1468-3083.2011.04105.x; Leaute-Labreze C, 2011, J EUR ACAD DERMATOL, V25, P1245, DOI 10.1111/j.1468-3083.2011.04102.x; Lee BB, 2007, PHLEBOLOGY, V22, P249, DOI 10.1258/026835507782655236; Lowe LH, 2012, SEMIN ROENTGENOL, V47, P106, DOI 10.1053/j.ro.2011.11.002; Mulliken JB, 2004, J AM ACAD DERMATOL, V50, P875, DOI 10.1016/j.jaad.2003.10.670; MULLIKEN JB, 1982, PLAST RECONSTR SURG, V69, P412, DOI 10.1097/00006534-198203000-00002; Orlow SJ, 1997, J PEDIATR-US, V131, P643, DOI 10.1016/S0022-3476(97)70079-9; Rao RP, 2008, PEDIATR CARDIOL, V29, P793, DOI 10.1007/s00246-008-9204-5; Starkey E, 2011, ARCH DIS CHILD, V96, P890, DOI 10.1136/adc.2010.208884; Stier ME, 2008, J AM ACAD DERMATOL, V58, P261, DOI 10.1016/j.jaad.2007.10.492	23	0	0	0	3	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JUN 12	2014	348								g3810	10.1136/bmj.g3810	http://dx.doi.org/10.1136/bmj.g3810			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AJ1HW	24923589				2022-12-28	WOS:000337407700001
J	Dajani, R				Dajani, Rana			Jordan's stem-cell law can guide the Middle East	NATURE			English	Editorial Material									Hashemite Univ, Zarqa, Jordan	Hashemite University	Dajani, R (corresponding author), Hashemite Univ, Zarqa, Jordan.	rdajani@hu.edu.jo	Dajani, Rana/C-3466-2014	Dajani, Rana/0000-0002-4355-9977					0	10	10	0	6	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 12	2014	510	7504					189	189		10.1038/510189a	http://dx.doi.org/10.1038/510189a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI7AT	24919888	Bronze			2022-12-28	WOS:000337032400004
J	Gottlieb, DJ; Punjabi, NM; Mehra, R; Patel, SR; Quan, SF; Babineau, DC; Tracy, RP; Rueschman, M; Blumenthal, RS; Lewis, EF; Bhatt, DL; Redline, S				Gottlieb, Daniel J.; Punjabi, Naresh M.; Mehra, Reena; Patel, Sanjay R.; Quan, Stuart F.; Babineau, Denise C.; Tracy, Russell P.; Rueschman, Michael; Blumenthal, Roger S.; Lewis, Eldrin F.; Bhatt, Deepak L.; Redline, Susan			CPAP versus Oxygen in Obstructive Sleep Apnea	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							POSITIVE AIRWAY PRESSURE; CORONARY-ARTERY-DISEASE; BLOOD-PRESSURE; INTERMITTENT HYPOXIA; CARDIOVASCULAR OUTCOMES; SYSTEMIC HYPERTENSION; SYMPATHETIC ACTIVITY; SUPPLEMENTAL OXYGEN; ASSOCIATION; STROKE	BACKGROUND Obstructive sleep apnea is associated with hypertension, inflammation, and increased cardiovascular risk. Continuous positive airway pressure (CPAP) reduces blood pressure, but adherence is often suboptimal, and the benefit beyond management of conventional risk factors is uncertain. Since intermittent hypoxemia may underlie cardiovascular sequelae of sleep apnea, we evaluated the effects of nocturnal supplemental oxygen and CPAP on markers of cardiovascular risk. METHODS We conducted a randomized, controlled trial in which patients with cardiovascular disease or multiple cardiovascular risk factors were recruited from cardiology practices. Patients were screened for obstructive sleep apnea with the use of the Berlin questionnaire, and home sleep testing was used to establish the diagnosis. Participants with an apnea-hypopnea index of 15 to 50 events per hour were randomly assigned to receive education on sleep hygiene and healthy lifestyle alone (the control group) or, in addition to education, either CPAP or nocturnal supplemental oxygen. Cardiovascular risk was assessed at baseline and after 12 weeks of the study treatment. The primary outcome was 24-hour mean arterial pressure. RESULTS Of 318 patients who underwent randomization, 281 (88%) could be evaluated for ambulatory blood pressure at both baseline and follow-up. On average, the 24-hour mean arterial pressure at 12 weeks was lower in the group receiving CPAP than in the control group (-2.4 mm Hg; 95% confidence interval [CI], -4.7 to -0.1; P = 0.04) or the group receiving supplemental oxygen (-2.8 mm Hg; 95% CI, -5.1 to -0.5; P = 0.02). There was no significant difference in the 24-hour mean arterial pressure between the control group and the group receiving oxygen. A sensitivity analysis performed with the use of multiple imputation approaches to assess the effect of missing data did not change the results of the primary analysis. CONCLUSIONS In patients with cardiovascular disease or multiple cardiovascular risk factors, the treatment of obstructive sleep apnea with CPAP, but not nocturnal supplemental oxygen, resulted in a significant reduction in blood pressure.	[Gottlieb, Daniel J.; Babineau, Denise C.] Vet Affairs Boston Healthcare Syst, Boston, MA USA; [Gottlieb, Daniel J.; Patel, Sanjay R.; Quan, Stuart F.; Rueschman, Michael; Lewis, Eldrin F.; Bhatt, Deepak L.; Redline, Susan] Brigham & Womens Hosp, Boston, MA 02115 USA; [Gottlieb, Daniel J.] Boston Univ, Sch Med, Boston, MA 02118 USA; [Patel, Sanjay R.; Redline, Susan] Beth Israel Deaconess Med Ctr, Boston, MA 02215 USA; [Punjabi, Naresh M.; Blumenthal, Roger S.] Johns Hopkins Univ, Baltimore, MD USA; [Mehra, Reena] Cleveland Clin, Cleveland, OH USA; [Mehra, Reena; Babineau, Denise C.] Case Western Reserve Univ, Cleveland, OH 44106 USA; [Tracy, Russell P.] Univ Vermont, Colchester, Essex, England	US Department of Veterans Affairs; Veterans Health Administration (VHA); Harvard University; VA Boston Healthcare System; Harvard University; Brigham & Women's Hospital; Boston University; Harvard University; Beth Israel Deaconess Medical Center; Johns Hopkins University; Cleveland Clinic Foundation; Case Western Reserve University	Gottlieb, DJ (corresponding author), Brigham & Womens Hosp, Div Sleep Med, 221 Longwood Ave,BLI 225E, Boston, MA 02115 USA.	djgottlieb@partners.org	Mehra, Reena/ABA-5710-2021; Blumenthal, Roger S/H-3223-2018; Quan, Stuart/J-5026-2019; Punjabi, Naresh/EMH-1007-2022	Blumenthal, Roger S/0000-0003-1910-3168; Quan, Stuart/0000-0002-9474-7679; Patel, Sanjay/0000-0002-9142-5172; Mehra, Reena/0000-0002-6222-2675	National Heart, Lung, and Blood Institute [RC2 HL101417, 1R01HL109493, R21HL108226]; National Center for Research Resources [UL1 RR024989]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000439, UL1TR001079] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR024989] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL109493, RC2HL101417, R21HL108226] Funding Source: NIH RePORTER	National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	Supported by grants from the National Heart, Lung, and Blood Institute (RC2 HL101417, 1R01HL109493, and R21HL108226) and by a grant from the National Center for Research Resources (UL1 RR024989).	Barbe F, 2012, JAMA-J AM MED ASSOC, V307, P2161, DOI 10.1001/jama.2012.4366; Barbe F, 2010, AM J RESP CRIT CARE, V181, P718, DOI 10.1164/rccm.200901-0050OC; Bazzano LA, 2007, HYPERTENSION, V50, P417, DOI 10.1161/HYPERTENSIONAHA.106.085175; Brooks D, 1997, J CLIN INVEST, V99, P106, DOI 10.1172/JCI119120; Doherty LS, 2005, CHEST, V127, P2076, DOI 10.1378/chest.127.6.2076; Duran-Cantolla J, 2010, BMJ-BRIT MED J, V341, DOI 10.1136/bmj.c5991; Friedman O, 2009, INTEGR BLOOD PRESS C, V2, P25; Gottlieb DJ, 2010, CIRCULATION, V122, P352, DOI 10.1161/CIRCULATIONAHA.109.901801; Greenberg H, 2006, BIOCHEM BIOPH RES CO, V343, P591, DOI 10.1016/j.bbrc.2006.03.015; Iber C., 2007, AASM MANUAL SCORING; Jelic S, 2008, TRENDS CARDIOVAS MED, V18, P253, DOI 10.1016/j.tcm.2008.11.008; Kapur VK, 2005, SLEEP, V28, P472, DOI 10.1093/sleep/28.4.472; Kohler M, 2009, THORAX, V64, P67, DOI 10.1136/thx.2008.097931; Law MR, 2009, BMJ-BRIT MED J, V338, DOI 10.1136/bmj.b1665; Lewington S, 2002, LANCET, V360, P1903, DOI 10.1016/S0140-6736(02)11911-8; Loredo JS, 2006, SLEEP, V29, P564, DOI 10.1093/sleep/29.4.564; Lozano L, 2010, J HYPERTENS, V28, P2161, DOI 10.1097/HJH.0b013e32833b9c63; Marin JM, 2005, LANCET, V365, P1046, DOI 10.1016/S0140-6736(05)71141-7; Marin JM, 2012, JAMA-J AM MED ASSOC, V307, P2169, DOI 10.1001/jama.2012.3418; Maronna RA, 2000, J STAT PLAN INFER, V89, P197, DOI 10.1016/S0378-3758(99)00208-6; McArdle N, 1999, AM J RESP CRIT CARE, V159, P1108, DOI 10.1164/ajrccm.159.4.9807111; Milleron O, 2004, EUR HEART J, V25, P728, DOI 10.1016/j.ehj.2004.02.008; Mooe T, 2001, AM J RESP CRIT CARE, V164, P1910, DOI 10.1164/ajrccm.164.10.2101072; Netzer NC, 1999, ANN INTERN MED, V131, P485, DOI 10.7326/0003-4819-131-7-199910050-00002; Nieto FJ, 2000, JAMA-J AM MED ASSOC, V283, P1829, DOI 10.1001/jama.283.14.1829; Nieto FJ, 2002, JAMA-J AM MED ASSOC, V288, P1985; Norman D, 2006, HYPERTENSION, V47, P840, DOI 10.1161/01.HYP.0000217128.41284.78; Peker Y, 2002, AM J RESP CRIT CARE, V166, P159, DOI 10.1164/rccm.2105124; Pepin JL, 2010, AM J RESP CRIT CARE, V182, P954, DOI 10.1164/rccm.200912-1803OC; Peppard PE, 2000, NEW ENGL J MED, V342, P1378, DOI 10.1056/NEJM200005113421901; PHILLIPS BA, 1990, CHEST, V98, P325, DOI 10.1378/chest.98.2.325; Punjabi NM, 2009, DRUGS, V69, P13, DOI 10.2165/11531150-000000000-00000; Redline S, 2010, AM J RESP CRIT CARE, V182, P269, DOI 10.1164/rccm.200911-1746OC; Ryan Silke, 2008, Archives of Physiology and Biochemistry, V114, P261, DOI [10.1080/13813450802307337, 10.1080/13813450802307337 ]; Schneider H, 2000, J APPL PHYSIOL, V88, P1093, DOI 10.1152/jappl.2000.88.3.1093; Somers VK, 2008, CIRCULATION, V118, P1080, DOI [10.1161/CIRCULATIONAHA.107.189420, 10.1161/CIRCULATIONAHA.107.189375]; SOMERS VK, 1989, J APPL PHYSIOL, V67, P2101, DOI 10.1152/jappl.1989.67.5.2101; Somers VK, 2009, NY TIMES        1026, V119, pe380; Tamisier R, 2011, EUR RESPIR J, V37, P119, DOI 10.1183/09031936.00204209; Yaggi HK, 2005, NEW ENGL J MED, V353, P2034, DOI 10.1056/NEJMoa043104; YOUNG T, 1993, NEW ENGL J MED, V328, P1230, DOI 10.1056/NEJM199304293281704	42	233	234	2	45	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUN 12	2014	370	24					2276	2285		10.1056/NEJMoa1306766	http://dx.doi.org/10.1056/NEJMoa1306766			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AI7BB	24918372	Green Accepted			2022-12-28	WOS:000337033700007
J	Lis, D; Backus, EHG; Hunger, J; Parekh, SH; Bonn, M				Lis, Dan; Backus, Ellen H. G.; Hunger, Johannes; Parekh, Sapun H.; Bonn, Mischa			Liquid flow along a solid surface reversibly alters interfacial chemistry	SCIENCE			English	Article							SUM-FREQUENCY GENERATION; WATER-STRUCTURE; ELECTROKINETIC BEHAVIOR; ISOELECTRIC POINT; FLUORITE; SILICA; SALT; DISSOLUTION; MOLECULES; KINETICS	In nature, aqueous solutions often move collectively along solid surfaces (for example, raindrops falling on the ground and rivers flowing through riverbeds). However, the influence of such motion on water-surface interfacial chemistry is unclear. In this work, we combine surface-specific sum frequency generation spectroscopy and microfluidics to show that at immersed calcium fluoride and fused silica surfaces, flow leads to a reversible modification of the surface charge and subsequent realignment of the interfacial water molecules. Obtaining equivalent effects under static conditions requires a substantial change in bulk solution pH (up to 2 pH units), demonstrating the coupling between flow and chemistry. These marked flow-induced variations in interfacial chemistry should substantially affect our understanding and modeling of chemical processes at immersed surfaces.	[Lis, Dan] Univ Namur, Dept Phys, B-5000 Namur, Belgium; [Backus, Ellen H. G.; Hunger, Johannes; Parekh, Sapun H.; Bonn, Mischa] Max Planck Inst Polymer Res, Dept Mol Spect, D-55128 Mainz, Germany	University of Namur; Max Planck Society	Lis, D (corresponding author), Univ Namur, Dept Phys, Rue Bruxelles 61, B-5000 Namur, Belgium.	dan.lis@unamur.be; bonn@mpip-mainz.mpg.de	Hunger, Johannes/G-3242-2010; Bonn, Mischa/H-7446-2012	Hunger, Johannes/0000-0002-4419-5220; Bonn, Mischa/0000-0001-6851-8453	Belgian Fund for Scientific Research-Fonds de la Recherche Scientifique (F.R.S.-FNRS); Marie Curie Foundation [CIG322284, CIG334368]	Belgian Fund for Scientific Research-Fonds de la Recherche Scientifique (F.R.S.-FNRS)(Fonds de la Recherche Scientifique - FNRS); Marie Curie Foundation(European Commission)	We gratefully acknowledge D. Bonn, H.-J. Butt, and G. Auernhammer for fruitful discussions, as well as the anonymous referees for their insightful comments that resulted in a more accurate interpretation of our results. We thank P. Lambin and F. Cecchet for reading the manuscript, H. Burg for measuring the surface roughness of the CaF<INF>2</INF> prism, and M. Steiert for the inductively coupled plasma optical emission spectrometry measurements. D. L. is supported by the Belgian Fund for Scientific Research-Fonds de la Recherche Scientifique (F.R.S.-FNRS). S. H. P. and E. H. G. B. are supported by the Marie Curie Foundation, with grants CIG322284 and CIG334368, respectively.	Allen HC, 2009, PHYS CHEM CHEM PHYS, V11, P5538, DOI 10.1039/b901209e; Assemi S, 2006, LANGMUIR, V22, P1403, DOI 10.1021/la052806o; Becraft KA, 2004, PHYS CHEM CHEM PHYS, V6, P1880, DOI 10.1039/b313513f; Becraft KA, 2001, LANGMUIR, V17, P7721, DOI 10.1021/la011133g; Brown GE, 1999, CHEM REV, V99, P77, DOI 10.1021/cr980011z; Covert PA, 2014, J PHYS CHEM LETT, V5, P143, DOI 10.1021/jz402052s; Delgado AV, 2005, PURE APPL CHEM, V77, P1753, DOI 10.1351/pac200577101753; DU Q, 1994, PHYS REV LETT, V72, P238, DOI 10.1103/PhysRevLett.72.238; Eisenthal KB, 1996, CHEM REV, V96, P1343, DOI 10.1021/cr9502211; Fenter P, 2004, PROG SURF SCI, V77, P171, DOI 10.1016/j.progsurf.2004.12.001; Flores SC, 2012, J PHYS CHEM C, V116, P5730, DOI 10.1021/jp210791j; Glover PWJ, 2012, GEOPHYSICS, V77, pD17, DOI [10.1190/geo2011-0364.1, 10.1190/GEO2011-0364.1]; Holinga GJ, 2011, J AM CHEM SOC, V133, P6243, DOI 10.1021/ja1101954; Hu YH, 1997, J COLLOID INTERF SCI, V190, P224, DOI 10.1006/jcis.1997.4899; Icenhower JP, 2000, GEOCHIM COSMOCHIM AC, V64, P4193, DOI 10.1016/S0016-7037(00)00487-7; Jena KC, 2011, J PHYS CHEM LETT, V2, P1056, DOI 10.1021/jz200251h; Jena KC, 2010, PHYS CHEM CHEM PHYS, V12, P14383, DOI 10.1039/c0cp00260g; Jena KC, 2009, J PHYS CHEM C, V113, P15364, DOI 10.1021/jp905475m; Li I, 2004, LANGMUIR, V20, P10474, DOI 10.1021/la048639u; Maccarini M, 2007, BIOINTERPHASES, V2, pMR1, DOI 10.1116/1.2768902; MILLER JD, 1972, J COLLOID INTERF SCI, V41, P567, DOI 10.1016/0021-9797(72)90378-5; Miller JD, 2004, COLLOID SURFACE A, V238, P91, DOI 10.1016/j.colsurfa.2004.02.030; Nilsson A, 2011, CHEM PHYS, V389, P1, DOI 10.1016/j.chemphys.2011.07.021; Noguchi H, 2008, PHYS CHEM CHEM PHYS, V10, P4987, DOI 10.1039/b807297n; Putnis A, 2014, SCIENCE, V343, P1441, DOI 10.1126/science.1250884; Schoch RB, 2008, REV MOD PHYS, V80, P839, DOI 10.1103/RevModPhys.80.839; Seidel A, 1997, SOLID STATE IONICS, V101, P713, DOI 10.1016/S0167-2738(97)00289-0; Service RF, 2012, SCIENCE, V337, P146, DOI 10.1126/science.337.6091.146; Sheffer MR, 2007, GEOPHYS J INT, V169, P839, DOI 10.1111/j.1365-246X.2007.03397.x; Sovago M, 2008, PHYS REV LETT, V100, DOI 10.1103/PhysRevLett.100.173901; Suarez D. L., 1994, MODELING SOIL SOLUTI; Vacha R, 2008, PHYS CHEM CHEM PHYS, V10, P4975, DOI 10.1039/b806432f; Wernet P, 2004, SCIENCE, V304, P995, DOI 10.1126/science.1096205; Wilkin RT, 2010, ENVIRON SCI TECHNOL, V44, P4821, DOI 10.1021/es100559j; Yang Z, 2009, J PHYS CHEM C, V113, P8201, DOI 10.1021/jp811517p; Ye SJ, 2012, LANGMUIR, V28, P1374, DOI 10.1021/la203690p; Yeganeh MS, 1999, PHYS REV LETT, V83, P1179, DOI 10.1103/PhysRevLett.83.1179	37	145	147	8	249	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 6	2014	344	6188					1138	1142		10.1126/science.1253793	http://dx.doi.org/10.1126/science.1253793			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI3UU	24904160				2022-12-28	WOS:000336791200042
J	van Hees, F; Habbema, JDF; Meester, RG; Lansdorp-Vogelaar, I; van Ballegooijen, M; Zauber, AG				van Hees, Frank; Habbema, J. Dik F.; Meester, Reinier G.; Lansdorp-Vogelaar, Iris; van Ballegooijen, Marjolein; Zauber, Ann G.			Should Colorectal Cancer Screening Be Considered in Elderly Persons Without Previous Screening? A Cost-Effectiveness Analysis	ANNALS OF INTERNAL MEDICINE			English	Article							LARGE-INTESTINE; LARGE-BOWEL; TASK-FORCE; COLONOSCOPY; POLYPS; PREVALENCE; GUIDELINES; SIGMOIDOSCOPY; NECROPSY; STATES	Background: The U.S. Preventive Services Task Force recommends against routine screening for colorectal cancer (CRC) in adequately screened persons older than 75 years but does not address the appropriateness of screening in elderly persons without previous screening. Objective: To determine at what ages CRC screening should be considered in unscreened elderly persons and to determine which test is indicated at each age. Design: Microsimulation modeling study. Data Sources: Observational and experimental studies. Target Population: Unscreened persons aged 76 to 90 years with no, moderate, and severe comorbid conditions. Time Horizon: Lifetime. Perspective: Societal. Intervention: One-time colonoscopy, sigmoidoscopy, or fecal immunochemical test (FIT) screening. Outcome Measures: Quality-adjusted life-years gained, costs, and costs per quality-adjusted life-year gained. Results of Base-Case Analysis: In unscreened elderly persons with no comorbid conditions, CRC screening was cost-effective up to age 86 years. Screening with colonoscopy was indicated up to age 83 years, sigmoidoscopy was indicated at age 84 years, and FIT was indicated at ages 85 and 86 years. In unscreened persons with moderate comorbid conditions, screening was cost-effective up to age 83 years (colonoscopy indicated up to age 80 years, sigmoidoscopy at age 81 years, and FIT at ages 82 and 83 years). In unscreened persons with severe comorbid conditions, screening was cost-effective up to age 80 years (colonoscopy indicated up to age 77 years, sigmoidoscopy at age 78 years, and FIT at ages 79 and 80 years). Results of Sensitivity Analyses: Results were most sensitive to assuming a lower willingness to pay per quality-adjusted life-year gained. Limitation: Only persons at average risk for CRC were considered. Conclusion: In unscreened elderly persons CRC screening should be considered well beyond age 75 years. A colonoscopy is indicated at most ages.	Erasmus Univ, Med Ctr, NL-3000 CA Rotterdam, Netherlands; Mem Sloan Kettering Canc Ctr, New York, NY 10065 USA	Erasmus University Rotterdam; Erasmus MC; Memorial Sloan Kettering Cancer Center	van Hees, F (corresponding author), Erasmus Univ, Med Ctr, Dept Publ Hlth, POB 2040, NL-3000 CA Rotterdam, Netherlands.	f.vanhees@erasmusmc.nl			National Cancer Institute as part of the Cancer Intervention and Surveillance Modeling Network [U01-CA152959]; NATIONAL CANCER INSTITUTE [U01CA152959, P30CA008748] Funding Source: NIH RePORTER	National Cancer Institute as part of the Cancer Intervention and Surveillance Modeling Network; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	By the National Cancer Institute (grant U01-CA152959) as part of the Cancer Intervention and Surveillance Modeling Network.	ARMINSKI T. C., 1964, DIS COLON RECTUM, V7, P249, DOI 10.1007/BF02630528; Atkin WS, 2010, LANCET, V375, P1624, DOI 10.1016/S0140-6736(10)60551-X; Blatt LJ., 1961, DIS COLON RECTUM, V4, P277; BOMBI JA, 1988, CANCER-AM CANCER SOC, V61, P1472, DOI 10.1002/1097-0142(19880401)61:7<1472::AID-CNCR2820610734>3.0.CO;2-E; Bureau of Labor Statistics, 2013, CONS PRIC IND; Bureau of Labor Statistics, 2013, CURR EMPL STAT NAT; Calonge N, 2008, ANN INTERN MED, V149, P627, DOI 10.7326/0003-4819-149-9-200811040-00243; CHAPMAN I, 1963, ANN SURG, V157, P223, DOI 10.1097/00000658-196302000-00007; Cho H, 2013, ANN INTERN MED, V159, P667, DOI 10.7326/0003-4819-159-10-201311190-00005; CLARK JC, 1985, INT J CANCER, V36, P179, DOI 10.1002/ijc.2910360209; Freedman AN, 2009, J CLIN ONCOL, V27, P686, DOI 10.1200/JCO.2008.17.4797; Gatto NM, 2003, J NATL CANCER I, V95, P230, DOI 10.1093/jnci/95.3.230; Goodwin JS, 2011, ARCH INTERN MED, V171, P1335, DOI 10.1001/archinternmed.2011.212; JASS JR, 1992, GUT, V33, P1508, DOI 10.1136/gut.33.11.1508; JOHANNSEN LGK, 1989, SCAND J GASTROENTERO, V24, P799, DOI 10.3109/00365528909089217; Jorgensen OD, 2002, GUT, V50, P29, DOI 10.1136/gut.50.1.29; Ko CW, 2005, GASTROENTEROLOGY, V129, P1163, DOI 10.1053/j.gastro.2005.07.027; Lansdorp-Vogelaar I, 2009, CANCER-AM CANCER SOC, V115, P2410, DOI 10.1002/cncr.24256; Lansdorp-Vogelaar I, 2009, GASTROINTEST ENDOSC, V70, P96, DOI 10.1016/j.gie.2008.08.040; Leffler DA, 2010, ARCH INTERN MED, V170, P1752, DOI 10.1001/archinternmed.2010.373; Lieberman DA, 2012, GASTROENTEROLOGY, V143, P844, DOI 10.1053/j.gastro.2012.06.001; Lin OS, 2006, JAMA-J AM MED ASSOC, V295, P2357, DOI 10.1001/jama.295.20.2357; Mandel JS, 1999, J NATL CANCER I, V91, P434, DOI 10.1093/jnci/91.5.434; Ness RM, 1999, AM J GASTROENTEROL, V94, P1650; Painter J, 1999, ENDOSCOPY, V31, P227, DOI 10.1055/s-1999-13673; RICKERT RR, 1979, CANCER-AM CANCER SOC, V43, P1847, DOI 10.1002/1097-0142(197905)43:5<1847::AID-CNCR2820430538>3.0.CO;2-L; Rozen P, 2011, EUR J CANCER PREV, V20, P46, DOI 10.1097/CEJ.0b013e328341e309; Rutter CM, 2013, JNCI-J NATL CANCER I, V105, P1806, DOI 10.1093/jnci/djt299; Shapiro JA, 2012, CANCER EPIDEM BIOMAR, V21, P895, DOI 10.1158/1055-9965.EPI-12-0192; Shellnut JK, 2010, DIS COLON RECTUM, V53, P5, DOI 10.1007/DCR.0b013e3181bc01d1; Surveillance Epidemiology and End Results (SEER) Program, 2002, SEER STAT DAT INC SE; van Rijn JC, 2006, AM J GASTROENTEROL, V101, P343, DOI 10.1111/j.1572-0241.2006.00390.x; VATN MH, 1982, CANCER, V49, P819, DOI 10.1002/1097-0142(19820215)49:4<819::AID-CNCR2820490435>3.0.CO;2-D; Warren JL, 2009, ANN INTERN MED, V150, P849, DOI 10.7326/0003-4819-150-12-200906160-00008; WILLIAMS AR, 1982, GUT, V23, P835, DOI 10.1136/gut.23.10.835; Yabroff KR, 2008, JNCI-J NATL CANCER I, V100, P630, DOI 10.1093/jnci/djn103; Zauber AG, 2007, COST EFFECTIVENESS D; Zauber AG, 2008, ANN INTERN MED, V149, P659, DOI 10.7326/0003-4819-149-9-200811040-00244	39	77	77	0	17	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JUN 3	2014	160	11					750	+		10.7326/M13-2263	http://dx.doi.org/10.7326/M13-2263			24	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AJ0MT	24887616	Green Accepted			2022-12-28	WOS:000337348700002
J	Kradin, RL; Fidias, P; Digumarthy, S; Mark, EJ				Kradin, Richard L.; Fidias, Panos; Digumarthy, Subba; Mark, Eugene J.			Case 17-2014: A 64-Year-Old Man with Chest Pain and a Pleural Effusion	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							MALIGNANT MESOTHELIOMA; ASBESTOS EXPOSURE; LUNG-CANCER; PHASE-III; EPIDEMIOLOGY; CISPLATIN; SURVEILLANCE		[Kradin, Richard L.] Massachusetts Gen Hosp, Dept Med, Boston, MA 02114 USA; [Kradin, Richard L.; Mark, Eugene J.] Massachusetts Gen Hosp, Dept Pathol, Boston, MA 02114 USA; [Fidias, Panos] Massachusetts Gen Hosp, Div Med Oncol, Boston, MA 02114 USA; [Digumarthy, Subba] Massachusetts Gen Hosp, Dept Radiol, Boston, MA 02114 USA; [Kradin, Richard L.; Fidias, Panos] Harvard Univ, Sch Med, Dept Med, Boston, MA USA; [Kradin, Richard L.; Mark, Eugene J.] Harvard Univ, Sch Med, Dept Pathol, Boston, MA 02115 USA; [Digumarthy, Subba] Harvard Univ, Sch Med, Dept Radiol, Boston, MA 02115 USA	Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School	Kradin, RL (corresponding author), Massachusetts Gen Hosp, Dept Med, Boston, MA 02114 USA.				Genentech	Genentech(Roche HoldingGenentech)	Drs. Kradin and Mark report receiving payments for providing expert testimony in litigation regarding asbestos on behalf of patients. Dr. Fidias reports receiving fees from Genentech for serving on an advisory board. No other potential conflict of interest relevant to this article was reported.	BAKER DB, 1991, ANN NY ACAD SCI, V643, P61, DOI 10.1111/j.1749-6632.1991.tb24444.x; Craighead JE, 2011, RECENT RESULTS CANC, V189, P13, DOI 10.1007/978-3-642-10862-4_2; Fennell DA, 2011, RECENT RESULTS CANC, V189, P149, DOI 10.1007/978-3-642-10862-4_9; Flores RM, 2007, J THORAC ONCOL, V2, P957, DOI 10.1097/JTO.0b013e31815608d9; Flores RM, 2010, J THORAC ONCOL, V5, P1649, DOI 10.1097/JTO.0b013e3181f1903e; Goldberg S, 2010, OCCUP ENVIRON MED, V67, P417, DOI 10.1136/oem.2009.050336; Hardt JS, 2014, OCCUP ENVIRON MED, V71, P282, DOI 10.1136/oemed-2013-101735; HARWOOD TR, 1976, AM J CLIN PATHOL, V65, P159; IWATSUBO Y, 1994, AM J IND MED, V26, P77, DOI 10.1002/ajim.4700260107; Landrigan P J, 1991, Ann N Y Acad Sci, V643, pxv, DOI 10.1111/j.1749-6632.1991.tb24438.x; MARK EJ, 1991, ANN NY ACAD SCI, V643, P196, DOI 10.1111/j.1749-6632.1991.tb24463.x; PETERSON JT, 1984, CANCER, V54, P951, DOI 10.1002/1097-0142(19840901)54:5<951::AID-CNCR2820540536>3.0.CO;2-A; Price B, 2004, AM J EPIDEMIOL, V159, P107, DOI 10.1093/aje/kwh025; Rodelsperger K, 2001, AM J IND MED, V39, P262; Roggli VL, 1992, PATHOLOGY ASBESTOS A, P299; ROHL AN, 1982, SCIENCE, V216, P518, DOI 10.1126/science.7071597; Santoro A, 2008, J THORAC ONCOL, V3, P756, DOI 10.1097/JTO.0b013e31817c73d6; Smith AH, 1996, AM J IND MED, V30, P252, DOI 10.1002/(SICI)1097-0274(199609)30:3<252::AID-AJIM2>3.0.CO;2-0; Stayner L, 2013, ANNU REV PUBL HEALTH, V34, P205, DOI 10.1146/annurev-publhealth-031811-124704; Sugarbaker DJ, 1999, J THORAC CARDIOV SUR, V117, P54, DOI 10.1016/S0022-5223(99)70469-1; van Meerbeeck JP, 2005, J CLIN ONCOL, V23, P6881, DOI 10.1200/JCO.20005.14.589; Vogelzang NJ, 2003, J CLIN ONCOL, V21, P2636, DOI 10.1200/JCO.2003.11.136; Welch LS, 2007, INT J OCCUP ENV HEAL, V13, P318, DOI 10.1179/oeh.2007.13.3.318; Wylie AG, 2000, AM MINERAL, V85, P1540, DOI 10.2138/am-2000-1028	24	2	2	0	2	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAY 29	2014	370	22					2132	2140		10.1056/NEJMcpc1400835	http://dx.doi.org/10.1056/NEJMcpc1400835			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AH9BM	24869724				2022-12-28	WOS:000336434000012
J	Selak, V; Elley, CR; Bullen, C; Crengle, S; Wadham, A; Rafter, N; Parag, V; Harwood, M; Doughty, RN; Arroll, B; Milne, RJ; Bramley, D; Bryant, L; Jackson, R; Rodgers, A				Selak, Vanessa; Elley, C. Raina; Bullen, Chris; Crengle, Sue; Wadham, Angela; Rafter, Natasha; Parag, Varsha; Harwood, Matire; Doughty, Robert N.; Arroll, Bruce; Milne, Richard J.; Bramley, Dale; Bryant, Linda; Jackson, Rod; Rodgers, Anthony			Effect of fixed dose combination treatment on adherence and risk factor control among patients at high risk of cardiovascular disease: randomised controlled trial in primary care	BMJ-BRITISH MEDICAL JOURNAL			English	Article							PREVENTION; STRATEGY; DESIGN; CVD	Objective To evaluate whether provision of fixed dose combination treatment improves adherence and risk factor control compared with usual care of patients at high risk of cardiovascular disease in primary care. Design Open label randomised control trial: IMPACT (IMProving Adherence using Combination Therapy). Setting 54 general practices in the Auckland and Waikato regions of New Zealand, July 2010 to August 2013. Participants 513 adults (including 257 indigenous Maori) at high risk of cardiovascular disease (established cardiovascular disease or five year risk >= 15%) who were recommended for treatment with antiplatelet, statin, and two or more blood pressure lowering drugs. 497 (97%) completed 12 months' follow-up. Interventions Participants were randomised to continued usual care or to fixed dose combination treatment (with two versions available: aspirin 75 mg, simvastatin 40 mg, and lisinopril 10 mg with either atenolol 50 mg or hydrochlorothiazide 12.5 mg). All drugs in both treatment arms were prescribed by their usual general practitioners and dispensed by local community pharmacists. Main outcome measures Primary outcomes were self reported adherence to recommended drugs (antiplatelet, statin, and two or more blood pressure lowering agents) and mean change in blood pressure and low density lipoprotein cholesterol at 12 months. Results Adherence to all four recommended drugs was greater among fixed dose combination than usual care participants at 12 months (81% v 46%; relative risk 1.75, 95% confidence interval 1.52 to 2.03, P<0.001; number needed to treat 2.9, 95% confidence interval 2.3 to 3.7). Adherence for each drug type at 12 months was high in both groups but especially in the fixed dose combination group: for antiplatelet treatment it was 93% fixed dose combination v 83% usual care (P<0.001), for statin 94% v 89% (P=0.06), for combination blood pressure lowering 89% v 59% (P<0.001), and for any blood pressure lowering 96% v 91% (P=0.02). Self reported adherence was highly concordant with dispensing data (dispensing of all four recommended drugs 79% fixed dose combination v 47% usual care, relative risk 1.67, 95% confidence interval 1.44 to 1.93, P<0.001). There was no statistically significant improvement in risk factor control between the fixed dose combination and usual care groups over 12 months: the difference in systolic blood pressure was -2.2 mm Hg (-4.5 v -2.3, 95% confidence interval -5.6 to 1.2, P=0.21), in diastolic blood pressure -1.2 mm Hg (-2.1 v -0.9, -3.2 to 0.8, P=0.22) and in low density lipoprotein cholesterol -0.05 mmol/L (-0.20 v -0.15, -0.17 to 0.08, P=0.46). The number of participants with cardiovascular events or serious adverse events was similar in both treatment groups (fixed dose combination 16 v usual care 18 (P=0.73), 99 v 93 (P=0.56), respectively). Fixed dose combination treatment was discontinued in 94 participants (37%). The most commonly reported reason for discontinuation was a side effect (54/75, 72%). Overall, 89% (227/256) of fixed dose combination participants' general practitioners completed a post-trial survey, and the fixed dose combination strategy was rated as satisfactory or very satisfactory for starting treatment (206/227, 91%), blood pressure control (180/220, 82%), cholesterol control (170/218, 78%), tolerability (181/223, 81%), and prescribing according to local guidelines (185/219, 84%). When participants were asked at 12 months how easy they found taking their prescribed drugs, most responded very easy or easy (224/246, 91% fixed dose combination v 212/246, 86% usual care, P=0.09). At 12 months the change in other lipid fractions, difference in EuroQol-5D, and difference in barriers to adherence did not differ significantly between the treatment groups. Conclusions Among this well treated primary care population, fixed dose combination treatment improved adherence to the combination of all recommended drugs but improvements in clinical risk factors were small and did not reach statistical significance. Acceptability was high for both general practitioners and patients, although the discontinuation rate was high.	[Selak, Vanessa; Bullen, Chris; Crengle, Sue; Wadham, Angela; Rafter, Natasha; Parag, Varsha; Doughty, Robert N.] Univ Auckland, Natl Inst Hlth Innovat, Auckland Mail Ctr, Auckland 1142, New Zealand; [Elley, C. Raina; Arroll, Bruce; Bryant, Linda] Univ Auckland, Dept Gen Practice & Primary Hlth Care, Auckland 1142, New Zealand; [Harwood, Matire] Univ Auckland, Auckland 1142, New Zealand; [Milne, Richard J.; Jackson, Rod] Univ Auckland, Epidemiol & Biostat Sect, Auckland 1142, New Zealand; [Bramley, Dale] Waitemata Dist Hlth Board, Auckland, New Zealand; [Rodgers, Anthony] George Inst Global Hlth, Sydney, NSW, Australia	University of Auckland; University of Auckland; University of Auckland; University of Auckland; George Institute for Global Health; University of Sydney	Selak, V (corresponding author), Univ Auckland, Natl Inst Hlth Innovat, Auckland Mail Ctr, Private Bag 92019, Auckland 1142, New Zealand.	v.selak@auckland.ac.nz	Milne, Richard/GNH-1930-2022; Bullen, Chris/E-4594-2017; Crengle, Sue/E-6774-2010	Bullen, Chris/0000-0001-6807-2930; Crengle, Sue/0000-0001-9367-1492; Jackson, Rod/0000-0001-5914-6934; Selak, Vanessa/0000-0002-9824-8674; Harwood, Matire/0000-0003-1240-5139; Rodgers, Anthony/0000-0003-1282-1896	New Zealand Health Research Council [06/582, 12/889]; National Heart Foundation of New Zealand [1376]; New Zealand Lotteries Grants Board [230904-310308]; Elsie Shrimpton Fund (University of Auckland); PHARMAC (New Zealand's Pharmaceutical Management Agency) [A499735-QA24208]; Te Kupenga Hauora Maori (University of Auckland); Auckland regional district health boards (Auckland, County Waitemata) [12/889]; Auckland regional district health boards (Auckland, County Manukau) [12/889]; Faculty Research Development Fund (University of Auckland); Auckland Medical Research Foundation; National Heart Foundation of New Zealand; DRL	New Zealand Health Research Council(Health Research Council of New Zealand); National Heart Foundation of New Zealand; New Zealand Lotteries Grants Board; Elsie Shrimpton Fund (University of Auckland); PHARMAC (New Zealand's Pharmaceutical Management Agency); Te Kupenga Hauora Maori (University of Auckland); Auckland regional district health boards (Auckland, County Waitemata); Auckland regional district health boards (Auckland, County Manukau); Faculty Research Development Fund (University of Auckland); Auckland Medical Research Foundation; National Heart Foundation of New Zealand; DRL	The trial was funded by project grants from: New Zealand Health Research Council (06/582, 12/889), National Heart Foundation of New Zealand (1376), New Zealand Lotteries Grants Board (230904-310308), the Elsie Shrimpton Fund (University of Auckland), PHARMAC (New Zealand's Pharmaceutical Management Agency; A499735-QA24208), Te Kupenga Hauora Maori (University of Auckland), Auckland regional district health boards (Auckland, Counties Manukau, and Waitemata; 12/889), the Faculty Research Development Fund (University of Auckland), and the Auckland Medical Research Foundation. VS (1384) and NR (1156) received National Heart Foundation of New Zealand research fellowships while working on the trial. DRL (Hyderabad, India) provided free of charge the fixed dose combination treatment for use in the trial. The George Institute for Global Health (employer of AR) received a grant from DRL for the SPACE collaboration coordinating centre (www.spacecollaboration.org) which provides academic and administrative support to achieve collaboration between this and two other clinical trials involving fixed dose combination treatment provided by DRL free of charge. Researcher independence and access to data: None of the trial sponsor, funders or DRL had any role in study design; the collection, analysis, or interpretation of data; the writing of the article; or the decision to submit the article for publication. All authors are independent from trial funders. All authors had full access to all of the data in the study and can take responsibility for the integrity of the data and the accuracy of the data analysis.	Bryant L, 2013, J PRIM HEALTH CARE, V5, P28; Doyle C, 2013, BMJ OPEN, V3, DOI 10.1136/bmjopen-2012-001570; Dresser GK, 2013, J HYPERTENS, V31, P1702, DOI 10.1097/HJH.0b013e3283619d6a; Elley CR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052145; Holt S, 2009, NEW ZEAL MED J, V122, P116; Law MR, 2009, BMJ-BRIT MED J, V338, DOI 10.1136/bmj.b1665; Mehta S, 2011, J PRIM HEALTH CARE, V3, P93, DOI 10.1071/HC11093; Ministry for Culture and Heritage, 2012, READ TREAT; National Institute for Health and Care Excellence, 2010, SEC PREV COR HEART D; New Zealand Guidelines Group, 2003, EV BAS BEST PRACT GU; New Zealand Guidelines Group, 2009, NZ CARD GUID HDB SUM; Patel A., 2014, EUR J PREV CARDIOL; Perk J, 2012, EUR J PREV CARDIOL, V19, P585, DOI 10.1177/2047487312450228; Perkins MRV, 2004, QUAL LIFE RES, V13, P271, DOI 10.1023/B:QURE.0000015300.28109.38; Sanz G, 2011, AM HEART J, V162, DOI 10.1016/j.ahj.2011.08.012; Selak V, 2013, INT J EQUITY HEALTH, V12, DOI 10.1186/1475-9276-12-44; Selak V, 2011, CONTEMP CLIN TRIALS, V32, P909, DOI 10.1016/j.cct.2011.07.006; Smith SC, 2011, CIRCULATION, V124, P2458, DOI 10.1161/CIR.0b013e318235eb4d; Thom S, 2013, JAMA-J AM MED ASSOC, V310, P918, DOI 10.1001/jama.2013.277064; University of Auckland Health Quality & Safety Commission, 2012, CARD OUTC HLTH QUAL; Viera AJ, 2011, PREV MED, V52, P10, DOI 10.1016/j.ypmed.2010.09.016; Virdee SK, 2013, BMJ OPEN, V3, DOI 10.1136/bmjopen-2012-002498; Wald NJ, 2003, BMJ-BRIT MED J, V326, P1419, DOI 10.1136/bmj.326.7404.1419; Webster R, 2013, INT J CARDIOL, V170, P30, DOI 10.1016/j.ijcard.2013.10.007; Wood D, 2005, HEART, V91, P1, DOI 10.1136/hrt.2005.079988; World Health Organization, 2002, WELLC TRUST M REP 1; Yusuf S, 2002, LANCET, V360, P2, DOI 10.1016/S0140-6736(02)09358-3; Yusuf S, 2011, LANCET, V378, P1231, DOI 10.1016/S0140-6736(11)61215-4; Zamorano J, 2011, CURR MED RES OPIN, V27, P821, DOI 10.1185/03007995.2011.555754	29	105	106	0	12	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	MAY 27	2014	348								g3318	10.1136/bmj.g3318	http://dx.doi.org/10.1136/bmj.g3318			15	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AI3EB	24868083	Green Published, hybrid			2022-12-28	WOS:000336741400007
J	Raj, DK; Nixon, CP; Nixon, CE; Dvorin, JD; DiPetrillo, CG; Pond-Tor, S; Wu, HW; Jolly, G; Pischel, L; Lu, AL; Michelow, IC; Cheng, L; Conteh, S; McDonald, EA; Absalon, S; Holte, SE; Friedman, JF; Fried, M; Duffy, PE; Kurtis, JD				Raj, Dipak K.; Nixon, Christian P.; Nixon, Christina E.; Dvorin, Jeffrey D.; DiPetrillo, Christen G.; Pond-Tor, Sunthorn; Wu, Hai-Wei; Jolly, Grant; Pischel, Lauren; Lu, Ailin; Michelow, Ian C.; Cheng, Ling; Conteh, Solomon; McDonald, Emily A.; Absalon, Sabrina; Holte, Sarah E.; Friedman, Jennifer F.; Fried, Michal; Duffy, Patrick E.; Kurtis, Jonathan D.			Antibodies to PfSEA-1 block parasite egress from RBCs and protect against malaria infection	SCIENCE			English	Article							PLASMODIUM-FALCIPARUM; HUMAN RESISTANCE; INVASION; GROWTH	Novel vaccines are urgently needed to reduce the burden of severe malaria. Using a differential whole-proteome screening method, we identified Plasmodium falciparum schizont egress antigen-1 (PfSEA-1), a 244-kilodalton parasite antigen expressed in schizont-infected red blood cells (RBCs). Antibodies to PfSEA-1 decreased parasite replication by arresting schizont rupture, and conditional disruption of PfSEA-1 resulted in a profound parasite replication defect. Vaccination of mice with recombinant Plasmodium berghei PbSEA-1 significantly reduced parasitemia and delayed mortality after lethal challenge with the Plasmodium berghei strain ANKA. Tanzanian children with antibodies to recombinant PfSEA-1A (rPfSEA-1A) did not experience severe malaria, and Kenyan adolescents and adults with antibodies to rPfSEA-1A had significantly lower parasite densities than individuals without these antibodies. By blocking schizont egress, PfSEA-1 may synergize with other vaccines targeting hepatocyte and RBC invasion.	[Raj, Dipak K.; Nixon, Christian P.; Nixon, Christina E.; Pond-Tor, Sunthorn; Wu, Hai-Wei; Pischel, Lauren; Lu, Ailin; Michelow, Ian C.; Cheng, Ling; McDonald, Emily A.; Friedman, Jennifer F.; Kurtis, Jonathan D.] Brown Univ, Rhode Isl Hosp, Warren Alpert Med Sch, Ctr Int Hlth Res, Providence, RI 02903 USA; [Dvorin, Jeffrey D.; DiPetrillo, Christen G.; Absalon, Sabrina] Boston Childrens Hosp, Div Infect Dis, Boston, MA 02115 USA; [Dvorin, Jeffrey D.; DiPetrillo, Christen G.; Absalon, Sabrina] Harvard Univ, Sch Med, Boston, MA 02115 USA; [Wu, Hai-Wei; Michelow, Ian C.; Friedman, Jennifer F.] Brown Univ, Rhode Isl Hosp, Warren Alpert Med Sch, Dept Pediat, Providence, RI 02903 USA; [Jolly, Grant; Kurtis, Jonathan D.] Brown Univ, Warren Alpert Med Sch, Rhode Isl Hosp, Dept Pathol & Lab Med, Providence, RI 02906 USA; [Conteh, Solomon; Fried, Michal; Duffy, Patrick E.] NIAID, Lab Malaria Immunol & Vaccinol, NIH, Rockville, MD 20892 USA; [Holte, Sarah E.] Univ Washington, Fred Hutchinson Canc Res Ctr, Program Biostat & Biomath, Dept Biostat & Global Hlth, Seattle, WA 98109 USA	Brown University; Lifespan Health Rhode Island; Rhode Island Hospital; Harvard University; Boston Children's Hospital; Harvard University; Harvard Medical School; Brown University; Lifespan Health Rhode Island; Rhode Island Hospital; Brown University; Lifespan Health Rhode Island; Rhode Island Hospital; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); Fred Hutchinson Cancer Center; University of Washington; University of Washington Seattle	Kurtis, JD (corresponding author), Brown Univ, Rhode Isl Hosp, Warren Alpert Med Sch, Ctr Int Hlth Res, Providence, RI 02903 USA.	jonathan_kurtis@brown.edu	Michelow, Ian C./AAH-2373-2020	Michelow, Ian C./0000-0002-8399-480X; Nixon, Christina/0000-0003-1934-958X; Dvorin, Jeffrey/0000-0002-5883-7271; Absalon, Sabrina/0000-0002-4167-3071; Friedman, Jennifer/0000-0001-5804-9921	U.S. National Institutes of Health (NIH) [R01-AI52059]; Bill & Melinda Gates Foundation [1364]; Intramural Research Program of the National Institute of Allergy and Infectious Diseases-NIH; NIH [R01-AI076353, R01-AI102907, DP2-AI112219, T32-DA013911, 1K08AI100997-01A1]; internal Lifespan Hospital System Research Pilot Award Grant; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI001153, P30AI042853, R01AI102907, R01AI052059, R01AI076353, ZIAAI001134, K08AI100997, DP2AI112219] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P20GM103421] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [T32DA013911] Funding Source: NIH RePORTER	U.S. National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Bill & Melinda Gates Foundation(Bill & Melinda Gates FoundationCGIAR); Intramural Research Program of the National Institute of Allergy and Infectious Diseases-NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); internal Lifespan Hospital System Research Pilot Award Grant; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	The authors thank the Mother Offspring Malaria Study project staff for their efforts in collecting clinical data, processing samples, and interpreting malaria blood smears, as well as the study participants and their families. Ethical clearance was obtained from the institutitional review boards of the Seattle Biomedical Research Institute and Rhode Island Hospital; the Medical Research Coordinating Committee of the National Institute for Medical Research, Tanzania; and the Kenyan Medical Research Institute. We thank A. Muehlenbachs for assistance in interpreting the electron microscopy images, B. Morrison for assistance with data management, and D. Lanar for the LSA proteins. This work was supported by grants from the U.S. National Institutes of Health (NIH) (grant R01-AI52059) and the Bill & Melinda Gates Foundation (grant 1364) to P. E. D., the Intramural Research Program of the National Institute of Allergy and Infectious Diseases-NIH, and grants from NIH (grant R01-AI076353) and an internal Lifespan Hospital System Research Pilot Award Grant to J.D.K., and grants from NIH to J.D.D. (R01-AI102907 and DP2-AI112219). C.E.N. (grant T32-DA013911) and I.C.M. (grant 1K08AI100997-01A1) were supported by NIH. We also acknowledge research core services provided by the Rhode Island Hospital imaging core (G. Hovanesian) and core services supported by Lifespan/Tufts/Brown Center for Aids Research (P30AI042853) and Center for Biomedical Research Excellence (P20GM103421). The DNA sequence for PfSEA-1 is available in PlasmoDB (www.Plasmodb.org) as ID no. PF3D7_1021800. The work presented in this manuscript has been submitted in partial support of patent application PCT/US12/67404 filed with the U.S. Patent Office. J.D.K., J.F.F., M.F., and P.E.D. designed the study; J.D.K., D.K.R., J.F.F., M. F., and P. E. D. drafted the manuscript; M. F. and P. E. D. conducted the field-based sample and epidemiologic data collection; C.P.N. conducted the differential screening; D. K. R, L. P., A. L., C.E.N., and L. C. performed the in vitro growth assays; D. K. R. and G.J. performed the immunolocalization; D. K. R. performed the gene knockout studies; C. G. D., E. A. M., S. A., and J.D.D. performed the conditional gene knockdown studies; I. C. M. performed the single-nucleotide polymorphism detection; S.P.-T., L.C., and H.-W.W. performed the antibody detection assays; S.P.-T. expressed and purified rPf SEA-1A and rPbSEA-1A; D.K.R., C.E.N., and S. C. performed the vaccination studies; J.F.F., J.D.K., and S.E.H. performed the statistical analyses; and J.D.K., J.F.F., M.F., and P.E.D. supervised the study. The authors declare no competing financial interests.	Ahlborg N, 1996, EXP PARASITOL, V82, P155, DOI 10.1006/expr.1996.0020; [Anonymous], N ENGL J MED; [Anonymous], MAL VACC RAINB TABL; BEIER JC, 1994, AM J TROP MED HYG, V50, P529, DOI 10.4269/ajtmh.1994.50.529; Bergmann-Leitner ES, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-183; BLACKMAN MJ, 1990, J EXP MED, V172, P379, DOI 10.1084/jem.172.1.379; Bull PC, 2005, J INFECT DIS, V192, P1119, DOI 10.1086/432761; Crosnier C, 2011, NATURE, V480, P534, DOI 10.1038/nature10606; Dvorin JD, 2010, SCIENCE, V328, P910, DOI 10.1126/science.1188191; Farrell A, 2012, SCIENCE, V335, P218, DOI 10.1126/science.1210829; Gomez ND, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025477; Goodyer ID, 1997, MOL BIOCHEM PARASIT, V87, P13, DOI 10.1016/S0166-6851(97)00039-X; Hodder AN, 2001, INFECT IMMUN, V69, P3286, DOI 10.1128/IAI.69.5.3286-3294.2001; Kadekoppala M, 2008, EUKARYOT CELL, V7, P2123, DOI 10.1128/EC.00274-08; Kurtis JD, 2001, INFECT IMMUN, V69, P123, DOI 10.1128/IAI.69.1.123-128.2001; Kurtis JD, 1999, INFECT IMMUN, V67, P3424, DOI 10.1128/IAI.67.7.3424-3429.1999; Manske M, 2012, NATURE, V487, P375, DOI 10.1038/nature11174; Murray CJL, 2012, LANCET, V379, P413, DOI 10.1016/S0140-6736(12)60034-8; Mutabingwa TK, 2005, PLOS MED, V2, P1260, DOI 10.1371/journal.pmed.0020407; Nixon CP, 2005, J INFECT DIS, V192, P861, DOI 10.1086/432550; Okie S, 2005, NEW ENGL J MED, V353, P1877, DOI 10.1056/NEJMp058217; SABCHAREON A, 1991, AM J TROP MED HYG, V45, P297, DOI 10.4269/ajtmh.1991.45.297; Spaccapelo R, 2011, SCI REP-UK, V1, DOI 10.1038/srep00039; Treeck M, 2011, CELL HOST MICROBE, V10, P410, DOI 10.1016/j.chom.2011.09.004; WHO, 2012, WORLD MALARIA REPORT 2012, P1; Yoshida S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013727	26	78	79	0	24	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 23	2014	344	6186					871	877		10.1126/science.1254417	http://dx.doi.org/10.1126/science.1254417			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AH6IL	24855263	Green Accepted			2022-12-28	WOS:000336233800040
J	Richter, KP; Levy, S				Richter, Kimber P.; Levy, Sharon			Big Marijuana - Lessons from Big Tobacco	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Richter, Kimber P.] Univ Kansas, Med Ctr, Dept Prevent Med & Publ Hlth, Kansas City, KS USA; [Richter, Kimber P.] Univ Kansas, Ctr Canc, Kansas City, KS USA; [Levy, Sharon] Boston Childrens Hosp, Div Dev Med, Boston, MA USA; [Levy, Sharon] Boston Childrens Hosp, Adolescent Subst Abuse Program, Boston, MA USA; [Levy, Sharon] Harvard Univ, Sch Med, Boston, MA USA	University of Kansas; University of Kansas Medical Center; University of Kansas; Harvard University; Boston Children's Hospital; Harvard University; Boston Children's Hospital; Harvard University; Harvard Medical School	Richter, KP (corresponding author), Univ Kansas, Med Ctr, Dept Prevent Med & Publ Hlth, Kansas City, KS USA.							Calabria B, 2010, DRUG ALCOHOL REV, V29, P318, DOI 10.1111/j.1465-3362.2009.00149.x; Hall W, 2003, CNS DRUGS, V17, P689, DOI 10.2165/00023210-200317100-00001; Hall W., 1999, HLTH EFFECTS CANNABI, P477; McLaren J, 2008, ADDICTION, V103, P1100, DOI 10.1111/j.1360-0443.2008.02230.x; MILMORE B K, 1956, Public Health Monogr, V45, P107	5	55	56	0	10	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUL 31	2014	371	5					399	401		10.1056/NEJMp1406074	http://dx.doi.org/10.1056/NEJMp1406074			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	AM0SK	24918955				2022-12-28	WOS:000339556900004
J	Pinan-Lucarre, B; Tu, HJ; Pierron, M; Cruceyra, PI; Zhan, H; Stigloher, C; Richmond, JE; Bessereau, JL				Pinan-Lucarre, Berangere; Tu, Haijun; Pierron, Marie; Cruceyra, Pablo Ibanez; Zhan, Hong; Stigloher, Christian; Richmond, Janet E.; Bessereau, Jean-Louis			C. elegans Punctin specifies cholinergic versus GABAergic identity of postsynaptic domains	NATURE			English	Article							RECEPTOR ALPHA-SUBUNIT; CAENORHABDITIS-ELEGANS; ACETYLCHOLINE-RECEPTOR; NEUROMUSCULAR-JUNCTION; EXTRACELLULAR-MATRIX; GABA RECEPTOR; GENE ENCODES; PROTEIN; COMPLEX	Because most neurons receive thousands of synaptic inputs, the neuronal membrane is a mosaic of specialized microdomains where neurotransmitter receptors cluster in register with the corresponding presynaptic neurotransmitter release sites. In many cases the coordinated differentiation of presynaptic and postsynaptic domains implicates trans-synaptic interactions between membrane-associated proteins such as neurexins and neuroligins(1-3). The Caenorhabditis elegans neuromuscular junction (NMJ) provides a genetically tractable system in which to analyse the segregation of neurotransmitter receptors, because muscle cells receive excitatory innervation from cholinergic neurons and inhibitory innervation from GABAergic neurons(4). Here we show that Ce-Punctin/madd-4 (ref.5), the C. elegans orthologue of mammalian punctin-1 and punctin-2, encodes neurally secreted isoforms that specify the excitatory or inhibitory identity of postsynaptic NMJ domains. These proteins belong to the ADAMTS (a disintegrin and metalloprotease with thrombospondin repeats)like family, a class of extracellular matrix proteins related to the ADAM proteases but devoid of proteolytic activity(6). Ce-Punctin deletion causes the redistribution of synaptic acetylcholine and GABA(A) (gamma-aminobutyric acid type A) receptors into extrasynaptic clusters, whereas neuronal presynaptic boutons remain unaltered. Alternative promoters generate different Ce-Punctin isoforms with distinct functions. A short isoform is expressed by cholinergic and GABAergic motoneurons and localizes to excitatory and inhibitory NMJs, whereas long isoforms are expressed exclusively by cholinergic motoneurons and are confined to cholinergic NMJs. The differential expression of these isoforms controls the congruence between presynaptic and postsynaptic domains: specific disruption of the short isoform relocalizes GABAA receptors from GABAergic to cholinergic synapses, whereas expression of a long isoform in GABAergic neurons recruits acetylcholine receptors to GABAergic NMJs. These results identify Ce-Punctin as a previously unknown synaptic organizer and show that presynaptic and postsynaptic domain identities can be genetically uncoupled in vivo. Because human punctin-2 was identified as a candidate gene for schizophrenia(7), ADAMTS-like proteins may also control synapse organization in the mammalian central nervous system.	[Pinan-Lucarre, Berangere; Tu, Haijun; Pierron, Marie; Cruceyra, Pablo Ibanez; Zhan, Hong; Stigloher, Christian; Bessereau, Jean-Louis] Ecole Normale Super, Inst Biol, F-75005 Paris, France; [Pinan-Lucarre, Berangere; Tu, Haijun; Pierron, Marie; Zhan, Hong; Bessereau, Jean-Louis] Univ Lyon 1, CGphiMC UMR CNRS 5534, F-69622 Villeurbanne, France; [Richmond, Janet E.] Univ Illinois, Dept Biol Sci, Chicago, IL 60607 USA	UDICE-French Research Universities; PSL Research University Paris; Ecole Normale Superieure (ENS); UDICE-French Research Universities; Universite Claude Bernard Lyon 1; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital	Bessereau, JL (corresponding author), Ecole Normale Super, Inst Biol, F-75005 Paris, France.	jean-louis.bessereau@univ-lyon1.fr	Zhan, Hong/AAS-8840-2020; Bessereau, Jean-Louis/M-2988-2017; Stigloher, Christian/E-4762-2015; Pinan-Lucarre, Berangere/H-4542-2017	Zhan, Hong/0000-0002-7625-3528; Bessereau, Jean-Louis/0000-0002-3088-7621; Stigloher, Christian/0000-0001-6941-2669; Pinan-Lucarre, Berangere/0000-0002-6866-4714	National Institutes of Health Office of Research Infrastructure Programs [P40 OD010440]; Association Francaise contre les Myopathies; Fondation pour la Recherche Medicale; Neuropole de Recherche Francilien; Fondation Pierre-Gilles de Gennes; Human Frontier Science Program Long-Term Fellowship; Agence Nationale de la Recherche [ANR-2010-BLAN-1618-01, ANR-11-BSV4-019]; Fondation pour la Recherche Medicale ('Equipe FRM' grant)	National Institutes of Health Office of Research Infrastructure Programs; Association Francaise contre les Myopathies(Association Francaise contre les Myopathies); Fondation pour la Recherche Medicale(Fondation pour la Recherche Medicale); Neuropole de Recherche Francilien; Fondation Pierre-Gilles de Gennes; Human Frontier Science Program Long-Term Fellowship(Human Frontier Science Program); Agence Nationale de la Recherche(French National Research Agency (ANR)); Fondation pour la Recherche Medicale ('Equipe FRM' grant)	We thank C. Lena for expert assistance with analysis of postsynaptic receptor distributions; A. Boyanov for whole genome sequencing; L. Briseno-Roa for technical advice; T. Boulin and M. Jospin for critical reading of the manuscript; M. J. Caron for suggestions on the figure display; A. Valfort, H. Gendrot, P. Muller and B. Mathieu for technical help; J. Rand for the anti-UNC-17 antibodies; M. Hammarlund and E. Jorgensen for plasmids; and P. Roy, the Caenorhabditis Genetic Center (which is funded by National Institutes of Health Office of Research Infrastructure Programs, P40 OD010440) and the International C. elegans Gene Knockout Consortium for strains. B. P.-L. was supported by the Association Francaise contre les Myopathies; H.T. by the Fondation pour la Recherche Medicale and by the Neuropole de Recherche Francilien; M.P. by the Neuropole de Recherche Francilien; H.Z. by the Fondation Pierre-Gilles de Gennes; and C.S. by a Human Frontier Science Program Long-Term Fellowship. This work was funded by the Agence Nationale de la Recherche (ANR-2010-BLAN-1618-01 and ANR-11-BSV4-019), the Fondation pour la Recherche Medicale ('Equipe FRM' grant to J.-L.B.) and the Association Francaise contre les Myopathies (J.-L.B.).	Apte SS, 2009, J BIOL CHEM, V284, P31493, DOI 10.1074/jbc.R109.052340; Bamber BA, 1999, J NEUROSCI, V19, P5348; Boulin T, 2008, P NATL ACAD SCI USA, V105, P18590, DOI 10.1073/pnas.0806933105; Boulin T, 2012, NAT NEUROSCI, V15, P1374, DOI 10.1038/nn.3197; BRENNER S, 1974, GENETICS, V77, P71; Chatzigeorgiou M, 2010, NAT NEUROSCI, V13, P861, DOI 10.1038/nn.2581; Culetto E, 2004, J BIOL CHEM, V279, P42476, DOI 10.1074/jbc.M404370200; Dixon SJ, 2005, DEVELOPMENT, V132, P3079, DOI 10.1242/dev.01883; Dow DJ, 2011, SCHIZOPHR RES, V127, P28, DOI 10.1016/j.schres.2010.12.009; Fleming JT, 1997, J NEUROSCI, V17, P5843; Francis MM, 2005, NEURON, V46, P581, DOI 10.1016/j.neuron.2005.04.010; Frokjaer-Jensen C, 2008, NAT GENET, V40, P1375, DOI 10.1038/ng.248; Frokjaer-Jensen C, 2010, NAT METHODS, V7, P451, DOI [10.1038/NMETH.1454, 10.1038/nmeth.1454]; Gally C, 2004, NATURE, V431, P578, DOI 10.1038/nature02893; Gally C, 2003, J NEUROSCI, V23, P2591; Gendrel M, 2009, NATURE, V461, P992, DOI 10.1038/nature08430; Glass DJ, 1996, CELL, V85, P513, DOI 10.1016/S0092-8674(00)81252-0; Gottschalk A, 2006, J NEUROSCI METH, V154, P68, DOI 10.1016/j.jneumeth.2005.11.016; Hall NG, 2003, MATRIX BIOL, V22, P501, DOI 10.1016/S0945-053X(03)00075-1; Hirohata S, 2002, J BIOL CHEM, V277, P12182, DOI 10.1074/jbc.M109665200; Le Goff C, 2008, NAT GENET, V40, P1119, DOI 10.1038/ng.199; Lein ES, 2007, NATURE, V445, P168, DOI 10.1038/nature05453; MELLO CC, 1991, EMBO J, V10, P3959, DOI 10.1002/j.1460-2075.1991.tb04966.x; Rapti G, 2011, EMBO J, V30, P706, DOI 10.1038/emboj.2010.355; Richard M, 2013, P NATL ACAD SCI USA, V110, pE1055, DOI 10.1073/pnas.1216154110; Richmond J. E, 2006, WORMBOOK; Richmond JE, 1999, NAT NEUROSCI, V2, P791, DOI 10.1038/12160; Robert V, 2007, EMBO J, V26, P170, DOI 10.1038/sj.emboj.7601463; Sancar F, 2011, J BIOL CHEM, V286, P33501, DOI 10.1074/jbc.M111.227678; Seetharaman A, 2011, DEV CELL, V21, P669, DOI 10.1016/j.devcel.2011.07.020; Shen K, 2010, ANNU REV NEUROSCI, V33, P473, DOI 10.1146/annurev.neuro.051508.135302; Siddiqui TJ, 2011, CURR OPIN NEUROBIOL, V21, P132, DOI 10.1016/j.conb.2010.08.016; Stigloher C, 2011, J NEUROSCI, V31, P4388, DOI 10.1523/JNEUROSCI.6164-10.2011; Sudhof TC, 2008, NATURE, V455, P903, DOI 10.1038/nature07456; Touroutine D, 2005, J BIOL CHEM, V280, P27013, DOI 10.1074/jbc.M502818200; Towers PR, 2005, J NEUROCHEM, V93, P1, DOI 10.1111/j.1471-4159.2004.02951.x; Tsutsui K, 2010, J BIOL CHEM, V285, P4870, DOI 10.1074/jbc.M109.076919; Tursun B, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004625; WHITE JG, 1986, PHILOS T R SOC B, V314, P1, DOI 10.1098/rstb.1986.0056; Wu HT, 2010, DEVELOPMENT, V137, P1017, DOI 10.1242/dev.038711; Zhen M, 1999, NATURE, V401, P371, DOI 10.1038/43886	41	40	43	1	25	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 24	2014	511	7510					466	+		10.1038/nature13313	http://dx.doi.org/10.1038/nature13313			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AL7SO	24896188				2022-12-28	WOS:000339335700046
J	Dyachuk, V; Furlan, A; Shahidi, MK; Giovenco, M; Kaukua, N; Konstantinidou, C; Pachnis, V; Memic, F; Marklund, U; Muller, T; Birchmeier, C; Fried, K; Ernfors, P; Adameyko, I				Dyachuk, Vyacheslav; Furlan, Alessandro; Shahidi, Maryam Khatibi; Giovenco, Marcela; Kaukua, Nina; Konstantinidou, Chrysoula; Pachnis, Vassilis; Memic, Fatima; Marklund, Ulrika; Mueller, Thomas; Birchmeier, Carmen; Fried, Kaj; Ernfors, Patrik; Adameyko, Igor			Parasympathetic neurons originate from nerve-associated peripheral glial progenitors	SCIENCE			English	Article							NEURAL CREST; DIFFERENTIATION; SPECIFICATION; MELANOCYTES; CELLS; ERBB2	The peripheral autonomic nervous system reaches far throughout the body and includes neurons of diverse functions, such as sympathetic and parasympathetic. We show that the parasympathetic system in mice-including trunk ganglia and the cranial ciliary, pterygopalatine, lingual, submandibular, and otic ganglia-arise from glial cells in nerves, not neural crest cells. The parasympathetic fate is induced in nerve-associated Schwann cell precursors at distal peripheral sites. We used multicolor Cre-reporter lineage tracing to show that most of these neurons arise from bi-potent progenitors that generate both glia and neurons. This nerve origin places cellular elements for generating parasympathetic neurons in diverse tissues and organs, which may enable wiring of the developing parasympathetic nervous system.	[Dyachuk, Vyacheslav; Furlan, Alessandro; Giovenco, Marcela; Memic, Fatima; Marklund, Ulrika; Ernfors, Patrik] Karolinska Inst, Dept Med Biochem & Biophys, Mol Neurobiol Unit, Stockholm, Sweden; [Dyachuk, Vyacheslav] Russian Acad Sci, AV Zhirmunsky Inst Marine Biol, Far Eastern Branch, Vladivostok 690022, Russia; [Shahidi, Maryam Khatibi] Karolinska Inst, Dept Dent Med, Stockholm, Sweden; [Kaukua, Nina; Fried, Kaj] Karolinska Inst, Dept Neurosci, Stockholm, Sweden; [Konstantinidou, Chrysoula; Pachnis, Vassilis] Med Res Council MRC Natl Inst Med Res, Div Mol Neurobiol, London, England; [Mueller, Thomas; Birchmeier, Carmen] Max Delbruck Ctr Mol Med, Dept Neurosci, Berlin, Germany; [Adameyko, Igor] Karolinska Inst, Dept Physiol & Pharmacol, Stockholm, Sweden	Karolinska Institutet; Russian Academy of Sciences; National Scientific Center of Marine Biology, Far East Branch of the Russian Academy of Sciences; Karolinska Institutet; Karolinska Institutet; Helmholtz Association; Max Delbruck Center for Molecular Medicine; Karolinska Institutet	Ernfors, P (corresponding author), Karolinska Inst, Dept Med Biochem & Biophys, Mol Neurobiol Unit, Stockholm, Sweden.	patrik.ernfors@ki.se; igor.adameyko@ki.se	Dyachuk, Vyacheslav/U-9115-2019; Marklund, Ulrika/I-8814-2012; Furlan, Alessandro/AAM-4680-2021	Dyachuk, Vyacheslav/0000-0001-8100-7367; Marklund, Ulrika/0000-0003-1426-1271; Furlan, Alessandro/0000-0001-5149-6331; Adameyko, Igor/0000-0001-5471-0356; Pachnis, Vassilis/0000-0001-9733-7686; Muller, Thomas/0000-0001-8096-1853	Swedish Research Council for Medicine and Health; Swedish Cancer Society; Strategiska Forskningsomradena (SFO); Swedish Brain Foundation; Wallenberg Scholar; Soderberg Foundation; European Research Council (ERC) [232675]; Swedish Research Council; Bertil Hallsten Research Foundation; SFO on Stem Cells and Regenerative Medicine (StratRegen); Knut and Alice Wallenberg Foundation (CLICK); Swedish Dental Association; Stockholm County Council; Swedish National Graduate School in Odontological Science; German Science Foundation [SFB 665]; MRC [A2525RF00]; MRC National Institute of Medical Research; Knut and Alice Wallenberg Foundation [KAW2008.0123]; Swedish Research Council [521-2012-1676]; Swedish Doctoral Society [SLS330921, SLS331191]; Ruth and Richard Julin Foundation [36938]; Ake Wiberg Foundation [613512953]; Eva and Oscar Ahren Foundation; Medical Research Council [MC_U117537087] Funding Source: researchfish; MRC [MC_U117537087] Funding Source: UKRI	Swedish Research Council for Medicine and Health; Swedish Cancer Society(Swedish Cancer Society); Strategiska Forskningsomradena (SFO); Swedish Brain Foundation; Wallenberg Scholar; Soderberg Foundation; European Research Council (ERC)(European Research Council (ERC)European Commission); Swedish Research Council(Swedish Research CouncilEuropean Commission); Bertil Hallsten Research Foundation; SFO on Stem Cells and Regenerative Medicine (StratRegen); Knut and Alice Wallenberg Foundation (CLICK)(Knut & Alice Wallenberg Foundation); Swedish Dental Association; Stockholm County Council(Stockholm County Council); Swedish National Graduate School in Odontological Science; German Science Foundation(German Research Foundation (DFG)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC National Institute of Medical Research(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Knut and Alice Wallenberg Foundation(Knut & Alice Wallenberg Foundation); Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Doctoral Society; Ruth and Richard Julin Foundation; Ake Wiberg Foundation; Eva and Oscar Ahren Foundation; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	We thank M. Lubke for breeding Ret mice; J.-F. Brunet, M. Wegner, and F. Lallemend for generously providing Phox2b, Sox10, and 2H3 antibodies; H. Clevers for Confetti; H. Enomoto (RIKEN) for Ret <SUP>CFP</SUP> mice; and the CLICK Imaging Facility supported by the Wallenberg Foundation. This work was supported by the Swedish Research Council for Medicine and Health, the Swedish Cancer Society and Strategiska Forskningsomradena (SFO) grants, the Swedish Brain Foundation, Wallenberg Scholar, Soderberg Foundation, and European Research Council (ERC) advanced grant (232675) to P. E. I. A. and K. F. were supported by grants from Swedish Research Council, The Bertil Hallsten Research Foundation, SFO on Stem Cells and Regenerative Medicine (StratRegen), and the Knut and Alice Wallenberg Foundation (CLICK). N.K. and M. K. S. received support from the Swedish Dental Association and Stockholm County Council. M. K. S. also received support from Swedish National Graduate School in Odontological Science. C. B. was supported by a grant from German Science Foundation (SFB 665). V. P. was supported by MRC (grant-in-aid A2525RF00). C. K. is a recipient of a Ph.D. studentship from the MRC National Institute of Medical Research. U. M. was supported by the Knut and Alice Wallenberg Foundation (KAW2008.0123), Swedish Research Council (521-2012-1676), Swedish Doctoral Society (SLS330921 and SLS331191), Ruth and Richard Julin Foundation (36938), Ake Wiberg Foundation (613512953), and Eva and Oscar Ahren Foundation. In-house-generated plasmids and antibodies are freely available from the authors. Mouse strains Plp<SUP>CreERT2</SUP>, Ascl1<SUP>CreERT2</SUP>, R26R<SUP>YFP</SUP>, R26R<SUP>TOMATO</SUP>, and R26R<SUP>Confetti</SUP> are freely available from The Jacksons Laboratory (United States). Other strains will require materials transfer agreements (MTAs) of future users: Sox10<SUP>CreERT2</SUP> and Ascl1<SUP>NGN2</SUP>(MTA from MRC), ErbB3 KO (MTA from the Max Delbruck Center for Molecular Medicine), and Ret <SUP>CFP</SUP> (MTA from RIKEN). MTA for Ret <SUP>CFP</SUP> mice is attached with submission. The supplementary materials contain additional data.	Adameyko I, 2012, DEVELOPMENT, V139, P397, DOI 10.1242/dev.065581; Adameyko I, 2009, CELL, V139, P366, DOI 10.1016/j.cell.2009.07.049; Aoki Y, 2003, DEV BIOL, V259, P19, DOI 10.1016/S0012-1606(03)00161-1; DAMICOMARTEL A, 1983, AM J ANAT, V166, P445, DOI 10.1002/aja.1001660406; Enomoto H, 2000, DEVELOPMENT, V127, P4877; GUILLEMOT F, 1993, MECH DEVELOP, V42, P171, DOI 10.1016/0925-4773(93)90006-J; GUILLEMOT F, 1993, CELL, V75, P463, DOI 10.1016/0092-8674(93)90381-Y; Honore SM, 2003, DEV BIOL, V259, P502; Howard MJ, 2005, DEV BIOL, V277, P271, DOI 10.1016/j.ydbio.2004.09.034; Le Douarin N, 1999, NEURAL CREST, Vxxiii; Lee VM, 2003, DEV BIOL, V263, P176, DOI 10.1016/j.ydbio.2003.07.004; Muller F, 2002, DEVELOPMENT, V129, P5707, DOI 10.1242/dev.00165; Parras CM, 2002, GENE DEV, V16, P324, DOI 10.1101/gad.940902; Pattyn A, 1999, NATURE, V399, P366, DOI 10.1038/20700; Riethmacher D, 1997, NATURE, V389, P725, DOI 10.1038/39593; SLIWKOWSKI MX, 1994, J BIOL CHEM, V269, P14661; Snippert HJ, 2010, CELL, V143, P134, DOI 10.1016/j.cell.2010.09.016; White PM, 2001, NEURON, V29, P57, DOI 10.1016/S0896-6273(01)00180-5; Woldeyesus MT, 1999, GENE DEV, V13, P2538, DOI 10.1101/gad.13.19.2538; Young HM, 2011, AUTON NEUROSCI-BASIC, V165, P10, DOI 10.1016/j.autneu.2010.03.002	20	134	134	0	44	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 4	2014	345	6192					82	87		10.1126/science.1253281	http://dx.doi.org/10.1126/science.1253281			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK2XU	24925909				2022-12-28	WOS:000338284400055
J	Espinosa-Medina, I; Outin, E; Picard, CA; Chettouh, Z; Dymecki, S; Consalez, GG; Coppola, E; Brunet, JF				Espinosa-Medina, I.; Outin, E.; Picard, C. A.; Chettouh, Z.; Dymecki, S.; Consalez, G. G.; Coppola, E.; Brunet, J. -F.			Parasympathetic ganglia derive from Schwann cell precursors	SCIENCE			English	Article							STEM-CELLS; NEUROGENIN 2; MOUSE LINE; EXPRESSION; DIFFERENTIATION; PHOX2B; ORIGIN	Neural crest cells migrate extensively and give rise to most of the peripheral nervous system, including sympathetic, parasympathetic, enteric, and dorsal root ganglia. We studied how parasympathetic ganglia form close to visceral organs and what their precursors are. We find that many cranial nerve-associated crest cells coexpress the pan-autonomic determinant Paired-like homeodomain 2b (Phox2b) together with markers of Schwann cell precursors. Some give rise to Schwann cells after down-regulation of PHOX2b. Others form parasympathetic ganglia after being guided to the site of ganglion formation by the nerves that carry preganglionic fibers, a parsimonious way of wiring the pathway. Thus, cranial Schwann cell precursors are the source of parasympathetic neurons during normal development.	[Espinosa-Medina, I.; Outin, E.; Picard, C. A.; Chettouh, Z.; Coppola, E.; Brunet, J. -F.] Inserm U1024, Ecole Normale Super, Inst Biol, F-75005 Paris, France; [Espinosa-Medina, I.; Outin, E.; Picard, C. A.; Chettouh, Z.; Coppola, E.; Brunet, J. -F.] CNRS UMR 8197, F-75005 Paris, France; [Dymecki, S.] Harvard Univ, Sch Med, Dept Genet, Boston, MA 02115 USA; [Consalez, G. G.] Ist Sci San Raffaele, Div Neurosci, I-20132 Milan, Italy	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; PSL Research University Paris; Ecole Normale Superieure (ENS); Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Harvard University; Harvard Medical School; Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele	Brunet, JF (corresponding author), Inserm U1024, Ecole Normale Super, Inst Biol, F-75005 Paris, France.	jfbrunet@biologie.ens.fr	Consalez, Giacomo/AAA-2146-2019	Consalez, Giacomo/0000-0003-4594-6273; Brunet, Jean-Francois/0000-0002-1985-6103	Agence Nationale de la Recherche [ANR-12-BSV4-0007-01]; Investissements d'Avenir [ANR-10-LABX-54 MEMO LIFE, ANR-11-IDEX-0001-02]; Federation pour la Recherche sur le Cerveau; NIH [R01 DK067826, R21 DA023643, P01 HD036379]; Fondazione CARIPLO, Milan, Italy; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P01HD036379] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK067826] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R21DA023643] Funding Source: NIH RePORTER	Agence Nationale de la Recherche(French National Research Agency (ANR)); Investissements d'Avenir(French National Research Agency (ANR)); Federation pour la Recherche sur le Cerveau; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Fondazione CARIPLO, Milan, Italy(Fondazione Cariplo); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	We thank M. Lazdunski for the ASIC2a<SUP>G430F</SUP> clone; C. Birchmeier, T. Muller, and M. Wegner for antibodies; M.-C. Tiveron for the original discovery of the limb ganglion; V. Michel for preliminary experiments; the imaging facilities of IBENS and Institut de la Vision, B. Mathieu, and D. Godefroy for technical assistance; and C. Goridis for helpful discussions. This work was supported by the Agence Nationale de la Recherche (ANR-12-BSV4-0007-01) and Investissements d'Avenir (ANR-10-LABX-54 MEMO LIFE and ANR-11-IDEX-0001-02 PSL* Research University) (to J.-F.B.); Federation pour la Recherche sur le Cerveau (to Institut de la Vision); and NIH grants R01 DK067826, R21 DA023643, and P01 HD036379 (to S.D.). G.G.C. was funded by the Fondazione CARIPLO, Milan, Italy, and I.-E.M. received a Ph.D. studentship.	Adameyko I, 2009, CELL, V139, P366, DOI 10.1016/j.cell.2009.07.049; Al J, 2007, NEUROSCIENCE, V149, P845, DOI 10.1016/j.neuroscience.2007.07.062; Blessing W, 1997, LOWER BRAINSTEM BODI; Brockschniedier D, 2006, GENESIS, V44, P322, DOI 10.1002/dvg.20218; Coppola E, 2010, P NATL ACAD SCI USA, V107, P2066, DOI 10.1073/pnas.0910213107; D'Autreaux F, 2011, P NATL ACAD SCI USA, V108, P20018, DOI 10.1073/pnas.1110416108; ECHELARD Y, 1994, DEVELOPMENT, V120, P2213; Florio M, 2012, DEVELOPMENT, V139, P2308, DOI 10.1242/dev.075861; Fode C, 1998, NEURON, V20, P483, DOI 10.1016/S0896-6273(00)80989-7; FURBER S, 1987, J NEUROSCI, V7, P1816; Harbinder S, 1997, P NATL ACAD SCI USA, V94, P13128, DOI 10.1073/pnas.94.24.13128; Hirsch MR, 2013, GENESIS, V51, P506, DOI 10.1002/dvg.22393; Hirsch MR, 1998, DEVELOPMENT, V125, P599; Jensen P, 2008, NAT NEUROSCI, V11, P417, DOI 10.1038/nn2050; Jessen KR, 2005, NAT REV NEUROSCI, V6, P671, DOI 10.1038/nrn1746; Joseph NM, 2004, DEVELOPMENT, V131, P5599, DOI 10.1242/dev.01429; Kandel E.R., 2012, PRINCIPLES NEURAL SC; Le Douarin NM, 1999, NEURAL CREST, V2; Morrison SJ, 1999, CELL, V96, P737, DOI 10.1016/S0092-8674(00)80583-8; Pattyn A, 1997, DEVELOPMENT, V124, P4065; Pattyn A, 1999, NATURE, V399, P366, DOI 10.1038/20700; Takahashi Y, 2013, SCIENCE, V341, P860, DOI 10.1126/science.1230717; Tiveron MC, 1996, J NEUROSCI, V16, P7649; Waldmann R, 1996, J BIOL CHEM, V271, P10433, DOI 10.1074/jbc.271.18.10433; Wegner M, 2005, TRENDS NEUROSCI, V28, P583, DOI 10.1016/j.tins.2005.08.008; White PM, 2001, NEURON, V29, P57, DOI 10.1016/S0896-6273(01)00180-5	26	127	128	1	20	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 4	2014	345	6192					87	90		10.1126/science.1253286	http://dx.doi.org/10.1126/science.1253286			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK2XU	24925912				2022-12-28	WOS:000338284400056
J	Hirsch, E; Novelli, F				Hirsch, Emilio; Novelli, Francesco			CANCER Natural-born killers unleashed	NATURE			English	Editorial Material							CELLS		[Hirsch, Emilio] Univ Turin, Ctr Mol Biotechnol, Dept Mol Biotechnol & Hlth Sci, I-10126 Turin, Italy; [Novelli, Francesco] Univ Turin, Ctr Expt Res & Med Studies, Dept Mol Biotechnol & Hlth Sci, I-10126 Turin, Italy	University of Turin; University of Turin	Hirsch, E (corresponding author), Univ Turin, Ctr Mol Biotechnol, Dept Mol Biotechnol & Hlth Sci, I-10126 Turin, Italy.	emilio.hirsch@unito.it; franco.novelli@unito.it	Novelli, Francesco/Z-5990-2019; Hirsch, Emilio/F-4848-2013	NOVELLI, FRANCESCO/0000-0002-6259-5666; Hirsch, Emilio/0000-0002-9073-6024				Ali K, 2014, NATURE, V510, P407, DOI 10.1038/nature13444; Couzin-Frankel J, 2013, SCIENCE, V342, P1432, DOI 10.1126/science.342.6165.1432; Fruman DA, 2014, NEW ENGL J MED, V370, P1061, DOI 10.1056/NEJMe1400055; Hirsch E., 2013, ONCOGENE; Okkenhaug K, 2013, ANNU REV IMMUNOL, V31, P675, DOI 10.1146/annurev-immunol-032712-095946; Putz EM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040852; Sakaguchi S, 2010, NAT REV IMMUNOL, V10, P490, DOI 10.1038/nri2785; Vanhaesebroeck B, 2010, NAT REV MOL CELL BIO, V11, P329, DOI 10.1038/nrm2882	8	6	6	0	10	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 19	2014	510	7505					342	343		10.1038/nature13503	http://dx.doi.org/10.1038/nature13503			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AJ0NG	24919150				2022-12-28	WOS:000337350200020
J	Xu, K; Wu, ZH; Renier, N; Antipenko, A; Tzvetkova-Robev, D; Xu, Y; Minchenko, M; Nardi-Dei, V; Rajashankar, KR; Himanen, J; Tessier-Lavigne, M; Nikolov, DB				Xu, Kai; Wu, Zhuhao; Renier, Nicolas; Antipenko, Alexander; Tzvetkova-Robev, Dorothea; Xu, Yan; Minchenko, Maria; Nardi-Dei, Vincenzo; Rajashankar, Kanagalaghatta R.; Himanen, Juha; Tessier-Lavigne, Marc; Nikolov, Dimitar B.			NEURAL MIGRATION Structures of netrin-1 bound to two receptors provide insight into its axon guidance mechanism	SCIENCE			English	Article							HEPARAN-SULFATE; DCC; BINDING; EXPRESSION; FAMILY; MOLECULE; MIDLINE; UNC5; SLIT	Netrins are secreted proteins that regulate axon guidance and neuronal migration. Deleted in colorectal cancer (DCC) is a well-established netrin-1 receptor mediating attractive responses. We provide evidence that its close relative neogenin is also a functional netrin-1 receptor that acts with DCC to mediate guidance in vivo. We determined the structures of a functional netrin-1 region, alone and in complexes with neogenin or DCC. Netrin-1 has a rigid elongated structure containing two receptor-binding sites at opposite ends through which it brings together receptor molecules. The ligand/receptor complexes reveal two distinct architectures: a 2:2 heterotetramer and a continuous ligand/receptor assembly. The differences result from different lengths of the linker connecting receptor domains fibronectin type III domain 4 (FN4) and FN5, which differs among DCC and neogenin splice variants, providing a basis for diverse signaling outcomes.	[Xu, Kai; Antipenko, Alexander; Tzvetkova-Robev, Dorothea; Xu, Yan; Minchenko, Maria; Nardi-Dei, Vincenzo; Himanen, Juha; Nikolov, Dimitar B.] Mem Sloan Kettering Canc Ctr, Struct Biol Program, New York, NY 10065 USA; [Wu, Zhuhao; Renier, Nicolas; Tessier-Lavigne, Marc] Rockefeller Univ, Lab Brain Dev & Repair, New York, NY 10065 USA; [Rajashankar, Kanagalaghatta R.] Cornell Univ, Dept Chem & Chem Biol, Argonne, IL 60439 USA; [Rajashankar, Kanagalaghatta R.] Argonne Natl Lab, Adv Photon Source, Northeastern Collaborat Access Team, Argonne, IL 60439 USA	Memorial Sloan Kettering Cancer Center; Rockefeller University; Cornell University; United States Department of Energy (DOE); Argonne National Laboratory	Tessier-Lavigne, M (corresponding author), Rockefeller Univ, Lab Brain Dev & Repair, New York, NY 10065 USA.	marctl@mail.rockefeller.edu; nikolovd@mskcc.org	Renier, Nicolas/E-1855-2018; Wu, Zhuhao/I-5852-2018	Renier, Nicolas/0000-0003-2642-4402; Wu, Zhuhao/0000-0002-2471-0555	National Institute of General Medical Sciences from NIH [P41 GM103403]; U.S. DOE [DE-AC02-06CH11357]; Bristol-Myers Squibb postdoctoral fellowship at the Rockefeller University; European Molecular Biology Organization long-term postdoctoral fellowship; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P41GM103403] Funding Source: NIH RePORTER	National Institute of General Medical Sciences from NIH; U.S. DOE(United States Department of Energy (DOE)); Bristol-Myers Squibb postdoctoral fellowship at the Rockefeller University; European Molecular Biology Organization long-term postdoctoral fellowship; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank M. Kolev for technical support, M. Himanen for illustrations, Y. Goldgur for help with data collection and processing, and O. Olsen for help and support. X-ray diffraction studies were conducted at the Advanced Photon Source on the Northeastern Collaborative Access Team beamlines, which are supported by a grant from the National Institute of General Medical Sciences (P41 GM103403) from NIH. Use of the Advanced Photon Source, an Office of Science User Facility operated for the U.S. Department of Energy (DOE) Office of Science by Argonne National Laboratory, was supported by the U.S. DOE under contract no. DE-AC02-06CH11357. Z.W. was supported in part by a Bristol-Myers Squibb postdoctoral fellowship at the Rockefeller University; N.R. was supported by a European Molecular Biology Organization long-term postdoctoral fellowship. The netrin-1, netrin-1/neogenin, and netrin-1/DCC structures have been deposited in the Protein Data Bank under codes 4PLM, 4PLN, and 4PLO, respectively.	Bell CH, 2013, SCIENCE, V341, P77, DOI 10.1126/science.1232322; Brasch J, 2011, J MOL BIOL, V414, P723, DOI 10.1016/j.jmb.2011.10.030; Carafoli F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042473; Engle EC, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a001784; Fazeli A, 1997, NATURE, V386, P796, DOI 10.1038/386796a0; Forcet C, 2002, NATURE, V417, P443, DOI 10.1038/nature748; Geisbrecht BV, 2003, J BIOL CHEM, V278, P32561, DOI 10.1074/jbc.M302943200; Hussain SA, 2011, EMBO REP, V12, P276, DOI 10.1038/embor.2011.3; Kappler J, 2000, BIOCHEM BIOPH RES CO, V271, P287, DOI 10.1006/bbrc.2000.2583; Kastenhuber E, 2009, J NEUROSCI, V29, P8914, DOI 10.1523/JNEUROSCI.0568-09.2009; KeinoMasu K, 1996, CELL, V87, P175, DOI 10.1016/S0092-8674(00)81336-7; Kruger RP, 2004, J NEUROSCI, V24, P10826, DOI 10.1523/JNEUROSCI.3715-04.2004; Manitt C, 2004, J NEUROSCI RES, V77, P690, DOI 10.1002/jnr.20199; Matsumoto Y, 2007, J NEUROSCI, V27, P4342, DOI 10.1523/JNEUROSCI.0700-07.2007; Mille F, 2009, CELL DEATH DIFFER, V16, P1344, DOI 10.1038/cdd.2009.75; Moore SW, 2007, ADV EXP MED BIOL, V621, P17, DOI 10.1007/978-0-387-76715-4_2; Palmesino E, 2012, J NEUROSCI, V32, P411, DOI 10.1523/JNEUROSCI.3563-11.2012; Rajagopalan S, 2004, NAT CELL BIOL, V6, P756, DOI 10.1038/ncb1156; Rajasekharan S, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-9-239; Sabatier C, 2004, CELL, V117, P157, DOI 10.1016/S0092-8674(04)00303-4; Seiradake E, 2011, EMBO J, V30, P4479, DOI 10.1038/emboj.2011.346; Serafini T, 1996, CELL, V87, P1001, DOI 10.1016/S0092-8674(00)81795-X; SERAFINI T, 1994, CELL, V78, P409, DOI 10.1016/0092-8674(94)90420-0; Shen H, 2002, MECH DEVELOP, V118, P219, DOI 10.1016/S0925-4773(02)00255-1; Srinivasan K, 2003, DEV CELL, V4, P371, DOI 10.1016/S1534-5807(03)00054-6; Srour M, 2010, SCIENCE, V328, P592, DOI 10.1126/science.1186463; TessierLavigne M, 1996, SCIENCE, V274, P1123, DOI 10.1126/science.274.5290.1123; Vulliemoz S, 2005, LANCET NEUROL, V4, P87, DOI 10.1016/S1474-4422(05)00990-7; Wang H, 1999, J NEUROSCI, V19, P4938; Wilson NH, 2006, DEV BIOL, V296, P485, DOI 10.1016/j.ydbio.2006.06.018	30	118	118	1	41	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 13	2014	344	6189					1275	1279		10.1126/science.1255149	http://dx.doi.org/10.1126/science.1255149			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI7ND	24876346	Green Accepted			2022-12-28	WOS:000337077500039
J	Torjesen, I				Torjesen, Ingrid			Hospital staff caring for tracheotomy patients need better training, enquiry finds	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																		National Confidential Enquiry into Patient Outcomes and Death, 2014, RIGHT TRACH REV CAR	1	0	0	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JUN 12	2014	348								g3827	10.1136/bmj.g3827	http://dx.doi.org/10.1136/bmj.g3827			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AJ1HW	24923590				2022-12-28	WOS:000337407700002
J	Martin, WF; Sousa, FL; Lane, N				Martin, William F.; Sousa, Filipa L.; Lane, Nick			EVOLUTION Energy at life's origin	SCIENCE			English	Editorial Material							CARBON; FIXATION; DEEP; ACID		[Martin, William F.; Sousa, Filipa L.] Univ Dusseldorf, Inst Mol Evolut, D-40225 Dusseldorf, Germany; [Lane, Nick] UCL, Res Dept Genet Evolut & Environm, London WC1E 6BT, England	Heinrich Heine University Dusseldorf; University of London; University College London	Martin, WF (corresponding author), Univ Dusseldorf, Inst Mol Evolut, Univ Str 1, D-40225 Dusseldorf, Germany.	bill@hhu.de	Sousa, Filipa L./H-6192-2012; Martin, William F./O-5446-2015; Sousa, Filipa/ACC-2848-2022	Sousa, Filipa L./0000-0002-4075-1701; Martin, William F./0000-0003-1478-6449; Sousa, Filipa/0000-0002-4084-1942; Lane, Nick/0000-0002-5433-3973				Arndt NT, 2012, ANNU REV EARTH PL SC, V40, P521, DOI 10.1146/annurev-earth-042711-105316; BAROSS JA, 1985, ORIGINS LIFE EVOL B, V15, P327, DOI 10.1007/BF01808177; Buckel W, 2013, BBA-BIOENERGETICS, V1827, P94, DOI 10.1016/j.bbabio.2012.07.002; Chivian D, 2008, SCIENCE, V322, P275, DOI 10.1126/science.1155495; DECKER K, 1970, ANGEW CHEM INT EDIT, V9, P138, DOI 10.1002/anie.197001381; ECK RV, 1966, SCIENCE, V152, P363, DOI 10.1126/science.152.3720.363; Ferry JG, 2006, MOL BIOL EVOL, V23, P1286, DOI 10.1093/molbev/msk014; Fuchs G, 2011, ANNU REV MICROBIOL, V65, P631, DOI 10.1146/annurev-micro-090110-102801; Huber C, 1997, SCIENCE, V276, P245, DOI 10.1126/science.276.5310.245; Lane N, 2012, CELL, V151, P1406, DOI 10.1016/j.cell.2012.11.050; Mayer F, 2014, FEMS MICROBIOL REV, V38, P449, DOI 10.1111/1574-6976.12043; McCollom TM, 2013, ELEMENTS, V9, P129, DOI 10.2113/gselements.9.2.129; Mulkidjanian AY, 2012, P NATL ACAD SCI USA, V109, pE821, DOI 10.1073/pnas.1117774109; Russell MJ, 1997, J GEOL SOC LONDON, V154, P377, DOI 10.1144/gsjgs.154.3.0377; Schrenk MO, 2013, REV MINERAL GEOCHEM, V75, P575, DOI 10.2138/rmg.2013.75.18	15	81	84	2	129	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 6	2014	344	6188					1092	1093		10.1126/science.1251653	http://dx.doi.org/10.1126/science.1251653			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AI3UU	24904143				2022-12-28	WOS:000336791200024
J	Nepstad, D; McGrath, D; Stickler, C; Alencar, A; Azevedo, A; Swette, B; Bezerra, T; DiGiano, M; Shimada, J; da Motta, RS; Armijo, E; Castello, L; Brando, P; Hansen, MC; McGrath-Horn, M; Carvalho, O; Hess, L				Nepstad, Daniel; McGrath, David; Stickler, Claudia; Alencar, Ane; Azevedo, Andrea; Swette, Briana; Bezerra, Tathiana; DiGiano, Maria; Shimada, Joao; da Motta, Ronaldo Seroa; Armijo, Eric; Castello, Leandro; Brando, Paulo; Hansen, Matt C.; McGrath-Horn, Max; Carvalho, Oswaldo; Hess, Laura			Slowing Amazon deforestation through public policy and interventions in beef and soy supply chains	SCIENCE			English	Review							LAND-USE; BRAZILIAN AMAZON; CONSERVATION; FRONTIER; FORESTS; CLIMATE; FIRE	The recent 70% decline in deforestation in the Brazilian Amazon suggests that it is possible to manage the advance of a vast agricultural frontier. Enforcement of laws, interventions in soy and beef supply chains, restrictions on access to credit, and expansion of protected areas appear to have contributed to this decline, as did a decline in the demand for new deforestation. The supply chain interventions that fed into this deceleration are precariously dependent on corporate risk management, and public policies have relied excessively on punitive measures. Systems for delivering positive incentives for farmers to forgo deforestation have been designed but not fully implemented. Territorial approaches to deforestation have been effective and could consolidate progress in slowing deforestation while providing a framework for addressing other important dimensions of sustainable development.	[Nepstad, Daniel; McGrath, David; Stickler, Claudia; Swette, Briana; Bezerra, Tathiana; DiGiano, Maria; Shimada, Joao; Armijo, Eric; McGrath-Horn, Max; Carvalho, Oswaldo] Earth Innovat Inst, San Francisco, CA 94110 USA; [McGrath, David] Univ Fed Oeste Para, BR-68040470 Santarem, Para, Brazil; [Alencar, Ane; Azevedo, Andrea; Brando, Paulo] Inst Pesquisa Ambiental Amazonia, BR-71503505 Brasilia, DF, Brazil; [da Motta, Ronaldo Seroa] Univ Estado Rio de Janeiro, BR-20550011 Rio De Janeiro, Brazil; [Castello, Leandro] Virginia Polytech Inst & State Univ, Blacksburg, VA 24061 USA; [Brando, Paulo] Carnegie Inst Sci, Stanford, CA 94305 USA; [Hansen, Matt C.] Univ Maryland, Dept Geog Sci, College Pk, MD 20742 USA; [Hess, Laura] Univ Calif Santa Barbara, Earth Res Inst, Santa Barbara, CA 93106 USA	Universidade Federal do Oeste do Para; Universidade do Estado do Rio de Janeiro; Virginia Polytechnic Institute & State University; Carnegie Institution for Science; University System of Maryland; University of Maryland College Park; University of California System; University of California Santa Barbara	Nepstad, D (corresponding author), Earth Innovat Inst, 3180 18th St,Suite 205, San Francisco, CA 94110 USA.	dnepstad@earthinnovation.org	Lobo, Diele/I-9106-2012; Brando, Paulo M/C-4302-2012; mahsum, masot/ABC-4546-2020; Hansen, Matthew C/ABE-7226-2020; Brando, Paulo/AAC-9396-2019; /AAX-3684-2020; Armijo, Eric/AGQ-9868-2022; Castello, Leandro/K-4389-2012	Brando, Paulo M/0000-0001-8952-7025; Brando, Paulo/0000-0001-8952-7025; /0000-0001-5605-7469; Castello, Leandro/0000-0002-9968-1584; McGrath-Horn, Maxwell/0000-0002-7785-1466	Norwegian Agency for Development Cooperation [QZA-0186, QZA-13/0548]; U.S. National Science Foundation [1146206]; Gordon and Betty Moore Foundation [3980]; Linden Conservation Trust	Norwegian Agency for Development Cooperation; U.S. National Science Foundation(National Science Foundation (NSF)); Gordon and Betty Moore Foundation(Gordon and Betty Moore Foundation); Linden Conservation Trust	K. Schwalbe helped with text editing and formatting; M. Nepstad designed Fig. 4. This work was funded through grants from the Norwegian Agency for Development Cooperation (QZA-0186, QZA-13/0548), the U.S. National Science Foundation (1146206), the Gordon and Betty Moore Foundation (3980), the Linden Conservation Trust, and Roger and Vicki Sant to the Earth Innovation Institute, Instituto de Pesquisa Ambiental da Amazonia International Program, or the Woods Hole Research Center.	ABIEC Associacao Brasileira das Industrias Exportadoras de Carne, 2012, MAP PLANT FRIG; Alianca da Terra, 2014, MAP GER CCS; Asner GP, 2013, P NATL ACAD SCI USA, V110, P18454, DOI 10.1073/pnas.1318271110; Assuncao J., 2013, DOES CREDIT AFFECT D; Brando PM, 2013, PHILOS T R SOC B, V368, DOI 10.1098/rstb.2012.0152; Brando PM, 2014, P NATL ACAD SCI USA, V111, P6347, DOI 10.1073/pnas.1305499111; Campos MT, 2006, CONSERV BIOL, V20, P1553, DOI 10.1111/j.1523-1739.2006.00546.x; Castello L, 2013, CONSERV LETT, V6, P217, DOI 10.1111/conl.12008; Certificacion Forestal Voluntaria, 2011, OP FOR CERT; Cohn A. S., 2014, P NATL ACAD SCI US; Davidson EA, 2012, NATURE, V481, P321, DOI 10.1038/nature10717; Galford GL, 2010, EARTH INTERACT, V14, DOI 10.1175/2010EI327.1; Hanson MA, 2012, SCIENCE, V335, P851, DOI [10.1126/science.1244693, 10.1126/science.1215904]; Hargrave J, 2013, ENVIRON RESOUR ECON, V54, P471, DOI 10.1007/s10640-012-9610-2; Imazon, 2011, DESM NOS ASS REF AGR; Instituto Brasileiro de Geografia e Estatistica, 2013, PROD AGR MUN; Instituto Socioambiental, 2011, AR PROT AM; Joyce H., 2013, ECONOMIST; Lewis SL, 2011, SCIENCE, V331, P554, DOI 10.1126/science.1200807; Macedo MN, 2012, P NATL ACAD SCI USA, V109, P1341, DOI 10.1073/pnas.1111374109; Martins H., 2013, DESMATAMENTO AREAS P; Ministerio do Meio Ambiente, 2014, LIST MUN PRIOR AM; Nassar A., 2014, BRAZILS PATHWAY LOW; Nepstad D, 2006, CONSERV BIOL, V20, P65, DOI 10.1111/j.1523-1739.2006.00351.x; Nepstad D, 2013, CARBON MANAG, V4, P639, DOI [10.4155/cmt.13.65, 10.4155/CMT.13.65]; Nepstad D, 2009, SCIENCE, V326, P1350, DOI 10.1126/science.1182108; Nepstad DC, 2008, PHILOS T R SOC B, V363, P1737, DOI 10.1098/rstb.2007.0036; Nepstad DC, 2013, PHILOS T R SOC B, V368, DOI 10.1098/rstb.2012.0167; Nepstad DC, 2006, CONSERV BIOL, V20, P1595, DOI 10.1111/j.1523-1739.2006.00510.x; Rajao R, 2012, PUBLIC ADMIN DEVELOP, V32, P229, DOI 10.1002/pad.1620; Santos D., 2013, ESTADO AMAZONIA USO; Schwartzman S, 2010, J ENVIRON DEV, V19, P274, DOI 10.1177/1070496510367627; Soares BS, 2006, NATURE, V440, P520, DOI 10.1038/nature04389; Soares B, 2014, SCIENCE, V344, P363, DOI 10.1126/science.1246663; Soares B, 2010, P NATL ACAD SCI USA, V107, P10821, DOI 10.1073/pnas.0913048107; Stickler CM, 2013, PHILOS T R SOC B, V368, DOI 10.1098/rstb.2012.0160; Rudorff BFT, 2011, REMOTE SENS-BASEL, V3, P185, DOI 10.3390/rs3010185	37	633	636	13	425	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 6	2014	344	6188					1118	1123		10.1126/science.1248525	http://dx.doi.org/10.1126/science.1248525			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI3UU	24904156				2022-12-28	WOS:000336791200038
J	Seow, H; Brazil, K; Sussman, J; Pereira, J; Marshall, D; Austin, PC; Husain, A; Rangrej, J; Barbera, L				Seow, Hsien; Brazil, Kevin; Sussman, Jonathan; Pereira, Jose; Marshall, Denise; Austin, Peter C.; Husain, Amna; Rangrej, Jagadish; Barbera, Lisa			Impact of community based, specialist palliative care teams on hospitalisations and emergency department visits late in life and hospital deaths: a pooled analysis	BMJ-BRITISH MEDICAL JOURNAL			English	Article							END-OF-LIFE; POPULATION-BASED-COHORT; RANDOMIZED-TRIAL; CANCER-PATIENTS; PROPENSITY-SCORE; HOME-CARE; ADMINISTRATIVE DATA; IMPROVE OUTCOMES; TERMINALLY-ILL; INTERVENTION	Objective To determine the pooled effect of exposure to one of 11 specialist palliative care teams providing services in patients' homes. Design Pooled analysis of a retrospective cohort study. Setting Ontario, Canada. Participants 3109 patients who received care from specialist palliative care teams in 2009-11 (exposed) matched by propensity score to 3109 patients who received usual care (unexposed). Intervention The palliative care teams studied served different geographies and varied in team composition and size but had the same core team members and role: a core group of palliative care physicians, nurses, and family physicians who provide integrated palliative care to patients in their homes. The teams' role was to manage symptoms, provide education and care, coordinate services, and be available without interruption regardless of time or day. Main outcome measures Patients (a) being in hospital in the last two weeks of life; (b) having an emergency department visit in the last two weeks of life; or (c) dying in hospital. Results In both exposed and unexposed groups, about 80% had cancer and 78% received end of life homecare services for the same average duration. Across all palliative care teams, 970 (31.2%) of the exposed group were in hospital and 896 (28.9%) had an emergency department visit in the last two weeks of life respectively, compared with 1219 (39.3%) and 1070 (34.5%) of the unexposed group (P<0.001). The pooled relative risks of being in hospital and having an emergency department visit in late life comparing exposed versus unexposed were 0.68 (95% confidence interval 0.61 to 0.76) and 0.77 (0.69 to 0.86) respectively. Fewer exposed than unexposed patients died in hospital (503 (16.2%) v 887 (28.6%), P<0.001), and the pooled relative risk of dying in hospital was 0.46 (0.40 to 0.52). Conclusions Community based specialist palliative care teams, despite variation in team composition and geographies, were effective at reducing acute care use and hospital deaths at the end of life.	[Seow, Hsien; Sussman, Jonathan] McMaster Univ, Dept Oncol, Hamilton, ON L8V 5C2, Canada; [Brazil, Kevin] Queens Univ Belfast, Sch Nursing & Midwifery, Belfast, Antrim, North Ireland; [Pereira, Jose] Univ Ottawa, Fac Med, Div Palliat Care, Ottawa, ON, Canada; [Marshall, Denise] McMaster Univ, Dept Family Med, Hamilton, ON L8V 5C2, Canada; [Austin, Peter C.] Univ Toronto, Inst Hlth Policy Management & Evaluat, Dalla Lana Sch Publ Hlth, Toronto, ON, Canada; [Husain, Amna] Univ Toronto, Dept Family & Community Med, Toronto, ON M5S 1A1, Canada; [Rangrej, Jagadish] Inst Clin Evaluat Sci, Toronto, ON, Canada; [Barbera, Lisa] Univ Toronto, Inst Hlth Policy Management & Evaluat, Dept Radiat Oncol, Toronto, ON, Canada	McMaster University; Queens University Belfast; University of Ottawa; McMaster University; University of Toronto; University of Toronto; University of Toronto; University of Toronto	Seow, H (corresponding author), McMaster Univ, Dept Oncol, Hamilton, ON L8V 5C2, Canada.	seowh@mcmaster.ca	Sussman, Jonathan/AAQ-1588-2021; Husain, Amna/G-5827-2018; Seow, Hsien/AAQ-1438-2021	Sussman, Jonathan/0000-0002-7702-8816; Husain, Amna/0000-0001-8638-3943; Seow, Hsien/0000-0001-6701-1714; Austin, Peter/0000-0003-3337-233X	Canadian Institutes of Health Research [115112]; Ontario Ministry of Health and Long term Care	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Ontario Ministry of Health and Long term Care(Ministry of Health and Long-Term Care, Ontario)	This study was funded by a grant from the Canadian Institutes of Health Research (No 115112) and used databases maintained by the Institute for Clinical Evaluative Sciences, which receives funding by the Ontario Ministry of Health and Long term Care. The opinions, results, and conclusions reported in this paper are those of the authors and are independent from the funding sources.	Aiken LS, 2006, J PALLIAT MED, V9, P111, DOI 10.1089/jpm.2006.9.111; Almaawiy U, 2014, PALLIATIVE MED, V28, P176, DOI 10.1177/0269216313493125; Austin PC, 2008, STAT MED, V27, P2037, DOI 10.1002/sim.3150; Austin PC, 2009, STAT MED, V28, P3083, DOI 10.1002/sim.3697; Austin PC, 2009, INT J BIOSTAT, V5, DOI 10.2202/1557-4679.1146; Bakitas M, 2009, JAMA-J AM MED ASSOC, V302, P741, DOI 10.1001/jama.2009.1198; Barbera Lisa, 2010, Healthc Policy, V5, pe125; Barbera L, 2010, CAN MED ASSOC J, V182, P563, DOI 10.1503/cmaj.091187; Brumley R, 2007, J AM GERIATR SOC, V55, P993, DOI 10.1111/j.1532-5415.2007.01234.x; CARR D, 2002, AHRQ PUBLICATION; Carstairs S., 2005, QUALITY END OF LIFE, P1; Covinsky KE, 1997, ANN INTERN MED, V126, P417, DOI 10.7326/0003-4819-126-6-199703150-00001; Earle CC, 2003, J CLIN ONCOL, V21, P1133, DOI 10.1200/JCO.2003.03.059; Fassbender K, 2009, J PAIN SYMPTOM MANAG, V38, P75, DOI 10.1016/j.jpainsymman.2009.04.007; Gomes B, 2006, BMJ-BRIT MED J, V332, P515, DOI 10.1136/bmj.38740.614954.55; Gray Bradford H, 2011, Issue Brief (Commonw Fund), V15, P1; Healthcare Commission, 2009, SPOTL COMPL REP 2 ST; Hearn J, 1998, PALLIATIVE MED, V12, P317, DOI 10.1191/026921698676226729; Higginson I J, 2000, J Palliat Med, V3, P287, DOI 10.1089/jpm.2000.3.287; Higginson IJ, 2003, J PAIN SYMPTOM MANAG, V25, P150, DOI 10.1016/S0885-3924(02)00599-7; Higginson IJ, 2010, CANCER J, V16, P423, DOI 10.1097/PPO.0b013e3181f684e5; Higginson IJ, 2009, J PAIN SYMPTOM MANAG, V38, P816, DOI 10.1016/j.jpainsymman.2009.07.002; HUGHES SL, 1992, HEALTH SERV RES, V26, P801; Hughes SL, 2000, JAMA-J AM MED ASSOC, V284, P2877, DOI 10.1001/jama.284.22.2877; Jordhoy MS, 2000, LANCET, V356, P888, DOI 10.1016/S0140-6736(00)02678-7; Luckett T, 2013, J PAIN SYMPTOM MANAG, V45, P279, DOI 10.1016/j.jpainsymman.2012.02.017; Marshall D, 2008, CAN FAM PHYSICIAN, V54, pe7; Marshall D, 2008, CAN FAM PHYSICIAN, V54, P1703; Paz-Ruiz S, 2009, J PAIN SYMPTOM MANAG, V38, P87, DOI 10.1016/j.jpainsymman.2009.04.011; Pocock L, 2014, BMJ SUPPORT PALLIAT, V4, P105; Rabow MW, 2004, ARCH INTERN MED, V164, P83, DOI 10.1001/archinte.164.1.83; ROSENBAUM PR, 1983, BIOMETRIKA, V70, P41, DOI 10.1093/biomet/70.1.41; ROSENBAUM PR, 1985, AM STAT, V39, P33, DOI 10.2307/2683903; Seow H, 2010, J PALLIAT CARE, V26, P270, DOI 10.1177/082585971002600403; Seow H, 2010, MED CARE, V48, P118, DOI 10.1097/MLR.0b013e3181c162ef; Sibley LM, 2010, MED CARE, V48, P175, DOI 10.1097/MLR.0b013e3181c16102; Statistics Canada, 2013, TABL 102 0509 DEATHS; Sussman J, 2012, PALLIATIVE MED, V26, P322, DOI 10.1177/0269216311416697; World Health Organization, 2004, SOLID FACTS PALLIATI; ZIMMER JG, 1985, AM J PUBLIC HEALTH, V75, P134, DOI 10.2105/AJPH.75.2.134	40	127	133	0	18	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JUN 6	2014	348								g3496	10.1136/bmj.g3496	http://dx.doi.org/10.1136/bmj.g3496			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AI7CE	24906901	hybrid, Green Published			2022-12-28	WOS:000337038000001
J	Zamaninasab, M; Clausen-Brown, E; Savolainen, T; Tchekhovskoy, A				Zamaninasab, M.; Clausen-Brown, E.; Savolainen, T.; Tchekhovskoy, A.			Dynamically important magnetic fields near accreting supermassive black holes	NATURE			English	Article							ACTIVE GALACTIC NUCLEI; RELATIVISTIC MAGNETOHYDRODYNAMIC SIMULATIONS; RADIO LOUDNESS; EXTRAGALACTIC JET; ASTRONOMICAL DATA; KINETIC POWER; CENTAURUS-A; LINE; MASS; LUMINOSITY	Accreting supermassive black holes at the centres of active galaxies often produce 'jets'-collimated bipolar outflows of relativistic particles(1). Magnetic fields probably play a critical role in jet formation(2,3) and in accretion disk physics(4). A dynamically important magnetic field was recently found near the Galactic Centre black hole(5). If this is common and if the field continues to near the black hole event horizon, disk structures will be affected, invalidating assumptions made in standard models(3,6,7). Here we report that jet magnetic field and accretion disk luminosity are tightly correlated over seven orders of magnitude for a sample of 76 radio-loud active galaxies. We conclude that the jet-launching regions of these radio-loud galaxies are threaded by dynamically important fields, which will affect the disk properties. These fields obstruct gas infall, compress the accretion disk vertically, slow down the disk rotation by carrying away its angular momentum in an outflow(3) and determine the directionality of jets(8).	[Zamaninasab, M.; Clausen-Brown, E.; Savolainen, T.] Max Planck Inst Radioastron, D-53121 Bonn, Germany; [Tchekhovskoy, A.] Univ Calif Berkeley, Lawrence Berkeley Natl Lab, Berkeley, CA 94720 USA; [Tchekhovskoy, A.] Univ Calif Berkeley, Dept Astron, Berkeley, CA 94720 USA; [Tchekhovskoy, A.] Univ Calif Berkeley, Theoret Astrophys Ctr, Berkeley, CA 94720 USA	Max Planck Society; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley; University of California System; University of California Berkeley; University of California System; University of California Berkeley	Zamaninasab, M (corresponding author), Max Planck Inst Radioastron, Hugel 69, D-53121 Bonn, Germany.	m.zamaninasab@gmail.com	Tchekhovskoy, Alexander/AAN-6908-2020	Savolainen, Tuomas/0000-0001-6214-1085; Tchekhovskoy, Alexander/0000-0002-9182-2047	German Deutsche Forschungsgemeinschaft, DFG [SFB 956]; Princeton Center for Theoretical Science fellowship; NASA through the Einstein fellowship program [PF3-140115]	German Deutsche Forschungsgemeinschaft, DFG(German Research Foundation (DFG)); Princeton Center for Theoretical Science fellowship; NASA through the Einstein fellowship program	We thank A. Lobanov, M. Sikora and J. McKinney for discussions and N. Sabha for comments on the manuscript. M.Z. was supported by the German Deutsche Forschungsgemeinschaft, DFG, via grant SFB 956 project A2. A.T. was supported by a Princeton Center for Theoretical Science fellowship and by NASA through the Einstein fellowship program, grant PF3-140115.	Akritas MG, 1996, MON NOT R ASTRON SOC, V278, P919, DOI 10.1093/mnras/278.4.919; Balbus S. A., 1991, ASTROPHYS J, V376, P223; BALBUS SA, 1991, ASTROPHYS J, V376, P214, DOI 10.1086/170270; BLANDFORD RD, 1977, MON NOT R ASTRON SOC, V179, P433, DOI 10.1093/mnras/179.3.433; BLANDFORD RD, 1979, ASTROPHYS J, V232, P34, DOI 10.1086/157262; Celotti A, 1997, MON NOT R ASTRON SOC, V286, P415, DOI 10.1093/mnras/286.2.415; Clausen-Brown E, 2013, ASTRON ASTROPHYS, V558, DOI 10.1051/0004-6361/201322203; Di Matteo T, 2003, ASTROPHYS J, V582, P133, DOI 10.1086/344504; Eatough RP, 2013, NATURE, V501, P391, DOI 10.1038/nature12499; Evans DA, 2004, ASTROPHYS J, V612, P786, DOI 10.1086/422806; Fabian AC, 2009, NATURE, V459, P540, DOI 10.1038/nature08007; Gabuzda DC, 2008, MON NOT R ASTRON SOC, V384, P1003, DOI 10.1111/j.1365-2966.2007.12773.x; Gebhardt K, 2011, ASTROPHYS J, V729, DOI 10.1088/0004-637X/729/2/119; Ghisellini G, 2010, MON NOT R ASTRON SOC, V402, P497, DOI 10.1111/j.1365-2966.2009.15898.x; Gonzalez-Martin O, 2009, ASTROPHYS J, V704, P1570, DOI 10.1088/0004-637X/704/2/1570; Greene JE, 2005, ASTROPHYS J, V630, P122, DOI 10.1086/431897; Gu MF, 2009, MON NOT R ASTRON SOC, V396, P984, DOI 10.1111/j.1365-2966.2009.14758.x; Hada K, 2011, NATURE, V477, P185, DOI 10.1038/nature10387; Hawley JF, 2006, ASTROPHYS J, V641, P103, DOI 10.1086/500385; Hirotani K, 2005, ASTROPHYS J, V619, P73, DOI 10.1086/426497; Ho LC, 2008, ANNU REV ASTRON ASTR, V46, P475, DOI 10.1146/annurev.astro.45.051806.110546; Hovatta T, 2009, ASTRON ASTROPHYS, V494, P527, DOI 10.1051/0004-6361:200811150; Kadler M, 2004, ASTRON ASTROPHYS, V426, P481, DOI 10.1051/0004-6361:20041051; Kaspi S, 2000, ASTROPHYS J, V533, P631, DOI 10.1086/308704; Kaspi S, 2005, ASTROPHYS J, V629, P61, DOI 10.1086/431275; Kelly BC, 2007, ASTROPHYS J, V665, P1489, DOI 10.1086/519947; King AL, 2013, ASTROPHYS J, V771, DOI 10.1088/0004-637X/771/2/84; Kino M, 2005, MON NOT R ASTRON SOC, V364, P659, DOI 10.1111/j.1365-2966.2005.09580.x; Komissarov SS, 2009, MON NOT R ASTRON SOC, V394, P1182, DOI 10.1111/j.1365-2966.2009.14410.x; Kovalev YY, 2008, ASTRON ASTROPHYS, V483, P759, DOI 10.1051/0004-6361:20078679; Liu Y, 2006, ASTROPHYS J, V637, P669, DOI 10.1086/498639; Lobanov AP, 1998, ASTRON ASTROPHYS, V330, P79; Markoff S, 2008, ASTROPHYS J, V681, P905, DOI 10.1086/588718; Markwardt CB, 2009, ASTR SOC P, V411, P251; Marti-Vidal I, 2011, ASTRON ASTROPHYS, V533, DOI 10.1051/0004-6361/201117211; McKinney JC, 2005, ASTROPHYS J, V630, pL5, DOI 10.1086/468184; McKinney JC, 2006, MON NOT R ASTRON SOC, V368, P1561, DOI 10.1111/j.1365-2966.2006.10256.x; McKinney JC, 2013, SCIENCE, V339, P49, DOI 10.1126/science.1230811; McKinney JC, 2012, MON NOT R ASTRON SOC, V423, P3083, DOI 10.1111/j.1365-2966.2012.21074.x; McLure RJ, 2002, MON NOT R ASTRON SOC, V337, P109, DOI 10.1046/j.1365-8711.2002.05871.x; McNamara BR, 2011, ASTROPHYS J, V727, DOI 10.1088/0004-637X/727/1/39; Meier D. L., 2012, BLACK HOLE ASTROPHYS; Muller C, 2011, ASTRON ASTROPHYS, V530, DOI 10.1051/0004-6361/201116605; Narayan R, 2003, PUBL ASTRON SOC JPN, V55, pL69, DOI 10.1093/pasj/55.6.L69; Neumayer N, 2007, ASTROPHYS J, V671, P1329, DOI 10.1086/523039; Novikov I., 1973, LES ASTRES OCCLUS, V343; O'Sullivan SP, 2009, MON NOT R ASTRON SOC, V400, P26, DOI 10.1111/j.1365-2966.2009.15428.x; Palma NI, 2011, ASTROPHYS J, V735, DOI 10.1088/0004-637X/735/1/60; Punsly B, 2011, MON NOT R ASTRON SOC, V412, pL123, DOI 10.1111/j.1745-3933.2011.01019.x; Pushkarev AB, 2012, ASTRON ASTROPHYS, V545, DOI 10.1051/0004-6361/201219173; Pushkarev AB, 2009, ASTRON ASTROPHYS, V507, pL33, DOI 10.1051/0004-6361/200913422; Savolainen T, 2010, ASTRON ASTROPHYS, V512, DOI 10.1051/0004-6361/200913740; Shaw MS, 2012, ASTROPHYS J, V748, DOI 10.1088/0004-637X/748/1/49; Shen Y, 2011, ASTROPHYS J SUPPL S, V194, DOI 10.1088/0067-0049/194/2/45; Sikora M, 2007, ASTROPHYS J, V658, P815, DOI 10.1086/511972; Sikora M, 2013, ASTROPHYS J LETT, V764, DOI 10.1088/2041-8205/764/2/L24; Sokolovsky KV, 2011, ASTRON ASTROPHYS, V532, DOI 10.1051/0004-6361/201016072; Tchekhovskoy A, 2008, MON NOT R ASTRON SOC, V388, P551, DOI 10.1111/j.1365-2966.2008.13425.x; Tchekhovskoy A, 2012, J PHYS CONF SER, V372, DOI 10.1088/1742-6596/372/1/012040; Tchekhovskoy A, 2012, MON NOT R ASTRON SOC, V423, pL55, DOI 10.1111/j.1745-3933.2012.01256.x; Tchekhovskoy A, 2011, MON NOT R ASTRON SOC, V418, pL79, DOI 10.1111/j.1745-3933.2011.01147.x; Tchekhovskoy A, 2010, ASTROPHYS J, V711, P50, DOI 10.1088/0004-637X/711/1/50; Tchekhovskoy A, 2009, ASTROPHYS J, V699, P1789, DOI 10.1088/0004-637X/699/2/1789; Torrealba J, 2012, REV MEX ASTRON ASTR, V48, P9; Volonteri M, 2013, ASTROPHYS J, V775, DOI 10.1088/0004-637X/775/2/94; Wandel A, 1999, ASTROPHYS J, V526, P579, DOI 10.1086/308017; Woo JH, 2002, ASTROPHYS J, V579, P530, DOI 10.1086/342878; Zamaninasab M, 2013, MON NOT R ASTRON SOC, V436, P3341, DOI 10.1093/mnras/stt1816	69	168	171	0	17	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 5	2014	510	7503					126	+		10.1038/nature13399	http://dx.doi.org/10.1038/nature13399			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI3NR	24899311				2022-12-28	WOS:000336768900041
J	Finkelstein, Y; Macdonald, EM; Li, P; Hutson, JR; Juurlink, DN				Finkelstein, Yaron; Macdonald, Erin M.; Li, Ping; Hutson, Janine R.; Juurlink, David N.			Recurrence and Mortality Following Severe Cutaneous Adverse Reactions	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Letter							STEVENS-JOHNSON-SYNDROME; TOXIC EPIDERMAL NECROLYSIS		[Finkelstein, Yaron; Hutson, Janine R.] Hosp Sick Children, Dept Pediat, Toronto, ON M5G 1X8, Canada; [Macdonald, Erin M.; Li, Ping] Inst Clin Evaluat Sci, Toronto, ON, Canada; [Juurlink, David N.] Sunnybrook Res Inst, Toronto, ON, Canada	University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; University of Toronto; Sunnybrook Research Institute; University Toronto Affiliates; Sunnybrook Health Science Center	Finkelstein, Y (corresponding author), Hosp Sick Children, 555 Univ Ave, Toronto, ON M5G 1X8, Canada.	yaron.finkelstein@sickkids.ca			Canadian Institutes of Health Research Funding Source: Medline	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR))		Chung WH, 2004, NATURE, V428, P486, DOI 10.1038/428486a; Finkelstein Y, 2011, PEDIATRICS, V128, P723, DOI 10.1542/peds.2010-3322; Mockenhaupt M, 2011, EXPERT REV CLIN IMMU, V7, P803, DOI [10.1586/eci.11.66, 10.1586/ECI.11.66]; Papay J, 2012, PHARMACOEPIDEM DR S, V21, P289, DOI 10.1002/pds.2276; Park-Wyllie LY, 2011, JAMA-J AM MED ASSOC, V305, P783, DOI 10.1001/jama.2011.190; Phillips EJ, 2011, J ALLERGY CLIN IMMUN, V127, pS60, DOI 10.1016/j.jaci.2010.11.046	6	36	36	0	1	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUN 4	2014	311	21					2231	2232		10.1001/jama.2014.839	http://dx.doi.org/10.1001/jama.2014.839			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AI2DU	24893093				2022-12-28	WOS:000336668400027
J	Rapsomaniki, E; Timmis, A; George, J; Pujades-Rodriguez, M; Shah, AD; Denaxas, S; White, IR; Caulfield, MJ; Deanfield, JE; Smeeth, L; Williams, B; Hingorani, A; Hemingway, H				Rapsomaniki, Eleni; Timmis, Adam; George, Julie; Pujades-Rodriguez, Mar; Shah, Anoop D.; Denaxas, Spiros; White, Ian R.; Caulfield, Mark J.; Deanfield, John E.; Smeeth, Liam; Williams, Bryan; Hingorani, Aroon; Hemingway, Harry			Blood pressure and incidence of twelve cardiovascular diseases: lifetime risks, healthy life-years lost, and age-specific associations in 1.25 million people	LANCET			English	Article							PERIPHERAL ARTERIAL-DISEASE; ABDOMINAL AORTIC-ANEURYSMS; PREVALENCE; EVENTS; STROKE	Background The associations of blood pressure with the different manifestations of incident cardiovascular disease in a contemporary population have not been compared. In this study, we aimed to analyse the associations of blood pressure with 12 different presentations of cardiovascular disease. Methods We used linked electronic health records from 1997 to 2010 in the CALIBER (CArdiovascular research using LInked Bespoke studies and Electronic health Records) programme to assemble a cohort of 1 . 25 million patients, 30 years of age or older and initially free from cardiovascular disease, a fifth of whom received blood pressure-lowering treatments. We studied the heterogeneity in the age-specific associations of clinically measured blood pressure with 12 acute and chronic cardiovascular diseases, and estimated the lifetime risks (up to 95 years of age) and cardiovascular disease-free life-years lost adjusted for other risk factors at index ages 30, 60, and 80 years. This study is registered at ClinicalTrials.gov, number NCT01164371. Findings During 5 . 2 years median follow-up, we recorded 83 098 initial cardiovascular disease presentations. In each age group, the lowest risk for cardiovascular disease was in people with systolic blood pressure of 90-114 mm Hg and diastolic blood pressure of 60-74 mm Hg, with no evidence of a J-shaped increased risk at lower blood pressures. The effect of high blood pressure varied by cardiovascular disease endpoint, from strongly positive to no effect. Associations with high systolic blood pressure were strongest for intracerebral haemorrhage (hazard ratio 1.44 [95% CI 1.32-1.58]), subarachnoid haemorrhage (1.43 [1.25-1.63]), and stable angina (1.41 [1.36-1.46]), and weakest for abdominal aortic aneurysm (1.08 [1.00-1.17]). Compared with diastolic blood pressure, raised systolic blood pressure had a greater effect on angina, myocardial infarction, and peripheral arterial disease, whereas raised diastolic blood pressure had a greater effect on abdominal aortic aneurysm than did raised systolic pressure. Pulse pressure associations were inverse for abdominal aortic aneurysm (HR per 10 mm Hg 0.91 [95% CI 0.86-0.98]) and strongest for peripheral arterial disease (1.23 [1.20-1.27]). People with hypertension (blood pressure >= 140/90 mm Hg or those receiving blood pressure-lowering drugs) had a lifetime risk of overall cardiovascular disease at 30 years of age of 63.3% (95% CI 62.9-63.8) compared with 46.1% (45.5-46.8) for those with normal blood pressure, and developed cardiovascular disease 5 . 0 years earlier (95% CI 4.8-5.2). Stable and unstable angina accounted for most (43%) of the cardiovascular disease-free years of life lost associated with hypertension from index age 30 years, whereas heart failure and stable angina accounted for the largest proportion (19% each) of years of life lost from index age 80 years. Interpretation The widely held assumptions that blood pressure has strong associations with the occurrence of all cardiovascular diseases across a wide age range, and that diastolic and systolic associations are concordant, are not supported by the findings of this high-resolution study. Despite modern treatments, the lifetime burden of hypertension is substantial. These findings emphasise the need for new blood pressure-lowering strategies, and will help to inform the design of randomised trials to assess them.	[Rapsomaniki, Eleni; Timmis, Adam; George, Julie; Pujades-Rodriguez, Mar; Shah, Anoop D.; Denaxas, Spiros; Caulfield, Mark J.; Deanfield, John E.; Smeeth, Liam; Williams, Bryan; Hingorani, Aroon; Hemingway, Harry] Farr Inst Hlth Informat Res, London NW1 2DA, England; [Rapsomaniki, Eleni; George, Julie; Pujades-Rodriguez, Mar; Shah, Anoop D.; Denaxas, Spiros; Williams, Bryan; Hingorani, Aroon; Hemingway, Harry] UCL, London, England; [Deanfield, John E.] UCL, Natl Ctr Cardiovasc Prevent & Outcomes, Inst Cardiovasc Sci, London, England; [Timmis, Adam] Queen Mary Univ London, Barts & London Natl Inst Hlth Res Cardiovasc Biom, London, England; [Caulfield, Mark J.] Queen Mary Univ London, William Harvey Res Inst, London, England; [Caulfield, Mark J.] Queen Mary Univ London, Barts Natl Inst Hlth Res Biomed Res Unit, London, England; [Smeeth, Liam] London Sch Hyg & Trop Med, London WC1, England; [Williams, Bryan] Natl Inst Hlth Res UCL Hosp Biomed Res Ctr, London, England; [White, Ian R.] MRC Biostat Unit, Cambridge, England	University of London; University College London; University of London; University College London; University of London; Queen Mary University London; University of London; Queen Mary University London; University of London; Queen Mary University London; University of London; London School of Hygiene & Tropical Medicine; University of London; University College London; MRC Biostatistics Unit	Rapsomaniki, E (corresponding author), Farr Inst Hlth Informat Res, 3rd Floor,222 Euston Rd, London NW1 2DA, England.	e.rapsomaniki@ucl.ac.uk	Shah, Anoop Dinesh/D-4396-2014; Pujades-Rodriguez, Mar/T-1129-2018; Smeeth, Liam/X-5862-2018; Hemingway, Harry/C-1219-2009	Shah, Anoop Dinesh/0000-0002-8907-5724; Pujades-Rodriguez, Mar/0000-0002-1375-1028; Smeeth, Liam/0000-0002-9168-6022; Hemingway, Harry/0000-0003-2279-0624; Denaxas, Spiros/0000-0001-9612-7791; White, Ian/0000-0002-6718-7661; Deanfield, John/0000-0001-8806-6052; George, Julie/0000-0003-2410-2696; Hingorani, Aroon/0000-0001-8365-0081; Williams, Bryan/0000-0002-8094-1841; Caulfield, Mark/0000-0001-9295-3594	Medical Research Council; National Institute for Health Research; Wellcome Trust; Economic and Social Research Council [ES/L007517/1] Funding Source: researchfish; Medical Research Council [G0902393, G9521010, MR/K006584/1, MC_U105260558, MC_PC_13090] Funding Source: researchfish; National Institute for Health Research [NF-SI-0510-10090, NF-SI-0512-10113, DRF-2009-02-50, RP-PG-0407-10314] Funding Source: researchfish; ESRC [ES/L007517/1] Funding Source: UKRI; MRC [MC_PC_13090, G9521010, MC_U105260558, G0902393] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); National Institute for Health Research(National Institute for Health Research (NIHR)); Wellcome Trust(Wellcome Trust); Economic and Social Research Council(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR)); ESRC(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	Medical Research Council, National Institute for Health Research, and Wellcome Trust.	Andersen PK, 2013, STAT MED, V32, P5278, DOI 10.1002/sim.5903; Beckett N, 2012, BMJ-BRIT MED J, V344, DOI 10.1136/bmj.d7541; Berry JD, 2012, NEW ENGL J MED, V366, P321, DOI 10.1056/NEJMoa1012848; Cadarso-Suarez C, 2010, STAT MODEL, V10, P291, DOI 10.1177/1471082X0801000303; Deanfield J, 2014, HEART, V100, P1, DOI 10.1136/heartjnl-2014-305693; Denaxas SC, 2012, INT J EPIDEMIOL, V41, P1625, DOI 10.1093/ije/dys188; Diao D, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006742.pub2; Forsdahl SH, 2009, CIRCULATION, V119, P2202, DOI 10.1161/CIRCULATIONAHA.108.817619; Franks PJ, 1996, EUR J VASC ENDOVASC, V11, P487, DOI 10.1016/S1078-5884(96)80186-9; Gallagher AM, 2011, PHARMACOEPIDEM DR S, V20, pS230; Go AS, 2013, CIRCULATION, V127, pE6, DOI 10.1161/CIR.0b013e31828124ad; Goff David C Jr, 2014, J Am Coll Cardiol, V63, P2935, DOI 10.1016/j.jacc.2013.11.005; Hemingway H, 2006, JAMA-J AM MED ASSOC, V295, P1404, DOI 10.1001/jama.295.12.1404; Herrett E, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f2350; Higgins JPT, 2009, J R STAT SOC A STAT, V172, P137, DOI 10.1111/j.1467-985X.2008.00552.x; Hippisley-Cox J, 2010, BMJ-BRIT MED J, V341, DOI 10.1136/bmj.c6624; Hirsch AT, 2013, LANCET, V382, P1312, DOI 10.1016/S0140-6736(13)61576-7; Kalbfleisch J.D., 2002, STAT ANAL FAILURE TI; Kannel WB, 2004, AM J CARDIOL, V94, P380, DOI 10.1016/j.amjcard.2004.04.043; Law MR, 2009, BMJ-BRIT MED J, V338, DOI 10.1136/bmj.b1665; Lewington S, 2002, LANCET, V360, P1903, DOI 10.1016/S0140-6736(02)11911-8; Lim SS, 2012, LANCET, V380, P2224, DOI 10.1016/S0140-6736(12)61766-8; Lloyd-Jones DM, 2005, HYPERTENSION, V45, P39, DOI 10.1161/01.HYP.0000149106.89470.13; Lloyd-Jones DM, 2002, CIRCULATION, V106, P3068, DOI 10.1161/01.CIR.0000039105.49749.6F; Murabito JM, 2002, AM HEART J, V143, P961, DOI 10.1067/mhj.2002.122871; National Clinical Guideline Centre (UK), 2011, HYP CLIN MAN PRIM HY; Rubin DB., 1987, MULTIPLE IMPUTATION, DOI 10.1002/9780470316696; Selvin E, 2004, CIRCULATION, V110, P738, DOI 10.1161/01.CIR.0000137913.26087.F0; Seshadri S, 2007, LANCET NEUROL, V6, P1106, DOI 10.1016/S1474-4422(07)70291-0; Social Exclusion Task Force, 2010, IMPR WAY WE MEET PRI; Turnbull F, 2003, LANCET, V362, P1527; Vlak MHM, 2013, J NEUROL NEUROSUR PS, V84, P619, DOI 10.1136/jnnp-2012-303783; Walley T, 1997, LANCET, V350, P1097, DOI 10.1016/S0140-6736(97)04248-7; Wilkins JT, 2012, JAMA-J AM MED ASSOC, V308, P1795, DOI 10.1001/jama.2012.14312; Williams B, 2008, LANCET, V371, P2219, DOI 10.1016/S0140-6736(08)60804-1; Wills AK, 2012, EPIDEMIOLOGY, V23, P203, DOI 10.1097/EDE.0b013e3182456567	36	910	946	2	105	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAY 31	2014	383	9932					1899	1911		10.1016/S0140-6736(14)60685-1	http://dx.doi.org/10.1016/S0140-6736(14)60685-1			13	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AI4PR	24881994	Green Published, Green Submitted, Green Accepted			2022-12-28	WOS:000336847800030
J	Frisch, S				Frisch, Suzy			Going hungry in America	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												suzyfrisch@yahoo.com						Bartlett S, 2013, HEALTHY INCENTIVES P; Beatty T, 2013, SUPPLEMENTAL NUTRITI; Gregory C, 2013, ECONOMIC RESEARCH RE; Seligman HK, 2010, J NUTR, V140, P304, DOI 10.3945/jn.109.112573; US Department of Agriculture Food and Nutrition Service Office of Research and Analysis, 2012, BUILDING A HEALTHY A; USDA, 2013, SUPPLEMENTAL NUTRITI	6	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	MAY 30	2014	348								g3548	10.1136/bmj.g3548	http://dx.doi.org/10.1136/bmj.g3548			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AI3EO	24879820				2022-12-28	WOS:000336742800003
J	Barr, B; Bambra, C; Whitehead, M; Duncan, WH				Barr, Ben; Bambra, Clare; Whitehead, Margaret; Duncan, W. H.			The impact of NHS resource allocation policy on health inequalities in England 2001-11: longitudinal ecological study	BMJ-BRITISH MEDICAL JOURNAL			English	Article							START LOCAL-PROGRAMS; SOCIOECONOMIC INEQUALITIES; MORTALITY; CARE; FORMULA; FAMILIES; CHILDREN; OUTCOMES; NATIONS; EUROPE	Objective To investigate whether the policy of increasing National Health Service funding to a greater extent in deprived areas in England compared with more affluent areas led to a reduction in geographical inequalities in mortality amenable to healthcare. Design Longitudinal ecological study. Setting 324 lower tier local authorities in England, classified by their baseline level of deprivation. Intervention Differential trends in NHS funds allocated to local areas resulting from the NHS resource allocation policy in England between 2001 and 2011. Main outcome measure Trends in mortality from causes considered amenable to healthcare in local authority areas in England. Using multivariate regression, we estimated the reduction in mortality that was associated with the allocation of additional NHS resources in these areas. Results Between 2001 and 2011 the increase in NHS resources to deprived areas accounted for a reduction in the gap between deprived and affluent areas in male mortality amenable to healthcare of 35 deaths per 100 000 population (95% confidence interval 27 to 42) and female mortality of 16 deaths per 100 000 (10 to 21). This explained 85% of the total reduction of absolute inequality in mortality amenable to healthcare during this time. Each additional (sic)10m of resources allocated to deprived areas was associated with a reduction in 4 deaths in males per 100 000 (3.1 to 4.9) and 1.8 deaths in females per 100 000 (1.1 to 2.4). The association between absolute increases in NHS resources and improvements in mortality amenable to healthcare in more affluent areas was not significant. Conclusion Between 2001 and 2011, the NHS health inequalities policy of increasing the proportion of resources allocated to deprived areas compared with more affluent areas was associated with a reduction in absolute health inequalities from causes amenable to healthcare. Dropping this policy may widen inequalities.	[Barr, Ben; Duncan, W. H.] Univ Liverpool, Inst Psychol Hlth & Soc, Dept Publ Hlth & Policy, Liverpool L69 3GB, Merseyside, England; [Bambra, Clare] Univ Durham, Wolfson Res Inst Hlth & Wellbeing, Dept Geog, Stockton On Tees, England	University of Liverpool; Durham University	Barr, B (corresponding author), Univ Liverpool, Inst Psychol Hlth & Soc, Dept Publ Hlth & Policy, Liverpool L69 3GB, Merseyside, England.	benbarr@liverpool.ac.uk	Barr, Ben R/W-9989-2018; Bambra, Clare l/C-1392-2010	Barr, Ben R/0000-0002-4208-9475; Bambra, Clare l/0000-0002-1294-6851	National Institute for Health Research [DRF-2009-02-12]; DEMETRIQ project; Commission of the European Communities [278511]; Medical Research Council [MR/K02325X/1] Funding Source: researchfish	National Institute for Health Research(National Institute for Health Research (NIHR)); DEMETRIQ project; Commission of the European Communities(European Commission); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	BB is supported by a National Institute for Health Research doctoral research fellowship (DRF-2009-02-12). The National Institute for Health Research had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. MMW is supported by the DEMETRIQ project, which is funded from the Commission of the European Communities seventh framework programme under grant agreement No 278511. The study does not necessarily reflect the commission's views and in no way anticipates the commission's future policy in this area.	Acheson D., 1998, INDEPENDENT INQUIRY; [Anonymous], 2013, NHS IC IND PORT; Asthana S, 2012, HLTH SERV J; Asthana S, 2012, BRIT MED J, V344, DOI 10.1136/bmj.e4133; Bajekal M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059608; Bambra CL, 2013, BMJ-BRIT MED J, V347, DOI 10.1136/bmj.f6146; Bambra CL, 2012, BRIT MED J, V344, DOI 10.1136/bmj.e3593; Barr B, 2014, BMJ-BRIT MED J, V348, DOI 10.1136/bmj.g160; Barr B, 2012, BRIT MED J, V345, DOI 10.1136/bmj.e7831; Belsky J, 2006, BMJ-BRIT MED J, V332, P1476, DOI 10.1136/bmj.38853.451748.2F; Bojke C, 2013, NHS PRODUCTIVITY 200; Buck D, 2013, IMPROVING ALLOCATION; Cook TD, 2002, EXPT QUASIEXPERIMENT, P1, DOI 10.1198/jasa.2005.s22; Cremieux PY, 1999, HEALTH ECON, V8, P627, DOI 10.1002/(SICI)1099-1050(199911)8:7<627::AID-HEC474>3.0.CO;2-8; Department of Health, 2013, EXP BOOK; Department of Health, 2013, EXP BOOK 2011 2012; Department of Health, 2000, NHS PLAN PLAN INV PL; Department of Health, 2008, RES ALL WEIGHT CAP F; Department of the Environment, 2000, TRANSP REG DETR IND; Desai M, 2011, J ROY SOC MED, V104, P370, DOI 10.1258/jrsm.2011.110120; Diderichsen F, 1997, BRIT MED J, V315, P875, DOI 10.1136/bmj.315.7112.875; Dixon J, 2011, BRIT MED J, V343, DOI 10.1136/bmj.d6608; Gibbons DC, 2012, J ROY SOC MED, V105, P422, DOI 10.1258/jrsm.2012.120178; Gilson L, 2007, KNOWLEDGE NETWORK HL; Gov.UK, 2013, US GDP DEFL SER PRAC; GRAVELLE HSE, 1987, SOC SCI MED, V25, P427, DOI 10.1016/0277-9536(87)90167-5; Harper S, 2010, MILBANK Q, V88, P4, DOI 10.1111/j.1468-0009.2010.00587.x; Hawkes N, 2012, BRIT MED J, V344, DOI 10.1136/bmj.e3362; Houweling Tanja Aj, 2007, Int J Equity Health, V6, P15, DOI 10.1186/1475-9276-6-15; King NB, 2012, BMJ-BRIT MED J, V345, DOI 10.1136/bmj.e5774; KUNST AE, 1988, EUR J POPUL, V4, P223, DOI 10.1007/BF01796895; Kunst AE, 2001, MON SOCIOECONOMIC IN; Low A, 2006, BRIT MED J, V332, P967, DOI 10.1136/bmj.332.7547.967; MACKENBACH JP, 1990, J EPIDEMIOL COMMUN H, V44, P106, DOI 10.1136/jech.44.2.106; Mackenbach JP, 1997, SOC SCI MED, V44, P757, DOI 10.1016/S0277-9536(96)00073-1; Martin S, 2008, J HEALTH ECON, V27, P826, DOI 10.1016/j.jhealeco.2007.12.002; Melhuish E, 2008, LANCET, V372, P1641, DOI 10.1016/S0140-6736(08)61687-6; Mimas UDS, 2013, GEOCONVERT; Mooney Gavin, 2004, Appl Health Econ Health Policy, V3, P29, DOI 10.2165/00148365-200403010-00006; National Audit Office, 2010, TACKL IN LIF EXP AR; NHS England, 2013, FUND REV ALL POL ANN; Nixon John, 2006, Eur J Health Econ, V7, P7, DOI 10.1007/s10198-005-0336-8; Nolte E, 2008, HEALTH AFFAIR, V27, P58, DOI 10.1377/hlthaff.27.1.58; Nolte E, 2011, HEALTH POLICY, V103, P47, DOI 10.1016/j.healthpol.2011.08.002; Office for National Statistics, 2013, NOMIS OFF LAB MARK S; Office for National Statistics, 2010, REG ACC METH GUID; Rabe-Hesketh S., 2008, MULTILEVEL LONGITUDI; Richardson EA, 2014, EUR J PUBLIC HEALTH, V24, P357, DOI 10.1093/eurpub/ckt084; Rose G, 2008, ROSE STRATEGY PREVEN; Stafford M, 2008, J EPIDEMIOL COMMUN H, V62, P298, DOI 10.1136/jech.2006.058628; Thompson G, 2009, NHS EXPENDITURE ENGL; Vagero D, 1997, LANCET, V350, P516, DOI 10.1016/S0140-6736(97)26033-2; Wiggins K, 2013, HLTH SERV J; Williams D., 2012, HLTH SERV J	54	39	40	0	15	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	MAY 27	2014	348								g3231	10.1136/bmj.g3231	http://dx.doi.org/10.1136/bmj.g3231			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	AI3EB	24865459	Green Published, Green Accepted, hybrid			2022-12-28	WOS:000336741400002
J	Caesar, J; Balasubramaniam, P				Caesar, Jenny; Balasubramaniam, Periasamy			A woman with a sore spot on her leg	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							PYODERMA-GANGRENOSUM; MANAGEMENT; THERAPY		[Caesar, Jenny; Balasubramaniam, Periasamy] Wrexham Maelor Hosp, Wrexham LL1 3TD, Wales		Caesar, J (corresponding author), Wrexham Maelor Hosp, Wrexham LL1 3TD, Wales.	jennycaesar@hotmail.co.uk						Ahronowitz I, 2012, AM J CLIN DERMATOL, V13, P191, DOI 10.2165/11595240-000000000-00000; Alam M, 2000, DERMATOL SURG, V26, P1063, DOI 10.1046/j.1524-4725.2000.0260111063.x; Baranska-Rybak W, 2011, AM SURGEON, V77, P1644; Bennett ML, 2000, MEDICINE, V79, P37, DOI 10.1097/00005792-200001000-00004; Binus AM, 2011, BRIT J DERMATOL, V165, P1244, DOI 10.1111/j.1365-2133.2011.10565.x; Callen JP, 1998, LANCET, V351, P581, DOI 10.1016/S0140-6736(97)10187-8; Fukuhara K, 1998, BRIT J DERMATOL, V139, P556; Moschella S, 2013, DATE; Powell FC, 2012, FITZPATRICKS DERMATO, VI, P371; Reichrath J, 2005, J AM ACAD DERMATOL, V53, P273, DOI 10.1016/j.jaad.2004.10.006; Ruocco E, 2009, J EUR ACAD DERMATOL, V23, P1008, DOI 10.1111/j.1468-3083.2009.03199.x; Saracino A, 2011, AUSTRALAS J DERMATOL, V52, P218, DOI 10.1111/j.1440-0960.2011.00750.x; Schadt C, 2013, DATE	13	0	0	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	MAY 27	2014	348								g3255	10.1136/bmj.g3255	http://dx.doi.org/10.1136/bmj.g3255			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AI3EB	24868082				2022-12-28	WOS:000336741400003
J	Tammemagi, MC; Lam, S				Tammemagi, Martin C.; Lam, Stephen			Screening for lung cancer using low dose computed tomography	BMJ-BRITISH MEDICAL JOURNAL			English	Review							RISK PREDICTION MODEL; THORACIC-SURGERY GUIDELINES; SUBSOLID PULMONARY NODULES; COST-EFFECTIVENESS; AMERICAN ASSOCIATION; SAVE LIVES; CT SCANS; TRIAL; PROBABILITY; MANAGEMENT	Screening for lung cancer with low dose computed tomography can reduce mortality from the disease by 20% in high risk smokers. This review covers the state of the art knowledge on several aspects of implementing a screening program. The most important are to identify people who are at high enough risk to warrant screening and the appropriate management of lung nodules found at screening. An accurate risk prediction model is more efficient than age and pack years of smoking alone at identifying those who will develop lung cancer and die from the disease. Algorithms are available for assessing people who screen positive to determine who needs additional imaging or invasive investigations. Concerns about low dose computed tomography screening include false positive results, overdiagnosis, radiation exposure, and costs. Further work is needed to define the frequency and duration of screening and to refine risk prediction models so that they can be used to assess the risk of lung cancer in special populations. Another important area is the use of computer vision software tools to facilitate high throughput interpretation of low dose computed tomography images so that costs can be reduced and the consistency of scan interpretation can be improved. Sufficient data are available to support the implementation of screening programs at the population level in stages that can be expanded when found to perform well to improve the outcome of patients with lung cancer.	[Tammemagi, Martin C.] Brock Univ, Dept Hlth Sci, St Catharines, ON L2S 3A1, Canada; [Lam, Stephen] British Columbia Canc Agcy, Vancouver, BC V5Z 1L3, Canada; [Lam, Stephen] Univ British Columbia, Vancouver, BC V5Z 1L3, Canada	Brock University; British Columbia Cancer Agency; University of British Columbia	Lam, S (corresponding author), British Columbia Canc Agcy, Vancouver, BC V5Z 1L3, Canada.	slam2@bccancer.bc.ca		Tammemagi, Martin/0000-0002-4989-5058				Aberle DR, 2013, NEW ENGL J MED, V369, P920, DOI 10.1056/NEJMoa1208962; Aberle DR, 2011, NEW ENGL J MED, V365, P395, DOI 10.1056/NEJMoa1102873; American Association of Physicists in Medicine, 2011, AAPM POS STAT RAD RI; American College of Radiology Imaging Network, 2013, CONT SCREEN DET LUNG; American Lung Association, 2012, AM LUNG ASS PROV GUI; [Anonymous], 2013, ANN INTERN MED; Armato SG, 2009, ACAD RADIOL, V16, P28, DOI 10.1016/j.acra.2008.05.022; Ashraf H, 2009, THORAX, V64, P388, DOI 10.1136/thx.2008.102475; Bach PB, 2013, J SURG ONCOL, V108, P287, DOI 10.1002/jso.23389; Bach PB, 2012, JAMA-J AM MED ASSOC, V307, P2418, DOI 10.1001/jama.2012.5521; Baldwin DR, 2011, THORAX, V66, P308, DOI 10.1136/thx.2010.152066; Balekian Alex A, 2013, Ann Am Thorac Soc, V10, P629, DOI 10.1513/AnnalsATS.201305-107OC; Becker N, 2012, J CANCER RES CLIN, V138, P1475, DOI 10.1007/s00432-012-1228-9; Black C, 2006, HEALTH TECHNOL ASSES, V10, pIII; Blanchon T, 2007, LUNG CANCER, V58, P50, DOI 10.1016/j.lungcan.2007.05.009; Boiselle PM, 2014, JAMA INTERN MED, V174, P286, DOI 10.1001/jamainternmed.2013.12693; BRAMBILLA E., 2014, WORLD CANC REPORT; Bunge EM, 2008, LUNG CANCER, V62, P385, DOI 10.1016/j.lungcan.2008.03.029; Byrne MM, 2008, MED DECIS MAKING, V28, P917, DOI 10.1177/0272989X08322013; Cassidy A, 2008, BRIT J CANCER, V98, P270, DOI 10.1038/sj.bjc.6604158; Castleberry AW, 2009, BRIT J CANCER, V101, P882, DOI 10.1038/sj.bjc.6605253; Chirikos TN, 2002, CHEST, V121, P1507, DOI 10.1378/chest.121.5.1507; Church TR, 2013, NEW ENGL J MED, V368, P1980, DOI 10.1056/NEJMoa1209120; Coleman MP, 2011, LANCET, V377, P127, DOI 10.1016/S0140-6736(10)62231-3; Couraud S, 2013, ANN ONCOL, V24, P586, DOI 10.1093/annonc/mds476; Cressman S, 2013, J THORAC ONCOL, V8, pS150; deKoning HJ, 2013, BENEFITS HARMS COMPU; Detterbeck FC, 2012, THORAX, V67, P842, DOI 10.1136/thoraxjnl-2012-201779; Etzel CJ, 2008, CANCER PREV RES, V1, P255, DOI 10.1158/1940-6207.CAPR-08-0082; Field JK, 2013, J SURG ONCOL, V108, P280, DOI 10.1002/jso.23383; Field JK, 2013, LANCET, V382, P732, DOI 10.1016/S0140-6736(13)61614-1; Field JK, 2012, J THORAC ONCOL, V7, P10, DOI 10.1097/JTO.0b013e31823c58ab; Fiore MC, 2008, TREATING TOBACCO USE; Goldstraw Peter, 2007, J Thorac Oncol, V2, P706, DOI 10.1097/JTO.0b013e31812f3c1a; Goulart BHL, 2012, J NATL COMPR CANC NE, V10, P267, DOI 10.6004/jnccn.2012.0023; Gould MK, 2007, CHEST, V131, P383, DOI 10.1378/chest.06-1261; Gould MK, 2013, CHEST, V143, pE93, DOI 10.1378/chest.12-2351; Grannis FW, 2013, J SURG ONCOL, V108, P289, DOI 10.1002/jso.23400; GURNEY JW, 1993, RADIOLOGY, V186, P415, DOI 10.1148/radiology.186.2.8421744; Harris RP, 2014, JAMA INTERN MED, V174, P281, DOI 10.1001/jamainternmed.2013.12745; Henschke CI, 2000, CANCER, V89, P2474; Henschke CI, 2006, NEW ENGL J MED, V355, P1763, DOI 10.1056/NEJMoa060476; Henschke CI, 2013, ANN INTERN MED, V159, P156, DOI 10.7326/0003-4819-159-2-201307160-00018; Henschke CI, 2013, ANN INTERN MED, V158, P246, DOI 10.7326/0003-4819-158-4-201302190-00004; Hensing TA, 2013, J SURG ONCOL, V108, P327, DOI 10.1002/jso.23382; Heuvelmans MA, 2013, EUR RADIOL, V23, P1836, DOI 10.1007/s00330-013-2799-9; Hippisley-Cox J, 2011, BRIT J GEN PRACT, V61, DOI 10.3399/bjgp11X606627; Hoggart C, 2012, CANCER PREV RES, V5, P834, DOI 10.1158/1940-6207.CAPR-11-0237; Horeweg N, 2013, EUR RESPIR J, V42, P1659, DOI 10.1183/09031936.00197712; Horeweg N, 2013, AM J RESP CRIT CARE, V188, P1035, DOI 10.1164/rccm.201305-0935LE; Humphrey L, 2013, SCREENING LUNG CAN S, V105; Humphrey LL, 2013, ANN INTERN MED, V159, P411, DOI 10.7326/0003-4819-159-6-201309170-00690; Ichinose J, 2013, ANN THORAC CARDIOVAS; Infante M, 2008, LUNG CANCER, V59, P355, DOI 10.1016/j.lungcan.2007.08.040; Infante M, 2009, AM J RESP CRIT CARE, V180, P445, DOI 10.1164/rccm.200901-0076OC; International Association for the Study of Lung Cancer (IASLC), 2013, J THORAC ON IN PRESS; Isbell JM, 2011, ANN THORAC SURG, V91, P227, DOI 10.1016/j.athoracsur.2010.08.054; Iyen-Omofoman B, 2013, THORAX, V68, P451, DOI 10.1136/thoraxjnl-2012-202348; Jacobs C, 2014, MED IMAGE ANAL, V18, P374, DOI 10.1016/j.media.2013.12.001; Jacobs C, 2011, LECT NOTES COMPUT SC, V6893, P207, DOI 10.1007/978-3-642-23626-6_26; Jacobson FL, 2012, J THORAC CARDIOV SUR, V144, P25, DOI 10.1016/j.jtcvs.2012.05.059; Jaklitsch MT, 2012, J THORAC CARDIOV SUR, V144, P33, DOI 10.1016/j.jtcvs.2012.05.060; Kaerlev L, 2012, BMC CANCER, V12, DOI 10.1186/1471-2407-12-188; Kantarjian HM, 2013, J CLIN ONCOL, V31, P3600, DOI 10.1200/JCO.2013.49.1845; Kovalchik SA, 2013, NEW ENGL J MED, V369, P245, DOI 10.1056/NEJMoa1301851; Lam S, 2013, ANN INTERN MED, V158, P289, DOI 10.7326/0003-4819-158-4-201302190-00011; Lassen B, 2013, IEEE T MED IMAGING, V32, P210, DOI 10.1109/TMI.2012.2219881; Li H, 2012, BMC MED GENET, V13, DOI 10.1186/1471-2350-13-118; Lim HJ, 2013, CHEST, V144, P1291, DOI 10.1378/chest.12-2987; Lindell RM, 2009, CHEST, V136, P1586, DOI 10.1378/chest.09-0915; MacMahon H, 2005, RADIOLOGY, V237, P395, DOI 10.1148/radiol.2372041887; Mahadevia PJ, 2003, JAMA-J AM MED ASSOC, V289, P313, DOI 10.1001/jama.289.3.313; Maisonneuve P, 2011, CANCER PREV RES, V4, P1778, DOI 10.1158/1940-6207.CAPR-11-0026; Maldonado F, 2013, NEW ENGL J MED, V369, P2060, DOI 10.1056/NEJMc1312411; Manser R, 2005, LUNG CANCER, V48, P171, DOI 10.1016/j.lungcan.2004.11.001; Manser RL, 2003, THORAX, V58, P784, DOI 10.1136/thorax.58.9.784; Marshall D, 2001, LUNG CANCER, V32, P227, DOI 10.1016/S0169-5002(00)00239-7; Mathers CD, 2006, PLOS MED, V3, DOI 10.1371/journal.pmed.0030442; McGovern PM, 2004, CANCER NURS, V27, P347; McMahon PM, 2011, J THORAC ONCOL, V6, P1841, DOI 10.1097/JTO.0b013e31822e59b3; McWilliams A, 2013, NEW ENGL J MED, V369, P910, DOI 10.1056/NEJMoa1214726; McWilliams AM, 2006, J THORAC ONCOL, V1, P61, DOI 10.1097/01243894-200601000-00012; Mehta HJ, 2014, CHEST, V145, P464, DOI 10.1378/chest.13-0708; Naidich DP, 2013, RADIOLOGY, V266, P304, DOI 10.1148/radiol.12120628; National Comprehensive Cancer Network Committee, 2014, NAT COMPR CANC NETW; Oken MM, 2011, JAMA-J AM MED ASSOC, V306, P1865, DOI 10.1001/jama.2011.1591; Park S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054823; Pastorino U, 2012, EUR J CANCER PREV, V21, P308, DOI 10.1097/CEJ.0b013e328351e1b6; Patz EF, 2014, JAMA INTERN MED, V174, P269, DOI 10.1001/jamainternmed.2013.12738; Pearce MS, 2012, LANCET, V380, P499, DOI 10.1016/S0140-6736(12)60815-0; Pedersen JH, 2009, J THORAC ONCOL, V4, P608, DOI 10.1097/JTO.0b013e3181a0d98f; Pegna AL, 2013, J THORAC ONCOL, V8, P866, DOI 10.1097/JTO.0b013e31828f68d6; Pegna AL, 2009, LUNG CANCER, V64, P34, DOI 10.1016/j.lungcan.2008.07.003; Pinsky PF, 2013, RADIOLOGY, V268, P865, DOI 10.1148/radiol.13121530; Pinsky PF, 2013, CANCER-AM CANCER SOC, V119, P593, DOI 10.1002/cncr.27774; Pyenson BS, 2012, HEALTH AFFAIR, V31, P770, DOI 10.1377/hlthaff.2011.0814; Reich JM, 2009, BRIT J CANCER, V101, P879, DOI 10.1038/sj.bjc.6605260; Roberts H, 2013, J THORAC ONCOL, V8, P1232, DOI 10.1097/JTO.0b013e31829fd3d5; Royston P, 2006, STAT MED, V25, P127, DOI 10.1002/sim.2331; Saghir Z, 2012, THORAX, V67, P296, DOI 10.1136/thoraxjnl-2011-200736; Schultz EM, 2008, THORAX, V63, P335, DOI 10.1136/thx.2007.084731; Shmueli A, 2013, VALUE HEALTH, V16, P922, DOI 10.1016/j.jval.2013.05.007; Siegel R, 2013, CA-CANCER J CLIN, V63, P11, DOI 10.3322/caac.21166; Sin DD, 2013, J CLIN ONCOL, V31, P4536, DOI 10.1200/JCO.2013.50.6105; Sozzi G, 2014, J CLIN ONCOL; Spitz MR, 2007, JNCI-J NATL CANCER I, V99, P715, DOI 10.1093/jnci/djk153; Spitz MR, 2008, CANCER PREV RES, V1, P250, DOI 10.1158/1940-6207.CAPR-08-0060; Styn MA, 2009, CANCER EPIDEM BIOMAR, V18, P3484, DOI 10.1158/1055-9965.EPI-09-0895; Swensen SJ, 2005, RADIOLOGY, V235, P259, DOI 10.1148/radiol.2351041662; Swensen SJ, 1997, ARCH INTERN MED, V157, P849, DOI 10.1001/archinte.157.8.849; Tammemagi MC, 2013, NEW ENGL J MED, V368, P728, DOI 10.1056/NEJMoa1211776; Tammemagi CM, 2011, JNCI-J NATL CANCER I, V103, P1058, DOI 10.1093/jnci/djr173; Tammemagi MC, 2011, CANCER PREV RES, V4, P552, DOI 10.1158/1940-6207.CAPR-10-0183; Tammemagi MC, J NATL CANC IN PRESS; Townsend CO, 2005, CANCER-AM CANCER SOC, V103, P2154, DOI 10.1002/cncr.21045; US Preventive Services Task Force, 2013, SCREEN LUNG CANC; van den Bergh KAM, 2011, EUR RESPIR J, V38, P154, DOI 10.1183/09031936.00123410; van den Bergh KAM, 2010, BRIT J CANCER, V102, P27, DOI 10.1038/sj.bjc.6605459; van Klaveren RJ, 2009, NEW ENGL J MED, V361, P2221, DOI 10.1056/NEJMoa0906085; Veronesi G, 2013, LUNG CANCER, V82, P426, DOI 10.1016/j.lungcan.2013.08.026; Veronesi G, 2012, ANN INTERN MED, V157, P776, DOI 10.7326/0003-4819-157-11-201212040-00005; Vierikko T, 2009, EUR J CANCER PREV, V18, P203, DOI 10.1097/CEJ.0b013e328329d800; Wender R, 2013, CA-CANCER J CLIN, V63, P107, DOI 10.3322/caac.21172; Wisnivesky JP, 2003, CHEST, V124, P614, DOI 10.1378/chest.124.2.614; Wood DE, 2012, J NATL COMPR CANC NE, V10, P240, DOI 10.6004/jnccn.2012.0022; Xie XQ, 2013, EUR RADIOL, V23, P139, DOI 10.1007/s00330-012-2570-7; Xu DM, 2006, LUNG CANCER, V54, P177, DOI 10.1016/j.lungcan.2006.08.006; Youlden DR, 2008, J THORAC ONCOL, V3, P819, DOI 10.1097/JTO.0b013e31818020eb; Young RP, 2009, POSTGRAD MED J, V85, P515, DOI 10.1136/pgmj.2008.077107	129	57	61	0	10	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	MAY 27	2014	348								g2253	10.1136/bmj.g2253	http://dx.doi.org/10.1136/bmj.g2253			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AI3EB	24865600				2022-12-28	WOS:000336741400001
J	Azhar, EI; El-Kafrawy, SA; Farraj, SA; Hassan, AM; Al-Saeed, MS; Hashem, AM; Madani, TA				Azhar, Esam I.; El-Kafrawy, Sherif A.; Farraj, Suha A.; Hassan, Ahmed M.; Al-Saeed, Muneera S.; Hashem, Anwar M.; Madani, Tariq A.			Evidence for Camel-to-Human Transmission of MERS Coronavirus	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							RESPIRATORY SYNDROME CORONAVIRUS; MIDDLE-EAST; DROMEDARY CAMELS	We describe the isolation and sequencing of Middle East respiratory syndrome coronavirus (MERS-CoV) obtained from a dromedary camel and from a patient who died of laboratory-confirmed MERS-CoV infection after close contact with camels that had rhinorrhea. Nasal swabs collected from the patient and from one of his nine camels were positive for MERS-CoV RNA. In addition, MERS-CoV was isolated from the patient and the camel. The full genome sequences of the two isolates were identical. Serologic data indicated that MERS-CoV was circulating in the camels but not in the patient before the human infection occurred. These data suggest that this fatal case of human MERS-CoV infection was transmitted through close contact with an infected camel.	[Azhar, Esam I.] King Abdulaziz Univ, Dept Med Lab Technol, Fac Appl Med Sci, Jeddah 21589, Saudi Arabia; [Azhar, Esam I.; El-Kafrawy, Sherif A.; Farraj, Suha A.; Hassan, Ahmed M.; Al-Saeed, Muneera S.; Hashem, Anwar M.] King Abdulaziz Univ, Special Infect Agents Unit, King Fahd Med Res Ctr, Jeddah 21589, Saudi Arabia; [Hashem, Anwar M.] King Abdulaziz Univ, Fac Med, Dept Med Microbiol & Parasitol, Jeddah 21589, Saudi Arabia; [Madani, Tariq A.] King Abdulaziz Univ, Fac Med, Dept Med, Jeddah 21589, Saudi Arabia	King Abdulaziz University; King Abdulaziz University; King Abdulaziz University; King Abdulaziz University	Madani, TA (corresponding author), King Abdulaziz Univ, Dept Med, POB 80215, Jeddah 21589, Saudi Arabia.	tmadani@kau.edu.sa	El-Kafrawy, Sherif A/C-8699-2012; Hashem, Anwar/E-9411-2011; Azhar, Esam/ABI-1044-2020; Hashem, Anwar M/B-2301-2017; Madani, Tariq/AAY-8909-2020; Hassan, Ahmed/AAB-7241-2019	El-Kafrawy, Sherif A/0000-0002-3667-7529; Hashem, Anwar M/0000-0002-8471-7011; Madani, Tariq/0000-0003-2453-0623; Farraj, Suha/0000-0003-0383-9779; Azhar, Esam/0000-0002-1736-181X				[Anonymous], 2013, LAB TEST MIDDL E RES; Assiri A, 2013, NEW ENGL J MED, V369, P407, DOI 10.1056/NEJMoa1306742; Bermingham A, 2012, EUROSURVEILLANCE, V17, P6; Corman VM, 2012, EUROSURVEILLANCE, V17, P2; Cotten M, 2013, LANCET, V382, P1993, DOI 10.1016/S0140-6736(13)61887-5; Guery B, 2013, LANCET, V381, P2254; Guery B, 2013, LANCET, V381, P2265, DOI 10.1016/S0140-6736(13)60982-4; Haagmans BL, 2014, LANCET INFECT DIS, V14, P140, DOI 10.1016/S1473-3099(13)70690-X; Ithete NL, 2013, EMERG INFECT DIS, V19, P1697, DOI 10.3201/eid1910.130946; Memish ZA, 2013, EMERG INFECT DIS, V19, P1819, DOI 10.3201/eid1911.131172; Memish ZA, 2013, NEW ENGL J MED, V368, P2487, DOI 10.1056/NEJMoa1303729; Perera RA, 2013, EUROSURVEILLANCE, V18, P8, DOI 10.2807/1560-7917.ES2013.18.36.20574; Reusken CBEM, 2013, LANCET INFECT DIS, V13, P859, DOI 10.1016/S1473-3099(13)70164-6; van Boheemen S, 2012, MBIO, V3, DOI 10.1128/mBio.00473-12; Zaki AM, 2013, NEW ENGL J MED, V369, P394; Zaki AM, 2012, NEW ENGL J MED, V367, P1814, DOI 10.1056/NEJMoa1211721	16	616	645	1	106	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUN 26	2014	370	26					2499	2505		10.1056/NEJMoa1401505	http://dx.doi.org/10.1056/NEJMoa1401505			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AJ6KY	24896817	Bronze, Green Published			2022-12-28	WOS:000337804400007
J	Seaquist, ER				Seaquist, Elizabeth R.			Addressing the Burden of Diabetes	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							HYPOGLYCEMIA; MORTALITY		Univ Minnesota, Div Endocrinol & Diabet, Minneapolis, MN 55455 USA	University of Minnesota System; University of Minnesota Twin Cities	Seaquist, ER (corresponding author), Univ Minnesota, Div Endocrinol & Diabet, MMC101,420 Delaware St SE, Minneapolis, MN 55455 USA.	seaqu001@umn.edu						Amer Diabet Assoc, 2014, DIABETES CARE, V37, pS14, DOI 10.2337/dc14-S014; Amer Diabet Assoc, 2013, DIABETES CARE, V36, P1033, DOI 10.2337/dc12-2625; Bonds DE, 2010, BMJ-BRIT MED J, V340, DOI 10.1136/bmj.b4909; Boyle JP, 2010, POPUL HEALTH METR, V8, DOI 10.1186/1478-7954-8-29; Centers for Disease Control and Prevention, DIABETES IN THE UNIT; Dabelea D, 2014, JAMA-J AM MED ASSOC, V311, P1778, DOI 10.1001/jama.2014.3201; Geller AI, 2014, JAMA INTERN MED, V174, P678, DOI 10.1001/jamainternmed.2014.136; Gregg EW, 2014, NEW ENGL J MED, V370, P1514, DOI 10.1056/NEJMoa1310799; Heller SR, 2007, DIABETOLOGIA, V50, P1140, DOI 10.1007/s00125-007-0599-y; Riddle MC, 2010, DIABETES CARE, V33, P983, DOI 10.2337/dc09-1278	10	24	24	0	6	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUN 11	2014	311	22					2267	2268		10.1001/jama.2014.6451	http://dx.doi.org/10.1001/jama.2014.6451			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AI6HL	24915253				2022-12-28	WOS:000336972600013
J	Simon, L				Simon, Lisa			Whose Story Is It, Anyway?	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									Harvard Univ, Sch Dent Med, Dept Oral Hlth Policy & Epidemiol, Boston, MA 02115 USA	Harvard University; Harvard School of Dental Medicine	Simon, L (corresponding author), Harvard Univ, Sch Dent Med, Dept Oral Hlth Policy & Epidemiol, 188 Longwood Ave, Boston, MA 02115 USA.	lisa_simon@hsdm.harvard.edu		Simon, Lisa/0000-0003-4870-1052					0	4	4	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUN 11	2014	311	22					2273	2274		10.1001/jama.2014.4518	http://dx.doi.org/10.1001/jama.2014.4518			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AI6HL	24915256				2022-12-28	WOS:000336972600016
J	O'Rourke, D				O'Rourke, Dara			The science of sustainable supply chains	SCIENCE			English	Review							PRODUCT CATEGORY RULES; ECOSYSTEM SERVICES; ENVIRONMENTAL PERFORMANCE; CARBON FOOTPRINT; MANAGEMENT; INDICATORS; CHALLENGES; INNOVATION; PROGRAMS	Recent advances in the science and technology of global supply chain management offer near-real-time demand-response systems for decision-makers across production networks. Technology is helping propel "fast fashion" and "lean manufacturing," so that companies are better able to deliver products consumers want most. Yet companies know much less about the environmental and social impacts of their production networks. The failure to measure and manage these impacts can be explained in part by limitations in the science of sustainability measurement, as well as by weaknesses in systems to translate data into information that can be used by decision-makers inside corporations and government agencies. There also remain continued disincentives for firms to measure and pay the full costs of their supply chain impacts. I discuss the current state of monitoring, measuring, and analyzing information related to supply chain sustainability, as well as progress that has been made in translating this information into systems to advance more sustainable practices by corporations and consumers. Better data, decision-support tools, and incentives will be needed to move from simply managing supply chains for costs, compliance, and risk reduction to predicting and preventing unsustainable practices.	Univ Calif Berkeley, Dept Environm Sci Policy & Management, Berkeley, CA 94720 USA	University of California System; University of California Berkeley	O'Rourke, D (corresponding author), Univ Calif Berkeley, Dept Environm Sci Policy & Management, 130 Mulford Hall, Berkeley, CA 94720 USA.	orourke@berkeley.edu	Helleno, André Luís/B-4439-2013	Helleno, André Luís/0000-0001-6054-5895				Bakshi B, 2011, J IND ECOL, V15, P477, DOI 10.1111/j.1530-9290.2011.00364.x; Benoit C, 2010, INT J LIFE CYCLE ASS, V15, P156, DOI 10.1007/s11367-009-0147-8; Blomqvist L, 2013, PLOS BIOL, V11, DOI 10.1371/journal.pbio.1001700; Bonanni L., 2010, P SIGCHI C HUM FACT, P937; Butchart SHM, 2010, SCIENCE, V328, P1164, DOI 10.1126/science.1187512; Caldeira K, 2011, P NATL ACAD SCI USA, V108, P8533, DOI 10.1073/pnas.1106517108; Chasan E., 2013, WALL STREET J; Chouinard Y, 2011, HARVARD BUS REV, V89, P52; Cucek L, 2012, J CLEAN PROD, V34, P9, DOI 10.1016/j.jclepro.2012.02.036; Dalin C, 2012, P NATL ACAD SCI USA, V109, P5989, DOI 10.1073/pnas.1203176109; Dangelico R, 2010, J BUS ETHICS, V95, P471, DOI 10.1007/s10551-010-0434-0; Dauvergne P, 2012, GLOBAL ENVIRON CHANG, V22, P36, DOI 10.1016/j.gloenvcha.2011.10.007; Davis SJ, 2011, P NATL ACAD SCI USA, V108, P18554, DOI 10.1073/pnas.1107409108; Dias AC, 2012, J CLEAN PROD, V24, P30, DOI 10.1016/j.jclepro.2011.11.005; Dingwerth K, 2010, GLOBAL ENVIRON POLIT, V10, P74, DOI 10.1162/GLEP_a_00015; Eccles RG, 2011, J APPL CORP FINANC, V23, P113, DOI 10.1111/j.1745-6622.2011.00357.x; Ewing BR, 2012, ECOL INDIC, V23, P1, DOI 10.1016/j.ecolind.2012.02.025; Finnveden G, 2009, J ENVIRON MANAGE, V91, P1, DOI 10.1016/j.jenvman.2009.06.018; Fonseca A, 2013, MINER ENG, V46-47, P180, DOI 10.1016/j.mineng.2013.04.008; Freidberg S, 2013, ECON SOC, V42, P571, DOI 10.1080/03085147.2012.760349; Galli A, 2012, ECOL INDIC, V16, P100, DOI 10.1016/j.ecolind.2011.06.017; Geyer R, 2010, INT J LIFE CYCLE ASS, V15, P454, DOI 10.1007/s11367-010-0170-9; Giljum S, 2011, RESOUR CONSERV RECY, V55, P300, DOI 10.1016/j.resconrec.2010.09.009; Gimenez C, 2013, J BUS ETHICS, V116, P189, DOI 10.1007/s10551-012-1458-4; Gloria TP, 2014, INT J LIFE CYCLE ASS, V19, P491, DOI 10.1007/s11367-013-0661-6; Gmelin H, 2014, J CLEAN PROD, V69, P1, DOI 10.1016/j.jclepro.2014.01.053; Golden JS, 2011, J IND ECOL, V15, P821, DOI 10.1111/j.1530-9290.2011.00381.x; Golden JS, 2010, ECOL SOC, V15; Golicic SL, 2013, J SUPPLY CHAIN MANAG, V49, P78, DOI 10.1111/jscm.12006; Grimm J. H., 2012, 1225 CLARK U GP MARS; Guinee JB, 2011, ENVIRON SCI TECHNOL, V45, P90, DOI 10.1021/es101316v; Hallstedt SI, 2013, J CLEAN PROD, V51, P277, DOI 10.1016/j.jclepro.2013.01.043; Hans J., 2013, SUPPLY CHAIN INNOVAT; Hansen MC, 2010, P NATL ACAD SCI USA, V107, P8650, DOI 10.1073/pnas.0912668107; Hassini E, 2012, INT J PROD ECON, V140, P69, DOI 10.1016/j.ijpe.2012.01.042; Hellweg S, 2014, SCIENCE, V344, P1109, DOI 10.1126/science.1248361; Herva M, 2011, J CLEAN PROD, V19, P1687, DOI 10.1016/j.jclepro.2011.05.019; Heuer M, 2011, BUS STRATEG ENVIRON, V20, P211, DOI 10.1002/bse.673; Hoejmose SU, 2012, J PURCH SUPPLY MANAG, V18, P232, DOI 10.1016/j.pursup.2012.06.002; Hoekstra AY, 2014, SCIENCE, V344, P1114, DOI 10.1126/science.1248365; Ingwersen WW, 2012, J CLEAN PROD, V24, P102, DOI 10.1016/j.jclepro.2011.10.040; Kastner T, 2011, ECOL ECON, V70, P1032, DOI 10.1016/j.ecolecon.2011.01.012; Kinzig AP, 2011, SCIENCE, V334, P603, DOI 10.1126/science.1210297; Lee KH, 2011, J CLEAN PROD, V19, P1216, DOI 10.1016/j.jclepro.2011.03.010; Makower J., 2013, TARGET GOODGUIDE TEA; Meinrenken CJ, 2012, J IND ECOL, V16, P669, DOI 10.1111/j.1530-9290.2012.00463.x; Nagurney A., 2013, NETWORKS TIME SUPPLY, P117, DOI [10.1007/978-1-4614-6277-4_6, DOI 10.1007/978-1-4614-6277-4_6]; Nelson EJ, 2013, FRONT ECOL ENVIRON, V11, P483, DOI 10.1890/120312; O'Shea T, 2013, BUS STRATEG ENVIRON, V22, P429, DOI 10.1002/bse.1745; Pagell M, 2014, J SUPPLY CHAIN MANAG, V50, P44, DOI 10.1111/jscm.12037; Pagell M, 2009, J SUPPLY CHAIN MANAG, V45, P37, DOI 10.1111/j.1745-493X.2009.03162.x; Porter ME, 2011, HARVARD BUS REV, V89, P62; Prakash A, 2012, J POLICY ANAL MANAG, V31, P123, DOI 10.1002/pam.20617; Rees W.E., 1992, ENVIRON URBAN, V4, P121, DOI [10.1177/095624789200400212, DOI 10.1177/095624789200400212]; Schor JB, 2013, CONSUM PUBLIC LIFE, P34; Seuring S, 2008, J CLEAN PROD, V16, P1699, DOI 10.1016/j.jclepro.2008.04.020; Seuring S, 2011, BUS STRATEG ENVIRON, V20, P471, DOI 10.1002/bse.702; Singh RK, 2009, ECOL INDIC, V9, P189, DOI 10.1016/j.ecolind.2008.05.011; Subramanian V, 2012, INT J LIFE CYCLE ASS, V17, P892, DOI 10.1007/s11367-012-0419-6; Trucost, 2013, NAT CAP RISK TOP 100; Wu ZH, 2011, J OPER MANAG, V29, P577, DOI 10.1016/j.jom.2010.10.001	61	162	164	14	448	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 6	2014	344	6188					1124	1127		10.1126/science.1248526	http://dx.doi.org/10.1126/science.1248526			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AI3UU	24904157	Green Submitted			2022-12-28	WOS:000336791200039
J	Pe'er, G; Dicks, LV; Visconti, P; Arlettaz, R; Baldi, A; Benton, TG; Collins, S; Dieterich, M; Gregory, RD; Hartig, F; Henle, K; Hobson, PR; Kleijn, D; Neumann, RK; Robijns, T; Schmidt, J; Shwartz, A; Sutherland, WJ; Turbe, A; Wulf, F; Scott, AV				Pe'er, G.; Dicks, L. V.; Visconti, P.; Arlettaz, R.; Baldi, A.; Benton, T. G.; Collins, S.; Dieterich, M.; Gregory, R. D.; Hartig, F.; Henle, K.; Hobson, P. R.; Kleijn, D.; Neumann, R. K.; Robijns, T.; Schmidt, J.; Shwartz, A.; Sutherland, W. J.; Turbe, A.; Wulf, F.; Scott, A. V.			AGRICULTURE POLICY EU agricultural reform fails on biodiversity	SCIENCE			English	Editorial Material							AGRI-ENVIRONMENT SCHEMES; FARMLAND BIODIVERSITY; HABITAT HETEROGENEITY; POPULATION TRENDS; CONSERVATION; EUROPE; MANAGEMENT; BIRDS; INTENSIFICATION; POLLINATORS		[Pe'er, G.; Henle, K.; Neumann, R. K.] UFZ Helmholtz Ctr Environm Res, Dept Conservat Biol, D-04318 Leipzig, Germany; [Pe'er, G.; Visconti, P.; Arlettaz, R.; Baldi, A.; Dieterich, M.] Soc Conservat Biol Europe Sect, Washington, DC 20001 USA; [Dicks, L. V.; Sutherland, W. J.] Univ Cambridge, Dept Zool, Cambridge CB2 3EJ, England; [Visconti, P.] Microsoft Res, Computat Sci Lab Cambridge, Cambridge CB1 2FB, England; [Arlettaz, R.] Univ Bern, Inst Ecol & Evolut, Dept Conservat Biol, Bern, Switzerland; [Baldi, A.] MTA Ctr Ecol Res, H-2163 Vacratot, Hungary; [Benton, T. G.] Univ Leeds, Sch Biol, Leeds LS2 9JT, W Yorkshire, England; [Collins, S.] Butterfly Conservat Europe, Wageningen, Netherlands; [Dieterich, M.] Univ Hohenheim, Inst Landscape & Plant Ecol, D-70599 Stuttgart, Germany; [Gregory, R. D.] The Lodge, RSPB Ctr Conservat Sci, Sandy SG19 2DL, Beds, England; [Hartig, F.] Univ Freiburg, Dept Biometry & Environm Syst Anal, D-79085 Freiburg, Germany; [Hobson, P. R.] Eberswalde Univ Sustainable Dev, Ctr Econ & Ecosyst Management, D-16225 Eberswalde, Germany; [Kleijn, D.] Wageningen Univ, Resource Ecol Grp, NL-6708 PB Wageningen, Netherlands; [Kleijn, D.] Alterra, Anim Ecol Team, NL-6700 AA Wageningen, Netherlands; [Robijns, T.] Stichting BirdLife Europe, B-1060 Brussels, Belgium; [Schmidt, J.] UFZ Helmholtz Ctr Environm Res, Dept Environm Polit, D-04318 Leipzig, Germany; [Shwartz, A.] Technion Israel Inst Technol, Fac Architecture & Town Planning, IL-32000 Haifa, Israel; [Shwartz, A.] Univ Kent, Durrell Inst Conservat & Ecol, Canterbury CT2 7NZ, Kent, England; [Turbe, A.] BIO Intelligence Serv, F-9200 Neuilly Sur Seine, France; [Wulf, F.] Pro Natura Friends Earth Switzerland, CH-4018 Basel, Switzerland; [Scott, A. V.] Univ Reading, Sch Agr Policy & Dev, CAER, Reading RG6 6AR, Berks, England	Helmholtz Association; Helmholtz Center for Environmental Research (UFZ); University of Cambridge; Microsoft; University of Bern; Eotvos Lorand Research Network; Hungarian Academy of Sciences; Hungarian Centre for Ecological Research; University of Leeds; University Hohenheim; Royal Society for Protection of Birds; University of Freiburg; Eberswalde University for Sustainable Development; Wageningen University & Research; Wageningen University & Research; Helmholtz Association; Helmholtz Center for Environmental Research (UFZ); Technion Israel Institute of Technology; University of Kent; University of Reading	Pe'er, G (corresponding author), UFZ Helmholtz Ctr Environm Res, Dept Conservat Biol, D-04318 Leipzig, Germany.	guy.peer@ufz.de; guy.peer@ufz.de	Arlettaz, Raphaël/O-2182-2016; Henle, Klaus/I-6837-2013; Dicks, Lynn V./AFH-5289-2022; Baldi, Andras/A-7501-2008; Hartig, Florian/G-4510-2010; Benton, Tim G/C-6493-2009; Kleijn, David/HCH-3477-2022; Visconti, Piero/A-3253-2009	Arlettaz, Raphaël/0000-0001-6360-5339; Henle, Klaus/0000-0002-6647-5362; Baldi, Andras/0000-0001-6063-3721; Hartig, Florian/0000-0002-6255-9059; Benton, Tim G/0000-0002-7448-1973; Visconti, Piero/0000-0001-6823-2826; Dicks, Lynn/0000-0002-8304-4468; Kleijn, David/0000-0003-2500-7164; Gregory, Richard/0000-0002-7419-5053; Sutherland, William/0000-0002-6498-0437	Biotechnology and Biological Sciences Research Council [BB/J005851/1] Funding Source: researchfish; Natural Environment Research Council [NE/K015419/1] Funding Source: researchfish; BBSRC [BB/J005851/1] Funding Source: UKRI; NERC [NE/K015419/1] Funding Source: UKRI	Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))		[Anonymous], 2011, OUR NAT CAP EU BIOD; AVIRON S, 2005, EVAL OKOMASS BER BIO; Babai D, 2014, AGR ECOSYST ENVIRON, V182, P123, DOI 10.1016/j.agee.2013.08.018; Baker DJ, 2012, J APPL ECOL, V49, P871, DOI 10.1111/j.1365-2664.2012.02161.x; Batary P, 2011, P ROY SOC B-BIOL SCI, V278, P1894, DOI 10.1098/rspb.2010.1923; Batary P, 2011, FRONT ECOL ENVIRON, V9, P152, DOI 10.1890/11.WB.006; Benton TG, 2003, TRENDS ECOL EVOL, V18, P182, DOI 10.1016/S0169-5347(03)00011-9; *BIRDLIFE INT, 2003, BIRDS EUR POP EST TR; Bommarco R, 2013, TRENDS ECOL EVOL, V28, P230, DOI 10.1016/j.tree.2012.10.012; *BTO, 2013, BIRD IND IND UPD OCT; Buri P, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085635; Buri P, 2013, AGR ECOSYST ENVIRON, V181, P22, DOI 10.1016/j.agee.2013.09.003; Burton RJF, 2013, LAND USE POLICY, V30, P628, DOI 10.1016/j.landusepol.2012.05.002; Butler SJ, 2010, AGR ECOSYST ENVIRON, V137, P348, DOI 10.1016/j.agee.2010.03.005; Carvalheiro LG, 2013, ECOL LETT, V16, P870, DOI 10.1111/ele.12121; Cizek O, 2012, J INSECT CONSERV, V16, P215, DOI 10.1007/s10841-011-9407-6; COLLINS S, 2014, IMPROVING MANAGEMENT; Dicks LV, 2014, CONSERV LETT, V7, P119, DOI 10.1111/conl.12046; Dicks LV, 2013, INSECT CONSERV DIVER, V6, P435, DOI 10.1111/j.1752-4598.2012.00221.x; DIETERICH M, 2012, DEFIZIT NAT 2000 SIT; Dover JW, 2011, J INSECT CONSERV, V15, P129, DOI 10.1007/s10841-010-9332-0; Emery SB, 2012, J RURAL STUD, V28, P218, DOI 10.1016/j.jrurstud.2012.02.004; *EUR COMM, 2010, CAP TOW 2020 MEET FO; *EUR COMM, 2013, 6 FIN REP COMM EUR P; *EUR COMM, 2012, EU BUDG 2012 500 MIL; *EUR COMM, 2012, NAT BIOD LIFE PROJ 2; *EUR ENV AG, 2010, 122010 EEA TECH REP; *EUR ENV AG, 2013, 112013 EEA TECH REP; European Environment Agency, 2004, EEA SIGN 2004 EUR EN; European Parliament, 2013, DIR GEN INT POL POL; FAO (Food and Agriculture Organization of the United Nations), 2013, FAO STAT YB 2013; *FED OFF AGR BLW, 2013, BUND LANDW 2013 AGR; Fischer J, 2008, FRONT ECOL ENVIRON, V6, P382, DOI 10.1890/070019; Fischer J, 2012, CONSERV LETT, V5, P167, DOI 10.1111/j.1755-263X.2012.00227.x; GEROWITT B., 2011, CHANCEN BIOL VIELFAL; Gilroy JJ, 2011, ANIM CONSERV, V14, P620, DOI 10.1111/j.1469-1795.2011.00480.x; Godfray HCJ, 2010, SCIENCE, V327, P812, DOI 10.1126/science.1185383; Gregory RD, 2005, PHILOS T R SOC B, V360, P269, DOI 10.1098/rstb.2004.1602; Gregory RD, 2010, ORNITHOL SCI, V9, P3, DOI 10.2326/osj.9.3; Hartel T, 2013, BIOL CONSERV, V166, P267, DOI 10.1016/j.biocon.2013.06.020; Helberg N, 2012, CAN J PLANT SCI, V92, P981, DOI [10.4141/CJPS2012-035, 10.4141/cjps2012-035]; Henle K, 2008, AGR ECOSYST ENVIRON, V124, P60, DOI 10.1016/j.agee.2007.09.005; Henle K, 2013, ECOL INDIC, V33, P5, DOI 10.1016/j.ecolind.2013.03.028; Hole DG, 2005, BIOL CONSERV, V122, P113, DOI 10.1016/j.biocon.2004.07.018; IEEP, 2012, BACKGR STUD BIOD PRO; Kleijn D, 2001, NATURE, V413, P723, DOI 10.1038/35099540; Kleijn D, 2006, ECOL LETT, V9, P243, DOI 10.1111/j.1461-0248.2005.00869.x; Kleijn D, 2011, TRENDS ECOL EVOL, V26, P474, DOI 10.1016/j.tree.2011.05.009; Knight AT, 2008, CONSERV BIOL, V22, P610, DOI 10.1111/j.1523-1739.2008.00914.x; Konvicka M, 2008, J INSECT CONSERV, V12, P519, DOI 10.1007/s10841-007-9092-7; MCCULLAGH P, 1989, GENERAL LINEAR MODEL; Merckx T, 2009, AGR ECOSYST ENVIRON, V130, P177, DOI 10.1016/j.agee.2009.01.006; Mikulcak F, 2013, ENVIRON CONSERV, V40, P129, DOI 10.1017/S0376892912000392; Oppermann R., 2012, COMMON AGR POLICY 20; Pannekoek J., 2003, TRIM 3 MANUAL TRENDS; PARACCHINI ML, 2008, HIGH NAT VALUE FARML; Pe'er G, 2014, BIOL CONSERV, V170, P92, DOI 10.1016/j.biocon.2013.12.011; Pe'er G, 2011, DIVERS DISTRIB, V17, P1186, DOI 10.1111/j.1472-4642.2011.00795.x; POLAKOVA J, 2011, REP DF AGR RURAL DEV; Pywell RF, 2012, BIOL LETTERS, V8, P772, DOI 10.1098/rsbl.2012.0367; RIBBE L, 2011, EINE OKOL ERSTE EINE; Rutz C., 2013, SOCIOL RURAL; *SOC CONS BIOL EUR, 2013, EVID GRASSL MAPP MEM; Stoate C, 2009, J ENVIRON MANAGE, V91, P22, DOI 10.1016/j.jenvman.2009.07.005; Sutherland LA, 2012, LAND USE POLICY, V29, P502, DOI 10.1016/j.landusepol.2011.09.003; Sutherland LA, 2010, LAND USE POLICY, V27, P415, DOI 10.1016/j.landusepol.2009.06.003; *TEEB, 2010, EC EC BIOD EC EC FOU; Tscharntke T, 2005, ECOL LETT, V8, P857, DOI 10.1111/j.1461-0248.2005.00782.x; Tscharntke T, 2012, BIOL REV, V87, P661, DOI 10.1111/j.1469-185X.2011.00216.x; Tscharntke T, 2011, AGR ECOSYST ENVIRON, V143, P37, DOI 10.1016/j.agee.2010.11.025; TUCK SL, 2014, J APPL ECOL; Tzanopoulos J, 2013, GLOBAL ENVIRON CHANG, V23, P167, DOI 10.1016/j.gloenvcha.2012.09.002; *UBA, 2014, OKOL VORR UNVERZ BIO; Van Herzele A, 2013, J ENVIRON MANAGE, V131, P110, DOI 10.1016/j.jenvman.2013.09.030; Van Strien AJ, 2001, BIRD STUDY, V48, P200, DOI 10.1080/00063650109461219; Vickery J., 2012, BIRDS HABITAT RELATI, P177, DOI DOI 10.1017/CBO9781139021654.009; Winqvist C, 2011, J APPL ECOL, V48, P570, DOI 10.1111/j.1365-2664.2010.01950.x; World Resources Institute, 2005, ECOS HUM WELL BEING	78	399	418	7	308	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 6	2014	344	6188					1090	1092		10.1126/science.1253425	http://dx.doi.org/10.1126/science.1253425			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AI3UU	24904142				2022-12-28	WOS:000336791200023
J	Loxterkamp, D				Loxterkamp, David			LETTER FROM NEW ENGLAND Life after work: a doctor's lonely hearts club	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									Seaport Community Hlth Ctr, Belfast, ME 04915 USA		Loxterkamp, D (corresponding author), Seaport Community Hlth Ctr, Belfast, ME 04915 USA.	david.loxterkamp@gmail.com						Christakis N.A., 2009, CONNECTED SURPRISING; Steptoe A, 2013, P NATL ACAD SCI USA, V110, P5797, DOI 10.1073/pnas.1219686110	2	0	0	0	4	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JUN 5	2014	348								g3715	10.1136/bmj.g3715	http://dx.doi.org/10.1136/bmj.g3715			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AI7CD	24904030				2022-12-28	WOS:000337037800012
J	Schneeweiss, S				Schneeweiss, Sebastian			Learning from Big Health Care Data	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Schneeweiss, Sebastian] Brigham & Womens Hosp, Dept Med, Div Pharmacoepidemiol & Pharmacoecon, Boston, MA 02115 USA; [Schneeweiss, Sebastian] Harvard Univ, Sch Med, Boston, MA USA	Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School	Schneeweiss, S (corresponding author), Brigham & Womens Hosp, Dept Med, Div Pharmacoepidemiol & Pharmacoecon, 75 Francis St, Boston, MA 02115 USA.		Schneeweiss, Sebastian/C-2125-2013	Schneeweiss, Sebastian/0000-0003-2575-467X				Choudhry NK, 2006, BMJ-BRIT MED J, V332, P141, DOI 10.1136/bmj.38698.709572.55; Faden RR, 2013, HASTINGS CENT REP, V43, pS16, DOI 10.1002/hast.134; Gabriel SE, 2012, NEW ENGL J MED, V367, P787, DOI 10.1056/NEJMp1207437; Institute of Medicine, 2012, LEARN HLTH CAR SYST; Schneeweiss S, 2005, J CLIN EPIDEMIOL, V58, P323, DOI 10.1016/j.jclinepi.2004.10.012	5	192	200	1	78	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUN 5	2014	370	23					2161	2163		10.1056/NEJMp1401111	http://dx.doi.org/10.1056/NEJMp1401111			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	AI3AF	24897079				2022-12-28	WOS:000336729900002
J	Steinhardt, P				Steinhardt, Paul			Big Bang blunder bursts the multiverse bubble	NATURE			English	Editorial Material									Princeton Univ, Princeton, NJ 08544 USA	Princeton University	Steinhardt, P (corresponding author), Princeton Univ, Princeton, NJ 08544 USA.	steinh@princeton.edu		Steinhardt, Paul/0000-0003-3488-1603				2014, NATURE, V507, P281	1	15	16	1	22	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 5	2014	510	7503					9	9		10.1038/510009a	http://dx.doi.org/10.1038/510009a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AI3NR	24899270	Bronze			2022-12-28	WOS:000336768900004
J	Smith, JM				Smith, Jeanette M.			Vegetable Dinner Peter Blume	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material																		BLUME P, 1999, ARCH AM ART J, V32, P2; WHITE MA, 2000, AM ART, V14, P81	2	0	0	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUN 4	2014	311	21					2152	2153		10.1001/jama.2013.279530	http://dx.doi.org/10.1001/jama.2013.279530			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AI2DU	24893073				2022-12-28	WOS:000336668400001
J	Kontorinis, G; Crowther, JA				Kontorinis, Georgios; Crowther, John A.			PICTURE QUIZ Asymmetric hearing loss and tinnitus	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							UNILATERAL ACOUSTIC NEUROMAS; VESTIBULAR SCHWANNOMAS; CONSERVATIVE MANAGEMENT; NATURAL-HISTORY; GROWTH		[Kontorinis, Georgios; Crowther, John A.] So Gen Hosp, Inst Neurol Sci, Dept Otolaryngol, Glasgow G51 4TF, Lanark, Scotland	University of Glasgow	Kontorinis, G (corresponding author), So Gen Hosp, Inst Neurol Sci, Dept Otolaryngol, Glasgow G51 4TF, Lanark, Scotland.	gkontorinis@gmail.com						Bonneville F, 2007, EUR RADIOL, V17, P2472, DOI 10.1007/s00330-007-0679-x; Doris L, 2005, ARCH OTOLARYNGOL, V131, P241, DOI 10.1001/archotol.131.3.241; ECKERMEIER L, 1979, ARCH OHREN NASEN KEH, V222, P1, DOI 10.1007/BF00456332; Evans DGR, 2009, GENET MED, V11, P599, DOI 10.1097/GIM.0b013e3181ac9a27; Evans DGR, 2005, OTOL NEUROTOL, V26, P93, DOI 10.1097/00129492-200501000-00016; Flint D, 2005, J LARYNGOL OTOL, V119, P424, DOI 10.1258/0022215054273089; Fortnum H, 2009, HEALTH TECHNOL ASSES, V13, P1, DOI 10.3310/hta13180; Herwadker A, 2005, OTOL NEUROTOL, V26, P86, DOI 10.1097/00129492-200501000-00015; LEONARD JR, 1970, ARCHIV OTOLARYNGOL, V91, P117; Martin TPC, 2009, OTOL NEUROTOL, V30, P381, DOI 10.1097/MAO.0b013e31819a8df6; Massick DD, 2000, LARYNGOSCOPE, V110, P1843, DOI 10.1097/00005537-200011000-00015; Matthies C, 1997, NEUROSURGERY, V40, P1; Moffat DA, 2004, CLIN OTOLARYNGOL, V29, P515, DOI 10.1111/j.1365-2273.2004.00854.x; Moffat DA, 2012, OTOL NEUROTOL, V33, P1053, DOI 10.1097/MAO.0b013e3182595454; Nikolopoulos TP, 2010, OTOL NEUROTOL, V31, P478, DOI 10.1097/MAO.0b013e3181d279a3; Pitts LH, 1998, NEW ENGL J MED, V339, P1471, DOI 10.1056/NEJM199811123392011; Saleh EA, 1996, AM J OTOL, V17, P127; Schmidt RJ, 2001, ARCH OTOLARYNGOL, V127, P19, DOI 10.1001/archotol.127.1.19; Smouha EE, 2005, LARYNGOSCOPE, V115, P450, DOI 10.1097/00005537-200503000-00011; Stangerup SE, 2010, NEUROSURGERY, V67, P1335, DOI 10.1227/NEU.0b013e3181f22660; Steiger J. R., 2005, HEAR J, V58, P38, DOI DOI 10.1097/01.HJ.0000287174.23086.36; Tierney PA, 1998, SKULL BASE SURG, V8, P149, DOI 10.1055/s-2008-1058574; Tschudi DC, 2000, AM J OTOL, V21, P722; Wolbers John G, 2013, BMJ Open, V3, DOI 10.1136/bmjopen-2012-001345; Yoshimoto Y, 2005, J NEUROSURG, V103, P59, DOI 10.3171/jns.2005.103.1.0059	25	8	8	0	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JUN 3	2014	348								g3601	10.1136/bmj.g3601	http://dx.doi.org/10.1136/bmj.g3601			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AI7CB	24895175				2022-12-28	WOS:000337037600007
J	Burke, JE; Inglis, AJ; Perisic, O; Masson, GR; McLaughlin, SH; Rutaganira, F; Shokat, KM; Williams, RL				Burke, John E.; Inglis, Alison J.; Perisic, Olga; Masson, Glenn R.; McLaughlin, Stephen H.; Rutaganira, Florentine; Shokat, Kevan M.; Williams, Roger L.			Structures of PI4KIII beta complexes show simultaneous recruitment of Rab11 and its effectors	SCIENCE			English	Article							PHOSPHATIDYLINOSITOL 4-KINASES; MEMBRANE RECRUITMENT; RECYCLING ENDOSOME; GOLGI-COMPLEX; REPLICATION; FAMILY; P110-ALPHA; COMPONENTS; PROTEINS; PATHWAY	Phosphatidylinositol 4-kinases (PI4Ks) and small guanosine triphosphatases (GTPases) are essential for processes that require expansion and remodeling of phosphatidylinositol 4-phosphate (PI4P)-containing membranes, including cytokinesis, intracellular development of malarial pathogens, and replication of a wide range of RNA viruses. However, the structural basis for coordination of PI4K, GTPases, and their effectors is unknown. Here, we describe structures of PI4K beta (PI4KIII beta) bound to the small GTPase Rab11a without and with the Rab11 effector protein FIP3. The Rab11-PI4KIII beta interface is distinct compared with known structures of Rab complexes and does not involve switch regions used by GTPase effectors. Our data provide a mechanism for how PI4KIII beta coordinates Rab11 and its effectors on PI4P-enrichedmembranes and also provide strategies for the design of specific inhibitors that could potentially target plasmodial PI4KIII beta to combat malaria.	[Burke, John E.; Inglis, Alison J.; Perisic, Olga; Masson, Glenn R.; McLaughlin, Stephen H.; Williams, Roger L.] MRC, Mol Biol Lab, Cambridge CB2 0QH, England; [Rutaganira, Florentine; Shokat, Kevan M.] Univ Calif San Francisco, Howard Hughes Med Inst, San Francisco, CA 94158 USA; [Rutaganira, Florentine; Shokat, Kevan M.] Univ Calif San Francisco, Dept Cellular & Mol Pharmacol, San Francisco, CA 94158 USA	MRC Laboratory Molecular Biology; Howard Hughes Medical Institute; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Burke, JE (corresponding author), Univ Victoria, Dept Biochem & Microbiol, Victoria, BC, Canada.	jeburke@uvic.ca; rlw@mrc-lmb.cam.ac.uk	Masson, Glenn/AAD-6546-2022; Burke, John/H-3922-2019	Burke, John/0000-0001-7904-9859; Williams, Roger/0000-0001-7754-4207; McLaughlin, Stephen/0000-0001-9135-6253; Masson, Glenn/0000-0002-1386-4719; Perisic, Olga/0000-0002-3842-2896; Inglis, Alison/0000-0002-9008-8565	British Heart Foundation [PG11/109/29247]; NSF; NIH [RO1AI099245]; UK MRC [MC_U105184308]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI099245] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM064337] Funding Source: NIH RePORTER; British Heart Foundation [PG/11/109/29247] Funding Source: researchfish; Medical Research Council [1358691, MC_U105184308] Funding Source: researchfish; MRC [MC_U105184308] Funding Source: UKRI	British Heart Foundation(British Heart Foundation); NSF(National Science Foundation (NSF)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); UK MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); British Heart Foundation(British Heart Foundation); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	We thank C. Mueller-Dieckmann and D. De Sanctis at the European Synchrotron Radiation Facility and C. Lobley at Diamond Light Source for assistance with beamlines ID23-EH2, ID29, and I04-1; S. Maslen, M. Skehel, and S. Y. Peak-Chew for help with HDX-MS setup; and M. Yu for help with x-ray data collection. J.E.B. was supported by a grant from the British Heart Foundation (PG11/109/29247) and F. Rutaganira by an NSF predoctoral fellowship. This work was funded by the NIH (RO1AI099245 to K. M. S.) and the UK MRC (MC_U105184308 to R. L. W). K. M. S. has filed for patent protection on PIK93 analogs in the following application between UCSF and Stanford University: PCT/US2012/059023. Coordinates and structure factors have been deposited in the Protein Data Bank with accession numbers 4D0L and 4D0M, for PI4KIII beta/Rab11a and PI4KIII beta/Rab11a/FIP3 complexes, respectively. Author contributions: J.E.B., O.P., and R. L. W. initiated the project and designed the experiments; J.E.B., A.J.I., G. R. M., and O.P. performed the experiments; J.E.B. and R. L. W. carried out the structure determination and analysis; S. H. M. performed SPR analysis; F. R. and K. M. S. synthesized PI4K inhibitors; and J.E.B., O.P., and R. L. W. wrote the manuscript.	Altan-Bonnet N, 2012, TRENDS BIOCHEM SCI, V37, P293, DOI 10.1016/j.tibs.2012.03.004; Arita M, 2011, J VIROL, V85, P2364, DOI 10.1128/JVI.02249-10; Audhya A, 2000, MOL BIOL CELL, V11, P2673, DOI 10.1091/mbc.11.8.2673; Balla A, 2008, BIOCHEMISTRY-US, V47, P1599, DOI 10.1021/bi7017927; Burke JE, 2012, P NATL ACAD SCI USA, V109, P15259, DOI 10.1073/pnas.1205508109; D'Angelo G, 2013, NATURE, V501, DOI 10.1038/nature12423; de Graaf P, 2004, MOL BIOL CELL, V15, P2038, DOI 10.1091/mbc.E03-12-0862; Dowler S, 2000, BIOCHEM J, V351, P19, DOI 10.1042/0264-6021:3510019; Eathiraj S, 2006, J MOL BIOL, V364, P121, DOI 10.1016/j.jmb.2006.08.064; Godi A, 1999, NAT CELL BIOL, V1, P280, DOI 10.1038/12993; Horgan CP, 2007, TRAFFIC, V8, P414, DOI 10.1111/j.1600-0854.2007.00543.x; Hsu NY, 2010, CELL, V141, P799, DOI 10.1016/j.cell.2010.03.050; Jagoe WN, 2006, STRUCTURE, V14, P1273, DOI 10.1016/j.str.2006.06.010; Jean S, 2012, NAT REV MOL CELL BIO, V13, P463, DOI 10.1038/nrm3379; Kelly EE, 2012, BIOCHEM SOC T, V40, P1360, DOI 10.1042/BST20120157; Khan AR, 2013, STRUCTURE, V21, P1284, DOI 10.1016/j.str.2013.06.016; Knight ZA, 2006, CELL, V125, P733, DOI 10.1016/j.cell.2006.03.035; Laskowski RA, 2011, J CHEM INF MODEL, V51, P2778, DOI 10.1021/ci200227u; Levine TP, 2002, CURR BIOL, V12, P695, DOI 10.1016/S0960-9822(02)00779-0; McNamara CW, 2013, NATURE, V504, P248, DOI 10.1038/nature12782; Miller S, 2010, SCIENCE, V327, P1638, DOI 10.1126/science.1184429; Mizuno-Yamasaki E, 2010, DEV CELL, V18, P828, DOI 10.1016/j.devcel.2010.03.016; Polevoy G, 2009, J CELL BIOL, V187, P847, DOI 10.1083/jcb.200908107; Santiago-Tirado FH, 2011, TRENDS CELL BIOL, V21, P515, DOI 10.1016/j.tcb.2011.05.005; Sciorra VA, 2005, MOL BIOL CELL, V16, P776, DOI 10.1091/mbc.e04-08-0700; Shiba T, 2006, P NATL ACAD SCI USA, V103, P15416, DOI 10.1073/pnas.0605357103; Toth B, 2006, J BIOL CHEM, V281, P36369, DOI 10.1074/jbc.M604935200; Ullrich O, 1996, J CELL BIOL, V135, P913, DOI 10.1083/jcb.135.4.913; van der Schaar HM, 2013, ANTIMICROB AGENTS CH, V57, P4971, DOI 10.1128/AAC.01175-13; Wilson GM, 2005, MOL BIOL CELL, V16, P849, DOI 10.1091/mbc.e04-10-0927	30	96	99	1	39	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 30	2014	344	6187					1035	1038		10.1126/science.1253397	http://dx.doi.org/10.1126/science.1253397			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AH9WM	24876499	Green Accepted			2022-12-28	WOS:000336495800047
J	Palmer, BA; Edwards-Gau, GR; Kariuki, BM; Harris, KDM; Dolbnya, IP; Collins, SP				Palmer, Benjamin A.; Edwards-Gau, Gregory R.; Kariuki, Benson M.; Harris, Kenneth D. M.; Dolbnya, Igor P.; Collins, Stephen P.			X-ray birefringence imaging	SCIENCE			English	Article							INCLUSION COMPOUND; LINEAR DICHROISM; ORIENTATION	The polarizing optical microscope has been used since the 19th century to study the structural anisotropy of materials, based on the phenomenon of optical birefringence. In contrast, the phenomenon of x-ray birefringence has been demonstrated only recently and has been shown to be a sensitive probe of the orientational properties of individual molecules and/or bonds in anisotropic solids. Here, we report a technique-x-ray birefringence imaging (XBI)-that enables spatially resolved mapping of x-ray birefringence of materials, representing the x-ray analog of the polarizing optical microscope. Our results demonstrate the utility and potential of XBI as a sensitive technique for imaging the local orientational properties of anisotropic materials, including characterization of changes in molecular orientational ordering associated with solid-state phase transitions and identification of the size, spatial distribution, and temperature dependence of domain structures.	[Palmer, Benjamin A.; Edwards-Gau, Gregory R.; Kariuki, Benson M.; Harris, Kenneth D. M.] Cardiff Univ, Sch Chem, Cardiff CF10 3AT, S Glam, Wales; [Dolbnya, Igor P.; Collins, Stephen P.] Diamond Light Source, Didcot OX11 0DE, Oxon, England	Cardiff University; Diamond Light Source	Harris, KDM (corresponding author), Cardiff Univ, Sch Chem, Pk Pl, Cardiff CF10 3AT, S Glam, Wales.	harriskdm@cardiff.ac.uk	Kariuki, Benson/AAC-5662-2021; Collins, Stephen/AAG-7910-2020; Kariuki, Benson/E-3469-2017	Kariuki, Benson/0000-0002-8658-3897; Kariuki, Benson/0000-0002-8658-3897	Engineering and Physical Sciences Research Council; Cardiff University	Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Cardiff University	We are grateful to Diamond Light Source for the award of beam-time for experiments on beamline B16. We thank the Engineering and Physical Sciences Research Council (studentships to B.A.P. and G.R.E.-G.) and Cardiff University for financial support.	ADE H, 1993, SCIENCE, V262, P1427, DOI 10.1126/science.262.5138.1427; Bowen D.K., 1998, HIGH RESOLUTION XRAY; BROUDER C, 1990, J PHYS-CONDENS MAT, V2, P701, DOI 10.1088/0953-8984/2/3/018; Chao MH, 2003, ANGEW CHEM INT EDIT, V42, P2982, DOI 10.1002/anie.200350891; Chen Y, 2009, APPL PHYS LETT, V94, DOI 10.1063/1.3078270; Collins BA, 2012, NAT MATER, V11, P536, DOI [10.1038/nmat3310, 10.1038/NMAT3310]; Collins SP, 2013, J PHYS CONF SER, V425, DOI 10.1088/1742-6596/425/13/132015; Collins SP, 2002, J PHYS-CONDENS MAT, V14, P123, DOI 10.1088/0953-8984/14/1/311; El Goresy A, 2001, SCIENCE, V293, P1467, DOI 10.1126/science.1062342; Hartshorne N. H., 1969, PRACTICAL OPTICAL CY; Howells M., 2007, SCI MICROSCOPY, P835, DOI DOI 10.1007/978-0-387-49762-4_13; Hughes L C, 2005, Eur Cell Mater, V9, P68; Iverson IK, 1999, J AM CHEM SOC, V121, P5801, DOI 10.1021/ja983803j; Jin LW, 2003, P NATL ACAD SCI USA, V100, P15294, DOI 10.1073/pnas.2534647100; Joly Y, 2012, PHYS REV B, V86, DOI 10.1103/PhysRevB.86.220101; Kaminsky W, 2004, CHEM SOC REV, V33, P514, DOI 10.1039/b201314m; KERKAM K, 1991, NATURE, V349, P596, DOI 10.1038/349596a0; Khan KM, 1999, SPORTS MED, V27, P393, DOI 10.2165/00007256-199927060-00004; MALAWIST.SE, 1968, SCIENCE, V160, P770, DOI 10.1126/science.160.3829.770; Palmer BA, 2012, J PHYS CHEM LETT, V3, P3216, DOI 10.1021/jz3013547; Palmer BA, 2012, CRYST GROWTH DES, V12, P577, DOI 10.1021/cg201656y; Palmer BA, 2011, J PHYS CHEM LETT, V2, P2346, DOI 10.1021/jz201026z; Sawhney KJS, 2010, AIP CONF PROC, V1234, P387, DOI 10.1063/1.3463220; SAYRE D, 1995, ACTA CRYSTALLOGR A, V51, P237, DOI 10.1107/S0108767394011803; Schmidt-Mende L, 2001, SCIENCE, V293, P1119, DOI 10.1126/science.293.5532.1119; Sirringhaus H, 2000, APPL PHYS LETT, V77, P406, DOI 10.1063/1.126991; Sirringhaus H, 1999, NATURE, V401, P685, DOI 10.1038/44359; Stasiak J, 2010, FUNCT MATER LETT, V3, P249, DOI 10.1142/S1793604710001342; Thibault P, 2008, SCIENCE, V321, P379, DOI 10.1126/science.1158573; Warriner HE, 1996, SCIENCE, V271, P969, DOI 10.1126/science.271.5251.969; Yang H, 1997, NATURE, V386, P692, DOI 10.1038/386692a0	31	23	23	1	56	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 30	2014	344	6187					1013	1016		10.1126/science.1253537	http://dx.doi.org/10.1126/science.1253537			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AH9WM	24876494				2022-12-28	WOS:000336495800041
J	Buchhave, LA; Bizzarro, M; Latham, DW; Sasselov, D; Cochran, WD; Endl, M; Isaacson, H; Juncher, D; Marcy, GW				Buchhave, Lars A.; Bizzarro, Martin; Latham, David W.; Sasselov, Dimitar; Cochran, William D.; Endl, Michael; Isaacson, Howard; Juncher, Diana; Marcy, Geoffrey W.			Three regimes of extrasolar planet radius inferred from host star metallicities	NATURE			English	Article							KEPLER PLANETS; MASS PLANETS; MIGRATION; PARAMETERS; EXOPLANETS; RANGE	Approximately half of the extrasolar planets (exoplanets) with radii less than four Earth radii are in orbits with short periods(1). Despite their sheer abundance, the compositions of such planets are largely unknown. The available evidence suggests that they range in composition from small, high-density rocky planets to low-density planets consisting of rocky cores surrounded by thick hydrogen and helium gas envelopes. Here we report the metallicities (that is, the abundances of elements heavier than hydrogen and helium) of more than 400 stars hosting 600 exoplanet candidates, and find that the exoplanets can be categorized into three populations defined by statistically distinct (similar to 4.5 sigma) metallicity regions. We interpret these regions as reflecting the formation regimes of terrestrial-like planets (radii less than 1.7 Earth radii), gas dwarf planets with rocky cores and hydrogen-helium envelopes (radii between 1.7 and 3.9 Earth radii) and ice or gas giant planets (radii greater than 3.9 Earth radii). These transitions correspond well with those inferred from dynamical mass estimates(2,3), implying that host star metallicity, which is a proxy for the initial solids inventory of the protoplanetary disk, is a key ingredient regulating the structure of planetary systems.	[Buchhave, Lars A.; Latham, David W.; Sasselov, Dimitar] Harvard Smithsonian Ctr Astrophys, Cambridge, MA 02138 USA; [Buchhave, Lars A.; Bizzarro, Martin; Juncher, Diana] Univ Copenhagen, Nat Hist Museum Denmark, Ctr Star & Planet Format, DK-1350 Copenhagen, Denmark; [Cochran, William D.; Endl, Michael] Univ Texas Austin, McDonald Observ, Austin, TX 78712 USA; [Isaacson, Howard; Marcy, Geoffrey W.] Univ Calif Berkeley, Berkeley, CA 94720 USA; [Juncher, Diana] Univ Copenhagen, Niels Bohr Inst, DK-2100 Copenhagen, Denmark	Harvard University; Smithsonian Astrophysical Observatory; Smithsonian Institution; University of Copenhagen; University of Texas System; University of Texas Austin; University of California System; University of California Berkeley; University of Copenhagen; Niels Bohr Institute	Buchhave, LA (corresponding author), Harvard Smithsonian Ctr Astrophys, 60 Garden St, Cambridge, MA 02138 USA.	lbuchhave@cfa.harvard.edu	Bizzarro, Martin/I-8701-2012; Bizzarro, Martin/M-7474-2019; Cochran, William D/M-4421-2014; Buchhave, Lars A./ABF-2000-2020; Marcy, Geoff/AAC-6050-2019	Bizzarro, Martin/0000-0001-9966-2124; Bizzarro, Martin/0000-0001-9966-2124; Cochran, William D/0000-0001-9662-3496; Buchhave, Lars A./0000-0003-1605-5666; 	Harvard Origins of Life Initiative; Danish National Research Foundation [DNRF97]; European Research Council [616027- STARDUST2ASTEROIDS]; Kepler Mission under NASA [NCC2-1390, NNX11AB99A, NNX13AB58A]; Smithsonian Astrophysical Observatory	Harvard Origins of Life Initiative; Danish National Research Foundation(Danmarks Grundforskningsfond); European Research Council(European Research Council (ERC)European Commission); Kepler Mission under NASA; Smithsonian Astrophysical Observatory	L.A.B. acknowledges support from the Harvard Origins of Life Initiative. M. B. acknowledges funding from the Danish National Research Foundation (grant number DNRF97) and from the European Research Council under ERC Consolidator grant agreement 616027- STARDUST2ASTEROIDS. D.W.L. acknowledges support from the Kepler Mission under NASA Cooperative Agreements NCC2-1390, NNX11AB99A and NNX13AB58A with the Smithsonian Astrophysical Observatory, and thanks the observers who helped obtain the TRES observations reported here, especially R. Stefanik, G. Esquerdo, P. Berlind and M. Calkins.	Batalha NM, 2013, ASTROPHYS J SUPPL S, V204, DOI 10.1088/0067-0049/204/2/24; Batalha NM, 2011, ASTROPHYS J, V729, DOI 10.1088/0004-637X/729/1/27; Buchhave LA, 2012, NATURE, V486, P375, DOI 10.1038/nature11121; Chiang E, 2013, MON NOT R ASTRON SOC, V431, P3444, DOI 10.1093/mnras/stt424; Everett ME, 2013, ASTROPHYS J, V771, DOI 10.1088/0004-637X/771/2/107; Fischer DA, 2005, ASTROPHYS J, V622, P1102, DOI 10.1086/428383; Fressin F, 2013, ASTROPHYS J, V766, DOI 10.1088/0004-637X/766/2/81; Ghezzi L, 2010, ASTROPHYS J, V720, P1290, DOI 10.1088/0004-637X/720/2/1290; Hansen BMS, 2013, ASTROPHYS J, V775, DOI 10.1088/0004-637X/775/1/53; Hansen BMS, 2012, ASTROPHYS J, V751, DOI 10.1088/0004-637X/751/2/158; Ida S, 2004, ASTROPHYS J, V616, P567, DOI 10.1086/424830; Lin DNC, 1996, NATURE, V380, P606, DOI 10.1038/380606a0; Lissauer JJ, 2013, ASTROPHYS J, V770, DOI 10.1088/0004-637X/770/2/131; Lissauer JJ, 2011, ASTROPHYS J SUPPL S, V197, DOI 10.1088/0067-0049/197/1/8; Lopez E. D., 2013, UNDERSTANDING MASS R; Marcy GW, 2014, ASTROPHYS J SUPPL S, V210, DOI 10.1088/0067-0049/210/2/20; Papaloizou JCB, 1999, ASTROPHYS J, V521, P823, DOI 10.1086/307581; Rafikov RR, 2006, ASTROPHYS J, V648, P666, DOI 10.1086/505695; Raymond S. N., 2014, NO UNIVERSAL MINIMUM; Santos NC, 2000, ASTRON ASTROPHYS, V363, P228; Sousa SG, 2008, ASTRON ASTROPHYS, V487, P373, DOI 10.1051/0004-6361:200809698; Terquem C, 2007, ASTROPHYS J, V654, P1110, DOI 10.1086/509497; Weiss LM, 2014, ASTROPHYS J LETT, V783, DOI 10.1088/2041-8205/783/1/L6; Yi S, 2001, ASTROPHYS J SUPPL S, V136, P417, DOI 10.1086/321795	29	190	191	0	20	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 29	2014	509	7502					593	+		10.1038/nature13254	http://dx.doi.org/10.1038/nature13254			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AH9JC	24870544	Green Submitted, Green Accepted			2022-12-28	WOS:000336457100043
J	Deweerdt, S				Deweerdt, Sarah			COMPARATIVE BIOLOGY Naked ambition	NATURE			English	Editorial Material							RAT HETEROCEPHALUS-GLABER; BLIND MOLE-RAT; CANCER RESISTANCE											Ashur-Fabian C, 2004, P NATL ACAD SCI USA, V101, P12236, DOI 10.1073/pnas.0404998101; Delaney MA, 2013, VET PATHOL, V50, P607, DOI 10.1177/0300985812471543; Gorbunova V, 2012, P NATL ACAD SCI USA, V109, P19392, DOI 10.1073/pnas.1217211109; Lewis KN, 2012, GERONTOLOGY, V58, P453, DOI 10.1159/000335966; Lewis KN, 2010, INTEGR COMP BIOL, V50, P829, DOI 10.1093/icb/icq034; Liang ST, 2010, AGING CELL, V9, P626, DOI 10.1111/j.1474-9726.2010.00588.x; Manov I, 2013, BMC BIOL, V11, DOI 10.1186/1741-7007-11-91; Seluanov A, 2009, P NATL ACAD SCI USA, V106, P19352, DOI 10.1073/pnas.0905252106; Tian X, 2013, NATURE, V499, P346, DOI 10.1038/nature12234	9	11	11	0	18	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 29	2014	509	7502					S60	S61		10.1038/509S60a	http://dx.doi.org/10.1038/509S60a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AH9JC	24870823	Bronze			2022-12-28	WOS:000336457100006
J	Mooser, A; Ulmer, S; Blaum, K; Franke, K; Kracke, H; Leiteritz, C; Quint, W; Rodegheri, CC; Smorra, C; Walz, J				Mooser, A.; Ulmer, S.; Blaum, K.; Franke, K.; Kracke, H.; Leiteritz, C.; Quint, W.; Rodegheri, C. C.; Smorra, C.; Walz, J.			Direct high-precision measurement of the magnetic moment of the proton	NATURE			English	Article							PENNING TRAP TECHNIQUE; ELECTRON; MASS; CPT; ION	One of the fundamental properties of the proton is its magnetic moment, mu(p). So far mu(p) has been measured only indirectly, by analysing the spectrum of an atomic hydrogen maser in a magnetic field(1). Here we report the direct high-precision measurement of the magnetic moment of a single proton using the double Penning-trap technique(2). We drive proton-spin quantum jumps by a magnetic radio-frequency field in a Penning trap with a homogeneous magnetic field. The induced spin transitions are detected in a second trap with a strong superimposed magnetic inhomogeneity(3). This enables the measurement of the spin-flip probability as a function of the drive frequency. In each measurement the proton's cyclotron frequency is used to determine the magnetic field of the trap. From the normalized resonance curve, we extract the particle's magnetic moment in terms of the nuclear magneton: mu(p) = 2.792847350(9)mu(N). This measurement outperforms previous Penning-trap measurements(4,5) in terms of precision by a factor of about 760. It improves the precision of the forty-year-old indirect measurement, in which significant theoretical bound state corrections(6) were required to obtain mu(p), by a factor of 3. By application of this method to the antiproton magnetic moment, the fractional precision of the recently reported value(7) can be improved by a factor of at least 1,000. Combined with the present result, this will provide a stringent test of matter/antimatter symmetry with baryons(8).	[Mooser, A.; Kracke, H.; Leiteritz, C.; Rodegheri, C. C.; Walz, J.] Johannes Gutenberg Univ Mainz, Inst Phys, D-55099 Mainz, Germany; [Mooser, A.; Kracke, H.; Walz, J.] Helmholtz Inst Mainz, D-55099 Mainz, Germany; [Ulmer, S.; Franke, K.; Smorra, C.] RIKEN, Ulmer Initiat Res Unit, Wako, Saitama 3510198, Japan; [Blaum, K.; Franke, K.; Rodegheri, C. C.] Max Planck Inst Kernphys, D-69117 Heidelberg, Germany; [Quint, W.] Heidelberg Univ, Fak Phys & Astron, D-69047 Heidelberg, Germany; [Quint, W.] GSI Helmholtzzentrum Schwerionenforsch, D-64291 Darmstadt, Germany	Johannes Gutenberg University of Mainz; RIKEN; Max Planck Society; Ruprecht Karls University Heidelberg; University of Wurzburg; Helmholtz Association; GSI Helmholtz-Center for Heavy Ion Research	Mooser, A (corresponding author), RIKEN, Ulmer Initiat Res Unit, 2-1 Hirosawa, Wako, Saitama 3510198, Japan.	mooser@uni-mainz.de	Smorra, Christian/C-5606-2017; Ulmer, Stefan/AAC-8087-2022	Ulmer, Stefan/0000-0002-4185-4147; Smorra, Christian/0000-0001-5584-7960	BMBF; EU (ERC) [290870-MEFUCO]; Helmholtz-Gemeinschaft; HGS-HIRE; Max-Planck Society; IMPRS-PTFS; RIKEN Initiative Research Unit Program	BMBF(Federal Ministry of Education & Research (BMBF)); EU (ERC)(European Research Council (ERC)European Commission); Helmholtz-Gemeinschaft(Helmholtz Association); HGS-HIRE; Max-Planck Society(Max Planck SocietyFoundation CELLEX); IMPRS-PTFS; RIKEN Initiative Research Unit Program	We acknowledge the financial support of the BMBF, and of the EU (ERC grant number 290870-MEFUCO), the Helmholtz-Gemeinschaft, HGS-HIRE, the Max-Planck Society, IMPRS-PTFS, and the RIKEN Initiative Research Unit Program.	Beringer J, 2012, PHYS REV D, V86, DOI 10.1103/PhysRevD.86.010001; Bluhm R, 1998, PHYS REV D, V57, P3932, DOI 10.1103/PhysRevD.57.3932; BROWN LS, 1985, ANN PHYS-NEW YORK, V159, P62, DOI 10.1016/0003-4916(85)90192-7; BROWN LS, 1986, REV MOD PHYS, V58, P233, DOI 10.1103/RevModPhys.58.233; CORNELL EA, 1990, PHYS REV A, V41, P312, DOI 10.1103/PhysRevA.41.312; DEHMELT H, 1973, B AM PHYS SOC, V18, P727; DiSciacca J, 2013, PHYS REV LETT, V110, DOI 10.1103/PhysRevLett.110.140406; DiSciacca J, 2013, PHYS REV LETT, V110, DOI 10.1103/PhysRevLett.110.130801; DiSciacca J, 2012, PHYS REV LETT, V108, DOI 10.1103/PhysRevLett.108.153001; GABRIELSE G, 1995, PHYS REV LETT, V74, P3544, DOI 10.1103/PhysRevLett.74.3544; Haffner H, 2003, EUR PHYS J D, V22, P163, DOI 10.1140/epjd/e2003-00012-2; Hanneke D, 2008, PHYS REV LETT, V100, DOI 10.1103/PhysRevLett.100.120801; Karshenboim SG, 2003, PHYS LETT B, V566, P27, DOI 10.1016/S0370-2693(03)00807-4; Mittleman RK, 1999, PHYS REV LETT, V83, P2116, DOI 10.1103/PhysRevLett.83.2116; Mooser A, 2013, PHYS LETT B, V723, P78, DOI 10.1016/j.physletb.2013.05.012; Mooser A, 2013, PHYS REV LETT, V110, DOI 10.1103/PhysRevLett.110.140405; Pohl R, 2010, NATURE, V466, P213, DOI 10.1038/nature09250; Rodegheri CC, 2012, NEW J PHYS, V14, DOI 10.1088/1367-2630/14/6/063011; Sivia D. S., 2010, DATA ANAL BAYESIAN T; Smorra C, 2014, HYPERFINE INTERACT, V228, P31, DOI 10.1007/s10751-014-1018-7; Sturm S, 2014, NATURE, V506, P467, DOI 10.1038/nature13026; Sturm S, 2013, PHYS REV A, V87, DOI 10.1103/PhysRevA.87.030501; Ulmer S, 2013, NUCL INSTRUM METH A, V705, P55, DOI 10.1016/j.nima.2012.12.071; Ulmer S, 2011, PHYS REV LETT, V107, DOI 10.1103/PhysRevLett.107.103002; Ulmer S, 2011, PHYS REV LETT, V106, DOI 10.1103/PhysRevLett.106.253001; Ulmer S., 2013, SPSCTDR002 CERN; Van Dyck RS, 1999, AIP CONF PROC, V457, P101, DOI 10.1063/1.57450; VANDYCK RS, 1987, PHYS REV LETT, V59, P26, DOI 10.1103/PhysRevLett.59.26; WINELAND DJ, 1975, J APPL PHYS, V46, P919, DOI 10.1063/1.321602; WINKLER PF, 1972, PHYS REV A, V5, P83, DOI 10.1103/PhysRevA.5.83	30	65	69	0	29	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 29	2014	509	7502					596	599		10.1038/nature13388	http://dx.doi.org/10.1038/nature13388			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AH9JC	24870545	Green Submitted			2022-12-28	WOS:000336457100044
J	Byrd, JC; Brown, JR; O'Brien, S; Barrientos, JC; Kay, NE; Reddy, NM; Coutre, S; Tam, CS; Mulligan, SP; Jaeger, U; Devereux, S; Barr, PM; Furman, RR; Kipps, TJ; Cymbalista, F; Pocock, C; Thornton, P; Caligaris-Cappio, F; Robak, T; Delgado, J; Schuster, SJ; Montillo, M; Schuh, A; de Vos, S; Gill, D; Bloor, A; Dearden, C; Moreno, C; Jones, JJ; Chu, AD; Fardis, M; McGreivy, J; Clow, F; James, DF; Hillmen, P				Byrd, J. C.; Brown, J. R.; O'Brien, S.; Barrientos, J. C.; Kay, N. E.; Reddy, N. M.; Coutre, S.; Tam, C. S.; Mulligan, S. P.; Jaeger, U.; Devereux, S.; Barr, P. M.; Furman, R. R.; Kipps, T. J.; Cymbalista, F.; Pocock, C.; Thornton, P.; Caligaris-Cappio, F.; Robak, T.; Delgado, J.; Schuster, S. J.; Montillo, M.; Schuh, A.; de Vos, S.; Gill, D.; Bloor, A.; Dearden, C.; Moreno, C.; Jones, J. J.; Chu, A. D.; Fardis, M.; McGreivy, J.; Clow, F.; James, D. F.; Hillmen, P.		RESONATE Investigators	Ibrutinib versus Ofatumumab in Previously Treated Chronic Lymphoid Leukemia	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							CHRONIC LYMPHOCYTIC-LEUKEMIA; NON-HODGKINS-LYMPHOMAS; PHASE-II; FLUDARABINE; GUIDELINES; PCI-32765; RITUXIMAB; DIAGNOSIS; LENALIDOMIDE; THERAPY	Background In patients with chronic lymphoid leukemia (CLL) or small lymphocytic lymphoma (SLL), a short duration of response to therapy or adverse cytogenetic abnormalities are associated with a poor outcome. We evaluated the efficacy of ibrutinib, a covalent inhibitor of Bruton's tyrosine kinase, in patients at risk for a poor outcome. Methods In this multicenter, open-label, phase 3 study, we randomly assigned 391 patients with relapsed or refractory CLL or SLL to receive daily ibrutinib or the anti-CD20 antibody ofatumumab. The primary end point was the duration of progression-free survival, with the duration of overall survival and the overall response rate as secondary end points. Results At a median follow-up of 9.4 months, ibrutinib significantly improved progression-free survival; the median duration was not reached in the ibrutinib group (with a rate of progression-free survival of 88% at 6 months), as compared with a median of 8.1 months in the ofatumumab group (hazard ratio for progression or death in the ibrutinib group, 0.22; P<0.001). Ibrutinib also significantly improved overall survival (hazard ratio for death, 0.43; P = 0.005). At 12 months, the overall survival rate was 90% in the ibrutinib group and 81% in the ofatumumab group. The overall response rate was significantly higher in the ibrutinib group than in the ofatumumab group (42.6% vs. 4.1%, P<0.001). An additional 20% of ibrutinib-treated patients had a partial response with lymphocytosis. Similar effects were observed regardless of whether patients had a chromosome 17p13.1 deletion or resistance to purine analogues. The most frequent nonhematologic adverse events were diarrhea, fatigue, pyrexia, and nausea in the ibrutinib group and fatigue, infusion-related reactions, and cough in the ofatumumab group. Conclusions Ibrutinib, as compared with ofatumumab, significantly improved progression-free survival, overall survival, and response rate among patients with previously treated CLL or SLL. (Funded by Pharmacyclics and Janssen; RESONATE ClinicalTrials.gov number, NCT01578707.)	[Byrd, J. C.; Jones, J. J.] Ohio State Univ, Ctr Comprehens Canc, Columbus, OH 43210 USA; [Brown, J. R.] Dana Farber Canc Inst, Boston, MA 02115 USA; [O'Brien, S.] Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USA; [Barrientos, J. C.] Hofstra North Shore LIJ Sch Med, Hempstead, NY USA; [Barr, P. M.] Univ Rochester, Ctr Canc, Rochester, NY 14627 USA; [Furman, R. R.] New York Presbyterian Hosp, New York, NY USA; [Furman, R. R.] Weill Cornell Med Coll, New York, NY USA; [Kay, N. E.] Mayo Clin, Rochester, MN USA; [Reddy, N. M.] Vanderbilt Ingram Canc Ctr, Nashville, TN USA; [Coutre, S.] Stanford Univ, Sch Med, Stanford, CA 94305 USA; [Coutre, S.] Stanford Canc Inst, Stanford, CA USA; [Kipps, T. J.] Moores UCSD Canc Ctr, San Diego, CA USA; [de Vos, S.] Univ Calif Los Angeles, David Geffen Sch Med, Los Angeles, CA 90095 USA; [Chu, A. D.; Fardis, M.; Clow, F.; James, D. F.] Pharmacyclics, Sunnyvale, CA USA; [Tam, C. S.] Peter MacCallum Canc Ctr, Melbourne, Vic, Australia; [Tam, C. S.] St Vincents Hosp, Melbourne, Vic, Australia; [Mulligan, S. P.] Royal N Shore Hosp, Sydney, NSW, Australia; [Gill, D.] Princess Alexandra Hosp, Brisbane, Qld 4102, Australia; [Jaeger, U.] Med Univ Vienna, Vienna, Austria; [Devereux, S.] Kings Coll Hosp London, Natl Hlth Serv NHS Fdn Trust, London, England; [Pocock, C.] East Kent Hosp, Canterbury, Kent, England; [Schuh, A.] Oxford Biomed Res Ctr, Oxford, England; [Bloor, A.] Christie NHS Fdn Trust Hematol & Transplant Unit, Manchester, Lancs, England; [Dearden, C.] Royal Marsden Hosp, Sutton, Surrey, England; [Dearden, C.] Inst Canc Res, Sutton, Surrey, England; [Hillmen, P.] Leeds Teaching Hosp, St James Inst Oncol, Leeds, W Yorkshire, England; [Clow, F.] Hop Avicenne, Paris, France; [Thornton, P.] Beaumont Hosp, Dublin 9, Ireland; [Caligaris-Cappio, F.] Univ Vita Salute San Raffaele, Milan, Italy; [Montillo, M.] Osped Niguarda Ca Granda, Milan, Italy; [Robak, T.] Med Univ Lodz, Lodz, Poland; [Robak, T.] Copernicus Mem Hosp, Lodz, Poland; [Delgado, J.] Hosp Clin Barcelona, Barcelona, Spain; [Moreno, C.] Hosp Santa Creu St Pau, Barcelona, Spain; [Schuster, S. J.] Univ Penn, Abramson Canc Ctr, Philadelphia, PA 19104 USA	James Cancer Hospital & Solove Research Institute; University System of Ohio; Ohio State University; Harvard University; Dana-Farber Cancer Institute; University of Texas System; UTMD Anderson Cancer Center; Hofstra University; Northwell Health; University of Rochester; NewYork-Presbyterian Hospital; Cornell University; Mayo Clinic; Vanderbilt University; Stanford University; Stanford Cancer Institute; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; Pharmacyclics; Peter Maccallum Cancer Center; St Vincent's Hospital Melbourne; Royal North Shore Hospital; University of Sydney; Medical University of Vienna; King's College Hospital NHS Foundation Trust; King's College Hospital; University of Oxford; Christie NHS Foundation Trust; Royal Marsden NHS Foundation Trust; University of London; Institute of Cancer Research - UK; Saint James's University Hospital; University of Leeds; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Avicenne - APHP; Vita-Salute San Raffaele University; IRCCS Ca Granda Ospedale Maggiore Policlinico; Ospedale Niguarda Ca' Granda; Medical University Lodz; University of Barcelona; Hospital Clinic de Barcelona; Hospital of Santa Creu i Sant Pau; University of Pennsylvania; Pennsylvania Medicine	Byrd, JC (corresponding author), B302 Starling Loving Hall,320 W 10th Ave, Columbus, OH 43210 USA.	john.byrd@osumc.edu	Delgado, Julio/D-4891-2013; Greil, Richard F/C-7673-2017; Barr, Paul/V-2574-2019; Robak, Tadeusz/AAW-7365-2021; Jones, Jeffrey A/E-3321-2011; Barrientos, Jacqueline/AAE-6683-2022; Devereux, Stephen/B-4766-2009	Delgado, Julio/0000-0002-5157-4376; Greil, Richard F/0000-0002-4462-3694; Barr, Paul/0000-0002-9733-401X; Robak, Tadeusz/0000-0002-3411-6357; Barrientos, Jacqueline Claudia/0000-0001-6018-5535; Bannerji, Rajat/0000-0002-0770-644X; Devereux, Stephen/0000-0002-8046-0386; o'dwyer, michael/0000-0002-6173-7140; Tam, Constantine/0000-0002-9759-5017; Coutre, Steven/0000-0001-8420-5748; Vandenberghe, Elisabeth/0000-0002-7731-9437; Anna, schuh/0000-0002-3938-8490	Pharmacyclics; Janssen; NATIONAL CANCER INSTITUTE [P50CA140158, R01CA183444, P01CA095426, P30CA016058, R01CA177292, P30CA016672, P01CA081534] Funding Source: NIH RePORTER	Pharmacyclics; Janssen(Johnson & JohnsonJohnson & Johnson USAJanssen Biotech Inc); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	Funded by Pharmacyclics and Janssen; RESONATE ClinicalTrials.gov number, NCT01578707.	Advani RH, 2013, J CLIN ONCOL, V31, P88, DOI 10.1200/JCO.2012.42.7906; Badoux XC, 2013, J CLIN ONCOL, V31, P584, DOI 10.1200/JCO.2012.42.8623; Byrd JC, 2014, NEW ENGL J MED, V370, P786, DOI 10.1056/NEJMx130049; Byrd JC, 2013, NEW ENGL J MED, V369, P32, DOI 10.1056/NEJMoa1215637; Chen CI, 2011, J CLIN ONCOL, V29, P1175, DOI 10.1200/JCO.2010.29.8133; Cheson BD, 1996, BLOOD, V87, P4990, DOI 10.1182/blood.V87.12.4990.bloodjournal87124990; Eichhorst B, 2011, ANN ONCOL, V22, pvi50, DOI 10.1093/annonc/mdr377; Farooqui M, 2014, BLOOD; Ferrajoli A, 2008, BLOOD, V111, P5291, DOI 10.1182/blood-2007-12-130120; Fischer K, 2011, J CLIN ONCOL, V29, P3559, DOI 10.1200/JCO.2010.33.8061; Flinn IW, 2012, BLOOD, V120, DOI 10.1182/blood.V120.21.719.719; Goede V, 2014, NEW ENGL J MED, V370, P1101, DOI 10.1056/NEJMoa1313984; Hallek M, 2010, LANCET, V376, P1164, DOI 10.1016/S0140-6736(10)61381-5; Hallek M, 2012, BLOOD; Hallek M, 2008, BLOOD, V111, P5446, DOI 10.1182/blood-2007-06-093906; Hallek M, 2013, AM J HEMATOL, V88, P803, DOI 10.1002/ajh.23491; Honigberg LA, 2010, P NATL ACAD SCI USA, V107, P13075, DOI 10.1073/pnas.1004594107; Lemery SJ, 2010, CLIN CANCER RES, V16, P4331, DOI 10.1158/1078-0432.CCR-10-0570; Moreno C, 2013, BLOOD, V122; Neffendorf JE, 2013, NEW ENGL J MED, V369, P1277, DOI 10.1056/NEJMc1309710; OBRIEN PC, 1979, BIOMETRICS, V35, P549, DOI 10.2307/2530245; OKEN MM, 1982, AM J CLIN ONCOL-CANC, V5, P649, DOI 10.1097/00000421-198212000-00014; Ponader S, 2012, BLOOD, V119, P1182, DOI 10.1182/blood-2011-10-386417; Wierda WG, 2010, J CLIN ONCOL, V28, P1749, DOI 10.1200/JCO.2009.25.3187; Woyach JA, 2014, BLOOD, V123, P1810, DOI 10.1182/blood-2013-09-527853; Zelenetz AD, 2013, J NATL COMPR CANC NE, V11, P257, DOI 10.6004/jnccn.2013.0037; Zelenetz AD, 2010, J NATL COMPR CANC NE, V8, P288, DOI 10.6004/jnccn.2010.0021	27	1160	1184	1	80	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUL 17	2014	371	3					213	223		10.1056/NEJMoa1400376	http://dx.doi.org/10.1056/NEJMoa1400376			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AL3BK	24881631	Green Accepted			2022-12-28	WOS:000338999800005
J	Naganuma, M; Sekine, S; Chong, YE; Guo, M; Yang, XL; Gamper, H; Hou, YM; Schimmel, P; Yokoyama, S				Naganuma, Masahiro; Sekine, Shun-ichi; Chong, Yeeting Esther; Guo, Min; Yang, Xiang-Lei; Gamper, Howard; Hou, Ya-Ming; Schimmel, Paul; Yokoyama, Shigeyuki			The selective tRNA aminoacylation mechanism based on a single G center dot U pair	NATURE			English	Article							CRYSTAL-STRUCTURE; ACCEPTOR-STEM; MAJOR DETERMINANT; SYNTHETASE; RECOGNITION; IDENTITY; TRNA(ALA); SEQUENCE; CRYSTALLOGRAPHY; SPECIFICITY	Ligation of tRNAs with their cognate amino acids, by aminoacyl-tRNA synthetases, establishes the genetic code. Throughout evolution, tRNA(Ala) selection by alanyl-tRNAsynthetase (AlaRS) has depended predominantly on a single wobble base pair in the acceptor stem, G3 center dot U70, mainly on the k(cat) level. Here we report the crystal structures of an archaeal AlaRS in complex with tRNAAla with G3 center dot U70 and its A3 center dot U70 variant. AlaRS interacts with both the minor-and the major-groove sides of G3 center dot U70, widening the major groove. The geometry difference between G3 center dot U70 and A3 center dot U70 is transmitted along the acceptor stemto the 3'-CCA region. Thus, the 3'-CCA region of tRNA(Ala) with G3 center dot U70 is oriented to the reactive route that reaches the active site, whereas that of the A3 center dot U70 variant is folded back into the non-reactive route. This novel mechanism enables the single wobble pair to dominantly determine the specificity of tRNA selection, by an approximate 100-fold difference in k(cat) .	[Naganuma, Masahiro; Sekine, Shun-ichi; Yokoyama, Shigeyuki] RIKEN Syst & Struct Biol Ctr, Tsurumi Ku, Yokohama, Kanagawa 2300045, Japan; [Naganuma, Masahiro; Sekine, Shun-ichi; Yokoyama, Shigeyuki] Univ Tokyo, Grad Sch Sci, Dept Biophys & Biochem & Lab Struct Biol, Bunkyo Ku, Tokyo 1130033, Japan; [Naganuma, Masahiro; Yokoyama, Shigeyuki] RIKEN Struct Biol Lab, Tsurumi Ku, Yokohama, Kanagawa 2300045, Japan; [Sekine, Shun-ichi] RIKEN Ctr Life Sci Technol, Div Struct & Synthet Biol, Tsurumi Ku, Yokohama, Kanagawa 2300045, Japan; [Chong, Yeeting Esther; Guo, Min; Yang, Xiang-Lei; Schimmel, Paul] Scripps Res Inst, Skaggs Inst Chem Biol, La Jolla, CA 92037 USA; [Chong, Yeeting Esther; Guo, Min; Yang, Xiang-Lei; Schimmel, Paul] Scripps Res Inst, Dept Cell & Mol Biol, La Jolla, CA 92037 USA; [Gamper, Howard; Hou, Ya-Ming] Thomas Jefferson Univ, Dept Biochem & Mol Biol, Philadelphia, PA 19107 USA; [Schimmel, Paul] Scripps Florida Res Inst, Jupiter, FL 33458 USA	RIKEN; University of Tokyo; RIKEN; RIKEN; Scripps Research Institute; Scripps Research Institute; Jefferson University; State University System of Florida; University of Florida	Yokoyama, S (corresponding author), RIKEN Syst & Struct Biol Ctr, Tsurumi Ku, 1-7-22 Suehiro cho, Yokohama, Kanagawa 2300045, Japan.	yokoyama@riken.jp	Sekine, Shun-ichi/N-5450-2015; Chong, Yeeting/AAE-3792-2020; Yang, Xiang-Lei/AAR-7107-2020; Yokoyama, Shigeyuki/N-6911-2015	Sekine, Shun-ichi/0000-0001-8174-8704; Yokoyama, Shigeyuki/0000-0003-3133-7338; Yang, Xiang-Lei/0000-0003-2554-084X; Hou, Ya-Ming/0000-0001-6546-2597	Targeted Proteins Research Program; Platform for Drug Discovery, Informatics, and Structural Life Science from the Ministry of Education, Culture, Sports, Science and Technology (MEXT), Japan; Japan Society for the Promotion of Science [20247008]; MEXT; Global COE Program (Integrative Life Science Based on the Study of Biosignaling Mechanisms) from MEXT; National Institutes of Health [GM015539, GM023562, NS085092]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM100136, R01GM023562, R01GM108972, R37GM015539, R01GM015539] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS085092] Funding Source: NIH RePORTER	Targeted Proteins Research Program(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Platform for Drug Discovery, Informatics, and Structural Life Science from the Ministry of Education, Culture, Sports, Science and Technology (MEXT), Japan; Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); MEXT(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Global COE Program (Integrative Life Science Based on the Study of Biosignaling Mechanisms) from MEXT(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We are grateful to the staff of the beam line AR-NW12A at the Photon Factory and the beam lines BL32XU and BL41XU at SPring-8 for their assistance during data collection. This work was supported by the Targeted Proteins Research Program, and the Platform for Drug Discovery, Informatics, and Structural Life Science from the Ministry of Education, Culture, Sports, Science and Technology (MEXT), Japan. This work was also supported by a Grant-in-Aid for Scientific Research (No. 20247008) from the Japan Society for the Promotion of Science and MEXT, and the Global COE Program (Integrative Life Science Based on the Study of Biosignaling Mechanisms) from MEXT. Research support was also provided by National Institutes of Health grants GM015539 and GM023562 to P.S. and NS085092 to X.-L.Y.	Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Beebe K, 2003, EMBO J, V22, P668, DOI 10.1093/emboj/cdg065; Beuning PJ, 1999, BIOPOLYMERS, V52, P1; Beuning PJ, 2002, RNA, V8, P659, DOI 10.1017/S1355838202020277; Beuning PJ, 1997, J AM CHEM SOC, V119, P8397, DOI 10.1021/ja971020c; BIOU V, 1994, SCIENCE, V263, P1404, DOI 10.1126/science.8128220; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Brunger AT, 2007, NAT PROTOC, V2, P2728, DOI 10.1038/nprot.2007.406; Chang KY, 1999, P NATL ACAD SCI USA, V96, P11764, DOI 10.1073/pnas.96.21.11764; CUSACK S, 1995, NAT STRUCT BIOL, V2, P824, DOI 10.1038/nsb1095-824; DEDUVE C, 1988, NATURE, V333, P117, DOI 10.1038/333117a0; Dignam JD, 2011, BIOCHEMISTRY-US, V50, P9886, DOI 10.1021/bi2012004; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; ERIANI G, 1990, NATURE, V347, P203, DOI 10.1038/347203a0; FRANCKLYN C, 1989, NATURE, V337, P478, DOI 10.1038/337478a0; FRANCKLYN C, 1992, SCIENCE, V255, P1121, DOI 10.1126/science.1546312; Fukunaga R, 2007, NAT STRUCT MOL BIOL, V14, P272, DOI 10.1038/nsmb1219; Fukunaga R, 2007, ACTA CRYSTALLOGR F, V63, P224, DOI 10.1107/S1744309107006264; Gabriel K, 1996, SCIENCE, V271, P195, DOI 10.1126/science.271.5246.195; Giege R, 1998, NUCLEIC ACIDS RES, V26, P5017, DOI 10.1093/nar/26.22.5017; Goldgur Y, 1997, STRUCTURE, V5, P59, DOI 10.1016/S0969-2126(97)00166-4; Guo M, 2009, NATURE, V462, P808, DOI 10.1038/nature08612; Guo M, 2009, SCIENCE, V325, P744, DOI 10.1126/science.1174343; Guth E, 2005, BIOCHEMISTRY-US, V44, P3785, DOI 10.1021/bi047923h; HOU YM, 1989, BIOCHEMISTRY-US, V28, P6800, DOI 10.1021/bi00443a003; HOU YM, 1988, NATURE, V333, P140, DOI 10.1038/333140a0; JASIN M, 1983, NATURE, V306, P441, DOI 10.1038/306441a0; KIM SH, 1974, SCIENCE, V185, P435, DOI 10.1126/science.185.4149.435; MCCLAIN WH, 1988, SCIENCE, V242, P1681, DOI 10.1126/science.2462282; MCCLAIN WH, 1988, SCIENCE, V240, P793, DOI 10.1126/science.2452483; McClain WH, 1999, J MOL BIOL, V290, P391, DOI 10.1006/jmbi.1999.2884; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; MILLER WT, 1991, BIOCHEMISTRY-US, V30, P2635, DOI 10.1021/bi00224a011; Mueller U, 1999, RNA, V5, P670, DOI 10.1017/S1355838299982304; MUSIERFORSYTH K, 1992, NATURE, V357, P513, DOI 10.1038/357513a0; MUSIERFORSYTH K, 1991, SCIENCE, V253, P784, DOI 10.1126/science.1876835; Naganuma M, 2009, P NATL ACAD SCI USA, V106, P8489, DOI 10.1073/pnas.0901572106; Nakagawa H, 2013, PROTEINS, V81, P1232, DOI 10.1002/prot.24273; Nozawa K, 2009, NATURE, V457, P1163, DOI 10.1038/nature07611; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; PARK SJ, 1989, BIOCHEMISTRY-US, V28, P2740, DOI 10.1021/bi00432a056; PUTZ J, 1993, EMBO J, V12, P2949, DOI 10.1002/j.1460-2075.1993.tb05957.x; Ramos A, 1997, NUCLEIC ACIDS RES, V25, P2083, DOI 10.1093/nar/25.11.2083; ROBERTUS JD, 1974, NATURE, V250, P546, DOI 10.1038/250546a0; ROGERS MJ, 1994, P NATL ACAD SCI USA, V91, P291, DOI 10.1073/pnas.91.1.291; RUFF M, 1991, SCIENCE, V252, P1682, DOI 10.1126/science.2047877; Sankaranarayanan R, 1999, CELL, V97, P371, DOI 10.1016/S0092-8674(00)80746-1; Sekine S, 2003, EMBO J, V22, P676, DOI 10.1093/emboj/cdg053; SHI JP, 1990, BIOCHEMISTRY-US, V29, P3621, DOI 10.1021/bi00467a005; Sokabe M, 2009, P NATL ACAD SCI USA, V106, P11028, DOI 10.1073/pnas.0904645106; Swairjo MA, 2004, MOL CELL, V13, P829, DOI 10.1016/S1097-2765(04)00126-1; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; UEDA H, 1991, BIOCHIM BIOPHYS ACTA, V1080, P126, DOI 10.1016/0167-4838(91)90138-P; Uter NT, 2004, P NATL ACAD SCI USA, V101, P14396, DOI 10.1073/pnas.0404017101; Varani G, 2000, EMBO REP, V1, P18, DOI 10.1093/embo-reports/kvd001; WEYGANDDURASEVIC I, 1994, J MOL BIOL, V240, P111, DOI 10.1006/jmbi.1994.1425; Yamashita S, 2011, PROTEIN SCI, V20, P118, DOI 10.1002/pro.543; Yaremchuk A, 2001, J MOL BIOL, V309, P989, DOI 10.1006/jmbi.2001.4712; Zhang CM, 2006, J MOL BIOL, V361, P300, DOI 10.1016/j.jmb.2006.06.015	61	55	60	1	44	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 26	2014	510	7506					507	511		10.1038/nature13440	http://dx.doi.org/10.1038/nature13440			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AJ6LK	24919148	Green Accepted			2022-12-28	WOS:000337806300040
J	Duffy, MA				Duffy, Meghan A.			EPIDEMIOLOGY It helps to be well connected	SCIENCE			English	Editorial Material							METAPOPULATION DYNAMICS; SPREAD		Univ Michigan, Dept Ecol & Evolutionary Biol, Ann Arbor, MI 48104 USA	University of Michigan System; University of Michigan	Duffy, MA (corresponding author), Univ Michigan, Dept Ecol & Evolutionary Biol, Ann Arbor, MI 48104 USA.	duffymeg@umich.edu	Duffy, Meghan/AFN-5376-2022; Duffy, Meghan A/E-6867-2016	Duffy, Meghan/0000-0002-8142-0802; Duffy, Meghan A/0000-0002-8142-0802				Combes Claude., 2001, PARASITISM ECOLOGY E; Hanski I, 1999, OIKOS, V87, P209, DOI 10.2307/3546736; Jousimo J, 2014, SCIENCE, V344, P1289, DOI 10.1126/science.1253621; Jules ES, 2002, ECOLOGY, V83, P3167, DOI 10.1890/0012-9658(2002)083[3167:SOAIPO]2.0.CO;2; Keeling MJ, 2000, NATURE, V407, P903, DOI 10.1038/35038073; Keeling MJ., 2008, MODELING INFECT DIS, DOI DOI 10.1515/9781400841035; Metcalf CJE, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074696; Ostfeld R. S. et al., 2008, INFECT DIS ECOLOGY E; Russell CA, 2005, PLOS BIOL, V3, P382, DOI 10.1371/journal.pbio.0030088; Schoener TW, 2011, SCIENCE, V331, P426, DOI 10.1126/science.1193954; Viboud C, 2006, SCIENCE, V312, P447, DOI 10.1126/science.1125237; Xia YC, 2004, AM NAT, V164, P267, DOI 10.1086/422341	12	0	0	0	13	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 13	2014	344	6189					1229	1230		10.1126/science.1255350	http://dx.doi.org/10.1126/science.1255350			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI7ND	24926004				2022-12-28	WOS:000337077500020
J	Xia, YC; Lucifora, J; Reisinger, F; Heikenwalder, M; Protzer, U				Xia, Yuchen; Lucifora, Julie; Reisinger, Florian; Heikenwalder, Mathias; Protzer, Ulrike			VIROLOGY Response to Comment on "Specific and nonhepatotoxic degradation of nuclear hepatitis B virus cccDNA"	SCIENCE			English	Editorial Material							INFECTION; CELLS; MICE	Chisari et al. challenge our central conclusion that the hepatitis B virus (HBV) persistent form, the covalently closed circular DNA (cccDNA), is degraded in a noncytotoxic and specific fashion in the nucleus of infected hepatocytes. Specificity of the assays used, exclusion of cell division or death, and activity of APOBEC3 deaminases in the nucleus, however, were addressed in the paper.	[Xia, Yuchen; Lucifora, Julie; Reisinger, Florian; Heikenwalder, Mathias; Protzer, Ulrike] Tech Univ Munich, Inst Virol, Helmholtz Zentrum Munchen, D-80290 Munich, Germany	Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Technical University of Munich	Protzer, U (corresponding author), Tech Univ Munich, Inst Virol, Helmholtz Zentrum Munchen, D-80290 Munich, Germany.	protzer@tum.de	Heikenwalder, Mathias/AAA-2269-2020; Protzer, Ulrike/D-5915-2015; Xia, Yuchen/H-8546-2019; LUCIFORA, Julie/L-7449-2017	Protzer, Ulrike/0000-0002-9421-1911; Xia, Yuchen/0000-0001-8460-3893; LUCIFORA, Julie/0000-0003-0482-7809				Chisari FV, 2014, SCIENCE, V344, DOI 10.1126/science.1254082; Glebe D, 2003, J VIROL, V77, P9511, DOI 10.1128/JVI.77.17.9511-9521.2003; GUIDOTTI LG, 1994, J VIROL, V68, P5469, DOI 10.1128/JVI.68.9.5469-5475.1994; Guidotti LG, 1996, IMMUNITY, V4, P25, DOI 10.1016/S1074-7613(00)80295-2; Guidotti LG, 1999, SCIENCE, V284, P825, DOI 10.1126/science.284.5415.825; Haybaeck J, 2009, CANCER CELL, V16, P295, DOI 10.1016/j.ccr.2009.08.021; Lucifora J, 2014, SCIENCE, V343, P1221, DOI 10.1126/science.1243462; Protzer U, 1999, P NATL ACAD SCI USA, V96, P10818, DOI 10.1073/pnas.96.19.10818; Sprinzl MF, 2001, J VIROL, V75, P5108, DOI 10.1128/JVI.75.11.5108-5118.2001; Summers J, 2003, P NATL ACAD SCI USA, V100, P11652, DOI 10.1073/pnas.1635109100; Untergasser A, 2006, HEPATOLOGY, V43, P539, DOI 10.1002/hep.21048; Wieland SF, 2004, P NATL ACAD SCI USA, V101, P2129, DOI 10.1073/pnas.0308478100; Wolf MJ, 2010, ONCOGENE, V29, P5006, DOI 10.1038/onc.2010.260	13	25	25	0	15	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 13	2014	344	6189								10.1126/science.1254083	http://dx.doi.org/10.1126/science.1254083			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI7ND	24926011				2022-12-28	WOS:000337077500029
J	Sjostrom, L; Peltonen, M; Jacobson, P; Ahlin, S; Andersson-Assarsson, J; Anveden, A; Bouchard, C; Carlsson, B; Karason, K; Lonroth, H; Naslund, I; Sjostrom, E; Taube, M; Wedel, H; Svensson, PA; Sjoholm, K; Carlsson, LMS				Sjostrom, Lars; Peltonen, Markku; Jacobson, Peter; Ahlin, Sofie; Andersson-Assarsson, Johanna; Anveden, Asa; Bouchard, Claude; Carlsson, Bjorn; Karason, Kristjan; Lonroth, Hans; Naslund, Ingmar; Sjostrom, Elisabeth; Taube, Magdalena; Wedel, Hans; Svensson, Per-Arne; Sjoholm, Kajsa; Carlsson, Lena M. S.			Association of Bariatric Surgery With Long-term Remission of Type 2 Diabetes and With Microvascular and Macrovascular Complications	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							GASTRIC BYPASS-SURGERY; LIFE-STYLE; MEDICAL THERAPY; OBESE SUBJECTS; RISK-FACTORS; PREVENTION; ADULTS; PREVALENCE; OUTCOMES; DISEASE	IMPORTANCE Short-term studies show that bariatric surgery causes remission of diabetes. The long-term outcomes for remission and diabetes-related complications are not known. OBJECTIVES To determine the long-term diabetes remission rates and the cumulative incidence of microvascular and macrovascular diabetes complications after bariatric surgery. DESIGN, SETTING, AND PARTICIPANTS The Swedish Obese Subjects (SOS) is a prospective matched cohort study conducted at 25 surgical departments and 480 primary health care centers in Sweden. Of patients recruited between September 1,1987, and January 31, 2001, 260 of 2037 control patients and 343 of 2010 surgery patients had type 2 diabetes at baseline. For the current analysis, diabetes status was determined at SOS health examinations until May 22, 2013. Information on diabetes complications was obtained from national health registers until December 31, 2012. Participation rates at the 2-, 10-, and 15-year examinations were 81%, 58%, and 41% in the control group and 90%, 76%, and 47% in the surgery group. For diabetes assessment, the median follow-up time was 10 years (interquartile range [IQR], 2-15) and 10 years (IQR, 10-15) in the control and surgery groups, respectively. For diabetes complications, the median follow-up time was 17.6 years (IQR, 14.2-19.8) and 18.1 years (IQR, 15.2-21.1) in the control and surgery groups, respectively. INTERVENTIONS Adjustable or nonadjustable banding (n = 61), vertical banded gastroplasty (n = 227), or gastric bypass (n = 55) procedures were performed in the surgery group, and usual obesity and diabetes care was provided to the control group. MAIN OUTCOMES AND MEASURES Diabetes remission, relapse, and diabetes complications. Remission was defined as blood glucose <110 mg/dL and no diabetes medication. RESULTS The diabetes remission rate 2 years after surgery was 16.4% (95% CL, 11.7%-22.2%; 34/207) for control patients and 72.3% (95% Cl, 66.9%-77.2%; 219/303) for bariatric surgery patients (odds ratio [OR], 13.3; 95% Cl, 8.5-20.7; P < .001). At 15 years, the diabetes remission rates decreased to 6.5% (4/62) for control patients and to 30.4% (35/115) for bariatric surgery patients (OR, 6.3; 95% Cl, 2.1-18.9; P < .001). With long-term follow-up, the cumulative incidence of microvascular complications was 41.8 per 1000 person-years (95% Cl, 35.3-49.5) for control patients and 20.6 per 1000 person-years (95% Cl, 17.0-24.9) in the surgery group (hazard ratio [HR], 0.44; 95% Cl, 0.34-0.56; P < .001). Macrovascular complications were observed in 44.2 per 1000 person-years (95% Cl, 37.5-52.1) in control patients and 31.7 per 1000 person-years (95% Cl, 27.0-37.2) for the surgical group (HR, 0.68; 95% Cl, 0.54-0.85; P = .001). CONCLUSIONS AND RELEVANCE In this very long-term follow-up observational study of obese patients with type 2 diabetes, bariatric surgery was associated with more frequent diabetes remission and fewer complications than usual care. These findings require confirmation in randomized trials.	[Sjostrom, Lars; Jacobson, Peter; Ahlin, Sofie; Andersson-Assarsson, Johanna; Anveden, Asa; Carlsson, Bjorn; Karason, Kristjan; Sjostrom, Elisabeth; Taube, Magdalena; Svensson, Per-Arne; Sjoholm, Kajsa; Carlsson, Lena M. S.] Univ Gothenburg, Inst Med, Gothenburg, Sweden; [Lonroth, Hans] Univ Gothenburg, Inst Surg, Gothenburg, Sweden; [Wedel, Hans] Univ Gothenburg, Sahlgrenska Acad, Gothenburg, Sweden; [Wedel, Hans] Nord Sch Publ Hlth, Gothenburg, Sweden; [Naslund, Ingmar] Univ Hosp, Dept Surg, Orebro, Sweden; [Peltonen, Markku] Natl Inst Hlth & Welf, Dept Chron Dis Prevent, Helsinki, Finland; [Bouchard, Claude] Louisiana State Univ Syst, Pennington Biomed Res Ctr, Baton Rouge, LA USA	University of Gothenburg; University of Gothenburg; University of Gothenburg; Orebro University; Finland National Institute for Health & Welfare; Louisiana State University System; Louisiana State University; Pennington Biomedical Research Center	Sjostrom, L (corresponding author), Sahlgrens Univ Hosp, SOS Secretariat, Vita Straket 15, S-41345 Gothenburg, Sweden.	lars.v.sjostrom@medfak.gu.se	Bouchard, Claude/A-7637-2009; Bouchard, Claude/AAE-2035-2019; Andersson-Assarsson, Johanna/M-2524-2019; Carlsson, Lena/F-7570-2018; Svensson, Per-Arne/R-4626-2019; Peltonen, Markku/F-3037-2015	Bouchard, Claude/0000-0002-0048-491X; Andersson-Assarsson, Johanna/0000-0001-9082-8589; Carlsson, Lena/0000-0003-4145-6242; Peltonen, Markku/0000-0002-3767-4223; Ahlin, Sofie/0000-0003-0619-2683; Jacobson, Peter/0000-0002-1769-1827; Svensson, Per-Arne/0000-0002-6731-806X; Sjoholm, Kajsa/0000-0003-0146-8193; Karason, Kristjan/0000-0002-2802-1191; Taube, Magdalena/0000-0002-7944-9673	Swedish Research Council [K2012-55X-22082-01, K2013-54X-11285-19, K2013-99X-22279-01]; Swedish Foundation for Strategic Research; Swedish federal government under the LUA/ALF; Diabetesfonden; VINNOVA-VINNMER program; Hoffmann-La Roche; AstraZeneca; Cederroth; sanofi-aventis; Johnson Johnson	Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Foundation for Strategic Research(Swedish Foundation for Strategic Research); Swedish federal government under the LUA/ALF; Diabetesfonden; VINNOVA-VINNMER program(Vinnova); Hoffmann-La Roche(Hoffmann-La Roche); AstraZeneca(AstraZeneca); Cederroth; sanofi-aventis(Sanofi-Aventis); Johnson Johnson(Johnson & JohnsonJohnson & Johnson USA)	This study was supported by grants from the Swedish Research Council (K2012-55X-22082-01, K2013-54X-11285-19, K2013-99X-22279-01), the Swedish Foundation for Strategic Research (to Sahlgrenska Center for Cardiovascular and Metabolic Research), the Swedish federal government under the LUA/ALF agreement concerning research and education of doctors, Diabetesfonden, and the VINNOVA-VINNMER program. The SOS study has previously been supported by grants to authors from Hoffmann-La Roche, AstraZeneca, Cederroth, sanofi-aventis, and Johnson & Johnson.	Adams TD, 2012, JAMA-J AM MED ASSOC, V308, P1122, DOI 10.1001/2012.jama.11164; American Diabetes Association, 2011, Diabetes Care, V34 Suppl 1, pS4, DOI 10.2337/dc11-S004; [Anonymous], 992 WHO; [Anonymous], EXT REV VAL SWED NAT; Arterburn DE, 2013, OBES SURG, V23, P93, DOI 10.1007/s11695-012-0802-1; Brethauer SA, 2013, ANN SURG, V258, P628, DOI 10.1097/SLA.0b013e3182a5034b; BROLIN RE, 1987, GASTROENTEROL CLIN N, V16, P317; Buchwald H, 2009, AM J MED, V122, P248, DOI 10.1016/j.amjmed.2008.09.041; Carlsson LMS, 2012, NEW ENGL J MED, V367, P695, DOI 10.1056/NEJMoa1112082; Colagiuri S, 2010, DIABETES OBES METAB, V12, P463, DOI 10.1111/j.1463-1326.2009.01182.x; Dixon JB, 2008, JAMA-J AM MED ASSOC, V299, P316, DOI 10.1001/jama.299.3.316; Dixon JB, 2013, DIABETES CARE, V36, P20, DOI 10.2337/dc12-0779; Eriksson JK, 2013, ARTHRIT CARE RES, V65, P870, DOI 10.1002/acr.21900; Flegal KM, 2012, JAMA-J AM MED ASSOC, V307, P491, DOI 10.1001/jama.2012.39; Heneghan HM, 2013, SURG OBES RELAT DIS, V9, P7, DOI 10.1016/j.soard.2012.08.016; Ikramuddin S, 2013, JAMA-J AM MED ASSOC, V309, P2240, DOI 10.1001/jama.2013.5835; James WPT, 2010, NEW ENGL J MED, V363, P905, DOI 10.1056/NEJMoa1003114; Kashyap SR, 2013, DIABETES CARE, V36, P2175, DOI 10.2337/dc12-1596; Maggard-Gibbons M, 2013, JAMA-J AM MED ASSOC, V309, P2250, DOI 10.1001/jama.2013.4851; Maruthur NM, 2013, CURR DIABETES REP, V13, P786, DOI 10.1007/s11892-013-0426-4; Merlo J, 2000, EUR J EPIDEMIOL, V16, P235, DOI 10.1023/A:1007634722658; Mingrone G, 2012, NEW ENGL J MED, V366, P1577, DOI 10.1056/NEJMoa1200111; Neovius M, 2011, ANN RHEUM DIS, V70, P516, DOI 10.1136/ard.2010.130914; Nissen SE, 2008, JAMA-J AM MED ASSOC, V299, P1547, DOI 10.1001/jama.299.13.1547; Norris SL, 2005, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD004096.pub2, 10.1002/14651858.CD004095.pub2, 10.1002/14651858.CD005270]; Norris SL, 2005, COCHRANE DB SYST REV, DOI DOI 10.1002/14651858.CD004096.PUB2; Patel A, 2008, NEW ENGL J MED, V358, P2560, DOI 10.1056/NEJMoa0802987; Ramos-Levi AM, 2014, ENDOCRINOL NUTR, V61, P35, DOI [10.1016/j.endonu.2013.04.006, 10.1016/j.endoen.2014.01.012]; Robert M, 2013, OBES SURG, V23, P770, DOI 10.1007/s11695-013-0868-4; Romeo S, 2012, DIABETES CARE, V35, P2613, DOI 10.2337/dc12-0193; Saydah SH, 2004, JAMA-J AM MED ASSOC, V291, P335, DOI 10.1001/jama.291.3.335; Schauer PR, 2012, NEW ENGL J MED, V366, P1567, DOI 10.1056/NEJMoa1200225; Sjostrom L, 2004, NEW ENGL J MED, V351, P2683, DOI 10.1056/NEJMoa035622; Sjostrom L, 2012, JAMA-J AM MED ASSOC, V307, P56, DOI 10.1001/jama.2011.1914; Tandon N, 2012, AM J CARDIOVASC DRUG, V12, P7, DOI 10.2165/11594650-000000000-00000; Thomas DR, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD002968.pub2; Torgerson JS, 2004, DIABETES CARE, V27, P155, DOI 10.2337/diacare.27.1.155; Wing R, 2013, NEW ENGL J MED, V369, P145, DOI 10.1056/NEJMoa1212914; Yamaoka K, 2005, DIABETES CARE, V28, P2780, DOI 10.2337/diacare.28.11.2780	39	638	659	1	48	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUN 11	2014	311	22					2297	2304		10.1001/jama.2014.5988	http://dx.doi.org/10.1001/jama.2014.5988			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AI6HL	24915261	Bronze			2022-12-28	WOS:000336972600021
J	Yang, G; Lai, CSW; Cichon, J; Ma, L; Li, W; Gan, WB				Yang, Guang; Lai, Cora Sau Wan; Cichon, Joseph; Ma, Lei; Li, Wei; Gan, Wen-Biao			Sleep promotes branch-specific formation of dendritic spines after learning	SCIENCE			English	Article							SYNAPTIC HOMEOSTASIS; PLASTICITY; NEURONS; REPLAY; OSCILLATIONS; HIPPOCAMPUS; CORTEX; STATE	How sleep helps learning and memory remains unknown. We report in mouse motor cortex that sleep after motor learning promotes the formation of postsynaptic dendritic spines on a subset of branches of individual layer V pyramidal neurons. New spines are formed on different sets of dendritic branches in response to different learning tasks and are protected from being eliminated when multiple tasks are learned. Neurons activated during learning of a motor task are reactivated during subsequent non-rapid eye movement sleep, and disrupting this neuronal reactivation prevents branch-specific spine formation. These findings indicate that sleep has a key role in promoting learning-dependent synapse formation and maintenance on selected dendritic branches, which contribute to memory storage.	[Yang, Guang; Lai, Cora Sau Wan; Cichon, Joseph; Ma, Lei; Gan, Wen-Biao] NYU, Sch Med, Dept Neurosci & Physiol, Skirball Inst, New York, NY 10016 USA; [Yang, Guang] NYU, Sch Med, Dept Anesthesiol, New York, NY 10016 USA; [Ma, Lei; Li, Wei] Peking Univ, Shenzhen Grad Sch, Key Lab Chem Genom, Drug Discovery Ctr, Shenzhen 518055, Peoples R China	New York University; New York University; Peking University; University Town of Shenzhen	Gan, WB (corresponding author), NYU, Sch Med, Dept Neurosci & Physiol, Skirball Inst, New York, NY 10016 USA.	gan@saturn.med.nyu.edu	, 0000-0002-5721-4259/K-3037-2019; ma, Lei/GOV-5903-2022	, 0000-0002-5721-4259/0000-0002-5721-4259; Yang, Guang/0000-0002-5739-9126; ma, lei/0000-0001-9673-0224	NIH [R01 NS047325, P01 NS074972]; Whitehall Foundation research grant; American Federation for Aging Research grant; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS047325, P01NS074972] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Whitehall Foundation research grant; American Federation for Aging Research grant; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank all the members in the Gan laboratory and T. Franke for comments on the manuscript. This work was supported by NIH R01 NS047325 and P01 NS074972 to W.-B.G. and by a Whitehall Foundation research grant and an American Federation for Aging Research grant to G.Y.	Aton SJ, 2009, NEURON, V61, P454, DOI 10.1016/j.neuron.2009.01.007; BAILEY CH, 1993, ANNU REV PHYSIOL, V55, P397, DOI 10.1146/annurev.ph.55.030193.002145; Benington JH, 2003, PROG NEUROBIOL, V69, P71, DOI 10.1016/S0301-0082(03)00018-2; Bhatt DH, 2009, ANNU REV PHYSIOL, V71, P261, DOI 10.1146/annurev.physiol.010908.163140; Born J, 2012, NEURON, V75, P933, DOI 10.1016/j.neuron.2012.09.007; Bushey D, 2011, SCIENCE, V332, P1576, DOI 10.1126/science.1202839; Campbell IG, 1996, J NEUROPHYSIOL, V76, P3714, DOI 10.1152/jn.1996.76.6.3714; Chauvette S, 2012, NEURON, V75, P1105, DOI 10.1016/j.neuron.2012.08.034; Chen TW, 2013, NATURE, V499, P295, DOI 10.1038/nature12354; Cirelli C, 1999, ANN MED, V31, P117, DOI 10.3109/07853899908998787; Crunelli V, 2010, NAT NEUROSCI, V13, P10, DOI 10.1038/nn.2445; Dave AS, 2000, SCIENCE, V290, P812, DOI 10.1126/science.290.5492.812; Dave AS, 1998, SCIENCE, V282, P2250, DOI 10.1126/science.282.5397.2250; Diekelmann S, 2010, NAT REV NEUROSCI, V11, P114, DOI 10.1038/nrn2762; Donlea JM, 2009, SCIENCE, V324, P105, DOI 10.1126/science.1166657; Frank MG, 2012, NEURAL PLAST, V2012, DOI 10.1155/2012/264378; Frank MG, 2001, NEURON, V30, P275, DOI 10.1016/S0896-6273(01)00279-3; Ji DY, 2007, NAT NEUROSCI, V10, P100, DOI 10.1038/nn1825; Jouvet-Mounier D, 1970, Dev Psychobiol, V2, P216; Lichtman JW, 2000, NEURON, V25, P269, DOI 10.1016/S0896-6273(00)80893-4; Liston C, 2013, NAT NEUROSCI, V16, P698, DOI 10.1038/nn.3387; Llinas RR, 2006, J NEUROPHYSIOL, V95, P3297, DOI 10.1152/jn.00166.2006; Maquet P, 2001, SCIENCE, V294, P1048, DOI 10.1126/science.1062856; Maret S, 2011, NAT NEUROSCI, V14, P1418, DOI 10.1038/nn.2934; PAVLIDES C, 1989, J NEUROSCI, V9, P2907; Ribeiro S, 2004, PLOS BIOL, V2, P126, DOI 10.1371/journal.pbio.0020024; ROFFWARG HP, 1966, SCIENCE, V152, P604, DOI 10.1126/science.152.3722.604; Seibt J, 2012, CURR BIOL, V22, P676, DOI 10.1016/j.cub.2012.02.016; Siegel JM, 2005, NATURE, V437, P1264, DOI 10.1038/nature04285; Skaggs WE, 1996, SCIENCE, V271, P1870, DOI 10.1126/science.271.5257.1870; Stickgold R, 2005, NATURE, V437, P1272, DOI 10.1038/nature04286; Timofeev I, 2011, PROG BRAIN RES, V193, P121, DOI 10.1016/B978-0-444-53839-0.00009-0; Tononi G, 2003, BRAIN RES BULL, V62, P143, DOI 10.1016/j.brainresbull.2003.09.004; Vyazovskiy VV, 2008, NAT NEUROSCI, V11, P200, DOI 10.1038/nn2035; Wang G, 2011, TRENDS NEUROSCI, V34, P452, DOI 10.1016/j.tins.2011.07.005; WILSON MA, 1994, SCIENCE, V265, P676, DOI 10.1126/science.8036517; Yang Guang, 2013, Methods Mol Biol, V1010, P35, DOI 10.1007/978-1-62703-411-1_3; Yang G, 2012, DEV NEUROBIOL, V72, P1391, DOI 10.1002/dneu.20996; Yang G, 2009, NATURE, V462, P920, DOI 10.1038/nature08577; Zelenin PV, 2011, J NEUROPHYSIOL, V105, P2698, DOI 10.1152/jn.00120.2011	40	357	368	5	180	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 6	2014	344	6188					1173	1178		10.1126/science.1249098	http://dx.doi.org/10.1126/science.1249098			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI3UU	24904169	Green Accepted			2022-12-28	WOS:000336791200051
J	Beura, LK; Masopust, D				Beura, Lalit K.; Masopust, David			SnapShot: Resident Memory T Cells	CELL			English	Editorial Material							CUTTING EDGE; TISSUE; INFECTION; DIFFERENTIATION; PROTECTION; IMMUNITY; VIRUS; SKIN		[Beura, Lalit K.; Masopust, David] Univ Minnesota, Sch Med, Dept Microbiol, Minneapolis, MN 55455 USA; [Beura, Lalit K.; Masopust, David] Univ Minnesota, Sch Med, Ctr Immunol, Minneapolis, MN 55455 USA	University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities	Beura, LK (corresponding author), Univ Minnesota, Sch Med, Dept Microbiol, Minneapolis, MN 55455 USA.		masopust, david/B-5027-2008; Beura, Lalit/W-6281-2019					Casey KA, 2012, J IMMUNOL, V188, P4866, DOI 10.4049/jimmunol.1200402; Cauley LS, 2013, MUCOSAL IMMUNOL, V6, P14, DOI 10.1038/mi.2012.96; Gebhardt T, 2009, NAT IMMUNOL, V10, P524, DOI 10.1038/ni.1718; Jiang XD, 2012, NATURE, V483, P227, DOI 10.1038/nature10851; Klonowski KD, 2004, IMMUNITY, V20, P551, DOI 10.1016/S1074-7613(04)00103-7; Lee YT, 2011, J VIROL, V85, P4085, DOI 10.1128/JVI.02493-10; Mackay LK, 2013, NAT IMMUNOL, V14, P1294, DOI 10.1038/ni.2744; Masopust D, 2006, J IMMUNOL, V176, P2079, DOI 10.4049/jimmunol.176.4.2079; Skon CN, 2013, NAT IMMUNOL, V14, P1285, DOI 10.1038/ni.2745; Teijaro JR, 2011, J IMMUNOL, V187, P5510, DOI 10.4049/jimmunol.1102243	10	24	25	0	4	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUN 5	2014	157	6					1488	+	1488.e1	10.1016/j.cell.2014.05.026	http://dx.doi.org/10.1016/j.cell.2014.05.026			2	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	AN8UV	24906159	Bronze			2022-12-28	WOS:000340881400022
J	Psaty, BM; Breckenridge, AM				Psaty, Bruce M.; Breckenridge, Alasdair M.			Mini-Sentinel and Regulatory Science - Big Data Rendered Fit and Functional	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							RISK		[Psaty, Bruce M.] Univ Washington, Dept Med, Cardiovasc Hlth Res Unit, Seattle, WA USA; [Psaty, Bruce M.] Univ Washington, Dept Epidemiol, Cardiovasc Hlth Res Unit, Seattle, WA 98195 USA; [Psaty, Bruce M.] Univ Washington, Dept Hlth Serv, Cardiovasc Hlth Res Unit, Seattle, WA 98195 USA; [Psaty, Bruce M.] Grp Hlth Cooperat Puget Sound, Grp Hlth Res Inst, Seattle, WA USA; [Breckenridge, Alasdair M.] Univ Liverpool, Dept Pharmacol & Therapeut, Liverpool L69 3BX, Merseyside, England	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; Group Health Cooperative; University of Liverpool	Psaty, BM (corresponding author), Univ Washington, Dept Med, Cardiovasc Hlth Res Unit, Seattle, WA USA.							Avorn J, 2013, CIRCULATION, V128, P745, DOI 10.1161/CIRCULATIONAHA.113.003419; Institute of Medicine, 2006, FUT DRUG SAF PROM PR; Madigan D, 2013, AM J EPIDEMIOL, V178, P645, DOI 10.1093/aje/kwt010; Toh S, 2013, ARCH INTERN MED, V173, P14; Toh S, 2012, ARCH INTERN MED, V172, P1582, DOI 10.1001/2013.jamainternmed.34; Yih WK, 2014, NEW ENGL J MED, V370, P503, DOI 10.1056/NEJMoa1303164	6	62	65	0	36	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUN 5	2014	370	23					2165	2167		10.1056/NEJMp1401664	http://dx.doi.org/10.1056/NEJMp1401664			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	AI3AF	24897081				2022-12-28	WOS:000336729900004
J	Kirby, T				Kirby, Tony			Profile Marshall Lightowlers: tackling parasitic diseases	LANCET			English	Biographical-Item																			0	0	0	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	MAY 31	2014	383	9932					1879	1879		10.1016/S0140-6736(14)60904-1	http://dx.doi.org/10.1016/S0140-6736(14)60904-1			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AI4PR	24881981				2022-12-28	WOS:000336847800015
J	Fournier, JA; Johnson, CJ; Wolke, CT; Weddle, GH; Wolk, AB; Johnson, MA				Fournier, Joseph A.; Johnson, Christopher J.; Wolke, Conrad T.; Weddle, Gary H.; Wolk, Arron B.; Johnson, Mark A.			Vibrational spectral signature of the proton defect in the three-dimensional H+(H2O)(21) cluster	SCIENCE			English	Article							WATER CLUSTERS; INFRARED-SPECTRA; HYDRATED PROTON; GLOBAL MINIMA; AB-INITIO; SPECTROSCOPY; ION; HYDRONIUM; ISOMERS; COMPLEXES	The way in which a three-dimensional network of water molecules accommodates an excess proton is hard to discern from the broad vibrational spectra of dilute acids. The sharper bands displayed by cold gas-phase clusters, H+(H2O)(n), are therefore useful because they encode the network-dependent speciation of the proton defect and yet are small enough to be accurately treated with electronic structure theory. We identified the previously elusive spectral signature of the proton defect in the three-dimensional cage structure adopted by the particularly stable H+(H2O)(21) cluster. Cryogenically cooling the ion and tagging it with loosely bound deuterium (D-2) enabled detection of its vibrational spectrum over the 600 to 4000 cm(-1) range. The excess charge is consistent with a tricoordinated H3O+ moiety embedded on the surface of a clathrate-like cage.	[Fournier, Joseph A.; Johnson, Christopher J.; Wolke, Conrad T.; Weddle, Gary H.; Wolk, Arron B.; Johnson, Mark A.] Yale Univ, Sterling Chem Lab, New Haven, CT 06520 USA	Yale University	Johnson, MA (corresponding author), Yale Univ, Sterling Chem Lab, New Haven, CT 06520 USA.	mark.johnson@yale.edu	Johnson, Christopher/A-9687-2014	Johnson, Christopher/0000-0003-1859-5615	U.S. Department of Energy [DE-FG02-06ER15800]; Air Force Office of Scientific Research [FA9550-13-1-0007]; U.S. Department of Defense for support through a National Defense Science and Engineering Graduate Fellowship; NSF [CNS 08-21132]	U.S. Department of Energy(United States Department of Energy (DOE)); Air Force Office of Scientific Research(United States Department of DefenseAir Force Office of Scientific Research (AFOSR)); U.S. Department of Defense for support through a National Defense Science and Engineering Graduate Fellowship; NSF(National Science Foundation (NSF))	M.A.J. thanks the U.S. Department of Energy for support under grant DE-FG02-06ER15800. Development of the cryogenic ion spectrometer was supported by the Air Force Office of Scientific Research under grant FA9550-13-1-0007. J.A.F. thanks the U.S. Department of Defense for support through a National Defense Science and Engineering Graduate Fellowship. This work was supported in part by the facilities and staff of the Yale University Faculty of Arts and Sciences High Performance Computing Center, and by NSF grant CNS 08-21132, which partially funded acquisition of the facilities.	Asmis KR, 2003, SCIENCE, V299, P1375, DOI 10.1126/science.1081634; Barone V, 2005, J CHEM PHYS, V122, DOI 10.1063/1.1824881; Cheng TC, 2012, J AM CHEM SOC, V134, P13046, DOI 10.1021/ja3038245; Douberly GE, 2010, J PHYS CHEM A, V114, P4570, DOI 10.1021/jp100778s; Douberly GE, 2009, J PHYS CHEM A, V113, P8449, DOI 10.1021/jp9052709; Garand E, 2012, SCIENCE, V335, P694, DOI 10.1126/science.1214948; Headrick JM, 2005, SCIENCE, V308, P1765, DOI 10.1126/science.1113094; Heine N, 2013, J AM CHEM SOC, V135, P8266, DOI 10.1021/ja401359t; Hodges MP, 2000, CHEM PHYS LETT, V324, P279, DOI 10.1016/S0009-2614(00)00584-4; Iyengar SS, 2005, J CHEM PHYS, V123, DOI 10.1063/1.2007628; Jiang JC, 2000, J AM CHEM SOC, V122, P1398, DOI 10.1021/ja990033i; Kamrath MZ, 2011, INT J MASS SPECTROM, V300, P91, DOI 10.1016/j.ijms.2010.10.021; Kelterbaum R., 1996, THEOCHEM, V371, P205, DOI 10.1016/S0166-1280(96)04736-7; Khan A, 2000, CHEM PHYS LETT, V319, P440, DOI 10.1016/S0009-2614(00)00175-5; Kim J, 2002, J CHEM PHYS, V116, P737, DOI 10.1063/1.1423327; Knight C, 2012, ACCOUNTS CHEM RES, V45, P101, DOI 10.1021/ar200140h; Kulig W, 2014, J PHYS CHEM B, V118, P278, DOI 10.1021/jp410446d; Laasonen KE, 1997, J PHYS CHEM A, V101, P98, DOI 10.1021/jp962513r; Lin CK, 2005, PHYS CHEM CHEM PHYS, V7, P938, DOI 10.1039/b412281j; McCoy AB, 2012, PHYS CHEM CHEM PHYS, V14, P7205, DOI 10.1039/c2cp24110b; Miyazaki M, 2004, SCIENCE, V304, P1134, DOI 10.1126/science.1096037; Mizuse K, 2007, J CHEM PHYS, V126, DOI 10.1063/1.2750669; Mizuse K, 2013, CHEM PHYS, V419, P2, DOI 10.1016/j.chemphys.2012.07.012; Mizuse K, 2011, J PHYS CHEM LETT, V2, P2130, DOI 10.1021/jz200996q; Mizuse K, 2010, ANGEW CHEM INT EDIT, V49, P10119, DOI 10.1002/anie.201003662; Nagornova NS, 2012, SCIENCE, V336, P320, DOI 10.1126/science.1218709; OKUMURA M, 1986, J CHEM PHYS, V85, P2328, DOI 10.1063/1.451079; OKUMURA M, 1990, J PHYS CHEM-US, V94, P3416, DOI 10.1021/j100372a014; SEARCY JQ, 1974, J CHEM PHYS, V61, P5282, DOI 10.1063/1.1681876; SHI Z, 1993, J CHEM PHYS, V99, P8009, DOI 10.1063/1.465678; Shin JW, 2004, SCIENCE, V304, P1137, DOI 10.1126/science.1096466; Torrent-Sucarrat M, 2011, J CHEM THEORY COMPUT, V7, P467, DOI 10.1021/ct100692x; Wang XB, 2008, J PHYS CHEM A, V112, P13271, DOI 10.1021/jp808769m; WEI S, 1991, J CHEM PHYS, V94, P3268, DOI 10.1063/1.459796; Wolk AB, 2014, ACCOUNTS CHEM RES, V47, P202, DOI 10.1021/ar400125a; Wu CC, 2005, J CHEM PHYS, V122, DOI 10.1063/1.1843816; Xantheas SS, 2012, CAN J CHEM ENG, V90, P843, DOI 10.1002/cjce.21645; Xu JQ, 2011, J PHYS CHEM LETT, V2, P81, DOI 10.1021/jz101536b; YEH LI, 1989, J CHEM PHYS, V91, P7319, DOI 10.1063/1.457305	39	98	98	8	134	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 30	2014	344	6187					1009	1012		10.1126/science.1253788	http://dx.doi.org/10.1126/science.1253788			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AH9WM	24876493	Green Submitted			2022-12-28	WOS:000336495800040
J	Kattepur, AK; Gopinath, KS				Kattepur, Abhay K.; Gopinath, Kodaganur S.			Metastasis from Thyroid Carcinoma	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Kattepur, Abhay K.; Gopinath, Kodaganur S.] HCG Bangalore Inst Oncol, Bangalore, Karnataka, India		Kattepur, AK (corresponding author), HCG Bangalore Inst Oncol, Bangalore, Karnataka, India.	drgopinath1@hotmail.com							0	1	1	0	1	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAY 29	2014	370	22					2131	2131		10.1056/NEJMicm1312669	http://dx.doi.org/10.1056/NEJMicm1312669			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	AH9BM	24869723				2022-12-28	WOS:000336434000011
J	Pezzella, F; Harris, AL				Pezzella, Francesco; Harris, Adrian L.			When Cancer Co-opts the Vasculature	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							METASTASIS		[Pezzella, Francesco] Univ Oxford, John Radcliffe Hosp, Radcliffe Dept Med, Nuffield Div Clin Lab Sci, Oxford OX3 9DU, England; [Harris, Adrian L.] Univ Oxford, Mol Oncol Labs, Dept Med Oncol, Weatherall Inst Mol Med, Oxford, England	University of Oxford; University of Oxford	Pezzella, F (corresponding author), Univ Oxford, John Radcliffe Hosp, Radcliffe Dept Med, Nuffield Div Clin Lab Sci, Oxford OX3 9DU, England.		Harris, Adrian L/ABA-3343-2020	Harris, Adrian L/0000-0003-1376-8409	National Institute for Health Research [NF-SI-0611-10163] Funding Source: researchfish; Cancer Research UK [11359] Funding Source: Medline	National Institute for Health Research(National Institute for Health Research (NIHR)); Cancer Research UK(Cancer Research UK)		Dome B, 2007, AM J PATHOL, V170, P1, DOI 10.2353/ajpath.2007.060302; Hu JT, 2005, ONCOGENE, V24, P1212, DOI 10.1038/sj.onc.1208242; Pezzella F, 1997, AM J PATHOL, V151, P1417; Valiente M, 2014, CELL, V156, P1002, DOI 10.1016/j.cell.2014.01.040; Van den Eynden GG, 2013, CANCER RES, V73, P2031, DOI 10.1158/0008-5472.CAN-12-3931	5	5	5	0	5	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAY 29	2014	370	22					2146	2147		10.1056/NEJMcibr1402407	http://dx.doi.org/10.1056/NEJMcibr1402407			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	AH9BM	24869725				2022-12-28	WOS:000336434000015
J	Reisman, A				Reisman, Anna			Hounded	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									Yale Univ, Sch Med, Dept Internal Med, New Haven, CT 06510 USA	Yale University	Reisman, A (corresponding author), Yale Univ, Sch Med, Dept Internal Med, New Haven, CT 06510 USA.	anna.reisman@yale.edu							0	0	0	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAY 28	2014	311	20					2069	2069		10.1001/jama.2014.3270	http://dx.doi.org/10.1001/jama.2014.3270			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AH8MQ	24867010				2022-12-28	WOS:000336392400020
J	Smith, JM				Smith, Jeanette M.			The Ball on Shipboard	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material																			0	0	0	0	1	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAY 28	2014	311	20					2048	2049		10.1001/jama.2013.279516	http://dx.doi.org/10.1001/jama.2013.279516			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AH8MQ	24866994				2022-12-28	WOS:000336392400001
J	Briguori, C; Condorelli, G				Briguori, Carlo; Condorelli, Gerolama			Hydration in contrast-induced acute kidney injury	LANCET			English	Editorial Material							INDUCED NEPHROPATHY; PREVENTION; PREDICTION; FUROSEMIDE; SYSTEM		[Briguori, Carlo] Clin Mediterranea, Lab Intervent Cardiol, I-80121 Naples, Italy; [Briguori, Carlo] Clin Mediterranea, Dept Cardiol, I-80121 Naples, Italy; [Condorelli, Gerolama] Univ Naples Federico II, Dept Mol Med & Med Biotechnol, Naples, Italy; [Condorelli, Gerolama] Univ Naples Federico II, Inst Expt Endocrinol & Oncol G Salvatore, Naples, Italy	Mediterranean Clinic; Mediterranean Clinic; University of Naples Federico II; University of Naples Federico II	Briguori, C (corresponding author), Clin Mediterranea, Lab Intervent Cardiol, I-80121 Naples, Italy.	carlobriguori@clinicamediterranea.it	Condorelli, Gerolama/AAC-3472-2022	Condorelli, Gerolama/0000-0003-0177-8829				Brar SS, 2014, LANCET, V383, P1814, DOI 10.1016/S0140-6736(14)60689-9; Brar SS, 2009, CLIN J AM SOC NEPHRO, V4, P1584, DOI 10.2215/CJN.03120509; Briguori C, 2011, CIRCULATION, V124, P1260, DOI 10.1161/CIRCULATIONAHA.111.030759; Chertow GM, 2005, J AM SOC NEPHROL, V16, P3365, DOI 10.1681/ASN.2004090740; Clavijo LC, 2006, AM J CARDIOL, V97, P981, DOI 10.1016/j.amjcard.2005.10.033; Dorval JF, 2013, INT J CARDIOL, V166, P482, DOI 10.1016/j.ijcard.2011.11.035; Gurm HS, 2013, J AM COLL CARDIOL, V61, P2242, DOI 10.1016/j.jacc.2013.03.026; Marenzi G, 2012, JACC-CARDIOVASC INTE, V5, P90, DOI 10.1016/j.jcin.2011.08.017; Mehran R, 2004, J AM COLL CARDIOL, V44, P1393, DOI 10.1016/j.jacc.2004.06.068; NOSSEN JO, 1995, SCAND J CLIN LAB INV, V55, P341, DOI 10.3109/00365519509104972; Romano G, 2008, EUR HEART J, V29, P2569, DOI 10.1093/eurheartj/ehn197; SOLOMON R, 1994, NEW ENGL J MED, V331, P1416, DOI 10.1056/NEJM199411243312104; Stevens NA, 1999, J AM COLL CARDIOL, V33, P403	13	14	17	0	6	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAY 24	2014	383	9931					1786	1788		10.1016/S0140-6736(14)60753-4	http://dx.doi.org/10.1016/S0140-6736(14)60753-4			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AH6US	24856014				2022-12-28	WOS:000336267800006
J	Bynum, W				Bynum, William			When kidneys fail	LANCET			English	Editorial Material												w.bynum@ucl.ac.uk						Cameron JS, 2002, HIST TREATMENT RENAL; Chasis H, 1965, HW SMITH HIS LITERAR; Fox R., 1974, COURAGE FAIL SOCIAL; Peitzman SJ, 2007, DROPSY DIALYSSI TRAN; Schlich T., 2010, ORIGINS ORGAN TRANPL	5	0	0	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	MAY 24	2014	383	9931					1798	1799		10.1016/S0140-6736(14)60870-9	http://dx.doi.org/10.1016/S0140-6736(14)60870-9			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	AH6US	24868570				2022-12-28	WOS:000336267800013
J	Ortiz, A; Covic, A; Fliser, D; Fouque, D; Goldsmith, D; Kanbay, M; Mallamaci, F; Massy, ZA; Rossignol, P; Vanholder, R; Wiecek, A; Zoccali, C; London, GM				Ortiz, Alberto; Covic, Adrian; Fliser, Danilo; Fouque, Denis; Goldsmith, David; Kanbay, Mehmet; Mallamaci, Francesca; Massy, Ziad A.; Rossignol, Patrick; Vanholder, Raymond; Wiecek, Andrzej; Zoccali, Carmine; London, Gerard M.		Board EURECA-m Working Grp	Epidemiology, contributors to, and clinical trials of mortality risk in chronic kidney failure	LANCET			English	Article							STAGE RENAL-DISEASE; ERYTHROPOIESIS-STIMULATING AGENTS; ALL-CAUSE MORTALITY; HEMODIALYSIS-PATIENTS; CARDIOVASCULAR EVENTS; ONLINE HEMODIAFILTRATION; PERITONEAL-DIALYSIS; PRACTICE PATTERNS; REPLACEMENT THERAPY; PHOSPHATE BINDERS	Patients with chronic kidney failure-defined as a glomerular filtration rate persistently below 15 mL/min per 1.73 m(2)-have an unacceptably high mortality rate. In developing countries, mortality results primarily from an absence of access to renal replacement therapy. Additionally, cardiovascular and non-cardiovascular mortality are several times higher in patients on dialysis or post-renal transplantation than in the general population. Mortality of patients on renal replacement therapy is affected by a combination of socioeconomic factors, pre-existing medical disorders, renal replacement treatment modalities, and kidney failure itself. Characterisation of the key pathophysiological contributors to increased mortality and cardiorenal risk staging systems are needed for the rational design of clinical trials aimed at decreasing mortality. Policy changes to improve access to renal replacement therapy should be combined with research into low-cost renal replacement therapy and optimum clinical care, which should include multifaceted approaches simultaneously targeting several of the putative contributors to increased mortality.	[Ortiz, Alberto] IIS Fdn Jimenez Diaz, Div Nephrol, Madrid 28040, Spain; [Ortiz, Alberto] Univ Autonoma Madrid, Dept Med, Madrid, Spain; [Ortiz, Alberto] Red Invest Renal REDINREN, Madrid, Spain; [Ortiz, Alberto] IRSIN, Madrid, Spain; [Covic, Adrian] Grigore T Popa Univ Med & Pharm, PaArhon Univ Hosp, Iasi, Romania; [Fliser, Danilo] Univ Saarland, Med Ctr, Clin Renal & Hypertens Dis, Homburg, Germany; [Fouque, Denis] Univ Lyon, Carmen CENS, Ctr Hosp Lyon Sud, Dept Nephrol Nutr & Dialysis, Lyon, France; [Goldsmith, David] Guys & St Thomas Hosp, Renal & Transplantat Dept, London SE1 9RT, England; [Kanbay, Mehmet] Istanbul Medeniyet Univ, Sch Med, Dept Nephrol, Istanbul, Turkey; [Mallamaci, Francesca; Zoccali, Carmine] Osped Riuniti Reggio Calabria, Nephrol Hypertens & Renal Transplantat Unit, Reggio Di Calabria, Italy; [Mallamaci, Francesca; Zoccali, Carmine] CNR IFC Clin Epidemiol & Pathophysiol Renal Dis &, Reggio Di Calabria, Italy; [Massy, Ziad A.] Paris Ile France Ouest Univ UVSQ, Ambroise Pare Hosp, Div Nephrol, Paris, France; [Massy, Ziad A.] INSERM, U1088, Amiens, France; [Rossignol, Patrick] Ctr Invest Clin 1433, INSERM, Nancy, France; [Rossignol, Patrick] INSERM, U1116, Nancy, France; [Rossignol, Patrick] CHU Nancy, Ctr Invest Clin, Vandoeuvre Les Nancy, France; [Rossignol, Patrick] Univ Lorraine, Ctr Invest, Vandoeuvre Les Nancy, France; [Rossignol, Patrick] Assoc Lorraine Traitement Insuffisance Renale, Vandoeuvre Les Nancy, France; [Vanholder, Raymond] Univ Hosp Ghent, Dept Internal Med, Nephrol Sect, Ghent, Belgium; [Wiecek, Andrzej] Med Univ Silesia, Dept Nephrol Endocrinol & Metab Dis, Katowice, Poland; [London, Gerard M.] Hop Europeen Georges Pompidou, INSERM, U970, Paris, France	Fundacion Jimenez Diaz; Autonomous University of Madrid; Grigore T Popa University of Medicine & Pharmacy; Saarland University; CHU Lyon; Guy's & St Thomas' NHS Foundation Trust; Istanbul Medeniyet University; Consiglio Nazionale delle Ricerche (CNR); Istituto di Fisiologia Clinica (IFC-CNR); Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Ambroise-Pare - APHP; UDICE-French Research Universities; Universite Paris Saclay; Institut National de la Sante et de la Recherche Medicale (Inserm); Institut National de la Sante et de la Recherche Medicale (Inserm); Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Lorraine; CHU de Nancy; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Lorraine; Ghent University; Ghent University Hospital; Medical University Silesia; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Europeen Georges-Pompidou - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite	Ortiz, A (corresponding author), IIS Fdn Jimenez Diaz, Av Reyes Catolicos 2, Madrid 28040, Spain.	aortiz@fjd.es	Carmen, Team1/Y-7382-2019; 1, 1/L-6277-2019; Covic, Adrian/G-5017-2016; Zoccali, Carmine/B-9445-2009; Goldsmith, David J A/H-6965-2018; Zoccali, Carmine/AAR-4473-2020; ortiz, alberto/Y-7582-2018	Carmen, Team1/0000-0003-4234-1746; Covic, Adrian/0000-0002-9985-2486; Goldsmith, David J A/0000-0002-4349-9193; Zoccali, Carmine/0000-0002-6616-1996; ortiz, alberto/0000-0002-9805-9523; Lab, Carmen/0000-0002-5935-3236	Programa Intensificacion (ISCII, Spanish Government); RETIC REDINREN [012/0021]; CYTED IBERERC	Programa Intensificacion (ISCII, Spanish Government); RETIC REDINREN; CYTED IBERERC	AO receives support from Programa Intensificacion (ISCII, Spanish Government), RETIC REDINREN 012/0021, and CYTED IBERERC.	Abbott KC, 2004, ARCH INTERN MED, V164, P2465, DOI 10.1001/archinte.164.22.2465; Agarwal R, 2009, HYPERTENSION, V53, P860, DOI 10.1161/HYPERTENSIONAHA.108.128116; Anand S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072860; Baigent C, 2011, LANCET, V377, P2181, DOI 10.1016/S0140-6736(11)60739-3; Bargman JM, 2001, J AM SOC NEPHROL, V12, P2158, DOI 10.1681/ASN.V12102158; Beaglehole R, 2007, LANCET, V370, P2152, DOI 10.1016/S0140-6736(07)61700-0; Besarab A, 1998, NEW ENGL J MED, V339, P584, DOI 10.1056/NEJM199808273390903; Blankestijn PJ, 2010, KIDNEY INT, V77, P581, DOI 10.1038/ki.2009.541; Bottomley MJ, 2013, BRIT MED BULL, V106, P117, DOI 10.1093/bmb/ldt012; Bradbury BD, 2007, CLIN J AM SOC NEPHRO, V2, P89, DOI 10.2215/CJN.01170905; Bray BD, 2014, NEPHROL DIAL TRANSPL, V29, P681, DOI 10.1093/ndt/gft197; Briet M, 2012, KIDNEY INT, V82, P388, DOI 10.1038/ki.2012.131; Cano NJM, 2007, J AM SOC NEPHROL, V18, P2583, DOI 10.1681/ASN.2007020184; Chertow GM, 2012, NEW ENGL J MED, V367, P2482, DOI 10.1056/NEJMoa1205624; Chertow GM, 2010, NEW ENGL J MED, V363, P2287, DOI 10.1056/NEJMoa1001593; Cheung AK, 2003, J AM SOC NEPHROL, V14, P3251, DOI 10.1097/01.ASN.0000096373.13406.94; Cice G, 2003, J AM COLL CARDIOL, V41, P1438, DOI 10.1016/S0735-1097(03)00241-9; Cice G, 2010, J AM COLL CARDIOL, V56, P1701, DOI 10.1016/j.jacc.2010.03.105; Cleemput I, 2013, HEALTH POLICY, V110, P172, DOI 10.1016/j.healthpol.2013.03.001; CONVERSE RL, 1992, NEW ENGL J MED, V327, P1912, DOI 10.1056/NEJM199212313272704; Cooper BA, 2010, NEW ENGL J MED, V363, P609, DOI 10.1056/NEJMoa1000552; Culleton BF, 2007, JAMA-J AM MED ASSOC, V298, P1291, DOI 10.1001/jama.298.11.1291; de Jager DJ, 2009, JAMA-J AM MED ASSOC, V302, P1782, DOI 10.1001/jama.2009.1488; De Mauri A, 2011, J AM SOC NEPHROL, V22, P571, DOI 10.1681/ASN.2010070784; Di Iorio B, 2013, AM J KIDNEY DIS, V62, P771, DOI 10.1053/j.ajkd.2013.03.023; Duranton F, 2012, J AM SOC NEPHROL, V23, P1258, DOI 10.1681/ASN.2011121175; Eghan BA, 2009, HEMODIAL INT, V13, P467, DOI 10.1111/j.1542-4758.2009.00379.x; Eloot S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076838; ERA-EDTA Registry, ANN REP 2011; Fellstrom BC, 2009, NEW ENGL J MED, V360, P1395, DOI 10.1056/NEJMoa0810177; Foley RN, 2004, J AM SOC NEPHROL, V15, P1038, DOI 10.1097/01.ASN.0000119144.95922.C4; Fouque D, 2009, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001892.pub3; Fouque D, 2011, KIDNEY INT, V80, P348, DOI 10.1038/ki.2011.118; Go AS, 2004, NEW ENGL J MED, V351, P1296, DOI 10.1056/NEJMoa041031; Grassmann A, 2005, NEPHROL DIAL TRANSPL, V20, P2587, DOI 10.1093/ndt/gfi159; Green D, 2011, AM J KIDNEY DIS, V57, P921, DOI 10.1053/j.ajkd.2011.02.376; Grooteman MPC, 2012, J AM SOC NEPHROL, V23, P1087, DOI 10.1681/ASN.2011121140; Group KAW, 2012, KIDNEY INT, V2, P279, DOI DOI 10.1038/kisup.2012.37; Gutierrez OM, 2010, CLIN J AM SOC NEPHRO, V5, P1710, DOI 10.2215/CJN.02640310; Hu MC, 2011, J AM SOC NEPHROL, V22, P124, DOI 10.1681/ASN.2009121311; Ikizler TA, 2013, KIDNEY INT, V84, P1096, DOI 10.1038/ki.2013.147; Institute for Health Metrics and Evaluatoin, GBD ARR DIAGR; Jamal SA, 2013, LANCET, V382, P1268, DOI 10.1016/S0140-6736(13)60897-1; James MT, 2008, ANN INTERN MED, V148, P596, DOI 10.7326/0003-4819-148-8-200804150-00004; Jun M, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD008176.pub2; Kalantar-Zadeh K, 2003, KIDNEY INT, V63, P793, DOI 10.1046/j.1523-1755.2003.00803.x; Karopadi AN, 2013, NEPHROL DIAL TRANSPL, V28, P2553, DOI 10.1093/ndt/gft214; Kato S, 2008, CLIN J AM SOC NEPHRO, V3, P1526, DOI 10.2215/CJN.00950208; Kawaguchi T, 2013, J AM SOC NEPHROL, V24, P1493, DOI 10.1681/ASN.2012080831; Kidney Disease: Improving Global Outcomes (KDIGO) CKD-MBD Work Group, 2009, Kidney Int Suppl, pS1, DOI 10.1038/ki.2009.188; Koulouridis I, 2013, AM J KIDNEY DIS, V61, P44, DOI 10.1053/j.ajkd.2012.07.014; Kramer A, 2012, CLIN J AM SOC NEPHRO, V7, P1655, DOI 10.2215/CJN.10461011; Kurosu H, 2005, SCIENCE, V309, P1829, DOI 10.1126/science.1112766; Lauer MS, 2013, NEW ENGL J MED, V369, P1579, DOI 10.1056/NEJMp1310102; Levin A, 2012, KIDNEY INT S, V2013, P1, DOI DOI 10.1038/kisup.2012.73; Li PKT, 2013, J AM SOC NEPHROL, V24, P1889, DOI 10.1681/ASN.2012100987; LINDNER A, 1974, NEW ENGL J MED, V290, P697, DOI 10.1056/NEJM197403282901301; Locatelli F, 2009, J AM SOC NEPHROL, V20, P645, DOI 10.1681/ASN.2008060590; Lok CE, 2013, CLIN J AM SOC NEPHRO, V8, P1213, DOI 10.2215/CJN.01690213; London GM, 2012, J NEPHROL, V25, P619, DOI 10.5301/jn.5000187; London GM, 1997, KIDNEY INT, V51, P1678, DOI 10.1038/ki.1997.233; Loniewski I, 2014, KIDNEY INT, V85, P529, DOI 10.1038/ki.2013.401; Maduell F, 2013, J AM SOC NEPHROL, V24, P487, DOI 10.1681/ASN.2012080875; Maisonneuve P, 1999, LANCET, V354, P93, DOI 10.1016/S0140-6736(99)06154-1; Massy ZA, 2013, KIDNEY INT, V84, P451, DOI 10.1038/ki.2013.181; Massy ZA, 2013, CURR OPIN NEPHROL HY, V22, P405, DOI 10.1097/MNH.0b013e328362155b; Matsumoto Y, 2014, J AM COLL CARDIOL, V63, P529, DOI 10.1016/j.jacc.2013.09.056; Mitsnefes MM, 2013, JAMA-J AM MED ASSOC, V309, P1921, DOI 10.1001/jama.2013.4208; Moreno JA, 2011, J AM SOC NEPHROL, V22, P1315, DOI 10.1681/ASN.2010101073; Ocak G, 2012, J THROMB HAEMOST, V10, P2484, DOI 10.1111/j.1538-7836.2012.04921.x; Ok E, 2013, NEPHROL DIAL TRANSPL, V28, P192, DOI 10.1093/ndt/gfs407; Ortiz A, 2012, NAT REV NEPHROL, V8, P141, DOI 10.1038/nrneph.2011.170; Palmer SC, 2013, COCHRANE DB SYST REV, V2; Palmer SC, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001436; Palmer SC, 2012, ANN INTERN MED, V157, P263, DOI 10.7326/0003-4819-157-4-201208210-00007; Palmer SC, 2010, ANN INTERN MED, V153, P23, DOI 10.7326/0003-4819-153-1-201007060-00252; Pan Y, 2012, BRIT J NUTR, V108, P400, DOI 10.1017/S0007114511007033; Paniagua R, 2002, J AM SOC NEPHROL, V13, DOI 10.1681/ASN.V1351307; Pauly RP, 2009, NEPHROL DIAL TRANSPL, V24, P2915, DOI 10.1093/ndt/gfp295; Pitt B, 2014, J AM COLL CARDIOL, V63, P537, DOI 10.1016/j.jacc.2013.09.057; Ramirez SPB, 2012, DIABETES CARE, V35, P2527, DOI 10.2337/dc12-0573; Roberts MA, 2011, AM J KIDNEY DIS, V58, P64, DOI 10.1053/j.ajkd.2011.01.024; Rojas-Rivera J, 2010, NEPHROL DIAL TRANSPL, V25, P2850, DOI 10.1093/ndt/gfq313; Salahudeen AK, 2013, J AM SOC NEPHROL, V24, P26, DOI 10.1681/ASN.2012070690; Sarnak MJ, 2001, CHEST, V120, P1883, DOI 10.1378/chest.120.6.1883; Shebl FM, 2012, BMC NEPHROL, V13, DOI 10.1186/1471-2369-13-65; Shibiru T, 2013, BMC NEPHROL, V14, DOI 10.1186/1471-2369-14-127; Shlipak MG, 2005, JAMA-J AM MED ASSOC, V293, P1737, DOI 10.1001/jama.293.14.1737; Slinin Y, 2006, KIDNEY INT, V70, P1135, DOI 10.1038/sj.ki.5001714; Solid CA, 2012, AM J NEPHROL, V35, P498, DOI 10.1159/000338518; Speer T, 2013, IMMUNITY, V38, P754, DOI 10.1016/j.immuni.2013.02.009; Steenkamp R, 2013, NEPHRON CLIN PRACT, V123, P93, DOI 10.1159/000353324; Stengel B, 2010, J NEPHROL, V23, P253; Stenvinkel P, 2013, AM J KIDNEY DIS, V62, P339, DOI 10.1053/j.ajkd.2012.11.051; Suki WN, 2007, KIDNEY INT, V72, P1130, DOI 10.1038/sj.ki.5002466; Sumaili EK, 2009, NEPHROL DIAL TRANSPL, V24, P117, DOI 10.1093/ndt/gfn469; Susantitaphong P, 2012, AM J KIDNEY DIS, V59, P829, DOI 10.1053/j.ajkd.2012.01.015; Swanepoel CR, 2013, NAT REV NEPHROL, V9, P610, DOI 10.1038/nrneph.2013.168; Tamura MK, 2009, NEW ENGL J MED, V361, P1539, DOI 10.1056/NEJMoa0904655; Tang WHW, 2013, NEW ENGL J MED, V368, P1575, DOI 10.1056/NEJMoa1109400; Tentori F, 2012, NEPHROL DIAL TRANSPL, V27, P4180, DOI 10.1093/ndt/gfs021; Tonelli M, 2014, KIDNEY INT, V85, P1269, DOI 10.1038/ki.2012.488; Tonelli M, 2012, LANCET, V380, P807, DOI 10.1016/S0140-6736(12)60572-8; Toyohara T, 2009, J AM SOC NEPHROL, V20, P2546, DOI 10.1681/ASN.2009070696; Turin TC, 2012, J AM SOC NEPHROL, V23, P1569, DOI 10.1681/ASN.2012020164; Vanholder R, 2005, NEPHROL DIAL TRANSPL, V20, P1048, DOI 10.1093/ndt/gfh813; Vanholder R, 2012, J AM SOC NEPHROL, V23, P1291, DOI 10.1681/ASN.2011111094; Wanner C, 2005, NEW ENGL J MED, V353, P238, DOI 10.1056/NEJMoa043545; Wu C, 2013, NATURE, V496, P513, DOI 10.1038/nature11984; Xia Y, 2013, NAT CELL BIOL, V15, P1507, DOI 10.1038/ncb2872; Yoshino M, 2006, J AM SOC NEPHROL, V17, P3510, DOI 10.1681/ASN.2006020156; Zannad F, 2006, KIDNEY INT, V70, P1318, DOI 10.1038/sj.ki.5001657; Zoccali C, 2004, NEPHROL DIAL TRANSPL, V19, P67, DOI 10.1093/ndt/gfh1059; Zoccali C, 2002, J AM SOC NEPHROL, V13, DOI 10.1681/ASN.V133729; Zoccali C, 2002, CIRCULATION, V105, P1354, DOI 10.1161/hc1102.105261	115	270	281	4	21	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAY 24	2014	383	9931					1831	1843		10.1016/s0140-6736(14)60384-6	http://dx.doi.org/10.1016/s0140-6736(14)60384-6			13	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AH6US	24856028				2022-12-28	WOS:000336267800030
J	Riera, CE; Huising, MO; Follett, P; Leblanc, M; Halloran, J; Van Andel, R; de Magalhaes, CD; Merkwirth, C; Dillin, A				Riera, Celine E.; Huising, Mark O.; Follett, Patricia; Leblanc, Mathias; Halloran, Jonathan; Van Andel, Roger; de Magalhaes Filho, Carlos Daniel; Merkwirth, Carsten; Dillin, Andrew			TRPV1 Pain Receptors Regulate Longevity and Metabolism by Neuropeptide Signaling	CELL			English	Article							GENE-RELATED PEPTIDE; LIFE-SPAN EXTENSION; INSULIN-SECRETION; CAPSAICIN RECEPTOR; MESSENGER-RNA; MICE LACKING; SUBSTANCE-P; ION-CHANNEL; BETA-CELLS; CALCITONIN	The sensation of pain is associated with increased mortality, but it is unknown whether pain perception can directly affect aging. We find that mice lacking TRPV1 pain receptors are long- lived, displaying a youthful metabolic profile at old age. Loss of TRPV1 inactivates a calcium- signaling cascade that ends in the nuclear exclusion of the CREB- regulated transcriptional coactivator CRTC1 within pain sensory neurons originating from the spinal cord. In long- lived TRPV1 knockout mice, CRTC1 nuclear exclusion decreases production of the neuropeptide CGRP from sensory endings innervating the pancreatic islets, subsequently promoting insulin secretion and metabolic health. In contrast, CGRP homeostasis is disrupted with age in wild- type mice, resulting in metabolic decline. We show that pharmacologic inactivation of CGRP receptors in old wildtype animals can restore metabolic health. These data suggest that ablation of select pain sensory receptors or the inhibition of CGRP are associated with increased metabolic health and control longevity.	[Riera, Celine E.; Halloran, Jonathan; Van Andel, Roger; Dillin, Andrew] Univ Calif Berkeley, Berkeley, CA 94720 USA; [Riera, Celine E.; Follett, Patricia; Dillin, Andrew] Howard Hughes Med Inst, Chevy Chase, MD 20815 USA; [Riera, Celine E.; Follett, Patricia; Leblanc, Mathias; de Magalhaes Filho, Carlos Daniel; Merkwirth, Carsten; Dillin, Andrew] Glenn Ctr Aging Res, La Jolla, CA 92037 USA; [Huising, Mark O.] Salk Inst Biol Studies, Clayton Fdn Labs Peptide Biol, La Jolla, CA 92037 USA	University of California System; University of California Berkeley; Howard Hughes Medical Institute; Salk Institute	Dillin, A (corresponding author), Univ Calif Berkeley, Berkeley, CA 94720 USA.	dillin@berkeley.edu	Merkwirth, Carsten/H-5992-2012; Huising, Mark O./H-3885-2019	Merkwirth, Carsten/0000-0001-8895-3495; Huising, Mark O./0000-0002-6594-2205	Glenn Foundation for Medical Research; Howard Hughes Medical Institute; Swiss National Foundation (SNF/FNS)	Glenn Foundation for Medical Research; Howard Hughes Medical Institute(Howard Hughes Medical Institute); Swiss National Foundation (SNF/FNS)	We thank M. Allen, T. van der Meulen, L. Pei, S. Jordan, J. Mathur, A. Patapoutian, A. Friedman, and W. Mair for technical assistance and advice. We thank S. C. Wolff and D. Hockemeyer for valuable suggestions on the manuscript. C. E. R. is a recipient of the Swiss National Foundation (SNF/FNS). A. D. is cofounder of Proteostasis Therapeutics and Mitokyne and declares no financial interest related to this work. This work was supported by the Glenn Foundation for Medical Research and the Howard Hughes Medical Institute (C. E. R. and A. D.). We dedicate this work to Dr. W. Vale (Salk Institute).	AHREN B, 1987, DIABETOLOGIA, V30, P354, DOI 10.1007/BF00299030; Akiba Y, 2004, BIOCHEM BIOPH RES CO, V321, P219, DOI 10.1016/j.bbrc.2004.06.149; Alcedo J, 2004, NEURON, V41, P45, DOI 10.1016/S0896-6273(03)00816-X; Apfeld J, 1999, NATURE, V402, P804, DOI 10.1038/45544; Bernardini N, 2004, NEUROSCIENCE, V126, P585, DOI 10.1016/j.neuroscience.2004.03.017; Bluher M, 2003, SCIENCE, V299, P572, DOI 10.1126/science.1078223; BrownBorg HM, 1996, NATURE, V384, P33, DOI 10.1038/384033a0; Caterina MJ, 2000, SCIENCE, V288, P306, DOI 10.1126/science.288.5464.306; Caterina MJ, 1997, NATURE, V389, P816, DOI 10.1038/39807; Ch'ng TH, 2012, CELL, V150, P207, DOI 10.1016/j.cell.2012.05.027; Chavez AE, 2010, NAT NEUROSCI, V13, P1511, DOI 10.1038/nn.2684; Colbert HA, 1997, J NEUROSCI, V17, P8259; Coschigano KT, 2000, ENDOCRINOLOGY, V141, P2608, DOI 10.1210/en.141.7.2608; Dong MQ, 2007, SCIENCE, V317, P660, DOI 10.1126/science.1139952; EMESON RB, 1989, NATURE, V341, P76, DOI 10.1038/341076a0; Flurkey K, 2001, P NATL ACAD SCI USA, V98, P6736, DOI 10.1073/pnas.111158898; Flurkey K, 2002, MECH AGEING DEV, V123, P121, DOI 10.1016/S0047-6374(01)00339-6; Gram DX, 2007, EUR J NEUROSCI, V25, P213, DOI 10.1111/j.1460-9568.2006.05261.x; Gram DX, 2005, EUR J ENDOCRINOL, V153, P963, DOI 10.1530/eje.1.02046; Holzenberger M, 2003, NATURE, V421, P182, DOI 10.1038/nature01298; Houtkooper RH, 2011, SCI REP-UK, V1, DOI 10.1038/srep00134; Huising MO, 2010, P NATL ACAD SCI USA, V107, P912, DOI 10.1073/pnas.0913610107; Jordan SD, 2011, NAT CELL BIOL, V13, P434, DOI 10.1038/ncb2211; KOGIRE M, 1991, PANCREAS, V6, P459, DOI 10.1097/00006676-199107000-00013; Kovacs KA, 2007, P NATL ACAD SCI USA, V104, P4700, DOI 10.1073/pnas.0607524104; Kurosu H, 2005, SCIENCE, V309, P1829, DOI 10.1126/science.1112766; Libert S, 2007, SCIENCE, V315, P1133, DOI 10.1126/science.1136610; Mair W, 2011, NATURE, V470, P404, DOI 10.1038/nature09706; Marsch R, 2007, J NEUROSCI, V27, P832, DOI 10.1523/JNEUROSCI.3303-06.2007; McBeth J, 2003, ARTHRITIS RHEUM, V48, P1686, DOI 10.1002/art.10973; Mellstrom B, 2008, PHYSIOL REV, V88, P421, DOI 10.1152/physrev.00041.2005; MELNYK A, 1995, OBES RES, V3, P337, DOI 10.1002/j.1550-8528.1995.tb00159.x; Mezey E, 2000, P NATL ACAD SCI USA, V97, P3655, DOI 10.1073/pnas.060496197; Moreno H, 2012, HIPPOCAMPUS, V22, P1107, DOI 10.1002/hipo.20957; Motter AL, 2008, FEBS LETT, V582, P2257, DOI 10.1016/j.febslet.2008.05.021; Nakanishi M, 2010, MOL BIOL CELL, V21, P2568, DOI 10.1091/mbc.E10-01-0049; Nitter AK, 2013, SCAND J PAIN, V4, P86, DOI 10.1016/j.sjpain.2012.12.002; Noble MD, 2006, AM J PHYSIOL-GASTR L, V291, pG128, DOI 10.1152/ajpgi.00442.2005; Ortega-Molina A, 2012, CELL METAB, V15, P382, DOI 10.1016/j.cmet.2012.02.001; Park TJ, 2003, J COMP NEUROL, V465, P104, DOI 10.1002/cne.10824; PETTERSSON M, 1986, ENDOCRINOLOGY, V119, P865, DOI 10.1210/endo-119-2-865; Poyner DR, 1998, BRIT J PHARMACOL, V124, P1659, DOI 10.1038/sj.bjp.0702032; Price TJ, 2007, J PAIN, V8, P263, DOI 10.1016/j.jpain.2006.09.005; Razavi R, 2006, CELL, V127, P1123, DOI 10.1016/j.cell.2006.10.038; Screaton RA, 2004, CELL, V119, P61, DOI 10.1016/j.cell.2004.09.015; Selman C, 2008, FASEB J, V22, P807, DOI 10.1096/fj.07-9261com; Selman C, 2009, SCIENCE, V326, P140, DOI 10.1126/science.1177221; Speakman JR, 2004, PHYSIOL BIOCHEM ZOOL, V77, P900, DOI 10.1086/427059; Suri A, 2008, TRENDS PHARMACOL SCI, V29, P29, DOI 10.1016/j.tips.2007.10.016; Szallasi A, 1995, BRAIN RES, V703, P175, DOI 10.1016/0006-8993(95)01094-7; Taguchi A, 2007, SCIENCE, V317, P369, DOI 10.1126/science.1142179; Tanaka H, 2011, LIFE SCI, V88, P559, DOI 10.1016/j.lfs.2011.01.016; Tobin DM, 2002, NEURON, V35, P307, DOI 10.1016/S0896-6273(02)00757-2; Torrance N, 2010, EUR J PAIN, V14, P380, DOI 10.1016/j.ejpain.2009.07.006; Venkatachalam K, 2007, ANNU REV BIOCHEM, V76, P387, DOI 10.1146/annurev.biochem.75.103004.142819; WEST MJ, 1994, LANCET, V344, P769, DOI 10.1016/S0140-6736(94)92338-8; WEST MJ, 1993, NEUROBIOL AGING, V14, P287, DOI 10.1016/0197-4580(93)90113-P; Westerterp-Plantenga MS, 2005, INT J OBESITY, V29, P682, DOI 10.1038/sj.ijo.0802862; Woods JA, 2012, AGING DIS, V3, P130; Zhang SY, 2004, DEVELOPMENT, V131, P1629, DOI 10.1242/dev.01047; Zhang Y, 2012, ELIFE, V1, DOI 10.7554/eLife.00065	62	133	138	2	52	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAY 22	2014	157	5					1023	1036		10.1016/j.cell.2014.03.051	http://dx.doi.org/10.1016/j.cell.2014.03.051			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	AH9CG	24855942	Bronze			2022-12-28	WOS:000336437200007
J	Chen, J; Petrov, A; Johansson, M; Tsai, A; O'Leary, SE; Puglisi, JD				Chen, Jin; Petrov, Alexey; Johansson, Magnus; Tsai, Albert; O'Leary, Sean E.; Puglisi, Joseph D.			Dynamic pathways of-1 translational frameshifting	NATURE			English	Article							SINGLE-MOLECULE FLUORESCENCE; TRANSFER-RNA SELECTION; MESSENGER-RNA; HYBRID STATE; REAL-TIME; COMPOSITIONAL DYNAMICS; P-SITE; RIBOSOME; TRANSLOCATION; CODON	Spontaneous changes in the reading frame of translation are rare (frequency of 10(-3) to 10(-4) per codon)(1), but can be induced by specific features in the messenger RNA (mRNA). In the presence of mRNA secondary structures, a heptanucleotide 'slippery sequence' usually defined by the motif X XXY YYZ, and (in some prokaryotic cases) mRNA sequences that base pair with the 39 end of the 16S ribosomal rRNA (internal Shine-Dalgarno sequences), there is an increased probability that a specific programmed change of frame occurs, wherein the ribosome shifts one nucleotide backwards into an overlapping reading frame(-1 frame) and continues by translating a new sequence of amino acids(2,3). Despite extensive biochemical and genetic studies, there is no clear mechanistic description for frameshifting. Here we apply single-molecule fluorescence to track the compositional and conformational dynamics of individual ribosomes at each codon during translation of a frameshift-inducing mRNA from the dnaX gene in Escherichia coli. Ribosomes that frameshift into the -1 frame are characterized by a tenfold longer pause in elongation compared to non-frameshifted ribosomes, which translate through unperturbed. During the pause, interactions of the ribosome with the mRNA stimulatory elements uncouple EF-Gcatalysed translocation from normal ribosomal subunit reverse-rotation, leaving the ribosome in a non-canonical intersubunit rotated state with an exposed codon in the aminoacyl-tRNA site (A site). tRNA(Lys) sampling and accommodation to the empty A site and EF-G action either leads to the slippage of the tRNAs into the-1 frame or maintains the ribosome into the 0 frame. Our results provide a general mechanistic and conformational framework for -1 frameshifting, highlighting multiple kinetic branchpoints during elongation.	[Chen, Jin; Tsai, Albert] Stanford Univ, Dept Appl Phys, Stanford, CA 94305 USA; [Chen, Jin; Petrov, Alexey; Johansson, Magnus; Tsai, Albert; O'Leary, Sean E.; Puglisi, Joseph D.] Stanford Univ, Sch Med, Dept Biol Struct, Stanford, CA 94305 USA	Stanford University; Stanford University	Puglisi, JD (corresponding author), Stanford Univ, Sch Med, Dept Biol Struct, Stanford, CA 94305 USA.	puglisi@stanford.edu	Johansson, Magnus/J-8841-2014	Johansson, Magnus/0000-0001-8811-2629; Tsai, Albert/0000-0002-1643-0780	US National Institutes of Health (NIH) [GM51266]; NIH [GM099687]; Wenner-Gren Foundations (Stockholm); Stanford Interdisciplinary Graduate Fellowship; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM051266, R01GM099687] Funding Source: NIH RePORTER	US National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Wenner-Gren Foundations (Stockholm); Stanford Interdisciplinary Graduate Fellowship; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by US National Institutes of Health (NIH) grant GM51266 to J.C., A. T. and J.D.P.; by NIH grant GM099687 to A. P., S.E.O'L. and J.D.P.; Wenner-Gren Foundations (Stockholm) to M.J.; and by a Stanford Interdisciplinary Graduate Fellowship to J.C. The authors thank D. Hsu and R. Dalal (Pacific Biosciences Inc.) for their assistance on the ZMW instrumentation; and S. Yan, H. K. Kim and I. Tinoco Jr (University of California at Berkeley) for helpful discussions. J.C. would like to thank I Lin for support.	Agirrezabala X, 2008, MOL CELL, V32, P190, DOI 10.1016/j.molcel.2008.10.001; Aitken CE, 2008, BIOPHYS J, V94, P1826, DOI 10.1529/biophysj.107.117689; Aitken CE, 2010, NAT STRUCT MOL BIOL, V17, P793, DOI 10.1038/nsmb.1828; Baranov PV, 2004, RNA, V10, P221, DOI 10.1261/rna.5122604; Bertrand C, 2002, RNA, V8, P16, DOI 10.1017/S1355838202012086; Blanchard SC, 2004, NAT STRUCT MOL BIOL, V11, P1008, DOI 10.1038/nsmb831; Blanchard SC, 2004, P NATL ACAD SCI USA, V101, P12893, DOI 10.1073/pnas.0403884101; Chen J, 2014, P NATL ACAD SCI USA, V111, P664, DOI 10.1073/pnas.1315735111; Chen J, 2013, NAT STRUCT MOL BIOL, V20, P718, DOI 10.1038/nsmb.2567; Chen J, 2012, J AM CHEM SOC, V134, P5734, DOI 10.1021/ja2119964; Cornish PV, 2008, MOL CELL, V30, P578, DOI 10.1016/j.molcel.2008.05.004; Dorywalska M, 2005, NUCLEIC ACIDS RES, V33, P182, DOI 10.1093/nar/gki151; Frank J, 2000, NATURE, V406, P318, DOI 10.1038/35018597; HORSFIELD JA, 1995, NUCLEIC ACIDS RES, V23, P1487, DOI 10.1093/nar/23.9.1487; HUGHES D, 1987, EMBO J, V6, P4235, DOI 10.1002/j.1460-2075.1987.tb02772.x; JACKS T, 1988, NATURE, V331, P280, DOI 10.1038/331280a0; JACKS T, 1988, CELL, V55, P447, DOI 10.1016/0092-8674(88)90031-1; Jenner LB, 2010, NAT STRUCT MOL BIOL, V17, P555, DOI 10.1038/nsmb.1790; Johansson M, 2012, P NATL ACAD SCI USA, V109, P131, DOI 10.1073/pnas.1116480109; Kim HK, 2014, P NATL ACAD SCI USA, V111, P5538, DOI 10.1073/pnas.1403457111; Larsen B, 1997, J MOL BIOL, V271, P47, DOI 10.1006/jmbi.1997.1162; LARSEN B, 1994, J BACTERIOL, V176, P6842, DOI 10.1128/JB.176.22.6842-6851.1994; Leger M, 2007, NUCLEIC ACIDS RES, V35, P5581, DOI 10.1093/nar/gkm578; Li GW, 2012, NATURE, V484, P538, DOI 10.1038/nature10965; Liao PY, 2011, NUCLEIC ACIDS RES, V39, P300, DOI 10.1093/nar/gkq761; Liu CY, 2011, BIOPHYS J, V100, P2201, DOI 10.1016/j.bpj.2011.03.023; Lopinski JD, 2000, MOL CELL BIOL, V20, P1095, DOI 10.1128/MCB.20.4.1095-1103.2000; Marshall RA, 2008, P NATL ACAD SCI USA, V105, P15364, DOI 10.1073/pnas.0805299105; Marshall RA, 2009, MOL CELL, V35, P37, DOI 10.1016/j.molcel.2009.06.008; MOAZED D, 1989, NATURE, V342, P142, DOI 10.1038/342142a0; Munro JB, 2007, MOL CELL, V25, P505, DOI 10.1016/j.molcel.2007.01.022; Namy O, 2006, NATURE, V441, P244, DOI 10.1038/nature04735; Plant EP, 2003, RNA, V9, P168, DOI 10.1261/rna.2132503; Qin PW, 2014, EMBO REP, V15, P185, DOI 10.1002/embr.201337762; Qu XH, 2011, NATURE, V475, P118, DOI 10.1038/nature10126; Tinoco I, 2013, BIOPOLYMERS, V99, P1147, DOI 10.1002/bip.22293; Tourigny DS, 2013, SCIENCE, V340, P1542, DOI 10.1126/science.1235490; TSUCHIHASHI Z, 1990, P NATL ACAD SCI USA, V87, P2516, DOI 10.1073/pnas.87.7.2516; TSUCHIHASHI Z, 1992, GENE DEV, V6, P511, DOI 10.1101/gad.6.3.511; Uemura S, 2010, NATURE, V464, P1012, DOI 10.1038/nature08925; Valle M, 2003, CELL, V114, P123, DOI 10.1016/S0092-8674(03)00476-8; WEISS R B, 1989, New Biologist, V1, P159; Wen JD, 2008, NATURE, V452, P598, DOI 10.1038/nature06716	43	111	112	1	63	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 21	2014	512	7514					328	+		10.1038/nature13428	http://dx.doi.org/10.1038/nature13428			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN3SF	24919156	Green Accepted			2022-12-28	WOS:000340508200039
J	Afonso, O; Matos, I; Pereira, AJ; Aguiar, P; Lampson, MA; Maiato, H				Afonso, Olga; Matos, Irina; Pereira, Antonio J.; Aguiar, Paulo; Lampson, Michael A.; Maiato, Helder			Feedback control of chromosome separation by a midzone Aurora B gradient	SCIENCE			English	Article							MITOTIC CHROMOSOMES; CENTRAL SPINDLE; CONDENSIN-I; REPO-MAN; MITOSIS; CYTOKINESIS; KINASE; EXIT; PHOSPHORYLATION; ASSOCIATION	Accurate chromosome segregation during mitosis requires the physical separation of sister chromatids before nuclear envelope reassembly (NER). However, how these two processes are coordinated remains unknown. Here, we identified a conserved feedback control mechanism that delays chromosome decondensation and NER in response to incomplete chromosome separation during anaphase. A midzone-associated Aurora B gradient was found to monitor chromosome position along the division axis and to prevent premature chromosome decondensation by retaining Condensin I. PP1/PP2A phosphatases counteracted this gradient and promoted chromosome decondensation and NER. Thus, an Aurora B gradient appears to mediate a surveillance mechanism that prevents chromosome decondensation and NER until effective separation of sister chromatids is achieved. This allows the correction and reintegration of lagging chromosomes in the main nuclei before completion of NER.	[Afonso, Olga; Matos, Irina; Pereira, Antonio J.; Aguiar, Paulo; Maiato, Helder] Univ Porto, Inst Biol Mol & Celular, Chromosome Instabil & Dynam Lab, P-4150180 Oporto, Portugal; [Aguiar, Paulo] Univ Porto, Ctr Math, P-4169007 Oporto, Portugal; [Lampson, Michael A.] Univ Penn, Dept Biol, Philadelphia, PA 19104 USA; [Maiato, Helder] Univ Porto, Fac Med, Dept Expt Biol, Cell Div Unit, P-4200319 Oporto, Portugal	Universidade do Porto; Universidade do Porto; University of Pennsylvania; Universidade do Porto	Maiato, H (corresponding author), Univ Porto, Inst Biol Mol & Celular, Chromosome Instabil & Dynam Lab, Rua Campo Alegre 823, P-4150180 Oporto, Portugal.	maiato@ibmc.up.pt	Afonso, Olga/N-4802-2017; Aguiar, Paulo/AAD-2462-2020; Maiato, Helder/J-9466-2013	Afonso, Olga/0000-0002-5054-2460; Aguiar, Paulo/0000-0003-4164-5713; Pereira, Antonio/0000-0002-1053-8715; Maiato, Helder/0000-0002-6200-9997	COMPETE [FCOMP-01-0124-FEDER-015941 (PTDC/SAU-ONC/112917/2009)]; Fundacao para a Ciencia e a Tecnologia of Portugal; Human Frontier Science Program; European Research Council; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM083988] Funding Source: NIH RePORTER; Fundação para a Ciência e a Tecnologia [PTDC/SAU-ONC/112917/2009] Funding Source: FCT	COMPETE; Fundacao para a Ciencia e a Tecnologia of Portugal(Portuguese Foundation for Science and Technology); Human Frontier Science Program(Human Frontier Science Program); European Research Council(European Research Council (ERC)European Commission); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Fundação para a Ciência e a Tecnologia	We thank all colleagues who provided reagents and P. Sampaio for technical help with FRET. H. M. is funded by FCOMP-01-0124-FEDER-015941 (PTDC/SAU-ONC/112917/2009) through COMPETE and Fundacao para a Ciencia e a Tecnologia of Portugal, the Human Frontier Science Program, and PRECISE grant from the European Research Council. Data described can be found in the main figures and supplementary materials. The authors declare no conflict of interests.	Cesario JM, 2006, J CELL SCI, V119, P4770, DOI 10.1242/jcs.03235; Crasta K, 2012, NATURE, V482, P53, DOI 10.1038/nature10802; Fuller BG, 2008, NATURE, V453, P1132, DOI 10.1038/nature06923; Giet R, 2001, J CELL BIOL, V152, P669, DOI 10.1083/jcb.152.4.669; Gruneberg U, 2004, J CELL BIOL, V166, P167, DOI 10.1083/jcb.200403084; Guttinger S, 2009, NAT REV MOL CELL BIO, V10, P178, DOI 10.1038/nrm2641; HARTWELL LH, 1989, SCIENCE, V246, P629, DOI 10.1126/science.2683079; Hummer S, 2009, CURR BIOL, V19, P607, DOI 10.1016/j.cub.2009.02.046; Janssen A, 2011, SCIENCE, V333, P1895, DOI 10.1126/science.1210214; Lipp JJ, 2007, J CELL SCI, V120, P1245, DOI 10.1242/jcs.03425; Mendoza M, 2009, NAT CELL BIOL, V11, P477, DOI 10.1038/ncb1855; Murata-Hori M, 2002, MOL BIOL CELL, V13, P1099, DOI 10.1091/mbc.01-09-0467; Nakazawa N, 2011, J CELL SCI, V124, P1795, DOI 10.1242/jcs.078733; Neurohr G, 2011, SCIENCE, V332, P465, DOI 10.1126/science.1201578; Norden C, 2006, CELL, V125, P85, DOI 10.1016/j.cell.2006.01.045; Parry DH, 2001, CURR BIOL, V11, P671, DOI 10.1016/S0960-9822(01)00204-4; Qian JB, 2013, CURR BIOL, V23, P1136, DOI 10.1016/j.cub.2013.05.017; Ramadan K, 2007, NATURE, V450, P1258, DOI 10.1038/nature06388; Schmitz MHA, 2010, NAT CELL BIOL, V12, P886, DOI 10.1038/ncb2092; SIGRIST S, 1995, EMBO J, V14, P4827, DOI 10.1002/j.1460-2075.1995.tb00164.x; Smurnyy Yegor, 2010, ACS Chem Biol, V5, P1015, DOI 10.1021/cb1001685; Steigemann P, 2009, CELL, V136, P473, DOI 10.1016/j.cell.2008.12.020; Tada K, 2011, NATURE, V474, P477, DOI 10.1038/nature10179; Takemoto A, 2007, NUCLEIC ACIDS RES, V35, P2403, DOI 10.1093/nar/gkm157; Vagnarelli P, 2011, DEV CELL, V21, P328, DOI 10.1016/j.devcel.2011.06.020; Wheatley SP, 1997, J CELL BIOL, V138, P385, DOI 10.1083/jcb.138.2.385	26	79	81	0	24	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 18	2014	345	6194					332	336		10.1126/science.1251121	http://dx.doi.org/10.1126/science.1251121			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AL8PG	24925910	Green Submitted, Green Accepted			2022-12-28	WOS:000339400700053
J	LeFevre, ML				LeFevre, Michael L.		US Preventive Serv Task Force	Screening for Hepatitis B Virus Infection in Nonpregnant Adolescents and Adults: US Preventive Services Task Force Recommendation Statement	ANNALS OF INTERNAL MEDICINE			English	Article							UNITED-STATES; HEPATOCELLULAR-CARCINOMA; VIRAL-HEPATITIS; HIGH-RISK; LAMIVUDINE; EFFICACY; VACCINE; EPIDEMIOLOGY; PREVALENCE; UPDATE	Description: Update of the 2004 U. S. Preventive Services Task Force (USPSTF) recommendation on screening for hepatitis B virus (HBV) infection. Methods: The USPSTF reviewed the evidence on the benefits and harms of antiviral treatment, the benefits of education or behavior change counseling, and the association between improvements in intermediate and clinical outcomes after antiviral therapy. Population: This recommendation applies to asymptomatic, nonpregnant adolescents and adults at high risk for HBV infection (including those at high risk who were vaccinated before being screened for HBV infection). Recommendation: The USPSTF concludes that persons at high risk for infection should be screened for HBV infection. (B recommendation)	[LeFevre, Michael L.; US Preventive Serv Task Force] US Prevent Serv Task Force, Rockville, MD 20850 USA		LeFevre, ML (corresponding author), US Prevent Serv Task Force, Rockville, MD 20850 USA.			Pignone, Michael/0000-0002-6657-7342	Agency for Healthcare Research and Quality	Agency for Healthcare Research and Quality(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality)	The USPSTF is an independent, voluntary body. The U.S. Congress mandates that the Agency for Healthcare Research and Quality support the operations of the USPSTF.	Alter MJ, 2006, J HEPATOL, V44, pS6, DOI 10.1016/j.jhep.2005.11.004; Andreone P, 2004, J VIRAL HEPATITIS, V11, P439, DOI 10.1111/j.1365-2893.2004.00564.x; [Anonymous], 2014, CLIN PREV SERV HEP B; Calonge N, 2009, ANN INTERN MED, V150, P869; Centers for Disease Control and Prevention, 2013, VIR HEP SURV US 2010; Centers for Disease Control and Prevention . Viral Hepatitis Surveillance United States, 2013, VIR HEP STAT SURV; Chen W, 2005, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD000100.pub3; Chou R, 2014, EVIDENCE SYNTHESIS, V110; Chou R, 2014, ANN INTERN MED, V161, P31, DOI 10.7326/M13-2837; COUTINHO RA, 1983, BRIT MED J, V286, P1305, DOI 10.1136/bmj.286.6374.1305; FRANCIS DP, 1982, ANN INTERN MED, V97, P362, DOI 10.7326/0003-4819-97-3-362; Institute of Medicine, 2010, HEP LIV CANC NAT STR; Ioannou GN, 2011, ANN INTERN MED, V154, P319, DOI 10.7326/0003-4819-154-5-201103010-00006; Kowdley KV, 2012, HEPATOLOGY, V56, P422, DOI 10.1002/hep.24804; Liaw YF, 2004, NEW ENGL J MED, V351, P1521, DOI 10.1056/NEJMoa033364; Lin SY, 2007, HEPATOLOGY, V46, P1034, DOI 10.1002/hep.21784; Lok ASF, 2009, HEPATOLOGY, V50, P661, DOI 10.1002/hep.23190; Ly KN, 2012, ANN INTERN MED, V156, P271, DOI 10.7326/0003-4819-156-4-201202210-00004; Mast Eric E., 2006, Morbidity and Mortality Weekly Report, V55, P1; Mast Eric E., 2005, Morbidity and Mortality Weekly Report, V54, P1; Ott JJ, 2012, VACCINE, V30, P2212, DOI 10.1016/j.vaccine.2011.12.116; Papatheodoridis GV, 2011, GUT, V60, P1109, DOI 10.1136/gut.2010.221846; Spenatto N, 2013, J HEPATOL, V58, P690, DOI 10.1016/j.jhep.2012.11.044; SZMUNESS W, 1980, NEW ENGL J MED, V303, P833, DOI 10.1056/NEJM198010093031501; Torbenson M, 2004, HEPATOLOGY, V39, P51, DOI 10.1002/hep.20025; U.S. Preventive Services Task Force, 2004, AHRQ PUBLICATION; Weinbaum Cindy M., 2008, Morbidity and Mortality Weekly Report, V57, P1, DOI 10.1002/hep.22882; Wilkins T, 2010, AM FAM PHYSICIAN, V81, P965	28	86	88	0	6	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JUL 1	2014	161	1					58	+		10.7326/M14-1018	http://dx.doi.org/10.7326/M14-1018			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AK4UN	24863637				2022-12-28	WOS:000338419700006
J	Hill, SM; Hao, XX; Liu, BD; Nystrom, T				Hill, Sandra Malmgren; Hao, Xinxin; Liu, Beidong; Nystrom, Thomas			Life-span extension by a metacaspase in the yeast Saccharomyces cerevisiae	SCIENCE			English	Article							DAMAGED PROTEINS; ASYMMETRIC INHERITANCE; SEGREGATION; DEATH; APOPTOSIS; MUTANTS; SYSTEM; HSP104; ACTIN; YCA1	Single-cell species harbor ancestral structural homologs of caspase proteases, although the evolutionary benefit of such apoptosis-related proteins in unicellular organisms is unclear. Here, we found that the yeast metacaspase Mca1 is recruited to the insoluble protein deposit (IPOD) and juxtanuclear quality-control compartment (JUNQ) during aging and proteostatic stress. Elevating MCA1 expression counteracted accumulation of unfolded proteins and aggregates and extended life span in a heat shock protein Hsp104 disaggregase- and proteasome-dependent manner. Consistent with a role in protein quality control, genetic interaction analysis revealed that MCA1 buffers against deficiencies in the Hsp40 chaperone YDJ1 in a caspase cysteine-dependent manner. Life-span extension and aggregate management by Mca1 was only partly dependent on its conserved catalytic cysteine, which suggests that Mca1 harbors both caspase-dependent and independent functions related to life-span control.	[Hill, Sandra Malmgren; Hao, Xinxin; Liu, Beidong; Nystrom, Thomas] Gothenburg Univ, Dept Chem & Mol Biol CMB, S-41390 Gothenburg, Sweden	University of Gothenburg	Liu, BD (corresponding author), Gothenburg Univ, Dept Chem & Mol Biol CMB, Medicinaregatan 9C, S-41390 Gothenburg, Sweden.	beidong.liu@cmb.gu.se; thomas.nystrom@cmb.gu.se	Liu, Beidong/L-2485-2015; Hill, Sandra/U-4787-2017	Liu, Beidong/0000-0001-6052-8411; Hill, Sandra/0000-0001-7969-097X	Swedish Natural Research Council (VR); Knut and Alice Wallenberg Foundation; European Research Council; Swedish Cancer Society [CAN 2012/601]; Stiftelsen Olle Engkvist Byggmastare Foundation	Swedish Natural Research Council (VR)(Swedish Research Council); Knut and Alice Wallenberg Foundation(Knut & Alice Wallenberg Foundation); European Research Council(European Research Council (ERC)European Commission); Swedish Cancer Society(Swedish Cancer Society); Stiftelsen Olle Engkvist Byggmastare Foundation	The authors thank C. Boone for providing strain collections for the SGA analysis, L. Megeney for the MCA1C276A strain and the pLM1010 plasmid, W.-K. Huh for the pSIK1-RFP plasmid, D. Kaganovich for the pUBC9ts-RFP plasmid, D. Cyr for the pRS423-Cup1-Rnq1-mRFP plasmid, E. Deuerling for the Mca1 antibody, C. Andreasson and U. Hartl for the luciferase plasmids, F. Eisele for the pFE15 (CPY) plasmid, and A. Sigurdsson for assistance in complementation assays. This work was supported by grants from the Swedish Natural Research Council (VR) (T.N. and B. L.) and the Knut and Alice Wallenberg Foundation (Wallenberg Scholar) and European Research Council (Advanced Grant; QualiAge) to T.N., the Swedish Cancer Society (CAN 2012/601) and Stiftelsen Olle Engkvist Byggmastare Foundation to B.L.	Aguilaniu H, 2003, SCIENCE, V299, P1751, DOI 10.1126/science.1080418; Alnemri ES, 1996, CELL, V87, P171, DOI 10.1016/S0092-8674(00)81334-3; Bufalino MR, 2013, J CELL BIOL, V201, P523, DOI 10.1083/jcb.201207052; Carmona-Gutierrez D, 2010, CELL DEATH DIFFER, V17, P377, DOI 10.1038/cdd.2009.198; Danial NN, 2004, CELL, V116, P205, DOI 10.1016/S0092-8674(04)00046-7; Eisele F, 2008, FEBS LETT, V582, P4143, DOI 10.1016/j.febslet.2008.11.015; Erjavec N, 2007, GENE DEV, V21, P2410, DOI 10.1101/gad.439307; Glover JR, 1998, CELL, V94, P73, DOI 10.1016/S0092-8674(00)81223-4; Gregersen PK, 2007, NEW ENGL J MED, V356, P1263, DOI 10.1056/NEJMe078017; Gupta R, 2011, NAT METHODS, V8, P879, DOI [10.1038/NMETH.1697, 10.1038/nmeth.1697]; Hartl FU, 2009, NAT STRUCT MOL BIOL, V16, P574, DOI 10.1038/nsmb.1591; Herker E, 2004, J CELL BIOL, V164, P501, DOI 10.1083/jcb.200310014; Kaganovich D, 2008, NATURE, V454, P1088, DOI 10.1038/nature07195; Kruegel U, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002253; Lee REC, 2010, P NATL ACAD SCI USA, V107, P13348, DOI 10.1073/pnas.1006610107; Lee REC, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002956; Liu BD, 2011, CELL, V147, P959, DOI 10.1016/j.cell.2011.11.018; Liu BD, 2010, CELL, V140, P257, DOI 10.1016/j.cell.2009.12.031; Madeo F, 2002, MOL CELL, V9, P911, DOI 10.1016/S1097-2765(02)00501-4; Madeo F, 1997, J CELL BIOL, V139, P729, DOI 10.1083/jcb.139.3.729; Oling D, 2014, EMBO J, V33, P747, DOI 10.1002/embj.201386822; Rujano MA, 2006, PLOS BIOL, V4, P2325, DOI 10.1371/journal.pbio.0040417; Shrestha A, 2012, FRONT ONCOL, V2, P1, DOI 10.3389/fonc.2012.00078; Shrestha A, 2013, J PROTEOMICS, V81, P24, DOI 10.1016/j.jprot.2013.01.014; Spokoini R, 2012, CELL REP, V2, P738, DOI 10.1016/j.celrep.2012.08.024; Sung MK, 2007, YEAST, V24, P767, DOI 10.1002/yea.1504; Szallies A, 2002, FEBS LETT, V517, P144, DOI 10.1016/S0014-5793(02)02608-X; Tessarz P, 2009, MOL CELL BIOL, V29, P3738, DOI 10.1128/MCB.00201-09; Tong AHY, 2001, SCIENCE, V294, P2364, DOI 10.1126/science.1065810; Uren AG, 2000, MOL CELL, V6, P961, DOI 10.1016/S1097-2765(05)00086-9; Wong AHH, 2012, J BIOL CHEM, V287, P29251, DOI 10.1074/jbc.M112.381806; Yuan Junying, 2004, Cell, VS116, pS53, DOI 10.1016/S0092-8674(04)00028-5	32	84	86	1	53	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 20	2014	344	6190					1389	1392		10.1126/science.1252634	http://dx.doi.org/10.1126/science.1252634			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AJ2YQ	24855027				2022-12-28	WOS:000337531700038
J	Ordureau, A; Harper, JW				Ordureau, Alban; Harper, J. Wade			CELL BIOLOGY Balancing act	NATURE			English	Editorial Material							PARKIN; ACTIVATION; MECHANISMS; MITOPHAGY		[Ordureau, Alban; Harper, J. Wade] Harvard Univ, Sch Med, Dept Cell Biol, Boston, MA 02115 USA	Harvard University; Harvard Medical School	Ordureau, A (corresponding author), Harvard Univ, Sch Med, Dept Cell Biol, Boston, MA 02115 USA.		Ordureau, Alban/C-7558-2012	Ordureau, Alban/0000-0002-4924-8520; Harper, Jeffrey/0000-0002-6944-7236	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R37NS083524] Funding Source: NIH RePORTER; NINDS NIH HHS [R37 NS083524] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Bingol B, 2014, NATURE, V510, P370, DOI 10.1038/nature13418; Chan NC, 2011, HUM MOL GENET, V20, P1726, DOI 10.1093/hmg/ddr048; Cornelissen T., 2014, HUM MOL GENET; Exner N, 2012, EMBO J, V31, P3038, DOI 10.1038/emboj.2012.170; Greene JC, 2003, P NATL ACAD SCI USA, V100, P4078, DOI 10.1073/pnas.0737556100; Kondapalli C, 2012, OPEN BIOL, V2, DOI 10.1098/rsob.120080; Lee BH, 2010, NATURE, V467, P179, DOI 10.1038/nature09299; Narendra D, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a011338; Sang TK, 2007, J NEUROSCI, V27, P981, DOI 10.1523/JNEUROSCI.4810-06.2007; Sarraf SA, 2013, NATURE, V496, P372, DOI 10.1038/nature12043; Shiba-Fukushima K, 2012, SCI REP-UK, V2, DOI 10.1038/srep01002; Trempe JF, 2013, SCIENCE, V340, P1451, DOI 10.1126/science.1237908	12	5	6	0	8	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 19	2014	510	7505					347	348		10.1038/nature13500	http://dx.doi.org/10.1038/nature13500			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AJ0NG	24896184				2022-12-28	WOS:000337350200024
J	Smallwood, CAH; Arbuthnott, KG; Banczak-Mysiak, B; Borodina, M; Coutinho, AP; Payne-Hallstrom, L; Lipska, E; Lyashko, V; Miklasz, M; Miskiewicz, P; Nitzan, D; Pokanevych, I; Posobkiewicz, M; Rockenschaub, G; Sadkowska-Todys, M; Sinelnik, S; Smiley, D; Tomialoic, R; Yurchenko, V; Memish, ZA; Heymann, D; Endericks, T; McCloskey, B; Zumla, A; Barbeschi, M				Smallwood, Catherine A. H.; Arbuthnott, Katherine G.; Banczak-Mysiak, Barbara; Borodina, Mariya; Coutinho, Ana Paula; Payne-Hallstrom, Lara; Lipska, Elzbieta; Lyashko, Viktor; Miklasz, Miroslaw; Miskiewicz, Paulina; Nitzan, Dorit; Pokanevych, Igor; Posobkiewicz, Marek; Rockenschaub, Gerald; Sadkowska-Todys, Malgorzata; Sinelnik, Svetlana; Smiley, Daniel; Tomialoic, Rysard; Yurchenko, Volodimir; Memish, Ziad A.; Heymann, David; Endericks, Tina; McCloskey, Brian; Zumla, Alimuddin; Barbeschi, Maurizio			Euro 2012 European Football Championship Finals: planning for a health legacy	LANCET			English	Article							MASS-GATHERING MEDICINE; PARALYMPIC GAMES; SURVEILLANCE; SYDNEY; RISKS; CROWD; CUP	The revised international health regulations off er a framework that can be used by host countries to organise public health activities for mass gatherings. From June 8, to July 1, 2012, Poland and Ukraine jointly hosted the Union of European Football Associations European Football Championship Finals (Euro 2012). More than 8 million people from around the world congregated to watch the games. Host countries and international public health agencies planned extensively to assess and build capacity in the host countries and to develop effective strategies for dissemination of public health messages. The effectiveness of public health services was maximised through rapid sharing of information between parties, early use of networks of experienced individuals, and the momentum of existing national health programmes. Organisers of future mass gatherings for sporting events should share best practice and their experiences through the WHO International Observer Program. Research about behaviour of large crowds is needed for crowd management and the evidence base translated into practice. A framework to measure and evaluate the legacy of Euro 2012 is needed based on the experiences and the medium-term and long-term benefits of the tournament.	[Smallwood, Catherine A. H.; Arbuthnott, Katherine G.; Barbeschi, Maurizio] WHO, CH-1211 Geneva, Switzerland; [Nitzan, Dorit; Pokanevych, Igor] WHO, Country Off Ukraine, Kiev, Ukraine; [Borodina, Mariya; Smiley, Daniel] WHO Virtual Interdisciplinary Advisory Grp Mass G, Geneva, Switzerland; [Sinelnik, Svetlana; Yurchenko, Volodimir] Minist Hlth, Kiev, Ukraine; [Coutinho, Ana Paula; Rockenschaub, Gerald] WHO, Reg Off Europe, DK-2100 Copenhagen, Denmark; [Payne-Hallstrom, Lara] European Ctr Dis Prevent & Control, Surveillance & Response Support Unit, Stockholm, Sweden; [Banczak-Mysiak, Barbara; Posobkiewicz, Marek] Chief Sanit Inspectorate, Warsaw, Poland; [Lipska, Elzbieta] Natl Healthcare & Rescue Coordinat, Warsaw, Poland; [Lyashko, Viktor] State Sanit Inspectorate, Kiev, Ukraine; [Sadkowska-Todys, Malgorzata] Natl Inst Publ Hlth, Warsaw, Poland; [Miklasz, Miroslaw; Miskiewicz, Paulina] WHO, Minist Hlth, Country Off Poland, Warsaw, Poland; [Memish, Ziad A.] Minist Hlth, Riyadh, Saudi Arabia; [Heymann, David] Chatham House, London, England; [Heymann, David] London Sch Hyg & Trop Med, London WC1, England; [Heymann, David] Publ Hlth England, London, England; [Tomialoic, Rysard] European Programme Intervent Epidemiol Training, Stockholm, Sweden; [Endericks, Tina; McCloskey, Brian] Publ Hlth England, WHO Collaborating Ctr Mass Gatherings, London, England; [Zumla, Alimuddin] UCL, Div Infect & Immun, London, England; [Zumla, Alimuddin] Univ Coll London Hosp NHS Fdn Trust, London, England	World Health Organization; World Health Organization; World Health Organization; European Centre for Disease Prevention & Control; National Institute of Public Health (NIPH); World Health Organization; Ministry of Health - Saudi Arabia; University of London; London School of Hygiene & Tropical Medicine; Public Health England; Public Health England; University of London; University College London; University College London Hospitals NHS Foundation Trust; University of London; University College London	Smallwood, CAH (corresponding author), WHO, 20 Ave Appia, CH-1211 Geneva, Switzerland.	smallwoodc@who.int	ZUMLA, Alimuddin/ABA-8208-2020; Memish, Ziad Ahmed/AEJ-9424-2022	ZUMLA, Alimuddin/0000-0002-5111-5735; Memish, Ziad Ahmed/0000-0002-5099-0714; Borodina, Mariya/0000-0002-8487-0905; Nitzan, Dorit/0000-0002-4280-2939	European Commission Framework-7 RiD-RTI grant; NIHR Biomedical Research Centre, University College London Hospitals, London, UK; European Developing Countries Clinical Trials Partnership TB NEAT; European Developing Countries Clinical Trials Partnership PANACEA	European Commission Framework-7 RiD-RTI grant; NIHR Biomedical Research Centre, University College London Hospitals, London, UK; European Developing Countries Clinical Trials Partnership TB NEAT; European Developing Countries Clinical Trials Partnership PANACEA	We thank the following individuals for their input and support for this paper: Przemyslaw Bilinski, Ute Enderlein, Jan Erisman, Marek Haber, Cornelis de Joncheere, Nicolas Isla, Izabela Kucharska, Wojciech Kutyla, Jas Mantero, Mark Nunn, Anna Piekkala, Cezary Rzemek, Edward Wlodarczyk, and Maryanna Zaichykova. In addition, we thank the valuable support provided by Poland and Ukraine through their national authorities, and from UEFA. AZ receives support from the European Developing Countries Clinical Trials Partnership TB NEAT and PANACEA grants; European Commission Framework-7 RiD-RTI grant; and the NIHR Biomedical Research Centre, University College London Hospitals, London, UK.	Abubakar I, 2012, LANCET INFECT DIS, V12, P66, DOI 10.1016/S1473-3099(11)70246-8; Arbon P, 2001, Prehosp Disaster Med, V16, P150; Arbon P, 2007, PREHOSP DISASTER MED, V22, P131, DOI 10.1017/S1049023X00004507; Baleta A, 2010, LANCET INFECT DIS, V10, P373, DOI 10.1016/S1473-3099(10)70110-9; Blumberg LH, 2010, J TRAVEL MED, V17, P150, DOI 10.1111/j.1708-8305.2010.00413.x; Chief Sanitary Inspectorate Poland, 2012, COORD M OP INT EARL; Coletta M., 2006, Morbidity and Mortality Weekly Report, V55, P71; Dutch MJ, 2008, EMERG MED AUSTRALAS, V20, P228, DOI 10.1111/j.1742-6723.2008.01085.x; ECDC, 2012, RAP RISK ASS OUTBR M; Enock KE, 2008, PUBLIC HEALTH, V122, P1229, DOI 10.1016/j.puhe.2008.04.016; Enock KE, 2011, UKR REP 14 CHOL CAS; Helbing D, 2000, NATURE, V407, P487, DOI 10.1038/35035023; Helbing D, 2012, EPJ DATA SCI, V1, DOI 10.1140/epjds7; Il AHY, 2008, PUBLIC HEALTH, V122, P1020, DOI 10.1016/j.puhe.2007.11.005; Janiec J, 2012, EUROSURVEILLANCE, V17, P5; Johansson A, 2012, LANCET INFECT DIS, V12, P150, DOI 10.1016/S1473-3099(11)70287-0; Josephsen J, 2006, EUROSURVEILLANCE, V11; Kaiser R, 2006, EUROSURVEILLANCE, V11, P3100; Khan K, 2012, LANCET INFECT DIS, V12, P222, DOI 10.1016/S1473-3099(11)70313-9; Khan K, 2010, CAN MED ASSOC J, V182, P579, DOI 10.1503/cmaj.100093; Krause J, 2011, LANCET, V377, P903, DOI 10.1016/S0140-6736(11)60351-6; Lund A, 2012, PREHOSP DISASTER MED, V27, P601, DOI 10.1017/S1049023X12001367; Mahtani KR, 2013, BMJ OPEN, V3, DOI 10.1136/bmjopen-2012-002058; McCloskey B, 2014, LANCET; McCloskey B, 2013, LEARNING LONDON 2012; Morimura N, 2007, EUR J EMERG MED, V14, P115, DOI 10.1097/01.mej.0000224439.74493.b3; Murphy Niamh M, 2007, J Phys Act Health, V4, P193; Ranse J, 2012, PREHOSP DISASTER MED, V27, P543, DOI 10.1017/S1049023X12001288; Roshchin G, 2013, PREHOSP DISASTER MED, V28, pS1; Smith MWH, 2008, MED J AUSTRALIA, V189, P630, DOI 10.5694/j.1326-5377.2008.tb02221.x; Steffen R, 2012, LANCET INFECT DIS, V12, P142, DOI 10.1016/S1473-3099(11)70293-6; Tam JS, 2012, LANCET INFECT DIS, V12, P231, DOI 10.1016/S1473-3099(11)70353-X; Thackway S, 2009, BMC PUBLIC HEALTH, V9, DOI 10.1186/1471-2458-9-324; Tsouros AD, 2007, MASS GATHERINGS PUBL; Union of European Football Associations, 2012, EUR 2012 POL UKR TEC; Union of European Football Associations, 2012, EUR 2012 TOURN OP MA; Union of European Football Associations, 2011, CONC MED CAR UEFA EU; Weed M, 2012, PERSPECT PUBLIC HEAL, V132, P75, DOI 10.1177/1757913911435758; WHO, 2012, GLOBAL TUBERCULOSIS REPORT 2012, P1; WHO, 2012, HLTH ADV TRAV 2012 U; WHO, INT PLANN CONS MASS; WHO, HOSP SAF IND; WHO, 2011, REP WHO SUPP 2010 FI; WHO Western Pacific Region, HLTH LEG 2008 BEIJ O; World Health Organisation (WHO), 2008, COMM DIS AL RESP MAS; World Health Organization. Regional Office for Europe, 2012, ASS HLTH SYST CRIS P; World Health Organization (WHO), 2010, ASS HLTH SYST CRIS P; Zielinski Andrzej, 2010, Przegl Epidemiol, V64, P9; Zielinski Andrzej, 2009, Przegl Epidemiol, V63, P477; Zielinski Andrzej, 2009, Przegl Epidemiol, V63, P343	50	25	26	0	16	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JUN 14	2014	383	9934					2090	2097		10.1016/S0140-6736(13)62384-3	http://dx.doi.org/10.1016/S0140-6736(13)62384-3			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AI9VZ	24857705				2022-12-28	WOS:000337292400029
J	Huang, Q; Yu, DL; Xu, B; Hu, WT; Ma, YM; Wang, YB; Zhao, ZS; Wen, B; He, JL; Liu, ZY; Tian, YJ				Huang, Quan; Yu, Dongli; Xu, Bo; Hu, Wentao; Ma, Yanming; Wang, Yanbin; Zhao, Zhisheng; Wen, Bin; He, Julong; Liu, Zhongyuan; Tian, Yongjun			Nanotwinned diamond with unprecedented hardness and stability	NATURE			English	Article							CUBIC BORON-NITRIDE; POLYCRYSTALLINE DIAMONDS; MAXIMUM STRENGTH; CARBON ONIONS; HIGH-PRESSURE; OXIDATION; MICROSTRUCTURES; TEMPERATURE; GRAPHITE; CRYSTALS	Although diamond is the hardest material for cutting tools, poor thermal stability has limited its applications, especially at high temperatures. Simultaneous improvement of the hardness and thermal stability of diamond has long been desirable. According to the Hall-Petch effect(1,2), the hardness of diamond can be enhanced by nanostructuring (by means of nanograined and nanotwinned microstructures), as shown in previous studies(3-7). However, for well-sintered nanograined diamonds, the grain sizes are technically limited to 10-30 nm (ref. 3), with degraded thermal stability(4) compared with that of natural diamond. Recent success in synthesizing nanotwinned cubic boron nitride (nt-cBN) with a twin thickness down to similar to 3.8 nm makes it feasible to simultaneously achieve smaller nanosize, ultrahardness and superior thermal stability(5). At present, nanotwinned diamond (nt-diamond) has not been fabricated successfully through direct conversions of various carbon precursors(3,6,7) (such as graphite, amorphous carbon, glassy carbon and C-60). Here we report the direct synthesis of nt-diamond with an average twin thickness of similar to 5 nm, using a precursor of onion carbon nanoparticles at high pressure and high temperature, and the observation of a new monoclinic crystalline form of diamond coexisting with nt-diamond. The pure synthetic bulk nt-diamond material shows unprecedented hardness and thermal stability, with Vickers hardness up to similar to 200 GPa and an in-air oxidization temperature more than 200 degrees C higher than that of natural diamond. The creation of nanotwinned microstructures offers a general pathway for manufacturing new advanced carbon-based materials with exceptional thermal stability and mechanical properties.	[Huang, Quan; Yu, Dongli; Xu, Bo; Hu, Wentao; Zhao, Zhisheng; Wen, Bin; He, Julong; Liu, Zhongyuan; Tian, Yongjun] Yanshan Univ, State Key Lab Metastable Mat Sci & Technol, Qinhuangdao 066004, Peoples R China; [Ma, Yanming] Jilin Univ, State Key Lab Superhard Mat, Changchun 130012, Peoples R China; [Wang, Yanbin] Univ Chicago, Ctr Adv Radiat Sources, Chicago, IL 60439 USA	Yanshan University; Jilin University; University of Chicago	Tian, YJ (corresponding author), Yanshan Univ, State Key Lab Metastable Mat Sci & Technol, Qinhuangdao 066004, Peoples R China.	fhcl@ysu.edu.cn	Zhao, Zhisheng/AAA-7969-2021; Tian, Yongjun/A-1693-2010; Ma, Yanming/ABE-8450-2020; Xu, Bo/C-6925-2008; Zhao, Zhisheng/G-8199-2015; Ma, Yanming/A-7297-2008; Wen, Bin/G-8404-2012	Zhao, Zhisheng/0000-0001-8492-0151; Tian, Yongjun/0000-0002-4594-4879; Xu, Bo/0000-0002-9804-1614; Zhao, Zhisheng/0000-0001-8492-0151; Ma, Yanming/0000-0003-3711-0011; Wen, Bin/0000-0001-9846-5452; Yu, Dongli/0000-0002-0914-6837; Liu, Zhongyuan/0000-0002-5600-8998; Wang, Yanbin/0000-0001-5716-3183	National Natural Science Foundation of China [51121061, 51332005, 51172197, 11025418, 91022029]; Ministry of Science and Technology of China [2011CB808205, 2010CB731605]; US National Science Foundation [EAR-0968456]; Directorate For Geosciences [1361276, 0968863, 0968456] Funding Source: National Science Foundation; Division Of Earth Sciences [0968823] Funding Source: National Science Foundation	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Ministry of Science and Technology of China(Ministry of Science and Technology, China); US National Science Foundation(National Science Foundation (NSF)); Directorate For Geosciences(National Science Foundation (NSF)NSF - Directorate for Geosciences (GEO)); Division Of Earth Sciences(National Science Foundation (NSF)NSF - Directorate for Geosciences (GEO))	This work was supported by the National Natural Science Foundation of China (51121061), the Ministry of Science and Technology of China (2011CB808205 and 2010CB731605), the National Natural Science Foundation of China (51332005, 51172197, 11025418 and 91022029) and the US National Science Foundation (EAR-0968456).	Banhart F, 1996, NATURE, V382, P433, DOI 10.1038/382433a0; Chaudhri MM, 2005, NAT MATER, V4, P4, DOI 10.1038/nmat1288; Choucair M, 2012, CARBON, V50, P1109, DOI 10.1016/j.carbon.2011.10.023; Dubrovinskaia N, 2006, NANO LETT, V6, P824, DOI 10.1021/nl0602084; Gao FM, 2003, PHYS REV LETT, V91, DOI 10.1103/PhysRevLett.91.015502; HALL EO, 1951, P PHYS SOC LOND B, V64, P747, DOI 10.1088/0370-1301/64/9/303; Irifune T, 2003, NATURE, V421, P599, DOI 10.1038/421599b; JOHNSON CE, 1995, J MATER RES, V10, P2555, DOI 10.1557/JMR.1995.2555; JOSHI A, 1990, J VAC SCI TECHNOL A, V8, P2137, DOI 10.1116/1.577028; LAMMER A, 1988, MATER SCI TECH SER, V4, P949, DOI 10.1179/026708388790329909; Li XY, 2010, NATURE, V464, P877, DOI 10.1038/nature08929; Lu K, 2009, SCIENCE, V324, P349, DOI 10.1126/science.1159610; Lu L, 2004, SCIENCE, V304, P422, DOI 10.1126/science.1092905; Lu L, 2009, SCIENCE, V323, P607, DOI 10.1126/science.1167641; PETCH NJ, 1953, J IRON STEEL I, V174, P25; Silva F, 2005, DIAM RELAT MATER, V14, P398, DOI 10.1016/j.diamond.2004.11.019; Solozhenko VL, 2012, ADV MATER, V24, P1540, DOI 10.1002/adma.201104361; Sumiya H, 2007, J MATER RES, V22, P2345, DOI 10.1557/JMR.2007.0295; Sumiya H, 2012, DIAM RELAT MATER, V24, P44, DOI 10.1016/j.diamond.2011.10.013; SUN Q, 1992, J ELECTROCHEM SOC, V139, P933, DOI 10.1149/1.2069328; Sussmann RS, 1998, NUOVO CIMENTO D, V20, P503, DOI 10.1007/BF03185545; Tamir A, 1994, IMPINGING STREAM REA; Tian YJ, 2013, NATURE, V502, pE2, DOI 10.1038/nature12621; Tian YJ, 2013, NATURE, V493, P385, DOI 10.1038/nature11728; Tian YJ, 2012, INT J REFRACT MET H, V33, P93, DOI 10.1016/j.ijrmhm.2012.02.021; Upadhyaya GS, 2001, MATER DESIGN, V22, P483, DOI 10.1016/S0261-3069(01)00007-3; Weissmuller J, 1997, ACTA MATER, V45, P1899, DOI 10.1016/S1359-6454(96)00314-X; Yan CS, 2004, PHYS STATUS SOLIDI A, V201, pR25, DOI 10.1002/pssa.200409033; Yang CC, 2008, J PHYS CHEM C, V112, P1423, DOI 10.1021/jp076049+; Yip S, 1998, NATURE, V391, P532, DOI 10.1038/35254	30	462	490	74	1018	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 12	2014	510	7504					250	+		10.1038/nature13381	http://dx.doi.org/10.1038/nature13381			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI7AT	24919919				2022-12-28	WOS:000337032400046
J	Wark, D				Wark, David			PARTICLE PHYSICS The hunt for Majorana neutrinos hots up	NATURE			English	Editorial Material									[Wark, David] Univ Oxford, Dept Phys, Didcot OX11 0QX, Oxon, England; [Wark, David] STFC Rutherford Appleton Lab, Particle Phys Dept, Didcot OX11 0QX, Oxon, England	University of Oxford; UK Research & Innovation (UKRI); Science & Technology Facilities Council (STFC); STFC Rutherford Appleton Laboratory	Wark, D (corresponding author), Univ Oxford, Dept Phys, Didcot OX11 0QX, Oxon, England.	david.wark@stfc.ac.uk						Agostini M, 2013, PHYS REV LETT, V111, DOI 10.1103/PhysRevLett.111.122503; Albert JB, 2014, NATURE, V510, P229, DOI 10.1038/nature13432; Auger M, 2012, PHYS REV LETT, V109, DOI 10.1103/PhysRevLett.109.032505; Fogli GL, 2013, NUCL PHYS B-PROC SUP, V235, P125, DOI 10.1016/j.nuclphysbps.2013.04.002; Gando A, 2013, PHYS REV LETT, V110, DOI 10.1103/PhysRevLett.110.062502	6	1	1	0	5	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 12	2014	510	7504					224	225		10.1038/nature13501	http://dx.doi.org/10.1038/nature13501			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI7AT	24896177				2022-12-28	WOS:000337032400039
J	Gornall, J				Gornall, Jonathan			ALCOHOL World Cup 2014: festival of football or alcohol?	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												jgornall@mac.com						All Party Parliamentary Beer Group, REG ALL PART GROUPS; [Anonymous], 2010, DUTCH NEWS      0717; [Anonymous], 2009, REUTERS; Brown L, 2013, MORNING ADVERTI 1220; Charles G., 2011, MARKETING; Clarke Miles, 2010, COMMUNICATION; Conn D., 2013, GUARDIAN; Costa B., 2014, WALL STREET J; Crumley B., 1997, ADVERTISING AGE; Fifa, 2004, SAF GUID; Foottit L., 2009, MORNING ADVERTI 1208; Gornall J, 2014, BMJ-BRIT MED J, V348, DOI 10.1136/bmj.f7646; Hogan T., 2013, IRISH INDEPENDE 0327; Home Office, 2014, WORLD CUP LIC HOURS; Joint Committee on Transport and Communications, 2013, REP SPONS SPORTS ALC; Joseph S., 2014, MARKETING WEEK; Kelso Paul, 2009, TELEGRAPH; Quigg Z, 2012, EUR J PUBLIC HLTH; Rigaud A, 2004, GLOBE, V1, P1; Simoes C, 2014, BLOOMBERG; South African Sport and Recreation Department, 2013, 2010 FIF WORLD CUP C	21	4	4	0	3	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JUN 11	2014	348								g3772	10.1136/bmj.g3772	http://dx.doi.org/10.1136/bmj.g3772			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AJ1GY	24916959				2022-12-28	WOS:000337405200009
J	Sen, A; Wang, J; Laue-Gizzi, H; Lee, T; Ghougassian, D; Somerville, ER				Sen, Arjune; Wang, Justine; Laue-Gizzi, Hanka; Lee, Teresa; Ghougassian, Daniel; Somerville, Ernest R.			Pathognomonic seizures in limbic encephalitis associated with anti-LGI1 antibodies	LANCET			English	Editorial Material							FACIOBRACHIAL DYSTONIC SEIZURES; IMMUNOTHERAPY		[Sen, Arjune; Laue-Gizzi, Hanka; Somerville, Ernest R.] Prince Wales Hosp, Comprehens Epilepsy Serv, Sydney, NSW 2031, Australia; [Wang, Justine; Ghougassian, Daniel] Prince Wales Hosp, Dept Neurol, Sydney, NSW 2031, Australia; [Lee, Teresa] Prince Wales Hosp, Neuropsychiat Inst, Sydney, NSW 2031, Australia; [Sen, Arjune] John Radcliffe Hosp, Natl Inst Hlth Res, Biomed Res Ctr, Oxford Epilepsy Res Grp, Oxford OX3 9DU, England; [Sen, Arjune; Lee, Teresa; Ghougassian, Daniel; Somerville, Ernest R.] Univ New S Wales, Prince Wales Clin Sch, Sydney, NSW, Australia	University of Oxford; University of New South Wales Sydney	Somerville, ER (corresponding author), Prince Wales Hosp, Comprehens Epilepsy Serv, Sydney, NSW 2031, Australia.	e.somerville@unsw.edu.au	Somerville, Ernest/R-8147-2019	Somerville, Ernest/0000-0001-8789-1122				Irani SR, 2008, NEUROLOGY, V71, P1647, DOI 10.1212/01.wnl.0000326572.93762.51; Irani SR, 2013, BRAIN, V136, P3151, DOI 10.1093/brain/awt212; Irani SR, 2011, DISCOV MED, V11, P449; Irani SR, 2011, ANN NEUROL, V69, P892, DOI 10.1002/ana.22307; Vincent A, 2011, LANCET NEUROL, V10, P759, DOI 10.1016/S1474-4422(11)70096-5	5	19	20	0	4	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	JUN 7	2014	383	9933					2018	2018		10.1016/S0140-6736(14)60684-X	http://dx.doi.org/10.1016/S0140-6736(14)60684-X			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AI4PV	24910233				2022-12-28	WOS:000336848200030
J	Euston, DR; Steenland, HW				Euston, David R.; Steenland, Hendrik W.			NEUROSCIENCE Memories-getting wired during sleep	SCIENCE			English	Editorial Material							CONSOLIDATION; REACTIVATION; PLASTICITY; NEOCORTEX; CORTEX		[Euston, David R.; Steenland, Hendrik W.] Univ Lethbridge, Canadian Ctr Behav Neurosci, Lethbridge, AB T1K 3M4, Canada	University of Lethbridge	Euston, DR (corresponding author), Univ Lethbridge, Canadian Ctr Behav Neurosci, Lethbridge, AB T1K 3M4, Canada.	david.euston@gmail.com						Aton SJ, 2009, NEURON, V61, P454, DOI 10.1016/j.neuron.2009.01.007; Diekelmann S, 2010, NAT REV NEUROSCI, V11, P114, DOI 10.1038/nrn2762; Euston DR, 2007, SCIENCE, V318, P1147, DOI 10.1126/science.1148979; Hebb D.O., 1949, ORG BEHAV NEUROPSYCH; Hoffman KL, 2002, SCIENCE, V297, P2070, DOI 10.1126/science.1073538; Maret S, 2011, NAT NEUROSCI, V14, P1418, DOI 10.1038/nn.2934; Mayford M, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a005751; MCCLELLAND JL, 1995, PSYCHOL REV, V102, P419, DOI 10.1037/0033-295X.102.3.419; Stickgold R, 2005, NATURE, V437, P1272, DOI 10.1038/nature04286; Tononi G, 2014, NEURON, V81, P12, DOI 10.1016/j.neuron.2013.12.025; WILSON MA, 1994, SCIENCE, V265, P676, DOI 10.1126/science.8036517; Yang G, 2014, SCIENCE, V344, P1173, DOI 10.1126/science.1249098; Yang G, 2009, NATURE, V462, P920, DOI 10.1038/nature08577	13	6	8	0	38	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 6	2014	344	6188					1087	1088		10.1126/science.1255649	http://dx.doi.org/10.1126/science.1255649			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AI3UU	24904140				2022-12-28	WOS:000336791200021
J	Jones, SV; Ambros-Rudolph, C; Nelson-Piercy, C				Jones, Samantha Vaughan; Ambros-Rudolph, Christina; Nelson-Piercy, Catherine			Skin disease in pregnancy	BMJ-BRITISH MEDICAL JOURNAL			English	Review							PEMPHIGUS-VULGARIS; MANAGEMENT; MELANOMA; CORTICOSTEROIDS; DERMATOSES; PSORIASIS; OUTCOMES; NEVI		[Jones, Samantha Vaughan] Ashford & St Peters Fdn Trust, Dept Dermatol, Chertsey KT16 0PZ, Surrey, England; [Ambros-Rudolph, Christina] Med Univ Graz, Dept Dermatol, Graz, Austria; [Nelson-Piercy, Catherine] Guys & St Thomas Fdn Trust, Womens Serv, London, England	Medical University of Graz; Guy's & St Thomas' NHS Foundation Trust	Jones, SV (corresponding author), Ashford & St Peters Fdn Trust, Dept Dermatol, Chertsey KT16 0PZ, Surrey, England.	Vaughan-Jones@asph.nhs.uk						Acosta KA, 2013, AM J CLIN DERMATOL, V14, P215, DOI 10.1007/s40257-013-0024-x; Ahmadi Sharareh, 2005, Australas J Dermatol, V46, P53, DOI 10.1111/j.1440-0960.2005.00160.x; Akturk AS, 2007, J EUR ACAD DERMATOL, V21, P1086, DOI 10.1111/j.1468-3083.2007.02204.x; Al Arfaj AS, 2010, LUPUS, V19, P1665, DOI 10.1177/0961203310378669; Ambros-Rudolph C. M., 2008, OBSTET GYNECOLOGIC D, P49; Ambros-Rudolph CM, 2006, J AM ACAD DERMATOL, V54, P395, DOI 10.1016/j.jaad.2005.12.012; Anderka MT, 2009, AM J MED GENET A, V149A, P1241, DOI 10.1002/ajmg.a.32685; BONATI M, 1992, INT J GYNECOL OBSTET, V39, P185; Bozdag K, 2012, CUTAN OCUL TOXICOL, V31, P67, DOI 10.3109/15569527.2011.602035; Briggs GG., 2017, DRUGS PREGNANCY LACT; British Medical Association Royal Pharmaceutical Society of Great Britain, 2014, ANT PREGN; Butler DC, 2014, J AM ACAD DERMATOL, V70, P426, DOI 10.1016/j.jaad.2013.09.009; Buyon JP, 1998, J AM COLL CARDIOL, V31, P1658, DOI 10.1016/S0735-1097(98)00161-2; Chi CC, 2011, BRIT J DERMATOL, V165, P943, DOI 10.1111/j.1365-2133.2011.10513.x; Chi CC, 2009, BRIT J DERMATOL, V160, P1222, DOI 10.1111/j.1365-2133.2009.09086.x; Chi CC, 2013, JAMA DERMATOL, V149, P1274, DOI 10.1001/jamadermatol.2013.5768; Daneshpazhooh M, 2011, INDIAN J DERMATOL VE, V77, P141, DOI 10.4103/0378-6323.82404; Drago F, 2008, J AM ACAD DERMATOL, V58, pS78, DOI 10.1016/j.jaad.2007.05.030; Driscoll MS, 2006, DERMATOL CLIN, V24, P199, DOI 10.1016/j.det.2006.01.003; Garcia-Gonzalez E, 1999, INT J DERMATOL, V38, P721, DOI 10.1046/j.1365-4362.1999.00810.x; Geenes V, 2009, WORLD J GASTROENTERO, V15, P2049, DOI 10.3748/wjg.15.2049; Harger JH, 2002, OBSTET GYNECOL, V100, P260, DOI 10.1016/S0029-7844(02)02059-8; Hern S, 1998, CLIN EXP DERMATOL, V23, P260; Jenkins R, 2008, OBSTET GYNECOLOGIC D, V3rd, P37; Jones SAV, 1999, BRIT J DERMATOL, V141, P71; Kalayciyan A, 2002, BRIT J DERMATOL, V147, P396, DOI 10.1046/j.1365-2133.2002.48299.x; Kallen BAJ, 2005, REPROD TOXICOL, V20, P209, DOI 10.1016/j.reprotox.2005.01.010; Kallen BAJ, 2003, REPROD TOXICOL, V17, P255, DOI 10.1016/S0890-6238(03)00012-1; Kardos M, 2009, OBSTET GYNECOL SURV, V64, P739, DOI 10.1097/OGX.0b013e3181bea089; Khamashta MA, 2006, BEST PRACT RES CL RH, V20, P685, DOI 10.1016/j.berh.2006.04.003; Khosrotehrani K, 2011, AM J PATHOL, V178, P1870, DOI 10.1016/j.ajpath.2010.12.044; LIPSON AH, 1993, LANCET, V341, P1352, DOI 10.1016/0140-6736(93)90868-H; Miller E, 2010, J PLAST RECONSTR AES, V63, P1163, DOI 10.1016/j.bjps.2009.05.050; Mor G, 2010, AM J REPROD IMMUNOL, V63, P425, DOI 10.1111/j.1600-0897.2010.00836.x; Murase JE, 2014, J AM ACAD DERMATOL, V70, DOI 10.1016/j.jaad.2013.09.010; Mytton OT, 2007, BJOG-INT J OBSTET GY, V114, P582, DOI 10.1111/j.1471-0528.2007.01290.x; NACHBAR F, 1994, J AM ACAD DERMATOL, V30, P551, DOI 10.1016/S0190-9622(94)70061-3; Okubo S, 2003, ARCH DERMATOL, V139, P1217, DOI 10.1001/archderm.139.9.1217; Pages C, 2010, BRIT J DERMATOL, V162, P274, DOI 10.1111/j.1365-2133.2009.09240.x; Pennoyer JW, 1997, J AM ACAD DERMATOL, V36, P378, DOI 10.1016/S0190-9622(97)80212-5; Rudolph CM, 2006, BRIT J DERMATOL, V154, P54, DOI 10.1111/j.1365-2133.2005.06856.x; Schaefer C, 2007, DRUGS DURING PREGNANCY AND LACTATION: TREATMENT OPTIONS AND RISK ASSESSMENT, 2ND EDITION, P1; Silipo V, 2006, MELANOMA RES, V16, P497, DOI 10.1097/01.cmr.0000232295.91536.09; Vaughan Jones SA, 2008, OBSTET GYNAECOLOGIC, P23; Weatherhead S, 2007, BRIT MED J, V334, P1218, DOI 10.1136/bmj.39202.518484.80; Yang YW, 2011, J AM ACAD DERMATOL, V64, P71, DOI 10.1016/j.jaad.2010.02.005; Zeichner JA, 2011, ARCH DERMATOL, V147, P537, DOI 10.1001/archdermatol.2011.96; Zillikens D., 2003, JEADV SS3, V17, P7; Zip C, 2006, Skin Therapy Lett, V11, P1	49	9	9	0	6	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JUN 3	2014	348								g3489	10.1136/bmj.g3489	http://dx.doi.org/10.1136/bmj.g3489			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AI7CB	24895225				2022-12-28	WOS:000337037600003
J	May, M				May, Mike			ATTACKING AN EPIDEMIC	NATURE			English	Editorial Material																			0	26	28	0	10	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 29	2014	509	7502					S50	S51		10.1038/509S50a	http://dx.doi.org/10.1038/509S50a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AH9JC	24870819	Bronze			2022-12-28	WOS:000336457100002
J	Schmalen, I; Reischl, S; Wallach, T; Klemz, R; Grudziecki, A; Prabu, JR; Benda, C; Kramer, A; Wolf, E				Schmalen, Ira; Reischl, Silke; Wallach, Thomas; Klemz, Roman; Grudziecki, Astrid; Prabu, J. Rajan; Benda, Christian; Kramer, Achim; Wolf, Eva			Interaction of Circadian Clock Proteins CRY1 and PER2 Is Modulated by Zinc Binding and Disulfide Bond Formation	CELL			English	Article							CRYPTOCHROME1 TRANSGENIC MICE; CRYSTAL-STRUCTURE; MAMMALIAN CRY1; C-TERMINUS; RHYTHMS; IDENTIFICATION; DEGRADATION; NUCLEUS; CELLS	Period (PER) proteins are essential components of the mammalian circadian clock. They form complexes with cryptochromes (CRY), which negatively regulate CLOCK/BMAL1-dependent transactivation of clock and clock-controlled genes. To define the roles of mammalian CRY/PER complexes in the circadian clock, we have determined the crystal structure of a complex comprising the photolyase homology region of mouse CRY1 (mCRY1) and a C-terminal mouse PER2 (mPER2) fragment. mPER2 winds around the helical mCRY1 domain covering the binding sites of FBXL3 and CLOCK/BMAL1, but not the FAD binding pocket. Our structure revealed an unexpected zinc ion in one interface, which stabilizes mCRY1-mPER2 interactions in vivo. We provide evidence that mCRY1/mPER2 complex formation is modulated by an interplay of zinc binding and mCRY1 disulfide bond formation, which may be influenced by the redox state of the cell. Our studies may allow for the development of circadian and metabolic modulators.	[Schmalen, Ira; Prabu, J. Rajan; Benda, Christian; Wolf, Eva] Max Planck Inst Biochem, Dept Struct Cell Biol, D-82152 Martinsried, Germany; [Wolf, Eva] Univ Munich, Butenandt Inst, Dept Physiol Chem, D-81377 Munich, Germany; [Reischl, Silke; Wallach, Thomas; Klemz, Roman; Grudziecki, Astrid; Kramer, Achim] Charite, Lab Chronobiol, D-10115 Berlin, Germany	Max Planck Society; University of Munich; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin	Kramer, A (corresponding author), Charite, Lab Chronobiol, Hessische Str 3-4, D-10115 Berlin, Germany.	achim.kramer@charite.de; evawolf1@uni-mainz.de		Kramer, Achim/0000-0001-9671-6078; Benda, Christian/0000-0001-5551-1332	DFG grants [Wo695-3 (FOR526), Wo695-4, Wo695-6, SFB740/D2]; Studienstiftung des deutschen Volkes	DFG grants(German Research Foundation (DFG)); Studienstiftung des deutschen Volkes	We thank the beamline staff at Swiss Light Source (SLS, Villingen) for excellent assistance and the Max Planck Institute (MPI) of Biochemistry Crystallization Facility and Biochemistry Core Facility, especially Elisabeth Wehyer-Stingl, for technical assistance and support. Further, we thank Helmut Hartl and Jaroslava Obel (Department of Chemistry and Pharmacy, LMU Munich) for ICP-OES analysis. We thank our colleagues of the Department of Structural Cell Biology at the MPI of Biochemistry for help with data collection, fruitful discussions, and critical comments. We are indebted to Claire Basquin for assistance with ITC, thermofluor, and other biophysical methods and to Michaela Rode for assistance with insect cell culture. Anna Czarna, Sebastian Falk, Kai Hell, Debora Makino, Michael Taschner, and Justine Witosch are thanked for valuable suggestions and discussions. This study was supported by DFG grants Wo695-3 (FOR526), Wo695-4, and Wo695-6 to E.W., DFG grant SFB740/D2 to A.K., and a fellowship of the Studienstiftung des deutschen Volkes to I.S.	Auld DS, 2001, BIOMETALS, V14, P271, DOI 10.1023/A:1012976615056; Barclay JL, 2013, AM J PHYSIOL-ENDOC M, V304, pE1053, DOI 10.1152/ajpendo.00512.2012; Chaves I, 2006, MOL CELL BIOL, V26, P1743, DOI 10.1128/MCB.26.5.1743-1753.2006; Czarna A, 2013, CELL, V153, P1394, DOI 10.1016/j.cell.2013.05.011; Czarna A, 2011, J BIOL CHEM, V286, P22414, DOI 10.1074/jbc.M111.244749; Eckel-Mahan K, 2009, NAT STRUCT MOL BIOL, V16, P462, DOI 10.1038/nsmb.1595; Edgar RS, 2012, NATURE, V485, P459, DOI 10.1038/nature11088; Eide EJ, 2002, J BIOL CHEM, V277, P17248, DOI 10.1074/jbc.M111466200; Evans JC, 2002, STRUCTURE, V10, P1159, DOI 10.1016/S0969-2126(02)00796-7; Gatfield D, 2007, SCIENCE, V316, P1135, DOI 10.1126/science.1144165; Griffin EA, 1999, SCIENCE, V286, P768, DOI 10.1126/science.286.5440.768; Hirano A, 2013, CELL, V152, P1106, DOI 10.1016/j.cell.2013.01.054; Hirota T, 2012, SCIENCE, V337, P1094, DOI 10.1126/science.1223710; Huang NA, 2012, SCIENCE, V337, P189, DOI 10.1126/science.1222804; Ilbert M, 2006, ANTIOXID REDOX SIGN, V8, P835, DOI 10.1089/ars.2006.8.835; King DP, 1997, GENETICS, V146, P1049; Koike N, 2012, SCIENCE, V338, P349, DOI 10.1126/science.1226339; Kucera N, 2012, P NATL ACAD SCI USA, V109, P3311, DOI 10.1073/pnas.1113280109; Kume K, 1999, CELL, V98, P193, DOI 10.1016/S0092-8674(00)81014-4; Lamia KA, 2011, NATURE, V480, P552, DOI 10.1038/nature10700; Lamia KA, 2009, SCIENCE, V326, P437, DOI 10.1126/science.1172156; Marcheva B, 2010, NATURE, V466, P627, DOI 10.1038/nature09253; Maret W, 2012, J INORG BIOCHEM, V111, P110, DOI 10.1016/j.jinorgbio.2011.11.018; Miyazaki K, 2001, MOL CELL BIOL, V21, P6651, DOI 10.1128/MCB.21.19.6651-6659.2001; Muller M, 2009, CURR OPIN STRUC BIOL, V19, P277, DOI 10.1016/j.sbi.2009.05.003; O'Neill JS, 2011, NATURE, V469, P498, DOI 10.1038/nature09702; O'Neill JS, 2011, NATURE, V469, P554, DOI 10.1038/nature09654; Okano S, 2013, J DIABETES INVEST, V4, P428, DOI 10.1111/jdi.12080; Okano S, 2010, EUR J CLIN INVEST, V40, P1011, DOI 10.1111/j.1365-2362.2010.02359.x; Okano S, 2009, NEUROSCI LETT, V451, P246, DOI 10.1016/j.neulet.2009.01.014; Oteiza PI, 2012, FREE RADICAL BIO MED, V53, P1748, DOI 10.1016/j.freeradbiomed.2012.08.568; Ozber N, 2010, BMC MOL BIOL, V11, DOI 10.1186/1471-2199-11-69; Templeton DJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015012; Tomita T, 2010, BBA-MOL CELL RES, V1803, P492, DOI 10.1016/j.bbamcr.2010.01.012; van der Horst GTJ, 1999, NATURE, V398, P627, DOI 10.1038/19323; Wang TA, 2012, SCIENCE, V337, P839, DOI 10.1126/science.1222826; Weir JR, 2010, P NATL ACAD SCI USA, V107, P12139, DOI 10.1073/pnas.1004953107; Wu HH, 2000, BIOCHEM J, V351, P87, DOI 10.1042/0264-6021:3510087; Xing WM, 2013, NATURE, V496, P64, DOI 10.1038/nature11964; Yagita K, 2002, EMBO J, V21, P1301, DOI 10.1093/emboj/21.6.1301; Ye R, 2011, J BIOL CHEM, V286, P25891, DOI 10.1074/jbc.M111.254680; Yoo SH, 2013, CELL, V152, P1091, DOI 10.1016/j.cell.2013.01.055; Young MW, 2001, NAT REV GENET, V2, P702, DOI 10.1038/35088576; Zhang EE, 2010, NAT MED, V16, P1152, DOI 10.1038/nm.2214	44	122	124	1	50	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAY 22	2014	157	5					1203	1215		10.1016/j.cell.2014.03.057	http://dx.doi.org/10.1016/j.cell.2014.03.057			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	AH9CG	24855952	Bronze			2022-12-28	WOS:000336437200020
J	Beer, TM; Armstrong, AJ; Rathkopf, DE; Loriot, Y; Sternberg, CN; Higano, CS; Iversen, P; Bhattacharya, S; Carles, J; Chowdhury, S; Davis, ID; de Bono, JS; Evans, CP; Fizazi, K; Joshua, AM; Kim, CS; Kimura, G; Mainwaring, P; Mansbach, H; Miller, K; Noonberg, SB; Perabo, F; Phung, D; Saad, F; Scher, HI; Taplin, ME; Venner, PM; Tombal, B				Beer, T. M.; Armstrong, A. J.; Rathkopf, D. E.; Loriot, Y.; Sternberg, C. N.; Higano, C. S.; Iversen, P.; Bhattacharya, S.; Carles, J.; Chowdhury, S.; Davis, I. D.; de Bono, J. S.; Evans, C. P.; Fizazi, K.; Joshua, A. M.; Kim, C-S; Kimura, G.; Mainwaring, P.; Mansbach, H.; Miller, K.; Noonberg, S. B.; Perabo, F.; Phung, D.; Saad, F.; Scher, H. I.; Taplin, M-E; Venner, P. M.; Tombal, B.		PREVAIL Investigators	Enzalutamide in Metastatic Prostate Cancer before Chemotherapy	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							INCREASED SURVIVAL; CASTRATION; MITOXANTRONE; ANTIANDROGEN; ABIRATERONE; PREDNISONE	BACKGROUND Enzalutamide is an oral androgen-receptor inhibitor that prolongs survival in men with metastatic castration-resistant prostate cancer in whom the disease has progressed after chemotherapy. New treatment options are needed for patients with metastatic prostate cancer who have not received chemotherapy, in whom the disease has progressed despite androgen-deprivation therapy. METHODS In this double-blind, phase 3 study, we randomly assigned 1717 patients to receive either enzalutamide (at a dose of 160 mg) or placebo once daily. The coprimary end points were radiographic progression-free survival and overall survival. RESULTS The study was stopped after a planned interim analysis, conducted when 540 deaths had been reported, showed a benefit of the active treatment. The rate of radiographic progression-free survival at 12 months was 65% among patients treated with enzalutamide, as compared with 14% among patients receiving placebo (81% risk reduction; hazard ratio in the enzalutamide group, 0.19; 95% confidence interval [CI], 0.15 to 0.23; P<0.001). A total of 626 patients (72%) in the enzalutamide group, as compared with 532 patients (63%) in the placebo group, were alive at the data-cutoff date (29% reduction in the risk of death; hazard ratio, 0.71; 95% CI, 0.60 to 0.84; P<0.001). The benefit of enzalutamide was shown with respect to all secondary end points, including the time until the initiation of cytotoxic chemotherapy (hazard ratio, 0.35), the time until the first skeletal-related event (hazard ratio, 0.72), a complete or partial soft-tissue response (59% vs. 5%), the time until prostate-specific antigen (PSA) progression (hazard ratio, 0.17), and a rate of decline of at least 50% in PSA (78% vs. 3%) (P<0.001 for all comparisons). Fatigue and hypertension were the most common clinically relevant adverse events associated with enzalutamide treatment. CONCLUSIONS Enzalutamide significantly decreased the risk of radiographic progression and death and delayed the initiation of chemotherapy in men with metastatic prostate cancer. (Funded by Medivation and Astellas Pharma; PREVAIL ClinicalTrials.gov number, NCT01212991.)	[Beer, T. M.] Oregon Hlth & Sci Univ, OHSU Knight Canc Inst, Portland, OR 97239 USA; [Armstrong, A. J.] Duke Univ, Duke Canc Inst, Div Med Oncol, Durham, NC USA; [Armstrong, A. J.] Duke Univ, Duke Canc Inst, Div Urol, Durham, NC USA; [Rathkopf, D. E.; Scher, H. I.] Mem Sloan Kettering Canc Ctr, New York, NY 10021 USA; [Rathkopf, D. E.; Scher, H. I.] Weill Cornell Med Coll, New York, NY USA; [Loriot, Y.; Fizazi, K.] Univ Paris 11, Inst Gustave Roussy, Villejuif, France; [Sternberg, C. N.] San Camillo Hosp, Rome, Italy; [Sternberg, C. N.] Forlanini Hosp, Rome, Italy; [Higano, C. S.] Univ Washington, Seattle Canc Care Alliance, Seattle, WA 98195 USA; [Iversen, P.] Univ Copenhagen, Rigshosp, DK-2100 Copenhagen, Denmark; [Bhattacharya, S.; Mansbach, H.; Noonberg, S. B.] Medivation, San Francisco, CA USA; [Carles, J.] Vall dHebron Univ Hosp, Dept Med Oncol, Barcelona, Spain; [Carles, J.] Vall dHebron Inst Oncol, Barcelona, Spain; [Chowdhury, S.] Guys Hosp, London, England; [de Bono, J. S.] Royal Marsden Hosp, London, England; [de Bono, J. S.] Inst Canc Res, London, England; [Davis, I. D.] Monash Univ, Clayton, Vic, Australia; [Davis, I. D.] Eastern Hlth, Clayton, Vic, Australia; [Mainwaring, P.] Icon Canc Care, South Brisbane, Qld, Australia; [Evans, C. P.] Univ Calif Davis, Ctr Comprehens Canc, Sacramento, CA 95817 USA; [Joshua, A. M.] Princess Margaret Canc Ctr, Toronto, ON, Canada; [Saad, F.] Ctr Hosp Univ Montreal, Montreal, PQ, Canada; [Venner, P. M.] Cross Canc Inst, Edmonton, AB T6G 1Z2, Canada; [Venner, P. M.] Univ Alberta, Edmonton, AB, Canada; [Kim, C-S] Asan Med Ctr, Seoul, South Korea; [Kimura, G.] Nippon Med Sch, Tokyo 113, Japan; [Miller, K.] Charite, D-13353 Berlin, Germany; [Perabo, F.; Phung, D.] Astellas Pharma Global Dev, Northbrook, IL USA; [Taplin, M-E] Dana Farber Canc Inst, Boston, MA 02115 USA; [Tombal, B.] Clin Univ St Luc, B-1200 Brussels, Belgium	Oregon Health & Science University; Duke University; Duke University; Memorial Sloan Kettering Cancer Center; Cornell University; UDICE-French Research Universities; Universite Paris Saclay; UNICANCER; Gustave Roussy; Azienda Ospedaliera San Camillo-Forlanini; Seattle Cancer Care Alliance; University of Washington; University of Washington Seattle; Rigshospitalet; University of Copenhagen; Hospital Universitari Vall d'Hebron; Vall d'Hebron Institut d'Oncologia (VHIO); Vall d'Hebron Institut d'Oncologia (VHIO); Guy's & St Thomas' NHS Foundation Trust; Royal Marsden NHS Foundation Trust; Royal Marsden NHS Foundation Trust; University of London; Institute of Cancer Research - UK; Monash University; ICON plc; University of California System; University of California Davis; University of Toronto; University Toronto Affiliates; University Health Network Toronto; Princess Margaret Cancer Centre; Universite de Montreal; University of Alberta; University of Alberta; Nippon Medical School; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Astellas Pharmaceuticals; Harvard University; Dana-Farber Cancer Institute; Universite Catholique Louvain; Cliniques Universitaires Saint-Luc	Beer, TM (corresponding author), Oregon Hlth & Sci Univ, OHSU Knight Canc Inst, 3303 SW Bond Ave,CH14R, Portland, OR 97239 USA.	beert@ohsu.edu	Loriot, Yohann/W-5572-2019; Gil-Bazo, Ignacio/E-4581-2019; Davis, Ian D/A-1430-2012; Mulders, Peter F.A./H-8076-2014; Kimura, Go/Y-7843-2018; Vaarala, Markku/B-4116-2013	Gil-Bazo, Ignacio/0000-0002-2626-5109; Davis, Ian D/0000-0002-9066-8244; Kimura, Go/0000-0003-0088-9324; Alcaraz Asensio, Antonio/0000-0003-2612-5250; Hoskin, Peter/0000-0001-8323-9567; Chiong, Edmund/0000-0002-5241-5000; McNeel, Douglas/0000-0003-1471-6723; Lacombe, Louis/0000-0003-4811-0308; McLaren, Duncan/0000-0002-9862-4158; de Bono, Johann S/0000-0002-2034-595X; Gallardo, Enrique/0000-0002-1375-3488; de Jong, Igle J./0000-0002-3444-5548; Carles, Joan/0000-0002-9983-5934; Hadaschik, Boris/0000-0002-1052-2692; Rathkopf, Dana/0000-0002-4503-7582; Vaarala, Markku/0000-0003-4735-815X; Joshua, Anthony/0000-0001-5159-4580; OUDARD, Stephane/0000-0003-0893-285X; Bompas, Emmanuelle/0000-0003-4414-7760; Krainer, Michael/0000-0002-7011-4957	Medivation; Astellas Pharma; NATIONAL CANCER INSTITUTE [P30CA069533, P30CA008748, P30CA014236] Funding Source: NIH RePORTER	Medivation; Astellas Pharma(Astellas Pharmaceuticals); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	Supported by Medivation and Astellas Pharma, which also funded editorial support.	Attard G, 2011, CLIN CANCER RES, V17, P3867, DOI 10.1158/1078-0432.CCR-11-0943; Bolla M, 1997, NEW ENGL J MED, V337, P295, DOI 10.1056/NEJM199707313370502; Chen CD, 2004, NAT MED, V10, P33, DOI 10.1038/nm972; De Bono JS, 2011, NEW ENGL J MED, V364, P1995, DOI 10.1056/NEJMoa1014618; de Bono JS, 2010, LANCET, V376, P1147, DOI 10.1016/S0140-6736(10)61389-X; Harris V, 2011, CLIN ONCOL-UK, V23, P706, DOI 10.1016/j.clon.2011.04.014; HOLM S, 1979, SCAND J STAT, V6, P65; Huggins C, 1941, CANCER RES, V1, P293; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20115, 10.3322/caac.20107]; Kantoff PW, 2010, NEW ENGL J MED, V363, P411, DOI 10.1056/NEJMoa1001294; Knudsen KE, 2009, CLIN CANCER RES, V15, P4792, DOI 10.1158/1078-0432.CCR-08-2660; Lissbrant IF, 2013, ACTA ONCOL, V52, P1593, DOI 10.3109/0284186X.2013.770164; Massard C, 2011, CLIN CANCER RES, V17, P3876, DOI 10.1158/1078-0432.CCR-10-2815; Messing EM, 2006, LANCET ONCOL, V7, P472, DOI 10.1016/S1470-2045(06)70700-8; Montgomery RB, 2008, CANCER RES, V68, P4447, DOI 10.1158/0008-5472.CAN-08-0249; Nair B, 2002, COCHRANE DB SYST REV, V1; Parker C, 2013, NEW ENGL J MED, V369, P213, DOI 10.1056/NEJMoa1213755; Ryan CJ, 2013, NEW ENGL J MED, V368, P138, DOI 10.1056/NEJMoa1209096; Scher HI, 2008, J CLIN ONCOL, V26, P1148, DOI 10.1200/JCO.2007.12.4487; Scher HI, 2012, NEW ENGL J MED, V367, P1187, DOI 10.1056/NEJMoa1207506; Scher HI, 2010, LANCET, V375, P1437, DOI 10.1016/S0140-6736(10)60172-9; Studer UE, 2013, EUR UROL; Tannock IF, 2004, NEW ENGL J MED, V351, P1502, DOI 10.1056/NEJMoa040720; Tran C, 2009, SCIENCE, V324, P787, DOI 10.1126/science.1168175	24	1936	1985	2	116	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUL 31	2014	371	5					424	433		10.1056/NEJMoa1405095	http://dx.doi.org/10.1056/NEJMoa1405095			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AM0SK	24881730	Bronze, Green Published, Green Accepted			2022-12-28	WOS:000339556900007
J	Maartens, G; Celum, C; Lewin, SR				Maartens, Gary; Celum, Connie; Lewin, Sharon R.			HIV infection: epidemiology, pathogenesis, treatment, and prevention	LANCET			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; SUB-SAHARAN AFRICA; CD4(+) T-CELLS; TEST-AND-TREAT; COMBINATION ANTIRETROVIRAL THERAPY; SEXUALLY-TRANSMITTED-DISEASES; MALE CIRCUMCISION; MICROBIAL TRANSLOCATION; MIDDLE-INCOME; DOUBLE-BLIND	HIV prevalence is increasing worldwide because people on antiretroviral therapy are living longer, although new infections decreased from 3 3 million in 2002, to 2 3 million in 2012. Global AIDS-related deaths peaked at 2 3 million in 2005, and decreased to 1 6 million by 2012. An estimated 9 7 million people in low-income and middle-income countries had started antiretroviral therapy by 2012. New insights into the mechanisms of latent infection and the importance of reservoirs of infection might eventually lead to a cure. The role of immune activation in the pathogenesis of non-AIDS clinical events (major causes of morbidity and mortality in people on antiretroviral therapy) is receiving increased recognition. Breakthroughs in the prevention of HIV important to public health include male medical circumcision, antiretrovirals to prevent mother-to-child transmission, antiretroviral therapy in people with HIV to prevent transmission, and antiretrovirals for pre-exposure prophylaxis. Research into other prevention interventions, notably vaccines and vaginal microbicides, is in progress.	[Maartens, Gary] Univ Cape Town, Dept Med, Div Clin Pharmacol, ZA-7925 Cape Town, South Africa; [Celum, Connie] Univ Washington, Dept Global Hlth, Seattle, WA 98195 USA; [Celum, Connie] Univ Washington, Dept Med, Seattle, WA USA; [Celum, Connie] Univ Washington, Dept Epidemiol, Seattle, WA 98195 USA; [Lewin, Sharon R.] Monash Univ, Dept Infect Dis, Melbourne, Vic 3004, Australia; [Lewin, Sharon R.] Alfred Hosp, Infect Dis Unit, Melbourne, Vic, Australia; [Lewin, Sharon R.] Burnet Inst, Ctr Biomed Res, Melbourne, Vic, Australia	University of Cape Town; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; Monash University; Florey Institute of Neuroscience & Mental Health; Burnet Institute	Maartens, G (corresponding author), Univ Cape Town Hlth Sci Faulty, Dept Med, Div Clin Pharmacol, ZA-7925 Cape Town, South Africa.	gary.maartens@uct.ac.za	Maartens, Gary/F-3836-2014; Lewin, Sharon/Z-3297-2019; Maartens, Gary/S-2788-2019	Maartens, Gary/0000-0003-3080-6606; Maartens, Gary/0000-0003-3080-6606; Lewin, Sharon Ruth/0000-0002-0330-8241	Merck Sharp and Dohme; Merck Sharp and Dohme, Gilead; Janssen; Bristol-Myers Squibb; ViiV Healthcare	Merck Sharp and Dohme(Merck & Company); Merck Sharp and Dohme, Gilead; Janssen(Johnson & JohnsonJohnson & Johnson USAJanssen Biotech Inc); Bristol-Myers Squibb(Bristol-Myers Squibb); ViiV Healthcare	SL's institution has received funding from Merck Sharp and Dohme, Gilead, Janssen, Bristol-Myers Squibb, and ViiV Healthcare for her participation in investigator initiated research, preparation of educational materials, presentations at symposia, and consultancy work. GM and CC declare no competing interests. There was no funding source for this Seminar.	Abrams D, 2009, NEW ENGL J MED, V361, P1548, DOI 10.1056/NEJMoa0903175; Almeida JR, 2007, J EXP MED, V204, P2473, DOI 10.1084/jem.20070784; Alter G, 2011, NATURE, V476, P96, DOI 10.1038/nature10237; Ananworanich J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033948; Ancuta P, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002516; Andrade BB, 2013, J INFECT DIS, V207, P1379, DOI 10.1093/infdis/jit033; [Anonymous], 2019, IDF DIABETES ATLAS, V9th; [Anonymous], 2013, 2013 PROGR REP GLOB; Archin NM, 2012, NATURE, V487, P482, DOI 10.1038/nature11286; Atashili J, 2008, AIDS, V22, P1493, DOI 10.1097/QAD.0b013e3283021a37; Auvert B, 2005, PLOS MED, V2, P1112, DOI 10.1371/journal.pmed.0020298; Baeten JM, 2012, NEW ENGL J MED, V367, P399, DOI 10.1056/NEJMoa1108524; Baeten JM, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3001888; Baggaley RF, 2010, INT J EPIDEMIOL, V39, P1048, DOI 10.1093/ije/dyq057; Bailey RC, 2007, LANCET, V369, P643, DOI 10.1016/S0140-6736(07)60312-2; Ballard C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037410; Barnabas RV, 2012, CURR HIV RES, V10, P228, DOI 10.2174/157016212800618156; Barnabas RV, 2011, AIDS, V25, P1559, DOI 10.1097/QAD.0b013e3283491e3e; Beyrer C, 2013, AIDS, V27, P2665, DOI 10.1097/01.aids.0000432449.30239.fe; Birrell PJ, 2013, LANCET INFECT DIS, V13, P313, DOI 10.1016/S1473-3099(12)70341-9; Boulle A, 2013, 20 C RETR OPP INF AT; Boulle A, 2010, AIDS, V24, P563, DOI 10.1097/QAD.0b013e328333bfb7; Boyer S, 2013, LANCET INFECT DIS, V13, P577, DOI 10.1016/S1473-3099(13)70073-2; Brenchley JM, 2006, NAT MED, V12, P1365, DOI 10.1038/nm1511; Buchbinder SP, 2008, LANCET, V372, P1881, DOI 10.1016/S0140-6736(08)61591-3; Butler AR, 2013, AIDS, V27, P105, DOI 10.1097/QAD.0b013e32835a5a52; Buzon MJ, 2010, NAT MED, V16, P460, DOI 10.1038/nm.2111; Celum C, 2010, NEW ENGL J MED, V362, P427, DOI 10.1056/NEJMoa0904849; Centers for Disease Control and Prevention, VIT SIGNS HIV PREV C; Chen P, 2011, J AM SOC NEPHROL, V22, P496, DOI 10.1681/ASN.2010040379; Chomont N, 2009, NAT MED, V15, P893, DOI 10.1038/nm.1972; Choopanya K, 2013, LANCET, V381, P2083, DOI 10.1016/S0140-6736(13)61127-7; Chun TW, 2008, J INFECT DIS, V197, P714, DOI 10.1086/527324; Coates T, 2013, 20 C RETR OPP INF CR; Cohen MS, 2011, NEW ENGL J MED, V365, P493, DOI [10.1056/NEJMoa1105243, 10.1056/NEJMoa1600693]; Cohen MS, 2011, NEW ENGL J MED, V364, P1943, DOI 10.1056/NEJMra1011874; Cohen T, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000296; Cooper A, 2013, NATURE, V498, P376, DOI 10.1038/nature12274; Coovadia HM, 2012, LANCET, V379, P221, DOI 10.1016/S0140-6736(11)61653-X; Cosgrove C, 2013, BLOOD, V121, P951, DOI 10.1182/blood-2012-06-436436; Coutsoudis A, 2004, J INFECT DIS, V189, P2154, DOI 10.1086/420834; Crawford ND, 2010, JAIDS-J ACQ IMM DEF, V55, pS84, DOI 10.1097/QAI.0b013e3181fbca5a; Cusini A, 2013, JAIDS-J ACQ IMM DEF, V62, P28, DOI 10.1097/QAI.0b013e318274e2b0; Degenhardt L, 2010, LANCET, V376, P285, DOI 10.1016/S0140-6736(10)60742-8; Dutta A, 2012, CURR OPIN HIV AIDS, V7, P362, DOI 10.1097/COH.0b013e328354a0b5; Ellery P, 2004, 11 C RETR OPP INF SA; Elliott J, 2013, 20 C RETR OPP INF AT; Epstein H, 2011, J INT AIDS SOC, V14, DOI 10.1186/1758-2652-14-13; Finzi D, 1999, NAT MED, V5, P512, DOI 10.1038/8394; Fonner VA, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001224.pub4; Ford N, 2012, AIDS, V26, P559, DOI 10.1097/QAD.0b013e32834f3264; Freiberg MS, 2013, JAMA INTERN MED, V173, P614, DOI 10.1001/jamainternmed.2013.3728; Garcia F, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3004682; Gardner EM, 2011, CLIN INFECT DIS, V52, P793, DOI 10.1093/cid/ciq243; Gardner EM, 2009, AIDS, V23, P1035, DOI 10.1097/QAD.0b013e32832ba8ec; Gill J, 2010, CLIN INFECT DIS, V50, P1387, DOI 10.1086/652283; Glaziou P, 2013, SEMIN RESP CRIT CARE, V34, P3, DOI 10.1055/s-0032-1333467; Glynn JR, 2009, AIDS, V23, P1595, DOI 10.1097/QAD.0b013e32832e15e8; Gonzalez VD, 2009, J VIROL, V83, P11407, DOI 10.1128/JVI.01211-09; Goonetilleke N, 2009, J EXP MED, V206, P1253, DOI 10.1084/jem.20090365; Gorry P, 1998, J NEUROVIROL, V4, P377, DOI 10.3109/13550289809114536; Grant RM, 2010, NEW ENGL J MED, V363, P2587, DOI 10.1056/NEJMoa1011205; Gray RH, 2007, LANCET, V369, P657, DOI 10.1016/S0140-6736(07)60313-4; Gray RH, 2013, SEX TRANSM INFECT, V89, P345, DOI 10.1136/sextrans-2012-050595; GROSSKURTH H, 1995, LANCET, V346, P530, DOI 10.1016/S0140-6736(95)91380-7; Hallett TB, 2011, SEX TRANSM INFECT, V87, P88, DOI 10.1136/sti.2010.043372; Hansen SG, 2013, NATURE, V502, P100, DOI 10.1038/nature12519; Haynes BF, 2013, CURR OPIN HIV AIDS, V8, P326, DOI 10.1097/COH.0b013e328361d178; Haynes BF, 2012, NEW ENGL J MED, V366, P1275, DOI 10.1056/NEJMoa1113425; Helleberg M, 2012, INFECTION, V40, P627, DOI 10.1007/s15010-012-0293-y; Hemelaar J, 2011, AIDS, V25, P679, DOI 10.1097/QAD.0b013e328342ff93; Herrera C, 2013, CURR TOP MICROBIOL I; Holmes CB, 2006, JAIDS-J ACQ IMM DEF, V42, P464, DOI 10.1097/01.qai.0000225729.79610.b7; Hrecka K, 2011, NATURE, V474, P658, DOI 10.1038/nature10195; Hsue PY, 2006, AIDS, V20, P2275, DOI 10.1097/QAD.0b013e3280108704; Hsue PY, 2012, J AM HEART ASSOC, V1, DOI 10.1161/JAHA.111.000422; Huang JL, 2007, NAT MED, V13, P1241, DOI 10.1038/nm1639; Hutter G, 2009, NEW ENGL J MED, V360, P692, DOI 10.1056/NEJMoa0802905; Hughes JP, 2012, J INFECT DIS, V205, P358, DOI 10.1093/infdis/jir747; Hunt PW, 2011, J INFECT DIS, V203, P1474, DOI 10.1093/infdis/jir060; Jardine J, 2013, SCIENCE, V340, P711, DOI 10.1126/science.1234150; Jewkes RK, 2010, LANCET, V376, P41, DOI 10.1016/S0140-6736(10)60548-X; Joshi D, 2011, LANCET, V377, P1198, DOI 10.1016/S0140-6736(10)62001-6; Karim QA, 2010, SCIENCE, V329, P1168, DOI 10.1126/science.1193748; Keele BF, 2008, P NATL ACAD SCI USA, V105, P7552, DOI 10.1073/pnas.0802203105; Keiser O, 2008, PLOS MED, V5, P1102, DOI 10.1371/journal.pmed.0050148; Kennedy CE, 2010, B WORLD HEALTH ORGAN, V88, P615, DOI 10.2471/BLT.09.068213; Kerrigan DL, 2013, AIDS BEHAV, V17, P1926, DOI 10.1007/s10461-013-0458-4; Klein F, 2013, CELL, V153, P126, DOI 10.1016/j.cell.2013.03.018; Kourtis AP, 2006, LANCET INFECT DIS, V6, P726, DOI 10.1016/S1473-3099(06)70629-6; Kranzer K, 2012, J INT AIDS SOC, V15, DOI 10.7448/IAS.15.2.17383; Kulkarni SP, 2013, AM J PUBLIC HEALTH, V103, pE14, DOI 10.2105/AJPH.2013.301273; Kuller LH, 2008, PLOS MED, V5, P1496, DOI 10.1371/journal.pmed.0050203; Ladell K, 2013, IMMUNITY, V38, P425, DOI 10.1016/j.immuni.2012.11.021; Laguette N, 2011, NATURE, V474, P654, DOI 10.1038/nature10117; Lawn SD, 2011, EXPERT REV ANTI-INFE, V9, P415, DOI [10.1586/eri.11.21, 10.1586/ERI.11.21]; Lewin SR, 2011, AIDS, V25, P885, DOI 10.1097/QAD.0b013e3283467041; Li LJ, 2013, MOL THER, V21, P1259, DOI 10.1038/mt.2013.65; Liao HX, 2013, NATURE, V496, P469, DOI 10.1038/nature12053; Lichtfuss GF, 2011, BIOMARK MED, V5, P171, DOI [10.2217/bmm.11.15, 10.2217/BMM.11.15]; Lingappa JR, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012598; Lingappa JR, 2010, LANCET, V375, P824, DOI 10.1016/S0140-6736(09)62038-9; Liu Y, 2004, J VIROL, V78, P4120, DOI 10.1128/JVI.78.8.4120-4133.2004; Lodi S, 2012, ARCH INTERN MED, V172, P1252, DOI 10.1001/archinternmed.2012.2719; Lorimer K, 2013, AIDS CARE, V25, P133, DOI 10.1080/09540121.2012.699672; Maertens G, 2003, J BIOL CHEM, V278, P33528, DOI 10.1074/jbc.M303594200; Marks MA, 2013, AIDS, V27, P469, DOI 10.1097/QAD.0b013e32835c1333; Marrazzo JM, 2013, 20 C RETR OPP INF CR; Mayer KH, 2011, CLIN INFECT DIS, V52, P1371, DOI 10.1093/cid/cir206; Meda N, 2011, LANCET INFECT DIS, V11, P171, DOI 10.1016/S1473-3099(10)70288-7; Mehandru S, 2007, J VIROL, V81, P599, DOI 10.1128/JVI.01739-06; Meier A, 2009, NAT MED, V15, P955, DOI 10.1038/nm.2004; Meintjes G, 2010, AIDS, V24, P2381, DOI 10.1097/QAD.0b013e32833dfc68; Muller M, 2010, LANCET INFECT DIS, V10, P251, DOI 10.1016/S1473-3099(10)70026-8; Mugo NR, 2011, AIDS, V25, P1887, DOI 10.1097/QAD.0b013e32834a9338; Mugwanya K, 2011, J INFECT DIS, V204, P1912, DOI 10.1093/infdis/jir649; Nachega JB, 2012, AIDS, V26, P2039, DOI 10.1097/QAD.0b013e328359590f; Neil SJD, 2008, NATURE, V451, P425, DOI 10.1038/nature06553; Ng BE, 2011, COCHRANE DB SYST REV, V3; Obiero J, 2012, BMC INFECT DIS, V12, DOI 10.1186/1471-2334-12-289; Ortblad KF, 2013, AIDS, V27, P2003, DOI 10.1097/QAD.0b013e328362ba67; Papagno L, 2011, AIDS, V25, P27, DOI 10.1097/QAD.0b013e328340fe55; Parrish NF, 2013, P NATL ACAD SCI USA, V110, P6626, DOI 10.1073/pnas.1304288110; Persaud D, 2013, NEW ENGL J MED, V369, P1828, DOI 10.1056/NEJMoa1302976; Polis CB, 2013, LANCET INFECT DIS, V13, P797, DOI 10.1016/S1473-3099(13)70155-5; Prendergast A, 2010, AIDS, V24, P491, DOI 10.1097/QAD.0b013e3283344895; Quinn TC, 2000, NEW ENGL J MED, V342, P921, DOI 10.1056/NEJM200003303421303; Rajasuriar R, 2013, AIDS, V27, P1199, DOI 10.1097/QAD.0b013e32835ecb8b; Rajasuriar R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020713; Rerks-Ngarm S, 2009, NEW ENGL J MED, V361, P2209, DOI 10.1056/NEJMoa0908492; Richman DD, 2003, P NATL ACAD SCI USA, V100, P4144, DOI 10.1073/pnas.0630530100; Rodger AJ, 2013, AIDS, V27, P973, DOI 10.1097/QAD.0b013e32835cae9c; Rottingen JA, 2001, SEX TRANSM DIS, V28, P579; Sabapathy K, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001351; Sabin CA, 2013, AIDS, V27, P1839, DOI 10.1097/QAD.0b013e328360d546; Saez-Cirion A, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003211; Saleh S, 2007, BLOOD, V110, P4161, DOI 10.1182/blood-2007-06-097907; Scott-Sheldon LAJ, 2011, JAIDS-J ACQ IMM DEF, V58, P489, DOI 10.1097/QAI.0b013e31823554d7; Sereti I, 2009, BLOOD, V113, P6304, DOI 10.1182/blood-2008-10-186601; Shan L, 2012, IMMUNITY, V36, P491, DOI 10.1016/j.immuni.2012.01.014; Sharp PM, 2011, CSH PERSPECT MED, V1, DOI 10.1101/cshperspect.a006841; Sheehy AM, 2003, NAT MED, V9, P1404, DOI 10.1038/nm945; Siegfried N, 2009, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003362.pub2; Sigaloff KCE, 2011, JAIDS-J ACQ IMM DEF, V58, P23, DOI 10.1097/QAI.0b013e318227fc34; Sonnenberg P, 2005, J INFECT DIS, V191, P150, DOI 10.1086/426827; Sood N, 2013, CLIN INFECT DIS, V56, P1789, DOI 10.1093/cid/cit158; Stacey AR, 2009, J VIROL, V83, P3719, DOI 10.1128/JVI.01844-08; Stremlau M, 2004, NATURE, V427, P848, DOI 10.1038/nature02343; Tanser F, 2013, SCIENCE, V339, P966, DOI 10.1126/science.1228160; Tanser F, 2011, LANCET, V378, P247, DOI 10.1016/S0140-6736(11)60779-4; Thigpen MC, 2012, NEW ENGL J MED, V367, P423, DOI 10.1056/NEJMoa1110711; Thior I, 2006, JAMA-J AM MED ASSOC, V296, P794, DOI 10.1001/jama.296.7.794; Thomas TK, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001015; Thompson MA, 2012, JAMA-J AM MED ASSOC, V308, P387, DOI 10.1001/jama.2012.7961; Trautmann L, 2006, NAT MED, V12, P1198, DOI 10.1038/nm1482; Tuboi SH, 2007, JAIDS-J ACQ IMM DEF, V45, P52, DOI 10.1097/QAI.0b013e318042e1c3; UNAIDS, 2010, REP GLOB AIDS EP 201; Uthman OA, 2011, VALUE HEALTH, V14, P70, DOI 10.1016/j.jval.2010.10.011; Van Damme L, 2012, NEW ENGL J MED, V367, P411, DOI 10.1056/NEJMoa1202614; Van Lint C, 2013, RETROVIROLOGY, V10, DOI 10.1186/1742-4690-10-67; Vandergeeten C, 2013, BLOOD, V121, P4321, DOI 10.1182/blood-2012-11-465625; Walker BR, 2014, DAVIDSONS PRINCIPLES; Walker BD, 2013, NEW ENGL J MED, V368, P279, DOI 10.1056/NEJMe1213734; Walker LM, 2011, NATURE, V477, P466, DOI 10.1038/nature10373; Wariki WMV, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD005272.pub3; Weiss HA, 2000, AIDS, V14, P2361, DOI 10.1097/00002030-200010200-00018; Wettstein C, 2012, AIDS, V26, P2361, DOI 10.1097/QAD.0b013e328359ab0c; WHO, 2013, GLOB UPD HIV TREATME; WHO, 2012, WHO HIV DRUG RES REP; Wightman F, 2010, J INFECT DIS, V202, P1738, DOI 10.1086/656721; Yan N, 2010, NAT IMMUNOL, V11, P1005, DOI 10.1038/ni.1941; Yang HC, 2009, J CLIN INVEST, V119, P3473, DOI 10.1172/JCI39199; Yukl SA, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003347; Zaidi J, 2013, AIDS, V27, P2301, DOI 10.1097/QAD.0b013e328362e832; Zeng M, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002437	175	454	483	17	301	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JUL 19	2014	384	9939					258	271		10.1016/S0140-6736(14)60164-1	http://dx.doi.org/10.1016/S0140-6736(14)60164-1			14	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AL8JI	24907868				2022-12-28	WOS:000339384100028
J	Zahreddine, HA; Culjkovic-Kraljacic, B; Assouline, S; Gendron, P; Romeo, AA; Morris, SJ; Cormack, G; Jaquith, JB; Cerchietti, L; Cocolakis, E; Amri, A; Bergeron, J; Leber, B; Becker, MW; Pei, SS; Jordan, CT; Miller, WH; Borden, KLB				Zahreddine, Hiba Ahmad; Culjkovic-Kraljacic, Biljana; Assouline, Sarit; Gendron, Patrick; Romeo, Andrea A.; Morris, Stephen J.; Cormack, Gregory; Jaquith, James B.; Cerchietti, Leandro; Cocolakis, Eftihia; Amri, Abdellatif; Bergeron, Julie; Leber, Brian; Becker, Michael W.; Pei, Shanshan; Jordan, Craig T.; Miller, Wilson H., Jr.; Borden, Katherine L. B.			The sonic hedgehog factor GLI1 imparts drug resistance through inducible glucuronidation	NATURE			English	Article							ACUTE MYELOID-LEUKEMIA; LIVER-MICROSOMES; ONCOGENE EIF4E; INHIBITION; EXPRESSION; TRIALS; AZT	Drug resistance is a major hurdle in oncology. Responses of acute myeloid leukaemia (AML) patients to cytarabine (Ara-C)-based therapies are often short lived with a median overall survival of months(1-4). Therapies are under development to improve outcomes and include targeting the eukaryotic translation initiation factor (eIF4E) with its inhibitor ribavirin(5-7). In a Phase II clinical trial in poor prognosis AML(5), ribavirin monotherapy yielded promising responses including remissions; however, all patients relapsed. Here we identify a novel form of drug resistance to ribavirin and Ara-C. We observe that the sonic hedgehog transcription factor glioma-associated protein 1 (GLI1) and the UDP glucuronosyltransferase (UGT1A) family of enzymes are elevated in resistant cells. UGT1As add glucuronic acid to many drugs, modifying their activity in diverse tissues(8). GLI1 alone is sufficient to drive UGT1A-dependent glucuronidation of ribavirin and Ara-C, and thus drug resistance. Resistance is overcome by genetic or pharmacological inhibition of GLI1, revealing a potential strategy to overcome drug resistance in some patients.	[Zahreddine, Hiba Ahmad; Culjkovic-Kraljacic, Biljana; Gendron, Patrick; Cormack, Gregory; Amri, Abdellatif; Borden, Katherine L. B.] Univ Montreal, Inst Res Immunol & Canc, Montreal, PQ H3C 3J7, Canada; [Zahreddine, Hiba Ahmad; Culjkovic-Kraljacic, Biljana; Gendron, Patrick; Cormack, Gregory; Amri, Abdellatif; Borden, Katherine L. B.] Univ Montreal, Dept Pathol & Cell Biol, Montreal, PQ H3C 3J7, Canada; [Assouline, Sarit; Cocolakis, Eftihia; Miller, Wilson H., Jr.] McGill Univ, Jewish Gen Hosp, Lady Davis Inst, Segal Canc Ctr, Montreal, PQ H3T 1E2, Canada; [Romeo, Andrea A.; Morris, Stephen J.; Jaquith, James B.] Pharmascience Inc, Montreal, PQ H4P 2T4, Canada; [Cerchietti, Leandro] Cornell Univ, Div Hematol & Oncol, Dept Med, Weill Cornell Med Coll, New York, NY 10021 USA; [Bergeron, Julie] Hop Maison Neuve Rosemont, Montreal, PQ H1T 2M4, Canada; [Leber, Brian] McMaster Univ, Hamilton Hlth Sci, Hamilton, ON L8L 2X2, Canada; [Becker, Michael W.] Univ Rochester, Dept Med, Div Hematol Oncol, Rochester, NY 14627 USA; [Pei, Shanshan; Jordan, Craig T.] Univ Colorado Denver, Dept Med,Univ, Div Hematol, Aurora, CO 80045 USA	Universite de Montreal; Universite de Montreal; Lady Davis Institute; McGill University; Cornell University; Universite de Montreal; McMaster University; University of Rochester; Children's Hospital Colorado; University of Colorado System; University of Colorado Anschutz Medical Campus	Borden, KLB (corresponding author), Univ Montreal, Inst Res Immunol & Canc, POB 6128, Montreal, PQ H3C 3J7, Canada.	katherine.borden@umontreal.ca	PEI, SHANSHAN/D-8200-2016; Romeo, Andrea Antonino/AAY-2175-2021; jordan, craig/D-7666-2014	PEI, SHANSHAN/0000-0001-9619-2614; Romeo, Andrea Antonino/0000-0002-1579-2480; Leber, Brian/0000-0001-5502-1480; Gendron, Patrick/0000-0001-9829-2600; Cerchietti, Leandro/0000-0003-0608-1350; Becker, Michael/0000-0001-9890-8815; jordan, craig/0000-0003-0869-3465	National Institutes of Health [RO1 80728, 98571]; IRICoR; Leukemia and Lymphoma Society USA; Cole Foundation Fellowship; CNRS Lebanon Fellowship; NATIONAL CANCER INSTITUTE [R01CA080728, R01CA098571] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); IRICoR; Leukemia and Lymphoma Society USA(Leukemia and Lymphoma Society); Cole Foundation Fellowship; CNRS Lebanon Fellowship; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We are grateful for reading of the manuscript by A. Kentsis, M. Osborne, F. Pettersson, S. del Rincon and C. Perreault. We are grateful for the use of Pharmascience facilities thanks to M. Goodman and D. Goodman, for specimens from the Banques de Cellules Leucemiques Du Quebec (BCLQ), and for technical discussions with M. Ouellet. We thank nursing and support staff at all the clinical sites, and A. Ramteke for technical support. K.L.B.B. is supported by funds from the National Institutes of Health (RO1 80728 and 98571), IRICoR and Translational Research Program grants from the Leukemia and Lymphoma Society USA. K.L.B.B. holds a Canada Research Chair and H.A.Z. holds a Cole Foundation Fellowship and a CNRS Lebanon Fellowship.	Anders S, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-10-r106; Assouline S, 2009, BLOOD, V114, P257, DOI 10.1182/blood-2009-02-205153; Barbier O, 2000, DRUG METAB DISPOS, V28, P497; Cheson BD, 2003, J CLIN ONCOL, V21, P4642, DOI 10.1200/JCO.2003.04.036; Culjkovic-Kraljacic B, 2012, CELL REP, V2, P207, DOI 10.1016/j.celrep.2012.07.007; Deschler B, 2006, HAEMATOLOGICA, V91, P1513; Deschler B, 2006, CANCER-AM CANCER SOC, V107, P2099, DOI 10.1002/cncr.22233; Dutton G., 1980, GLUCURONIDATION DRUG; Engtrakul JJ, 2005, DRUG METAB DISPOS, V33, P1621, DOI 10.1124/dmd.105.005058; Fisher MB, 2000, DRUG METAB DISPOS, V28, P560; Hiddemann W, 1999, J CLIN ONCOL, V17, P3569, DOI 10.1200/JCO.1999.17.11.3569; HORNY HP, 1994, HUM PATHOL, V25, P810, DOI 10.1016/0046-8177(94)90251-8; Jarvis SM, 1998, BRIT J PHARMACOL, V123, P1587, DOI 10.1038/sj.bjp.0701775; Kentsis A, 2004, P NATL ACAD SCI USA, V101, P18105, DOI 10.1073/pnas.0406927102; Kraljacic BC, 2011, LEUKEMIA, V25, P1197, DOI 10.1038/leu.2011.57; Lauth M, 2007, P NATL ACAD SCI USA, V104, P8455, DOI 10.1073/pnas.0609699104; Ley TJ, 2013, NEW ENGL J MED, V368, P2059, DOI 10.1056/NEJMoa1301689; LoRusso PM, 2011, CLIN CANCER RES, V17, P5774, DOI 10.1158/1078-0432.CCR-11-0972; Mas C, 2010, BIOCHEM PHARMACOL, V80, P712, DOI 10.1016/j.bcp.2010.04.016; Olah E, 1996, ANTICANCER RES, V16, P2469; Pulsoni A, 2004, HAEMATOLOGICA, V89, P296; Tukey RH, 2000, ANNU REV PHARMACOL, V40, P581, DOI 10.1146/annurev.pharmtox.40.1.581; WILLIS RC, 1978, P NATL ACAD SCI USA, V75, P3042, DOI 10.1073/pnas.75.7.3042	23	137	143	0	33	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 3	2014	511	7507					90	U459		10.1038/nature13283	http://dx.doi.org/10.1038/nature13283			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK1TN	24870236	Green Accepted			2022-12-28	WOS:000338199400042
J	Alonso-Gonzalez, P; Nikitin, AY; Golmar, F; Centeno, A; Pesquera, A; Velez, S; Chen, J; Navickaite, G; Koppens, F; Zurutuza, A; Casanova, F; Hueso, LE; Hillenbrand, R				Alonso-Gonzalez, P.; Nikitin, A. Y.; Golmar, F.; Centeno, A.; Pesquera, A.; Velez, S.; Chen, J.; Navickaite, G.; Koppens, F.; Zurutuza, A.; Casanova, F.; Hueso, L. E.; Hillenbrand, R.			Controlling graphene plasmons with resonant metal antennas and spatial conductivity patterns	SCIENCE			English	Article							SURFACE-PLASMONS; METAMATERIALS; POLARIZATION; EXCITATION; OPTICS	Graphene plasmons promise unique possibilities for controlling light in nanoscale devices and for merging optics with electronics. We developed a versatile platform technology based on resonant optical antennas and conductivity patterns for launching and control of propagating graphene plasmons, an essential step for the development of graphene plasmonic circuits. We launched and focused infrared graphene plasmons with geometrically tailored antennas and observed how they refracted when passing through a two-dimensional conductivity pattern, here a prism-shaped bilayer. To that end, we directly mapped the graphene plasmon wavefronts by means of an imaging method that will be useful in testing future design concepts for nanoscale graphene plasmonic circuits and devices.	[Alonso-Gonzalez, P.; Nikitin, A. Y.; Golmar, F.; Velez, S.; Chen, J.; Casanova, F.; Hueso, L. E.; Hillenbrand, R.] CIC NanoGUNE, Donostia San Sebastian 20018, Spain; [Nikitin, A. Y.; Casanova, F.; Hueso, L. E.; Hillenbrand, R.] Basque Fdn Sci, IKERBASQUE, Bilbao 48011, Spain; [Golmar, F.] INTI CONICET, Buenos Aires, DF, Argentina; [Golmar, F.] ECyT UNSAM, Buenos Aires, DF, Argentina; [Centeno, A.; Pesquera, A.; Zurutuza, A.] Graphenea SA, Donostia San Sebastian 20018, Spain; [Navickaite, G.; Koppens, F.] ICFO Inst Ciencies Foton, Barcelona 08860, Spain; [Hillenbrand, R.] Univ Basque Country, Donostia San Sebastian 20018, Spain	Basque Foundation for Science; Instituto Nacional de Tecnologia Industrial (INTI); Barcelona Institute of Science & Technology; Universitat Politecnica de Catalunya; Institut de Ciencies Fotoniques (ICFO); University of Basque Country	Hillenbrand, R (corresponding author), Basque Fdn Sci, IKERBASQUE, Bilbao 48011, Spain.	r.hillenbrand@nanogune.eu	Nikitin, Alexey/ABG-1886-2020; Koppens, Frank/X-4422-2018; Hillenbrand, Rainer/N-3428-2016; Golmar, Federico/C-2933-2017; Hueso, Luis E/C-8713-2009; Alonso-González, Pablo/B-8101-2013; Chen, Jianing/G-2140-2012; Nikitin, Alexey/C-4010-2009; Casanova, Felix/B-4639-2013; Velez, Saul/I-4826-2015	Nikitin, Alexey/0000-0002-2327-0164; Koppens, Frank/0000-0001-9764-6120; Hillenbrand, Rainer/0000-0002-1904-4551; Golmar, Federico/0000-0002-4023-2899; Hueso, Luis E/0000-0002-7918-8047; Alonso-González, Pablo/0000-0002-4597-9326; Chen, Jianing/0000-0002-7525-1424; Nikitin, Alexey/0000-0002-2327-0164; Casanova, Felix/0000-0003-0316-2163; Velez, Saul/0000-0002-0019-2271; nanoGUNE, CIC/0000-0001-7874-5254	European Union through ERC; NMP (HINTS); NMP (Grafol); Marie Curie Career Integration Grant (ITAMOSCINOM); Marie Curie Career Integration Grant (GRANOP); European Commission [CNECT-ICT-604391]; Spanish Ministry of Economy and Competitiveness [MAT2012-36580, MAT2012-37638]; Basque Government [PI2011-1]; Fundacio Cellex Barcelona	European Union through ERC; NMP (HINTS); NMP (Grafol); Marie Curie Career Integration Grant (ITAMOSCINOM); Marie Curie Career Integration Grant (GRANOP); European Commission(European CommissionEuropean Commission Joint Research Centre); Spanish Ministry of Economy and Competitiveness(Spanish Government); Basque Government(Basque Government); Fundacio Cellex Barcelona(Foundation CELLEXEuropean Commission)	We thank P. S. Carney, A. Kuzmenko, I. Nechaev, and F. Guinea for stimulating discussions. Supported by the European Union through ERC starting grants (TERATOMO, SPINTROS and CarbonLight), NMP (HINTS and Grafol), Marie Curie Career Integration Grants (ITAMOSCINOM and GRANOP); the European Commission under Graphene Flagship (contract no. CNECT-ICT-604391); the Spanish Ministry of Economy and Competitiveness (National Projects MAT2012-36580 and MAT2012-37638) and from the Basque Government (Project PI2011-1). F. K. acknowledges support from the Fundacio Cellex Barcelona. R. H. is co-founder of Neaspec GmbH, a company producing scattering-type scanning near-field optical microscope systems such as the one used in this study. All other authors declare no competing financial interests.	Barnes WL, 2003, NATURE, V424, P824, DOI 10.1038/nature01937; Boltasseva A, 2011, SCIENCE, V331, P290, DOI 10.1126/science.1198258; Born M., 1959, PRINCIPLES OPTICS; Bozhevolnyi SI, 2006, NATURE, V440, P508, DOI 10.1038/nature04594; Chen JN, 2012, NATURE, V487, P77, DOI 10.1038/nature11254; Fang ZY, 2012, ACS NANO, V6, P10222, DOI 10.1021/nn304028b; Fei Z, 2012, NATURE, V487, P82, DOI 10.1038/nature11253; de Abajo FJG, 2013, SCIENCE, V339, P917, DOI 10.1126/science.1231119; Grigorenko AN, 2012, NAT PHOTONICS, V6, P749, DOI [10.1038/nphoton.2012.262, 10.1038/NPHOTON.2012.262]; Hanson GW, 2008, J APPL PHYS, V103, DOI 10.1063/1.2891452; Jablan M, 2009, PHYS REV B, V80, DOI 10.1103/PhysRevB.80.245435; Ju L, 2011, NAT NANOTECHNOL, V6, P630, DOI [10.1038/nnano.2011.146, 10.1038/NNANO.2011.146]; Koppens FHL, 2011, NANO LETT, V11, P3370, DOI 10.1021/nl201771h; Lin J, 2013, SCIENCE, V340, P331, DOI 10.1126/science.1233746; Lin YM, 2008, NANO LETT, V8, P2119, DOI 10.1021/nl080241l; Liu YM, 2012, NANO LETT, V12, P4853, DOI 10.1021/nl302339z; Lopez-Tejeira F, 2007, NAT PHYS, V3, P324, DOI 10.1038/nphys584; Maier S.A., 2007, PLASMONICS FUNDAMENT, DOI DOI 10.1007/0-387-37825-1; Muhlschlegel P, 2005, SCIENCE, V308, P1607, DOI 10.1126/science.1111886; Nikitin AY, 2011, PHYS REV B, V84, DOI 10.1103/PhysRevB.84.195446; Polini M, 2008, PHYS REV B, V77, DOI 10.1103/PhysRevB.77.081411; Rodriguez-Fortuno FJ, 2013, SCIENCE, V340, P328, DOI 10.1126/science.1233739; Schnell M, 2009, NAT PHOTONICS, V3, P287, DOI 10.1038/NPHOTON.2009.46; SHUNG KWK, 1986, PHYS REV B, V34, P979, DOI 10.1103/PhysRevB.34.979; Vafek O, 2006, PHYS REV LETT, V97, DOI 10.1103/PhysRevLett.97.266406; Vakil A, 2011, SCIENCE, V332, P1291, DOI 10.1126/science.1202691; Wunsch B, 2006, NEW J PHYS, V8, DOI 10.1088/1367-2630/8/12/318; Yan HG, 2013, NAT PHOTONICS, V7, P394, DOI [10.1038/NPHOTON.2013.57, 10.1038/nphoton.2013.57]; Yan HG, 2012, NAT NANOTECHNOL, V7, P330, DOI [10.1038/nnano.2012.59, 10.1038/NNANO.2012.59]; Yao Y, 2013, NANO LETT, V13, P1257, DOI 10.1021/nl3047943	30	268	273	21	495	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 20	2014	344	6190					1369	1373		10.1126/science.1253202	http://dx.doi.org/10.1126/science.1253202			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AJ2YQ	24855026				2022-12-28	WOS:000337531700033
J	McCloskey, B; Endericks, T; Catchpole, M; Zambon, M; McLauchlin, J; Shetty, N; Manuel, R; Turbitt, D; Smith, G; Crook, P; Severi, E; Jones, J; Ibbotson, S; Marshall, R; Smallwood, CAH; Isla, N; Memish, ZA; Al-Rabeeah, AA; Barbeschi, M; Heymann, DL; Zumla, A				McCloskey, Brian; Endericks, Tina; Catchpole, Mike; Zambon, Maria; McLauchlin, Jim; Shetty, Nandini; Manuel, Rohini; Turbitt, Deborah; Smith, Gillian; Crook, Paul; Severi, Ettore; Jones, Jane; Ibbotson, Sue; Marshall, Roberta; Smallwood, Catherine A. H.; Isla, Nicolas; Memish, Ziad A.; Al-Rabeeah, Abdullah A.; Barbeschi, Maurizio; Heymann, David L.; Zumla, Alimuddin			London 2012 Olympic and Paralympic Games: public health surveillance and epidemiology	LANCET			English	Article							TRIATHLON PARTICIPANTS; MASS GATHERINGS; MUSIC-FESTIVAL; ROCK FESTIVAL; JULY 2009; INFLUENZA; OUTBREAK; INFECTION; LEPTOSPIROSIS; SYSTEM	Mass gatherings are regarded as potential risks for transmission of infectious diseases, and might compromise the health system of countries in which they are hosted. The evidence for increased transmission of infectious diseases at international sporting mass gatherings that attract many visitors from all over the world is not clear, and the evidence base for public health surveillance, epidemiology, and response at events such as the Olympics is small. However, infectious diseases are a recognised risk, and public health planning is, and should remain, a crucial part of the overall planning of sporting events. In this Series paper, we set out the planning and the surveillance systems that were used to monitor public health risks during the London 2012 Olympic and Paralympic Games in the summer of 2012, and draw attention to the public health issues-infectious diseases and chemical, radiation, and environmental hazards-that arose. Although the absolute risk of health-protection problems, including infectious diseases, at sporting mass gatherings is small, the need for reassurance of the absence of problems is higher than has previously been considered; this could challenge conventional public health surveillance systems. Recognition of the limitations of health-surveillance systems needs to be part of the planning for future sporting events.	[McCloskey, Brian; Memish, Ziad A.; Al-Rabeeah, Abdullah A.; Barbeschi, Maurizio; Heymann, David L.; Zumla, Alimuddin] Global Ctr Mass Gathering Med, Riyadh, Saudi Arabia; [McCloskey, Brian; Endericks, Tina; Zambon, Maria; Shetty, Nandini; Manuel, Rohini; Turbitt, Deborah; Heymann, David L.] Publ Hlth England, London SE1 8UG, England; [McCloskey, Brian; Endericks, Tina] Publ Hlth England, WHO Collaborating Ctr Mass Gatherings, London SE1 8UG, England; [Catchpole, Mike] Publ Hlth England, Ctr Infect Dis Surveillance & Control, London SE1 8UG, England; [McLauchlin, Jim] Publ Hlth England, Food Water & Environm Microbiol Serv, London SE1 8UG, England; [Smith, Gillian] Publ Hlth England, Real Time Syndr Surveillance Team, London SE1 8UG, England; [Crook, Paul] Publ Hlth England, Field Epidemiol Serv, London SE1 8UG, England; [Severi, Ettore] Publ Hlth England, European Programme Intervent Epidemiol Training, London SE1 8UG, England; [Jones, Jane] Publ Hlth England, Travel & Migrant Hlth Sect, London SE1 8UG, England; [Ibbotson, Sue] Publ Hlth England, PHE Ctr West Midlands, London SE1 8UG, England; [Marshall, Roberta] Publ Hlth England, North East PHE Ctr, London SE1 8UG, England; [Smallwood, Catherine A. H.; Isla, Nicolas; Barbeschi, Maurizio] WHO, CH-1211 Geneva, Switzerland; [Memish, Ziad A.; Al-Rabeeah, Abdullah A.] Minist Hlth, Riyadh, Saudi Arabia; [Memish, Ziad A.] Al Faisal Univ, Riyadh, Saudi Arabia; [Heymann, David L.] Chatham House, Royal Inst Int Affairs, London, England; [Heymann, David L.] London Sch Hyg & Trop Med, London WC1, England; [Zumla, Alimuddin] UCL, Div Infect & Immun, London, England; [Zumla, Alimuddin] Univ Coll London Hosp NHS Fdn Trust, London, England	Public Health England; Public Health England; Public Health England; Public Health England; Public Health England; Public Health England; Public Health England; Public Health England; Public Health England; Public Health England; World Health Organization; Ministry of Health - Saudi Arabia; Alfaisal University; University of London; London School of Hygiene & Tropical Medicine; University of London; University College London; University College London Hospitals NHS Foundation Trust; University of London; University College London	McCloskey, B (corresponding author), Publ Hlth England, Wellington House,133-135 Waterloo Rd, London SE1 8UG, England.	Brian.McCloskey@phe.gov.uk	ZUMLA, Alimuddin/ABA-8208-2020; Memish, Ziad Ahmed/AEJ-9424-2022	ZUMLA, Alimuddin/0000-0002-5111-5735; Memish, Ziad Ahmed/0000-0002-5099-0714; Crook, Paul/0000-0003-4965-2619				Abubakar I, 2012, LANCET INFECT DIS, V12, P66, DOI 10.1016/S1473-3099(11)70246-8; Amiri N, 2010, CAN MED ASSOC J, V182, pE229, DOI 10.1503/cmaj.109-3170; Bishop NC, 2012, FUTURE MICROBIOL, V7, P913, DOI [10.2217/FMB.12.65, 10.2217/fmb.12.65]; Blyth CC, 2010, EMERG INFECT DIS, V16, P809, DOI 10.3201/eid1605.091136; Botelho-Nevers E, 2010, J TRAVEL MED, V17, P197, DOI 10.1111/j.1708-8305.2010.00410.x; Brockmann S, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-91; Crampin M, 1999, EUR J CLIN MICROBIOL, V18, P286, DOI 10.1007/s100960050278; Elliot AJ, 2012, EMERG MED J, V29, P954, DOI 10.1136/emermed-2011-200684; Enock KE, 2008, PUBLIC HEALTH, V122, P1229, DOI 10.1016/j.puhe.2008.04.016; Gulland A, 2012, BRIT MED J, V344, DOI 10.1136/bmj.e3620; Gundlapalli AV, 2006, EMERG INFECT DIS, V12, P144, DOI 10.3201/eid1201.050645; Gutierrez I, 2009, EUROSURVEILLANCE, V14, P18; Harcourt SE, 2012, EPIDEMIOL INFECT, V140, P2152, DOI 10.1017/S0950268812001781; Health Protection Agency, S E REG REP LOND 201; Health Protection Agency, CTR RAD CHEM ENV HAZ; Health Protection Agency, LOCOG POL LOND 2012; Health Protection Agency, 2012, S W REG REP LOND 201; Health Protection Agency, LEARN LOND 2012 PRAC; Health Protection Agency, INT INF DIS SURV LON; Health Protection Agency, LOND REG REP LOND 20; Health Protection Agency, MICR SERV PREP RESP; Health Protection Agency, SYNDR SURV REP LOND; Health Protection Agency, 2013, SHAR KNOWL EXP LOND; Health Protection Agency (HPA), 2012, SYNDR SYST B ARCH; Heinsbroek E, 2012, EUROSURVEILLANCE, V17, P16; Jones J, 2013, EUROSURVEILLANCE, V18, P23, DOI 10.2807/1560-7917.ES2013.18.32.20554; Jorm LR, 2003, J EPIDEMIOL COMMUN H, V57, P102, DOI 10.1136/jech.57.2.102; LEE LA, 1991, AM J EPIDEMIOL, V133, P608, DOI 10.1093/oxfordjournals.aje.a115933; Lim HC, 2010, BRIT J SPORT MED, V44, P528, DOI 10.1136/bjsm.2009.069831; Loncarevic G, 2009, EUROSURVEILLANCE, V14, P14; London 2012, 2010, EV GAM GUID LOND 201; Memish ZA, 2010, J ROY SOC MED, V103, P386, DOI 10.1258/jrsm.2010.100263; Moran-Gilad J, 2012, EPIDEMIOL INFECT, V140, P2142, DOI 10.1017/S0950268812001835; MORGAN D, 1994, EUR J EPIDEMIOL, V10, P581, DOI 10.1007/BF01719576; Morgan J, 2002, CLIN INFECT DIS, V34, P1593, DOI 10.1086/340615; Moy GG, 2010, FOODBORNE PATHOG DIS, V7, P981, DOI 10.1089/fpd.2009.0473; Office for National Statistics (ONS), 2012, LOND 2012 GAM ATTR H; Schmid D, 2008, Euro Surveill, V13; Sejvar J, 2003, EMERG INFECT DIS, V9, P702; Severi E, 2012, EUROSURVEILLANCE, V17, P8; Smith G E, 2006, Euro Surveill, V11, P220; Smith G, 2007, J PUBLIC HEALTH, V29, P75, DOI 10.1093/pubmed/fdl078; Thackway S, 2009, BMC PUBLIC HEALTH, V9, DOI 10.1186/1471-2458-9-324; Tsouros AD, 2007, MASS GATHERINGS PUBL; World Health Organisation (WHO), 2008, COMM DIS AL RESP MAS; World Health Organization (WHO EURO), 2012, HLTH PLANN LARG PUBL	46	55	55	1	27	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	JUN 14	2014	383	9934					2083	2089		10.1016/S0140-6736(13)62342-9	http://dx.doi.org/10.1016/S0140-6736(13)62342-9			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AI9VZ	24857700	Green Published, hybrid			2022-12-28	WOS:000337292400028
J	Roberts, JW				Roberts, Jeffrey W.			MOLECULAR BIOLOGY Molecular basis of transcription pausing	SCIENCE			English	Editorial Material							RNA-POLYMERASE; STRUCTURAL BASIS; SITE		Cornell Univ, Dept Mol Biol & Genet, Ithaca, NY 14853 USA	Cornell University	Roberts, JW (corresponding author), Cornell Univ, Dept Mol Biol & Genet, Ithaca, NY 14853 USA.	jwr7@cornell.edu						Chamberlin M., 1976, RNA POLYMERASE, V6, P193; CHAN CL, 1993, J MOL BIOL, V233, P25, DOI 10.1006/jmbi.1993.1482; Churchman LS, 2011, NATURE, V469, P368, DOI 10.1038/nature09652; Herbert KM, 2006, CELL, V125, P1083, DOI 10.1016/j.cell.2006.04.032; LANDICK R, 1996, ESCHERICHIA COLI SAL, V1, P1263; Larson MH, 2014, SCIENCE, V344, P1042, DOI 10.1126/science.1251871; LEE DN, 1990, J BIOL CHEM, V265, P15145; Perdue SA, 2011, J MOL BIOL, V412, P782, DOI 10.1016/j.jmb.2011.02.011; Toulokhonov I, 2007, MOL CELL, V27, P406, DOI 10.1016/j.molcel.2007.06.008; Vvedenskaya IO, 2014, SCIENCE, V344, P1285, DOI 10.1126/science.1253458; Weixlbaumer A, 2013, CELL, V152, P431, DOI 10.1016/j.cell.2012.12.020; Zhang Y, 2012, SCIENCE, V338, P1076, DOI 10.1126/science.1227786	12	2	2	1	17	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 13	2014	344	6189					1226	1227		10.1126/science.1255712	http://dx.doi.org/10.1126/science.1255712			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI7ND	24926002				2022-12-28	WOS:000337077500018
J	Hollowed, AB; Sundby, S				Hollowed, Anne B.; Sundby, Svein			ECOLOGY Change is coming to the northern oceans	SCIENCE			English	Editorial Material							POLLOCK THERAGRA-CHALCOGRAMMA; EASTERN BERING-SEA; CLIMATE-CHANGE; RECRUITMENT; ATLANTIC		[Hollowed, Anne B.] NOAA, Alaska Fisheries Sci Ctr, Natl Marine Fisheries Serv, Seattle, WA 98115 USA; [Sundby, Svein] Inst Marine Res, N-5005 Bergen, Norway; [Sundby, Svein] Hjort Ctr Marine Ecosyst Dynam, N-5005 Bergen, Norway	National Oceanic Atmospheric Admin (NOAA) - USA; Institute of Marine Research - Norway	Hollowed, AB (corresponding author), NOAA, Alaska Fisheries Sci Ctr, Natl Marine Fisheries Serv, Seattle, WA 98115 USA.	anne.hollowed@noaa.gov; svein.sundby@imr.no		Sundby, Svein/0000-0002-0815-9740				Drinkwater KF, 2006, PROG OCEANOGR, V68, P134, DOI 10.1016/j.pocean.2006.02.011; ELLERTSEN B, 1989, RAP PROCES, V191, P209; Gaichas S, 2009, PROG OCEANOGR, V81, P47, DOI 10.1016/j.pocean.2009.04.005; Heintz RA, 2013, DEEP-SEA RES PT II, V94, P150, DOI 10.1016/j.dsr2.2013.04.006; International Council for the Exploration of the Sea, 2013, 2013ACOM05 ICES CM, P05; Kjesbu OS, 2014, P NATL ACAD SCI USA, V111, P3478, DOI 10.1073/pnas.1316342111; Kotwicki S, 2013, DEEP-SEA RES PT II, V94, P231, DOI 10.1016/j.dsr2.2013.03.017; Mueter FJ, 2011, ICES J MAR SCI, V68, P1284, DOI 10.1093/icesjms/fsr022; NAKKEN O, 1994, ICES MAR SC, V198, P212; North Pacific Fishery Management Council (NPFMC), 2013, BER SEA AL ISL GROUN; Overland JE, 2012, DEEP-SEA RES PT II, V65-70, P6, DOI 10.1016/j.dsr2.2012.02.013; Saetersdal B., 1987, FISH RES, V5, P253; Sigler MF, 2011, OCEANOGRAPHY, V24, P250, DOI 10.5670/oceanog.2011.77; Sundby S, 2008, ICES J MAR SCI, V65, P953, DOI 10.1093/icesjms/fsn085	14	33	35	1	56	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 6	2014	344	6188					1084	1085		10.1126/science.1251166	http://dx.doi.org/10.1126/science.1251166			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AI3UU	24904138				2022-12-28	WOS:000336791200019
J	Thiele, S; Balestro, F; Ballou, R; Klyatskaya, S; Ruben, M; Wernsdorfer, W				Thiele, Stefan; Balestro, Franck; Ballou, Rafik; Klyatskaya, Svetlana; Ruben, Mario; Wernsdorfer, Wolfgang			Electrically driven nuclear spin resonance in single-molecule magnets	SCIENCE			English	Article							ELECTRON-SPIN; QUANTUM-DOT; READ-OUT; MAGNETIZATION; CIRCUIT; SILICON; QUBIT	Recent advances in addressing isolated nuclear spins have opened up a path toward using nuclear-spin-based quantum bits. Local magnetic fields are normally used to coherently manipulate the state of the nuclear spin; however, electrical manipulation would allow for fast switching and spatially confined spin control. Here, we propose and demonstrate coherent single nuclear spin manipulation using electric fields only. Because there is no direct coupling between the spin and the electric field, we make use of the hyperfine Stark effect as a magnetic field transducer at the atomic level. This quantum-mechanical process is present in all nuclear spin systems, such as phosphorus or bismuth atoms in silicon, and offers a general route toward the electrical control of nuclear-spin-based devices.	[Thiele, Stefan; Balestro, Franck; Ballou, Rafik; Wernsdorfer, Wolfgang] CNRS, Inst NEEL, F-38042 Grenoble, France; [Thiele, Stefan; Balestro, Franck; Ballou, Rafik; Wernsdorfer, Wolfgang] Univ Grenoble Alpes, Inst NEEL, F-38042 Grenoble, France; [Balestro, Franck] Inst Univ France, F-75005 Paris, France; [Klyatskaya, Svetlana; Ruben, Mario] Karlsruhe Inst Technol, Inst Nanotechnol, D-76344 Eggenstein Leopoldshafen, Germany; [Ruben, Mario] CNRS, Inst Phys & Chim Mat Strasbourg, F-67034 Strasbourg, France	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); Institut Universitaire de France; Helmholtz Association; Karlsruhe Institute of Technology; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg	Wernsdorfer, W (corresponding author), CNRS, Inst NEEL, F-38042 Grenoble, France.	wolfgang.wernsdorfer@neel.cnrs.fr	Ruben, Mario/C-6816-2008; BALLOU, Rafik/H-9893-2019; Wernsdorfer, Wolfgang/M-2280-2016	Ruben, Mario/0000-0002-7718-7016; BALLOU, Rafik/0000-0002-9308-1860; Wernsdorfer, Wolfgang/0000-0003-4602-5257; Cador, Olivier/0000-0003-2064-6223	MoQuaS [FP7-ICT-2013-10]; Deutsche Forschungsgemeinschaft [SPP 1459, TRR 88 3Met, ANR-12-JS10-007, ANR-13-BS10-0001 MolQuSpin]; European Research Council [226558]	MoQuaS; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); European Research Council(European Research Council (ERC)European Commission)	This work was partially supported by MoQuaS FP7-ICT-2013-10, the Deutsche Forschungsgemeinschaft Programs no. SPP 1459 and TRR 88 3Met, ANR-12-JS10-007, ANR-13-BS10-0001 MolQuSpin, and European Research Council Advanced Grant MolNanoSpin no. 226558. The samples were manufactured at the NANOFAB facilities of the Neel Institute. We acknowledge E. Bonet, O. Buisson, Y. Deschanels, F. Evers, E. Eyraud, O. Gaier, M. Ganzhorn, C. Godfrin, C. Grupe, C. Hoarau, D. Lepoittevin, T. Meunier, N. Roch, C. Thirion, M. Urdampiletta, and R. Vincent.	BAKER JM, 1965, PROC R SOC LON SER-A, V286, P352, DOI 10.1098/rspa.1965.0149; DiCarlo L, 2010, NATURE, V467, P574, DOI 10.1038/nature09416; Elzerman JM, 2004, NATURE, V430, P431, DOI 10.1039/nature02693; Friedman JR, 1996, PHYS REV LETT, V76, P3830, DOI 10.1103/PhysRevLett.76.3830; Ganzhorn M, 2013, NAT NANOTECHNOL, V8, P165, DOI [10.1038/nnano.2012.258, 10.1038/NNANO.2012.258]; HAUN RD, 1957, PHYS REV, V107, P107, DOI 10.1103/PhysRev.107.107; HUTCHISON CA, 1958, J CHEM PHYS, V29, P754, DOI 10.1063/1.1744587; Ishikawa N, 2005, ANGEW CHEM INT EDIT, V44, P2931, DOI 10.1002/anie.200462638; Kane BE, 1998, NATURE, V393, P133, DOI 10.1038/30156; Koppens FHL, 2006, NATURE, V442, P766, DOI 10.1038/nature05065; Landau L., 1932, PHYZ SOWJETUNION, V2, P46, DOI DOI 10.1098/RSPA.1932.0165; Loss D, 1998, PHYS REV A, V57, P120, DOI 10.1103/PhysRevA.57.120; Maurer PC, 2012, SCIENCE, V336, P1283, DOI 10.1126/science.1220513; Neumann P, 2010, SCIENCE, V329, P542, DOI 10.1126/science.1189075; Obata T, 2007, REV SCI INSTRUM, V78, DOI 10.1063/1.2799735; Pla JJ, 2013, NATURE, V496, P334, DOI 10.1038/nature12011; Rahman R, 2007, PHYS REV LETT, V99, DOI 10.1103/PhysRevLett.99.036403; Thiele S, 2013, PHYS REV LETT, V111, DOI 10.1103/PhysRevLett.111.037203; Thomas L, 1996, NATURE, V383, P145, DOI 10.1038/383145a0; Urdampilleta M, 2013, PHYS REV B, V87, DOI 10.1103/PhysRevB.87.195412; Vincent R, 2012, NATURE, V488, P357, DOI 10.1038/nature11341; Wallraff A, 2004, NATURE, V431, P162, DOI 10.1038/nature02851; Zener C, 1932, P R SOC LOND A-CONTA, V137, P696, DOI 10.1098/rspa.1932.0165	24	549	552	10	325	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 6	2014	344	6188					1135	1138		10.1126/science.1249802	http://dx.doi.org/10.1126/science.1249802			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI3UU	24904159				2022-12-28	WOS:000336791200041
J	Zhang, Z; Wang, J; Schultz, N; Zhang, F; Parhad, SS; Tu, S; Vreven, T; Zamore, PD; Weng, ZP; Theurkauf, WE				Zhang, Zhao; Wang, Jie; Schultz, Nadine; Zhang, Fan; Parhad, Swapnil S.; Tu, Shikui; Vreven, Thom; Zamore, Phillip D.; Weng, Zhiping; Theurkauf, William E.			The HP1 Homolog Rhino Anchors a Nuclear Complex that Suppresses piRNA Precursor Splicing	CELL			English	Article							WIDE RNAI SCREEN; I-TASSER; PROTEIN; HETEROCHROMATIN; REQUIRES; PATHWAY; GENE; CAP; MECHANISM; CUTOFF	piRNAs guide an adaptive genome defense system that silences transposons during germline development. The Drosophila HP1 homolog Rhino is required for germline piRNA production. We show that Rhino binds specifically to the heterochromatic clusters that produce piRNA precursors, and that binding directly correlates with piRNA production. Rhino colocalizes to germline nuclear foci with Rai1/DXO-related protein Cuff and the DEAD box protein UAP56, which are also required for germline piRNA production. RNA sequencing indicates that most cluster transcripts are not spliced and that rhino, cuff, and uap56 mutations increase expression of spliced cluster transcripts over 100-fold. LacI::Rhino fusion protein binding suppresses splicing of a reporter transgene and is sufficient to trigger piRNA production from a trans combination of sense and antisense reporters. We therefore propose that Rhino anchors a nuclear complex that suppresses cluster transcript splicing and speculate that stalled splicing differentiates piRNA precursors from mRNAs.	[Zhang, Zhao; Schultz, Nadine; Zhang, Fan; Theurkauf, William E.] Univ Massachusetts, Sch Med, Program Mol Med, Worcester, MA 01605 USA; [Wang, Jie; Tu, Shikui; Vreven, Thom; Weng, Zhiping] Univ Massachusetts, Sch Med, Program Bioinformat & Integrat Biol, Worcester, MA 01605 USA; [Zhang, Zhao; Zamore, Phillip D.] Univ Massachusetts, Sch Med, Dept Biochem & Mol Pharmacol, Worcester, MA 01605 USA; [Zhang, Zhao; Zamore, Phillip D.] Univ Massachusetts, Sch Med, RNA Therapeut Inst, Worcester, MA 01605 USA; [Zamore, Phillip D.] Howard Hughes Med Inst, Chevy Chase, MD USA	University of Massachusetts System; University of Massachusetts Worcester; University of Massachusetts System; University of Massachusetts Worcester; University of Massachusetts System; University of Massachusetts Worcester; University of Massachusetts System; University of Massachusetts Worcester; Howard Hughes Medical Institute	Weng, ZP (corresponding author), Univ Massachusetts, Sch Med, Program Bioinformat & Integrat Biol, 368 Plantation St, Worcester, MA 01605 USA.	zhiping.weng@umassmed.edu; william.theurkauf@umassmed.edu	Parhad, Swapnil S./J-7174-2019	Parhad, Swapnil S./0000-0002-5723-9384; Zamore, Phillip/0000-0002-4505-9618; Theurkauf, William/0000-0001-7342-1912	National Institute of Child Health and Human Development, NIH [R01HD049116]; National Institutes of Health [GM62862]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD049116] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM062862, R37GM062862] Funding Source: NIH RePORTER	National Institute of Child Health and Human Development, NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank members of the Theurkauf and Weng labs and the UMass RNA biology community for critical feedback and encouragement. This work was supported by a grant R01HD049116 from the National Institute of Child Health and Human Development, NIH, to W. E. T., Z.W. and P.D.Z., and in part by National Institutes of Health grant GM62862 to P.D.Z.	Aravin A, 2006, NATURE, V442, P203, DOI 10.1038/nature04916; Beck CR, 2010, CELL, V141, P1159, DOI 10.1016/j.cell.2010.05.021; Bennetzen JL, 2000, PLANT MOL BIOL, V42, P251, DOI 10.1023/A:1006344508454; Brennecke J, 2007, CELL, V128, P1089, DOI 10.1016/j.cell.2007.01.043; Chen Y, 2007, CURR BIOL, V17, P637, DOI 10.1016/j.cub.2007.02.027; Czech B, 2013, MOL CELL, V50, P749, DOI 10.1016/j.molcel.2013.04.007; Danzer JR, 2004, DEVELOPMENT, V131, P3571, DOI 10.1242/dev.01223; Dumesic PA, 2013, CELL, V152, P957, DOI 10.1016/j.cell.2013.01.046; Fleckner J, 1997, GENE DEV, V11, P1864, DOI 10.1101/gad.11.14.1864; Girard A, 2006, NATURE, V442, P199, DOI 10.1038/nature04917; Gornemann J, 2005, MOL CELL, V19, P53, DOI 10.1016/j.molcel.2005.05.007; Graveley BR, 2011, NATURE, V471, P473, DOI 10.1038/nature09715; Grewal SIS, 2010, CURR OPIN GENET DEV, V20, P134, DOI 10.1016/j.gde.2010.02.003; Grivna ST, 2006, GENE DEV, V20, P1709, DOI 10.1101/gad.1434406; Gunawardane LS, 2007, SCIENCE, V315, P1587, DOI 10.1126/science.1140494; Guzzardo PM, 2013, CURR OPIN GENET DEV, V23, P44, DOI 10.1016/j.gde.2012.12.003; Handler D, 2013, MOL CELL, V50, P762, DOI 10.1016/j.molcel.2013.04.031; Horwich MD, 2007, CURR BIOL, V17, P1265, DOI 10.1016/j.cub.2007.06.030; Iida T, 2008, MOL CELL, V31, P178, DOI 10.1016/j.molcel.2008.07.003; IZAURRALDE E, 1994, CELL, V78, P657, DOI 10.1016/0092-8674(94)90530-4; Jiao XF, 2013, MOL CELL, V50, P104, DOI 10.1016/j.molcel.2013.02.017; Keller C, 2012, MOL CELL, V47, P215, DOI 10.1016/j.molcel.2012.05.009; Khurana JS, 2011, CELL, V147, P1551, DOI 10.1016/j.cell.2011.11.042; Khurana JS, 2010, J CELL BIOL, V191, P905, DOI 10.1083/jcb.201006034; Klattenhoff C, 2009, CELL, V138, P1137, DOI 10.1016/j.cell.2009.07.014; Lau NC, 2006, SCIENCE, V313, P363, DOI 10.1126/science.1130164; Li CJ, 2009, CELL, V137, P509, DOI 10.1016/j.cell.2009.04.027; Malone CD, 2009, CELL, V137, P522, DOI 10.1016/j.cell.2009.03.040; MCCLINTOCK B, 1950, P NATL ACAD SCI USA, V36, P344, DOI 10.1073/pnas.36.6.344; Muerdter F, 2013, MOL CELL, V50, P736, DOI 10.1016/j.molcel.2013.04.006; Muerdter F, 2012, RNA, V18, P42, DOI 10.1261/rna.029769.111; Pane A, 2011, EMBO J, V30, P4601, DOI 10.1038/emboj.2011.334; Quinlan AR, 2010, BIOINFORMATICS, V26, P841, DOI 10.1093/bioinformatics/btq033; Roy A, 2010, NAT PROTOC, V5, P725, DOI 10.1038/nprot.2010.5; Saito K, 2007, GENE DEV, V21, P1603, DOI 10.1101/gad.1563607; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; Siomi MC, 2011, NAT REV MOL CELL BIO, V12, P246, DOI 10.1038/nrm3089; Tabach Y, 2013, NATURE, V493, P694, DOI 10.1038/nature11779; Topisirovic I, 2011, WIRES RNA, V2, P277, DOI 10.1002/wrna.52; Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120; Vagin VV, 2006, SCIENCE, V313, P320, DOI 10.1126/science.1129333; Verdel A, 2004, SCIENCE, V303, P672, DOI 10.1126/science.1093686; Zhang F, 2012, CELL, V151, P871, DOI 10.1016/j.cell.2012.09.040; Zhang Y, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-40; Zhang Zhao, 2012, Silence, V3, P9, DOI 10.1186/1758-907X-3-9; Zhang Z, 2011, MOL CELL, V44, P572, DOI 10.1016/j.molcel.2011.10.011	46	133	139	0	19	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUN 5	2014	157	6					1353	1363		10.1016/j.cell.2014.04.030	http://dx.doi.org/10.1016/j.cell.2014.04.030			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	AN8UV	24906152	Green Accepted, Bronze			2022-12-28	WOS:000340881400012
J	Fakhri, N; Wessel, AD; Willms, C; Pasquali, M; Klopfenstein, DR; MacKintosh, FC; Schmidt, CF				Fakhri, Nikta; Wessel, Alok D.; Willms, Charlotte; Pasquali, Matteo; Klopfenstein, Dieter R.; MacKintosh, Frederick C.; Schmidt, Christoph F.			High-resolution mapping of intracellular fluctuations using carbon nanotubes	SCIENCE			English	Article							MULTIPLE-PARTICLE-TRACKING; BLEBBISTATIN INHIBITION; CELL MECHANICS; LIVING CELLS; LIVE CELLS; MYOSIN-II; SINGLE; TRANSPORT; MOVEMENT; MOTORS	Cells are active systems with molecular force generation that drives complex dynamics at the supramolecular scale. We present a quantitative study of molecular motions in cells over times from milliseconds to hours. Noninvasive tracking was accomplished by imaging highly stable near-infrared luminescence of single-walled carbon nanotubes targeted to kinesin-1 motor proteins in COS-7 cells. We observed a regime of active random "stirring" that constitutes an intermediate mode of transport, different from both thermal diffusion and directed motor activity. High-frequency motion was found to be thermally driven. At times greater than 100 milliseconds, nonequilibrium dynamics dominated. In addition to directed transport along microtubules, we observed strong random dynamics driven by myosins that result in enhanced nonspecific transport. We present a quantitative model connecting molecular mechanisms to mesoscopic fluctuations.	[Fakhri, Nikta; Wessel, Alok D.; Willms, Charlotte; Klopfenstein, Dieter R.; Schmidt, Christoph F.] Univ Gottingen, Drittes Phys Inst Biophys, D-37077 Gottingen, Germany; [Pasquali, Matteo] Rice Univ, Smalley Inst Nanoscale Sci & Technol, Dept Chem & Biomol Engn, Dept Chem, Houston, TX 77005 USA; [MacKintosh, Frederick C.] Vrije Univ Amsterdam, Dept Phys & Astron, NL-1081 HV Amsterdam, Netherlands	University of Gottingen; Rice University; Vrije Universiteit Amsterdam	MacKintosh, FC (corresponding author), Vrije Univ Amsterdam, Dept Phys & Astron, NL-1081 HV Amsterdam, Netherlands.	fcmack@gmail.com; christoph.schmidt@phys.uni-goettingen.de	MacKintosh, Frederick/AAB-9332-2021; MacKintosh, Fred C/A-9450-2008; Fakhri, Nikta/B-4657-2008; Schmidt, Christoph/G-3787-2011; Pasquali, Matteo/A-2489-2008	MacKintosh, Frederick/0000-0002-2607-9541; MacKintosh, Fred C/0000-0002-2607-9541; Fakhri, Nikta/0000-0003-1261-7465; Schmidt, Christoph/0000-0003-2864-6973; Pasquali, Matteo/0000-0001-5951-395X	Center for Nanoscale Microscopy and Molecular Physiology of the Brain - Deutsche Forschungsgemeinschaft; Collaborative Research Center - Deutsche Forschungsgemeinschaft [SFB 937]; Foundation for Fundamental Research on Matter of the Netherlands Organization for Scientific Research, Welch Foundation [C-1668]; NSF [NSF PHY11-25915]; Human Frontier Science Program Fellowship	Center for Nanoscale Microscopy and Molecular Physiology of the Brain - Deutsche Forschungsgemeinschaft; Collaborative Research Center - Deutsche Forschungsgemeinschaft; Foundation for Fundamental Research on Matter of the Netherlands Organization for Scientific Research, Welch Foundation; NSF(National Science Foundation (NSF)); Human Frontier Science Program Fellowship(Human Frontier Science Program)	We thank L. Cognet, J. Enderlein, M. Guo, J. Lippincott-Schwartz, and D. A. Weitz for helpful discussions; I. Schaap and M. Platen for atomic force microscopy measurements; and the Kavli Institute for Theoretical Physics (University of California, Santa Barbara) for hospitality and useful discussions. Supported by the Center for Nanoscale Microscopy and Molecular Physiology of the Brain and the Collaborative Research Center SFB 937 (Project A2), both funded by the Deutsche Forschungsgemeinschaft, as well as by the Foundation for Fundamental Research on Matter of the Netherlands Organization for Scientific Research, Welch Foundation grant C-1668, and NSF grant NSF PHY11-25915. N.F. was supported by a Human Frontier Science Program Fellowship. N. F. and C. F. S. are inventors on a provisional U. S. patent application on the method used in the paper, filed by Georg-August-Universitat. The single-walled carbon nanotubes are available from M. P. under a material transfer agreement with Rice University.	Bachilo SM, 2002, SCIENCE, V298, P2361, DOI 10.1126/science.1078727; Balint S, 2013, P NATL ACAD SCI USA, V110, P3375, DOI 10.1073/pnas.1219206110; Basu A, 2008, EUR PHYS J E, V27, P149, DOI 10.1140/epje/i2008-10364-9; Berciaud S, 2008, PHYS REV LETT, V101, DOI 10.1103/PhysRevLett.101.077402; Brangwynne CP, 2006, J CELL BIOL, V173, P733, DOI 10.1083/jcb.200601060; Brangwynne CP, 2008, PHYS REV LETT, V100, DOI 10.1103/PhysRevLett.100.118104; Brangwynne CP, 2008, J CELL BIOL, V183, P583, DOI 10.1083/jcb.200806149; Cai DW, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000216; Courty S, 2006, NANO LETT, V6, P1491, DOI 10.1021/nl060921t; Crocker JC, 2007, METHOD CELL BIOL, V83, P141, DOI 10.1016/S0091-679X(07)83007-X; Dunn S, 2008, J CELL SCI, V121, P1085, DOI 10.1242/jcs.026492; Fabry B, 2001, PHYS REV LETT, V87, DOI 10.1103/PhysRevLett.87.148102; Fakhri N, 2010, SCIENCE, V330, P1804, DOI 10.1126/science.1197321; Fakhri N, 2009, P NATL ACAD SCI USA, V106, P14219, DOI 10.1073/pnas.0904148106; Fletcher DA, 2010, NATURE, V463, P485, DOI 10.1038/nature08908; Greenleaf WJ, 2007, ANNU REV BIOPH BIOM, V36, P171, DOI 10.1146/annurev.biophys.36.101106.101451; Hirokawa N, 2009, NAT REV MOL CELL BIO, V10, P682, DOI 10.1038/nrm2774; Howard J., 2001, MECH MOTOR PROTEINS; Huang B, 2010, CELL, V143, P1047, DOI 10.1016/j.cell.2010.12.002; Huber F, 2013, ADV PHYS, V62, P1, DOI 10.1080/00018732.2013.771509; Janmey PA, 2007, ANNU REV BIOMED ENG, V9, P1, DOI 10.1146/annurev.bioeng.9.060906.151927; Kim H, 2013, REP PROG PHYS, V76, DOI 10.1088/0034-4885/76/1/016601; Kovacs M, 2004, J BIOL CHEM, V279, P35557, DOI 10.1074/jbc.M405319200; Kulic IM, 2008, P NATL ACAD SCI USA, V105, P10011, DOI 10.1073/pnas.0800031105; Lau AWC, 2003, PHYS REV LETT, V91, DOI 10.1103/PhysRevLett.91.198101; Leduc C, 2007, P NATL ACAD SCI USA, V104, P10847, DOI 10.1073/pnas.0701B64104; Levine AJ, 2009, J PHYS CHEM B, V113, P3820, DOI 10.1021/jp808192w; Los GV, 2008, ACS CHEM BIOL, V3, P373, DOI 10.1021/cb800025k; MacKintosh FC, 2008, PHYS REV LETT, V100, DOI 10.1103/PhysRevLett.100.018104; Ramamurthy B, 2004, BIOCHEMISTRY-US, V43, P14832, DOI 10.1021/bi0490284; Rubinstein M., 2003, POLYM PHYS CHEM; Straight AF, 2003, SCIENCE, V299, P1743, DOI 10.1126/science.1081412; Stricker J, 2010, J BIOMECH, V43, P9, DOI 10.1016/j.jbiomech.2009.09.003; Tseng Y, 2002, BIOPHYS J, V83, P3162, DOI 10.1016/S0006-3495(02)75319-8; Tsyboulski DA, 2005, NANO LETT, V5, P975, DOI 10.1021/nl050366f; Verhey KJ, 2011, ANNU REV BIOPHYS, V40, P267, DOI 10.1146/annurev-biophys-042910-155310; Weisman RB, 2010, ANAL BIOANAL CHEM, V396, P1015, DOI 10.1007/s00216-009-3062-8	39	143	145	1	202	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 30	2014	344	6187					1031	1035		10.1126/science.1250170	http://dx.doi.org/10.1126/science.1250170			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AH9WM	24876498				2022-12-28	WOS:000336495800046
J	Gumbinger, C; Reuter, B; Stock, C; Sauer, T; Wietholter, H; Bruder, I; Rode, S; Kern, R; Ringleb, P; Hennerici, MG; Hacke, W				Gumbinger, Christoph; Reuter, Bjoern; Stock, Christian; Sauer, Tamara; Wiethoelter, Horst; Bruder, Ingo; Rode, Susanne; Kern, Rolf; Ringleb, Peter; Hennerici, Michael G.; Hacke, Werner		AG Schlaganfall	Time to treatment with recombinant tissue plasminogen activator and outcome of stroke in clinical practice: retrospective analysis of hospital quality assurance data with comparison with results from randomised clinical trials	BMJ-BRITISH MEDICAL JOURNAL			English	Article							ACUTE ISCHEMIC-STROKE; INTRAVENOUS THROMBOLYSIS; SAFE IMPLEMENTATION; POOLED ANALYSIS; SITS-ISTR; ALTEPLASE; ATLANTIS; GERMANY; NINDS; ECASS	Objective To study the time dependent effectiveness of thrombolytic therapy for acute ischaemic stroke in daily clinical practice. Design A retrospective cohort study using data from a large scale, comprehensive population based state-wide stroke registry in Germany. Setting All 148 hospitals involved in acute stroke care in a large state in southwest Germany with 10.4 million inhabitants. Participants Data from 84 439 patients with acute ischaemic stroke were analysed, 10 263 (12%) were treated with thrombolytic therapy and 74 176 (88%) were not treated. Main outcome measures Primary endpoint was the dichotomised score on a modified Rankin scale at discharge ("favourable outcome" score 0 or 1 or "unfavourable outcome" score 2-6) analysed by binary logistic regression. Patients treated with recombinant tissue plasminogen activator (rtPA) were categorised according to time from onset of stroke to treatment. Analogous analyses were conducted for the association between rtPA treatment of stroke and in-hospital mortality. As a co-primary endpoint the chance of a lower modified Rankin scale score at discharge was analysed by ordinal logistic regression analysis (shift analysis). Results After adjustment for characteristics of patients, hospitals, and treatment, rtPA was associated with better outcome in a time dependent pattern. The number needed to treat ranged from 4.5 (within first 1.5 hours after onset; odds ratio 2.49) to 18.0 (up to 4.5 hours; odds ratio 1.26), while mortality did not vary up to 4.5 hours. Patients treated with rtPA beyond 4.5 hours (including mismatch based approaches) showed a significantly better outcome only in dichotomised analysis (odds ratio 1.25, 95% confidence interval 1.01 to 1.55) but the mortality risk was higher (1.45, 1.08 to 1.92). Conclusion The effectiveness of thrombolytic therapy in daily clinical practice might be comparable with the effectiveness shown in randomised clinical trials and pooled analysis. Early treatment was associated with favourable outcome in daily clinical practice, which underlines the importance of speeding up the process for thrombolytic therapy in hospital and before admission to achieve shorter time from door to needle and from onset to treatment for thrombolytic therapy.	[Gumbinger, Christoph; Ringleb, Peter; Hacke, Werner] Heidelberg Univ, Dept Neurol Heidelberg, D-69120 Heidelberg, Germany; [Reuter, Bjoern; Sauer, Tamara; Kern, Rolf; Hennerici, Michael G.] Heidelberg Univ, Dept Neurol Mannheim, D-68167 Mannheim, Germany; [Stock, Christian] Heidelberg Univ, Inst Med Biometry & Informat, D-69120 Heidelberg, Germany; [Bruder, Ingo; Rode, Susanne] Baden Wuerttemberg Hosp Federat, Off Qual Assurance Hosp GeQiK Stuttgart, D-70191 Stuttgart, Germany	Ruprecht Karls University Heidelberg; Ruprecht Karls University Heidelberg; Ruprecht Karls University Heidelberg	Hacke, W (corresponding author), Heidelberg Univ, Dept Neurol Heidelberg, D-69120 Heidelberg, Germany.	werner.hacke@med.uni-heidelberg.de	Hacke, Werner/ABE-8661-2020; Stock, Christian/F-6180-2015	Stock, Christian/0000-0002-3493-3234; Gumbinger, Christoph/0000-0002-6137-1169	department of neurology, University of Heidelberg, Heidelberg; department of neurology, Mannheim Campus; German network "Health Services Research Baden-Wuerttemberg" of the Ministry of Science, Research and Arts; Ministry of Employment and Social Order, Family, Women and Senior Citizens, Baden-Wuerttemberg; Institute for Applied Quality Improvement and Research in Health Care GmbH (AQUA Institute)	department of neurology, University of Heidelberg, Heidelberg; department of neurology, Mannheim Campus; German network "Health Services Research Baden-Wuerttemberg" of the Ministry of Science, Research and Arts; Ministry of Employment and Social Order, Family, Women and Senior Citizens, Baden-Wuerttemberg; Institute for Applied Quality Improvement and Research in Health Care GmbH (AQUA Institute)	This study was funded by internal research funds from the departments of neurology, University of Heidelberg, Heidelberg, and Mannheim Campus. The study was supported by the young scientists programme of the German network "Health Services Research Baden-Wuerttemberg" of the Ministry of Science, Research and Arts in collaboration with the Ministry of Employment and Social Order, Family, Women and Senior Citizens, Baden-Wuerttemberg, in collaboration with the Institute for Applied Quality Improvement and Research in Health Care GmbH (AQUA Institute) (scholarship holder CG). The sources of funding had no role in study design, data collection, analyses, interpretation, and decision to submit the article for publication.	Ahmed N, 2013, JAMA NEUROL, V70, P837, DOI 10.1001/jamaneurol.2013.406; Ahmed N, 2010, LANCET NEUROL, V9, P866, DOI 10.1016/S1474-4422(10)70165-4; Bath PMW, 2012, STROKE, V43, P1171, DOI 10.1161/STROKEAHA.111.641456; Bender R, 2002, J CLIN EPIDEMIOL, V55, P525, DOI 10.1016/S0895-4356(01)00510-8; BROTT T, 1989, STROKE, V20, P864, DOI 10.1161/01.STR.20.7.864; Dirks M, 2013, LANCET NEUROL, V12, P120, DOI 10.1016/S1474-4422(12)70304-6; Emberson JR, 2014, ISC 2014 SAN DIEG CA; Gumbinger C, 2013, NEUROEPIDEMIOLOGY, V41, P161, DOI 10.1159/000354356; Hacke W, 2004, LANCET, V363, P768; Hacke W, 2008, NEW ENGL J MED, V359, P1317, DOI 10.1056/NEJMoa0804656; Hacke W, 2008, CEREBROVASC DIS, V25, P457, DOI 10.1159/000131083; Lees KR, 2010, LANCET, V375, P1695, DOI 10.1016/S0140-6736(10)60491-6; MARLER JR, 1995, NEW ENGL J MED, V333, P1581, DOI 10.1056/nejm199512143332401; Meretoja A, 2012, NEUROLOGY, V79, P306, DOI 10.1212/WNL.0b013e31825d6011; Ovbiagele B, 2010, CEREBROVASC DIS, V29, P50, DOI 10.1159/000255974; Palm F, 2010, STROKE, V41, P1865, DOI 10.1161/STROKEAHA.110.592642; Sandercock P, 2012, LANCET, V379, P2352, DOI 10.1016/S0140-6736(12)60768-5; Saposnik G, 2005, NEUROLOGY, V65, P1169, DOI 10.1212/01.wnl.0000180687.75907.4b; Saver JL, 2007, STROKE, V38, P3055, DOI 10.1161/STROKEAHA.107.488536; Saver JL, 2013, JAMA-J AM MED ASSOC, V309, P2480, DOI 10.1001/jama.2013.6959; Scott PA, 2013, LANCET NEUROL, V12, P139, DOI 10.1016/S1474-4422(12)70311-3; Sobesky J, 2007, CEREBROVASC DIS, V24, P56, DOI 10.1159/000103117; Strbian D, 2010, STROKE, V41, P712, DOI 10.1161/STROKEAHA.109.571976; Wahlgren N, 2008, LANCET, V372, P1303, DOI 10.1016/S0140-6736(08)61339-2; Wahlgren N, 2007, LANCET, V369, P275, DOI 10.1016/S0140-6736(07)60149-4	25	58	64	0	11	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	MAY 30	2014	348								g3429	10.1136/bmj.g3429	http://dx.doi.org/10.1136/bmj.g3429			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AI3EO	24879819	Green Published, hybrid			2022-12-28	WOS:000336742800002
J	Reed, C				Reed, Christina			Winter is coming	SCIENCE			English	Editorial Material													Abreu, Carlos A F de/AGB-1792-2022	Abreu, Carlos A F de/0000-0001-5440-9563					0	0	0	0	6	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 30	2014	344	6187					1054	1054		10.1126/science.344.6187.1054	http://dx.doi.org/10.1126/science.344.6187.1054			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AH9WM	24876500				2022-12-28	WOS:000336495800050
J	Gogotsi, Y				Gogotsi, Yury			Energy storage wrapped up	NATURE			English	Editorial Material							ELECTRODES		Drexel Univ, AJ Drexel Nanomat Inst, Dept Mat Sci & Engn, Philadelphia, PA 19104 USA	Drexel University	Gogotsi, Y (corresponding author), Drexel Univ, AJ Drexel Nanomat Inst, Dept Mat Sci & Engn, Philadelphia, PA 19104 USA.	gogotsi@drexel.edu	Gogotsi, Yury/B-2167-2008	Gogotsi, Yury/0000-0001-9423-4032				[Anonymous], 2014, Science, V343, P600, DOI 10.1126/science.343.6171.600; Christodoulou L, 2003, JOM-J MIN MET MAT S, V55, P39, DOI 10.1007/s11837-003-0008-z; Conway BE, 2013, ELECTROCHEMICAL SUPE; Jost K., 2014, J MAT CHEM A; Kwon YH, 2012, ADV MATER, V24, P5192, DOI 10.1002/adma.201202196; Lindley D, 2010, NATURE, V463, P18, DOI 10.1038/463018a; Simon P, 2014, SCIENCE, V343, P1210, DOI 10.1126/science.1249625; Le VT, 2013, ACS NANO, V7, P5940, DOI 10.1021/nn4016345; Yu Z., 2014, ADV MAT	9	144	147	4	186	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 29	2014	509	7502					568	570		10.1038/509568a	http://dx.doi.org/10.1038/509568a			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AH9JC	24870536				2022-12-28	WOS:000336457100034
J	Wittenberg, M				Wittenberg, Marc			Will ultrasound scanners replace the stethoscope?	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												mwittenberg@bmj.com						Centre for Workforce Intelligence, 2012, SEC FUT WORKF SUPPL; European Federation of Societies for Ultrasound in Medicine and Biology, 2009, MIN TRAIN REQ PRACT; Monitor NHS England, 2014, 2014 15 NAT TAR PAYM; Moore CL, 2011, NEW ENGL J MED, V364, P749, DOI 10.1056/NEJMra0909487; Sippel S, 2011, INT J EMERG MED, V4, DOI 10.1186/1865-1380-4-72; The National Ultrasound Steering Group, 2008, ULTR CLIN GOV; The Royal College of Radiologists, 2012, INV CLIN RAD WORKF Q	7	18	19	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	MAY 29	2014	348								g3463	10.1136/bmj.g3463	http://dx.doi.org/10.1136/bmj.g3463			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AI3EK	24875141				2022-12-28	WOS:000336742400005
J	Watts, G				Watts, Geoff			Richard John Cremer Obituary	LANCET			English	Biographical-Item																			0	0	0	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	MAY 24	2014	383	9931					1800	1800		10.1016/S0140-6736(14)60871-0	http://dx.doi.org/10.1016/S0140-6736(14)60871-0			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AH6US	24868571				2022-12-28	WOS:000336267800014
J	Delidakis, C				Delidakis, Christos			Tempering Temperature Changes for Robust Development	CELL			English	Editorial Material							NOTCH RECEPTOR	Developmental signaling pathways needed to evolve to be robust against environmental fluctuations. In this issue, Shimizu et al. reveal a complex system of interacting endocytic pathways that help to maintain consistent levels of Notch activity across a range of temperatures.	[Delidakis, Christos] Univ Crete, Fdn Res & Technol Hellas, Inst Mol Biol & Biotechnol, Iraklion 70013, Greece; [Delidakis, Christos] Univ Crete, Dept Biol, Iraklion 70013, Greece	Foundation for Research & Technology - Hellas (FORTH); University of Crete; University of Crete	Delidakis, C (corresponding author), Univ Crete, Fdn Res & Technol Hellas, Inst Mol Biol & Biotechnol, Iraklion 70013, Greece.	delidaki@imbb.forth.gr		Delidakis, Christos/0000-0003-3912-701X				Hori K, 2013, J CELL SCI, V126, P2135, DOI 10.1242/jcs.127308; Hori K, 2011, J CELL BIOL, V195, P1005, DOI 10.1083/jcb.201104146; Lake RJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006728; Lauwers E, 2010, TRENDS CELL BIOL, V20, P196, DOI 10.1016/j.tcb.2010.01.004; Leonardi J, 2011, DEVELOPMENT, V138, P3569, DOI 10.1242/dev.068361; Musse AA, 2012, SEMIN CELL DEV BIOL, V23, P429, DOI 10.1016/j.semcdb.2012.01.011; Seugnet L, 1997, DEV BIOL, V192, P585, DOI 10.1006/dbio.1997.8723; Shimizu H, 2014, CELL, V157, P1160, DOI 10.1016/j.cell.2014.03.050; Vaccari T, 2010, DEVELOPMENT, V137, P1825, DOI 10.1242/dev.045484; Zhao YY, 2013, ELIFE, V2, DOI 10.7554/eLife.00459	10	0	0	0	6	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAY 22	2014	157	5					1010	1012		10.1016/j.cell.2014.05.007	http://dx.doi.org/10.1016/j.cell.2014.05.007			4	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	AH9CG	24855940	Bronze			2022-12-28	WOS:000336437200005
J	Tellis, JC; Primer, DN; Molander, GA				Tellis, John C.; Primer, David N.; Molander, Gary A.			Single-electron transmetalation in organoboron cross-coupling by photoredox/nickel dual catalysis	SCIENCE			English	Article							TRANSITION-METAL-COMPLEXES; REAGENTS; HALIDES; MECHANISMS; ALKENYL; COPPER; ACIDS; ARYL	The routine application of C-sp3-hybridized nucleophiles in cross-coupling reactions remains an unsolved challenge in organic chemistry. The sluggish transmetalation rates observed for the preferred organoboron reagents in such transformations are a consequence of the two-electron mechanism underlying the standard catalytic approach. We describe a mechanistically distinct single-electron transfer-based strategy for the activation of organoboron reagents toward transmetalation that exhibits complementary reactivity patterns. Application of an iridium photoredox catalyst in tandem with a nickel catalyst effects the cross-coupling of potassium alkoxyalkyl- and benzyltrifluoroborates with an array of aryl bromides under exceptionally mild conditions (visible light, ambient temperature, no strong base). The transformation has been extended to the asymmetric and stereoconvergent cross-coupling of a secondary benzyltrifluoroborate.	[Tellis, John C.; Primer, David N.; Molander, Gary A.] Univ Penn, Dept Chem, Roy & Diana Vagelos Labs, Philadelphia, PA 19104 USA	University of Pennsylvania	Molander, GA (corresponding author), Univ Penn, Dept Chem, Roy & Diana Vagelos Labs, Philadelphia, PA 19104 USA.	gmolandr@sas.upenn.edu		Primer, David/0000-0003-1764-4497	NIH [R01 GM-081376]; Pfizer; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM081376] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Pfizer(Pfizer); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Supported by NIH (grant R01 GM-081376) and Pfizer. We thank Frontier Scientific for providing all of the organoboron precursors used in our work.	Aufiero M, 2012, ANGEW CHEM INT EDIT, V51, P7226, DOI 10.1002/anie.201202504; Cannes C, 1996, J ELECTROANAL CHEM, V412, P85, DOI 10.1016/0022-0728(96)04605-0; Cordier CJ, 2013, J AM CHEM SOC, V135, P10946, DOI 10.1021/ja4054114; de Meijere A., 2004, METAL CATALYZED CROS, V2nd, DOI 10.1002/9783527619535; Deng JZ, 2009, ORG LETT, V11, P345, DOI 10.1021/ol802556f; Do HQ, 2013, J AM CHEM SOC, V135, P16288, DOI 10.1021/ja408561b; Doucet H, 2008, EUR J ORG CHEM, V2008, P2013, DOI 10.1002/ejoc.200700984; FINCH A, 1967, T FARADAY SOC, V63, P1880, DOI 10.1039/tf9676301880; Flaherty A, 2005, ORG LETT, V7, P4975, DOI 10.1021/ol051929x; Hartwig J. F, 2009, ORGANOTRANSITION MET; HAYASHI T, 1976, J AM CHEM SOC, V98, P3718, DOI 10.1021/ja00428a061; HAYASHI T, 1982, J AM CHEM SOC, V104, P180, DOI 10.1021/ja00365a033; Hegedus L. S., 2010, TRANSITION METALS SY; Imao D, 2009, J AM CHEM SOC, V131, P5024, DOI 10.1021/ja8094075; Jain P, 2013, J HETEROCYCLIC CHEM, V50, pE166, DOI 10.1002/jhet.1109; Kalyani D, 2011, J AM CHEM SOC, V133, P18566, DOI 10.1021/ja208068w; LABADIE JW, 1983, J AM CHEM SOC, V105, P6129, DOI 10.1021/ja00357a026; Li L, 2013, CHINA AGR ECON REV, V5, P5, DOI 10.1108/17561371311294739; Lockner JW, 2011, ORG LETT, V13, P5628, DOI 10.1021/ol2023505; Lowry MS, 2005, CHEM MATER, V17, P5712, DOI 10.1021/cm051312+; Miyazawa K, 2013, CHEM COMMUN, V49, P7249, DOI 10.1039/c3cc42695e; Molander GA, 2001, ORG LETT, V3, P393, DOI 10.1021/ol006896u; Molander GA, 2012, J AM CHEM SOC, V134, P16856, DOI 10.1021/ja307861n; Molander GA, 2011, ORG LETT, V13, P1852, DOI 10.1021/ol2003572; Moriya K, 2014, ORG LETT, V16, P924, DOI 10.1021/ol403673e; Prier CK, 2013, CHEM REV, V113, P5322, DOI 10.1021/cr300503r; Rudolph A, 2009, ANGEW CHEM INT EDIT, V48, P2656, DOI 10.1002/anie.200803611; Sahoo B, 2013, J AM CHEM SOC, V135, P5505, DOI 10.1021/ja400311h; Schultz DM, 2014, SCIENCE, V343, P985, DOI 10.1126/science.1239176; Welsch ME, 2010, CURR OPIN CHEM BIOL, V14, P347, DOI 10.1016/j.cbpa.2010.02.018; Yasu Y, 2012, ADV SYNTH CATAL, V354, P3414, DOI 10.1002/adsc.201200588; Ye YD, 2012, J AM CHEM SOC, V134, P9034, DOI 10.1021/ja301553c; Zou G, 2001, TETRAHEDRON LETT, V42, P7213, DOI 10.1016/S0040-4039(01)01536-2	33	830	831	26	511	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 25	2014	345	6195					433	436		10.1126/science.1253647	http://dx.doi.org/10.1126/science.1253647			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM2CB	24903560	Green Accepted			2022-12-28	WOS:000339655100038
J	Popow, J; Jurkin, J; Schleiffer, A; Martinez, J				Popow, Johannes; Jurkin, Jennifer; Schleiffer, Alexander; Martinez, Javier			Analysis of orthologous groups reveals archease and DDX1 as tRNA splicing factors	NATURE			English	Article							3,5-PHOSPHODIESTER LINKAGE; M(5)C METHYLTRANSFERASE; SUBSTRATE-SPECIFICITY; JUNCTION PHOSPHATE; SEQUENCE ALIGNMENT; VIRUS-REPLICATION; CELL EXTRACT; LIGASE; PROTEINS; COMPLEX	RNA ligases have essential roles in many cellular processes in eukaryotes, archaea and bacteria, including in RNA repair(1,2) and stress-induced splicing of messenger RNA(3). In archaea and eukaryotes, RNA ligases also have a role in transfer RNA splicing to generate functional tRNAs required for protein synthesis(4-7). We recently identified the human tRNA splicing ligase, a multimeric protein complex with RTCB (also known as HSPC117, C22orf28, FAAP and D10Wsu52e) as the essential subunit(8). The functions of the additional complex components ASW (also known as C2orf49), CGI-99 (also known as C14orf166), FAM98B and the DEAD-box helicase DDX1 in the context of RNA ligation have remained unclear. Taking advantage of clusters of eukaryotic orthologous groups, here we find that archease (ARCH; also known as ZBTB8OS), a protein of unknown function, is required for full activity of the human tRNA ligase complex and, in cooperation with DDX1, facilitates the formation of an RTCB-guanylate intermediate central to mammalian RNA ligation. Our findings define a role for DDX1 in the context of the human tRNA ligase complex and suggest that the widespread co-occurrence of archease and RtcB proteins implies evolutionary conservation of their functional interplay.	[Popow, Johannes; Jurkin, Jennifer; Martinez, Javier] Austrian Acad Sci IMBA, Inst Mol Biotechnol, A-1030 Vienna, Austria; [Popow, Johannes] European Mol Biol Lab, D-69117 Heidelberg, Germany; [Schleiffer, Alexander] Res Inst Mol Pathol IMP, IMP IMBA Bioinformat Core Facil, A-1030 Vienna, Austria	Austrian Academy of Sciences; Vienna Biocenter (VBC); Institute of Molecular Biotechnology (IMBA); European Molecular Biology Laboratory (EMBL); Vienna Biocenter (VBC); Research Institute of Molecular Pathology (IMP)	Martinez, J (corresponding author), Austrian Acad Sci IMBA, Inst Mol Biotechnol, A-1030 Vienna, Austria.	javier.martinez@imba.oeaw.ac.at		Martinez, Javier/0000-0001-9152-7323; Popow, Johannes/0000-0002-1093-0936; Schleiffer, Alexander/0000-0001-6251-2747	Fonds zur Forderung der wissenschaftlichen Forschung [P24687]; GEN-AU 3 research programme [820982]; Institute of Molecular Biotechnology of the Austrian Academy of Sciences; Austrian Science Fund (FWF) [P 24687] Funding Source: researchfish	Fonds zur Forderung der wissenschaftlichen Forschung(Austrian Science Fund (FWF)); GEN-AU 3 research programme; Institute of Molecular Biotechnology of the Austrian Academy of Sciences; Austrian Science Fund (FWF)(Austrian Science Fund (FWF))	We would like to thank S. Ameres, B. Beckmann, R. Hartmann, M. Hentze, M. Jantsch, B. Klaus, B. Mair, A.F. Nielsen, J.-M. Peters, T. Rapoport, R. Schroeder and S. Weitzer for help and advice, S. Bandini for the preparation of Flag-TSEN2 cell lines and critical discussions and J. Dammann and T. Lendl for technical assistance. This work has been funded by the Fonds zur Forderung der wissenschaftlichen Forschung (P24687), the GEN-AU 3 research programme (820982 Non-coding RNAs) (J.P.) and the Institute of Molecular Biotechnology of the Austrian Academy of Sciences (J.M.).	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Auxilien S, 2007, J BIOL CHEM, V282, P18711, DOI 10.1074/jbc.M607459200; Brzezicha B, 2006, NUCLEIC ACIDS RES, V34, P6034, DOI 10.1093/nar/gkl765; Canaves JM, 2004, PROTEINS, V56, P19, DOI 10.1002/prot.20141; Cao D, 2009, RNA, V15, P1971, DOI 10.1261/rna.1782209; Chakravarty AK, 2012, P NATL ACAD SCI USA, V109, P6072, DOI 10.1073/pnas.1201207109; Chan CM, 2009, SCIENCE, V326, P247, DOI 10.1126/science.1179480; Ciria R, 2004, BIOINFORMATICS, V20, P2307, DOI 10.1093/bioinformatics/bth216; Dandekar T, 1998, TRENDS BIOCHEM SCI, V23, P324, DOI 10.1016/S0968-0004(98)01274-2; Desai K. K., 2014, NUCL ACIDS RES; Edgcomb SP, 2012, J MOL BIOL, V415, P61, DOI 10.1016/j.jmb.2011.10.032; Englert M, 2005, NUCLEIC ACIDS RES, V33, P388, DOI 10.1093/nar/gki174; FILIPOWICZ W, 1983, CELL, V32, P547, DOI 10.1016/0092-8674(83)90474-9; Godbout R, 1998, J BIOL CHEM, V273, P21161, DOI 10.1074/jbc.273.33.21161; Kanai Y, 2004, NEURON, V43, P513, DOI 10.1016/j.neuron.2004.07.022; Katoh K, 2008, BRIEF BIOINFORM, V9, P286, DOI 10.1093/bib/bbn013; KONARSKA M, 1982, P NATL ACAD SCI-BIOL, V79, P1474, DOI 10.1073/pnas.79.5.1474; KONARSKA M, 1981, NATURE, V293, P112, DOI 10.1038/293112a0; Koonin EV, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-2-r7; LASKI FA, 1983, J BIOL CHEM, V258, P1974; Nandakumar J, 2008, MOL CELL, V31, P278, DOI 10.1016/j.molcel.2008.05.019; PAUSE A, 1992, EMBO J, V11, P2643, DOI 10.1002/j.1460-2075.1992.tb05330.x; Paushkin SV, 2004, CELL, V117, P311, DOI 10.1016/S0092-8674(04)00342-3; Pei JM, 2001, BIOINFORMATICS, V17, P700, DOI 10.1093/bioinformatics/17.8.700; PERKINS KK, 1985, P NATL ACAD SCI USA, V82, P684, DOI 10.1073/pnas.82.3.684; PHIZICKY EM, 1992, J BIOL CHEM, V267, P4577; Popow J, 2012, CELL MOL LIFE SCI, V69, P2657, DOI 10.1007/s00018-012-0944-2; Popow J, 2011, SCIENCE, V331, P760, DOI 10.1126/science.1197847; Sidrauski C, 1996, CELL, V87, P405, DOI 10.1016/S0092-8674(00)81361-6; Tanaka N, 2011, J BIOL CHEM, V286, P43134, DOI 10.1074/jbc.M111.302133; Tatusov RL, 2003, BMC BIOINFORMATICS, V4, DOI 10.1186/1471-2105-4-41; Thompson Julie D, 2002, Curr Protoc Bioinformatics, VChapter 2, DOI 10.1002/0471250953.bi0203s00; van de Wetering M, 2003, EMBO REP, V4, P609, DOI 10.1038/sj.embor.embor865; Yee A, 2002, P NATL ACAD SCI USA, V99, P1825, DOI 10.1073/pnas.042684599; Zhang ZQ, 2011, IMMUNITY, V34, P866, DOI 10.1016/j.immuni.2011.03.027; Zofallova L, 2000, RNA, V6, P1019, DOI 10.1017/S1355838200000613	36	68	74	1	28	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 3	2014	511	7507					104	U508		10.1038/nature13284	http://dx.doi.org/10.1038/nature13284			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK1TN	24870230	Green Accepted			2022-12-28	WOS:000338199400045
J	Lee, SY; Shen, L; Keimig, EL				Lee, Sarah Y.; Shen, Lisa; Keimig, Emily L.			A Solitary Red Patch	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							SQUAMOUS-CELL CARCINOMA; NECROBIOSIS LIPOIDICA		[Lee, Sarah Y.; Shen, Lisa; Keimig, Emily L.] Northwestern Univ, Dept Dermatol, Feinberg Sch Med, Chicago, IL 60611 USA	Northwestern University; Feinberg School of Medicine	Keimig, EL (corresponding author), Northwestern Univ, Dept Dermatol, Feinberg Sch Med, 676 N St Clair St,Ste 1600, Chicago, IL 60611 USA.	emily.keimig@northwestern.edu		Shen, Lisa/0000-0002-4112-278X				Imtiaz KE, 2001, DIABETIC MED, V18, P325, DOI 10.1046/j.1464-5491.2001.00452.x; Lim C, 2006, J CUTAN PATHOL, V33, P581, DOI 10.1111/j.1600-0560.2006.00487.x; MULLER SA, 1966, ARCH DERMATOL, V93, P272, DOI 10.1001/archderm.93.3.272; Reid SD, 2013, J AM ACAD DERMATOL, V69, P783, DOI 10.1016/j.jaad.2013.05.034	4	0	0	0	1	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUN 11	2014	311	22					2328	2329		10.1001/jama.2014.132	http://dx.doi.org/10.1001/jama.2014.132			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AI6HL	24915265				2022-12-28	WOS:000336972600025
J	Lipska, KJ; Ross, JS; Van Houten, HK; Beran, D; Yudkin, JS; Shah, ND				Lipska, Kasia J.; Ross, Joseph S.; Van Houten, Holly K.; Beran, David; Yudkin, John S.; Shah, Nilay D.			Use and Out-of-Pocket Costs of Insulin for Type 2 Diabetes Mellitus From 2000 Through 2010	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Letter									[Lipska, Kasia J.; Ross, Joseph S.] Yale Univ, Sch Med, Dept Internal Med, New Haven, CT 06520 USA; [Beran, David] Univ Geneva, Fac Med, Geneva, Switzerland; [Yudkin, John S.] UCL, London, England; [Van Houten, Holly K.; Shah, Nilay D.] Mayo Clin, Div Hlth Care Policy & Res, Rochester, MN USA	Yale University; University of Geneva; University of London; University College London; Mayo Clinic	Lipska, KJ (corresponding author), Yale Univ, Sch Med, Dept Internal Med, POB 208020, New Haven, CT 06520 USA.	kasia.lipska@yale.edu	Beran, David/E-4422-2013; Yudkin, John S/C-1988-2008	Beran, David/0000-0001-7229-3920; Ross, Joseph/0000-0002-9218-3320	AHRQ HHS [R21HS17628] Funding Source: Medline; NCATS NIH HHS [UL1 TR000142] Funding Source: Medline; NIA NIH HHS [K08 AG032886, P30 AG021342, R03 AG045086, K23 AG048359, R03AG045086, P30 AG21342] Funding Source: Medline; AGENCY FOR HEALTHCARE RESEARCH AND QUALITY [R21HS017628] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000142] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P30AG021342, R03AG045086, K23AG048359, K08AG032886] Funding Source: NIH RePORTER	AHRQ HHS(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); NCATS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); AGENCY FOR HEALTHCARE RESEARCH AND QUALITY(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Gale EAM, 2012, BMJ-BRIT MED J, V345, DOI 10.1136/bmj.e4611; Gill GV, 2011, DIABETOLOGIA, V54, P19, DOI 10.1007/s00125-010-1897-3; Ginde Adit A, 2008, BMC Endocr Disord, V8, P4, DOI 10.1186/1472-6823-8-4; Holden SE, 2011, BMJ OPEN, V1, DOI 10.1136/bmjopen-2011-000258; Horvath K, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD005613.pub3	5	62	63	0	12	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUN 11	2014	311	22					2331	2333		10.1001/jama.2014.6316	http://dx.doi.org/10.1001/jama.2014.6316			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AI6HL	24915266	Bronze, Green Accepted			2022-12-28	WOS:000336972600026
J	Wallia, A; Molitch, ME				Wallia, Amisha; Molitch, Mark E.			Insulin Therapy for Type 2 Diabetes Mellitus	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Review							TO-TARGET TRIAL; BETA-CELL FUNCTION; GLUCOSE-LOWERING DRUGS; ADD-ON THERAPY; NPH INSULIN; GLYCEMIC CONTROL; BASAL INSULIN; COST-EFFECTIVENESS; FOLLOW-UP; TREATMENT INTENSIFICATION	IMPORTANCE The incidence and prevalence of type 2 diabetes mellitus are increasing. OBJECTIVE To review currently available insulin therapy, as well as evidence on the use, application, initiation, and intensification of insulin in the outpatient setting. EVIDENCE REVIEW Data sources included PubMed for trials and investigations in type 2 diabetes examining insulin use from January 1998 to April 2014. FINDINGS The hemoglobin A(1c) target for most patients with type 2 diabetes is 7% but needs to be modified when there is increased risk of hypoglycemia, reduced life expectancy, extensive comorbidities, or reduced resources. Insulin therapy may be considered early or late in the disease course; adverse effects include weight gain and hypoglycemia. Basal insulin can be added to oral hypoglycemic agents (generally stopping sulfonylureas) initially, and later, prandial insulin can be added in a stepwise fashion. Insulin treatment must be individualized, and there are a number of challenges to insulin initiation and intensification. CONCLUSIONS AND RELEVANCE Insulin can help achieve ideal hemoglobin A1c goals for patients with type 2 diabetes. Barriers such as adherence, patient preferences, clinician preferences, and resource allocation must be addressed.	[Wallia, Amisha; Molitch, Mark E.] Northwestern Univ, Div Endocrinol Metab & Mol Med, Feinberg Sch Med, Chicago, IL 60611 USA	Northwestern University; Feinberg School of Medicine	Molitch, ME (corresponding author), Northwestern Univ, Div Endocrinol Metab & Mol Med, Feinberg Sch Med, 645 N Michigan Ave, Chicago, IL 60611 USA.	molitch@northwestern.edu			Merck; sanofi-aventis; Eli Lilly Co; NovoNordisk; Novartis; Bayer	Merck(Merck & Company); sanofi-aventis(Sanofi-Aventis); Eli Lilly Co(Eli Lilly); NovoNordisk(Novo Nordisk); Novartis(Novartis); Bayer(Bayer AG)	The authors have completed and submitted the ICMJE Form for Disclosure of Potential Conflicts of Interest. Dr Wallia reports having received research grant funding support from Merck and honoraria from Janssen. Dr Molitch reports having received research grant support from sanofi-aventis, Eli Lilly & Co, NovoNordisk, Novartis, and Bayer and has received honoraria for consultations from Abbott Laboratories, Merck, NovoNordisk, Eli Lilly & Co, Novartis, Bristol-Myers Squibb, AstraZeneca, and Janssen. No other disclosures were reported.	Ahmann A, 2014, DIABETES TECHNOL THE, V16, P76, DOI 10.1089/dia.2013.0172; Amer Diabet Assoc, 2014, DIABETES CARE, V37, pS14, DOI 10.2337/dc14-S014; Anderson Barbara J, 2011, J Diabetes Sci Technol, V5, P1563; Arakawa M, 2013, DIABETES METAB SYND, V7, P223, DOI 10.1016/j.dsx.2013.10.002; Aroda VR, 2012, CLIN THER, V34, P1247, DOI 10.1016/j.clinthera.2012.04.013; Asche CV, 2012, DIABETES OBES METAB, V14, P47, DOI 10.1111/j.1463-1326.2011.01487.x; Baldwin D, 2012, DIABETES CARE, V35, P1970, DOI 10.2337/dc12-0578; Bennett WL, 2011, ANN INTERN MED, V154, P602, DOI 10.7326/0003-4819-154-9-201105030-00336; Bergenstal RM, 2008, DIABETES CARE, V31, P1305, DOI 10.2337/dc07-2137; Bergenstal RM, 2012, DIABETES CARE, V35, P2140, DOI 10.2337/dc12-0060; BINDER C, 1984, DIABETES CARE, V7, P188, DOI 10.2337/diacare.7.2.188; Bloomgarden ZT, 2010, DIABETES CARE, V33, pE60, DOI [10.2337/dc10-zb09, 10.2337/dc10-zb01, 10.2337/dc10-zb03, 10.2337/dc10-zb02, 10.2337/dc10-zb08, 10.2337/dc10-zb07, 10.2337/dc10-zb05]; Borgono CA, 2012, ENDOCRIN METAB CLIN, V41, P1, DOI 10.1016/j.ecl.2012.03.002; Branda ME, 2013, BMC HEALTH SERV RES, V13, DOI 10.1186/1472-6963-13-301; Buse JB, 2011, ANN INTERN MED, V154, P103, DOI 10.7326/0003-4819-154-2-201101180-00300; Chen HS, 2008, DIABETES CARE, V31, P1927, DOI 10.2337/dc08-0075; Chiesa Gaia, 2005, Acta Biomed, V76 Suppl 3, P44; Clar C, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006112; Davidson MB, 2011, ENDOCR PRACT, V17, P395, DOI 10.4158/EP10323.OR; Davis SN, 2011, ENDOCR PRACT, V17, P845, DOI 10.4158/EP10401.OR; de la Pena A, 2011, DIABETES CARE, V34, P2496, DOI 10.2337/dc11-0721; DeFronzo RA, 2009, DIABETES, V58, P773, DOI 10.2337/db09-9028; Duckworth W, 2009, NEW ENGL J MED, V360, P129, DOI 10.1056/NEJMoa0808431; Fisher L, 2013, DIABETES CARE, V36, P2551, DOI 10.2337/dc12-2493; Fonseca V, 2011, DIABETES OBES METAB, V13, P814, DOI 10.1111/j.1463-1326.2011.01412.x; Garber AJ, 2013, DIABETES OBES METAB, V15, P11, DOI 10.1111/dom.12067; GARVEY WT, 1985, DIABETES, V34, P222, DOI 10.2337/diabetes.34.3.222; Gejl M, 2010, EXPERT OPIN PHARMACO, V11, P2027, DOI 10.1517/14656566.2010.494831; Gerstein HC, 2008, NEW ENGL J MED, V358, P2545, DOI 10.1056/NEJMoa0802743; Gerstein HC, 2012, NEW ENGL J MED, V367, P319, DOI 10.1056/NEJMoa1203858; Gillespie SJ, 1998, J AM DIET ASSOC, V98, P897, DOI 10.1016/S0002-8223(98)00206-5; Giugliano D, 2011, DIABETES CARE, V34, P510, DOI 10.2337/dc10-1710; Gough SCL, 2013, DIABETES CARE, V36, P2536, DOI 10.2337/dc12-2329; Harris SB, 2014, DIABETES CARE, V37, P604, DOI 10.2337/dc13-1636; Heise T, 2004, DIABETES, V53, P1614, DOI 10.2337/diabetes.53.6.1614; Hermansen K, 2006, DIABETES CARE, V29, P1269, DOI 10.2337/dc05-1365; Hohberg C, 2009, DIABETES OBES METAB, V11, P464, DOI 10.1111/j.1463-1326.2008.00975.x; Holman RR, 2008, NEW ENGL J MED, V359, P1577, DOI 10.1056/NEJMoa0806470; Holman RR, 2007, NEW ENGL J MED, V357, P1716, DOI 10.1056/NEJMoa075392; Holman RR, 2009, NEW ENGL J MED, V361, P1736, DOI 10.1056/NEJMoa0905479; Home PD, 2010, DIABETES OBES METAB, V12, P772, DOI 10.1111/j.1463-1326.2010.01232.x; International Diabetes Federation Clinical Guidelines Task Force, 2012, GLOBAL GUIDELINE FOR; Inzucchi SE, 2012, DIABETES CARE, V35, P1364, DOI 10.2337/dc12-0413; Ismail-Beigi F, 2011, ANN INTERN MED, V154, P554, DOI 10.7326/0003-4819-154-8-201104190-00007; Kahn SE, 2006, NEW ENGL J MED, V355, P2427, DOI 10.1056/NEJMoa066224; Klonoff DC, 2011, J CLIN ENDOCR METAB, V96, P2968, DOI 10.1210/jc.2010-2756; Kramer CK, 2013, LANCET DIABETES ENDO, V1, P28, DOI 10.1016/S2213-8587(13)70006-8; Leahy JL, 2012, ENDOCRIN METAB CLIN, V41, P119, DOI 10.1016/j.ecl.2012.03.004; Lepore M, 2000, DIABETES, V49, P2142, DOI 10.2337/diabetes.49.12.2142; Li CJ, 2012, CARDIOVASC DIABETOL, V11, DOI 10.1186/1475-2840-11-142; Li R, 2010, DIABETES CARE, V33, P1872, DOI 10.2337/dc10-0843; Li YB, 2004, DIABETES CARE, V27, P2597, DOI 10.2337/diacare.27.11.2597; Malik S, 2007, DIABETES RES CLIN PR, V77, P126, DOI 10.1016/j.diabres.2006.10.016; Meneghini L, 2011, ENDOCR PRACT, V17, P727, DOI 10.4158/EP10367.OR; Monnier L, 2003, DIABETES CARE, V26, P881, DOI 10.2337/diacare.26.3.881; Nathan DM, 2013, DIABETES, V62, P3976, DOI 10.2337/db13-1093; National Collaborating Centre for Chronic Conditions, 2008, TYPE 2 DIABETES NATL; National Diabetes Information Clearinghouse, NATIONAL DIABETES ST; National Institute for Health and Clinical Excellence, 2011, TYPE 2 DIABETES NEWE; Okamoto T, 2008, GERIATR GERONTOL INT, V8, P218, DOI 10.1111/j.1447-0594.2008.00477.x; Owens DR, 2011, DIABETES OBES METAB, V13, P1020, DOI 10.1111/j.1463-1326.2011.01459.x; Pandya N, 2013, DRUG AGING, V30, P429, DOI 10.1007/s40266-013-0069-9; Patel A, 2008, NEW ENGL J MED, V358, P2560, DOI 10.1056/NEJMoa0802987; Patrick AR, 2014, J GEN INTERN MED, V29, P320, DOI 10.1007/s11606-013-2643-6; Pawaskar MD, 2007, CLIN THER, V29, P1294, DOI 10.1016/j.clinthera.2007.07.007; Peyrot M, 2005, DIABETES CARE, V28, P2673, DOI 10.2337/diacare.28.11.2673; Polinski JM, 2013, DIABETES EDUCATOR, V39, P53, DOI 10.1177/0145721712467696; Polonsky WH, 2005, DIABETES CARE, V28, P2543, DOI 10.2337/diacare.28.10.2543; Polonsky W, 2007, DIABETES EDUCATOR, V33, p241S, DOI 10.1177/0145721707305701; Pontiroli AE, 2012, DIABETES OBES METAB, V14, P433, DOI 10.1111/j.1463-1326.2011.01543.x; Raskin P, 2005, DIABETES CARE, V28, P260, DOI 10.2337/diacare.28.2.260; Reutrakul Sirimon, 2012, J Diabetes Sci Technol, V6, P412; Reznik Y, 2013, DIABETES CARE, V36, pS219, DOI 10.2337/dcS13-2027; Ridderstrale Martin, 2013, J Med Econ, V16, P468, DOI 10.3111/13696998.2013.768999; Riddle M, 2011, DIABETES CARE, V34, P2508, DOI 10.2337/dc11-0632; Riddle MC, 2012, DIABETES CARE, V35, P2100, DOI 10.2337/dc12-0650; Riddle MC, 2010, DIABETES CARE, V33, P983, DOI 10.2337/dc09-1278; Riddle MC, 2003, DIABETES CARE, V26, P3080, DOI 10.2337/diacare.26.11.3080; Rolla A, 2004, INT J OBESITY, V28, pS3, DOI 10.1038/sj.ijo.0802743; Rosenstock J, 2008, DIABETOLOGIA, V51, P408, DOI 10.1007/s00125-007-0911-x; Ross SA, 2013, AM J MED, V126, pS38, DOI 10.1016/j.amjmed.2013.06.012; Rubin DJ, 2011, DIABETES CARE, V34, P1723, DOI 10.2337/dc10-2434; Rubin RR, 2005, AM J MED, V118, P27, DOI 10.1016/j.amjmed.2005.04.012; Ryan EA, 2004, DIABETES CARE, V27, P1028, DOI 10.2337/diacare.27.5.1028; Rys P, 2011, DIABETES METAB, V37, P190, DOI 10.1016/j.diabet.2010.12.003; Safren SA, 2016, DIABETES CARE, V39, P1065, DOI [10.2337/dc16-er06, 10.2337/dc13-0816]; Saydah SH, 2004, JAMA-J AM MED ASSOC, V291, P335, DOI 10.1001/jama.291.3.335; Seaquist ER, 2012, DIABETES CARE, V35, P409, DOI 10.2337/dc11-0996; SHAMOON H, 1993, NEW ENGL J MED, V329, P977, DOI 10.1056/nejm199309303291401; Singh SR, 2009, CAN MED ASSOC J, V180, P385, DOI 10.1503/cmaj.081041; Swinnen SG, 2011, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006383.pub2; Turner RC, 1998, LANCET, V352, P854, DOI 10.1016/s0140-6736(98)07037-8; Turner RC, 1998, LANCET, V352, P837, DOI 10.1016/s0140-6736(98)07019-6; Umpierrez GE, 2013, DIABETES CARE, V36, P2169, DOI 10.2337/dc12-1988; Valentine WJ, 2012, DIABETIC MED, V29, P303, DOI 10.1111/j.1464-5491.2011.03461.x; van Avendonk MJP, 2009, DIABETES OBES METAB, V11, P415, DOI 10.1111/j.1463-1326.2008.00981.x; Weng JP, 2008, LANCET, V371, P1753, DOI 10.1016/S0140-6736(08)60762-X; Yki-Jarvinen H, 2000, DIABETES CARE, V23, P1130, DOI 10.2337/diacare.23.8.1130; Yki-Jarvinen H, 2013, DIABETES CARE, V36, P3875, DOI 10.2337/dc12-2718; Zinman B, 2012, DIABETES CARE, V35, P2464, DOI 10.2337/dc12-1205	100	97	102	0	31	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUN 11	2014	311	22					2315	2325		10.1001/jama.2014.5951	http://dx.doi.org/10.1001/jama.2014.5951			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AI6HL	24915263				2022-12-28	WOS:000336972600023
J	Wijeyeratne, YD; Walters, N				Wijeyeratne, Yanushi Dullewe; Walters, Nicola			An unusual case of epigastric pain	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							PORTAL-VEIN THROMBOSIS; JAK2 V617F MUTATION; VENOUS SYSTEM; DIAGNOSIS		[Wijeyeratne, Yanushi Dullewe; Walters, Nicola] St George Hosp, London SW17 0QT, England; [Wijeyeratne, Yanushi Dullewe] St Georges Univ London, Cardiovasc & Cell Sci Res Inst, London SW17 0RE, England	St Georges University London; St Georges University London	Wijeyeratne, YD (corresponding author), St George Hosp, London SW17 0QT, England.	ywijeyer@sgul.ac.uk		Wijeyeratne, Yanushi/0000-0003-0656-5769	National Institute for Health Research [ACF-2012-16-001] Funding Source: researchfish	National Institute for Health Research(National Institute for Health Research (NIHR))		Austin SK, 2008, BRIT J HAEMATOL, V143, P307, DOI 10.1111/j.1365-2141.2008.07258.x; Balthazar EJ, 2000, J COMPUT ASSIST TOMO, V24, P755, DOI 10.1097/00004728-200009000-00017; COHEN J, 1992, AM J MED, V92, P173, DOI 10.1016/0002-9343(92)90109-O; Colaizzo D, 2007, J THROMB HAEMOST, V5, P55, DOI 10.1111/j.1538-7836.2006.02277.x; Congly Stephen E, 2013, Curr Gastroenterol Rep, V15, P306, DOI 10.1007/s11894-012-0306-0; DeLeve LD, 2009, HEPATOLOGY, V49, P1729, DOI 10.1002/hep.22772; Ertugrul I, 2008, J CLIN GASTROENTEROL, V42, P835, DOI 10.1097/MCG.0b013e318046eadc; Hall TC, 2013, HEPATO-GASTROENTEROL, V60, P311, DOI 10.5754/hge11588; Hill A, 2013, BLOOD, V121, P4985, DOI 10.1182/blood-2012-09-311381; Huard G, 2012, INT J HEPATOL, V2012, DOI 10.1155/2012/672986; Ikeda M, 2005, ANN SURG, V241, P208, DOI 10.1097/01.sla.0000151794.28392.a6; Krauth MT, 2008, HAEMATOL-HEMATOL J, V93, P1227, DOI 10.3324/haematol.12682; McMahon C, 2007, AM J CLIN PATHOL, V127, P736, DOI 10.1309/JA1WD8JNVLGYNQYE; Ponziani FR, 2010, WORLD J GASTROENTERO, V16, P143, DOI 10.3748/wjg.v16.i2.143; Rajani R, 2010, ALIMENT PHARM THER, V32, P1154, DOI 10.1111/j.1365-2036.2010.04454.x; Shetty S, 2010, AM J CLIN PATHOL, V134, P82, DOI 10.1309/AJCP7VO4HAIZYATP; Singal AK, 2013, MAYO CLIN PROC, V88, P285, DOI 10.1016/j.mayocp.2013.01.012; Smalberg JH, 2012, BLOOD, V120, P4921, DOI 10.1182/blood-2011-09-376517; Stamou KM, 2006, ARCH SURG-CHICAGO, V141, P663, DOI 10.1001/archsurg.141.7.663; Valla Dominique-Charles, 2002, J Gastroenterol Hepatol, V17 Suppl 3, pS224, DOI 10.1046/j.1440-1746.17.s3.4.x; Wang Jing-Tong, 2005, Hepatobiliary Pancreat Dis Int, V4, P515; Webster GJM, 2005, ALIMENT PHARM THER, V21, P1, DOI 10.1111/j.1365-2036.2004.02301.x; Wong K, 2013, J COMMUNITY HOSP INT, V3, DOI 10.3402/jchimp.v3i2.20732; Zhang DL, 2013, J INT MED RES, V41, P664, DOI 10.1177/0300060513483413	24	1	1	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JUN 9	2014	348								g3689	10.1136/bmj.g3689	http://dx.doi.org/10.1136/bmj.g3689			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AJ1DS	24912654				2022-12-28	WOS:000337396600010
J	Hoekstra, AY; Wiedmann, TO				Hoekstra, Arjen Y.; Wiedmann, Thomas O.			Humanity's unsustainable environmental footprint	SCIENCE			English	Review							WATER FOOTPRINT; ECOLOGICAL FOOTPRINT; CARBON FOOTPRINT; INTERNATIONAL-TRADE; LAND; NITROGEN; ENERGY; SUSTAINABILITY; EXPLORATION; CONSUMPTION	Within the context of Earth's limited natural resources and assimilation capacity, the current environmental footprint of humankind is not sustainable. Assessing land, water, energy, material, and other footprints along supply chains is paramount in understanding the sustainability, efficiency, and equity of resource use from the perspective of producers, consumers, and government. We review current footprints and relate those to maximum sustainable levels, highlighting the need for future work on combining footprints, assessing trade-offs between them, improving computational techniques, estimating maximum sustainable footprint levels, and benchmarking efficiency of resource use. Ultimately, major transformative changes in the global economy are necessary to reduce humanity's environmental footprint to sustainable levels.	[Hoekstra, Arjen Y.] Univ Twente, Twente Water Ctr, Inst Innovat & Governance Studies, NL-7500 AE Enschede, Netherlands; [Wiedmann, Thomas O.] UNSW Australia, Sch Civil & Environm Engn, Sydney, NSW 2052, Australia; [Wiedmann, Thomas O.] Univ Sydney, Sch Phys, Sydney, NSW 2006, Australia	University of Twente; University of New South Wales Sydney; University of Sydney	Hoekstra, AY (corresponding author), Univ Twente, Twente Water Ctr, Inst Innovat & Governance Studies, POB 217, NL-7500 AE Enschede, Netherlands.	a.y.hoekstra@utwente.nl	Wiedmann, Thomas/C-9158-2011; Hoekstra, Arjen Y./B-4980-2008	Wiedmann, Thomas/0000-0002-6395-8887; Hoekstra, Arjen Y./0000-0002-4769-5239				Allen MR, 2009, NATURE, V458, P1163, DOI 10.1038/nature08019; [Anonymous], 2010, GLOB IND EN EFF BENC; Boden T.A., 2010, GLOBAL REGIONAL NATL; Borucke M, 2013, ECOL INDIC, V24, P518, DOI 10.1016/j.ecolind.2012.08.005; Chakravarty D, 2013, CURR OPIN ENV SUST, V5, P216, DOI 10.1016/j.cosust.2013.03.001; Chenoweth J., 2013, HYDROL EARTH SYST SC, V10, P9389, DOI [10.5194/hessd-10-9389-2013, DOI 10.5194/HESSD-10-9389-2013]; Cucek L, 2012, J CLEAN PROD, V34, P9, DOI 10.1016/j.jclepro.2012.02.036; Cucek L, 2011, CHEM ENGINEER TRANS, V25, P923, DOI 10.3303/CET1125154; Dittrich M., 2012, GREEN EC WORLD IMPLI; Ercin AE, 2014, ENVIRON INT, V64, P71, DOI 10.1016/j.envint.2013.11.019; Fang K, 2014, ECOL INDIC, V36, P508, DOI 10.1016/j.ecolind.2013.08.017; Fiala N, 2008, ECOL ECON, V67, P519, DOI 10.1016/j.ecolecon.2008.07.023; Foley JA, 2011, NATURE, V478, P337, DOI 10.1038/nature10452; Galli A, 2012, ECOL INDIC, V16, P100, DOI 10.1016/j.ecolind.2011.06.017; Gerbens-Leenes PW, 2012, GLOBAL ENVIRON CHANG, V22, P764, DOI 10.1016/j.gloenvcha.2012.04.001; Gerbens-Leenes W, 2009, P NATL ACAD SCI USA, V106, P10219, DOI 10.1073/pnas.0812619106; Gerten D, 2013, CURR OPIN ENV SUST, V5, P551, DOI 10.1016/j.cosust.2013.11.001; Giljum S, 2011, RESOUR CONSERV RECY, V55, P300, DOI 10.1016/j.resconrec.2010.09.009; Hanasaki N, 2010, J HYDROL, V384, P232, DOI 10.1016/j.jhydrol.2009.09.028; Harvey M, 2011, FOOD POLICY, V36, pS40, DOI 10.1016/j.foodpol.2010.11.009; Hertwich EG, 2009, ENVIRON SCI TECHNOL, V43, P6414, DOI 10.1021/es803496a; Herva M, 2011, J CLEAN PROD, V19, P1687, DOI 10.1016/j.jclepro.2011.05.019; Hoekstra AY, 2009, ECOL ECON, V68, P1963, DOI 10.1016/j.ecolecon.2008.06.021; Hoekstra AY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032688; Hoekstra AY, 2012, P NATL ACAD SCI USA, V109, P3232, DOI 10.1073/pnas.1109936109; Hoekstra AY., 2013, WATER FOOTPRINT MODE; Huang YA, 2009, ENVIRON SCI TECHNOL, V43, P8509, DOI 10.1021/es901643a; Jackson T., 2009, PROSPERITY GROWTH EC, DOI 10.4324/9781315677453; Jackson T, 2008, ECOL ECON, V68, P80, DOI 10.1016/j.ecolecon.2008.01.026; Jones CM, 2011, ENVIRON SCI TECHNOL, V45, P4088, DOI 10.1021/es102221h; Kounina A, 2013, INT J LIFE CYCLE ASS, V18, P707, DOI 10.1007/s11367-012-0519-3; Lamers P, 2011, RENEW SUST ENERG REV, V15, P2655, DOI 10.1016/j.rser.2011.01.022; Leach AM, 2012, ENVIRON DEV, V1, P40, DOI 10.1016/j.envdev.2011.12.005; Lenzen M, 2012, NATURE, V486, P109, DOI 10.1038/nature11145; Lenzen M, 2007, ECOL ECON, V61, P27, DOI 10.1016/j.ecolecon.2006.05.018; Liu C, 2012, ECOL INDIC, V18, P42, DOI 10.1016/j.ecolind.2011.10.005; Matthews HS, 2008, ENVIRON SCI TECHNOL, V42, P5839, DOI 10.1021/es703112w; Meinshausen M, 2009, NATURE, V458, P1158, DOI 10.1038/nature08017; Minx J, 2013, ENVIRON RES LETT, V8, DOI 10.1088/1748-9326/8/3/035039; Moore D, 2012, ECOL INDIC, V16, P3, DOI 10.1016/j.ecolind.2011.03.013; Niccolucci V, 2012, ECOL INDIC, V16, P23, DOI 10.1016/j.ecolind.2011.09.002; Peters GP, 2008, CLIMATIC CHANGE, V86, P51, DOI 10.1007/s10584-007-9280-1; Peters GP, 2012, NAT CLIM CHANGE, V2, P2, DOI 10.1038/nclimate1332; Peters GP, 2011, P NATL ACAD SCI USA, V108, P8903, DOI 10.1073/pnas.1006388108; Rees W.E., 1996, OUR ECOLOGICAL FOOTP; Rockstrom J, 2009, NATURE, V461, P472, DOI 10.1038/461472a; Rulli MC, 2013, P NATL ACAD SCI USA, V110, P892, DOI 10.1073/pnas.1213163110; Shiklomanov I.A., 2004, WORLD WATER RESOURCE, P417; Steen-Olsen K, 2012, ENVIRON SCI TECHNOL, V46, P10883, DOI 10.1021/es301949t; UNEP, 2012, EMISS GAP REP 2012; Vanham D, 2013, ENVIRON INT, V61, P45, DOI 10.1016/j.envint.2013.09.011; Wang F, 2011, J ENVIRON QUAL, V40, P1081, DOI 10.2134/jeq2010.0444; Weinzettel J, 2013, GLOBAL ENVIRON CHANG, V23, P433, DOI 10.1016/j.gloenvcha.2012.12.010; Wiedmann T., 2008, ECOLOGICAL EC RES TR, P1, DOI DOI 10.1088/978-0-750-31040-6; Wiedmann T, 2009, ECOL ECON, V68, P1975, DOI 10.1016/j.ecolecon.2008.06.023; Wiedmann TO, 2015, P NATL ACAD SCI USA, V112, P6271, DOI 10.1073/pnas.1220362110; Wiedmann TO, 2009, J IND ECOL, V13, P361, DOI 10.1111/j.1530-9290.2009.00125.x; WRI/WBCSD, 2011, GREENH GAS PROT CORP	58	558	576	84	885	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 6	2014	344	6188					1114	1117		10.1126/science.1248365	http://dx.doi.org/10.1126/science.1248365			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AI3UU	24904155				2022-12-28	WOS:000336791200037
J	Garg, AX; Devereaux, PJ; Yusuf, S; Cuerden, MS; Parikh, CR; Coca, SG; Walsh, M; Novick, R; Cook, RJ; Jain, AR; Pan, XB; Noiseux, N; Vik, K; Stolf, NA; Ritchie, A; Favaloro, RR; Parvathaneni, S; Whitlock, RP; Ou, YN; Lawrence, M; Lamy, A				Garg, Amit X.; Devereaux, P. J.; Yusuf, Salim; Cuerden, Meaghan S.; Parikh, Chirag R.; Coca, Steven G.; Walsh, Michael; Novick, Richard; Cook, Richard J.; Jain, Anil R.; Pan, Xiangbin; Noiseux, Nicolas; Vik, Karel; Stolf, Noedir A.; Ritchie, Andrew; Favaloro, Roberto R.; Parvathaneni, Sirish; Whitlock, Richard P.; Ou, Yongning; Lawrence, Mitzi; Lamy, Andre		CORONARY Investigators	Kidney Function After Off-Pump or On-Pump Coronary Artery Bypass Graft Surgery A Randomized Clinical Trial	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							ACUTE-RENAL-FAILURE; PERITUBULAR CAPILLARIES; INJURY; DISEASE; RISK; INCREASES; DESIGN; ISSUES	IMPORTANCE Most acute kidney injury observed in the hospital is defined by sudden mild or moderate increases in the serum creatinine concentration, which may persist for several days. Such acute kidney injury is associated with lower long-term kidney function. However, it has not been demonstrated that an intervention that reduces the risk of such acute kidney injury better preserves long-term kidney function. OBJECTIVES To characterize the risk of acute kidney injury with an intervention in a randomized clinical trial and to determine if there is a difference between the 2 treatment groups in kidney function 1 year later. DESIGN, SETTING, AND PARTICIPANTS The Coronary Artery Bypass Grafting Surgery Off- or On-pump Revascularisation Study (CORONARY) enrolled 4752 patients undergoing first isolated coronary artery bypass graft (CABG) surgery at 79 sites in 19 countries. Patients were randomized to receive CABG surgery either with a beating-heart technique (off-pump) or with cardiopulmonary bypass (on-pump). From January 2010 to November 2011, 2932 patients (from 63 sites in 16 countries) from CORONARY were enrolled into a kidney function substudy to record serum creatinine concentrations during the postoperative period and at 1 year. The last 1-year serum creatinine concentration was recorded on January 18, 2013. MAIN OUTCOMES AND MEASURES Acute kidney injury within 30 days of surgery (>= 50% increase in serum creatinine concentration from prerandomization concentration) and loss of kidney function at 1 year (>= 20% loss in estimated glomerular filtration rate from prerandomization level). RESULTS Off-pump (n = 1472) vs on-pump (n = 1460) CABG surgery reduced the risk of acute kidney injury (17.5% vs 20.8%, respectively; relative risk, 0.83 [95% CI, 0.72-0.97], P = .01); however, there was no significant difference between the 2 groups in the loss of kidney function at 1 year (17.1% vs 15.3%, respectively; relative risk, 1.10 [95% CI, 0.95-1.29], P = .23). Results were consistent with multiple alternate continuous and categorical definitions of acute kidney injury or kidney function loss, and in the subgroup with baseline chronic kidney disease. CONCLUSIONS AND RELEVANCE Use of off-pump compared with on-pump CABG surgery reduced the risk of postoperative acute kidney injury, without evidence of better preserved kidney function with off-pump CABG surgery at 1 year. In this setting, an intervention that reduced the risk of mild to moderate acute kidney injury did not alter longer-term kidney function. Copyright 2014 American Medical Association. All rights reserved.	[Garg, Amit X.; Cuerden, Meaghan S.] Univ Western Ontario, Dept Med, Div Nephrol, London, ON, Canada; [Garg, Amit X.] Univ Western Ontario, Dept Epidemiol & Biostat, London, ON, Canada; [Garg, Amit X.; Devereaux, P. J.; Yusuf, Salim; Walsh, Michael; Whitlock, Richard P.; Lamy, Andre] McMaster Univ, Dept Clin Epidemiol & Biostat, Hamilton, ON, Canada; [Devereaux, P. J.; Yusuf, Salim; Walsh, Michael; Whitlock, Richard P.; Ou, Yongning; Lawrence, Mitzi; Lamy, Andre] Populat Hlth Res Inst, Hamilton, ON, Canada; [Cuerden, Meaghan S.; Cook, Richard J.] Univ Waterloo, Dept Stat & Actuarial Sci, Waterloo, ON N2L 3G1, Canada; [Parikh, Chirag R.; Coca, Steven G.] Yale Univ, Sch Med, Nephrol Sect, New Haven, CT USA; [Novick, Richard] Univ Western Ontario, Div Cardiac Surg, London, ON, Canada; [Jain, Anil R.] SAL Hosp & Med Inst, Ahmadabad, India; [Pan, Xiangbin] Chinese Acad Med Sci, Peking Union Med Coll, Dept Cardiovasc Surg, Fuiwai Hosp, Beijing 100730, Peoples R China; [Noiseux, Nicolas] CHUM, Dept Cardiac Surg, Montreal, PQ, Canada; [Vik, Karel] Univ Hosp Motol, Prague, Czech Republic; [Stolf, Noedir A.] Hosp Clin Sao Paulo, Inst Coracao, Sao Paulo, Brazil; [Ritchie, Andrew] Essex Cardiothorac Ctr, Basildon, Essex, England; [Ritchie, Andrew] Anglia Ruskin Univ, Cambridge, Essex, England; [Favaloro, Roberto R.] Hosp Univ Fdn Favaloro, Dept Cardiovasc Surg, Buenos Aires, DF, Argentina; [Parvathaneni, Sirish] Mercy Hosp, Springfield, MO USA; [Whitlock, Richard P.; Lamy, Andre] McMaster Univ, Div Cardiac Surg, Hamilton, ON, Canada	Western University (University of Western Ontario); Western University (University of Western Ontario); McMaster University; Population Health Research Institute; University of Waterloo; Yale University; Western University (University of Western Ontario); Chinese Academy of Medical Sciences - Peking Union Medical College; Fu Wai Hospital - CAMS; Peking Union Medical College; Universite de Montreal; Motol University Hospital; Universidade de Sao Paulo; Anglia Ruskin University; University of Buenos Aires; McMaster University	Garg, AX (corresponding author), London Hlth Sci Ctr, 800 Commissioners Rd E, London, ON N6A 4G5, Canada.	amit.garg@lhsc.on.ca	Garg, Amit X/G-3295-2011; Coca, Steven/L-7801-2019; LAMY, ANDRE/AAS-3855-2021; Brat, Radim/G-7925-2019; Olavegogeascoechea, Pablo/Q-2834-2018; Devereaux, PJ/AAY-1757-2021; Devereaux, PJ/AAF-2862-2019; Gogayeva, Olena/B-8386-2017; Whitlock, Richard/AAQ-1593-2021; Stolf, Noedir Antonio Groppo/ABG-2530-2020; Walsh, Michael/ABE-1278-2021; Zamvar, Vipin/J-3430-2013	Coca, Steven/0000-0002-0928-9168; Brat, Radim/0000-0001-9381-9135; Olavegogeascoechea, Pablo/0000-0002-2625-2922; Gogayeva, Olena/0000-0002-7338-475X; Whitlock, Richard/0000-0002-6863-5884; Stolf, Noedir Antonio Groppo/0000-0002-5893-8216; Walsh, Michael/0000-0001-8292-2014; Zamvar, Vipin/0000-0003-2447-828X; Devereaux, PJ/0000-0003-2935-637X; Cook, Richard/0000-0002-1414-4908; Yusuf, Salim/0000-0003-4776-5601; Parikh, Chirag/0000-0001-9051-7385	Canadian Institutes of Health Research	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR))	The Coronary Artery Bypass Grafting Surgery Off- or On-pump Revascularisation Study (CORONARY) and this kidney function substudy were financially supported by grants from the Canadian Institutes of Health Research.	Austin PC, 2010, J CLIN EPIDEMIOL, V63, P2, DOI 10.1016/j.jclinepi.2008.11.004; Bagshaw SM, 2006, ARCH INTERN MED, V166, P161, DOI 10.1001/archinte.166.2.161; Basile DP, 2007, KIDNEY INT, V72, P151, DOI 10.1038/sj.ki.5002312; Basile DP, 2004, CURR OPIN NEPHROL HY, V13, P1, DOI 10.1097/00041552-200401000-00001; Basile DP, 2001, AM J PHYSIOL-RENAL, V281, pF887, DOI 10.1152/ajprenal.0050.2001; Cairns JA, 2010, CAN J CARDIOL, V26, P353, DOI 10.1016/S0828-282X(10)70408-6; Chawla LS, 2012, KIDNEY INT, V82, P516, DOI 10.1038/ki.2012.208; Coca SG, 2012, KIDNEY INT, V81, P442, DOI 10.1038/ki.2011.379; Faubel S, 2012, CLIN J AM SOC NEPHRO, V7, P861, DOI 10.2215/CJN.12191111; Garg AX, 2012, BMJ OPEN, V2, DOI 10.1136/bmjopen-2012-001080; Ishani A, 2011, ARCH INTERN MED, V171, P226, DOI 10.1001/archinternmed.2010.514; James MT, 2010, KIDNEY INT, V78, P803, DOI 10.1038/ki.2010.258; Kellum JA, 2013, CRIT CARE, V17, DOI 10.1186/cc11454; Koch GG, 1998, STAT MED, V17, P1863, DOI 10.1002/(SICI)1097-0258(19980815/30)17:15/16<1863::AID-SIM989>3.0.CO;2-M; Lamy A, 2013, NEW ENGL J MED, V368, P1179, DOI 10.1056/NEJMoa1301228; Lamy A, 2012, NEW ENGL J MED, V366, P1489, DOI 10.1056/NEJMoa1200388; Lamy A, 2012, AM HEART J, V163, P1, DOI 10.1016/j.ahj.2011.10.007; Levey AS, 2009, ANN INTERN MED, V150, P604, DOI 10.7326/0003-4819-150-9-200905050-00006; Liu KD, 2009, CURR OPIN NEPHROL HY, V18, P241, DOI 10.1097/MNH.0b013e328329d0a3; Lo LJ, 2009, KIDNEY INT, V76, P893, DOI 10.1038/ki.2009.289; Mariscalco G, 2011, ANN THORAC SURG, V92, P1539, DOI 10.1016/j.athoracsur.2011.04.123; Myers GL, 2006, CLIN CHEM, V52, P5, DOI 10.1373/clinchem.2005.0525144; Newsome BB, 2008, ARCH INTERN MED, V168, P609, DOI 10.1001/archinte.168.6.609; Nigwekar SU, 2009, AM J KIDNEY DIS, V54, P413, DOI 10.1053/j.ajkd.2009.01.267; Palevsky PM, 2012, CLIN J AM SOC NEPHRO, V7, P844, DOI 10.2215/CJN.12791211; Rifkin DE, 2012, J AM SOC NEPHROL, V23, P979, DOI 10.1681/ASN.2011121185; Rosner MH, 2006, CLIN J AM SOC NEPHRO, V1, P19, DOI 10.2215/CJN.00240605; Seabra VF, 2010, CLIN J AM SOC NEPHRO, V5, P1734, DOI 10.2215/CJN.02800310; Siew ED, 2012, J AM SOC NEPHROL, V23, P305, DOI 10.1681/ASN.2011030315; Zink RC, NPARCOV3 SAS IML MAC; Zoungas S, 2009, ANN INTERN MED, V151, P631, DOI 10.7326/0003-4819-151-9-200911030-00008	31	123	135	0	15	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUN 4	2014	311	21					2191	2198		10.1001/jama.2014.4952	http://dx.doi.org/10.1001/jama.2014.4952			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AI2DU	24886787	Bronze			2022-12-28	WOS:000336668400020
J	McCartney, M				McCartney, Margaret			NO HOLDS BARRED Coffee time is about much more than coffee	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												margaret@margaretmccartney.com	mccartney, margaret/AAR-4727-2020	McCartney, Margaret/0000-0002-7238-6358					0	2	2	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JUN 3	2014	348								g3444	10.1136/bmj.g3444	http://dx.doi.org/10.1136/bmj.g3444			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AI7CB	24895148	Bronze, Green Published			2022-12-28	WOS:000337037600002
J	Snyder, A				Snyder, Alison			Charles Farthing Obituary	LANCET			English	Biographical-Item												amsnyder@alum.mit.edu							0	0	0	0	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	MAY 31	2014	383	9932					1882	1882		10.1016/S0140-6736(14)60906-5	http://dx.doi.org/10.1016/S0140-6736(14)60906-5			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AI4PR	24892174	Bronze			2022-12-28	WOS:000336847800017
J	Dormuth, CR; Filion, KB; Paterson, JM; James, MT; Teare, GF; Raymond, CB; Rahme, E; Tamim, H; Lipscombe, L				Dormuth, Colin R.; Filion, Kristian B.; Paterson, J. Michael; James, Matthew T.; Teare, Gary F.; Raymond, Colette B.; Rahme, Elham; Tamim, Hala; Lipscombe, Lorraine		Canadian Network Observational	Higher potency statins and the risk of new diabetes: multicentre, observational study of administrative databases	BMJ-BRITISH MEDICAL JOURNAL			English	Article							ACUTE KIDNEY INJURY; MYOCARDIAL-INFARCTION; ATORVASTATIN; CHOLESTEROL; SIMVASTATIN; PREVENTION; MELLITUS; THERAPY; DISEASE	Objective To evaluate the incremental increase in new onset diabetes from higher potency statins compared with lower potency statins when used for secondary prevention. Design Eight population based cohort studies and a meta-analysis. Setting Six Canadian provinces and two international databases from the UK and US. Participants 136 966 patients aged >= 40 years newly treated with statins between 1 January 1997 and 31 March 2011. Methods Within each cohort of patients newly prescribed a statin after hospitalisation for a major cardiovascular event or procedure, we performed as-treated, nested case-control analyses to compare diabetes incidence in users of higher potency statins with incidence in users of lower potency statins. Rate ratios of new diabetes events were estimated using conditional logistic regression on different lengths of exposure to higher potency versus lower potency statins; adjustment for confounding was achieved using high dimensional propensity scores. Meta-analytic methods were used to estimate overall effects across sites. Main outcome measures Hospitalisation for new onset diabetes, or a prescription for insulin or an oral antidiabetic drug. Results In the first two years of regular statin use, we observed a significant increase in the risk of new onset diabetes with higher potency statins compared with lower potency agents (rate ratio 1.15, 95% confidence interval 1.05 to 1.26). The risk increase seemed to be highest in the first four months of use (rate ratio 1.26, 1.07 to 1.47). Conclusions Higher potency statin use is associated with a moderate increase in the risk of new onset diabetes compared with lower potency statins in patients treated for secondary prevention of cardiovascular disease. Clinicians should consider this risk when prescribing higher potency statins in secondary prevention patients.	[Dormuth, Colin R.] Univ British Columbia, Dept Anesthesiol Pharmacol & Therapeut, Victoria, BC V8W 1Y2, Canada; [Filion, Kristian B.] McGill Univ, Jewish Gen Hosp, Lady Davis Inst, Ctr Clin Epidemiol, Montreal, PQ H3T 1E2, Canada; [Paterson, J. Michael; Lipscombe, Lorraine] Inst Clin Evaluat Sci, Toronto, ON, Canada; [James, Matthew T.] Univ Calgary, Dept Med, Calgary, AB, Canada; [Teare, Gary F.] Hlth Qual Council, Saskatoon, SK, Canada; [Raymond, Colette B.] Univ Manitoba, Manitoba Ctr Hlth Policy, Winnipeg, MB, Canada; [Rahme, Elham] McGill Univ, Dept Med, Montreal, PQ, Canada; [Tamim, Hala] York Univ, Sch Kinesiol & Hlth Sci, Toronto, ON M3J 2R7, Canada	University of British Columbia; Lady Davis Institute; McGill University; University of Toronto; University of Calgary; University of Manitoba; McGill University; York University - Canada	Dormuth, CR (corresponding author), Univ British Columbia, Dept Anesthesiol Pharmacol & Therapeut, Victoria, BC V8W 1Y2, Canada.	colin.dormuth@ti.ubc.ca		Lipscombe, Lorraine/0000-0001-7412-7993; Dormuth, Colin/0000-0001-8577-8783; Filion, Kristian/0000-0001-6055-0088	Canadian Institutes of Health Research [DSE-111845]	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR))	CNODES is a collaborating centre of the Drug Safety and Effectiveness Network (DSEN), funded by the Canadian Institutes of Health Research (Grant No DSE-111845). The funding source was not involved in the writing of the manuscript or the decision to submit it for publication.	[Anonymous], 2013, HIGH DIMENSIONAL PRO; Armitage J, 2010, LANCET, V376, P1658, DOI 10.1016/S0140-6736(10)60310-8; Bell DSH, 2014, DIABETES OBES METAB, V16, P689, DOI 10.1111/dom.12254; Brugts JJ, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b2376; Carter AA, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f2610; Chen CW, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071817; Currie O, 2013, BMJ OPEN, V3, DOI 10.1136/bmjopen-2013-003475; Dormuth CR, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f880; Essebag Vidal, 2005, BMC Med Res Methodol, V5, P5, DOI 10.1186/1471-2288-5-5; Filion KB, 2014, GUT, V63, P552, DOI 10.1136/gutjnl-2013-304738; Food and Drug Administration, 2012, FDA DRUG SAF COMM IM; Hux JE, 2002, DIABETES CARE, V25, P512, DOI 10.2337/diacare.25.3.512; Kheterpal S, 2007, ANESTHESIOLOGY, V107, P892, DOI 10.1097/01.anes.0000290588.29668.38; Ko DT, 2013, CIRC-CARDIOVASC QUAL, V6, P315, DOI 10.1161/CIRCOUTCOMES.111.000015; LaRosa JC, 2005, NEW ENGL J MED, V352, P1425, DOI 10.1056/NEJMoa050461; Law MR, 2003, BRIT MED J, V326, P1423, DOI 10.1136/bmj.326.7404.1423; Molnar AO, 2011, J AM SOC NEPHROL, V22, P939, DOI 10.1681/ASN.2010050442; Navarese EP, 2014, AM J CARDIOVASC DRUG, V14, P79, DOI 10.1007/s40256-013-0053-0; Ouattara A, 2009, J CARDIOTHOR VASC AN, V23, P633, DOI 10.1053/j.jvca.2009.02.008; Pedersen TR, 2005, JAMA-J AM MED ASSOC, V294, P2437, DOI 10.1001/jama.294.19.2437; Preiss D, 2011, JAMA-J AM MED ASSOC, V305, P2556, DOI 10.1001/jama.2011.860; Rajpathak SN, 2009, DIABETES CARE, V32, P1924, DOI 10.2337/dc09-0738; Ray KK, 2010, ARCH INTERN MED, V170, P1024, DOI 10.1001/archinternmed.2010.182; Sattar N, 2010, LANCET, V375, P735, DOI 10.1016/S0140-6736(09)61965-6; Suissa S, 2008, AM J EPIDEMIOL, V167, P492, DOI 10.1093/aje/kwm324; Suissa Samy, 2012, Open Med, V6, pe134; Taylor F, 2011, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004816.pub4; Therapeutics Initiative, 2012, THERAPEUTICS LETT; Wang KL, 2014, AM J CARDIOL, V113, P631, DOI 10.1016/j.amjcard.2013.10.043	30	112	118	0	13	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	MAY 29	2014	348								g3244	10.1136/bmj.g3244	http://dx.doi.org/10.1136/bmj.g3244			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AI3EK	24874977	Green Published, hybrid			2022-12-28	WOS:000336742400001
J	Zhang, L; Meng, Y; Yang, WG; Wang, L; Mao, WL; Zeng, QS; Jeong, JS; Wagner, AJ; Mkhoyan, KA; Liu, WJ; Xu, RQ; Mao, HK				Zhang, Li; Meng, Yue; Yang, Wenge; Wang, Lin; Mao, Wendy L.; Zeng, Qiao-Shi; Jeong, Jong Seok; Wagner, Andrew J.; Mkhoyan, K. Andre; Liu, Wenjun; Xu, Ruqing; Mao, Ho-kwang			Disproportionation of (Mg,Fe)SiO3 perovskite in Earth's deep lower mantle	SCIENCE			English	Article							EQUATION-OF-STATE; POST-PEROVSKITE; PHASE-TRANSITION; D''-LAYER; IRON; TEMPERATURE; MGSIO3; HETEROGENEITY; SOLUBILITY; MODEL	The mineralogical constitution of the Earth's mantle dictates the geophysical and geochemical properties of this region. Previous models of a perovskite-dominant lower mantle have been built on the assumption that the entire lower mantle down to the top of the D" layer contains ferromagnesian silicate [(Mg,Fe)SiO3] with nominally 10 mole percent Fe. On the basis of experiments in laser-heated diamond anvil cells, at pressures of 95 to 101 gigapascals and temperatures of 2200 to 2400 kelvin, we found that such perovskite is unstable; it loses its Fe and disproportionates to a nearly Fe-free MgSiO3 perovskite phase and an Fe-rich phase with a hexagonal structure. This observation has implications for enigmatic seismic features beyond similar to 2000 kilometers depth and suggests that the lower mantle may contain previously unidentified major phases.	[Zhang, Li; Yang, Wenge; Wang, Lin; Mao, Ho-kwang] Ctr High Pressure Sci & Technol Adv Res HPSTAR, Shanghai 201203, Peoples R China; [Zhang, Li; Mao, Ho-kwang] Carnegie Inst Sci, Geophys Lab, Washington, DC 20015 USA; [Meng, Yue] CIW, Geophys Lab, HPCAT, Argonne, IL 60439 USA; [Yang, Wenge; Wang, Lin] CIW, Geophys Lab, High Pressure Synerget Consortium HPSynC, Argonne, IL 60439 USA; [Mao, Wendy L.; Zeng, Qiao-Shi] Stanford Univ, Stanford, CA 94305 USA; [Mao, Wendy L.] SLAC Natl Accelerator Lab, Menlo Pk, CA 94025 USA; [Jeong, Jong Seok; Wagner, Andrew J.; Mkhoyan, K. Andre] Univ Minnesota, Dept Chem Engn & Mat Sci, Minneapolis, MN 55455 USA; [Liu, Wenjun; Xu, Ruqing] Argonne Natl Lab, Adv Photon Source, Argonne, IL 60439 USA	Carnegie Institution for Science; Carnegie Institution for Science; Carnegie Institution for Science; Stanford University; Stanford University; United States Department of Energy (DOE); SLAC National Accelerator Laboratory; University of Minnesota System; University of Minnesota Twin Cities; United States Department of Energy (DOE); Argonne National Laboratory	Zhang, L (corresponding author), Ctr High Pressure Sci & Technol Adv Res HPSTAR, Shanghai 201203, Peoples R China.	zhangli@hpstar.ac.cn	Wang, Lin/N-4161-2017; Xu, Ruqing/K-3586-2012; Zeng, Qiaoshi/I-8688-2012; Zhang, Li/I-4658-2013; liu, wen/HGE-3071-2022; Zhang, Li/K-1633-2017; Jeong, Jong Seok/G-5022-2010; zeng, qiaoshi/V-8250-2019	Xu, Ruqing/0000-0003-1037-0059; Zeng, Qiaoshi/0000-0001-5960-1378; Jeong, Jong Seok/0000-0002-5570-748X; zeng, qiaoshi/0000-0001-5960-1378; Mkhoyan, Andre/0000-0003-3568-5452	National Science Foundation (NSF) grants [EAR-0911492, EAR-1119504, EAR-1141929, EAR-1345112]; U.S. Department of Energy-National Nuclear Security Administration (DOE-NNSA) [DE-NA0001974]; DOE-Basic Energy Sciences (BES) [DE-FG02-99ER45775]; NSF; EFree, an Energy Frontier Research Center - DOE-BES [DE-SC0001057]; NSF-Earth Sciences [EAR-1128799]; DOE-GeoSciences [DE-FG02-94ER14466]; DOE-BES [DE-AC02-06CH11357]; Materials Research and Engineering Center program of the NSF [DMR-0819885]	National Science Foundation (NSF) grants; U.S. Department of Energy-National Nuclear Security Administration (DOE-NNSA); DOE-Basic Energy Sciences (BES)(United States Department of Energy (DOE)); NSF(National Science Foundation (NSF)); EFree, an Energy Frontier Research Center - DOE-BES; NSF-Earth Sciences(National Science Foundation (NSF)); DOE-GeoSciences(United States Department of Energy (DOE)); DOE-BES(United States Department of Energy (DOE)); Materials Research and Engineering Center program of the NSF	We thank Y. Fei for providing the pv10 starting material; J. Shu, M. Somayazulu, E. Rod, G. Shen, S. Sinogeikin, P. Dera, V. Prakapenka, and S. Tkachev for their technical support. We also thank S. Merkel for introducing us to the indexing software. The research is supported by National Science Foundation (NSF) grants EAR-0911492, EAR-1119504, EAR-1141929, and EAR-1345112. This work was performed at HPCAT (Sector 16), Advanced Photon Source (APS), Argonne National Laboratory. HPCAT operations are supported by the U.S. Department of Energy-National Nuclear Security Administration (DOE-NNSA) under award DE-NA0001974 and DOE-Basic Energy Sciences (BES) under award DE-FG02-99ER45775, with partial instrumentation funding by NSF. HPSynC is supported as part of EFree, an Energy Frontier Research Center funded by DOE-BES under grant DE-SC0001057. Portions of this work were performed at GeoSoilEnviroCARS (sector 13), APS, supported by the NSF-Earth Sciences (EAR-1128799) and DOE-GeoSciences (DE-FG02-94ER14466), at 34ID-E beamline, APS, and at 15U1, Shanghai Synchrotron Radiation Facility. Use of the APS facility was supported by DOE-BES under contract DE-AC02-06CH11357. This work was also partially supported by the Materials Research and Engineering Center program of the NSF under award DMR-0819885. Part of this work was carried out in the Characterization Facility of the University of Minnesota. All other data used to support conclusions in this manuscript are provided in the supplementary materials	Badro J, 2003, SCIENCE, V300, P789, DOI 10.1126/science.1081311; Badro J, 2004, SCIENCE, V305, P383, DOI 10.1126/science.1098840; Dorfman SM, 2013, EARTH PLANET SC LETT, V361, P249, DOI 10.1016/j.epsl.2012.10.033; FEI Y, 1994, AM MINERAL, V79, P826; Fei YW, 1996, J GEOPHYS RES-SOL EA, V101, P11525, DOI 10.1029/96JB00408; Garnero EJ, 2008, SCIENCE, V320, P626, DOI 10.1126/science.1148028; Hutko AR, 2008, SCIENCE, V320, P1070, DOI 10.1126/science.1155822; Jackson JM, 2005, AM MINERAL, V90, P199, DOI 10.2138/am.2005.1633; Li J, 2004, P NATL ACAD SCI USA, V101, P14027, DOI 10.1073/pnas.0405804101; Lin JF, 2008, NAT GEOSCI, V1, P688, DOI 10.1038/ngeo310; Lundin S, 2008, PHYS EARTH PLANET IN, V168, P97, DOI 10.1016/j.pepi.2008.05.002; Mao WL, 2005, P NATL ACAD SCI USA, V102, P9751, DOI 10.1073/pnas.0503737102; Murakami M, 2004, SCIENCE, V304, P855, DOI 10.1126/science.1095932; Murakami M, 2012, NATURE, V485, P90, DOI 10.1038/nature11004; Oganov AR, 2004, NATURE, V430, P445, DOI 10.1038/nature02701; Ohtani E, 2008, PHYS EARTH PLANET IN, V170, P240, DOI 10.1016/j.pepi.2008.07.024; Panning M, 2004, SCIENCE, V303, P351, DOI 10.1126/science.1091524; Ricolleau A, 2009, GEOPHYS RES LETT, V36, DOI 10.1029/2008GL036759; Sinmyo R, 2011, J GEOPHYS RES-SOL EA, V116, DOI 10.1029/2010JB008179; Sorensen HO, 2012, Z KRIST-CRYST MATER, V227, P63, DOI 10.1524/zkri.2012.1438; Stackhouse S, 2008, NAT GEOSCI, V1, P648, DOI 10.1038/ngeo327; SU WJ, 1994, J GEOPHYS RES-SOL EA, V99, P6945, DOI 10.1029/93JB03408; Tange Y, 2009, J GEOPHYS RES-SOL EA, V114, DOI 10.1029/2008JB005891; Tateno S, 2007, PHYS EARTH PLANET IN, V160, P319, DOI 10.1016/j.pepi.2006.11.010; Tsuchiya T, 2004, EARTH PLANET SC LETT, V224, P241, DOI 10.1016/j.epsl.2004.05.017; van der Hilst RD, 1999, SCIENCE, V283, P1885, DOI 10.1126/science.283.5409.1885; Wang L, 2010, P NATL ACAD SCI USA, V107, P6140, DOI 10.1073/pnas.1001141107	27	64	72	1	159	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 23	2014	344	6186					877	882		10.1126/science.1250274	http://dx.doi.org/10.1126/science.1250274			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AH6IL	24855264				2022-12-28	WOS:000336233800041
J	Zhong, XH; Du, JM; Hale, CJ; Gallego-Bartolome, J; Feng, SH; Vashisht, AA; Chory, J; Wohlschlegel, JA; Patel, DJ; Jacobsen, SE				Zhong, Xuehua; Du, Jiamu; Hale, Christopher J.; Gallego-Bartolome, Javier; Feng, Suhua; Vashisht, Ajay A.; Chory, Joanne; Wohlschlegel, James A.; Patel, Dinshaw J.; Jacobsen, Steven E.			Molecular Mechanism of Action of Plant DRM De Novo DNA Methyltransferases	CELL			English	Article							RNA-POLYMERASE V; METHYLATION; MAINTENANCE; REVEALS; ARGONAUTE4; DOMAINS; BINDING	DNA methylation is a conserved epigenetic generegulation mechanism. DOMAINS REARRANGED METHYLTRANSFERASE (DRM) is a key de novo methyltransferase in plants, but how DRM acts mechanistically is poorly understood. Here, we report the crystal structure of the methyltransferase domain of tobacco DRM (NtDRM) and reveal a molecular basis for its rearranged structure. NtDRM forms a functional homodimer critical for catalytic activity. We also show that Arabidopsis DRM2 exists in complex with the small interfering RNA (siRNA) effector ARGONAUTE4 (AGO4) and preferentially methylates one DNA strand, likely the strand acting as the template for RNA polymerase V- mediated noncoding RNA transcripts. This strand- biased DNA methylation is also positively correlated with strand- biased siRNA accumulation. These data suggest a model in which DRM2 is guided to target loci by AGO4- siRNA and involves base-pairing of associated siRNAs with nascent RNA transcripts.	[Zhong, Xuehua; Hale, Christopher J.; Gallego-Bartolome, Javier; Feng, Suhua; Jacobsen, Steven E.] Univ Calif Los Angeles, Dept Mol Cell & Dev Biol, Los Angeles, CA 90095 USA; [Du, Jiamu; Patel, Dinshaw J.] Mem Sloan Kettering Canc Ctr, Struct Biol Program, New York, NY 10065 USA; [Gallego-Bartolome, Javier; Chory, Joanne] Salk Inst Biol Studies, Plant Biol Lab, La Jolla, CA 92037 USA; [Feng, Suhua; Jacobsen, Steven E.] Univ Calif Los Angeles, Howard Hughes Med Inst, Los Angeles, CA 90095 USA; [Feng, Suhua; Jacobsen, Steven E.] Univ Calif Los Angeles, Eli & Edythe Broad Ctr Regenerat Med & Stem Cell, Los Angeles, CA 90095 USA; [Vashisht, Ajay A.; Wohlschlegel, James A.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Biol Chem, Los Angeles, CA 90095 USA; [Chory, Joanne] Salk Inst Biol Studies, Howard Hughes Med Inst, La Jolla, CA 92037 USA	University of California System; University of California Los Angeles; Memorial Sloan Kettering Cancer Center; Salk Institute; Howard Hughes Medical Institute; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; Howard Hughes Medical Institute; Salk Institute	Patel, DJ (corresponding author), Mem Sloan Kettering Canc Ctr, Struct Biol Program, New York, NY 10065 USA.	pateld@mskcc.org; jacobsen@ucla.edu	Du, Jiamu/I-1334-2013; Gallego-Bartolomé, Javier/AAV-7369-2020	Du, Jiamu/0000-0002-1337-0786; Gallego-Bartolome, Javier/0000-0003-2225-7168	Ruth L. Kirschstein National Research Service Award [F32GM096483-01]; Frontiers Science Program [LT000425/2012-L]; Abby Rockefeller Mauze Trust; Maloris foundation; STARR foundation; NIH [GM60398, GM094428]; NATIONAL CANCER INSTITUTE [P30CA008748] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM060398, F32GM096483, R01GM094428, R01GM060398, R01GM089778] Funding Source: NIH RePORTER	Ruth L. Kirschstein National Research Service Award(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Frontiers Science Program; Abby Rockefeller Mauze Trust; Maloris foundation; STARR foundation; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank the staff members at Shanghai Synchrotron Radiation Facility (SSRF) and Advanced Photon Source for their support in diffraction data collection and the staff members at the UCLA BSCRC BioSequencing core for high-throughput sequencing. We are grateful to Craig Pikaard for discussions on strand-biased DNA methylation, Dr. Jianping Ding for access to data collection at the SSRF, and Dr. Eerappa Rajakumara for assistance with cloning. X.Z. is a research fellow of Ruth L. Kirschstein National Research Service Award (F32GM096483-01). C.J.H. is a HHMI fellow of the Damon Runyon Cancer Research Foundation. S. F. is a special fellow of the Leukemia & Lymphoma Society. J.G-B is a Human Frontiers Science Program fellow (LT000425/2012-L). This work was supported by the Abby Rockefeller Mauze Trust and Maloris and STARR foundations (to D.J.P.), NIH grant GM089778 and the UCLA Jonsson Cancer Center (to J.A.W.), NIH grant GM60398 (to S.E.J.), and NIH grant GM094428 (to J.C.). S.E.J. and J.C. are investigators of the Howard Hughes Medical Institute.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Cao XF, 2002, CURR BIOL, V12, P1138, DOI 10.1016/S0960-9822(02)00925-9; Cao XF, 2000, P NATL ACAD SCI USA, V97, P4979, DOI 10.1073/pnas.97.9.4979; CHENG XD, 1993, CELL, V74, P299, DOI 10.1016/0092-8674(93)90421-L; Cokus SJ, 2008, NATURE, V452, P215, DOI 10.1038/nature06745; Du JM, 2012, CELL, V151, P167, DOI 10.1016/j.cell.2012.07.034; Earley KW, 2006, PLANT J, V45, P616, DOI 10.1111/j.1365-313X.2005.02617.x; El-Shami M, 2007, GENE DEV, V21, P2539, DOI 10.1101/gad.451207; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Finnegan EJ, 2000, PLANT MOL BIOL, V43, P189, DOI 10.1023/A:1006427226972; FINNEGAN EJ, 1993, NUCLEIC ACIDS RES, V21, P2383, DOI 10.1093/nar/21.10.2383; Greenberg MVC, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003946; Henderson IR, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001182; Jia D, 2007, NATURE, V449, P248, DOI 10.1038/nature06146; Johnson LM, 2014, NATURE, V507, P124, DOI 10.1038/nature12931; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Law JA, 2010, NAT REV GENET, V11, P204, DOI 10.1038/nrg2719; Lee TF, 2012, EPIGENETICS-US, V7, P781, DOI 10.4161/epi.20290; Li CF, 2006, CELL, V126, P93, DOI 10.1016/j.cell.2006.05.032; Lindroth AM, 2001, SCIENCE, V292, P2077, DOI 10.1126/science.1059745; Lister R, 2008, CELL, V133, P523, DOI 10.1016/j.cell.2008.03.029; Lister R, 2009, NATURE, V462, P315, DOI 10.1038/nature08514; Luo S, 2003, P NATL ACAD SCI USA, V100, P11133, DOI 10.1073/pnas.1831011100; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Qi YJ, 2006, NATURE, V443, P1008, DOI 10.1038/nature05198; Schubert HL, 2003, TRENDS BIOCHEM SCI, V28, P329, DOI 10.1016/S0968-0004(03)00090-2; Song JK, 2012, SCIENCE, V335, P709, DOI 10.1126/science.1214453; Song JK, 2011, SCIENCE, V331, P1036, DOI 10.1126/science.1195380; Stroud H, 2014, NAT STRUCT MOL BIOL, V21, P64, DOI 10.1038/nsmb.2735; Stroud H, 2013, CELL, V152, P352, DOI 10.1016/j.cell.2012.10.054; Wada Y, 2003, J BIOL CHEM, V278, P42386, DOI 10.1074/jbc.M303892200; Wierzbicki AT, 2009, NAT GENET, V41, P630, DOI 10.1038/ng.365; Xi YP, 2009, BMC BIOINFORMATICS, V10, DOI [10.1186/1471-2105-10-S1-S58, 10.1186/1471-2105-10-232]; Zemach A, 2013, CELL, V153, P193, DOI 10.1016/j.cell.2013.02.033; Zhang H, 2013, P NATL ACAD SCI USA, V110, P8290, DOI 10.1073/pnas.1300585110; Zhong XH, 2012, NAT STRUCT MOL BIOL, V19, P870, DOI 10.1038/nsmb.2354	36	182	191	4	62	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAY 22	2014	157	5					1050	1060		10.1016/j.cell.2014.03.056	http://dx.doi.org/10.1016/j.cell.2014.03.056			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	AH9CG	24855943	Green Accepted, Bronze			2022-12-28	WOS:000336437200009
J	Loymans, RJB; Gemperli, A; Cohen, J; Rubinstein, SM; Sterk, PJ; Reddel, HK; Juni, P; ter Riet, G				Loymans, Rik J. B.; Gemperli, Armin; Cohen, Judith; Rubinstein, Sidney M.; Sterk, Peter J.; Reddel, Helen K.; Jueni, Peter; ter Riet, Gerben			Comparative effectiveness of long term drug treatment strategies to prevent asthma exacerbations: network meta-analysis	BMJ-BRITISH MEDICAL JOURNAL			English	Article							DOSE FLUTICASONE PROPIONATE; REGULAR INHALED SALBUTAMOL; MILD PERSISTENT ASTHMA; ACTING BETA-AGONIST; TO-MODERATE ASTHMA; RELIEVER THERAPY; BUDESONIDE/FORMOTEROL MAINTENANCE; DOUBLE-BLIND; SALMETEROL/FLUTICASONE PROPIONATE; SINGLE INHALER	Objective To determine the comparative effectiveness and safety of current maintenance strategies in preventing exacerbations of asthma. Design Systematic review and network meta-analysis using Bayesian statistics. Data sources Cochrane systematic reviews on chronic asthma, complemented by an updated search when appropriate. Eligibility criteria Trials of adults with asthma randomised to maintenance treatments of at least 24 weeks duration and that reported on asthma exacerbations in full text. Low dose inhaled corticosteroid treatment was the comparator strategy. The primary effectiveness outcome was the rate of severe exacerbations. The secondary outcome was the composite of moderate or severe exacerbations. The rate of withdrawal was analysed as a safety outcome. Results 64 trials with 59 622 patient years of follow-up comparing 15 strategies and placebo were included. For prevention of severe exacerbations, combined inhaled corticosteroids and long acting beta agonists as maintenance and reliever treatment and combined inhaled corticosteroids and long acting beta agonists in a fixed daily dose performed equally well and were ranked first for effectiveness. The rate ratios compared with low dose inhaled corticosteroids were 0.44 (95% credible interval 0.29 to 0.66) and 0.51 (0.35 to 0.77), respectively. Other combined strategies were not superior to inhaled corticosteroids and all single drug treatments were inferior to single low dose inhaled corticosteroids. Safety was best for conventional best (guideline based) practice and combined maintenance and reliever therapy. Conclusions Strategies with combined inhaled corticosteroids and long acting beta agonists are most effective and safe in preventing severe exacerbations of asthma, although some heterogeneity was observed in this network meta-analysis of full text reports.	[Loymans, Rik J. B.; Cohen, Judith; ter Riet, Gerben] Univ Amsterdam, Acad Med Ctr, Dept Gen Practice, NL-1105 DE Amsterdam, Netherlands; [Gemperli, Armin; Jueni, Peter] Univ Bern, Inst Social & Prevent Med, Div Clin Epidemiol & Biostat, Bern, Switzerland; [Gemperli, Armin] Univ Lucerne, Dept Hlth Sci & Hlth Policy, Luzern, Switzerland; [Gemperli, Armin] Swiss Parapleg Res, Nottwil, Switzerland; [Rubinstein, Sidney M.] Vrije Univ Amsterdam, Sect Hlth Econ & Hlth Technol Assessment, Dept Hlth Sci, Amsterdam, Netherlands; [Sterk, Peter J.] Univ Amsterdam, Acad Med Ctr, Dept Resp Med, NL-1105 DE Amsterdam, Netherlands; [Reddel, Helen K.] Univ Sydney, Woolcock Inst Med Res, Clin Management Grp, Sydney, NSW 2006, Australia	University of Amsterdam; Academic Medical Center Amsterdam; University of Bern; University of Lucerne; Swiss Paraplegic Research; Vrije Universiteit Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam; University of Sydney; Woolcock Institute of Medical Research	Loymans, RJB (corresponding author), Univ Amsterdam, Acad Med Ctr, Dept Gen Practice, POB 22700, NL-1105 DE Amsterdam, Netherlands.	r.j.loijmans@amc.nl	Reddel, Helen/ABD-6338-2021; Juni, Peter/Q-8700-2016; Reddel, Helen/AAC-3394-2020; Sterk, P.J./AAK-8175-2020; Riet, Gerben ter/A-6943-2011	Juni, Peter/0000-0002-5985-0670; Reddel, Helen/0000-0002-6695-6350; Riet, Gerben ter/0000-0002-2231-7637; Rubinstein, Sidney/0000-0002-4819-994X	AstraZeneca; Boehringer Ingelheim; Getz; GlaxoSmithKline; Merck; Abbott Vascular; Biosensors; Medtronic; St Jude Medical; Ablynx; Amgen; Biotronic; Boehrhinger Ingelheim; Eisai; Eli Lilly; Exelixis; Geron; Gilead Sciences; Nestle; Novartis; Novo Nordisc; Padma; Roche; Schering-Plough; Swiss Cardio Technologies	AstraZeneca(AstraZeneca); Boehringer Ingelheim(Boehringer Ingelheim); Getz; GlaxoSmithKline(GlaxoSmithKline); Merck(Merck & Company); Abbott Vascular(Abbott Laboratories); Biosensors; Medtronic(Medtronic); St Jude Medical(St. Jude Medical); Ablynx(Ablynx); Amgen(Amgen); Biotronic; Boehrhinger Ingelheim; Eisai(Eisai Co Ltd); Eli Lilly(Eli Lilly); Exelixis; Geron; Gilead Sciences(Gilead Sciences); Nestle(Nestle SA); Novartis(Novartis); Novo Nordisc(Novo Nordisk); Padma; Roche(Roche Holding); Schering-Plough(Merck & CompanySchering Plough Corporation); Swiss Cardio Technologies	All authors have completed the ICMJE uniform disclosure form at www.icmje.org/coi_disclosure.pdf and declare: no support from any organisation for the submitted work; HKR has participated on advisory boards for AstraZeneca, Boehringer Ingelheim, GlaxoSmithKline, and Novartis, is participating on a joint data monitoring committee for AstraZeneca, GlaxoSmithKline, Merck, and Novartis, has provided consultancy services for AstraZeneca, GlaxoSmithKline, and Mundipharma, has provided continuing medical education presentations at symposiums funded by AstraZeneca, Boehringer Ingelheim, Getz, GlaxoSmithKline, and Merck, and has received unconditional research funding from AstraZeneca and GlaxoSmithKline. PJ is an unpaid member of steering groups or executive committees of trials funded by Abbott Vascular, Biosensors, Medtronic, and St Jude Medical. CTU Bern, which is part of the University of Bern, has a staff policy of not accepting individual honorariums or consultancy fees. However, CTU Bern is involved in the design, conduct, or analysis of clinical studies funded by Abbott Vascular, Ablynx, Amgen, AstraZeneca, Biosensors, Biotronic, Boehrhinger Ingelheim, Eisai, Eli Lilly, Exelixis, Geron, Gilead Sciences, Nestle, Novartis, Novo Nordisc, Padma, Roche, Schering-Plough, St Jude Medical, and Swiss Cardio Technologies; there are no non-financial interests that may be relevant to the submitted work.	Aalbers R, 2004, CURR MED RES OPIN, V20, P225, DOI 10.1185/030079903125002928; Aaron SD, 2008, THORAX, V63, P122, DOI 10.1136/thx.2007.082636; Atienza T, 2013, RESPIROLOGY, V18, P354, DOI 10.1111/resp.12009; Bailey W, 2008, CURR MED RES OPIN, V24, P1669, DOI 10.1185/03007990802119111; Bateman ED, 2004, AM J RESP CRIT CARE, V170, P836, DOI 10.1164/rccm.200401-033OC; Bateman ED, 2010, J ALLERGY CLIN IMMUN, V125, P600, DOI 10.1016/j.jaci.2009.11.033; Bjermer L, 2003, BMJ-BRIT MED J, V327, P891, DOI 10.1136/bmj.327.7420.891; Bousquet J, 2007, RESP MED, V101, P2437, DOI 10.1016/j.rmed.2007.07.014; Brown RW, 2012, J ALLERGY CLIN IMMUN, V130, P362, DOI 10.1016/j.jaci.2012.03.028; Brusselle GG, 2013, THORAX, V68, P322, DOI 10.1136/thoraxjnl-2012-202698; Busse W, 2001, J ALLERGY CLIN IMMUN, V107, P461, DOI 10.1067/mai.2001.114657; Busse WW, 2008, J ALLERGY CLIN IMMUN, V121, P1407, DOI 10.1016/j.jaci.2008.03.019; Busse WW, 2013, THORAX, V68, P513, DOI 10.1136/thoraxjnl-2012-202606; Caldwell DM, 2005, BMJ-BRIT MED J, V331, P897, DOI 10.1136/bmj.331.7521.897; Cates CJ, 2009, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD007313.pub2; Cates CJ, 2009, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD007085.pub2; Chuchalin A, 2005, RESP MED, V99, P461, DOI 10.1016/j.rmed.2004.09.012; Chuchalin A, 2008, CLIN DRUG INVEST, V28, P169, DOI 10.2165/00044011-200828030-00004; Condemi JJ, 1999, ANN ALLERG ASTHMA IM, V82, P383, DOI 10.1016/S1081-1206(10)63288-7; COUCH AHC, 1977, PRACTITIONER, V219, P751; D'Urzo AD, 2001, CHEST, V119, P714, DOI 10.1378/chest.119.3.714; Dennis SM, 2000, LANCET, V355, P1675, DOI 10.1016/S0140-6736(00)02238-8; Ducharme F, 2004, COCHRANE DB SYST REV, V2; Ducharme FM, 2011, COCHRANE DB SYST REV, V5; Ducharme FM, 2010, COCHRANE DB SYST REV, V5; Ducharme FM, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD005533.pub2; Edwards SJ, 2010, INT J CLIN PRACT, V64, P619, DOI 10.1111/j.1742-1241.2009.02320.x; FitzGerald JM, 1999, J ALLERGY CLIN IMMUN, V103, P427, DOI 10.1016/S0091-6749(99)70467-7; FitzGerald JM, 2005, CLIN THER, V27, P393, DOI 10.1016/j.clinthera.2005.03.006; Gibson PG, 2007, J ALLERGY CLIN IMMUN, V119, P344, DOI 10.1016/j.jaci.2006.10.043; Gibson PG, 2005, COCHRANE DB SYST REV, V4; Global Strategy for Asthma Management and Prevention, 2010, GLOB IN ASTHM GINA; GREENING AP, 1994, LANCET, V344, P219, DOI 10.1016/S0140-6736(94)92996-3; Guevara JP, 2006, COCHRANE DB SYST REV, V2; Hanania NA, 2011, ANN INTERN MED, V154, P573, DOI 10.7326/0003-4819-154-9-201105030-00002; Hayashi K, 2003, COCHRANE DB SYST REV, V2; Higgins JPT., 2008, COCHRANE HDB SYSTEMA, V1 edn; Hoaglin DC, 2011, VALUE HEALTH, V14, P429, DOI 10.1016/j.jval.2011.01.011; Huchon G, 2009, RESP MED, V103, P41, DOI 10.1016/j.rmed.2008.09.002; Ilowite J, 2004, ANN ALLERG ASTHMA IM, V92, P641, DOI 10.1016/S1081-1206(10)61430-5; Ind PW, 2003, RESP MED, V97, P555, DOI 10.1053/rmed.2003.1483; Irvin CG, 2007, AM J RESP CRIT CARE, V175, P235, DOI 10.1164/rccm.200603-416OC; Ivanova JI, 2012, J ALLERGY CLIN IMMUN, V129, P1229, DOI 10.1016/j.jaci.2012.01.039; Jackson DJ, 2011, J ALLERGY CLIN IMMUN, V128, P1165, DOI 10.1016/j.jaci.2011.10.024; Jarjour NN, 2006, J ALLERGY CLIN IMMUN, V118, P44, DOI 10.1016/j.jaci.2006.03.043; Jenkins C, 2000, RESP MED, V94, P715, DOI 10.1053/rmed.2000.0875; Katial RK, 2011, ALLERGY ASTHMA PROC, V32, P127, DOI 10.2500/aap.2011.32.3426; Kelsen SG, 1999, J ASTHMA, V36, P703, DOI 10.3109/02770909909055422; KERWIN E, 2011, CLIN RES REGUL AFF, V28, P14, DOI DOI 10.3109/10601333.2010.544315; Kips JC, 2000, AM J RESP CRIT CARE, V161, P996, DOI 10.1164/ajrccm.161.3.9812056; Koopmans JG, 2006, THORAX, V61, P306, DOI 10.1136/thx.2005.051292; Kuna P, 2007, INT J CLIN PRACT, V61, P725, DOI 10.1111/j.1742-1241.2007.01338.x; Liu MC, 1996, J ALLERGY CLIN IMMUN, V98, P859, DOI 10.1016/S0091-6749(96)80002-9; Louis R, 2009, INT J CLIN PRACT, V63, P1479, DOI 10.1111/j.1742-1241.2009.02185.x; Lu G, 2004, STAT MED, V23, P3105, DOI 10.1002/sim.1875; Lumley T, 2002, STAT MED, V21, P2313, DOI 10.1002/sim.1201; Lundback B, 2006, RESP MED, V100, P2, DOI 10.1016/j.rmed.2005.09.006; Lundborg M, 2006, CURR MED RES OPIN, V22, P809, DOI 10.1185/030079906X100212; Meltzer EO, 2012, EUR RESPIR J, V39, P279, DOI 10.1183/09031936.00020310; Meltzer EO, 2002, MAYO CLIN PROC, V77, P437; Murray JJ, 1999, ALLERGY ASTHMA PROC, V20, P173, DOI 10.2500/108854199778553028; Nathan RA, 1999, ANN ALLERG ASTHMA IM, V82, P521, DOI 10.1016/S1081-1206(10)63159-6; Nathan RA, 2010, ALLERGY ASTHMA PROC, V31, P269, DOI 10.2500/aap.2010.31.3364; Ng D, 2004, COCHRANE DB SYST REV, V2; Ni CM, 2009, COCHRANE DB SYST REV, V4; Nie HX, 2013, RESP MED, V107, P347, DOI 10.1016/j.rmed.2012.12.004; O'Byrne PM, 2011, J ALLERGY CLIN IMMUN, V128, P257, DOI 10.1016/j.jaci.2011.03.035; O'Byrne PM, 2001, AM J RESP CRIT CARE, V164, P1392, DOI 10.1164/ajrccm.164.8.2104102; O'Byrne PM, 2005, AM J RESP CRIT CARE, V171, P129, DOI 10.1164/rccm.200407-884OC; Papi A, 2007, NEW ENGL J MED, V356, P2040, DOI 10.1056/NEJMoa063861; Papi A, 2013, LANCET RESP MED, V1, P23, DOI 10.1016/S2213-2600(13)70012-2; Patel M, 2013, LANCET RESP MED, V1, P32, DOI 10.1016/S2213-2600(13)70007-9; Pauwels RA, 1997, NEW ENGL J MED, V337, P1405, DOI 10.1056/NEJM199711133372001; Pauwels RA, 2003, LANCET, V361, P1071, DOI 10.1016/S0140-6736(03)12891-7; Pavord ID, 2009, J ALLERGY CLIN IMMUN, V123, P1083, DOI 10.1016/j.jaci.2009.02.034; Peters SP, 2008, ALLERGY ASTHMA PROC, V29, P499, DOI 10.2500/aap.2008.29.3147; Postma DS, 2011, CHEST, V139, P311, DOI 10.1378/chest.09-1735; Price D, 2002, THORAX, V57, P791, DOI 10.1136/thorax.57.9.791; Price D, 2011, NEW ENGL J MED, V364, P1695, DOI 10.1056/NEJMoa1010846; Quirce S, 2011, J ASTHMA, V48, P839, DOI 10.3109/02770903.2011.611954; Rabe KF, 2006, CHEST, V129, P246, DOI 10.1378/chest.129.2.246; Rabe KF, 2006, LANCET, V368, P744, DOI 10.1016/S0140-6736(06)69284-2; Reddel Helen K, 2008, Prim Care Respir J, V17, P39, DOI 10.3132/pcrj.2008.00014; Reddel HK, 2009, AM J RESP CRIT CARE, V180, P59, DOI 10.1164/rccm.200801-060ST; Renzi PM, 2010, RESP MED, V104, P510, DOI 10.1016/j.rmed.2009.10.025; Richeldi L, 2005, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD002997.pub3; Riemersma RA, 2012, PRIM CARE RESP J, V21, P50, DOI 10.4104/pcrj.2011.00090; Rosenhall L, 2002, INT J CLIN PRACT, V56, P427; Rosenthal RR, 1999, CHEST, V116, P595, DOI 10.1378/chest.116.3.595; Salanti G, 2011, J CLIN EPIDEMIOL, V64, P163, DOI 10.1016/j.jclinepi.2010.03.016; Scicchitano R, 2004, CURR MED RES OPIN, V20, P1403, DOI 10.1185/030079904X2051; Sears MR, 2008, EUR RESPIR J, V31, P982, DOI 10.1183/09031936.00104007; Sin DD, 2004, JAMA-J AM MED ASSOC, V292, P367, DOI 10.1001/jama.292.3.367; Smith TC, 1995, STAT MED, V14, P2685, DOI 10.1002/sim.4780142408; Soes-Petersen U, 2011, CLIN RESPIR J, V5, P173, DOI 10.1111/j.1752-699X.2010.00217.x; Song F, 2008, J CLIN EPIDEMIOL, V61, P455, DOI 10.1016/j.jclinepi.2007.06.006; Sovani MP, 2008, BRIT J GEN PRACT, V58, P37, DOI 10.3399/bjgp08X263802; Spiegelhalter DJ, 2004, BAYESIAN APPROACHES, DOI DOI 10.1002/0470092602; Stallberg B, 2008, RESP MED, V102, P1360, DOI 10.1016/j.rmed.2008.06.017; Stallberg B, 2003, INT J CLIN PRACT, V57, P656; Strand AM, 2004, RESP MED, V98, P1008, DOI 10.1016/j.rmed.2004.03.004; Suissa S, 2006, AM J RESP CRIT CARE, V173, P842, DOI 10.1164/rccm.200508-1338PP; Taylor DR, 2008, EUR RESPIR J, V32, P545, DOI 10.1183/09031936.00155307; Taylor DR, 1998, THORAX, V53, P744, DOI 10.1136/thx.53.9.744; Tee AK, 2007, COCHRANE DB SYST REV, V3; Turner EH, 2008, NEW ENGL J MED, V358, P252, DOI 10.1056/NEJMsa065779; vanderMolen T, 1997, THORAX, V52, P535, DOI 10.1136/thx.52.6.535; Vogelmeier C, 2005, EUR RESPIR J, V26, P819, DOI 10.1183/09031936.05.00028305; Walker S, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003559.pub3; Walters EH, 2002, COCHRANE DB SYST REV, V4; Westby M., 2004, COCHRANE DB SYST REV, V3; Woolcock A, 1996, AM J RESP CRIT CARE, V153, P1481, DOI 10.1164/ajrccm.153.5.8630590	113	43	44	2	28	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	MAY 13	2014	348								g3009	10.1136/bmj.g3009	http://dx.doi.org/10.1136/bmj.g3009			16	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AH5CN	24919052	Green Published, hybrid			2022-12-28	WOS:000336146200005
J	Nigg, D; Muller, M; Martinez, EA; Schindler, P; Hennrich, M; Monz, T; Martin-Delgado, MA; Blatt, R				Nigg, D.; Mueller, M.; Martinez, E. A.; Schindler, P.; Hennrich, M.; Monz, T.; Martin-Delgado, M. A.; Blatt, R.			Quantum computations on a topologically encoded qubit	SCIENCE			English	Article							ERROR-CORRECTING CODES; TRAPPED IONS; REALIZATION; COMPUTERS; THRESHOLD; CIRCUITS; MEMORY	The construction of a quantum computer remains a fundamental scientific and technological challenge because of the influence of unavoidable noise. Quantum states and operations can be protected from errors through the use of protocols for quantum computing with faulty components. We present a quantum error-correcting code in which one qubit is encoded in entangled states distributed over seven trapped-ion qubits. The code can detect one bit flip error, one phase flip error, or a combined error of both, regardless on which of the qubits they occur. We applied sequences of gate operations on the encoded qubit to explore its computational capabilities. This seven-qubit code represents a fully functional instance of a topologically encoded qubit, or color code, and opens a route toward fault-tolerant quantum computing.	[Nigg, D.; Martinez, E. A.; Schindler, P.; Hennrich, M.; Monz, T.; Blatt, R.] Univ Innsbruck, Inst Expt Phys, A-6020 Innsbruck, Austria; [Mueller, M.; Martin-Delgado, M. A.] Univ Complutense, Dept Fis Teor 1, E-28040 Madrid, Spain; [Blatt, R.] Austrian Acad Sci, Inst Quantenopt & Quanteninformat, A-6020 Innsbruck, Austria	University of Innsbruck; Complutense University of Madrid; Austrian Academy of Sciences	Nigg, D (corresponding author), Univ Innsbruck, Inst Expt Phys, A-6020 Innsbruck, Austria.	daniel.nigg@uibk.ac.at; mueller@ucm.es	Martin-Delgado, Miguel Angel/C-1141-2017; Martin-Delgado, Miguel Angel/I-4593-2018; Müller, Markus/I-6530-2012; Hennrich, Markus/D-2475-2009; Monz, Thomas/E-1285-2017; Blatt, Rainer/H-9527-2014; Schindler, Philipp/E-1485-2017; Schindler, Philipp/AAB-4803-2019; Müller, Markus/AAV-2927-2020	Martin-Delgado, Miguel Angel/0000-0003-2746-5062; Martin-Delgado, Miguel Angel/0000-0003-2746-5062; Hennrich, Markus/0000-0003-2955-7980; Schindler, Philipp/0000-0002-9461-9650; Schindler, Philipp/0000-0002-9461-9650; Müller, Markus/0000-0002-2813-3097; Monz, Thomas/0000-0001-7410-4804	Spanish MICINN [FIS2009-10061, FIS2012-33152]; CAM research consortium QUITEMAD [S2009-ESP-1594]; European Commission PICC: FP7 [249958]; integrated project SIQS [600645]; UCM-BS grant [GICC-910758]; Austrian Science Fund (FWF) through the SFB FoQus (FWF project) [F4002-N16]; Institut fur Quanteninformation GmbH; U.S. Army Research Office [W911NF-14-1-0103]; Office of the Director of National Intelligence (ODNI), Intelligence Advanced Research Projects Activity (IARPA), through Army Research Office [W911NF-10-1-0284]	Spanish MICINN(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); CAM research consortium QUITEMAD; European Commission PICC: FP7; integrated project SIQS; UCM-BS grant; Austrian Science Fund (FWF) through the SFB FoQus (FWF project)(Austrian Science Fund (FWF)); Institut fur Quanteninformation GmbH; U.S. Army Research Office; Office of the Director of National Intelligence (ODNI), Intelligence Advanced Research Projects Activity (IARPA), through Army Research Office	Supported by Spanish MICINN grants FIS2009-10061 and FIS2012-33152; CAM research consortium QUITEMAD grant S2009-ESP-1594; European Commission PICC: FP7 2007-2013, grant 249958; integrated project SIQS (grant 600645); UCM-BS grant GICC-910758; the Austrian Science Fund (FWF) through the SFB FoQus (FWF project no. F4002-N16), and the Institut fur Quanteninformation GmbH. This research was partially supported by the U.S. Army Research Office through grant W911NF-14-1-0103. This research was partially funded by the Office of the Director of National Intelligence (ODNI), Intelligence Advanced Research Projects Activity (IARPA), through Army Research Office grant W911NF-10-1-0284. All statements of fact, opinion, or conclusions contained herein are those of the authors and should not be construed as representing the official views or policies of IARPA, the ODNI, or the U.S. Government.	Barreiro JT, 2011, NATURE, V470, P486, DOI 10.1038/nature09801; Benhelm J, 2008, NAT PHYS, V4, P463, DOI 10.1038/nphys961; Bombin H, 2007, PHYS REV LETT, V98, DOI 10.1103/PhysRevLett.98.160502; Bombin H, 2006, PHYS REV LETT, V97, DOI 10.1103/PhysRevLett.97.180501; Bravyi S, 2005, PHYS REV A, V71, DOI 10.1103/PhysRevA.71.022316; Calderbank AR, 1996, PHYS REV A, V54, P1098, DOI 10.1103/PhysRevA.54.1098; Chiaverini J, 2004, NATURE, V432, P602, DOI 10.1038/nature03074; Dennis E, 2002, J MATH PHYS, V43, P4452, DOI 10.1063/1.1499754; Gottesman D, 1996, PHYS REV A, V54, P1862, DOI 10.1103/PhysRevA.54.1862; Harty T. P., 2014, ARXIV14031524; Katzgraber HG, 2009, PHYS REV LETT, V103, DOI 10.1103/PhysRevLett.103.090501; Kitaev AY, 2003, ANN PHYS-NEW YORK, V303, P2, DOI 10.1016/S0003-4916(02)00018-0; Knill E, 2001, PHYS REV LETT, V86, P5811, DOI 10.1103/PhysRevLett.86.5811; Kumph M., 2014, ARXIV14020791; Ladd TD, 2010, NATURE, V464, P45, DOI 10.1038/nature08812; Nielsen Michael A., 2002, QUANTUM COMPUTATION; Raussendorf R, 2007, PHYS REV LETT, V98, DOI 10.1103/PhysRevLett.98.190504; Reed MD, 2012, NATURE, V482, P382, DOI 10.1038/nature10786; Schindler P, 2013, NEW J PHYS, V15, DOI 10.1088/1367-2630/15/12/123012; Schindler P, 2011, SCIENCE, V332, P1059, DOI 10.1126/science.1203329; Shor P. W., 1996, IEEE S FDN COMP SCI; SHOR PW, 1995, PHYS REV A, V52, pR2493, DOI 10.1103/PhysRevA.52.R2493; Steane AM, 1996, PHYS REV LETT, V77, P793, DOI 10.1103/PhysRevLett.77.793; Wang DS, 2010, QUANTUM INF COMPUT, V10, P780; Yao XC, 2012, NATURE, V482, P489, DOI 10.1038/nature10770	28	249	257	3	82	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 18	2014	345	6194					302	305		10.1126/science.1253742	http://dx.doi.org/10.1126/science.1253742			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AL8PG	24925911	Green Accepted, Green Submitted			2022-12-28	WOS:000339400700045
J	Farvid, MS; Cho, E; Chen, WY; Eliassen, AH; Willett, WC				Farvid, Maryam S.; Cho, Eunyoung; Chen, Wendy Y.; Eliassen, A. Heather; Willett, Walter C.			Dietary protein sources in early adulthood and breast cancer incidence: prospective cohort study	BMJ-BRITISH MEDICAL JOURNAL			English	Article							PHASEOLUS-VULGARIS L.; TOTAL-ENERGY-INTAKE; FOOD-CONSUMPTION; FATTY-ACIDS; MEAT INTAKE; RISK; WOMEN; METAANALYSIS; NUTRITION; HEALTH	Objective To investigate the association between dietary protein sources in early adulthood and risk of breast cancer. Design Prospective cohort study. Setting Health professionals in the United States. Participants 88 803 premenopausal women from the Nurses' Health Study II who completed a questionnaire on diet in 1991. Main outcome measure Incident cases of invasive breast carcinoma, identified through self report and confirmed by pathology report. Results We documented 2830 cases of breast cancer during 20 years of follow-up. Higher intake of total red meat was associated with an increased risk of breast cancer overall (relative risk 1.22, 95% confidence interval 1.06 to 1.40; P-trend=0.01, for highest fifth v lowest fifth of intake). However, higher intakes of poultry, fish, eggs, legumes, and nuts were not related to breast cancer overall. When the association was evaluated by menopausal status, higher intake of poultry was associated with a lower risk of breast cancer in postmenopausal women (0.73, 0.58 to 0.91; P-trend=0.02, for highest fifth v lowest fifth of intake) but not in premenopausal women (0.93, 0.78 to 1.11; P-trend=0.60, for highest fifth v lowest fifth of intake). In estimating the effects of exchanging different protein sources, substituting one serving/day of legumes for one serving/day of red meat was associated with a 15% lower risk of breast cancer among all women (0.85, 0.73 to 0.98) and a 19% lower risk among premenopausal women (0.81, 0.66 to 0.99). Also, substituting one serving/day of poultry for one serving/day of red meat was associated with a 17% lower risk of breast cancer overall (0.83, 0.72 to 0.96) and a 24% lower risk of postmenopausal breast cancer (0.76, 0.59 to 0.99). Furthermore, substituting one serving/day of combined legumes, nuts, poultry, and fish for one serving/day of red meat was associated with a 14% lower risk of breast cancer overall (0.86, 0.78 to 0.94) and premenopausal breast cancer (0.86, 0.76 to 0.98). Conclusion Higher red meat intake in early adulthood may be a risk factor for breast cancer, and replacing red meat with a combination of legumes, poultry, nuts and fish may reduce the risk of breast cancer.	[Farvid, Maryam S.; Willett, Walter C.] Harvard Univ, Sch Publ Hlth, Dept Nutr, Boston, MA 02115 USA; [Farvid, Maryam S.] Shahid Beheshti Univ Med Sci, Fac Nutr Sci & Food Technol, Dept Community Nutr, Tehran, Iran; [Cho, Eunyoung] Brown Univ, Warren Alpert Med Sch, Dept Dermatol, Providence, RI 02912 USA; [Cho, Eunyoung; Chen, Wendy Y.; Eliassen, A. Heather; Willett, Walter C.] Brigham & Womens Hosp, Dept Med, Channing Div Network Med, Boston, MA 02115 USA; [Cho, Eunyoung; Chen, Wendy Y.; Eliassen, A. Heather; Willett, Walter C.] Harvard Univ, Sch Med, Boston, MA 02115 USA; [Chen, Wendy Y.] Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02115 USA; [Eliassen, A. Heather; Willett, Walter C.] Harvard Univ, Sch Publ Hlth, Dept Epidemiol, Boston, MA 02115 USA	Harvard University; Harvard T.H. Chan School of Public Health; Shahid Beheshti University Medical Sciences; Brown University; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Harvard University; Dana-Farber Cancer Institute; Harvard University; Harvard T.H. Chan School of Public Health	Farvid, MS (corresponding author), Harvard Univ, Sch Publ Hlth, Dept Nutr, Boston, MA 02115 USA.	mfarvid@hsph.harvard.edu	f, m/AAM-2063-2021; Cho, Eunyoung/AAV-4469-2020	Cho, Eunyoung/0000-0001-6594-2582; Eliassen, A Heather/0000-0002-3961-6609; Farvid, Maryam/0000-0003-1783-4186	National Institutes of Health [R01CA050385]; NATIONAL CANCER INSTITUTE [R01CA050385, UM1CA176726] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This study was supported by the National Institutes of Health grant (R01CA050385). The study sponsors were not involved in the study design and collection, analysis, and interpretation of data, or the writing of the article or the decision to submit it for publication. The authors were independent from study sponsors.	Alexander DD, 2010, NUTR RES REV, V23, P349, DOI 10.1017/S0954422410000235; Andersson AM, 1999, EUR J ENDOCRINOL, V140, P477, DOI 10.1530/eje.0.1400477; Aune D, 2012, ANN ONCOL, V23, P1394, DOI 10.1093/annonc/mdr589; Buck K, 2010, AM J CLIN NUTR, V92, P141, DOI 10.3945/ajcn.2009.28573; Carruba G, 2006, NUTR CANCER, V56, P253, DOI 10.1207/s15327914nc5602_18; Cho EY, 2006, ARCH INTERN MED, V166, P2253, DOI 10.1001/archinte.166.20.2253; COLDITZ GA, 1987, AM J EPIDEMIOL, V126, P319, DOI 10.1093/aje/126.2.319; DeStefani E, 1997, CANCER EPIDEM BIOMAR, V6, P573; Dial S, 1995, TOCOPHEROLS TOCOTRIE, P327; Engeset D, 2006, INT J CANCER, V119, P175, DOI 10.1002/ijc.21819; Farvid MS, 2014, BREAST CANCER RES TR, V145, P255, DOI 10.1007/s10549-014-2895-9; Ferrucci LM, 2009, BRIT J CANCER, V101, P178, DOI 10.1038/sj.bjc.6605118; Gago-Dominguez M, 2003, BRIT J CANCER, V89, P1686, DOI 10.1038/sj.bjc.6601340; Genkinger JM, 2013, CANCER CAUSE CONTROL, V24, P675, DOI 10.1007/s10552-013-0146-8; Halton TL, 2006, AM J CLIN NUTR, V83, P284; Holland GWA, 1991, COMPOSITION FOODS; Holmes MD, 2003, INT J CANCER, V104, P221, DOI 10.1002/ijc.10910; Kallianpur AR, 2008, BREAST CANCER RES TR, V107, P123, DOI 10.1007/s10549-007-9538-3; Kushi LH, 2012, CA-CANCER J CLIN, V62, P30, DOI 10.3322/caac.20140; Land CE, 2003, RADIAT RES, V160, P707, DOI 10.1667/RR3082; Lauber SN, 2004, CARCINOGENESIS, V25, P2509, DOI 10.1093/carcin/bgh268; Levine ME, 2014, CELL METAB, V19, P407, DOI 10.1016/j.cmet.2014.02.006; Missmer SA, 2002, INT J EPIDEMIOL, V31, P78, DOI 10.1093/ije/31.1.78; Nutrient Database for Standard Reference Release 14, 2001, NUTR DAT STAND REF R; Pala V, 2009, AM J CLIN NUTR, V90, P602, DOI 10.3945/ajcn.2008.27173; SALVINI S, 1989, INT J EPIDEMIOL, V18, P858, DOI 10.1093/ije/18.4.858; Steck SE, 2007, EPIDEMIOLOGY, V18, P373, DOI 10.1097/01.ede.0000259968.11151.06; Swerdlow AJ, 2000, J CLIN ONCOL, V18, P498, DOI 10.1200/JCO.2000.18.3.498; Thompson MD, 2012, CELL CYCLE, V11, P835, DOI 10.4161/cc.11.5.19676; Thompson MD, 2012, CARCINOGENESIS, V33, P226, DOI 10.1093/carcin/bgr247; Wahner-Roedler DL, 2003, MAYO CLIN PROC, V78, P708, DOI 10.4065/78.6.708; Weroha SJ, 2012, ENDOCRIN METAB CLIN, V41, P335, DOI 10.1016/j.ecl.2012.04.014; WILLETT W, 1986, AM J EPIDEMIOL, V124, P17, DOI 10.1093/oxfordjournals.aje.a114366; Willett WC, 1997, AM J CLIN NUTR, V65, P1220, DOI 10.1093/ajcn/65.4.1220S; Willett WC, 1997, AM J CLIN NUTR, P1229; Zheng JS, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f3706	36	72	73	0	23	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JUN 10	2014	348								g3437	10.1136/bmj.g3437	http://dx.doi.org/10.1136/bmj.g3437			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AJ1FH	24916719	Green Published, hybrid			2022-12-28	WOS:000337400800001
J	Yeo, B; Turner, NC; Jones, A				Yeo, Belinda; Turner, Nicholas C.; Jones, Alison			An update on the medical management of breast cancer	BMJ-BRITISH MEDICAL JOURNAL			English	Review							LYMPH-NODE BIOPSY; BONE METASTASES; ADJUVANT CHEMOTHERAPY; AMERICAN SOCIETY; RANDOMIZED-TRIAL; PLUS DOCETAXEL; FOLLOW-UP; TRASTUZUMAB; TAMOXIFEN; SURVIVAL		[Yeo, Belinda; Turner, Nicholas C.] Royal Marsden Hosp, Breast Unit, London SW3 6JJ, England; [Turner, Nicholas C.] Inst Canc Res, Breakthrough Breast Canc Res Ctr, London SW3 6JB, England; [Jones, Alison] Royal Free Hosp, London NW3 2QG, England	Royal Marsden NHS Foundation Trust; Royal Marsden NHS Foundation Trust; University of London; Institute of Cancer Research - UK; University of London; University College London; Royal Free London NHS Foundation Trust; UCL Medical School	Jones, A (corresponding author), Royal Free Hosp, Pond St, London NW3 2QG, England.	nicholas.turner@icr.ac.uk; Alisonjones6@nhs.net		Yeo, Belinda/0000-0002-9218-9917; Turner, Nicholas/0000-0001-8937-0873	Cancer Research UK [16642] Funding Source: researchfish	Cancer Research UK(Cancer Research UK)		Abe O, 2005, LANCET, V365, P1687, DOI 10.1016/s0140-6736(05)66544-0; Al-Mubarak M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088238; Baron R, 2011, BONE, V48, P677, DOI 10.1016/j.bone.2010.11.020; Baselga J, 2012, NEW ENGL J MED, V366, P520, DOI 10.1056/NEJMoa1109653; Baselga J, 2012, NEW ENGL J MED, V366, P109, DOI 10.1056/NEJMoa1113216; Clarke M, 2008, LANCET, V371, P29, DOI 10.1016/S0140-6736(08)60069-0; Coleman R, 2013, 2013 SAN ANT BREAST; COLEMAN RE, 1987, BRIT J CANCER, V55, P61, DOI 10.1038/bjc.1987.13; Curtis C, 2012, NATURE, V486, P346, DOI 10.1038/nature10983; Davies C, 2011, LANCET, V378, P771, DOI 10.1016/S0140-6736(11)60993-8; Davies C, 2013, LANCET, V381, P805, DOI 10.1016/S0140-6736(12)61963-1; Dowsett M, 2010, J CLIN ONCOL, V28, P509, DOI 10.1200/JCO.2009.23.1274; Fisher B, 1997, J CLIN ONCOL, V15, P2483, DOI 10.1200/JCO.1997.15.7.2483; Fisher B, 2002, NEW ENGL J MED, V347, P1233, DOI 10.1056/NEJMoa022152; Geyer CE, 2006, NEW ENGL J MED, V355, P2733, DOI 10.1056/NEJMoa064320; Giordano SH, 2004, CANCER, V100, P44, DOI 10.1002/cncr.11859; Giuliano AE, 2010, ANN SURG, V252, P426, DOI 10.1097/SLA.0b013e3181f08f32; Goldstein LJ, 2008, J CLIN ONCOL, V26, P4092, DOI 10.1200/JCO.2008.16.7841; Goss PE, 2005, JNCI-J NATL CANCER I, V97, P1262, DOI 10.1093/jnci/dji250; Gray R, 2013, J CLIN ONCOL S, V31; Hortobagyi GN, 2002, SEMIN ONCOL, V29, P134, DOI 10.1053/sonc.2002.34066; Kanis JA, 2013, OSTEOPOROSIS INT, V24, P23, DOI 10.1007/s00198-012-2074-y; Kennecke H, 2010, J CLIN ONCOL, V28, P3271, DOI 10.1200/JCO.2009.25.9820; Kim T, 2006, CANCER-AM CANCER SOC, V106, P4, DOI 10.1002/cncr.21568; Koboldt DC, 2012, NATURE, V490, P61, DOI 10.1038/nature11412; Lin NU, 2007, CLIN CANCER RES, V13, P1648, DOI 10.1158/1078-0432.CCR-06-2478; Lyman GH, 2014, J CLIN ONCOL, V32, P1365, DOI 10.1200/JCO.2013.54.1177; Marmot MG, 2012, LANCET, V380, P1778, DOI 10.1016/S0140-6736(12)61611-0; Miller TW, 2011, CANCER DISCOV, V1, P338, DOI 10.1158/2159-8290.CD-11-0101; Moran MS, 2014, J CLIN ONCOL, V32, P1507, DOI 10.1200/JCO.2013.53.3935; Pavlakis N, 2005, COCHRANE DB SYST REV, V3; Perou CM, 2000, NATURE, V406, P747, DOI 10.1038/35021093; Phillips GDL, 2008, CANCER RES, V68, P9280, DOI 10.1158/0008-5472.CAN-08-1776; Piccart-Gebhart MJ, 2005, NEW ENGL J MED, V353, P1659, DOI 10.1056/NEJMoa052306; Rutgers EJ, 2013, J CLIN ONCOL S, V31; Saad F, 2012, RECENT RESULTS CANC, V192, P109, DOI 10.1007/978-3-642-21892-7_5; Slamon DJ, 2001, NEW ENGL J MED, V344, P783, DOI 10.1056/NEJM200103153441101; SLAMON DJ, 1987, SCIENCE, V235, P177, DOI 10.1126/science.3798106; Smith I, 2007, LANCET, V369, P29, DOI 10.1016/S0140-6736(07)60028-2; Sorlie T, 2003, P NATL ACAD SCI USA, V100, P8418, DOI 10.1073/pnas.0932692100; Sperduto PW, 2010, INT J RADIAT ONCOL, V77, P655, DOI 10.1016/j.ijrobp.2009.08.025; Stopeck Alison, 2010, Clin Adv Hematol Oncol, V8, P159; Suter TM, 2007, J CLIN ONCOL, V25, P3859, DOI 10.1200/JCO.2006.09.1611; Swain SM, 2013, LANCET ONCOL, V14, P461, DOI 10.1016/S1470-2045(13)70130-X; Turner NC, 2008, BMJ-BRIT MED J, V337, DOI 10.1136/bmj.a540; Turner NC, 2008, BMJ-BRIT MED J, V337, DOI 10.1136/bmj.a421; UK Cancer Research, BREAST CANC INC STAT; Verma S, 2012, NEW ENGL J MED, V367, P1783, DOI 10.1056/NEJMoa1209124; von Minckwitz G, 2012, J CLIN ONCOL, V30, P1796, DOI 10.1200/JCO.2011.38.8595	49	45	47	1	21	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JUN 9	2014	348								g3608	10.1136/bmj.g3608	http://dx.doi.org/10.1136/bmj.g3608			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AJ1DS	24912480				2022-12-28	WOS:000337396600003
J	Sedgwick, P				Sedgwick, Philip			What are the four phases of clinical research trials?	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									Univ London, Ctr Med & Healthcare Educ, London, England	St Georges University London; University of London	Sedgwick, P (corresponding author), Univ London, Ctr Med & Healthcare Educ, London, England.	p.sedgwick@sgul.ac.uk	Sedgwick, Philip/C-6997-2019	Sedgwick, Philip/0000-0001-8859-2175				Gringras P, 2012, BRIT MED J, V345, DOI 10.1136/bmj.e6664	1	3	4	0	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JUN 6	2014	348								g3727	10.1136/bmj.g3727	http://dx.doi.org/10.1136/bmj.g3727			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AI7CE	24906716				2022-12-28	WOS:000337038000008
J	Weekes, MP; Tomasec, P; Huttlin, EL; Fielding, CA; Nusinow, D; Stanton, RJ; Wang, ECY; Aicheler, R; Murrell, I; Wilkinson, GWG; Lehner, PJ; Gygi, SP				Weekes, Michael P.; Tomasec, Peter; Huttlin, Edward L.; Fielding, Ceri A.; Nusinow, David; Stanton, Richard J.; Wang, Eddie C. Y.; Aicheler, Rebecca; Murrell, Isa; Wilkinson, Gavin W. G.; Lehner, Paul J.; Gygi, Steven P.			Quantitative Temporal Viromics: An Approach to Investigate Host-Pathogen Interaction	CELL			English	Article							DOWN-REGULATION; FAMILY-MEMBERS; GENE-PRODUCTS; CYTOMEGALOVIRUS; PROTEIN; DEGRADATION; EXPRESSION; PHOSPHORYLATION; TRANSCRIPTION; RECOGNITION	A systematic quantitative analysis of temporal changes in host and viral proteins throughout the course of a productive infection could provide dynamic insights into virus-host interaction. We developed a proteomic technique called "quantitative temporal viromics" (QTV), which employs multiplexed tandem-mass-tag-based mass spectrometry. Human cytomegalovirus (HCMV) is not only an important pathogen but a paradigm of viral immune evasion. QTV detailed how HCMV orchestrates the expression of >8,000 cellular proteins, including 1,200 cell-surface proteins to manipulate signaling pathways and counterintrinsic, innate, and adaptive immune defenses. QTV predicted natural killer and T cell ligands, as well as 29 viral proteins present at the cell surface, potential therapeutic targets. Temporal profiles of >80% of HCMV canonical genes and 14 noncanonical HCMV open reading frames were defined. QTV is a powerful method that can yield important insights into viral infection and is applicable to any virus with a robust in vitro model.	[Weekes, Michael P.; Huttlin, Edward L.; Nusinow, David; Gygi, Steven P.] Harvard Univ, Sch Med, Dept Cell Biol, Boston, MA 02115 USA; [Tomasec, Peter; Fielding, Ceri A.; Stanton, Richard J.; Wang, Eddie C. Y.; Aicheler, Rebecca; Murrell, Isa; Wilkinson, Gavin W. G.] Cardiff Univ, Sch Med, Cardiff CF14 4XX, S Glam, Wales; [Weekes, Michael P.; Lehner, Paul J.] Univ Cambridge, Cambridge Inst Med Res, Cambridge CB2 0XY, England	Harvard University; Harvard Medical School; Cardiff University; University of Cambridge	Weekes, MP (corresponding author), Harvard Univ, Sch Med, Dept Cell Biol, 240 Longwood Ave, Boston, MA 02115 USA.	mpw1001@cam.ac.uk; steven_gygi@hms.harvard.edu	Wilkinson, Gavin WG/J-6388-2015; Fielding, Ceri A/F-5638-2014; Stanton, Richard James/B-4695-2008; Nusinow, David/AAJ-4284-2020	Wilkinson, Gavin WG/0000-0002-5623-0126; Fielding, Ceri A/0000-0002-5817-3153; Stanton, Richard James/0000-0002-6799-1182; Nusinow, David/0000-0002-7819-5261; Weekes, Michael/0000-0003-3196-5545; Wang, Eddie/0000-0002-2243-4964; Lehner, Paul Joseph/0000-0001-9383-1054; Huttlin, Edward/0000-0002-1822-1173	Wellcome Trust [093966/Z/10/Z, G1000236, WT090323MA, 084957/Z/08/Z]; MRC; National Institute of Health [GM067945]; Cambridge Biomedical Research Centre, UK; MRC [MR/L008734/1, G0901119, G1000236] Funding Source: UKRI; Medical Research Council [MR/L018373/1, G1000236, G0901119, MR/L008734/1] Funding Source: researchfish; Wellcome Trust [090323/Z/09/Z] Funding Source: researchfish; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM067945] Funding Source: NIH RePORTER	Wellcome Trust(Wellcome TrustEuropean Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Cambridge Biomedical Research Centre, UK; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); Wellcome Trust(Wellcome TrustEuropean Commission); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We are grateful to Dr. Andrew Davison for assistance with the assembly of HCMV FASTA files; to Joao Paulo, Ryan Kunz, and Martin Wuehr for mass spectrometry and to Alexander Devaux for technical assistance. This work was supported by a Wellcome Trust Fellowship (093966/Z/10/Z) to M. P. W.; an MRC Project Grant and a Wellcome Trust Programme Grant (G1000236, WT090323MA) to G. W. G. W., P. T., and E.C.Y.W.; a Wellcome Trust Senior Fellowship (084957/Z/08/Z) to P.J.L. and National Institute of Health grant (GM067945) to S. P. G. This study was additionally supported by the Cambridge Biomedical Research Centre, UK. We have filed a provisional patent based on our findings.	Alexander BT, 2010, PHARMACOTHERAPY, V30, P554, DOI 10.1592/phco.30.6.554; Alwine JC, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002878; Amsler L, 2013, J MOL BIOL, V425, P4857, DOI 10.1016/j.jmb.2013.08.023; Angelova M, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002959; Bonneville M, 2010, NAT REV IMMUNOL, V10, P467, DOI 10.1038/nri2781; Ceeraz S, 2013, TRENDS IMMUNOL, V34, P556, DOI 10.1016/j.it.2013.07.003; Chambers J, 1999, J VIROL, V73, P5757, DOI 10.1128/JVI.73.7.5757-5766.1999; Duggal NK, 2012, NAT REV IMMUNOL, V12, P687, DOI 10.1038/nri3295; Dunn C, 2003, J EXP MED, V197, P1427, DOI 10.1084/jem.20022059; Feng XY, 2006, J VIROL, V80, P8371, DOI 10.1128/JVI.00399-06; Gariano GR, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002498; Hansen SG, 2013, NATURE, V502, P100, DOI 10.1038/nature12519; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Hubo M, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00082; Hunter S, 2012, NUCLEIC ACIDS RES, V40, pD306, DOI 10.1093/nar/gkr948; Huttlin EL, 2010, CELL, V143, P1174, DOI 10.1016/j.cell.2010.12.001; Khan Z, 2014, CARCINOGENESIS, V35, P145, DOI 10.1093/carcin/bgt292; Kim YE, 2011, J VIROL, V85, P11928, DOI 10.1128/JVI.00758-11; Koyuncu E, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003333; Le VTK, 2008, J GEN VIROL, V89, P2416, DOI 10.1099/vir.0.2008/001669-0; Ma YP, 2012, FUTURE MICROBIOL, V7, P577, DOI [10.2217/FMB.12.32, 10.2217/fmb.12.32]; McAlister GC, 2012, ANAL CHEM, V84, P7469, DOI 10.1021/ac301572t; Mocarski E. S., 2013, CYTOMEGALOVIRUSES; Nichols WG, 2002, J INFECT DIS, V185, P273, DOI 10.1086/338624; Nikolov DB, 2013, BBA-PROTEINS PROTEOM, V1834, P2160, DOI 10.1016/j.bbapap.2013.04.020; Omoto S, 2014, J VIROL, V88, P120, DOI 10.1128/JVI.02983-13; Paludan SR, 2011, NAT REV IMMUNOL, V11, P143, DOI 10.1038/nri2937; Pease BN, 2013, J PROTEOME RES, V12, P4028, DOI 10.1021/pr400394g; Powers C, 2008, CURR TOP MICROBIOL, V325, P333; Prod'homme V, 2010, J GEN VIROL, V91, P2034, DOI 10.1099/vir.0.021931-0; Rahm N, 2012, CURR OPIN HIV AIDS, V7, P180, DOI 10.1097/COH.0b013e32835048e1; Schoggins JW, 2011, NATURE, V472, P481, DOI 10.1038/nature09907; Scott I, 2009, MICROBES INFECT, V11, P973, DOI 10.1016/j.micinf.2009.07.001; Stanton RJ, 2007, J VIROL, V81, P7860, DOI 10.1128/JVI.02247-06; STENBERG RM, 1989, J VIROL, V63, P2699, DOI 10.1128/JVI.63.6.2699-2708.1989; Stern-Ginossar N, 2012, SCIENCE, V338, P1088, DOI 10.1126/science.1227919; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; SULLIVAN R, 1971, APPL MICROBIOL, V22, P61, DOI 10.1128/AEM.22.1.61-65.1971; Takamatsu H, 2012, TRENDS IMMUNOL, V33, P127, DOI 10.1016/j.it.2012.01.008; Terhune SS, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000965; Ting L, 2011, NAT METHODS, V8, P937, DOI [10.1038/NMETH.1714, 10.1038/nmeth.1714]; Tomasec P, 2005, NAT IMMUNOL, V6, P181, DOI 10.1038/ni1156; van der Wal FJ, 2002, CURR TOP MICROBIOL, V269, P37; Varnum SM, 2004, J VIROL, V78, P10960, DOI 10.1128/JVI.78.20.10960-10966.2004; Vavassori S, 2013, NAT IMMUNOL, V14, P908, DOI 10.1038/ni.2665; Vivier E, 2008, NAT IMMUNOL, V9, P503, DOI 10.1038/ni1582; Weekes MP, 2013, SCIENCE, V340, P199, DOI 10.1126/science.1235047; Weekes MP, 2012, J PROTEOME RES, V11, P1475, DOI 10.1021/pr201135e; Wilkinson GWG, 2008, J CLIN VIROL, V41, P206, DOI 10.1016/j.jcv.2007.10.027; Witherden DA, 2012, IMMUNITY, V37, P314, DOI 10.1016/j.immuni.2012.05.026	50	285	294	1	51	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUN 5	2014	157	6					1460	1472		10.1016/j.cell.2014.04.028	http://dx.doi.org/10.1016/j.cell.2014.04.028			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	AN8UV	24906157	Green Published, Green Accepted, hybrid			2022-12-28	WOS:000340881400020
J	Gopinathan, U; Hougendobler, D; Watts, N; Cuadrado, C; Guinto, RR; Lefebvre, A; Meganathan, S; Wanjau, W; Jorem, J; Habibullah, NK; Asilia, P; Mushtaq, UA				Gopinathan, Unni; Hougendobler, Daniel; Watts, Nick; Cuadrado, Cristobal; Guinto, Renzo R.; Lefebvre, Alexandre; Meganathan, Saveetha; Wanjau, Waruguru; Jorem, Jacob; Habibullah, Nilofer Khan; Asilia, Peter; Mushtaq, Usman Ahmad			Rethinking the foundations of global governance for health: the youth response	LANCET			English	Editorial Material									[Gopinathan, Unni] Univ Oslo, Inst Hlth & Soc, N-0318 Oslo, Norway; [Hougendobler, Daniel] Georgetown Univ, Ctr Law, ONeill Inst Natl & Global Hlth Law, Washington, DC USA; [Watts, Nick] UCL, Inst Global Hlth, London, England; [Cuadrado, Cristobal] Univ Chile, Sch Publ Hlth, Inst Populat Hlth, Santiago, Chile; [Guinto, Renzo R.] Univ Philippines Manila, Natl Inst Hlth, Universal Hlth Care Study Grp, Manila, Philippines; [Lefebvre, Alexandre] Univ Montreal, Fac Med, Montreal, PQ H3C 3J7, Canada; [Meganathan, Saveetha] Univ Delhi, Dept Social Work, Delhi Sch Econ, Delhi 110007, India; [Wanjau, Waruguru] Univ Nairobi, Sch Med, Coll Hlth Sci, Kenyatta Natl Hosp, Nairobi, Kenya; [Jorem, Jacob] Norwegian Univ Sci & Technol, Fac Med, N-7034 Trondheim, Norway; [Jorem, Jacob] Univ Oslo, Fac Law, N-0318 Oslo, Norway; [Habibullah, Nilofer Khan] Amer Int Med Univ, Sch Med, Gros Islet, St Lucia; [Asilia, Peter] Muhimbili Univ Hlth & Allied Sci, Dar Es Salaam, Tanzania; [Mushtaq, Usman Ahmad] Univ Oslo, Fac Med, N-0318 Oslo, Norway	University of Oslo; Georgetown University; University of London; University College London; Universidad de Chile; University of the Philippines System; University of the Philippines Manila; Universite de Montreal; Delhi School of Economics; University of Delhi; Kenyatta National Hospital; University of Nairobi; Norwegian University of Science & Technology (NTNU); University of Oslo; Muhimbili University of Health & Allied Sciences; University of Oslo	Gopinathan, U (corresponding author), Univ Oslo, Inst Hlth & Soc, N-0318 Oslo, Norway.	unni.gnathan@gmail.com	Cuadrado, Cristobal/J-2572-2014; Cuadrado, Cristobal/Q-3705-2019	Cuadrado, Cristobal/0000-0002-0174-5958; Cuadrado, Cristobal/0000-0002-0174-5958; Guinto, Ramon Lorenzo Luis/0000-0002-3181-0423; Lefebvre, Alexandre/0000-0001-7461-5540				[Anonymous], 1999, DEV FREEDOM; Commission on Social Determinants of Health, 2008, CLOS GAP GEN HLTH EQ, P246; Gopinathan U, 2014, ADV HLTH ENHANCING C; Nussbaum M., 2001, WOMEN HUMAN DEV CAPA, V3; Ottersen OP, 2014, LANCET, V383, P630, DOI 10.1016/S0140-6736(13)62407-1; Ruger JP, 2010, AM J PUBLIC HEALTH, V100, P41, DOI 10.2105/AJPH.2008.143651; Venkatapuram S., 2011, HLTH JUSTICE ARGUMEN; Wilson J, 2009, PUBLIC HEALTH ETH-UK, V2, P184, DOI 10.1093/phe/php012	8	1	1	0	7	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	MAY 31	2014	383	9932					E16	E17		10.1016/S0140-6736(14)60766-2	http://dx.doi.org/10.1016/S0140-6736(14)60766-2			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	AI4PR	24872256				2022-12-28	WOS:000336847800001
J	[Anonymous]				[Anonymous]			Hypertension: an urgent need for global control and prevention	LANCET			English	Editorial Material																			0	13	15	0	4	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	MAY 31	2014	383	9932					1861	1861		10.1016/S0140-6736(14)60460-8OF	http://dx.doi.org/10.1016/S0140-6736(14)60460-8OF			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	AI4PR	24881973				2022-12-28	WOS:000336847800004
J	Gertler, P; Heckman, J; Pinto, R; Zanolini, A; Vermeersch, C; Walker, S; Chang, SM; Grantham-McGregor, S				Gertler, Paul; Heckman, James; Pinto, Rodrigo; Zanolini, Arianna; Vermeersch, Christel; Walker, Susan; Chang, Susan M.; Grantham-McGregor, Sally			Labor market returns to an early childhood stimulation intervention in Jamaica	SCIENCE			English	Article							NUTRITIONAL SUPPLEMENTATION; PSYCHOSOCIAL STIMULATION; DEVELOPING-COUNTRIES; YOUNG-CHILDREN; STUNTED CHILDREN; ADULT HEALTH; HEAD-START; LOW-INCOME; FOLLOW-UP; BENEFITS	A substantial literature shows that U. S. early childhood interventions have important long-term economic benefits. However, there is little evidence on this question for developing countries. We report substantial effects on the earnings of participants in a randomized intervention conducted in 1986-1987 that gave psychosocial stimulation to growth-stunted Jamaican toddlers. The intervention consisted of weekly visits from community health workers over a 2-year period that taught parenting skills and encouraged mothers and children to interact in ways that develop cognitive and socioemotional skills. The authors reinterviewed 105 out of 129 study participants 20 years later and found that the intervention increased earnings by 25%, enough for them to catch up to the earnings of a nonstunted comparison group identified at baseline (65 out of 84 participants).	[Gertler, Paul] Univ Calif Berkeley, Berkeley, CA 94720 USA; [Gertler, Paul] Natl Bur Econ Res, Cambridge, MA 02138 USA; [Heckman, James; Pinto, Rodrigo; Zanolini, Arianna] Univ Chicago, Chicago, IL 60637 USA; [Heckman, James] Amer Bar Fdn, Chicago, IL 60611 USA; [Heckman, James] UCL, Inst Fiscal Studies, London, England; [Vermeersch, Christel] World Bank, Washington, DC 20433 USA; [Walker, Susan; Chang, Susan M.] Univ W Indies, Kingston 7, Jamaica; [Grantham-McGregor, Sally] UCL, London, England	University of California System; University of California Berkeley; National Bureau of Economic Research; University of Chicago; University of London; London School Economics & Political Science; University College London; The World Bank; University West Indies Mona Jamaica; University of London; University College London	Gertler, P (corresponding author), Univ Calif Berkeley, Berkeley, CA 94720 USA.	gertler@haas.berkeley.edu			World Bank Strategic Impact Evaluation Fund; American Bar Foundation; Pritzker Children's Initiative; Eunice Kennedy Shriver National Institute of Child Health and Human Development [R37HD065072, R01HD54702]; Human Capital and Economic Opportunity Global Working Group-an initiative of the Becker Friedman Institute for Research in Economics; Institute for New Economic Thinking (INET); University College Dublin; DEVHEALTH [269874]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R37HD065072] Funding Source: NIH RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD054702] Funding Source: NIH RePORTER	World Bank Strategic Impact Evaluation Fund; American Bar Foundation; Pritzker Children's Initiative; Eunice Kennedy Shriver National Institute of Child Health and Human Development(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); Human Capital and Economic Opportunity Global Working Group-an initiative of the Becker Friedman Institute for Research in Economics; Institute for New Economic Thinking (INET); University College Dublin; DEVHEALTH; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	We gratefully acknowledge research support from the World Bank Strategic Impact Evaluation Fund; the American Bar Foundation; The Pritzker Children's Initiative; grants R37HD065072 and R01HD54702 from the Eunice Kennedy Shriver National Institute of Child Health and Human Development; the Human Capital and Economic Opportunity Global Working Group-an initiative of the Becker Friedman Institute for Research in Economics funded by the Institute for New Economic Thinking (INET); a European Research Council grant hosted by University College Dublin; DEVHEALTH 269874; and an anonymous funder. We have benefited from comments of participants in seminars at the University of Chicago; University of California, Berkeley; Massachusetts Institute of Technology; the 2011 LACEA Meetings in Santiago, Chile; and the 2013 AEA Meetings. We thank the study participants for their continued cooperation and willingness to participate, and S. Pellington for conducting the interviews. The authors have not received any compensation for the research nor do they have any financial stake in the analyses reported here. Replication data for this article have been deposited at Interuniversity Consortium for Political and Social Research (ICPSR) and can be accessed at http://doi.org/10.3886/E2402V1.	Almond D., 2007, LONG TERM EFFECTS 19; Almond D, 2011, HBK ECON, V4, P1315, DOI 10.1016/S0169-7218(11)02413-0; Aughinbaugh A, 2001, J HUM RESOUR, V36, P641, DOI 10.2307/3069637; Bleakley H, 2007, Q J ECON, V122, P73, DOI 10.1162/qjec.121.1.73; Caldwell B., 1984, HOME OBSERVATION MEA; CALDWELL BM, 1967, PEDIATRICS, V40, P46; CAMPBELL FA, 2002, APPL DEVELOPMENTAL S, V0006; Campbell F, 2014, SCIENCE, V343, P1478, DOI 10.1126/science.1248429; Campbell FA, 2012, DEV PSYCHOL, V48, P1033, DOI 10.1037/a0026644; Carneiro P, 2003, INEQUALITY IN AMERICA, P77; Cunha F., 2006, HDB EC ED, P697; Engle PL, 2007, LANCET, V369, P229, DOI 10.1016/S0140-6736(07)60112-3; Engle PL, 2011, LANCET, V378, P1339, DOI 10.1016/S0140-6736(11)60889-1; Fernald LCH, 2012, P NATL ACAD SCI USA, V109, P17273, DOI 10.1073/pnas.1121241109; Garces E, 2002, AM ECON REV, V92, P999, DOI 10.1257/00028280260344560; Grantham-McGregor S, 2007, LANCET, V369, P60, DOI 10.1016/S0140-6736(07)60032-4; GranthamMcGregor SM, 1997, AM J CLIN NUTR, V66, P247, DOI 10.1093/ajcn/66.2.247; GRANTHAMMCGREGOR SM, 1991, LANCET, V338, P1, DOI 10.1016/0140-6736(91)90001-6; Heckman J.J, 2000, RES ECON, V54, P3, DOI DOI 10.1006/REEC.1999.0225; Heckman J, 2010, QUANT ECON, V1, P1, DOI 10.3982/QE8; Heckman JJ, 2008, ECON INQ, V46, P289, DOI 10.1111/j.1465-7295.2008.00163.x; Heckman JJ, 2006, SCIENCE, V312, P1900, DOI 10.1126/science.1128898; Heckman JJ, 2010, J PUBLIC ECON, V94, P114, DOI 10.1016/j.jpubeco.2009.11.001; Hoddinott J, 2008, LANCET, V371, P411, DOI 10.1016/S0140-6736(08)60205-6; Huttenlocher P.R., 2002, NEURAL PLASTICITY EF; HUTTENLOCHER PR, 1979, BRAIN RES, V163, P195; Knudsen EI, 2006, P NATL ACAD SCI USA, V103, P10155, DOI 10.1073/pnas.0600888103; MacCini S, 2009, AM ECON REV, V99, P1006, DOI 10.1257/aer.99.3.1006; Paxson C, 2007, J HUM RESOUR, V42, P49, DOI 10.3368/jhr.XLII.1.49; Psacharopoulos G., 2004, EDUC ECON, V12, P111, DOI [DOI 10.1080/0964529042000239140, 10.1080/0964529042000239140]; Reynolds AJ, 2004, CHILD DEV, V75, P1299, DOI 10.1111/j.1467-8624.2004.00742.x; Reynolds AJ, 2007, ARCH PEDIAT ADOL MED, V161, P730, DOI 10.1001/archpedi.161.8.730; Reynolds AJ, 2011, SCIENCE, V333, P360, DOI 10.1126/science.1203618; ROBINS JM, 1994, J AM STAT ASSOC, V89, P846, DOI 10.2307/2290910; Romano JR, 2005, J AM STAT ASSOC, V100, P94, DOI 10.1198/016214504000000539; Thompson RA, 2001, AM PSYCHOL, V56, P5, DOI 10.1037//0003-066X.56.1.5; Van Den Berg GJ, 2006, AM ECON REV, V96, P290, DOI 10.1257/000282806776157740; Walker SP, 2005, LANCET, V366, P1804, DOI 10.1016/S0140-6736(05)67574-5; WALKER SP, 1990, EUR J CLIN NUTR, V44, P527; Walker SP, 2000, J PEDIATR-US, V137, P36, DOI 10.1067/mpd.2000.106227; Walker SP, 2007, LANCET, V369, P145, DOI 10.1016/S0140-6736(07)60076-2; Walker SP, 2011, PEDIATRICS, V127, P849, DOI 10.1542/peds.2010-2231	42	273	281	1	65	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 30	2014	344	6187					998	1001		10.1126/science.1251178	http://dx.doi.org/10.1126/science.1251178			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AH9WM	24876490	Green Accepted, Green Published			2022-12-28	WOS:000336495800037
J	Karakas, E; Furukawa, H				Karakas, Erkan; Furukawa, Hiro			Crystal structure of a heterotetrameric NMDA receptor ion channel	SCIENCE			English	Article							AMINO-TERMINAL DOMAIN; K+ CHANNEL; SUBUNIT ARRANGEMENT; BINDING DOMAIN; MECHANISM; SENSITIVITY; INSIGHTS; COMPLEX; RESIDUE	N-Methyl-D-aspartate (NMDA) receptors belong to the family of ionotropic glutamate receptors, which mediate most excitatory synaptic transmission in mammalian brains. Calcium permeation triggered by activation of NMDA receptors is the pivotal event for initiation of neuronal plasticity. Here, we show the crystal structure of the intact heterotetrameric GluN1-GluN2B NMDA receptor ion channel at 4 angstroms. The NMDA receptors are arranged as a dimer of GluN1-GluN2B heterodimers with the twofold symmetry axis running through the entire molecule composed of an amino terminal domain (ATD), a ligand-binding domain (LBD), and a transmembrane domain (TMD). The ATD and LBD are much more highly packed in the NMDA receptors than non-NMDA receptors, which may explain why ATD regulates ion channel activity in NMDA receptors but not in non-NMDA receptors.	[Karakas, Erkan; Furukawa, Hiro] Cold Spring Harbor Lab, WM Keck Struct Biol Lab, Cold Spring Harbor, NY 11724 USA	Cold Spring Harbor Laboratory	Furukawa, H (corresponding author), Cold Spring Harbor Lab, WM Keck Struct Biol Lab, One Bungtown Rd, Cold Spring Harbor, NY 11724 USA.	furukawa@cshl.edu			NIH [MH085926]; Mirus Research Award; Robertson Research Fund of Cold Spring Harbor Laboratory; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM105730] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH085926] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Mirus Research Award; Robertson Research Fund of Cold Spring Harbor Laboratory; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	We thank staffs at the 23-ID-B and D beamlines at the Advanced Photon System in the Argonne National Laboratory and the BL41XU beamline at the Spring 8 for their excellent beamline supports. We thank N. Simorowski for her technical support, H. Yuan and S. Traynelis for sharing unpublished data with us and for critical comments on this manuscript, and S. Harrison for making important comments on this work. This work was supported by NIH (MH085926 to H. F.), Mirus Research Award (to H. F.), and a Robertson Research Fund of Cold Spring Harbor Laboratory (to H. F.). Coordinates and structure factors have been deposited in the Protein Data Bank under accession code 4PE5. DNA constructs, recombinant virus, and proteins used in this study are available from H. F. under a material transfer agreement with Cold Spring Harbor Laboratory.	Das U, 2010, P NATL ACAD SCI USA, V107, P8463, DOI 10.1073/pnas.1000838107; Farina AN, 2011, J NEUROSCI, V31, P3565, DOI 10.1523/JNEUROSCI.6041-10.2011; Furukawa H, 2005, NATURE, V438, P185, DOI 10.1038/nature04089; Gielen M, 2009, NATURE, V459, P703, DOI 10.1038/nature07993; Hansen KB, 2010, MOL PHARMACOL, V78, P535, DOI 10.1124/mol.110.067157; Hayashi T, 1954, KEIO J MED, V3; IMOTO K, 1988, NATURE, V335, P645, DOI 10.1038/335645a0; Inanobe A, 2005, NEURON, V47, P71, DOI 10.1016/j.neuron.2005.05.022; Jespersen A, 2014, NEURON, V81, P366, DOI 10.1016/j.neuron.2013.11.033; Karakas E, 2011, NATURE, V475, P249, DOI 10.1038/nature10180; Karakas E, 2009, EMBO J, V28, P3910, DOI 10.1038/emboj.2009.338; Kashiwagi K, 1996, MOL PHARMACOL, V49, P1131; Kawate T, 2009, NATURE, V460, P592, DOI 10.1038/nature08198; Lau AY, 2013, NEURON, V79, P492, DOI 10.1016/j.neuron.2013.06.003; Li WY, 2009, P NATL ACAD SCI USA, V106, P1075, DOI 10.1073/pnas.0812008106; LIDDINGTON RC, 1991, NATURE, V354, P278, DOI 10.1038/354278a0; Long SB, 2007, NATURE, V450, P376, DOI 10.1038/nature06265; MAYER ML, 1984, NATURE, V309, P261, DOI 10.1038/309261a0; Mony L, 2011, EMBO J, V30, P3134, DOI 10.1038/emboj.2011.203; Murshudov GN, 2011, ACTA CRYSTALLOGR D, V67, P355, DOI 10.1107/S0907444911001314; Rachline J, 2005, J NEUROSCI, V25, P308, DOI 10.1523/JNEUROSCI.3967-04.2005; Regalado MP, 2001, NEURON, V32, P1085, DOI 10.1016/S0896-6273(01)00539-6; Retchless BS, 2012, NAT NEUROSCI, V15, P406, DOI 10.1038/nn.3025; Riou M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035134; Salussolia CL, 2011, J NEUROSCI, V31, P11295, DOI 10.1523/JNEUROSCI.5612-10.2011; Schroder GF, 2010, NATURE, V464, P1218, DOI 10.1038/nature08892; Sobolevsky AI, 2009, NATURE, V462, P745, DOI 10.1038/nature08624; TRAYNELIS SF, 1995, SCIENCE, V268, P873, DOI 10.1126/science.7754371; Traynelis SF, 2010, PHARMACOL REV, V62, P405, DOI 10.1124/pr.109.002451; Vance KM, 2012, J PHYSIOL-LONDON, V590, P3857, DOI 10.1113/jphysiol.2012.234062; Vance KM, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1295; Watanabe J, 2002, J NEUROSCI, V22, P10209; Yao Y, 2008, EMBO J, V27, P2158, DOI 10.1038/emboj.2008.140; Ye S, 2010, NAT STRUCT MOL BIOL, V17, P1019, DOI 10.1038/nsmb.1865; Yuan HJ, 2009, J NEUROSCI, V29, P12045, DOI 10.1523/JNEUROSCI.1365-09.2009; Zheng F, 2001, NAT NEUROSCI, V4, P894, DOI 10.1038/nn0901-894; Zhou YF, 2001, NATURE, V414, P43, DOI 10.1038/35102009; Zuo J, 1997, NATURE, V388, P769, DOI 10.1038/42009	38	400	409	3	94	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 30	2014	344	6187					992	997		10.1126/science.1251915	http://dx.doi.org/10.1126/science.1251915			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AH9WM	24876489	Green Accepted			2022-12-28	WOS:000336495800036
J	Khajetoorians, AA; Wiebe, J				Khajetoorians, Alexander Ako; Wiebe, Jens			Hitting the limit of magnetic anisotropy	SCIENCE			English	Editorial Material							SPIN; ATOM		[Khajetoorians, Alexander Ako; Wiebe, Jens] Univ Hamburg, Inst Appl Phys, D-20355 Hamburg, Germany	University of Hamburg	Khajetoorians, AA (corresponding author), Univ Hamburg, Inst Appl Phys, D-20355 Hamburg, Germany.	akhajeto@physnet.uni-hamburg.de; jwiebe@physnet.uni-hamburg.de	Khajetoorians, Alexander A/F-9698-2015; Wiebe, Jens/C-7580-2018	Wiebe, Jens/0000-0003-1668-6142				Gambardella P, 2003, SCIENCE, V300, P1130, DOI 10.1126/science.1082857; Heinrich AJ, 2004, SCIENCE, V306, P466, DOI 10.1126/science.1101077; Khajetoorians AA, 2011, PHYS REV LETT, V106, DOI 10.1103/PhysRevLett.106.037205; Khajetoorians AA, 2013, SCIENCE, V339, P55, DOI 10.1126/science.1228519; Khajetoorians AA, 2011, SCIENCE, V332, P1062, DOI 10.1126/science.1201725; Loth S, 2012, SCIENCE, V335, P196, DOI 10.1126/science.1214131; Loth S, 2010, SCIENCE, V329, P1628, DOI [10.1126/science.1191688, 10.1126/science.191688]; Rau IG, 2014, SCIENCE, V344, P988, DOI 10.1126/science.1252841; Wiebe J, 2011, J PHYS D APPL PHYS, V44, DOI 10.1088/0022-3727/44/46/464009	9	29	30	0	76	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 30	2014	344	6187					976	977		10.1126/science.1254402	http://dx.doi.org/10.1126/science.1254402			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AH9WM	24876483				2022-12-28	WOS:000336495800024
J	Lidin, S				Lidin, Sven			Mapping bond orientations with polarized x-rays	SCIENCE			English	Editorial Material							BIREFRINGENCE		Lund Univ, Dept Polymer & Mat Chem, S-22100 Lund, Sweden	Lund University	Lidin, S (corresponding author), Lund Univ, Dept Polymer & Mat Chem, S-22100 Lund, Sweden.	sven.lidin@chem.lu.se		Lidin, Sven/0000-0001-9057-8233				Harris KDM, 1997, CHEM SOC REV, V26, P279, DOI 10.1039/cs9972600279; Ishibashi T, 2005, J KOREAN PHYS SOC, V46, P228; Joly Y, 2012, PHYS REV B, V86, DOI 10.1103/PhysRevB.86.220101; Palmer BA, 2014, SCIENCE, V344, P1013, DOI 10.1126/science.1253537; Palmer BA, 2011, J PHYS CHEM LETT, V2, P2346, DOI 10.1021/jz201026z; TEMPLETON DH, 1989, PHYS REV B, V40, P6505, DOI 10.1103/PhysRevB.40.6505	6	3	3	0	20	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 30	2014	344	6187					969	970		10.1126/science.1254902	http://dx.doi.org/10.1126/science.1254902			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AH9WM	24876478				2022-12-28	WOS:000336495800019
J	Cotton, PB; Durkalski, V; Romagnuolo, J; Pauls, Q; Fogel, E; Tarnasky, P; Aliperti, G; Freeman, M; Kozarek, R; Jamidar, P; Wilcox, M; Serrano, J; Brawman-Mintzer, O; Elta, G; Mauldin, P; Thornhill, A; Hawes, R; Wood-Williams, A; Orrell, K; Drossman, D; Robuck, P				Cotton, Peter B.; Durkalski, Valerie; Romagnuolo, Joseph; Pauls, Qi; Fogel, Evan; Tarnasky, Paul; Aliperti, Giuseppe; Freeman, Martin; Kozarek, Richard; Jamidar, Priya; Wilcox, Mel; Serrano, Jose; Brawman-Mintzer, Olga; Elta, Grace; Mauldin, Patrick; Thornhill, Andre; Hawes, Robert; Wood-Williams, April; Orrell, Kyle; Drossman, Douglas; Robuck, Patricia			Effect of Endoscopic Sphincterotomy for Suspected Sphincter of Oddi Dysfunction on Pain-Related Disability Following Cholecystectomy The EPISOD Randomized Clinical Trial	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							FUNCTIONAL GASTROINTESTINAL DISORDERS; FINDINGS TYPE-I; HEALTH-STATUS; RISK-FACTORS; ERCP; GALLBLADDER; SYMPTOMS; BILIARY; PRESENTATIONS; COMPLICATIONS	IMPORTANCE Abdominal pain after cholecystectomy is common and may be attributed to sphincter of Oddi dysfunction. Management often involves endoscopic retrograde cholangiopancreatography (ERCP) with manometry and sphincterotomy. OBJECTIVE To determine whether endoscopic sphincterotomy reduces pain and whether sphincter manometric pressure is predictive of pain relief. DESIGN, SETTING, AND PATIENTS Multicenter, sham-controlled, randomized trial involving 214 patients with pain after cholecystectomy without significant abnormalities on imaging or laboratory studies, and no prior sphincter treatment or pancreatitis randomly assigned (August 6, 2008-March 23, 2012) to undergo sphincterotomy or sham therapy at 7 referral medical centers. One-year follow-up was blinded. The final follow-up visit was March 21, 2013. INTERVENTIONS After ERCP, patients were randomized 2: 1 to sphincterotomy (n = 141) or sham (n = 73) irrespective of manometry findings. Those randomized to sphincterotomy with elevated pancreatic sphincter pressures were randomized again (1: 1) to biliary or to both biliary and pancreatic sphincterotomies. Seventy-two were entered into an observational study with conventional ERCP managemeny. MAIN OUTCOMES AND MEASURES Success of treatment was defined as less than 6 days of disability due to pain in the prior 90 days both at months 9 and 12 after randomization, with no narcotic use and no further sphincter intervention. RESULTS Twenty-seven patients (37%; 95% CI, 25.9%-48.1%) in the sham treatment group vs 32 (23%; 95% CI, 15.8%-29.6%) in the sphincterotomy group experienced successful treatment (adjusted risk difference, -15.6%; 95% CI, -28.0% to -3.3%; P =.01). Of the patients with pancreatic sphincter hypertension, 14 (30%; 95% CI, 16.7%-42.9%) who underwent dual sphincterotomy and 10 (20%; 95% CI, 8.7%-30.5%) who underwent biliary sphincterotomy alone experienced successful treatment. Thirty-seven treated patients (26%; 95% CI, 19%-34%) and 25 patients (34%; 95% CI, 23%-45%) in the sham group underwent repeat ERCP interventions (P =.22). Manometry results were not associated with the outcome. No clinical subgroups appeared to benefit from sphincterotomy more than others. Pancreatitis occurred in 15 patients (11%) after primary sphincterotomies and in 11 patients (15%) in the sham group. Of the nonrandomized patients in the observational study group, 5 (24%; 95% CI, 6%-42%) who underwent biliary sphincterotomy, 12 (31%; 95% CI, 16%-45%) who underwent dual sphincterotomy, and 2 (17%; 95% CI, 0%-38%) who did not undergo sphincterotomy had successful treatment. CONCLUSIONS AND RELEVANCE In patients with abdominal pain after cholecystectomy undergoing ERCP with manometry, sphincterotomy vs sham did not reduce disability due to pain. These findings do not support ERCP and sphincterotomy for these patients.	[Cotton, Peter B.; Durkalski, Valerie; Romagnuolo, Joseph; Pauls, Qi; Mauldin, Patrick; Thornhill, Andre; Hawes, Robert; Wood-Williams, April; Orrell, Kyle] Med Univ S Carolina, Charleston, SC 29425 USA; [Fogel, Evan] Indiana Univ, Indianapolis, IN 46204 USA; [Tarnasky, Paul] Dallas Med Ctr, Dallas, TX USA; [Aliperti, Giuseppe] Midwest Therapeut Endoscopy Consultants, St Louis, MO USA; [Freeman, Martin] Univ Minnesota, Sch Med, Minneapolis, MN 55455 USA; [Kozarek, Richard] Virginia Mason Med Ctr, Seattle, WA 98101 USA; [Jamidar, Priya] Yale Univ, New Haven, CT USA; [Wilcox, Mel] Univ Alabama Birmingham, Birmingham, AL USA; [Serrano, Jose; Robuck, Patricia] Natl Inst Diabet & Digest & Kidney Dis, Bethesda, MD USA; [Brawman-Mintzer, Olga] Ralph H Johnson VA Med Ctr, Charleston, SC USA; [Elta, Grace] Univ Michigan, Ann Arbor, MI 48109 USA; [Hawes, Robert] Florida Hosp, Orlando, FL USA; [Drossman, Douglas] Univ N Carolina, Chapel Hill, NC USA; [Drossman, Douglas] Drossman Gastroenterol PLLC, Chapel Hill, NC USA	Medical University of South Carolina; Indiana University System; Indiana University-Purdue University Indianapolis; University of Minnesota System; University of Minnesota Twin Cities; Virginia Mason Medical Center; Yale University; University of Alabama System; University of Alabama Birmingham; National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK); US Department of Veterans Affairs; Veterans Health Administration (VHA); Ralph H Johnson VA Medical Center; University of Michigan System; University of Michigan; Adventist Health Services; AdventHealth; University of North Carolina; University of North Carolina Chapel Hill	Cotton, PB (corresponding author), Med Univ S Carolina, Ctr Digest Dis, ART 7094,MSC 290,25 Courtenay Dr, Charleston, SC 29425 USA.	cottonp@musc.edu	Kozarek, Richard/AAF-2695-2020	Casas Gallegos, Isabel/0000-0002-2805-4604; Romagnuolo, Joseph/0000-0002-5630-3022	National Institutes of Diabetes and Digestive and Kidney Diseases [U01 DK074739]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [U01DK074739] Funding Source: NIH RePORTER	National Institutes of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This study was funded by grant U01 DK074739 from the National Institutes of Diabetes and Digestive and Kidney Diseases.	BARMEIR S, 1984, HEPATOLOGY, V4, P328, DOI 10.1002/hep.1840040225; Beck A.T., 1996, BDI 2 BECK DEPRESSIO, DOI [10.1037/t00742-000, DOI 10.1037/T00742-000]; Behar J, 2006, GASTROENTEROLOGY, V130, P1498, DOI 10.1053/j.gastro.2005.11.063; Berger MY, 2003, SURG ENDOSC, V17, P1723, DOI 10.1007/s00464-002-9154-6; Bielefeldt K, 2013, ALIMENT PHARM THER, V37, P98, DOI 10.1111/apt.12105; BLACK NA, 1994, GUT, V35, P1301, DOI 10.1136/gut.35.9.1301; Brawman-Mintzer O, 2014, AM J GASTROENTEROL, V109, P436, DOI 10.1038/ajg.2013.467; Cohen S, 2002, GASTROINTEST ENDOSC, V56, P803, DOI 10.1067/mge.2002.129875; COTTON PB, 1991, GASTROINTEST ENDOSC, V37, P383, DOI 10.1016/S0016-5107(91)70740-2; Cotton PB, 2001, GASTROINTEST ENDOSC, V54, P535, DOI 10.1067/mge.2001.118446; Cotton PB, 2010, GASTROINTEST ENDOSC, V72, P986, DOI 10.1016/j.gie.2010.08.022; Cotton PB, 2009, GASTROINTEST ENDOSC, V70, P80, DOI 10.1016/j.gie.2008.10.039; DROSSMAN DA, 1993, DIGEST DIS SCI, V38, P1569, DOI 10.1007/BF01303162; Drossman DA, 2000, PSYCHOSOM MED, V62, P309, DOI 10.1097/00006842-200005000-00004; Drossman DA, 2006, GASTROENTEROLOGY, V130, P1377, DOI 10.1053/j.gastro.2006.03.008; Duncan CB, 2012, J GASTROINTEST SURG, V16, P2011, DOI 10.1007/s11605-012-2024-1; Durkalski V, 2010, WORLD J GASTROENTERO, V16, P4416, DOI 10.3748/wjg.v16.i35.4416; Freeman ML, 2007, J CLIN GASTROENTEROL, V41, P94, DOI 10.1097/01.mcg.0000225584.40212.fb; Freeman ML, 2001, GASTROINTEST ENDOSC, V54, P425, DOI 10.1067/mge.2001.117550; GEENEN JE, 1989, NEW ENGL J MED, V320, P82, DOI 10.1056/NEJM198901123200203; Leserman J, 1997, PSYCHOSOM MED, V59, P152, DOI 10.1097/00006842-199703000-00007; Luman W, 1996, GUT, V39, P863, DOI 10.1136/gut.39.6.863; OBRIEN PC, 1979, BIOMETRICS, V35, P549, DOI 10.2307/2530245; Park SH, 2003, GASTROINTEST ENDOSC, V57, P483, DOI 10.1067/mge.2003.138; Pasricha PJ, 2002, GASTROINTEST ENDOSC, V56, pS267, DOI 10.1067/mge.2002.129012; Petersen BT, 2004, GASTROINTEST ENDOSC, V59, P670, DOI 10.1016/S0016-5107(04)00297-4; Petersen BT, 2004, GASTROINTEST ENDOSC, V59, P525, DOI 10.1016/S0016-5107(04)00012-4; Price DD, 2008, ANNU REV PSYCHOL, V59, P565, DOI 10.1146/annurev.psych.59.113006.095941; Rana JS, 2005, AM J CARDIOL, V95, P1456, DOI 10.1016/j.amjcard.2005.02.013; Romagnuolo J, 2014, GASTROINTEST ENDOSC, V79, P765, DOI 10.1016/j.gie.2013.11.037; Sgouros SN, 2006, ALIMENT PHARM THER, V24, P237, DOI 10.1111/j.1365-2036.2006.02971.x; Sheehan DV, 1998, J CLIN PSYCHIAT, V59, P22, DOI 10.4088/JCP.09m05305whi; Sherman S, 2001, JOP, V2, P382; Sherman S, 1994, GASTROINTEST ENDOSC, V40, p125A; Toouli J, 2000, GUT, V46, P98, DOI 10.1136/gut.46.1.98; Topazian M, 2004, J CLIN GASTROENTEROL, V38, P692, DOI 10.1097/01.mcg.0000135371.03222.df; Vetrhus M, 2005, J GASTROINTEST SURG, V9, P826, DOI 10.1016/j.gassur.2005.01.291; WARE JE, 1992, MED CARE, V30, P473, DOI 10.1097/00005650-199206000-00002; Wilcox CM, 2008, GASTROINTEST ENDOSC, V67, P123, DOI 10.1016/j.gie.2007.09.003; ZIGMOND AS, 1983, ACTA PSYCHIAT SCAND, V67, P361, DOI 10.1111/j.1600-0447.1983.tb09716.x	40	113	128	0	19	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAY 28	2014	311	20					2101	2109		10.1001/jama.2014.5220	http://dx.doi.org/10.1001/jama.2014.5220			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AH8MQ	24867013	Green Accepted, Bronze			2022-12-28	WOS:000336392400026
J	Schittny, R; Kadic, M; Buckmann, T; Wegener, M				Schittny, Robert; Kadic, Muamer; Bueckmann, Tiemo; Wegener, Martin			Invisibility cloaking in a diffusive light scattering medium	SCIENCE			English	Article								In vacuum, air, and other surroundings that support ballistic light propagation according to Maxwell's equations, invisibility cloaks that are macroscopic, three-dimensional, broadband, passive, and that work for all directions and polarizations of light are not consistent with the laws of physics. We show that the situation is different for surroundings leading to multiple light scattering, according to Fick's diffusion equation. We have fabricated cylindrical and spherical invisibility cloaks made of thin shells of polydimethylsiloxane doped with melamine-resin microparticles. The shells surround a diffusively reflecting hollow core, in which arbitrary objects can be hidden. We find good cloaking performance in a water-based diffusive surrounding throughout the entire visible spectrum and for all illumination conditions and incident polarizations of light.	[Schittny, Robert; Kadic, Muamer; Bueckmann, Tiemo; Wegener, Martin] Karlsruhe Inst Technol, Inst Appl Phys, D-76128 Karlsruhe, Germany; [Schittny, Robert; Bueckmann, Tiemo; Wegener, Martin] KIT, CFN, DFG, D-76128 Karlsruhe, Germany; [Kadic, Muamer; Wegener, Martin] KIT, Inst Nanotechnol, D-76021 Karlsruhe, Germany	Helmholtz Association; Karlsruhe Institute of Technology; German Research Foundation (DFG); Helmholtz Association; Karlsruhe Institute of Technology; Helmholtz Association; Karlsruhe Institute of Technology	Wegener, M (corresponding author), Karlsruhe Inst Technol, Inst Appl Phys, D-76128 Karlsruhe, Germany.	martin.wegener@kit.edu	Wegener, Martin/ABD-5353-2021; Wegener, Martin/S-5456-2016; Kadic, Muamer/J-9478-2015	Wegener, Martin/0000-0002-9770-2441; Wegener, Martin/0000-0002-9770-2441; Kadic, Muamer/0000-0002-4692-5696	DFG-CFN Karlsruhe School of Optics & Photonics (KSOP)	DFG-CFN Karlsruhe School of Optics & Photonics (KSOP)	We thank A. Naber (KIT) and X. He (visitor at KIT) for discussions and J. Westhauser (KIT) for technical assistance. We acknowledge support by the DFG-CFN through subproject A1.5 and by the Karlsruhe School of Optics & Photonics (KSOP). We also thank the Hector Fellow Academy for support.	Alu A, 2005, PHYS REV E, V72, DOI 10.1103/PhysRevE.72.016623; Chen XZ, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1176; Einstein A, 1905, ANN PHYS-BERLIN, V17, P549, DOI 10.1002/andp.19053220806; Ergin T, 2011, PHYS REV LETT, V107, DOI 10.1103/PhysRevLett.107.173901; Ergin T, 2010, SCIENCE, V328, P337, DOI 10.1126/science.1186351; Fick A., 1855, ANN PHYS-NEW YORK, V94, P59, DOI [10.1002/andp.18551700105, DOI 10.1002/ANDP.18551700105]; Gabrielli LH, 2009, NAT PHOTONICS, V3, P461, DOI 10.1038/NPHOTON.2009.117; Gomory F, 2012, SCIENCE, V335, P1466, DOI 10.1126/science.1218316; Goodman JW., 2020, SPECKLE PHENOMENA OP; Guenneau S, 2013, J R SOC INTERFACE, V10, DOI 10.1098/rsif.2013.0106; Han TC, 2014, PHYS REV LETT, V112, DOI 10.1103/PhysRevLett.112.054302; Hashemi H, 2010, PHYS REV LETT, V104, DOI 10.1103/PhysRevLett.104.253903; Leonhardt U, 2006, SCIENCE, V312, P1777, DOI 10.1126/science.1126493; Liu R, 2009, SCIENCE, V323, P366, DOI 10.1126/science.1166949; Miller DAB, 2006, OPT EXPRESS, V14, P12457, DOI 10.1364/OE.14.012457; Milton GW., 2002, THEORY COMPOSITES; Schittny R, 2013, PHYS REV LETT, V110, DOI 10.1103/PhysRevLett.110.195901; Schurig D, 2006, SCIENCE, V314, P977, DOI 10.1126/science.1133628; Schwartz T, 2007, NATURE, V446, P52, DOI 10.1038/nature05623; Shalaev VM, 2008, SCIENCE, V322, P384, DOI 10.1126/science.1166079; Soukoulis C. M., 2001, PHOTONIC CRYSTALS LI; Valentine J, 2009, NAT MATER, V8, P568, DOI [10.1038/nmat2461, 10.1038/NMAT2461]; Wegener M, 2013, SCIENCE, V342, P939, DOI 10.1126/science.1246545; Xu HY, 2014, PHYS REV LETT, V112, DOI 10.1103/PhysRevLett.112.054301	24	131	132	5	160	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 25	2014	345	6195					427	429		10.1126/science.1254524	http://dx.doi.org/10.1126/science.1254524			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM2CB	24903561				2022-12-28	WOS:000339655100036
J	Cathomen, T; Ehl, S				Cathomen, Toni; Ehl, Stephan			Translating the Genomic Revolution - Targeted Genome Editing in Primates	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							GENE; CELLS		[Cathomen, Toni; Ehl, Stephan] Univ Med Ctr Freiburg, Ctr Chron Immunodeficiency, Freiburg, Germany; [Cathomen, Toni] Univ Med Ctr Freiburg, Inst Cell & Gene Therapy, Freiburg, Germany; [Ehl, Stephan] Univ Med Ctr Freiburg, Dept Pediat & Adolescent Med, Freiburg, Germany	University of Freiburg; University of Freiburg; University of Freiburg	Cathomen, T (corresponding author), Univ Med Ctr Freiburg, Ctr Chron Immunodeficiency, Freiburg, Germany.		Ehl, Stephan/AAM-6006-2020; Cathomen, Toni/ABG-8410-2021; Cathomen, Toni/GZL-2702-2022	Cathomen, Toni/0000-0002-7757-4630; Cathomen, Toni/0000-0002-7757-4630; Ehl, Stephan/0000-0002-9265-2721				[Anonymous], 2013, SCIENCE, V342, P1434; de Souza N, 2012, NAT METHODS, V9, P27, DOI 10.1038/nmeth.1848; Garate Z, 2013, HUM GENE THER, V24, P571, DOI 10.1089/hum.2012.251; Liu HL, 2014, CELL STEM CELL, V14, P323, DOI 10.1016/j.stem.2014.01.018; Niu YY, 2014, CELL, V156, P836, DOI 10.1016/j.cell.2014.01.027; Tebas P, 2014, NEW ENGL J MED, V370, P901, DOI 10.1056/NEJMoa1300662	6	15	15	0	7	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUN 12	2014	370	24					2342	2345		10.1056/NEJMcibr1403629	http://dx.doi.org/10.1056/NEJMcibr1403629			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AI7BB	24918378				2022-12-28	WOS:000337033700015
J	Halpin, A; Johnson, PJM; Miller, RJD				Halpin, Alexei; Johnson, Philip J. M.; Miller, R. J. Dwayne			Comment on "Engineering coherence among excited states in synthetic heterodimer systems"	SCIENCE			English	Editorial Material							FEMTOSECOND PHOTON-ECHOES; QUANTUM COHERENCE; RESONANCE RAMAN; ENERGY-TRANSFER; DIMERS; TEMPERATURE; MOLECULES	Hayes et al. (Reports, 21 June 2013, p. 1431) used two-dimensional (2D) electronic spectroscopy to study molecular heterodimers and reported a general mechanism for the prolongation of electronic coherences, consistent with previous interpretations of 2D spectra for light-harvesting systems. We argue that the dynamics attributed to electronic coherences are inconclusive based on experimental inconsistencies arising from limited sample characterization and insufficient control measurements.	[Halpin, Alexei; Johnson, Philip J. M.; Miller, R. J. Dwayne] Univ Toronto, Inst Opt Sci, Toronto, ON M5S 3H6, Canada; [Halpin, Alexei; Johnson, Philip J. M.; Miller, R. J. Dwayne] Univ Toronto, Dept Chem, Toronto, ON M5S 3H6, Canada; [Halpin, Alexei; Johnson, Philip J. M.; Miller, R. J. Dwayne] Univ Toronto, Dept Phys, Toronto, ON M5S 3H6, Canada; [Miller, R. J. Dwayne] Max Planck Inst Struct & Dynam Matter, Atom Resolved Dynam Div, D-22761 Hamburg, Germany	University of Toronto; University of Toronto; University of Toronto; Max Planck Society	Miller, RJD (corresponding author), Univ Toronto, Inst Opt Sci, 80 St George St, Toronto, ON M5S 3H6, Canada.	dwayne.miller@mpsd.mpg.de		Halpin, Alexei/0000-0002-2625-8718; Johnson, Philip/0000-0002-7251-4815				BECKER PC, 1989, PHYS REV LETT, V63, P505, DOI 10.1103/PhysRevLett.63.505; BIGOT JY, 1991, PHYS REV LETT, V66, P1138, DOI 10.1103/PhysRevLett.66.1138; Butkus V, 2012, CHEM PHYS LETT, V545, P40, DOI 10.1016/j.cplett.2012.07.014; Collini E, 2010, NATURE, V463, P644, DOI 10.1038/nature08811; FULTON RL, 1964, J CHEM PHYS, V41, P2280, DOI 10.1063/1.1726260; Halpin A, 2013, EPJ WEB CONF, V41, DOI 10.1051/epjconf/20134105032; Hayes D, 2013, SCIENCE, V340, P1431, DOI 10.1126/science.1233828; KASHA M, 1963, RADIAT RES, V20, P55, DOI 10.2307/3571331; Kelley AM, 2003, J CHEM PHYS, V119, P3320, DOI 10.1063/1.1588995; Leng WN, 2004, J PHYS CHEM B, V108, P10284, DOI 10.1021/jp037371x; Mukamel S, 2013, J PHYS CHEM A, V117, P10563, DOI 10.1021/jp4071086; Panitchayangkoon G, 2010, P NATL ACAD SCI USA, V107, P12766, DOI 10.1073/pnas.1005484107; Polyutov S, 2012, CHEM PHYS, V394, P21, DOI 10.1016/j.chemphys.2011.12.006; Tiwari V, 2013, P NATL ACAD SCI USA, V110, P1203, DOI 10.1073/pnas.1211157110; Turner DB, 2012, PHYS CHEM CHEM PHYS, V14, P4857, DOI 10.1039/c2cp23670b; Womick JM, 2011, J PHYS CHEM B, V115, P1347, DOI 10.1021/jp106713q	16	8	8	0	70	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 6	2014	344	6188								10.1126/science.1250926	http://dx.doi.org/10.1126/science.1250926			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AI3UU	24904149				2022-12-28	WOS:000336791200031
J	Kruijer, TS; Touboul, M; Fischer-Godde, M; Bermingham, KR; Walker, RJ; Kleine, T				Kruijer, T. S.; Touboul, M.; Fischer-Goedde, M.; Bermingham, K. R.; Walker, R. J.; Kleine, T.			Protracted core formation and rapid accretion of protoplanets	SCIENCE			English	Article							IVB IRON-METEORITES; PARENT BODIES; ISOTOPE SYSTEMATICS; MELTING RELATIONS; FE-FES; DIFFERENTIATION; HF-182-W-182; CHRONOLOGY; PLANETESIMALS; CHONDRITES	Understanding core formation in meteorite parent bodies is critical for constraining the fundamental processes of protoplanet accretion and differentiation within the solar protoplanetary disk. We report variations of 5 to 20 parts per million in W-182, resulting from the decay of now-extinct Hf-182, among five magmatic iron meteorite groups. These W-182 variations indicate that core formation occurred over an interval of similar to 1 million years and may have involved an early segregation of Fe-FeS and a later segregation of Fe melts. Despite this protracted interval of core formation, the iron meteorite parent bodies probably accreted concurrently similar to 0.1 to 0.3 million years after the formation of Ca-Al-rich inclusions. Variations in volatile contents among these bodies, therefore, did not result from accretion at different times from an incompletely condensed solar nebula but must reflect local processes within the nebula.	[Kruijer, T. S.; Fischer-Goedde, M.; Kleine, T.] Univ Munster, Inst Planetol, DE-48149 Munster, Germany; [Kruijer, T. S.] ETH, Inst Geochem & Petr, CH-8092 Zurich, Switzerland; [Touboul, M.; Bermingham, K. R.; Walker, R. J.] Univ Maryland, Dept Geol, College Pk, MD 20742 USA	University of Munster; Swiss Federal Institutes of Technology Domain; ETH Zurich; University System of Maryland; University of Maryland College Park	Kruijer, TS (corresponding author), Univ Munster, Inst Planetol, Wilhelm Klemm Str 10, DE-48149 Munster, Germany.		Walker, Richard/K-6869-2016; Kleine, Thorsten/S-2792-2017	Walker, Richard/0000-0003-0348-2407; Kleine, Thorsten/0000-0003-4657-5961; Fischer-Godde, Mario/0000-0001-6839-9001; Kruijer, Thomas/0000-0003-0974-4324	Forderungsprofessur of the Swiss National Science Foundation [PP00P2_123470]; NASA Cosmochemistry grant [NNX13AF83G]	Forderungsprofessur of the Swiss National Science Foundation; NASA Cosmochemistry grant	We thank T. Elliott, A. Halliday, and an anonymous reviewer for their comprehensive and constructive reviews. We gratefully acknowledge the Field Museum of Natural History (Chicago), the Smithsonian Institution (Washington, DC), and the American Museum of Natural History (New York City) for providing the samples for this study. We also thank R. Wieler, J. Wasson, R. Hin, F. Nimmo, and W. van Westrenen for discussions and U. Heitmann for technical support during sample preparation. This study was supported by a Forderungsprofessur to T. K. of the Swiss National Science Foundation (grant no. PP00P2_123470) and NASA Cosmochemistry grant NNX13AF83G to R.J.W.. The data reported in this paper are tabulated in the supplementary materials (tables S1 to S6).	Benedix G. K., 2014, TREATISE GEOCHEMISTR, V2nd, P267; Boss A. P., 1990, ORIGIN EARTH, P3; BRETT R, 1969, EARTH PLANET SC LETT, V6, P479, DOI 10.1016/0012-821X(69)90119-8; Campbell AJ, 2005, GEOCHIM COSMOCHIM AC, V69, P4733, DOI 10.1016/j.gca.2005.06.004; Fei YW, 1997, SCIENCE, V275, P1621, DOI 10.1126/science.275.5306.1621; Humayun M, 2000, ORIGIN EARTH MOON, P3; Kleine T, 2005, GEOCHIM COSMOCHIM AC, V69, P5805, DOI 10.1016/j.gca.2005.07.012; Kleine T, 2004, GEOCHIM COSMOCHIM AC, V68, P2935, DOI 10.1016/j.gca.2004.01.009; Kleine T, 2009, GEOCHIM COSMOCHIM AC, V73, P5150, DOI 10.1016/j.gca.2008.11.047; Kruijer T. S., 2014, 45 LUN PLAN SCI C HO; Kruijer TS, 2013, EARTH PLANET SC LETT, V361, P162, DOI 10.1016/j.epsl.2012.10.014; Markowski A, 2006, EARTH PLANET SC LETT, V242, P1, DOI 10.1016/j.epsl.2005.11.048; Qin LP, 2008, EARTH PLANET SC LETT, V273, P94, DOI 10.1016/j.epsl.2008.06.018; Schersten A, 2006, EARTH PLANET SC LETT, V241, P530, DOI 10.1016/j.epsl.2005.11.025; SCOTT ERD, 1975, REV GEOPHYS, V13, P527, DOI 10.1029/RG013i004p00527; Walker RJ, 2008, GEOCHIM COSMOCHIM AC, V72, P2198, DOI 10.1016/j.gca.2008.01.021; Wittig N, 2013, EARTH PLANET SC LETT, V361, P152, DOI 10.1016/j.epsl.2012.10.013; Yoshino T, 2003, NATURE, V422, P154, DOI 10.1038/nature01459	18	188	189	1	87	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 6	2014	344	6188					1150	1154		10.1126/science.1251766	http://dx.doi.org/10.1126/science.1251766			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI3UU	24904163				2022-12-28	WOS:000336791200045
J	Narni-Mancinelli, E; Vivier, E				Narni-Mancinelli, Emilie; Vivier, Eric			Delivering Three Punches to Knockout Intracellular Bacteria	CELL			English	Editorial Material							GRANULYSIN; CELLS; DEATH	Cytotoxic lymphocytes kill bacteria-infected cells, but the mechanisms at work remain unclear. Walch et al. show that these lymphocytes deliver a toxic molecular trio in a two-step process, penetrating first the infected cells and then delivering bactericidal granzymes into the intracytoplasmic bacteria.	[Narni-Mancinelli, Emilie; Vivier, Eric] UM2 Aix Marseille Univ, Ctr Immunol Marseille Luminy, ctrimm, F-13288 Marseille, France; [Narni-Mancinelli, Emilie; Vivier, Eric] INSERM, U1104, F-13288 Marseille, France; [Narni-Mancinelli, Emilie; Vivier, Eric] CNRS, UMR7280, F-13288 Marseille, France; [Vivier, Eric] Hop Conception, Assistance Publ Hop Marseille, Serv Immunol, F-13285 Marseille, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Aix-Marseille Universite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Aix-Marseille Universite; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Aix-Marseille Universite; UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille	Vivier, E (corresponding author), UM2 Aix Marseille Univ, Ctr Immunol Marseille Luminy, ctrimm, F-13288 Marseille, France.	vivier@ciml.univ-mrs.fr	Narni-Mancinelli, Emilie/X-1888-2018; Vivier, Eric/F-8939-2010	Narni-Mancinelli, Emilie/0000-0002-7001-1026; Vivier, Eric/0000-0001-7022-8287				Clayberger C, 2003, CURR OPIN IMMUNOL, V15, P560, DOI 10.1016/S0952-7915(03)00097-9; Huang LP, 2007, J IMMUNOL, V178, P77, DOI 10.4049/jimmunol.178.1.77; Jouanguy E, 2013, CURR OPIN ALLERGY CL, V13, P589, DOI 10.1097/ACI.0000000000000011; Martinvalet D, 2005, IMMUNITY, V22, P355, DOI 10.1016/j.immuni.2005.02.004; Martinvalet D, 2008, CELL, V133, P681, DOI 10.1016/j.cell.2008.03.032; Park GH, 2012, DNA CELL BIOL, V31, P1492, DOI 10.1089/dna.2012.1709; Pipkin ME, 2007, CURR OPIN IMMUNOL, V19, P301, DOI 10.1016/j.coi.2007.04.011; Stenger S, 1998, SCIENCE, V282, P121, DOI 10.1126/science.282.5386.121; Walch M, 2014, CELL, V157, P1309, DOI 10.1016/j.cell.2014.03.062; Zheng CF, 2007, BLOOD, V109, P2049, DOI 10.1182/blood-2006-03-009720	10	4	4	0	4	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUN 5	2014	157	6					1251	1252		10.1016/j.cell.2014.05.023	http://dx.doi.org/10.1016/j.cell.2014.05.023			2	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	AN8UV	24906142	Bronze			2022-12-28	WOS:000340881400002
J	Platt, FM				Platt, Frances M.			Sphingolipid lysosomal storage disorders	NATURE			English	Review							TAY-SACHS-DISEASE; ENZYME REPLACEMENT THERAPY; PICK-C DISEASE; GAUCHER-DISEASE; SANDHOFF-DISEASE; GENE-THERAPY; GLUCOCEREBROSIDASE MUTATIONS; N-BUTYLDEOXYNOJIRIMYCIN; PARKINSONS-SYNDROME; CLINICAL-FEATURES	Lysosomal storage diseases are inborn errors of metabolism, the hallmark of which is the accumulation, or storage, of macromolecules in the late endocytic system. They are monogenic disorders that occur at a collective frequency of 1 in 5,000 live births and are caused by inherited defects in genes that mainly encode lysosomal proteins, most commonly lysosomal enzymes. A subgroup of these diseases involves the lysosomal storage of glycosphingolipids. Through our understanding of the genetics, biochemistry and, more recently, cellular aspects of sphingolipid storage disorders, we have gained insights into fundamental aspects of cell biology that would otherwise have remained opaque. In addition, study of these disorders has led to significant progress in the development of therapies, several of which are now in routine clinical use. Emerging mechanistic links with more common diseases suggest we need to rethink our current concept of disease boundaries.	Univ Oxford, Dept Pharmacol, Oxford OX1 3QT, England	University of Oxford	Platt, FM (corresponding author), Univ Oxford, Dept Pharmacol, S Parks Rd, Oxford OX1 3QT, England.	frances.platt@pharm.ox.ac.uk		Platt, Frances/0000-0001-7614-0403	Royal Society	Royal Society(Royal Society of London)	Thanks to D. Priestman for creating Fig. 1 and to N. Platt for his comments on the manuscript. F.M.P is a Royal Society Wolfson Research Merit Award holder.	Bembi B, 2003, NEUROLOGY, V61, P99, DOI 10.1212/01.WNL.0000072482.70963.D7; Bersano A, 2012, ACTA NEUROL SCAND, V126, P77, DOI 10.1111/j.1600-0404.2012.01661.x; Beutler E, 2006, ACTA PAEDIATR, V95, P103, DOI 10.1080/08035320600619039; Boukhris A, 2013, AM J HUM GENET, V93, P118, DOI 10.1016/j.ajhg.2013.05.006; Bradbury AM, 2013, MOL THER, V21, P1306, DOI 10.1038/mt.2013.86; Brady RO, 2006, ANNU REV MED, V57, P283, DOI 10.1146/annurev.med.57.110104.115650; Brady RO, 2003, PHILOS T ROY SOC B, V358, P915, DOI 10.1098/rstb.2003.1269; Brady RO, 2001, J INHERIT METAB DIS, V24, P18, DOI 10.1023/A:1012451320105; Brady RO, 2001, ADV GENET, V44, P51; Cachon-Gonzalez MB, 2006, P NATL ACAD SCI USA, V103, P10373, DOI 10.1073/pnas.0603765103; Chauhan S, 2013, MOL CELL, V50, P16, DOI 10.1016/j.molcel.2013.01.024; Chen FW, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015054; Chien YH, 2013, J INHERIT METAB DIS, V36, P129, DOI 10.1007/s10545-012-9479-9; Christofferson DE, 2010, CURR OPIN CELL BIOL, V22, P263, DOI 10.1016/j.ceb.2009.12.003; Coutelle Charles, 2012, Methods Mol Biol, V891, P1, DOI 10.1007/978-1-61779-873-3_1; Cox T, 2000, LANCET, V355, P1481, DOI 10.1016/S0140-6736(00)02161-9; Cox TM, 2013, AM J HEMATOL, V88, P163, DOI 10.1002/ajh.23399; Cox TM, 1997, BAILLIERE CLIN HAEM, V10, P657, DOI 10.1016/S0950-3536(97)80033-9; Davidson CD, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006951; Davies JP, 2000, SCIENCE, V290, P2295, DOI 10.1126/science.290.5500.2295; de Fost M, 2003, NETH J MED, V61, P3; Dehay B, 2013, MOVEMENT DISORD, V28, P725, DOI 10.1002/mds.25462; Ellinwood NM, 2011, MOL THER, V19, P251, DOI 10.1038/mt.2010.265; Foust KD, 2010, NAT BIOTECHNOL, V28, P271, DOI 10.1038/nbt.1610; Fullgrabe J, 2014, NAT REV MOL CELL BIO, V15, P65, DOI 10.1038/nrm3716; Futerman AH, 2010, INT J CLIN PHARM TH, V48, pS6; Futerman A. H., 2013, BIOCHIM BIOPHYS ACTA, V1841, P671; Ghavami S, 2014, PROG NEUROBIOL, V112, P24, DOI 10.1016/j.pneurobio.2013.10.004; Goker-Alpan O, 2006, NEUROLOGY, V67, P908, DOI 10.1212/01.wnl.0000230215.41296.18; Gravel R. A., 2001, METABOLIC MOL BASES, V3, P3827; GREWAL RP, 1991, ARCH NEUROL-CHICAGO, V48, P1271, DOI 10.1001/archneur.1991.00530240075025; HADFIELD MG, 1977, J PATHOL, V123, P137, DOI 10.1002/path.1711230303; Harlalka GV, 2013, BRAIN, V136, P3618, DOI 10.1093/brain/awt270; Hemsley KM, 2010, J INHERIT METAB DIS, V33, P363, DOI 10.1007/s10545-010-9078-6; Holler N, 2000, NAT IMMUNOL, V1, P489, DOI 10.1038/82732; Hruska KS, 2006, J BIOMED BIOTECHNOL, DOI 10.1155/JBB/2006/78549; Ioannou YA, 2001, NAT REV MOL CELL BIO, V2, P657, DOI 10.1038/35089558; Ioannou YA, 2001, AM J HUM GENET, V68, P14, DOI 10.1086/316953; Ioannou YA, 2000, MOL GENET METAB, V71, P175, DOI 10.1006/mgme.2000.3061; Jaiswal JK, 2002, J CELL BIOL, V159, P625, DOI 10.1083/jcb.200208154; JesionekKupnicka D, 1997, FOLIA NEUROPATHOL, V35, P155; Jeyakumar M, 2004, ANN NEUROL, V56, P642, DOI 10.1002/ana.20242; Jeyakumar M, 2001, BLOOD, V97, P327, DOI 10.1182/blood.V97.1.327; Jmoudiak M, 2005, BRIT J HAEMATOL, V129, P178, DOI 10.1111/j.1365-2141.2004.05351.x; Kalburgi SN, 2013, DISCOV MED, V15, P111; Kirkegaard T, 2010, NATURE, V463, P549, DOI 10.1038/nature08710; Lachmann RH, 2006, DRUG TODAY, V42, P29, DOI 10.1358/dot.2006.42.1.937457; Laurijssens Bart, 2013, Drug Discov Today Technol, V10, pe319, DOI 10.1016/j.ddtec.2012.04.001; Linkermann A, 2014, NEW ENGL J MED, V370, P455, DOI 10.1056/NEJMra1310050; Liscum L, 2000, TRAFFIC, V1, P218, DOI 10.1034/j.1600-0854.2000.010304.x; Liu B, 2010, J LIPID RES, V51, P933, DOI 10.1194/jlr.M000257; Lloyd-Evans E, 2008, NAT MED, V14, P1247, DOI 10.1038/nm.1876; Lloyd-Evans E, 2010, TRAFFIC, V11, P419, DOI 10.1111/j.1600-0854.2010.01032.x; Lyseng-Williamson KA, 2014, DRUGS, V74, P61, DOI 10.1007/s40265-013-0164-6; Machaczka M, 1999, AM J HEMATOL, V61, P216, DOI 10.1002/(SICI)1096-8652(199907)61:3<216::AID-AJH12>3.3.CO;2-2; MAHURAN DJ, 1990, CLIN BIOCHEM, V23, P409, DOI 10.1016/0009-9120(90)90153-L; Mattar CN, 2012, BEST PRACT RES CL OB, V26, P697, DOI 10.1016/j.bpobgyn.2012.06.006; Medina DL, 2011, DEV CELL, V21, P421, DOI 10.1016/j.devcel.2011.07.016; Mengel E, 2013, ORPHANET J RARE DIS, V8, DOI 10.1186/1750-1172-8-166; Nanba E., 2001, METABOLIC MOL BASES, V3, P3775; Neefjes J, 2014, TRENDS NEUROSCI, V37, P66, DOI 10.1016/j.tins.2013.11.006; Neudorfer O, 1996, QJM-MON J ASSOC PHYS, V89, P691; Neufeld EF, 2011, ANNU REV BIOCHEM, V80, P1, DOI 10.1146/annurev.biochem.031209.093756; Nixon RA, 2013, NAT MED, V19, P983, DOI 10.1038/nm.3232; Oberst A, 2011, NATURE, V471, P363, DOI 10.1038/nature09852; Oshima M., 1995, METABOLIC MOL BASES, V2, P2785; Palmieri M, 2011, HUM MOL GENET, V20, P3852, DOI 10.1093/hmg/ddr306; Pastores GM, 2002, J AM SOC NEPHROL, V13, pS130, DOI 10.1097/01.ASN.0000015236.70757.C4; Patterson MC, 2007, LANCET NEUROL, V6, P765, DOI 10.1016/S1474-4422(07)70194-1; Patterson MC, 2012, MOL GENET METAB, V106, P330, DOI 10.1016/j.ymgme.2012.03.012; Petersen NHT, 2010, BIOCHEM SOC T, V38, P1479, DOI 10.1042/BST0381479; PLATT FM, 1994, J BIOL CHEM, V269, P8362; Platt FM, 2008, ACTA PAEDIATR, V97, P88, DOI 10.1111/j.1651-2227.2008.00656.x; Platt FM, 2012, J CELL BIOL, V199, P723, DOI 10.1083/jcb.201208152; Pontikis CC, 2013, J INHERIT METAB DIS, V36, P491, DOI 10.1007/s10545-012-9583-x; Proia RL, 2004, NAT GENET, V36, P1147, DOI 10.1038/ng1104-1147; Proia RL, 2003, PHILOS T R SOC B, V358, P879, DOI 10.1098/rstb.2003.1268; Rahim AA, 2011, FASEB J, V25, P3505, DOI 10.1096/fj.11-182311; Ramirez CM, 2010, PEDIATR RES, V68, P309, DOI 10.1203/00006450-201011001-00604; RAPOLA J, 1994, PATHOL RES PRACT, V190, P759, DOI 10.1016/S0344-0338(11)80422-X; Reddy A, 2001, CELL, V106, P157, DOI 10.1016/S0092-8674(01)00421-4; Rombach SM, 2013, ORPHANET J RARE DIS, V8, DOI 10.1186/1750-1172-8-29; Rosenbaum AI, 2011, J NEUROCHEM, V116, P789, DOI 10.1111/j.1471-4159.2010.06976.x; Ruderman EM, 2013, BULL HOSP JT DIS, V71, pS29; Saftig P, 2009, NAT REV MOL CELL BIO, V10, P623, DOI 10.1038/nrm2745; Sandhoff K, 2003, PHILOS T R SOC B, V358, P847, DOI 10.1098/rstb.2003.1265; Sano R, 2009, MOL CELL, V36, P500, DOI 10.1016/j.molcel.2009.10.021; Sardiello M, 2009, CELL CYCLE, V8, P4021, DOI 10.4161/cc.8.24.10263; Sardiello M, 2009, SCIENCE, V325, P473, DOI 10.1126/science.1174447; Schnaar R. L., 2005, NEUROGLYCOBIOLOGY, P95; Schultz ML, 2011, TRENDS NEUROSCI, V34, P401, DOI 10.1016/j.tins.2011.05.006; Sedel F, 2007, REV MED INTERNE, V28, pS292, DOI 10.1016/j.revmed.2007.09.017; Shachar T, 2011, MOVEMENT DISORD, V26, P1593, DOI 10.1002/mds.23774; Shapiro BE, 2008, MUSCLE NERVE, V38, P1012, DOI 10.1002/mus.21061; Sidransky E, 2009, NEW ENGL J MED, V361, P1651, DOI 10.1056/NEJMoa0901281; Sidransky E, 2012, DISCOV MED, V14, P273; Simpson MA, 2004, NAT GENET, V36, P1225, DOI 10.1038/ng1460; Smith D, 2009, NEUROBIOL DIS, V36, P242, DOI 10.1016/j.nbd.2009.07.010; Stanley P, 2009, ESSENTIALS GLYCOBIOL; Stein VM, 2012, J NEUROPATH EXP NEUR, V71, P434, DOI 10.1097/NEN.0b013e31825414a6; Tayebi N, 2003, MOL GENET METAB, V79, P104, DOI 10.1016/S1096-7192(03)00071-4; Tayebi N, 2001, MOL GENET METAB, V73, P313, DOI 10.1006/mgme.2001.3201; Taylor R. M., 2004, LYSOSOMAL DISORDERS, V1, P257; te Vruchte D., 2014, J CLIN INVEST; Tomanin R, 2012, ACTA PAEDIATR, V101, P692, DOI 10.1111/j.1651-2227.2012.02674.x; van der Beek NAME, 2012, ORPHANET J RARE DIS, V7, DOI 10.1186/1750-1172-7-88; Vanier MT, 2010, ORPHANET J RARE DIS, V5, DOI 10.1186/1750-1172-5-16; Varkonyi J, 2003, AM J MED GENET A, V116A, P348, DOI 10.1002/ajmg.a.10028; Vitner EB, 2014, NAT MED, V20, P204, DOI 10.1038/nm.3449; Vitner EB, 2010, J BIOL CHEM, V285, P20423, DOI 10.1074/jbc.R110.134452; Walterfang M, 2012, ORPHANET J RARE DIS, V7, DOI 10.1186/1750-1172-7-76; Wenger DA, 1997, HUM MUTAT, V10, P268, DOI 10.1002/(SICI)1098-1004(1997)10:4<268::AID-HUMU2>3.0.CO;2-D; Wraith J E, 2002, Semin Neonatol, V7, P75, DOI 10.1053/siny.2001.0088; Wraith J. E., 2004, LYSOSOMAL DISORDERS, P50; Wu YP, 2004, P NATL ACAD SCI USA, V101, P8425, DOI 10.1073/pnas.0400625101; Yamashita T, 1999, P NATL ACAD SCI USA, V96, P9142, DOI 10.1073/pnas.96.16.9142; Yew NS, 2013, PEDIATR ENDOCR REV P, V11, P99; YOSHIDA K, 1994, NEUROLOGY, V44, P2376, DOI 10.1212/WNL.44.12.2376; Zeng BJ, 2008, MOL GENET METAB, V95, P59, DOI 10.1016/j.ymgme.2008.06.010; Zervas M, 2001, CURR BIOL, V11, P1283, DOI 10.1016/S0960-9822(01)00396-7; Ziegler RJ, 2002, HUM GENE THER, V13, P935, DOI 10.1089/10430340252939041	121	203	211	0	71	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 5	2014	510	7503					68	75		10.1038/nature13476	http://dx.doi.org/10.1038/nature13476			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI3NR	24899306				2022-12-28	WOS:000336768900033
J	Honigsbaum, M				Honigsbaum, Mark			The art of medicine In search of sick parrots: Karl Friedrich Meyer, disease detective	LANCET			English	Editorial Material									Queen Mary Univ London, London, England	University of London; Queen Mary University London	Honigsbaum, M (corresponding author), Queen Mary Univ London, London, England.	mark.honigsbaum@qmul.ac.uk		honigsbaum, mark/0000-0002-1891-8763	Wellcome Trust [103159] Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)			0	2	2	0	2	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	MAY 31	2014	383	9932					1880	1881		10.1016/S0140-6736(14)60905-3	http://dx.doi.org/10.1016/S0140-6736(14)60905-3			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	AI4PR	24892173	Green Published, Green Accepted, Bronze			2022-12-28	WOS:000336847800016
J	Pellissier, L; Leprieur, F; Parravicini, V; Cowman, PF; Kulbicki, M; Litsios, G; Olsen, SM; Wisz, MS; Bellwood, DR; Mouillot, D				Pellissier, Loic; Leprieur, Fabien; Parravicini, Valeriano; Cowman, Peter F.; Kulbicki, Michel; Litsios, Glenn; Olsen, Steffen M.; Wisz, Mary S.; Bellwood, David R.; Mouillot, David			Quaternary coral reef refugia preserved fish diversity	SCIENCE			English	Article							GLOBAL PATTERNS; ASSEMBLY RULES; BIODIVERSITY; HOTSPOTS; CRADLES; MUSEUMS; AREAS	The most prominent pattern in global marine biogeography is the biodiversity peak in the Indo-Australian Archipelago. Yet the processes that underpin this pattern are still actively debated. By reconstructing global marine paleoenvironments over the past 3 million years on the basis of sediment cores, we assessed the extent to which Quaternary climate fluctuations can explain global variation in current reef fish richness. Comparing global historical coral reef habitat availability with the present-day distribution of 6316 reef fish species, we find that distance from stable coral reef habitats during historical periods of habitat loss explains 62% of the variation in fish richness, outweighing present-day environmental factors. Our results highlight the importance of habitat persistence during periods of climate change for preserving marine biodiversity.	[Pellissier, Loic] Univ Fribourg, Dept Biol, CH-1700 Fribourg, Switzerland; [Pellissier, Loic; Wisz, Mary S.] Aarhus Univ, Dept Biosci, DK-8000 Aarhus C, Denmark; [Leprieur, Fabien; Mouillot, David] UM1, UM2, Inst Francais Rech Exploitat Mer, IRD,CNRS,Lab Ecol Syst Marins Cotiers UMR 5119,Cc, Pl E Bataillon, FR-34095 Montpellier 5, France; [Parravicini, Valeriano; Kulbicki, Michel] IRD, UR CoReUs 227, LABEX Lab Excellence Corail, Lab Arago, FR-66651 Banyuls Sur Mer, France; [Parravicini, Valeriano] FRB, CESAB Ctr Synth & Anal Biodiversite, FR-13857 Aix En Provence 3, France; [Cowman, Peter F.] Australian Natl Univ, Res Sch Biol, Ctr Macroevolut & Macroecol, Canberra, ACT 0200, Australia; [Litsios, Glenn] Univ Lausanne, Dept Ecol & Evolut, CH-1015 Lausanne, Switzerland; [Litsios, Glenn] Swiss Inst Bioinformat, CH-1015 Lausanne, Switzerland; [Olsen, Steffen M.] Danish Meteorol Inst, Ctr Ocean & Ice, DK-2100 Copenhagen, Denmark; [Wisz, Mary S.] DHI Water & Environm, Dept Ecol & Environm, DK-2970 Horsholm, Denmark; [Bellwood, David R.; Mouillot, David] James Cook Univ, Australian Res Council, Ctr Excellence Coral Reef Studies, Townsville, Qld 4811, Australia; [Bellwood, David R.; Mouillot, David] James Cook Univ, Sch Marine & Trop Biol, Townsville, Qld 4811, Australia	University of Fribourg; Aarhus University; Centre National de la Recherche Scientifique (CNRS); Ifremer; Institut de Recherche pour le Developpement (IRD); Universite de Montpellier; Institut de Recherche pour le Developpement (IRD); Australian National University; University of Lausanne; Swiss Institute of Bioinformatics; Danish Meteorological Institute DMI; James Cook University; James Cook University	Mouillot, D (corresponding author), UM1, UM2, Inst Francais Rech Exploitat Mer, IRD,CNRS,Lab Ecol Syst Marins Cotiers UMR 5119,Cc, Pl E Bataillon, FR-34095 Montpellier 5, France.	david.mouillot@univ-montp2.fr	Pellissier, Loïc/J-2563-2015; Cowman, Peter Francis/G-9998-2017; Parravicini, Valeriano/A-8539-2011; Pellissier, Loïc/AAG-1013-2020; Leprieur, Fabien/ABA-4433-2020	Pellissier, Loïc/0000-0002-2289-8259; Cowman, Peter Francis/0000-0001-5977-5327; Pellissier, Loïc/0000-0002-2289-8259; Parravicini, Valeriano/0000-0002-3408-1625; Kulbicki, Michel/0000-0003-1258-5061; Wisz, Mary S./0000-0002-5357-6367	Danish Council for Independent Research [12-126430]; Marie Curie [IOF-GA-2009-236316]	Danish Council for Independent Research(Det Frie Forskningsrad (DFF)); Marie Curie(European Commission)	This study was supported by grants from the Danish Council for Independent Research no. 12-126430 to L. P., Marie Curie IOF-GA-2009-236316 to D. M., FRB CESAB-General Approach to Species-Abundance Relationships in a context of global change, reef fish species as a model, and the Australian Research Council. We thank three anonymous reviewers for valuable comments on the manuscript. We thank J. P. Krajewski and S. Gingins for the fish images. Data are available in the supplementary materials.	Barber PH, 2005, MOL PHYLOGENET EVOL, V35, P235, DOI 10.1016/j.ympev.2004.10.004; Bellwood D. R., 2002, CORAL REEF FISHES DY, P5; Bellwood DR, 2009, J BIOGEOGR, V36, P569, DOI 10.1111/j.1365-2699.2008.02029.x; Bellwood DR, 2001, SCIENCE, V292, P1532, DOI 10.1126/science.1058635; Bonin MC, 2011, ECOLOGY, V92, P1503, DOI 10.1890/10-0627.1; Carnaval AC, 2009, SCIENCE, V323, P785, DOI 10.1126/science.1166955; Chown SL, 2000, TRENDS ECOL EVOL, V15, P311, DOI 10.1016/S0169-5347(00)01910-8; Connell JH, 1997, ECOL MONOGR, V67, P461, DOI 10.1890/0012-9615(1997)067[0461:AYSOCA]2.0.CO;2; Cowman PF, 2013, J BIOGEOGR, V40, P209, DOI 10.1111/jbi.12003; Fjeldsa J, 1997, BIODIVERS CONSERV, V6, P325, DOI 10.1023/A:1018356506390; Graham CH, 2006, P NATL ACAD SCI USA, V103, P632, DOI 10.1073/pnas.0505754103; Herbert TD, 2010, SCIENCE, V328, P1530, DOI 10.1126/science.1185435; Hughes TP, 2012, CURR BIOL, V22, P736, DOI 10.1016/j.cub.2012.02.068; Kiessling W, 2012, P NATL ACAD SCI USA, V109, P21378, DOI 10.1073/pnas.1214037110; Kleypas JA, 1999, AM ZOOL, V39, P146; Kohn A. J., 1995, P 5 INT COR REEF C, V4, P139; Luiz OJ, 2013, P NATL ACAD SCI USA, V110, P16498, DOI 10.1073/pnas.1304074110; McKenna DD, 2006, P NATL ACAD SCI USA, V103, P10947, DOI 10.1073/pnas.0602712103; McManus J. W., 1985, P 5 INT COR REEF C T, P133; Miller KG, 2005, SCIENCE, V310, P1293, DOI 10.1126/science.1116412; Mora C, 2003, NATURE, V421, P933, DOI 10.1038/nature01393; Mora C, 2013, PLOS BIOL, V11, DOI 10.1371/journal.pbio.1001682; O'Dea A, 2007, P NATL ACAD SCI USA, V104, P5501, DOI 10.1073/pnas.0610947104; Paddack MJ, 2009, CURR BIOL, V19, P590, DOI 10.1016/j.cub.2009.02.041; Pandolfi JM, 2011, SCIENCE, V333, P418, DOI 10.1126/science.1204794; Parravicini V, 2013, ECOGRAPHY, V36, P1254, DOI 10.1111/j.1600-0587.2013.00291.x; PAULAY G, 1990, PALEOBIOLOGY, V16, P415, DOI 10.1017/S0094837300010162; Potts D. C., 1985, PROC 5 INT CORAL REE, V4, P127; Price SA, 2011, ECOL LETT, V14, P462, DOI 10.1111/j.1461-0248.2011.01607.x; Renema W, 2008, SCIENCE, V321, P654, DOI 10.1126/science.1155674; Rosenzweig Michael L., 1995, DOI 10.1017/CBO9780511623387.002; Sandel B, 2011, SCIENCE, V334, P660, DOI 10.1126/science.1210173; Veron J.E.N., 2000, CORALS WORLD, V1-3	33	127	130	2	112	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 30	2014	344	6187					1016	1019		10.1126/science.1249853	http://dx.doi.org/10.1126/science.1249853			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AH9WM	24876495	Green Submitted			2022-12-28	WOS:000336495800042
J	Wilhelm, BG; Mandad, S; Truckenbrodt, S; Krohnert, K; Schafer, C; Rammner, B; Koo, SJ; Classen, GA; Krauss, M; Haucke, V; Urlaub, H; Rizzoli, SO				Wilhelm, Benjamin G.; Mandad, Sunit; Truckenbrodt, Sven; Kroehnert, Katharina; Schaefer, Christina; Rammner, Burkhard; Koo, Seong Joo; Classen, Gala A.; Krauss, Michael; Haucke, Volker; Urlaub, Henning; Rizzoli, Silvio O.			Composition of isolated synaptic boutons reveals the amounts of vesicle trafficking proteins	SCIENCE			English	Article							NEUROTRANSMITTER RELEASE; SYNTAXIN CLUSTERS; MEMBRANE; FUSION; POOL; QUANTIFICATION; EXOCYTOSIS; SYNAPSES; ENDOCYTOSIS; SUFFICIENT	Synaptic vesicle recycling has long served as a model for the general mechanisms of cellular trafficking. We used an integrative approach, combining quantitative immunoblotting and mass spectrometry to determine protein numbers; electron microscopy to measure organelle numbers, sizes, and positions; and super-resolution fluorescence microscopy to localize the proteins. Using these data, we generated a three-dimensional model of an "average" synapse, displaying 300,000 proteins in atomic detail. The copy numbers of proteins involved in the same step of synaptic vesicle recycling correlated closely. In contrast, copy numbers varied over more than three orders of magnitude between steps, from about 150 copies for the endosomal fusion proteins to more than 20,000 for the exocytotic ones.	[Wilhelm, Benjamin G.; Truckenbrodt, Sven; Kroehnert, Katharina; Schaefer, Christina; Rammner, Burkhard; Rizzoli, Silvio O.] Univ Gottingen, European Neurosci Inst, Cluster Excellence Nanoscale Microscopy & Mol Phy, Med Ctr,Dept Neuro & Sensory Physiol, D-37073 Gottingen, Germany; [Wilhelm, Benjamin G.] Int Max Planck Res Sch Neurosci, D-37077 Gottingen, Germany; [Mandad, Sunit; Urlaub, Henning] Max Planck Inst Biophys Chem, Bioanalyt Mass Spectrometry Grp, D-37077 Gottingen, Germany; [Urlaub, Henning] Univ Med Ctr Gottingen, Dept Clin Chem, D-37075 Gottingen, Germany; [Truckenbrodt, Sven] Int Max Planck Res Sch Mol Biol, D-37077 Gottingen, Germany; [Koo, Seong Joo; Classen, Gala A.; Krauss, Michael; Haucke, Volker] Leibniz Inst Mol Pharmacol, Dept Mol Pharmacol & Cell Biol, D-13125 Berlin, Germany	University of Gottingen; Max Planck Society; Max Planck Society; University of Gottingen; Max Planck Society; Leibniz Forschungsinstitut furr Molekulare Pharmakologie (FMP)	Rizzoli, SO (corresponding author), Univ Gottingen, European Neurosci Inst, Cluster Excellence Nanoscale Microscopy & Mol Phy, Med Ctr,Dept Neuro & Sensory Physiol, D-37073 Gottingen, Germany.	srizzol@gwdg.de	889, CRC/L-1607-2018; Rizzoli, Silvio/ABG-2227-2020	889, CRC/0000-0002-6678-3138; Haucke, Volker/0000-0003-3119-6993; Rizzoli, Silvio/0000-0002-1667-7839; Truckenbrodt, Sven/0000-0002-7741-3837; Krauss, Michael/0000-0003-1010-9723	Boehringer Ingelheim Fonds PhD Fellowship; Excellence Stipend of the Gottingen Graduate School for Neurosciences, Biophysics, and Molecular Biosciences (GGNB); European Research Council (FP7 NANOMAP and ERC-CoG NeuroMolAnatomy); Deutsche Forschungsgemeinschaft (DFG) Cluster of Excellence Nanoscale Microscopy and Molecular Physiology of the Brain; DFG [RI 1967 2/1, RI 1967 3/1, SFB 889/A5, Exc-257-Neurocure, SFB 958/A01, SFB 889, SFB 958/A11]	Boehringer Ingelheim Fonds PhD Fellowship(Boehringer Ingelheim); Excellence Stipend of the Gottingen Graduate School for Neurosciences, Biophysics, and Molecular Biosciences (GGNB); European Research Council (FP7 NANOMAP and ERC-CoG NeuroMolAnatomy); Deutsche Forschungsgemeinschaft (DFG) Cluster of Excellence Nanoscale Microscopy and Molecular Physiology of the Brain(German Research Foundation (DFG)); DFG(German Research Foundation (DFG))	We thank the following collaborators for providing purified proteins and antibodies: R. Jahn, C. Griesinger, B. Shwaller, and A. Roux. We thank H. Martens for technical help and support, B. Rizzoli for helpful comments on the manuscript, and T. Sargeant for providing the carve source code for creation of the voltage-dependent anion channel (VDAC)-based mitochondrial membrane cut-outs. B. G. W. was supported by a Boehringer Ingelheim Fonds PhD Fellowship. S. T. was supported by an Excellence Stipend of the Gottingen Graduate School for Neurosciences, Biophysics, and Molecular Biosciences (GGNB). The work was supported by grants to S.O.R. from the European Research Council (FP7 NANOMAP and ERC-2013-CoG NeuroMolAnatomy) and from the Deutsche Forschungsgemeinschaft (DFG) Cluster of Excellence Nanoscale Microscopy and Molecular Physiology of the Brain, as well as from DFG grants RI 1967 2/1, RI 1967 3/1, and SFB 889/A5. We acknowledge support by the DFG to V. H. (Exc-257-Neurocure and SFB 958/A01), H. U. (SFB 889), and M. K. (SFB 958/A11). Author contributions: B. G. W. prepared the synaptosomes and performed all immunoblotting experiments. K. K. performed the electron microscopy imaging and all neuromuscular junction imaging. C. S. performed the hippocampal culture imaging. S. T. performed the synaptosome imaging. B. R. generated the synapse model. S.J.K., G. A. C., and M. K. participated in the biochemistry experiments. S. M. and H. U. designed and performed all mass spectrometry experiments. S.O.R., B. G. W., and V. H. designed the experiments. All authors analyzed the data and contributed to writing the manuscript.	Bar-On D, 2012, J BIOL CHEM, V287, P27158, DOI 10.1074/jbc.M112.353250; Bonanomi D, 2006, PROG NEUROBIOL, V80, P177, DOI 10.1016/j.pneurobio.2006.09.002; Cheng YF, 2007, J MOL BIOL, V365, P892, DOI 10.1016/j.jmb.2006.10.036; Cohen LD, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063191; Cox J, 2011, J PROTEOME RES, V10, P1794, DOI 10.1021/pr101065j; Cox J, 2008, NAT BIOTECHNOL, V26, P1367, DOI 10.1038/nbt.1511; Darna M, 2009, J BIOL CHEM, V284, P4300, DOI 10.1074/jbc.M805480200; Denker A, 2011, P NATL ACAD SCI USA, V108, P17183, DOI 10.1073/pnas.1112690108; Denker A, 2011, P NATL ACAD SCI USA, V108, P17177, DOI 10.1073/pnas.1112688108; Haucke V, 2011, NAT REV NEUROSCI, V12, P127, DOI 10.1038/nrn2948; Hoopmann P, 2010, P NATL ACAD SCI USA, V107, P19055, DOI 10.1073/pnas.1007037107; Jahn R, 2012, NATURE, V490, P201, DOI 10.1038/nature11320; Kitagawa N, 2008, J BIOL CHEM, V283, P3329, DOI 10.1074/jbc.M707924200; Marra V, 2012, NEURON, V76, P579, DOI 10.1016/j.neuron.2012.08.042; McMahon HT, 2011, NAT REV MOL CELL BIO, V12, P517, DOI 10.1038/nrm3151; Mohrmann R, 2010, SCIENCE, V330, P502, DOI 10.1126/science.1193134; Murthy VN, 2001, NEURON, V32, P673, DOI 10.1016/S0896-6273(01)00500-1; Mutch SA, 2011, J NEUROSCI, V31, P1461, DOI 10.1523/JNEUROSCI.3805-10.2011; NICHOLLS DG, 1986, NATURE, V321, P772, DOI 10.1038/321772a0; Opazo F, 2010, TRAFFIC, V11, P800, DOI 10.1111/j.1600-0854.2010.01058.x; Rizzoli SO, 2006, TRAFFIC, V7, P1163, DOI 10.1111/j.1600-0854.2006.00466.x; Rizzoli SO, 2014, EMBO J, V33, P788, DOI 10.1002/embj.201386357; Rose T, 2013, NEURON, V77, P1109, DOI 10.1016/j.neuron.2013.01.021; Schwanhausser B, 2011, NATURE, V473, P337, DOI 10.1038/nature10098; Shnyrova AV, 2013, SCIENCE, V339, P1433, DOI 10.1126/science.1233920; Shupliakov O, 2009, NEUROSCIENCE, V158, P204, DOI 10.1016/j.neuroscience.2008.03.035; Sieber JJ, 2006, BIOPHYS J, V90, P2843, DOI 10.1529/biophysj.105.079574; Sieber JJ, 2007, SCIENCE, V317, P1072, DOI 10.1126/science.1141727; Sinha R, 2011, P NATL ACAD SCI USA, V108, P14318, DOI 10.1073/pnas.1101818108; Sudhof TC, 2004, ANNU REV NEUROSCI, V27, P509, DOI 10.1146/annurev.neuro.26.041002.131412; Takamori S, 2006, CELL, V127, P831, DOI 10.1016/j.cell.2006.10.030; Uytterhoeven V, 2011, CELL, V145, P117, DOI 10.1016/j.cell.2011.02.039; van den Bogaart G, 2010, NAT STRUCT MOL BIOL, V17, P358, DOI 10.1038/nsmb.1748; Willig KI, 2006, NATURE, V440, P935, DOI 10.1038/nature04592	34	432	438	5	128	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 30	2014	344	6187					1023	1028		10.1126/science.1252884	http://dx.doi.org/10.1126/science.1252884			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AH9WM	24876496				2022-12-28	WOS:000336495800044
J	Woolhouse, M; Farrar, J				Woolhouse, Mark; Farrar, Jeremy			An intergovernmental panel on antimicrobial resistance	NATURE			English	Editorial Material							ANTIBIOTIC-RESISTANCE		[Woolhouse, Mark] Univ Edinburgh, Ctr Immun Infect & Evolut, Edinburgh EH8 9YL, Midlothian, Scotland; [Farrar, Jeremy] Wellcome Trust Res Labs, London, England	University of Edinburgh	Woolhouse, M (corresponding author), Univ Edinburgh, Ctr Immun Infect & Evolut, Edinburgh EH8 9YL, Midlothian, Scotland.	mark.woolhouse@ed.ac.uk; j.farrar@wellcome.ac.uk	Farrar, Jeremy J./HGA-7610-2022	Farrar, Jeremy/0000-0002-2700-623X				Cooper MA, 2011, NATURE, V472, P32, DOI 10.1038/472032a; D'Costa VM, 2011, NATURE, V477, P457, DOI 10.1038/nature10388; Harris SR, 2010, SCIENCE, V327, P469, DOI 10.1126/science.1182395; Laxminarayan R, 2013, LANCET INFECT DIS, V13, P1057, DOI 10.1016/S1473-3099(13)70318-9; Vernet G, 2014, EMERG INFECT DIS, V20, P434, DOI [10.3201/eid2003.121157, 10.3201/EID2003.121157]; Wertheim HFL, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001429; Whitman WB, 1998, P NATL ACAD SCI USA, V95, P6578, DOI 10.1073/pnas.95.12.6578; World Health Organization, 2016, ANTIMICROBIAL RESIST	8	106	110	0	47	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 29	2014	509	7502					555	557		10.1038/509555a	http://dx.doi.org/10.1038/509555a			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AH9JC	24877180	Bronze			2022-12-28	WOS:000336457100023
J	Neuman, MD; Goldstein, JN; Cirullo, MA; Schwartz, JS				Neuman, Mark D.; Goldstein, Jennifer N.; Cirullo, Michael A.; Schwartz, J. Sanford			Durability of Class I American College of Cardiology/American Heart Association Clinical Practice Guideline Recommendations	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							PERIOPERATIVE CARDIOVASCULAR EVALUATION; ELEVATION MYOCARDIAL-INFARCTION; ACC/AHA 2007 GUIDELINES; TASK-FORCE; WRITING COMMITTEE; OF-CARDIOLOGY; ATRIAL-FIBRILLATION; THORACIC-SURGERY; EUROPEAN-SOCIETY; MANAGEMENT	IMPORTANCE Little is known regarding the durability of clinical practice guideline recommendations over time. OBJECTIVE To characterize variations in the durability of class I ("procedure/treatment should be performed/administered") American College of Cardiology/American Heart Association (ACC/AHA) guideline recommendations. DESIGN, SETTING, AND PARTICIPANTS Textual analysis by 4 independent reviewers of 11 guidelines published between 1998 and 2007 and revised between 2006 and 2013. MAIN OUTCOMES AND MEASURES We abstracted all class I recommendations from the first of the 2 most recent versions of each guideline and identified corresponding recommendations in the subsequent version. We classified recommendations replaced by less determinate or contrary recommendations as having been downgraded or reversed; we classified recommendations for which no corresponding item could be identified as having been omitted. We tested for differences in the durability of recommendations according to guideline topic and underlying level of evidence using bivariable hypothesis tests and conditional logistic regression. RESULTS Of 619 index recommendations, 495 (80.0%; 95% CI, 76.6%-83.1%) were retained in the subsequent guideline version, 57 (9.2%; 95% CI, 7.0%-11.8%) were downgraded or reversed, and 67 (10.8%; 95% CI, 8.4%-13.3%) were omitted. The percentage of recommendations retained varied across guidelines from 15.4%(95% CI, 1.9%-45.4%) to 94.1%(95% CI, 80.3%-99.3%; P <.001). Among recommendations with available information on level of evidence, 90.5%(95% CI, 83.2%-95.3%) of recommendations supported by multiple randomized studies were retained, vs 81.0% (95% CI, 74.8%-86.3%) of recommendations supported by 1 randomized trial or observational data and 73.7%(95% CI, 65.8%-80.5%) of recommendations supported by opinion (P =.001). After accounting for guideline-level factors, the probability of being downgraded, reversed, or omitted was greater for recommendations based on opinion (odds ratio, 3.14; 95% CI, 1.69-5.85; P <.001) or on 1 trial or observational data (odds ratio, 3.49; 95% CI, 1.45-8.41; P =.005) vs recommendations based on multiple trials. CONCLUSIONS AND RELEVANCE The durability of class I cardiology guideline recommendations for procedures and treatments promulgated by the ACC/AHA varied across individual guidelines and levels of evidence. Downgrades, reversals, and omissions were most common among recommendations not supported by multiple randomized studies.	[Neuman, Mark D.; Cirullo, Michael A.] Univ Penn, Dept Anesthesiol & Crit Care, Perelman Sch Med, Philadelphia, PA 19104 USA; [Neuman, Mark D.; Schwartz, J. Sanford] Univ Penn, Leonard Davis Inst Hlth Econ, Philadelphia, PA 19104 USA; [Goldstein, Jennifer N.; Schwartz, J. Sanford] Univ Penn, Div Gen Internal Med, Perelman Sch Med, Dept Med, Philadelphia, PA 19104 USA; [Schwartz, J. Sanford] Univ Penn, Dept Hlth Care Management, Wharton Sch Business, Philadelphia, PA 19104 USA	University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania	Neuman, MD (corresponding author), Univ Penn, Dept Anesthesiol & Crit Care, Perelman Sch Med, 423 Guardian Dr,1119A Blockley Hall, Philadelphia, PA 19104 USA.	neumanm@mail.med.upenn.edu			National Institute on Aging [K08AG043548-02]; NATIONAL INSTITUTE ON AGING [K08AG043548] Funding Source: NIH RePORTER	National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	Dr Neuman received funding from the National Institute on Aging (K08AG043548-02).	American College of Cardiology, 2006, J Am Coll Cardiol, V48, pe1, DOI 10.1016/j.jacc.2006.05.021; Anderson JL, 2007, J AM COLL CARDIOL, V50, P652, DOI 10.1016/j.jacc.2007.02.028; [Anonymous], US PREV SERV TASK FO; Antman Elliott M., 2004, J Am Coll Cardiol, V44, pE1, DOI 10.1016/j.jacc.2004.07.014; Bonow R O, 1998, J Heart Valve Dis, V7, P672; Braunwald E, ACC AHA 2002 GUID UP; Cabana MD, 1999, JAMA-J AM MED ASSOC, V282, P1458, DOI 10.1001/jama.282.15.1458; Eagle KA, ACC AHA GUIDELINE UP; Eagle Kim A, 2004, Circulation, V110, pe340; Epstein Andrew E, 2008, J Am Coll Cardiol, V51, pe1, DOI 10.1016/j.hrthm.2008.04.014; Fihn SD, 2012, CIRCULATION, V126, P3097, DOI 10.1161/CIR.0b013e3182776f83; Fleisher LA, 2007, J AM COLL CARDIOL, V50, P1707, DOI 10.1016/j.jacc.2007.09.001; Fleisher LA, 2006, CIRCULATION, V113, P2662, DOI 10.1161/CIRCULATIONAHA.106.176009; Frye R L, 1984, Circulation, V70, p331A; Fuster V, 2001, EUR HEART J, V22, P1852, DOI 10.1053/euhj.2001.2983; Fuster V, 2006, CIRCULATION, V114, pE257, DOI 10.1161/CIRCULATIONAHA.106.177292; Garber AM, 2005, HEALTH AFFAIR, V24, P174, DOI 10.1377/hlthaff.24.1.174; Gibbons RJ, ACC AHA 2002 GUID UP; Gregoratos G, ACC AHA NASPE 2002 G; Guyatt GH, 2008, BRIT MED J, V336, P924, DOI 10.1136/bmj.39489.470347.AD; Hillis LD, 2011, J AM COLL CARDIOL, V58, pE123, DOI 10.1016/j.jacc.2011.08.009; Hunt SA, 2005, CIRCULATION, V112, pE154, DOI 10.1161/CIRCULATIONAHA.105.167586; Institute of Medicine, 2011, CLIN PRACTICE GUIDEL; Lenzer J, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f3830; Levine, 2012, CIRCULATION, V125, pE412, DOI 10.1161/CIR.0b013e31824da922; Levine GN, 2011, CIRCULATION, V124, pE574, DOI 10.1161/CIR.0b013e31823ba622; Mosca, 2011, CIRCULATION, V123, pE624, DOI 10.1161/CIR.0b013e318222b330; Mosca L, 2007, J AM COLL CARDIOL, V49, P1230, DOI 10.1016/j.jacc.2007.02.020; O'Gara PT, 2013, J AM COLL CARDIOL, V61, pE78, DOI [10.1016/j.jacc.2012.11.019, 10.1161/CIR.0b013e3182742cf6]; Ortiz E, CURRENT VALIDITY AHR; Prasad V, 2013, MAYO CLIN PROC, V88, P790, DOI 10.1016/j.mayocp.2013.05.012; Prasad V, 2012, JAMA-J AM MED ASSOC, V307, P37, DOI 10.1001/jama.2011.1960; Prasad V, 2011, ARCH INTERN MED, V171, P1675, DOI 10.1001/archinternmed.2011.295; Pronovost PJ, 2013, JAMA-J AM MED ASSOC, V310, P2501, DOI 10.1001/jama.2013.281334; Ryan TJ, 1996, J AM COLL CARDIOL, V28, P1328; Shekelle PG, 2001, JAMA-J AM MED ASSOC, V286, P1461, DOI 10.1001/jama.286.12.1461; Smith SC, 2006, CIRCULATION, V113, pE166, DOI 10.1161/CIRCULATIONAHA.106.173220; Smith SC, 2006, J AM COLL CARDIOL, V47, P2130, DOI 10.1016/j.jacc.2006.04.026; Smith SC, 2011, CIRCULATION, V124, P2458, DOI 10.1161/CIR.0b013e318235eb4d; Spertus JA, 2005, CIRCULATION, V111, P1703, DOI 10.1161/01.CIR.0000157096.95223.D7; Tricoci P, 2009, JAMA-J AM MED ASSOC, V301, P831, DOI 10.1001/jama.2009.205; Weisz G, 2007, MILBANK Q, V85, P691, DOI 10.1111/j.1468-0009.2007.00505.x; Yancy CW, 2013, J AM COLL CARDIOL, V62, pE147, DOI 10.1016/j.jacc.2013.05.019	43	61	62	0	2	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAY 28	2014	311	20					2092	2100		10.1001/jama.2014.4949	http://dx.doi.org/10.1001/jama.2014.4949			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AH8MQ	24867012	Bronze, Green Accepted			2022-12-28	WOS:000336392400025
J	Couzin-Frankel, J				Couzin-Frankel, Jennifer			A lonely crusade	SCIENCE			English	Editorial Material																			0	0	0	0	7	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 23	2014	344	6186					793	797		10.1126/science.344.6186.793	http://dx.doi.org/10.1126/science.344.6186.793			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AH6IL	24855236				2022-12-28	WOS:000336233800008
J	Sato, Y; Maekawa, S; Ishii, R; Sanada, M; Morikawa, T; Shiraishi, Y; Yoshida, K; Nagata, Y; Sato-Otsubo, A; Yoshizato, T; Suzuki, H; Shiozawa, Y; Kataoka, K; Kon, A; Aoki, K; Chiba, K; Tanaka, H; Kume, H; Miyano, S; Fukayama, M; Nureki, O; Homma, Y; Ogawa, S				Sato, Yusuke; Maekawa, Shigekatsu; Ishii, Ryohei; Sanada, Masashi; Morikawa, Teppei; Shiraishi, Yuichi; Yoshida, Kenichi; Nagata, Yasunobu; Sato-Otsubo, Aiko; Yoshizato, Tetsuichi; Suzuki, Hiromichi; Shiozawa, Yusuke; Kataoka, Keisuke; Kon, Ayana; Aoki, Kosuke; Chiba, Kenichi; Tanaka, Hiroko; Kume, Haruki; Miyano, Satoru; Fukayama, Masashi; Nureki, Osamu; Homma, Yukio; Ogawa, Seishi			Recurrent somatic mutations underlie corticotropin-independent Cushing's syndrome	SCIENCE			English	Article							PROTEIN-KINASE; ADRENAL-HYPERPLASIA; CATALYTIC SUBUNIT; RESPONSE-ELEMENT; PHOSPHODIESTERASE; BINDING; GENE; PDE11A	Cushing's syndrome is caused by excess cortisol production from the adrenocortical gland. In corticotropin-independent Cushing's syndrome, the excess cortisol production is primarily attributed to an adrenocortical adenoma, in which the underlying molecular pathogenesis has been poorly understood. We report a hotspot mutation (L206R) in PRKACA, which encodes the catalytic subunit of cyclic adenosine monophosphate (cAMP)-dependent protein kinase (PKA), in more than 50% of cases with adrenocortical adenomas associated with corticotropin-independent Cushing's syndrome. The L206R PRKACA mutant abolished its binding to the regulatory subunit of PKA (PRKAR1A) that inhibits catalytic activity of PRKACA, leading to constitutive, cAMP-independent PKA activation. These results highlight the major role of cAMP-independent activation of cAMP/PKA signaling by somatic mutations in corticotropin-independent Cushing's syndrome, providing insights into the diagnosis and therapeutics of this syndrome.	[Sato, Yusuke; Sanada, Masashi; Yoshida, Kenichi; Nagata, Yasunobu; Sato-Otsubo, Aiko; Yoshizato, Tetsuichi; Suzuki, Hiromichi; Shiozawa, Yusuke; Kataoka, Keisuke; Kon, Ayana; Aoki, Kosuke; Ogawa, Seishi] Kyoto Univ, Grad Sch Med, Dept Pathol & Tumor Biol, Kyoto, Japan; [Sato, Yusuke; Maekawa, Shigekatsu; Kume, Haruki; Homma, Yukio] Univ Tokyo, Grad Sch Med, Dept Urol, Tokyo, Japan; [Ishii, Ryohei; Nureki, Osamu] Univ Tokyo, Grad Sch Sci, Dept Biophys & Biochem, Tokyo 113, Japan; [Morikawa, Teppei; Fukayama, Masashi] Univ Tokyo, Grad Sch Med, Dept Pathol, Tokyo, Japan; [Shiraishi, Yuichi; Chiba, Kenichi; Miyano, Satoru] Univ Tokyo, Inst Med Sci, Ctr Human Genome, Lab DNA Informat Anal, Tokyo, Japan; [Tanaka, Hiroko; Miyano, Satoru] Univ Tokyo, Inst Med Sci, Ctr Human Genome, Lab Sequence Anal, Tokyo, Japan	Kyoto University; University of Tokyo; University of Tokyo; University of Tokyo; University of Tokyo; University of Tokyo	Homma, Y (corresponding author), Univ Tokyo, Grad Sch Med, Dept Urol, Tokyo, Japan.	homma-uro@umin.ac.jp; sogawa-tky@umin.ac.jp	Ogawa, Seishi/AAE-7088-2019; NUREKI, OSAMU/G-4960-2014; Suzuki, Hiromichi/AAO-4664-2021; Yoshizato, Tetsuichi/AAD-7308-2019; Kataoka, Keisuke/AAS-2546-2020	Suzuki, Hiromichi/0000-0002-8858-0294; Yoshizato, Tetsuichi/0000-0003-4283-2983; Kataoka, Keisuke/0000-0002-8263-9902; Ishii, Ryohei/0000-0003-2486-1393; Yoshida, Kenichi/0000-0003-4612-2778; Miyano, Satoru/0000-0002-1753-6616	Japan Society for the Promotion of Science (JSPS) [22134006]; Funding Program for World-Leading Innovative Research and Development on Science and Technology (FIRST Program)	Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Funding Program for World-Leading Innovative Research and Development on Science and Technology (FIRST Program)	We thank Y. Mori, M. Nakamura, N. Mizota, S. Ichimura, and M. Yamakawa for their technical assistance. The retroviral vector, pGCDNsamIRES-EGFP, was kindly provided by M. Onodera (National Research Institute for Child Health and Development). This work was supported by the Japan Society for the Promotion of Science (JSPS) through Grants-in-Aid for Scientific Research (KAKENHI) grant number 22134006 and the Funding Program for World-Leading Innovative Research and Development on Science and Technology (FIRST Program). Data for exome sequencing, as well as SNP array analysis, are found in the European Genome-phenome Archive (EGA) under accession EGAS00001000661. Author contributions: Y.Sa., S.Ma., K.Y., Y.N., T.Y., H.S., and A.K. performed library preparation and DNA sequencing. Y.Shira., Y.Shio., K.C., H.T., and S.Mi. were committed to bioinformatics analyses of resequencing data. Y.Sa. and A.S.-O. performed SNP array analysis. Y.Sa., S.Ma., M.S., RI., K.K., and O.N. performed the functional analyses of PRKACA mutant. T. M., H. K., M. F., and Y.H. provided specimens and were also involved in planning the project. Y.Sa., S.Ma., M. S., R. I., and S.O. generated figures and tables and wrote the manuscript. S.O. led the entire project. All authors participated in the discussion and interpretation of data and results. Y.Sa., S.Ma., M.S., Y.H., and S.O. are inventors on a patent applied for by Kyoto University that covers the inspection method for Cushing's syndrome and biomarker and theraputic agent thereof (2014-37189).	Assie G, 2013, NEW ENGL J MED, V369, P2105, DOI 10.1056/NEJMoa1304603; Beuschlein F, 2014, NEW ENGL J MED, V370, P1019, DOI 10.1056/NEJMoa1310359; HAROOTUNIAN AT, 1993, MOL BIOL CELL, V4, P993, DOI 10.1091/mbc.4.10.993; Hatipoglu BA, 2012, J SURG ONCOL, V106, P565, DOI 10.1002/jso.23197; Horvath A, 2008, NEW ENGL J MED, V358, P750, DOI 10.1056/NEJMc0706182; Horvath A, 2006, NAT GENET, V38, P794, DOI 10.1038/ng1809; Horvath A, 2006, CANCER RES, V66, P11571, DOI 10.1158/0008-5472.CAN-06-2914; Kim C, 2005, SCIENCE, V307, P690, DOI 10.1126/science.1104607; Kim C, 2007, CELL, V130, P1032, DOI 10.1016/j.cell.2007.07.018; Kirschner LS, 2000, HUM MOL GENET, V9, P3037, DOI 10.1093/hmg/9.20.3037; Kirschner LS, 2000, NAT GENET, V26, P89, DOI 10.1038/79238; Lefrancois-Martinez AM, 2011, J BIOL CHEM, V286, P32976, DOI 10.1074/jbc.M111.218016; MONTMINY MR, 1987, NATURE, V328, P175, DOI 10.1038/328175a0; Moore MJ, 2003, J BIOL CHEM, V278, P10613, DOI 10.1074/jbc.M210807200; MOUNTJOY KG, 1992, SCIENCE, V257, P1248, DOI 10.1126/science.1325670; Newell-Price J, 2006, LANCET, V367, P1605, DOI 10.1016/S0140-6736(06)68699-6; Nieman LK, 2008, J CLIN ENDOCR METAB, V93, P1526, DOI 10.1210/jc.2008-0125; ORTH DN, 1995, NEW ENGL J MED, V332, P791, DOI 10.1056/NEJM199503233321207; Stratakis Constantine A., 2008, V13, P117, DOI 10.1159/000134829; WEINSTEIN LS, 1991, NEW ENGL J MED, V325, P1688, DOI 10.1056/NEJM199112123252403	20	136	138	0	20	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 23	2014	344	6186					917	920		10.1126/science.1252328	http://dx.doi.org/10.1126/science.1252328			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AH6IL	24855271				2022-12-28	WOS:000336233800052
J	Futier, E				Futier, Emmanuel			Positive end-expiratory pressure in surgery: good or bad?	LANCET			English	Editorial Material							ACUTE LUNG INJURY; MECHANICAL VENTILATION; GENERAL-ANESTHESIA; ABDOMINAL-SURGERY; RECRUITMENT; OXYGENATION; ATELECTASIS; MORTALITY; STRATEGY; TRIAL		CHU Clermont Ferrand, Hop Estaing, Dept Anesthesie & Reanimatol, F-63003 Clermont Ferrand, France	CHU Clermont Ferrand	Futier, E (corresponding author), CHU Clermont Ferrand, Hop Estaing, Dept Anesthesie & Reanimatol, F-63003 Clermont Ferrand, France.	efutier@chu-clermontferrand.fr						BENDIXEN HH, 1963, NEW ENGL J MED, V269, P991, DOI 10.1056/NEJM196311072691901; Esteban A, 2013, AM J RESP CRIT CARE, V188, P220, DOI 10.1164/rccm.201212-2169OC; Fanelli V, 2009, CRIT CARE MED, V37, P1046, DOI 10.1097/CCM.0b013e3181968e7e; Futier E, 2013, NEW ENGL J MED, V369, P428, DOI 10.1056/NEJMoa1301082; Futier E, 2010, EUR J ANAESTH, V27, P508, DOI 10.1097/EJA.0b013e3283398806; Khuri SF, 2005, ANN SURG, V242, P326, DOI 10.1097/01.sla.0000179621.33268.83; Levin MA, 2014, BR J ANAESTH; Lim SC, 2004, CRIT CARE MED, V32, P2378, DOI 10.1097/01.CCM.0000147444.58070.72; Lumb AB, 2010, BRIT J ANAESTH, V104, P643, DOI 10.1093/bja/aeq080; Pearse RM, 2012, LANCET, V380, P1059, DOI 10.1016/S0140-6736(12)61148-9; Pinsky MR, 1997, INTENS CARE MED, V23, P493, DOI 10.1007/s001340050364; Rubenfeld GD, 2010, JAMA-J AM MED ASSOC, V303, P883, DOI 10.1001/jama.2010.226; Severgnini P, 2013, ANESTHESIOLOGY, V118, P1307, DOI 10.1097/ALN.0b013e31829102de; The PROVE Network Investigators for the Clinical Trial Network of the European Society of Anaesthesiology, 2014, LANCET; Tusman G, 1999, BRIT J ANAESTH, V82, P8, DOI 10.1093/bja/82.1.8	15	9	10	0	5	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	AUG 9	2014	384	9942					472	474		10.1016/S0140-6736(14)60894-1	http://dx.doi.org/10.1016/S0140-6736(14)60894-1			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	AM9JR	24894576				2022-12-28	WOS:000340198300005
J	Bhatia, V; Barroso, SI; Garcia-Rubio, ML; Tumini, E; Herrera-Moyano, E; Aguilera, A				Bhatia, Vaibhav; Barroso, Sonia I.; Garcia-Rubio, Maria L.; Tumini, Emanuela; Herrera-Moyano, Emilia; Aguilera, Andres			BRCA2 prevents R-loop accumulation and associates with TREX-2 mRNA export factor PCID2	NATURE			English	Article							REPLICATION FORK PROGRESSION; FANCONI-ANEMIA; TRANSCRIPTION ELONGATION; GENOMIC INSTABILITY; IN-VITRO; COMPLEX; IMPAIRMENT; STABILITY; GENES; RECOMBINATION	Genome instability is central to ageing, cancer and other diseases. It is not only proteins involved in DNA replication or the DNA damage response (DDR) that are important for maintaining genome integrity: from yeast to higher eukaryotes, mutations in genes involved in pre-mRNA splicing and in the biogenesis and export of messenger ribonudeoprotein (mRNP) also induce DNA damage and genome instability. This instability is frequently mediated by R-loops formed by DNA-RNA hybrids and a displaced single-stranded DNA(1). Here we show that the human TREX-2 complex, which is involved in mRNP biogenesis and export, prevents genome instability as determined by the accumulation of gamma-H2AX (Ser-139 phosphorylated histone H2AX) and 53BP1 foci and single-cell electrophoresis in cells depleted of the TREX-2 subunits PCID2, GANP and DSSI. We show that the BRCA2 repair factor, which binds to DSS1, also associates with PCID2 in the cell. The use of an enhanced green fluorescent protein-tagged hybrid-binding domain of RNase HI and the S9.6 antibody did not detect R-loops in TREX-2-depleted cells, but did detect the accumulation of R-loops in BRCA2-depleted cells. The results indicate that R-loops are frequently formed in cells and that BRCA2 is required for their processing. This link between BRCA2 and RNA-mediated genome instability indicates that R-loops may be a chief source of replication stress and cancer-associated instability.	[Bhatia, Vaibhav; Barroso, Sonia I.; Garcia-Rubio, Maria L.; Tumini, Emanuela; Herrera-Moyano, Emilia; Aguilera, Andres] Univ Seville, Ctr Andaluz Biol Mol & Med Regenerat CABIMER, Seville 41092, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); Universidad Pablo de Olavide; University of Sevilla; CSIC - Centro Andaluz de Biologia Molecular y Medicina Regenerativa (CABIMER)	Aguilera, A (corresponding author), Univ Seville, Ctr Andaluz Biol Mol & Med Regenerat CABIMER, Ave Amer Vespucio S-N, Seville 41092, Spain.	aguilo@us.es	Aguilera, Andres/L-1825-2014; Herrera-Moyano, Emilia/AAV-4989-2020; Tumini, Emanuela/C-2163-2017; Barroso, Sonia/F-2288-2016; Herrera-Moyano, Emilia/F-3314-2016; Garcia-Rubio, Maria/C-2061-2017	Aguilera, Andres/0000-0003-4782-1714; Herrera-Moyano, Emilia/0000-0003-3948-3874; Tumini, Emanuela/0000-0001-9412-9355; Barroso, Sonia/0000-0002-0062-2016; Garcia-Rubio, Maria/0000-0003-0981-0555; bhatia, vaibhav/0000-0003-4553-7824	Spanish Ministry of Economy and Competitiveness [C5D2007-00015, BFU2010-16372]; Junta de Andalucia [CVI4567]; European Union (FEDER)	Spanish Ministry of Economy and Competitiveness(Spanish Government); Junta de Andalucia(Junta de Andalucia); European Union (FEDER)(European Commission)	We thank J.C. Reyes and A. G. Rondon for comments on the manuscript,and D. Haun for style supervision. Research was funded by grants from the Spanish Ministry of Economy and Competitiveness (Consolider C5D2007-00015 and BFU2010-16372), the Junta de Andalucia (CVI4567) and the European Union (FEDER).	Aguilera A, 2012, MOL CELL, V46, P115, DOI 10.1016/j.molcel.2012.04.009; Bayani J., 2005, CURR PROTOC CELL BIO, V25; Bermejo R, 2011, CELL, V146, P233, DOI 10.1016/j.cell.2011.06.033; Cabal GG, 2006, NATURE, V441, P770, DOI 10.1038/nature04752; Castellano-Pozo M, 2012, EMBO REP, V13, P923, DOI 10.1038/embor.2012.119; Dominguez-Sanchez MS, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002386; El Hage A, 2010, GENE DEV, V24, P1546, DOI 10.1101/gad.573310; Ellisdon AM, 2012, NAT STRUCT MOL BIOL, V19, P328, DOI 10.1038/nsmb.2235; Gallardo M, 2003, J BIOL CHEM, V278, P24225, DOI 10.1074/jbc.M302900200; Gan WJ, 2011, GENE DEV, V25, P2041, DOI 10.1101/gad.17010011; Ginno PA, 2012, MOL CELL, V45, P814, DOI 10.1016/j.molcel.2012.01.017; Gomez-Gonzalez B, 2011, EMBO J, V30, P3106, DOI 10.1038/emboj.2011.206; Gravells P, 2013, ONCOGENE, V32, P5338, DOI 10.1038/onc.2012.627; Helmrich A, 2011, MOL CELL, V44, P966, DOI 10.1016/j.molcel.2011.10.013; Huertas P, 2003, MOL CELL, V12, P711, DOI 10.1016/j.molcel.2003.08.010; Jani D, 2012, NUCLEIC ACIDS RES, V40, P4562, DOI 10.1093/nar/gks059; Kaneko S, 2007, P NATL ACAD SCI USA, V104, P17620, DOI 10.1073/pnas.0708866104; Li J, 2006, ONCOGENE, V25, P1186, DOI 10.1038/sj.onc.1209153; Lomonosov M, 2003, GENE DEV, V17, P3017, DOI 10.1101/gad.279003; Mischo HE, 2011, MOL CELL, V41, P21, DOI 10.1016/j.molcel.2010.12.007; Moldovan GL, 2009, ANNU REV GENET, V43, P223, DOI 10.1146/annurev-genet-102108-134222; Schlacher K, 2012, CANCER CELL, V22, P106, DOI 10.1016/j.ccr.2012.05.015; Schlacher K, 2011, CELL, V145, P529, DOI 10.1016/j.cell.2011.03.041; Skourti-Stathaki K, 2011, MOL CELL, V42, P794, DOI 10.1016/j.molcel.2011.04.026; Smith AL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016206; Soderberg O, 2006, NAT METHODS, V3, P995, DOI 10.1038/nmeth947; ten Asbroek ALMA, 2002, EUR J BIOCHEM, V269, P583, DOI 10.1046/j.0014-2956.2001.02686.x; Tous C, 2007, BIOCHEM BIOPH RES CO, V360, P428, DOI 10.1016/j.bbrc.2007.06.098; Tuduri S, 2009, NAT CELL BIOL, V11, P1315, DOI 10.1038/ncb1984; Umlauf D, 2013, J CELL SCI, V126, P2656, DOI 10.1242/jcs.118000; Urtishak KA, 2009, J BIOL CHEM, V284, P8768, DOI 10.1074/jbc.M806103200; Wellinger RE, 2006, MOL CELL BIOL, V26, P3327, DOI 10.1128/MCB.26.8.3327-3334.2006; Yang HJ, 2002, SCIENCE, V297, P1837, DOI 10.1126/science.297.5588.1837	33	313	321	1	69	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 17	2014	511	7509					362	+		10.1038/nature13374	http://dx.doi.org/10.1038/nature13374			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AL2YR	24896180				2022-12-28	WOS:000338992200039
J	Pagani, O; Regan, MM; Walley, BA; Fleming, GF; Colleoni, M; Lang, I; Gomez, HL; Tondini, C; Burstein, HJ; Perez, EA; Ciruelos, E; Stearns, V; Bonnefoi, HR; Martino, S; Geyer, CE; Pinotti, G; Puglisi, F; Crivellari, D; Ruhstaller, T; Winer, EP; Rabaglio-Poretti, M; Maibach, R; Ruepp, B; Giobbie-Hurder, A; Price, KN; Bernhard, J; Luo, WX; Ribi, K; Viale, G; Coates, AS; Gelber, RD; Goldhirsch, A; Francis, PA				Pagani, Olivia; Regan, Meredith M.; Walley, Barbara A.; Fleming, Gini F.; Colleoni, Marco; Lang, Istvan; Gomez, Henry L.; Tondini, Carlo; Burstein, Harold J.; Perez, Edith A.; Ciruelos, Eva; Stearns, Vered; Bonnefoi, Herve R.; Martino, Silvana; Geyer, Charles E., Jr.; Pinotti, Graziella; Puglisi, Fabio; Crivellari, Diana; Ruhstaller, Thomas; Winer, Eric P.; Rabaglio-Poretti, Manuela; Maibach, Rudolf; Ruepp, Barbara; Giobbie-Hurder, Anita; Price, Karen N.; Bernhard, Juerg; Luo, Weixiu; Ribi, Karin; Viale, Giuseppe; Coates, Alan S.; Gelber, Richard D.; Goldhirsch, Aron; Francis, Prudence A.		TEXT SOFT Investigators Int Breast	Adjuvant Exemestane with Ovarian Suppression in Premenopausal Breast Cancer	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							POSTMENOPAUSAL WOMEN; ENDOCRINE THERAPY; AMERICAN-SOCIETY; FOLLOW-UP; TAMOXIFEN; TRIAL; METAANALYSIS; LETROZOLE; SEQUENCE	BACKGROUND Adjuvant therapy with an aromatase inhibitor improves outcomes, as compared with tamoxifen, in postmenopausal women with hormone-receptor-positive breast cancer. METHODS In two phase 3 trials, we randomly assigned premenopausal women with hormone-receptor-positive early breast cancer to the aromatase inhibitor exemestane plus ovarian suppression or tamoxifen plus ovarian suppression for a period of 5 years. Suppression of ovarian estrogen production was achieved with the use of the gonadotropin-releasing-hormone agonist triptorelin, oophorectomy, or ovarian irradiation. The primary analysis combined data from 4690 patients in the two trials. RESULTS After a median follow-up of 68 months, disease-free survival at 5 years was 91.1% in the exemestane-ovarian suppression group and 87.3% in the tamoxifen-ovarian suppression group (hazard ratio for disease recurrence, second invasive cancer, or death, 0.72; 95% confidence interval [CI], 0.60 to 0.85; P<0.001). The rate of freedom from breast cancer at 5 years was 92.8% in the exemestane-ovarian suppression group, as compared with 88.8% in the tamoxifen-ovarian suppression group (hazard ratio for recurrence, 0.66; 95% CI, 0.55 to 0.80; P<0.001). With 194 deaths (4.1% of the patients), overall survival did not differ significantly between the two groups (hazard ratio for death in the exemestane-ovarian suppression group, 1.14; 95% CI, 0.86 to 1.51; P = 0.37). Selected adverse events of grade 3 or 4 were reported for 30.6% of the patients in the exemestane-ovarian suppression group and 29.4% of those in the tamoxifen-ovarian suppression group, with profiles similar to those for postmenopausal women. CONCLUSIONS In premenopausal women with hormone-receptor-positive early breast cancer, adjuvant treatment with exemestane plus ovarian suppression, as compared with tamoxifen plus ovarian suppression, significantly reduced recurrence. (Funded by Pfizer and others; TEXT and SOFT ClinicalTrials.gov numbers, NCT00066703 and NCT00066690, respectively.)	[Pagani, Olivia] Kantonsspital St Gallen, Breast Ctr, Inst Oncol Southern Switzerland, St Gallen, Switzerland; [Regan, Meredith M.; Bernhard, Juerg] Univ Hosp Inselspital, Bern, Switzerland; [Regan, Meredith M.; Maibach, Rudolf; Ruepp, Barbara; Bernhard, Juerg; Ribi, Karin] Coordinating Ctr, Int Breast Canc Study Grp IBCSG, Bern, Switzerland; [Regan, Meredith M.] Harvard Univ, Sch Med, Dana Farber Canc Inst, IBCSG Stat Ctr, Boston, MA 02115 USA; [Burstein, Harold J.; Winer, Eric P.] Harvard Univ, Sch Med, Dana Farber Canc Inst, Susan F Smith Ctr Womens Canc, Boston, MA 02115 USA; [Giobbie-Hurder, Anita; Luo, Weixiu] Harvard Univ, Sch Med, Dana Farber Canc Inst, IBCSG Stat Ctr, Boston, MA 02115 USA; [Price, Karen N.] Harvard Univ, Sch Med, Dana Farber Canc Inst, IBCSG Stat Ctr,Frontier Sci & Technol Res Fdn, Boston, MA 02115 USA; [Gelber, Richard D.] Harvard Univ, Sch Publ Hlth, Sch Med, IBCSG Stat Ctr,Dana Farber Canc Inst,Frontier Sci, Boston, MA 02115 USA; [Walley, Barbara A.] Tom Baker Canc Clin, Calgary, AB, Canada; [Fleming, Gini F.] Univ Chicago, Med Ctr, Chicago, IL 60637 USA; [Colleoni, Marco] Univ Milan, European Inst Oncol, IBCSG Cent Pathol Ctr, Div Med Senol, Milan, Italy; [Goldhirsch, Aron] European Inst Oncol, Milan, Italy; [Tondini, Carlo] Osped Papa Giovanni XXIII, Bergamo, Italy; [Pinotti, Graziella] Osped Circolo Varese, Varese, Italy; [Pinotti, Graziella] Fdn Macchi, Varese, Italy; [Puglisi, Fabio] Univ Udine, Dept Oncol, Univ Hosp Udine, I-33100 Udine, Italy; [Crivellari, Diana] Ctr Riferimento Oncol, Aviano, Italy; [Lang, Istvan] Natl Inst Oncol, Budapest, Hungary; [Gomez, Henry L.] Inst Nacl Enfermedades Neoplas, Lima, Peru; [Perez, Edith A.] Mayo Clin, Jacksonville, FL 32224 USA; [Ciruelos, Eva] Hosp Univ 12 Octubre, Madrid, Spain; [Stearns, Vered] Johns Hopkins Sidney Kimmel Comprehens Canc Ctr, Baltimore, MD USA; [Bonnefoi, Herve R.] Univ Bordeaux, Inst Bergonie Comprehens Canc Ctr, INSERM, U916, Bordeaux, France; [Martino, Silvana] Angeles Clin & Res Inst, Santa Monica, CA USA; [Geyer, Charles E., Jr.] Virginia Commonwealth Univ, Sch Med, Massey Canc Ctr, Richmond, VA 23284 USA; [Coates, Alan S.] Univ Sydney, Sydney, NSW 2006, Australia; [Francis, Prudence A.] Univ Melbourne, St Vincents Hosp, Peter MacCallum Canc Ctr, Melbourne, Vic, Australia	Kantonsspital St. Gallen; University of Bern; University Hospital of Bern; International Breast Cancer Study Group; Harvard University; Dana-Farber Cancer Institute; Harvard Medical School; Harvard University; Dana-Farber Cancer Institute; Harvard Medical School; Harvard University; Dana-Farber Cancer Institute; Harvard Medical School; Frontier Science Foundation; Harvard University; Dana-Farber Cancer Institute; Harvard Medical School; Harvard University; Dana-Farber Cancer Institute; Harvard Medical School; Harvard T.H. Chan School of Public Health; Tom Baker Cancer Clinic; University of Calgary; University of Chicago; University of Chicago Medical Center; IRCCS European Institute of Oncology (IEO); University of Milan; IRCCS European Institute of Oncology (IEO); ASST Papa Giovanni XXIII; Ospedale Circolo & Fondazione Macchi; Hospital Santa Maria della Misericordia; University of Udine; University Hospital of Udine; IRCCS Aviano (CRO); National Institute of Oncology Hungary; Instituto Nacional de Enfermedades Neoplasicas; Mayo Clinic; Hospital Universitario 12 de Octubre; Johns Hopkins University; Johns Hopkins Medicine; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite de Bordeaux; Angeles Clinic & Research Institute; Virginia Commonwealth University; University of Sydney; Peter Maccallum Cancer Center; St Vincent's Hospital Melbourne; University of Melbourne	Pagani, O (corresponding author), Osped San Giovanni Bellinzona, Inst Oncol Southern Switzerland, CH-6500 Bellinzona, Switzerland.	ibcsgcc@ibcsg.org	Lluch, Ana/R-5493-2019; Colleoni, Marco/AAN-8647-2020; Pagani, Olivia/ABF-3164-2020; TONDINI, CARLO ALBERTO/AAB-7786-2019; Geyer, Charles/AGY-0119-2022; Francis, Prudence A/J-4003-2012; Giobbie-Hurder, Anita/AAU-6193-2021; Saini, Kamal S./ABD-5499-2021; Puglisi, Fabio/N-3863-2017; Viale, Giuseppe/AAE-8921-2019; Perren, Timothy/D-5387-2013	Lluch, Ana/0000-0003-2766-407X; Colleoni, Marco/0000-0002-5743-3013; TONDINI, CARLO ALBERTO/0000-0003-0635-8954; Geyer, Charles/0000-0002-2379-5702; Francis, Prudence A/0000-0002-7207-9286; Saini, Kamal S./0000-0001-6301-3309; Puglisi, Fabio/0000-0003-0573-4938; Haba Rodriguez, Juan Rafael de la/0000-0001-5111-1702; Rabaglio, Manuela/0000-0002-6764-1844; Llombart Cussac, Antonio/0000-0003-4515-8293; Gomez, Henry/0000-0003-2660-1843; Di Leo, Angelo/0000-0002-3665-9056; Villanova Biazus, Jorge/0000-0002-3821-5264; Ciruelos, Eva/0000-0002-2796-1042; Bliss, Judith/0000-0001-7957-7424; Perren, Timothy/0000-0001-8472-8856; Earl, Helena/0000-0003-1549-8094; Kroep, Judith/0000-0003-2671-1903	Pfizer; Ipsen; International Breast Cancer Study Group; National Cancer Institute; Boehringer Ingelheim; Taiho Pharmaceutical; AbbVie; AstraZeneca; Novartis; Roche; Eli Lilly; NATIONAL CANCER INSTITUTE [U10CA180888, U10CA180867, U24CA075362] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR001079] Funding Source: NIH RePORTER	Pfizer(Pfizer); Ipsen(Ipsen); International Breast Cancer Study Group; National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Boehringer Ingelheim(Boehringer Ingelheim); Taiho Pharmaceutical; AbbVie(AbbVie); AstraZeneca(AstraZeneca); Novartis(Novartis); Roche(Roche Holding); Eli Lilly(Eli Lilly); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS))	Supported by Pfizer, Ipsen, the International Breast Cancer Study Group, and the National Cancer Institute.; Dr. Fleming reports receiving a study drug for investigation in a clinical trial from Corcept Therapeutics; Dr. Colleoni, receiving fees for serving on advisory boards from Boehringer Ingelheim, Taiho Pharmaceutical, AbbVie, and AstraZeneca and consulting and lecture fees from Novartis; Dr. Stearns, receiving grant support from Pfizer and Novartis; Dr. Ruhstaller, receiving travel support and fees for serving on an advisory board from Novartis; and Dr. Viale, receiving fees for serving on advisory boards from Novartis, Roche, and Eli Lilly. No other potential conflict of interest relevant to this article was reported.	Bernhard J, 2014, J CLIN ONCOL, V32, DOI 10.1200/jco.2014.32.15_suppl.557; Burstein HJ, 2010, J CLIN ONCOL, V28, P3784, DOI 10.1200/JOP.000082; Carlson RW, 2009, J NATL COMPR CANC NE, V7, P122, DOI 10.6004/jnccn.2009.0012; Colleoni M, 2011, J CLIN ONCOL, V29, P1117, DOI 10.1200/JCO.2010.31.6455; Coombes RC, 2007, LANCET, V369, P559, DOI 10.1016/S0140-6736(07)60200-1; Cuzick J, 2007, LANCET, V369, P1711; Davies C, 2011, LANCET, V378, P771, DOI 10.1016/S0140-6736(11)60993-8; Gnant M, 2011, LANCET ONCOL, V12, P631, DOI 10.1016/S1470-2045(11)70122-X; Goldhirsch A, 2013, ANN ONCOL, V24, P2206, DOI 10.1093/annonc/mdt303; Goss PE, 2013, J CLIN ONCOL, V31, P1398, DOI 10.1200/JCO.2012.44.7805; Howell A, 2005, LANCET, V365, P60, DOI 10.1016/s0140-6736(04)17666-6; Mouridsen H, 2009, NEW ENGL J MED, V361, P766, DOI 10.1056/NEJMoa0810818; Regan MM, 2013, BREAST, V22, P1094, DOI 10.1016/j.breast.2013.08.009; Regan MM, 2011, LANCET ONCOL, V12, P1101, DOI 10.1016/S1470-2045(11)70270-4; van de Velde CJH, 2011, LANCET, V377, P321, DOI 10.1016/S0140-6736(10)62312-4; Winer EP, 2005, J CLIN ONCOL, V23, P619, DOI 10.1200/JCO.2005.09.121	16	478	512	2	69	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUL 10	2014	371	2					107	118		10.1056/NEJMoa1404037	http://dx.doi.org/10.1056/NEJMoa1404037			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AK7YZ	24881463	Green Published, Green Accepted			2022-12-28	WOS:000338645500007
J	Potenski, CJ; Niu, HY; Sung, P; Klein, HL				Potenski, Catherine J.; Niu, Hengyao; Sung, Patrick; Klein, Hannah L.			Avoidance of ribonucleotide-induced mutations by RNase H2 and Srs2-Exo1 mechanisms	NATURE			English	Article							RAD51 PRESYNAPTIC FILAMENT; SACCHAROMYCES-CEREVISIAE; MISMATCH REPAIR; SRS2 HELICASE; ANTI-RECOMBINASE; TOPOISOMERASE-I; DNA; YEAST; PROTEIN; SIGNALS	Srs2 helicase is known to dismantle nucleofilaments of Rad51 recombinase to prevent spurious recombination events(1-6) and unwind trinucleotide sequences that are prone to hairpin formation(7). Here we document a new, unexpected genome maintenance role of Srs2 in the suppression of mutations arising from mis-insertion of ribonucleoside monophosphates during DNA replication. In cells lacking RNase H2, Srs2 unwinds DNA from the 5' side of a nick generated by DNA topoisomerase I-8 at a ribonucleoside monophosphate residue. In addition, Srs2 interacts with and enhances the activity of the nuclease Exo1, to generate a DNA gap in preparation for repair. Srs2-Exo1 thus functions in a new pathway of nick processing-gap filling that mediates tolerance of ribonucleoside monophosphates in the genome. Our results have implications for understanding the basis of Aicardi-Goutieres syndrome, which stems from inactivation of the human RNase H2 complex(9).	[Potenski, Catherine J.; Klein, Hannah L.] NYU, Dept Biochem & Mol Pharmacol, Sch Med, New York, NY 10016 USA; [Niu, Hengyao; Sung, Patrick] Yale Univ, Sch Med, New Haven, CT 06520 USA	New York University; Yale University	Sung, P (corresponding author), Yale Univ, Sch Med, 333 Cedar St, New Haven, CT 06520 USA.	patrick.sung@yale.edu; Hannah.Klein@nyumc.org	Niu, Hengyao/AAE-9269-2020	Klein, Hannah/0000-0003-4228-8535; Potenski, Catherine/0000-0002-4843-7071	National Institutes of Health [RO1GM053738, RO1ES007061, K99ES021441]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000142] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES007061, K99ES021441] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM053738] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank S. Jinks-Robertson and T. Kunkel for plasmids used in strain construction, R. Bermejo and M. Foiani for the genome sequencing of the original hpr4 strain, and G.-M. Li and S. Lee for providing hEXO1. This work was supported by National Institutes of Health grants RO1GM053738 (to H. L. K.), RO1ES007061 (to P. S.) and K99ES021441 (to H.N.).	ABOUSSEKHRA A, 1992, MOL CELL BIOL, V12, P3224, DOI 10.1128/MCB.12.7.3224; Adkins NL, 2013, NAT STRUCT MOL BIOL, V20, P836, DOI 10.1038/nsmb.2585; AGUILERA A, 1988, GENETICS, V119, P779; Bhattacharyya S, 2004, MOL CELL BIOL, V24, P7324, DOI 10.1128/MCB.24.17.7324-7330.2004; Chanet R, 1996, MOL CELL BIOL, V16, P4782; Chen C, 1998, MOL CELL, V2, P9, DOI 10.1016/S1097-2765(00)80109-4; Cho JE, 2013, DNA REPAIR, V12, P205, DOI 10.1016/j.dnarep.2012.12.004; Colavito S, 2009, NUCLEIC ACIDS RES, V37, P6754, DOI 10.1093/nar/gkp748; Crow YJ, 2006, NAT GENET, V38, P910, DOI 10.1038/ng1842; Fiorani S, 2008, CELL CYCLE, V7, P493, DOI 10.4161/cc.7.4.5323; Genschel J, 2002, J BIOL CHEM, V277, P13302, DOI 10.1074/jbc.M111854200; Ghodgaonkar MM, 2013, MOL CELL, V50, P323, DOI 10.1016/j.molcel.2013.03.019; Kim N, 2011, SCIENCE, V332, P1561, DOI 10.1126/science.1205016; Krejci L, 2003, NATURE, V423, P305, DOI 10.1038/nature01577; Krejci L, 2004, J BIOL CHEM, V279, P23193, DOI 10.1074/jbc.M402586200; Lisby M, 2001, P NATL ACAD SCI USA, V98, P8276, DOI 10.1073/pnas.121006298; Lujan SA, 2013, MOL CELL, V50, P437, DOI 10.1016/j.molcel.2013.03.017; McElhinny SAN, 2010, NAT CHEM BIOL, V6, P774, DOI [10.1038/NCHEMBIO.424, 10.1038/nchembio.424]; McElhinny SAN, 2010, P NATL ACAD SCI USA, V107, P4949, DOI 10.1073/pnas.0914857107; Scheller J, 2000, GENETICS, V155, P1069; Sekiguchi J, 1997, MOL CELL, V1, P89, DOI 10.1016/S1097-2765(00)80010-6; Seong C, 2009, J BIOL CHEM, V284, P24363, DOI 10.1074/jbc.M109.032953; Sparks JL, 2012, MOL CELL, V47, P980, DOI 10.1016/j.molcel.2012.06.035; Spell Rachelle Miller, 2004, Methods Mol Biol, V262, P3; Van Komen S, 2003, J BIOL CHEM, V278, P44331, DOI 10.1074/jbc.M307256200; Veaute X, 2003, NATURE, V423, P309, DOI 10.1038/nature01585	26	69	69	0	21	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 10	2014	511	7508					251	+		10.1038/nature13292	http://dx.doi.org/10.1038/nature13292			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK8AP	24896181	Green Accepted			2022-12-28	WOS:000338649800050
J	Howard, M; Wallman, J; Veitch, V; Emerson, J				Howard, Mark; Wallman, Joel; Veitch, Victor; Emerson, Joseph			Contextuality supplies the 'magic' for quantum computation	NATURE			English	Article							HIDDEN-VARIABLES; MECHANICS; COMPUTER	Quantum computers promise dramatic advantages over their classical counterparts, but the source of the power in quantum computing has remained elusive. Here we prove a remarkable equivalence between the onset of contextuality and the possibility of universal quantum computation via 'magic state' distillation, which is the leading model for experimentally realizing a fault-tolerant quantum computer. This is a conceptually satisfying link, because contextuality, which precludes a simple 'hidden variable' model of quantum mechanics, provides one of the fundamental characterizations of uniquely quantum phenomena. Furthermore, this connection suggests a unifying paradigm for the resources of quantum information: the non-locality of quantum theory is a particular kind of contextuality, and non-locality is already known to be a critical resource for achieving advantages with quantum communication. In addition to clarifying these fundamental issues, this work advances the resource framework for quantum computation, which has a number of practical applications, such as characterizing the efficiency and trade-offs between distinct theoretical and experimental schemes for achieving robust quantum computation, and putting bounds on the overhead cost for the classical simulation of quantum algorithms.	[Howard, Mark] Natl Univ Ireland, Dept Math Phys, Maynooth, Kildare, Ireland; [Howard, Mark; Wallman, Joel; Veitch, Victor; Emerson, Joseph] Univ Waterloo, Inst Quantum Comp, Waterloo, ON N2L 3G1, Canada; [Howard, Mark; Wallman, Joel; Veitch, Victor; Emerson, Joseph] Univ Waterloo, Dept Appl Math, Waterloo, ON N2L 3G1, Canada; [Veitch, Victor] Univ Toronto, Dept Stat, Toronto, ON M5S 3G3, Canada	Maynooth University; University of Waterloo; University of Waterloo; University of Toronto	Emerson, J (corresponding author), Univ Waterloo, Inst Quantum Comp, Waterloo, ON N2L 3G1, Canada.	jemerson@math.uwaterloo.ca	Howard, Mark/C-3737-2018; Wallman, Joel/X-5516-2019	Howard, Mark/0000-0002-6910-185X; Wallman, Joel/0000-0001-6943-5334	Irish Research Council (IRC) as part of the Empower Fellowship programme; CIFAR; Government of Canada through NSERC	Irish Research Council (IRC) as part of the Empower Fellowship programme(Irish Research Council for Science, Engineering and Technology); CIFAR(Canadian Institute for Advanced Research (CIFAR)); Government of Canada through NSERC(Natural Sciences and Engineering Research Council of Canada (NSERC))	M.H. was supported by the Irish Research Council (IRC) as part of the Empower Fellowship programme, and all authors acknowledge support from CIFAR and the Government of Canada through NSERC.	Aaronson S, 2004, PHYS REV A, V70, DOI 10.1103/PhysRevA.70.052328; Acin A., 2012, COMBINATORIAL APPROA; Acin A, 2007, PHYS REV LETT, V98, DOI 10.1103/PhysRevLett.98.230501; Anwar H., 2013, EFFICIENT DECODERS Q; Appleby DM, 2008, J MATH PHYS, V49, DOI 10.1063/1.2824479; BELL JS, 1966, REV MOD PHYS, V38, P447, DOI 10.1103/RevModPhys.38.447; Bravyi S, 2005, PHYS REV A, V71, DOI 10.1103/PhysRevA.71.022316; Brodutch A, 2013, PHYS REV A, V88, DOI 10.1103/PhysRevA.88.022307; Buhrman H, 2010, REV MOD PHYS, V82, P665, DOI 10.1103/RevModPhys.82.665; Cabello A., 2010, NONCONTEXTUALITY PHY; Cabello A, 2014, PHYS REV LETT, V112, DOI 10.1103/PhysRevLett.112.040401; Campbell ET, 2012, PHYS REV X, V2, DOI 10.1103/PhysRevX.2.041021; Cormick C, 2006, PHYS REV A, V73, DOI 10.1103/PhysRevA.73.012301; Datta A, 2008, PHYS REV LETT, V100, DOI 10.1103/PhysRevLett.100.050502; Dennis E, 2002, J MATH PHYS, V43, P4452, DOI 10.1063/1.1499754; DEUTSCH D, 1985, P ROY SOC LOND A MAT, V400, P97, DOI 10.1098/rspa.1985.0070; Fowler AG, 2012, PHYS REV A, V86, DOI 10.1103/PhysRevA.86.032324; Gibbons KS, 2004, PHYS REV A, V70, DOI 10.1103/PhysRevA.70.062101; Gottesman D, 1998, PHYS REV A, V57, P127, DOI 10.1103/PhysRevA.57.127; Gross D, 2006, J MATH PHYS, V47, DOI 10.1063/1.2393152; Hoban MJ, 2011, PHYS REV A, V84, DOI 10.1103/PhysRevA.84.062107; Howard M, 2013, ENTROPY-SWITZ, V15, P2340, DOI 10.3390/e15062340; Howard M, 2012, PHYS REV A, V86, DOI 10.1103/PhysRevA.86.022316; Kitaev AY, 2003, ANN PHYS-NEW YORK, V303, P2, DOI 10.1016/S0003-4916(02)00018-0; Knill E, 2005, NATURE, V434, P39, DOI 10.1038/nature03350; Knill E, 1998, PHYS REV LETT, V81, P5672, DOI 10.1103/PhysRevLett.81.5672; Lloyd S, 1996, SCIENCE, V273, P1073, DOI 10.1126/science.273.5278.1073; Mari A, 2012, PHYS REV LETT, V109, DOI 10.1103/PhysRevLett.109.230503; Ostergard PRJ, 2002, DISCRETE APPL MATH, V120, P197, DOI 10.1016/S0166-218X(01)00290-6; PERES A, 1991, J PHYS A-MATH GEN, V24, pL175, DOI 10.1088/0305-4470/24/4/003; Raussendorf R, 2006, ANN PHYS-NEW YORK, V321, P2242, DOI 10.1016/j.aop.2006.01.012; Raussendorf R, 2013, PHYS REV A, V88, DOI 10.1103/PhysRevA.88.022322; Reichardt BW, 2013, NATURE, V496, P456, DOI 10.1038/nature12035; Shor P. W., 1994, Proceedings. 35th Annual Symposium on Foundations of Computer Science (Cat. No.94CH35717), P124, DOI 10.1109/SFCS.1994.365700; Spekkens RW, 2005, PHYS REV A, V71, DOI 10.1103/PhysRevA.71.052108; Steane A. M., 2000, QUANTUM COMPUTER ONL; van Dam W, 2011, PHYS REV A, V83, DOI 10.1103/PhysRevA.83.032310; Van den Nest M, 2013, PHYS REV LETT, V110, DOI 10.1103/PhysRevLett.110.060504; Vazirani U., 2012, FULLY DEVICE INDEPEN; Vedral V, 2010, FOUND PHYS, V40, P1141, DOI 10.1007/s10701-010-9452-0; Veitch V, 2014, NEW J PHYS, V16, DOI 10.1088/1367-2630/16/1/013009; Veitch V, 2012, NEW J PHYS, V14, DOI 10.1088/1367-2630/14/11/113011; Vidal G, 2003, PHYS REV LETT, V91, DOI 10.1103/PhysRevLett.91.147902; Wallman JJ, 2012, PHYS REV A, V85, DOI 10.1103/PhysRevA.85.062121; Wootters W. K., 1986, ANN NY ACAD SCI, V480, P275	48	303	304	5	82	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 19	2014	510	7505					351	355		10.1038/nature13460	http://dx.doi.org/10.1038/nature13460			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AJ0NG	24919152	Green Submitted			2022-12-28	WOS:000337350200026
J	Cai, WJ; Santoso, A; Wang, GJ; Weller, E; Wu, LX; Ashok, K; Masumoto, Y; Yamagata, T				Cai, Wenju; Santoso, Agus; Wang, Guojian; Weller, Evan; Wu, Lixin; Ashok, Karumuri; Masumoto, Yukio; Yamagata, Toshio			Increased frequency of extreme Indian Ocean Dipole events due to greenhouse warming	NATURE			English	Article							EL-NINO; FOREST-FIRES; SHORT RAINS; VARIABILITY; CIRCULATION; INDONESIA; RAINFALL; PROJECT; MODELS; IMPACT	The Indian Ocean dipole is a prominent mode of coupled ocean-atmosphere variability(1-4), affecting the lives of millions of people in Indian Ocean rim countries(5-15). In its positive phase, sea surface temperatures are lower than normal off the Sumatra-Java coast, but higher in the western tropical Indian Ocean. During the extreme positive-IOD (pIOD) events of 1961, 1994 and 1997, the eastern cooling strengthened and extended westward along the equatorial Indian Ocean through strong reversal of both the mean westerly winds and the associated eastward-flowing upper ocean currents(1,2). This created anomalously dry conditions from the eastern to the central Indian Ocean along the Equator and atmospheric convergence farther west, leading to catastrophic floods in eastern tropical African countries(13,14) but devastating droughts in eastern Indian Ocean rim countries(8-10,16,17). Despite these serious consequences, the response of pIOD events to greenhouse warming is unknown. Here, using an ensemble of climate models forced by a scenario of high greenhouse gas emissions (Representative Concentration Pathway 8.5), we project that the frequency of extreme pIOD events will increase by almost a factor of three, from one event every 17.3 years over the twentieth century to one event every 6.3 years over the twenty-first century. We find that a mean state change-with weakening of both equatorial westerly winds and eastward oceanic currents in association with a faster warming in the western than the eastern equatorial Indian Ocean-facilitates more frequent occurrences of wind and oceanic current reversal. This leads to more frequent extreme pIOD events, suggesting an increasing frequency of extreme climate and weather events in regions affected by the pIOD.	[Cai, Wenju; Wang, Guojian; Weller, Evan] CSIRO Marine & Atmospher Res, Aspendale, Vic 3195, Australia; [Cai, Wenju; Wang, Guojian; Wu, Lixin] Ocean Univ China, Qingdao Collaborat Innovat Ctr Marine Sci & Techn, Phys Oceanog Lab, Qingdao 266003, Peoples R China; [Santoso, Agus] Univ New S Wales, Climate Change Res Ctr, Sydney, NSW 2052, Australia; [Santoso, Agus] Univ New S Wales, ARC Ctr Excellence Climate Syst Sci, Sydney, NSW 2052, Australia; [Ashok, Karumuri] Indian Inst Trop Meteorol, Ctr Climate Change Res, Pune 411008, Maharashtra, India; [Masumoto, Yukio] Univ Tokyo, Dept Earth & Planetary Sci, Grad Sch Sci, Bunkyo Ku, Tokyo 1130033, Japan; [Masumoto, Yukio] Japan Agcy Marine Earth Sci & Technol JAMSTEC, Climate Variat Predictabil & Applicatabil Res Pro, Kanazawa Ku, Yokohama, Kanagawa 2360001, Japan; [Yamagata, Toshio] JAMSTEC, Applicat Lab, Kanazawa Ku, Yokohama, Kanagawa 2360001, Japan	Commonwealth Scientific & Industrial Research Organisation (CSIRO); Ocean University of China; University of New South Wales Sydney; ARC Centre of Excellence for Climate System Science; University of New South Wales Sydney; Ministry of Earth Sciences (MoES) - India; Indian Institute of Tropical Meteorology (IITM); Centre for Climate Change Research - India; University of Tokyo; Japan Agency for Marine-Earth Science & Technology (JAMSTEC); Japan Agency for Marine-Earth Science & Technology (JAMSTEC)	Cai, WJ (corresponding author), CSIRO Marine & Atmospher Res, Aspendale, Vic 3195, Australia.	wenju.cai@csiro.au	Santoso, Agus/J-7350-2012; Cai, Wenju/C-2864-2012; MASUMOTO, YUKIO/G-5021-2014; Yamagata, Toshio/A-1807-2009; Santoso, Agus/P-1918-2019; Wang, Guojian/AAF-9297-2020	Santoso, Agus/0000-0001-7749-8124; Cai, Wenju/0000-0001-6520-0829; Santoso, Agus/0000-0001-7749-8124; Wang, Guojian/0000-0002-8881-7394; Ashok, Karumuri/0000-0002-5937-8089; Weller, Evan/0000-0002-7454-9827	Australian Climate Change Science Program; Goyder Institute; CSIRO Office of Chief Executive Science Leader award; Australian Research Council	Australian Climate Change Science Program; Goyder Institute; CSIRO Office of Chief Executive Science Leader award; Australian Research Council(Australian Research Council)	W.C. and E. W. are supported by the Australian Climate Change Science Program, and the Goyder Institute. W. C. is also supported by a CSIRO Office of Chief Executive Science Leader award. A. S. is supported by the Australian Research Council.	Abram NJ, 2003, SCIENCE, V301, P952, DOI 10.1126/science.1083841; Adler RF, 2003, J HYDROMETEOROL, V4, P1147, DOI 10.1175/1525-7541(2003)004<1147:TVGPCP>2.0.CO;2; Ashok K, 2003, GEOPHYS RES LETT, V30, DOI 10.1029/2003GL017926; Ashok K, 2007, J GEOPHYS RES-OCEANS, V112, DOI 10.1029/2006JC003798; Austin PC, 2004, AM STAT, V58, P131, DOI 10.1198/0003130043277; Balmaseda MA, 2008, MON WEATHER REV, V136, P3018, DOI 10.1175/2008MWR2433.1; Behera SK, 2005, J CLIMATE, V18, P4514, DOI 10.1175/JCLI3541.1; Black E, 2003, MON WEATHER REV, V131, P74, DOI 10.1175/1520-0493(2003)131<0074:AOSOTR>2.0.CO;2; Cai W, 2009, GEOPHYS RES LETT, V36, DOI [10.1029/2009GL037604, 10.1029/2009GL039902]; Cai WJ, 2014, NAT CLIM CHANGE, V4, P111, DOI [10.1038/NCLIMATE2100, 10.1038/nclimate2100]; Cai WJ, 2013, NAT GEOSCI, V6, P999, DOI [10.1038/ngeo2009, 10.1038/NGEO2009]; Collins M, 2010, NAT GEOSCI, V3, P391, DOI 10.1038/NGEO868; Emmanuel S C, 2000, Respirology, V5, P175, DOI 10.1046/j.1440-1843.2000.00247.x; Feng M, 2003, DEEP-SEA RES PT II, V50, P2263, DOI 10.1016/S0967-0645(03)00056-0; Fischer AS, 2005, J CLIMATE, V18, P3428, DOI 10.1175/JCLI3478.1; Frankenberg E, 2005, DEMOGRAPHY, V42, P109, DOI 10.1353/dem.2005.0004; Guilyardi E, 2009, B AM METEOROL SOC, V90, P325, DOI 10.1175/2008BAMS2387.1; Hashizume M, 2012, SCI REP-UK, V2, DOI 10.1038/srep00269; Hong CC, 2008, J CLIMATE, V21, P4834, DOI 10.1175/2008JCLI2222.1; Izumo T, 2010, NAT GEOSCI, V3, P168, DOI 10.1038/NGEO760; Kalnay E, 1996, B AM METEOROL SOC, V77, P437, DOI 10.1175/1520-0477(1996)077<0437:TNYRP>2.0.CO;2; Lorenz EN, 1956, 1 MIT DEP MET; Luo JJ, 2010, J CLIMATE, V23, P726, DOI 10.1175/2009JCLI3104.1; Meyers G, 2007, J CLIMATE, V20, P2872, DOI 10.1175/JCLI4152.1; Murtugudde R, 2000, J GEOPHYS RES-OCEANS, V105, P3295, DOI 10.1029/1999JC900294; Page SE, 2002, NATURE, V420, P61, DOI 10.1038/nature01131; Rayner NA, 2003, J GEOPHYS RES-ATMOS, V108, DOI 10.1029/2002JD002670; Saji NH, 1999, NATURE, V401, P360, DOI 10.1038/43854; Schott FA, 2009, REV GEOPHYS, V47, DOI 10.1029/2007RG000245; Taylor KE, 2012, B AM METEOROL SOC, V93, P485, DOI 10.1175/BAMS-D-11-00094.1; Udea H., 2000, J METEOR SOC JAPAN, V78, P803; Ummenhofer CC, 2009, GEOPHYS RES LETT, V36, DOI 10.1029/2008GL036801; Vecchi GA, 2007, J CLIMATE, V20, P4316, DOI 10.1175/JCLI4258.1; Webster PJ, 1999, NATURE, V401, P356, DOI 10.1038/43848; Wijffels S, 2004, J PHYS OCEANOGR, V34, P1232, DOI 10.1175/1520-0485(2004)034<1232:AIOOWV>2.0.CO;2; WYRTKI K, 1973, SCIENCE, V181, P264; Yu LS, 1999, GEOPHYS RES LETT, V26, P735, DOI 10.1029/1999GL900072; Zheng XT, 2013, J CLIMATE, V26, P6067, DOI 10.1175/JCLI-D-12-00638.1; Zubair L, 2003, GEOPHYS RES LETT, V30, DOI 10.1029/2002GL015639	39	211	220	11	158	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 12	2014	510	7504					254	+		10.1038/nature13327	http://dx.doi.org/10.1038/nature13327			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI7AT	24919920				2022-12-28	WOS:000337032400047
J	Elliott, T				Elliott, Tim			PLANETARY SCIENCE Speed metal	SCIENCE			English	Editorial Material							IRON-METEORITES; CORE FORMATION; PARENT BODIES; ACCRETION; CHONDRULES; ANOMALIES; DISK		Univ Bristol, Sch Earth Sci, Clifton BS8 1RJ, Avon, England	University of Bristol	Elliott, T (corresponding author), Univ Bristol, Sch Earth Sci, Queens Rd, Clifton BS8 1RJ, Avon, England.	tim.elliott@bristol.ac.uk		Elliott, Tim/0000-0002-0984-0191				Amelin Y, 2002, SCIENCE, V297, P1678, DOI 10.1126/science.1073950; Burkhardt C, 2012, ASTROPHYS J LETT, V753, DOI 10.1088/2041-8205/753/1/L6; Kita NT, 2000, GEOCHIM COSMOCHIM AC, V64, P3913, DOI 10.1016/S0016-7037(00)00488-9; Kleine T, 2005, GEOCHIM COSMOCHIM AC, V69, P5805, DOI 10.1016/j.gca.2005.07.012; Kleine T, 2009, GEOCHIM COSMOCHIM AC, V73, P5150, DOI 10.1016/j.gca.2008.11.047; Markowski A, 2006, EARTH PLANET SC LETT, V242, P1, DOI 10.1016/j.epsl.2005.11.048; Qin LP, 2008, ASTROPHYS J, V674, P1234, DOI 10.1086/524882; Regelous M, 2008, EARTH PLANET SC LETT, V272, P330, DOI 10.1016/j.epsl.2008.05.001; Schersten A, 2006, EARTH PLANET SC LETT, V241, P530, DOI 10.1016/j.epsl.2005.11.025	12	0	0	0	10	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 6	2014	344	6188					1086	1087		10.1126/science.1254943	http://dx.doi.org/10.1126/science.1254943			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AI3UU	24904139				2022-12-28	WOS:000336791200020
J	Jiang, Y; Xie, M; Chen, WB; Talbot, R; Maddox, JF; Faraut, T; Wu, CH; Muzny, DM; Li, YX; Zhang, WG; Stanton, JA; Brauning, R; Barris, WC; Hourlier, T; Aken, BL; Searle, SMJ; Adelson, DL; Bian, C; Cam, GR; Chen, YL; Cheng, SF; DeSilva, U; Dixen, K; Dong, Y; Fan, GY; Franklin, IR; Fu, SY; Fuentes-Utrilla, P; Guan, R; Highland, MA; Holder, ME; Huang, GD; Ingham, AB; Jhangiani, SN; Kalra, D; Kovar, CL; Lee, SL; Liu, WQ; Liu, X; Lu, CX; Lv, T; Mathew, T; McWilliam, S; Menzies, M; Pan, SK; Robelin, D; Servin, B; Townley, D; Wang, WL; Wei, B; White, SN; Yang, XH; Ye, C; Yue, YJ; Zeng, P; Zhou, Q; Hansen, JB; Kristiansen, K; Gibbs, RA; Flicek, P; Warkup, CC; Jones, HE; Oddy, VH; Nicholas, FW; McEwan, JC; Kijas, JW; Wang, J; Worley, KC; Archibald, AL; Cockett, N; Xu, X; Wang, W; Dalrymple, BP				Jiang, Yu; Xie, Min; Chen, Wenbin; Talbot, Richard; Maddox, Jillian F.; Faraut, Thomas; Wu, Chunhua; Muzny, Donna M.; Li, Yuxiang; Zhang, Wenguang; Stanton, Jo-Ann; Brauning, Rudiger; Barris, Wesley C.; Hourlier, Thibaut; Aken, Bronwen L.; Searle, Stephen M. J.; Adelson, David L.; Bian, Chao; Cam, Graham R.; Chen, Yulin; Cheng, Shifeng; DeSilva, Udaya; Dixen, Karen; Dong, Yang; Fan, Guangyi; Franklin, Ian R.; Fu, Shaoyin; Fuentes-Utrilla, Pablo; Guan, Rui; Highland, Margaret A.; Holder, Michael E.; Huang, Guodong; Ingham, Aaron B.; Jhangiani, Shalini N.; Kalra, Divya; Kovar, Christie L.; Lee, Sandra L.; Liu, Weiqing; Liu, Xin; Lu, Changxin; Lv, Tian; Mathew, Tittu; McWilliam, Sean; Menzies, Moira; Pan, Shengkai; Robelin, David; Servin, Bertrand; Townley, David; Wang, Wenliang; Wei, Bin; White, Stephen N.; Yang, Xinhua; Ye, Chen; Yue, Yaojing; Zeng, Peng; Zhou, Qing; Hansen, Jacob B.; Kristiansen, Karsten; Gibbs, Richard A.; Flicek, Paul; Warkup, Christopher C.; Jones, Huw E.; Oddy, V. Hutton; Nicholas, Frank W.; McEwan, John C.; Kijas, James W.; Wang, Jun; Worley, Kim C.; Archibald, Alan L.; Cockett, Noelle; Xu, Xun; Wang, Wen; Dalrymple, Brian P.			The sheep genome illuminates biology of the rumen and lipid metabolism	SCIENCE			English	Article							PROLINE-RICH PROTEINS; IDENTIFICATION; EVOLUTIONARY; EXPRESSION; ENVELOPES; RUMINANT; GENES; SITE; FAT	Sheep (Ovis aries) are a major source of meat, milk, and fiber in the form of wool and represent a distinct class of animals that have a specialized digestive organ, the rumen, that carries out the initial digestion of plant material. We have developed and analyzed a high-quality reference sheep genome and transcriptomes from 40 different tissues. We identified highly expressed genes encoding keratin cross-linking proteins associated with rumen evolution. We also identified genes involved in lipid metabolism that had been amplified and/or had altered tissue expression patterns. This may be in response to changes in the barrier lipids of the skin, an interaction between lipid metabolism and wool synthesis, and an increased role of volatile fatty acids in ruminants compared with nonruminant animals.	[Jiang, Yu; Zhang, Wenguang; Dong, Yang; Wang, Wen] Chinese Acad Sci, Kunming Inst Zool, State Key Lab Genet Resources & Evolut, Kunming 650223, Peoples R China; [Jiang, Yu; Barris, Wesley C.; Adelson, David L.; Cam, Graham R.; DeSilva, Udaya; Franklin, Ian R.; Ingham, Aaron B.; McWilliam, Sean; Menzies, Moira; Townley, David; Kijas, James W.; Dalrymple, Brian P.] Commonwealth Sci & Ind Res Org Anim Food & Hlth S, St Lucia, Qld 4067, Australia; [Jiang, Yu; Chen, Yulin] Northwest A&F Univ, Coll Anim Sci & Technol, Yangling 712100, Peoples R China; [Xie, Min; Chen, Wenbin; Li, Yuxiang; Bian, Chao; Cheng, Shifeng; Fan, Guangyi; Guan, Rui; Huang, Guodong; Liu, Weiqing; Liu, Xin; Lu, Changxin; Lv, Tian; Pan, Shengkai; Wang, Wenliang; Wei, Bin; Yang, Xinhua; Ye, Chen; Zeng, Peng; Zhou, Qing; Wang, Jun; Xu, Xun] BGI Shenzhen, Shenzhen 518083, Peoples R China; [Talbot, Richard; Fuentes-Utrilla, Pablo] Univ Edinburgh, Ediburgh Genom, Easter Bush EH25 9RG, Midlothian, Scotland; [Maddox, Jillian F.; Wu, Chunhua; Cockett, Noelle] Utah State Univ, Logan, UT 84322 USA; [Faraut, Thomas; Robelin, David; Servin, Bertrand] INRA, Lab Genet Cellulaire, UMR 444, F-31326 Castanet Tolosan, France; [Muzny, Donna M.; Holder, Michael E.; Jhangiani, Shalini N.; Kalra, Divya; Kovar, Christie L.; Lee, Sandra L.; Mathew, Tittu; Gibbs, Richard A.; Worley, Kim C.] Baylor Coll Med, Human Genome Sequencing Ctr, Houston, TX 77030 USA; [Zhang, Wenguang; Fu, Shaoyin] Inner Mongolia Agr Univ, Hohhot 010018, Peoples R China; [Zhang, Wenguang] Nei Mongol Bioinformat, Inst ATCG, Hohhot, Peoples R China; [Stanton, Jo-Ann] Univ Otago, Dept Anat, Dunedin 9054, New Zealand; [Brauning, Rudiger; McEwan, John C.] AgResearch, Invermay Agr Ctr, Mosgiel 9053, New Zealand; [Hourlier, Thibaut; Aken, Bronwen L.; Searle, Stephen M. J.] Wellcome Trust Sanger Inst, Cambridge CB10 1SA, England; [Dixen, Karen; Hansen, Jacob B.] Univ Copenhagen, Dept Biol, DK-2100 Copenhagen O, Denmark; [Highland, Margaret A.; White, Stephen N.] Washington State Univ, USDA ARS, Anim Dis Res Unit, Pullman, WA 99164 USA; [Highland, Margaret A.; White, Stephen N.] Washington State Univ, Dept Vet Microbiol & Pathol, Pullman, WA 99164 USA; [Wei, Bin] Sichuan Agr Univ, Maize Res Inst, Chengdu 611130, Peoples R China; [Yue, Yaojing] Lanzhou Inst Husb & Pharmaceut Sci, Lanzhou 730050, Peoples R China; [Kristiansen, Karsten; Wang, Jun] Univ Copenhagen, Dept Biol, DK-2200 Copenhagen N, Denmark; [Hourlier, Thibaut; Aken, Bronwen L.; Flicek, Paul] European Bioinformat Inst, European Mol Biol Lab, Cambridge CB10 1SA, England; [Warkup, Christopher C.; Jones, Huw E.] Roslin Inst, Biosci Knowledge Transfer Network, Easter Bush EH25 9RG, Midlothian, Scotland; [Oddy, V. Hutton] Univ New England, Sch Environm & Rural Sci, Armidale, NSW 2351, Australia; [Nicholas, Frank W.] Univ Sydney, Fac Vet Sci, Sydney, NSW 2006, Australia; [Wang, Jun] King Abdulaziz Univ, Princess Al Jawhara Ctr Excellence Res Hereditary, Jeddah 21589, Saudi Arabia; [Wang, Jun] Macau Univ Sci & Technol, Macau 999078, Peoples R China; [Archibald, Alan L.] Roslin Inst, Easter Bush EH25 9RG, Midlothian, Scotland; [Archibald, Alan L.] Univ Edinburgh, Royal Dick Sch Vet Studies, Easter Bush EH25 9RG, Midlothian, Scotland	Chinese Academy of Sciences; Kunming Institute of Zoology; Commonwealth Scientific & Industrial Research Organisation (CSIRO); Northwest A&F University - China; Beijing Genomics Institute (BGI); University of Edinburgh; Utah System of Higher Education; Utah State University; INRAE; Baylor College of Medicine; Inner Mongolia Agricultural University; University of Otago; AgResearch - New Zealand; Wellcome Trust Sanger Institute; University of Copenhagen; United States Department of Agriculture (USDA); Washington State University; Washington State University; Sichuan Agricultural University; Chinese Academy of Agricultural Sciences; Lanzhou Institute of Husbandry & Pharmaceutical Sciences, CAAS; University of Copenhagen; European Molecular Biology Laboratory (EMBL); UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Roslin Institute; University of New England; University of Sydney; King Abdulaziz University; Macau University of Science & Technology; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Roslin Institute; University of Edinburgh	Dalrymple, BP (corresponding author), Commonwealth Sci & Ind Res Org Anim Food & Hlth S, St Lucia, Qld 4067, Australia.	kworley@bcm.edu; alan.archibald@roslin.ed.ac.uk; noelle.cockett@usu.edu; xuxun@genomics.cn; wwang@mail.kiz.ac.cn; brian.dalrymple@csiro.au	McWilliam, Sean M/H-8978-2013; Kalra, D/H-6661-2019; Wang, Wen/AAP-9873-2020; Nicholas, Frank William/AAE-5566-2022; Servin, Bertrand/B-2206-2008; XIE, MIN/P-8062-2019; Adelson, David L/E-5506-2011; Jiang, Yu/O-5114-2015; Nicholas, Frank/AGY-8318-2022; Highland, Margaret/ABF-3396-2021; Hansen, Jacob B/F-3775-2010; Li, yu/HHZ-5236-2022; Stanton, Jo-Ann L/C-6621-2009; Xu, Xun/AAI-6763-2020; McEwan, John/A-1143-2008; Menzies, Moira/AAY-2850-2020; Dalrymple, Brian P/F-8721-2010; Kalra, Divya/N-5453-2014; Ingham, Aaron/C-1166-2008; Kristiansen, Karsten/J-5148-2014; Kijas, James W/A-4656-2011; Wang, Jun/C-8434-2016; Wang, Jun/B-9503-2016	McWilliam, Sean M/0000-0002-3148-0428; Kalra, D/0000-0001-5254-4067; Nicholas, Frank William/0000-0002-9178-3965; Servin, Bertrand/0000-0001-5141-0913; XIE, MIN/0000-0002-5652-5039; Adelson, David L/0000-0003-2404-5636; Jiang, Yu/0000-0003-4821-3585; Nicholas, Frank/0000-0002-9178-3965; Hansen, Jacob B/0000-0001-5249-2586; Stanton, Jo-Ann L/0000-0001-8139-4694; Xu, Xun/0000-0002-5338-5173; McEwan, John/0000-0003-4801-6207; Menzies, Moira/0000-0002-5752-0846; Dalrymple, Brian P/0000-0003-3891-5233; Ingham, Aaron/0000-0001-8006-9443; Kristiansen, Karsten/0000-0002-6024-0917; Kijas, James W/0000-0002-1417-8278; Guan, Rui/0000-0003-0862-2368; DeSilva, Udaya/0000-0003-2517-6566; Hourlier, Thibaut/0000-0003-4894-7773; Flicek, Paul/0000-0002-3897-7955; White, Stephen N./0000-0001-9255-6054; Liu, Xin/0000-0003-3256-2940; Aken, Bronwen/0000-0002-3032-4095; Wang, Jun/0000-0002-8540-8931; Brauning, Rudiger/0000-0001-5068-9166; Wang, Wen/0000-0002-7801-2066; Worley, Kim/0000-0002-0282-1000; Bian, Chao/0000-0001-9904-721X; Archibald, Alan/0000-0001-9213-1830; Oddy, Hutton/0000-0003-1783-1049; Wang, Jun/0000-0002-2113-5874	one 973 Program [2013CB835200]; one CAS Program [XDB13000000]; BGI-Shenzhen [ZYC200903240077A, ZYC200903240078A]; Inner Mongolia Agricultural University [30960246, 31260538]; Roslin Institute; University of Edinburgh and Biotechnology; Biological Sciences Research Council, UK (BBSRC) [BB/1025360/1, BB/I025328/1]; Institute Strategic Programme; National Capability Grants; Roslin Foundation; Scottish Government, UK; Department for Environment, Food and Rural Affairs/Higher Education Funding Council/Scottish Higher Education Funding Council Veterinary Training and Research Initiative, UK; USDA-ARS, USA; USDA-National Research Initiative Competitive Grants Program, USA [2008-03923, 2009-03305]; Wellcome Trust [WT095908, WT098051]; BBSRC [BB/I025506/1, BB/I025360/1]; European Molecular Biology Laboratory; USDA-NRSP-8, USA; USDA-ARS [5348-32000-031-00D]; Meat and Livestock Australia; Australian Wool Innovation Limited through SheepGENOMICS, Australia; Australian Government International Science Linkages Grant, Australia [CG090143]; University of Sydney, Australia; CSIRO, Australia; AgResearch, NZ, Beef + Lamb NZ through Ovita, New Zealand; INRA, France; Agence Nationale de la Recherche project SheepSNPQTL, France; European Union through the Seventh Framework Programme Quantomics project [KBBE222664]; 3SR project [KBBE245140]; Ole Romer grant from Danish Natural Science Research Council, BGI-Shenzhen, China; Earmarked Fund for Modern China Wool & Cashmere Technology Research System [nycytx-40-3]; Australian Department of Agriculture Food and Fisheries, Filling the Research Gap project, "Host control of methane emissions"; BBSRC [BB/I025360/2, BBS/E/D/20310000, BBS/E/D/05191130, BBS/E/D/20211552, BBS/E/D/20211550, BB/I025328/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/I025506/1, BBS/E/D/20310000, BBS/E/D/20211552, BB/I025328/1, BBS/E/D/20211550, BB/I025360/2, BB/I025360/1, BBS/E/D/05191130] Funding Source: researchfish; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U54HG003273] Funding Source: NIH RePORTER	one 973 Program; one CAS Program; BGI-Shenzhen; Inner Mongolia Agricultural University; Roslin Institute(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); University of Edinburgh and Biotechnology; Biological Sciences Research Council, UK (BBSRC)(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Institute Strategic Programme; National Capability Grants; Roslin Foundation; Scottish Government, UK; Department for Environment, Food and Rural Affairs/Higher Education Funding Council/Scottish Higher Education Funding Council Veterinary Training and Research Initiative, UK; USDA-ARS, USA(United States Department of Agriculture (USDA)USDA Agricultural Research Service); USDA-National Research Initiative Competitive Grants Program, USA(United States Department of Agriculture (USDA)); Wellcome Trust(Wellcome TrustEuropean Commission); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); European Molecular Biology Laboratory; USDA-NRSP-8, USA; USDA-ARS(United States Department of Agriculture (USDA)USDA Agricultural Research Service); Meat and Livestock Australia(Meat and Livestock Australia); Australian Wool Innovation Limited through SheepGENOMICS, Australia(Australian Wool Innovation); Australian Government International Science Linkages Grant, Australia(Australian GovernmentDepartment of Industry, Innovation and Science); University of Sydney, Australia(University of Sydney); CSIRO, Australia(Commonwealth Scientific & Industrial Research Organisation (CSIRO)); AgResearch, NZ, Beef + Lamb NZ through Ovita, New Zealand; INRA, France; Agence Nationale de la Recherche project SheepSNPQTL, France(French National Research Agency (ANR)); European Union through the Seventh Framework Programme Quantomics project; 3SR project; Ole Romer grant from Danish Natural Science Research Council, BGI-Shenzhen, China; Earmarked Fund for Modern China Wool & Cashmere Technology Research System; Australian Department of Agriculture Food and Fisheries, Filling the Research Gap project, "Host control of methane emissions"(Australian GovernmentDepartment of Agriculture and Water Resources); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	The International Sheep Genomics Sequencing Consortium is grateful to the following for funding support for the sheep genome sequencing project: one 973 Program (no. 2013CB835200) and one CAS Program (XDB13000000) to Kunming Institute of Zoology, China; BGI-Shenzhen (ZYC200903240077A and ZYC200903240078A); China National GeneBank-Shenzhen for support for the storage of samples and data; Inner Mongolia Agricultural University (30960246 and 31260538); The Roslin Institute, University of Edinburgh and Biotechnology and Biological Sciences Research Council, UK (BBSRC): BB/1025360/1, BB/I025328/1, Institute Strategic Programme, and National Capability Grants; The Roslin Foundation; The Scottish Government, UK; Department for Environment, Food and Rural Affairs/Higher Education Funding Council/Scottish Higher Education Funding Council Veterinary Training and Research Initiative, UK; USDA-ARS, USA, USDA-National Research Initiative Competitive Grants Program, USA (grant nos. 2008-03923 and 2009-03305); Wellcome Trust (grant nos. WT095908 and WT098051), BBSRC (grant nos. BB/I025506/1 and BB/I025360/1) and European Molecular Biology Laboratory; USDA-NRSP-8, USA; USDA-ARS grant 5348-32000-031-00D; Meat and Livestock Australia and Australian Wool Innovation Limited through SheepGENOMICS, Australia; Australian Government International Science Linkages Grant (CG090143), Australia; University of Sydney, Australia; CSIRO, Australia; AgResearch, NZ, Beef + Lamb NZ through Ovita, New Zealand; INRA and Agence Nationale de la Recherche project SheepSNPQTL, France; European Union through the Seventh Framework Programme Quantomics (KBBE222664) and 3SR (KBBE245140) projects; the Ole Romer grant from Danish Natural Science Research Council, BGI-Shenzhen, China; the Earmarked Fund for Modern China Wool & Cashmere Technology Research System (no. nycytx-40-3); and the Australian Department of Agriculture Food and Fisheries, Filling the Research Gap project, "Host control of methane emissions." We thank B. Freking (USDA-ARS-U.S. Meat Animal Research Center) for provision of Texel ram tissue samples for DNA extraction and sequencing. We thank the sequencing teams and other contributors; full details are in the acknowledgements section of the supplementary materials. We thank SheepGENOMICS and Utah State University for access to the genotyping data for the SheepGENOMICS and Louisiana State University flocks, respectively. We thank L. Goodman for help with condensing the text. The genome assemblies have been deposited in GenBank, Oar v1.0 (GCA_000005525.1), and Oar v3.1 (GCA_000298735.1) and in GigaDB, Oar v2.0 (http://dx.doi.org/10.5524/100023). The Ensembl annotation of the Oar v3.1 assembly is available at http://e74.ensembl.org, and the gene builds are available from ftp://ftp.ensembl.org/pub/release-74/bam/ovis_aries/genebuild/. The RNA-Seq data sets have been deposited in public databases: 83 samples from The Roslin Institute (European Nucleotide Archive (ENA) study accession PRJEB6169), seven tissues from the genome-sequenced Texel ewe and Gansu alpine fine wool sheep skin (GenBank accession GSE56643), and three blood samples (GenBank BioProject accession PRJNA245615). The methylated DNA immunoprecipitation sequencing (MeDIP-seq) raw reads from the Texel ewe liver have been deposited in GenBank (GSE56644). The bacterial artificial chromosome sequence assembly has been deposited in GenBank (KJ735098).; The raw reads of the genome sequencing projects have been deposited in public nucleotide databases: Texel ewe (GenBank accession SRA059406), Texel ram (ENA study accession PRJEB6251, GenBank accession SRP015759), and 0.5-fold coverage 454 sequencing of six animals (GenBank accessions SRP000982, SRP003883, and SRP006794). The authors declare no competing financial interests.	BERGMAN EN, 1990, PHYSIOL REV, V70, P567, DOI 10.1152/physrev.1990.70.2.567; Bobe G, 2004, J DAIRY SCI, V87, P3105, DOI 10.3168/jds.S0022-0302(04)73446-3; Cheng D, 2003, J BIOL CHEM, V278, P13611, DOI 10.1074/jbc.C300042200; Clop A, 2006, NAT GENET, V38, P813, DOI 10.1038/ng1810; Deng J, 2000, J BIOL CHEM, V275, P5739, DOI 10.1074/jbc.275.8.5739; Edwards EJ, 2010, SCIENCE, V328, P587, DOI 10.1126/science.1177216; Feingold KR, 2007, J LIPID RES, V48, P2531, DOI 10.1194/jlr.R700013-JLR200; Hackmann TJ, 2010, J DAIRY SCI, V93, P1320, DOI 10.3168/jds.2009-2071; Hall AM, 2012, J LIPID RES, V53, P990, DOI 10.1194/jlr.P025536; HOFMANN RR, 1989, OECOLOGIA, V78, P443, DOI 10.1007/BF00378733; INGLE DL, 1972, J NUTR, V102, P617, DOI 10.1093/jn/102.5.617; Inoue A, 2011, EMBO J, V30, P4248, DOI 10.1038/emboj.2011.296; JOHNSON KA, 1995, J ANIM SCI, V73, P2483; Kazantseva A, 2006, SCIENCE, V314, P982, DOI 10.1126/science.1133276; Kypriotou M, 2012, EXP DERMATOL, V21, P643, DOI 10.1111/j.1600-0625.2012.01472.x; Marshall D, 2001, P NATL ACAD SCI USA, V98, P13031, DOI 10.1073/pnas.231489198; Radner FPW, 2011, DERM-ENDOCRINOL, V3, P77, DOI 10.4161/derm.3.2.15472; SCHLOSSMAN ML, 1978, J AM OIL CHEM SOC, V55, P447, DOI 10.1007/BF02911911; Song HJ, 1999, GENOMICS, V55, P28, DOI 10.1006/geno.1998.5607; Steinert PM, 1998, J STRUCT BIOL, V122, P76, DOI 10.1006/jsbi.1998.3957; Stewart M. E., 1986, BIOL INTEGUMENT, V2, P824; Stromberg CAE, 2011, ANNU REV EARTH PL SC, V39, P517, DOI 10.1146/annurev-earth-040809-152402; Wang LQ, 1996, BIOCHEM J, V317, P225, DOI 10.1042/bj3170225; WOLIN MJ, 1981, SCIENCE, V213, P1463, DOI 10.1126/science.7280665	24	282	309	10	323	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 6	2014	344	6188					1168	1173		10.1126/science.1252806	http://dx.doi.org/10.1126/science.1252806			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI3UU	24904168	Green Accepted			2022-12-28	WOS:000336791200050
J	Handel, MA; Eppig, JJ; Schimenti, JC				Handel, Mary Ann; Eppig, John J.; Schimenti, John C.			Applying "Gold Standards" to In-Vitro-Derived Germ Cells	CELL			English	Article							EMBRYONIC STEM-CELLS; METABOLIC COOPERATIVITY; MOUSE; MEIOSIS; OOCYTES; FATE; OOGENESIS; GENETICS; OVARIES; MICE	Germ cells are the ultimate stem cells, and reports of their in vitro derivation generate excitement due to potential applications in reproductive medicine. To date, there is no firm evidence that meiosis, the hallmark of gametogenesis, can be faithfully replicated outside of the gonad. We propose benchmarks for evaluating in vitro derivation of germ cells, facilitating realization of their potential.	[Handel, Mary Ann; Eppig, John J.] Jackson Lab, Bar Harbor, ME 04609 USA; [Schimenti, John C.] Cornell Univ, Ithaca, NY 14853 USA	Jackson Laboratory; Cornell University	Handel, MA (corresponding author), Jackson Lab, 600 Main St, Bar Harbor, ME 04609 USA.	maryann.handel@jax.org; jcs92@cornell.edu			NATIONAL CANCER INSTITUTE [P30CA034196] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM045415] Funding Source: NIH RePORTER; NCI NIH HHS [P30 CA034196] Funding Source: Medline; NIGMS NIH HHS [R01 GM045415] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Bolcun-Filas E, 2012, INT REV CEL MOL BIO, V298, P179, DOI 10.1016/B978-0-12-394309-5.00005-5; Dokshin GA, 2013, NAT GENET, V45, P877, DOI 10.1038/ng.2672; Duncan FE, 2009, BIOL REPROD, V81, P768, DOI 10.1095/biolreprod.109.077909; Eguizabal C, 2011, STEM CELLS, V29, P1186, DOI 10.1002/stem.672; Handel MA, 2010, NAT REV GENET, V11, P124, DOI 10.1038/nrg2723; Hayashi K, 2012, SCIENCE, V338, P971, DOI 10.1126/science.1226889; Lei L, 2013, P NATL ACAD SCI USA, V110, P8585, DOI 10.1073/pnas.1306189110; Lister R, 2011, NATURE, V471, P68, DOI 10.1038/nature09798; Morgan CT, 2013, P NATL ACAD SCI USA, V110, P3411, DOI 10.1073/pnas.1300928110; Nakaki F, 2013, NATURE, V501, P222, DOI 10.1038/nature12417; Nayernia K, 2006, DEV CELL, V11, P125, DOI 10.1016/j.devcel.2006.05.010; Oatley J, 2012, BIOL REPROD, V86, DOI 10.1095/biolreprod.112.100297; Okae H, 2014, HUM MOL GENET, V23, P992, DOI 10.1093/hmg/ddt495; Ramathal C, 2014, CELL REP, V7, P1284, DOI 10.1016/j.celrep.2014.03.067; Su YQ, 2008, DEVELOPMENT, V135, P111, DOI 10.1242/dev.009068; Sugiura K, 2005, DEV BIOL, V279, P20, DOI 10.1016/j.ydbio.2004.11.027; Toyooka Y, 2003, P NATL ACAD SCI USA, V100, P11457, DOI 10.1073/pnas.1932826100; White YAR, 2012, NAT MED, V18, P413, DOI 10.1038/nm.2669; Woods DC, 2013, REPROD SCI, V20, P7, DOI 10.1177/1933719112462632; Wu GM, 2005, GENETICS, V170, P327, DOI 10.1534/genetics.104.039479; Yuan JH, 2013, STEM CELLS, V31, P2538, DOI 10.1002/stem.1480; Zhang H, 2012, P NATL ACAD SCI USA, V109, P12580, DOI 10.1073/pnas.1206600109	22	60	63	3	30	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUN 5	2014	157	6					1257	1261		10.1016/j.cell.2014.05.019	http://dx.doi.org/10.1016/j.cell.2014.05.019			5	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	AN8UV	24906145	Green Accepted, Bronze			2022-12-28	WOS:000340881400005
J	Lee, SD; Tontonoz, P				Lee, Stephen D.; Tontonoz, Peter			Eosinophils in Fat: Pink Is the New Brown	CELL			English	Editorial Material								Subcutaneous white adipose tissue can be induced to undergo "browning" and acquire thermogenic capacity in response to physiological stimuli such as cold exposure or exercise. In this issue of Cell, Qiu et al. and Rao et al. demonstrate that pink-staining eosinophils and alternatively activated macrophages play key roles in an immune cascade mediating this metabolic switch.	[Lee, Stephen D.; Tontonoz, Peter] Univ Calif Los Angeles, Howard Hughes Med Inst, Dept Pathol & Lab Med, Los Angeles, CA 90095 USA	Howard Hughes Medical Institute; University of California System; University of California Los Angeles	Tontonoz, P (corresponding author), Univ Calif Los Angeles, Howard Hughes Med Inst, Dept Pathol & Lab Med, Los Angeles, CA 90095 USA.	ptontonoz@mednet.ucla.edu	Lee, Stephen D./B-6616-2008	Lee, Stephen D./0000-0002-4663-9534				Bartelt A, 2014, NAT REV ENDOCRINOL, V10, P24, DOI 10.1038/nrendo.2013.204; Cohen P, 2014, CELL, V156, P304, DOI 10.1016/j.cell.2013.12.021; Nguyen KD, 2011, NATURE, V480, P104, DOI 10.1038/nature10653; Qiu YF, 2014, CELL, V157, P1292, DOI 10.1016/j.cell.2014.03.066; Rao RR, 2014, CELL, V157, P1279, DOI 10.1016/j.cell.2014.03.065; Rosen ED, 2014, CELL, V156, P20, DOI 10.1016/j.cell.2013.12.012; Ruas JL, 2012, CELL, V151, P1319, DOI 10.1016/j.cell.2012.10.050; Shabalina IG, 2013, CELL REP, V5, P1196, DOI 10.1016/j.celrep.2013.10.044; Wu J, 2012, CELL, V150, P366, DOI 10.1016/j.cell.2012.05.016	9	27	27	1	10	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUN 5	2014	157	6					1249	1250		10.1016/j.cell.2014.05.025	http://dx.doi.org/10.1016/j.cell.2014.05.025			2	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	AN8UV	24906141	Bronze			2022-12-28	WOS:000340881400001
J	Song, R; Walentek, P; Sponer, N; Klimke, A; Lee, JS; Dixon, G; Harland, R; Wan, Y; Lishko, P; Lize, M; Kessel, M; He, L				Song, Rui; Walentek, Peter; Sponer, Nicole; Klimke, Alexander; Lee, Joon Sub; Dixon, Gary; Harland, Richard; Wan, Ying; Lishko, Polina; Lize, Muriel; Kessel, Michael; He, Lin			miR-34/449 miRNAs are required for motile ciliogenesis by repressing cp110	NATURE			English	Article							PRIMARY CILIARY DYSKINESIA; EPITHELIAL-CELLS; BASAL BODIES; SMALL RNAS; C-ELEGANS; MICRORNA; XENOPUS; BIOGENESIS; EXPRESSION; MUTATIONS	The mir-34/449 family consists of six homologous miRNAs at three genomic loci. Redundancy of miR-34/449 miRNAs and their dominant expression in multiciliated epithelia suggest a functional significance in ciliogenesis. Here we report that mice deficient for all miR-34/449 miRNAs exhibited postnatal mortality, infertility and strong respiratory dysfunction caused by defective mucociliary clearance. In both mouse and Xenopus, miR-34/449-deficient multiciliated cells (MCCs) exhibited a significant decrease in cilia length and number, due to defective basal body maturation and apical docking. The effect of miR-34/449 on ciliogenesis was mediated, at least in part, by post-transcriptional repression of Cp110, a centriolar protein suppressing cilia assembly. Consistent with this, cp110 knockdown in miR-34/449-deficient MCCs restored ciliogenesis by rescuing basal body maturation and docking. Altogether, our findings elucidate conserved cellular and molecular mechanisms through which miR-34/449 regulate motile ciliogenesis.	[Song, Rui; Sponer, Nicole; Lee, Joon Sub; Dixon, Gary; Lishko, Polina; He, Lin] Univ Calif Berkeley, Div Cellular & Dev Biol, MCB Dept, Berkeley, CA 94705 USA; [Walentek, Peter; Harland, Richard] Univ Calif Berkeley, Div Genet Genom & Dev, MCB Dept, Ctr Integrat Genom, Berkeley, CA 94705 USA; [Klimke, Alexander; Kessel, Michael] Max Planck Inst Biophys Chem, Dept Mol Cell Biol, D-37077 Gottingen, Germany; [Wan, Ying] Third Mil Med Univ, Chongqing 400038, Peoples R China; [Lize, Muriel] Univ Gottingen, Dept Mol Oncol, D-37073 Gottingen, Germany	University of California System; University of California Berkeley; University of California System; University of California Berkeley; Max Planck Society; Army Medical University; University of Gottingen	He, L (corresponding author), Univ Calif Berkeley, Div Cellular & Dev Biol, MCB Dept, Berkeley, CA 94705 USA.	rui.song@berkeley.edu; lhe@berkeley.edu	Lishko, Polina/GQH-9569-2022; Lishko, Polina/L-1191-2017	Lize, Muriel/0000-0002-4954-3503; Lee, Joon Sub/0000-0003-1151-1343; Walentek, Peter/0000-0002-2332-6068	NCI [R01 CA139067, 1R21CA175560-01]; CIRM new faculty award [RN2-00923-1]; TRDRP research grant [21RT-0133]; American Cancer Society (ACS) [123339-RSG-12-265-01-RMC]; Siebel postdoctoral fellowship; CIRM postdoctoral fellowship; Deutsche Forschungsgemeinschaft (DFG) [Wa 3365/1-1]; NIH [GM42341]; Dorothea Schloezer Fellowship; NATIONAL CANCER INSTITUTE [R21CA175560, R01CA139067] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM042341] Funding Source: NIH RePORTER	NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); CIRM new faculty award; TRDRP research grant; American Cancer Society (ACS)(American Cancer Society); Siebel postdoctoral fellowship; CIRM postdoctoral fellowship; Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Dorothea Schloezer Fellowship; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank M. J. Bennett, M. Butler, B. Dynlacht, W. Finkbeiner, P. Kysar, B. Lee, T. Machen, B. Mitchell and J. Wallingford for constructs, technical assistance, stimulating discussions and helpful input. We also thank P. Margolis for careful reading of our manuscript. L. H. acknowledges an R01 and an R21 grant from NCI (R01 CA139067, 1R21CA175560-01), a CIRM new faculty award (RN2-00923-1), a TRDRP research grant (21RT-0133), and a research scholar award from American Cancer Society (ACS, 123339-RSG-12-265-01-RMC). R. S. acknowledges the support of Siebel postdoctoral fellowship and CIRM postdoctoral fellowship. P. W. was funded by the Deutsche Forschungsgemeinschaft (DFG, Wa 3365/1-1), and frog work in the Harland laboratory was funded by NIH grant GM42341. M. L. would like to thank M. Dobbelstein for support and discussions, and was financed by a Dorothea Schloezer Fellowship.	Ambros V, 2004, NATURE, V431, P350, DOI 10.1038/nature02871; Avasthi P, 2012, DIFFERENTIATION, V83, pS30, DOI 10.1016/j.diff.2011.11.015; Cao JL, 2012, NAT CELL BIOL, V14, P697, DOI 10.1038/ncb2512; Castleman VH, 2009, AM J HUM GENET, V84, P197, DOI 10.1016/j.ajhg.2009.01.011; Chang TC, 2007, MOL CELL, V26, P745, DOI 10.1016/j.molcel.2007.05.010; Choi YJ, 2011, NAT CELL BIOL, V13, P1353, DOI 10.1038/ncb2366; D'Angiolella V, 2010, NATURE, V466, P138, DOI 10.1038/nature09140; Deblandre GA, 1999, DEVELOPMENT, V126, P4715; Dehring DAK, 2013, DEV CELL, V27, P103, DOI 10.1016/j.devcel.2013.08.021; Delaval B, 2011, CELL CYCLE, V10, P3964, DOI 10.4161/cc.10.22.18150; Du TT, 2005, DEVELOPMENT, V132, P4645, DOI 10.1242/dev.02070; Fliegauf M, 2007, NAT REV MOL CELL BIO, V8, P880, DOI 10.1038/nrm2278; Gomperts BN, 2004, J CELL SCI, V117, P1329, DOI 10.1242/jcs.00978; Hagenlocher Cathrin, 2013, Cilia, V2, P12, DOI 10.1186/2046-2530-2-12; HE L, 2004, NAT REV GENET, V5, P522; He L, 2007, NAT REV CANCER, V7, P819, DOI 10.1038/nrc2232; He L, 2007, NATURE, V447, P1130, DOI 10.1038/nature05939; Hermeking H, 2007, CANCER CELL, V12, P414, DOI 10.1016/j.ccr.2007.10.028; Hoh RA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052166; Kim VN, 2005, MOL CELLS, V19, P1; Kott E, 2013, AM J HUM GENET, V93, P561, DOI 10.1016/j.ajhg.2013.07.013; Kunimoto K, 2012, CELL, V148, P189, DOI 10.1016/j.cell.2011.10.052; Lai YY, 2011, J ALLERGY CLIN IMMUN, V128, P1207, DOI 10.1016/j.jaci.2011.09.001; LEE RC, 1993, CELL, V75, P843, DOI 10.1016/0092-8674(93)90529-Y; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Li J, 2013, NATURE, V495, P255, DOI 10.1038/nature11941; Lize M, 2011, CELL CYCLE, V10, P2874, DOI 10.4161/cc.10.17.17181; Loges NT, 2008, AM J HUM GENET, V83, P547, DOI 10.1016/j.ajhg.2008.10.001; Marcet B, 2011, NAT CELL BIOL, V13, P693, DOI 10.1038/ncb2241; Marshall WF, 2008, CURR TOP DEV BIOL, V85, P1, DOI 10.1016/S0070-2153(08)00801-6; Marson A, 2008, CELL, V134, P521, DOI 10.1016/j.cell.2008.07.020; Martinez-Anton A, 2013, AM J RESP CELL MOL, V49, P384, DOI 10.1165/rcmb.2012-0368OC; Miranda KC, 2006, CELL, V126, P1203, DOI 10.1016/j.cell.2006.07.031; Miska EA, 2007, PLOS GENET, V3, P2395, DOI 10.1371/journal.pgen.0030215; Okada N., 2014, GENES DEV; Park CY, 2012, CELL REP, V1, P385, DOI 10.1016/j.celrep.2012.02.008; Park TJ, 2008, NAT GENET, V40, P871, DOI 10.1038/ng.104; Raver-Shapira N, 2007, MOL CELL, V26, P731, DOI 10.1016/j.molcel.2007.05.017; Satir P, 2007, ANNU REV PHYSIOL, V69, P377, DOI 10.1146/annurev.physiol.69.040705.141236; Sive Hazel L., 2000, EARLY DEV XENOPUS LA; Spektor A, 2007, CELL, V130, P678, DOI 10.1016/j.cell.2007.06.027; Stubbs JL, 2008, NAT GENET, V40, P1454, DOI 10.1038/ng.267; Tanos BE, 2013, GENE DEV, V27, P163, DOI 10.1101/gad.207043.112; Tsang William Y, 2013, Cilia, V2, P9, DOI 10.1186/2046-2530-2-9; Tsao PN, 2009, DEVELOPMENT, V136, P2297, DOI 10.1242/dev.034884; Vladar EK, 2013, METHOD ENZYMOL, V525, P285, DOI 10.1016/B978-0-12-397944-5.00014-6; Walentek P, 2014, DEVELOPMENT, V141, P1526, DOI 10.1242/dev.102343; Walentek P, 2012, CELL REP, V1, P516, DOI 10.1016/j.celrep.2012.03.005; Werner ME, 2012, GENESIS, V50, P176, DOI 10.1002/dvg.20824; WIGHTMAN B, 1993, CELL, V75, P855, DOI 10.1016/0092-8674(93)90530-4	50	144	149	0	40	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 5	2014	510	7503					115	+		10.1038/nature13413	http://dx.doi.org/10.1038/nature13413			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI3NR	24899310	Green Accepted, Green Submitted			2022-12-28	WOS:000336768900039
J	Wilhelm, M; Schlegl, J; Hahne, H; Gholami, AM; Lieberenz, M; Savitski, MM; Ziegler, E; Butzmann, L; Gessulat, S; Marx, H; Mathieson, T; Lemeer, S; Schnatbaum, K; Reimer, U; Wenschuh, H; Mollenhauer, M; Slotta-Huspenina, J; Boese, JH; Bantscheff, M; Gerstmair, A; Faerber, F; Kuster, B				Wilhelm, Mathias; Schlegl, Judith; Hahne, Hannes; Gholami, Amin Moghaddas; Lieberenz, Marcus; Savitski, Mikhail M.; Ziegler, Emanuel; Butzmann, Lars; Gessulat, Siegfried; Marx, Harald; Mathieson, Toby; Lemeer, Simone; Schnatbaum, Karsten; Reimer, Ulf; Wenschuh, Holger; Mollenhauer, Martin; Slotta-Huspenina, Julia; Boese, Joos-Hendrik; Bantscheff, Marcus; Gerstmair, Anja; Faerber, Franz; Kuster, Bernhard			Mass-spectrometry-based draft of the human proteome	NATURE			English	Article							GROWTH-FACTOR RECEPTOR; NONCODING RNAS; IDENTIFICATION; EXPRESSION; QUANTIFICATION; PROTEINS; DATABASE; REVEALS; PEPTIDE; PROJECT	Proteomes are characterized by large protein-abundance differences, cell-type- and time-dependent expression patterns and post-translational modifications, all of which carry biological information that is not accessible by genomics or transcriptomics. Here we present a mass-spectrometry-based draft of the human proteome and a public, high-performance, in-memory database for real-time analysis of terabytes of big data, called ProteomicsDB. The information assembled from human tissues, cell lines and body fluids enabled estimation of the size of the protein-coding genome, and identified organ-specific proteins and a large number of translated lincRNAs (long intergenic non-coding RNAs). Analysis of messenger RNA and protein-expression profiles of human tissues revealed conserved control of protein abundance, and integration of drug-sensitivity data enabled the identification of proteins predicting resistance or sensitivity. The proteome profiles also hold considerable promise for analysing the composition and stoichiometry of protein complexes. ProteomicsDB thus enables navigation of proteomes, provides biological insight and fosters the development of proteomic technology.	[Wilhelm, Mathias; Hahne, Hannes; Gholami, Amin Moghaddas; Marx, Harald; Lemeer, Simone; Kuster, Bernhard] Tech Univ Munich, Chair Prote & Bioanalyt, D-85354 Freising Weihenstephan, Germany; [Wilhelm, Mathias; Schlegl, Judith; Lieberenz, Marcus; Ziegler, Emanuel; Butzmann, Lars; Gessulat, Siegfried; Boese, Joos-Hendrik; Gerstmair, Anja; Faerber, Franz] SAP AG, D-69190 Walldorf, Germany; [Savitski, Mikhail M.; Mathieson, Toby; Bantscheff, Marcus] Cellzome GmbH, D-69117 Heidelberg, Germany; [Schnatbaum, Karsten; Reimer, Ulf; Wenschuh, Holger] JPT Peptide Technol GmbH, D-12489 Berlin, Germany; [Mollenhauer, Martin; Slotta-Huspenina, Julia] Tech Univ Munich, Inst Pathol, D-81675 Munich, Germany; [Kuster, Bernhard] Ctr Integrated Prot Sci Munich, Munich, Germany	Technical University of Munich; SAP; GlaxoSmithKline; Cellzome GmbH; Technical University of Munich; University of Munich	Kuster, B (corresponding author), Tech Univ Munich, Chair Prote & Bioanalyt, Emil Erlenmeyer Forum 5, D-85354 Freising Weihenstephan, Germany.	kuster@tum.de	Kuster, Bernhard/Q-6031-2016; Ziegler, Emanuel CM/V-4496-2018; Lemeer, Simone/I-4363-2016; Bantscheff, Marcus/AAQ-2903-2021	Kuster, Bernhard/0000-0002-9094-1677; Ziegler, Emanuel CM/0000-0001-8330-7144; Bantscheff, Marcus/0000-0002-8343-8977; Gessulat, Siegfried/0000-0001-5530-0674; Mathieson, Toby/0000-0002-6153-3113; Reimer, Ulf/0000-0002-3375-6889; Wilhelm, Mathias/0000-0002-9224-3258				Ahrne E, 2013, PROTEOMICS, V13, P2567, DOI 10.1002/pmic.201300135; Apweiler R, 2013, NUCLEIC ACIDS RES, V41, pD43, DOI 10.1093/nar/gks1068; Argenzio E, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2010.118; Banfai B, 2012, GENOME RES, V22, P1646, DOI 10.1101/gr.134767.111; Barretina J, 2012, NATURE, V483, P603, DOI 10.1038/nature11003; Beausoleil SA, 2006, NAT BIOTECHNOL, V24, P1285, DOI 10.1038/nbt1240; Beck M, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.82; Cabili MN, 2011, GENE DEV, V25, P1915, DOI 10.1101/gad.17446611; Cox J, 2008, NAT BIOTECHNOL, V26, P1367, DOI 10.1038/nbt.1511; Djebali S, 2012, NATURE, V489, P101, DOI 10.1038/nature11233; Domon B, 2012, PROTEOM CLIN APPL, V6, P609, DOI 10.1002/prca.201200111; Fagerberg L, 2014, MOL CELL PROTEOMICS, V13, P397, DOI 10.1074/mcp.M113.035600; Farrah T, 2014, J PROTEOME RES, V13, P60, DOI 10.1021/pr4010037; Flintoft L, 2013, NAT REV GENET, V14, P3534, DOI 10.1038/nrg3534; Gallien S, 2012, MOL CELL PROTEOMICS, V11, P1709, DOI 10.1074/mcp.O112.019802; Geiger T, 2013, MOL CELL PROTEOMICS, V12, P1709, DOI 10.1074/mcp.M112.024919; Geiger T, 2012, MOL CELL PROTEOMICS, V11, DOI 10.1074/mcp.M111.014050; Gholami AM, 2013, CELL REP, V4, P609, DOI 10.1016/j.celrep.2013.07.018; Gupta N, 2011, J AM SOC MASS SPECTR, V22, P1111, DOI 10.1007/s13361-011-0139-3; Guttman M, 2013, CELL, V154, P240, DOI 10.1016/j.cell.2013.06.009; Havugimana PC, 2012, CELL, V150, P1068, DOI 10.1016/j.cell.2012.08.011; Higdon R, 2011, J PROTEOMICS, V75, P116, DOI 10.1016/j.jprot.2011.06.003; Hisamatsu H, 1996, J EXP MED, V183, P1807, DOI 10.1084/jem.183.4.1807; Hughes GM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0084714; Ingolia NT, 2011, CELL, V147, P789, DOI 10.1016/j.cell.2011.10.002; Johansson HJ, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3175; Klingelhofer J, 2009, FEBS J, V276, P5936, DOI 10.1111/j.1742-4658.2009.07274.x; Koumangoye RB, 2013, MOL CANCER, V12, DOI 10.1186/1476-4598-12-167; Lane L, 2014, J PROTEOME RES, V13, P15, DOI 10.1021/pr401144x; Low TY, 2013, CELL REP, V5, P1469, DOI 10.1016/j.celrep.2013.10.041; Mallick P, 2007, NAT BIOTECHNOL, V25, P125, DOI 10.1038/nbt1275; Marx H, 2013, NAT BIOTECHNOL, V31, P557, DOI 10.1038/nbt.2585; Mertins P, 2013, NAT METHODS, V10, P634, DOI 10.1038/nmeth.2518; Nagaraj N, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.81; Nandi D, 1996, J IMMUNOL, V156, P2361; Ori A, 2013, MOL SYST BIOL, V9, DOI 10.1038/msb.2013.4; Paik YK, 2012, NAT BIOTECHNOL, V30, P221, DOI 10.1038/nbt.2152; Perkins DN, 1999, ELECTROPHORESIS, V20, P3551, DOI 10.1002/(SICI)1522-2683(19991201)20:18<3551::AID-ELPS3551>3.0.CO;2-2; Reiter L, 2009, MOL CELL PROTEOMICS, V8, P2405, DOI 10.1074/mcp.M900317-MCP200; Schirle M, 2003, MOL CELL PROTEOMICS, V2, P1297, DOI 10.1074/mcp.M300087-MCP200; Schwanhausser B, 2011, NATURE, V473, P337, DOI 10.1038/nature10098; Shiromizu T, 2013, J PROTEOME RES, V12, P2414, DOI 10.1021/pr300825v; Tran JC, 2011, NATURE, V480, P254, DOI 10.1038/nature10575; Uhlen M, 2010, NAT BIOTECHNOL, V28, P1248, DOI 10.1038/nbt1210-1248; Vizcaino JA, 2014, NAT BIOTECHNOL, V32, P223, DOI 10.1038/nbt.2839; Wang M, 2012, MOL CELL PROTEOMICS, V11, P492, DOI 10.1074/mcp.O111.014704	46	1259	1289	8	595	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 29	2014	509	7502					582	+		10.1038/nature13319	http://dx.doi.org/10.1038/nature13319			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AH9JC	24870543				2022-12-28	WOS:000336457100041
J	Majeed, A				Majeed, Azeem			PRIMARY CARE Statins for primary prevention of cardiovascular disease	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									[Majeed, Azeem] Univ London Imperial Coll Sci Technol & Med, London, England; [Majeed, Azeem] Univ London Imperial Coll Sci Technol & Med, Dept Primary Care & Publ Hlth, London, England	Imperial College London; Imperial College London	Majeed, A (corresponding author), Univ London Imperial Coll Sci Technol & Med, London, England.	a.majeed@imperial.ac.uk		Majeed, Azeem/0000-0002-2357-9858	Department of Health Funding Source: Medline	Department of Health		Artac M, 2013, FAM PRACT, V30, P426, DOI 10.1093/fampra/cmt002; Artac M, 2013, PREV MED, V57, P129, DOI 10.1016/j.ypmed.2013.05.002; Iacobucci G, 2014, BMJ-BRIT MED J, V348, DOI 10.1136/bmj.g1748; Majeed A, 2014, BMJ; NICE, LIP MOD UPD GUID CON; OECD, 2013, HLTH GLANC 2013 OECD	6	6	6	1	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	MAY 27	2014	348								g3491	10.1136/bmj.g3491	http://dx.doi.org/10.1136/bmj.g3491			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AI3EB	24868092				2022-12-28	WOS:000336741400013
J	Austin, J				Austin, Jim			A science career story	SCIENCE			English	Editorial Material																			0	1	1	0	2	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 23	2014	344	6186					934	934		10.1126/science.344.6186.934	http://dx.doi.org/10.1126/science.344.6186.934			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AH6IL	24855272				2022-12-28	WOS:000336233800054
J	Chiang, CL; Xu, C; Han, ZM; Ho, W				Chiang, Chi-lun; Xu, Chen; Han, Zhumin; Ho, W.			Real-space imaging of molecular structure and chemical bonding by single-molecule inelastic tunneling probe	SCIENCE			English	Article							ATOMIC-FORCE MICROSCOPY; VIBRATIONAL SPECTROSCOPY; RESOLUTION	The arrangement of atoms and bonds in a molecule influences its physical and chemical properties. The scanning tunneling microscope can provide electronic and vibrational signatures of single molecules. However, these signatures do not relate simply to the molecular structure and bonding. We constructed an inelastic tunneling probe based on the scanning tunneling microscope to sense the local potential energy landscape of an adsorbed molecule with a carbon monoxide (CO)-terminated tip. The skeletal structure and bonding of the molecule are revealed from imaging the spatial variations of a CO vibration as the CO-terminated tip probes the core of the interactions between adjacent atoms. An application of the inelastic tunneling probe reveals the sharing of hydrogen atoms among multiple centers in intramolecular and extramolecular bonding.	[Chiang, Chi-lun; Xu, Chen; Han, Zhumin; Ho, W.] Univ Calif Irvine, Dept Phys & Astron, Irvine, CA 92697 USA; [Ho, W.] Univ Calif Irvine, Dept Chem, Irvine, CA 92697 USA	University of California System; University of California Irvine; University of California System; University of California Irvine	Ho, W (corresponding author), Univ Calif Irvine, Dept Phys & Astron, Irvine, CA 92697 USA.	wilsonho@uci.edu	Xu, Chen/GLN-4071-2022; Xu, Chen/B-4517-2014	Xu, Chen/0000-0003-2730-1025	Chemical Science, Geo- and Bioscience Division, Office of Science, U.S. Department of Energy [DE-FG02-04ER15595]	Chemical Science, Geo- and Bioscience Division, Office of Science, U.S. Department of Energy(United States Department of Energy (DOE))	Supported by the Chemical Science, Geo- and Bioscience Division, Office of Science, U.S. Department of Energy, under grant DE-FG02-04ER15595.	Bartels L, 1998, PHYS REV LETT, V80, P2004, DOI 10.1103/PhysRevLett.80.2004; de Oteyza DG, 2013, SCIENCE, V340, P1434, DOI 10.1126/science.1238187; Giessibl FJ, 2000, APPL PHYS LETT, V76, P1470, DOI 10.1063/1.126067; Gross L, 2012, SCIENCE, V337, P1326, DOI 10.1126/science.1225621; Gross L, 2010, NAT CHEM, V2, P821, DOI [10.1038/NCHEM.765, 10.1038/nchem.765]; Gross L, 2009, SCIENCE, V325, P1110, DOI 10.1126/science.1176210; Hahn JR, 2001, PHYS REV LETT, V87, DOI [10.1103/PhysRevLett.87.166102, 10.1103/PhysRevLett.87.196102]; Ham U, 2013, J CHEM PHYS, V138, DOI 10.1063/1.4790704; Ho W, 2002, J CHEM PHYS, V117, P11033, DOI 10.1063/1.1521153; Kichin G, 2011, J AM CHEM SOC, V133, P16847, DOI 10.1021/ja204624g; Lauhon LJ, 2001, REV SCI INSTRUM, V72, P216, DOI 10.1063/1.1327311; Lee HJ, 1999, SCIENCE, V286, P1719, DOI 10.1126/science.286.5445.1719; Liljeroth P, 2007, SCIENCE, V317, P1203, DOI 10.1126/science.1144366; Repp J, 2005, PHYS REV LETT, V94, DOI 10.1103/PhysRevLett.94.026803; Rozas I, 1998, J PHYS CHEM A, V102, P9925, DOI 10.1021/jp9824813; Steiner T, 2002, ANGEW CHEM INT EDIT, V41, P48, DOI 10.1002/1521-3773(20020104)41:1<48::AID-ANIE48>3.0.CO;2-U; Stipe BC, 1998, SCIENCE, V280, P1732, DOI 10.1126/science.280.5370.1732; Weiss C, 2010, PHYS REV LETT, V105, DOI 10.1103/PhysRevLett.105.086103; Weiss C, 2010, J AM CHEM SOC, V132, P11864, DOI 10.1021/ja104332t; Weymouth AJ, 2014, SCIENCE, V343, P1120, DOI 10.1126/science.1249502; Wu SW, 2006, SCIENCE, V312, P1362, DOI 10.1126/science.1124881; Zhang J, 2013, SCIENCE, V342, P611, DOI 10.1126/science.1242603	22	120	123	3	245	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 23	2014	344	6186					885	888		10.1126/science.1253405	http://dx.doi.org/10.1126/science.1253405			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AH6IL	24855265				2022-12-28	WOS:000336233800043
J	Wilensky, GR				Wilensky, Gail R.			The Medicare Data Release Conundrum	ANNALS OF INTERNAL MEDICINE			English	Editorial Material									Project HOPE, Bethesda, MD 20814 USA		Wilensky, GR (corresponding author), Project HOPE, 7500 Old Georgetown Rd,Suite 600, Bethesda, MD 20814 USA.	gwilensky@projecthope.org						Institute of Medicine, 2013, VAR HLTH CAR SPEND T	1	0	0	0	0	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	AUG 19	2014	161	4					293	+		10.7326/M14-1080	http://dx.doi.org/10.7326/M14-1080			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AP8RU	24910966				2022-12-28	WOS:000342347300020
J	Marcotte, L; Moriates, C; Milstein, A				Marcotte, Leah; Moriates, Christopher; Milstein, Arnold			Professional Organizations' Role in Supporting Physicians to Improve Value in Health Care	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							PAYMENT MODIFIER		[Marcotte, Leah] Univ Washington, Dept Med, Seattle, WA 98112 USA; [Moriates, Christopher] Univ Calif San Francisco, Dept Med, San Francisco, CA 94143 USA; [Milstein, Arnold] Stanford Univ, Sch Med, Clin Excellence Res Ctr, Stanford, CA 94305 USA	University of Washington; University of Washington Seattle; University of California System; University of California San Francisco; Stanford University	Marcotte, L (corresponding author), Univ Washington, Dept Med, 619 24th Ave E, Seattle, WA 98112 USA.	leahmar@uw.edu		Moriates, Christopher/0000-0002-3153-2558				American College of Physicians, HIGH VAL CAR; American College of Radiology, ACR APPR CRIT OV; Anderson JL, 2014, CIRCULATION, V129, P2329, DOI 10.1161/CIR.0000000000000042; [Anonymous], UNN TESTS PROC HLTH; Chien AT, 2013, NEW ENGL J MED, V369, P2076, DOI 10.1056/NEJMp1311957; Pollack A., 2014, NY TIMES, pA1; VanLare JM, 2012, JAMA-J AM MED ASSOC, V308, P2089, DOI 10.1001/jama.2012.14834	7	9	9	0	6	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUL 16	2014	312	3					231	232		10.1001/jama.2014.6762	http://dx.doi.org/10.1001/jama.2014.6762			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AL2FC	24901503				2022-12-28	WOS:000338940300016
J	Brennan, N; Conway, PH; Tavenner, M				Brennan, Niall; Conway, Patrick H.; Tavenner, Marilyn			The Medicare Physician-Data Release - Context and Rationale	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Brennan, Niall; Conway, Patrick H.; Tavenner, Marilyn] Ctr Medicare Serv, Baltimore, MD 21244 USA; [Brennan, Niall; Conway, Patrick H.; Tavenner, Marilyn] Ctr Medicaid Serv, Baltimore, MD USA; [Conway, Patrick H.] Cincinnati Childrens Hosp Med Ctr, Dept Pediat, Cincinnati, OH 45229 USA	Centers for Medicare & Medicaid Services; Centers for Medicare & Medicaid Services; Cincinnati Children's Hospital Medical Center	Brennan, N (corresponding author), Ctr Medicare Serv, Baltimore, MD 21244 USA.							[Anonymous], 2014, WASHINGTON POST; [Anonymous], 2014, NY TIMES; Centers for Medicare and Medicaid Services, 2013, QUAL ENT PROGR; Centers for Medicare and Medicaid Services, PUBL COMM REL MED PH	4	24	24	0	0	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUL 10	2014	371	2					99	101		10.1056/NEJMp1405026	http://dx.doi.org/10.1056/NEJMp1405026			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	AK7YZ	24869599				2022-12-28	WOS:000338645500004
J	Fuentes, I; Stegemann, S; Golczyk, H; Karcher, D; Bock, R				Fuentes, Ignacia; Stegemann, Sandra; Golczyk, Hieronim; Karcher, Daniel; Bock, Ralph			Horizontal genome transfer as an asexual path to the formation of new species	NATURE			English	Article							COMPLETE NUCLEOTIDE-SEQUENCE; INTERCELLULAR MOVEMENT; TISSUE; PLANTS; ORGANIZATION; POLYPLOIDY; PROTOPLASM; DIVERSITY; NUCLEAR; GLAUCA	Allopolyploidization, the combination of the genomes from two different species, has been a major source of evolutionary innovation and a driver of speciation and environmental adaptation(1-4). Inplants, it has also contributed greatly to crop domestication, as the superior properties of many modern crop plants were conferred by ancient allopolyploidization events(5,6). It is generally thought that allopolyploidization occurred through hybridization events between species, accompanied or followed by genome duplication(6,7). Although many allopolyploids arose from closely related species (congeners), there are also allopolyploid species that were formed from more distantly related progenitor species belonging to different genera or even different tribes(8). Here we have examined the possibility that allopolyploidization can also occur by asexual mechanisms. We show that upon grafting-a mechanism of plant-plant interaction that is widespread in nature-entire nuclear genomes can be transferred between plant cells. We provide direct evidence for this process resulting in speciation by creating a new allopolyploid plant species from a herbaceous species and a woody species in the nightshade family. The new species is fertile and produces fertile progeny. Our data highlight natural grafting as a potential asexual mechanism of speciation and also provide a method for the generation of novel allopolyploid crop species.	[Fuentes, Ignacia; Stegemann, Sandra; Karcher, Daniel; Bock, Ralph] Max Planck Inst Mol Pflanzenphysiol, D-14476 Potsdam, Germany; [Golczyk, Hieronim] John Paul II Catholic Univ Lublin, Inst Biotechnol, Dept Mol Biol, PL-20708 Lublin, Poland	Max Planck Society; Catholic University of Lublin	Bock, R (corresponding author), Max Planck Inst Mol Pflanzenphysiol, Muhlenberg 1, D-14476 Potsdam, Germany.	rbock@mpimp-golm.mpg.de	Fuentes, Ignacia/G-4785-2016; Bock, Ralph/B-4352-2009	Bock, Ralph/0000-0001-7502-6940; Karcher, Daniel/0000-0001-6393-7376	Max Planck Society	Max Planck Society(Max Planck SocietyFoundation CELLEX)	We thank the MPI-MP Green Team for help with plant transformation, K. Kohl for providing the hpt vector and S. Ruf (MPI-MP) for discussions. We are grateful to J. Fuchs (IPK Gatersleben) for advice on flow cytometry measurements. This research was financed by the Max Planck Society.	Beddie A. D., 1942, T P R SOC NZ, V71, P199; Bock R, 2010, TRENDS PLANT SCI, V15, P11, DOI 10.1016/j.tplants.2009.10.001; Chester M, 2012, P NATL ACAD SCI USA, V109, P1176, DOI 10.1073/pnas.1112041109; Comai L, 2005, NAT REV GENET, V6, P836, DOI 10.1038/nrg1711; Dolezel J, 2007, NAT PROTOC, V2, P2233, DOI 10.1038/nprot.2007.310; Doyle JJ., 1987, FOCUS, V19, P11, DOI DOI 10.2307/2419362; EVANS DA, 1980, PHYSIOL PLANTARUM, V48, P225, DOI 10.1111/j.1399-3054.1980.tb03246.x; GALBRAITH DW, 1983, SCIENCE, V220, P1049, DOI 10.1126/science.220.4601.1049; Greiner S, 2013, BIOESSAYS, V35, P354, DOI 10.1002/bies.201200137; Hegarty MJ, 2008, CURR BIOL, V18, pR435, DOI 10.1016/j.cub.2008.03.043; Joly S, 2009, MOL PHYLOGENET EVOL, V51, P365, DOI 10.1016/j.ympev.2009.02.015; KUSTER E, 1899, JB WISS BOT, V0033, P00487; Larson P.R., 1994, SPRINGER SERIES, P1; Leitch AR, 2008, SCIENCE, V320, P481, DOI 10.1126/science.1153585; Madlung A, 2005, PLANT J, V41, P221, DOI 10.1111/j.1365-313X.2004.02297.x; Madlung A, 2013, HEREDITY, V110, P99, DOI 10.1038/hdy.2012.79; MELARAGNO JE, 1993, PLANT CELL, V5, P1661, DOI 10.1105/tpc.5.11.1661; Moon HS, 2008, GENOME, V51, P547, DOI 10.1139/G08-039; Mudge K., 2009, Horticultural Reviews, V35, P437; MURASHIGE T, 1962, PHYSIOL PLANTARUM, V15, P473, DOI 10.1111/j.1399-3054.1962.tb08052.x; Mursalimov SR, 2013, PLANTA, V238, P415, DOI 10.1007/s00425-013-1914-0; Paterson AH, 2005, GENETICA, V123, P191, DOI 10.1007/s10709-003-2742-0; Pontes O, 2004, P NATL ACAD SCI USA, V101, P18240, DOI 10.1073/pnas.0407258102; Seidel C. F., 1879, NATURWISS GES ISIS D, P161; SHEPARD JF, 1983, SCIENCE, V219, P683, DOI 10.1126/science.219.4585.683; SHINOZAKI K, 1986, EMBO J, V5, P2043, DOI 10.1002/j.1460-2075.1986.tb04464.x; Sobel JM, 2010, EVOLUTION, V64, P295, DOI 10.1111/j.1558-5646.2009.00877.x; Soltis PS, 2009, ANNU REV PLANT BIOL, V60, P561, DOI 10.1146/annurev.arplant.043008.092039; Stegemann S, 2012, P NATL ACAD SCI USA, V109, P2434, DOI 10.1073/pnas.1114076109; Stegemann S, 2009, SCIENCE, V324, P649, DOI 10.1126/science.1170397; Sugiyama Y, 2005, MOL GENET GENOMICS, V272, P603, DOI 10.1007/s00438-004-1075-8; Thyssen G, 2012, P NATL ACAD SCI USA, V109, P2439, DOI 10.1073/pnas.1114297109; Trojak-Goluch A, 2003, J APPL GENET, V44, P45; Xiong ZY, 2011, P NATL ACAD SCI USA, V108, P7908, DOI 10.1073/pnas.1014138108; YU HS, 1994, PLANT CELL, V6, P1477, DOI 10.1105/tpc.6.10.1477; ZHANG WC, 1990, PROTOPLASMA, V153, P193, DOI 10.1007/BF01354004; Zhang WC, 2002, ACTA BOT SIN, V44, P1068	37	123	140	7	185	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 10	2014	511	7508					232	+		10.1038/nature13291	http://dx.doi.org/10.1038/nature13291			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK8AP	24909992				2022-12-28	WOS:000338649800046
J	Rodgers, JT; King, KY; Brett, JO; Cromie, MJ; Charville, GW; Maguire, KK; Brunson, C; Mastey, N; Liu, L; Tsai, CR; Goodell, MA; Rando, TA				Rodgers, Joseph T.; King, Katherine Y.; Brett, Jamie O.; Cromie, Melinda J.; Charville, Gregory W.; Maguire, Katie K.; Brunson, Christopher; Mastey, Namrata; Liu, Ling; Tsai, Chang-Ru; Goodell, Margaret A.; Rando, Thomas A.			mTORC1 controls the adaptive transition of quiescent stem cells from G(0) to G(Alert)	NATURE			English	Article							HEPATOCYTE GROWTH-FACTOR; SKELETAL-MUSCLE; MOLECULAR REGULATION; EXPRESSION DATA; REGENERATION; PROGENITORS; RENEWAL; EVENTS; SYSTEM; INJURY	A unique property of many adult stem cells is their ability to exist in a non-cycling, quiescent state(1). Although quiescence serves an essential role in preserving stem cell function until the stem cell is needed in tissue homeostasis or repair, defects in quiescence can lead to an impairment in tissue function(2). The extent to which stem cells can regulate quiescence is unknown. Here we show that the stem cell quiescent state is composed of two distinct functional phases, G(0) and an 'alert' phase we term G(Alert). Stem cells actively and reversibly transition between these phases in response to injury-induced systemic signals. Using genetic mouse models specific to muscle stem cells (or satellite cells), we show that mTORC1 activity is necessary and sufficient for the transition of satellite cells from G(0) into G(Alert) and that signalling through the HGF receptor cMet is also necessary. We also identify G(0)-to-G(Alert) transitions in several populations of quiescent stem cells. Quiescent stem cells that transition into GAlert possess enhanced tissue regenerative function. We propose that the transition of quiescent stem cells into G(Alert) functions as an 'alerting' mechanism, an adaptive response that positions stem cells to respond rapidly under conditions of injury and stress, priming them for cell cycle entry.	[Rodgers, Joseph T.; Brett, Jamie O.; Cromie, Melinda J.; Charville, Gregory W.; Maguire, Katie K.; Brunson, Christopher; Mastey, Namrata; Liu, Ling; Rando, Thomas A.] Stanford Univ, Sch Med, Paul F Glenn Labs Biol Aging, Stanford, CA 94305 USA; [Rodgers, Joseph T.; Brett, Jamie O.; Cromie, Melinda J.; Charville, Gregory W.; Maguire, Katie K.; Brunson, Christopher; Mastey, Namrata; Liu, Ling; Rando, Thomas A.] Stanford Univ, Sch Med, Dept Neurol & Neurol Sci, Stanford, CA 94305 USA; [King, Katherine Y.; Tsai, Chang-Ru; Goodell, Margaret A.] Baylor Coll Med, Dept Pediat, Houston, TX 77030 USA; [King, Katherine Y.; Tsai, Chang-Ru; Goodell, Margaret A.] Baylor Coll Med, Program Dev Biol, Houston, TX 77030 USA; [Rando, Thomas A.] Vet Affairs Palo Alto Hlth Care Syst, Neurol Serv, Palo Alto, CA 94304 USA; [Rando, Thomas A.] Vet Affairs Palo Alto Hlth Care Syst, Rehabil Res & Dev Ctr Excellence, Palo Alto, CA 94304 USA	Stanford University; Stanford University; Baylor College of Medicine; Baylor College of Medicine; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Palo Alto Health Care System; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Palo Alto Health Care System	Rando, TA (corresponding author), Stanford Univ, Sch Med, Paul F Glenn Labs Biol Aging, Stanford, CA 94305 USA.	rando@stanford.edu	King, Katherine/AAI-2436-2021	Goodell, Margaret A./0000-0003-1111-2932; Rodgers, Joseph/0000-0002-6598-5520; Rando, Thomas/0000-0001-5843-8564; King, Katherine/0000-0002-5093-6005	Glenn Foundation for Medical Research; Department of Veterans Affairs; National Institutes of Health [K99 AG041764, K08 HL098898, R01 DK092883, P01 AG036695, R01 AG23806, R01 AR062185]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K08HL098898] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR062185] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK092883] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG047820, R37AG023806, K99AG041764, R01AG023806, F30AG035521, P01AG036695] Funding Source: NIH RePORTER; Veterans Affairs [I01BX002324] Funding Source: NIH RePORTER	Glenn Foundation for Medical Research; Department of Veterans Affairs(US Department of Veterans Affairs); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Veterans Affairs(US Department of Veterans Affairs)	We would like to thank members of the Rando laboratory for discussions critical to the preparation of this manuscript, especially T. Cheung and S. Biressi. We thank L. Rott for providing assistance with FACS. This work was supported by The Glenn Foundation for Medical Research, by a grant from the Department of Veterans Affairs to T. A. R., and grants from the National Institutes of Health to J.T.R. (K99 AG041764), K.Y.K (K08 HL098898), M.A.G. (R01 DK092883) and to T.A.R. (P01 AG036695, R01 AG23806 and R01 AR062185).	Baldridge MT, 2010, NATURE, V465, P793, DOI 10.1038/nature09135; Brack AS, 2012, CELL STEM CELL, V10, P504, DOI 10.1016/j.stem.2012.04.001; Breitling R, 2004, FEBS LETT, V573, P83, DOI 10.1016/j.febslet.2004.07.055; Chakkalakal JV, 2012, NATURE, V490, P355, DOI 10.1038/nature11438; Charge SBP, 2004, PHYSIOL REV, V84, P209, DOI 10.1152/physrev.00019.2003; Chen C, 2008, J EXP MED, V205, P2397, DOI 10.1084/jem.20081297; Cheung TH, 2013, NAT REV MOL CELL BIO, V14, P329, DOI 10.1038/nrm3591; Cheung TH, 2012, NATURE, V482, P524, DOI 10.1038/nature10834; Fontanillo C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024289; Gan B, 2008, P NATL ACAD SCI USA, V105, P19384, DOI 10.1073/pnas.0810584105; Hong FX, 2006, BIOINFORMATICS, V22, P2825, DOI 10.1093/bioinformatics/btl476; Huh CG, 2004, P NATL ACAD SCI USA, V101, P4477, DOI 10.1073/pnas.0306068101; Joe AWB, 2010, NAT CELL BIOL, V12, P153, DOI 10.1038/ncb2015; Johnson WE, 2007, BIOSTATISTICS, V8, P118, DOI 10.1093/biostatistics/kxj037; Kanehisa M, 2012, NUCLEIC ACIDS RES, V40, pD109, DOI 10.1093/nar/gkr988; Kwiatkowski DJ, 2002, HUM MOL GENET, V11, P525, DOI 10.1093/hmg/11.5.525; Laplante M, 2012, CELL, V149, P274, DOI 10.1016/j.cell.2012.03.017; Li LH, 2010, SCIENCE, V327, P542, DOI 10.1126/science.1180794; Liu L, 2013, CELL REP, V4, P189, DOI 10.1016/j.celrep.2013.05.043; Mieczkowski J, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-104; Miller JA, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-322; Miyazawa K, 2010, FEBS J, V277, P2208, DOI 10.1111/j.1742-4658.2010.07637.x; Nakamura T, 2010, P JPN ACAD B-PHYS, V86, P588, DOI 10.2183/pjab.86.588; Nishijo K, 2009, FASEB J, V23, P2681, DOI 10.1096/fj.08-128116; PARDEE AB, 1989, SCIENCE, V246, P603, DOI 10.1126/science.2683075; Rossi L, 2012, CELL STEM CELL, V11, P302, DOI 10.1016/j.stem.2012.08.006; Seale P, 2000, CELL, V102, P777, DOI 10.1016/S0092-8674(00)00066-0; Sengupta S, 2010, NATURE, V468, P1100, DOI 10.1038/nature09584; SOPRANO KJ, 1994, J CELL BIOCHEM, V54, P405, DOI 10.1002/jcb.240540407; Tatsumi R, 1998, DEV BIOL, V194, P114, DOI 10.1006/dbio.1997.8803; Trusolino L, 2010, NAT REV MOL CELL BIO, V11, P834, DOI 10.1038/nrm3012; Uezumi A, 2010, NAT CELL BIOL, V12, P143, DOI 10.1038/ncb2014; Valentini G, 2006, BIOINFORMATICS, V22, P369, DOI 10.1093/bioinformatics/bti817; Wilson A, 2008, CELL, V135, P1118, DOI 10.1016/j.cell.2008.10.048; Yamada M, 2010, AM J PHYSIOL-CELL PH, V298, pC465, DOI 10.1152/ajpcell.00449.2009	35	404	420	1	40	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	JUN 19	2014	510	7505					393	+		10.1038/nature13255	http://dx.doi.org/10.1038/nature13255			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AJ0NG	24870234	Green Accepted			2022-12-28	WOS:000337350200034
J	Chatterjee, P; Vardhan, H				Chatterjee, Patralekha; Vardhan, Harsh			ELECTIONS 2014 Who is India's new health minister?	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												patralekha.chatterjee@gmail.com						Ministry of Health and Family Welfare, 2014, FREE DRUG POL BE STR; Tiwary D., 2014, CORRUPTION TAINT DID	2	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JUN 10	2014	348								g3854	10.1136/bmj.g3854	http://dx.doi.org/10.1136/bmj.g3854			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AJ1FH	24915971				2022-12-28	WOS:000337400800009
J	Holman, RR; Sourij, H; Califf, RM				Holman, Rury R.; Sourij, Harald; Califf, Robert M.			Cardiovascular outcome trials of glucose-lowering drugs or strategies in type 2 diabetes	LANCET			English	Article							ACUTE MYOCARDIAL-INFARCTION; FOLLOW-UP; CLINICAL-TRIAL; VASCULAR COMPLICATIONS; SEVERE HYPOGLYCEMIA; FDA GUIDANCE; RISK; INSULIN; MORTALITY; DESIGN	Few trials of glucose-lowering drugs or strategies in people with type 2 diabetes have investigated cardiovascular outcomes, even though most patients die from cardiovascular causes despite the beneficial effects of lipid-reducing and blood pressure-lowering treatments. The evidence-based reduction in risk of microvascular disease with glucose lowering has resulted in guidelines worldwide recommending optimisation of glycosylated haemoglobin, but no trial results have shown unequivocal cardiovascular risk reduction with glucose lowering. However, results of the post-trial follow-up of the UK Prospective Diabetes Study, and of a meta-analysis of the four glucose-lowering outcome trials completed to date, suggest about a 15% cardiovascular relative risk reduction per 1% decrement in HbA(1c). The 2008 US Food and Drug Administration industry guidance for licensing of antidiabetic drugs greatly increased the number of cardiovascular outcome trials in diabetes, but most trials opted for non-inferiority designs aiming primarily to show absence of cardiovascular toxicity in the shortest possible time. This unintended consequence of the new regulations has meant that the potential long-term benefits, and the possible risks of new therapies, are not being assessed effectively. Also, essential head-to-head trials of therapies for this complex progressive disease, to answer issues such as how best to achieve and maintain optimum glycaemia without promoting weight gain or hypoglycaemia, are not being undertaken. In this Series paper, we summarise randomised controlled cardiovascular outcome trials in type 2 diabetes, provide an overview of ongoing trials and their limitations, and speculate on how future trials could be made more efficient and effective.	[Holman, Rury R.; Sourij, Harald] Univ Oxford, Diabet Trials Unit, Oxford, England; [Sourij, Harald] Med Univ Graz, Div Endocrinol & Metab, Graz, Austria; [Califf, Robert M.] Duke Univ, Sch Med, Duke Clin Res Inst, Durham, NC USA	University of Oxford; Medical University of Graz; Duke University	Holman, RR (corresponding author), Churchill Hosp, OCDEM, Diabet Trials Unit, Old Rd, Oxford OX3 7LJ, England.	rury.holman@dtu.ox.ac.uk	Sourij, Harald/V-3370-2019	Sourij, Harald/0000-0003-3510-9594				[Anonymous], 2012, GUID CLIN INV MED PR; Bari D Study Grp, 2009, NEW ENGL J MED, V360, P2503, DOI 10.1056/NEJMoa0805796; Barker AD, CLIN PHARM, V86, P97; Bethel MA, 2012, DIABETES, V61, pA264; Bethel MA, 2012, CURR CARDIOL REP, V14, DOI 10.1007/s11886-011-0229-7; Bonds DE, 2010, BMJ-BRIT MED J, V340, DOI 10.1136/bmj.b4909; Cleland JGE, 2004, EUR J HEART FAIL, V6, P1, DOI 10.1016/j.eheart.2003.12.001; Cobo Erik, 2008, Bull World Health Organ, V86, pC; Dormandy JA, 2005, LANCET, V366, P1279, DOI 10.1016/S0140-6736(05)67528-9; Dormandy J, 2009, DRUG SAFETY, V32, P187, DOI 10.2165/00002018-200932030-00002; Duckworth W, 2009, NEW ENGL J MED, V360, P129, DOI 10.1056/NEJMoa0808431; Endocrinologic and Metabolic Drug Advisory Committee Novo Nordisk, BRIEF DOC INS DEGL I; Ferwana M, 2013, DIABETIC MED, V30, P1026, DOI 10.1111/dme.12144; Frederich R, 2010, POSTGRAD MED, V122, P16, DOI 10.3810/pgm.2010.05.2138; Frobert O, 2013, NEW ENGL J MED, V369, P1587, DOI 10.1056/NEJMoa1308789; Gallin EK, 2013, ACAD MED, V88, P1220, DOI 10.1097/ACM.0b013e31829ed2a7; Gerstein HC, 2008, NEW ENGL J MED, V358, P2545, DOI 10.1056/NEJMoa0802743; Gerstein HC, 2012, NEW ENGL J MED, V367, P319, DOI 10.1056/NEJMoa1203858; Griffin SJ, 2011, LANCET, V378, P156, DOI 10.1016/S0140-6736(11)60698-3; Hemkens LG, 2009, DIABETOLOGIA, V52, P1732, DOI 10.1007/s00125-009-1418-4; Hess CN, 2013, AM HEART J, V166, P421, DOI 10.1016/j.ahj.2013.06.013; Holman RR, 2008, NEW ENGL J MED, V359, P1577, DOI 10.1056/NEJMoa0806470; Home PD, 2009, LANCET, V373, P2125, DOI 10.1016/S0140-6736(09)60953-3; International Diabetes Federation, DIABETES ATLAS, V9th; Inzucchi SE, 2012, DIABETOLOGIA, V55, P1577, DOI 10.1007/s00125-012-2534-0; Jonasson JM, 2009, DIABETOLOGIA, V52, P1745, DOI 10.1007/s00125-009-1444-2; Kahn SE, 2008, DIABETES CARE, V31, P845, DOI 10.2337/dc07-2270; Kent DM, 2010, TRIALS, V11, DOI 10.1186/1745-6215-11-85; Lauer MS, 2013, NEW ENGL J MED, V369, P1579, DOI 10.1056/NEJMp1310102; Little RJ, 2012, NEW ENGL J MED, V367, P1355, DOI 10.1056/NEJMsr1203730; Malmberg K, 2005, EUR HEART J, V26, P650, DOI 10.1093/eurheartj/ehi199; Malmberg K, 1997, BRIT MED J, V314, P1512, DOI 10.1136/bmj.314.7093.1512; MEINERT CL, 1970, DIABETES, V19, P789; Mellbin LG, 2013, EUR HEART J, V34, P3137, DOI 10.1093/eurheartj/eht332; Monami M, 2010, NUTR METAB CARDIOVAS, V20, P224, DOI 10.1016/j.numecd.2009.03.015; Nathan DM, 2005, NEW ENGL J MED, V353, P2643, DOI 10.1056/nejmoa052187; Nissen SE, 2007, NEW ENGL J MED, V356, P2457, DOI 10.1056/NEJMoa072761; Nissen SE, 2010, ARCH INTERN MED, V170, P1191, DOI 10.1001/archinternmed.2010.207; Patel A, 2008, NEW ENGL J MED, V358, P2560, DOI 10.1056/NEJMoa0802987; Punthakee Z, 2012, DIABETOLOGIA, V55, P36, DOI 10.1007/s00125-011-2357-4; Raz I, 2009, DIABETES CARE, V32, P381, DOI 10.2337/dc08-1671; Riddle MC, 2010, DIABETES CARE, V33, P983, DOI 10.2337/dc09-1278; Scirica BM, 2013, NEW ENGL J MED, V369, P1317, DOI 10.1056/NEJMoa1307684; Selby JV, 2014, NEW ENGL J MED, V370, P592, DOI 10.1056/NEJMp1313061; Seshasai SRK, 2011, NEW ENGL J MED, V364, P829, DOI 10.1056/NEJMoa1008862; SIPERSTEIN MD, 1968, J CLIN INVEST, V47, P1973, DOI 10.1172/JCI105886; Stearne MR, 1998, BMJ-BRIT MED J, V317, P703; Turnbull FM, 2009, DIABETOLOGIA, V52, P2288, DOI 10.1007/s00125-009-1470-0; Turner RC, 1998, LANCET, V352, P854, DOI 10.1016/s0140-6736(98)07037-8; Turner RC, 1998, LANCET, V352, P837, DOI 10.1016/s0140-6736(98)07019-6; US Department of Health and Human Services Food and Drug Administration, 2013, JOINT M END MET DRUG; US Department of Health and Human Services Food and Drug Administration, SUMM REV LIN; US Department of Health and Human Services Food and Drug Administration Center for Drug Evaluation and Research, GUID IND DIAB MELL E; White WB, 2013, NEW ENGL J MED, V369, P1327, DOI 10.1056/NEJMoa1305889; Wing R, 2013, NEW ENGL J MED, V369, P145, DOI 10.1056/NEJMoa1212914; Zoungas S, 2010, NEW ENGL J MED, V363, P1410, DOI 10.1056/NEJMoa1003795	56	165	170	1	32	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JUN 7	2014	383	9933					2008	2017		10.1016/S0140-6736(14)60794-7	http://dx.doi.org/10.1016/S0140-6736(14)60794-7			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AI4PV	24910232				2022-12-28	WOS:000336848200029
J	Ley, SH; Hamdy, O; Mohan, V; Hu, FB				Ley, Sylvia H.; Hamdy, Osama; Mohan, Viswanathan; Hu, Frank B.			Prevention and management of type 2 diabetes: dietary components and nutritional strategies	LANCET			English	Article							IMPAIRED GLUCOSE-TOLERANCE; CORONARY-HEART-DISEASE; LIFE-STYLE; CARDIOVASCULAR-DISEASE; INSULIN-RESISTANCE; WEIGHT-LOSS; POSTMENOPAUSAL WOMEN; ALCOHOL-CONSUMPTION; LOW-CARBOHYDRATE; MAGNESIUM INTAKE	In the past couple of decades, evidence from prospective observational studies and clinical trials has converged to support the importance of individual nutrients, foods, and dietary patterns in the prevention and management of type 2 diabetes. The quality of dietary fats and carbohydrates consumed is more crucial than is the quantity of these macronutrients. Diets rich in wholegrains, fruits, vegetables, legumes, and nuts; moderate in alcohol consumption; and lower in refined grains, red or processed meats, and sugar-sweetened beverages have been shown to reduce the risk of diabetes and improve glycaemic control and blood lipids in patients with diabetes. With an emphasis on overall diet quality, several dietary patterns such as Mediterranean, low glycaemic index, moderately low carbohydrate, and vegetarian diets can be tailored to personal and cultural food preferences and appropriate calorie needs for weight control and diabetes prevention and management. Although much progress has been made in development and implementation of evidence-based nutrition recommendations in developed countries, concerted worldwide efforts and policies are warranted to alleviate regional disparities.	[Ley, Sylvia H.; Hu, Frank B.] Harvard Univ, Sch Publ Hlth, Dept Nutr, Boston, MA 02115 USA; [Hu, Frank B.] Harvard Univ, Sch Publ Hlth, Dept Epidemiol, Boston, MA 02115 USA; [Hamdy, Osama] Joslin Diabet Ctr, Boston, MA 02215 USA; [Mohan, Viswanathan] Dr Mohans Diabet Special Ctr, Madras, Tamil Nadu, India; [Mohan, Viswanathan] Madras Diabet Res Fdn, Madras, Tamil Nadu, India	Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Joslin Diabetes Center, Inc.; Madras Diabetes Research Foundation	Hu, FB (corresponding author), Harvard Univ, Sch Publ Hlth, Dept Nutr, 665 Huntington Ave, Boston, MA 02115 USA.	frank.hu@channing.harvard.edu		Ley, Sylvia/0000-0003-0084-2630; hamdy, osama/0000-0002-1919-0268	NIH [DK58845, U54 CA155626, HL60712, P30DK046200]; CIHR; NATIONAL CANCER INSTITUTE [U54CA155626] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL060712] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK058845, P30DK046200] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); CIHR(Canadian Institutes of Health Research (CIHR)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	FBH is supported by NIH grants DK58845, U54 CA155626, HL60712, and P30DK046200. SHL is supported by a CIHR Fellowship Award. These funding sources had no involvement in the writing of the review.	Ajala O, 2013, AM J CLIN NUTR, V97, P505, DOI 10.3945/ajcn.112.042457; Amer Diabet Assoc, 2014, DIABETES CARE, V37, pS14, DOI 10.2337/dc14-S014; Appel LJ, 1997, NEW ENGL J MED, V336, P1117, DOI 10.1056/NEJM199704173361601; Aune D, 2013, EUR J EPIDEMIOL, V28, P845, DOI 10.1007/s10654-013-9852-5; Azadbakht L, 2011, J NUTR, V141, P1083, DOI 10.3945/jn.110.136739; Azadbakht L, 2011, DIABETES CARE, V34, P55, DOI 10.2337/dc10-0676; Baliunas DO, 2009, DIABETES CARE, V32, P2123, DOI 10.2337/dc09-0227; Bantle AE, 2008, METABOLISM, V57, P241, DOI 10.1016/j.metabol.2007.09.007; Barnard ND, 2009, AM J CLIN NUTR, V89, pS1588, DOI 10.3945/ajcn.2009.26736H; Bhupathiraju SN, 2014, AM J CLIN NUTR, V100, P218, DOI 10.3945/ajcn.113.079533; Bosch J, 2012, NEW ENGL J MED, V367, P309, DOI 10.1056/NEJMoa1203859; Carter Patrice, 2010, BMJ, V341, pc4229, DOI 10.1136/bmj.c4229; Chiuve SE, 2012, J NUTR, V142, P1009, DOI 10.3945/jn.111.157222; Cooper AJ, 2012, EUR J CLIN NUTR, V66, P1082, DOI 10.1038/ejcn.2012.85; De Koning L, 2011, DIABETES CARE, V34, P1150, DOI 10.2337/dc10-2352; Ding M, 2014, DIABETES CARE, V37, P569, DOI 10.2337/dc13-1203; Dong JY, 2011, DIABETES CARE, V34, P2116, DOI 10.2337/dc11-0518; Dworatzek PD, 2013, CAN J DIABETES, V37, pS45, DOI 10.1016/j.jcjd.2013.01.019; Dyson PA, 2011, DIABETIC MED, V28, P1282, DOI [10.1111/dme.13603, 10.1111/j.1464-5491.2011.03371.x]; Ekinci EI, 2011, DIABETES CARE, V34, P703, DOI 10.2337/dc10-1723; Espeland M, 2007, DIABETES CARE, V30, P1374; Esposito K, 2010, DIABETES RES CLIN PR, V89, P97, DOI 10.1016/j.diabres.2010.04.019; Esposito K, 2009, ANN INTERN MED, V151, P306, DOI 10.7326/0003-4819-151-5-200909010-00004; Estruch R, 2013, NEW ENGL J MED, V368, P1279, DOI 10.1056/NEJMoa1200303; Evert AB, 2013, DIABETES CARE, V36, P3821, DOI 10.2337/dc13-2042; Ezzati M, 2013, NEW ENGL J MED, V369, P954, DOI 10.1056/NEJMra1203528; Faulconbridge LF, 2012, OBESITY, V20, P783, DOI 10.1038/oby.2011.315; Foster GD, 2009, ARCH INTERN MED, V169, P1619, DOI 10.1001/archinternmed.2009.266; Fung TT, 2004, ARCH INTERN MED, V164, P2235, DOI 10.1001/archinte.164.20.2235; Gardner C, 2012, CIRCULATION, V126, P509, DOI 10.1161/CIR.0b013e31825c42ee; Gerstein HC, 2013, NEW ENGL J MED, V369, P189, DOI 10.1056/NEJMe1306987; Gloy VL, 2013, BMJ-BRIT MED J, V347, DOI 10.1136/bmj.f5934; Halton TL, 2008, AM J CLIN NUTR, V87, P339, DOI 10.1093/ajcn/87.2.339; Hauner H, 2012, ANN NUTR METAB, V60, P1, DOI 10.1159/000335326; Heidemann C, 2005, DIABETOLOGIA, V48, P1126, DOI 10.1007/s00125-005-1743-1; Hu EA, 2012, BMJ-BRIT MED J, V15, P344, DOI DOI 10.1136/BMJ.E1454; Hu FB, 2001, NEW ENGL J MED, V345, P790, DOI 10.1056/NEJMoa010492; Hu FB, 2003, CIRCULATION, V107, P1852, DOI 10.1161/01.CIR.0000062644.42133.5F; Hu FB, 2001, DIABETOLOGIA, V44, P805, DOI 10.1007/s001250100547; Hu FB, 2008, METABOLIC CONSEQUENC, P149; Hu FB, 2011, DIABETES CARE, V34, P1249, DOI 10.2337/dc11-0442; Imamura F, 2009, AM J CLIN NUTR, V90, P1075, DOI 10.3945/ajcn.2009.28009; InterAct Project, 2011, DIABETES CARE, V34, P1913, DOI 10.2337/dc11-0891; International Diabetes Federation, 2013, IDF DIABETES ATLAS; Jiang R, 2002, JAMA-J AM MED ASSOC, V288, P2554, DOI 10.1001/jama.288.20.2554; Joosten MM, 2008, DIABETOLOGIA, V51, P1375, DOI 10.1007/s00125-008-1031-y; Knowler WC, 2002, NEW ENGL J MED, V346, P393, DOI 10.1056/NEJMoa012512; Koppes LLJ, 2006, DIABETOLOGIA, V49, P648, DOI 10.1007/s00125-005-0127-x; Liese AD, 2009, DIABETES CARE, V32, P1434, DOI 10.2337/dc09-0228; Liese AD, 2009, DIABETES CARE, V32, P263, DOI 10.2337/dc08-1325; Malik VS, 2010, DIABETES CARE, V33, P2477, DOI 10.2337/dc10-1079; Mann JI, 2004, NUTR METAB CARDIOVAS, V14, P373, DOI 10.1016/S0939-4753(04)80028-0; Martinez-Gonzalez MA, 2013, NEW ENGL J MED, V369, P2357, DOI 10.1056/NEJMc1312802; McNaughton SA, 2008, DIABETES CARE, V31, P1343, DOI 10.2337/dc07-1946; Mitri J, 2011, EUR J CLIN NUTR, V65, P1005, DOI 10.1038/ejcn.2011.118; Muraki I, 2013, BMJ-BRIT MED J, V347, DOI 10.1136/bmj.f5001; Pan A, 2013, J NUTR, V143, P512, DOI 10.3945/jn.112.172171; Pan A, 2011, AM J CLIN NUTR, V94, P1088, DOI 10.3945/ajcn.111.018978; Pan A, 2012, AM J CLIN NUTR, V95, P1454, DOI 10.3945/ajcn.111.032698; Pan XR, 1997, DIABETES CARE, V20, P537, DOI 10.2337/diacare.20.4.537; Pan Y, 2008, AM J CLIN NUTR, V88, P660, DOI 10.1093/ajcn/88.3.660; Phelan S, 2012, J UROLOGY, V187, P939, DOI 10.1016/j.juro.2011.10.139; Popkin BM, 2012, NUTR REV, V70, P3, DOI 10.1111/j.1753-4887.2011.00456.x; Ramachandran A, 2006, DIABETOLOGIA, V49, P289, DOI 10.1007/s00125-005-0097-z; Riserus U, 2009, PROG LIPID RES, V48, P44, DOI 10.1016/j.plipres.2008.10.002; Rizos EC, 2012, JAMA-J AM MED ASSOC, V308, P1024, DOI 10.1001/2012.jama.11374; Romaguera D, 2013, DIABETOLOGIA, V56, P1520, DOI 10.1007/s00125-013-2899-8; Sacks FM, 2001, NEW ENGL J MED, V344, P3, DOI 10.1056/NEJM200101043440101; Salas-Salvado J, 2014, ANN INTERN MED, V160, P1, DOI 10.7326/M13-1725; Salas-Salvado J, 2011, DIABETES CARE, V34, P14, DOI 10.2337/dc10-1288; Salmeron J, 2001, AM J CLIN NUTR, V73, P1019; Schulze MB, 2007, ARCH INTERN MED, V167, P956, DOI 10.1001/archinte.167.9.956; Schulze MB, 2005, AM J CLIN NUTR, V82, P675, DOI 10.1093/ajcn/82.3.675; Schwingshackl L, 2011, ANN NUTR METAB, V59, P176, DOI 10.1159/000334071; Shai I, 2008, NEW ENGL J MED, V359, P229, DOI 10.1056/NEJMoa0708681; Silva FM, 2013, NUTR REV, V71, P790, DOI 10.1111/nure.12076; Sjostrom L, 2012, JAMA-J AM MED ASSOC, V307, P56, DOI 10.1001/jama.2011.1914; Song YQ, 2013, DIABETES CARE, V36, P1422, DOI 10.2337/dc12-0962; Stanhope KL, 2009, J CLIN INVEST, V119, P1322, DOI 10.1172/JCI37385; Tanasescu M, 2004, AM J CLIN NUTR, V79, P999; Thomas DE, 2010, BRIT J NUTR, V104, P797, DOI 10.1017/S0007114510001534; Tinker LF, 2008, ARCH INTERN MED, V168, P1500, DOI 10.1001/archinte.168.14.1500; Tong X, 2011, EUR J CLIN NUTR, V65, P1027, DOI 10.1038/ejcn.2011.62; Tonstad S, 2013, NUTR METAB CARDIOVAS, V23, P292, DOI 10.1016/j.numecd.2011.07.004; Tuomilehto J, 2001, NEW ENGL J MED, V344, P1343, DOI 10.1056/NEJM200105033441801; Vazquez G, 2007, EPIDEMIOL REV, V29, P115, DOI 10.1093/epirev/mxm008; Williamson DA, 2009, ARCH INTERN MED, V169, P163, DOI 10.1001/archinternmed.2008.544; Wing R, 2013, NEW ENGL J MED, V369, P145, DOI 10.1056/NEJMoa1212914; Wu JHY, 2012, BRIT J NUTR, V107, pS214, DOI 10.1017/S0007114512001602; Zhao ZX, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041641	90	637	655	10	359	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JUN 7	2014	383	9933					1999	2007		10.1016/S0140-6736(14)60613-9	http://dx.doi.org/10.1016/S0140-6736(14)60613-9			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AI4PV	24910231	Green Accepted			2022-12-28	WOS:000336848200028
J	Koren, I; Dagan, G; Altaratz, O				Koren, Ilan; Dagan, Guy; Altaratz, Orit			From aerosol-limited to invigoration of warm convective clouds	SCIENCE			English	Article							CONDENSATION NUCLEI; CCN CONCENTRATIONS; PRECIPITATION; MODEL; UNCERTAINTY; ALGORITHM; PRODUCTS; RAIN	Among all cloud-aerosol interactions, the invigoration effect is the most elusive. Most of the studies that do suggest this effect link it to deep convective clouds with a warm base and cold top. Here, we provide evidence from observations and numerical modeling of a dramatic aerosol effect on warm clouds. We propose that convective-cloud invigoration by aerosols can be viewed as an extension of the concept of aerosol-limited clouds, where cloud development is limited by the availability of cloud-condensation nuclei. A transition from pristine to slightly polluted atmosphere yields estimated negative forcing of similar to 15 watts per square meter (cooling), suggesting that a substantial part of this anthropogenic forcing over the oceans occurred at the beginning of the industrial era, when the marine atmosphere experienced such transformation.	[Koren, Ilan; Dagan, Guy; Altaratz, Orit] Weizmann Inst Sci, Dept Earth & Planetary Sci, IL-76100 Rehovot, Israel	Weizmann Institute of Science	Koren, I (corresponding author), Weizmann Inst Sci, Dept Earth & Planetary Sci, IL-76100 Rehovot, Israel.	ilan.koren@weizmann.ac.il	Keyes, Dennis/AAZ-9285-2021; Koren, Ilan/K-1417-2012; Dagan, Guy/ABH-4574-2020	Koren, Ilan/0000-0001-6759-6265; Dagan, Guy/0000-0002-8391-6334	European Research Council (ERC) under the European Union's Seventh Framework Programme (FP7)/ERC [306965]	European Research Council (ERC) under the European Union's Seventh Framework Programme (FP7)/ERC(European Research Council (ERC))	The research leading to these results received funding from the European Research Council (ERC) under the European Union's Seventh Framework Programme (FP7/2007-2013)/ERC Grant agreement no. 306965 (CAPRI).	Altaratz O, 2013, ENVIRON RES LETT, V8, DOI 10.1088/1748-9326/8/3/034025; Andreae MO, 2008, EARTH-SCI REV, V89, P13, DOI 10.1016/j.earscirev.2008.03.001; Andreae MO, 2009, ATMOS CHEM PHYS, V9, P543, DOI 10.5194/acp-9-543-2009; Andreae MO, 2007, SCIENCE, V315, P50, DOI 10.1126/science.1136529; Andreae MO, 2004, SCIENCE, V303, P1337, DOI 10.1126/science.1092779; BAKER MB, 1990, NATURE, V345, P142, DOI 10.1038/345142a0; Carslaw KS, 2013, NATURE, V503, P67, DOI 10.1038/nature12674; Forster P, 2007, AR4 CLIMATE CHANGE 2007: THE PHYSICAL SCIENCE BASIS, P129; HEGG DA, 1991, J GEOPHYS RES-ATMOS, V96, P18727, DOI 10.1029/91JD01870; HINDMAN EE, 1994, ATMOS ENVIRON, V28, P3393, DOI 10.1016/1352-2310(94)00171-G; Huffman GJ, 2007, J HYDROMETEOROL, V8, P38, DOI 10.1175/JHM560.1; Jiang HL, 2006, J GEOPHYS RES-ATMOS, V111, DOI 10.1029/2005JD006138; Kaufman YJ, 2005, GEOPHYS RES LETT, V32, DOI 10.1029/2005GL023125; Kaufman YJ, 2005, P NATL ACAD SCI USA, V102, P11207, DOI 10.1073/pnas.0505191102; Koren I, 2005, GEOPHYS RES LETT, V32, DOI 10.1029/2005GL023187; Koren I, 2010, ATMOS CHEM PHYS, V10, P8855, DOI 10.5194/acp-10-8855-2010; Koren I, 2010, ATMOS CHEM PHYS, V10, P5001, DOI 10.5194/acp-10-5001-2010; Koren I, 2009, ATMOS CHEM PHYS, V9, P155, DOI 10.5194/acp-9-155-2009; Koren I, 2007, GEOPHYS RES LETT, V34, DOI 10.1029/2007GL029253; Koren I, 2012, NAT GEOSCI, V5, P118, DOI [10.1038/ngeo1364, 10.1038/NGEO1364]; Lohmann U, 2005, ATMOS CHEM PHYS, V5, P715, DOI 10.5194/acp-5-715-2005; PARRISH DF, 1992, MON WEATHER REV, V120, P1747, DOI 10.1175/1520-0493(1992)120<1747:TNMCSS>2.0.CO;2; Pierce JR, 2009, ATMOS CHEM PHYS, V9, P1339, DOI 10.5194/acp-9-1339-2009; Platnick S, 2003, IEEE T GEOSCI REMOTE, V41, P459, DOI 10.1109/TGRS.2002.808301; Reisin T, 1996, J APPL METEOROL, V35, P1416, DOI 10.1175/1520-0450(1996)035<1416:SCCWIN>2.0.CO;2; Remer LA, 2005, J ATMOS SCI, V62, P947, DOI 10.1175/JAS3385.1; Reutter P, 2009, ATMOS CHEM PHYS, V9, P7067, DOI 10.5194/acp-9-7067-2009; Rosenfeld D., 2013, CLIMATE SCI SERVING, P105, DOI [DOI 10.1007/978-94-007-6692-1_5, 10.1007/978-94-007-6692-1_5]; Rosenfeld D, 2008, SCIENCE, V321, P1309, DOI 10.1126/science.1160606; Rosenfeld D, 2014, SCIENCE, V343, P379, DOI 10.1126/science.1247490; Tao WK, 2012, REV GEOPHYS, V50, DOI 10.1029/2011RG000369; TRIPOLI GJ, 1980, J APPL METEOROL, V19, P1037, DOI 10.1175/1520-0450(1980)019<1037:ANIOSF>2.0.CO;2; TWOMEY S, 1959, TELLUS, V11, P408; TZIVION S, 1994, J APPL METEOROL, V33, P252, DOI 10.1175/1520-0450(1994)033<0252:NSOHSI>2.0.CO;2; Wang M, 2009, ATMOS CHEM PHYS, V9, P239, DOI 10.5194/acp-9-239-2009; Wen GY, 2007, J GEOPHYS RES-ATMOS, V112, DOI 10.1029/2006JD008267; Wielicki BA, 1998, IEEE T GEOSCI REMOTE, V36, P1127, DOI 10.1109/36.701020; Xue HW, 2008, J ATMOS SCI, V65, P392, DOI 10.1175/2007JAS2428.1; Yu HB, 2009, J GEOPHYS RES-ATMOS, V114, DOI 10.1029/2008JD010648; Yuan T, 2011, ATMOS CHEM PHYS, V11, P7119, DOI 10.5194/acp-11-7119-2011; Yum SS, 2004, J GEOPHYS RES-ATMOS, V109, DOI 10.1029/2003JD003864	41	153	155	5	112	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 6	2014	344	6188					1143	1146		10.1126/science.1252595	http://dx.doi.org/10.1126/science.1252595			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI3UU	24904161				2022-12-28	WOS:000336791200043
J	Boccaletti, V; Di Nuzzo, S				Boccaletti, Valeria; Di Nuzzo, Sergio			Linear IgA Bullous Disease	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Boccaletti, Valeria; Di Nuzzo, Sergio] Parma Univ Hosp, Parma, Italy	University of Parma; University Hospital of Parma	Boccaletti, V (corresponding author), Parma Univ Hosp, Parma, Italy.	valeria.boccaletti@gmail.com		DI NUZZO, Sergio/0000-0003-0216-5178					0	0	0	0	0	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUN 5	2014	370	23					2228	2228		10.1056/NEJMicm1311170	http://dx.doi.org/10.1056/NEJMicm1311170			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AI3AF	24897086				2022-12-28	WOS:000336729900011
J	Volkow, ND; Baler, RD; Compton, WM; Weiss, SRB				Volkow, Nora D.; Baler, Ruben D.; Compton, Wilson M.; Weiss, Susan R. B.			Adverse Health Effects of Marijuana Use	NEW ENGLAND JOURNAL OF MEDICINE			English	Review							ONSET CANNABIS USE; ILLICIT DRUG-USE; EDUCATIONAL-ATTAINMENT; CORTICAL DEVELOPMENT; YOUNG-PEOPLE; EXPOSURE; PRESSURE; ALCOHOL; SMOKING; RISK		[Volkow, Nora D.; Baler, Ruben D.; Compton, Wilson M.; Weiss, Susan R. B.] NIDA, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute on Drug Abuse (NIDA)	Volkow, ND (corresponding author), NIDA, 6001 Execut Blvd,Rm 5274, Bethesda, MD 20892 USA.	nvolkow@nida.nih.gov			NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [ZIAAA000550] Funding Source: NIH RePORTER; Intramural NIH HHS [Z99 DA999999] Funding Source: Medline	NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)		Agrawal A, 2004, PSYCHOL MED, V34, P1227, DOI 10.1017/S0033291704002545; Batalla A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055821; Brady JE, 2014, AM J EPIDEMIOL, V179, P692, DOI 10.1093/aje/kwt327; Bray JW, 2000, HEALTH ECON, V9, P9, DOI 10.1002/(SICI)1099-1050(200001)9:1<9::AID-HEC471>3.0.CO;2-Z; Brook JS, 2013, SUBST ABUS, V34, P298, DOI 10.1080/08897077.2013.775092; Brown HL, 2013, CLIN OBSTET GYNECOL, V56, P107, DOI 10.1097/GRF.0b013e318282377d; Callaghan RC, 2013, CANCER CAUSE CONTROL, V24, P1811, DOI 10.1007/s10552-013-0259-0; Caspi A, 2005, BIOL PSYCHIAT, V57, P1117, DOI 10.1016/j.biopsych.2005.01.026; Center for Behavioral Health Statistics and Quality, 2013, NAT SURV DRUG US HLT, V2015; Centonze D, 2009, NEUROL SCI, V30, P531, DOI 10.1007/s10072-009-0136-5; Chen CY, 2009, ADDICT BEHAV, V34, P319, DOI 10.1016/j.addbeh.2008.10.021; Chen J, 2005, BIOCHEM BIOPH RES CO, V330, P1062, DOI 10.1016/j.bbrc.2005.03.095; Chiou Lih-Chu, 2013, Acta Anaesthesiol Taiwan, V51, P161, DOI 10.1016/j.aat.2013.10.004; Collin C, 2007, EUR J NEUROL, V14, P290, DOI 10.1111/j.1468-1331.2006.01639.x; Cooper ZD, 2013, NEUROPSYCHOPHARMACOL, V38, P1984, DOI 10.1038/npp.2013.97; Crean RD, 2011, J ADDICT MED, V5, P1, DOI 10.1097/ADM.0b013e31820c23fa; Cristiani SA, 2004, J NEUROPSYCH CLIN N, V16, P330, DOI 10.1176/appi.neuropsych.16.3.330; D'Souza G, 2012, JAIDS-J ACQ IMM DEF, V61, P618, DOI 10.1097/QAI.0b013e318273ab3a; Degenhardt L, 2012, LANCET, V379, P55, DOI 10.1016/S0140-6736(11)61138-0; Di Forti M., 2014, SCHIZOPHR B; DiNieri JA, 2012, METHODS MOL BIOL, V829, P231, DOI 10.1007/978-1-61779-458-2_14; DiNieri JA, 2011, BIOL PSYCHIAT, V70, P763, DOI 10.1016/j.biopsych.2011.06.027; Drug Abuse Warning Network, 2011, 2011 NAT EST DRUG RE; El Sohly MA., 2014, POTENCY MONITORING P; Esposito G, 2013, PHYTOTHER RES, V27, P633, DOI 10.1002/ptr.4781; Fergusson DM, 2008, ADDICTION, V103, P969, DOI 10.1111/j.1360-0443.2008.02221.x; Filbey F, 2013, AM J DRUG ALCOHOL AB, V39, P382, DOI 10.3109/00952990.2013.841710; Gaffuri AL, 2012, PHARMACOLOGY, V90, P19, DOI 10.1159/000339075; Gogtay N, 2004, P NATL ACAD SCI USA, V101, P8174, DOI 10.1073/pnas.0402680101; Gorelick DA, 2012, DRUG ALCOHOL DEPEN, V123, P141, DOI 10.1016/j.drugalcdep.2011.11.007; Hall W, 2007, CURR OPIN PSYCHIATR, V20, P393, DOI 10.1097/YCO.0b013e32812144cc; Hall W, 2009, LANCET, V374, P1383, DOI 10.1016/S0140-6736(09)61037-0; Hartman RL, 2013, CLIN CHEM, V59, P478, DOI 10.1373/clinchem.2012.194381; Hashibe M, 2006, CANCER EPIDEM BIOMAR, V15, P1829, DOI 10.1158/1055-9965.EPI-06-0330; HEPLER RS, 1971, J AMER MED ASSOC, V217, P1392, DOI 10.1001/jama.1971.03190100074024; Hill TDM, 2013, BRIT J PHARMACOL, V170, P679, DOI 10.1111/bph.12321; Hirvonen J, 2012, MOL PSYCHIATR, V17, P642, DOI 10.1038/mp.2011.82; Johnston L. D., 2014, MONITORING FUTURE NA; Joy JE, 1999, MARIJUANA MED ASSESS; Jutras-Aswad D, 2009, EUR ARCH PSY CLIN N, V259, P395, DOI 10.1007/s00406-009-0027-z; Kogan Natalya M, 2007, Dialogues Clin Neurosci, V9, P413; Lenne MG, 2010, ACCIDENT ANAL PREV, V42, P859, DOI 10.1016/j.aap.2009.04.021; Levine A, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3003062; Lopez-Quintero C, 2011, DRUG ALCOHOL DEPEN, V115, P120, DOI 10.1016/j.drugalcdep.2010.11.004; Lutge EE, 2013, COCHRANE DB SYST REV, V4; Lynskey M, 2000, ADDICTION, V95, P1621, DOI 10.1046/j.1360-0443.2000.951116213.x; Macleod J, 2004, LANCET, V363, P1579, DOI 10.1016/S0140-6736(04)16200-4; Mechoulam R, 2013, ANNU REV PSYCHOL, V64, P21, DOI 10.1146/annurev-psych-113011-143739; Meier MH, 2012, P NATL ACAD SCI USA, V109, pE2657, DOI 10.1073/pnas.1206820109; MERRITT JC, 1980, OPHTHALMOLOGY, V87, P222; Nagarkatti P, 2009, FUTURE MED CHEM, V1, P1333, DOI 10.4155/FMC.09.93; Niedbala S, 2004, J ANAL TOXICOL, V28, P546, DOI 10.1093/jat/28.7.546; Nucci C, 2008, PROG BRAIN RES, V173, P451, DOI 10.1016/S0079-6123(08)01131-X; Owen K, 2014, CLIN REV ALLERG IMMU, V46, P65, DOI 10.1007/s12016-013-8374-y; Panlilio LV, 2013, NEUROPSYCHOPHARMACOL, V38, P1198, DOI 10.1038/npp.2013.16; Parker LA, 2004, PSYCHOPHARMACOLOGY, V171, P156, DOI 10.1007/s00213-003-1571-2; Patton GC, 2002, BMJ-BRIT MED J, V325, P1195, DOI 10.1136/bmj.325.7374.1195; Peck RC, 2008, J SAFETY RES, V39, P311, DOI 10.1016/j.jsr.2008.02.030; Pistis M, 2004, BIOL PSYCHIAT, V56, P86, DOI 10.1016/j.biopsych.2004.05.006; Pletcher MJ, 2012, JAMA-J AM MED ASSOC, V307, P173, DOI 10.1001/jama.2011.1961; Porter BE, 2013, EPILEPSY BEHAV, V29, P574, DOI 10.1016/j.yebeh.2013.08.037; Ramaekers JG, 2004, DRUG ALCOHOL DEPEN, V73, P109, DOI 10.1016/j.drugalcdep.2003.10.008; Rezkalla SH, 2003, ANN EMERG MED, V42, P365, DOI 10.1016/S0196-0644(03)00426-8; SALLAN SE, 1975, NEW ENGL J MED, V293, P795, DOI 10.1056/NEJM197510162931603; Schweinsburg Alecia D, 2008, Curr Drug Abuse Rev, V1, P99; Solowij N, 2002, JAMA-J AM MED ASSOC, V287, P1123, DOI 10.1001/jama.287.9.1123; Song ZH, 2000, J PHARMACOL EXP THER, V292, P136; Stanley C, 2014, BRIT J PHARMACOL, V171, P1361, DOI 10.1111/bph.12560; Tashkin Donald P, 2013, Ann Am Thorac Soc, V10, P239, DOI 10.1513/AnnalsATS.201212-127FR; Thomas G, 2014, AM J CARDIOL, V113, P187, DOI 10.1016/j.amjcard.2013.09.042; Tortoriello G, 2014, EMBO J, V33, P668, DOI 10.1002/embj.201386035; Verweij KJH, 2013, DRUG ALCOHOL DEPEN, V133, P580, DOI 10.1016/j.drugalcdep.2013.07.034; Wallace M, 2007, ANESTHESIOLOGY, V107, P785, DOI 10.1097/01.anes.0000286986.92475.b7; Wilsey B, 2008, J PAIN, V9, P506, DOI 10.1016/j.jpain.2007.12.010; Wilsey B, 2013, J PAIN, V14, P136, DOI 10.1016/j.jpain.2012.10.009; Zalesky A, 2012, BRAIN, V135, P2245, DOI 10.1093/brain/aws136; Zuardi AW, 2008, REV BRAS PSIQUIATR, V30, P271, DOI 10.1590/S1516-44462008000300015	77	1553	1579	14	517	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUN 5	2014	370	23					2219	2227		10.1056/NEJMra1402309	http://dx.doi.org/10.1056/NEJMra1402309			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AI3AF	24897085	Green Accepted			2022-12-28	WOS:000336729900010
J	Mortensen, EM; Halm, EA; Pugh, MJ; Copeland, LA; Metersky, M; Fine, MJ; Johnson, CS; Alvarez, CA; Frei, CR; Good, C; Restrepo, MI; Downs, JR; Anzueto, A				Mortensen, Eric M.; Halm, Ethan A.; Pugh, Mary Jo; Copeland, Laurel A.; Metersky, Mark; Fine, Michael J.; Johnson, Christopher S.; Alvarez, Carlos A.; Frei, Christopher R.; Good, Chester; Restrepo, Marcos I.; Downs, John R.; Anzueto, Antonio			Association of Azithromycin With Mortality and Cardiovascular Events Among Older Patients Hospitalized With Pneumonia	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							COMMUNITY-ACQUIRED PNEUMONIA; EMPIRIC ANTIBIOTIC-THERAPY; ELDERLY-PATIENTS; ANTIMICROBIAL THERAPY; SECONDARY PREVENTION; VETERANS-AFFAIRS; BETA-LACTAM; MACROLIDE; OUTCOMES; QUALITY	IMPORTANCE Although clinical practice guidelines recommend combination therapy with macrolides, including azithromycin, as first-line therapy for patients hospitalized with pneumonia, recent research suggests that azithromycin may be associated with increased cardiovascular events. OBJECTIVE To examine the association of azithromycin use with all-cause mortality and cardiovascular events for patients hospitalized with pneumonia. DESIGN Retrospective cohort study comparing older patients hospitalized with pneumonia from fiscal years 2002 through 2012 prescribed azithromycin therapy and patients receiving other guideline-concordant antibiotic therapy. SETTING This study was conducted using national Department of Veterans Affairs administrative data of patients hospitalized at any Veterans Administration acute care hospital. PARTICIPANTS Patients were included if they were aged 65 years or older, were hospitalized with pneumonia, and received antibiotic therapy concordant with national clinical practice guidelines. MAIN OUTCOMES AND MEASURES Outcomes included 30- and 90-day all-cause mortality and 90-day cardiac arrhythmias, heart failure, myocardial infarction, and any cardiac event. Propensity score matching was used to control for the possible effects of known confounders with conditional logistic regression. RESULTS Of 73 690 patients from 118 hospitals identified, propensity-matched groups were composed of 31 863 patients exposed to azithromycin and 31 863 matched patients who were not exposed. There were no significant differences in potential confounders between groups after matching. Ninety-day mortality was significantly lower in those who received azithromycin (exposed, 17.4%, vs unexposed, 22.3%; odds ratio [On 0.73; 95% CI, 0.70-0.76). However, we found significantly increased odds of myocardial infarction (5.1% vs 4.4%; OR, 1.17; 95% CI,1.08-1.25) but not any cardiac event (43.0% vs 42.7%; OR, 1.01; 95% CI, 0.98-1.05), cardiac arrhythmias (25.8% vs 26.0%; OR, 0.99; 95% CI, 0.95-1.02), or heart failure (26.3% vs 26.2%; OR, 1.01; 95% CI, 0.97-1.04). CONCLUSIONS AND RELEVANCE Among older patients hospitalized with pneumonia, treatment that included azithromycin compared with other antibiotics was associated with a lower risk of 90-day mortality and a smaller increased risk of myocardial infarction. These findings are consistent with a net benefit associated with azithromycin use. Copyright 2014 American Medical Association. All rights reserved.	[Mortensen, Eric M.; Johnson, Christopher S.; Alvarez, Carlos A.] VA North Texas Hlth Care Syst, Dallas, TX USA; [Mortensen, Eric M.; Halm, Ethan A.; Johnson, Christopher S.; Alvarez, Carlos A.] Univ Texas SW Med Ctr Dallas, Dallas, TX 75390 USA; [Alvarez, Carlos A.] Texas Tech Univ, Hlth Sci Ctr, Dallas, TX USA; [Pugh, Mary Jo; Restrepo, Marcos I.; Downs, John R.; Anzueto, Antonio] South Texas Vet Hlth Care Syst, VERDICT Res Program, San Antonio, TX USA; [Pugh, Mary Jo; Frei, Christopher R.; Restrepo, Marcos I.; Downs, John R.; Anzueto, Antonio] Univ Texas Hlth Sci Ctr San Antonio, San Antonio, TX 78229 USA; [Fine, Michael J.; Good, Chester] Univ Pittsburgh, VA Ctr Hlth Equ Res & Promot, VA Pittsburgh Healthcare Syst, Pittsburgh, PA USA; [Copeland, Laurel A.] Cent Texas Vet Hlth Care Syst Jointly Scott & Whi, Ctr Appl Hlth Res, Temple, TX USA; [Metersky, Mark] Univ Connecticut, Med Ctr, Farmington, CT USA; [Frei, Christopher R.] Univ Texas Austin, Austin, TX 78712 USA	US Department of Veterans Affairs; Veterans Health Administration (VHA); VA North Texas Health Care System; University of Texas System; University of Texas Southwestern Medical Center Dallas; Texas Tech University System; Texas Tech University; US Department of Veterans Affairs; Veterans Health Administration (VHA); Audie L. Murphy Memorial Veterans Hospital; University of Texas System; University of Texas Health San Antonio; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Pittsburgh Healthcare System; University of Connecticut; University of Texas System; University of Texas Austin	Mortensen, EM (corresponding author), Dallas VA Med Ctr, Gen Internal Med Sect, 4500 S Lancaster,Ste 111E, Dallas, TX 75216 USA.	eric.mortensen@utsouthwestern.edu	Pugh, Mary Jo/K-5336-2019; Restrepo, Marcos I/H-4442-2014; Frei, Christopher/AAI-1421-2020; Copeland, Laurel A/C-3763-2017; Mortensen, Eric/AAF-2713-2020; Good, Chester B/K-2818-2019	Pugh, Mary Jo/0000-0003-4196-7763; Frei, Christopher/0000-0002-0692-4787; Copeland, Laurel A/0000-0002-9478-0209; Good, Chester B/0000-0003-4388-4558; Mortensen, Eric/0000-0002-3880-5563	National Institute of Nursing Research [R01NR010828]; National Heart, Lung, and Blood Institute [K23HL096054]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR001120, KL2TR001118, KL2TR001103, UL1TR001105] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [KL2RR024983] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K23HL096054] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NURSING RESEARCH [R01NR010828] Funding Source: NIH RePORTER	National Institute of Nursing Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Nursing Research (NINR)); National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF NURSING RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Nursing Research (NINR))	This study was supported by a grant from the National Institute of Nursing Research (R01NR010828), and Dr Restrepo was supported by the National Heart, Lung, and Blood Institute (K23HL096054). This material is the result of work supported with resources and the use of facilities at the VA North Texas Health Care System.	Anderson JL, 1999, CIRCULATION, V99, P1540, DOI 10.1161/01.CIR.99.12.1540; Angrist JD, 2009, MOSTLY HARMLESS ECONOMETRICS: AN EMPIRICISTS COMPANION, P1; Asadi L, 2012, CLIN INFECT DIS, V55, P371, DOI 10.1093/cid/cis414; Ashitani J, 1998, EUR RESPIR J, V11, P104, DOI 10.1183/09031936.98.11010104; Battleman DS, 2002, ARCH INTERN MED, V162, P682, DOI 10.1001/archinte.162.6.682; Culic O, 2002, EUR J PHARMACOL, V450, P277, DOI 10.1016/S0014-2999(02)02042-3; Culic O, 2001, EUR J PHARMACOL, V429, P209, DOI 10.1016/S0014-2999(01)01321-8; DEYO RA, 1992, J CLIN EPIDEMIOL, V45, P613, DOI 10.1016/0895-4356(92)90133-8; Frei CR, 2006, AM J MED, V119, P865, DOI 10.1016/j.amjmed.2006.02.014; Gleason PP, 1999, ARCH INTERN MED, V159, P2562, DOI 10.1001/archinte.159.21.2562; Heron Melonie, 2012, Natl Vital Stat Rep, V60, P1; Houck PM, 2001, CHEST, V119, P1420, DOI 10.1378/chest.119.5.1420; Huang BH, 2007, PACE, V30, P1579, DOI 10.1111/j.1540-8159.2007.00912.x; Ianaro A, 2000, J PHARMACOL EXP THER, V292, P156; Kadota J, 2003, RESP MED, V97, P844, DOI 10.1016/S0954-6111(03)00042-8; Kazis LE, 1998, ARCH INTERN MED, V158, P626, DOI 10.1001/archinte.158.6.626; Knirsch CA, 2012, NEW ENGL J MED, V367, P772, DOI [10.1056/NEJMoa1003833, 10.1056/NEJMc1207269]; Kudoh S, 1998, AM J RESP CRIT CARE, V157, P1829, DOI 10.1164/ajrccm.157.6.9710075; Labro M. T., 1998, Journal of Antimicrobial Chemotherapy, V41, P37, DOI 10.1093/jac/41.suppl_2.37; Leuven E, PSMATCH2 STATA MODUL; Lodise TP, 2007, ANTIMICROB AGENTS CH, V51, P3977, DOI 10.1128/AAC.00006-07; Mandell LA, 2007, CLIN INFECT DIS, V44, pS27, DOI 10.1086/511159; Martinez JA, 2003, CLIN INFECT DIS, V36, P389, DOI 10.1086/367541; Matsunaga Naohisa, 2003, N Z Med J, V116, pU666; Meehan TP, 1997, JAMA-J AM MED ASSOC, V278, P2080, DOI 10.1001/jama.278.23.2080; Meterky ML, 2007, CHEST, V131, P466, DOI 10.1378/chest.06-1426; Mortensen EM, 2004, AM J MED, V117, P726, DOI 10.1016/j.amjmed.2004.06.028; Mortensen EM, 2002, ARCH INTERN MED, V162, P1059, DOI 10.1001/archinte.162.9.1059; Mortensen EM, 2006, CRIT CARE, V10, DOI 10.1186/cc3934; Musher DM, 2007, CLIN INFECT DIS, V45, P158, DOI 10.1086/518849; O'Connor CM, 2003, JAMA-J AM MED ASSOC, V290, P1459, DOI 10.1001/jama.290.11.1459; Owens RC, 2006, CLIN INFECT DIS, V43, P1603, DOI 10.1086/508873; Perry TW, 2011, AM J MED, V124, P244, DOI 10.1016/j.amjmed.2010.11.014; Ramirez J, 2008, CLIN INFECT DIS, V47, P182, DOI 10.1086/589246; Restrepo MI, 2009, EUR RESPIR J, V33, P153, DOI 10.1183/09031936.00054108; Rodriguez A, 2007, CRIT CARE MED, V35, P1493, DOI 10.1097/01.CCM.0000266755.75844.05; Sehdev AES, 2001, ARCH INTERN MED, V161, P277, DOI 10.1001/archinte.161.2.277; Sohn Min-Woong, 2006, Popul Health Metr, V4, P2, DOI 10.1186/1478-7954-4-2; Stahl JE, 1999, ARCH INTERN MED, V159, P2576, DOI 10.1001/archinte.159.21.2576; Svanstrom H, 2013, NEW ENGL J MED, V368, P1704, DOI 10.1056/NEJMoa1300799; Tamaoki J, 2004, AM J MED, V117, P5, DOI 10.1016/j.amjmed.2004.07.023; Terza JV, 2008, J HEALTH ECON, V27, P531, DOI 10.1016/j.jhealeco.2007.09.009; Waterer GW, 2001, ARCH INTERN MED, V161, P1837, DOI 10.1001/archinte.161.15.1837; Wilson BZ, 2012, CRIT CARE MED, V40, P2310, DOI 10.1097/CCM.0b013e31825151a8; Yamamoto M, 1990, Nihon Kyobu Shikkan Gakkai Zasshi, V28, P1305	45	110	116	0	14	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUN 4	2014	311	21					2199	2208		10.1001/jama.2014.4304	http://dx.doi.org/10.1001/jama.2014.4304			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AI2DU	24893087	Green Accepted, Bronze			2022-12-28	WOS:000336668400021
J	Moynihan, R				Moynihan, Ray			REALITY CHECK Was the flu drug zanamivir a breakthrough or money for old rope?	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									Bond Univ, Southport, Qld 4229, Australia	Bond University	Moynihan, R (corresponding author), Bond Univ, Southport, Qld 4229, Australia.	RayMoynihan@bond.edu.au	Moynihan, Ray/ABC-3010-2020					[Anonymous], 2003, FRONTLINE; [Anonymous], 2002, BMJ; Heneghan CJ, 2014, BMJ-BRIT MED J, V348, DOI 10.1136/bmj.g2547; Loder E, 2014, BMJ-BRIT MED J, V348, DOI 10.1136/bmj.g2630; Moynihan R., 1999, BULLETIN	5	1	1	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JUN 2	2014	348								g3611	10.1136/bmj.g3611	http://dx.doi.org/10.1136/bmj.g3611			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AI7CA	24891329				2022-12-28	WOS:000337037500006
J	Giles, TD; Weber, MA; Basile, J; Gradman, AH; Bharucha, DB; Chen, W; Pattathil, M				Giles, Thomas D.; Weber, Michael A.; Basile, Jan; Gradman, Alan H.; Bharucha, David B.; Chen, Wei; Pattathil, Manoj		NAC-MD-01 Study Investigators	Efficacy and safety of nebivolol and valsartan as fixed-dose combination in hypertension: a randomised, multicentre study	LANCET			English	Article							BETA-BLOCKERS; THERAPY; TOLERABILITY; MONOTHERAPY; METAANALYSIS	Background The fixed-dose combination of any two antihypertensive drugs from different drug classes is typically more effective in reducing blood pressure than a dose increase of component monotherapy. We assessed the efficacy and safety of a fixed-dose combination of a vasodilating beta blocker (nebivolol) and an angiotensin II receptor blocker (valsartan) in adults with hypertension. Methods We did an 8-week, phase 3, multicentre, randomised, double-blind, placebo-controlled, parallel-group trial at 401 US sites. Participants (age >= 18 years) with hypertension but with blood pressure less than 180/110 mm Hg were randomly assigned (2:2:2:2:2:2:2:1) by a 24-h interactive web response system in blocks of 15 to 4 weeks of double-blind treatment with nebivolol and valsartan fixed-dose combination (5 and 80 mg/day, 5 and 160 mg/day, or 10 and 160 mg/day), nebivolol (5 mg/day or 20 mg/day), valsartan (80 mg/day or 160 mg/day), or placebo. Doses were doubled in weeks 5-8; results are reported according to the final dose. Participants and research staff were masked to treatment allocation. The primary and key secondary endpoints were changes from baseline to week 8 in diastolic and systolic blood pressure, respectively. The primary statistical comparison was between the highest fixed-dose combination dose and the highest monotherapy doses; lower doses were then compared if this comparison was positive (Hochberg method for multiple testing). Efficacy analyses were by intention to treat. Safety assessments included monitoring of adverse events. Continuous efficacy parameters were analysed using an ANCOVA model; binary outcomes were analysed using a logistic regression model. This study is registered with ClinicalTrials.gov, NCT01508026. Findings Between Jan 6, 2012, and March 15, 2013, 4161 patients were randomly assigned (277 to placebo and 554-555 to each active comparator group), 4118 of whom were included in the primary analysis. At week 8, the fixed-dose combination 20 and 320 mg/day group had significantly greater reductions in diastolic blood pressure from baseline than both nebivolol 40 mg/day (least-squares mean difference -1.2 mm Hg, 95% CI -2.3 to -0.1; p=0.030) and valsartan 320 mg/day (-4.4 mm Hg, -5.4 to -3.3; p<0.0001); all other comparisons were also significant, favouring the fixed-dose combinations (all p<0.0001). All systolic blood pressure comparisons were also significant (all p<0.01). At least one treatment-emergent adverse event was experienced by 30-36% of participants in each group. Interpretation Nebivolol and valsartan fixed-dose combination is an effective and well-tolerated treatment option for patients with hypertension.	[Giles, Thomas D.] Tulane Univ, Dept Med, New Orleans, LA 70118 USA; [Weber, Michael A.] SUNY, Downstate Coll Med, Div Cardiovasc Med, Brooklyn, NY USA; [Basile, Jan] Med Univ S Carolina, Dept Med, Div Cardiol, Charleston, SC 29425 USA; [Gradman, Alan H.] Temple Univ, Dept Med, Sch Med, Pittsburgh, PA USA; [Bharucha, David B.; Pattathil, Manoj] Forest Res Inst, Dept Clin Dev, Jersey City, NJ USA; [Chen, Wei] Forest Res Inst, Dept Biostat, Jersey City, NJ USA	Tulane University; State University of New York (SUNY) System; State University of New York (SUNY) Downstate Medical Center; SUNY Maritime College; Medical University of South Carolina; Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University	Giles, TD (corresponding author), 109 Holly Dr, Metairie, LA 70005 USA.	tgiles4@cox.net	Group, Prescott Medical Communications/AAE-7494-2019		Forest Research Institute	Forest Research Institute	Forest Research Institute.	Ambrosioni E, 2005, HIGH BLOOD PRESS CAR, V12, P27, DOI 10.2165/00151642-200512010-00005; Bangalore S, 2007, AM J MED, V120, P713, DOI 10.1016/j.amjmed.2006.08.033; Chobanian AV, 2003, HYPERTENSION, V42, P1206, DOI 10.1161/01.HYP.0000107251.49515.c2; Gao YS, 2012, J CARDIOVASC PHARM, V59, P16, DOI 10.1097/FJC.0b013e3182073e27; Gradman AH, 2010, J AM SOC HYPERTENS, V4, P90, DOI [10.1016/j.jash.2010.03.001, 10.1016/j.jash.2010.02.005]; HOCHBERG Y, 1988, BIOMETRIKA, V75, P800, DOI 10.1093/biomet/75.4.800; Hussein O, 2002, J CARDIOVASC PHARM, V40, P28, DOI 10.1097/00005344-200207000-00004; ICH Expert Working Group (CH), 2000, INT C HARM TECHN REQ; Imaizumi S, 2013, CURR PHARM DESIGN, V19, P3002; Kountz DS, 2009, POSTGRAD MED, V121, P14, DOI 10.3810/pgm.2009.01.1951; Makani H, 2014, EUR HEART J, V35, P1732, DOI 10.1093/eurheartj/eht333; Mancia G, 2013, EUR HEART J, V34, P2159, DOI 10.1093/eurheartj/eht151; Markham A, 1997, DRUGS, V54, P299, DOI 10.2165/00003495-199754020-00009; Ogawa S, 2006, HYPERTENSION, V47, P699, DOI 10.1161/01.HYP.0000203826.15076.4b; Salahuddin A, 2013, J AM SOC HYPERTENS, V7, P401, DOI 10.1016/j.jash.2013.04.013; Sherrill B, 2011, J CLIN HYPERTENS, V13, P898, DOI 10.1111/j.1751-7176.2011.00550.x; Vanhoutte PM, 2013, CURR OPIN PHARMACOL, V13, P265, DOI 10.1016/j.coph.2012.12.002; Wald DS, 2009, AM J MED, V122, P290, DOI 10.1016/j.amjmed.2008.09.038; Weir MR, 2007, AM J HYPERTENS, V20, P807, DOI 10.1016/j.amjhyper.2007.02.017; Weiss RJ, 2011, CLIN THER, V33, P1150, DOI 10.1016/j.clinthera.2011.07.020	20	42	43	0	25	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAY 31	2014	383	9932					1889	1898		10.1016/S0140-6736(14)60614-0	http://dx.doi.org/10.1016/S0140-6736(14)60614-0			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AI4PR	24881993				2022-12-28	WOS:000336847800029
J	Hansen, M; Potapov, P; Margono, B; Stehman, S; Turubanova, S; Tyukavina, A				Hansen, M.; Potapov, P.; Margono, B.; Stehman, S.; Turubanova, S.; Tyukavina, A.			Response to Comment on "High-resolution global maps of 21st-century forest cover change"	SCIENCE			English	Editorial Material								Tropek et al. critique the Hansen et al. global forest loss paper in terms of its utility and accuracy. Both criticisms suffer from a miscomprehension of the definition of forest employed as well as the requirements of product validation. Utility of the product is enhanced through its integration with forest type, carbon stock, protected area status, and other ancillary data.	[Hansen, M.; Potapov, P.; Margono, B.; Turubanova, S.; Tyukavina, A.] Univ Maryland, Dept Geog Sci, College Pk, MD 20742 USA; [Stehman, S.] SUNY Syracuse, Dept Forest & Nat Resources Management, Syracuse, NY 13210 USA	University System of Maryland; University of Maryland College Park; State University of New York (SUNY) System	Hansen, M (corresponding author), Univ Maryland, Dept Geog Sci, College Pk, MD 20742 USA.	mhansen@umd.edu	Tyukavina, Alexandra/AGW-0785-2022; Stehman, Stephen/AAZ-6801-2021; potapov, peter/AAE-7388-2019; Hansen, Matthew C/ABE-7226-2020	Suprastiwi, Endang/0000-0001-8712-1355; Potapov, Peter/0000-0003-3977-0021; Tyukavina, Alexandra/0000-0003-3872-9844				Hanson MA, 2012, SCIENCE, V335, P851, DOI [10.1126/science.1244693, 10.1126/science.1215904]; Stehman SV, 1998, REMOTE SENS ENVIRON, V64, P331, DOI 10.1016/S0034-4257(98)00010-8; Tropek R, 2014, SCIENCE, V344, DOI 10.1126/science.1248753; Tyukavina A, 2013, ENVIRON RES LETT, V8, DOI 10.1088/1748-9326/8/4/044039	4	60	61	5	188	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 30	2014	344	6187								10.1126/science.1248817	http://dx.doi.org/10.1126/science.1248817			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AH9WM	24876488				2022-12-28	WOS:000336495800031
J	Marx, V				Marx, Vivien			TECHNOLOGY FEATURE AN ATLAS OF EXPRESSION	NATURE			English	Editorial Material																		Fagerberg L, 2014, MOL CELL PROTEOMICS, V13, P397, DOI 10.1074/mcp.M113.035600; Kampf C, 2012, JOVE-J VIS EXP, DOI 10.3791/3620; Kim MS, 2014, NATURE, V509, P575, DOI 10.1038/nature13302; Wilhelm M, 2014, NATURE, V509, P582, DOI 10.1038/nature13319	4	13	14	0	0	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 29	2014	509	7502					645	649		10.1038/509645a	http://dx.doi.org/10.1038/509645a			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AH9JC	24870547	Bronze			2022-12-28	WOS:000336457100054
J	Oresanya, LB; Lyons, WL; Finlayson, E				Oresanya, Lawrence B.; Lyons, William L.; Finlayson, Emily			Preoperative Assessment of the Older Patient A Narrative Review	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Review							PERIPROSTHETIC JOINT INFECTION; HIP FRACTURE SURGERY; LOWER-LIMB ISCHEMIA; PATIENTS AGED 80; BODY-MASS INDEX; QUALITY-OF-LIFE; POSTOPERATIVE DELIRIUM; RISK-FACTORS; ELDERLY-PATIENTS; ABDOMINAL-SURGERY	IMPORTANCE Surgery in older patients often poses risks of death, complications, and functional decline. Prior to surgery, evaluations of health-related priorities, realistic assessments of surgical risks, and individualized optimization strategies are essential. OBJECTIVE To review surgical decision making for older adult patients by 2 measures: defining treatment goals for elderly patients and reviewing the evidence relating risk factors to adverse outcomes. Assessment and optimization strategies for older surgical patients are proposed. EVIDENCE ACQUISITION A review of studies relating geriatric conditions such as functional and cognitive impairment, malnutrition, facility residence, and frailty to postoperative mortality and complications (including delirium, discharge to an institution, and functional decline). Medline, EMBASE, and Web of Science databases were searched for articles published between January 1, 2000, and December 31, 2013, that included patients older than 60 years. RESULTS This review identified 54 studies of older patients; 28 that examined preoperative clinical features associated with mortality (n = 1 422 433 patients) and 26 that examined factors associated with surgical complications (n = 136 083 patients). There was substantial heterogeneity in study methods, measures, and outcomes. The absolute risk and risk ratios relating preoperative clinical conditions to mortality varied widely: 10% to 40% for cognitive impairment (adjusted hazard ratio [HR], 1.26 [95% CI, 1.06-1.49] to 5.77 [95% CI, 1.55-21.55]), 10% to 17% for malnutrition (adjusted odds ratio [OR], 0.88 [95% CI, 0.78-1.01] to 59.2 [95% CI, 3.6-982.9]), and 11% to 41% for institutionalization (adjusted OR, 1.5 [95% CI, 1.02-2.21] to 3.27 [95% CI, 2.81-3.81]).) Risk ratios for functional dependence relating to mortality ranged from an adjusted HR of 1.02 (95% CI, 0.99-1.04) to an adjusted OR of 18.7 (95% CI, 1.6-215.3) and for frailty relating to mortality, ranged from an adjusted HR of 1.10 (95% CI, 1.04-1.16) to an adjusted OR of 11.7 (95% CI not reported) (P <.001). Preoperative cognitive impairment (adjusted OR, 2.2; 95% CI, 1.4-2.7) was associated with postoperative delirium (adjusted OR, 17.0; 95% CI, 1.2-239.8; P < .05). Frailty was associated with a 3-to 13-fold increased risk of discharge to a facility (adjusted OR, 3.16 [95% CI, 1.0-9.99] to 13.02 [95% CI, 5.14-32.98]). CONCLUSIONS AND RELEVANCE Geriatric conditions may be associated with adverse surgical outcomes. A comprehensive evaluation of treatment goals and communication of realistic risk estimates are essential to guide individualized decision making.	[Oresanya, Lawrence B.; Finlayson, Emily] Univ Calif San Francisco, Dept Surg, Philip R Lee Inst Hlth Policy Studies, San Francisco, CA USA; [Lyons, William L.] Univ Nebraska Med Ctr, Dept Med, Div Geriatr Med, Omaha, NE USA	University of California System; University of California San Francisco; University of Nebraska System; University of Nebraska Medical Center	Finlayson, E (corresponding author), Philip R Lee Inst Hlth Policy Studies, 3333 Calif St, San Francisco, CA 94118 USA.	emily.finlayson@ucsfmedctr.org			SCAN Foundation	SCAN Foundation	This work was supported by funding from The SCAN Foundation	Aharonoff GB, 2004, GERONTOLOGY, V50, P298, DOI 10.1159/000079127; Alagiakrishnan K, 2007, J AM GERIATR SOC, V55, P314, DOI 10.1111/j.1532-5415.2007.01058.x; Ansaloni L, 2010, BRIT J SURG, V97, P273, DOI 10.1002/bjs.6843; Apter AJ, 2008, J GEN INTERN MED, V23, P2117, DOI 10.1007/s11606-008-0803-x; Bakker RC, 2012, EUR J CARDIO-THORAC, V41, P544, DOI 10.1093/ejcts/ezr031; Barry PJ, 2007, AGE AGEING, V36, P632, DOI 10.1093/ageing/afm118; Bellelli G, 2012, J AM MED DIR ASSOC, V13, DOI DOI 10.1016/J.JAMDA.2012.06.007; Billick SB, 2009, J FORENSIC SCI, V54, P943, DOI 10.1111/j.1556-4029.2009.01047.x; Bozic KJ, 2012, J BONE JOINT SURG AM, V94A, P794, DOI 10.2106/JBJS.K.00072; Bozic KJ, 2012, CLIN ORTHOP RELAT R, V470, P130, DOI 10.1007/s11999-011-2043-3; Briggs LA, 2004, J PROF NURS, V20, P47, DOI 10.1016/j.profnurs.2003.12.001; Carli F, 2010, BRIT J SURG, V97, P1187, DOI 10.1002/bjs.7102; Chow WB, 2012, J AM COLL SURGEONS, V215, P453, DOI 10.1016/j.jamcollsurg.2012.06.017; Chrispal Anugrah, 2010, J Assoc Physicians India, V58, P15; Clegg A, 2011, AGE AGEING, V40, P23, DOI 10.1093/ageing/afq140; Cohen ME, 2009, J AM COLL SURGEONS, V208, P1009, DOI 10.1016/j.jamcollsurg.2009.01.043; Connolly A, 2011, AGING MENT HEALTH, V15, P978, DOI 10.1080/13607863.2011.596805; Coulter A, 2007, BMJ-BRIT MED J, V335, P24, DOI 10.1136/bmj.39246.581169.80; Dai YT, 2000, GERONTOLOGY, V46, P28, DOI 10.1159/000022130; Devon KM, 2011, SURGERY, V149, P705, DOI 10.1016/j.surg.2010.12.014; Ditmyer Marcia M, 2002, Orthop Nurs, V21, P43; Dubljanin-Raspopovic E, 2013, CLIN ORTHOP RELAT R, V471, P2703, DOI 10.1007/s11999-013-2955-1; Elixhauser A, 2010, ARCH SURG-CHICAGO, V145, P1201, DOI 10.1001/archsurg.2010.269; Farhat JS, 2012, J TRAUMA ACUTE CARE, V72, P1526, DOI 10.1097/TA.0b013e3182542fab; Finlayson E V, 2001, Eff Clin Pract, V4, P172; Finlayson E, 2012, J AM GERIATR SOC, V60, P967, DOI 10.1111/j.1532-5415.2012.03915.x; Finlayson E, 2011, ANN SURG, V254, P921, DOI 10.1097/SLA.0b013e3182383a78; Finlayson E, 2011, J AM GERIATR SOC, V59, P2139, DOI 10.1111/j.1532-5415.2011.03567.x; Flinn DR, 2009, J AM COLL SURGEONS, V209, P261, DOI 10.1016/j.jamcollsurg.2009.03.008; Freter SH, 2005, AGE AGEING, V34, P169, DOI 10.1093/ageing/afh245; Fried TR, 2011, ARCH INTERN MED, V171, P75, DOI 10.1001/archinternmed.2010.318; Furlaneto Maria Elizabet, 2006, Clinics, V61, P35, DOI 10.1590/S1807-59322006000100007; Ganai S, 2007, ARCH SURG-CHICAGO, V142, P1072, DOI 10.1001/archsurg.142.11.1072; Guyatt G., 2008, USERS GUIDES MEDICAL; Hallenbeck J. L., 2003, PALLIATIVE CARE PERS; Hamel MB, 2005, J AM GERIATR SOC, V53, P424, DOI 10.1111/j.1532-5415.2005.53159.x; Hamilton Hilary J, 2009, BMC Geriatr, V9, P5, DOI 10.1186/1471-2318-9-5; Harari D, 2007, AGE AGEING, V36, P190, DOI 10.1093/ageing/afl163; Ho PM, 2005, AM J GERIATR CARDIOL, V14, P176, DOI 10.1111/j.1076-7460.2005.04312.x; Jack S, 2011, BEST PRAC RES-CL ANA, V25, P461, DOI 10.1016/j.bpa.2011.07.003; Juliebo V, 2009, J AM GERIATR SOC, V57, P1354, DOI 10.1111/j.1532-5415.2009.02377.x; Kaldjian LC, 2008, AM J HOSP PALLIAT ME, V25, P501, DOI 10.1177/1049909108328256; Kennedy GD, 2011, ANN SURG, V253, P508, DOI 10.1097/SLA.0b013e3181f19518; Kim SM, 2012, BONE, V50, P1343, DOI 10.1016/j.bone.2012.02.633; Kiran RP, 2013, ANN SURG, V257, P905, DOI 10.1097/SLA.0b013e318269d337; Koebrugge B, 2009, DIGEST SURG, V26, P63, DOI 10.1159/000194947; Kristjansson SR, 2012, J GERIATR ONCOL, V3, P1, DOI 10.1016/j.jgo.2011.09.002; Kristjansson SR, 2010, J GERIATR ONCOL, V1, P57, DOI 10.1016/j.jgo.2010.06.001; Kwon S, 2012, AM SURGEON, V78, P1336; Lee HB, 2011, J AM GERIATR SOC, V59, P2306, DOI 10.1111/j.1532-5415.2011.03725.x; Leung JM, 2011, ANESTH ANALG, V112, P1199, DOI 10.1213/ANE.0b013e31820c7c06; Leung JM, 2005, J GERONTOL A-BIOL, V60, P1563, DOI 10.1093/gerona/60.12.1563; Li C, 2013, SURG ENDOSC, V27, P1072, DOI 10.1007/s00464-012-2560-5; Lidsky ME, 2012, SURGERY, V152, P465, DOI 10.1016/j.surg.2012.06.038; Makary MA, 2010, J AM COLL SURGEONS, V210, P901, DOI 10.1016/j.jamcollsurg.2010.01.028; Massarweh NN, 2009, ARCH SURG-CHICAGO, V144, P1108, DOI 10.1001/archsurg.2009.204; Maurer MS, 2002, J AM GERIATR SOC, V50, P988, DOI 10.1046/j.1532-5415.2002.50251.x; Mayo NE, 2011, SURGERY, V150, P505, DOI 10.1016/j.surg.2011.07.045; McNicol L, 2007, MED J AUSTRALIA, V186, P447, DOI 10.5694/j.1326-5377.2007.tb00994.x; Mirbagheri N, 2010, J AM GERIATR SOC, V58, P104, DOI 10.1111/j.1532-5415.2009.02612.x; Modini C, 2012, COLORECTAL DIS, V14, pE312, DOI 10.1111/j.1463-1318.2012.02934.x; Morgan TM, 2011, J UROLOGY, V186, P829, DOI 10.1016/j.juro.2011.04.089; Morris RL, 2011, CHRONIC ILLN, V7, P147, DOI 10.1177/1742395310393365; Morrison RS, 2005, J AM GERIATR SOC, V53, P290, DOI 10.1111/j.1532-5415.2005.53116.x; Nafiu OO, 2011, ANESTH ANALG, V112, P23, DOI 10.1213/ANE.0b013e3181fcc51a; Neuman HB, 2013, CANCER-AM CANCER SOC, V119, P639, DOI 10.1002/cncr.27765; Nie HL, 2012, ARCH GERONTOL GERIAT, V54, pE172, DOI 10.1016/j.archger.2011.09.012; Nielsen PR, 2008, BMC HEALTH SERV RES, V8, DOI 10.1186/1472-6963-8-209; Nielsen PR, 2010, CLIN REHABIL, V24, P137, DOI 10.1177/0269215509347432; O'Connor AM, 2009, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD001431.pub2, 10.1002/14651858.CD001431.pub3, 10.1002/14651858.CD001431.pub4]; Otomo S, 2013, INTERACT CARDIOV TH, V17, P799, DOI 10.1093/icvts/ivt304; PODSIADLO D, 1991, J AM GERIATR SOC, V39, P142, DOI 10.1111/j.1532-5415.1991.tb01616.x; Reuben DB, 2009, JAMA-J AM MED ASSOC, V302, P2686, DOI 10.1001/jama.2009.1871; Robinson TN, 2013, ANN SURG, V258, P582, DOI 10.1097/SLA.0b013e3182a4e96c; Robinson TN, 2011, J AM COLL SURGEONS, V213, P37, DOI 10.1016/j.jamcollsurg.2011.01.056; Robinson TN, 2009, ANN SURG, V250, P449, DOI 10.1097/SLA.0b013e3181b45598; Robinson TN, 2009, ANN SURG, V249, P173, DOI 10.1097/SLA.0b013e31818e4776; Rudolph JL, 2007, AM J MED, V120, P807, DOI 10.1016/j.amjmed.2007.02.026; Rudolph JL, 2009, CIRCULATION, V119, P229, DOI 10.1161/CIRCULATIONAHA.108.795260; Sasajima Y, 2000, EUR J VASC ENDOVASC, V20, P132, DOI 10.1053/ejvs.2000.1130; Sasajima Y, 2012, EUR J VASC ENDOVASC, V44, P411, DOI 10.1016/j.ejvs.2012.06.028; Schaller F, 2012, BONE, V51, P347, DOI 10.1016/j.bone.2012.06.004; Sessums LL, 2011, JAMA-J AM MED ASSOC, V306, P420, DOI 10.1001/jama.2011.1023; Story DA, 2010, ANAESTHESIA, V65, P1022, DOI 10.1111/j.1365-2044.2010.06478.x; Sudore RL, 2010, ANN INTERN MED, V153, P256, DOI 10.7326/0003-4819-153-4-201008170-00008; Sundermann S, 2011, INTERACT CARDIOV TH, V13, P119, DOI 10.1510/icvts.2010.251884; Tei M, 2010, SURG ENDOSC, V24, P2135, DOI 10.1007/s00464-010-0911-7; Thomas D, 2006, J NUTR HEALTH AGING, V10, P463; Turrentine FE, 2006, J AM COLL SURGEONS, V203, P865, DOI 10.1016/j.jamcollsurg.2006.08.026; Vellas B, 2006, J NUTR HEALTH AGING, V10, P456; Visser BC, 2009, ARCH SURG-CHICAGO, V144, P1021, DOI 10.1001/archsurg.2009.197; Weimann A, 2006, CLIN NUTR, V25, P224, DOI 10.1016/j.clnu.2006.01.015; Wolff JL, 2012, J AM GERIATR SOC, V60, P106, DOI 10.1111/j.1532-5415.2011.03770.x; Yourman LC, 2012, JAMA-J AM MED ASSOC, V307, P182, DOI 10.1001/jama.2011.1966	94	199	206	1	38	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAY 28	2014	311	20					2110	2120		10.1001/jama.2014.4573	http://dx.doi.org/10.1001/jama.2014.4573			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AH8MQ	24867014				2022-12-28	WOS:000336392400027
J	Aizer, A; Currie, J				Aizer, Anna; Currie, Janet			The intergenerational transmission of inequality: Maternal disadvantage and health at birth	SCIENCE			English	Review							INFANT HEALTH; SOCIOECONOMIC-STATUS; ADULT OUTCOMES; LONG-RUN; WEIGHT; EXPOSURE; US; CHILDHOOD; INFLUENZA; PREGNANCY	Health at birth is an important predictor of long-term outcomes, including education, income, and disability. Recent evidence suggests that maternal disadvantage leads to worse health at birth through poor health behaviors; exposure to harmful environmental factors; worse access to medical care, including family planning; and worse underlying maternal health. With increasing inequality, those at the bottom of the distribution now face relatively worse economic conditions, but newborn health among the most disadvantaged has actually improved. The most likely explanation is increasing knowledge about determinants of infant health and how to protect it along with public policies that put this knowledge into practice.	[Aizer, Anna] Brown Univ, Dept Econ, Providence, RI 02912 USA; [Aizer, Anna; Currie, Janet] Natl Bur Econ Res, Cambridge, MA 02138 USA; [Currie, Janet] Princeton Univ, Dept Econ, Princeton, NJ 08544 USA	Brown University; National Bureau of Economic Research; Princeton University	Currie, J (corresponding author), Natl Bur Econ Res, Cambridge, MA 02138 USA.	jcurrie@princeton.edu			John D. and Catherine T. MacArthur Foundation; U.S. Environmental Protection Agency (EPA) grant [EPA G2009-STAR-B1]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R24HD041020, P2CHD047879] Funding Source: NIH RePORTER	John D. and Catherine T. MacArthur Foundation; U.S. Environmental Protection Agency (EPA) grant; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	The authors thank H. Schwandt for assistance in preparing the figures. J.C. received financial support from the John D. and Catherine T. MacArthur Foundation and for support from U.S. Environmental Protection Agency (EPA) grant EPA G2009-STAR-B1. The authors have no conflicts of interest to report.	Abu-Saad K, 2010, EPIDEMIOL REV, V32, P5, DOI 10.1093/epirev/mxq001; Aizer A., 2012, 18422 NBER; Aizer A, 2011, J HUM RESOUR, V46, P518, DOI 10.1353/jhr.2011.0024; Almond D, 2012, 18535 NBER; Almond D, 2006, J POLIT ECON, V114, P672, DOI 10.1086/507154; Almond D, 2012, LABOUR ECON, V19, P475, DOI 10.1016/j.labeco.2012.05.015; Almond D, 2011, AM ECON J-APPL ECON, V3, P56, DOI 10.1257/app.3.4.56; Almond D, 2011, HBK ECON, V4, P1315, DOI 10.1016/S0169-7218(11)02413-0; Almond D, 2011, REV ECON STAT, V93, P387, DOI 10.1162/REST_a_00089; Ananat EO, 2009, REV ECON STAT, V91, P124, DOI 10.1162/rest.91.1.124; [Anonymous], [No title captured]; Autor DH, 2014, SCIENCE, V344, P843, DOI 10.1126/science.1251868; Bharadwaj P., 2012, I STUDY LABOR IZA DI; Bharadwaj P., 2010, U CALIFORNIA SAN DIE; Black SE, 2007, Q J ECON, V122, P409, DOI 10.1162/qjec.122.1.409; Bleakley H, 2010, AM ECON J-APPL ECON, V2, P1, DOI 10.1257/app.2.2.1; Campbell F, 2014, SCIENCE, V343, P1478, DOI 10.1126/science.1248429; Central Intelligence Agency, 2013, WORLD FACTB 2013 201; Chamberlain C, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001055.pub4; Chay KY, 2003, Q J ECON, V118, P1121, DOI 10.1162/00335530360698513; Conde-Agudelo A, 2006, JAMA-J AM MED ASSOC, V295, P1809, DOI 10.1001/jama.295.15.1809; Cunha F, 2010, ECONOMETRICA, V78, P883, DOI 10.3982/ECTA6551; Cunha Flavio., 2012, 18429 NBER; Currie J, 1996, J POLIT ECON, V104, P1263, DOI 10.1086/262059; Currie J., 2013, 18876 NBER; Currie J, 2007, J LABOR ECON, V25, P231, DOI 10.1086/511377; Currie J, 2013, P NATL ACAD SCI USA, V110, P13228, DOI 10.1073/pnas.1307582110; Currie J, 2013, J HEALTH ECON, V32, P487, DOI 10.1016/j.jhealeco.2013.01.004; Currie J, 2011, AM ECON REV, V101, P1, DOI 10.1257/aer.101.3.1; Currie J, 2011, AM ECON J-APPL ECON, V3, P65, DOI 10.1257/app.3.1.65; Currie J, 2009, J HEALTH ECON, V28, P688, DOI 10.1016/j.jhealeco.2009.02.001; Dahl GB, 2012, AM ECON REV, V102, P1927, DOI 10.1257/aer.102.5.1927; Del Bono E, 2012, J LABOR ECON, V30, P657, DOI 10.1086/664831; Eckenrode J, 2010, ARCH PEDIAT ADOL MED, V164, P9, DOI 10.1001/archpediatrics.2009.240; Evans W., 2011, 18206 NBER; Ferrie J, 2011, EXPLOR ECON HIST, V48, P445, DOI 10.1016/j.eeh.2011.06.001; Field E, 2009, AM ECON J-APPL ECON, V1, P140, DOI 10.1257/app.1.4.140; Finer LB, 2011, CONTRACEPTION, V84, P478, DOI 10.1016/j.contraception.2011.07.013; Geronimus AT, 1996, SOC SCI MED, V42, P589, DOI 10.1016/0277-9536(95)00159-X; Guryan J, 2008, J ECON PERSPECT, V22, P23, DOI 10.1257/jep.22.3.23; Heckman J., 2013, NBER WORK PAP SER; Heckman J, 2013, AM ECON REV, V103, P2052, DOI 10.1257/aer.103.6.2052; Hoynes H. W., 2009, J ECON PERSPECT, V20, P47; Hoynes H. W., 2012, 18206 NBER; Hsin A, 2012, DEMOGRAPHY, V49, P1385, DOI 10.1007/s13524-012-0123-y; Isen Adam, 2013, 19858 NBER; Kearney MS, 2009, REV ECON STAT, V91, P137, DOI 10.1162/rest.91.1.137; Kelly E, 2011, J HUM RESOUR, V46, P669, DOI 10.1353/jhr.2011.0004; KOST K, 1995, FAM PLANN PERSPECT, V27, P11, DOI 10.2307/2135971; Lauderdale DS, 2006, DEMOGRAPHY, V43, P185, DOI 10.1353/dem.2006.0008; Lien DS, 2005, J HUM RESOUR, V40, P373; Lin M, 2013, WORKING PAPER; Lin WC, 2009, HEALTH ECON, V18, P823, DOI 10.1002/hec.1407; Ludwig DS, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001521; Ludwig DS, 2010, LANCET, V376, P984, DOI 10.1016/S0140-6736(10)60751-9; McCormick MC, 2006, PEDIATRICS, V117, P771, DOI 10.1542/peds.2005-1316; McEwen BS, 2010, ANN NY ACAD SCI, V1186, P190, DOI 10.1111/j.1749-6632.2009.05331.x; Milligan K, 2011, AM ECON J-ECON POLIC, V3, P175, DOI 10.1257/pol.3.3.175; Nelson RE, 2010, HEALTH ECON, V19, P1181, DOI 10.1002/hec.1544; Nilsson J. P, 2014, WORKING PAPER; Olds DL, 2007, PEDIATRICS, V120, pE832, DOI 10.1542/peds.2006-2111; Oreopoulos P, 2008, J HUM RESOUR, V43, P88; Parker JD, 2008, EPIDEMIOLOGY, V19, P820, DOI 10.1097/EDE.0b013e3181883d5d; Piketty T, 2014, SCIENCE, V344, P838, DOI 10.1126/science.1251936; Quinn SC, 2011, AM J PUBLIC HEALTH, V101, P285, DOI 10.2105/AJPH.2009.188029; Rossin-Slater M, 2013, J PUBLIC ECON, V102, P51, DOI 10.1016/j.jpubeco.2013.03.009; Royer H, 2009, AM ECON J-APPL ECON, V1, P49, DOI 10.1257/app.1.1.49; Sanders NJ, 2012, J HUM RESOUR, V47, P826, DOI 10.3368/jhr.47.3.826; Seeman T, 2010, ANN NY ACAD SCI, V1186, P223, DOI 10.1111/j.1749-6632.2009.05341.x; Smits LJM, 2001, LANCET, V358, P2074, DOI 10.1016/S0140-6736(01)07105-7; Vest JR, 2002, AM J PREV MED, V22, P156, DOI 10.1016/S0749-3797(01)00431-7; Wooten K. G., 2012, J VACCINE, V6, P6927; Yeung WJ, 2002, CHILD DEV, V73, P1861, DOI 10.1111/1467-8624.t01-1-00511; Zavodny M, 2010, SOC SCI MED, V71, P918, DOI 10.1016/j.socscimed.2010.05.046; Zhu BP, 2005, INT J GYNECOL OBSTET, V89, pS25, DOI 10.1016/j.ijgo.2004.08.002	75	195	200	5	105	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 23	2014	344	6186					856	861		10.1126/science.1251872	http://dx.doi.org/10.1126/science.1251872			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AH6IL	24855261	Green Accepted			2022-12-28	WOS:000336233800038
J	Ekstrand, MI; Nectow, AR; Knight, ZA; Latcha, KN; Pomeranz, LE; Friedman, JM				Ekstrand, Mats I.; Nectow, Alexander R.; Knight, Zachary A.; Latcha, Kaamashri N.; Pomeranz, Lisa E.; Friedman, Jeffrey M.			Molecular Profiling of Neurons Based on Connectivity	CELL			English	Article							CNS CELL-TYPES; NUCLEUS-ACCUMBENS; RABIES VIRUS; CRE RECOMBINASE; DOPAMINE; NANOBODIES; SYSTEM; REWARD; CONNECTOMICS; CIRCUITS	The complexity and cellular heterogeneity of neural circuitry presents a major challenge to understanding the role of discrete neural populations in controlling behavior. While neuroanatomical methods enable high- resolution mapping of neural circuitry, these approaches do not allow systematic molecular profiling of neurons based on their connectivity. Here, we report the development of an approach for molecularly profiling projective neurons. We show that ribosomes can be tagged with a camelid nanobody raised against GFP and that this system can be engineered to selectively capture translating mRNAs from neurons retrogradely labeled with GFP. Using this system, we profiled neurons projecting to the nucleus accumbens. We then used an AAV to selectively profile midbrain dopamine neurons projecting to the nucleus accumbens. By comparing the captured mRNAs from each experiment, we identified a number of markers specific to VTA dopaminergic projection neurons. The current method provides a means for profiling neurons based on their projections.	[Ekstrand, Mats I.; Nectow, Alexander R.; Knight, Zachary A.; Latcha, Kaamashri N.; Pomeranz, Lisa E.; Friedman, Jeffrey M.] Rockefeller Univ, Howard Hughes Med Inst, Mol Genet Lab, New York, NY 10065 USA	Howard Hughes Medical Institute; Rockefeller University	Friedman, JM (corresponding author), Rockefeller Univ, Howard Hughes Med Inst, Mol Genet Lab, 1230 York Ave, New York, NY 10065 USA.	friedj@rockefeller.edu	Core, Vector/CAF-4832-2022	Pomeranz, Lisa/0000-0002-8117-7355; Knight, Zachary/0000-0001-7621-1478	Howard Hughes Medical Institute; JPB Foundation; NIDA [1RO1DA018799-01]; New York Stem Cell Foundation; Klingenstein Fund; Sloan Foundation; McKnight Foundation; Brain and Behavior Research Foundations; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R00DK083531] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM095654] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [U01MH105941] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA018799] Funding Source: NIH RePORTER	Howard Hughes Medical Institute(Howard Hughes Medical Institute); JPB Foundation; NIDA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); New York Stem Cell Foundation; Klingenstein Fund(Klingenstein Philanthropies); Sloan Foundation(Alfred P. Sloan Foundation); McKnight Foundation; Brain and Behavior Research Foundations; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported by the Howard Hughes Medical Institute, the JPB Foundation, and NIDA grant 1RO1DA018799-01 (J.M.F.). Z.A.K. acknowledges support from the New York Stem Cell Foundation, the Klingenstein Fund, Sloan Foundation, the McKnight Foundation, and the Brain and Behavior Research Foundations. We thank Scott Dewell and the Rockefeller University Genomics Core for help with RNA-seq and bioinformatics, and Ana Milosevic, Yong Kim, and Paul Greengard for contributing p11-EGFP mice. We thank Karl Deisseroth for contributing the plasmid pAAV-EF1a-DIO-hChR2(H134R)-mCherry (Addgene 20297), which was used in the creation of AAV-FLEX-NBL10. We also thank Eric F. Schmidt for helpful discussions. Imaging was performed at the Rockefeller University Bio-Imaging Resource Center. CAV-GFP was obtained from the Montpellier vector platform.	Armbruster BN, 2007, P NATL ACAD SCI USA, V104, P5163, DOI 10.1073/pnas.0700293104; Atasoy D, 2008, J NEUROSCI, V28, P7025, DOI 10.1523/JNEUROSCI.1954-08.2008; Backman CM, 2006, GENESIS, V44, P383, DOI 10.1002/dvg.20228; Bargmann CI, 2012, BIOESSAYS, V34, P458, DOI 10.1002/bies.201100185; Boyden ES, 2005, NAT NEUROSCI, V8, P1263, DOI 10.1038/nn1525; Bru T, 2010, VIRUSES-BASEL, V2, P2134, DOI 10.3390/v2092134; Chaudhury D, 2013, NATURE, V493, P532, DOI 10.1038/nature11713; Chung CY, 2005, HUM MOL GENET, V14, P1709, DOI 10.1093/hmg/ddi178; Croizier S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015471; Dolen G, 2013, NATURE, V501, P179, DOI 10.1038/nature12518; Doyle JP, 2008, CELL, V135, P749, DOI 10.1016/j.cell.2008.10.029; Georgescu D, 2005, J NEUROSCI, V25, P2933, DOI 10.1523/JNEUROSCI.1714-04.2005; Heiman M, 2008, CELL, V135, P738, DOI 10.1016/j.cell.2008.10.028; Helmstaedter M, 2013, NATURE, V500, P168, DOI 10.1038/nature12346; Hnasko TS, 2006, P NATL ACAD SCI USA, V103, P8858, DOI 10.1073/pnas.0603081103; Kempadoo KA, 2013, J NEUROSCI, V33, P7618, DOI 10.1523/JNEUROSCI.2588-12.2013; Knight ZA, 2012, CELL, V151, P1126, DOI 10.1016/j.cell.2012.10.039; Lammel S, 2008, NEURON, V57, P760, DOI 10.1016/j.neuron.2008.01.022; Lammel S, 2012, NATURE, V491, P212, DOI 10.1038/nature11527; Lammel S, 2011, NEURON, V70, P855, DOI 10.1016/j.neuron.2011.03.025; Lein ES, 2007, NATURE, V445, P168, DOI 10.1038/nature05453; Li XP, 2013, BRAIN STRUCT FUNCT, V218, P1159, DOI 10.1007/s00429-012-0452-z; Lichtman JW, 2011, SCIENCE, V334, P618, DOI 10.1126/science.1209168; Lim BK, 2012, NATURE, V487, P183, DOI 10.1038/nature11160; Lo LC, 2011, NEURON, V72, P938, DOI 10.1016/j.neuron.2011.12.002; Lobo MK, 2006, NAT NEUROSCI, V9, P443, DOI 10.1038/nn1654; Ludwig DS, 2001, J CLIN INVEST, V107, P379, DOI 10.1172/JCI10660; Luscher C, 2011, NEURON, V69, P650, DOI 10.1016/j.neuron.2011.01.017; Maisak MS, 2013, NATURE, V500, P212, DOI 10.1038/nature12320; Micheva KD, 2010, NEURON, V68, P639, DOI 10.1016/j.neuron.2010.09.024; Morgan JL, 2013, NAT METHODS, V10, P494, DOI 10.1038/nmeth.2480; Mosharov EV, 2009, NEURON, V62, P218, DOI 10.1016/j.neuron.2009.01.033; Muyldermans S, 2013, ANNU REV BIOCHEM, V82, P775, DOI 10.1146/annurev-biochem-063011-092449; Oh YS, 2013, CELL, V152, P831, DOI 10.1016/j.cell.2013.01.014; Osakada F, 2013, NAT PROTOC, V8, P1583, DOI 10.1038/nprot.2013.094; Ries J, 2012, NAT METHODS, V9, P582, DOI [10.1038/NMETH.1991, 10.1038/nmeth.1991]; Rothbauer U, 2006, NAT METHODS, V3, P887, DOI 10.1038/NMETH953; Sanz E, 2009, P NATL ACAD SCI USA, V106, P13939, DOI 10.1073/pnas.0907143106; Schmidt EF, 2012, CELL, V149, P1152, DOI 10.1016/j.cell.2012.03.038; Sesack SR, 2010, NEUROPSYCHOPHARMACOL, V35, P27, DOI 10.1038/npp.2009.93; Silva JP, 2009, NATURE, V462, P646, DOI 10.1038/nature08589; Stanley S, 2013, CELL METAB, V18, P596, DOI 10.1016/j.cmet.2013.09.002; Sugino K, 2006, NAT NEUROSCI, V9, P99, DOI 10.1038/nn1618; Svenningsson P, 2006, SCIENCE, V311, P77, DOI 10.1126/science.1117571; Takemura S, 2013, NATURE, V500, P175, DOI 10.1038/nature12450; Tang JCY, 2013, CELL, V154, P928, DOI 10.1016/j.cell.2013.07.021; Tsien RY, 1998, ANNU REV BIOCHEM, V67, P509, DOI 10.1146/annurev.biochem.67.1.509; Tye KM, 2013, NATURE, V493, P537, DOI 10.1038/nature11740; Wall NR, 2013, NEURON, V79, P347, DOI 10.1016/j.neuron.2013.05.014; Wall NR, 2010, P NATL ACAD SCI USA, V107, P21848, DOI 10.1073/pnas.1011756107; WHITE JG, 1986, PHILOS T R SOC B, V314, P1, DOI 10.1098/rstb.1986.0056; Wickersham IR, 2007, NAT METHODS, V4, P47, DOI 10.1038/NMETH999	52	95	96	1	48	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAY 22	2014	157	5					1230	1242		10.1016/j.cell.2014.03.059	http://dx.doi.org/10.1016/j.cell.2014.03.059			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	AH9CG	24855954	Green Accepted, Bronze			2022-12-28	WOS:000336437200022
J	Krapivinsky, G; Krapivinsky, L; Manasian, Y; Clapham, DE				Krapivinsky, Grigory; Krapivinsky, Luba; Manasian, Yunona; Clapham, David E.			The TRPM7 Chanzyme Is Cleaved to Release a Chromatin-Modifying Kinase	CELL			English	Article							HISTONE H3 PHOSPHORYLATION; MG2+ HOMEOSTASIS; PROTEIN; CHANNEL; TRANSCRIPTION; CELL; ACETYLATION; INTERACTS; COMPLEX; GENE	TRPM7 is a ubiquitous ion channel and kinase, a unique "chanzyme," required for proper early embryonic development. It conducts Zn2+, Mg2+, and Ca2+ as well as monovalent cations and contains a functional serine/threonine kinase at its carboxyl terminus. Here, we show that in normal tissues and cell lines, the kinase is proteolytically cleaved from the channel domain in a cell-type-specific manner. These TRPM7 cleaved kinase fragments (M7CKs) translocate to the nucleus and bind multiple components of chromatin-remodeling complexes, including Polycomb group proteins. In the nucleus, the kinase phosphorylates specific serines/threonines of histones. M7CK-dependent phosphorylation of H3Ser10 at promoters of TRPM7-dependent genes correlates with their activity. We also demonstrate that cytosolic free [Zn2+] is TRPM7 dependent and regulates M7CK binding to transcription factors containing zinc-finger domains. These findings suggest that TRPM7-mediated modulation of intracellular Zn2+ concentration couples ion-channel signaling to epigenetic chromatin covalent modifications that affect gene expression patterns.	[Krapivinsky, Grigory; Krapivinsky, Luba; Manasian, Yunona; Clapham, David E.] Boston Childrens Hosp, Howard Hughes Med Inst, Dept Cardiol, Boston, MA 02115 USA; [Clapham, David E.] Harvard Univ, Sch Med, Dept Neurobiol, Boston, MA 02115 USA	Harvard University; Boston Children's Hospital; Howard Hughes Medical Institute; Harvard University; Harvard Medical School	Clapham, DE (corresponding author), Boston Childrens Hosp, Howard Hughes Med Inst, Dept Cardiol, Enders Bldg 1309,320 Longwood Ave, Boston, MA 02115 USA.	dclapham@enders.tch.harvard.edu	Clapham, David/R-5974-2019; Clapham, David/S-1123-2019	Clapham, David/0000-0002-4459-9428	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P30HD018655] Funding Source: NIH RePORTER; Howard Hughes Medical Institute Funding Source: Medline; NICHD NIH HHS [P30 HD018655] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); Howard Hughes Medical Institute(Howard Hughes Medical Institute); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		Badeaux AI, 2013, NAT REV MOL CELL BIO, V14, P211, DOI 10.1038/nrm3545; Baek SH, 2011, MOL CELL, V42, P274, DOI 10.1016/j.molcel.2011.03.022; Banerjee T, 2011, MOL CELL BIOL, V31, P4858, DOI 10.1128/MCB.05631-11; Bauer A, 2000, EMBO J, V19, P6121, DOI 10.1093/emboj/19.22.6121; Berger SL, 2010, COLD SH Q B, V75, P23, DOI 10.1101/sqb.2010.75.044; Bryja V, 2006, NAT PROTOC, V1, P2082, DOI 10.1038/nprot.2006.355; Burckstummer T, 2006, NAT METHODS, V3, P1013, DOI 10.1038/nmeth968; Cai Y, 2007, NAT STRUCT MOL BIOL, V14, P872, DOI 10.1038/nsmb1276; Cheung P, 2000, MOL CELL, V5, P905, DOI 10.1016/S1097-2765(00)80256-7; Cheung P, 2000, CELL, V103, P263, DOI 10.1016/S0092-8674(00)00118-5; Chini CCS, 2010, J BIOL CHEM, V285, P40830, DOI 10.1074/jbc.M110.153270; Clark K, 2006, EMBO J, V25, P290, DOI 10.1038/sj.emboj.7600931; Clark K, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001876; Clark K, 2008, J MOL BIOL, V378, P790, DOI 10.1016/j.jmb.2008.02.057; Demeuse P, 2006, J GEN PHYSIOL, V127, P421, DOI 10.1085/jgp.200509410; Dittmer PJ, 2009, J BIOL CHEM, V284, P16289, DOI 10.1074/jbc.M900501200; Dorovkov MV, 2004, J BIOL CHEM, V279, P50643, DOI 10.1074/jbc.C400441200; Du JY, 2010, CIRC RES, V106, P992, DOI 10.1161/CIRCRESAHA.109.206771; Duan Q, 2008, J BIOL CHEM, V283, P33585, DOI 10.1074/jbc.M803312200; Eberharter A, 2002, EMBO REP, V3, P224, DOI 10.1093/embo-reports/kvf053; Fisher CL, 2011, CURR OPIN GENET DEV, V21, P140, DOI 10.1016/j.gde.2011.01.015; Gallant P, 2007, TRENDS CELL BIOL, V17, P187, DOI 10.1016/j.tcb.2007.02.005; Garcia E, 1999, EMBO J, V18, P3404, DOI 10.1093/emboj/18.12.3404; Gehani SS, 2010, MOL CELL, V39, P886, DOI 10.1016/j.molcel.2010.08.020; Goto H, 2002, GENES CELLS, V7, P11, DOI 10.1046/j.1356-9597.2001.00498.x; Hanano T, 2004, J PHARMACOL SCI, V95, P403, DOI 10.1254/jphs.FP0040273; Higa LA, 2006, NAT CELL BIOL, V8, P1277, DOI 10.1038/ncb1490; Huen J, 2010, BIOCHEM CELL BIOL, V88, P29, DOI [10.1139/o09-122, 10.1139/O09-122]; Inoue K, 2009, CARDIOVASC RES, V83, P547, DOI 10.1093/cvr/cvp153; Iovine B, 2011, INT J BIOCHEM CELL B, V43, P1664, DOI 10.1016/j.biocel.2011.09.001; Jacob Eyal, 2011, J Mol Signal, V6, P5, DOI 10.1186/1750-2187-6-5; Jin J, 2008, SCIENCE, V322, P756, DOI 10.1126/science.1163493; Jin J, 2012, P NATL ACAD SCI USA, V109, pE225, DOI 10.1073/pnas.1120033109; Kim JH, 2005, NATURE, V434, P921, DOI 10.1038/nature03452; Krapivinsky G, 2006, NEURON, V52, P485, DOI 10.1016/j.neuron.2006.09.033; Krapivinsky G, 2011, P NATL ACAD SCI USA, V108, P19234, DOI 10.1073/pnas.1117231108; Krezel A, 2006, J BIOL INORG CHEM, V11, P1049, DOI 10.1007/s00775-006-0150-5; Lau PNI, 2011, P NATL ACAD SCI USA, V108, P2801, DOI 10.1073/pnas.1012798108; Lee BC, 2011, CELL PHYSIOL BIOCHEM, V27, P313, DOI 10.1159/000327958; Li X, 2009, AM J PATHOL, V175, P1246, DOI 10.2353/ajpath.2009.090042; Matsushita M, 2005, J BIOL CHEM, V280, P20793, DOI 10.1074/jbc.M413671200; Middelbeek J, 2012, CANCER RES, V72, P4250, DOI 10.1158/0008-5472.CAN-11-3863; Miranda JG, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049371; Monteilh-Zoller MK, 2003, J GEN PHYSIOL, V121, P49, DOI 10.1085/jgp.20028740; Nadler MJS, 2001, NATURE, V411, P590, DOI 10.1038/35079092; Perraud AL, 2011, CELL SIGNAL, V23, P586, DOI 10.1016/j.cellsig.2010.11.011; RAJU B, 1989, AM J PHYSIOL, V256, pC540, DOI 10.1152/ajpcell.1989.256.3.C540; Runnels LW, 2001, SCIENCE, V291, P1043, DOI 10.1126/science.1058519; Ryazanova LV, 2010, NAT COMMUN, V1, DOI 10.1038/ncomms1108; Ryazanova LV, 2004, J BIOL CHEM, V279, P3708, DOI 10.1074/jbc.M308820200; Sah R, 2013, CIRCULATION, V128, P101, DOI 10.1161/CIRCULATIONAHA.112.000768; Satijn DPE, 2001, MOL CELL BIOL, V21, P1360, DOI 10.1128/MCB.21.4.1360-1369.2001; Sawicka A, 2012, BIOCHIMIE, V94, P2193, DOI 10.1016/j.biochi.2012.04.018; Schmitz C, 2005, J BIOL CHEM, V280, P37763, DOI 10.1074/jbc.M509175200; Schmitz C, 2003, CELL, V114, P191, DOI 10.1016/S0092-8674(03)00556-7; Sierra J, 2006, GENE DEV, V20, P586, DOI 10.1101/gad.1385806; Simon JA, 2013, MOL CELL, V49, P808, DOI 10.1016/j.molcel.2013.02.013; Strahl BD, 2000, NATURE, V403, P41, DOI 10.1038/47412; Surface LE, 2010, CELL STEM CELL, V7, P288, DOI 10.1016/j.stem.2010.08.004; Taki M, 2004, J AM CHEM SOC, V126, P712, DOI 10.1021/ja039073j; Tavares L, 2012, CELL, V148, P664, DOI 10.1016/j.cell.2011.12.029; Thompson SR, 2012, WIRES RNA, V3, P697, DOI 10.1002/wrna.1129; Vella P, 2012, NUCLEIC ACIDS RES, V40, P3403, DOI 10.1093/nar/gkr1290; Vinkenborg JL, 2009, NAT METHODS, V6, P737, DOI [10.1038/nmeth.1368, 10.1038/NMETH.1368]; Wei Y, 1999, CELL, V97, P99, DOI 10.1016/S0092-8674(00)80718-7; Wu S, 2007, NAT STRUCT MOL BIOL, V14, P1165, DOI 10.1038/nsmb1332; Xu Y, 2011, CELL CYCLE, V10, P261, DOI 10.4161/cc.10.2.14543; Yamaguchi H, 2001, MOL CELL, V7, P1047, DOI 10.1016/S1097-2765(01)00256-8; Yang WW, 2012, CELL, V150, P685, DOI 10.1016/j.cell.2012.07.018; Ying QL, 2003, NAT BIOTECHNOL, V21, P183, DOI 10.1038/nbt780; Zhao WH, 2008, NATURE, V451, P587, DOI 10.1038/nature06515	71	102	104	0	12	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAY 22	2014	157	5					1061	1072		10.1016/j.cell.2014.03.046	http://dx.doi.org/10.1016/j.cell.2014.03.046			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	AH9CG	24855944	Green Accepted, Bronze			2022-12-28	WOS:000336437200010
J	Lamkanfi, M; Dixit, VM				Lamkanfi, Mohamed; Dixit, Vishva M.			Mechanisms and Functions of Inflammasomes	CELL			English	Review							COLD AUTOINFLAMMATORY SYNDROME; III SECRETION APPARATUS; ANTHRAX LETHAL TOXIN; LONG-TERM EFFICACY; NLRP3 INFLAMMASOME; MACULAR DEGENERATION; NALP3 INFLAMMASOME; HOST-DEFENSE; CELL-DEATH; INTERLEUKIN-1-BETA SECRETION	Recent studies have offered a glimpse into the sophisticated mechanisms by which inflammasomes respond to danger and promote secretion of interleukin (IL)-1 beta and IL-18. Activation of caspases 1 and 11 in canonical and noncanonical inflammasomes, respectively, also protects against infection by triggering pyroptosis, a proinflammatory and lytic mode of cell death. The therapeutic potential of inhibiting these proinflammatory caspases in infectious and autoimmune diseases is raised by the successful deployment of anti-IL-1 therapies to control autoinflammatory diseases associated with aberrant inflammasome signaling. This Review summarizes recent insights into inflammasome biology and discusses the questions that remain in the field.	[Lamkanfi, Mohamed] VIB, Dept Med Prot Res, B-9000 Ghent, Belgium; [Lamkanfi, Mohamed] Univ Ghent, Dept Biochem, B-9000 Ghent, Belgium; [Dixit, Vishva M.] Genentech Inc, Dept Physiol Chem, San Francisco, CA 94080 USA	Flanders Institute for Biotechnology (VIB); Ghent University; Roche Holding; Genentech	Lamkanfi, M (corresponding author), VIB, Dept Med Prot Res, B-9000 Ghent, Belgium.	mohamed.lamkanfi@vib-ugent.be; dixit.vishva@gene.com	dixit, vishva m/A-4496-2012	dixit, vishva m/0000-0001-6983-0326	Ghent University Concerted Research Actions [BOF14/GOA/013]; European Research Council [281600]; Fund for Scientific Research (FWO)-Flanders [G030212N]	Ghent University Concerted Research Actions; European Research Council(European Research Council (ERC)European Commission); Fund for Scientific Research (FWO)-Flanders(FWO)	The authors apologize to those whose citations were omitted owing to space limitations. M. L. is supported, in part, by the Ghent University Concerted Research Actions (BOF14/GOA/013), the European Research Council (Grant 281600), and the Fund for Scientific Research (FWO)-Flanders (grant G030212N). V.M.D. is a shareholder and employee of Genentech, Inc.	Aachoui Y, 2013, SCIENCE, V339, P975, DOI 10.1126/science.1230751; Alnemri ES, 2010, J CLIN IMMUNOL, V30, P512, DOI 10.1007/s10875-010-9419-0; Amer A, 2006, J BIOL CHEM, V281, P35217, DOI 10.1074/jbc.M604933200; Arlehamn CSL, 2010, J BIOL CHEM, V285, P10508, DOI 10.1074/jbc.M109.067298; Bauernfeind F, 2011, J IMMUNOL, V187, P613, DOI 10.4049/jimmunol.1100613; Bauernfeind FG, 2009, J IMMUNOL, V183, P787, DOI 10.4049/jimmunol.0901363; Boehm T, 2012, ANNU REV GENOM HUM G, V13, P127, DOI 10.1146/annurev-genom-090711-163747; Boyden ED, 2006, NAT GENET, V38, P240, DOI 10.1038/ng1724; Broz P, 2012, NATURE, V490, P288, DOI 10.1038/nature11419; Broz P, 2010, CELL HOST MICROBE, V8, P471, DOI 10.1016/j.chom.2010.11.007; Broz P, 2010, J EXP MED, V207, P1745, DOI 10.1084/jem.20100257; Brydges SD, 2013, J CLIN INVEST, V123, P4695, DOI 10.1172/JCI71543; Cai X, 2014, CELL, V156, P1207, DOI 10.1016/j.cell.2014.01.063; Cain K, 2001, J BIOL CHEM, V276, P41985, DOI 10.1074/jbc.M107419200; Case CL, 2013, P NATL ACAD SCI USA, V110, P1851, DOI 10.1073/pnas.1211521110; Casson CN, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003400; Chavarria-Smith J, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003452; Craft JM, 2005, J NEUROINFLAMM, V2, DOI 10.1186/1742-2094-2-15; Dinarello CA, 2012, NAT REV DRUG DISCOV, V11, P633, DOI 10.1038/nrd3800; Dinarello CA, 2009, ANNU REV IMMUNOL, V27, P519, DOI 10.1146/annurev.immunol.021908.132612; Doitsh G, 2014, NATURE, V505, P509, DOI 10.1038/nature12940; Dowds TA, 2004, J BIOL CHEM, V279, P21924, DOI 10.1074/jbc.M401178200; Doyle SL, 2012, NAT MED, V18, P791, DOI 10.1038/nm.2717; Duncan JA, 2007, P NATL ACAD SCI USA, V104, P8041, DOI 10.1073/pnas.0611496104; Ermler ME, 2014, VIROLOGY, V449, P174, DOI 10.1016/j.virol.2013.11.015; Faustin B, 2007, MOL CELL, V25, P713, DOI 10.1016/j.molcel.2007.01.032; Feldmann J, 2002, AM J HUM GENET, V71, P198, DOI 10.1086/341357; Fernandes-Alnemri T, 2013, J IMMUNOL, V191, P3995, DOI 10.4049/jimmunol.1301681; Fink SL, 2008, P NATL ACAD SCI USA, V105, P4312, DOI 10.1073/pnas.0707370105; Goldbach-Mansky R, 2006, NEW ENGL J MED, V355, P581, DOI 10.1056/NEJMoa055137; Gurung P, 2012, J BIOL CHEM, V287, P34474, DOI 10.1074/jbc.M112.401406; Hagar JA, 2013, SCIENCE, V341, P1250, DOI 10.1126/science.1240988; Halle A, 2008, NAT IMMUNOL, V9, P857, DOI 10.1038/ni.1636; He Y, 2013, EUR J IMMUNOL, V43, P1147, DOI 10.1002/eji.201243187; Hellmich KA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049741; Heneka MT, 2013, NATURE, V493, P674, DOI 10.1038/nature11729; Hoffman HM, 2012, CLIN THER, V34, P2091, DOI 10.1016/j.clinthera.2012.09.009; Hoffman HM, 2001, NAT GENET, V29, P301, DOI 10.1038/ng756; Hornung V, 2008, NAT IMMUNOL, V9, P847, DOI 10.1038/ni.1631; Hu ZH, 2013, SCIENCE, V341, P172, DOI 10.1126/science.1236381; Iyer SS, 2013, IMMUNITY, V39, P311, DOI 10.1016/j.immuni.2013.08.001; Jankovic D, 2013, J EXP MED, V210, P1899, DOI 10.1084/jem.20130084; Jourdan T, 2013, NAT MED, V19, P1132, DOI 10.1038/nm.3265; Juliana C, 2012, J BIOL CHEM, V287, P36617, DOI 10.1074/jbc.M112.407130; Kanneganti TD, 2010, NAT REV IMMUNOL, V10, P688, DOI 10.1038/nri2851; Kayagaki N, 2013, SCIENCE, V341, P1246, DOI 10.1126/science.1240248; Kayagaki N, 2011, NATURE, V479, P117, DOI 10.1038/nature10558; Kim HY, 2014, NAT MED, V20, P54, DOI 10.1038/nm.3423; Kim SU, 2005, J NEUROSCI RES, V81, P302, DOI 10.1002/jnr.20562; Koch U, 2011, ANNU REV CELL DEV BI, V27, P539, DOI 10.1146/annurev-cellbio-092910-154008; Kofoed EM, 2011, NATURE, V477, P592, DOI 10.1038/nature10394; Kovarova M, 2012, J IMMUNOL, V189, P2006, DOI 10.4049/jimmunol.1201065; Kuemmerle-Deschner JB, 2011, ANN RHEUM DIS, V70, P2095, DOI 10.1136/ard.2011.152728; Lamkanfi M, 2012, ANNU REV CELL DEV BI, V28, P137, DOI 10.1146/annurev-cellbio-101011-155745; Lamkanfi M, 2011, J IMMUNOL, V187, P597, DOI 10.4049/jimmunol.1100229; Lamkanfi M, 2011, NAT REV IMMUNOL, V11, P213, DOI 10.1038/nri2936; Lamkanfi M, 2010, J IMMUNOL, V185, P4385, DOI 10.4049/jimmunol.1000803; Larsen CM, 2007, NEW ENGL J MED, V356, P1517, DOI 10.1056/NEJMoa065213; Lin KM, 2014, P NATL ACAD SCI USA, V111, P775, DOI 10.1073/pnas.1320294111; Lopez-Castejon G, 2013, J BIOL CHEM, V288, P2721, DOI 10.1074/jbc.M112.422238; Lu A, 2014, CELL, V156, P1193, DOI 10.1016/j.cell.2014.02.008; Lu B, 2012, NATURE, V488, P670, DOI 10.1038/nature11290; Mariathasan S, 2004, NATURE, V430, P213, DOI 10.1038/nature02664; Marneros AG, 2013, CELL REP, V4, P945, DOI 10.1016/j.celrep.2013.08.002; Martinon F, 2002, MOL CELL, V10, P417, DOI 10.1016/S1097-2765(02)00599-3; Masters SL, 2012, IMMUNITY, V37, P1009, DOI 10.1016/j.immuni.2012.08.027; Masters SL, 2010, NAT IMMUNOL, V11, P897, DOI 10.1038/ni.1935; Miao EA, 2006, NAT IMMUNOL, V7, P569, DOI 10.1038/ni1344; Miao EA, 2010, NAT IMMUNOL, V11, P1136, DOI 10.1038/ni.1960; Miao EA, 2010, P NATL ACAD SCI USA, V107, P3076, DOI 10.1073/pnas.0913087107; Misawa T, 2013, NAT IMMUNOL, V14, P454, DOI 10.1038/ni.2550; Moayeri M, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001222; Munoz-Planillo R, 2013, IMMUNITY, V38, P1142, DOI 10.1016/j.immuni.2013.05.016; Nakahira K, 2011, NAT IMMUNOL, V12, P222, DOI 10.1038/ni.1980; Neven B, 2010, ARTHRITIS RHEUM-US, V62, P258, DOI 10.1002/art.25057; Paludan SR, 2013, IMMUNITY, V38, P870, DOI 10.1016/j.immuni.2013.05.004; Petrilli V, 2007, CELL DEATH DIFFER, V14, P1583, DOI 10.1038/sj.cdd.4402195; Py BF, 2013, MOL CELL, V49, P331, DOI 10.1016/j.molcel.2012.11.009; Qu Y, 2012, NATURE, V490, P539, DOI 10.1038/nature11429; Rathinam VAK, 2012, CELL, V150, P606, DOI 10.1016/j.cell.2012.07.007; Rathinam VAK, 2010, NAT IMMUNOL, V11, P395, DOI 10.1038/ni.1864; Rayamajhi M, 2013, J IMMUNOL, V191, P3986, DOI 10.4049/jimmunol.1301549; Riedl SJ, 2007, NAT REV MOL CELL BIO, V8, P405, DOI 10.1038/nrm2153; Sastalla I, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-188; Sauer JD, 2010, CELL HOST MICROBE, V7, P412, DOI 10.1016/j.chom.2010.04.004; Schroder K, 2012, IMMUNOBIOLOGY, V217, P1325, DOI 10.1016/j.imbio.2012.07.020; Shimada K, 2012, IMMUNITY, V36, P401, DOI 10.1016/j.immuni.2012.01.009; Simard AR, 2006, NEURON, V49, P489, DOI 10.1016/j.neuron.2006.01.022; Stack JH, 2005, J IMMUNOL, V175, P2630, DOI 10.4049/jimmunol.175.4.2630; Stienstra R, 2011, P NATL ACAD SCI USA, V108, P15324, DOI 10.1073/pnas.1100255108; Strowig T, 2012, NATURE, V481, P278, DOI 10.1038/nature10759; Subramanian N, 2013, CELL, V153, P348, DOI 10.1016/j.cell.2013.02.054; Takeuchi O, 2010, CELL, V140, P805, DOI 10.1016/j.cell.2010.01.022; Tarallo V, 2012, CELL, V149, P847, DOI 10.1016/j.cell.2012.03.036; ter Haar N, 2013, ANN RHEUM DIS, V72, P678, DOI 10.1136/annrheumdis-2011-201268; Terra JK, 2010, J IMMUNOL, V184, P17, DOI 10.4049/jimmunol.0903114; Van Opdenbosch N, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4209; Vandanmagsar B, 2011, NAT MED, V17, P179, DOI 10.1038/nm.2279; von Moltke J, 2012, NATURE, V490, P107, DOI 10.1038/nature11351; Wang SY, 1998, CELL, V92, P501, DOI 10.1016/S0092-8674(00)80943-5; Wen HT, 2011, NAT IMMUNOL, V12, P408, DOI 10.1038/ni.2022; Wu JH, 2010, J CLIN IMMUNOL, V30, P693, DOI 10.1007/s10875-010-9425-2; Yang JL, 2013, P NATL ACAD SCI USA, V110, P14408, DOI 10.1073/pnas.1306376110; Zhang WJ, 2013, J CLIN IMMUNOL, V33, P925, DOI 10.1007/s10875-013-9881-6; Zhao Y, 2011, NATURE, V477, P596, DOI 10.1038/nature10510; Zhou RB, 2011, NATURE, V469, P221, DOI 10.1038/nature09663; Zhou RB, 2010, NAT IMMUNOL, V11, P136, DOI 10.1038/ni.1831	107	1493	1585	9	330	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAY 22	2014	157	5					1013	1022		10.1016/j.cell.2014.04.007	http://dx.doi.org/10.1016/j.cell.2014.04.007			10	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	AH9CG	24855941	Bronze			2022-12-28	WOS:000336437200006
J	Jacobson, IM; Dore, GJ; Foster, GR; Fried, MW; Radu, M; Rafalsky, VV; Moroz, L; Craxi, A; Peeters, M; Lenz, O; Ouwerkerk-Mahadevan, S; De La Rosa, G; Kalmeijer, R; Scott, J; Sinha, R; Beumont-Mauviel, M				Jacobson, Ira M.; Dore, Gregory J.; Foster, Graham R.; Fried, Michael W.; Radu, Monica; Rafalsky, Vladimir V.; Moroz, Larysa; Craxi, Antonio; Peeters, Monika; Lenz, Oliver; Ouwerkerk-Mahadevan, Sivi; De La Rosa, Guy; Kalmeijer, Ronald; Scott, Jane; Sinha, Rekha; Beumont-Mauviel, Maria			Simeprevir with pegylated interferon alfa 2a plus ribavirin in treatment-naive patients with chronic hepatitis C virus genotype 1 infection (QUEST-1): a phase 3, randomised, double-blind, placebo-controlled trial	LANCET			English	Article							ONCE-DAILY TMC435; IN-VITRO; VIROLOGICAL RESPONSE; TELAPREVIR; PEGINTERFERON; BOCEPREVIR; THERAPY; PROFILE; IMPACT; SAFETY	Background Although the addition of the HCV NS3/4A protease inhibitors boceprevir and telaprevir to pegylated interferon (peginterferon) alfa plus ribavirin has improved sustained virological response (SVR) in treatment-naive and treatment-experienced patients infected with hepatitis C virus (HCV) genotype 1, the regimens have a high pill burden and are associated with increased rates and severity of adverse events, such as anaemia and rash. The efficacy and safety of the combination of simeprevir, a one pill, once-daily, oral HCV NS3/4A protease inhibitor, plus peginterferon alfa 2a plus ribavirin were assessed in treatment-naive patients with HCV genotype 1 infection. Methods In QUEST-1, a phase 3, randomised, double-blind multicentre trial undertaken in 13 countries (Australia, Europe, North America, Puerto Rico, and New Zealand), 394 patients (aged >= 18 years) with chronic HCV genotype 1 infection and no history of HCV treatment, stratified by HCV subtype and host IL28B genotype, were randomly assigned in a 2: 1 ratio with a computer-generated allocation sequence to receive simeprevir (150 mg once daily, orally) plus peginterferon alfa 2a plus ribavirin for 12 weeks, followed by peginterferon alfa 2a plus ribavirin (simeprevir group), or placebo orally plus peginterferon alfa 2a plus ribavirin for 12 weeks, followed by peginterferon alfa 2a plus ribavirin (placebo group). Treatment duration was 24 weeks or 48 weeks in the simeprevir group according to criteria for response-guided therapy (ie, HCV RNA <25 IU/mL [undetectable or detectable] at week 4 and <25 IU/mL undetectable at week 12) and 48 weeks in the placebo group. Patients, study personnel, and the sponsor were masked to the treatment group assignment. The primary efficacy endpoint was sustained virological response 12 weeks after the planned end of treatment (SVR12) and was assessed with an intention-to-treat analysis. The results of the primary analysis (week 60) are presented for safety and SVR12. This trial is registered with ClinicalTrials.gov, number NCT01289782. Findings Treatment with simeprevir, peginterferon alfa 2a, and ribavirin was superior to placebo, peginterferon alfa 2a, and ribavirin (SVR12 in 210 [80%] patients of 264 vs 65 [50%] of 130, respectively, adjusted difference 29.3% [95% CI 20.1-38.6; p<0.0001). Adverse events in the first 12 weeks of treatment led to discontinuation of simeprevir in two (<1%) patients and discontinuation of placebo in one patient (<1%); fatigue (106 [40%] vs 49 [38%] patients, respectively) and headache (81 [31%] vs 48 [37%], respectively) were the most common adverse events. The prevalences of anaemia (42 [16%] vs 14 [11%], respectively) and rash (72 [27%] vs 33 [25%]) were similar in the simeprevir and placebo groups. Addition of simeprevir did not increase severity of patient-reported fatigue and functioning limitations, but shortened their duration. Interpretation Simeprevir once daily with peginterferon alfa 2a and ribavirin shortens therapy in treatment-naive patients with HCV genotype 1 infection without worsening the adverse event profiles associated with peginterferon alfa 2a plus ribavirin.	[Jacobson, Ira M.] Weill Cornell Med Coll, New York, NY 10021 USA; [Dore, Gregory J.] Univ New S Wales, Kirby Inst, Darlinghurst, NSW, Australia; [Foster, Graham R.] Univ London, London, England; [Fried, Michael W.] Univ N Carolina, Chapel Hill, NC USA; [Radu, Monica] Inst Boli Infect, Bucharest, Romania; [Rafalsky, Vladimir V.] Smolensk State Med Acad, Smolensk Reg Clin Hosp, Smolensk Oblast, Russia; [Moroz, Larysa] Vinnytsia Natl Med Univ, Vinnytsia, Ukraine; [Craxi, Antonio] Azienda Osped Univ, Policlin Paolo Giaccone, Palermo, Italy; [Peeters, Monika; Lenz, Oliver; Sinha, Rekha; Beumont-Mauviel, Maria] Janssen Infect Dis, Beerse, Belgium; [Ouwerkerk-Mahadevan, Sivi] Janssen Res & Dev, Beerse, Belgium; [De La Rosa, Guy] Janssen Res & Dev, Titusville, NJ USA; [Scott, Jane] Janssen Global Serv, High Wycombe, Bucks, England	Cornell University; University of New South Wales Sydney; Kirby Institute; University of London; University of North Carolina; University of North Carolina Chapel Hill; National Pirogov Memorial Medical University Vinnytsya; University of Palermo; Policlinico Paolo Giaccone; Johnson & Johnson; Janssen Pharmaceuticals; Johnson & Johnson; Janssen Pharmaceuticals	Jacobson, IM (corresponding author), Weill Cornell Med Coll, 1305 York Ave,Floor 4, New York, NY 10021 USA.	imj2001@med.cornell.edu	Rafalskiy, Vladimir V/G-3172-2013; Moroz, Larysa V/I-3185-2018; Dore, Gregory John/ABD-5665-2021; Craxi, Antonio/K-9529-2016	Rafalskiy, Vladimir V/0000-0002-2503-9580; Moroz, Larysa V/0000-0002-7111-3155; Dore, Gregory John/0000-0002-4741-2622; Foster, Graham/0000-0002-3704-386X; Craxi, Antonio/0000-0002-4480-9544	Janssen Infectious Diseases-Diagnostics	Janssen Infectious Diseases-Diagnostics	Janssen Infectious Diseases-Diagnostics.	Asselah T, 2012, LIVER INT, V32, P88, DOI 10.1111/j.1478-3231.2011.02699.x; Bacon BR, 2011, NEW ENGL J MED, V364, P1207, DOI 10.1056/NEJMoa1009482; Bedossa P, 1996, HEPATOLOGY, V24, P289, DOI 10.1002/hep.510240201; Buti M, 2012, HEPATOLOGY, V56, p191A; Casey LC, 2012, CURR OPIN GASTROEN, V28, P188, DOI 10.1097/MOG.0b013e3283528e1e; Fried MW, 2013, HEPATOLOGY, V58, P1918, DOI 10.1002/hep.26641; Fried MW, 2002, NEW ENGL J MED, V347, P975, DOI 10.1056/NEJMoa020047; Gao X, 2012, EXPERT REV PHARM OUT, V12, P335, DOI [10.1586/ERP.12.10, 10.1586/erp.12.10]; Ge DL, 2009, NATURE, V461, P399, DOI 10.1038/nature08309; Ghany MG, 2011, HEPATOLOGY, V54, P1433, DOI 10.1002/hep.24641; Hezode C, 2012, LIVER INT, V32, P32, DOI 10.1111/j.1478-3231.2011.02707.x; Hezode C, 2009, NEW ENGL J MED, V360, P1839, DOI 10.1056/NEJMoa0807650; Huisman MT, 2010, HEPATOLOGY, V52, p461A; Jacobson IM, 2013, HEPATOLOGY, V58, p1379A; Jacobson IM, 2011, NEW ENGL J MED, V364, P2405, DOI 10.1056/NEJMoa1012912; Kleinman L, 2000, QUAL LIFE RES, V9, P499, DOI 10.1023/A:1008960710415; Kwo Paul Y, 2011, Gastroenterol Hepatol (N Y), V7, P43; Legrand-Abravanel F, 2009, J MED VIROL, V81, P2029, DOI 10.1002/jmv.21583; Lenz O, 2010, ANTIMICROB AGENTS CH, V54, P1878, DOI 10.1128/AAC.01452-09; Lin TI, 2009, ANTIMICROB AGENTS CH, V53, P1377, DOI 10.1128/AAC.01058-08; Lozano R, 2012, LANCET, V380, P2095, DOI 10.1016/S0140-6736(12)61728-0; Manns M, 2011, ANTIVIR THER, V16, P1021, DOI 10.3851/IMP1894; Manns MP, 2001, LANCET, V358, P958, DOI 10.1016/S0140-6736(01)06102-5; MCEWAN P, 2011, J HEPATOL S1, V54, pS461; McHutchison JG, 2010, NEW ENGL J MED, V362, P1292, DOI 10.1056/NEJMoa0908014; Moreno C, 2012, J HEPATOL, V56, P1247, DOI 10.1016/j.jhep.2011.12.033; Poordad F, 2011, NEW ENGL J MED, V364, P1195, DOI 10.1056/NEJMoa1010494; Qin HM, 2012, CLIN DRUG INVEST, V32, P665, DOI [10.1007/BF03261920, 10.2165/11633240-000000000-00000]; Radloff LS, 1977, APPL PSYCH MEAS, V1, P385, DOI DOI 10.1177/014662167700100306; Reesink HW, 2010, GASTROENTEROLOGY, V138, P913, DOI 10.1053/j.gastro.2009.10.033; REILLY MC, 1993, PHARMACOECONOMICS, V4, P353, DOI 10.2165/00019053-199304050-00006; Sherman KE, 2011, NEW ENGL J MED, V365, P1014, DOI 10.1056/NEJMoa1014463; Sherman M, 2006, GUT, V55, P1631, DOI 10.1136/gut.2005.083113; Stattermayer AF, 2011, CLIN GASTROENTEROL H, V9, P344, DOI 10.1016/j.cgh.2010.07.019; WILLIAMS A, 1990, HEALTH POLICY, V16, P199; Zeuzem S, 2013, GASTROENTEROLOGY, V146; Zeuzem S, 2011, NEW ENGL J MED, V364, P2417, DOI 10.1056/NEJMoa1013086	37	351	381	0	30	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	AUG 2	2014	384	9941					403	413		10.1016/S0140-6736(14)60494-3	http://dx.doi.org/10.1016/S0140-6736(14)60494-3			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AM9IV	24907225				2022-12-28	WOS:000340195800024
J	Viros, A; Sanchez-Laorden, B; Pedersen, M; Furney, SJ; Rae, J; Hogan, K; Ejiama, S; Girotti, MR; Cook, M; Dhomen, N; Marais, R				Viros, Amaya; Sanchez-Laorden, Berta; Pedersen, Malin; Furney, Simon J.; Rae, Joel; Hogan, Kate; Ejiama, Sarah; Girotti, Maria Romina; Cook, Martin; Dhomen, Nathalie; Marais, Richard			Ultraviolet radiation accelerates BRAF-driven melanomagenesis by targeting TP53	NATURE			English	Article							MELANOCYTIC NEVI; SEQUENCING DATA; P53 GAIN; MUTATIONS; MICE; SUNSCREEN; CANCER; EXPRESSION; PREVENTION; EXPOSURE	Cutaneous melanoma is epidemiologically linked to ultraviolet radiation (UVR), but the molecular mechanisms by which UVR drives melanomagenesis remain unclear(1,2). The most common somatic mutation in melanoma is a V600E substitution in BRAF, which is an early event(3). To investigate how UVR accelerates oncogenic BRAF-driven melanomagenesis, we used a BRAF(V600E) mouse model. In mice expressing BRAF(V600E) in their melanocytes, a single dose of UVR that mimicked mild sunburn in humans induced clonal expansion of the melanocytes, and repeated doses of UVR increased melanoma burden. Here we show that sunscreen (UVA superior, UVB sun protection factor (SPF) 50) delayed the onset of UVR-driven melanoma, but only provided partial protection. The UVR-exposed tumours showed increased numbers of single nucleotide variants and we observed mutations (H39Y, S124F, R245C, R270C, C272G) in the Trp53 tumour suppressor in approximately 40% of cases. TP53 is an accepted UVR target in human non-melanoma skin cancer, but is not thought to have a major role in melanoma(4). However, we show that, in mice, mutant Trp53 accelerated BRAF(V600E)-driven melanomagenesis, and that TP53 mutations are linked to evidence of UVR-induced DNA damage inhuman melanoma. Thus, we provide mechanistic insight into epidemiological data linking UVR to acquired naevi in humans(5). Furthermore, we identify TP53/Trp53 as a UVR-target gene that cooperates with BRAF(V600E) to induce melanoma, providing molecular insight into how UVR accelerates melanomagenesis. Our study validates public health campaigns that promote sunscreen protection for individuals at risk of melanoma.	[Viros, Amaya; Sanchez-Laorden, Berta; Furney, Simon J.; Hogan, Kate; Ejiama, Sarah; Girotti, Maria Romina; Cook, Martin; Marais, Richard] Univ Manchester, Canc Res UK Manchester Inst, Mol Oncol Grp, Manchester M20 4BX, Lancs, England; [Pedersen, Malin; Rae, Joel; Dhomen, Nathalie; Marais, Richard] Inst Canc Res, Signal Transduct Team, London SW3 6JB, England; [Cook, Martin] Royal Surrey Cty Hosp, Guildford GU2 7XX, Surrey, England	Cancer Research UK; University of Manchester; Royal Marsden NHS Foundation Trust; University of London; Institute of Cancer Research - UK; Royal Surrey County Hospital	Marais, R (corresponding author), Univ Manchester, Canc Res UK Manchester Inst, Mol Oncol Grp, Wilmslow Rd, Manchester M20 4BX, Lancs, England.	richard.marais@cruk.manchester.ac.uk	Sanchez-Laorden, Berta/T-2177-2017	Sanchez-Laorden, Berta/0000-0002-6499-6332; Viros, Amaya/0000-0001-5177-5015; Furney, Simon/0000-0002-8920-6800; Marais, Richard/0000-0001-7484-4183; Dhomen, Nathalie/0000-0003-1961-2173	Cancer Research UK [C107/A10433, C5759/A12328, A13540, A17240]; Wenner-Gren Foundations; Stockholm; Teggerstiftelsen; FEBS Long-Term Fellowship; Cancer Research UK [17240, 19279] Funding Source: researchfish	Cancer Research UK(Cancer Research UK); Wenner-Gren Foundations; Stockholm; Teggerstiftelsen; FEBS Long-Term Fellowship; Cancer Research UK(Cancer Research UK)	This work was supported by Cancer Research UK (C107/A10433; C5759/A12328; A13540; A17240), the Wenner-Gren Foundations, Stockholm, Teggerstiftelsen (M.P.) and a FEBS Long-Term Fellowship (B.S.-L.). We thank G. Ashton for technical assistance and A. Young for helpful discussions. We would like to acknowledge the contribution of the melanoma specimen donors and research groups to The Cancer Genome Atlas.	Bald T, 2014, NATURE, V507, P109, DOI 10.1038/nature13111; Dankort D, 2009, NAT GENET, V41, P544, DOI 10.1038/ng.356; Dhomen N, 2009, CANCER CELL, V15, P294, DOI 10.1016/j.ccr.2009.02.022; Gilchrest BA, 1999, NEW ENGL J MED, V340, P1341, DOI 10.1056/NEJM199904293401707; Goel VK, 2009, ONCOGENE, V28, P2289, DOI 10.1038/onc.2009.95; Goldenhersh MA, 2011, J CLIN ONCOL, V29, pE557, DOI 10.1200/JCO.2011.35.5727; Green A, 1999, LANCET, V354, P723, DOI 10.1016/S0140-6736(98)12168-2; Green AC, 2011, J CLIN ONCOL, V29, P257, DOI 10.1200/JCO.2010.28.7078; HARRISON SL, 1994, LANCET, V344, P1529, DOI 10.1016/S0140-6736(94)90348-4; Hodis E, 2012, CELL, V150, P251, DOI 10.1016/j.cell.2012.06.024; Kato S, 2003, P NATL ACAD SCI USA, V100, P8424, DOI 10.1073/pnas.1431692100; Koboldt DC, 2012, GENOME RES, V22, P568, DOI 10.1101/gr.129684.111; Krauthammer M, 2012, NAT GENET, V44, P1006, DOI 10.1038/ng.2359; Larson DE, 2012, BIOINFORMATICS, V28, P311, DOI 10.1093/bioinformatics/btr665; Li H, 2009, BIOINFORMATICS, V25, P2078, DOI 10.1093/bioinformatics/btp352; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Luo C, 2013, CANCER RES, V73, P4337, DOI 10.1158/0008-5472.CAN-12-4454; McKenna A, 2010, GENOME RES, V20, P1297, DOI 10.1101/gr.107524.110; McLaren W, 2010, BIOINFORMATICS, V26, P2069, DOI 10.1093/bioinformatics/btq330; Noonan FP, 2001, NATURE, V413, P271, DOI 10.1038/35095108; Olive KP, 2004, CELL, V119, P847, DOI 10.1016/j.cell.2004.11.004; Patton EE, 2005, ZEBRAFISH, V1, P363, DOI 10.1089/zeb.2005.1.363; Pfeifer GP, 2005, MUTAT RES-FUND MOL M, V571, P19, DOI 10.1016/j.mrfmmm.2004.06.057; Planta MB, 2011, J AM BOARD FAM MED, V24, P735, DOI 10.3122/jabfm.2011.06.100178; Pollock PM, 2003, NAT GENET, V33, P19, DOI 10.1038/ng1054; PONTEN F, 1995, J INVEST DERMATOL, V105, P402, DOI 10.1111/1523-1747.ep12321071; Rudolph P, 1998, HUM PATHOL, V29, P1480, DOI 10.1016/S0046-8177(98)90019-3; Song H, 2007, NAT CELL BIOL, V9, P573, DOI 10.1038/ncb1571; Thomas NE, 2007, CANCER EPIDEM BIOMAR, V16, P991, DOI 10.1158/1055-9965.EPI-06-1038; Tsao H, 2012, GENE DEV, V26, P1131, DOI 10.1101/gad.191999.112; Turajlic S, 2012, GENOME RES, V22, P196, DOI 10.1101/gr.125591.111; Viros A, 2008, PLOS MED, V5, P941, DOI 10.1371/journal.pmed.0050120; Vultur Adina, 2013, Cancer Cell, V23, P706, DOI 10.1016/j.ccr.2013.05.001; Whiteman DC, 2003, J NATL CANCER I, V95, P806, DOI 10.1093/jnci/95.11.806; Willis A, 2004, ONCOGENE, V23, P2330, DOI 10.1038/sj.onc.1207396; Workman P, 2010, BRIT J CANCER, V102, P1555, DOI 10.1038/sj.bjc.6605642; Yeh I, 2013, JNCI-J NATL CANCER I, V105, P917, DOI 10.1093/jnci/djt119; Zaidi MR, 2011, NATURE, V469, P548, DOI 10.1038/nature09666	38	147	150	2	62	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 24	2014	511	7510					478	+		10.1038/nature13298	http://dx.doi.org/10.1038/nature13298			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AL7SO	24919155	Green Accepted			2022-12-28	WOS:000339335700049
J	Kim, YK; Krupin, O; Denlinger, JD; Bostwick, A; Rotenberg, E; Zhao, Q; Mitchell, JF; Allen, JW; Kim, BJ				Kim, Y. K.; Krupin, O.; Denlinger, J. D.; Bostwick, A.; Rotenberg, E.; Zhao, Q.; Mitchell, J. F.; Allen, J. W.; Kim, B. J.			Fermi arcs in a doped pseudospin-1/2 Heisenberg antiferromagnet	SCIENCE			English	Article							SUPERCONDUCTORS; CA2-XNAXCUO2CL2; PSEUDOGAP; SR2IRO4; STATE; PHASE	High-temperature superconductivity in cuprates arises from an electronic state that remains poorly understood. We report the observation of a related electronic state in a noncuprate material, strontium iridate (Sr2IrO4), in which the distinct cuprate fermiology is largely reproduced. Upon surface electron doping through in situ deposition of alkali-metal atoms, angle-resolved photoemission spectra of Sr2IrO4 display disconnected segments of zero-energy states, known as Fermi arcs, and a gap as large as 80 millielectron volts. Its evolution toward a normal metal phase with a closed Fermi surface as a function of doping and temperature parallels that in the cuprates. Our result suggests that Sr2IrO4 is a useful model system for comparison to the cuprates.	[Kim, Y. K.; Krupin, O.; Denlinger, J. D.; Bostwick, A.; Rotenberg, E.] Univ Calif Berkeley, Lawrence Berkeley Natl Lab, Adv Light Source, Berkeley, CA 94720 USA; [Zhao, Q.; Mitchell, J. F.; Kim, B. J.] Argonne Natl Lab, Div Mat Sci, 9700 S Cass Ave, Argonne, IL 60439 USA; [Allen, J. W.; Kim, B. J.] Univ Michigan, Randall Lab Phys, Ann Arbor, MI 48109 USA; [Kim, B. J.] Max Planck Inst Solid State Res, D-70569 Stuttgart, Germany	United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley; United States Department of Energy (DOE); Argonne National Laboratory; University of Michigan System; University of Michigan; Max Planck Society	Kim, BJ (corresponding author), Argonne Natl Lab, Div Mat Sci, 9700 S Cass Ave, Argonne, IL 60439 USA.	bjkim@fkf.mpg.de	Rotenberg, Eli/B-3700-2009; Mitchell, John F/A-1907-2012; Kim, Yeong Kwan/L-8207-2016; Bostwick, Aaron/E-8549-2010	Rotenberg, Eli/0000-0002-3979-8844; Bostwick, Aaron/0000-0002-9008-2980	U.S. NSF [DMR-07-04480]; Institute for Complex Adaptive Matter; U.S. Department of Energy (DOE) Office of Science, Basic Energy Sciences, Materials Science and Engineering Division; Office of Science, Office of Basic Energy Sciences of the U.S. DOE [DE-AC02-05CH11231]; National Research Foundation [20100018092]	U.S. NSF(National Science Foundation (NSF)); Institute for Complex Adaptive Matter; U.S. Department of Energy (DOE) Office of Science, Basic Energy Sciences, Materials Science and Engineering Division(United States Department of Energy (DOE)); Office of Science, Office of Basic Energy Sciences of the U.S. DOE(United States Department of Energy (DOE)); National Research Foundation	We thank J. H. Shim, K. Haule, G. Kotliar, C. Kim, M. Norman, and G. Khaliullin for helpful discussions. Work at the University of Michigan was supported by the U.S. NSF under grant no. DMR-07-04480. B. J. K. acknowledges the Institute for Complex Adaptive Matter for a travel grant that enabled a visit and helpful discussions at Rutgers University. Work in the Materials Science Division of Argonne National Laboratory (sample preparation and characterization) was supported by the U.S. Department of Energy (DOE) Office of Science, Basic Energy Sciences, Materials Science and Engineering Division. The Advanced Light Source is supported by the Director, Office of Science, Office of Basic Energy Sciences of the U.S. DOE under contract no. DE-AC02-05CH11231. Y.K.K. is supported through the National Research Foundation (grant no. 20100018092).	Abbamonte P, 2005, NAT PHYS, V1, P155, DOI 10.1038/nphys178; Arita R, 2012, PHYS REV LETT, V108, DOI 10.1103/PhysRevLett.108.086403; Chaloupka J, 2008, PHYS REV LETT, V100, DOI 10.1103/PhysRevLett.100.016404; Damascelli A, 2003, REV MOD PHYS, V75, P473, DOI 10.1103/RevModPhys.75.473; DYNES RC, 1978, PHYS REV LETT, V41, P1509, DOI 10.1103/PhysRevLett.41.1509; Feng DL, 2002, PHYS REV LETT, V88, DOI 10.1103/PhysRevLett.88.107001; Fujiyama S, 2012, PHYS REV LETT, V108, DOI 10.1103/PhysRevLett.108.247212; Ge M, 2011, PHYS REV B, V84, DOI 10.1103/PhysRevB.84.100402; Ghiringhelli G, 2012, SCIENCE, V337, P821, DOI 10.1126/science.1223532; Hanaguri T, 2004, NATURE, V430, P1001, DOI 10.1038/nature02861; Hossain MA, 2008, NAT PHYS, V4, P527, DOI 10.1038/nphys998; Hsieh D, 2012, PHYS REV B, V86, DOI 10.1103/PhysRevB.86.035128; Jackeli G, 2009, PHYS REV LETT, V102, DOI 10.1103/PhysRevLett.102.017205; Kanigel A, 2006, NAT PHYS, V2, P447, DOI 10.1038/nphys334; Kim BJ, 2009, SCIENCE, V323, P1329, DOI 10.1126/science.1167106; Kim BJ, 2008, PHYS REV LETT, V101, DOI 10.1103/PhysRevLett.101.076402; Kim J, 2012, PHYS REV LETT, V108, DOI 10.1103/PhysRevLett.108.177003; Korneta OB, 2010, PHYS REV B, V82, DOI 10.1103/PhysRevB.82.115117; Lee PA, 2006, REV MOD PHYS, V78, P17, DOI 10.1103/RevModPhys.78.17; Li Q, 2013, SCI REP-UK, V3, DOI 10.1038/srep03073; Martins C, 2011, PHYS REV LETT, V107, DOI 10.1103/PhysRevLett.107.266404; Okazaki K, 2012, SCIENCE, V337, P1314, DOI 10.1126/science.1222793; Reber TJ, 2012, NAT PHYS, V8, P606, DOI [10.1038/NPHYS2352, 10.1038/nphys2352]; Rice TM, 2006, AIP CONF PROC, V816, P92, DOI 10.1063/1.2178034; Senechal D, 2004, PHYS REV LETT, V92, DOI 10.1103/PhysRevLett.92.126401; Shen KM, 2005, SCIENCE, V307, P901, DOI 10.1126/science.1103627; TRANQUADA JM, 1995, NATURE, V375, P561, DOI 10.1038/375561a0; Wang F, 2011, PHYS REV LETT, V106, DOI 10.1103/PhysRevLett.106.136402; Watanabe H, 2013, PHYS REV LETT, V110, DOI 10.1103/PhysRevLett.110.027002; Yamasaki A., BULK NATURE LAYERED; Yoshida T, 2009, PHYS REV LETT, V103, DOI 10.1103/PhysRevLett.103.037004; Yoshida T, 2012, J PHYS SOC JPN, V81, DOI 10.1143/JPSJ.81.011006	32	234	235	5	242	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 11	2014	345	6193					187	190		10.1126/science.1251151	http://dx.doi.org/10.1126/science.1251151			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AL8SS	24925913	Green Submitted			2022-12-28	WOS:000339409900046
J	Alcaide, M; Scordato, ESC; Price, TD; Irwin, DE				Alcaide, Miguel; Scordato, Elizabeth S. C.; Price, Trevor D.; Irwin, Darren E.			Genomic divergence in a ring species complex	NATURE			English	Article							PHYLLOSCOPUS-TROCHILOIDES; SPECIATION; EVOLUTION; ADAPTATION; COMPONENT; SYMPATRY; SOFTWARE; DISTANCE	Ring species provide particularly clear demonstrations of how one species can gradually evolve into two, but are rare in nature(1-3). In the greenish warbler (Phylloscopus trochiloides) species complex, a ring of populations wraps around Tibet. Two reproductively isolated forms co-exist in central Siberia, with a gradient of genetic and phenotypic characteristics through the southern chain of populations connecting them(4-6). Previous genetic evidence has proven inconclusive, however, regarding whether species divergence took place in the face of continuous gene flow and whether hybridization between the terminal forms of the ring ever occurred(7-9). Here we use genome-wide analyses to show that, although spatial patterns of genetic variation are currently mostly as expected of a ring species, historical breaks in gene flow have existed at more than one location around the ring, and the two Siberian forms have occasionally interbred. Substantial periods of geographical isolation occurred not only in the north but also in the western Himalayas, where there is now an extensive hybrid zone between genetically divergent forms. Limited asymmetric introgression has occurred directly between the Siberian forms, although it has not caused a blending of those forms, suggesting selection against introgressed genes in the novel genetic background. Levels of reproductive isolation and genetic introgression are consistent with levels of phenotypic divergence around the ring, with phenotypic similarity and extensive interbreeding across the southwestern contact zone and strong phenotypic divergence and nearly complete reproductive isolation across the northern contact zone. These results cast doubt on the hypothesis that the greenish warbler should be viewed as a rare example of speciation by distance(6), but demonstrate that the greenish warbler displays a continuum from slightly divergent neighbouring populations to almost fully reproductively isolated species.	[Alcaide, Miguel; Irwin, Darren E.] Univ British Columbia, Dept Zool, Vancouver, BC V6T 1Z4, Canada; [Alcaide, Miguel; Irwin, Darren E.] Univ British Columbia, Biodivers Res Ctr, Vancouver, BC V6T 1Z4, Canada; [Alcaide, Miguel] CSIC, Dept Evolutionary Ecol, Estn Biol Donana, Seville 41092, Spain; [Scordato, Elizabeth S. C.; Price, Trevor D.] Univ Chicago, Dept Ecol & Evolut, Chicago, IL 60637 USA; [Scordato, Elizabeth S. C.] Univ Colorado, Dept Ecol & Evolutionary Biol, Boulder, CO 80309 USA	University of British Columbia; University of British Columbia; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Estacion Biologica de Donana (EBD); University of Chicago; University of Colorado System; University of Colorado Boulder	Irwin, DE (corresponding author), Univ British Columbia, Dept Zool, 6270 Univ Blvd, Vancouver, BC V6T 1Z4, Canada.	irwin@zoology.ubc.ca	Irwin, Darren E./G-6183-2012	Irwin, Darren E./0000-0002-1050-5841; Alcaide, Miguel/0000-0001-6945-0972	Marie Curie International Outgoing Fellowship within the 7th European Community Framework Programme [273773]; NSERC discovery grant [311931]; US NSF	Marie Curie International Outgoing Fellowship within the 7th European Community Framework Programme; NSERC discovery grant(Natural Sciences and Engineering Research Council of Canada (NSERC)); US NSF(National Science Foundation (NSF))	This research was supported by a Marie Curie International Outgoing Fellowship within the 7th European Community Framework Programme (project no. 273773) and an NSERC discovery grant (no. 311931). Original collections were made with a grant from the US NSF. We thank Z. Benowitz-Fredericks, J. Gibson, S. Gross, J. Irwin, G. Kelberg, A. Knorre, K. Marchetti and B. Sheldon for assistance in the field. For additional samples we thank P. Alstrom, K. Marchetti, U. Olsson, A. Richman and J. Tiainen. We thank J. Irwin and L. Rieseberg for comments and discussion and A. Kuzmin for assistance during library preparation.	BARTON NH, 1989, NATURE, V341, P497, DOI 10.1038/341497a0; Cacho NI, 2012, P ROY SOC B-BIOL SCI, V279, P3377, DOI 10.1098/rspb.2012.0498; Coyne J.A., 2004, SPECIATION; Dobzhansky T., 1958, CENTURY DARWIN, P19; Drummond AJ, 2011, GENEIOUS V5 5; Earl DA, 2012, CONSERV GENET RESOUR, V4, P359, DOI 10.1007/s12686-011-9548-7; Elshire RJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019379; Endler J.A., 1977, Monographs in Population Biology, pi; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; GRANT PR, 1992, SCIENCE, V256, P193, DOI 10.1126/science.256.5054.193; Irwin DE, 2008, J EVOLUTION BIOL, V21, P435, DOI 10.1111/j.1420-9101.2007.01499.x; Irwin D.E., 2012, CREATING CONSILIENCE, P163; Irwin Darren E., 2005, P27; Irwin DE, 2012, AM NAT, V180, P35, DOI 10.1086/666002; Irwin DE, 2005, SCIENCE, V307, P414, DOI 10.1126/science.1105201; Irwin DE, 2001, GENETICA, V112, P223, DOI 10.1023/A:1013319217703; Irwin DE, 2001, NATURE, V409, P333, DOI 10.1038/35053059; Jakobsson M, 2007, BIOINFORMATICS, V23, P1801, DOI 10.1093/bioinformatics/btm233; Kovylov NS, 2012, BIOL BULL+, V39, P729, DOI 10.1134/S1062359012090038; Martins AB, 2013, P NATL ACAD SCI USA, V110, P5080, DOI 10.1073/pnas.1217034110; MAYR E., 1942, Systematics and the origin of species from the viewpoint of a zoologist.; Mayr E., 1963, ANIMAL SPECIES EVOLU; McCarthy EM, 2006, HDB AVIAN HYBRIDS WO; MORITZ C, 1992, SYST BIOL, V41, P273, DOI 10.2307/2992567; Novembre J, 2008, NAT GENET, V40, P646, DOI 10.1038/ng.139; Peakall R, 2012, BIOINFORMATICS, V28, P2537, DOI 10.1093/bioinformatics/bts460; Price T, 2008, SPECIATION BIRDS; Price TD, 2002, EVOLUTION, V56, P2083; Pritchard JK, 2000, GENETICS, V155, P945; Rheindt FE, 2011, AUK, V128, P620, DOI 10.1525/auk.2011.128.4.620; Ticehurst CB., 1938, SYSTEMATIC REV GENUS; Wake DB, 2001, NATURE, V409, P299, DOI 10.1038/35053264; Warren WC, 2010, NATURE, V464, P757, DOI 10.1038/nature08819; Weir JT, 2011, AM NAT, V177, P462, DOI 10.1086/658910	34	93	99	1	202	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	JUL 3	2014	511	7507					83	U433		10.1038/nature13285	http://dx.doi.org/10.1038/nature13285			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK1TN	24870239				2022-12-28	WOS:000338199400040
J	Silver, J				Silver, Jonathan			Drugs for Macular Degeneration, Price Discrimination, and Medicare's Responsibility Not to Overpay	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									George Washington Univ, Washington, DC 20052 USA	George Washington University	Silver, J (corresponding author), George Washington Univ, 801 22nd St NW,Ste 739, Washington, DC 20052 USA.	jesilver@gwu.edu		Silver, Jonathan/0000-0001-9231-6368				[Anonymous], 2012, MED PAYM DRUGS US TE; [Anonymous], REV MED PART B AV LU; Martin DF, 2012, OPHTHALMOLOGY, V119, DOI 10.1016/j.ophtha.2012.03.053; Rodwin Marc, 2013, MANAGING OFF LABEL D	4	10	10	0	1	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUL 2	2014	312	1					23	24		10.1001/jama.2014.6672	http://dx.doi.org/10.1001/jama.2014.6672			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AK0UK	24860863				2022-12-28	WOS:000338131100012
J	Herwartz, D; Pack, A; Friedrichs, B; Bischoff, A				Herwartz, Daniel; Pack, Andreas; Friedrichs, Bjarne; Bischoff, Addi			Identification of the giant impactor Theia in lunar rocks	SCIENCE			English	Article							OXYGEN-ISOTOPE COMPOSITION; CARBONACEOUS CHONDRITES; SOLAR-SYSTEM; MOON; EARTH; METEORITES; ORIGIN; MANTLE; DIFFERENTIATION; HETEROGENEITY	The Moon was probably formed by a catastrophic collision of the proto-Earth with a planetesimal named Theia. Most numerical models of this collision imply a higher portion of Theia in the Moon than in Earth. Because of the isotope heterogeneity among solar system bodies, the isotopic composition of Earth and the Moon should thus be distinct. So far, however, all attempts to identify the isotopic component of Theia in lunar rocks have failed. Our triple oxygen isotope data reveal a 12 +/- 3 parts per million difference in Delta O-17 between Earth and the Moon, which supports the giant impact hypothesis of Moon formation. We also show that enstatite chondrites and Earth have different Delta O-17 values, and we speculate on an enstatite chondrite-like composition of Theia. The observed small compositional difference could alternatively be explained by a carbonaceous chondrite-dominated late veneer.	[Herwartz, Daniel; Pack, Andreas; Friedrichs, Bjarne] Univ Gottingen, Geowissensch Zentrum, Abt Isotopengeol, D-37073 Gottingen, Germany; [Herwartz, Daniel] Univ Cologne, Inst Geol & Mineral, D-50674 Cologne, Germany; [Bischoff, Addi] Univ Munster, Inst Planetol, D-48149 Munster, Germany	University of Gottingen; University of Cologne; University of Munster	Herwartz, D (corresponding author), Univ Gottingen, Geowissensch Zentrum, Abt Isotopengeol, Goldschmidtstr 1, D-37073 Gottingen, Germany.	d.herwartz@uni-koeln.de	Herwartz, Daniel/B-5356-2019	Herwartz, Daniel/0000-0003-3604-8295; Pack, Andreas/0000-0002-2618-2768; Friedrichs, Bjarne/0000-0001-8555-128X				Bischoff A, 2010, METEORIT PLANET SCI, V45, P1638, DOI 10.1111/j.1945-5100.2010.01108.x; CAMERON AGW, 1991, ICARUS, V92, P204, DOI 10.1016/0019-1035(91)90046-V; Canup RM, 2001, NATURE, V412, P708, DOI 10.1038/35089010; Canup RM, 2012, SCIENCE, V338, P1052, DOI 10.1126/science.1226073; CLAYTON RN, 1984, J GEOPHYS RES, V89, pC245, DOI 10.1029/JB089iS01p0C245; Clayton RN, 1999, GEOCHIM COSMOCHIM AC, V63, P2089, DOI 10.1016/S0016-7037(99)00090-3; CLAYTON RN, 1973, SCIENCE, V182, P485, DOI 10.1126/science.182.4111.485; Clayton RN, 1996, GEOCHIM COSMOCHIM AC, V60, P1999, DOI 10.1016/0016-7037(96)00074-9; Clayton RN., 1975, P LUN SCI C, V6, P1761; Cuk M, 2012, SCIENCE, V338, P1047, DOI 10.1126/science.1225542; Hallis LJ, 2010, GEOCHIM COSMOCHIM AC, V74, P6885, DOI 10.1016/j.gca.2010.09.023; Javoy M, 2010, EARTH PLANET SC LETT, V293, P259, DOI 10.1016/j.epsl.2010.02.033; Munker C, 2003, SCIENCE, V301, P84, DOI 10.1126/science.1084662; Newton J, 2000, METEORIT PLANET SCI, V35, P689, DOI 10.1111/j.1945-5100.2000.tb01452.x; Pack A, 2014, EARTH PLANET SC LETT, V390, P138, DOI 10.1016/j.epsl.2014.01.017; Pahlevan K, 2007, EARTH PLANET SC LETT, V262, P438, DOI 10.1016/j.epsl.2007.07.055; Regelous M, 2008, EARTH PLANET SC LETT, V272, P330, DOI 10.1016/j.epsl.2008.05.001; Reufer A, 2012, ICARUS, V221, P296, DOI 10.1016/j.icarus.2012.07.021; Simon JI, 2010, EARTH PLANET SC LETT, V289, P457, DOI 10.1016/j.epsl.2009.11.035; Spicuzza MJ, 2007, EARTH PLANET SC LETT, V253, P254, DOI 10.1016/j.epsl.2006.10.030; Taylor S.R., 2007, ENCY SOLAR SYSTEM, P227, DOI [1016/B978-012088589-3/50016-5, 10.1016/B978-012088589-3/50016-5, DOI 10.1016/B978-012088589-3/50016-5]; Touboul M, 2007, NATURE, V450, P1206, DOI 10.1038/nature06428; Trinquier A, 2007, ASTROPHYS J, V655, P1179, DOI 10.1086/510360; Walker RJ, 2009, CHEM ERDE-GEOCHEM, V69, P101, DOI 10.1016/j.chemer.2008.10.001; Warren PH, 2011, EARTH PLANET SC LETT, V311, P93, DOI 10.1016/j.epsl.2011.08.047; Wiechert U, 2001, SCIENCE, V294, P345, DOI 10.1126/science.1063037; Willbold M, 2011, NATURE, V477, P195, DOI 10.1038/nature10399; Young ED, 2002, GEOCHIM COSMOCHIM AC, V66, P1095, DOI 10.1016/S0016-7037(01)00832-8; Zhang JJ, 2012, NAT GEOSCI, V5, P251, DOI [10.1038/NGEO1429, 10.1038/ngeo1429]	30	114	116	2	103	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 6	2014	344	6188					1146	1150		10.1126/science.1251117	http://dx.doi.org/10.1126/science.1251117			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI3UU	24904162				2022-12-28	WOS:000336791200044
J	Li, PY; Qian, H; Wu, JH				Li, Peiyue; Qian, Hui; Wu, Jianhua			Accelerate research on land creation	NATURE			English	Editorial Material									[Li, Peiyue; Qian, Hui; Wu, Jianhua] Changan Univ, Sch Environm Sci & Engn, Xian, Peoples R China	Chang'an University	Li, PY (corresponding author), Changan Univ, Sch Environm Sci & Engn, Xian, Peoples R China.	lipy2@163.com	Qian, Hui/B-9558-2019; Wu, Jianhua/G-4389-2017; Li, Peiyue/F-3831-2011	Qian, Hui/0000-0002-9354-4060; Wu, Jianhua/0000-0001-6423-1762; Li, Peiyue/0000-0001-8771-3369				Allen F, 2005, J FINANC ECON, V77, P57, DOI 10.1016/j.jfineco.2004.06.010; Burns Shirley Stewart, 2007, BRINGING MOUNTAINS I; Crotty M.G., 2002, VILLANOVA ENV LAW J, V13, P287; Li M., 1992, POPULATION MODERN CH, P83; Qian W., 2013, NEWSWEEK, V2, P26; Song Q., 2013, CHINA CONSTRUCTION, V20, P21; Sun JZ, 2005, LOESSOLOGY, V1; [张明泉 ZHANG Ming-quan], 2009, [干旱区资源与环境, Journal of Arid Land Resources and Environment], V23, P77; Zhao F., 2013, CHINA BUS J A, VA13, P1	9	175	202	20	89	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 5	2014	510	7503					29	31		10.1038/510029a	http://dx.doi.org/10.1038/510029a			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AI3NR	24910868	Bronze			2022-12-28	WOS:000336768900015
J	Maund, E; Tendal, B; Hrobjartsson, A; Jorgensen, KJ; Lundh, A; Schroll, J; Gotzsche, PC				Maund, Emma; Tendal, Britta; Hrobjartsson, Asbjorn; Jorgensen, Karsten Juhl; Lundh, Andreas; Schroll, Jeppe; Gotzsche, Peter C.			Benefits and harms in clinical trials of duloxetine for treatment of major depressive disorder: comparison of clinical study reports, trial registries, and publications	BMJ-BRITISH MEDICAL JOURNAL			English	Article							PLACEBO; PROTOCOLS; INDUSTRY; RELAPSE; ACCESS	Objective To determine, using research on duloxetine for major depressive disorder as an example, if there are inconsistencies between protocols, clinical study reports, and main publicly available sources (journal articles and trial registries), and within clinical study reports themselves, with respect to benefits and major harms. Design Data on primary efficacy analysis and major harms extracted from each data source and compared. Setting Nine randomised placebo controlled trials of duloxetine (total 2878 patients) submitted to the European Medicines Agency (EMA) for marketing approval for major depressive disorder. Data sources Clinical study reports, including protocols as appendices (total 13 729 pages), were obtained from the EMA in May 2011. Journal articles were identified through relevant literature databases and contacting the manufacturer, Eli Lilly. Clinicaltrials.gov and the manufacturer's online clinical trial registry were searched for trial results. Results Clinical study reports fully described the primary efficacy analysis and major harms (deaths (including suicides), suicide attempts, serious adverse events, and discontinuations because of adverse events). There were minor inconsistencies in the population in the primary efficacy analysis between the protocol and clinical study report and within the clinical study report for one trial. Furthermore, we found contradictory information within the reports for seven serious adverse events and eight adverse events that led to discontinuation but with no apparent bias. In each trial, a median of 406 (range 177-645) and 166 (100-241) treatment emergent adverse events (adverse events that emerged or worsened after study drug was started) in the randomised phase were not reported in journal articles and Lilly trial registry reports, respectively. We also found publication bias in relation to beneficial effects. Conclusion Clinical study reports contained extensive data on major harms that were unavailable in journal articles and in trial registry reports. There were inconsistencies between protocols and clinical study reports and within clinical study reports. Clinical study reports should be used as the data source for systematic reviews of drugs, but they should first be checked against protocols and within themselves for accuracy and consistency.	[Maund, Emma; Tendal, Britta; Hrobjartsson, Asbjorn; Jorgensen, Karsten Juhl; Lundh, Andreas; Schroll, Jeppe; Gotzsche, Peter C.] Rigshosp, Nord Cochrane Ctr, Dept 7811, DK-2100 Copenhagen, Denmark; [Lundh, Andreas] Hvidovre Univ Hosp, Dept Infect Dis, DK-2650 Hvidovre, Denmark	Rigshospitalet; University of Copenhagen; University of Copenhagen	Maund, E (corresponding author), Rigshosp, Nord Cochrane Ctr, Dept 7811, DK-2100 Copenhagen, Denmark.	em@cochrane.dk		Schroll, Jeppe Bennekou/0000-0002-1776-0562; Jorgensen, Karsten/0000-0001-8554-0388; Lundh, Andreas/0000-0002-4982-8680	Rigshospitalets Forskningsudvalg	Rigshospitalets Forskningsudvalg	This study is part of a PhD (EM) funded by Rigshospitalets Forskningsudvalg. The funding source had no role in the design and conduct of the study; data collection, management, analysis, and interpretation; preparation, review, and approval of the manuscript; or the decision to submit the paper for publication.	[Anonymous], 1995, STRUCT CONT CLIN STU; [Anonymous], 2002, GUID GOOD CLIN PRACT; Chan AW, 2008, PLOS MED, V5, P1533, DOI 10.1371/journal.pmed.0050230; Chan AW, 2004, JAMA-J AM MED ASSOC, V291, P2457, DOI 10.1001/jama.291.20.2457; Committee for medicinal products for human use (CHMP), NOT GUID INCL APP CL; Detke MJ, 2002, J PSYCHIATR RES, V36, P383, DOI 10.1016/S0022-3956(02)00060-2; Detke MJ, 2002, J CLIN PSYCHIAT, V63, P308, DOI 10.4088/JCP.v63n0407; Detke MJ, 2004, EUR NEUROPSYCHOPHARM, V14, P457, DOI 10.1016/j.euroneuro.2004.01.002; Doshi P, 2013, JAMA INTERN MED, V173, DOI 10.1001/jamainternmed.2013.9989; Dyer C, 2013, BMJ BRIT MED J, V346, DOI 10.1136/bmj.f3588; Eyding D, 2010, BMJ-BRIT MED J, V341, DOI 10.1136/bmj.c4737; Fava M, 2006, J PSYCHIATR RES, V40, P328, DOI 10.1016/j.jpsychires.2005.06.005; Goldstein DJ, 2002, J CLIN PSYCHIAT, V63, P225, DOI 10.4088/JCP.v63n0309; Goldstein DJ, 2004, J CLIN PSYCHOPHARM, V24, P389, DOI 10.1097/01.jcp.0000132448.65972.d9; Gotzsche PC, 2011, BMJ-BRIT MED J, V342, DOI 10.1136/bmj.d2686; Haddad PM., 2007, ADV PSYCHIAT TREATME, V13, P447, DOI [10.1192/apt.bp.105.001966, DOI 10.1192/APT.BP.105.001966]; Hudson JI, 2007, BMC PSYCHIATRY, V7, DOI 10.1186/1471-244X-7-43; Jefferson T, 2012, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD008965.pub4, 10.1002/14651858.CD008965.pub3]; Jefferson T, 2011, BMJ-BRIT MED J, V342, DOI 10.1136/bmj.c7258; Jureidini JN, 2008, INT J RISK SAF MED, V29, P73, DOI DOI 10.3233/JRS-2008-0426; Lee KP, 2006, MED J AUSTRALIA, V184, P621, DOI 10.5694/j.1326-5377.2006.tb00418.x; Melander H, 2003, BMJ-BRIT MED J, V326, P1171, DOI 10.1136/bmj.326.7400.1171; Perahia DGS, 2006, EUR PSYCHIAT, V21, P367, DOI 10.1016/j.eurpsy.2006.03.004; Perahia DG, 2006, BRIT J PSYCHIAT, V188, P346, DOI 10.1192/bjp.188.4.346; Rodgers MA, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f3981; Scherer RW, 2007, COCHRANE DB SYST REV, DOI [10.1002/14651858.MR000005.pub3, 10.1002/14651858.MR000005.pub4]; Smith R, 2005, PLOS MED, V2, P364, DOI 10.1371/journal.pmed.0020138.g001; Turner EH, 2008, NEW ENGL J MED, V358, P252, DOI 10.1056/NEJMsa065779; Wieseler B, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001526	29	31	31	0	7	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JUN 4	2014	348								g3510	10.1136/bmj.g3510	http://dx.doi.org/10.1136/bmj.g3510			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AI7CC	24899650	Green Published, hybrid			2022-12-28	WOS:000337037700001
J	Vongpatanasin, W				Vongpatanasin, Wanpen			Resistant Hypertension A Review of Diagnosis and Management	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Review							AMBULATORY BLOOD-PRESSURE; OBSTRUCTIVE SLEEP-APNEA; ASSESSING MEDICATION ADHERENCE; LEFT-VENTRICULAR HYPERTROPHY; ADD-ON THERAPY; DOUBLE-BLIND; ARTERIAL-HYPERTENSION; PRIMARY ALDOSTERONISM; HIGH-RISK; ANTIHYPERTENSIVE THERAPY	Resistant hypertension uncontrolled hypertension with 3 or more antihypertensive agents is increasingly common in clinical practice. Clinicians should exclude pseudoresistant hypertension, which results from nonadherence to medications or from elevated blood pressure related to the white coat syndrome. In patients with truly resistant hypertension, thiazide diuretics, particularly chlorthalidone, should be considered as one of the initial agents. The other 2 agents should include calcium channel blockers and angiotensin-converting enzyme inhibitors for cardiovascular protection. An increasing body of evidence has suggested benefits of mineralocorticoid receptor antagonists, such as eplerenone and spironolactone, in improving blood pressure control in patients with resistant hypertension, regardless of circulating aldosterone levels. Thus, this class of drugs should be considered for patients whose blood pressure remains elevated after treatment with a 3-drug regimen to maximal or near maximal doses. Resistant hypertension may be associated with secondary causes of hypertension including obstructive sleep apnea or primary aldosteronism. Treating these disorders can significantly improve blood pressure beyond medical therapy alone. The role of device therapy for treating the typical patient with resistant hypertension remains unclear.	Univ Texas SW Med Ctr Dallas, Hypertens Sect, Div Cardiol, Dallas, TX 75390 USA	University of Texas System; University of Texas Southwestern Medical Center Dallas	Vongpatanasin, W (corresponding author), Univ Texas SW Med Ctr Dallas, Hypertens Sect, Div Cardiol, 5323 Harry Hines Blvd, Dallas, TX 75390 USA.	wanpen.vongpatanasin@utsouthwestern.edu		Vongpatanasin, Wanpen/0000-0002-7531-9388	Forest Research Institute	Forest Research Institute	The author has completed and submitted the ICMJE Form for Disclosure of Potential Conflicts of Interest and reported that he received grant support from Forest Research Institute.	Alvarez-Alvarez Beatriz, 2010, J Hypertens, V28, P2329, DOI 10.1097/HJH.0b013e32833d4c99; [Anonymous], 2012, Treat Guidel Med Lett, V10, P1; Benjamin MM, 2014, AM J CARDIOL, V113, P687, DOI 10.1016/j.amjcard.2013.10.046; Bhatt DL, 2014, NEW ENGL J MED, V370, P1393, DOI 10.1056/NEJMoa1402670; Bisognano JD, 2011, J AM COLL CARDIOL, V58, P765, DOI 10.1016/j.jacc.2011.06.008; Bobrie G, 2012, J HYPERTENS, V30, P1656, DOI 10.1097/HJH.0b013e3283551e98; Brinker S, 2014, J AM COLL CARDIOL, V63, P834, DOI 10.1016/j.jacc.2013.10.067; Calhoun DA, 2002, HYPERTENSION, V40, P892, DOI 10.1161/01.HYP.0000040261.30455.B6; Calhoun DA, 2008, CIRCULATION, V117, pE510, DOI 10.1161/CIRCULATIONAHA.108.189141; Chapman N, 2008, CIRCULATION, V118, P42, DOI 10.1161/CIRCULATIONAHA.107.737957; Chobanian AV, 2003, HYPERTENSION, V42, P1206, DOI 10.1161/01.HYP.0000107251.49515.c2; Cooper CJ, 2014, NEW ENGL J MED, V370, P13, DOI 10.1056/NEJMoa1310753; Dahlof B, 2002, LANCET, V359, P995, DOI 10.1016/S0140-6736(02)08089-3; Dahlof B, 2005, LANCET, V366, P895, DOI 10.1016/S0140-6736(05)67185-1; Daugherty SL, 2012, HYPERTENSION, V60, P303, DOI 10.1161/HYPERTENSIONAHA.112.192096; Daugherty SL, 2012, CIRCULATION, V125, P1635, DOI 10.1161/CIRCULATIONAHA.111.068064; de Faria APC, 2013, HYPERTENS RES, V36, P1067, DOI 10.1038/hr.2013.92; Moraes CD, 2013, J HUM HYPERTENS, V27, P225, DOI 10.1038/jhh.2012.29; de la Sierra A, 2011, HYPERTENSION, V57, P898, DOI 10.1161/HYPERTENSIONAHA.110.168948; De Nicola L, 2013, J AM COLL CARDIOL, V61, P2461, DOI 10.1016/j.jacc.2012.12.061; Dimeo F, 2012, HYPERTENSION, V60, P653, DOI 10.1161/HYPERTENSIONAHA.112.197780; Ding SJ, 2013, ARCH GERONTOL GERIAT, V57, P423, DOI 10.1016/j.archger.2013.04.006; Drummond W, 2011, AM J CARDIOVASC DRUG, V11, P327, DOI 10.2165/11591970-000000000-00000; Egan BM, 2013, HYPERTENSION, V62, P691, DOI 10.1161/HYPERTENSIONAHA.113.01448; Egan BM, 2011, CIRCULATION, V124, P1046, DOI 10.1161/CIRCULATIONAHA.111.030189; Esler MD, 2010, LANCET, V376, P1903, DOI 10.1016/S0140-6736(10)62039-9; Franklin SS, 2012, HYPERTENSION, V59, P564, DOI 10.1161/HYPERTENSIONAHA.111.180653; Funder JW, 2008, J CLIN ENDOCR METAB, V93, P3266, DOI 10.1210/jc.2008-0104; Furberg CD, 2002, JAMA-J AM MED ASSOC, V288, P2981; Gaddam K, 2010, HYPERTENSION, V55, P1137, DOI 10.1161/HYPERTENSIONAHA.109.141531; Gaddam KK, 2008, ARCH INTERN MED, V168, P1159, DOI 10.1001/archinte.168.11.1159; Gupta AK, 2011, J HYPERTENS, V29, P2004, DOI 10.1097/HJH.0b013e32834a8a42; He FJ, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f1325; Irvin MR, 2012, J CLIN HYPERTENS, V14, P694, DOI 10.1111/j.1751-7176.2012.00690.x; Jamerson K, 2008, NEW ENGL J MED, V359, P2417, DOI 10.1056/NEJMoa0806182; James PA, 2014, JAMA-J AM MED ASSOC, V311, P507, DOI 10.1001/jama.2013.284427; Karns AD, 2013, J CLIN HYPERTENS, V15, P186, DOI 10.1111/jch.12051; Kontak AC, 2010, J CLIN ENDOCR METAB, V95, P4756, DOI 10.1210/jc.2010-0823; Kumbhani DJ, 2013, EUR HEART J, V34, P1204, DOI 10.1093/eurheartj/ehs368; Lee JY, 1996, AM J HYPERTENS, V9, P719, DOI 10.1016/0895-7061(96)00056-8; Loria Catherine M., 2011, Morbidity and Mortality Weekly Report, V60, P1413; Lozano L, 2010, J HYPERTENS, V28, P2161, DOI 10.1097/HJH.0b013e32833b9c63; Mancia G, 2013, J HYPERTENS, V31, P1281, DOI 10.1097/01.hjh.0000431740.32696.cc; Martinez-Garcia MA, 2013, JAMA-J AM MED ASSOC, V310, P2407, DOI 10.1001/jama.2013.281250; Muxfeldt ES, 2012, HYPERTENSION, V59, P384, DOI 10.1161/HYPERTENSIONAHA.111.185405; Nair KV, 2011, PATIENT PREFER ADHER, V5, P195, DOI 10.2147/PPA.S18481; National Clinical Guideline Centre (UK), 2011, HYPERTENSION THE CLI; Oxlund CS, 2013, J HYPERTENS, V31, P2094, DOI 10.1097/HJH.0b013e3283638b1a; Parthasarathy HK, 2011, J HYPERTENS, V29, P980, DOI 10.1097/HJH.0b013e3283455ca5; Parving HH, 2012, NEW ENGL J MED, V367, P2204, DOI 10.1056/NEJMoa1208799; Pedrosa RP, 2011, HYPERTENSION, V58, P811, DOI 10.1161/HYPERTENSIONAHA.111.179788; Persell SD, 2011, HYPERTENSION, V57, P1076, DOI 10.1161/HYPERTENSIONAHA.111.170308; Peterzan MA, 2012, HYPERTENSION, V59, P1104, DOI 10.1161/HYPERTENSIONAHA.111.190637; Pickering TG, 2005, CIRCULATION, V111, P697, DOI 10.1161/01.CIR.0000154900.76284.F6; Pierdomenico SD, 2005, AM J HYPERTENS, V18, P1422, DOI 10.1016/j.amjhyper.2005.05.014; Pimenta E, 2009, HYPERTENSION, V54, P475, DOI 10.1161/HYPERTENSIONAHA.109.131235; Ritchie J, 2014, AM J KIDNEY DIS, V63, P186, DOI 10.1053/j.ajkd.2013.07.020; Rossi GP, 2013, HYPERTENSION, V62, P62, DOI 10.1161/HYPERTENSIONAHA.113.01316; Sang XJ, 2013, J HYPERTENS, V31, P1465, DOI 10.1097/HJH.0b013e328360ddf6; Sarafidis PA, 2013, NAT REV NEPHROL, V9, P51, DOI 10.1038/nrneph.2012.260; Schmieder RE, 2013, J HYPERTENS, V31, P610, DOI 10.1097/HJH.0b013e32835d6e53; Shimbo D, 2013, J HYPERTENS, V31, P370, DOI 10.1097/HJH.0b013e32835b6be7; Strauch B, 2013, J HYPERTENS, V31, P2455, DOI 10.1097/HJH.0b013e3283652c61; Taler SJ, 2002, HYPERTENSION, V39, P982, DOI 10.1161/01.HYP.0000016176.16042.2F; Trinquart L, 2010, HYPERTENSION, V56, P525, DOI 10.1161/HYPERTENSIONAHA.110.152918; Umpierrez GE, 2007, DIABETES CARE, V30, P1699, DOI 10.2337/dc07-0031; Vaclavik J, 2011, HYPERTENSION, V57, P1069, DOI 10.1161/HYPERTENSIONAHA.111.169961; van Onzenoort HAW, 2010, AM J HYPERTENS, V23, P149, DOI 10.1038/ajh.2009.207; Withiam-Leitch M, 2008, TEACH LEARN MED, V20, P136, DOI 10.1080/10401330801991642; Worsnop CJ, 1998, AM J RESP CRIT CARE, V157, P111, DOI 10.1164/ajrccm.157.1.9609063; Yusuf S, 2008, NEW ENGL J MED, V358, P1547, DOI 10.1056/NEJMoa0801317; Zeller A, 2008, J CLIN EPIDEMIOL, V61, P282, DOI 10.1016/j.jclinepi.2007.04.007	72	84	86	0	34	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUN 4	2014	311	21					2216	2224		10.1001/jama.2014.5180	http://dx.doi.org/10.1001/jama.2014.5180			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AI2DU	24893089				2022-12-28	WOS:000336668400023
J	Kern, LM; Edwards, A; Kaushal, R				Kern, Lisa M.; Edwards, Alison; Kaushal, Rainu			The Patient-Centered Medical Home, Electronic Health Records, and Quality of Care	ANNALS OF INTERNAL MEDICINE			English	Article							PHYSICIAN PRACTICES	Background: The patient-centered medical home (PCMH) model of primary care is being implemented widely, although its effects on quality are unclear. The PCMH typically involves electronic health records (EHRs), organizational practice change, and payment reform. Objective: To compare quality of care provided by physicians in PCMHs with that provided by physicians using paper medical records and, separately, with that provided by physicians using EHRs without the PCMH (to determine whether effects were driven by EHRs). Design: Prospective cohort study (2008 to 2010). (ClinicalTrials.gov: NCT00793065). Setting: The Hudson Valley, a 7-county, multipayer, multiprovider region in New York. Participants: 675 primary care physicians in 312 practices and 143 489 patients. Measurements: Claims for 10 quality measures from the Healthcare Effectiveness Data and Information Set were used. Differences in quality were determined using generalized estimating equations adjusted for 8 physician characteristics and 4 patient characteristics. Results: The PCMH group improved significantly more over time than either the paper group or the EHR group for 4 of the 10 measures (by 1 to 9 percentage points per measure): eye examinations and hemoglobin A(1c) testing for patients with diabetes, chlamydia screening, and colorectal cancer screening (adjusted P < 0.05 for each). The odds of overall quality improvement in the PCMH group were 7% higher than in the paper group and 6% higher than in the EHR group (adjusted P < 0.01 for each). Limitation: This study was observational, and the possibility of unmeasured confounders cannot be excluded. Conclusion: The PCMH was associated with modest quality improvement. The aspects of the PCMH that drive improvement are distinct from but may be enabled by the EHR.	[Kern, Lisa M.; Edwards, Alison; Kaushal, Rainu] Weill Cornell Med Coll, New York, NY 10065 USA	Cornell University	Kern, LM (corresponding author), Weill Cornell Med Coll, 425 East 61st St,Suite 301, New York, NY 10065 USA.	lmk2003@med.cornell.edu	Kern, Lisa/AAI-9781-2021	Kern, Lisa/0000-0003-1191-8100	Commonwealth Fund [20080473]; New York State Department of Health [C023699]	Commonwealth Fund; New York State Department of Health	By The Commonwealth Fund (grant 20080473) and the New York State Department of Health (contract C023699).	Bitton A, 2010, J GEN INTERN MED, V25, P584, DOI 10.1007/s11606-010-1262-8; Buntin MB, 2011, HEALTH AFFAIR, V30, P464, DOI 10.1377/hlthaff.2011.0178; Cebul RD, 2011, NEW ENGL J MED, V365, P825, DOI 10.1056/NEJMsa1102519; Fifield J, 2013, J GEN INTERN MED, V28, P778, DOI 10.1007/s11606-013-2386-4; Hoff T, 2012, MED CARE RES REV, V69, P619, DOI 10.1177/1077558712447688; Jackson GL, 2013, ANN INTERN MED, V158, P169, DOI 10.7326/0003-4819-158-3-201302050-00579; Jaen Carlos Roberto, 2010, Ann Fam Med, V8 Suppl 1, pS57, DOI 10.1370/afm.1121; [Johns Hopkins Bloomberg School of Public Health Health Services Research and Development Center], 2011, J HOPK ACG SYST TECH; Kern LM, 2013, J GEN INTERN MED, V28, P496, DOI 10.1007/s11606-012-2237-8; Maeng DD, 2012, AM J MED QUAL, V27, P210, DOI 10.1177/1062860611417421; National Committee for Quality Assurance, 2008, STAND GUID PHYS PRAC; National Committee for Quality Assurance, 2014, HEDIS PERF MEAS; New York State Department of Health, 2014, NEW YORK STAT COMM H; Nutting PA, 2011, HEALTH AFFAIR, V30, P439, DOI 10.1377/hlthaff.2010.0159; Peikes D, 2012, AM J MANAG CARE, V18, P105; Reid RJ, 2010, HEALTH AFFAIR, V29, P835, DOI 10.1377/hlthaff.2010.0158; Reid RJ, 2009, AM J MANAG CARE, V15, pE71; Rittenhouse DR, 2008, HEALTH AFFAIR, V27, P1246, DOI 10.1377/hlthaff.27.5.1246; Rittenhouse DR, 2011, HEALTH AFFAIR, V30, P1575, DOI 10.1377/hlthaff.2010.1210; Rittenhouse DR, 2010, MED CARE RES REV, V67, P301, DOI 10.1177/1077558709353324; Rosenthal M., 2012, RECOMMENDED CORE MEA; Scholle SH, 2008, AM J MANAG CARE, V14, P829; Scholle SH, 2009, AM J MANAG CARE, V15, P67; Stuard SS, 2011, J GEN INTERN MED, V26, P1371, DOI 10.1007/s11606-011-1817-3; U.S. Census Bureau, 2013, GEOGR 2010 CENS URB; U. S. Census Bureau, 2014, STAT COUNT QUICKFACT; Werner RM, 2013, MED CARE, V51, P487, DOI 10.1097/MLR.0b013e31828d4d29; ZEGER SL, 1986, BIOMETRICS, V42, P121, DOI 10.2307/2531248	28	57	58	0	19	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JUN 3	2014	160	11					741	+		10.7326/M13-1798	http://dx.doi.org/10.7326/M13-1798			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AJ0MT	24887615				2022-12-28	WOS:000337348700001
J	Bourzac, K				Bourzac, Katherine			BIOLOGY Three known unknowns	NATURE			English	Editorial Material																		Chaffer CL, 2011, SCIENCE, V331, P1559, DOI 10.1126/science.1203543	1	32	34	1	27	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 29	2014	509	7502					S69	S71		10.1038/509S69a	http://dx.doi.org/10.1038/509S69a			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AH9JC	24870828	Bronze			2022-12-28	WOS:000336457100011
J	Williams, Q				Williams, Quentin			Deep mantle matters	SCIENCE			English	Editorial Material							PROVINCES; BOUNDARY		Univ Calif Santa Cruz, Dept Earth & Planetary Sci, Santa Cruz, CA 95064 USA	University of California System; University of California Santa Cruz	Williams, Q (corresponding author), Univ Calif Santa Cruz, Dept Earth & Planetary Sci, Santa Cruz, CA 95064 USA.	qwilliam@ucsc.edu						Andrault D, 2014, SCIENCE, V344, P892, DOI 10.1126/science.1250466; Anzellini S, 2013, SCIENCE, V340, P464, DOI 10.1126/science.1233514; Austermann J, 2014, GEOPHYS J INT, V197, P1, DOI 10.1093/gji/ggt500; Deschamps F, 2012, EARTH PLANET SC LETT, V349, P198, DOI 10.1016/j.epsl.2012.07.012; Katsura T, 2010, PHYS EARTH PLANET IN, V183, P212, DOI 10.1016/j.pepi.2010.07.001; Lin JF, 2013, REV GEOPHYS, V51, P244, DOI 10.1002/rog.20010; Murakami M, 2004, SCIENCE, V304, P855, DOI 10.1126/science.1095932; Ni SD, 2005, GEOPHYS J INT, V161, P283, DOI 10.1111/j.1365-246X.2005.02508.x; Rost S, 2005, NATURE, V435, P666, DOI 10.1038/nature03620; Thorne MS, 2013, EARTH PLANET SC LETT, V364, P59, DOI 10.1016/j.epsl.2012.12.034; Wysession M., 1998, GEODYN SER, V28, P319; Zhang L, 2014, SCIENCE, V344, P877, DOI [10.1126/science.1254417, 10.1126/science.1250274]	12	2	3	0	32	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 23	2014	344	6186					800	801		10.1126/science.1254399	http://dx.doi.org/10.1126/science.1254399			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AH6IL	24855238				2022-12-28	WOS:000336233800010
J	Chivukula, RR; Shi, GL; Acharya, A; Mills, EW; Zeitels, LR; Anandam, JL; Abdelnaby, AA; Balch, GC; Mansour, JC; Yopp, AC; Maitra, A; Mendell, JT				Chivukula, Raghu R.; Shi, Guanglu; Acharya, Asha; Mills, Eric W.; Zeitels, Lauren R.; Anandam, Joselin L.; Abdelnaby, Abier A.; Balch, Glen C.; Mansour, John C.; Yopp, Adam C.; Maitra, Anirban; Mendell, Joshua T.			An Essential Mesenchymal Function for miR-143/145 in Intestinal Epithelial Regeneration	CELL			English	Article							SMOOTH-MUSCLE-CELLS; GENE-EXPRESSION; STEM-CELLS; IN-VIVO; MICRORNAS; CANCER; MYOFIBROBLASTS; GROWTH; COLON; CRYPT	Downregulation of the miR-143/145 microRNA (miRNA) cluster has been repeatedly reported in colon cancer and other epithelial tumors. In addition, overexpression of these miRNAs inhibits tumorigenesis, leading to broad consensus that they function as cell-autonomous epithelial tumor suppressors. We generated mice with deletion of miR-143/145 to investigate the functions of these miRNAs in intestinal physiology and disease in vivo. Although intestinal development proceeded normally in the absence of these miRNAs, epithelial regeneration after injury was dramatically impaired. Surprisingly, we found that miR-143/145 are expressed and function exclusively within the mesenchymal compartment of intestine. Defective epithelial regeneration in miR-143/145-deficient mice resulted from the dysfunction of smooth muscle and myofibroblasts and was associated with derepression of the miR-143 target Igfbp5, which impaired IGF signaling after epithelial injury. These results provide important insights into the regulation of epithelial wound healing and argue against a cell-autonomous tumor suppressor role for miR-143/145 in colon cancer.	[Chivukula, Raghu R.; Mills, Eric W.; Zeitels, Lauren R.] Johns Hopkins Univ, Sch Med, Med Scientist Training Program, Baltimore, MD 21205 USA; [Shi, Guanglu; Acharya, Asha; Mendell, Joshua T.] UT Southwestern Med Ctr, Dept Mol Biol, Dallas, TX 75390 USA; [Anandam, Joselin L.; Abdelnaby, Abier A.; Balch, Glen C.; Mansour, John C.; Yopp, Adam C.] UT Southwestern Med Ctr, Dept Surg, Dallas, TX 75390 USA; [Maitra, Anirban] UT MD Anderson Canc Ctr, Sheikh Ahmed Bin Zayed Al Nahyan Ctr Pancreat Can, Houston, TX 77030 USA; [Mendell, Joshua T.] UT Southwestern Med Ctr, Harold C Simmons Canc Ctr, Dallas, TX 75390 USA	Johns Hopkins University; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; University of Texas Southwestern Medical Center Dallas	Mendell, JT (corresponding author), UT Southwestern Med Ctr, Dept Mol Biol, Dallas, TX 75390 USA.	joshua.mendell@utsouthwestern.edu	Shi, Guanglu/G-1641-2013	Shi, Guanglu/0000-0001-5562-111X; Balch, Glen/0000-0002-1575-9170	CPRIT [R1008]; NIH [R01CA120185, P01CA134292, 5P30CA142543, 5T32GM007309]; NATIONAL CANCER INSTITUTE [R01CA120185, P30CA142543, P30CA016672, P01CA134292] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007814, T32GM007309] Funding Source: NIH RePORTER	CPRIT; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank Chip Hawkins in the Johns Hopkins Transgenic Core for assistance with generation of miR-143/145<SUP>Neo/+</SUP> mice, John Shelton in the UT Southwestern Molecular Pathology Core for assistance with histopathology, Cheryl Lewis in the UT Southwestern Tissue Resource Core for assistance with human tissue specimens, Jose Cabrera for assistance with figures, and Eric Olson and Kathryn O'Donnell for helpful suggestions on the manuscript. This work was supported by grants from CPRIT (R1008 to J.T.M.) and the NIH (R01CA120185 to J.T.M., P01CA134292 to J.T.M. and A. M., 5P30CA142543 to the UTSW Simmons Cancer Center, and 5T32GM007309 to R.R.C., L.R.Z., and E.M.).	Acharya A, 2012, DEVELOPMENT, V139, P2139, DOI 10.1242/dev.079970; Andoh A, 2007, PHARMACOL THERAPEUT, V114, P94, DOI 10.1016/j.pharmthera.2006.12.004; Bandres E, 2006, MOL CANCER, V5, DOI 10.1186/1476-4598-5-29; Barker N, 2007, NATURE, V449, P1003, DOI 10.1038/nature06196; Boettger T, 2009, J CLIN INVEST, V119, P2634, DOI 10.1172/JCI38864; Brown SL, 2007, J CLIN INVEST, V117, P258, DOI 10.1172/JCI29159; Chen X, 2009, ONCOGENE, V28, P1385, DOI 10.1038/onc.2008.474; Cheng YH, 2009, CIRC RES, V105, P158, DOI 10.1161/CIRCRESAHA.109.197517; Clape C, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007542; Clapper ML, 2007, ACTA PHARMACOL SIN, V28, P1450, DOI 10.1111/j.1745-7254.2007.00695.x; Cordes KR, 2009, NATURE, V460, P705, DOI 10.1038/nature08195; Geske MJ, 2008, DEVELOPMENT, V135, P2959, DOI 10.1242/dev.020453; Haigis KM, 2002, P NATL ACAD SCI USA, V99, P8927, DOI 10.1073/pnas.132275099; He L, 2005, NATURE, V435, P828, DOI 10.1038/nature03552; He XC, 2004, NAT GENET, V36, P1117, DOI 10.1038/ng1430; Hergenreider E, 2012, NAT CELL BIOL, V14, P249, DOI 10.1038/ncb2441; Howarth GS, 1998, SCAND J GASTROENTERO, V33, P180; Iorio MV, 2005, CANCER RES, V65, P7065, DOI 10.1158/0008-5472.CAN-05-1783; Kent OA, 2010, GENE DEV, V24, P2754, DOI 10.1101/gad.1950610; Kong YW, 2012, LANCET ONCOL, V13, pE249, DOI 10.1016/S1470-2045(12)70073-6; Lamlum H, 2000, P NATL ACAD SCI USA, V97, P2225, DOI 10.1073/pnas.040564697; LEE RC, 1993, CELL, V75, P843, DOI 10.1016/0092-8674(93)90529-Y; Leung AKL, 2010, MOL CELL, V40, P205, DOI 10.1016/j.molcel.2010.09.027; Lu J, 2005, NATURE, V435, P834, DOI 10.1038/nature03702; Lujambio A, 2012, NATURE, V482, P347, DOI 10.1038/nature10888; Madison BB, 2005, DEVELOPMENT, V132, P279, DOI 10.1242/dev.01576; Madison BB, 2002, J BIOL CHEM, V277, P33275, DOI 10.1074/jbc.M204935200; Medina PP, 2010, NATURE, V467, P86, DOI 10.1038/nature09284; Mendell JT, 2012, CELL, V148, P1172, DOI 10.1016/j.cell.2012.02.005; Michael MZ, 2003, MOL CANCER RES, V1, P882; Miska EA, 2007, PLOS GENET, V3, P2395, DOI 10.1371/journal.pgen.0030215; Motoyama K, 2009, INT J ONCOL, V34, P1069, DOI 10.3892/ijo_00000233; Muzumdar MD, 2007, GENESIS, V45, P593, DOI 10.1002/dvg.20335; Otte JM, 2003, GASTROENTEROLOGY, V124, P1866, DOI 10.1016/S0016-5085(03)00403-7; Papaconstantinou IG, 2013, PANCREAS, V42, P67, DOI 10.1097/MPA.0b013e3182592ba7; Pollak M, 2008, NAT REV CANCER, V8, P915, DOI 10.1038/nrc2536; Powell DW, 2011, ANNU REV PHYSIOL, V73, P213, DOI 10.1146/annurev.physiol.70.113006.100646; Reinhart BJ, 2000, NATURE, V403, P901, DOI 10.1038/35002607; Sachdeva M, 2009, P NATL ACAD SCI USA, V106, P3207, DOI 10.1073/pnas.0808042106; Sangiorgi E, 2008, NAT GENET, V40, P915, DOI 10.1038/ng.165; Sato T, 2009, NATURE, V459, P262, DOI 10.1038/nature07935; Schepeler T, 2008, CANCER RES, V68, P6416, DOI 10.1158/0008-5472.CAN-07-6110; Shaker A, 2010, J CLIN INVEST, V120, P2081, DOI 10.1172/JCI40676; Shao JY, 2006, CANCER RES, V66, P846, DOI 10.1158/0008-5472.CAN-05-2606; Shi GL, 2009, GASTROENTEROLOGY, V136, P1368, DOI 10.1053/j.gastro.2008.12.066; Slaby O, 2007, ONCOLOGY-BASEL, V72, P397, DOI 10.1159/000113489; Sosic D, 2003, CELL, V112, P169, DOI 10.1016/S0092-8674(03)00002-3; Takagi T, 2009, ONCOLOGY-BASEL, V77, P12, DOI 10.1159/000218166; Takeda N, 2011, SCIENCE, V334, P1420, DOI 10.1126/science.1213214; Tian H, 2011, NATURE, V478, P255, DOI 10.1038/nature10408; van Rooij E, 2007, SCIENCE, V316, P575, DOI 10.1126/science.1139089; WIGHTMAN B, 1993, CELL, V75, P855, DOI 10.1016/0092-8674(93)90530-4; Xin HB, 2002, PHYSIOL GENOMICS, V10, P211, DOI 10.1152/physiolgenomics.00054.2002; Xin M, 2009, GENE DEV, V23, P2166, DOI 10.1101/gad.1842409; Yan KS, 2012, P NATL ACAD SCI USA, V109, P466, DOI 10.1073/pnas.1118857109; Yu K, 2003, DEVELOPMENT, V130, P3063, DOI 10.1242/dev.00491; Zeng L, 2012, DEV BIOL, V367, P178, DOI 10.1016/j.ydbio.2012.05.009; Zhu HY, 2011, MOL CANCER RES, V9, P960, DOI 10.1158/1541-7786.MCR-10-0531; Zhu WD, 2008, NATURE, V454, P345, DOI 10.1038/nature07027	59	162	166	1	40	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAY 22	2014	157	5					1104	1116		10.1016/j.cell.2014.03.055	http://dx.doi.org/10.1016/j.cell.2014.03.055			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	AH9CG	24855947	Bronze, Green Accepted			2022-12-28	WOS:000336437200013
J	Horwitz, EM; Weinberg, DS				Horwitz, Eric M.; Weinberg, David S.			Medicare Physician Payment Data: Is This Transparency?	ANNALS OF INTERNAL MEDICINE			English	Editorial Material							HEALTH-CARE		[Horwitz, Eric M.] Fox Chase Canc Ctr, Dept Radiat Oncol, Philadelphia, PA 19111 USA; [Weinberg, David S.] Fox Chase Canc Ctr, Dept Med, Philadelphia, PA 19111 USA	Fox Chase Cancer Center; Fox Chase Cancer Center	Horwitz, EM (corresponding author), Fox Chase Canc Ctr, Dept Radiat Oncol, 333 Cottman Ave, Philadelphia, PA 19111 USA.	eric.horwitz@fccc.edu						Abelson RCS, 2014, NY TIMES, pA1; Cooperberg MR, 2009, UROL ONCOL-SEMIN ORI, V27, P411, DOI 10.1016/j.urolonc.2009.01.015; Fisher ES, 2009, NEW ENGL J MED, V360, P849, DOI 10.1056/NEJMp0809794; Halm EA, 2002, ANN INTERN MED, V137, P511, DOI 10.7326/0003-4819-137-6-200209170-00012; Medicare Payment Advisory Commission, 2013, DAT BOOK HLTH CAR SP; Newhouse JP., 2013, INTERIM REPORT COMMI	6	3	3	0	1	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	AUG 19	2014	161	4					291	+		10.7326/M14-0913	http://dx.doi.org/10.7326/M14-0913			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AP8RU	24912560				2022-12-28	WOS:000342347300019
J	Perkins, RB; Stier, EA				Perkins, Rebecca B.; Stier, Elizabeth A.			Should U.S. Women Be Screened for Cervical Cancer With Pap Tests, HPV Tests, or Both?	ANNALS OF INTERNAL MEDICINE			English	Editorial Material							HUMAN-PAPILLOMAVIRUS; ABNORMALITIES; CYTOLOGY		[Perkins, Rebecca B.; Stier, Elizabeth A.] Boston Univ, Sch Med, Boston, MA 02118 USA	Boston University	Perkins, RB (corresponding author), Boston Univ, Sch Med, 85 East Concord St,6th Floor, Boston, MA 02118 USA.	rbperkin@bu.edu		Stier, Elizabeth/0000-0003-3526-0032; Perkins, Rebecca/0000-0002-7054-3014				Dillner J, 2008, BRIT MED J, V337, DOI 10.1136/bmj.a1754; Gertig DM, 2013, BMC MED, V11, DOI 10.1186/1741-7015-11-227; Katki HA, 2011, LANCET ONCOL, V12, P663, DOI 10.1016/S1470-2045(11)70145-0; Mayrand M, 2007, NEW ENGL J MED, V357, P1579, DOI 10.1056/NEJMoa071430; Murphy J, 2012, J OBSTET GYNAECOL CA, V34, P443, DOI 10.1016/S1701-2163(16)35241-0; Nanda K, 2000, ANN INTERN MED, V132, P810, DOI 10.7326/0003-4819-132-10-200005160-00009; Sankaranarayanan R, 2009, NEW ENGL J MED, V360, P1385, DOI 10.1056/NEJMoa0808516; Saslow D, 2012, AM J CLIN PATHOL, V137, P516, DOI [10.1309/AJCPTGD94EVRSJCG, 10.3322/caac.21139]; Schiffman M, 2003, ARCH PATHOL LAB MED, V127, P946; U.S. Department of Health and Human Services, 2014, BRIEF SUMM MICR DEV; Zhao C, 2014, ARCH PATHOL LAB MED	11	4	5	0	2	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	AUG 19	2014	161	4					295	+		10.7326/M14-1043	http://dx.doi.org/10.7326/M14-1043			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AP8RU	24912666				2022-12-28	WOS:000342347300021
J	Boumahdi, S; Driessens, G; Lapouge, G; Rorive, S; Nassar, D; Le Mercier, M; Delatte, B; Caauwe, A; Lenglez, S; Nkusi, E; Brohee, S; Salmon, I; Dubois, C; del Marmol, V; Fuks, F; Beck, B; Blanpain, C				Boumahdi, Soufiane; Driessens, Gregory; Lapouge, Gaelle; Rorive, Sandrine; Nassar, Dany; Le Mercier, Marie; Delatte, Benjamin; Caauwe, Amelie; Lenglez, Sandrine; Nkusi, Erwin; Brohee, Sylvain; Salmon, Isabelle; Dubois, Christine; del Marmol, Veronique; Fuks, Francois; Beck, Benjamin; Blanpain, Cedric			SOX2 controls tumour initiation and cancer stem-cell functions in squamous-cell carcinoma	NATURE			English	Article							SELF-RENEWAL; EXPRESSION; DIFFERENTIATION; MAINTENANCE; POPULATIONS; SURVIVAL; ABLATION; CATENIN; MARKER; GENES	Cancer stem cells (CSCs) have been reported in various cancers, including in skin squamous-cell carcinoma (SCC)(1-4). The molecular mechanisms regulating tumour initiation and stemness are still poorly characterized. Here we find that Sox2, a transcription factor expressed in various types of embryonic and adult stem cells(5,6), was the most upregulated transcription factor in the CSCs of squamous skin tumours in mice. SOX2 is absent in normal epidermis but begins to be expressed in the vast majority of mouse and human pre-neoplastic skin tumours, and continues to be expressed in a heterogeneous manner in invasive mouse and human SCCs. In contrast to other SCCs, in which SOX2 is frequently genetically amplified(7), the expression of SOX2 in mouse and human skin SCCs is transcriptionally regulated. Conditional deletion of Sox2 in the mouse epidermis markedly decreases skin tumour formation after chemical-induced carcinogenesis. Using green fluorescent protein (GFP) as a reporter of Sox2 transcriptional expression (SOX2-GFP knock-in mice), we showed that SOX2-expressing cells in invasive SCC are greatly enriched in tumour-propagating cells, which further increase upon serial transplantations. Lineage ablation of SOX2-expressing cells within primary benign and malignant SCCs leads to tumour regression, consistent with the critical role of SOX2-expressing cells in tumour maintenance. Conditional Sox2 deletion in pre-existing skin papilloma and SCC leads to tumour regression and decreases the ability of cancer cells to be propagated upon transplantation into immunodeficient mice, supporting the essential role of SOX2 in regulating CSC functions. Transcriptional profiling of SOX2-GFP expressing CSCs and of tumour epithelial cells upon Sox2 deletion uncovered a gene network regulated by SOX2 in primary tumour cells in vivo. Chromatin immunoprecipitation identified several direct SOX2 target genes controlling tumour stemness, survival, proliferation, adhesion, invasion and paraneoplastic syndrome. We demonstrate that SOX2, by marking and regulating the functions of skin tumour-initiating cells and CSCs, establishes a continuum between tumour initiation and progression in primary skin tumours.	[Boumahdi, Soufiane; Driessens, Gregory; Lapouge, Gaelle; Nassar, Dany; Caauwe, Amelie; Lenglez, Sandrine; Nkusi, Erwin; Dubois, Christine; Beck, Benjamin; Blanpain, Cedric] Univ Libre Bruxelles, IRIBHM, B-1070 Brussels, Belgium; [Rorive, Sandrine; Le Mercier, Marie; Salmon, Isabelle] Univ Libre Bruxelles, Erasme Hosp, Dept Pathol, B-1070 Brussels, Belgium; [Rorive, Sandrine; Salmon, Isabelle] CMMI, DIAPATH, B-6041 Gosselies, Belgium; [Delatte, Benjamin; Fuks, Francois] Univ Libre Bruxelles, Lab Canc Epigenet, B-1070 Brussels, Belgium; [Brohee, Sylvain] Univ Libre Bruxelles, Fac Sci, Dept Comp Sci, Machine Learning Grp, B-1050 Brussels, Belgium; [del Marmol, Veronique] Univ Libre Bruxelles, Erasme Hosp, Dept Dermatol, B-1070 Brussels, Belgium; [Blanpain, Cedric] Univ Libre Bruxelles, WELBIO, B-1070 Brussels, Belgium	Universite Libre de Bruxelles; Universite Catholique Louvain; Cliniques Universitaires Saint-Luc; Universite Libre de Bruxelles; Universite Libre de Bruxelles; Universite Libre de Bruxelles; Universite Libre de Bruxelles; Universite Libre de Bruxelles; WELBIO	Blanpain, C (corresponding author), Univ Libre Bruxelles, IRIBHM, B-1070 Brussels, Belgium.	Cedric.Blanpain@ulb.ac.be	Blanpain, Cedric/ABD-8392-2021; del marmol, veronique/AAZ-8117-2020; Delatte, Benjamin/AAE-9276-2020	Delatte, Benjamin/0000-0002-6798-0600; Nassar, Dany/0000-0001-6780-0721; Beck, Benjamin/0000-0001-8162-7566	FNRS/FRIA; FNRS; TELEVIE; Brussels Region through the BB2B program; BB2B; IUAP; Fondation Contre le Cancer; ULB foundation; Fonds Yvonne Boel; Fonds Gaston Ithier; foundation Bettencourt Schueller; European Research Council	FNRS/FRIA(Fonds de la Recherche Scientifique - FNRS); FNRS(Fonds de la Recherche Scientifique - FNRS); TELEVIE; Brussels Region through the BB2B program; BB2B; IUAP; Fondation Contre le Cancer; ULB foundation; Fonds Yvonne Boel; Fonds Gaston Ithier; foundation Bettencourt Schueller; European Research Council(European Research Council (ERC)European Commission)	We thank our colleagues who provided us with reagents. We also thank the animal house facility of the Universite Libre de Bruxelles (ULB) (Erasme campus). C. B. is an investigator of WELBIO. S.Bo., B. B., B. D., S.Br., G. L. and D.N. are supported by a FNRS/FRIA, FNRS and TELEVIE fellowships. G. D. is supported by the Brussels Region through the BB2B program. This work was supported by the FNRS, TELEVIE, BB2B program, the IUAP program, a research grant from the Fondation Contre le Cancer, the ULB foundation, the Fonds Yvonne Boel, the Fonds Gaston Ithier, the foundation Bettencourt Schueller, and a starting grant from the European Research Council.	Abel EL, 2009, NAT PROTOC, V4, P1350, DOI 10.1038/nprot.2009.120; Alam M, 2001, NEW ENGL J MED, V344, P975, DOI 10.1056/NEJM200103293441306; Arnold K, 2011, CELL STEM CELL, V9, P317, DOI 10.1016/j.stem.2011.09.001; Bardot ES, 2013, EMBO J, V32, P1990, DOI 10.1038/emboj.2013.110; Barker N, 2007, NATURE, V449, P1003, DOI 10.1038/nature06196; Bass AJ, 2009, NAT GENET, V41, P1238, DOI 10.1038/ng.465; Beck B, 2013, NAT REV CANCER, V13, P727, DOI 10.1038/nrc3597; Beck B, 2011, NATURE, V478, P399, DOI 10.1038/nature10525; Blanpain C, 2004, CELL, V118, P635, DOI 10.1016/j.cell.2004.08.012; Chuang WY, 2013, HISTOL HISTOPATHOL, V28, P293, DOI 10.14670/HH-28.293; Coletta A, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-11-r104; Copley MR, 2013, NAT CELL BIOL, V15, P916, DOI 10.1038/ncb2783; Driskell RR, 2009, DEVELOPMENT, V136, P2815, DOI 10.1242/dev.038620; Ellis P, 2004, DEV NEUROSCI-BASEL, V26, P148, DOI 10.1159/000082134; Esbrit P, 2001, Clin Lab, V47, P67; Ezhkova E, 2011, GENE DEV, V25, P485, DOI 10.1101/gad.2019811; Ezhkova E, 2009, CELL, V136, P1122, DOI 10.1016/j.cell.2008.12.043; Fang XF, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-11; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Granter S. R., 2008, PATHOLOGY SKIN CLIN; Grosse-Gehling P, 2013, J PATHOL, V229, P355, DOI 10.1002/path.4086; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Himburg HA, 2012, CELL REP, V2, P964, DOI 10.1016/j.celrep.2012.09.002; Hu YF, 2009, J IMMUNOL METHODS, V347, P70, DOI 10.1016/j.jim.2009.06.008; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huang DW, 2009, NUCLEIC ACIDS RES, V37, P1, DOI 10.1093/nar/gkn923; Ivanova A, 2005, GENESIS, V43, P129, DOI 10.1002/gene.20162; Janiszewska M, 2012, GENE DEV, V26, P1926, DOI 10.1101/gad.188292.112; Jonkers J, 2001, NAT GENET, V29, P418, DOI 10.1038/ng747; Laga AC, 2010, AM J PATHOL, V176, P903, DOI 10.2353/ajpath.2010.090495; Lapouge G, 2012, EMBO J, V31, P4563, DOI 10.1038/emboj.2012.312; Lapouge G, 2011, P NATL ACAD SCI USA, V108, P7431, DOI 10.1073/pnas.1012720108; Liborio TN, 2011, HISTOPATHOLOGY, V58, P225, DOI 10.1111/j.1365-2559.2011.03751.x; Liu KC, 2013, CELL SIGNAL, V25, P1264, DOI 10.1016/j.cellsig.2013.02.013; Malanchi I, 2008, NATURE, V452, P650, DOI 10.1038/nature06835; Marson A, 2008, CELL, V134, P521, DOI 10.1016/j.cell.2008.07.020; Masui S, 2007, NAT CELL BIOL, V9, P625, DOI 10.1038/ncb1589; McCall MN, 2010, BIOSTATISTICS, V11, P242, DOI 10.1093/biostatistics/kxp059; Meacham CE, 2013, NATURE, V501, P328, DOI 10.1038/nature12624; Means AL, 2008, GENESIS, V46, P318, DOI 10.1002/dvg.20397; Nishino J, 2008, CELL, V135, P227, DOI 10.1016/j.cell.2008.09.017; Philip E., 2006, WHO CLASSIFICATION T, P20; Rorive S, 2010, MODERN PATHOL, V23, P1418, DOI 10.1038/modpathol.2010.136; Sarkar A, 2013, CELL STEM CELL, V12, P15, DOI 10.1016/j.stem.2012.12.007; Schober M, 2011, P NATL ACAD SCI USA, V108, P10544, DOI 10.1073/pnas.1107807108; Soh BS, 2007, STEM CELLS, V25, P3029, DOI 10.1634/stemcells.2007-0372; Sotiropoulou PA, 2010, NAT CELL BIOL, V12, P572, DOI 10.1038/ncb2059; Taranova OV, 2006, GENE DEV, V20, P1187, DOI 10.1101/gad.1407906; Tuveson DA, 2004, CANCER CELL, V5, P375, DOI 10.1016/S1535-6108(04)00085-6; van de Wiel MA, 2007, BIOINFORMATICS, V23, P892, DOI 10.1093/bioinformatics/btm030; Vasioukhin V, 1999, P NATL ACAD SCI USA, V96, P8551, DOI 10.1073/pnas.96.15.8551; Vasioukhin V, 2001, CELL, V104, P605, DOI 10.1016/S0092-8674(01)00246-X; Venkatraman ES, 2007, BIOINFORMATICS, V23, P657, DOI 10.1093/bioinformatics/btl646	53	442	458	6	97	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 10	2014	511	7508					246	+		10.1038/nature13305	http://dx.doi.org/10.1038/nature13305			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK8AP	24909994				2022-12-28	WOS:000338649800049
J	Karayannis, T; Au, E; Patel, JC; Kruglikov, I; Markx, S; Delorme, R; Heron, D; Salomon, D; Glessner, J; Restituito, S; Gordon, A; Rodriguez-Murillo, L; Roy, NC; Gogos, JA; Rudy, B; Rice, ME; Karayiorgou, M; Hakonarson, H; Keren, B; Huguet, G; Bourgeron, T; Hoeffer, C; Tsien, RW; Peles, E; Fishell, G				Karayannis, T.; Au, E.; Patel, J. C.; Kruglikov, I.; Markx, S.; Delorme, R.; Heron, D.; Salomon, D.; Glessner, J.; Restituito, S.; Gordon, A.; Rodriguez-Murillo, L.; Roy, N. C.; Gogos, J. A.; Rudy, B.; Rice, M. E.; Karayiorgou, M.; Hakonarson, H.; Keren, B.; Huguet, G.; Bourgeron, T.; Hoeffer, C.; Tsien, R. W.; Peles, E.; Fishell, G.			Cntnap4 differentially contributes to GABAergic and dopaminergic synaptic transmission	NATURE			English	Article							CORTICAL INTERNEURONS; GABA(A) RECEPTORS; PREPULSE INHIBITION; TOURETTES-SYNDROME; SCHIZOPHRENIA; SYNAPSES; NUMBER; ASSOCIATION; LINKAGE; RELEASE	Although considerable evidence suggests that the chemical synapse is a lynchpin underlying affective disorders, how molecular insults differentially affect specific synaptic connections remains poorly understood. For instance, Neurexin 1a and 2 (NRXN1 and NRXN2) and CNTNAP2 (also known as CASPR2), all members of the neurexin superfamily of transmembrane molecules, have been implicated in neuropsychiatric disorders. However, their loss leads to deficits that have been best characterized with regard to their effect on excitatory cells(1,2). Notably, other disease-associated genes such as BDNF and ERBB4 implicate specific interneuron synapses in psychiatric disorders(3,4). Consistent with this, cortical interneuron dysfunction has been linked to epilepsy, schizophrenia and autism(5,6). Using a microarray screen that focused upon synapse-associated molecules, we identified Cntnap4 (contactin associated protein-like 4, also known as Caspr4) as highly enriched in developing murine interneurons. In this study we show that Cntnap4 is localized presynaptically and its loss leads to a reduction in the output of cortical parvalbumin (PV)-positive GABAergic (gamma-aminobutyric acid producing) basket cells. Paradoxically, the loss of Cntnap4 augments midbrain dopaminergic release in the nucleus accumbens. In Cntnap4 mutant mice, synaptic defects in these disease-relevant neuronal populations are mirrored by sensory-motor gating and grooming endophenotypes; these symptoms could be pharmacologically reversed, providing promise for therapeutic intervention in psychiatric disorders.	[Karayannis, T.; Au, E.; Kruglikov, I.; Restituito, S.; Roy, N. C.; Rudy, B.; Hoeffer, C.; Tsien, R. W.; Fishell, G.] NYU, Dept Neurosci & Physiol, Neurosci Inst, New York, NY 10016 USA; [Patel, J. C.; Rice, M. E.] NYU, Dept Neurosurg Neurosci & Physiol, Langone Med Ctr, New York, NY 10016 USA; [Markx, S.; Rodriguez-Murillo, L.; Karayiorgou, M.] Columbia Univ Coll Phys & Surg, Dept Psychiat, New York, NY 10032 USA; [Delorme, R.; Hakonarson, H.; Huguet, G.; Bourgeron, T.] Inst Pasteur, Human Genet & Cognit Funct Unit, F-75724 Paris, France; [Delorme, R.; Huguet, G.; Bourgeron, T.] Inst Pasteur, URA Genes Synapses & Cognit 2182, CNRS, F-75724 Paris, France; [Delorme, R.] Hop Robert Debre, AP HP, Dept Child & Adolescent Psychiat, F-75019 Paris, France; [Heron, D.] Grp Hosp Pitie Salpetriere, AP HP, Unite Fonct Genet Med, Dept Genet & Cytogenet,Ctr Reference,CRicm,UMR S9, F-75013 Paris, France; [Salomon, D.; Gordon, A.] Weizmann Inst Sci, Dept Mol Cell Biol, IL-76100 Rehovot, Israel; [Glessner, J.] Childrens Hosp Philadelphia, Ctr Appl Genom, Philadelphia, PA 19104 USA; [Roy, N. C.] Natl Inst Deafness & Other Commun Disorders, Sect Synapt Transmiss, NIH, Bethesda, MD 20892 USA; [Gogos, J. A.] Columbia Univ, Med Ctr, Dept Physiol, New York, NY 10032 USA; [Gogos, J. A.] Columbia Univ, Med Ctr, Dept Cellular Biophys & Neurosci, New York, NY 10032 USA; [Keren, B.] Grp Hosp Pitie Salpetriere, AP HP, Unite Fonct Genet Chromosom, Dept Genet & Cytogenet,CRicm,UMR S975, F-75013 Paris, France; [Huguet, G.; Bourgeron, T.] Univ Paris Diderot, Sorbonne Paris Cite, F-75005 Paris, France; [Bourgeron, T.] FondaMental Fdn, F-94000 Creteil, France	New York University; New York University; NYU Langone Medical Center; Columbia University; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; UDICE-French Research Universities; Universite Paris Cite; Centre National de la Recherche Scientifique (CNRS); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Robert-Debre - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite; Weizmann Institute of Science; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; National Institutes of Health (NIH) - USA; NIH National Institute on Deafness & Other Communication Disorders (NIDCD); Columbia University; Columbia University; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite; UDICE-French Research Universities; Universite Paris Cite	Fishell, G (corresponding author), NYU, Dept Neurosci & Physiol, Neurosci Inst, New York, NY 10016 USA.	gordon.fishell@med.nyu.edu	Kruglikov, Ilya/AAC-9131-2020; Karayannis, Theofanis/GRR-3982-2022; Huguet, Guillaume/GPX-3656-2022; Karayannis, Theofanis/O-5194-2014	Kruglikov, Ilya/0000-0002-1575-4636; Karayannis, Theofanis/0000-0002-3267-6254; Huguet, Guillaume/0000-0002-4746-6030; Patel, Jyoti/0000-0003-0295-6180; Fishell, Gordon/0000-0002-9640-9278; Rice, Margaret/0000-0003-1793-2798; Bourgeron, Thomas/0000-0001-8164-9220; Glessner, Joseph/0000-0001-5131-2811; Delorme, Richard/0000-0002-5614-3663; Peles, Elior/0000-0002-3325-0597; Au, Edmund/0000-0003-3190-9711; Rudy, Bernardo/0000-0001-5748-6900	NIH [R01 NS081297, R01 MH071679, R01 NS074972, P01 NS074972, R01 NS036362, R01 DA033811, NS30989, NS50220]; Simons Foundation [94534]; Attilio and Olympia Ricciardi Research Fund; Israel Science Foundation; Patterson Trust; Roche; New York State through its NYSTEM initiative [C024326]; Canadian Institutes of Health Research; NYU COE Addiction Seed Grant; Institut Pasteur; INSERM; AP-HP; University Paris Diderot; Bettencourt-Schueller foundation; Orange foundation; FondaMental foundation; Conny-Maeva foundation; Cognacq-Jay foundation	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Simons Foundation; Attilio and Olympia Ricciardi Research Fund; Israel Science Foundation(Israel Science Foundation); Patterson Trust; Roche(Roche Holding); New York State through its NYSTEM initiative; Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); NYU COE Addiction Seed Grant; Institut Pasteur(European Commission); INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); AP-HP; University Paris Diderot; Bettencourt-Schueller foundation; Orange foundation; FondaMental foundation; Conny-Maeva foundation; Cognacq-Jay foundation	The authors are grateful to R. Froemke for critically reading the manuscript, to B. Benedetti, M. McKenzie Chang, L. Cobbs, B. A. Heller, T. Petros and N. Yumoto (all NYU) for help with experiments and analysis and to Charles Nicholson (NYU) for providing specialized software to analyse Vmax. Research in the Fishell laboratory is supported by the NIH (grants R01 NS081297, R01 MH071679, R01 NS074972, P01 NS074972 to B. R. and G. F.) and the Simons Foundation (94534). The Rice laboratory is supported by the NIH (grants R01 NS036362 and R01 DA033811) and the Attilio and Olympia Ricciardi Research Fund. The Rudy laboratory is supported by the NIH (NS30989). The Peles laboratory is supported by the NIH (grant NS50220) and the Israel Science Foundation. T. K. support was provided through postdoctoral fellowships from the Patterson Trust and Roche. E. A. support was provided by New York State through its NYSTEM initiative (C024326) and fellowship from Canadian Institutes of Health Research. J.C.P support was provided by NYU COE Addiction Seed Grant. This work was funded by the Institut Pasteur, INSERM, AP-HP, University Paris Diderot and the Bettencourt-Schueller, Orange, FondaMental, Conny-Maeva, Cognacq-Jay foundations.	Abecasis GR, 2004, AM J HUM GENET, V74, P403, DOI 10.1086/381713; Ashrafi S, 2014, NEURON, V81, P120, DOI 10.1016/j.neuron.2013.10.060; Atasoy D, 2007, P NATL ACAD SCI USA, V104, P2525, DOI 10.1073/pnas.0611003104; Batista-Brito R, 2009, NEURON, V63, P466, DOI 10.1016/j.neuron.2009.08.005; Belzil C, 2013, J BIOL CHEM, V288, P24452, DOI 10.1074/jbc.M113.483107; Berghuis P, 2004, EUR J NEUROSCI, V20, P1290, DOI 10.1111/j.1460-9568.2004.03561.x; Blatt GJ, 2011, ANAT REC, V294, P1646, DOI 10.1002/ar.21252; Brandon NJ, 2003, MOL CELL NEUROSCI, V22, P87, DOI 10.1016/S1044-7431(02)00017-9; Castellanos FX, 1996, BIOL PSYCHIAT, V39, P33, DOI 10.1016/0006-3223(95)00101-8; Cathala L, 2005, NAT NEUROSCI, V8, P1310, DOI 10.1038/nn1534; Champagne FA, 2004, J NEUROSCI, V24, P4113, DOI 10.1523/JNEUROSCI.5322-03.2004; Chang MC, 2010, NAT NEUROSCI, V13, P1090, DOI 10.1038/nn.2621; Chao HT, 2010, NATURE, V468, P263, DOI 10.1038/nature09582; Close J, 2012, J NEUROSCI, V32, P17690, DOI 10.1523/JNEUROSCI.3583-12.2012; CONDE F, 1994, J COMP NEUROL, V341, P95, DOI 10.1002/cne.903410109; Crowley JJ, 2012, PHARMACOGENOMICS J, V12, P147, DOI 10.1038/tpj.2010.82; Doischer D, 2008, J NEUROSCI, V28, P12956, DOI 10.1523/JNEUROSCI.2890-08.2008; Elia J, 2012, NAT GENET, V44, P78, DOI 10.1038/ng.1013; Etherton MR, 2009, P NATL ACAD SCI USA, V106, P17998, DOI 10.1073/pnas.0910297106; Fazzari P, 2010, NATURE, V464, P1376, DOI 10.1038/nature08928; Feinberg K, 2010, NEURON, V65, P490, DOI 10.1016/j.neuron.2010.02.004; Foster AC, 2004, J PHARMACOL EXP THER, V311, P547, DOI 10.1124/jpet.103.063487; Geyer MA, 2001, PSYCHOPHARMACOLOGY, V156, P117, DOI 10.1007/s002130100811; Glessner JT, 2010, P NATL ACAD SCI USA, V107, P10584, DOI 10.1073/pnas.1000274107; Glessner JT, 2009, NATURE, V459, P569, DOI 10.1038/nature07953; Gonzalez MI, 2013, EPILEPSIA, V54, P616, DOI 10.1111/epi.12063; Grados MA, 2009, CURR PSYCHIAT REP, V11, P162, DOI 10.1007/s11920-009-0025-x; HAYCOCK JW, 1987, BRAIN RES BULL, V19, P619, DOI 10.1016/0361-9230(87)90046-3; Hefft S, 2005, NAT NEUROSCI, V8, P1319, DOI 10.1038/nn1542; Ho A, 2003, P NATL ACAD SCI USA, V100, P1409, DOI 10.1073/pnas.252774899; Hoeffer CA, 2008, NEURON, V60, P832, DOI 10.1016/j.neuron.2008.09.037; Hoon M, 2009, J NEUROSCI, V29, P8039, DOI 10.1523/JNEUROSCI.0534-09.2009; Jordan BA, 2004, MOL CELL PROTEOMICS, V3, P857, DOI 10.1074/mcp.M400045-MCP200; Karayiorgou M, 2004, AM J MED GENET B, V124B, P20, DOI 10.1002/ajmg.b.20090; Klausberger T, 2002, J NEUROSCI, V22, P2513, DOI 10.1523/JNEUROSCI.22-07-02513.2002; Krueger DD, 2012, CURR OPIN NEUROBIOL, V22, P412, DOI 10.1016/j.conb.2012.02.012; Labasque M, 2010, FEBS LETT, V584, P1787, DOI 10.1016/j.febslet.2009.08.025; Lewis DA, 2012, EUR J NEUROSCI, V35, P1871, DOI 10.1111/j.1460-9568.2012.08156.x; Li MY, 2006, AM J HUM GENET, V78, P778, DOI 10.1086/503711; Li MY, 2005, AM J HUM GENET, V76, P934, DOI 10.1086/430277; Li XT, 2010, J NEUROSCI, V30, P1788, DOI 10.1523/JNEUROSCI.5604-09.2010; Li Y, 2010, GENET EPIDEMIOL, V34, P816, DOI 10.1002/gepi.20533; MacAskill AF, 2009, NEURON, V61, P541, DOI 10.1016/j.neuron.2009.01.030; Miyoshi G, 2007, J NEUROSCI, V27, P7786, DOI 10.1523/JNEUROSCI.1807-07.2007; Miyoshi G, 2012, NEURON, V74, P1045, DOI 10.1016/j.neuron.2012.04.025; Miyoshi G, 2010, J NEUROSCI, V30, P1582, DOI 10.1523/JNEUROSCI.4515-09.2010; Nicholson C., 2010, P 13 INT C IN VIV ME, P328; Nikolaev A, 2009, NATURE, V457, P981, DOI 10.1038/nature07767; Osten P, 1998, NEURON, V21, P99, DOI 10.1016/S0896-6273(00)80518-8; Panzanelli P, 2011, J PHYSIOL-LONDON, V589, P4959, DOI 10.1113/jphysiol.2011.216028; Patel Jyoti C, 2013, Methods Mol Biol, V964, P243, DOI 10.1007/978-1-62703-251-3_15; Patel JC, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2144; Peca J, 2011, NATURE, V472, P437, DOI 10.1038/nature09965; Penagarikano O, 2011, CELL, V147, P235, DOI 10.1016/j.cell.2011.08.040; Petroski RE, 2006, J PHARMACOL EXP THER, V317, P369, DOI 10.1124/jpet.105.096701; Phillips GR, 2001, NEURON, V32, P63, DOI 10.1016/S0896-6273(01)00450-0; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Restituito S, 2011, J NEUROSCI, V31, P12083, DOI 10.1523/JNEUROSCI.2513-11.2011; Rice ME, 2011, NEUROSCIENCE, V198, P112, DOI 10.1016/j.neuroscience.2011.08.066; Spiegel I, 2002, MOL CELL NEUROSCI, V20, P283, DOI 10.1006/mcne.2002.1110; Spiegel I, 2007, NAT NEUROSCI, V10, P861, DOI 10.1038/nn1915; Stark KL, 2009, INT J NEUROPSYCHOPH, V12, P983, DOI 10.1017/S1461145709000492; Sylwestrak EL, 2012, SCIENCE, V338, P536, DOI 10.1126/science.1222482; Thomas A, 2009, PSYCHOPHARMACOLOGY, V204, P361, DOI 10.1007/s00213-009-1466-y; Xu B, 2008, NAT GENET, V40, P880, DOI 10.1038/ng.162; Xu B, 2009, P NATL ACAD SCI USA, V106, P16746, DOI 10.1073/pnas.0908584106	66	104	111	0	54	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 10	2014	511	7508					236	+		10.1038/nature13248	http://dx.doi.org/10.1038/nature13248			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK8AP	24870235	Green Accepted			2022-12-28	WOS:000338649800047
J	Kubo, A; Shlager, L; Marks, AR; Lakritz, D; Beaumont, C; Gabellini, K; Corley, DA				Kubo, Ai; Shlager, Lyle; Marks, Amy R.; Lakritz, Dena; Beaumont, Colette; Gabellini, Kim; Corley, Douglas A.			Prevention of Vertical Transmission of Hepatitis B An Observational Study	ANNALS OF INTERNAL MEDICINE			English	Article							VIRUS INFECTION; PERINATAL TRANSMISSION; UNITED-STATES; ANTIGEN; IMMUNIZATION; CHILDREN; VACCINE; INFANTS; MOTHERS	Background: For mothers with chronic hepatitis B virus (HBV) infection, the Centers for Disease Control and Prevention recommends immunoprophylaxis to decrease perinatal transmission. However, its effectiveness and risk factors for failure have not been well-studied in community practice. Objective: To investigate the effectiveness of a contemporary immunoprophylaxis protocol. Design: Observational study. Setting: An HBV perinatal immunoprophylaxis program within Kaiser Permanente Northern California. Patients: 4446 infants born to 3253 HBV-positive mothers between 1997 and 2010. Measurements: Adherence to immunoprophylaxis, follow-up testing rates, maternal risk factors for HBV transmission, and transmission rates. Results: The infant infection rate was 0.75 per 100 births from 1997 to 2010 (Poisson 95% CI, 0.48 to 1.10). Rates per 100 births were 3.37 (CI, 2.08 to 5.14) for e antigen-positive mothers and 0.04 (CI, 0.001 to 0.24) for e antigen-negative mothers. Among mothers with viral load testing, the lowest level associated with transmission was 6.32 x 10(7) IU/mL. Infection rates per 100 births were 3.61 (CI, 0.75 to 10.56) among the 83 births to mothers with viral loads of 5 x 10(7) IU/mL or greater and 0 among the 831 births to mothers with viral loads less than 5 x 10(7) IU/mL, regardless of e antigen status. Limitations: Testing for HBV immunity and infection was less complete in earlier years. Viral load testing was only consistently available starting in 2007. Conclusion: Prenatal HBV screening followed by postnatal prophylaxis is highly effective in preventing vertical transmission of HBV. A negative e antigen status or a viral load less than 5 x 10(7) IU/mL (90.9% of women tested) identifies women at extremely low risk for transmission after immunoprophylaxis who are unlikely to benefit from further interventions.	[Kubo, Ai] Kaiser Permanente, Div Res, Oakland, CA 94612 USA; Oakland Med Ctr, Oakland, CA USA; Kaiser Permanente, San Francisco Med Ctr, San Francisco, CA USA	Kaiser Permanente; Kaiser Permanente	Kubo, A (corresponding author), Kaiser Permanente, Div Res, 2000 Broadway, Oakland, CA 94612 USA.	ai.kubo@kp.org		Marks, Amy/0000-0002-3047-5379	Kaiser Permanente Community Benefit [CN-09LShla-01-H]; National Cancer Institute; National Institutes of Health Office of Research on Women's Health (career development award) [K07CA166143-01A1]; National Center for Advancing Translational Sciences of the National Institutes of Health [KL2TR000143]; NATIONAL CANCER INSTITUTE [R43CA094612, K07CA166143, R44CA094612] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [KL2TR000143] Funding Source: NIH RePORTER	Kaiser Permanente Community Benefit; National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Institutes of Health Office of Research on Women's Health (career development award); National Center for Advancing Translational Sciences of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS))	By the Kaiser Permanente Community Benefit (grant CN-09LShla-01-H). Dr. Kubo is also supported by the National Cancer Institute and the National Institutes of Health Office of Research on Women's Health (career development award K07CA166143-01A1) and the National Center for Advancing Translational Sciences of the National Institutes of Health (KL2TR000143).	Benson Ruthie, 2012, Morbidity and Mortality Weekly Report, V61, P768; Bracebridge S, 2004, Commun Dis Public Health, V7, P138; BURK RD, 1994, J INFECT DIS, V170, P1418, DOI 10.1093/infdis/170.6.1418; Centers for Disease Control and Prevention, 2010, HEP B INF HLTH PROF; Chang MH, 2007, SEMIN FETAL NEONAT M, V12, P160, DOI 10.1016/j.siny.2007.01.013; Doherty R, 2009, PEDIATR INFECT DIS J, V28, P777, DOI 10.1097/INF.0b013e3181a06fad; Keeffe EB, 2008, CLIN GASTROENTEROL H, V6, P268, DOI 10.1016/j.cgh.2007.12.043; KRIEGER N, 1992, AM J PUBLIC HEALTH, V82, P703, DOI 10.2105/AJPH.82.5.703; Lee CF, 2006, BMJ-BRIT MED J, V332, P328, DOI 10.1136/bmj.38719.435833.7C; Mast Eric E., 2005, Morbidity and Mortality Weekly Report, V54, P1; Roque D. M., 2011, Morbidity and Mortality Weekly Report, V60, P410; Sherman Morris, 2007, Can J Gastroenterol, V21 Suppl C, p5C; Singh AE, 2011, J VIRAL HEPATITIS, V18, P468, DOI 10.1111/j.1365-2893.2010.01333.x; Smith EA, 2012, PEDIATRICS, V129, P609, DOI 10.1542/peds.2011-2866; STEVENS CE, 1985, JAMA-J AM MED ASSOC, V253, P1740, DOI 10.1001/jama.253.12.1740; STEVENS CE, 1975, NEW ENGL J MED, V292, P771, DOI 10.1056/NEJM197504102921503; Wiseman E, 2009, MED J AUSTRALIA, V190, P489, DOI 10.5694/j.1326-5377.2009.tb02524.x; Yao JL, 1996, GUT, V38, pS37, DOI 10.1136/gut.38.Suppl_2.S37; Zhu QR, 1997, CHINESE MED J-PEKING, V110, P145	19	72	81	0	8	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JUN 17	2014	160	12					828	U42		10.7326/M13-2529	http://dx.doi.org/10.7326/M13-2529			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AJ0VR	24862434	Green Accepted			2022-12-28	WOS:000337374900016
J	Memish, ZA; Zumla, A; McCloskey, B; Heymann, D; Al Rabeeah, AA; Barbeschi, M; Horton, R				Memish, Ziad A.; Zumla, Alimuddin; McCloskey, Brian; Heymann, David; Al Rabeeah, Abdullah A.; Barbeschi, Maurizio; Horton, Richard			Mass gatherings medicine: international cooperation and progress	LANCET			English	Editorial Material							RESPIRATORY SYNDROME CORONAVIRUS; SAUDI-ARABIA; INFECTIONS		[Memish, Ziad A.; Al Rabeeah, Abdullah A.] Minist Hlth, Global Ctr Mass Gathering Med, Riyadh 11176, Saudi Arabia; [Memish, Ziad A.] Al Faisal Univ, Riyadh, Saudi Arabia; [Zumla, Alimuddin] UCL, Div Infect & Immun, London, England; [Zumla, Alimuddin] Univ Coll London Hosp, London, England; [McCloskey, Brian] Publ Hlth England, London, England; [McCloskey, Brian] Publ Hlth England, WHO Collaborating Ctr Mass Gatherings, London, England; [Heymann, David] Chatham House, London, England; [Heymann, David] London Sch Hyg & Trop Med, London WC1, England; [Barbeschi, Maurizio] WHO, CH-1211 Geneva, Switzerland; [Horton, Richard] Lancet, London, England	Alfaisal University; University of London; University College London; University College London Hospitals NHS Foundation Trust; University of London; University College London; Public Health England; Public Health England; University of London; London School of Hygiene & Tropical Medicine; World Health Organization	Memish, ZA (corresponding author), Minist Hlth, Global Ctr Mass Gathering Med, Riyadh 11176, Saudi Arabia.	zmemish@yahoo.com	Memish, Ziad Ahmed/AEJ-9424-2022; ZUMLA, Alimuddin/ABA-8208-2020	Memish, Ziad Ahmed/0000-0002-5099-0714; ZUMLA, Alimuddin/0000-0002-5111-5735				Al Rabeeah A, 2012, LANCET, V380, P3, DOI 10.1016/S0140-6736(12)61073-3; Assiri A, 2013, LANCET INFECT DIS, V13, P752, DOI 10.1016/S1473-3099(13)70204-4; Assiri A, 2013, NEW ENGL J MED, V369, P407, DOI 10.1056/NEJMoa1306742; Cotten M, 2013, LANCET, V382, P1993, DOI 10.1016/S0140-6736(13)61887-5; McCloskey B, 2014, LANCET; McCloskey B, 2013, LANCET INFECT DIS, V13, P384, DOI 10.1016/S1473-3099(13)70082-3; Memish ZA, 2014, CLIN MICROBIOL INFEC, V20, P469, DOI 10.1111/1469-0691.12562; Memish ZA, 2014, LANCET; Memish ZA, 2013, B WORLD HEALTH ORGAN, V91, P899, DOI 10.2471/BLT.13.132266; Memish ZA, 2013, NEW ENGL J MED, V369, P884, DOI 10.1056/NEJMc1308698; Memish ZA, 2013, NEW ENGL J MED, V368, P2487, DOI 10.1056/NEJMoa1303729; Ministry of Health, 2012, WHO GEN ASS EMBR SAU; Smallwood CAH, 2014, LANCET; The Lancet, 2012, LANCET, V380, P1; WHO, 2013, WHO IHR EM COMM MIDD; World Health Organisation (WHO), 2008, COMM DIS AL RESP MAS; Zaki AM, 2012, NEW ENGL J MED, V367, P1814, DOI 10.1056/NEJMoa1211721	17	21	22	0	3	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	JUN 14	2014	383	9934					2030	2032		10.1016/S0140-6736(14)60225-7	http://dx.doi.org/10.1016/S0140-6736(14)60225-7			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	AI9VZ	24857704	Green Published, Bronze			2022-12-28	WOS:000337292400010
J	Mann, C				Mann, Clifford			World Cup's extended pub opening hours make no sense	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									Coll Emergency Med, Taunton, Somerset, England		Mann, C (corresponding author), Coll Emergency Med, Taunton, Somerset, England.	cliff.mann@me.com						Alcohol Concern, 2010, FACTSH GRASP NETTL A; [Anonymous], 2001, J SUBST ABUSE, V6, P235; Galanter M., 1997, RECENT DEV ALCOHOLIS, V13; Home Office, 2014, CONS REL LIC HOURS F; National Treatment Agency for Substance Misuse, 2013, ALC TREATM ENGL 2011; Newton, 2007, EMJ, V24, P532	6	0	0	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JUN 11	2014	348								g3805	10.1136/bmj.g3805	http://dx.doi.org/10.1136/bmj.g3805			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AJ1GY	24916687				2022-12-28	WOS:000337405200014
J	Caprio, J; Shimohara, M; Marui, T; Harada, S; Kiyohara, S				Caprio, John; Shimohara, Mami; Marui, Takayuki; Harada, Shuitsu; Kiyohara, Sadao			Marine teleost locates live prey through pH sensing	SCIENCE			English	Article							CHANNEL CATFISH; ION-CHANNEL; TASTE-BUDS; OCEAN; BEHAVIOR; CARBON; FISH; ABILITY; CELLS	We report that the Japanese sea catfish Plotosus japonicus senses local pH-associated increases in H+/CO2 equating to a decrease of <= 0.1 pH unit in ambient seawater. We demonstrated that these sensors, located on the external body of the fish, detect undamaged cryptic respiring prey, such as polychaete worms. Sensitivity is maximal at the natural pH of seawater (pH 8.1 to 8.2) and decreases dramatically in seawater with a pH <8.0.	[Caprio, John] Louisiana State Univ, Dept Biol Sci, Baton Rouge, LA 70803 USA; [Shimohara, Mami; Kiyohara, Sadao] Kagoshima Univ, Grad Sch Sci & Engn, Dept Chem & BioSci, Kagoshima 8900065, Japan; [Harada, Shuitsu] Kagoshima Univ, Grad Sch Med & Dent Sci, Dept Oral Physiol, Kagoshima 8908544, Japan	Louisiana State University System; Louisiana State University; Kagoshima University; Kagoshima University	Caprio, J (corresponding author), Louisiana State Univ, Dept Biol Sci, Baton Rouge, LA 70803 USA.	jcap@lsu.edu			NIH U.S.-Japan Brain Research Cooperative Program [NS-04-014]; Louisiana State University College of Science; Ministry of Education, Science, Sports, and Culture of Japan [22580205]	NIH U.S.-Japan Brain Research Cooperative Program(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Louisiana State University College of Science; Ministry of Education, Science, Sports, and Culture of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	We thank A. Nikonov, M. Brown, and J. Belanger for aid in preparation of Fig. 1; A. Kiyohara for Fig. 1A; C. Derby, A. Hansen, W. C. Michel, W. Silver, D. Mulkey, and T. Dietz for their constructive comments on the manuscript; and C. Derby for statistical aid. We also thank M. Kirino, T. Ikenaga, R. Kawabata and K. Kawano for assitance in the laboratory. Supported in part by the NIH U.S.-Japan Brain Research Cooperative Program (grant NS-04-014) and the George C. Kent Professorship (Louisiana State University College of Science) to J. C. and a grant (22580205) to S. K. from the Ministry of Education, Science, Sports, and Culture of Japan. All primary electrophysiological data (VCR tapes) are archived in the Department of Biological Sciences, Louisiana State University. The authors declare no competing financial interests. Readers are welcome to comment on the online version of the paper. Correspondence and requests for materials should be addressed to J. C. (jcap@lsu.edu).	ATEMA J, 1971, BRAIN BEHAV EVOLUT, V4, P273, DOI 10.1159/000125438; Caldeira K, 2003, NATURE, V425, P365, DOI 10.1038/425365a; Chen XM, 2007, J BIOL CHEM, V282, P30406, DOI 10.1074/jbc.M702229200; Clark Eugenie, 2011, Aqua, V17, P211; DAVENPORT CJ, 1982, J COMP PHYSIOL, V147, P217, DOI 10.1007/BF00609846; Dixson DL, 2010, ECOL LETT, V13, P68, DOI 10.1111/j.1461-0248.2009.01400.x; Ferrari MCO, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031478; FINGER TE, 1976, J COMP NEUROL, V165, P513, DOI 10.1002/cne.901650407; Finger TE, 1997, BRAIN BEHAV EVOLUT, V50, P234, DOI 10.1159/000113337; Finger TE, 1996, J COMP NEUROL, V373, P129, DOI 10.1002/(SICI)1096-9861(19960909)373:1<129::AID-CNE11>3.0.CO;2-F; FINGER TE, 1991, J COMP NEUROL, V314, P55, DOI 10.1002/cne.903140106; Gourine AV, 2010, SCIENCE, V329, P571, DOI 10.1126/science.1190721; Guyenet PG, 2010, J COMP NEUROL, V518, P3883, DOI 10.1002/cne.22435; Hofmann GE, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028983; Kasai M, 2010, J COMP PHYSIOL A, V196, P901, DOI 10.1007/s00359-010-0572-y; KIYOHARA S, 1986, BRAIN RES, V379, P353, DOI 10.1016/0006-8993(86)90789-4; KOTRSCHAL K, 1992, ENVIRON BIOL FISH, V35, P273, DOI 10.1007/BF00001894; Kristensen E, 2001, Geochem Trans, V2, P92, DOI 10.1186/1467-4866-2-92; Meigh L, 2013, ELIFE, V2, DOI 10.7554/eLife.01213; Munday PL, 2009, P NATL ACAD SCI USA, V106, P1848, DOI 10.1073/pnas.0809996106; Nilsson GE, 2012, NAT CLIM CHANGE, V2, P201, DOI [10.1038/nclimate1352, 10.1038/NCLIMATE1352]; Perry SF, 2012, RESP PHYSIOL NEUROBI, V184, P309, DOI 10.1016/j.resp.2012.06.013; REUTTER K, 1974, CELL TISSUE RES, V149, P143; SCHARRER E, 1947, J COMP NEUROL, V86, P183, DOI 10.1002/cne.900860204; Service RF, 2012, SCIENCE, V337, P146, DOI 10.1126/science.337.6091.146; SILVER WL, 1984, J COMP PHYSIOL, V154, P167, DOI 10.1007/BF00604982; Simpson SD, 2011, BIOL LETTERS, V7, P917, DOI 10.1098/rsbl.2011.0293; Sorensen P. W., 1997, PHYSL FISHES, P375; Springauf A, 2010, J PHYSIOL-LONDON, V588, P809, DOI 10.1113/jphysiol.2009.182931; Wang S, 2013, J NEUROSCI, V33, P16033, DOI 10.1523/JNEUROSCI.2451-13.2013; Yoshino Tetsuo, 2008, Bulletin of the National Museum of Nature and Science Series A-Zoology, P1	31	27	27	3	50	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 6	2014	344	6188					1154	1156		10.1126/science.1252697	http://dx.doi.org/10.1126/science.1252697			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI3UU	24904164				2022-12-28	WOS:000336791200046
J	Rao, RR; Long, JZ; White, JP; Svensson, KJ; Lou, J; Lokurkar, I; Jedrychowski, MP; Ruas, JL; Wrann, CD; Lo, JC; Camera, DM; Lachey, J; Gygi, S; Seehra, J; Hawley, JA; Spiegelman, BM				Rao, Rajesh R.; Long, Jonathan Z.; White, James P.; Svensson, Katrin J.; Lou, Jesse; Lokurkar, Isha; Jedrychowski, Mark P.; Ruas, Jorge L.; Wrann, Christiane D.; Lo, James C.; Camera, Donny M.; Lachey, Jenn; Gygi, Steven; Seehra, Jasbir; Hawley, John A.; Spiegelman, Bruce M.			Meteorin-like Is a Hormone that Regulates Immune-Adipose Interactions to Increase Beige Fat Thermogenesis	CELL			English	Article							SKELETAL-MUSCLE; WHITE FAT; EXERCISE; PGC-1-ALPHA; MACROPHAGES; COACTIVATOR; ACTIVATION; DYSFUNCTION; ADIPOCYTES; PREVENTION	Exercise training benefits many organ systems and offers protection against metabolic disorders such as obesity and diabetes. Using the recently identified isoform of PGC1-alpha (PGC1-alpha 4) as a discovery tool, we report the identification of meteorin-like (Metrnl), a circulating factor that is induced in muscle after exercise and in adipose tissue upon cold exposure. Increasing circulating levels of Metrnl stimulates energy expenditure and improves glucose tolerance and the expression of genes associated with beige fat thermogenesis and anti-inflammatory cytokines. Metrnl stimulates an eosinophil-dependent increase in IL-4 expression and promotes alternative activation of adipose tissue macrophages, which are required for the increased expression of the thermogenic and anti-inflammatory gene programs in fat. Importantly, blocking Metrnl actions in vivo significantly attenuates chronic cold-exposure-induced alternative macrophage activation and thermogenic gene responses. Thus, Metrnl links host-adaptive responses to the regulation of energy homeostasis and tissue inflammation and has therapeutic potential for metabolic and inflammatory diseases.	[Rao, Rajesh R.; Long, Jonathan Z.; White, James P.; Svensson, Katrin J.; Lou, Jesse; Lokurkar, Isha; Wrann, Christiane D.; Lo, James C.; Spiegelman, Bruce M.] Dana Farber Canc Inst, Dept Canc Biol, Boston, MA 02115 USA; [Rao, Rajesh R.; Long, Jonathan Z.; White, James P.; Svensson, Katrin J.; Lou, Jesse; Lokurkar, Isha; Jedrychowski, Mark P.; Wrann, Christiane D.; Lo, James C.; Gygi, Steven; Spiegelman, Bruce M.] Harvard Univ, Sch Med, Dept Cell Biol, Boston, MA 02115 USA; [Ruas, Jorge L.] Karolinska Inst, Dept Physiol & Pharmacol, S-17177 Stockholm, Sweden; [Camera, Donny M.; Hawley, John A.] Australian Catholic Univ, Dept Exercise Sci, Exercise & Nutr Res Grp, Fitzroy, Vic 3065, Australia; [Hawley, John A.] Liverpool John Moores Univ, Res Inst Sport & Exercise Sci, Liverpool L3 2AJ, Merseyside, England; [Lachey, Jenn; Seehra, Jasbir] Ember Therapeut Inc, Watertown, MA 02472 USA	Harvard University; Dana-Farber Cancer Institute; Harvard University; Harvard Medical School; Karolinska Institutet; Australian Catholic University; Liverpool John Moores University	Spiegelman, BM (corresponding author), Dana Farber Canc Inst, Dept Canc Biol, Boston, MA 02115 USA.	bruce_spiegelman@dfci.harvard.edu	Ruas, Jorge/AAE-6094-2019; Camera, Donny/J-1571-2018; Hawley, John A/U-3814-2018; Svensson, Katrin J./AAA-4770-2021; Lo, James/GYR-1149-2022	Ruas, Jorge/0000-0002-1110-2606; Camera, Donny/0000-0002-6494-9472; Hawley, John A/0000-0002-0886-9881; Svensson, Katrin J./0000-0001-5376-5128; Lo, James/0000-0003-0244-1670; Long, Jonathan/0000-0003-2631-7463	National Institutes of Health [DK061562]; JPB foundation; Irvington Institute Fellowship Program of the Cancer Research Institute; American Diabetics Association/Canadian Diabetics Association (ADA/CDA) joint postdoctoral fellowship; Swedish Research Council; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [K08DK097303, R01DK061562, P30DK043351] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R00NS087096, K99NS087096] Funding Source: NIH RePORTER; Novo Nordisk Fonden [NNF12OC1016062] Funding Source: researchfish	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); JPB foundation; Irvington Institute Fellowship Program of the Cancer Research Institute; American Diabetics Association/Canadian Diabetics Association (ADA/CDA) joint postdoctoral fellowship; Swedish Research Council(Swedish Research CouncilEuropean Commission); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Novo Nordisk Fonden(Novo Nordisk Foundation)	We thank members of the Spiegelman laboratory for useful discussions and suggestions on the manuscript. This work was funded by National Institutes of Health grant (DK061562) to B. M. S. and a grant from the JPB foundation. R. R. R. is supported by Irvington Institute Fellowship Program of the Cancer Research Institute. J.Z.L. is supported by the American Diabetics Association/Canadian Diabetics Association (ADA/CDA) joint postdoctoral fellowship. K.J.S. was supported by a Swedish Research Council postdoctoral fellowship. B. M. S. is a consultant and shareholder in Ember Therapeutics.	Akimoto T, 2005, J BIOL CHEM, V280, P19587, DOI 10.1074/jbc.M408862200; Arnold L, 2007, J EXP MED, V204, P1057, DOI 10.1084/jem.20070075; Baynard T, 2012, MEDIAT INFLAMM, V2012, DOI 10.1155/2012/767953; Bostrom P, 2012, NATURE, V481, P463, DOI 10.1038/nature10777; Cederberg A, 2001, CELL, V106, P563, DOI 10.1016/S0092-8674(01)00474-3; Chiang SH, 2009, CELL, V138, P961, DOI 10.1016/j.cell.2009.06.046; Chinsomboon J, 2009, P NATL ACAD SCI USA, V106, P21401, DOI 10.1073/pnas.0909131106; Cohen P, 2014, CELL, V156, P304, DOI 10.1016/j.cell.2013.12.021; COUSIN B, 1992, J CELL SCI, V103, P931; Fisher FM, 2012, GENE DEV, V26, P271, DOI 10.1101/gad.177857.111; Gleeson M, 2011, NAT REV IMMUNOL, V11, P607, DOI 10.1038/nri3041; Goh YPS, 2013, P NATL ACAD SCI USA, V110, P9914, DOI 10.1073/pnas.1304046110; Hawley JA, 2004, DIABETES-METAB RES, V20, P383, DOI 10.1002/dmrr.505; Hotamisligil GS, 2006, NATURE, V444, P860, DOI 10.1038/nature05485; HOTAMISLIGIL GS, 1993, SCIENCE, V259, P87, DOI 10.1126/science.7678183; Karamanlidis G, 2007, J BIOL CHEM, V282, P24660, DOI 10.1074/jbc.M703101200; Lin J, 2002, NATURE, V418, P797, DOI 10.1038/nature00904; Martinez FO, 2009, ANNU REV IMMUNOL, V27, P451, DOI 10.1146/annurev.immunol.021908.132532; Mathai AS, 2008, J APPL PHYSIOL, V105, P1098, DOI 10.1152/japplphysiol.00847.2007; Nguyen KD, 2011, NATURE, V480, P104, DOI 10.1038/nature10653; Odegaard JI, 2011, ANNU REV PATHOL-MECH, V6, P275, DOI 10.1146/annurev-pathol-011110-130138; PACY PJ, 1986, SPORTS MED, V3, P89, DOI 10.2165/00007256-198603020-00002; Puigserver P, 1998, CELL, V92, P829, DOI 10.1016/S0092-8674(00)81410-5; Ruas JL, 2012, CELL, V151, P1319, DOI 10.1016/j.cell.2012.10.050; Seale P, 2008, NATURE, V454, P961, DOI 10.1038/nature07182; Wrann CD, 2013, CELL METAB, V18, P649, DOI 10.1016/j.cmet.2013.09.008; Wu D, 2011, SCIENCE, V332, P243, DOI 10.1126/science.1201475; Wu J, 2012, CELL, V150, P366, DOI 10.1016/j.cell.2012.05.016; Xu XH, 2011, AM J PHYSIOL-REG I, V300, pR1115, DOI 10.1152/ajpregu.00806.2010; Xue BZ, 2005, MOL CELL BIOL, V25, P8311, DOI 10.1128/MCB.25.18.8311-8322.2005; Yu CN, 2002, J EXP MED, V195, P1387, DOI 10.1084/jem.20020656; Zhang Y, 2014, DIABETES, V63, P514, DOI 10.2337/db13-1106	32	549	575	12	92	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUN 5	2014	157	6					1279	1291		10.1016/j.cell.2014.03.065	http://dx.doi.org/10.1016/j.cell.2014.03.065			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	AN8UV	24906147	Green Accepted, Bronze			2022-12-28	WOS:000340881400007
J	Rice, CM; Saeed, M				Rice, Charles M.; Saeed, Mohsan			Treatment triumphs	NATURE			English	Editorial Material							GENOTYPE 1 INFECTION; CHRONIC HEPATITIS-C; HCV; SOFOSBUVIR; LEDIPASVIR; ABT-450/R-OMBITASVIR; RIBAVIRIN; DASABUVIR; VIRUS		[Rice, Charles M.; Saeed, Mohsan] Rockefeller Univ, Ctr Study Hepatitis C, Lab Virol & Infect Dis, New York, NY 10065 USA	Rockefeller University	Rice, CM (corresponding author), Rockefeller Univ, Ctr Study Hepatitis C, Lab Virol & Infect Dis, New York, NY 10065 USA.	ricec@rockefeller.edu	Saeed, Mohsan/AAM-8375-2021					Afdhal N, 2014, NEW ENGL J MED, V370, P1889, DOI 10.1056/NEJMoa1402454; Afdhal N, 2014, NEW ENGL J MED, V370, P1483, DOI 10.1056/NEJMoa1316366; ALTER HJ, 1975, LANCET, V2, P838, DOI 10.1016/S0140-6736(75)90234-2; CHOO QL, 1989, SCIENCE, V244, P359, DOI 10.1126/science.2523562; Denniston MM, 2012, HEPATOLOGY, V55, P1652, DOI 10.1002/hep.25556; Dore GJ, 2014, J VIRAL HEPATITIS, V21, P1, DOI 10.1111/jvh.12253; Feld JJ, 2014, NEW ENGL J MED, V370, P1594, DOI 10.1056/NEJMoa1315722; Hanafiah KM, 2013, HEPATOLOGY, V57, P1333, DOI 10.1002/hep.26141; Heim MH, 2013, NAT REV IMMUNOL, V13, P535, DOI 10.1038/nri3463; Kowdley KV, 2014, NEW ENGL J MED, V370, P1879, DOI 10.1056/NEJMoa1402355; Kowdley KV, 2014, NEW ENGL J MED, V370, P222, DOI 10.1056/NEJMoa1306227; Lawitz E, 2013, NEW ENGL J MED, V368, P1878, DOI 10.1056/NEJMoa1214853; PRINCE AM, 1974, LANCET, V2, P241; Sulkowski MS, 2014, NEW ENGL J MED, V370, P1560, DOI 10.1056/NEJMc1401726; Zeuzem S, 2014, NEW ENGL J MED, V370, P1604, DOI 10.1056/NEJMoa1401561	15	28	30	0	12	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 5	2014	510	7503					43	44		10.1038/510043a	http://dx.doi.org/10.1038/510043a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AI3NR	24899301				2022-12-28	WOS:000336768900028
J	Normile, D; Clery, D				Normile, Dennis; Clery, Daniel			Lost at sea	SCIENCE			English	Editorial Material																			0	8	8	0	6	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 30	2014	344	6187					963	965		10.1126/science.344.6187.963	http://dx.doi.org/10.1126/science.344.6187.963			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AH9WM	24876475				2022-12-28	WOS:000336495800016
J	Quackenbush, J				Quackenbush, John			PERSPECTIVE Learning to share	NATURE			English	Editorial Material									Dana Farber Canc Inst, Ctr Canc Computat Biol, Boston, MA 02115 USA	Harvard University; Dana-Farber Cancer Institute	Quackenbush, J (corresponding author), Dana Farber Canc Inst, Ctr Canc Computat Biol, Boston, MA 02115 USA.	johnq@jimmy.harvard.edu		Quackenbush, John/0000-0002-2702-5879	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL111759] Funding Source: NIH RePORTER; NHLBI NIH HHS [R01 HL111759] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))			0	1	2	0	4	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 29	2014	509	7502					S68	S68		10.1038/509S68a	http://dx.doi.org/10.1038/509S68a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AH9JC	24870827	Green Accepted			2022-12-28	WOS:000336457100010
J	Glendenning, P; Bell, DA; Clifton-Bligh, RJ				Glendenning, Paul; Bell, Damon A.; Clifton-Bligh, Roderick J.			RATIONAL TESTING Investigating hypophosphataemia	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							PRIMARY HYPERPARATHYROIDISM; 25-HYDROXYVITAMIN D; VITAMIN-D; PHOSPHATE; MANAGEMENT; CALCIUM	This series of occasional articles provides an update on the best use of key diagnostic tests in the initial investigation of common or important clinical presentations. The series advisers are Steve Atkin, professor, head of department of academic endocrinology, diabetes, and metabolism, Hull York Medical School; and Eric Kilpatrick, honorary professor, department of clinical biochemistry, Hull Royal Infirmary, Hull York Medical School. To suggest a topic for this series, please email us at practice@bmj.com.	[Glendenning, Paul; Bell, Damon A.] Univ Western Australia, Royal Perth Hosp, Sch Med & Pharmacol, Perth, WA 6009, Australia; [Glendenning, Paul; Bell, Damon A.] Royal Perth Hosp, Dept Clin Biochem, PathWest Lab Med, Perth, WA 6000, Australia; [Clifton-Bligh, Roderick J.] Kolling Inst Royal North Shore Hosp, St Leonards, NSW, Australia	Royal Perth Hospital; University of Western Australia; Royal Perth Hospital; Royal North Shore Hospital; University of Sydney; Kolling Institute of Medical Research	Glendenning, P (corresponding author), Royal Perth Hosp, Dept Clin Biochem, PathWest Lab Med, Perth, WA 6000, Australia.	Paul.Glendenning@health.wa.gov.au		Clifton-Bligh, Roderick/0000-0002-1545-0368; Bell, Damon/0000-0002-6592-6184				Bhattacharyya N, 2012, TRENDS ENDOCRIN MET, V23, P610, DOI 10.1016/j.tem.2012.07.002; Brunelli SM, 2007, J AM SOC NEPHROL, V18, P1999, DOI 10.1681/ASN.2007020143; Chong WH, 2011, ENDOCR-RELAT CANCER, V18, pR53, DOI 10.1530/ERC-11-0006; Felsenfeld AJ, 2012, AM J KIDNEY DIS, V60, P655, DOI 10.1053/j.ajkd.2012.03.024; Girgis CM, 2013, ENDOCR REV, V34, P33, DOI 10.1210/er.2012-1012; Glendenning P, 2013, ANN CLIN BIOCHEM, V50, P191, DOI 10.1177/0004563213482892; Gok DE, 2011, J ENDOCRINOL INVEST, V34, P3, DOI [10.1007/BF03346687, 10.3275/6902]; Jayasena CN, 2013, CLIN ENDOCRINOL, V78, P838, DOI 10.1111/cen.12062; Kim YJ, 2012, TRANSPL P, V44, P651, DOI 10.1016/j.transproceed.2011.12.050; Liamis G, 2010, QJM-INT J MED, V103, P449, DOI 10.1093/qjmed/hcq039; Moosgaard B, 2007, CLIN ENDOCRINOL, V66, P35, DOI 10.1111/j.1365-2265.2006.02680.x; Payne RB, 1998, ANN CLIN BIOCHEM, V35, P201, DOI 10.1177/000456329803500203; Priemel M, 2010, J BONE MINER RES, V25, P305, DOI 10.1359/jbmr.090728; RAANANI P, 1992, POSTGRAD MED J, V68, P283, DOI 10.1136/pgmj.68.798.283; Skipper A, 2012, NUTR CLIN PRACT, V27, P34, DOI 10.1177/0884533611427916; Witteveen JE, 2013, EUR J ENDOCRINOL, V168, pR45, DOI 10.1530/EJE-12-0528	16	11	11	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	MAY 28	2014	348								g3172	10.1136/bmj.g3172	http://dx.doi.org/10.1136/bmj.g3172			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AI3EH	24871308				2022-12-28	WOS:000336742000001
J	Vanholder, R; Van Biesen, W; Lameire, N				Vanholder, Raymond; Van Biesen, Wim; Lameire, Norbert			Renal replacement therapy: how can we contain the costs?	LANCET			English	Editorial Material							DIALYSIS; DISEASE		[Vanholder, Raymond; Van Biesen, Wim] Ghent Univ Hosp, Sect Internal Med, Div Renal, B-9000 Ghent, Belgium; [Lameire, Norbert] Ghent Univ Hosp, B-9000 Ghent, Belgium	Ghent University; Ghent University Hospital; Ghent University; Ghent University Hospital	Vanholder, R (corresponding author), Ghent Univ Hosp, Sect Internal Med, Div Renal, B-9000 Ghent, Belgium.	raymond.vanholder@ugent.be						Couchoud C, 2009, NEPHROL DIAL TRANSPL, V24, P1553, DOI 10.1093/ndt/gfn698; Desai AA, 2009, CLIN J AM SOC NEPHRO, V4, P772, DOI 10.2215/CJN.05661108; Icks A, 2010, NEPHROL DIAL TRANSPL, V25, P1647, DOI 10.1093/ndt/gfp672; Jassal SV, 2002, NEPHROL DIAL TRANSPL, V17, P474, DOI 10.1093/ndt/17.3.474; Kleophas Werner, 2007, Int J Health Care Finance Econ, V7, P185, DOI 10.1007/s10754-007-9020-0; Lameire N, 2010, NEW ENGL J MED, V363, P678, DOI 10.1056/NEJMe1006669; Laupacis A, 1996, KIDNEY INT, V50, P235, DOI 10.1038/ki.1996.307; Murtagh FEM, 2007, NEPHROL DIAL TRANSPL, V22, P1955, DOI 10.1093/ndt/gfm153; Ponce P, 2012, BLOOD PURIF; Robinson BM, 2014, KIDNEY INT, V85, P158, DOI 10.1038/ki.2013.252; Rubin HR, 2004, JAMA-J AM MED ASSOC, V291, P697, DOI 10.1001/jama.291.6.697; Swanepoel CR, 2013, NAT REV NEPHROL, V9, P610, DOI 10.1038/nrneph.2013.168; Vanholder R, 2012, J AM SOC NEPHROL, V23, P1291, DOI 10.1681/ASN.2011111094	13	14	14	0	8	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	MAY 24	2014	383	9931					1783	1785		10.1016/S0140-6736(14)60721-2	http://dx.doi.org/10.1016/S0140-6736(14)60721-2			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	AH6US	24856012				2022-12-28	WOS:000336267800004
J	DasGupta, S; Ferreira, CH; Miesenbock, G				DasGupta, Shamik; Ferreira, Clara Howcroft; Miesenboeck, Gero			FoxP influences the speed and accuracy of a perceptual decision in Drosophila	SCIENCE			English	Article							NEURAL BASIS; DISCRIMINATION; NEURONS; GENE; PLASTICITY; MODELS; TIME	Decisions take time if information gradually accumulates to a response threshold, but the neural mechanisms of integration and thresholding are unknown. We characterized a decision process in Drosophila that bears the behavioral signature of evidence accumulation. As stimulus contrast in trained odor discriminations decreased, reaction times increased and perceptual accuracy declined, in quantitative agreement with a drift-diffusion model. FoxP mutants took longer than wild-type flies to form decisions of similar or reduced accuracy, especially in difficult, low-contrast tasks. RNA interference with FoxP expression in ab core Kenyon cells, or the overexpression of a potassium conductance in these neurons, recapitulated the FoxP mutant phenotype. A mushroom body subdomain whose development or function require the transcription factor FoxP thus supports the progression of a decision toward commitment.	[DasGupta, Shamik; Ferreira, Clara Howcroft; Miesenboeck, Gero] Univ Oxford, Ctr Neural Circuits & Behav, Oxford OX1 3SR, England	University of Oxford	Miesenbock, G (corresponding author), Univ Oxford, Ctr Neural Circuits & Behav, Tinsley Bldg,Mansfield Rd, Oxford OX1 3SR, England.	gero.miesenboeck@cncb.ox.ac.uk		DasGupta, Shamik/0000-0001-5803-8982; Ferreira, Clara/0000-0002-3955-1059; DasGupta, Shamik/0000-0001-5566-7548; Miesenboeck, Gero/0000-0003-2940-3228	Wellcome Trust; Gatsby Charitable Foundation; NIH; Oxford Martin School; Human Frontier Science Program; Fundacao Champalimaud; Fundacao para a Ciencia e Tecnologia; Marie Curie Actions Fellowships; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA030601] Funding Source: NIH RePORTER; Medical Research Council [G0701225, G0700888] Funding Source: researchfish; Wellcome Trust [090309/Z/09/Z] Funding Source: researchfish; MRC [G0701225, G0700888] Funding Source: UKRI	Wellcome Trust(Wellcome TrustEuropean Commission); Gatsby Charitable Foundation; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Oxford Martin School; Human Frontier Science Program(Human Frontier Science Program); Fundacao Champalimaud; Fundacao para a Ciencia e Tecnologia(Portuguese Foundation for Science and TechnologyEuropean Commission); Marie Curie Actions Fellowships; NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); Wellcome Trust(Wellcome TrustEuropean Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	We thank M. Shadlen for discussions and code; J. Flint, A. Lin, and S. Waddell for comments; and M. Ramaswami for flies. This work was supported by the Wellcome Trust, the Gatsby Charitable Foundation, NIH, and the Oxford Martin School (G.M.); Human Frontier Science Program and Marie Curie Actions Fellowships (S.D.G.); and Fundacao Champalimaud and Fundacao para a Ciencia e Tecnologia (C.H.F.).	Abraham NM, 2004, NEURON, V44, P865, DOI 10.1016/j.neuron.2004.11.017; Bogacz R, 2006, PSYCHOL REV, V113, P700, DOI 10.1037/0033-295X.113.4.700; Claridge-Chang A, 2009, CELL, V139, P405, DOI 10.1016/j.cell.2009.08.034; Connolly JB, 1996, SCIENCE, V274, P2104, DOI 10.1126/science.274.5295.2104; Santos ME, 2011, MOL BIOL EVOL, V28, P237, DOI 10.1093/molbev/msq182; French CA, 2012, MOL PSYCHIATR, V17, P1077, DOI 10.1038/mp.2011.105; Gold JI, 2007, ANNU REV NEUROSCI, V30, P535, DOI 10.1146/annurev.neuro.29.051605.113038; Groszer M, 2008, CURR BIOL, V18, P354, DOI 10.1016/j.cub.2008.01.060; Haesler S, 2007, PLOS BIOL, V5, P2885, DOI 10.1371/journal.pbio.0050321; Hamdan FF, 2010, AM J HUM GENET, V87, P671, DOI 10.1016/j.ajhg.2010.09.017; Ito K, 1997, DEVELOPMENT, V124, P761; Konopka G, 2012, NEURON, V75, P601, DOI 10.1016/j.neuron.2012.05.034; Konopka G, 2009, NATURE, V462, P213, DOI 10.1038/nature08549; Lai CSL, 2001, NATURE, V413, P519, DOI 10.1038/35097076; Luce R. D., 1986, RESPONSE TIMES; Mauk MD, 2004, ANNU REV NEUROSCI, V27, P307, DOI 10.1146/annurev.neuro.27.070203.144247; McGuire SE, 2003, SCIENCE, V302, P1765, DOI 10.1126/science.1089035; Palmer J, 2005, J VISION, V5, P376, DOI 10.1167/5.5.1; Perisse E, 2013, NEURON, V79, P945, DOI 10.1016/j.neuron.2013.07.045; Qin HT, 2012, CURR BIOL, V22, P608, DOI 10.1016/j.cub.2012.02.014; Ratcliff R, 2004, PSYCHOL REV, V111, P333, DOI 10.1037/0033-295X.111.2.333; Rinberg D, 2006, NEURON, V51, P351, DOI 10.1016/j.neuron.2006.07.013; ROBINSON DA, 1989, ANNU REV NEUROSCI, V12, P33, DOI 10.1146/annurev.neuro.12.1.33; Roitman JD, 2002, J NEUROSCI, V22, P9475; Shadlen MN, 1996, P NATL ACAD SCI USA, V93, P628, DOI 10.1073/pnas.93.2.628; Sia GM, 2013, SCIENCE, V342, P987, DOI 10.1126/science.1245079; Tanaka NK, 2008, J COMP NEUROL, V508, P711, DOI 10.1002/cne.21692; Uchida N, 2003, NAT NEUROSCI, V6, P1224, DOI 10.1038/nn1142; Wang XJ, 2002, NEURON, V36, P955, DOI 10.1016/S0896-6273(02)01092-9; WATSON AB, 1979, VISION RES, V19, P515, DOI 10.1016/0042-6989(79)90136-6	30	63	64	1	41	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 23	2014	344	6186					901	904		10.1126/science.1252114	http://dx.doi.org/10.1126/science.1252114			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AH6IL	24855268	Green Accepted			2022-12-28	WOS:000336233800048
J	McPherson, K				McPherson, Klim			Reducing the global prevalence of overweight and obesity	LANCET			English	Editorial Material							PREVENTION; FOOD		Univ Oxford New Coll, Oxford OX1 3BN, England	University of Oxford	McPherson, K (corresponding author), Univ Oxford New Coll, Oxford OX1 3BN, England.	klim.mcpherson@obs-gyn.ox.ac.uk						Butland BJ, 2007, FORESIGHT TACKLING O; Feng JH, 2014, BMJ OPEN, V4; Gortmaker SL, 2011, LANCET, V378, P838, DOI 10.1016/S0140-6736(11)60815-5; International Association for the Study of obesity, 2014, PREV OB NCDS CHALL O; Lobstein T, 2011, P NUTR SOC, V70, P506, DOI 10.1017/S0029665111003156; Moodie R, 2013, LANCET, V381, P670, DOI 10.1016/S0140-6736(12)62089-3; Ng M., 2014, LANCET; Popkin B, 2013, OBES REV, V14, P1, DOI 10.1111/obr.12108; Swinburn B, 2013, OBES REV, V14, P24, DOI 10.1111/obr.12073; Swinburn BA, 2011, LANCET, V378, P804, DOI 10.1016/S0140-6736(11)60813-1; Wang YC, 2011, LANCET, V378, P815, DOI 10.1016/S0140-6736(11)60814-3	11	32	34	2	15	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	AUG 30	2014	384	9945					728	730		10.1016/S0140-6736(14)60767-4	http://dx.doi.org/10.1016/S0140-6736(14)60767-4			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	AO5DD	24880831				2022-12-28	WOS:000341361500012
J	Pahor, M; Guralnik, JM; Ambrosius, WT; Blair, S; Bonds, DE; Church, TS; Espeland, MA; Fielding, RA; Gill, TM; Groessl, EJ; King, AC; Kritchevsky, SB; Manini, TM; McDermott, MM; Miller, ME; Newman, AB; Rejeski, WJ; Sink, KM; Williamson, JD				Pahor, Marco; Guralnik, Jack M.; Ambrosius, Walter T.; Blair, Steven; Bonds, Denise E.; Church, Timothy S.; Espeland, Mark A.; Fielding, Roger A.; Gill, Thomas M.; Groessl, Erik J.; King, Abby C.; Kritchevsky, Stephen B.; Manini, Todd M.; McDermott, Mary M.; Miller, Michael E.; Newman, Anne B.; Rejeski, W. Jack; Sink, Kaycee M.; Williamson, Jeff D.		LIFE Study Investigators	Effect of Structured Physical Activity on Prevention of Major Mobility Disability in Older Adults The LIFE Study Randomized Clinical Trial	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							LOWER-EXTREMITY FUNCTION; STYLE INTERVENTIONS; KNEE OSTEOARTHRITIS; GAIT SPEED; INDEPENDENCE; PERFORMANCE; ELDERS; PREDICTORS; MORTALITY; LIMITATION	IMPORTANCE In older adults reduced mobility is common and is an independent risk factor for morbidity, hospitalization, disability, and mortality. Limited evidence suggests that physical activity may help prevent mobility disability; however, there are no definitive clinical trials examining whether physical activity prevents or delays mobility disability. OBJECTIVE To test the hypothesis that a long-term structured physical activity program is more effective than a health education program (also referred to as a successful aging program) in reducing the risk of major mobility disability. DESIGN, SETTING, AND PARTICIPANTS The Lifestyle Interventions and Independence for Elders (LIFE) study was a multicenter, randomized trial that enrolled participants between February 2010 and December 2011, who participated for an average of 2.6 years. Follow-up ended in December 2013. Outcome assessors were blinded to the intervention assignment. Participants were recruited from urban, suburban, and rural communities at 8 centers throughout the United States. We randomized a volunteer sample of 1635 sedentary men and women aged 70 to 89 years who had physical limitations, defined as a score on the Short Physical Performance Battery of 9 or below, but were able to walk 400 m. INTERVENTIONS Participants were randomized to a structured, moderate-intensity physical activity program (n = 818) conducted in a center (twice/wk) and at home (3-4 times/wk) that included aerobic, resistance, and flexibility training activities or to a health education program (n = 817) consisting of workshops on topics relevant to older adults and upper extremity stretching exercises. MAIN OUTCOMES AND MEASURES The primary outcome was major mobility disability objectively defined by loss of ability to walk 400 m. RESULTS Incident major mobility disability occurred in 30.1%(246 participants) of the physical activity group and 35.5%(290 participants) of the health education group (hazard ratio [HR], 0.82 [95% CI, 0.69-0.98], P = .03). Persistent mobility disability was experienced by 120 participants (14.7%) in the physical activity group and 162 participants (19.8%) in the health education group (HR, 0.72 [95% CI, 0.57-0.91]; P = .006). Serious adverse events were reported by 404 participants (49.4%) in the physical activity group and 373 participants (45.7%) in the health education group (risk ratio, 1.08 [95% CI, 0.98-1.20]). CONCLUSIONS AND RELEVANCE A structured, moderate-intensity physical activity program compared with a health education program reduced major mobility disability over 2.6 years among older adults at risk for disability. These findings suggest mobility benefit from such a program in vulnerable older adults.	[Pahor, Marco; Guralnik, Jack M.; Manini, Todd M.] Univ Florida, Dept Aging & Geriatr Res, Gainesville, FL 32610 USA; [Guralnik, Jack M.] Univ Maryland, Sch Med, Dept Epidemiol & Publ Hlth, Baltimore, MD 21201 USA; [Ambrosius, Walter T.; Espeland, Mark A.; Kritchevsky, Stephen B.; Miller, Michael E.; Rejeski, W. Jack; Sink, Kaycee M.; Williamson, Jeff D.] Wake Forest Univ, Dept Internal Med, Winston Salem, NC 27109 USA; [Ambrosius, Walter T.; Espeland, Mark A.; Kritchevsky, Stephen B.; Miller, Michael E.; Rejeski, W. Jack; Sink, Kaycee M.; Williamson, Jeff D.] Wake Forest Univ, Bowman Gray Sch Med, Winston Salem, NC USA; [Blair, Steven] Univ S Carolina, Dept Exercise Sci, Arnold Sch Publ Hlth, Columbia, SC 29208 USA; [Bonds, Denise E.] NHLBI, Div Cardiac Sci, Bethesda, MD 20892 USA; [Church, Timothy S.] Pennington Biomed Res Ctr, Dept Preventat Med, Baton Rouge, LA USA; [Fielding, Roger A.] Tufts Univ, Jean Mayer US Dept, Agr Human Nutr Res Ctr Aging, Boston, MA 02111 USA; [Gill, Thomas M.] Yale Univ, Sch Med, Dept Internal Med, New Haven, CT 06510 USA; [Groessl, Erik J.] Vet Affairs San Diego Healthcare Syst, San Diego, CA USA; [Groessl, Erik J.] Univ Calif San Diego, Dept Family & Prevent Med, San Diego, CA 92103 USA; [King, Abby C.] Stanford Univ, Sch Med, Dept Hlth Res & Policy, Stanford, CA 94305 USA; [King, Abby C.] Stanford Univ, Dept Med, Sch Med, Stanford, CA 94305 USA; [McDermott, Mary M.] Northwestern Univ, Dept Med & Prevent Med, Feinberg Sch Med, Chicago, IL 60611 USA; [Newman, Anne B.] Univ Pittsburgh, Grad Sch Publ Hlth, Dept Epidemiol, Pittsburgh, PA USA	State University System of Florida; University of Florida; University System of Maryland; University of Maryland Baltimore; Wake Forest University; Wake Forest University; Wake Forest Baptist Medical Center; University of South Carolina; University of South Carolina System; University of South Carolina Columbia; National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); Louisiana State University System; Louisiana State University; Pennington Biomedical Research Center; Tufts University; Yale University; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA San Diego Healthcare System; University of California System; University of California San Diego; Stanford University; Stanford University; Northwestern University; Feinberg School of Medicine; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Pahor, M (corresponding author), Univ Florida, Dept Aging & Geriatr Res, POB 100107, Gainesville, FL 32610 USA.	mpahor@ufl.edu	Beavers, Daniel P/G-5338-2016; Gill, Thomas M./H-7043-2019; Newman, Anne B./C-6408-2013; King, Abby/AAD-5257-2021; Buford, Thomas W/B-1111-2011; Sink, Kaycee/AAY-5920-2020	Gill, Thomas M./0000-0002-6450-0368; Newman, Anne B./0000-0002-0106-1150; Buford, Thomas W/0000-0002-9541-4358; Marsiske, Michael/0000-0001-5973-2116; Handberg, Eileen/0000-0002-7805-9577; Kaplan, Robert/0000-0003-4837-5330; King, Abby/0000-0002-7949-8811	National Institutes of Health (NIH) [UO1AG22376]; National Institute on Aging; National Heart, Lung, and Blood Institute [3U01AG022376-05A2S]; Intramural Research Program; Claude D. Pepper Older Americans Independence Centers at the University of Florida [1 P30 AG028740]; Wake Forest University [1 P30 AG21332]; Tufts University [1P30AG031679]; University of Pittsburgh [P30 AG024827]; Yale University [P30AG021342]; NIH/NCRR CTSA at Stanford University [UL1 RR025744]; NIH/NCRR CTSA at University of Florida [U54RR025208]; NIH/NCRR CTSA at Yale University [UL1 TR000142]; Boston Rehabilitation Outcomes Center [1R24HD065688-01A1]; National Institute on Aging [K07AG3587]; Department of Veterans Affairs; US Department of Agriculture [58-1950-0-014]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R24HD065688] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000064, UL1TR000142] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR029890, UL1RR025744] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL121023] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [U01AG022376, P30AG021342, P30AG028740, P30AG021332, P30AG031679, P30AG024827] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Intramural Research Program; Claude D. Pepper Older Americans Independence Centers at the University of Florida; Wake Forest University; Tufts University; University of Pittsburgh(University of Pittsburgh); Yale University; NIH/NCRR CTSA at Stanford University; NIH/NCRR CTSA at University of Florida; NIH/NCRR CTSA at Yale University; Boston Rehabilitation Outcomes Center; National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Department of Veterans Affairs(US Department of Veterans Affairs); US Department of Agriculture(United States Department of Agriculture (USDA)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	The Lifestyle Interventions and Independence for Elders Study is funded by cooperative agreement UO1AG22376 from the National Institutes of Health (NIH) and National Institute on Aging; supplement 3U01AG022376-05A2S from the National Heart, Lung, and Blood Institute; and was sponsored in part by the Intramural Research Program. The research is partially supported by the Claude D. Pepper Older Americans Independence Centers at the University of Florida (1 P30 AG028740), Wake Forest University (1 P30 AG21332), Tufts University (1P30AG031679), University of Pittsburgh (P30 AG024827), and Yale University (P30AG021342) and the NIH/NCRR CTSA at Stanford University (UL1 RR025744), at University of Florida (U54RR025208) and at Yale University (UL1 TR000142). Tufts University is also supported by the Boston Rehabilitation Outcomes Center (1R24HD065688-01A1). LIFE investigators are also partially supported by the following: Dr Thomas Gill (Yale University) is the recipient of an Academic Leadership Award (K07AG3587) from the National Institute on Aging. Dr Carlos Fragoso (Spirometry Reading Center, Yale University) is the recipient of a Career Development Award from the Department of Veterans Affairs. Dr Roger Fielding (Tufts University) is partially supported by the US Department of Agriculture, under agreement 58-1950-0-014.	Andresen EM, 1998, MED CARE, V36, P1349, DOI 10.1097/00005650-199809000-00007; Berry Michael J, 2003, J Cardiopulm Rehabil, V23, P60, DOI 10.1097/00008483-200301000-00011; Borg G., 1988, PERCEIVED EXERTION P; BRANCH LG, 1982, AM J PUBLIC HEALTH, V72, P1373, DOI 10.2105/AJPH.72.12.1373; BRANCH LG, 1991, J GERONTOL, V46, pM145, DOI 10.1093/geronj/46.4.M145; CORTI MC, 1994, JAMA-J AM MED ASSOC, V272, P1036, DOI 10.1001/jama.272.13.1036; Ettinger WH, 1997, JAMA-J AM MED ASSOC, V277, P25, DOI 10.1001/jama.277.1.25; Fielding RA, 2011, J GERONTOL A-BIOL, V66, P1226, DOI 10.1093/gerona/glr123; Guralnik JM, 2000, J GERONTOL A-BIOL, V55, pM221, DOI 10.1093/gerona/55.4.M221; GURALNIK JM, 1995, NEW ENGL J MED, V332, P556, DOI 10.1056/NEJM199503023320902; GURALNIK JM, 1993, AM J EPIDEMIOL, V137, P845, DOI 10.1093/oxfordjournals.aje.a116746; Hirvensalo M, 2000, J AM GERIATR SOC, V48, P493, DOI 10.1111/j.1532-5415.2000.tb04994.x; KATZ S, 1983, NEW ENGL J MED, V309, P1218, DOI 10.1056/NEJM198311173092005; Khokhar SR, 2001, J AM GERIATR SOC, V49, P1539, DOI 10.1046/j.1532-5415.2001.4911251.x; Lampinen P, 2003, AGING CLIN EXP RES, V15, P205; LONERGAN ET, 1991, NEW ENGL J MED, V324, P1825, DOI 10.1056/NEJM199106203242527; Marsh AP, 2013, J GERONTOL A-BIOL, V68, P1549, DOI 10.1093/gerona/glt064; Matthews CE, 2005, MED SCI SPORT EXER, V37, pS512, DOI 10.1249/01.mss.0000185659.11982.3d; Messier SP, 2004, ARTHRITIS RHEUM-US, V50, P1501, DOI 10.1002/art.20256; Newman AB, 2006, JAMA-J AM MED ASSOC, V295, P2018, DOI 10.1001/jama.295.17.2018; Pahor M, 2006, J GERONTOL A-BIOL, V61, P1157; Physical Activity Guidelines Advisory Committee, 2008, PHYS ACT GUID ADV CO; Rejeski WJ, 2013, CLIN INTERV AGING, V8, P657, DOI 10.2147/CIA.S44797; Rolland YM, 2004, J AM GERIATR SOC, V52, P972, DOI 10.1111/j.1532-5415.2004.52267.x; Shumway-Cook A, 2003, J AM GERIATR SOC, V51, P393, DOI 10.1046/j.1532-5415.2003.51114.x; Shumway-Cook A, 2002, PHYS THER, V82, P670, DOI 10.1093/ptj/82.7.670; Stewart AL, 2001, J GERONTOL A-BIOL, V56, pM465, DOI 10.1093/gerona/56.8.M465; Studenski S, 2011, JAMA-J AM MED ASSOC, V305, P50, DOI 10.1001/jama.2010.1923; Szanton SL, 2009, BIOL RES NURS, V10, P248, DOI 10.1177/1099800408323452; TENG EL, 1987, J CLIN PSYCHIAT, V48, P314; Therneau TM, 2000, MODELING SURVIVAL DA; van der Wal WM, 2011, J STAT SOFTW, V43, P1; Werner CA, OLDER POPULATION	33	845	855	16	208	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUN 18	2014	311	23					2387	2396		10.1001/jama.2014.5616	http://dx.doi.org/10.1001/jama.2014.5616			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	AI9XV	24866862	Green Accepted			2022-12-28	WOS:000337301500019
J	Kibble, T				Kibble, Tom			Gerald Guralnik (1936-2014) OBITUARY	NATURE			English	Biographical-Item									Univ London Imperial Coll Sci Technol & Med, London SW7 2AZ, England	Imperial College London	Kibble, T (corresponding author), Univ London Imperial Coll Sci Technol & Med, London SW7 2AZ, England.	kibble@ic.ac.uk						GURALNIK GS, PUBLICATION LIST	1	0	0	0	4	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 5	2014	510	7503					36	36		10.1038/510036a	http://dx.doi.org/10.1038/510036a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI3NR	24899298	Bronze			2022-12-28	WOS:000336768900023
J	Kush, R; Goldman, M				Kush, Rebecca; Goldman, Michel			Fostering Responsible Data Sharing through Standards	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Kush, Rebecca] Clin Data Interchange Stand Consortium, Austin, TX 78701 USA; [Goldman, Michel] Innovat Med Initiat, Brussels, Belgium		Kush, R (corresponding author), Clin Data Interchange Stand Consortium, Austin, TX 78701 USA.								0	21	21	0	10	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUN 5	2014	370	23					2163	2165		10.1056/NEJMp1401444	http://dx.doi.org/10.1056/NEJMp1401444			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	AI3AF	24897080				2022-12-28	WOS:000336729900003
J	Laganowsky, A; Reading, E; Allison, TM; Ulmschneider, MB; Degiacomi, MT; Baldwin, AJ; Robinson, CV				Laganowsky, Arthur; Reading, Eamonn; Allison, Timothy M.; Ulmschneider, Martin B.; Degiacomi, Matteo T.; Baldwin, Andrew J.; Robinson, Carol V.			Membrane proteins bind lipids selectively to modulate their structure and function	NATURE			English	Article							MOBILITY-MASS SPECTROMETRY; ATOM FORCE-FIELD; MYCOBACTERIUM-TUBERCULOSIS; MOLECULAR-DYNAMICS; ION-CHANNEL; COMPLEXES; MODEL; MSCL; PURIFICATION; WATER	Previous studies have established that the folding, structure and function of membrane proteins are influenced by their lipid environments(1-7) and that lipids can bind to specific sites, for example, in potassium channels(8). Fundamental questions remain however regarding the extent of membrane protein selectivity towards lipids. Here we report a mass spectrometry approach designed to determine the selectivity of lipid binding to membrane protein complexes. We investigate the mechanosensitive channel of large conductance (MscL) from Myco-bacterium tuberculosis and aquaporin Z (AqpZ) and the ammonia channel (AmtB) from Escherichia coli, using ion mobility mass spectrometry (IM-MS), which reports gas-phase collision cross-sections. We demonstrate that folded conformations of membrane protein complexes can exist in the gas phase. By resolving lipid-bound states, we then rank bound lipids on the basis of their ability to resist gas phase unfolding and thereby stabilize membrane protein structure. Lipids bind non-selectively and with high avidity to MscL, all imparting comparable stability; however, the highest-ranking lipid is phosphatidylinositol phosphate, in line with its proposed functional role in mechanosensation(9). AqpZ is also stabilized by many lipids, with cardiolipin imparting the most significant resistance to unfolding. Subsequently, through functional assays we show that cardiolipin modulates AqpZ function. Similar experiments identify AmtB as being highly selective for phosphatidylglycerol, prompting us to obtain an X-ray structure in this lipid membrane-like environment. The 2.3 angstrom resolution structure, when compared with others obtained without lipid bound, reveals distinct conformational changes that re-position AmtB residues to interact with the lipid bilayer. Our results demonstrate that resistance to unfolding correlates with specific lipid-binding events, enabling a distinction to be made between lipids that merely bind from those that modulate membrane protein structure and/or function. We anticipate that these findings will be important not only for defining the selectivity of membrane proteins towards lipids, but also for understanding the role of lipids in modulating protein function or drug binding.	[Laganowsky, Arthur; Reading, Eamonn; Allison, Timothy M.; Degiacomi, Matteo T.; Baldwin, Andrew J.; Robinson, Carol V.] Univ Oxford, Dept Chem, Oxford OX1 5QY, England; [Ulmschneider, Martin B.] Johns Hopkins Univ, Dept Mat Sci & Engn, Baltimore, MD 21218 USA	University of Oxford; Johns Hopkins University	Laganowsky, A (corresponding author), Univ Oxford, Dept Chem, S Parks Rd, Oxford OX1 5QY, England.	art.laganowsky@chem.ox.ac.uk; carol.robinson@chem.ox.ac.uk	Degiacomi, Matteo/M-4342-2017; Baldwin, Andrew/A-5830-2015; Ulmschneider, Martin/J-4374-2012	Degiacomi, Matteo/0000-0003-4672-471X; Baldwin, Andrew/0000-0001-7579-8844; robinson, carol/0000-0001-7829-5505; Laganowsky, Arthur/0000-0001-5012-5547; Reading, Eamonn/0000-0001-8219-0052; Ulmschneider, Martin/0000-0001-8103-0516	Medical Research Council (MRC); BBSRC; ERC; BBSRC [BB/J014346/1] Funding Source: UKRI; MRC [MC_PC_12020, G1000819] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/J014346/1] Funding Source: researchfish; Medical Research Council [MC_PC_12020, G1000819] Funding Source: researchfish	Medical Research Council (MRC)(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); ERC(European Research Council (ERC)European Commission); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	We thank J. Hobman and D. Lee for providing gene-doctoring plasmids, Z. Guan and C. Li for providing E. coli strains and plasmids containing cardiolipin genes. We also thank D. Staunton and N. Housden for training on the stopped-flow apparatus; and T. Mize, J. Benesch, M. McDonough, T. Walton and D. Rees for discussions. We also gratefully acknowledge E. Lowe and S. Lea for organizing synchrotron proposals and Diamond Light Source beam line I04 and staff, the Medical Research Council (MRC), BBSRC and ERC advanced grant (IMPRESS) for funding. A.L. is a Nicholas Kurti Junior Research Fellow of Brasenose College, A. J. B. is a BBSRC David Phillip's Fellow and C.V.R. is a Royal Society Professor.	Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; Baldwin AJ, 2011, STRUCTURE, V19, P1855, DOI 10.1016/j.str.2011.09.015; Barrera NP, 2008, SCIENCE, V321, P243, DOI 10.1126/science.1159292; Benesch JLP, 2011, CURR OPIN STRUC BIOL, V21, P641, DOI 10.1016/j.sbi.2011.08.002; BERENDSEN HJC, 1995, COMPUT PHYS COMMUN, V91, P43, DOI 10.1016/0010-4655(95)00042-E; BERENDSEN HJC, 1984, J CHEM PHYS, V81, P3684, DOI 10.1063/1.448118; Blakey D, 2002, BIOCHEM J, V364, P527, DOI 10.1042/BJ20011761; Borgnia MJ, 1999, J MOL BIOL, V291, P1169, DOI 10.1006/jmbi.1999.3032; Bush MF, 2010, ANAL CHEM, V82, P9557, DOI 10.1021/ac1022953; Bussi G, 2007, J CHEM PHYS, V126, DOI 10.1063/1.2408420; Cantor RS, 1999, CHEM PHYS LIPIDS, V101, P45, DOI 10.1016/S0009-3084(99)00054-7; Chang G, 1998, SCIENCE, V282, P2220, DOI 10.1126/science.282.5397.2220; Contreras FX, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a004705; DARDEN T, 1993, J CHEM PHYS, V98, P10089, DOI 10.1063/1.464397; Drew D, 2006, NAT METHODS, V3, P303, DOI 10.1038/nmeth0406-303; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Engelman DM, 2005, NATURE, V438, P578, DOI 10.1038/nature04394; FINE JB, 1982, J LIPID RES, V23, P660; FOLCH J, 1957, J BIOL CHEM, V226, P497; Gandhi CS, 2011, PROTEIN SCI, V20, P313, DOI 10.1002/pro.562; Gasteiger E., 2005, PROTEOMICS PROTOCOLS, P571, DOI [10.1385/1-59259-890-0:571, DOI 10.1385/1-59259-890-0:571]; Gonen T, 2005, NATURE, V438, P633, DOI 10.1038/nature04321; Hall Z, 2012, STRUCTURE, V20, P1596, DOI 10.1016/j.str.2012.07.001; Haswell ES, 2011, STRUCTURE, V19, P1356, DOI 10.1016/j.str.2011.09.005; Hess B, 1997, J COMPUT CHEM, V18, P1463, DOI 10.1002/(SICI)1096-987X(199709)18:12<1463::AID-JCC4>3.0.CO;2-H; Hilf RJC, 2008, NATURE, V452, P375, DOI 10.1038/nature06717; Hite RK, 2010, EMBO J, V29, P1652, DOI 10.1038/emboj.2010.68; Hong H, 2009, METHOD ENZYMOL, V455, P213, DOI 10.1016/S0076-6879(08)04208-0; Hunte C, 2008, CURR OPIN STRUC BIOL, V18, P406, DOI 10.1016/j.sbi.2008.03.008; Hunter JD, 2007, COMPUT SCI ENG, V9, P90, DOI 10.1109/MCSE.2007.55; Hyung SJ, 2009, CHEM BIOL, V16, P382, DOI 10.1016/j.chembiol.2009.02.008; Iscla I, 2012, BIOPHYS J, V103, P169, DOI 10.1016/j.bpj.2012.06.021; Izzo D., 2012, P ICATT; Izzo D, 2012, STUD COMPUT INTELL, V415, P151; Jones E., 2001, SCIPY OPEN SOURCE SC; Jorgensen WL, 1996, J AM CHEM SOC, V118, P11225, DOI 10.1021/ja9621760; JORGENSEN WL, 1983, J CHEM PHYS, V79, P926, DOI 10.1063/1.445869; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Khademi S, 2004, SCIENCE, V305, P1587, DOI 10.1126/science.1101952; Laganowsky A, 2013, NAT PROTOC, V8, P639, DOI 10.1038/nprot.2013.024; Laganowsky A, 2012, SCIENCE, V335, P1228, DOI 10.1126/science.1213151; Laganowsky A, 2010, PROTEIN SCI, V19, P1031, DOI 10.1002/pro.380; Lee AG, 2011, TRENDS BIOCHEM SCI, V36, P493, DOI 10.1016/j.tibs.2011.06.007; Lee DJ, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-252; Long SB, 2007, NATURE, V450, P376, DOI 10.1038/nature06265; MASON EA, 1958, ANN PHYS-NEW YORK, V4, P233, DOI 10.1016/0003-4916(58)90049-6; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Mesleh MF, 1996, J PHYS CHEM-US, V100, P16082, DOI 10.1021/jp961623v; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Newby ZER, 2009, NAT PROTOC, V4, P619, DOI 10.1038/nprot.2009.27; Pace C N, 1986, Methods Enzymol, V131, P266; Padilla JE, 2003, ACTA CRYSTALLOGR D, V59, P1124, DOI 10.1107/S0907444903007947; Powl AM, 2003, BIOCHEMISTRY-US, V42, P14306, DOI 10.1021/bi034995k; Romantsov T, 2010, J BACTERIOL, V192, P912, DOI 10.1128/JB.00967-09; Ruotolo BT, 2008, NAT PROTOC, V3, P1139, DOI 10.1038/nprot.2008.78; Ruotolo BT, 2005, SCIENCE, V310, P1658, DOI 10.1126/science.1120177; Sanders CR, 2011, BIOCHEMISTRY-US, V50, P7858, DOI 10.1021/bi2011527; Savage DF, 2010, P NATL ACAD SCI USA, V107, P17164, DOI 10.1073/pnas.1009864107; Savage DF, 2003, PLOS BIOL, V1, P334, DOI 10.1371/journal.pbio.0000072; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Schrodinger, 2010, PYMOL MOL GRAPHICS S; Shvartsburg AA, 1996, CHEM PHYS LETT, V261, P86, DOI 10.1016/0009-2614(96)00941-4; SINGER SJ, 1972, SCIENCE, V175, P720, DOI 10.1126/science.175.4023.720; Sobott F, 2002, ANAL CHEM, V74, P1402, DOI 10.1021/ac0110552; Stengel F, 2012, CHEM BIOL, V19, P599, DOI 10.1016/j.chembiol.2012.04.007; Tan BK, 2012, P NATL ACAD SCI USA, V109, P16504, DOI 10.1073/pnas.1212797109; Ulmschneider JP, 2009, J CHEM THEORY COMPUT, V5, P1803, DOI 10.1021/ct900086b; Whitelegge JP, 2013, ANAL CHEM, V85, P2558, DOI 10.1021/ac303064a; Yau WM, 1998, BIOCHEMISTRY-US, V37, P14713, DOI 10.1021/bi980809c; Zhong DL, 2013, BIOCHEMISTRY-US, V52, P5415, DOI 10.1021/bi400790j	70	497	507	15	515	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 5	2014	510	7503					172	+		10.1038/nature13419	http://dx.doi.org/10.1038/nature13419			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI3NR	24899312	Green Submitted, Green Accepted			2022-12-28	WOS:000336768900051
J	Serhan, CN				Serhan, Charles N.			Pro-resolving lipid mediators are leads for resolution physiology	NATURE			English	Review							TRIGGERED 15-EPI-LIPOXIN A(4); ACUTE INFLAMMATORY RESPONSES; DOCOSAHEXAENOIC ACID; LIPOXIN A(4); NEUROPROTECTIN D1; PROTECTIN D1; ANTIINFLAMMATORY PROPERTIES; STEREOCHEMICAL ASSIGNMENT; PRORESOLVING MEDIATORS; LEUKOCYTE RECRUITMENT	Advances in our understanding of the mechanisms that bring about the resolution of acute inflammation have uncovered a new genus of pro-resolving lipid mediators that include the lipoxin, resolvin, protectin and maresin families, collectively called specialized pro-resolving mediators. Synthetic versions of these mediators have potent bioactions when administered in vivo. In animal experiments, the mediators evoke anti-inflammatory and novel pro-resolving mechanisms, and enhance microbial clearance. Although they have been identified in inflammation resolution, specialized pro-resolving mediators are conserved structures that also function in host defence, pain, organ protection and tissue remodelling. This Review covers the mechanisms of specialized pro-resolving mediators and omega-3 essential fatty acid pathways that could help us to understand their physiological functions.	[Serhan, Charles N.] Brigham & Womens Hosp, Ctr Expt Therapeut & Reperfus Injury, Dept Anesthesiol Perioperat & Pain Med, Harvard Inst Med, Boston, MA 02115 USA; [Serhan, Charles N.] Harvard Univ, Sch Med, Boston, MA 02115 USA	Harvard University; Brigham & Women's Hospital; Harvard Medical School; Harvard University; Harvard Medical School	Serhan, CN (corresponding author), Brigham & Womens Hosp, Ctr Expt Therapeut & Reperfus Injury, Dept Anesthesiol Perioperat & Pain Med, Harvard Inst Med, 75 Francis St, Boston, MA 02115 USA.	cnserhan@zeus.bwh.harvard.edu			US National Institutes of Health [R01GM038765, P01GM095467]; Merieux Foundation (France); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P01GM095467, R01GM038765] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Merieux Foundation (France); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The author thanks S. Orr, J. Dalli and N. Chiang for their critical reading of this manuscript and grants from the US National Institutes of Health (R01GM038765 and P01GM095467) and the Merieux Foundation (France) for support of the author's research. I also thank our collaborators and investigators contributing to this area whose publications were not cited due to size limitations.	Abdelmoaty S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075543; Ariel A, 2005, J BIOL CHEM, V280, P43079, DOI 10.1074/jbc.M509796200; Ariel A, 2006, NAT IMMUNOL, V7, P1209, DOI 10.1038/ni1392; Arita M, 2005, J EXP MED, V201, P713, DOI 10.1084/jem.20042031; Bailey RL, 2013, JAMA INTERN MED, V173, P355, DOI 10.1001/jamainternmed.2013.2299; Baillie JK, 2013, NEW ENGL J MED, V369, P191, DOI 10.1056/NEJMcibr1304414; Bang S, 2012, BRIT J PHARMACOL, V165, P683, DOI 10.1111/j.1476-5381.2011.01568.x; Bannenberg GL, 2005, J IMMUNOL, V174, P4345, DOI 10.4049/jimmunol.174.7.4345; Bazan NG, 2012, EXP NEUROL, V236, P122, DOI 10.1016/j.expneurol.2012.04.007; Bazan NG, 2010, J LIPID RES, V51, P2018, DOI 10.1194/jlr.R001131; Birnbaum Y, 2006, CIRCULATION, V114, P929, DOI 10.1161/CIRCULATIONAHA.106.629907; Biswas SK, 2010, NAT IMMUNOL, V11, P889, DOI 10.1038/ni.1937; Borgeson E, 2011, FASEB J, V25, P2967, DOI 10.1096/fj.11-185017; Brancaleone V, 2013, BLOOD, V122, P608, DOI 10.1182/blood-2013-04-496661; Chan MMY, 2010, J IMMUNOL, V184, P6418, DOI 10.4049/jimmunol.0903816; Chiang N, 2012, NATURE, V484, P524, DOI 10.1038/nature11042; Cilloniz C, 2010, J VIROL, V84, P7613, DOI 10.1128/JVI.00553-10; Claria J, 2013, AM J PHYSIOL-CELL PH, V304, pC1141, DOI 10.1152/ajpcell.00351.2012; Colas R., 2014, AM J PHYSL CELL PHYS; Cooray SN, 2013, P NATL ACAD SCI USA, V110, P18232, DOI 10.1073/pnas.1308253110; Dalli J, 2013, FASEB J, V27, P2573, DOI 10.1096/fj.13-227728; Dalli J, 2013, CHEM BIOL, V20, P188, DOI 10.1016/j.chembiol.2012.11.010; Dalli J, 2012, BLOOD, V120, pE60, DOI 10.1182/blood-2012-04-423525; Dinarello CA, 2012, NAT REV DRUG DISCOV, V11, P633, DOI 10.1038/nrd3800; Divangahi M, 2009, NAT IMMUNOL, V10, P899, DOI 10.1038/ni.1758; El Kebir D, 2012, P NATL ACAD SCI USA, V109, P14983, DOI 10.1073/pnas.1206641109; Flower RJ, 2006, BRIT J PHARMACOL, V147, pS182, DOI 10.1038/sj.bjp.0706506; Fredman G, 2012, SCI REP-UK, V2, DOI 10.1038/srep00639; Fullerton JN, 2014, TRENDS IMMUNOL, V35, P12, DOI 10.1016/j.it.2013.10.008; Giera M, 2012, BBA-MOL CELL BIOL L, V1821, P1415, DOI 10.1016/j.bbalip.2012.07.011; Haas-Stapleton EJ, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001316; Hasturk H, 2006, FASEB J, V20, P401, DOI 10.1096/fj.05-4724fje; Hasturk H, 2007, J IMMUNOL, V179, P7021, DOI 10.4049/jimmunol.179.10.7021; Hong S, 2003, J BIOL CHEM, V278, P14677, DOI 10.1074/jbc.M300218200; Hong S, 2007, J AM SOC MASS SPECTR, V18, P128, DOI 10.1016/j.jasms.2006.09.002; Hsiao HM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058258; Isobe Y, 2013, J BIOCHEM, V153, P355, DOI 10.1093/jb/mvs151; Jones CN, 2012, P NATL ACAD SCI USA, V109, P20560, DOI 10.1073/pnas.1210269109; Jones ML, 2013, J LIPID RES, V54, P2247, DOI 10.1194/jlr.M039842; Kasuga K, 2008, J IMMUNOL, V181, P8677, DOI 10.4049/jimmunol.181.12.8677; Kim TH, 2012, INT IMMUNOPHARMACOL, V14, P384, DOI 10.1016/j.intimp.2012.08.005; Kowal-Bielecka O, 2007, NAT CLIN PRACT RHEUM, V3, P43, DOI 10.1038/ncprheum0375; Krishnamoorthy S, 2012, AM J PATHOL, V180, P2018, DOI 10.1016/j.ajpath.2012.01.028; Lands W., 2005, FISH OMEGA 3 HUMAN H; Levy BD, 2001, NAT IMMUNOL, V2, P612, DOI 10.1038/89759; Levy BD, 2007, J IMMUNOL, V178, P496, DOI 10.4049/jimmunol.178.1.496; Levy BD, 2014, ANNU REV PHYSIOL, V76, P467, DOI 10.1146/annurev-physiol-021113-170408; Li D, 2013, MUCOSAL IMMUNOL, V6, P1119, DOI 10.1038/mi.2013.7; Li YS, 2013, IMMUNITY, V39, P885, DOI 10.1016/j.immuni.2013.10.011; Lima-Garcia JF, 2011, BRIT J PHARMACOL, V164, P278, DOI 10.1111/j.1476-5381.2011.01345.x; Lucas C. D., 2013, MUCOSAL IMMUNOL; Lukiw WJ, 2005, J CLIN INVEST, V115, P2774, DOI 10.1172/JCI25420; Maderna P, 2009, BRIT J PHARMACOL, V158, P947, DOI 10.1111/j.1476-5381.2009.00386.x; Malawista SE, 2008, P NATL ACAD SCI USA, V105, P17949, DOI 10.1073/pnas.0802572105; Marcheselli VL, 2003, J BIOL CHEM, V278, P43807, DOI 10.1074/jbc.M305841200; Markworth JF, 2013, AM J PHYSIOL-REG I, V305, pR1281, DOI 10.1152/ajpregu.00128.2013; Martins V, 2009, J IMMUNOL, V182, P5374, DOI 10.4049/jimmunol.0802259; Mas E, 2012, CLIN CHEM, V58, P1476, DOI 10.1373/clinchem.2012.190199; Menon R., 2012, THESIS RUTGERS U; Merched AJ, 2008, FASEB J, V22, P3595, DOI 10.1096/fj.08-112201; Merched AJ, 2011, J NUTRIGENET NUTRIGE, V4, P12, DOI 10.1159/000326890; Miki Y, 2013, J EXP MED, V210, P1217, DOI 10.1084/jem.20121887; Miyahara T, 2013, FASEB J, V27, P2220, DOI 10.1096/fj.12-225615; Miyata J, 2013, J ALLERGY CLIN IMMUN, V131, P353, DOI 10.1016/j.jaci.2012.07.048; Mizwicki MT, 2013, J ALZHEIMERS DIS, V34, P155, DOI 10.3233/JAD-121735; Morita M, 2013, CELL, V153, P112, DOI 10.1016/j.cell.2013.02.027; Morris T, 2010, P NATL ACAD SCI USA, V107, P8842, DOI 10.1073/pnas.1000373107; Morris T, 2009, J IMMUNOL, V183, P2089, DOI 10.4049/jimmunol.0900477; Navarro-Xavier RA, 2010, J IMMUNOL, V184, P1516, DOI 10.4049/jimmunol.0902866; Nelson JW, 2014, AM J PHYSIOL-CELL PH, V306, pC178, DOI 10.1152/ajpcell.00284.2013; Norling LV, 2012, ARTERIOSCL THROM VAS, V32, P1970, DOI 10.1161/ATVBAHA.112.249508; Norling LV, 2011, J IMMUNOL, V186, P5543, DOI 10.4049/jimmunol.1003865; Oh SF, 2011, J CLIN INVEST, V121, P569, DOI 10.1172/JCI42545; Ohira T, 2010, J BIOL CHEM, V285, P3451, DOI 10.1074/jbc.M109.044131; Park CK, 2011, J NEUROSCI, V31, P15072, DOI 10.1523/JNEUROSCI.2443-11.2011; Piomelli D, 2014, NAT NEUROSCI, V17, P164, DOI 10.1038/nn.3612; Pouliot M, 2000, BIOCHEMISTRY-US, V39, P4761, DOI 10.1021/bi992551b; Prescott D, 2011, AM J PHYSIOL-GASTR L, V301, pG487, DOI 10.1152/ajpgi.00042.2011; Pruss H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055859; Psychogios N, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016957; Qu XL, 2012, J PATHOL, V228, P506, DOI 10.1002/path.4050; Raatz SK, 2011, J AGR FOOD CHEM, V59, P11278, DOI 10.1021/jf202576k; Rajasagi NK, 2013, INVEST OPHTH VIS SCI, V54, P6269, DOI 10.1167/iovs.13-12152; Rajasagi NK, 2011, J IMMUNOL, V186, P1735, DOI 10.4049/jimmunol.1003456; Ramon S, 2012, J IMMUNOL, V189, P1036, DOI 10.4049/jimmunol.1103483; Samuelsson B, 2012, J BIOL CHEM, V287, P10070, DOI 10.1074/jbc.X112.351437; Schwab JM, 2007, NATURE, V447, P869, DOI 10.1038/nature05877; Serhan CN, 2013, CURR OPIN PHARMACOL, V13, P632, DOI 10.1016/j.coph.2013.05.012; Serhan CN, 2012, FASEB J, V26, P1755, DOI 10.1096/fj.11-201442; Serhan CN, 2011, CHEM REV, V111, P5922, DOI 10.1021/cr100396c; Serhan CN, 2011, CHEM BIOL, V18, P976, DOI 10.1016/j.chembiol.2011.06.008; Serhan CN, 2011, FASEB J, V25, P1441, DOI 10.1096/fj.11-0502ufm; Serhan CN, 2006, J IMMUNOL, V176, P1848, DOI 10.4049/jimmunol.176.3.1848; Serhan CN, 2003, J IMMUNOL, V171, P6856, DOI 10.4049/jimmunol.171.12.6856; Serhan CN, 2005, NAT IMMUNOL, V6, P1191, DOI 10.1038/ni1276; Serhan CN, 2002, J EXP MED, V196, P1025, DOI 10.1084/jem.20020760; Serhan CN, 2000, J EXP MED, V192, P1197, DOI 10.1084/jem.192.8.1197; Settimio R, 2012, MEDIAT INFLAMM, V2012, DOI 10.1155/2012/318621; Sheets KG, 2013, MOL VIS, V19, P1747; Shen JH, 1996, J CLIN INVEST, V98, P2201, DOI 10.1172/JCI119029; Simiele F, 2012, FASEB J, V26, P1323, DOI 10.1096/fj.11-198069; Spite M, 2014, CELL METAB, V19, P21, DOI 10.1016/j.cmet.2013.10.006; Spite M, 2009, NATURE, V461, P1287, DOI 10.1038/nature08541; Stables MJ, 2011, BLOOD, V118, pE192, DOI 10.1182/blood-2011-04-345330; Svensson CI, 2007, J EXP MED, V204, P245, DOI 10.1084/jem.20061826; Tabas I, 2013, SCIENCE, V339, P166, DOI 10.1126/science.1230720; Takano T, 1998, J CLIN INVEST, V101, P819, DOI 10.1172/JCI1578; Tam VC, 2013, CELL, V154, P213, DOI 10.1016/j.cell.2013.05.052; Tang YN, 2013, DIABETES, V62, P618, DOI 10.2337/db12-0684; Terrando N, 2013, FASEB J, V27, P3564, DOI 10.1096/fj.13-230276; Tian HB, 2009, INVEST OPHTH VIS SCI, V50, P3613, DOI 10.1167/iovs.08-3146; Tobin DM, 2012, CELL, V148, P434, DOI 10.1016/j.cell.2011.12.023; Vassiliou EK, 2008, J IMMUNOL, V181, P4534, DOI 10.4049/jimmunol.181.7.4534; Walker J, 2011, SHOCK, V36, P410, DOI 10.1097/SHK.0b013e31822798c1; Wang SB, 2012, FASEB J, V26, P1506, DOI 10.1096/fj.11-198036; Wang X., 2014, ALZHEIMERS DEMENT; Weiss GA, 2013, LIPIDS HEALTH DIS, V12, DOI 10.1186/1476-511X-12-89; Wu SH, 2013, BRIT J DERMATOL, V168, P172, DOI 10.1111/j.1365-2133.2012.11177.x; Xu ZZ, 2010, NAT MED, V16, P592, DOI 10.1038/nm.2123; Yamada T, 2011, FASEB J, V25, P561, DOI 10.1096/fj.10-170027; Yates CM, 2014, PHARMACOL THERAPEUT, V141, P272, DOI 10.1016/j.pharmthera.2013.10.010	121	1752	1806	13	222	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 5	2014	510	7503					92	101		10.1038/nature13479	http://dx.doi.org/10.1038/nature13479			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI3NR	24899309	Green Accepted			2022-12-28	WOS:000336768900036
J	Al-Khatib, SM; Hellkamp, AS; Fonarow, GC; Mark, DB; Curtis, LH; Hernandez, AF; Anstrom, KJ; Peterson, ED; Sanders, GD; Al-Khalidi, HR; Hammill, BG; Heidenreich, PA; Hammill, SC				Al-Khatib, Sana M.; Hellkamp, Anne S.; Fonarow, Gregg C.; Mark, Daniel B.; Curtis, Lesley H.; Hernandez, Adrian F.; Anstrom, Kevin J.; Peterson, Eric D.; Sanders, Gillian D.; Al-Khalidi, Hussein R.; Hammill, Bradley G.; Heidenreich, Paul A.; Hammill, Stephen C.			Association Between Prophylactic Implantable Cardioverter-Defibrillators and Survival in Patients With Left Ventricular Ejection Fraction Between 30% and 35%	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							CONGESTIVE-HEART-FAILURE; MYOCARDIAL-INFARCTION; PREVENTION; PROGRAM; DISEASE; HF	IMPORTANCE Clinical trials of prophylactic implantable cardioverter-defibrillators (ICDs) have included a minority of patients with a left ventricular ejection fraction (LVEF) between 30% and 35%. Because a large number of ICDs in the United States are implanted in such patients, it is important to study survival associated with this therapy. OBJECTIVE To characterize patients with LVEF between 30% and 35% and compare the survival of those with and without ICDs. DESIGN, SETTING, AND PARTICIPANTS Retrospective cohort study of Medicare beneficiaries in the National Cardiovascular Data Registry ICD registry (January 1, 2006, through December 31, 2007) with an LVEF between 30% and 35% who received an ICD during a heart failure hospitalization and similar patients in the Get With The Guidelines-Heart Failure (GWTG-HF) database (January 1, 2005, through December 31, 2009) with no ICD. The analysis was repeated in patients with an LVEF less than 30%. There were 3120 patients with an LVEF between 30% and 35% (816 in matched cohorts) and 4578 with an LVEF less than 30% (2176 in matched cohorts). Propensity score matching and Cox models were applied. MAIN OUTCOMES AND MEASURES The primary outcome was all-cause mortality; data were obtained from Medicare claims through December 31, 2011. RESULTS There were no significant differences in the baseline characteristics of the matched groups (n = 408 for both groups). Among patients with an LVEF between 30% and 35%, there were 248 deaths in the ICD Registry group, within a median follow-up of 4.4 years (interquartile range, 2.7-4.9) and 249 deaths in the GWTG HF group, within a median follow-up of 2.9 years (interquartile range, 2.1-4.4). The risk of all-cause mortality in patients with an LVEF between 30% and 35% and an ICD was significantly lower than that in matched patients without an ICD (3-year mortality rates: 51.4% vs 55.0%; hazard ratio, 0.83 [95% CI, 0.69-0.991; P = .04). Presence of an ICD also was associated with better survival in patients with an LVEF less than 30% (3-year mortality rates: 45.0% vs 57.6%; 634 and 660 total deaths; hazard ratio, 0.72 [95% CI, 0.65-0.811; P < .001) (P = .20 for interaction). CONCLUSIONS AND RELEVANCE Among Medicare beneficiaries hospitalized for heart failure and with an LVEF between 30% and 35% and less than 30%, survival at 3 years was better in patients who received a prophylactic ICD than in comparable patients with no ICD. These findings support guideline recommendations to implant prophylactic ICDs in eligible patients with an LVEF of 35% or less. Copyright 2014 American Medical Association. All rights reserved.	[Al-Khatib, Sana M.; Hellkamp, Anne S.; Mark, Daniel B.; Curtis, Lesley H.; Hernandez, Adrian F.; Anstrom, Kevin J.; Peterson, Eric D.; Sanders, Gillian D.; Al-Khalidi, Hussein R.; Hammill, Bradley G.; Hammill, Stephen C.] Duke Univ, Med Ctr, Dept Med, Duke Clin Res Inst, Durham, NC 27710 USA; [Curtis, Lesley H.; Hammill, Stephen C.] Duke Univ, Med Ctr, Dept Med, Ctr Clin & Genet Econ, Durham, NC 27710 USA; [Al-Khatib, Sana M.; Mark, Daniel B.; Hernandez, Adrian F.; Peterson, Eric D.] Duke Univ, Med Ctr, Dept Med, Div Cardiol, Durham, NC 27710 USA; [Curtis, Lesley H.] Duke Univ, Med Ctr, Dept Med, Div Gen Internal Med, Durham, NC 27710 USA; [Fonarow, Gregg C.] Ronald Reagan UCLA Med Ctr, Ahmanson UCLA Cardiomyopathy Ctr, Los Angeles, CA USA; [Heidenreich, Paul A.] Stanford Univ, Palo Alto Vet Hlth Care Syst, Palo Alto, CA 94304 USA; [Hammill, Stephen C.] Mayo Clin, Rochester, MN USA	Duke University; Duke University; Duke University; Duke University; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; Ronald Reagan UCLA Medical Center; Stanford University; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Palo Alto Health Care System; Mayo Clinic	Al-Khatib, SM (corresponding author), Duke Clin Res Inst, POB 17969, Durham, NC 27715 USA.	alkha001@mc.duke.edu	Fonarow, Gregg C/D-5988-2014; Hernandez, Adrian F/A-7818-2016; Heidenreich, Paul/AAU-6864-2021; Peterson, Eric David/ABF-5033-2021	Fonarow, Gregg C/0000-0002-3192-8093; Hernandez, Adrian F/0000-0003-3387-9616; Heidenreich, Paul/0000-0001-7730-8490; Mark, Daniel/0000-0001-6340-8087	National Heart, Lung, and Blood Institute [1R01-HL093071-01A1]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL093071] Funding Source: NIH RePORTER	National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This analysis was funded by grant 1R01-HL093071-01A1 from the National Heart, Lung, and Blood Institute.	Al-Khatib SM, 2014, INT J CARDIOL, V172, P253, DOI 10.1016/j.ijcard.2013.12.278; Bardy GH, 2005, NEW ENGL J MED, V352, P225, DOI 10.1056/NEJMoa043399; Buxton AE, 1999, NEW ENGL J MED, V341, P1882, DOI 10.1056/NEJM199912163412503; Chen J, 2011, JAMA-J AM MED ASSOC, V306, P1669, DOI 10.1001/jama.2011.1474; Curtis LH, 2008, ARCH INTERN MED, V168, P2481, DOI 10.1001/archinte.168.22.2481; Epstein AE, 2008, CIRCULATION, V117, pE350, DOI 10.1161/CIRCUALTIONAHA.108.189742; Fonarow GC, 2004, AM HEART J, V148, P43, DOI 10.1016/j.ahj.2004.03.004; Gustafsson F, 2003, EUR HEART J, V24, P863, DOI 10.1016/S0195-668X(02)00845-X; Hammill BG, 2009, AM HEART J, V157, P995, DOI 10.1016/j.ahj.2009.04.002; Hammill SC, 2007, HEART RHYTHM, V4, P1260, DOI 10.1016/j.hrthm.2007.07.021; Hammill SC, 2009, HEART RHYTHM, V6, P1397, DOI 10.1016/j.hrthm.2009.07.015; Hellermann JP, 2005, EUR J HEART FAIL, V7, P119, DOI 10.1016/j.ejheart.2004.04.011; Hjalmarson A, 1999, LANCET, V353, P2001; Kadish A, 2004, NEW ENGL J MED, V350, P2151, DOI 10.1056/NEJMoa033088; Kremers MS, 2013, HEART RHYTHM, V10, pE59, DOI 10.1016/j.hrthm.2013.01.035; Messenger JC, 2012, J AM COLL CARDIOL, V60, P1484, DOI 10.1016/j.jacc.2012.07.020; Moss AJ, 1996, NEW ENGL J MED, V335, P1933, DOI 10.1056/NEJM199612263352601; Moss AJ, 2002, NEW ENGL J MED, V346, P877, DOI 10.1056/NEJMoa013474; ROSENBAUM PR, 1985, AM STAT, V39, P33, DOI 10.2307/2683903; Weir Robin A P, 2006, Curr Heart Fail Rep, V3, P175, DOI 10.1007/s11897-006-0019-5	20	22	22	0	6	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUN 4	2014	311	21					2209	2215		10.1001/jama.2014.5310	http://dx.doi.org/10.1001/jama.2014.5310			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AI2DU	24893088	Green Accepted, Bronze			2022-12-28	WOS:000336668400022
J	Herath, SC; Poole, P				Herath, Samantha C.; Poole, Phillippa			Prophylactic Antibiotic Therapy in Chronic Obstructive Pulmonary Disease	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							EXACERBATIONS; ERYTHROMYCIN; AZITHROMYCIN; PREVENTION; SPUTUM		[Herath, Samantha C.] Montreal Chest Inst, Dept Resp Med, Day Unit, 3650,Rue St Urbain,Level 4, Montreal, PQ H2X 2P4, Canada; [Poole, Phillippa] Univ Auckland, Dept Med, Auckland 1, New Zealand	McGill University; University of Auckland	Herath, SC (corresponding author), Montreal Chest Inst, Dept Resp Med, Day Unit, 3650,Rue St Urbain,Level 4, Montreal, PQ H2X 2P4, Canada.	scherath@yahoo.com						Albert RK, 2011, NEW ENGL J MED, V365, P689, DOI 10.1056/NEJMoa1104623; Banerjee D, 2005, RESP MED, V99, P208, DOI 10.1016/j.rmed.2004.06.009; He ZY, 2010, RESPIRATION, V80, P445, DOI 10.1159/000321374; Herath SC, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD009764.pub2; Mygind LH, 2010, PRESENTED AT EUROPEA; Seemungal TAR, 2008, AM J RESP CRIT CARE, V178, P1139, DOI 10.1164/rccm.200801-145OC; Sethi S, 2010, RESP RES, V11, DOI 10.1186/1465-9921-11-10; Staykova T., 2003, COCHRANE DB SYST REV, DOI DOI 10.1002/14651858.CD004105; Suzuki T, 2001, CHEST, V120, P730, DOI 10.1378/chest.120.3.730; Uzun S, 2014, LANCET RESP MED, V2, P361, DOI 10.1016/S2213-2600(14)70019-0	10	4	9	1	11	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUN 4	2014	311	21					2225	2226		10.1001/jama.2014.4929	http://dx.doi.org/10.1001/jama.2014.4929			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AI2DU	24893090				2022-12-28	WOS:000336668400024
J	Patel, CJ; Ioannidis, JPA				Patel, Chirag J.; Ioannidis, John P. A.			Studying the Elusive Environment in Large Scale	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Patel, Chirag J.] Harvard Univ, Sch Med, Ctr Biomed Informat, Boston, MA USA; [Ioannidis, John P. A.] Stanford Univ, Stanford Prevent Res Ctr, Dept Hlth Res & Policy, Dept Med,Sch Med, Stanford, CA 94305 USA; [Ioannidis, John P. A.] Stanford Univ, Dept Stat, Sch Humanities & Sci, Stanford, CA 94305 USA; [Ioannidis, John P. A.] Meta Res Innovat Ctr Stanford METRICS, Stanford, CA USA	Harvard University; Harvard Medical School; Stanford University; Stanford University	Ioannidis, JPA (corresponding author), Stanford Univ, 1265 Welch Rd,MSOB X306, Stanford, CA 94305 USA.	jioannid@stanford.edu	Ioannidis, John P. A./G-9836-2011		NHLBI NIH HHS [T32 HL007034] Funding Source: Medline; NIEHS NIH HHS [K99 ES023504] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL007034] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [K99ES023504] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIEHS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))		Hamilton CM, 2011, AM J EPIDEMIOL, V174, P253, DOI 10.1093/aje/kwr193; Louis GMB, 2012, STAT MED, V31, P2569, DOI 10.1002/sim.5496; Patel CJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010746; Rappaport SM, 2012, BIOMARKERS, V17, P483, DOI 10.3109/1354750X.2012.691553; Rappaport SM, 2010, SCIENCE, V330, P460, DOI 10.1126/science.1192603; Thomas DC, 2012, AM J EPIDEMIOL, V175, P203, DOI 10.1093/aje/kwr365; Tzoulaki I, 2012, CIRCULATION, V126, P2456, DOI 10.1161/CIRCULATIONAHA.112.114058; Wang ZN, 2011, NATURE, V472, P57, DOI 10.1038/nature09922	8	59	58	0	14	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUN 4	2014	311	21					2173	2174		10.1001/jama.2014.4129	http://dx.doi.org/10.1001/jama.2014.4129			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AI2DU	24893084	Green Accepted			2022-12-28	WOS:000336668400015
J	McManus, RJ; Mant, J				McManus, Richard J.; Mant, Jonathan			The drugs do work: blood pressure improvement in England	LANCET			English	Editorial Material							MANAGEMENT		[McManus, Richard J.] Univ Oxford, NIHR Sch Primary Care Res, Oxford OX1 2GG, England; [Mant, Jonathan] Univ Cambridge, Primary Care Unit, Cambridge, England	University of Oxford; University of Cambridge	McManus, RJ (corresponding author), Univ Oxford, NIHR Sch Primary Care Res, Oxford OX1 2GG, England.	richard.mcmanus@phc.ox.ac.uk		Mant, Jonathan/0000-0002-9531-0268	Department of Health [NIHR-RP-02-12-015, CDF/01/017, PB-PG-1207-15042, RP-PG-1209-10051] Funding Source: Medline; National Institute for Health Research [NIHR-RP-02-12-015, RP-PG-1209-10051, PB-PG-1207-15042, CDF/01/017] Funding Source: researchfish	Department of Health; National Institute for Health Research(National Institute for Health Research (NIHR))		[Anonymous], 2013, QOF 2012 13 RES HLTH; [Anonymous], 2013, STAT B AV MORT ENGL; Clark CE, 2014, BRIT J GEN PRACT, V64, pE223, DOI 10.3399/bjgp14X677851; Diao D, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006742.pub2; Falaschetti E, 2014, LANCET, V383, P1912, DOI 10.1016/S0140-6736(14)60688-7; Health and Social Care Information Centre, 2012, HLTH SURV ENGL 2011; Joffres M, 2013, BMJ OPEN, V3, DOI 10.1136/bmjopen-2013-003423; Law MR, 2009, BMJ-BRIT MED J, V338, DOI 10.1136/bmj.b1665; Mancia G, 2013, EUR HEART J, V34, P2159, DOI 10.1093/eurheartj/eht151; McManus R, 2010, LANCET, V376, P163, DOI 10.1016/S0140-6736(10)60964-6; NICE, 2011, PM22855971 NICE; Sheppard JP, 2012, BMJ-BRIT MED J, V345, DOI 10.1136/bmj.e4535	12	1	1	0	1	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAY 31	2014	383	9932					1868	1869		10.1016/S0140-6736(14)60811-4	http://dx.doi.org/10.1016/S0140-6736(14)60811-4			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AI4PR	24881979				2022-12-28	WOS:000336847800010
J	Buckley, YM; Han, Y				Buckley, Yvonne M.; Han, Yi			Managing the side effects of invasion control	SCIENCE			English	Editorial Material							SPECIES REMOVAL; ISLAND; RESTORATION; MANAGEMENT		[Buckley, Yvonne M.] Univ Dublin Trinity Coll, Sch Nat Sci, Dublin 2, Ireland; [Buckley, Yvonne M.] Univ Dublin Trinity Coll, Dept Zool, Trinity Ctr Biodivers Res, Dublin 2, Ireland; [Buckley, Yvonne M.; Han, Yi] Univ Queensland, Sch Biol Sci, ARC Ctr Excellence Environm Decis, Brisbane, Qld 4072, Australia	Trinity College Dublin; Trinity College Dublin; University of Queensland	Buckley, YM (corresponding author), Univ Dublin Trinity Coll, Sch Nat Sci, Dublin 2, Ireland.	buckleyy@tcd.ie	Buckley, Yvonne/B-1281-2008	Buckley, Yvonne/0000-0001-7599-3201				Bergstrom DM, 2009, J APPL ECOL, V46, P73, DOI 10.1111/j.1365-2664.2008.01601.x; Buckley YM, 2006, J APPL ECOL, V43, P848, DOI 10.1111/j.1365-2664.2006.01210.x; Firn J, 2010, J APPL ECOL, V47, P96, DOI 10.1111/j.1365-2664.2009.01741.x; Fowler SV, 2012, J APPL ECOL, V49, P307, DOI 10.1111/j.1365-2664.2011.02106.x; Grechi I, 2014, AGR SYST, V125, P1, DOI 10.1016/j.agsy.2013.11.005; Lampert A, 2014, SCIENCE, V344, P1028, DOI 10.1126/science.1250763; Raymond B, 2011, J APPL ECOL, V48, P181, DOI 10.1111/j.1365-2664.2010.01916.x; Rayner MJ, 2007, P NATL ACAD SCI USA, V104, P20862, DOI 10.1073/pnas.0707414105; Reid AM, 2009, BIOL CONSERV, V142, P2342, DOI 10.1016/j.biocon.2009.05.011; Rinella MJ, 2009, ECOL APPL, V19, P155, DOI 10.1890/07-1482.1; Yokomizo H, 2009, ECOL APPL, V19, P376, DOI 10.1890/08-0442.1; Zavaleta ES, 2001, TRENDS ECOL EVOL, V16, P454, DOI 10.1016/S0169-5347(01)02194-2	12	34	36	5	91	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 30	2014	344	6187					975	976		10.1126/science.1254662	http://dx.doi.org/10.1126/science.1254662			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AH9WM	24876482				2022-12-28	WOS:000336495800023
J	Friedrich, MW; Finster, KW				Friedrich, Michael W.; Finster, Kai W.			How sulfur beats iron	SCIENCE			English	Editorial Material							CYCLE; ZONE		[Friedrich, Michael W.] Univ Bremen, Dept Biol Chem, D-28359 Bremen, Germany; [Friedrich, Michael W.] Univ Bremen, MARUM Ctr Marine Environm Sci, D-28359 Bremen, Germany; [Finster, Kai W.] Aarhus Univ, Dept Biosci, DK-8000 Aarhus C, Denmark	University of Bremen; University of Bremen; Aarhus University	Friedrich, MW (corresponding author), Univ Bremen, Dept Biol Chem, D-28359 Bremen, Germany.	michael.friedrich@uni-bremen.de	Friedrich, Michael W./B-3151-2013; Finster, Kai W/I-7475-2013	Friedrich, Michael W./0000-0002-8055-3232; Finster, Kai W/0000-0002-9132-5542				Canfield DE, 2010, SCIENCE, V330, P1375, DOI 10.1126/science.1196889; Flynn TM, 2014, SCIENCE, V344, P1039, DOI 10.1126/science.1252066; Flynn TM, 2013, BMC MICROBIOL, V13, DOI 10.1186/1471-2180-13-146; Fredrickson JK, 2008, NAT REV MICROBIOL, V6, P592, DOI 10.1038/nrmicro1947; Holmes DE, 2004, APPL ENVIRON MICROB, V70, P1234, DOI 10.1128/AEM.70.2.1234-1237.2004; Holmkvist L, 2011, GEOCHIM COSMOCHIM AC, V75, P3581, DOI 10.1016/j.gca.2011.03.033; Holmkvist L, 2011, DEEP-SEA RES PT I, V58, P493, DOI 10.1016/j.dsr.2011.02.009; LOVLEY DR, 1988, GEOCHIM COSMOCHIM AC, V52, P2993, DOI 10.1016/0016-7037(88)90163-9; Pini D. L., 2005, ASTROBIOLOGY, VI, P83; Poser A, 2013, EXTREMOPHILES, V17, P1003, DOI 10.1007/s00792-013-0582-0; Russell MJ, 2014, ASTROBIOLOGY, V14, P308, DOI 10.1089/ast.2013.1110	11	8	13	2	99	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 30	2014	344	6187					974	975		10.1126/science.1255442	http://dx.doi.org/10.1126/science.1255442			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AH9WM	24876481				2022-12-28	WOS:000336495800022
J	Gravitz, L				Gravitz, Lauren			THERAPY This time it's personal	NATURE			English	Editorial Material							CANCER; IMMUNOTHERAPY											Davis ME, 2010, NATURE, V464, P1067, DOI 10.1038/nature08956; Fan XZ, 2014, J EXP MED, V211, P715, DOI 10.1084/jem.20130590; Murtaza M, 2013, NATURE, V497, P108, DOI 10.1038/nature12065; Topalian SL, 2012, NEW ENGL J MED, V366, P2443, DOI 10.1056/NEJMoa1200690; Vanneman M, 2012, NAT REV CANCER, V12, P237, DOI 10.1038/nrc3237; Welch JS, 2011, JAMA-J AM MED ASSOC, V305, P1577, DOI 10.1001/jama.2011.497	6	8	9	0	22	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 29	2014	509	7502					S52	S54		10.1038/509S52a	http://dx.doi.org/10.1038/509S52a			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AH9JC	24870820	Bronze			2022-12-28	WOS:000336457100003
J	Pape, JW; Rouzier, V				Pape, Jean William; Rouzier, Vanessa			Embracing Oral Cholera Vaccine - The Shifting Response to Cholera	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Pape, Jean William; Rouzier, Vanessa] Ctr GHESKIO, Port Au Prince, Haiti; [Pape, Jean William] Weill Cornell Med Coll, Ctr Global Hlth, Div Infect Dis, New York, NY USA	Cornell University	Pape, JW (corresponding author), Ctr GHESKIO, Port Au Prince, Haiti.							Ali M, 2012, B WORLD HEALTH ORGAN, V90, P209, DOI 10.2471/BLT.11.093427; Date KA, 2011, EMERG INFECT DIS, V17, P2105, DOI 10.3201/eid1711.110822; Ivers LC, 2013, AM J TROP MED HYG, V89, P617, DOI 10.4269/ajtmh.13-0183; Rouzier V, 2013, AM J TROP MED HYG, V89, P671, DOI 10.4269/ajtmh.13-0171; World Health Organization, 2012, WKLY EPIDEMIOL REC, V87, P289	5	10	11	2	11	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAY 29	2014	370	22					2067	2069		10.1056/NEJMp1402837	http://dx.doi.org/10.1056/NEJMp1402837			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	AH9BM	24869720	Bronze			2022-12-28	WOS:000336434000004
J	Ghany, MG; Gara, N				Ghany, Marc G.; Gara, Naveen			QUEST for a cure for hepatitis C virus: the end is in sight	LANCET			English	Editorial Material							HCV GENOTYPE 1; PLUS SOFOSBUVIR; ABT-450/R-OMBITASVIR; TELAPREVIR; LEDIPASVIR; RIBAVIRIN; DASABUVIR; SIMEPREVIR; BOCEPREVIR; VARIANTS		[Ghany, Marc G.] NIDDK, Liver Dis Branch, NIH, Bethesda, MD 20892 USA; [Gara, Naveen] Washington Hosp Ctr, Dept Gastroenterol, Washington, DC 20010 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK); MedStar Washington Hospital Center	Ghany, MG (corresponding author), NIDDK, Liver Dis Branch, NIH, Bethesda, MD 20892 USA.	marcg@intra.niddk.nih.gov	Ghany, Marc/AAU-4238-2021	Ghany, Marc/0000-0003-2837-0188	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [ZIADK075009] Funding Source: NIH RePORTER; Intramural NIH HHS [Z01 DK075009] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)		Afdhal N, 2014, NEW ENGL J MED, V370, P1889, DOI 10.1056/NEJMoa1402454; Afdhal N, 2014, NEW ENGL J MED, V370, P1483, DOI 10.1056/NEJMoa1316366; [Anonymous], 2000, Wkly Epidemiol Rec, V75, P18; Barnard RJO, 2013, VIROLOGY, V444, P329, DOI 10.1016/j.virol.2013.06.029; Feld JJ, 2014, NEW ENGL J MED, V370, P1594, DOI 10.1056/NEJMoa1315722; Forns X, 2014, GASTROENTEROLOGY, V146, P1669, DOI 10.1053/j.gastro.2014.02.051; Ge DL, 2009, NATURE, V461, P399, DOI 10.1038/nature08309; Hanafiah KM, 2013, HEPATOLOGY, V57, P1333, DOI 10.1002/hep.26141; Hezode C, 2014, GASTROENTEROLOGY, V147, P132, DOI 10.1053/j.gastro.2014.03.051; Jacobson IM, 2014, LANCET; Jacobson IM, 2013, HEPATOLOGY, V58, p1379A; Jacobson IM, 2011, NEW ENGL J MED, V364, P2405, DOI 10.1056/NEJMoa1012912; Janssen Therapeutics, 2013, OL SIM CAPS OR US FU; Kieffer TL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034372; Kowdley KV, 2014, NEW ENGL J MED, V370, P1879, DOI 10.1056/NEJMoa1402355; Lawitz E, 2014, J HEPATOL, V60, pS524, DOI 10.1016/S0168-8278(14)61460-4; Lawitz E, 2013, NEW ENGL J MED, V368, P1878, DOI 10.1056/NEJMoa1214853; Liang TJ, 2013, NEW ENGL J MED, V368, P1907, DOI 10.1056/NEJMra1213651; Lozano R, 2012, LANCET, V380, P2095, DOI 10.1016/S0140-6736(12)61728-0; Manns M, 2014, LANCET; Poordad F, 2014, NEW ENGL J MED, V370, P1973, DOI 10.1056/NEJMoa1402869; Poordad F, 2011, NEW ENGL J MED, V364, P1195, DOI 10.1056/NEJMoa1010494; Sulkowski MS, 2014, NEW ENGL J MED, V370, P211, DOI 10.1056/NEJMoa1306218; Sullivan JC, 2013, CLIN INFECT DIS, V57, P221, DOI 10.1093/cid/cit226; Susser S, 2011, J CLIN VIROL, V52, P321, DOI 10.1016/j.jcv.2011.08.015; van der Meer AJ, 2012, JAMA-J AM MED ASSOC, V308, P2584, DOI 10.1001/jama.2012.144878; WHO, 2014, GUID SCREEN CAR TREA; Zeuzem S, 2014, NEW ENGL J MED, V370, P1604, DOI 10.1056/NEJMoa1401561	28	6	6	0	10	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	AUG 2	2014	384	9941					381	383		10.1016/S0140-6736(14)60807-2	http://dx.doi.org/10.1016/S0140-6736(14)60807-2			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	AM9IV	24907223	Green Accepted			2022-12-28	WOS:000340195800006
J	Vargas-Rodriguez, O; Musier-Forsyth, K				Vargas-Rodriguez, Oscar; Musier-Forsyth, Karin			STRUCTURAL BIOLOGY Wobble puts RNA on target	NATURE			English	Editorial Material							MINOR-GROOVE; BASE-PAIR; IDENTITY; RECOGNITION; SYNTHETASE		[Vargas-Rodriguez, Oscar; Musier-Forsyth, Karin] Ohio State Univ, Dept Chem & Biochem, Ctr RNA Biol, Columbus, OH 43210 USA	Ohio State University	Vargas-Rodriguez, O (corresponding author), Ohio State Univ, Dept Chem & Biochem, Ctr RNA Biol, Columbus, OH 43210 USA.	musier@chemistry.ohio-state.edu		Vargas-Rodriguez, Oscar/0000-0002-2301-2800				Beebe K, 2008, NATURE, V451, P90, DOI 10.1038/nature06454; Beuning PJ, 1999, BIOPOLYMERS, V52, P1; DEDUVE C, 1988, NATURE, V333, P117, DOI 10.1038/333117a0; Gabriel K, 1996, SCIENCE, V271, P195, DOI 10.1126/science.271.5246.195; Giege R, 1998, NUCLEIC ACIDS RES, V26, P5017, DOI 10.1093/nar/26.22.5017; HOU YM, 1988, NATURE, V333, P140, DOI 10.1038/333140a0; IMURA N, 1969, NATURE, V222, P1147, DOI 10.1038/2221147a0; MCCLAIN WH, 1988, SCIENCE, V242, P1681, DOI 10.1126/science.2462282; MCCLAIN WH, 1988, SCIENCE, V240, P793, DOI 10.1126/science.2452483; MUSIERFORSYTH K, 1992, NATURE, V357, P513, DOI 10.1038/357513a0; MUSIERFORSYTH K, 1991, SCIENCE, V253, P784, DOI 10.1126/science.1876835; Naganuma M, 2014, NATURE, V510, P507, DOI 10.1038/nature13440; PARK SJ, 1989, BIOCHEMISTRY-US, V28, P2740, DOI 10.1021/bi00432a056; Perona JJ, 2012, BIOCHEMISTRY-US, V51, P8705, DOI 10.1021/bi301180x	14	3	3	0	7	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 26	2014	510	7506					480	481		10.1038/nature13502	http://dx.doi.org/10.1038/nature13502			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AJ6LK	24919145				2022-12-28	WOS:000337806300034
J	Garcia-Moreno, C				Garcia-Moreno, Claudia			Responding to sexual violence in conflict	LANCET			English	Editorial Material									WHO, Dept Reprod Hlth & Res, CH-1227 Geneva, Switzerland	World Health Organization	Garcia-Moreno, C (corresponding author), WHO, Dept Reprod Hlth & Res, CH-1227 Geneva, Switzerland.	garciamorenoc@who.int			World Health Organization [001] Funding Source: Medline	World Health Organization(World Health Organization)		Aranburu XA, 2010, LEIDEN J INT LAW, V23, P609, DOI 10.1017/S0922156510000245; Bass JK, 2013, NEW ENGL J MED, V368, P2182, DOI 10.1056/NEJMoa1211853; Dua T, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001122; Human Security Report Project, 2012, HUM SEC REP 2012 SEX; irc International Rescue Committee, 2012, LET ME NOT DIE MY TI; Jewekes R., 2002, WORLD REPORT VIOLENC, P147; Johnson K, 2010, JAMA-J AM MED ASSOC, V304, P553, DOI 10.1001/jama.2010.1086; Spangaro J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062600; Stark L, 2011, TRAUMA VIOLENCE ABUS, V12, P127, DOI 10.1177/1524838011404252; Tol WA., 2013, CONFL HEALTH, V7, P16, DOI [DOI 10.1186/1752-1505-7-16, 10.1186/1752-1505-7-16]; Tol WA, 2013, JAMA-J AM MED ASSOC, V310, P477, DOI 10.1001/jama.2013.166723; WHO/UNHCR, 2004, CLIN MAN RAP SURV DE; Wood EJ, 2006, POLIT SOC, V34, P307, DOI 10.1177/0032329206290426; World Health Organisation, 2013, RESPONDING INTIMATE; World Health Organization, 2007, WHO ETHICAL SAFETY R	15	13	13	0	4	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	JUN 14	2014	383	9934					2023	2024		10.1016/S0140-6736(14)60963-6	http://dx.doi.org/10.1016/S0140-6736(14)60963-6			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	AI9VZ	24923527				2022-12-28	WOS:000337292400006
J	Chang, YQ; Bruni, R; Kloss, B; Assur, Z; Kloppmann, E; Rost, B; Hendrickson, WA; Liu, Q				Chang, Yanqi; Bruni, Renato; Kloss, Brian; Assur, Zahra; Kloppmann, Edda; Rost, Burkhard; Hendrickson, Wayne A.; Liu, Qun			Structural basis for a pH-sensitive calcium leak across membranes	SCIENCE			English	Article							ENDOPLASMIC-RETICULUM CA2+; BAX INHIBITOR-1; CELL-DEATH; CRYSTAL-STRUCTURE; APOPTOSIS; TOPOLOGY; HOMEOSTASIS; EXPRESSION; PREDICTION; MECHANISM	Calcium homeostasis balances passive calcium leak and active calcium uptake. Human Bax inhibitor-1 (hBI-1) is an antiapoptotic protein that mediates a calcium leak and is representative of a highly conserved and widely distributed family, the transmembrane Bax inhibitor motif (TMBIM) proteins. Here, we present crystal structures of a bacterial homolog and characterize its calcium leak activity. The structure has a seven-transmembrane-helix fold that features two triple-helix sandwiches wrapped around a central C-terminal helix. Structures obtained in closed and open conformations are reversibly interconvertible by change of pH. A hydrogen-bonded, pK(a) (where K-a is the acid dissociation constant)-perturbed pair of conserved aspartate residues explains the pH dependence of this transition, and biochemical studies show that pH regulates calcium influx in proteoliposomes. Homology models for hBI-1 provide insights into TMBIM-mediated calcium leak and cytoprotective activity.	[Chang, Yanqi; Bruni, Renato; Kloss, Brian; Kloppmann, Edda; Rost, Burkhard; Hendrickson, Wayne A.; Liu, Qun] New York Struct Biol Ctr, New York Consortium Membrane Prot Struct, New York, NY 10027 USA; [Assur, Zahra; Hendrickson, Wayne A.] Columbia Univ, Dept Physiol & Cellular Biophys, New York, NY 10032 USA; [Kloppmann, Edda; Rost, Burkhard] Tech Univ Munich, Fak Informat, Dept Bioinformat & Computat Biol, Garching, Germany; [Hendrickson, Wayne A.; Liu, Qun] Brookhaven Natl Lab, Natl Synchrotron Light Source NSLS X4, New York Struct Biol Ctr, Upton, NY 11973 USA; [Hendrickson, Wayne A.] Columbia Univ, Dept Biochem & Mol Biophys, New York, NY 10032 USA	Columbia University; Technical University of Munich; United States Department of Energy (DOE); Brookhaven National Laboratory; Columbia University	Liu, Q (corresponding author), New York Struct Biol Ctr, New York Consortium Membrane Prot Struct, New York, NY 10027 USA.	qunliu@bnl.gov	Rost, Burkhard/A-1908-2016; Liu, Qun/A-8757-2011	Rost, Burkhard/0000-0003-0179-8424; Liu, Qun/0000-0002-1179-290X; Kloss, Brian/0000-0003-0130-8739; Bruni, Renato/0000-0002-2312-0254	NIH [GM095315, GM107462]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM107462, U54GM095315] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank J. Schwanof and R. Abramowitz at NSLS beamlines X4A and X4C for their assistance in data collection, J. Love for help in initial high-throughput screening, M. Punta for help in initial target selection, M. Su for help with the phylogenetic presentation, and F. Mancia and L. Shapiro for discussions. This work was supported in part by NIH grants GM095315 and GM107462. Beamlines X4A and X4C of the NSLS at Brookhaven National Laboratory, a U. S. Department of Energy facility, is supported by the New York Structural Biology Center. Atomic coordinates and structure factor files have been deposited in the Protein Data Bank (PDB) under the accession codes 4PGR for closed-form at pH 8, 4PGS for open-form at pH 6 by soaking, 4PGU for closed/open-form at pH 7 by back-soaking, 4PGV for closed-form at pH 8 by back-soaking, and 4PGW for open-form in C222<INF>1</INF> lattice. Q. L., Y.C., and W. A. H. are inventors on a patent application filed by the New York Structural Biology Center on uses of the three-dimensional structures of BsYetJ and homology models of hBI-1.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Bateman A, 2004, NUCLEIC ACIDS RES, V32, pD138, DOI [10.1093/nar/gkh121, 10.1093/nar/gkt1223, 10.1093/nar/gkr1065, 10.1093/nar/gkp985]; Benton R, 2006, PLOS BIOL, V4, P240, DOI 10.1371/journal.pbio.0040020; Berridge MJ, 2003, NAT REV MOL CELL BIO, V4, P517, DOI 10.1038/nrm1155; Bultynck G, 2012, J BIOL CHEM, V287, P2544, DOI 10.1074/jbc.M111.275354; Carrara G, 2012, J BIOL CHEM, V287, P15896, DOI 10.1074/jbc.M111.336149; de Mattia F, 2009, MOL BIOL CELL, V20, P3638, DOI 10.1091/mbc.E09-05-0385; Distelhorst CW, 2011, CELL CALCIUM, V50, P234, DOI 10.1016/j.ceca.2011.05.011; Fiser A, 2003, METHOD ENZYMOL, V374, P461, DOI 10.1016/S0076-6879(03)74020-8; Grzmil M, 2006, J PATHOL, V208, P340, DOI 10.1002/path.1902; Grzmil M, 2003, AM J PATHOL, V163, P543, DOI 10.1016/S0002-9440(10)63682-6; Henke N, 2011, CELL CALCIUM, V50, P251, DOI 10.1016/j.ceca.2011.05.005; Holm L, 2008, BIOINFORMATICS, V24, P2780, DOI 10.1093/bioinformatics/btn507; Hou XW, 2012, SCIENCE, V338, P1308, DOI 10.1126/science.1228757; Ihara-Ohori Y, 2007, PLANT PHYSIOL, V143, P650, DOI 10.1104/pp.106.090878; Kall L, 2007, NUCLEIC ACIDS RES, V35, pW429, DOI 10.1093/nar/gkm256; Kim HR, 2008, J BIOL CHEM, V283, P15946, DOI 10.1074/jbc.M800075200; Kiviluoto S, 2012, CELL DEATH DIS, V3, DOI 10.1038/cddis.2012.103; Kiviluoto S, 2013, CELL CALCIUM, V54, P186, DOI 10.1016/j.ceca.2013.06.002; Liao J, 2012, SCIENCE, V335, P686, DOI 10.1126/science.1215759; Liu Q, 2012, SCIENCE, V336, P1033, DOI 10.1126/science.1218753; Nishizawa T, 2013, SCIENCE, V341, P168, DOI 10.1126/science.1239002; Orrenius S, 2003, NAT REV MOL CELL BIO, V4, P552, DOI 10.1038/nrm1150; Palmer AE, 2004, P NATL ACAD SCI USA, V101, P17404, DOI 10.1073/pnas.0408030101; Pryor EE, 2013, SCIENCE, V339, P1600, DOI 10.1126/science.1232048; Quigley A, 2013, SCIENCE, V339, P1604, DOI 10.1126/science.1231513; Rasmussen SGF, 2007, NATURE, V450, P383, DOI 10.1038/nature06325; Sano R, 2012, GENE DEV, V26, P1041, DOI 10.1101/gad.184325.111; Scorrano L, 2003, SCIENCE, V300, P135, DOI 10.1126/science.1081208; Senes A, 2001, P NATL ACAD SCI USA, V98, P9056, DOI 10.1073/pnas.161280798; Smaili SS, 2013, CURR MOL MED, V13, P252; Sondergaard CR, 2011, J CHEM THEORY COMPUT, V7, P2284, DOI 10.1021/ct200133y; Tanaka R, 2006, CANCER-AM CANCER SOC, V106, P648, DOI 10.1002/cncr.21639; Venkatakrishnan AJ, 2013, NATURE, V494, P185, DOI 10.1038/nature11896; VONHEIJNE G, 1992, J MOL BIOL, V225, P487, DOI 10.1016/0022-2836(92)90934-C; Waight AB, 2013, NATURE, V499, P107, DOI 10.1038/nature12233; Westphalen BC, 2005, CELL DEATH DIFFER, V12, P304, DOI 10.1038/sj.cdd.4401547; Wu MS, 2013, P NATL ACAD SCI USA, V110, P11367, DOI 10.1073/pnas.1302515110; Xu CY, 2008, J BIOL CHEM, V283, P11477, DOI 10.1074/jbc.M708385200; Xu QL, 1998, MOL CELL, V1, P337, DOI 10.1016/S1097-2765(00)80034-9	40	69	71	0	48	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 6	2014	344	6188					1131	1135		10.1126/science.1252043	http://dx.doi.org/10.1126/science.1252043			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI3UU	24904158	Green Accepted			2022-12-28	WOS:000336791200040
J	Boucher, HW; Wilcox, M; Talbot, GH; Puttagunta, S; Das, AF; Dunne, MW				Boucher, Helen W.; Wilcox, Mark; Talbot, George H.; Puttagunta, Sailaja; Das, Anita F.; Dunne, Michael W.			Once-Weekly Dalbavancin versus Daily Conventional Therapy for Skin Infection	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							DISEASES SOCIETY; COMPLICATED SKIN; GUIDELINES; AMERICA	BACKGROUND Dalbavancin, a lipoglycopeptide antibiotic agent that is active against gram-positive pathogens, has a long plasma half-life, allowing for once-weekly dosing. DISCOVER 1 and DISCOVER 2 were identically designed noninferiority trials of dalbavancin for the treatment of acute bacterial skin and skin-structure infection. METHODS We randomly assigned patients to receive dalbavancin intravenously on days 1 and 8 or vancomycin intravenously for at least 3 days with the option to switch to oral linezolid to complete 10 to 14 days of therapy. The primary end point, early clinical response, required the cessation of spread of infection-related erythema and the absence of fever at 48 to 72 hours. Secondary end points at the end of therapy included clinical status and investigator's assessment of outcome. RESULTS Analysis of the primary end point showed noninferiority of dalbavancin in both DISCOVER 1 and DISCOVER 2. In the pooled analysis, 525 of 659 patients (79.7%) in the dalbavancin group and 521 of 653 (79.8%) in the vancomycin-linezolid group had an early clinical response indicating treatment success (weighted difference, -0.1 percentage point; 95% confidence interval, -4.5 to 4.2). The outcomes were similar in the analyses by study and the pooled analyses of clinical status at the end of therapy and the investigator's assessment of outcome. For patients infected with Staphylococcus aureus, including methicillin-resistant S. aureus, clinical success was seen in 90.6% of the patients treated with dalbavancin and 93.8% of those treated with vancomycin-linezolid. Adverse events and study days with an adverse event were less frequent in the dalbavancin group than in the vancomycin-linezolid group. The most common treatment-related adverse events in either group were nausea, diarrhea, and pruritus. CONCLUSIONS Once-weekly intravenous dalbavancin was not inferior to twice-daily intravenous vancomycin followed by oral linezolid for the treatment of acute bacterial skin and skin-structure infection. (Funded by Durata Therapeutics; DISCOVER 1 and DISCOVER 2 ClinicalTrials.gov numbers, NCT01339091 and NCT01431339.)	[Boucher, Helen W.] Tufts Med Ctr, Div Infect Dis & Geog Med, Boston, MA 02111 USA; [Boucher, Helen W.] Tufts Univ, Sch Med, Boston, MA 02111 USA; [Wilcox, Mark] Leeds Teaching Hosp, Dept Microbiol, Leeds, W Yorkshire, England; [Wilcox, Mark] Univ Leeds, Old Med Sch, Leeds, W Yorkshire, England; [Talbot, George H.] Talbot Advisors, Anna Maria, FL USA; [Puttagunta, Sailaja; Dunne, Michael W.] Durata Therapeut, Branford, CT USA; [Das, Anita F.] InClin, San Mateo, CA USA	Tufts Medical Center; Tufts University; University of Leeds; University of Leeds	Boucher, HW (corresponding author), Tufts Med Ctr, 800 Washington St,Box 238, Boston, MA 02111 USA.	hboucher@tuftsmedicalcenter.org	Dunne, Michael W/AAD-7418-2020	Dunne, Michael W/0000-0001-6186-5196	Durata Therapeutics	Durata Therapeutics	Funded by Durata Therapeutics; DISCOVER 1 and DISCOVER 2 ClinicalTrials.gov numbers, NCT01339091 and NCT01431339.	Corey GR, 2010, J ANTIMICROB CHEMOTH, V65, piv41, DOI 10.1093/jac/dkq254; Daum RS, 2007, NEW ENGL J MED, V357, P1357; Daum RS, 2007, NEW ENGL J MED, V357, P380, DOI 10.1056/NEJMcp070747; Dorr MB, 2005, J ANTIMICROB CHEMOTH, V55, P25, DOI 10.1093/jac/dki008; Food and Drug Administration, 2010, GUID IND AC BACT SKI; Jauregui LE, 2005, CLIN INFECT DIS, V41, P1407, DOI 10.1086/497271; Jenkins TC, 2011, ARCH INTERN MED, V171, P1072, DOI 10.1001/archinternmed.2011.29; Jenkins TC, 2010, CLIN INFECT DIS, V51, P895, DOI 10.1086/656431; Liu C, 2011, CLIN INFECT DIS, V53, P319, DOI [10.1093/cid/cir353, 10.1093/cid/ciq146]; MIETTINEN O, 1985, STAT MED, V4, P213, DOI 10.1002/sim.4780040211; Nord CE, 2006, J ANTIMICROB CHEMOTH, V58, P627, DOI 10.1093/jac/dkl281; Prokocimer P, 2013, JAMA-J AM MED ASSOC, V309, P559, DOI 10.1001/jama.2013.241; Raad I, 2005, CLIN INFECT DIS, V40, P374, DOI 10.1086/427283; Rybak MJ, 2009, CLIN INFECT DIS, V49, P1465, DOI 10.1086/647974; Rybak Michael, 2009, Am J Health Syst Pharm, V66, P82, DOI 10.2146/ajhp080434; Seltzer E, 2003, CLIN INFECT DIS, V37, P1298, DOI 10.1086/379015; Snodgrass W R, 1937, Br Med J, V2, P101; Snodgrass WR, 1937, BRIT MED J, V1937, P1156	18	288	291	1	29	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUN 5	2014	370	23					2169	2179		10.1056/NEJMoa1310480	http://dx.doi.org/10.1056/NEJMoa1310480			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AI3AF	24897082				2022-12-28	WOS:000336729900005
J	Roberts, JA; Morales, M; Rice, L				Roberts, Jordan A.; Morales, Mariela; Rice, Lawrence			Progressive Anemia and Left Upper Quadrant Pain in a Patient With Polycythemia Vera	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							PRIMARY ANGIOSARCOMA; SPLEEN; MANAGEMENT		[Roberts, Jordan A.] Houston Methodist Hosp, Weill Cornell Med Coll, Dept Pathol & Genom Med, Houston, TX 77030 USA; [Morales, Mariela] Houston Methodist Hosp, Weill Cornell Med Coll, Dept Med, Houston, TX 77030 USA; [Rice, Lawrence] Houston Methodist Hosp, Weill Cornell Med Coll, Dept Med, Div Hematol, Houston, TX 77030 USA	Cornell University; The Methodist Hospital System; The Methodist Hospital - Houston; Cornell University; The Methodist Hospital System; The Methodist Hospital - Houston; Cornell University; The Methodist Hospital System; The Methodist Hospital - Houston	Rice, L (corresponding author), Houston Methodist Hosp, Dept Med, 6550 Fannin St,Ste 1001, Houston, TX 77030 USA.	lrice@tmhs.org						FALK S, 1993, AM J SURG PATHOL, V17, P959, DOI 10.1097/00000478-199310000-00001; Hsu JT, 2005, J SURG ONCOL, V92, P312, DOI 10.1002/jso.20419; LIPSHUTZ M, 1977, JAMA-J AM MED ASSOC, V237, P792, DOI 10.1001/jama.237.8.792; Marchioli R, 2013, NEW ENGL J MED, V368, P22, DOI 10.1056/NEJMoa1208500; Mesa RA, 2006, CANCER, V107, P361, DOI 10.1002/cncr.22021; Neuhauser TS, 2000, MODERN PATHOL, V13, P978, DOI 10.1038/modpathol.3880178; Rice L, 2006, ARCH PATHOL LAB MED, V130, P1151; WACHSTEIN M, 1953, JAMA-J AM MED ASSOC, V152, P237, DOI 10.1001/jama.1953.63690030017006h	8	1	1	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUN 4	2014	311	21					2227	2228		10.1001/jama.2014.117	http://dx.doi.org/10.1001/jama.2014.117			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AI2DU	24893091				2022-12-28	WOS:000336668400025
J	Hu, S; Shaner, MR; Beardslee, JA; Lichterman, M; Brunschwig, BS; Lewis, NS				Hu, Shu; Shaner, Matthew R.; Beardslee, Joseph A.; Lichterman, Michael; Brunschwig, Bruce S.; Lewis, Nathan S.			Amorphous TiO2 coatings stabilize Si, GaAs, and GaP photoanodes for efficient water oxidation	SCIENCE			English	Article							OXYGEN EVOLUTION REACTION; ATOMIC LAYER DEPOSITION; SEMICONDUCTOR ELECTRODES; SILICON PHOTOANODES; PHOTOELECTROCHEMICAL BEHAVIOR; HYDROGEN-PRODUCTION; NICKEL-OXIDE; THIN-FILMS; CELLS; PERFORMANCE	Although semiconductors such as silicon (Si), gallium arsenide (GaAs), and gallium phosphide (GaP) have band gaps that make them efficient photoanodes for solar fuel production, these materials are unstable in aqueous media. We show that TiO2 coatings (4 to 143 nanometers thick) grown by atomic layer deposition prevent corrosion, have electronic defects that promote hole conduction, and are sufficiently transparent to reach the light-limited performance of protected semiconductors. In conjunction with a thin layer or islands of Ni oxide electrocatalysts, Si photoanodes exhibited continuous oxidation of 1.0 molar aqueous KOH to O-2 for more than 100 hours at photocurrent densities of >30 milliamperes per square centimeter and similar to 100% Faradaic efficiency. TiO2-coated GaAs and GaP photoelectrodes exhibited photovoltages of 0.81 and 0.59 V and light-limiting photocurrent densities of 14.3 and 3.4 milliamperes per square centimeter, respectively, for water oxidation.	[Hu, Shu; Shaner, Matthew R.; Beardslee, Joseph A.; Lichterman, Michael; Lewis, Nathan S.] CALTECH, Div Chem & Chem Engn, Pasadena, CA 91125 USA; [Hu, Shu; Shaner, Matthew R.; Lichterman, Michael; Lewis, Nathan S.] CALTECH, Joint Ctr Artificial Photosynth, Pasadena, CA 91125 USA; [Brunschwig, Bruce S.; Lewis, Nathan S.] CALTECH, Beckman Inst, Pasadena, CA 91125 USA; [Brunschwig, Bruce S.; Lewis, Nathan S.] CALTECH, Mol Mat Res Ctr, Pasadena, CA 91125 USA; [Lewis, Nathan S.] CALTECH, Kavli Nanosci Inst, Pasadena, CA 91125 USA	California Institute of Technology; California Institute of Technology; California Institute of Technology; California Institute of Technology; California Institute of Technology	Lewis, NS (corresponding author), CALTECH, Div Chem & Chem Engn, Pasadena, CA 91125 USA.	nslewis@caltech.edu	Brunschwig, Bruce/G-4249-2011; Hu, Shu/B-8120-2013	Brunschwig, Bruce/0000-0002-6135-6727	Office of Science of the U.S. Department of Energy (DOE) [DE-SC0004993]; Resnick Sustainability Institute; Beckman Institute at the California Institute of Technology	Office of Science of the U.S. Department of Energy (DOE)(United States Department of Energy (DOE)); Resnick Sustainability Institute; Beckman Institute at the California Institute of Technology	This work is supported through the Office of Science of the U.S. Department of Energy (DOE) under award no. DE-SC0004993 to the Joint Center for Artificial Photosynthesis, a DOE Energy Innovation Hub. M. S. acknowledges the Resnick Sustainability Institute for a graduate fellowship, and B. S. B. acknowledges the Beckman Institute at the California Institute of Technology for support. XPS was performed at the Molecular Materials Research Center in the Beckman Institute at the California Institute of Technology. TEM imaging and spectroscopy were performed at the Center for Electron Microscopy and Microanalysis, University of Southern California. We thank H.-J. Lewerenz, C. Koval, and F. Houle for fruitful discussions; Y. Guan for secondary-ion mass spectrometry measurements; S. R. Nutt for use of the microscopy and microanalysis facility; P. D. Dapkus for the use of the metal-organic chemical vapor deposition facility; S. Ardo for help in boron-diffusion doping; and K. Papadantonakis for assistance with editing this manuscript. The authors' institution (California Institute of Technology) has filed a provisional U.S. patent application directly relating to the work described in the paper (patent application no. 61/889,430, filed on 10 October 2013).	Avasthi S, 2013, APPL PHYS LETT, V102, DOI 10.1063/1.4803446; Campbell SA, 1999, IBM J RES DEV, V43, P383, DOI 10.1147/rd.433.0383; Chen YW, 2011, NAT MATER, V10, P539, DOI [10.1038/nmat3047, 10.1038/NMAT3047]; CORRIGAN DA, 1989, J ELECTROCHEM SOC, V136, P723, DOI 10.1149/1.2096717; DECKER F, 1983, J ELECTROCHEM SOC, V130, P2173, DOI 10.1149/1.2119547; Duenas S, 2005, SEMICOND SCI TECH, V20, P1044, DOI 10.1088/0268-1242/20/10/011; FAN FRF, 1981, J ELECTROCHEM SOC, V128, P2042, DOI 10.1149/1.2127794; FAN FRF, 1983, J AM CHEM SOC, V105, P220, DOI 10.1021/ja00340a013; Ghosh HN, 1998, J PHYS CHEM B, V102, P10208, DOI 10.1021/jp983502w; Grimm RL, 2012, J PHYS CHEM C, V116, P23569, DOI 10.1021/jp308461q; Hu S, 2013, ENERG ENVIRON SCI, V6, P2984, DOI 10.1039/c3ee40453f; KAINTHLA RC, 1987, J ELECTROCHEM SOC, V134, P841, DOI 10.1149/1.2100583; Kalanyan B, 2011, ECS TRANSACTIONS, V41, P285, DOI 10.1149/1.3633679; Kenney MJ, 2013, SCIENCE, V342, P836, DOI 10.1126/science.1241327; Lee MH, 2012, ANGEW CHEM INT EDIT, V51, P10760, DOI 10.1002/anie.201203174; Lewis NS, 2013, ELECTROCHEM SOC INTE, V22, P43; MATSUMOTO Y, 1986, MATER CHEM PHYS, V14, P397, DOI 10.1016/0254-0584(86)90045-3; McCrory CCL, 2013, J AM CHEM SOC, V135, P16977, DOI 10.1021/ja407115p; McKone JR, 2014, CHEM MATER, V26, P407, DOI 10.1021/cm4021518; NAKATO Y, 1975, CHEM LETT, P883, DOI 10.1246/cl.1975.883; Paracchino A, 2011, NAT MATER, V10, P456, DOI [10.1038/NMAT3017, 10.1038/nmat3017]; Pinaud BA, 2013, ENERG ENVIRON SCI, V6, P1983, DOI 10.1039/c3ee40831k; Pourbaix M., 1966, ATLAS ELECTROCHEMICA; Scheuermann AG, 2013, ENERG ENVIRON SCI, V6, P2487, DOI 10.1039/c3ee41178h; Seger B, 2013, J AM CHEM SOC, V135, P1057, DOI 10.1021/ja309523t; Shaner MR, 2013, APPL PHYS LETT, V103, DOI 10.1063/1.4822179; Strandwitz NC, 2013, J PHYS CHEM C, V117, P4931, DOI 10.1021/jp311207x; Sun K, 2012, ENERG ENVIRON SCI, V5, P7872, DOI 10.1039/c2ee21708b; Walter MG, 2010, CHEM REV, V110, P6446, DOI 10.1021/cr1002326; Yeo BS, 2012, J PHYS CHEM C, V116, P8394, DOI 10.1021/jp3007415	30	1015	1019	36	1365	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 30	2014	344	6187					1005	1009		10.1126/science.1251428	http://dx.doi.org/10.1126/science.1251428			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AH9WM	24876492				2022-12-28	WOS:000336495800039
J	Kim, MS; Pinto, SM; Getnet, D; Nirujogi, RS; Manda, SS; Chaerkady, R; Madugundu, AK; Kelkar, DS; Isserlin, R; Jain, S; Thomas, JK; Muthusamy, B; Leal-Rojas, P; Kumar, P; Sahasrabuddhe, NA; Balakrishnan, L; Advani, J; George, B; Renuse, S; Selvan, LDN; Patil, AH; Nanjappa, V; Radhakrishnan, A; Prasad, S; Subbannayya, T; Raju, R; Kumar, M; Sreenivasamurthy, SK; Marimuthu, A; Sathe, GJ; Chavan, S; Datta, KK; Subbannayya, Y; Sahu, A; Yelamanchi, SD; Jayaram, S; Rajagopalan, P; Sharma, J; Murthy, KR; Syed, N; Goel, R; Khan, AA; Ahmad, S; Dey, G; Mudgal, K; Chatterjee, A; Huang, TC; Zhong, J; Wu, XY; Shaw, PG; Freed, D; Zahari, MS; Mukherjee, KK; Shankar, S; Mahadevan, A; Lam, H; Mitchell, CJ; Shankar, SK; Satishchandra, P; Schroeder, JT; Sirdeshmukh, R; Maitra, A; Leach, SD; Drake, CG; Halushka, MK; Prasad, TSK; Hruban, RH; Kerr, CL; Bader, GD; Iacobuzio-Donahue, CA; Gowda, H; Pandey, A				Kim, Min-Sik; Pinto, Sneha M.; Getnet, Derese; Nirujogi, Raja Sekhar; Manda, Srikanth S.; Chaerkady, Raghothama; Madugundu, Anil K.; Kelkar, Dhanashree S.; Isserlin, Ruth; Jain, Shobhit; Thomas, Joji K.; Muthusamy, Babylakshmi; Leal-Rojas, Pamela; Kumar, Praveen; Sahasrabuddhe, Nandini A.; Balakrishnan, Lavanya; Advani, Jayshree; George, Bijesh; Renuse, Santosh; Selvan, Lakshmi Dhevi N.; Patil, Arun H.; Nanjappa, Vishalakshi; Radhakrishnan, Aneesha; Prasad, Samarjeet; Subbannayya, Tejaswini; Raju, Rajesh; Kumar, Manish; Sreenivasamurthy, Sreelakshmi K.; Marimuthu, Arivusudar; Sathe, Gajanan J.; Chavan, Sandip; Datta, Keshava K.; Subbannayya, Yashwanth; Sahu, Apeksha; Yelamanchi, Soujanya D.; Jayaram, Savita; Rajagopalan, Pavithra; Sharma, Jyoti; Murthy, Krishna R.; Syed, Nazia; Goel, Renu; Khan, Aafaque A.; Ahmad, Sartaj; Dey, Gourav; Mudgal, Keshav; Chatterjee, Aditi; Huang, Tai-Chung; Zhong, Jun; Wu, Xinyan; Shaw, Patrick G.; Freed, Donald; Zahari, Muhammad S.; Mukherjee, Kanchan K.; Shankar, Subramanian; Mahadevan, Anita; Lam, Henry; Mitchell, Christopher J.; Shankar, Susarla Krishna; Satishchandra, Parthasarathy; Schroeder, John T.; Sirdeshmukh, Ravi; Maitra, Anirban; Leach, Steven D.; Drake, Charles G.; Halushka, Marc K.; Prasad, T. S. Keshava; Hruban, Ralph H.; Kerr, Candace L.; Bader, Gary D.; Iacobuzio-Donahue, Christine A.; Gowda, Harsha; Pandey, Akhilesh			A draft map of the human proteome	NATURE			English	Article							IDENTIFICATION; DATABASE; KNOWLEDGE; PROTEINS; PROJECT; TANDEM	The availability of human genome sequence has transformed biomedical research over the past decade. However, an equivalent map for the human proteome with direct measurements of proteins and peptides does not exist yet. Here we present a draft map of the human proteome using high-resolution Fourier-transform mass spectrometry. In-depth proteomic profiling of 30 histologically normal human samples, including 17 adult tissues, 7 fetal tissues and 6 purified primary haematopoietic cells, resulted in identification of proteins encoded by 17,294 genes accounting for approximately 84% of the total annotated protein-coding genes in humans. A unique and comprehensive strategy for proteogenomic analysis enabled us to discover a number of novel protein-coding regions, which includes translated pseudogenes, non-coding RNAs and upstream open reading frames. This large human proteome catalogue ( available as an interactive web-based resource at http://www.humanproteomemap.org) will complement available human genome and transcriptome data to accelerate biomedical research in health and disease.	[Kim, Min-Sik; Getnet, Derese; Chaerkady, Raghothama; Leal-Rojas, Pamela; Prasad, Samarjeet; Huang, Tai-Chung; Zhong, Jun; Wu, Xinyan; Shaw, Patrick G.; Freed, Donald; Mitchell, Christopher J.; Leach, Steven D.; Pandey, Akhilesh] Johns Hopkins Univ, Sch Med, McKusick Nathans Inst Genet Med, Baltimore, MD 21205 USA; [Kim, Min-Sik; Chaerkady, Raghothama; Wu, Xinyan; Zahari, Muhammad S.; Pandey, Akhilesh] Johns Hopkins Univ, Sch Med, Dept Biol Chem, Baltimore, MD 21205 USA; [Pinto, Sneha M.; Nirujogi, Raja Sekhar; Manda, Srikanth S.; Madugundu, Anil K.; Kelkar, Dhanashree S.; Thomas, Joji K.; Muthusamy, Babylakshmi; Kumar, Praveen; Sahasrabuddhe, Nandini A.; Balakrishnan, Lavanya; Advani, Jayshree; George, Bijesh; Renuse, Santosh; Selvan, Lakshmi Dhevi N.; Patil, Arun H.; Nanjappa, Vishalakshi; Radhakrishnan, Aneesha; Subbannayya, Tejaswini; Raju, Rajesh; Kumar, Manish; Sreenivasamurthy, Sreelakshmi K.; Marimuthu, Arivusudar; Sathe, Gajanan J.; Chavan, Sandip; Datta, Keshava K.; Subbannayya, Yashwanth; Sahu, Apeksha; Yelamanchi, Soujanya D.; Jayaram, Savita; Rajagopalan, Pavithra; Sharma, Jyoti; Murthy, Krishna R.; Syed, Nazia; Goel, Renu; Khan, Aafaque A.; Ahmad, Sartaj; Dey, Gourav; Chatterjee, Aditi; Sirdeshmukh, Ravi; Prasad, T. S. Keshava; Gowda, Harsha; Pandey, Akhilesh] Inst Bioinformat, Bangalore 560066, Karnataka, India; [Getnet, Derese; Pandey, Akhilesh] Adrienne Helis Malvin Med Res Fdn, New Orleans, LA 70130 USA; [Isserlin, Ruth; Jain, Shobhit; Bader, Gary D.] Univ Toronto, Donnelly Ctr, Toronto, ON M5S 3E1, Canada; [Leal-Rojas, Pamela] Univ La Frontera, Dept Pathol, Ctr Genet & Immunol Studies Sci & Technol Bioreso, Temuco 4811230, Chile; [Mudgal, Keshav] Univ London Imperial Coll Sci Technol & Med, Sch Med, London SW7 2AZ, England; [Mukherjee, Kanchan K.] Postgrad Inst Med Educ & Res, Dept Neurosurg, Chandigarh 160012, India; [Shankar, Subramanian] Armed Forces Med Coll, Dept Internal Med, Pune 411040, Maharashtra, India; [Mahadevan, Anita; Shankar, Susarla Krishna] Natl Inst Mental Hlth & Neurosci, Dept Neuropathol, Bangalore 560029, Karnataka, India; [Mahadevan, Anita; Shankar, Susarla Krishna] Natl Inst Mental Hlth & Neurosci, Neurobiol Res Ctr, Bangalore 560029, Karnataka, India; [Lam, Henry] Hong Kong Univ Sci & Technol, Dept Chem & Biomol Engn, Hong Kong, Hong Kong, Peoples R China; [Lam, Henry] Hong Kong Univ Sci & Technol, Div Biomed Engn, Hong Kong, Hong Kong, Peoples R China; [Satishchandra, Parthasarathy] Natl Inst Mental Hlth & Neurosci, Dept Neurol, Bangalore 560029, Karnataka, India; [Schroeder, John T.] Johns Hopkins Univ, Sch Med, Dept Med, Baltimore, MD 21224 USA; [Maitra, Anirban; Halushka, Marc K.; Hruban, Ralph H.; Iacobuzio-Donahue, Christine A.; Pandey, Akhilesh] Johns Hopkins Univ, Dept Pathol, Sol Goldman Pancreat Canc Res Ctr, Sch Med, Baltimore, MD 21231 USA; [Maitra, Anirban; Drake, Charles G.; Hruban, Ralph H.; Iacobuzio-Donahue, Christine A.; Pandey, Akhilesh] Johns Hopkins Univ, Sch Med, Dept Oncol, Baltimore, MD 21231 USA; [Leach, Steven D.; Iacobuzio-Donahue, Christine A.] Johns Hopkins Univ, Sch Med, Dept Surg, Baltimore, MD 21231 USA; [Drake, Charles G.] Johns Hopkins Univ, Sch Med, Dept Immunol, Sidney Kimmel Comprehens Canc Ctr, Baltimore, MD 21231 USA; [Drake, Charles G.] Johns Hopkins Univ, Sch Med, Dept Urol, Sidney Kimmel Comprehens Canc Ctr, Baltimore, MD 21231 USA; [Kerr, Candace L.] Johns Hopkins Univ, Sch Med, Dept Obstet & Gynecol, Baltimore, MD 21205 USA; [Pandey, Akhilesh] Diana Helis Henry Med Res Fdn, New Orleans, LA 70130 USA	Johns Hopkins University; Johns Hopkins University; University of Toronto; Universidad de La Frontera; Imperial College London; Post Graduate Institute of Medical Education & Research (PGIMER), Chandigarh; Armed Forces Medical College; National Institute of Mental Health & Neurosciences - India; National Institute of Mental Health & Neurosciences - India; Hong Kong University of Science & Technology; Hong Kong University of Science & Technology; National Institute of Mental Health & Neurosciences - India; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins Medicine; Johns Hopkins University; Johns Hopkins Medicine; Johns Hopkins University	Gowda, H (corresponding author), Inst Bioinformat, Bangalore 560066, Karnataka, India.	harsha@ibioinformatics.org; pandey@jhmi.edu	Prasad, Keshava/F-7631-2010; Madugundu, Anil Kumar/ABE-2128-2021; Kim, Min-Sik/M-3488-2016; Sreenivasamurthy, Sreelakshmi K/ABD-4253-2021; M., Srikanth/H-7457-2012; Pinto, Sneha/Q-7308-2018; RENUSE, SANTOSH/A-2072-2010; Manda, Srinivas Srikanth/AAC-1376-2022; Lam, Henry/D-8629-2011; Kim, Min-Sik/N-5010-2018; Hanumana Gouda Patil, Arun Kumar/GLU-6821-2022; Sreenivasamurthy, Sreelakshmi Kenkere/W-1942-2019; Subbannayya, Yashwanth/A-7796-2012; Khan, Aafaque/AFA-0670-2022; Muthusamy, Babylakshmi/AAS-8226-2020; Zhong, Jun/D-1662-2010; Gowda, Harsha/A-8526-2011; Chavan, Sandip/K-6889-2015; John, Arivusudar Everad/ABB-1691-2020; Subbannayya, Tejaswini/A-5524-2012; Renuse, Santosh/ABA-6792-2020; Bader, Gary/C-1176-2009; Iacobuzio-Donahue, Christine/ABF-1295-2020; Raju, Rajesh/E-1104-2014; Mir, Sartaj Ahmad/J-8933-2014; Huang, Tai-Chung/I-3730-2013	Prasad, Keshava/0000-0002-6206-2384; Madugundu, Anil Kumar/0000-0003-4274-7316; Kim, Min-Sik/0000-0001-7317-5360; Sreenivasamurthy, Sreelakshmi K/0000-0002-8891-3714; M., Srikanth/0000-0003-1690-8403; Pinto, Sneha/0000-0001-8541-8761; RENUSE, SANTOSH/0000-0002-4051-5637; Manda, Srinivas Srikanth/0000-0003-1690-8403; Lam, Henry/0000-0001-7928-0364; Kim, Min-Sik/0000-0001-7317-5360; Hanumana Gouda Patil, Arun Kumar/0000-0002-3125-8958; Subbannayya, Yashwanth/0000-0002-3885-3514; Zhong, Jun/0000-0003-3148-4143; Gowda, Harsha/0000-0002-4118-6855; Chavan, Sandip/0000-0002-8469-7882; Subbannayya, Tejaswini/0000-0002-5384-0631; Bader, Gary/0000-0003-0185-8861; Iacobuzio-Donahue, Christine/0000-0002-4672-3023; Freed, Donald/0000-0003-4534-7254; Nirujogi, Raja Sekhar/0000-0002-3177-8566; Raju, Rajesh/0000-0003-2319-121X; Mukherjee, Kanchan Kumar/0000-0001-7525-6172; Sharma, Jyoti/0000-0003-3299-9907; Mudgal, Keshav/0000-0002-6065-0617; Dey, Gourav/0000-0002-2703-699X; Khan, Aafaque Ahmad/0000-0002-8127-9677; Halushka, Marc/0000-0002-7112-7389; Mir, Sartaj Ahmad/0000-0001-6032-0936; Huang, Tai-Chung/0000-0002-1625-7295; Yelamanchi, Soujanya D./0000-0002-8477-9618; Sathe, Gajanan/0000-0002-6239-5365; Syed, Nazia/0000-0002-0396-9357	NIH [U54GM103520]; NCI's Clinical Proteomic Tumor Analysis Consortium initiative [U24CA160036]; National Heart, Lung and Blood Institute [HHSN268201000032C]; Sol Goldman Pancreatic Cancer Research Center; National Resource for Network Biology [P41GM103504]; DBT Program Support on Neuroproteomics [BT/01/COE/08/05]; NIMHANS; Council of Scientific and Industrial Research; University Grants Commission; Department of Science and Technology, Government of India; NATIONAL CANCER INSTITUTE [U24CA160036] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U54GM103520, P41GM103504, T32GM007814] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NCI's Clinical Proteomic Tumor Analysis Consortium initiative(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Heart, Lung and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Sol Goldman Pancreatic Cancer Research Center; National Resource for Network Biology; DBT Program Support on Neuroproteomics; NIMHANS; Council of Scientific and Industrial Research(Council of Scientific & Industrial Research (CSIR) - India); University Grants Commission(University Grants Commission, India); Department of Science and Technology, Government of India(Department of Science & Technology (India)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We would like to acknowledge the National Development and Research Institutes for some of the tissues. We acknowledge the assistance of V. Sandhya, V. Puttamallesh, U. Guha and B. Cole for help with analysis of some of the samples. We thank L. Lane and B. Amos for their assistance with the list of missing genes. This work was supported by an NIH roadmap grant for Technology Centers of Networks and Pathways (U54GM103520), NCI's Clinical Proteomic Tumor Analysis Consortium initiative (U24CA160036), a contract (HHSN268201000032C) from the National Heart, Lung and Blood Institute and the Sol Goldman Pancreatic Cancer Research Center. The authors acknowledge the joint participation by the Adrienne Helis Malvin Medical Research Foundation and the Diana Helis Henry Medical Research Foundation through its direct engagement in the continuous active conduct of medical research in conjunction with The Johns Hopkins Hospital and the Johns Hopkins University School of Medicine and the Foundation's Parkinson's Disease Programs. The analysis work was partially supported by the National Resource for Network Biology (P41GM103504). A.Mah., S.K.Sh., P. S. and T. S. K. P. are supported by DBT Program Support on Neuroproteomics (BT/01/COE/08/05) to IOB and NIMHANS. H. G. is a Wellcome Trust-DBT India Alliance Early Career Fellow. We thank Council of Scientific and Industrial Research, University Grants Commission and Department of Science and Technology, Government of India for research fellowships for S. M. P., R.S.N., A. R., M. K., G.J.S., S. C., P. R., J.S., S. S. M., D. S. K., S. R., S.K.Sr., K. K. D., Y.S., A. S., S.D.Y., N.S., S. A. and G.D.	Aebersold R, 2003, NATURE, V422, P198, DOI 10.1038/nature01511; Altshuler DM, 2012, NATURE, V491, P56, DOI 10.1038/nature11632; Bensimon A, 2012, ANNU REV BIOCHEM, V81, P379, DOI 10.1146/annurev-biochem-072909-100424; Branca RMM, 2014, NAT METHODS, V11, P59, DOI [10.1038/NMETH.2732, 10.1038/nmeth.2732]; Craig R, 2004, J PROTEOME RES, V3, P1234, DOI 10.1021/pr049882h; Craig R, 2004, BIOINFORMATICS, V20, P1466, DOI 10.1093/bioinformatics/bth092; Cravatt BF, 2007, NATURE, V450, P991, DOI 10.1038/nature06525; Dunham I, 2012, NATURE, V489, P57, DOI 10.1038/nature11247; ENG JK, 1994, J AM SOC MASS SPECTR, V5, P976, DOI 10.1016/1044-0305(94)80016-2; Farrah T, 2013, J PROTEOME RES, V12, P162, DOI [10.1021/Pr301012j, 10.1021/pr301012j]; Ferrington DA, 2012, PROG MOL BIOL TRANSL, V109, P75, DOI 10.1016/B978-0-12-397863-9.00003-1; Fountoulakis M, 2002, PROTEOMICS, V2, P1547, DOI 10.1002/1615-9861(200211)2:11<1547::AID-PROT1547>3.0.CO;2-M; Gaudet P, 2013, J PROTEOME RES, V12, P293, DOI 10.1021/pr300830v; Ge H, 2001, NAT GENET, V29, P482, DOI 10.1038/ng776; Gholami AM, 2013, CELL REP, V4, P609, DOI 10.1016/j.celrep.2013.07.018; Guttman M, 2013, CELL, V154, P240, DOI 10.1016/j.cell.2013.06.009; Huttlin EL, 2010, CELL, V143, P1174, DOI 10.1016/j.cell.2010.12.001; Jansen R, 2002, GENOME RES, V12, P37, DOI 10.1101/gr.205602; Kall L, 2007, NAT METHODS, V4, P923, DOI 10.1038/NMETH1113; Kalyana-Sundaram S, 2012, CELL, V149, P1622, DOI 10.1016/j.cell.2012.04.041; Kelkar DS, 2011, MOL CELL PROTEOMICS, V10, DOI [10.1074/mcp.M111.011627, 10.1074/mcp.M111.011445]; Lane L, 2014, J PROTEOME RES, V13, P15, DOI 10.1021/pr401144x; Legrain P, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M111.009993; Marko-Varga G, 2013, J PROTEOME RES, V12, P1, DOI [10.1021/pr301183aIJ, 10.1021/pr301183a]; Meyer LR, 2013, NUCLEIC ACIDS RES, V41, pD64, DOI 10.1093/nar/gks1048; Mosley AL, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M110.000687; Nagaraj N, 2012, MOL CELL PROTEOMICS, V11, DOI 10.1074/mcp.M111.013722; Olsen JV, 2005, MOL CELL PROTEOMICS, V4, P2010, DOI 10.1074/mcp.T500030-MCP200; Paik YK, 2012, NAT BIOTECHNOL, V30, P221, DOI 10.1038/nbt.2152; Pei BK, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-9-r51; Peri S, 2001, TRENDS GENET, V17, P685, DOI 10.1016/S0168-9525(01)02493-3; Perkins DN, 1999, ELECTROPHORESIS, V20, P3551, DOI 10.1002/(SICI)1522-2683(19991201)20:18<3551::AID-ELPS3551>3.0.CO;2-2; Picotti P, 2013, NATURE, V494, P266, DOI 10.1038/nature11835; Pruitt KD, 2014, NUCLEIC ACIDS RES, V42, pD756, DOI 10.1093/nar/gkt1114; Razick S, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-405; Ruepp A, 2010, NUCLEIC ACIDS RES, V38, pD497, DOI 10.1093/nar/gkp914; Shevchenko A, 2006, NAT PROTOC, V1, P2856, DOI 10.1038/nprot.2006.468; Steen H, 2004, NAT REV MOL CELL BIO, V5, P699, DOI 10.1038/nrm1468; Sugimoto J, 2013, SCI REP-UK, V3, DOI 10.1038/srep01462; Uhlen M, 2010, NAT BIOTECHNOL, V28, P1248, DOI 10.1038/nbt1210-1248; Vizcaino JA, 2013, NUCLEIC ACIDS RES, V41, pD1063, DOI 10.1093/nar/gks1262; Wang YX, 2011, PROTEOMICS, V11, P2019, DOI 10.1002/pmic.201000722; Ying WT, 2006, MOL CELL PROTEOMICS, V5, P1703, DOI 10.1074/mcp.M500344-MCP200; Zuberi K, 2013, NUCLEIC ACIDS RES, V41, pW115, DOI 10.1093/nar/gkt533	44	1431	1460	18	520	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 29	2014	509	7502					575	+		10.1038/nature13302	http://dx.doi.org/10.1038/nature13302			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AH9JC	24870542	Green Accepted			2022-12-28	WOS:000336457100040
J	Kostelecky, VA				Kostelecky, V. Alan			The magnetic proton	NATURE			English	Editorial Material							CPT; ELECTRON		[Kostelecky, V. Alan] Indiana Univ, Dept Phys, Bloomington, IN 47405 USA; [Kostelecky, V. Alan] Indiana Univ, Ctr Spacetime Symmetries, Bloomington, IN 47405 USA	Indiana University System; Indiana University Bloomington; Indiana University System; Indiana University Bloomington	Kostelecky, VA (corresponding author), Indiana Univ, Dept Phys, Bloomington, IN 47405 USA.	kostelec@indiana.edu						Bluhm R, 1998, PHYS REV D, V57, P3932, DOI 10.1103/PhysRevD.57.3932; Dehmelt H, 1999, PHYS REV LETT, V83, P4694, DOI 10.1103/PhysRevLett.83.4694; DiSciacca J, 2012, PHYS REV LETT, V108, DOI 10.1103/PhysRevLett.108.153001; Greenberg OW, 2002, PHYS REV LETT, V89, DOI 10.1103/PhysRevLett.89.231602; Hanneke D, 2008, PHYS REV LETT, V100, DOI 10.1103/PhysRevLett.100.120801; Mittleman RK, 1999, PHYS REV LETT, V83, P2116, DOI 10.1103/PhysRevLett.83.2116; Mooser A, 2014, NATURE, V509, P596, DOI 10.1038/nature13388; Ospelkaus C, 2011, NATURE, V476, P181, DOI 10.1038/nature10290; Rodegheri CC, 2012, NEW J PHYS, V14, DOI 10.1088/1367-2630/14/6/063011; WINKLER PF, 1972, PHYS REV A, V5, P83, DOI 10.1103/PhysRevA.5.83	10	0	0	0	11	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 29	2014	509	7502					571	572		10.1038/509571a	http://dx.doi.org/10.1038/509571a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AH9JC	24870538				2022-12-28	WOS:000336457100036
J	Laskin, BL; Foster, BJ				Laskin, Benjamin L.; Foster, Bethany J.			Extracorporeal therapy for the smallest children	LANCET			English	Editorial Material							ACUTE KIDNEY INJURY; MORTALITY RISK; DIALYSIS; DISEASE; CARE		[Laskin, Benjamin L.] Childrens Hosp Philadelphia, Div Nephrol, Philadelphia, PA 19104 USA; [Foster, Bethany J.] Montreal Childrens Hosp, Div Nephrol, Montreal, PQ H3H 1P3, Canada	University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; McGill University	Laskin, BL (corresponding author), Childrens Hosp Philadelphia, Div Nephrol, Philadelphia, PA 19104 USA.	laskinb@email.chop.edu			NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR001425] Funding Source: NIH RePORTER	NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS))		[Anonymous], 2011, CRIT CARE, V15, pR146; Bresolin N, 2013, PEDIATR NEPHROL, V28, P485, DOI 10.1007/s00467-012-2357-8; Brophy PD, 2001, AM J KIDNEY DIS, V38, P173, DOI 10.1053/ajkd.2001.25212; Coca SG, 2013, CLIN J AM SOC NEPHRO, V8, P173, DOI 10.2215/CJN.12621212; Foster BJ, 2011, AM J TRANSPLANT, V11, P2432, DOI 10.1111/j.1600-6143.2011.03691.x; Koyner JL, 2013, AM J KIDNEY DIS, V61, P730, DOI 10.1053/j.ajkd.2012.12.006; McBryde KD, 2006, J PEDIATR-US, V148, P770, DOI 10.1016/j.jpeds.2006.01.004; Mitsnefes MM, 2013, JAMA-J AM MED ASSOC, V309, P1921, DOI 10.1001/jama.2013.4208; National Institute of Diabetes and Digestive and Kidney Disease, NEON AC KIDN INJ WOR; Picca S, 2008, SEMIN NEPHROL, V28, P477, DOI 10.1016/j.semnephrol.2008.05.007; RONCO C, 1986, KIDNEY INT, V29, P908, DOI 10.1038/ki.1986.85; Ronco C, 2014, LANCET, V383, P1807, DOI 10.1016/S0140-6736(14)60799-6; van Stralen KJ, 2014, KIDNEY INT, V86, P168, DOI 10.1038/ki.2013.561; Zurowska AM, 2013, PEDIATR NEPHROL, V28, P1739, DOI 10.1007/s00467-012-2300-z	14	1	2	0	0	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAY 24	2014	383	9931					1785	1786		10.1016/S0140-6736(14)60650-4	http://dx.doi.org/10.1016/S0140-6736(14)60650-4			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	AH6US	24856013				2022-12-28	WOS:000336267800005
J	Cai, DF; Chen, SC; Prasad, M; He, L; Wang, XB; Choesmel-Cadamuro, V; Sawyer, JK; Danuser, G; Montell, DJ				Cai, Danfeng; Chen, Shann-Ching; Prasad, Mohit; He, Li; Wang, Xiaobo; Choesmel-Cadamuro, Valerie; Sawyer, Jessica K.; Danuser, Gaudenz; Montell, Denise J.			Mechanical Feedback through E-Cadherin Promotes Direction Sensing during Collective Cell Migration	CELL			English	Article							VE-CADHERIN; RAC; GUIDANCE; TENSION; ACTIVATION; EXPRESSION; MOVEMENT; REVEALS; GROWTH	E-cadherin is a major homophilic cell-cell adhesion molecule that inhibits motility of individual cells on matrix. However, its contribution to migration of cells through cell-rich tissues is less clear. We developed an in vivo sensor of mechanical tension across E-cadherin molecules, which we combined with cell-type-specific RNAi, photoactivatable Rac, and morphodynamic profiling, to interrogate how E-cadherin contributes to collective migration of cells between other cells. Using the Drosophila ovary as a model, we found that adhesion between border cells and their substrate, the nurse cells, functions in a positive feedback loop with Rac and actin assembly to stabilize forward-directed protrusion and directionally persistent movement. Adhesion between individual border cells communicates direction from the lead cell to the followers. Adhesion between motile cells and polar cells holds the cluster together and polarizes each individual cell. Thus, E-cadherin is an integral component of the guidance mechanisms that orchestrate collective chemotaxis in vivo.	[Cai, Danfeng; Chen, Shann-Ching; Prasad, Mohit; He, Li; Wang, Xiaobo; Sawyer, Jessica K.; Montell, Denise J.] Johns Hopkins Sch Med, Dept Biol Chem, Baltimore, MD 21205 USA; [Cai, Danfeng; Montell, Denise J.] Univ Calif Santa Barbara, Mol Cellular & Dev Biol Dept, Santa Barbara, CA 93106 USA; [Chen, Shann-Ching; Danuser, Gaudenz] Scripps Res Inst, Dept Cell Biol, La Jolla, CA 92037 USA; [Wang, Xiaobo] Univ P Sabatier Toulouse III, F-31062 Toulouse 9, France; [Wang, Xiaobo] CNRS, LBCMCP, F-31062 Toulouse 9, France	Johns Hopkins University; Johns Hopkins Medicine; University of California System; University of California Santa Barbara; Scripps Research Institute; Centre National de la Recherche Scientifique (CNRS)	Montell, DJ (corresponding author), Johns Hopkins Sch Med, Dept Biol Chem, Baltimore, MD 21205 USA.	denise.montell@lifesci.ucsb.edu	Cai, Danfeng/E-7509-2016	Cai, Danfeng/0000-0003-1623-5077; HE, LI/0000-0003-2155-606X; Sawyer, Jessica/0000-0001-9026-0559; Danuser, Gaudenz/0000-0001-8583-2014; Wang, Xiaobo/0000-0002-3311-1378	Cell Migration Consortium [GM73164, GM46425, GM64346, GM71868]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U54GM064346, R29GM046425, R01GM046425, R01GM073164, R01GM071868] Funding Source: NIH RePORTER	Cell Migration Consortium; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank the D.J.M. lab for helpful discussions and Craig Montell for insightful comments on the manuscript. We thank the Erika Matunis laboratory and Bloomington Stock Center for generous sharing of fly stocks. Peter Allen produced the artwork in Figure 7 as well as the cover art. This work was supported by grants GM73164 and GM46425 (to D.J.M.), GM64346 (Cell Migration Consortium; to D.J.M. and G.D.), and GM71868 (to G.D.).	Arboleda-Estudillo Y, 2010, CURR BIOL, V20, P161, DOI 10.1016/j.cub.2009.11.036; Birukova AA, 2012, J CELL PHYSIOL, V227, P3405, DOI 10.1002/jcp.24041; Borghi N, 2012, P NATL ACAD SCI USA, V109, P19034, DOI 10.1073/pnas.1217417109; Carmona-Fontaine C, 2008, NATURE, V456, P957, DOI 10.1038/nature07441; Conway DE, 2013, CURR BIOL, V23, P1024, DOI 10.1016/j.cub.2013.04.049; Duchek P, 2001, CELL, V107, P17, DOI 10.1016/S0092-8674(01)00502-5; Duchek P, 2001, SCIENCE, V291, P131, DOI 10.1126/science.291.5501.131; Fernandez-Espartero CH, 2013, J CELL SCI, V126, P2285, DOI 10.1242/jcs.124438; Friedl P, 2009, NAT REV MOL CELL BIO, V10, P445, DOI 10.1038/nrm2720; Fulga TA, 2002, NAT CELL BIOL, V4, P715, DOI 10.1038/ncb848; Gariano RF, 2005, NATURE, V438, P960, DOI 10.1038/nature04482; Geisbrecht ER, 2004, CELL, V118, P111, DOI 10.1016/j.cell.2004.06.020; Grashoff C, 2010, NATURE, V466, P263, DOI 10.1038/nature09198; He L, 2010, NAT CELL BIOL, V12, P1133, DOI 10.1038/ncb2124; Houk AR, 2012, CELL, V148, P175, DOI 10.1016/j.cell.2011.10.050; Iglesias PA, 2012, CURR OPIN CELL BIOL, V24, P245, DOI 10.1016/j.ceb.2011.11.009; Ji L, 2008, NAT CELL BIOL, V10, P1393, DOI 10.1038/ncb1797; Kalluri R, 2009, J CLIN INVEST, V119, P1420, DOI 10.1172/JCI39104; Kardash E, 2010, NAT CELL BIOL, V12, P47, DOI 10.1038/ncb2003; Kunwar PS, 2008, J CELL BIOL, V183, P157, DOI 10.1083/jcb.200807049; McDonald JA, 2006, DEV BIOL, V296, P94, DOI 10.1016/j.ydbio.2006.04.438; McDonald Jocelyn A., 2004, V294, P175; Meinhardt H, 1999, J CELL SCI, V112, P2867; Montell DJ, 2012, NAT REV MOL CELL BIO, V13, P631, DOI 10.1038/nrm3433; MONTELL DJ, 1992, CELL, V71, P51, DOI 10.1016/0092-8674(92)90265-E; Murphy AM, 1996, J CELL BIOL, V133, P617, DOI 10.1083/jcb.133.3.617; Ng MR, 2012, J CELL BIOL, V199, P545, DOI 10.1083/jcb.201207148; Niessen CM, 2011, PHYSIOL REV, V91, P691, DOI 10.1152/physrev.00004.2010; Niewiadomska P, 1999, J CELL BIOL, V144, P533, DOI 10.1083/jcb.144.3.533; Prasad M, 2007, NAT PROTOC, V2, P2467, DOI 10.1038/nprot.2007.363; Prasad M, 2007, DEV CELL, V12, P997, DOI 10.1016/j.devcel.2007.03.021; Rakshit S, 2012, P NATL ACAD SCI USA, V109, P18815, DOI 10.1073/pnas.1208349109; Ramel D, 2013, NAT CELL BIOL, V15, P317, DOI 10.1038/ncb2681; Riedl J, 2008, NAT METHODS, V5, P605, DOI 10.1038/nmeth.1220; Rorth P, 1998, MECH DEVELOP, V78, P113, DOI 10.1016/S0925-4773(98)00157-9; Shih WT, 2012, J CELL SCI, V125, P3661, DOI 10.1242/jcs.103861; Theveneau E, 2012, CURR OPIN CELL BIOL, V24, P677, DOI 10.1016/j.ceb.2012.08.002; Van Doren M, 1998, CURR BIOL, V8, P243; Vitorino P, 2008, GENE DEV, V22, P3268, DOI 10.1101/gad.1725808; Wang XB, 2010, NAT CELL BIOL, V12, P591, DOI 10.1038/ncb2061; Wang XJ, 2006, DEV CELL, V10, P483, DOI 10.1016/j.devcel.2006.02.003; Weber GF, 2012, DEV CELL, V22, P104, DOI 10.1016/j.devcel.2011.10.013	42	303	307	1	81	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAY 22	2014	157	5					1146	1159		10.1016/j.cell.2014.03.045	http://dx.doi.org/10.1016/j.cell.2014.03.045			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	AH9CG	24855950	Green Accepted, Bronze			2022-12-28	WOS:000336437200016
J	Hatsukade, B; Ohta, K; Endo, A; Nakanishi, K; Tamura, Y; Hashimoto, T; Kohno, K				Hatsukade, B.; Ohta, K.; Endo, A.; Nakanishi, K.; Tamura, Y.; Hashimoto, T.; Kohno, K.			Two gamma-ray bursts from dusty regions with little molecular gas	NATURE			English	Article							HIGH-METALLICITY HOST; STAR-FORMATION; CONVERSION FACTOR; GALAXY; CO; REDSHIFT; AFTERGLOW; CONSTRAINTS; DEPENDENCE; GRB-051022	Long-duration gamma-ray bursts are associated with the explosions of massive stars(1) and are accordingly expected to reside in star-forming regions with molecular gas (the fuel for star formation). Previous searches for carbon monoxide (CO), a tracer of molecular gas, in burst host galaxies did not detect any emission(2-4). Molecules have been detected as absorption in the spectra of gamma-ray burst afterglows, and the molecular gas is similar to the translucent or diffuse molecular clouds of the Milky Way(5,6). Absorption lines probe the interstellar medium only along the line of sight, so it is not clear whether the molecular gas represents the general properties of the regions where the bursts occur. Here we report spatially resolved observations of CO line emission and millimetre-wavelength continuum emission in two galaxies hosting gamma-ray bursts. The bursts happened in regions rich in dust, but not particularly rich in molecular gas. The ratio of molecular gas to dust (<9-14) is significantly lower than in star-forming regions of the Milky Way and nearby star-forming galaxies, suggesting that much of the dense gas where stars form has been dissipated by other massive stars.	[Hatsukade, B.; Nakanishi, K.; Hashimoto, T.] Natl Astron Observ Japan, Mitaka, Tokyo 1818588, Japan; [Ohta, K.] Kyoto Univ, Dept Astron, Kyoto 6068502, Japan; [Endo, A.] Delft Univ Technol, Kavli Inst NanoSci, Fac Sci Appl, NL-2628 CJ Delft, Netherlands; [Nakanishi, K.] Joint ALMA Observ, Santiago 7630355, Chile; [Nakanishi, K.] Grad Univ Adv Studies SOKENDAI, Mitaka, Tokyo 1818588, Japan; [Tamura, Y.; Kohno, K.] Univ Tokyo, Inst Astron, Mitaka, Tokyo 1810015, Japan; [Kohno, K.] Univ Tokyo, Res Ctr Early Universe, Bunkyo Ku, Tokyo 1130033, Japan	National Institutes of Natural Sciences (NINS) - Japan; National Astronomical Observatory of Japan (NAOJ); Kyoto University; Delft University of Technology; Graduate University for Advanced Studies - Japan; University of Tokyo; University of Tokyo	Hatsukade, B (corresponding author), Natl Astron Observ Japan, 2-21-1 Osawa, Mitaka, Tokyo 1818588, Japan.	bunyo.hatsukade@nao.ac.jp	Endo, Akira/AAD-2718-2019; Tamura, Yoichi/W-1382-2019; Hashimoto, Tetsuya/ABG-3643-2021	Endo, Akira/0000-0003-0379-2341; Tamura, Yoichi/0000-0003-4807-8117; Hatsukade, Bunyo/0000-0001-6469-8725; Nakanishi, Kouichiro/0000-0002-6939-0372; Hashimoto, Tetsuya/0000-0001-7228-1428	Japan Society for the Promotion of Science (JSPS) [24540230, 25103503]; NWO (Veni grant) [639.041.023]; Grants-in-Aid for Scientific Research [25103503, 24103003, 25247019] Funding Source: KAKEN	Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); NWO (Veni grant); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	We acknowledge A. Kawamura and ALMA staff members for support. We thank K. Yabe and A. Seko for discussions. B. H. was supported by a Japan Society for the Promotion of Science (JSPS) Grant-in-Aid for JSPS Fellows. K.O. was supported by a JSPS Grant-in-Aid for Scientific Research (C) (grant number 24540230). A. E. was supported by the NWO (Veni grant number 639.041.023). Y.T. was supported by JSPS Grant-in-Aid for Scientific Research on Innovative Areas (grant number 25103503). ALMA is a partnership of ESO (representing its member states), the NSF (USA) and NINS (Japan), together with NRC (Canada) and NSC and ASIAA (Taiwan), in cooperation with the Republic of Chile. The Joint ALMA Observatory is operated by ESO, AUI/NRAO and NAOJ. This research is based in part on observations made with Herschel. Herschel is an ESA space observatory with science instruments provided by European-led Principal Investigator consortia and with important participation from NASA. This research makes use of data based on observations obtained at the Gemini Observatory, which is operated by the Association of Universities for Research in Astronomy, Inc., under a cooperative agreement with the NSF on behalf of the Gemini partnership: the National Science Foundation (USA), the National Research Council (Canada), CONICYT (Chile), the Australian Research Council (Australia), the Ministerio da Ciencia, Tecnologia e Inovacao (Brazil) and the Ministerio de Ciencia, Tecnologia e Innovacion Productiva (Argentina).	Bertin E, 1996, ASTRON ASTROPHYS SUP, V117, P393, DOI 10.1051/aas:1996164; Bolatto AD, 2013, ANNU REV ASTRON ASTR, V51, P207, DOI 10.1146/annurev-astro-082812-140944; Boone F, 2011, ASTRON ASTROPHYS, V525, DOI 10.1051/0004-6361/200912723; Bothwell MS, 2013, MON NOT R ASTRON SOC, V429, P3047, DOI 10.1093/mnras/sts562; Campana S, 2012, MON NOT R ASTRON SOC, V421, P1697, DOI 10.1111/j.1365-2966.2012.20428.x; Carilli CL, 2013, ANNU REV ASTRON ASTR, V51, P105, DOI 10.1146/annurev-astro-082812-140953; Castro-Tirado AJ, 2007, ASTRON ASTROPHYS, V475, P101, DOI 10.1051/0004-6361:20066748; Cenko SB, 2009, ASTROPHYS J, V693, P1484, DOI 10.1088/0004-637X/693/2/1484; Chen HW, 2009, ASTROPHYS J, V691, P152, DOI 10.1088/0004-637X/691/1/152; Daddi E, 2010, ASTROPHYS J, V713, P686, DOI 10.1088/0004-637X/713/1/686; De Breuck C, 2003, ASTRON ASTROPHYS, V401, P911, DOI 10.1051/0004-6361:20030171; Draine BT, 2007, ASTROPHYS J, V663, P866, DOI 10.1086/518306; Dunne L, 2003, MON NOT R ASTRON SOC, V341, P589, DOI 10.1046/j.1365-8711.2003.06440.x; Elbaz D, 2011, ASTRON ASTROPHYS, V533, DOI 10.1051/0004-6361/201117239; Endo A, 2007, ASTROPHYS J, V659, P1431, DOI 10.1086/512764; Gao Y, 2004, ASTROPHYS J, V606, P271, DOI 10.1086/382999; Genzel R, 2012, ASTROPHYS J, V746, DOI 10.1088/0004-637X/746/1/69; Graham JF, 2009, AIP CONF PROC, V1133, P269, DOI 10.1063/1.3155900; Hatsukade B, 2011, ASTROPHYS J, V738, DOI 10.1088/0004-637X/738/1/33; Hatsukade B, 2012, ASTROPHYS J, V748, DOI 10.1088/0004-637X/748/2/108; Hunt LK, 2014, ASTRON ASTROPHYS, V565, DOI 10.1051/0004-6361/201323340; Jakobsson P, 2004, ASTROPHYS J, V617, pL21, DOI 10.1086/427089; Jakobsson P, 2005, ASTROPHYS J, V629, P45, DOI 10.1086/431359; Kennicutt RC, 1998, ASTROPHYS J, V498, P541, DOI 10.1086/305588; Kohno K, 2005, PUBL ASTRON SOC JPN, V57, P147, DOI 10.1093/pasj/57.1.147; Kovac A, 2006, ASTROPHYS J, V650, P592, DOI 10.1086/506341; Kruhler T, 2013, ASTRON ASTROPHYS, V557, DOI 10.1051/0004-6361/201321772; Leroy AK, 2009, ASTRON J, V137, P4670, DOI 10.1088/0004-6256/137/6/4670; Levesque EM, 2010, ASTROPHYS J LETT, V712, pL26, DOI 10.1088/2041-8205/712/1/L26; McMullin JP, 2007, ASTR SOC P, V376, P127; Melchior AL, 2013, ASTRON ASTROPHYS, V549, DOI 10.1051/0004-6361/201220204; Perley DA, 2013, ASTROPHYS J, V778, DOI 10.1088/0004-637X/778/2/172; Perley DA, 2009, ASTRON J, V138, P1690, DOI 10.1088/0004-6256/138/6/1690; Pilbratt GL, 2010, ASTRON ASTROPHYS, V518, DOI 10.1051/0004-6361/201014759; Poglitsch A, 2010, ASTRON ASTROPHYS, V518, DOI 10.1051/0004-6361/201014535; Prochaska JX, 2009, ASTROPHYS J LETT, V691, pL27, DOI 10.1088/0004-637X/691/1/L27; Rol E, 2007, ASTROPHYS J, V669, P1098, DOI 10.1086/521336; Savaglio S, 2009, ASTROPHYS J, V691, P182, DOI 10.1088/0004-637X/691/1/182; Seaquist E, 2004, MON NOT R ASTRON SOC, V349, P1428, DOI 10.1111/j.1365-2966.2004.07612.x; Silva L, 1998, ASTROPHYS J, V509, P103, DOI 10.1086/306476; Solomon PM, 2005, ANNU REV ASTRON ASTR, V43, P677, DOI 10.1146/annurev.astro.43.051804.102221; Stanek KZ, 2003, ASTROPHYS J, V591, pL17, DOI 10.1086/376976; Stanway ER, 2010, MON NOT R ASTRON SOC, V409, pL74, DOI 10.1111/j.1745-3933.2010.00951.x; Sturm R, 2011, ASTRON ASTROPHYS, V529, DOI 10.1051/0004-6361/201015967; Svensson KM, 2010, MON NOT R ASTRON SOC, V405, P57, DOI 10.1111/j.1365-2966.2010.16442.x; Symeonidis M, 2013, MON NOT R ASTRON SOC, V431, P2317, DOI 10.1093/mnras/stt330; Tacconi LJ, 2013, ASTROPHYS J, V768, DOI 10.1088/0004-637X/768/1/74; Tumlinson J, 2007, ASTROPHYS J, V668, P667, DOI 10.1086/521294; Whalen D, 2008, ASTROPHYS J, V682, P1114, DOI 10.1086/589537; WILSON CD, 1995, ASTROPHYS J, V448, pL97, DOI 10.1086/309615; Yoldas AK, 2010, ASTRON ASTROPHYS, V515, DOI 10.1051/0004-6361/201014873	51	32	32	0	7	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 12	2014	510	7504					247	+		10.1038/nature13325	http://dx.doi.org/10.1038/nature13325			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI7AT	24919918	Green Submitted			2022-12-28	WOS:000337032400045
J	Mease, PJ; Genovese, MC; Greenwald, MW; Ritchlin, CT; Beaulieu, AD; Deodhar, A; Newmark, R; Feng, JY; Erondu, N; Nirula, A				Mease, Philip J.; Genovese, Mark C.; Greenwald, Maria W.; Ritchlin, Christopher T.; Beaulieu, Andre D.; Deodhar, Atul; Newmark, Richard; Feng, JingYuan; Erondu, Ngozi; Nirula, Ajay			Brodalumab, an Anti-IL17RA Monoclonal Antibody, in Psoriatic Arthritis	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							DOUBLE-BLIND; AMG 827; EFFICACY; MODERATE; SAFETY; SECUKINUMAB; VALIDATION; RECEPTOR	BACKGROUND We assessed the efficacy and safety of brodalumab, a human monoclonal antibody against interleukin-17 receptor A (IL17RA), in a phase 2, randomized, double-blind, placebo-controlled study involving patients with psoriatic arthritis. METHODS We randomly assigned patients with active psoriatic arthritis to receive brodalumab (140 or 280 mg subcutaneously) or placebo on day 1 and at weeks 1, 2, 4, 6, 8, and 10. At week 12, patients who had not discontinued their participation in the study were offered open-label brodalumab (280 mg) every 2 weeks. The primary end point was 20% improvement in American College of Rheumatology response criteria (ACR 20) at week 12. RESULTS Of the 168 patients who underwent randomization (57 in the brodalumab 140-mg group, 56 in the brodalumab 280-mg group, and 55 in the placebo group), 159 completed the double-blind phase and 134 completed 40 weeks of the open-label extension. At week 12, the brodalumab 140-mg and 280-mg groups had higher rates of ACR 20 than the placebo group (37% [P = 0.03] and 39% [P = 0.02], respectively, vs. 18%); they also had higher rates of 50% improvement (ACR 50) (14% [P = 0.05] and 14% [P = 0.05] vs. 4%). Rates of 70% improvement were not significantly higher in the brodalumab groups. Similar degrees of improvement were noted among patients who had received previous biologic therapy and those who had not received such therapy. At week 24, ACR 20 response rates in the brodalumab 140-mg and 280-mg groups were 51% and 64%, respectively, as compared with 44% among patients who switched from placebo to open-label brodalumab; responses were sustained through week 52. At week 12, serious adverse events had occurred in 3% of patients in the brodalumab groups and in 2% of those in the placebo group. CONCLUSIONS Brodalumab significantly improved response rates among patients with psoriatic arthritis. Larger studies of longer duration are necessary to assess adverse events.	[Mease, Philip J.] Swedish Med Ctr, Seattle, WA USA; [Mease, Philip J.] Univ Washington, Seattle, WA 98195 USA; [Deodhar, Atul] Oregon Hlth & Sci Univ, Portland, OR 97201 USA; [Genovese, Mark C.] Stanford Univ, Palo Alto, CA 94304 USA; [Greenwald, Maria W.] Desert Med Adv, Palm Desert, CA USA; [Newmark, Richard; Feng, JingYuan; Erondu, Ngozi; Nirula, Ajay] Amgen Inc, Thousand Oaks, CA USA; [Ritchlin, Christopher T.] Univ Rochester, Med Ctr, Rochester, NY 14642 USA; [Beaulieu, Andre D.] Univ Laval, Quebec City, PQ, Canada	Swedish Medical Center; University of Washington; University of Washington Seattle; Oregon Health & Science University; Stanford University; Amgen; University of Rochester; Laval University	Mease, PJ (corresponding author), Seattle Rheumatol Associates, 601 Broadway,Suite 600, Seattle, WA 98122 USA.	pmease@philipmease.com		ritchlin, christopher/0000-0002-2602-1219	Amgen	Amgen(Amgen)	Supported by Amgen. Brodalumab is being codeveloped by Amgen and AstraZeneca/MedImmune.	Aletaha D, 2005, ARTHRITIS RES THER, V7, pR796, DOI 10.1186/ar1740; [Anonymous], 2012, INTRO GUIDE MEDRA VE; [Anonymous], 2010, COMMON TERMINOLOGY C; Antoni C, 2005, ANN RHEUM DIS, V64, P1150, DOI 10.1136/ard.2004.032268; Antoni CE, 2005, ARTHRITIS RHEUM, V52, P1227, DOI 10.1002/art.20967; Bluett J, 2012, CURR RHEUMATOL REP, V14, P364, DOI 10.1007/s11926-012-0255-5; Bushnell DM, 2013, J DERMATOL TREAT, V24, P356, DOI 10.3109/09546634.2012.742950; FELSON DT, 1995, ARTHRITIS RHEUM, V38, P727, DOI 10.1002/art.1780380602; GARRETT S, 1994, J RHEUMATOL, V21, P2286; Gladman DD, 2005, ANN RHEUM DIS, V64, P14, DOI 10.1136/ard.2004.032482; Gladman DD, 1998, ARTHRITIS RHEUM-US, V41, P1103, DOI 10.1002/1529-0131(199806)41:6<1103::AID-ART18>3.0.CO;2-N; Grijalva CG, 2011, JAMA-J AM MED ASSOC, V306, P2331, DOI 10.1001/jama.2011.1692; Healy PJ, 2008, ARTHRIT RHEUM-ARTHR, V59, P686, DOI 10.1002/art.23568; Husted JA, 2001, ARTHRIT RHEUM-ARTHR, V45, P151; Jandus C, 2008, ARTHRITIS RHEUM, V58, P2307, DOI 10.1002/art.23655; LEONARD DG, 1978, MAYO CLIN PROC, V53, P511; Leonardi C, 2012, NEW ENGL J MED, V366, P1190, DOI 10.1056/NEJMoa1109997; Martin ML, 2013, J DERMATOL TREAT, V24, P255, DOI 10.3109/09546634.2012.759639; McInnes IB, 2014, ANN RHEUM DIS, V73, P349, DOI 10.1136/annrheumdis-2012-202646; Mease P, 2013, CURR OPIN RHEUMATOL, V25, P287, DOI 10.1097/BOR.0b013e32835fd8d5; Mease PJ, 2004, ARTHRITIS RHEUM-US, V50, P2264, DOI 10.1002/art.20335; Mease PJ, 2005, ARTHRITIS RHEUM-US, V52, P3279, DOI 10.1002/art.21306; Papp KA, 2013, BRIT J DERMATOL, V168, P412, DOI 10.1111/bjd.12110; Papp KA, 2012, J INVEST DERMATOL, V132, P2466, DOI 10.1038/jid.2012.163; Papp KA, 2012, NEW ENGL J MED, V366, P1181, DOI 10.1056/NEJMoa1109017; Patel DD, 2013, ANN RHEUM DIS, V72, P116, DOI 10.1136/annrheumdis-2012-202371; Pavelka K, 2012, AM COLL RHEUM ANN SC; PREVOO MLL, 1995, ARTHRITIS RHEUM, V38, P44, DOI 10.1002/art.1780380107; Raychaudhuri SP, 2012, MOL CELL BIOCHEM, V359, P419, DOI 10.1007/s11010-011-1036-6; Raychaudhuri SP, 2008, AM COLL RHEUM ANN SC; Sherlock JP, 2012, NAT MED, V18, P1069, DOI 10.1038/nm.2817; Targan SR, 2012, GASTROENTEROLOGY, V143, pE26, DOI 10.1053/j.gastro.2012.07.084; Taylor W, 2006, ARTHRITIS RHEUM, V54, P2665, DOI 10.1002/art.21972; Vincent FB, 2013, ANN RHEUM DIS, V72, P165, DOI 10.1136/annrheumdis-2012-202545; von Vietinghoff S, 2008, J IMMUNOL, V181, P5183, DOI 10.4049/jimmunol.181.8.5183; Waisman A, 2012, NEW ENGL J MED, V366, P1251, DOI 10.1056/NEJMe1201071; WARE JE, 1992, MED CARE, V30, P473, DOI 10.1097/00005650-199206000-00002; Ware JE., 2007, USER S MANUAL SF 36V; Zachariae H, 2002, ACTA DERM-VENEREOL, V82, P108, DOI 10.1080/00015550252948130	39	282	302	0	16	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUN 12	2014	370	24					2295	2306		10.1056/NEJMoa1315231	http://dx.doi.org/10.1056/NEJMoa1315231			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AI7BB	24918373				2022-12-28	WOS:000337033700009
J	Estrada, K; Aukrust, I; Bjorkhaug, L; Burtt, NP; Mercader, JM; Garcia-Ortiz, H; Huerta-Chagoya, A; Moreno-Macias, H; Walford, G; Flannick, J; Williams, AL; Gomez-Vazquez, MJ; Fernandez-Lopez, JC; Martinez-Hernandez, A; Centeno-Cruz, F; Mendoza-Caamal, E; Revilla-Monsalve, C; Islas-Andrade, S; Cordova, EJ; Soberon, X; Gonzalez-Villalpando, ME; Henderson, E; Wilkens, LR; Le Marchand, L; Arellano-Campos, O; Ordonez-Sanchez, ML; Rodriguez-Torres, M; Rodriguez-Guillen, R; Riba, L; Najmi, LA; Jacobs, SBR; Fennell, T; Gabriel, S; Fontanillas, P; Hanis, CL; Lehman, DM; Jenkinson, CP; Abboud, HE; Bell, GI; Cortes, ML; Boehnke, M; Gonzalez-Villalpando, C; Orozco, L; Haiman, CA; Tusie-Luna, T; Aguilar-Salinas, CA; Altshuler, D; Njolstad, PR; Florez, JC; MacArthur, DG				Estrada, Karol; Aukrust, Ingvild; Bjorkhaug, Lise; Burtt, Noel P.; Mercader, Josep M.; Garcia-Ortiz, Humberto; Huerta-Chagoya, Alicia; Moreno-Macias, Hortensia; Walford, Geoffrey; Flannick, Jason; Williams, Amy L.; Gomez-Vazquez, Maria J.; Fernandez-Lopez, Juan C.; Martinez-Hernandez, Angelica; Centeno-Cruz, Federico; Mendoza-Caamal, Elvia; Revilla-Monsalve, Cristina; Islas-Andrade, Sergio; Cordova, Emilio J.; Soberon, Xavier; Gonzalez-Villalpando, Maria E.; Henderson, E.; Wilkens, Lynne R.; Le Marchand, Loic; Arellano-Campos, Olimpia; Ordonez-Sanchez, Maria L.; Rodriguez-Torres, Maribel; Rodriguez-Guillen, Rosario; Riba, Laura; Najmi, Laeya A.; Jacobs, Suzanne B. R.; Fennell, Timothy; Gabriel, Stacey; Fontanillas, Pierre; Hanis, Craig L.; Lehman, Donna M.; Jenkinson, Christopher P.; Abboud, Hanna E.; Bell, Graeme I.; Cortes, Maria L.; Boehnke, Michael; Gonzalez-Villalpando, Clicerio; Orozco, Lorena; Haiman, Christopher A.; Tusie-Luna, Teresa; Aguilar-Salinas, Carlos A.; Altshuler, David; Njolstad, Pal R.; Florez, Jose C.; MacArthur, Daniel G.		SIGMA Type 2 Diabet Consortium	Association of a Low-Frequency Variant in HNF1A With Type 2 Diabetes in a Latino Population	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							GENOME-WIDE ASSOCIATION; MEXICAN-AMERICANS; YOUNG MODY; RARE VARIANTS; ONSET; MUTATIONS; MELLITUS; PREVALENCE; COMMON; HNF-1-ALPHA	IMPORTANCE Latino populations have one of the highest prevalences of type 2 diabetes worldwide. OBJECTIVES To investigate the association between rare protein-coding genetic variants and prevalence of type 2 diabetes in a large Latino population and to explore potential molecular and physiological mechanisms for the observed relationships. DESIGN, SETTING, AND PARTICIPANTS Whole-exome sequencing was performed on DNA samples from 3756 Mexican and US Latino individuals (1794 with type 2 diabetes and 1962 without diabetes) recruited from 1993 to 2013. One variant was further tested for allele frequency and association with type 2 diabetes in large multiethnic data sets of 14 276 participants and characterized in experimental assays. MAIN OUTCOME AND MEASURES Prevalence of type 2 diabetes. Secondary outcomes included age of onset, body mass index, and effect on protein function. RESULTS A single rare missense variant (c.1522G>A [p.E508K]) was associated with type 2 diabetes prevalence (odds ratio [OR], 5.48; 95% Cl, 2.83-10.61; P = 4.4 x 10(-7)) in hepatocyte nuclear factor 1-a (HNF1A), the gene responsible for maturity onset diabetes of the young type 3 (MODY3). This variant was observed in 0.36% of participants without type 2 diabetes and 2.1% of participants with it. In multiethnic replication data sets, the p.E508K variant was seen only in Latino patients (n = 1443 with type 2 diabetes and 1673 without it) and was associated with type 2 diabetes (OR, 4.16; 95% Cl, 1.75-9.92; P = .0013). In experimental assays, HNF-1A protein encoding the p.E508K mutant demonstrated reduced transactivation activity of its target promoter compared with a wild-type protein. In our data, carriers and noncarriers of the p.E508K mutation with type 2 diabetes had no significant differences in compared clinical characteristics, including age at onset. The mean (SD) age for carriers was 45.3 years (11.2) vs 47.5 years (11.5) for noncarriers (P = .49) and the mean (SD) BMI for carriers was 28.2 (5.5) vs 29.3 (5.3) for noncarriers (P = .19). CONCLUSIONS AND RELEVANCE Using whole-exome sequencing, we identified a single low-frequency variant in the MODY3-causing gene HNF1A that is associated with type 2 diabetes in Latino populations and may affect protein function. This finding may have implications for screening and therapeutic modification in this population, but additional studies are required.	[Estrada, Karol; Burtt, Noel P.; Mercader, Josep M.; Flannick, Jason; Williams, Amy L.; Jacobs, Suzanne B. R.; Fontanillas, Pierre; Altshuler, David; Florez, Jose C.; MacArthur, Daniel G.] Broad Inst Harvard & MIT, Program Med & Populat Genet, Cambridge, MA USA; [Estrada, Karol] Massachusetts Gen Hosp, Analyt & Translat Genet Unit, Boston, MA 02114 USA; [Estrada, Karol; Walford, Geoffrey; Altshuler, David; Florez, Jose C.; MacArthur, Daniel G.] Harvard Univ, Sch Med, Dept Med, Boston, MA USA; [Aukrust, Ingvild; Bjorkhaug, Lise; Najmi, Laeya A.; Njolstad, Pal R.] Univ Bergen, Dept Clin Sci, KG Jebsen Ctr Diabet Res, Bergen, Norway; [Bjorkhaug, Lise; Njolstad, Pal R.] Haukeland Hosp, Dept Pediat, N-5021 Bergen, Norway; [Aukrust, Ingvild] Univ Bergen, Dept Biomed, Bergen, Norway; [Mercader, Josep M.; Walford, Geoffrey; Altshuler, David; Florez, Jose C.] Massachusetts Gen Hosp, Ctr Human Genet Res, Boston, MA 02114 USA; [Mercader, Josep M.; Walford, Geoffrey; Altshuler, David; Florez, Jose C.] Massachusetts Gen Hosp, Diabet Res Ctr, Diabet Unit, Boston, MA 02114 USA; [Mercader, Josep M.] Barcelona Supercomp Ctr, Joint BSC CRG IRB Res Program Computat Biol, Barcelona, Spain; [Garcia-Ortiz, Humberto; Fernandez-Lopez, Juan C.; Martinez-Hernandez, Angelica; Centeno-Cruz, Federico; Mendoza-Caamal, Elvia; Cordova, Emilio J.; Soberon, Xavier; Orozco, Lorena] Inst Nacl Med Genom, Mexico City, DF, Mexico; [Huerta-Chagoya, Alicia; Riba, Laura; Tusie-Luna, Teresa] UNAM INCMNSZ, UNAM Unidad Biol Mol & Med Genom, Inst Invest Biomed, Mexico City, DF, Mexico; [Moreno-Macias, Hortensia] Univ Autonoma Metropolitana, Mexico City, DF, Mexico; [Gonzalez-Villalpando, Maria E.; Gonzalez-Villalpando, Clicerio] Inst Nacl Salud Publ, Ctr Estudios Diabet, Unidad Invest Diabet & Riesgo Cardiovasc, Ctr Invest Salud Poblac, Mexico City, DF, Mexico; [Flannick, Jason; Altshuler, David] Harvard Univ, Sch Med, Dept Mol Biol, Boston, MA USA; [Williams, Amy L.] Columbia Univ, Dept Biol Sci, New York, NY 10027 USA; [Boehnke, Michael] Univ Michigan, Dept Biostat, Ctr Stat Genet, Ann Arbor, MI 48109 USA; [Henderson, E.; Haiman, Christopher A.] Univ So Calif, Keck Sch Med, Dept Prevent Med, Los Angeles, CA 90033 USA; [Gomez-Vazquez, Maria J.; Arellano-Campos, Olimpia; Ordonez-Sanchez, Maria L.; Rodriguez-Torres, Maribel; Rodriguez-Guillen, Rosario; Tusie-Luna, Teresa; Aguilar-Salinas, Carlos A.] Inst Nacl Ciencias Med & Nutr Salvador Zubiran, Secc 16, Mexico City, DF, Mexico; [Altshuler, David] Harvard Univ, Sch Med, Dept Genet, Boston, MA USA; [Altshuler, David] Massachusetts Gen Hosp, Ctr Human Genet Res, Boston, MA 02114 USA; [Altshuler, David] MIT, Dept Biol, Cambridge, MA 02139 USA; [Revilla-Monsalve, Cristina; Islas-Andrade, Sergio] Inst Mexicano Seguro Social, CMN SXXI, Unidad Invest Med Enfermedades Metab, Mexico City, DF, Mexico; [Wilkens, Lynne R.; Le Marchand, Loic] Univ Hawaii, Ctr Canc, Program Epidemiol, Honolulu, HI 96822 USA; [Najmi, Laeya A.] Haukeland Hosp, Ctr Med Genet & Mol Med, N-5021 Bergen, Norway; [Fennell, Timothy; Gabriel, Stacey; Cortes, Maria L.] Broad Inst Harvard & MIT, Cambridge, MA USA; [Hanis, Craig L.] Univ Texas Hlth Sci Ctr Houston, Ctr Human Genet, Houston, TX 77030 USA; [Lehman, Donna M.; Jenkinson, Christopher P.; Abboud, Hanna E.] Univ Texas Hlth Sci Ctr San Antonio, Dept Med, San Antonio, TX 78229 USA; [Bell, Graeme I.] Univ Chicago, Dept Human Genet, Chicago, IL 60637 USA; [Bell, Graeme I.] Univ Chicago, Dept Med, Chicago, IL 60637 USA	Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; University of Bergen; University of Bergen; Haukeland University Hospital; University of Bergen; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Barcelona Institute of Science & Technology; Institute for Research in Biomedicine - IRB Barcelona; Universitat Politecnica de Catalunya; Barcelona Supercomputer Center (BSC-CNS); Instituto Nacional de Medicina Genomica; Universidad Autonoma Metropolitana - Mexico; Instituto Nacional de Salud Publica; Harvard University; Harvard Medical School; Columbia University; University of Michigan System; University of Michigan; University of Southern California; Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran - Mexico; Harvard University; Harvard Medical School; Harvard University; Massachusetts General Hospital; Massachusetts Institute of Technology (MIT); Instituto Mexicano del Seguro Social; Cancer Research Center of Hawaii; University of Hawaii System; University of Bergen; Haukeland University Hospital; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; University of Texas System; University of Texas Health Science Center Houston; University of Texas System; University of Texas Health San Antonio; University of Chicago; University of Chicago	Florez, JC (corresponding author), Massachusetts Gen Hosp, Dept Med, Ctr Human Genet Res, Diabet Unit, Boston, MA 02114 USA.	jcflorez@partners.org	Altshuler, David M/A-4476-2009; Najmi, Laeya Abdoli/AAC-9091-2019; /ABI-8453-2020; Aukrust, Ingvild/ABG-2219-2021; Salinas, Carlos A Aguilar/AAL-4491-2020; del Rosario, Rodriguez-Guillen Maria/ADO-2554-2022; Aukrust, Ingvild/ABB-4526-2021; Fernandez, Juan Carlos/C-4976-2013; Najmi, Laeya/AAB-5487-2022; Bjørkhaug, Lise/AAA-4356-2021; Aukrust, Ingvild/AAY-9434-2020; Revilla-Monsalve, Cristina/ABG-6663-2021	Altshuler, David M/0000-0002-7250-4107; /0000-0002-9402-4219; del Rosario, Rodriguez-Guillen Maria/0000-0002-6587-5786; Fernandez, Juan Carlos/0000-0003-3680-4193; Bjørkhaug, Lise/0000-0002-9695-4559; Orozco, Lorena/0000-0002-5801-9180; Huerta-Chagoya, Alicia/0000-0001-6218-3904; Revilla Monsalve, Maria Cristina/0000-0002-6202-1160; Mercader, Josep M/0000-0001-8494-3660; Garcia-Ortiz, Humberto/0000-0002-0453-980X; Centeno Cruz, Federico/0000-0002-3512-4519; MacArthur, Daniel/0000-0002-5771-2290; Jacobs, Suzanne/0000-0002-8103-1700; Williams, Amy L./0000-0003-0737-0533	Carlos Slim Health Institute in Mexico; Consejo Nacional de Ciencia y Tecnologia [138826, 128877, CONACT-SALUD 2009-01-115250, 86867]; Direccion General de Asuntos del Personal Academic, UNAM [IT 214711]; Instituto Carlos Slim de la Salud, A.C.; National Institutes of Health (NIH) [R01HL24799]; Consejo Nacional de Ciencia y Tenologia [2092, M9303, F677-M9407, 251M, 2005-C01-14502, SALUD 2010-2-151165]; NIH [CA164973, CA054281, CA063464, R01 CA55069, R35 CA53890, R01 CA80205, R01 CA144034, U01DK085526, U01DK085501]; National Medical Research Council of Singapore; Veterans Administration Epidemiologic grant; University of Bergen; Research Council of Norway; KG Jebsen Foundation; Helse Vest; European Research Council; Instituto Carlos III, Spain; Netherlands Organization for Scientific Research [825.12.023];  [R01 DK042273];  [R01 DK047482];  [R01DK053889];  [R01 DK057295];  [P01 HL045522]	Carlos Slim Health Institute in Mexico; Consejo Nacional de Ciencia y Tecnologia(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); Direccion General de Asuntos del Personal Academic, UNAM(Universidad Nacional Autonoma de Mexico); Instituto Carlos Slim de la Salud, A.C.; National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Consejo Nacional de Ciencia y Tenologia; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Medical Research Council of Singapore(National Medical Research Council, Singapore); Veterans Administration Epidemiologic grant; University of Bergen; Research Council of Norway(Research Council of Norway); KG Jebsen Foundation; Helse Vest; European Research Council(European Research Council (ERC)European Commission); Instituto Carlos III, Spain(Instituto de Salud Carlos III); Netherlands Organization for Scientific Research(Netherlands Organization for Scientific Research (NWO)); ; ; ; ; 	The work was conducted as part of the Slim Initiative for Genomic Medicine, a project funded by the Carlos Slim Health Institute in Mexico. The UNAM/INCMNSZ Diabetes Study was supported by Consejo Nacional de Ciencia y Tecnologia grants 138826, 128877, CONACT-SALUD 2009-01-115250, and a grant from Direccion General de Asuntos del Personal Academic, UNAM, IT 214711. The Diabetes in Mexico Study was supported by Consejo Nacional de Ciencia y Tecnologia grant 86867 and by Instituto Carlos Slim de la Salud, A.C. The Mexico City Diabetes Study was supported by National Institutes of Health (NIH) grant R01HL24799 and by the Consejo Nacional de Ciencia y Tenologia grants 2092, M9303, F677-M9407, 251M, and 2005-C01-14502, SALUD 2010-2-151165. The Multiethnic Cohort was supported by NIH grants CA164973, CA054281, and CA063464. The Singapore Chinese Health Study was funded by the National Medical Research Council of Singapore under its individual research grant scheme and by NIH grants R01 CA55069, R35 CA53890, R01 CA80205, and R01 CA144034. The Type 2 Diabetes Genetic Exploration by Next-generation sequencing in multi-Ethnic Samples (T2D-GENES) project was supported by NIH grants U01DK085526 and U01DK085501. The San Antonio Mexican American Family Studies (SAMAFS) were supported by R01 DK042273, R01 DK047482, R01DK053889, R01 DK057295, P01 HL045522, and a Veterans Administration Epidemiologic grant (R.A.D). The University of Bergen, Research Council of Norway, KG Jebsen Foundation, Helse Vest, and European Research Council funded the Norwegian team. Dr Mercader was supported by Sara Borrell Fellowship from the Instituto Carlos III, Spain. Dr Estrada was supported by The Netherlands Organization for Scientific Research under the Rubicon fellowship 825.12.023.	Albrechtsen A, 2013, DIABETOLOGIA, V56, P298, DOI 10.1007/s00125-012-2756-1; Altshuler D, 2008, SCIENCE, V322, P881, DOI 10.1126/science.1156409; Altshuler DM, 2012, NATURE, V491, P56, DOI 10.1038/nature11632; Aukrust I, 2013, J BIOL CHEM, V288, P5951, DOI 10.1074/jbc.M112.393769; Barquera S, 2003, ARCH MED RES, V34, P407, DOI 10.1016/S0188-4409(03)00075-4; BAUMHUETER S, 1990, GENE DEV, V4, P372, DOI 10.1101/gad.4.3.372; Bellanne-Chantelot C, 2008, DIABETES, V57, P503, DOI 10.2337/db07-0859; Bjorkhaug L, 2003, J CLIN ENDOCR METAB, V88, P920, DOI 10.1210/jc.2002-020945; Bjorkhaug L, 2000, BIOCHEM BIOPH RES CO, V279, P792, DOI 10.1006/bbrc.2000.4024; CHOUARD T, 1990, NUCLEIC ACIDS RES, V18, P5853, DOI 10.1093/nar/18.19.5853; Cowie CC, 2006, DIABETES CARE, V29, P1263, DOI 10.2337/dc06-0062; DePristo MA, 2011, NAT GENET, V43, P491, DOI 10.1038/ng.806; Eide SA, 2008, DIABETIC MED, V25, P775, DOI 10.1111/j.1464-5491.2008.02459.x; Ellard S, 2000, HUM MUTAT, V16, P377, DOI 10.1002/1098-1004(200011)16:5<377::AID-HUMU1>3.0.CO;2-2; FALCONER DS, 1967, ANN HUM GENET, V31, P1; Fang Qi-chen, 2004, Zhonghua Yi Xue Yi Chuan Xue Za Zhi, V21, P329; Flannick J, 2013, NAT GENET, V45, P1380, DOI 10.1038/ng.2794; Forlani G, 2010, DIABETES CARE, V33, P2336, DOI 10.2337/dc10-0561; HANIS CL, 1983, AM J EPIDEMIOL, V118, P659, DOI 10.1093/oxfordjournals.aje.a113677; Hara K, 2014, HUM MOL GENET, V23, P239, DOI 10.1093/hmg/ddt399; Hegele RA, 1999, J CLIN ENDOCR METAB, V84, P1077, DOI 10.1210/jc.84.3.1077; Hunt KJ, 2011, ANN EPIDEMIOL, V21, P899, DOI 10.1016/j.annepidem.2011.07.003; Kang HM, 2010, NAT GENET, V42, P348, DOI 10.1038/ng.548; Kolonel LN, 2000, AM J EPIDEMIOL, V151, P346, DOI 10.1093/oxfordjournals.aje.a010213; Kristinsson SY, 2001, DIABETOLOGIA, V44, P2098, DOI 10.1007/s001250100016; Kropff J, 2011, DIABETOLOGIA, V54, P1261, DOI 10.1007/s00125-011-2090-z; LEDERMANN HM, 1995, DIABETOLOGIA, V38, P1482, DOI 10.1007/BF00400611; Lee S, 2012, BIOSTATISTICS, V13, P762, DOI 10.1093/biostatistics/kxs014; Li BS, 2008, AM J HUM GENET, V83, P311, DOI 10.1016/j.ajhg.2008.06.024; Lohmueller KE, 2013, AM J HUM GENET, V93, P1072, DOI 10.1016/j.ajhg.2013.11.005; Lorenzo C, 2005, DIABETES CARE, V28, P2480, DOI 10.2337/diacare.28.10.2480; Mahajan A, 2014, NAT GENET, V46, P234, DOI 10.1038/ng.2897; Mitchell BD, 1996, CIRCULATION, V94, P2159, DOI 10.1161/01.CIR.94.9.2159; Molven A, 2011, EXPERT REV MOL DIAGN, V11, P313, DOI [10.1586/ERM.10.123, 10.1586/erm.10.123]; Morris AP, 2012, NAT GENET, V44, P981, DOI 10.1038/ng.2383; Nishigori H, 1998, J HUM GENET, V43, P107, DOI 10.1007/s100380050049; Pearson ER, 2003, LANCET, V362, P1275, DOI 10.1016/S0140-6736(03)14571-0; Shepherd M, 2009, DIABETIC MED, V26, P437, DOI 10.1111/j.1464-5491.2009.02690.x; Shields BM, 2010, DIABETOLOGIA, V53, P2504, DOI 10.1007/s00125-010-1799-4; Sovik O, 1998, DIABETOLOGIA, V41, P607, DOI 10.1007/s001250050956; Steinthorsdottir V, 2014, NAT GENET, V46, P294, DOI 10.1038/ng.2882; Tennessen JA, 2012, SCIENCE, V337, P64, DOI 10.1126/science.1219240; Tonooka N, 2002, DIABETOLOGIA, V45, P1709, DOI 10.1007/s00125-002-0978-3; TRONCHE F, 1992, BIOESSAYS, V14, P579, DOI 10.1002/bies.950140902; Villalpando S, 2010, SALUD PUBLICA MEXICO, V52, pS19, DOI 10.1590/S0036-36342010000700005; Voight BF, 2010, NAT GENET, V42, P579, DOI 10.1038/ng.609; Williams AL, 2014, NATURE, V506, P97, DOI 10.1038/nature12828; Winckler W, 2007, DIABETES, V56, P685, DOI 10.2337/db06-0202; Yorifuji T, 2012, PEDIATR DIABETES, V13, P26, DOI 10.1111/j.1399-5448.2011.00827.x; Zaitlen N, 2012, BIOINFORMATICS, V28, P1729, DOI 10.1093/bioinformatics/bts259; Zuk O, 2014, P NATL ACAD SCI USA, V111, pE455, DOI 10.1073/pnas.1322563111	51	152	153	0	27	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUN 11	2014	311	22					2305	2314		10.1001/jama.2014.6511	http://dx.doi.org/10.1001/jama.2014.6511			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AI6HL	24915262	Green Accepted, Bronze			2022-12-28	WOS:000336972600022
J	Knip, M; Akerblom, HK; Becker, D; Dosch, HM; Dupre, J; Fraser, W; Howard, N; Ilonen, J; Krischer, JP; Kordonouri, O; Lawson, ML; Palmer, JP; Savilahti, E; Vaarala, O; Virtanen, SM				Knip, Mikael; Akerblom, Hans K.; Becker, Dorothy; Dosch, Hans-Michael; Dupre, John; Fraser, William; Howard, Neville; Ilonen, Jorma; Krischer, Jeffrey P.; Kordonouri, Olga; Lawson, Margaret L.; Palmer, Jerry P.; Savilahti, Erkki; Vaarala, Outi; Virtanen, Suvi M.		TRIGR Study Grp	Hydrolyzed Infant Formula and Early beta-Cell Autoimmunity A Randomized Clinical Trial	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							TYPE-1; RISK; CHILDREN; INSULIN; MILK; AUTOANTIBODIES; MOTHERS; SIGNS	IMPORTANCE The disease process leading to clinical type 1 diabetes often starts during the first years of life. Early exposure to complex dietary proteins may increase the risk of beta-cell autoimmunity in children at genetic risk for type 1 diabetes. Extensively hydrolyzed formulas do not contain intact proteins. OBJECTIVE To test the hypothesis that weaning to an extensively hydrolyzed formula decreases the cumulative incidence of diabetes-associated autoantibodies in young children. DESIGN, SETTING, AND PARTICIPANTS A double-blind randomized clinical trial of 2159 infants with HLA-conferred disease susceptibility and a first-degree relative with type 1 diabetes recruited from May 2002 to January 2007 in 78 study centers in 15 countries; 1078 were randomized to be weaned to the extensively hydrolyzed casein formula and 1081 were randomized to be weaned to a conventional cows' milk-based formula. The participants were observed to April 16, 2013. INTERVENTIONS The participants received either a casein hydrolysate or a conventional cows' milk formula supplemented with 20% of the casein hydrolysate. MAIN OUTCOMES AND MEASURES Primary outcome was positivity for at least 2 diabetes-associated autoantibodies out of 4 analyzed. Autoantibodies to insulin, glutamic acid decarboxylase, and the insulinoma-associated-2 (IA-2) molecule were analyzed using radiobinding assays and islet cell antibodies with immunofluorescence during a median observation period of 7.0 years (mean, 6.3 years). RESULTS The absolute risk of positivity for 2 or more islet autoantibodies was 13.4% among those randomized to the casein hydrolysate formula (n = 139) vs 11.4% among those randomized to the conventional formula (n = 117). The unadjusted hazard ratio for positivity for 2 or more autoantibodies among those randomized to be weaned to the casein hydrolysate was 1.21 (95% Cl, 0.94-1.54), compared with those randomized to the conventional formula, while the hazard ratio adjusted for HLA risk, duration of breastfeeding, vitamin D use, study formula duration and consumption, and region was 1.23 (95% Cl, 0.96-1.58). There were no clinically significant differences in the rate of reported adverse events between the 2 groups. CONCLUSIONS AND RELEVANCE Among infants at risk for type 1 diabetes, the use of a hydrolyzed formula, when compared with a conventional formula, did not reduce the incidence of diabetes-associated autoantibodies after 7 years. These findings do not support a benefit from hydrolyzed formula.	[Knip, Mikael; Akerblom, Hans K.; Savilahti, Erkki] Univ Helsinki, FI-00014 Helsinki, Finland; [Becker, Dorothy] Univ Pittsburgh, Pittsburgh, PA USA; [Dosch, Hans-Michael] Univ Toronto, Toronto, ON, Canada; [Dupre, John] Univ Western Ontario, London, ON, Canada; [Fraser, William] Univ Montreal, Montreal, PQ, Canada; [Howard, Neville] Childrens Hosp Westmead, Sydney, NSW, Australia; [Ilonen, Jorma] Univ Turku, Turku, Finland; [Krischer, Jeffrey P.] Univ S Florida, Tampa, FL USA; [Kordonouri, Olga] Kinder & Jugendkrankenhaus BULT, Hannover, Germany; [Lawson, Margaret L.] Childrens Hosp Eastern Ontario, Ottawa, ON K1H 8L1, Canada; [Palmer, Jerry P.] Univ Washington, Seattle, WA 98195 USA; [Vaarala, Outi; Virtanen, Suvi M.] Natl Inst Hlth & Welf, Helsinki, Finland	University of Helsinki; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; University of Toronto; Western University (University of Western Ontario); Universite de Montreal; University of Sydney; University of Turku; State University System of Florida; University of South Florida; University of Ottawa; Children's Hospital of Eastern Ontario; University of Washington; University of Washington Seattle; Finland National Institute for Health & Welfare	Knip, M (corresponding author), Univ Helsinki, Childrens Hosp, POB 22,Stenbackinkatu 11, FI-00014 Helsinki, Finland.	mikael.knip@helsinki.fi	Feig, Denice/C-4606-2015; Zlatohlávková, Blanka/K-5821-2017; Casu, Anna/S-1914-2017; Serrano Ríos, Manuel/E-4625-2019; Bilbao, Jose Ramon/A-9177-2008; Virtanen, Suvi/AAP-1922-2021; Ludvigsson, Johnny/AAI-2051-2020; Knip, Mikael/AAL-3773-2020; Tillmann, Vallo/G-8118-2012; GIORDANO, Carla/R-4296-2017; Lawson, Margaret/M-6969-2015	Zlatohlávková, Blanka/0000-0002-2131-1786; Casu, Anna/0000-0001-6924-0617; Serrano Ríos, Manuel/0000-0002-3214-1444; Bilbao, Jose Ramon/0000-0002-3176-501X; Ludvigsson, Johnny/0000-0003-1695-5234; Tillmann, Vallo/0000-0002-5279-4493; de Beaufort, Carine/0000-0003-4310-6799; Knip, Mikael/0000-0003-0474-0033; GIORDANO, Carla/0000-0003-1731-9395; Mannu, Carla/0000-0002-5421-9193; Maxwell, Cynthia/0000-0003-4734-1251; Lawson, Margaret/0000-0002-2370-9552; Songini, Marco/0000-0003-3524-645X; Hyytinen, Mila Maarit/0000-0001-5361-6421; Metzger, Daniel/0000-0002-1715-4319; Huidobro Fernandez, Belen/0000-0001-6682-4393; Ilonen, Jorma/0000-0002-9973-2062; Castano, Luis/0000-0003-0437-9401; Pitocco, Dario/0000-0002-6220-686X; Virtanen, Suvi/0000-0001-8928-0878	National Institute of Child Health and Development (NICHD), the National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health [HD040364, HD042444, HD051997]; Canadian Institutes of Health Research; Juvenile Diabetes Research Foundation International; Commission of the European Communities [QLK1-2002-00372]; European Foundation for the Study of Diabetes/Juvenile Diabetes Research Foundation/Novo Nordisk Focused Research Grant,; Academy of Finland (Centre of Excellence in Molecular Systems Immunology and Physiology Research) [250114]; Dutch Diabetes Research Foundation; Finnish Diabetes Research Foundation; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [U01HD040364, U01HD042444, R01HD051997, U01HD051997] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000448] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK017047] Funding Source: NIH RePORTER	National Institute of Child Health and Development (NICHD), the National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health; Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Juvenile Diabetes Research Foundation International(Juvenile Diabetes Research Foundation); Commission of the European Communities(European Commission); European Foundation for the Study of Diabetes/Juvenile Diabetes Research Foundation/Novo Nordisk Focused Research Grant,; Academy of Finland (Centre of Excellence in Molecular Systems Immunology and Physiology Research)(Academy of Finland); Dutch Diabetes Research Foundation; Finnish Diabetes Research Foundation; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by the National Institute of Child Health and Development (NICHD), the National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health (grant numbers HD040364, HD042444, and HD051997), Canadian Institutes of Health Research, the Juvenile Diabetes Research Foundation International, and the Commission of the European Communities (specific RID program, Quality of Life and Management of Living Resources, contract number QLK1-2002-00372 Diabetes Prevention). Other funding came from the European Foundation for the Study of Diabetes/Juvenile Diabetes Research Foundation/Novo Nordisk Focused Research Grant, Academy of Finland (Centre of Excellence in Molecular Systems Immunology and Physiology Research 2012-2017, decision no 250114), Dutch Diabetes Research Foundation, and Finnish Diabetes Research Foundation. Mead Johnson Nutrition provided the blinded color-coded study formulas.	Akerblom HK, 2011, DIABETOLOGIA, V54, P627, DOI 10.1007/s00125-010-1964-9; Akerblom HK, 2005, DIABETOLOGIA, V48, P829, DOI 10.1007/s00125-005-1733-3; ARANDA P, 1991, J DAIRY SCI, V74, P4320, DOI 10.3168/jds.S0022-0302(91)78627-X; Dabelea D, 2014, JAMA-J AM MED ASSOC, V311, P1778, DOI 10.1001/jama.2014.3201; Harjutsalo V, 2013, JAMA-J AM MED ASSOC, V310, P427, DOI 10.1001/jama.2013.8399; Holmberg H, 2007, BRIT J NUTR, V97, P111, DOI 10.1017/S0007114507210189; Karges W, 1997, DIABETES, V46, P557, DOI 10.2337/diabetes.46.4.557; Kimpimaki T, 2001, J CLIN ENDOCR METAB, V86, P4782, DOI 10.1210/jc.86.10.4782; Knip M, 2002, HORM RES, V57, P6, DOI 10.1159/000053305; Knip M, 2002, DIABETES CARE, V25, P623, DOI 10.2337/diacare.25.3.623; Knip M, 2010, NEW ENGL J MED, V363, P1900, DOI 10.1056/NEJMoa1004809; Knip M, 2010, AM J CLIN NUTR, V91, p1506S, DOI 10.3945/ajcn.2010.28701C; Kulmala P, 1998, J CLIN INVEST, V101, P327, DOI 10.1172/JCI119879; Norris JM, 2003, JAMA-J AM MED ASSOC, V290, P1713, DOI 10.1001/jama.290.13.1713; Parkkola A, 2013, DIABETES CARE, V36, P348, DOI 10.2337/dc12-0445; Patterson CC, 2009, LANCET, V373, P2027, DOI 10.1016/S0140-6736(09)60568-7; Sorkio S, 2010, DIABETES-METAB RES, V26, P206, DOI 10.1002/dmrr.1074; Vaarala O, 1999, DIABETES, V48, P1389, DOI 10.2337/diabetes.48.7.1389; Vaarala O, 2012, ARCH PEDIAT ADOL MED, V166, P608, DOI 10.1001/archpediatrics.2011.1559; Virtanen SM, 2006, DIABETOLOGIA, V49, P1512, DOI 10.1007/s00125-006-0236-1; VIRTANEN SM, 1991, DIABETES CARE, V14, P415, DOI 10.2337/diacare.14.5.415; WARRAM JH, 1984, NEW ENGL J MED, V311, P149, DOI 10.1056/NEJM198407193110304; Ziegler AG, 2003, JAMA-J AM MED ASSOC, V290, P1721, DOI 10.1001/jama.290.13.1721; Ziegler AG, 1999, DIABETES, V48, P460, DOI 10.2337/diabetes.48.3.460; Ziegler AG, 2013, JAMA-J AM MED ASSOC, V309, P2473, DOI 10.1001/jama.2013.6285	25	97	98	0	42	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUN 11	2014	311	22					2279	2287		10.1001/jama.2014.5610	http://dx.doi.org/10.1001/jama.2014.5610			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AI6HL	24915259	Green Accepted, Green Published			2022-12-28	WOS:000336972600019
J	Kourtis, AP; Read, JS; Jamieson, DJ				Kourtis, Athena P.; Read, Jennifer S.; Jamieson, Denise J.			Pregnancy and Infection	NEW ENGLAND JOURNAL OF MEDICINE			English	Review							SURVEILLANCE NETWORK FOODNET; VARICELLA-ZOSTER-VIRUS; INFLUENZA-A H1N1; RISK-FACTORS; HEPATITIS-E; PLASMODIUM-FALCIPARUM; MALARIA; WOMEN; LISTERIOSIS; HERPES	BEFORE THE ADVENT OF ANTIBIOTIC AGENTS, PREGNANCY WAS A RECOGnized risk factor for severe complications of pneumococcal pneumonia, including death. 1 The influenza pandemic of 2009 provided a more recent reminder that certain infections may disproportionately affect pregnant women. Are pregnant women at increased risk for acquiring infections? Are pregnant women with infection at increased risk for severe disease? During pregnancy, several mechanical and pathophysiological changes occur (e. g., a decrease in respiratory volumes and urinary stasis due to an enlarging uterus), and immune adaptations are required to accommodate the fetus. In this article, we review and synthesize new knowledge about the severity of and susceptibility to infections in pregnant women. We focus on the infections for which there is evidence of increased severity or susceptibility during pregnancy that is not fully explained by mechanical or anatomical changes, and we discuss these infections in light of new findings on immunologic changes during pregnancy.	[Kourtis, Athena P.; Jamieson, Denise J.] Ctr Dis Control & Prevent, Div Reprod Hlth, Natl Ctr Chron Dis Prevent & Hlth Promot, Atlanta, GA USA; [Read, Jennifer S.] Univ Calif San Francisco, Dept Epidemiol & Biostat, San Francisco, CA 94143 USA	Centers for Disease Control & Prevention - USA; University of California System; University of California San Francisco	Kourtis, AP (corresponding author), 4770 Buford Hwy NE,MS F74, Atlanta, GA 30341 USA.			Kourtis, Athena/0000-0003-1585-1310; Bates, Matthew/0000-0003-0464-1529; Jamieson, Denise/0000-0003-2597-1201	Intramural CDC HHS [CC999999] Funding Source: Medline	Intramural CDC HHS		Adam I, 2005, MALARIA J, V4, DOI 10.1186/1475-2875-4-18; Aggarwal R, 2000, J GASTROEN HEPATOL, V15, P9, DOI 10.1046/j.1440-1746.2000.02006.x; Allen RH, 2005, OBSTET GYNECOL, V106, P1187, DOI 10.1097/01.AOG.0000160481.11517.a0; Bercovitch RS, 2011, CLIN INFECT DIS, V53, P363, DOI 10.1093/cid/cir410; BRABIN BJ, 1983, B WORLD HEALTH ORGAN, V61, P1005; BRAY RS, 1979, T ROY SOC TROP MED H, V73, P427, DOI 10.1016/0035-9203(79)90170-6; BROWN ZA, 1985, AM J OBSTET GYNECOL, V153, P24, DOI 10.1016/0002-9378(85)90584-8; Brutus L, 2013, EMERG INFECT DIS, V19, P1605, DOI 10.3201/eid1910.130308; Caldwell JW, 2000, OBSTET GYNECOL, V95, P236, DOI 10.1016/S0029-7844(99)00484-6; CARDENAS I, 2009, AM J REPROD IMMUNOL, V61, P397; Cervantes-Gonzalez M, 2010, EXPERT REV ANTI-INFE, V8, P981, DOI [10.1586/eri.10.83, 10.1586/ERI.10.83]; CHASE RA, 1987, REV INFECT DIS, V9, P329; Chotivanich K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034509; CLARKE AG, 1994, IMMUNOL TODAY, V15, P545, DOI 10.1016/0167-5699(94)90212-7; Constantin CM, 2007, J IMMUNOL, V179, P4383, DOI 10.4049/jimmunol.179.7.4383; Cvoro A, 2008, J IMMUNOL, V180, P630, DOI 10.4049/jimmunol.180.1.630; Dauby N, 2012, LANCET INFECT DIS, V12, P330, DOI 10.1016/S1473-3099(11)70341-3; ENDERS G, 1984, PROG MED VIROL, V29, P166; ESMONDE TF, 1989, THORAX, V44, P812, DOI 10.1136/thx.44.10.812; Finland M, 1939, J AMER MED ASSOC, V112, P1027, DOI 10.1001/jama.1939.02800110007002; Forbes RL, 2012, THORAX, V67, P209, DOI 10.1136/thoraxjnl-2011-200708; Fried M, 1996, SCIENCE, V272, P1502, DOI 10.1126/science.272.5267.1502; GELLIN BG, 1991, AM J EPIDEMIOL, V133, P392, DOI 10.1093/oxfordjournals.aje.a115893; GILLES HM, 1969, T ROY SOC TROP MED H, V63, P1; Goulet V, 2012, CLIN INFECT DIS, V54, P652, DOI 10.1093/cid/cir902; HAAKE DA, 1990, REV INFECT DIS, V12, P788; Healy CM, 2012, CLIN OBSTET GYNECOL, V55, P474, DOI 10.1097/GRF.0b013e31824f3acb; Jamieson DJ, 2006, EMERG INFECT DIS, V12, P1638, DOI 10.3201/eid1211.060152; Kang A H, 1999, Obstet Gynecol Surv, V54, P463, DOI 10.1097/00006254-199907000-00026; Khuroo MS, 2003, J VIRAL HEPATITIS, V10, P224, DOI 10.1046/j.1365-2893.2003.00415.x; Koga K, 2009, AM J REPROD IMMUNOL, V61, P196, DOI 10.1111/j.1600-0897.2008.00682.x; Kraus TA, 2012, J CLIN IMMUNOL, V32, P300, DOI 10.1007/s10875-011-9627-2; Kumar A, 2004, INT J GYNECOL OBSTET, V85, P240, DOI 10.1016/j.ijgo.2003.11.018; Lindsay L, 2006, AM J EPIDEMIOL, V163, P838, DOI 10.1093/aje/kwj095; Lissauer D, 2012, J IMMUNOL, V189, P1072, DOI 10.4049/jimmunol.1200544; MCGREGOR IA, 1984, AM J TROP MED HYG, V33, P517, DOI 10.4269/ajtmh.1984.33.517; MEDAWAR PB, 1953, SYM SOC EXP BIOL, V7, P320; Menendez C, 2006, CURR MOL MED, V6, P269, DOI 10.2174/156652406776055186; Mor G, 2010, AM J REPROD IMMUNOL, V63, P425, DOI 10.1111/j.1600-0897.2010.00836.x; Mosby LG, 2011, AM J OBSTET GYNECOL, V205, P10, DOI 10.1016/j.ajog.2010.12.033; Munoz FM, 2013, 2 INT MAT NEON IMM S; Mylonakis E, 2002, MEDICINE, V81, P260, DOI 10.1097/00005792-200207000-00002; Neuzil KM, 1998, AM J EPIDEMIOL, V148, P1094, DOI 10.1093/oxfordjournals.aje.a009587; Ohfuji S, 2011, J INFECT DIS, V203, P1301, DOI 10.1093/infdis/jir026; Ostensen M, 2002, TRANSPL IMMUNOL, V9, P155, DOI 10.1016/S0966-3274(02)00017-5; PARYANI SG, 1986, NEW ENGL J MED, V314, P1542, DOI 10.1056/NEJM198606123142403; Patra S, 2007, ANN INTERN MED, V147, P28, DOI 10.7326/0003-4819-147-1-200707030-00005; Pouillot R, 2012, CLIN INFECT DIS, V54, pS405, DOI 10.1093/cid/cis269; Rijken MJ, 2012, LANCET INFECT DIS, V12, P75, DOI 10.1016/S1473-3099(11)70315-2; Robinson DP, 2012, HORM BEHAV, V62, P263, DOI 10.1016/j.yhbeh.2012.02.023; Rogerson SJ, 2010, ADV EXP MED BIOL, V659, P139, DOI 10.1007/978-1-4419-0981-7_12; Rolland-Harris E, 2012, EPIDEMIOL INFECT, V140, P1316, DOI 10.1017/S0950268811001737; SIEGEL M, 1973, JAMA-J AM MED ASSOC, V226, P1521, DOI 10.1001/jama.226.13.1521; Silk BJ, 2012, CLIN INFECT DIS, V54, pS396, DOI 10.1093/cid/cis268; Siston AM, 2010, JAMA-J AM MED ASSOC, V303, P1517, DOI 10.1001/jama.2010.479; SMALE LE, 1970, AM J OBSTET GYNECOL, V107, P356, DOI 10.1016/0002-9378(70)90557-0; Smith JL, 1999, J FOOD PROTECT, V62, P818, DOI 10.4315/0362-028X-62.7.818; Somerset DA, 2004, IMMUNOLOGY, V112, P38, DOI 10.1111/j.1365-2567.2004.01869.x; Sperling RS, 2012, OBSTET GYNECOL, V119, P631, DOI 10.1097/AOG.0b013e318244ed20; Straub RH, 2007, ENDOCR REV, V28, P521, DOI 10.1210/er.2007-0001; SzekeresBartho J, 1996, J REPROD IMMUNOL, V31, P81, DOI 10.1016/0165-0378(96)00964-3; Taylor SM, 2011, J INFECT DIS, V204, P1762, DOI 10.1093/infdis/jir625; TRIEBWASSER JH, 1967, MEDICINE, V46, P409, DOI 10.1097/00005792-196709000-00003; van Eijk AM, 2002, T ROY SOC TROP MED H, V96, P586, DOI 10.1016/S0035-9203(02)90319-6; VAUGHAN J. E., 1951, CALIFORNIA MED, V74, P121; WACK EE, 1988, CHEST, V94, P376, DOI 10.1378/chest.94.2.376; WEGMANN TG, 1993, IMMUNOL TODAY, V14, P353, DOI 10.1016/0167-5699(93)90235-D; Yaziji H, 1997, SOUTH MED J, V90, P347, DOI 10.1097/00007611-199703000-00019; Zoller AL, 2007, IMMUNOLOGY, V121, P207, DOI 10.1111/j.1365-2567.2006.02559.x	70	399	412	6	68	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUN 5	2014	370	23					2211	2218		10.1056/NEJMra1213566	http://dx.doi.org/10.1056/NEJMra1213566			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AI3AF	24897084	Green Accepted, Green Published			2022-12-28	WOS:000336729900009
J	Mohn, F; Sienski, G; Handler, D; Brennecke, J				Mohn, Fabio; Sienski, Grzegorz; Handler, Dominik; Brennecke, Julius			The Rhino-Deadlock-Cutoff Complex Licenses Noncanonical Transcription of Dual-Strand piRNA Clusters in Drosophila	CELL			English	Article							QUALITY-CONTROL MECHANISM; SMALL RNAS; CHROMATIN STATE; MULTIPLE ROLES; GENOME DEFENSE; PIWI; HETEROCHROMATIN; GERMLINE; PROTEIN; TRANSPOSONS	Argonaute proteins of the PIWI clade are central to transposon silencing in animal gonads. Their target specificity is defined by 23-30 nt PIWI interacting RNAs (piRNAs), which mostly originate from discrete genomic loci termed piRNA clusters. Here, we show that a complex composed of Rhino, Deadlock, and Cutoff (RDC) defines dual-strand piRNA clusters genome-wide in Drosophila ovaries. The RDC is anchored to H3K9me3-marked chromatin in part via Rhino's chromodomain. Depletion of Piwi results in loss of the RDC and small RNAs at a subset of piRNA clusters, demonstrating a feedback loop between Piwi and piRNA source loci. Intriguingly, profiles of RNA polymerase II occupancy, nascent transcription, and steady-state RNA levels reveal that the RDC licenses noncanonical transcription of dual-strand piRNA clusters. Likely, this process involves 50 end protection of nascent RNAs and suppression of transcription termination. Our data provide key insight into the regulation and evolution of piRNA clusters.	[Mohn, Fabio; Sienski, Grzegorz; Handler, Dominik; Brennecke, Julius] Austrian Acad Sci IMBA, Inst Mol Biotechnol, A-1030 Vienna, Austria	Austrian Academy of Sciences; Vienna Biocenter (VBC); Institute of Molecular Biotechnology (IMBA)	Mohn, F (corresponding author), Austrian Acad Sci IMBA, Inst Mol Biotechnol, Dr Bohrgasse 3, A-1030 Vienna, Austria.	fabio.mohn@imba.oeaw.ac.at; julius.brennecke@imba.oeaw.ac.at	Brennecke, Julius/C-1626-2015; Brennecke, Julius/T-5883-2019	Brennecke, Julius/0000-0002-5141-0814; Brennecke, Julius/0000-0002-5141-0814; Mohn, Fabio/0000-0001-9889-5225; Handler, Dominik/0000-0002-1059-4960	Austrian Academy of Sciences; European Community (ERC) [260711EU]; Austrian Science Fund (FWF) [510-B12]; SNF; HFSP; Boehringer Ingelheim Fonds; Austrian Science Fund (FWF) [Y 510] Funding Source: researchfish	Austrian Academy of Sciences; European Community (ERC)(European Research Council (ERC)); Austrian Science Fund (FWF)(Austrian Science Fund (FWF)); SNF; HFSP(Human Frontier Science Program); Boehringer Ingelheim Fonds(Boehringer Ingelheim); Austrian Science Fund (FWF)(Austrian Science Fund (FWF))	We thank F. Gruber, K. Meixner, K. Senti, J. Batki, and A. Wenger for experimental support, M. Madalinski for antibody purifications, S. Lopez for fly injections, the VDRC, the TrIP collection, the Bloomington stock center, and B. Theurkauf, T. Schupbach for flies, A. Schleiffer, D. Jurczak, and R. Sachidanandam for bioinformatics support, the CSF NGS unit for deep sequencing and P. Refsing Andersen for comments on the manuscript. This work was supported by the Austrian Academy of Sciences, the European Community's 7th Framework Programme (FP7/2007-2013; ERC grant # 260711EU) and the Austrian Science Fund (FWF; Y 510-B12). F. M. is supported by SNF and HFSP fellowships; G. S. is supported by the Boehringer Ingelheim Fonds.	Andersen PR, 2013, NAT STRUCT MOL BIOL, V20, P1367, DOI 10.1038/nsmb.2703; Beliveau BJ, 2012, P NATL ACAD SCI USA, V109, P21301, DOI 10.1073/pnas.1213818110; Brennecke J, 2008, SCIENCE, V322, P1387, DOI 10.1126/science.1165171; Brennecke J, 2007, CELL, V128, P1089, DOI 10.1016/j.cell.2007.01.043; Czech B, 2013, MOL CELL, V50, P749, DOI 10.1016/j.molcel.2013.04.007; de Vanssay A, 2012, NATURE, V490, P112, DOI 10.1038/nature11416; Grewal SIS, 2010, CURR OPIN GENET DEV, V20, P134, DOI 10.1016/j.gde.2010.02.003; IZAURRALDE E, 1994, CELL, V78, P657, DOI 10.1016/0092-8674(94)90530-4; Jiao XF, 2013, MOL CELL, V50, P104, DOI 10.1016/j.molcel.2013.02.017; Jiao XF, 2010, NATURE, V467, P608, DOI 10.1038/nature09338; Keller C, 2012, MOL CELL, V47, P215, DOI 10.1016/j.molcel.2012.05.009; Kim M, 2004, NATURE, V432, P517, DOI 10.1038/nature03041; Klattenhoff C, 2009, CELL, V138, P1137, DOI 10.1016/j.cell.2009.07.014; Lau NC, 2009, GENOME RES, V19, P1776, DOI 10.1101/gr.094896.109; Le Thomas A, 2013, GENE DEV, V27, P390, DOI 10.1101/gad.209841.112; Li XZG, 2013, MOL CELL, V50, P67, DOI 10.1016/j.molcel.2013.02.016; Malone CD, 2009, CELL, V137, P522, DOI 10.1016/j.cell.2009.03.040; Malone CD, 2009, CELL, V136, P656, DOI 10.1016/j.cell.2009.01.045; Megosh HB, 2006, CURR BIOL, V16, P1884, DOI 10.1016/j.cub.2006.08.051; Moazed D, 2009, NATURE, V457, P413, DOI 10.1038/nature07756; Muerdter F, 2012, RNA, V18, P42, DOI 10.1261/rna.029769.111; Pane A, 2011, EMBO J, V30, P4601, DOI 10.1038/emboj.2011.334; Raj A, 2008, NAT METHODS, V5, P877, DOI 10.1038/NMETH.1253; Rangan P, 2011, CURR BIOL, V21, P1373, DOI 10.1016/j.cub.2011.06.057; Robine N, 2009, CURR BIOL, V19, P2066, DOI 10.1016/j.cub.2009.11.064; Rozhkov NV, 2013, GENE DEV, V27, P400, DOI 10.1101/gad.209767.112; Senti KA, 2010, TRENDS GENET, V26, P499, DOI 10.1016/j.tig.2010.08.007; Shpiz S, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004138; Sienski G, 2012, CELL, V151, P964, DOI 10.1016/j.cell.2012.10.040; Siomi MC, 2011, NAT REV MOL CELL BIO, V12, P246, DOI 10.1038/nrm3089; Smothers JF, 2000, CURR BIOL, V10, P27, DOI 10.1016/S0960-9822(99)00260-2; Vermaak D, 2005, PLOS GENET, V1, P96, DOI 10.1371/journal.pgen.0010009; Vermaak D, 2009, ANNU REV GENET, V43, P467, DOI 10.1146/annurev-genet-102108-134802; Wang SH, 2011, P NATL ACAD SCI USA, V108, P21164, DOI 10.1073/pnas.1107892109; Wehr K, 2006, DEV BIOL, V294, P406, DOI 10.1016/j.ydbio.2006.03.002; Zhang F, 2012, CELL, V151, P871, DOI 10.1016/j.cell.2012.09.040	36	202	213	1	23	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUN 5	2014	157	6					1364	1379		10.1016/j.cell.2014.04.031	http://dx.doi.org/10.1016/j.cell.2014.04.031			16	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	AN8UV	24906153	Bronze			2022-12-28	WOS:000340881400013
J	McCartney, M				McCartney, Margaret			NO HOLDS BARRED One problem	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							CARE					margaret@margaretmccartney.com	mccartney, margaret/AAR-4727-2020	McCartney, Margaret/0000-0002-7238-6358				Barnett K, 2012, LANCET, V380, P37, DOI 10.1016/S0140-6736(12)60240-2; Dunhill L, 2013, LANCASHIRE TELE 0418; NHS Information Centre, 2006, 2006 7 UK GEN PRACT; Ross T., 2014, DAILY TELEGRAPH; University of Manchester, 2013, 7 NAT GP WORKL SURV; van Walraven C, 2010, J EVAL CLIN PRACT, V16, P947, DOI 10.1111/j.1365-2753.2009.01235.x	6	2	2	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JUN 2	2014	348								G3584	10.1136/bmj.g3584	http://dx.doi.org/10.1136/bmj.g3584			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AI7CA	24888509				2022-12-28	WOS:000337037500007
J	Kahan, T				Kahan, Thomas			Focus on blood pressure as a major risk factor	LANCET			English	Editorial Material							RESISTANT HYPERTENSION; AGE; DENERVATION		[Kahan, Thomas] Karolinska Inst, Dept Clin Sci, Danderyd Hosp, Div Cardiovasc Med, SE-18288 Stockholm, Sweden; [Kahan, Thomas] Danderyd Univ Hosp Corp, Dept Cardiol, Stockholm, Sweden	Danderyds Hospital; Karolinska Institutet; Danderyds Hospital	Kahan, T (corresponding author), Karolinska Inst, Dept Clin Sci, Danderyd Hosp, Div Cardiovasc Med, SE-18288 Stockholm, Sweden.	thomas.kahan@ds.se	Kahan, Thomas/CAE-8515-2022	Kahan, Thomas/0000-0001-9909-4956				Beckett NS, 2008, NEW ENGL J MED, V358, P1887, DOI 10.1056/NEJMoa0801369; Diao D, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006742.pub2; Elmula FEMF, 2013, HYPERTENSION, V62, P526, DOI 10.1161/HYPERTENSIONAHA.113.01452; Lewington S, 2002, LANCET, V360, P1903, DOI 10.1016/S0140-6736(02)11911-8; Lim SS, 2012, LANCET, V380, P2224, DOI 10.1016/S0140-6736(12)61766-8; Mejhert M, 2013, EUR J INTERN MED, V24, P260, DOI 10.1016/j.ejim.2012.11.015; Persu A, 2014, HYPERTENSION, V63, P1319, DOI 10.1161/HYPERTENSIONAHA.114.03194; Qvarnstrom M, 2011, J HUM HYPERTENS, V25, P484, DOI 10.1038/jhh.2010.86; Qvarnstrom M, 2013, EUR J CLIN PHARMACOL, V69, P1955, DOI 10.1007/s00228-013-1555-z; Rapsomaniki E, 2014, LANCET, V383, P1899, DOI 10.1016/S0140-6736(14)60685-1; Redon J, 1998, HYPERTENSION, V31, P712, DOI 10.1161/01.HYP.31.2.712; Strauch B, 2013, J HYPERTENS, V31, P2455, DOI 10.1097/HJH.0b013e3283652c61	12	5	5	1	6	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAY 31	2014	383	9932					1866	1868		10.1016/S0140-6736(14)60896-5	http://dx.doi.org/10.1016/S0140-6736(14)60896-5			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	AI4PR	24881978				2022-12-28	WOS:000336847800009
J	Falke, SM; Rozzi, CA; Brida, D; Maiuri, M; Amato, M; Sommer, E; De Sio, A; Rubio, A; Cerullo, G; Molinari, E; Lienau, C				Falke, Sarah Maria; Rozzi, Carlo Andrea; Brida, Daniele; Maiuri, Margherita; Amato, Michele; Sommer, Ephraim; De Sio, Antonietta; Rubio, Angel; Cerullo, Giulio; Molinari, Elisa; Lienau, Christoph			Coherent ultrafast charge transfer in an organic photovoltaic blend	SCIENCE			English	Article							PHOTOINDUCED ELECTRON-TRANSFER; EXCITON DISSOCIATION; CARRIER GENERATION; SOLAR-CELLS; POLYMER; SEPARATION; DYNAMICS; P3HT/PCBM; NETWORK; ENERGY	Blends of conjugated polymers and fullerene derivatives are prototype systems for organic photovoltaic devices. The primary charge-generation mechanism involves a light-induced ultrafast electron transfer from the light-absorbing and electron-donating polymer to the fullerene electron acceptor. Here, we elucidate the initial quantum dynamics of this process. Experimentally, we observed coherent vibrational motion of the fullerene moiety after impulsive optical excitation of the polymer donor. Comparison with first-principle theoretical simulations evidences coherent electron transfer between donor and acceptor and oscillations of the transferred charge with a 25-femtosecond period matching that of the observed vibrational modes. Our results show that coherent vibronic coupling between electronic and nuclear degrees of freedom is of key importance in triggering charge delocalization and transfer in a noncovalently bound reference system.	[Falke, Sarah Maria; Sommer, Ephraim; De Sio, Antonietta; Lienau, Christoph] Carl von Ossietzky Univ Oldenburg, Inst Phys, D-26129 Oldenburg, Germany; [Falke, Sarah Maria; Sommer, Ephraim; De Sio, Antonietta; Lienau, Christoph] Carl von Ossietzky Univ Oldenburg, Ctr Interface Sci, D-26129 Oldenburg, Germany; [Rozzi, Carlo Andrea; Molinari, Elisa] CNR, Ist Nanosci, Ctr S3, Via Campi 213a, I-41125 Modena, Italy; [Brida, Daniele; Maiuri, Margherita; Cerullo, Giulio] Politecn Milan, CNR, Dipartimento Fis, Ist Foton & Nanotecnol, I-20133 Milan, Italy; [Brida, Daniele] Univ Konstanz, Dept Phys, D-78457 Constance, Germany; [Brida, Daniele] Univ Konstanz, Ctr Appl Photon, D-78457 Constance, Germany; [Amato, Michele] Univ Paris Sud, CNRS, UMR8622, Inst Elect Fondamentale, F-91405 Orsay, France; [Rubio, Angel] Univ Basque Country, Euskal Herriko Unibertsitatea, Ctr Phys Mat, CSIC,Nanobio Spect Grp, San Sebastian 20018, Spain; [Rubio, Angel] Univ Basque Country, Euskal Herriko Unibertsitatea, European Theoret Spect Facil Sci Dev Ctr, CSIC,Nanobio Spect Grp,Dept Fis Mat,Mat Phys Ctr, San Sebastian 20018, Spain; [Rubio, Angel] Donostia Int Phys Ctr, San Sebastian 20018, Spain; [Rubio, Angel] Max Planck Gesell, Fritz Haber Inst, D-14195 Berlin, Germany; [Molinari, Elisa] Univ Modena & Reggio Emilia, Dipartimento Sci Fis Informat & Matemat, I-41125 Modena, Italy	Carl von Ossietzky Universitat Oldenburg; Carl von Ossietzky Universitat Oldenburg; Consiglio Nazionale delle Ricerche (CNR); Istituto Nanoscienze (NANO-CNR); Consiglio Nazionale delle Ricerche (CNR); Polytechnic University of Milan; University of Konstanz; University of Konstanz; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay; Consejo Superior de Investigaciones Cientificas (CSIC); University of Basque Country; Consejo Superior de Investigaciones Cientificas (CSIC); University of Basque Country; CSIC - UPV EHU - Centro de Fisica de Materiales (CFM); European Theoretical Spectroscopy Facility (ETSF); Max Planck Society; Fritz Haber Institute of the Max Planck Society; Universita di Modena e Reggio Emilia	Molinari, E (corresponding author), CNR, Ist Nanosci, Ctr S3, Via Campi 213a, I-41125 Modena, Italy.	elisa.molinari@unimore.it; christoph.lienau@uni-oldenburg.de	Molinari, Elisa/E-8834-2010; Rubio, Angel/A-5507-2008; Rozzi, Carlo Andrea/D-4390-2013; Lienau, Christoph/L-5629-2013; Brida, Daniele/AAT-6672-2020; Amato, Michele/R-2726-2016; Amato, Michele/V-3067-2019; Brida, Daniele/A-9301-2010; Maiuri, Margherita/L-1494-2016	Molinari, Elisa/0000-0002-0692-6096; Rubio, Angel/0000-0003-2060-3151; Rozzi, Carlo Andrea/0000-0001-6429-4835; Lienau, Christoph/0000-0003-3854-5025; Brida, Daniele/0000-0003-2060-5480; Amato, Michele/0000-0002-3690-3194; Amato, Michele/0000-0002-3690-3194; Brida, Daniele/0000-0003-2060-5480; Maiuri, Margherita/0000-0001-9351-8551; Cerullo, Giulio/0000-0002-9534-2702; De Sio, Antonietta/0000-0003-2363-5634	European Union project CRONOS [280879-2]; Deutsche Forschungsgemeinschaft [SPP1391]; Korea Foundation for International Cooperation of Science and Technology (Global Research Laboratory project) [K20815000003]; Italian Fondo per gli Investimenti della Ricerca di Base (Flashit project); Partnership for Advanced Computing in Europe (project LAIT); European Community [228334, INFRASTRUCTURES-2008-1]; European Research Council [ERC-2010-AdG-267374, 291198]; Grupos Consolidados [IT578-13]; Ikerbasque;  [FIS2010-21282-C02-01]	European Union project CRONOS; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Korea Foundation for International Cooperation of Science and Technology (Global Research Laboratory project); Italian Fondo per gli Investimenti della Ricerca di Base (Flashit project); Partnership for Advanced Computing in Europe (project LAIT); European Community(European Commission); European Research Council(European Research Council (ERC)European Commission); Grupos Consolidados; Ikerbasque; 	Financial support by the European Union project CRONOS (grant number 280879-2), the Deutsche Forschungsgemeinschaft (SPP1391), the Korea Foundation for International Cooperation of Science and Technology (Global Research Laboratory project, K20815000003), and the Italian Fondo per gli Investimenti della Ricerca di Base (Flashit project) is gratefully acknowledged. C. A. R. and E. M. acknowledge the Partnership for Advanced Computing in Europe (project LAIT) for awarding us access to supercomputing resources at CINECA, Italy, and useful discussions with C. Cocchi and Y. Kanai. S. M. F. is grateful for a Ph.D. fellowship from Stiftung der Metallindustrie im Nord-Westen. C. L. and G. C. acknowledge support from the European Community (Seventh Framework Programme INFRASTRUCTURES-2008-1, Laserlab Europe II contract no. 228334); A. R. acknowledges financial support from the European Research Council (ERC-2010-AdG-267374), Spanish grant (FIS2010-21282-C02-01), Grupos Consolidados (IT578-13), Ikerbasque. G. C. acknowledges financial support by the European Research Council (ERC-2011-AdG no. 291198). C. L., S. M. F., G. C., C. A. R., and E. M. initiated this work. S. M. F. prepared the samples. S. M. F., D. B., M. M., E. S., and A. D. S. performed the ultrafast spectroscopy experiments. C. A. R. and M. A. performed DFT and TDDFT simulations. S. M. F., A. D. S., D. B., G. C., and C. L. analyzed and discussed the experimental data. C. A. R., M. A., E. M., and A. R. analyzed and discussed the theoretical data. C. A. R., E. M., G. C., A. D. S., and C. L. designed the paper. All authors discussed the implications and contributed to the writing of the paper. The authors declare no competing financial interests.	Andrade X, 2009, J CHEM THEORY COMPUT, V5, P728, DOI 10.1021/ct800518j; Bakulin AA, 2012, SCIENCE, V335, P1340, DOI 10.1126/science.1217745; Beenken WJD, 2013, PHYS CHEM CHEM PHYS, V15, P16494, DOI 10.1039/c3cp42236d; BETHUNE DS, 1990, CHEM PHYS LETT, V174, P219, DOI 10.1016/0009-2614(90)85335-A; Brabec CJ, 2010, ADV MATER, V22, P3839, DOI 10.1002/adma.200903697; Brabec CJ, 2001, CHEM PHYS LETT, V340, P232, DOI 10.1016/S0009-2614(01)00431-6; Brown PJ, 2003, PHYS REV B, V67, DOI 10.1103/PhysRevB.67.064203; Castro A, 2006, PHYS STATUS SOLIDI B, V243, P2465, DOI 10.1002/pssb.200642067; Clark J, 2007, PHYS REV LETT, V98, DOI 10.1103/PhysRevLett.98.206406; Collini E, 2010, NATURE, V463, P644, DOI 10.1038/nature08811; Collini E, 2009, SCIENCE, V323, P369, DOI 10.1126/science.1164016; Cook S, 2009, J PHYS CHEM C, V113, P2547, DOI 10.1021/jp8050774; Dennler G, 2009, ADV MATER, V21, P1323, DOI 10.1002/adma.200801283; Falke S, 2011, J RAMAN SPECTROSC, V42, P1897, DOI 10.1002/jrs.2966; Gelinas S, 2014, SCIENCE, V343, P512, DOI 10.1126/science.1246249; Grancini G, 2013, NAT MATER, V12, P29, DOI [10.1038/NMAT3502, 10.1038/nmat3502]; Grzegorczyk WJ, 2010, J PHYS CHEM C, V114, P5182, DOI 10.1021/jp9119364; Guo JM, 2010, J AM CHEM SOC, V132, P6154, DOI 10.1021/ja100302p; Hallermann M, 2008, APPL PHYS LETT, V93, DOI 10.1063/1.2969295; Howard IA, 2010, J AM CHEM SOC, V132, P14866, DOI 10.1021/ja105260d; Hwang IW, 2008, J PHYS CHEM C, V112, P4350, DOI 10.1021/jp075565x; Hwang IW, 2007, ADV MATER, V19, P2307, DOI 10.1002/adma.200602437; Jailaubekov AE, 2013, NAT MATER, V12, P66, DOI [10.1038/NMAT3500, 10.1038/nmat3500]; Kanai Y, 2010, J MATER CHEM, V20, P1053, DOI 10.1039/b913277p; Lee H, 2007, SCIENCE, V316, P1462, DOI 10.1126/science.1142188; Ma WL, 2005, ADV FUNCT MATER, V15, P1617, DOI 10.1002/adfm.200500211; Manzoni C, 2006, REV SCI INSTRUM, V77, DOI 10.1063/1.2167128; MARCUS RA, 1993, ANGEW CHEM INT EDIT, V32, P1111, DOI 10.1002/anie.199311113; Dang MT, 2011, ADV MATER, V23, P3597, DOI 10.1002/adma.201100792; Pandey L, 2012, MACROMOLECULES, V45, P6405, DOI 10.1021/ma301164e; Ren J, 2012, NANO RES, V5, P248, DOI 10.1007/s12274-012-0204-7; Rozzi CA, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2603; SARICIFTCI NS, 1992, SCIENCE, V258, P1474, DOI 10.1126/science.258.5087.1474; Scholes GD, 2011, NAT CHEM, V3, P763, DOI [10.1038/NCHEM.1145, 10.1038/nchem.1145]; Tamura H, 2013, J PHYS CHEM C, V117, P15020, DOI 10.1021/jp406224a; Tamura H, 2012, J CHEM PHYS, V137, DOI 10.1063/1.4751486; Tamura H, 2011, J PHYS CHEM C, V115, P10205, DOI 10.1021/jp203174e; YU G, 1995, SCIENCE, V270, P1789, DOI 10.1126/science.270.5243.1789	38	411	413	14	497	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 30	2014	344	6187					1001	1005		10.1126/science.1249771	http://dx.doi.org/10.1126/science.1249771			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AH9WM	24876491	Green Published			2022-12-28	WOS:000336495800038
J	Sedgwick, P				Sedgwick, Philip			Understanding statistical hypothesis testing	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							QUESTION		Univ London, Ctr Med & Healthcare Educ, London, England	St Georges University London; University of London	Sedgwick, P (corresponding author), Univ London, Ctr Med & Healthcare Educ, London, England.	p.sedgwick@sgul.ac.uk	Sedgwick, Philip/C-6997-2019	Sedgwick, Philip/0000-0001-8859-2175				Fagerstrom K, 2010, BMJ-BRIT MED J, V341, DOI 10.1136/bmj.c6549; Sedgwick P, 2014, BMJ-BRIT MED J, V348, DOI 10.1136/bmj.g2130; Sedgwick P, 2013, BMJ-BRIT MED J, V347, DOI 10.1136/bmj.f6282	3	12	12	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	MAY 30	2014	348								g3557	10.1136/bmj.g3557	http://dx.doi.org/10.1136/bmj.g3557			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AI3EO	24879817				2022-12-28	WOS:000336742800004
J	Holmes, D				Holmes, David			Raymond Vanholder: a titan of uraemic toxicity	LANCET			English	Biographical-Item																			0	0	0	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	MAY 24	2014	383	9931					1797	1797		10.1016/S0140-6736(14)60869-2	http://dx.doi.org/10.1016/S0140-6736(14)60869-2			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AH6US	24856017				2022-12-28	WOS:000336267800012
J	Baillie, JK				Baillie, J. Kenneth			Targeting the host immune response to fight infection	SCIENCE			English	Editorial Material							VIRUS; RESISTANCE; GENOME		[Baillie, J. Kenneth] Univ Edinburgh, Roslin Inst, Roslin EH25 9RG, Midlothian, Scotland; [Baillie, J. Kenneth] Royal Infirm Edinburgh NHS Trust, Intens Care Unit, Edinburgh EH16 4SA, Midlothian, Scotland	UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Roslin Institute; University of Edinburgh; Royal Infirmary of Edinburgh; University of Edinburgh	Baillie, JK (corresponding author), Univ Edinburgh, Roslin Inst, Roslin EH25 9RG, Midlothian, Scotland.	j.k.baillie@ed.ac.uk	Baillie, John Kenneth/F-3124-2011; Baillie, Kenneth/AEK-6650-2022	Baillie, John Kenneth/0000-0001-5258-793X; Baillie, Kenneth/0000-0001-5258-793X				Alejandria MM, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001090.pub2; Andersson R, 2014, NATURE, V507, P455, DOI 10.1038/nature12787; Angus DC, 2013, NEW ENGL J MED, V369, P840, DOI [10.1056/NEJMc1312359, 10.1056/NEJMra1208623]; Bousfiha A, 2010, CLIN IMMUNOL, V135, P204, DOI 10.1016/j.clim.2010.02.001; Brass AL, 2009, CELL, V139, P1243, DOI 10.1016/j.cell.2009.12.017; Busse PJ, 2002, J ALLERGY CLIN IMMUN, V109, P1001, DOI 10.1067/mai.2002.124999; Chaigne-Delalande B, 2013, SCIENCE, V341, P186, DOI 10.1126/science.1240094; Dunham I, 2012, NATURE, V489, P57, DOI 10.1038/nature11247; Everitt AR, 2012, NATURE, V484, P519, DOI 10.1038/nature10921; Forrest ARR, 2014, NATURE, V507, P462, DOI 10.1038/nature13182; Hutter G, 2009, NEW ENGL J MED, V360, P692, DOI 10.1056/NEJMoa0802905; Li QS, 2009, P NATL ACAD SCI USA, V106, P16410, DOI 10.1073/pnas.0907439106; Renzette N, 2014, J VIROL, V88, P272, DOI 10.1128/JVI.01067-13; Shapira SD, 2009, CELL, V139, P1255, DOI 10.1016/j.cell.2009.12.018; SORENSEN TIA, 1988, NEW ENGL J MED, V318, P727, DOI 10.1056/NEJM198803243181202	15	18	18	0	13	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 23	2014	344	6186					807	808		10.1126/science.1255074	http://dx.doi.org/10.1126/science.1255074			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AH6IL	24855243				2022-12-28	WOS:000336233800015
J	Eakin, CM				Eakin, C. Mark			Lamarck was partially right-and that is good for corals	SCIENCE			English	Editorial Material							REEF		NOAA, Ctr Satellite Applicat & Res, College Pk, MD 20740 USA	National Oceanic Atmospheric Admin (NOAA) - USA	Eakin, CM (corresponding author), NOAA, Ctr Satellite Applicat & Res, College Pk, MD 20740 USA.	mark.eakin@noaa.gov	Eakin, C. Mark/F-5585-2010	Eakin, C. Mark/0000-0002-5987-0858				Barshis DJ, 2010, MOL ECOL, V19, P1705, DOI 10.1111/j.1365-294X.2010.04574.x; Barshis DJ, 2013, P NATL ACAD SCI USA, V110, P1387, DOI 10.1073/pnas.1210224110; Berger SL, 2009, GENE DEV, V23, P781, DOI 10.1101/gad.1787609; Dodge RE, 2008, SCIENCE, V322, P189, DOI 10.1126/science.322.5899.189b; Gilbert Scott F, 2011, TRANSFORM LAMARCKISM, P283; Hoegh-Guldberg O, 2007, SCIENCE, V318, P1737, DOI 10.1126/science.1152509; Intergovernmental Panel on Climate Change, 2021, CLIM CHANG 2021 PHYS; LaJeunesse TC, 2010, P ROY SOC B-BIOL SCI, V277, P2925, DOI 10.1098/rspb.2010.0385; Logan CA, 2014, GLOBAL CHANGE BIOL, V20, P125, DOI 10.1111/gcb.12390; Palumbi SR, 2014, SCIENCE, V344, P895, DOI 10.1126/science.1251336; Pateman RM, 2012, SCIENCE, V336, P1028, DOI 10.1126/science.1216980; Yamano H, 2011, GEOPHYS RES LETT, V38, DOI 10.1029/2010GL046474	12	5	5	1	41	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 23	2014	344	6186					798	799		10.1126/science.1254136	http://dx.doi.org/10.1126/science.1254136			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AH6IL	24855237				2022-12-28	WOS:000336233800009
J	Lisnevskaia, L; Murphy, G; Isenberg, D				Lisnevskaia, Larissa; Murphy, Grainne; Isenberg, David			Systemic lupus erythematosus	LANCET			English	Article							ANTIPHOSPHOLIPID SYNDROME; MYCOPHENOLATE-MOFETIL; MONOCLONAL-ANTIBODY; DOUBLE-BLIND; ACCELERATED ATHEROSCLEROSIS; CLASSIFICATION CRITERIA; RHEUMATOID-ARTHRITIS; ANTIMALARIAL-DRUGS; DISEASE-ACTIVITY; RISK-FACTORS	Systemic lupus erythematosus is a remarkable and challenging disorder. Its diversity of clinical features is matched by the complexity of the factors (genetic, hormonal, and environmental) that cause it, and the array of autoantibodies with which it is associated. In this Seminar we reflect on changes in its classification criteria; consider aspects of its more serious clinical expression; and provide a brief review of its aetiopathogenesis, major complications, coping strategies, and conventional treatment. Increased understanding of the cells and molecules involved in the development of the diseases has encouraged the identification of new, better targeted biological approaches to its treatment. The precise role of these newer therapies remains to be established.	[Lisnevskaia, Larissa] Oshawa Clin, Oshawa, ON, Canada; [Murphy, Grainne; Isenberg, David] Univ Coll London Hosp, Dept Med, Ctr Rheumatol, London WC1E 6JF, England	University College London Hospitals NHS Foundation Trust; University of London; University College London	Isenberg, D (corresponding author), Univ Coll London Hosp, Dept Med, Ctr Rheumatol, Rayne Bldg,Room 424,5 Univ St, London WC1E 6JF, England.	d.isenberg@ucl.ac.uk	绾柚, 苏/ABG-4442-2021	Isenberg, David/0000-0001-9514-2455				Abu-Shakra M, 2001, LUPUS, V10, P152, DOI 10.1191/096120301676669495; Adler M, 2006, RHEUMATOLOGY, V45, P1144, DOI 10.1093/rheumatology/kel039; Alessandri C, 2011, AUTOIMMUN REV, V10, P609, DOI 10.1016/j.autrev.2011.04.011; Ames PRJ, 2009, J THROMB HAEMOST, V7, P537, DOI 10.1111/j.1538-7836.2009.03308.x; Bernatsky S, 2006, ARTHRITIS RHEUM-US, V54, P2550, DOI 10.1002/art.21955; Bertsias GK, 2012, ANN RHEUM DIS, V71, P1771, DOI 10.1136/annrheumdis-2012-201940; Blair PA, 2010, IMMUNITY, V32, P129, DOI 10.1016/j.immuni.2009.11.009; Bracewell C, 2009, EXPERT OPIN BIOL TH, V9, P909, DOI 10.1517/14712590903033919; Broder A, 2013, J RHEUMATOL, V40, P30, DOI 10.3899/jrheum.120157; Brucato A, 2011, CLIN REV ALLERG IMMU, V40, P27, DOI 10.1007/s12016-009-8190-6; Burness CB, 2011, DRUGS, V71, P2435, DOI 10.2165/11208440-000000000-00000; Buyon JP, 2005, ANN INTERN MED, V142, P953, DOI 10.7326/0003-4819-142-12_Part_1-200506210-00004; Caricchio R, 2003, J IMMUNOL, V171, P5778, DOI 10.4049/jimmunol.171.11.5778; Cervera R, 2009, LUPUS, V18, P869, DOI 10.1177/0961203309106831; Cervera R, 2010, REUMATOL CLIN, V6, P37, DOI 10.1016/j.reuma.2008.11.020; Clowse MEB, 2007, RHEUM DIS CLIN N AM, V33, P237, DOI 10.1016/j.rdc.2007.01.002; Condon MB, 2013, ANN RHEUM DIS, V72, P1280, DOI 10.1136/annrheumdis-2012-202844; Costenbader KH, 2007, ARTHRITIS RHEUM-US, V56, P1251, DOI 10.1002/art.22510; D'Cruz DP, 2007, LANCET, V369, P587, DOI 10.1016/S0140-6736(07)60279-7; David KM, 2005, CLIN TRANSPLANT, V19, P279, DOI 10.1111/j.1399-0012.2005.00338.x; Day CJ, 2009, NEPHROL DIAL TRANSPL, V24, P344, DOI 10.1093/ndt/gfn651; de Carvalho MRP, 2005, ARTHRIT RHEUM-ARTHR, V53, P838, DOI 10.1002/art.21605; Dobkin PL, 2001, J RHEUMATOL, V28, P2442; Dorner T, 2006, ARTHRITIS RES THER, V8, DOI 10.1186/ar1942; Dorner T, 2011, ARTHRITIS RES THER, V13, DOI 10.1186/ar3433; Dolff S, 2010, EXPERT REV CLIN IMMU, V6, P901, DOI 10.1586/ECI.10.79; Dooley MA, 2011, NEW ENGL J MED, V365, P1886, DOI 10.1056/NEJMoa1014460; dos Reis-Neto ET, 2013, RHEUMATOLOGY, V52, P2187, DOI 10.1093/rheumatology/ket283; El-Magadmi M, 2004, CIRCULATION, V110, P399, DOI 10.1161/01.CIR.0000136807.78534.50; Emer Jason J, 2009, J Clin Aesthet Dermatol, V2, P29; Escarcega RO, 2009, LUPUS, V18, P383, DOI 10.1177/0961203308101435; Ezeonyeji AN, 2012, RHEUMATOLOGY, V51, P476, DOI 10.1093/rheumatology/ker337; Furie R, 2011, ARTHRITIS RHEUM-US, V63, P3918, DOI 10.1002/art.30613; Giles I, 2012, LUPUS, V21, P1263, DOI 10.1177/0961203312458843; Ginzler EM, 2012, ARTHRITIS RES THER, V14, DOI 10.1186/ar3738; Guerra SG, 2012, ARTHRITIS RES THER, V14, DOI 10.1186/ar3844; Gustafsson JT, 2012, ARTHRITIS RES THER, V14, DOI 10.1186/ar3759; Ioannou Y, 2008, ANN RHEUM DIS, V67, P425, DOI 10.1136/ard.2007.078402; Isenberg D, 2013, ANN RHEUM DIS, V72, P258; Jacob N, 2011, ARTHRITIS RES THER, V13, DOI 10.1186/ar3349; Jajoria P, 2009, ANN NY ACAD SCI, V1173, P736, DOI 10.1111/j.1749-6632.2009.04815.x; Jung HJ, 2010, ARTHRITIS RHEUM-US, V62, P863, DOI 10.1002/art.27289; Kamen D, 2008, CURR OPIN RHEUMATOL, V20, P532, DOI 10.1097/BOR.0b013e32830a991b; Kiani AN, 2012, RHEUMATOL INT, V32, P2701, DOI 10.1007/s00296-011-2048-y; Kirou KA, 2013, CLIN IMMUNOL, V148, P303, DOI 10.1016/j.clim.2013.02.013; Kumar Deepak, 2010, Curr Rheumatol Rep, V12, P40, DOI 10.1007/s11926-009-0074-5; Lee YH, 2011, LUPUS, V20, P636, DOI 10.1177/0961203310389486; Lopez-Pedrera C, 2012, CURR RHEUMATOL REP, V14, P87, DOI 10.1007/s11926-011-0222-6; Manzi S, 1997, AM J EPIDEMIOL, V145, P408; Manzi S, 1999, ARTHRITIS RHEUM-US, V42, P51, DOI 10.1002/1529-0131(199901)42:1<51::AID-ANR7>3.0.CO;2-D; Mazzoni D, 2011, LUPUS, V20, P1117, DOI 10.1177/0961203311412994; Merrill JT, 2010, ARTHRITIS RHEUM-US, V62, P3077, DOI 10.1002/art.27601; Merrill JT, 2011, ANN RHEUM DIS, V70, P1905, DOI 10.1136/ard.2010.144485; Merrill JT, 2010, ARTHRITIS RHEUM-US, V62, P222, DOI 10.1002/art.27233; Miyakis S, 2006, J THROMB HAEMOST, V4, P295, DOI 10.1111/j.1538-7836.2006.01753.x; Moroni G, 2009, NEPHROL DIAL TRANSPL, V24, P15, DOI 10.1093/ndt/gfn565; Moulton VR, 2011, ARTHRITIS RES THER, V13, DOI 10.1186/ar3251; Navarra SV, 2011, LANCET, V377, P721, DOI 10.1016/S0140-6736(10)61354-2; Nikpour M, 2012, ARTHRITIS RHEUM-US, V64, P3052, DOI 10.1002/art.34541; Ntali S, 2011, CLIN REV ALLERG IMMU, V40, P181, DOI 10.1007/s12016-009-8196-0; Pepper R, 2009, NEPHROL DIAL TRANSPL, V24, P3717, DOI 10.1093/ndt/gfp336; Petri M, 2013, ARTHRITIS RHEUM-US, V65, P1011, DOI 10.1002/art.37824; Petri M, 2012, ARTHRITIS RHEUM-US, V64, P2677, DOI 10.1002/art.34473; Philip Errol J, 2009, J Allied Health, V38, P106; Pierangeli SS, 2010, LUPUS, V19, P475, DOI 10.1177/0961203310361489; Popescu A, 2011, CURR NEUROPHARMACOL, V9, P449, DOI 10.2174/157015911796557984; Rahman P, 1999, J RHEUMATOL, V26, P325; Renau AI, 2012, LUPUS, V21, P1041, DOI 10.1177/0961203312444771; Roman MJ, 2003, NEW ENGL J MED, V349, P2399, DOI 10.1056/NEJMoa035471; Rovin BH, 2012, ARTHRITIS RHEUM-US, V64, P1215, DOI 10.1002/art.34359; Ruiz-Irastorza G, 2008, LUPUS, V17, P271, DOI 10.1177/0961203307086643; Ruiz-Irastorza G, 2009, BEST PRACT RES CL RH, V23, P575, DOI 10.1016/j.berh.2009.04.004; Sardy M, 2009, ARCH DERMATOL RES, V301, P93, DOI 10.1007/s00403-008-0894-6; Shao WH, 2011, ARTHRITIS RES THER, V13, DOI 10.1186/ar3206; Somers EC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037000; Stohl W, 2012, NAT BIOTECHNOL, V30, P69, DOI 10.1038/nbt.2076; Symmons DPM, 2011, NAT REV RHEUMATOL, V7, P399, DOI 10.1038/nrrheum.2011.75; Teschner S, 2010, IMMUNOTHERAPY-UK, V2, P637, DOI [10.2217/imt.10.52, 10.2217/IMT.10.52]; Thompson A, 2010, TARASCON POCKET RHEU; Todd DJ, 2007, INT J CLIN PRACT, V61, P494, DOI 10.1111/j.1742-1241.2007.01289.x; Traczewski P, 2011, BRIT J CLIN PHARMACO, V71, P175, DOI 10.1111/j.1365-2125.2010.03767.x; Urowitz MB, 2008, J RHEUMATOL, V35, P2152, DOI 10.3899/jrheum.080214; Vasudevan A, 2010, RHEUM DIS CLIN N AM, V36, P1, DOI 10.1016/j.rdc.2009.12.005; Wahren-Herlenius M, 2013, LANCET, V382, P819, DOI 10.1016/S0140-6736(13)60954-X; Wallace DJ, 2014, ANN RHEUM DIS, V73, P183, DOI 10.1136/annrheumdis-2012-202760; Williams EL, 2009, RHEUMATOLOGY, V48, P716, DOI 10.1093/rheumatology/kep080; Wong J. M., 2005, Lupus, V14, P101, DOI 10.1191/0961203305lu2043rr; Yamaguchi H, 2008, J LEUKOCYTE BIOL, V83, P1300, DOI 10.1189/jlb.1107730; Yee CS, 2012, RHEUMATOLOGY, V51, P1877, DOI 10.1093/rheumatology/kes158; Zandman-Goddard G, 2012, LUPUS, V21, P241, DOI 10.1177/0961203311426568; Zandman-Goddard G, 2009, LUPUS, V18, P884, DOI 10.1177/0961203309106921; Zandman-Goddard G, 2007, SEMIN ARTHRITIS RHEU, V36, P297, DOI 10.1016/j.semarthrit.2006.11.003	92	454	492	18	138	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	NOV 22	2014	384	9957					1878	1888		10.1016/S0140-6736(14)60128-8	http://dx.doi.org/10.1016/S0140-6736(14)60128-8			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AT7LA	24881804				2022-12-28	WOS:000345116800028
J	Ali, K; Soond, DR; Pineiro, R; Hagemann, T; Pearce, W; Lim, EL; Bouabe, H; Scudamore, CL; Hancox, T; Maecker, H; Friedman, L; Turner, M; Okkenhaug, K; Vanhaesebroeck, B				Ali, Khaled; Soond, Dalya R.; Pineiro, Roberto; Hagemann, Thorsten; Pearce, Wayne; Lim, Ee Lyn; Bouabe, Hicham; Scudamore, Cheryl L.; Hancox, Timothy; Maecker, Heather; Friedman, Lori; Turner, Martin; Okkenhaug, Klaus; Vanhaesebroeck, Bart			Inactivation of PI(3)K p110 delta breaks regulatory T-cell-mediated immune tolerance to cancer	NATURE			English	Article							PHOSPHOINOSITIDE 3-KINASE; SUPPRESSOR-CELLS; INFLAMMATION; IDELALISIB; INHIBITION; ISOFORM; DELTA; PI3K	Inhibitors against thep110 delta isoform of phosphoinositide-3-OH kinase (PI(3) K) have shown remarkable therapeutic efficacy in some human leukaemias(1,2). As p110 delta is primarily expressed in leukocytes(3), drugs against p110 delta have not been considered for the treatment of solid tumours(4). Here we report that p110 delta inactivation in mice protects against a broad range of cancers, including non-haematological solid tumours. We demonstrate that p110 delta inactivation in regulatory T cells unleashes CD8(+) cytotoxic T cells and induces tumour regression. Thus, p110 delta inhibitors can break tumour-induced immune tolerance and should be considered for wider use in oncology.	[Ali, Khaled; Pineiro, Roberto; Pearce, Wayne; Vanhaesebroeck, Bart] UCL, UCL Canc Inst, London WC1E 6DD, England; [Soond, Dalya R.; Lim, Ee Lyn; Bouabe, Hicham; Turner, Martin; Okkenhaug, Klaus] Babraham Inst, Lab Lymphocyte Signalling & Dev, Cambridge CB22 3AT, England; [Hagemann, Thorsten] Queen Mary Univ London, Barts Canc Inst, Ctr Canc & Inflammat, London EC1M 6BQ, England; [Scudamore, Cheryl L.] MRC Harwell, Mary Lyon Ctr, Harwell OX11 0RD, Berks, England; [Hancox, Timothy] Piramed Pharma, Slough SL1 4NL, Berks, England; [Maecker, Heather; Friedman, Lori] Genentech Inc, Canc Signaling & Translat Oncol, San Francisco, CA 94080 USA	University of London; University College London; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Babraham Institute; University of London; Queen Mary University London; MRC Harwell; Roche Holding; Genentech	Ali, K (corresponding author), Amgen Inc, Oncol Res, 1120 Vet Blvd, San Francisco, CA 94080 USA.	khaleda@amgen.com; klaus.okkenhaug@babraham.ac.uk; bart.vanh@ucl.ac.uk	Piñeiro, Roberto/AAN-5561-2020; Okkenhaug, Klaus/H-3154-2019; Turner, Martin/N-9976-2014	Piñeiro, Roberto/0000-0001-9479-139X; Okkenhaug, Klaus/0000-0002-9432-4051; Pearce, Wayne/0000-0001-5407-4767; Turner, Martin/0000-0002-3801-9896; Scudamore, Cheryl/0000-0002-7101-1714; Lim, Ee Lyn/0000-0002-5173-2979; Maecker, Heather/0000-0002-5378-1141; , Dalya/0000-0001-9326-0896	Cancer Research UK [C23338/A10200, C23338/A15965, C18270/A12888]; Biotechnology and Biological Sciences Research Council [BB/E009867/1]; Wellcome Trust [095691/Z/11/Z]; BBSRC [BB/E009867/1, BBS/E/B/000C0407, BB/I007806/2] Funding Source: UKRI; MRC [G0901338, MC_UP_1502/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BBS/E/B/000C0407, BB/I007806/2, BBS/B/02010] Funding Source: researchfish; Cancer Research UK [12888, 15965, 14355] Funding Source: researchfish; Medical Research Council [G0901338, MC_UP_1502/1] Funding Source: researchfish	Cancer Research UK(Cancer Research UK); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Wellcome Trust(Wellcome TrustEuropean Commission); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Cancer Research UK(Cancer Research UK); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This research was supported by Cancer Research UK (C23338/A10200; C23338/A15965 to B. V. and C18270/A12888 to T. Hagemann), Biotechnology and Biological Sciences Research Council (BB/E009867/1 to K.O.) and Wellcome Trust (095691/Z/11/Z) (to K.O.). We thank D. Sutherlin, J. Nonomiya, J. Lesnick and K. Reif (Genentech) for technical assistance, M. Whitehead, D. Dubuisson, D. Patton, E. Slack, N. Harrington, G. Rosignoli, W. P. Day, A. Brown, P. Depledge, F. Leenders, J. Pang, L. Salphati and X. Zhang for experimental help, D. Fearon and J. Arnold for LLC-OVA cells, and A. Rudensky for FoxP3<SUP>YFP-Cre</SUP> mice.	Bunt SK, 2006, J IMMUNOL, V176, P284, DOI 10.4049/jimmunol.176.1.284; Curiel TJ, 2008, CURR OPIN IMMUNOL, V20, P241, DOI 10.1016/j.coi.2008.04.008; Fruman DA, 2014, NAT REV DRUG DISCOV, V13, P140, DOI 10.1038/nrd4204; Furman RR, 2014, NEW ENGL J MED, V370, P997, DOI 10.1056/NEJMoa1315226; Gabrilovich DI, 2012, NAT REV IMMUNOL, V12, P253, DOI 10.1038/nri3175; Gattinoni L, 2012, NAT REV CANCER, V12, P671, DOI 10.1038/nrc3322; Gopal AK, 2014, NEW ENGL J MED, V370, P1008, DOI 10.1056/NEJMoa1314583; Muranski P, 2009, CURR OPIN IMMUNOL, V21, P200, DOI 10.1016/j.coi.2009.02.004; Murray JM, 2012, J MED CHEM, V55, P7686, DOI 10.1021/jm300717c; Okkenhaug K, 2002, SCIENCE, V297, P1031; Okkenhaug K, 2006, J IMMUNOL, V177, P5122, DOI 10.4049/jimmunol.177.8.5122; Okkenhaug K, 2013, ANNU REV IMMUNOL, V31, P675, DOI 10.1146/annurev-immunol-032712-095946; Patton DT, 2006, J IMMUNOL, V177, P6598, DOI 10.4049/jimmunol.177.10.6598; Patton DT, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017359; Pulaski BA, 2002, CANCER RES, V62, P4406; Putz EM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040852; Safina BS, 2012, J MED CHEM, V55, P5887, DOI 10.1021/jm3003747; Schmid MC, 2011, CANCER CELL, V19, P715, DOI 10.1016/j.ccr.2011.04.016; Soler A, 2013, J EXP MED, V210, P1937, DOI 10.1084/jem.20121571; Soond DR, 2012, J IMMUNOL, V188, P5935, DOI 10.4049/jimmunol.1102116; Soond DR, 2010, BLOOD, V115, P2203, DOI 10.1182/blood-2009-07-232330; Vanhaesebroeck B, 1997, P NATL ACAD SCI USA, V94, P4330, DOI 10.1073/pnas.94.9.4330; Youn JI, 2008, J IMMUNOL, V181, P5791, DOI 10.4049/jimmunol.181.8.5791	23	360	376	2	62	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 19	2014	510	7505					407	+		10.1038/nature13444	http://dx.doi.org/10.1038/nature13444			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AJ0NG	24919154	Green Accepted			2022-12-28	WOS:000337350200037
J	Shalek, AK; Satija, R; Shuga, J; Trombetta, JJ; Gennert, D; Lu, DN; Chen, PL; Gertner, RS; Gaublomme, JT; Yosef, N; Schwartz, S; Fowler, B; Weaver, S; Wang, J; Wang, XH; Ding, RH; Raychowdhury, R; Friedman, N; Hacohen, N; Park, H; May, AP; Regev, A				Shalek, Alex K.; Satija, Rahul; Shuga, Joe; Trombetta, John J.; Gennert, Dave; Lu, Diana; Chen, Peilin; Gertner, Rona S.; Gaublomme, Jellert T.; Yosef, Nir; Schwartz, Schraga; Fowler, Brian; Weaver, Suzanne; Wang, Jing; Wang, Xiaohui; Ding, Ruihua; Raychowdhury, Raktima; Friedman, Nir; Hacohen, Nir; Park, Hongkun; May, Andrew P.; Regev, Aviv			Single-cell RNA-seq reveals dynamic paracrine control of cellular variation	NATURE			English	Article							GENE-EXPRESSION; I INTERFERON; IMMUNE; QUANTIFICATION; STOCHASTICITY; TRANSCRIPTOME; VARIABILITY; DETERMINES; ACTIVATION; PRINCIPLES	High-throughput single-cell transcriptomics offers an unbiased approach for understanding the extent, basis and function of gene expression variation between seemingly identical cells. Here we sequence single-cell RNA-seq libraries prepared from over 1,700 primary mouse bone-marrow-derived dendritic cells spanning several experimental conditions. We find substantial variation between identically stimulated dendritic cells, in both the fraction of cells detectably expressing a given messenger RNA and the transcript's level within expressing cells. Distinct gene modules are characterized by different temporal heterogeneity profiles. In particular, a 'core' module of antiviral genes is expressed very early by a few 'precocious' cells in response to uniform stimulation with a pathogenic component, but is later activated in all cells. By stimulating cells individually in sealed microfluidic chambers, analysing dendritic cells from knockout mice, and modulating secretion and extracellular signalling, we show that this response is coordinated by interferon-mediated paracrine signalling from these precocious cells. Notably, preventing cell-to-cell communication also substantially reduces variability between cells in the expression of an early-induced 'peaked' inflammatory module, suggesting that paracrine signalling additionally represses part of the inflammatory program. Our study highlights the importance of cell-to-cell communication in controlling cellular heterogeneity and reveals general strategies that multicellular populations can use to establish complex dynamic responses.	[Shalek, Alex K.; Gertner, Rona S.; Gaublomme, Jellert T.; Ding, Ruihua; Park, Hongkun] Harvard Univ, Dept Chem & Chem Biol, Cambridge, MA 02138 USA; [Shalek, Alex K.; Gertner, Rona S.; Gaublomme, Jellert T.; Ding, Ruihua; Park, Hongkun] Harvard Univ, Dept Phys, Cambridge, MA 02138 USA; [Shalek, Alex K.; Satija, Rahul; Trombetta, John J.; Gennert, Dave; Lu, Diana; Yosef, Nir; Schwartz, Schraga; Raychowdhury, Raktima; Hacohen, Nir; Park, Hongkun; Regev, Aviv] Broad Inst MIT & Harvard, Cambridge Ctr 7, Cambridge, MA 02142 USA; [Shuga, Joe; Chen, Peilin; Fowler, Brian; Weaver, Suzanne; Wang, Jing; Wang, Xiaohui; May, Andrew P.] Fluidigm Corp, San Francisco, CA 94080 USA; [Friedman, Nir] Hebrew Univ Jerusalem, Sch Comp Sci & Engn, IL-91904 Jerusalem, Israel; [Hacohen, Nir] Massachusetts Gen Hosp, Ctr Immunol & Inflammatory Dis, Charlestown, MA 02129 USA; [Hacohen, Nir] Massachusetts Gen Hosp, Dept Med, Charlestown, MA 02129 USA; [Regev, Aviv] MIT, Howard Hughes Med Inst, Dept Biol, Cambridge, MA 02140 USA	Harvard University; Harvard University; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Hebrew University of Jerusalem; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Howard Hughes Medical Institute; Massachusetts Institute of Technology (MIT)	Satija, R (corresponding author), Broad Inst MIT & Harvard, Cambridge Ctr 7, Cambridge, MA 02142 USA.	rahuls@broadinstitute.org; Hongkun_Park@harvard.edu; apmay1@gmail.com	Friedman, Nir/H-9692-2012; Park, Hongkun/R-9842-2019; Satija, Rahul/AAF-9564-2019; Shalek, Alex/Y-2434-2019	Friedman, Nir/0000-0002-9678-3550; Park, Hongkun/0000-0001-9576-8829; Shalek, Alex/0000-0001-5670-8778; Schwartz, Schraga/0000-0002-3671-9709	NIH [1F32HD075541-01, U54 AI057159, DP2 OD002230, 5DP1OD003893-03, DP1OD003958-01]; NIH CEGS [1P50HG006193-01]; Broad Institute; Klarman Cell Observatory at the Broad Institute; ISF-Broad Grant; ERC; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [F32HD075541] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [DP1CA174427] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [P50HG006193] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U54AI057159] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP2OD002230, DP1OD003958, DP1OD003893] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH CEGS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Broad Institute; Klarman Cell Observatory at the Broad Institute; ISF-Broad Grant; ERC(European Research Council (ERC)European Commission); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We thank B. Tilton, T. Rogers and M. Tam for assistance with cell sorting; E. Shefler, C. Guiducci, D. Thompson, and O. Rozenblatt-Rosen for project management and discussions and the Broad Genomics Platform for sequencing. We thank J. West, R. Lebofsky, A. Leyrat, M. Thu, M. Wong, W. Yorza, D. Toppani, M. Norris and B. Clerkson for contributions to C<INF>1</INF> system development; B. Alvarado, M. Ray and L. Knuttson for assistance with C<INF>1</INF> experiments; and M. Unger for discussions. Work was supported by an NIH Postdoctoral Fellowship (1F32HD075541-01, R.S.), an NIH grant (U54 AI057159, N.H.), an NIH New Innovator Award (DP2 OD002230, N.H.), an NIH CEGS(1P50HG006193-01, H.P., N.H., A.R.), NIH Pioneer Awards (5DP1OD003893-03 to H.P., DP1OD003958-01 to A.R.), the Broad Institute (H.P. and A.R.), HHMI (A.R.), the Klarman Cell Observatory at the Broad Institute (A.R.), an ISF-Broad Grant (N.F.), and the ERC (N.F.).	Amit I, 2009, SCIENCE, V326, P257, DOI 10.1126/science.1179050; Banchereau J, 2006, IMMUNITY, V25, P383, DOI 10.1016/j.immuni.2006.08.010; Bendall SC, 2011, SCIENCE, V332, P687, DOI 10.1126/science.1198704; Benveniste E. N., 2007, SCI STKE, V416, ppe70, DOI DOI 10.1126/STKE.4162007PE70; Chalancon G, 2012, TRENDS GENET, V28, P221, DOI 10.1016/j.tig.2012.01.006; Fang MQ, 2013, PLOS BIOL, V11, DOI 10.1371/journal.pbio.1001618; Feinerman O, 2010, MOL SYST BIOL, V6, DOI 10.1038/msb.2010.90; Freedberg IM, 2001, J INVEST DERMATOL, V116, P633, DOI 10.1046/j.1523-1747.2001.01327.x; Garber M, 2012, MOL CELL, V47, P810, DOI 10.1016/j.molcel.2012.07.030; Hall JC, 2010, NAT REV RHEUMATOL, V6, P40, DOI 10.1038/nrrheum.2009.237; Hashimshony T, 2012, CELL REP, V2, P666, DOI 10.1016/j.celrep.2012.08.003; Islam S., 2012, NATURE PROTOCOLS, V7, P823; Islam S, 2011, GENOME RES, V21, P1160, DOI 10.1101/gr.110882.110; Lee TK, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000599; Li B, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-323; Loewer A, 2011, CURR OPIN GENET DEV, V21, P753, DOI 10.1016/j.gde.2011.09.010; Marinov GK, 2014, GENOME RES, V24, P496, DOI 10.1101/gr.161034.113; McDavid A, 2013, BIOINFORMATICS, V29, P461, DOI 10.1093/bioinformatics/bts714; Rabani M, 2011, NAT BIOTECHNOL, V29, P436, DOI 10.1038/nbt.1861; Raj A, 2009, ANNU REV BIOPHYS, V38, P255, DOI 10.1146/annurev.biophys.37.032807.125928; Ramskold D, 2012, NAT BIOTECHNOL, V30, P777, DOI 10.1038/nbt.2282; Rand U, 2012, MOL SYST BIOL, V8, DOI 10.1038/msb.2012.17; Shalek AK, 2013, NATURE, V498, P236, DOI 10.1038/nature12172; Sharma SV, 2010, CELL, V141, P69, DOI 10.1016/j.cell.2010.02.027; Slacka MD, 2008, P NATL ACAD SCI USA, V105, P19306, DOI 10.1073/pnas.0807038105; Snijder B, 2009, NATURE, V461, P520, DOI 10.1038/nature08282; Spencer SL, 2009, NATURE, V459, P428, DOI 10.1038/nature08012; Storey JD, 2003, P NATL ACAD SCI USA, V100, P9440, DOI 10.1073/pnas.1530509100; Tang FC, 2009, NAT METHODS, V6, P377, DOI [10.1038/NMETH.1315, 10.1038/nmeth.1315]; Taniguchi Y, 2010, SCIENCE, V329, P533, DOI 10.1126/science.1188308; Tay S, 2010, NATURE, V466, P267, DOI 10.1038/nature09145; Veening JW, 2008, ANNU REV MICROBIOL, V62, P193, DOI 10.1146/annurev.micro.62.081307.163002; Waters CM, 2005, ANNU REV CELL DEV BI, V21, P319, DOI 10.1146/annurev.cellbio.21.012704.131001; Weibrecht I, 2012, NEW BIOTECHNOL, V29, P589, DOI 10.1016/j.nbt.2011.08.002; Wu AR, 2014, NAT METHODS, V11, P41, DOI 10.1038/nmeth.2694; Zhao MW, 2012, PLOS BIOL, V10, DOI 10.1371/journal.pbio.1001249	36	573	597	9	240	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 19	2014	510	7505					363	+		10.1038/nature13437	http://dx.doi.org/10.1038/nature13437			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AJ0NG	24919153	Green Accepted, Green Submitted			2022-12-28	WOS:000337350200028
J	Cappola, AR; Livingston, EH				Cappola, Anne R.; Livingston, Edward H.			Controlling the Metabolic Roller Coaster in Diabetes	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							PREVALENCE; CHILDREN		[Cappola, Anne R.; Livingston, Edward H.] Univ Penn, Perelman Sch Med, Div Endocrinol Diabet & Metab, Dept Med, Philadelphia, PA 19104 USA	University of Pennsylvania; Pennsylvania Medicine	Cappola, AR (corresponding author), Univ Penn, Perelman Sch Med, Div Endocrinol Diabet & Metab, 3400 Civ Ctr Blvd,Bldg 421,12th Floor, Philadelphia, PA 19104 USA.	acappola@mail.med.upenn.edu						Andrews MA, JAMA-J AM MED ASSOC, DOI [10.1001/jama.2014.4563, DOI 10.1001/JAMA.2014.4563]; Dabelea D, 2014, JAMA-J AM MED ASSOC, V311, P1778, DOI 10.1001/jama.2014.3201; Greevy RA, JAMA-J AM MED ASSOC, DOI [10.1001/jama.2014.4312, DOI 10.1001/JAMA.2014.4312]; Ikramuddin S, 2013, JAMA-J AM MED ASSOC, V309, P2240, DOI 10.1001/jama.2013.5835; Jampol LM, JAMA-J AM MED ASSOC, DOI [10.1001/jama.2014.2536, DOI 10.1001/JAMA.2014.2536]; Knip M, JAMA-J AM MED ASSOC, DOI [10.1001/jama.2014.5610, DOI 10.1001/JAMA.2014.5610]; Lipska KJ, JAMA-J AM MED ASSOC, DOI [10.1001/jama.2014.6316, DOI 10.1001/JAMA.2014.6316]; Sacks DB, JAMA-J AM MED ASSOC, DOI [10.1001/jama.2014.6342, DOI 10.1001/JAMA.2014.6342]; Safford MM, JAMA-J AM MED ASSOC, DOI [10.1001/jama.2014.4313, DOI 10.1001/JAMA.2014.4313]; Seaquist ER, JAMA-J AM MED ASSOC, DOI [10.1001/jama.2014.6451, DOI 10.1001/JAMA.2014.6451]; Sjostrom L, 2014, JAMA-J AM MED ASSOC, V311, P2297, DOI 10.1001/jama.2014.5988; The SIGMA Type 2 Diabetes Consortium, JAMA-J AM MED ASSOC, DOI [10.1001/jama.2014.6511, DOI 10.1001/JAMA.2014.6511]; Wallia A, JAMA-J AM MED ASSOC, DOI [10.1001/jama.2014.5951, DOI 10.1001/JAMA.2014.5951]; Xu Y, 2013, JAMA-J AM MED ASSOC, V310, P948, DOI 10.1001/jama.2013.168118; Ziegler AG, 2013, JAMA-J AM MED ASSOC, V309, P2473, DOI 10.1001/jama.2013.6285	15	0	0	0	3	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUN 11	2014	311	22					2277	2278		10.1001/jama.2014.6675	http://dx.doi.org/10.1001/jama.2014.6675			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AI6HL	24915258				2022-12-28	WOS:000336972600018
J	Jampol, LM; Bressler, NM; Glassman, AR				Jampol, Lee M.; Bressler, Neil M.; Glassman, Adam R.			Revolution to a New Standard Treatment of Diabetic Macular Edema	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							DEFERRED LASER; RANIBIZUMAB; PROMPT		[Jampol, Lee M.] Northwestern Univ, Feinberg Sch Med, Chicago, IL 60611 USA; [Bressler, Neil M.] Johns Hopkins Univ, Sch Med, Wilmer Eye Inst, Baltimore, MD 21205 USA; [Glassman, Adam R.] Jaeb Ctr Hlth Res, Tampa, FL 33647 USA	Northwestern University; Feinberg School of Medicine; Johns Hopkins University; Johns Hopkins Medicine; JAEB Center For Health Research	Glassman, AR (corresponding author), Jaeb Ctr Hlth Res, 15310 Amberly Dr,Ste 350, Tampa, FL 33647 USA.	drcrstat2@jaeb.org		Glassman, Adam/0000-0003-0173-1684	NATIONAL EYE INSTITUTE [U10EY023207, U10EY014231, U10EY018817, U10EY014229] Funding Source: NIH RePORTER; NEI NIH HHS [U10 EY014231, U10 EY023207, U10 EY014229, EY14231, EY023207, U10 EY018817, EY18817] Funding Source: Medline	NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		Aiello LP, 2011, OPHTHALMOLOGY, V118, pE5, DOI 10.1016/j.ophtha.2011.09.058; Bressler NM, 2014, JAMA OPHTHALMOL, V132, P168, DOI 10.1001/jamaophthalmol.2013.6426; Centers for Disease Control and Prevention, 2011 NAT DIAB FACT S; Elman MJ, 2012, OPHTHALMOLOGY, V119, P2312, DOI 10.1016/j.ophtha.2012.08.022; Elman MJ, 2011, OPHTHALMOLOGY, V118, P609, DOI 10.1016/j.ophtha.2010.12.033; PATZ A, 1985, ARCH OPHTHALMOL-CHIC, V103, P1796, DOI 10.1001/archopht.1985.01050120030015; Stearne MR, 1998, BMJ-BRIT MED J, V317, P703; Varma R, 2012, AM AC OPHTH 2012 ANN	8	32	33	0	4	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUN 11	2014	311	22					2269	2270		10.1001/jama.2014.2536	http://dx.doi.org/10.1001/jama.2014.2536			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AI6HL	24915254	Green Accepted			2022-12-28	WOS:000336972600014
J	Holmes, D				Holmes, David			Linong Ji: fighting to turn the tide against diabetes in China	LANCET			English	Biographical-Item																		JI L, PUBLICATION LIST	1	3	3	0	4	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	JUN 7	2014	383	9933					1961	1961		10.1016/S0140-6736(14)60942-9	http://dx.doi.org/10.1016/S0140-6736(14)60942-9			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AI4PV	24910223				2022-12-28	WOS:000336848200013
J	Chun, S; Westmoreland, JJ; Bayazitov, IT; Eddins, D; Pani, AK; Smeyne, RJ; Yu, J; Blundon, JA; Zakharenko, SS				Chun, Sungkun; Westmoreland, Joby J.; Bayazitov, Ildar T.; Eddins, Donnie; Pani, Amar K.; Smeyne, Richard J.; Yu, Jing; Blundon, Jay A.; Zakharenko, Stanislav S.			Specific disruption of thalamic inputs to the auditory cortex in schizophrenia models	SCIENCE			English	Article							DIGEORGE-SYNDROME REGION; HALLUCINATIONS; HYPOTHESIS; MICE	Auditory hallucinations in schizophrenia are alleviated by antipsychotic agents that inhibit D2 dopamine receptors (Drd2s). The defective neural circuits and mechanisms of their sensitivity to antipsychotics are unknown. We identified a specific disruption of synaptic transmission at thalamocortical glutamatergic projections in the auditory cortex in murine models of schizophrenia-associated 22q11 deletion syndrome (22q11DS). This deficit is caused by an aberrant elevation of Drd2 in the thalamus, which renders 22q11DS thalamocortical projections sensitive to antipsychotics and causes a deficient acoustic startle response similar to that observed in schizophrenic patients. Haploinsufficiency of the microRNA-processing gene Dgcr8 is responsible for the Drd2 elevation and hypersensitivity of auditory thalamocortical projections to antipsychotics. This suggests that Dgcr8-microRNA-Drd2-dependent thalamocortical disruption is a pathogenic event underlying schizophrenia-associated psychosis.	[Chun, Sungkun; Westmoreland, Joby J.; Bayazitov, Ildar T.; Eddins, Donnie; Pani, Amar K.; Smeyne, Richard J.; Yu, Jing; Blundon, Jay A.; Zakharenko, Stanislav S.] St Jude Childrens Res Hosp, Dept Dev Neurobiol, Memphis, TN 38105 USA	St Jude Children's Research Hospital	Zakharenko, SS (corresponding author), St Jude Childrens Res Hosp, Dept Dev Neurobiol, 332 N Lauderdale St, Memphis, TN 38105 USA.	stanislav.zakharenko@stjude.org	Zakharenko, Stanislav/D-3287-2013; Chun, Sungkun/R-1614-2016	Zakharenko, Stanislav/0000-0001-8115-202X; Chun, Sungkun/0000-0001-9837-2299; Smeyne, Richard/0000-0002-8459-5472	NIH [R01 MH097742, R01 MH095810, R01 DC012833]; American Lebanese Syrian Associated Charities; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH097742, R01MH095810] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC012833] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Lebanese Syrian Associated Charities(American Lebanese Syrian Associated Charities (ALSAC)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	This work was supported, in part, by NIH grants R01 MH097742, R01 MH095810, and R01 DC012833 and the American Lebanese Syrian Associated Charities. We thank E. Illingworth, P. Scambler, A. Wynshaw-Boris, J. Gogos, S. Strittmatter, B. Morrow, and E. Fuchs for providing mutant mice; A. Lessard and the Maryland Brain Collection for providing postmortem human brain samples; K. J. Sample and P. Devaraju for technical assistance; and St. Jude Children's Research Hospital, University of Tennessee, University of North Carolina, and University of Pennsylvania Vector Cores for producing adeno-associated viruses and lentiviruses.	Behrendt RP, 2003, CONSCIOUS COGN, V12, P413, DOI 10.1016/S1053-8100(03)00017-5; CARLSSON A, 1988, NEUROPSYCHOPHARMACOL, V1, P179, DOI 10.1016/0893-133X(88)90012-7; Coyle JT, 1996, HARVARD REV PSYCHIAT, V3, P241, DOI 10.3109/10673229609017192; Dierks T, 1999, NEURON, V22, P615, DOI 10.1016/S0896-6273(00)80715-1; Hubl D, 2007, BRIT J PSYCHIAT, V190, P57, DOI 10.1192/bjp.bp.106.022954; Insel TR, 2010, NATURE, V468, P187, DOI 10.1038/nature09552; Lindsay EA, 2001, NATURE, V410, P97, DOI 10.1038/35065105; Lindsay EA, 1999, NATURE, V401, P379, DOI 10.1038/43900; Miyamoto S, 2012, MOL PSYCHIATR, V17, P1206, DOI 10.1038/mp.2012.47; Smith PH, 2001, J COMP NEUROL, V436, P508, DOI 10.1002/cne.1084; Snyder SH, 1999, PHILOS T ROY SOC B, V354, P1985, DOI 10.1098/rstb.1999.0538; Woodward ND, 2012, AM J PSYCHIAT, V169, P1092, DOI 10.1176/appi.ajp.2012.12010056; Zakharenko SS, 2001, NAT NEUROSCI, V4, P711, DOI 10.1038/89498	13	81	82	1	34	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 6	2014	344	6188					1178	1182		10.1126/science.1253895	http://dx.doi.org/10.1126/science.1253895			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI3UU	24904170	Green Accepted			2022-12-28	WOS:000336791200052
J	Collin, J; Johnson, E; Hill, S				Collin, Jeff; Johnson, Emma; Hill, Sarah			Government support for alcohol industry: promoting exports, jeopardising global health?	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							TRADE AGREEMENTS		[Collin, Jeff; Hill, Sarah] Univ Edinburgh, Sch Social & Polit Sci, Global Publ Hlth Unit, Edinburgh EH8 9LD, Midlothian, Scotland; [Johnson, Emma] NHS Greater Glasgow & Clyde, Glasgow, Lanark, Scotland	University of Edinburgh	Collin, J (corresponding author), Univ Edinburgh, Sch Social & Polit Sci, Global Publ Hlth Unit, Edinburgh EH8 9LD, Midlothian, Scotland.	jeff.collin@ed.ac.uk		Hill, Sarah/0000-0003-3555-433X	Economic and Social Research Council [ES/L001284/1] Funding Source: researchfish; NATIONAL CANCER INSTITUTE [R01CA160695] Funding Source: NIH RePORTER; ESRC [ES/L001284/1] Funding Source: UKRI; NCI NIH HHS [R01 CA160695, R01CA160695] Funding Source: Medline	Economic and Social Research Council(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); ESRC(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		[Anonymous], 2011, HEALTH IS GLOBAL AN; Australian Government, 2011, TRADE POLICY STATEME; Department of Health, 2011, THE PUBLIC HEALTH RE; Department of Health, 2011, HEALTHY LIVES HEALTH; Department of Health, 2007, UK GOVERNMENT SIDE S; Department of Health Foreign and Commonwealth Office, 2013, UNITED KINGDOMS REVI; Diageo, ANNUAL REPORT 2013; Diageo, 2011, GENERATING PROSPERIT; Donaldson L., 2007, HEALTH IS GLOBAL; Euromonitor, 2012, LEGISLATION IN ALCOH; Euromonitor, 2013, ALCOHOLIC DRINKS IN; Euromonitor, 2012, ALCOHOLIC DRINKS FOR; Euromonitor, 2012, ALCOHOLIC DRINKS IN; Euromonitor, 2012, NEW PRODUCT DEVELOPM; Euromonitor, 2012, WHISKIES GROWTH OPPO; European Commission, 2013, FREE TRADE AGREEMENT; Gornall J., 2014, BMJ-BRIT MED J, V348, pf7646, DOI DOI 10.1136/BMJ.F7646; Hague W., 2011, PREFECT POLICE F PEC; HM Government, 2008, HEALTH IS GLOBAL A U; HM Government, 2011, TECHNICAL DOCUMENT D; HM Government, 2012, THE GOVERNMENTS ALCO; Jernigan D., 2008, ADDICTION.S, V104, P6; Kelsey J, 2012, ADDICTION, V107, P1719, DOI 10.1111/j.1360-0443.2012.03874.x; Lawrence F., 2012, GUARDIAN        0913; Lim SS, 2012, LANCET, V380, P2224, DOI 10.1016/S0140-6736(12)61766-8; McCambridge J, 2014, ADDICTION, V109, P519, DOI 10.1111/add.12356; Nair S, 2014, MONEYCONTROL; O'Brien P, 2013, DRUG ALCOHOL REV, V32, P5, DOI 10.1111/j.1465-3362.2012.00485.x; Organization WH, 2009, GLOB HLTH RISKS MORT; Pomfret J, 2011, REUTERS         0624; SABMiller, 2013, SABMILLER PLC QUARTE; SABMiller, 2012, INVESTOR RELATIONS Q; SABMiller, 2013, FIRST HALF RESULTS S; SABMiller, 2013, INVESTOR RELATIONS Q; SABMiller. Company snapshot, 2013, COMPANY SNAPSHOT 201; Scotch Whisky Association, 2013, TRADE MATTERS INTERN; The Scottish Government, 2009, CHANGING SCOTLANDS R; UK Trade and Investment, 2012, EXPANDING IN ETHIOPI; UK Trade and Investment Department for Environment and Rural Affairs, 2013, UK FOOD AND DRINK IN; United Nations, 2011, DRAFT POLITICAL DECL; United Nations, 2011, LIST OF CIVIL SOCIET; United Nations, 2013, NEW GLOB PARTN ER PO; WHO, 2011, GLOBAL STATUS REPORT; WHO, 2009, 2008 2013 ACTION PLA; World Trade Organization, 2010, TAXES ON ALCOHOLIC B; World Trade Organization, 2013, PHILIPPINES TAXES ON; World Trade Organization, 2010, INDIA MEASURES AFFEC; Zeigler DW, 2009, ADDICTION, V104, P13, DOI 10.1111/j.1360-0443.2008.02431.x	48	14	14	1	5	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JUN 6	2014	348								g3648	10.1136/bmj.g3648	http://dx.doi.org/10.1136/bmj.g3648			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	AI7CE	24906713	Green Published			2022-12-28	WOS:000337038000011
J	Hayes, D; Griffin, GB; Engel, GS				Hayes, Dugan; Griffin, Graham B.; Engel, Gregory S.			Response to Comment on "Engineering coherence among excited states in synthetic heterodimer systems"	SCIENCE			English	Editorial Material							SPECTROSCOPY	Halpin, Johnson, and Miller contest our assignment of quantum beating signals observed in the two-dimensional electronic spectra of a series of fluorescein heterodimers to electronic coherences. Here, we present resonance Raman spectra, statistical analysis on multiple data sets, and an explanation of differences between the family of molecules described in our Report and the homodimer examined by the commenters. We contend that these results all support our assignment of the beating signals to electronic coherences.	[Engel, Gregory S.] Univ Chicago, Dept Chem, Inst Biophys Dynam, Chicago, IL 60637 USA; Univ Chicago, James Franck Inst, Chicago, IL 60637 USA	University of Chicago; University of Chicago	Engel, GS (corresponding author), Univ Chicago, Dept Chem, Inst Biophys Dynam, 5735 S Ellis Ave, Chicago, IL 60637 USA.	gsengel@uchicago.edu		Hayes, Dugan/0000-0003-4171-5179				Akimov AV, 2013, J PHYS CHEM LETT, V4, P3857, DOI 10.1021/jz402035z; Brixner T, 2004, J CHEM PHYS, V121, P4221, DOI 10.1063/1.1776112; Chen X, 2010, J CHEM PHYS, V132, DOI 10.1063/1.3435211; Halpin A, 2013, EPJ WEB CONF, V41, DOI 10.1051/epjconf/20134105032; Halpin A, 2014, SCIENCE, V344, DOI 10.1126/science.1250926; Halpin A, 2014, NAT CHEM, V6, P196, DOI [10.1038/NCHEM.1834, 10.1038/nchem.1834]; Hayes D, 2013, SCIENCE, V340, P1431, DOI 10.1126/science.1233828	7	5	5	1	40	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 6	2014	344	6188								10.1126/science.1251717	http://dx.doi.org/10.1126/science.1251717			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AI3UU	24904150				2022-12-28	WOS:000336791200032
J	Wible, B; Mervis, J; Wigginton, NS				Wible, Brad; Mervis, Jeffrey; Wigginton, Nicholas S.			Rethinking the global supply chain	SCIENCE			English	Editorial Material													Wigginton, Nicholas/F-1747-2011	Wigginton, Nicholas/0000-0001-9161-6131					0	27	27	9	64	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 6	2014	344	6188					1100	1103		10.1126/science.344.6188.1100	http://dx.doi.org/10.1126/science.344.6188.1100			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AI3UU	24904151				2022-12-28	WOS:000336791200033
J	Holthuis, JCM; Menon, AK				Holthuis, Joost C. M.; Menon, Anant K.			Lipid landscapes and pipelines in membrane homeostasis	NATURE			English	Review							ENDOPLASMIC-RETICULUM STRESS; CTP-PHOSPHOCHOLINE CYTIDYLYLTRANSFERASE; OXYSTEROL-BINDING PROTEINS; GOLGI-APPARATUS REQUIRES; PLASMA-MEMBRANE; TRANSMEMBRANE DOMAINS; SACCHAROMYCES-CEREVISIAE; PHOSPHATIDYLCHOLINE SYNTHESIS; SPHINGOLIPID HOMEOSTASIS; NONVESICULAR TRANSPORT	The lipid composition of cellular organelles is tailored to suit their specialized tasks. A fundamental transition in the lipid landscape divides the secretory pathway in early and late membrane territories, allowing an adaptation from biogenic to barrier functions. Defending the contrasting features of these territories against erosion by vesicular traffic poses a major logistical problem. To this end, cells evolved a network of lipid composition sensors and pipelines along which lipids are moved by non-vesicular mechanisms. We review recent insights into the molecular basis of this regulatory network and consider examples in which malfunction of its components leads to system failure and disease.	[Holthuis, Joost C. M.] Univ Osnabruck, Fachbereich Biol Chem, D-49076 Osnabruck, Germany; [Holthuis, Joost C. M.] Univ Utrecht, Bijvoet Ctr Biomol Res, NL-3508 TC Utrecht, Netherlands; [Holthuis, Joost C. M.] Univ Utrecht, Inst Biomembranes, NL-3508 TC Utrecht, Netherlands; [Menon, Anant K.] Weill Cornell Med Coll, Dept Biochem, New York, NY 10065 USA	University Osnabruck; Utrecht University; Utrecht University; Cornell University	Holthuis, JCM (corresponding author), Univ Osnabruck, Fachbereich Biol Chem, Barbarastr 13, D-49076 Osnabruck, Germany.	holthuis@uos.de; akm2003@med.cornell.edu	Menon, Anant/AAN-8663-2021; Holthuis, Joost/AAL-9157-2020	Menon, Anant/0000-0001-6924-2698; Holthuis, Joost/0000-0001-8912-1586	European Union [289278]; Deutsche Forschungsgemeinschaft [SFB944-P14]; National Institutes of Health [GM071041]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM071041] Funding Source: NIH RePORTER	European Union(European Commission); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Work in the authors laboratories is supported by the European Union (MC-ITN Sphingonet Project 289278 to J.C.H.), the Deutsche Forschungsgemeinschaft (SFB944-P14 to J.C.H.) and the National Institutes of Health (grant GM071041 to A.K.M.).	Alder-Baerens N, 2006, MOL BIOL CELL, V17, P1632, DOI 10.1091/mbc.E05-10-0912; Alpy F, 2014, BIOCHIMIE, V96, P85, DOI 10.1016/j.biochi.2013.09.015; Attard GS, 2000, P NATL ACAD SCI USA, V97, P9032, DOI 10.1073/pnas.160260697; Banerji S, 2010, MOL BIOL CELL, V21, P4141, DOI 10.1091/mbc.E10-05-0424; Bankaitis Vytas A, 2012, Adv Biol Regul, V52, P115, DOI 10.1016/j.jbior.2011.11.001; Bartz R, 2007, J LIPID RES, V48, P837, DOI 10.1194/jlr.M600413-JLR200; Baumann NA, 2005, BIOCHEMISTRY-US, V44, P5816, DOI 10.1021/bi048296z; Bigay J, 2012, DEV CELL, V23, P886, DOI 10.1016/j.devcel.2012.10.009; Boumann HA, 2006, MOL BIOL CELL, V17, P1006, DOI 10.1091/mbc.E05-04-0344; Breslow DK, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a013326; Breslow DK, 2010, NATURE, V463, P1048, DOI 10.1038/nature08787; Brown DA, 1998, J MEMBRANE BIOL, V164, P103, DOI 10.1007/s002329900397; Brugger B, 2000, J CELL BIOL, V151, P507, DOI 10.1083/jcb.151.3.507; Cybulski LE, 2010, CURR BIOL, V20, P1539, DOI 10.1016/j.cub.2010.06.074; D'Angelo G, 2013, NATURE, V501, DOI 10.1038/nature12423; de Kroon AIPM, 2013, PROG LIPID RES, V52, P374, DOI 10.1016/j.plipres.2013.04.006; de Saint-Jean M, 2011, J CELL BIOL, V195, P965, DOI 10.1083/jcb.201104062; Deguil J, 2011, TRAFFIC, V12, P349, DOI 10.1111/j.1600-0854.2010.01150.x; Diakogiannaki E, 2008, J ENDOCRINOL, V197, P553, DOI 10.1677/JOE-08-0041; Estronca LMBB, 2007, BIOPHYS J, V93, P4244, DOI 10.1529/biophysj.107.112847; Inda ME, 2014, P NATL ACAD SCI USA, V111, P3579, DOI 10.1073/pnas.1317147111; Fairn GD, 2011, J CELL BIOL, V194, P257, DOI 10.1083/jcb.201012028; Fang DL, 2013, MOL CELL BIOCHEM, V381, P127, DOI 10.1007/s11010-013-1694-7; Frolov VA, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a004747; Fu SN, 2011, NATURE, V473, P528, DOI 10.1038/nature09968; Funato K, 2001, J CELL BIOL, V155, P949, DOI 10.1083/jcb.200105033; Georgiev AG, 2011, TRAFFIC, V12, P1341, DOI 10.1111/j.1600-0854.2011.01234.x; Grinstein S, 2010, AM J PHYSIOL-CELL PH, V299, pC876, DOI 10.1152/ajpcell.00342.2010; Halter D, 2007, J CELL BIOL, V179, P101, DOI 10.1083/jcb.200704091; Han SM, 2010, P NATL ACAD SCI USA, V107, P5851, DOI 10.1073/pnas.0911617107; Hanada K, 2003, NATURE, V426, P803, DOI 10.1038/nature02188; Heino S, 2000, P NATL ACAD SCI USA, V97, P8375, DOI 10.1073/pnas.140218797; HIKIJI T, 1988, J BIOCHEM-TOKYO, V104, P894, DOI 10.1093/oxfordjournals.jbchem.a122579; Holthuis JCM, 2001, PHYSIOL REV, V81, P1689, DOI 10.1152/physrev.2001.81.4.1689; Jonikas MC, 2009, SCIENCE, V323, P1693, DOI 10.1126/science.1167983; Kaiser HJ, 2011, P NATL ACAD SCI USA, V108, P16628, DOI 10.1073/pnas.1103742108; KAPLAN MR, 1985, J CELL BIOL, V101, P441, DOI 10.1083/jcb.101.2.441; Kawano M, 2006, J BIOL CHEM, V281, P30279, DOI 10.1074/jbc.M605032200; Kim YJ, 2011, DEV CELL, V21, P813, DOI 10.1016/j.devcel.2011.09.005; KOBAYASHI T, 1989, J BIOL CHEM, V264, P5966; KOYNOVA R, 1995, BBA-LIPID LIPID MET, V1255, P213, DOI 10.1016/0005-2760(94)00202-A; Koynova R, 1998, BBA-REV BIOMEMBRANES, V1376, P91, DOI 10.1016/S0304-4157(98)00006-9; Krahmer N, 2011, CELL METAB, V14, P504, DOI 10.1016/j.cmet.2011.07.013; Krumpe K, 2012, MOL BIOL CELL, V23, P3927, DOI 10.1091/mbc.E11-12-0994; Kumagai K, 2014, J BIOL CHEM, V289, P10748, DOI 10.1074/jbc.M113.528380; Kurbegov AC, 2003, GASTROENTEROLOGY, V125, P1227, DOI 10.1016/S0016-5085(03)01199-5; Kusminski CM, 2009, APOPTOSIS, V14, P1484, DOI 10.1007/s10495-009-0352-8; Lee J, 2014, J BIOL CHEM, V289, P1742, DOI 10.1074/jbc.M113.526970; LESTER RL, 1993, J BIOL CHEM, V268, P845; Lev S, 2010, NAT REV MOL CELL BIO, V11, P739, DOI 10.1038/nrm2971; Levine T, 2004, TRENDS CELL BIOL, V14, P483, DOI 10.1016/j.tcb.2004.07.017; Li YK, 2004, J BIOL CHEM, V279, P37030, DOI 10.1074/jbc.M405195200; Loewen CJR, 2003, EMBO J, V22, P2025, DOI 10.1093/emboj/cdg201; Maeda K, 2013, NATURE, V501, P257, DOI 10.1038/nature12430; Magalhaes MAO, 2010, J LEUKOCYTE BIOL, V87, P545, DOI 10.1189/jlb.0609390; Marsh D, 2007, BIOPHYS J, V93, P3884, DOI 10.1529/biophysj.107.107938; Maxfield FR, 2006, CURR OPIN CELL BIOL, V18, P379, DOI 10.1016/j.ceb.2006.06.012; Mesmin B, 2013, CELL, V155, P830, DOI 10.1016/j.cell.2013.09.056; Mesmin B, 2013, CELL MOL LIFE SCI, V70, P3405, DOI 10.1007/s00018-012-1247-3; MUNRO S, 1995, EMBO J, V14, P4695, DOI 10.1002/j.1460-2075.1995.tb00151.x; Nakano K, 2008, MOL BIOL CELL, V19, P1783, DOI 10.1091/mbc.E07-07-0646; Natarajan P, 2004, P NATL ACAD SCI USA, V101, P10614, DOI 10.1073/pnas.0404146101; Ngo M, 2009, MOL BIOL CELL, V20, P1388, DOI 10.1091/mbc.E08-09-0905; Nilsson IM, 2001, J BIOL CHEM, V276, P41748, DOI 10.1074/jbc.M105823200; Park E, 2012, ANNU REV BIOPHYS, V41, P21, DOI [10.1146/annurev-biophys-050511-102312, 10.1146/annurev-biophys-050511-402312]; Paulusma CC, 2006, HEPATOLOGY, V44, P195, DOI 10.1002/hep.21212; Paulusma CC, 2009, J BIOL CHEM, V284, P9947, DOI 10.1074/jbc.M808667200; Promlek T, 2011, MOL BIOL CELL, V22, P3520, DOI 10.1091/mbc.E11-04-0295; Quiroga R, 2013, J CELL SCI, V126, P5344, DOI 10.1242/jcs.130658; Radhakrishnan A, 2008, CELL METAB, V8, P512, DOI 10.1016/j.cmet.2008.10.008; Ridgway ND, 2010, SUBCELL BIOCHEM, V51, P159, DOI 10.1007/978-90-481-8622-8_6; Roelants FM, 2011, P NATL ACAD SCI USA, V108, P19222, DOI 10.1073/pnas.1116948108; Roelants FM, 2010, P NATL ACAD SCI USA, V107, P34, DOI 10.1073/pnas.0912497106; Saito S, 2008, J BIOL CHEM, V283, P6584, DOI 10.1074/jbc.M707691200; Sanyal AJ, 2005, NAT CLIN PRACT GASTR, V2, P46, DOI 10.1038/ncpgasthep0084; Sanyat S, 2009, ACS CHEM BIOL, V4, P895, DOI 10.1021/cb900163d; Schnabl M, 2005, BBA-MOL CELL BIOL L, V1687, P130, DOI 10.1016/j.bbalip.2004.11.016; Schneiter R, 1999, J CELL BIOL, V146, P741, DOI 10.1083/jcb.146.4.741; Schuck S, 2009, J CELL BIOL, V187, P525, DOI 10.1083/jcb.200907074; Sharpe HJ, 2010, CELL, V142, P158, DOI 10.1016/j.cell.2010.05.037; Shevchenko A, 2010, NAT REV MOL CELL BIO, V11, P593, DOI 10.1038/nrm2934; SILVIUS JR, 1993, BIOCHEMISTRY-US, V32, P13318, DOI 10.1021/bi00211a045; SLEIGHT RG, 1983, J BIOL CHEM, V258, P9050; Slotte JP, 2013, PROG LIPID RES, V52, P424, DOI 10.1016/j.plipres.2013.05.001; SLOTTE JP, 1988, BIOCHEM J, V250, P653, DOI 10.1042/bj2500653; Surma MA, 2013, MOL CELL, V51, P519, DOI 10.1016/j.molcel.2013.06.014; Tatsuta T, 2014, TRENDS CELL BIOL, V24, P44, DOI 10.1016/j.tcb.2013.07.011; URBANI L, 1990, J BIOL CHEM, V265, P1919; van Meer G, 2008, NAT REV MOL CELL BIO, V9, P112, DOI 10.1038/nrm2330; Vanni S, 2013, BIOPHYS J, V104, P575, DOI 10.1016/j.bpj.2012.11.3837; Volmer R, 2013, P NATL ACAD SCI USA, V110, P4628, DOI 10.1073/pnas.1217611110; Walker AK, 2011, CELL, V147, P840, DOI 10.1016/j.cell.2011.09.045; Wenk MR, 2005, NAT REV DRUG DISCOV, V4, P594, DOI 10.1038/nrd1776; WIRTZ KWA, 1991, ANNU REV BIOCHEM, V60, P73, DOI 10.1146/annurev.biochem.60.1.73; Yeagle P.L, 2016, MEMBRANES CELLS; Zambo V, 2013, WORLD J HEPATOL, V5, P550, DOI 10.4254/wjh.v5.i10.550	96	524	538	8	235	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 5	2014	510	7503					48	57		10.1038/nature13474	http://dx.doi.org/10.1038/nature13474			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI3NR	24899304				2022-12-28	WOS:000336768900031
J	Al-Khatib, SM; LaPointe, NMA; Chatterjee, R; Crowley, MJ; Dupre, ME; Kong, DF; Lopes, RD; Povsic, TJ; Raju, SS; Shah, B; Kosinski, AS; McBroom, AJ; Sanders, GD				Al-Khatib, Sana M.; LaPointe, Nancy M. Allen; Chatterjee, Ranee; Crowley, Matthew J.; Dupre, Matthew E.; Kong, David F.; Lopes, Renato D.; Povsic, Thomas J.; Raju, Shveta S.; Shah, Bimal; Kosinski, Andrzej S.; McBroom, Amanda J.; Sanders, Gillian D.			Rate- and Rhythm-Control Therapies in Patients With Atrial Fibrillation A Systematic Review	ANNALS OF INTERNAL MEDICINE			English	Review							PULMONARY-VEIN ISOLATION; QUALITY-OF-LIFE; ANTIARRHYTHMIC-DRUG-THERAPY; RANDOMIZED CONTROLLED-TRIAL; VENTRICULAR RATE CONTROL; RADIOFREQUENCY CATHETER ABLATION; ADDITIONAL LINEAR ABLATION; VALVULAR HEART-DISEASE; LONG-TERM MAINTENANCE; MONOPHASIC WAVE-FORM	Background: The comparative effectiveness of treatments for atrial fibrillation (AF) is uncertain. Purpose: To evaluate the comparative effectiveness of rate-and rhythm-control therapies. Data Sources: English-language studies in PubMed, EMBASE, and the Cochrane Database of Systematic Reviews between January 2000 and November 2013. Study Selection: Two reviewers independently screened citations to identify comparative studies that assessed rate-or rhythm-control therapies in patients with AF. Data Extraction: Reviewers extracted data on study design, participant characteristics, interventions, outcomes, applicability, and quality. Data Synthesis: 200 articles (162 studies) involving 28 836 patients were included. When pharmacologic rate-and rhythm-control strategies were compared, strength of evidence (SOE) was moderate supporting comparable efficacy with regard to all-cause mortality (odds ratio [OR], 1.34 [95% CI, 0.89 to 2.02]), cardiac mortality (OR, 0.96 [CI, 0.77 to 1.20]), and stroke (OR, 0.99 [CI, 0.76 to 1.30]) in older patients with mild AF symptoms. Few studies compared rate-control therapies and included outcomes of interest, which limited conclusions. For the effect of rhythm-control therapies in reducing AF recurrence, SOE was high favoring pulmonary vein isolation versus antiarrhythmic medications (OR, 5.87 [CI, 3.18 to 10.85]) and the surgical maze procedure (including pulmonary vein isolation) done during other cardiac surgery versus other cardiac surgery alone (OR, 7.94 [CI, 3.63 to 17.36]). Limitation: Studies were heterogeneous in interventions, populations, settings, and outcomes. Conclusion: Pharmacologic rate-and rhythm-control strategies have comparable efficacy across outcomes in primarily older patients with mild AF symptoms. Pulmonary vein isolation is better than antiarrhythmic medications at reducing recurrences of AF in younger patients with paroxysmal AF and mild structural heart disease. Future research should address uncertainties related to subgroups of interest and the effect of different therapies on long-term clinical outcomes.	Duke Univ, Sch Med, Duke Clin Res Inst, Durham, NC USA; Duke Univ, Sch Med, Duke Evidence Based Practice Ctr, Durham, NC USA; Durham Vet Affairs Med Ctr, Ctr Hlth Serv Res Primary Care, Durham, NC USA	Duke University; Duke University; US Department of Veterans Affairs; Veterans Health Administration (VHA); Durham VA Medical Center	Al-Khatib, SM (corresponding author), Duke Clin Res Inst, POB 17969, Durham, NC 27715 USA.	alkha001@mc.duke.edu	Dupre, Matthew/ABG-6728-2021	Dupre, Matthew/0000-0002-0976-4715; , Nancy/0000-0002-6390-8337	AHRQ [290-2007-10066-I]	AHRQ(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality)	By AHRQ (contract 290-2007-10066-I).	Abreu CAC, 2005, CIRCULATION, V112, pI20, DOI 10.1161/CIRCULATIONAHA.104.526301; Akpinar B, 2003, EUR J CARDIO-THORAC, V24, P223, DOI 10.1016/S1010-7940(03)00258-6; Al-Khatib SM, 2013, AHRQ PUBLICATION; Alatawi F, 2005, HEART RHYTHM, V2, P382, DOI 10.1016/j.hrthm.2004.12.024; Albrecht A, 2009, J THORAC CARDIOV SUR, V138, P454, DOI 10.1016/j.jtcvs.2009.04.023; Alp NJ, 2000, INT J CARDIOL, V75, P211, DOI 10.1016/S0167-5273(00)00326-0; Ambler JJS, 2006, RESUSCITATION, V71, P146, DOI 10.1016/j.resuscitation.2006.03.017; [Anonymous], 2014, METH GUID EFF COMP E; Arentz T, 2007, CIRCULATION, V115, P3057, DOI 10.1161/CIRCULATIONAHA.107.690578; Balla I, 2011, ANADOLU KARDIYOL DER, V11, P600, DOI 10.5152/akd.2011.162; Bellandi F, 2001, AM J CARDIOL, V88, P640, DOI 10.1016/S0002-9149(01)01806-9; Bertaglia E, 2002, EUR HEART J, V23, P1522, DOI 10.1053/euhj.2002.3167; Bittner A, 2011, HEART RHYTHM, V8, P1383, DOI 10.1016/j.hrthm.2011.03.051; Blomstrom Lundqvist C, 2007, EUR HEART J, V28, P2902, DOI 10.1093/eurheartj/ehm378; Boersma LVA, 2012, CIRCULATION, V125, P23, DOI 10.1161/CIRCULATIONAHA.111.074047; Bogun F, 2000, J CARDIOVASC ELECTR, V11, P136, DOI 10.1111/j.1540-8167.2000.tb00312.x; Boodhoo L, 2007, INT J CARDIOL, V114, P16, DOI 10.1016/j.ijcard.2005.11.108; Boos C, 2003, ANN NONINVAS ELECTRO, V8, P121, DOI 10.1046/j.1542-474X.2003.08205.x; Brazdzionyte Julija, 2006, Medicina (Kaunas), V42, P994; Brignole M, 2002, EUR HEART J, V23, P892, DOI 10.1053/euhj.2001.2971; Budera P, 2012, EUR HEART J, V33, P2644, DOI 10.1093/eurheartj/ehs290; Bulava A, 2010, PACE, V33, P1039, DOI 10.1111/j.1540-8159.2010.02807.x; Calo L, 2006, J AM COLL CARDIOL, V47, P2504, DOI 10.1016/j.jacc.2006.02.047; Capucci A, 2000, EUR HEART J, V21, P66, DOI 10.1053/euhj.1999.1734; Carlsson J, 2003, J AM COLL CARDIOL, V41, P1690, DOI 10.1016/S0735-1097(03)00332-2; Chen ML, 2011, J CARDIOVASC ELECTR, V22, P973, DOI 10.1111/j.1540-8167.2011.02051.x; Chen WS, 2013, J INT MED RES, V41, P1067, DOI 10.1177/0300060513489800; Chevalier P, 2009, ARCH CARDIOVASC DIS, V102, P769, DOI 10.1016/j.acvd.2009.08.010; Chung MK, 2005, J AM COLL CARDIOL, V46, P1891, DOI 10.1016/j.jacc.2005.07.040; Corrado A, 2010, J CARDIOVASC ELECTR, V21, P1, DOI 10.1111/j.1540-8167.2009.01577.x; de Lima GG, 2004, ANN THORAC SURG, V77, P2089, DOI 10.1016/j.athoracsur.2003.11.018; De Simone A, 2003, EUR HEART J, V24, P1425, DOI 10.1016/S0195-668X(03)00311-7; De Simone A, 2002, AM J CARDIOL, V90, P185, DOI 10.1016/S0002-9149(02)02450-5; Deakin CD, 2013, RESUSCITATION, V84, P286, DOI 10.1016/j.resuscitation.2012.07.010; Deisenhofer I, 2009, J CARDIOVASC ELECTR, V20, P514, DOI 10.1111/j.1540-8167.2008.01379.x; Delle Karth G, 2001, CRIT CARE MED, V29, P1149, DOI 10.1097/00003246-200106000-00011; Demircan C, 2005, EMERG MED J, V22, P411, DOI 10.1136/emj.2003.012047; Deneke T, 2002, EUR HEART J, V23, P558, DOI 10.1053/euhj.2001.2841; Di Biase L, 2009, CIRC-ARRHYTHMIA ELEC, V2, P113, DOI 10.1161/CIRCEP.108.798447; Dixit S, 2008, HEART RHYTHM, V5, P174, DOI 10.1016/j.hrthm.2007.09.024; Dixit S, 2006, J CARDIOVASC ELECTR, V17, P1074, DOI 10.1111/j.1540-8167.2006.00558.x; Dixit S, 2012, CIRC-ARRHYTHMIA ELEC, V5, P287, DOI 10.1161/CIRCEP.111.966226; Dorian P, 2000, J AM COLL CARDIOL, V36, P1303, DOI 10.1016/S0735-1097(00)00886-X; Doshi RN, 2005, J CARDIOVASC ELECTR, V16, P1160, DOI 10.1111/j.1540-8167.2005.50062.x; Doukas G, 2005, JAMA-J AM MED ASSOC, V294, P2323, DOI 10.1001/jama.294.18.2323; Elayi CS, 2008, HEART RHYTHM, V5, P1658, DOI 10.1016/j.hrthm.2008.09.016; Fassini G, 2005, J CARDIOVASC ELECTR, V16, P1150, DOI 10.1111/j.1540-8167.2005.50192.x; Fiala M, 2008, J INTERV CARD ELECTR, V22, P13, DOI 10.1007/s10840-008-9212-7; Fichtner S, 2013, CLIN CARDIOL, V36, P422, DOI 10.1002/clc.22132; Forleo GB, 2009, J CARDIOVASC ELECTR, V20, P22, DOI 10.1111/j.1540-8167.2008.01275.x; Fragakis N, 2009, EUROPACE, V11, P70, DOI 10.1093/europace/eun302; Fuster V, 2006, EUROPACE, V8, P651, DOI 10.1093/europace/eul097; Gaita F, 2008, CIRC-ARRHYTHMIA ELEC, V1, P269, DOI 10.1161/CIRCEP.108.774885; Gavin AR, 2012, J INTERV CARD ELECTR, V33, P101, DOI 10.1007/s10840-011-9614-9; Glover BM, 2008, HEART, V94, P884, DOI 10.1136/hrt.2007.120782; Go AS, 2001, JAMA-J AM MED ASSOC, V285, P2370, DOI 10.1001/jama.285.18.2370; Greene HL, 2003, J AM COLL CARDIOL, V42, P20, DOI 10.1016/S0735-1097(03)00559-X; Groenveld HF, 2009, AM HEART J, V158, P785, DOI 10.1016/j.ahj.2009.09.007; Hagens VE, 2004, J AM COLL CARDIOL, V43, P241, DOI 10.1016/j.jacc.2003.08.037; Haissaguerre M, 2004, CIRCULATION, V109, P3007, DOI 10.1161/01.CIR.0000130645.95357.97; Hassan S, 2007, J CARDIOVASC PHARM T, V12, P227, DOI 10.1177/1074248407303792; Hemels MEW, 2006, J AM COLL CARDIOL, V48, P1001, DOI 10.1016/j.jacc.2006.05.043; Hocini M, 2005, CIRCULATION, V112, P3688, DOI 10.1161/CIRCULATIONAHA.105.541052; Hofmann R, 2006, INT J CARDIOL, V110, P27, DOI 10.1016/j.ijcard.2005.06.048; Hohnloser SH, 2000, LANCET, V356, P1789, DOI 10.1016/S0140-6736(00)03230-X; Holming K, 2001, UPSALA J MED SCI, V106, P77, DOI 10.3109/2000-1967-175; Ionescu-Ittu R, 2012, ARCH INTERN MED, V172, P997, DOI 10.1001/archinternmed.2012.2266; Jais P, 2008, CIRCULATION, V118, P2498, DOI 10.1161/CIRCULATIONAHA.108.772582; Jessurun ER, 2003, J CARDIOVASC SURG, V44, P9; Joglar JA, 2000, AM J CARDIOL, V86, P348, DOI 10.1016/S0002-9149(00)00932-2; Jones DG, 2013, J AM COLL CARDIOL, V61, P1894, DOI 10.1016/j.jacc.2013.01.069; Jonsson A, 2012, J ATR FIBRILLATION, V5, P13; Joseph AP, 2000, ANN EMERG MED, V36, P1, DOI 10.1067/mem.2000.107655; Kanoupakis EM, 2004, AM J CARDIOL, V94, P659, DOI 10.1016/j.amjcard.2004.05.037; Karch MR, 2005, CIRCULATION, V111, P2875, DOI 10.1161/CIRCULATIONAHA.104.491530; Katkas NV, 2007, INT J CARDIOL, V118, P321, DOI 10.1016/j.ijcard.2006.07.017; Katritsis DG, 2003, AM J CARDIOL, V92, P1116, DOI 10.1016/j.amjcard.2003.07.009; Katritsis DG, 2004, J CARDIOVASC ELECTR, V15, P641, DOI 10.1046/j.1540-8167.2004.03620.x; Kawabata VS, 2007, EUROPACE, V9, P143, DOI 10.1093/europace/eul177; Khan MN, 2008, NEW ENGL J MED, V359, P1778, DOI 10.1056/NEJMoa0708234; Khand AU, 2003, J AM COLL CARDIOL, V42, P1944, DOI 10.1016/j.jacc.2003.07.020; Khaykin Y, 2003, J CARDIOVASC ELECTR, V14, P868, DOI 10.1046/j.1540-8167.2003.03133.x; Khaykin Y, 2009, CIRC-ARRHYTHMIA ELEC, V2, P481, DOI 10.1161/CIRCEP.109.848978; Kim YH, 2010, J CARDIOVASC ELECTR, V21, P959, DOI 10.1111/j.1540-8167.2010.01748.x; Kirchhof P, 2002, LANCET, V360, P1275, DOI 10.1016/S0140-6736(02)11315-8; Kirchhof P, 2005, EUR HEART J, V26, P1292, DOI 10.1093/eurheartj/ehi160; Kirkutis A, 2004, P W PHARMACOL SOC, P69; Knaut M., 2010, APPL CARDIOPULM PATH, V14, P220; Kochiadakis GE, 2000, HEART, V84, P251, DOI 10.1136/heart.84.3.251; Kochiadakis GE, 2004, AM J CARDIOL, V94, P1563, DOI 10.1016/j.amjcard.2004.08.041; Kochiadakis GE, 2000, PACE, V23, P1883; Kochiadakis GE, 2004, CHEST, V125, P377, DOI 10.1378/chest.125.2.377; Kochiadakis GE, 2001, EUROPACE, V3, P73, DOI 10.1053/eupc.2000.0140; Korantzopoulos P, 2006, HEART, V92, P631, DOI 10.1136/hrt.2005.072322; KRAHN AD, 1995, AM J MED, V98, P476, DOI 10.1016/S0002-9343(99)80348-9; Krittayaphong Rungroj, 2003, J Med Assoc Thai, V86 Suppl 1, pS8; Le Heuzey JY, 2010, J CARDIOVASC ELECTR, V21, P597, DOI 10.1111/j.1540-8167.2010.01764.x; Lee SH, 2000, PACE, V23, P966, DOI 10.1111/j.1540-8159.2000.tb00882.x; Levy T, 2001, HEART, V85, P171, DOI 10.1136/heart.85.2.171; Lindholm CJA, 2004, HEART, V90, P534, DOI 10.1136/hrt.2003.017707; Liu XP, 2006, CIRC J, V70, P1392, DOI 10.1253/circj.70.1392; Liu X, 2010, EUR HEART J, V31, P2633, DOI 10.1093/eurheartj/ehq201; MacDonald MR, 2011, HEART, V97, P740, DOI 10.1136/hrt.2010.207340; Maggioni AP, 2005, AM HEART J, V149, P548, DOI 10.1016/j.ahj.2004.09.033; Manios EG, 2003, CARDIOVASC DRUG THER, V17, P31, DOI 10.1023/A:1024203824761; Marinsek M, 2003, AM J CARDIOL, V92, P988, DOI 10.1016/S0002-9149(03)00986-X; Mazzocca G, 2006, J CARDIOVASC MED, V7, P124, DOI 10.2459/01.JCM.0000203851.75020.bd; McNamara R L, 2000, Evid Rep Technol Assess (Summ), P1; McNamara RL, 2003, ANN INTERN MED, V139, P1018, DOI 10.7326/0003-4819-139-12-200312160-00012; McNamara RL, 2001, AHRQ PUBLICATION; Mont L, 2014, EUR HEART J, V35, P501, DOI 10.1093/eurheartj/eht457; Mortensen K, 2008, CARDIOLOGY, V111, P57, DOI 10.1159/000113429; Mun HS, 2012, HEART, V98, P480, DOI 10.1136/heartjnl-2011-301107; Nergardh AK, 2007, EUR HEART J, V28, P1351, DOI 10.1093/eurheartj/ehl544; Nielsen JC, 2012, NEW ENGL J MED, V367, P1587, DOI 10.1056/NEJMoa1113566; Nilsson B, 2006, AM HEART J, V152, DOI 10.1016/j.ahj.2006.05.029; Okcun B, 2004, JPN HEART J, V45, P591, DOI 10.1536/jhj.45.591; Opolski G, 2004, CHEST, V126, P476, DOI 10.1378/chest.126.2.476; Oral H, 2005, HEART RHYTHM, V2, P1165, DOI 10.1016/j.hrthm.2005.08.003; Oral H, 2006, NEW ENGL J MED, V354, P934, DOI 10.1056/NEJMoa050955; Oral H, 2008, HEART RHYTHM, V5, P1658; Oral H, 2008, CIRC-ARRHYTHMIA ELEC, V1, P6, DOI 10.1161/CIRCEP.107.748780; Oral H, 2009, J AM COLL CARDIOL, V53, P782, DOI 10.1016/j.jacc.2008.10.054; Packer DL, 2013, J AM COLL CARDIOL, V61, P1713, DOI 10.1016/j.jacc.2012.11.064; Page RL, 2002, J AM COLL CARDIOL, V39, P1956, DOI 10.1016/S0735-1097(02)01898-3; Pappone C, 2006, J AM COLL CARDIOL, V48, P2340, DOI 10.1016/j.jacc.2006.08.037; Petrac D, 2005, CROAT MED J, V46, P922; Pires LM, 2010, PACE, V33, P1249, DOI 10.1111/j.1540-8159.2010.02805.x; Plewan A, 2001, EUR HEART J, V22, P1504, DOI 10.1053/euhj.2000.2546; Pontoppidan J, 2009, HEART, V95, P994, DOI 10.1136/hrt.2008.153965; Poole-Wilson PA, 2003, LANCET, V362, P7, DOI 10.1016/S0140-6736(03)13800-7; Rashba EJ, 2002, AM HEART J, V143, P541, DOI 10.1067/mhj.2002.120155; Rashba EJ, 2004, AM J CARDIOL, V94, P1572, DOI 10.1016/j.amjcard.2004.08.044; Redfearn DP, 2006, PACE, V29, P1089, DOI 10.1111/j.1540-8159.2006.00469.x; Ricard P, 2001, EUROPACE, V3, P96, DOI 10.1053/eupc.2001.0156; Roux JF, 2009, CIRCULATION, V120, pO6RG, DOI 10.1161/CIRCULATIONAHA.108.839639; Roy D, 2000, NEW ENGL J MED, V342, P913, DOI 10.1056/NEJM200003303421302; Sawhney N, 2010, CIRC-ARRHYTHMIA ELEC, V3, P243, DOI 10.1161/CIRCEP.109.924878; Scholten M, 2003, HEART, V89, P1032, DOI 10.1136/heart.89.9.1032; Schuetz A, 2003, EUR J CARDIO-THORAC, V24, P475, DOI 10.1016/S1010-7940(03)00377-4; Sheikh I, 2006, J INTERV CARD ELECTR, V17, P103, DOI 10.1007/s10840-006-9066-9; Shelton RJ, 2009, HEART, V95, P924, DOI 10.1136/hrt.2008.158931; Siaplaouras S, 2005, AM HEART J, V150, P150, DOI 10.1016/j.ahj.2004.08.009; Siaplaouras S, 2004, J CARDIOVASC ELECTR, V15, P895, DOI 10.1046/j.1540-8167.2004.04027.x; Simpson CS, 2001, AM HEART J, V142, P294, DOI 10.1067/mhj.2001.116767; Singh BN, 2005, NEW ENGL J MED, V352, P1861, DOI 10.1056/NEJMoa041705; Singh SN, 2006, J AM COLL CARDIOL, V48, P721, DOI 10.1016/j.jacc.2006.03.051; Siu CW, 2009, CRIT CARE MED, V37, P2174, DOI 10.1097/CCM.0b013e3181a02f56; Srivastava V, 2008, HEART LUNG CIRC, V17, P232, DOI 10.1016/j.hlc.2007.10.003; Stabile G, 2006, EUR HEART J, V27, P216, DOI 10.1093/eurheartj/ehi583; Suman-Horduna I, 2013, J AM COLL CARDIOL, V61, P455, DOI 10.1016/j.jacc.2012.10.031; Talajic M, 2010, J AM COLL CARDIOL, V55, P1796, DOI 10.1016/j.jacc.2010.01.023; Tamborero D, 2009, CIRC-ARRHYTHMIA ELEC, V2, P35, DOI 10.1161/CIRCEP.108.797944; Thomas SP, 2004, AM HEART J, V147, DOI 10.1016/S0002-8703(03)00526-X; Tsuneda T, 2006, CIRC J, V70, P965, DOI 10.1253/circj.70.965; Turco P, 2007, PACE, V30, pS112; Ulimoen SR, 2014, EUR HEART J, V35, P517, DOI 10.1093/eurheartj/eht429; Ulimoen SR, 2013, AM J CARDIOL, V111, P225, DOI 10.1016/j.amjcard.2012.09.020; Van Breugel HNAM, 2010, J CARDIOVASC ELECTR, V21, P511, DOI 10.1111/j.1540-8167.2009.01655.x; Van Gelder IC, 2002, NEW ENGL J MED, V347, P1834, DOI 10.1056/NEJMoa021375; Van Gelder IC, 2006, EUROPACE, V8, P935, DOI 10.1093/europace/eul106; Van Gelder IC, 2010, NEW ENGL J MED, V362, P1363, DOI 10.1056/NEJMoa1001337; Van Noord T, 2001, J CARDIOVASC ELECTR, V12, P766; Verma A, 2010, EUR HEART J, V31, P1344, DOI 10.1093/eurheartj/ehq041; Vijayalakshmi K, 2006, AM HEART J, V151, DOI 10.1016/j.ahj.2005.09.009; Villani G Q, 2000, Am Heart J, V140, pe12; von Oppell UO, 2009, EUR J CARDIO-THORAC, V35, P641, DOI 10.1016/j.ejcts.2008.12.042; Vora A, 2004, J CARDIOVASC PHARM T, V9, P65, DOI 10.1177/107424840400900201; Wang JG, 2009, EUR J CARDIO-THORAC, V35, P116, DOI 10.1016/j.ejcts.2008.09.014; Wang TJ, 2003, CIRCULATION, V107, P2920, DOI 10.1161/01.CIR.0000072767.89944.6E; Wang XH, 2008, EUROPACE, V10, P600, DOI 10.1093/europace/eun077; Wang YL, 2013, PACE, V36, P1202, DOI 10.1111/pace.12168; Wattanasuwan N, 2001, CHEST, V119, P502, DOI 10.1378/chest.119.2.502; Wazni O, 2003, CIRCULATION, V108, P2479, DOI 10.1161/01.CIR.0000101684.88679.AB; Wazni OM, 2005, JAMA-J AM MED ASSOC, V293, P2634, DOI 10.1001/jama.293.21.2634; Weerasooriya R, 2003, J AM COLL CARDIOL, V41, P1697, DOI 10.1016/S0735-1097(03)00338-3; Wilber DJ, 2010, JAMA-J AM MED ASSOC, V303, P333, DOI 10.1001/jama.2009.2029; Willems S, 2006, EUR HEART J, V27, P2871, DOI 10.1093/eurheartj/ehl093; WOLF PA, 1991, STROKE, V22, P983, DOI 10.1161/01.STR.22.8.983; Wyse DG, 2002, NEW ENGL J MED, V347, P1825, DOI 10.1056/nejmoa021328; Yildiz A, 2008, CIRC J, V72, P705, DOI 10.1253/circj.72.705; Zhao X, 2013, CIRC-ARRHYTHMIA ELEC, V6, P310, DOI 10.1161/CIRCEP.113.000196	182	124	130	0	20	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JUN 3	2014	160	11					760	+		10.7326/M13-1467	http://dx.doi.org/10.7326/M13-1467			17	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AJ0MT	24887617				2022-12-28	WOS:000337348700003
J	Bender, E				Bender, Eric			DEVELOPING WORLD Global warning	NATURE			English	Editorial Material																		Safaeian M, 2013, CANCER PREV RES, V6, P1242, DOI 10.1158/1940-6207.CAPR-13-0203; Shastri SS, 2014, JNCI-J NATL CANCER I, V106, DOI 10.1093/jnci/dju009; Stewart B, 2014, WORLD CANC REPORT 20	3	12	12	0	9	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 29	2014	509	7502					S64	S65		10.1038/509S64a	http://dx.doi.org/10.1038/509S64a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AH9JC	24870825	Bronze			2022-12-28	WOS:000336457100008
J	Friedman, J				Friedman, Jeffrey			Douglas Coleman (1931-2014) OBITUARY	NATURE			English	Biographical-Item									Rockefeller Univ, New York, NY 10021 USA	Rockefeller University	Friedman, J (corresponding author), Rockefeller Univ, 1230 York Ave, New York, NY 10021 USA.	friedj@mail.rockefeller.edu							0	1	1	0	5	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 29	2014	509	7502					564	564		10.1038/509564a	http://dx.doi.org/10.1038/509564a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AH9JC	24870535	Bronze			2022-12-28	WOS:000336457100031
J	Levy, A				Levy, Andy			RATIONAL TESTING Interpreting raised serum prolactin results	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							HYPERPROLACTINEMIA; WOMEN; DIAGNOSIS; SECRETION		Univ Bristol, Henry Wellcome Labs Integrat Neurosci & Endocrino, Bristol BS1 3NY, Avon, England	University of Bristol	Levy, A (corresponding author), Univ Bristol, Henry Wellcome Labs Integrat Neurosci & Endocrino, Dorothy Hodgkin Bldg, Bristol BS1 3NY, Avon, England.	mdal@bris.ac.uk						Bussen S, 1996, GYNECOL ENDOCRINOL, V10, P83, DOI 10.3109/09513599609097896; CARMINA E, 1984, ACTA ENDOCRINOL-COP, V105, P99, DOI 10.1530/acta.0.1050099; Carrero JJ, 2012, CLIN J AM SOC NEPHRO, V7, P207, DOI 10.2215/CJN.06840711; Hekimsoy Z, 2010, ENDOCR J, V57, P1011, DOI 10.1507/endocrj.K10E-215; HOU SH, 1985, AM J KIDNEY DIS, V6, P245, DOI 10.1016/S0272-6386(85)80181-5; Johnsen E, 2008, J CLIN PSYCHOPHARM, V28, P686, DOI 10.1097/JCP.0b013e31818ba5d8; Lennartsson AK, 2011, PSYCHONEUROENDOCRINO, V36, P1530, DOI 10.1016/j.psyneuen.2011.04.007; Melmed S, 2011, J CLIN ENDOCR METAB, V96, P273, DOI 10.1210/jc.2010-1692; Sobrinho Luis Goncalves, 2003, Pituitary, V6, P35, DOI 10.1023/A:1026229810876; Tay CCK, 1996, HUM REPROD, V11, P950; Vilar L, 2008, J ENDOCRINOL INVEST, V31, P436, DOI 10.1007/BF03346388	11	3	3	0	3	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	MAY 23	2014	348								g3207	10.1136/bmj.g3207	http://dx.doi.org/10.1136/bmj.g3207			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AH9AC	24859901				2022-12-28	WOS:000336429700002
J	Piketty, T; Saez, E				Piketty, Thomas; Saez, Emmanuel			Inequality in the long run	SCIENCE			English	Review							WEALTH CONCENTRATION; INCOME INEQUALITY; UNITED-STATES; TOP INCOMES; FRANCE; PARIS	This Review presents basic facts regarding the long-run evolution of income and wealth inequality in Europe and the United States. Income and wealth inequality was very high a century ago, particularly in Europe, but dropped dramatically in the first half of the 20th century. Income inequality has surged back in the United States since the 1970s so that the United States is much more unequal than Europe today. We discuss possible interpretations and lessons for the future.	[Piketty, Thomas] Paris Sch Econ, Dept Econ, Paris, France; [Saez, Emmanuel] Univ Calif Berkeley, Dept Econ, Berkeley, CA 94720 USA	Paris School of Economics; University of California System; University of California Berkeley	Piketty, T (corresponding author), Paris Sch Econ, Dept Econ, Paris, France.	thomas.piketty@psemail.eu	MOTREB, ayoub EL/AAB-1710-2019					Alvaredo F, 2013, J ECON PERSPECT, V27, P3, DOI 10.1257/jep.27.3.3; Atkinson A. B., 2010, TOP INCOMES GLOBAL P; Atkinson A.B., 1978, DISTRIBUTION PERSONA; Atkinson A.B., 2007, TOP INCOMES 20 CENTU, P18; Atkinson AB, 2005, J R STAT SOC A STAT, V168, P325, DOI 10.1111/j.1467-985X.2005.00351.x; Atkinson AB, 2011, J ECON LIT, V49, P3, DOI 10.1257/jel.49.1.3; Daumard A., 1973, ACTES C INT FORMATIO; Davies JB, 2011, ECON J, V121, P223, DOI 10.1111/j.1468-0297.2010.02391.x; Goldin Claudia, 2008, RACE ED TECHNOLOGY; Goldsmith R. W., 1985, COMP NATL BALANCE SH; Jones Alice Hanson, 1977, AM COLONIAL WEALTH D; Kopczuk W, 2004, NATL TAX J, V57, P445, DOI 10.17310/ntj.2004.2S.05; Kuznets S., 1953, SHARES UPPER INCOME; Lampman R.J., 1962, SHARE TOP WEALTH HOL; LINDERT PH, 1986, J POLIT ECON, V94, P1127, DOI 10.1086/261427; Nirei M., 2009, 0905 HITOTSUBASHI U; Ohlson H., 2008, PERSONAL WEALTH GLOB, P42; Piketty T, 2006, AM ECON REV, V96, P236, DOI 10.1257/000282806776157614; Piketty T, 2003, J POLIT ECON, V111, P1004, DOI 10.1086/376955; Piketty T, 2003, Q J ECON, V118, P1, DOI 10.1162/00335530360535135; Piketty T., 2014, Q J EC IN PRESS, V129; Piketty T., 2001, HAUTS REVENUS FRANCE; Piketty T., 2014, CAPITAL SIGLO 21; Piketty T, 2014, EXPLOR ECON HIST, V51, P21, DOI 10.1016/j.eeh.2013.07.004; Piketty T, 2011, Q J ECON, V126, P1071, DOI 10.1093/qje/qjr020; Roine J, 2009, SCAND J ECON, V111, P151, DOI 10.1111/j.1467-9442.2008.01558.x; Soltow L., 1989, DISTRIBUTION WEALTH; STIGLITZ JE, 1969, ECONOMETRICA, V37, P382, DOI 10.2307/1912788; Waldenstrom Daniel, 2009, LIFTING ALL BOATS EV; Zucman G, 2013, Q J ECON, V128, P1321, DOI 10.1093/qje/qjt012	30	426	432	19	241	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 23	2014	344	6186					838	843		10.1126/science.1251936	http://dx.doi.org/10.1126/science.1251936			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AH6IL	24855258				2022-12-28	WOS:000336233800035
J	Mandl, JN; Germain, RN				Mandl, Judith N.; Germain, Ronald N.			Focusing in on T Cell Cross-Reactivity	CELL			English	Editorial Material								To provide broad immunity to a vast array of foreign antigens with a limited number of T lymphocytes, each cell has to recognize many targets. By implementing a strategy to identify T cell receptor (TCR) ligands and investigating at a fine granularity their structure and sequence relationship, Birnbaum et al. demonstrate the surprisingly tight focus of such T cell cross-reactivity.	[Mandl, Judith N.; Germain, Ronald N.] NIAID, Lymphocyte Biol Sect, Lab Syst Biol, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)	Mandl, JN (corresponding author), NIAID, Lymphocyte Biol Sect, Lab Syst Biol, NIH, Bethesda, MD 20892 USA.	mandlj@niaid.nih.gov; rgermain@niaid.nih.gov	Germain, Ronald N./Z-1945-2019; Germain, Ronald/ABE-7090-2020		NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI000403] Funding Source: NIH RePORTER	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Birnbaum ME, 2014, CELL, V157, P1073, DOI 10.1016/j.cell.2014.03.047; Mason D, 1998, IMMUNOL TODAY, V19, P395, DOI 10.1016/S0167-5699(98)01299-7; Morris GP, 2012, NAT IMMUNOL, V13, P121, DOI 10.1038/ni.2190; Su LF, 2013, IMMUNITY, V38, P373, DOI 10.1016/j.immuni.2012.10.021; Zarnitsyna VI, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00485	5	2	2	0	14	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAY 22	2014	157	5					1006	1008		10.1016/j.cell.2014.05.002	http://dx.doi.org/10.1016/j.cell.2014.05.002			4	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	AH9CG	24855938	Bronze			2022-12-28	WOS:000336437200003
J	Schmid, M; Jensen, TH				Schmid, Manfred; Jensen, Torben Heick			SnapShot: Nuclear RNAPII Transcript Modification	CELL			English	Editorial Material									[Schmid, Manfred; Jensen, Torben Heick] Aarhus Univ, Dept Mol Biol & Genet, Ctr mRNP Biogenesis & Metab, DK-8000 Aarhus, Denmark	Aarhus University	Schmid, M (corresponding author), Aarhus Univ, Dept Mol Biol & Genet, Ctr mRNP Biogenesis & Metab, DK-8000 Aarhus, Denmark.		Schmid, Manfred/E-6725-2012; Jensen, Torben H/G-2954-2017	Schmid, Manfred/0000-0003-0516-3055; Jensen, Torben Heick/0000-0001-5127-1239	Novo Nordisk Fonden [NNF12OC0001211] Funding Source: researchfish	Novo Nordisk Fonden(Novo Nordisk Foundation)			0	0	0	2	42	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAY 22	2014	157	5							1244.e1	10.1016/j.cell.2014.05.003	http://dx.doi.org/10.1016/j.cell.2014.05.003			2	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	AH9CG	24855955	Bronze, Green Accepted			2022-12-28	WOS:000336437200024
J	Colussi, TM; Costantino, DA; Hammond, JA; Ruehle, GM; Nix, JC; Kieft, JS				Colussi, Timothy M.; Costantino, David A.; Hammond, John A.; Ruehle, Grant M.; Nix, Jay C.; Kieft, Jeffrey S.			The structural basis of transfer RNA mimicry and conformational plasticity by a viral RNA	NATURE			English	Article							MOSAIC-VIRUS RNA; MINUS-STRAND SYNTHESIS; STRUCTURE VALIDATION; CRYSTAL-STRUCTURE; 3' END; INITIATION; RIBOSOME; BINDING; VALINE; TRANSLATION	RNA is arguably the most functionally diverse biological macromolecule. In some cases a single discrete RNA sequence performs multiple roles, and this can be conferred by a complex three-dimensional structure. Such multifunctionality can also be driven or enhanced by the ability of a given RNA to assume different conformational (and therefore functional) states'. Despite its biological importance, a detailed structural understanding of the paradigm of RNA structure-driven multifunctionality is lacking. To address this gap it is useful to study examples from single-stranded positive-sense RNA viruses, a prototype being the tRNA-like structure (TLS) found at the 3' end of the turnip yellow mosaic virus (TYMV). This TLS not only acts like a tRNA to drive aminoacylation of the viral genomic (g)RNA(2-4), but also interacts with other structures in the 3' untranslated region of the gRNA(5), contains the promoter for negative-strand synthesis, and influences several infection-critical processes'. TLS RNA can provide a glimpse into the structural basis of RNA multifunctionality and plasticity, but for decades its high-resolution structure has remained elusive. Here we present the crystal structure of the complete TYMV TLS to 2.0 angstrom resolution. Globally, the RNA adopts a shape that mimics tRNA, but it uses a very different set of intramolecular interactions to achieve this shape. These interactions also allow the TLS to readily switch conformations. In addition, the TLS structure is 'two faced': one face closely mimics tRNA and drives aminoacylation, the other face diverges from tRNA and enables additional functionality. The TLS is thus structured to perform several functions and interact with diverse binding partners, and we demonstrate its ability to specifically bind to ribosomes.	[Colussi, Timothy M.; Costantino, David A.; Hammond, John A.; Ruehle, Grant M.; Kieft, Jeffrey S.] Univ Colorado, Denver Sch Med, Dept Biochem & Mol Genet, Aurora, CO 80045 USA; [Colussi, Timothy M.; Costantino, David A.; Kieft, Jeffrey S.] Univ Colorado, Denver Sch Med, Howard Hughes Med Inst, Aurora, CO 80045 USA; [Nix, Jay C.] Univ Calif Berkeley, Lawrence Berkeley Natl Lab, Mol Biol Consortium, Adv Light Source, Berkeley, CA 94720 USA	University of Colorado System; University of Colorado Anschutz Medical Campus; Howard Hughes Medical Institute; University of Colorado System; University of Colorado Anschutz Medical Campus; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley	Kieft, JS (corresponding author), Univ Colorado, Denver Sch Med, Dept Biochem & Mol Genet, Aurora, CO 80045 USA.	jeffrey.kieft@ucdenver.edu		Hammond, John/0000-0002-1170-3532	UC Cancer Center [P30CA046934]; Office of Science, Office of Basic Energy Sciences of the US Department of Energy [DE-ACO2-05CH11231]; National Institutes of Health [GM081346, GM097333]; NATIONAL CANCER INSTITUTE [P30CA046934] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM081346, R01GM097333] Funding Source: NIH RePORTER	UC Cancer Center; Office of Science, Office of Basic Energy Sciences of the US Department of Energy(United States Department of Energy (DOE)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank H. Noller for the gift of 70S ribosomes. We thank I. Tinoco Jr, C. Musselman and T. Dreher for critical reading of this manuscript. The University of Colorado (UC) Denver X-ray Facility is supported by UC Cancer Center Support Grant P30CA046934. The Advanced Light Source is supported by the Director, Office of Science, Office of Basic Energy Sciences of the US Department of Energy under contract #DE-ACO2-05CH11231. J.S.K. is supported by grants GM081346 and GM097333 from the National Institutes of Health and is an Early Career Scientist of the Howard Hughes Medical Institute.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Barends S, 2003, CELL, V112, P123, DOI 10.1016/S0092-8674(02)01256-4; BERTHELOT F, 1973, MOL CELL BIOCHEM, V1, P63, DOI 10.1007/BF01659939; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Cliffe AR, 2009, J VIROL, V83, P2321, DOI 10.1128/JVI.02303-08; Costantino D, 2005, RNA, V11, P332, DOI 10.1261/rna.7184705; Deiman BALM, 1998, J VIROL, V72, P3965, DOI 10.1128/JVI.72.5.3965-3972.1998; Dethoff EA, 2012, NATURE, V482, P322, DOI 10.1038/nature10885; Dreher TW, 2010, WIRES RNA, V1, P402, DOI 10.1002/wrna.42; Dreher TW, 2009, VIRUS RES, V139, P217, DOI 10.1016/j.virusres.2008.06.010; Dreher TW, 1998, NUCLEIC ACIDS RES, V26, P4356, DOI 10.1093/nar/26.19.4356; DREHER TW, 1992, BIOCHEMISTRY-US, V31, P9183, DOI 10.1021/bi00153a010; DUMAS P, 1987, J BIOMOL STRUCT DYN, V4, P707, DOI 10.1080/07391102.1987.10507674; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; FLORENTZ C, 1982, EMBO J, V1, P269, DOI 10.1002/j.1460-2075.1982.tb01158.x; Fukai S, 2000, CELL, V103, P793, DOI 10.1016/S0092-8674(00)00182-3; Giege R, 1998, CURR OPIN STRUC BIOL, V8, P286, DOI 10.1016/S0959-440X(98)80060-2; GIEGE R, 1993, BIOCHIMIE, V75, P569, DOI 10.1016/0300-9084(93)90063-X; Hammond JA, 2010, J MOL BIOL, V399, P450, DOI 10.1016/j.jmb.2010.04.016; Hammond JA, 2009, RNA, V15, P294, DOI 10.1261/rna.1360709; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P133, DOI 10.1107/S0907444909047374; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Karplus PA, 2012, SCIENCE, V336, P1030, DOI [10.1126/science.121823, 10.1126/science.1218231]; Keel AY, 2007, STRUCTURE, V15, P761, DOI 10.1016/j.str.2007.06.003; Kieft JS, 2001, RNA, V7, P194, DOI 10.1017/S1355838201001790; Kolk MH, 1998, SCIENCE, V280, P434, DOI 10.1126/science.280.5362.434; Leontis NB, 2001, RNA, V7, P499, DOI 10.1017/S1355838201002515; Litvak S, 1970, FEBS Lett, V11, P316, DOI 10.1016/0014-5793(70)80557-9; Matsuda D, 2004, VIROLOGY, V321, P36, DOI 10.1016/j.virol.2003.10.023; Matsuda D, 2004, VIROLOGY, V321, P47, DOI 10.1016/j.virol.2003.10.028; NISSEN P, 1995, SCIENCE, V270, P1464, DOI 10.1126/science.270.5241.1464; PINCK M, 1970, NATURE, V226, P954, DOI 10.1038/226954a0; RIETVELD K, 1983, EMBO J, V2, P1079, DOI 10.1002/j.1460-2075.1983.tb01549.x; RIETVELD K, 1982, NUCLEIC ACIDS RES, V10, P1929, DOI 10.1093/nar/10.6.1929; RIETVELD K, 1984, EMBO J, V3, P2613, DOI 10.1002/j.1460-2075.1984.tb02182.x; Shi HJ, 2000, RNA, V6, P1091, DOI 10.1017/S1355838200000364; Singh RN, 1997, VIROLOGY, V233, P430, DOI 10.1006/viro.1997.8621; Singh RN, 1998, RNA, V4, P1083, DOI 10.1017/S1355838298980694; Skuzeski JM, 1996, J VIROL, V70, P2107, DOI 10.1128/JVI.70.4.2107-2115.1996; Wientges J, 2000, BIOCHEMISTRY-US, V39, P6207, DOI 10.1021/bi992852l; Wilusz JE, 2008, CELL, V135, P919, DOI 10.1016/j.cell.2008.10.012; YOT P, 1970, P NATL ACAD SCI USA, V67, P1345, DOI 10.1073/pnas.67.3.1345; Zhu JY, 2011, P NATL ACAD SCI USA, V108, P1839, DOI 10.1073/pnas.1018582108	45	56	58	0	29	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 17	2014	511	7509					366	+		10.1038/nature13378	http://dx.doi.org/10.1038/nature13378			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AL2YR	24909993	Green Accepted			2022-12-28	WOS:000338992200040
J	Donoso, M; Collins, AGE; Koechlin, E				Donoso, Mael; Collins, Anne G. E.; Koechlin, Etienne			Foundations of human reasoning in the prefrontal cortex	SCIENCE			English	Article							COGNITIVE CONTROL; FRONTAL-CORTEX; INFORMATION	The prefrontal cortex (PFC) subserves reasoning in the service of adaptive behavior. Little is known, however, about the architecture of reasoning processes in the PFC. Using computational modeling and neuroimaging, we show here that the human PFC has two concurrent inferential tracks: (i) one from ventromedial to dorsomedial PFC regions that makes probabilistic inferences about the reliability of the ongoing behavioral strategy and arbitrates between adjusting this strategy versus exploring new ones from long-term memory, and (ii) another from polar to lateral PFC regions that makes probabilistic inferences about the reliability of two or three alternative strategies and arbitrates between exploring new strategies versus exploiting these alternative ones. The two tracks interact and, along with the striatum, realize hypothesis testing for accepting versus rejecting newly created strategies.	[Donoso, Mael; Koechlin, Etienne] INSERM, U960, Cognit Neurosci Lab, F-75005 Paris, France; [Donoso, Mael; Collins, Anne G. E.; Koechlin, Etienne] Ecole Normale Super, DEC, F-75005 Paris, France; [Donoso, Mael; Koechlin, Etienne] Univ Paris 06, Ctr Neuroimagerie Rech CENIR, F-75005 Paris, France; [Collins, Anne G. E.] Brown Univ, Providence, RI 02912 USA	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; PSL Research University Paris; Ecole Normale Superieure (ENS); UDICE-French Research Universities; Sorbonne Universite; Brown University	Koechlin, E (corresponding author), INSERM, U960, Cognit Neurosci Lab, 29 Rue Ulm, F-75005 Paris, France.	etienne.koechlin@upmc.fr	Koechlin, Etienne/E-5061-2016; Koechlin, Etienne/AAF-5717-2021	Koechlin, Etienne/0000-0002-6514-9311; Koechlin, Etienne/0000-0002-6514-9311	European Research Council Grant (ERC-AdG) [250106]	European Research Council Grant (ERC-AdG)	We thank C. Summerfield and S. Palminteri for their helpful comments. Funded by a European Research Council Grant (ERC-2009-AdG#250106) to E. K. MRI data are available at http://central.xnat.org, project ID: PROBE.	ALEXANDER GE, 1986, ANNU REV NEUROSCI, V9, P357, DOI 10.1146/annurev.ne.09.030186.002041; Alexander WH, 2011, NAT NEUROSCI, V14, P1338, DOI 10.1038/nn.2921; Badre D, 2010, NEURON, V66, P315, DOI 10.1016/j.neuron.2010.03.025; Behrens TEJ, 2007, NAT NEUROSCI, V10, P1214, DOI 10.1038/nn1954; Boorman ED, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001093; Boorman ED, 2009, NEURON, V62, P733, DOI 10.1016/j.neuron.2009.05.014; Charron S, 2010, SCIENCE, V328, P360, DOI 10.1126/science.1183614; Collins A, 2012, PLOS BIOL, V10, DOI 10.1371/journal.pbio.1001293; Cowan N, 2005, HUMAN LEARING AND MEMORY: ADVANCES IN THEORY AND APPLICATION, P155; Daw N, 2007, ADV NEURAL INFORM PR, V20, P369; De Martino B, 2013, NAT NEUROSCI, V16, P105, DOI 10.1038/nn.3279; Dosenbach NUF, 2006, NEURON, V50, P799, DOI 10.1016/j.neuron.2006.04.031; Doshi-Velez F., 2009, ADV NEURAL INFORM PR, V22, P477; Doya K, 2007, HFSP J, V1, P30, DOI [10.2976/1.2732246/10.2976/1, 10.2976/1.2732246]; Esterman M, 2010, NEUROIMAGE, V50, P572, DOI 10.1016/j.neuroimage.2009.10.092; Gershman SJ, 2010, PSYCHOL REV, V117, P197, DOI 10.1037/a0017808; Hampton AN, 2006, J NEUROSCI, V26, P8360, DOI 10.1523/JNEUROSCI.1010-06.2006; Koechlin E, 2003, SCIENCE, V302, P1181, DOI 10.1126/science.1088545; Koechlin E, 1999, NATURE, V399, P148, DOI 10.1038/20178; Koechlin E, 2007, SCIENCE, V318, P594, DOI 10.1126/science.1142995; Koechlin E, 2007, TRENDS COGN SCI, V11, P229, DOI 10.1016/j.tics.2007.04.005; Kolling N, 2012, SCIENCE, V336, P95, DOI 10.1126/science.1216930; Neubert FX, 2014, NEURON, V81, P700, DOI 10.1016/j.neuron.2013.11.012; O'Doherty J, 2004, SCIENCE, V304, P452, DOI 10.1126/science.1094285; Oaksford M, 2009, BEHAV BRAIN SCI, V32, P69, DOI 10.1017/S0140525X09000284; Ribas-Fernandes JJF, 2011, NEURON, V71, P370, DOI 10.1016/j.neuron.2011.05.042; Sakai K, 2003, NAT NEUROSCI, V6, P75, DOI 10.1038/nn987; Sakai K, 2008, ANNU REV NEUROSCI, V31, P219, DOI 10.1146/annurev.neuro.31.060407.125642; Schultz W, 1997, SCIENCE, V275, P1593, DOI 10.1126/science.275.5306.1593; Teffer K, 2012, PROG BRAIN RES, V195, P191, DOI 10.1016/B978-0-444-53860-4.00009-X; Teh YW, 2006, J AM STAT ASSOC, V101, P1566, DOI 10.1198/016214506000000302	31	224	225	0	90	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 27	2014	344	6191					1481	1486		10.1126/science.1252254	http://dx.doi.org/10.1126/science.1252254			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AJ7PZ	24876345				2022-12-28	WOS:000337889900041
J	Filippelli, G				Filippelli, Gabriel			OCEANS A salty start to modern ocean circulation	SCIENCE			English	Editorial Material							NORTHERN-HEMISPHERE GLACIATION		Indiana Univ Purdue Univ, Dept Earth Sci, Indianapolis, IN 46202 USA	Indiana University System; Indiana University-Purdue University Indianapolis	Filippelli, G (corresponding author), Indiana Univ Purdue Univ, Dept Earth Sci, Indianapolis, IN 46202 USA.	gfilippe@iupui.edu	Filippelli, Gabriel/R-6009-2019	Filippelli, Gabriel/0000-0003-3434-5982				Abrantes F, 2010, SCI DRILL, V9, P50, DOI 10.5194/sd-9-50-2010; Bartoli G, 2005, EARTH PLANET SC LETT, V237, P33, DOI 10.1016/j.epsl.2005.06.020; Cane MA, 2001, NATURE, V411, P157, DOI 10.1038/35075500; Hernandez-Molina FJ, 2014, SCIENCE, V344, P1244, DOI 10.1126/science.1251306; Hodell DA, 2013, SCI DRILL, V16, P13, DOI 10.5194/sd-16-13-2013; Martinez-Garcia P, 2013, BASIN RES, V25, P361, DOI 10.1111/bre.12005; Maslin MA, 1998, QUATERNARY SCI REV, V17, P411, DOI 10.1016/S0277-3791(97)00047-4; Rogerson M, 2012, REV GEOPHYS, V50, DOI 10.1029/2011RG000376; Roque C, 2012, MAR GEOL, V303, P42, DOI 10.1016/j.margeo.2011.11.001; Wunsch C, 2002, SCIENCE, V298, P1179, DOI 10.1126/science.1079329	10	1	2	0	17	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 13	2014	344	6189					1228	1229		10.1126/science.1255553	http://dx.doi.org/10.1126/science.1255553			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI7ND	24926003				2022-12-28	WOS:000337077500019
J	Meinert, F; Mark, MJ; Kirilov, E; Lauber, K; Weinmann, P; Grobner, M; Daley, AJ; Nagerl, HC				Meinert, Florian; Mark, Manfred J.; Kirilov, Emil; Lauber, Katharina; Weinmann, Philipp; Groebner, Michael; Daley, Andrew J.; Naegerl, Hanns-Christoph			QUANTUM GASES Observation of many-body dynamics in long-range tunneling after a quantum quench	SCIENCE			English	Article							OPTICAL LATTICES; MAGNETISM; SYSTEMS; ATOMS	Quantum tunneling is at the heart of many low-temperature phenomena. In strongly correlated lattice systems, tunneling is responsible for inducing effective interactions, and long-range tunneling substantially alters many-body properties in and out of equilibrium. We observe resonantly enhanced long-range quantum tunneling in one-dimensional Mott-insulating Hubbard chains that are suddenly quenched into a tilted configuration. Higher-order tunneling processes over up to five lattice sites are observed as resonances in the number of doubly occupied sites when the tilt per site is tuned to integer fractions of the Mott gap. This forms a basis for a controlled study of many-body dynamics driven by higher-order tunneling and demonstrates that when some degrees of freedom are frozen out, phenomena that are driven by small-amplitude tunneling terms can still be observed.	[Meinert, Florian; Mark, Manfred J.; Kirilov, Emil; Lauber, Katharina; Weinmann, Philipp; Groebner, Michael; Naegerl, Hanns-Christoph] Univ Innsbruck, Inst Expt Phys, A-6020 Innsbruck, Austria; [Meinert, Florian; Mark, Manfred J.; Kirilov, Emil; Lauber, Katharina; Weinmann, Philipp; Groebner, Michael; Naegerl, Hanns-Christoph] Univ Innsbruck, Zentrum Quantenphys, A-6020 Innsbruck, Austria; [Daley, Andrew J.] Univ Pittsburgh, Dept Phys & Astron, Pittsburgh, PA 15260 USA; [Daley, Andrew J.] Univ Strathclyde, Dept Phys, Glasgow G4 0NG, Lanark, Scotland; [Daley, Andrew J.] Univ Strathclyde, Scottish Univ Phys Alliance, Glasgow G4 0NG, Lanark, Scotland	University of Innsbruck; University of Innsbruck; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; University of Strathclyde; University of Strathclyde	Nagerl, HC (corresponding author), Univ Innsbruck, Inst Expt Phys, A-6020 Innsbruck, Austria.	christoph.naegerl@uibk.ac.at	Meinert, Florian/T-5302-2019; kirilov, emil/J-6038-2018; Daley, Andrew J/F-5366-2014; Naegerl, Hanns-Christoph/E-7329-2010; Mark, Manfred J/E-4286-2010	Meinert, Florian/0000-0002-9106-3001; kirilov, emil/0000-0003-0878-8296; Daley, Andrew J/0000-0001-9005-7761; Naegerl, Hanns-Christoph/0000-0002-7789-4431; Mark, Manfred J/0000-0001-8157-4716	European Research Council (ERC) [278417]; NSF [PHY-1148957]; Division Of Physics [1148957] Funding Source: National Science Foundation	European Research Council (ERC)(European Research Council (ERC)); NSF(National Science Foundation (NSF)); Division Of Physics(National Science Foundation (NSF)NSF - Directorate for Mathematical & Physical Sciences (MPS))	We are indebted to R. Grimm for generous support and thank J. Schachenmayer for discussions and contributions to numerical code development. We gratefully acknowledge funding by the European Research Council (ERC) under project no. 278417 and support in Pittsburgh from NSF grant PHY-1148957.	Amico L, 2008, REV MOD PHYS, V80, P517, DOI 10.1103/RevModPhys.80.517; Anderson PW, 2004, J PHYS-CONDENS MAT, V16, pR755, DOI 10.1088/0953-8984/16/24/R02; Ankerhold J., 2010, QUANTUM TUNNELING CO; Bakr WS, 2011, NATURE, V480, P500, DOI 10.1038/nature10668; Braakman FR, 2013, NAT NANOTECHNOL, V8, P432, DOI [10.1038/nnano.2013.67, 10.1038/NNANO.2013.67]; DAGOTTO E, 1994, REV MOD PHYS, V66, P763, DOI 10.1103/RevModPhys.66.763; Folling S, 2007, NATURE, V448, P1029, DOI 10.1038/nature06112; Greif D, 2013, SCIENCE, V340, P1307, DOI 10.1126/science.1236362; Kolodrubetz M, 2012, PHYS REV B, V85, DOI 10.1103/PhysRevB.85.100505; Lignier H, 2007, PHYS REV LETT, V99, DOI 10.1103/PhysRevLett.99.220403; Ma RC, 2011, PHYS REV LETT, V107, DOI 10.1103/PhysRevLett.107.095301; MACDONALD AH, 1988, PHYS REV B, V37, P9753, DOI 10.1103/PhysRevB.37.9753; Meinert F, 2013, PHYS REV LETT, V111, DOI 10.1103/PhysRevLett.111.053003; Morsch O, 2006, REV MOD PHYS, V78, P179, DOI 10.1103/RevModPhys.78.179; Norman MR, 2011, SCIENCE, V332, P196, DOI 10.1126/science.1200181; Pielawa S, 2011, PHYS REV B, V83, DOI 10.1103/PhysRevB.83.205135; Queisser F, 2012, PHYS REV A, V85, DOI 10.1103/PhysRevA.85.033625; Rigol M, 2008, NATURE, V452, P854, DOI 10.1038/nature06838; Sachdev S, 2002, PHYS REV B, V66, DOI 10.1103/PhysRevB.66.075128; Sachdev S, 2008, NAT PHYS, V4, P173, DOI 10.1038/nphys894; Sedghi G, 2011, NAT NANOTECHNOL, V6, P517, DOI [10.1038/nnano.2011.111, 10.1038/NNANO.2011.111]; Sias C, 2007, PHYS REV LETT, V98, DOI 10.1103/PhysRevLett.98.120403; Simon J, 2011, NATURE, V472, P307, DOI 10.1038/nature09994; Trotzky S, 2008, SCIENCE, V319, P295, DOI 10.1126/science.1150841; Trotzky S, 2012, NAT PHYS, V8, P325, DOI [10.1038/nphys2232, 10.1038/NPHYS2232]; Weber T, 2003, SCIENCE, V299, P232, DOI 10.1126/science.1079699; Winkler JR, 2014, J AM CHEM SOC, V136, P2930, DOI 10.1021/ja500215j	29	64	64	1	26	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 13	2014	344	6189					1259	1262		10.1126/science.1248402	http://dx.doi.org/10.1126/science.1248402			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI7ND	24926015	Green Accepted, Green Submitted			2022-12-28	WOS:000337077500034
J	Wahl, AS; Omlor, W; Rubio, JC; Chen, JL; Zheng, H; Schroter, A; Gullo, M; Weinmann, O; Kobayashi, K; Helmchen, F; Ommer, B; Schwab, ME				Wahl, A. S.; Omlor, W.; Rubio, J. C.; Chen, J. L.; Zheng, H.; Schroeter, A.; Gullo, M.; Weinmann, O.; Kobayashi, K.; Helmchen, F.; Ommer, B.; Schwab, M. E.			NEURONAL REPAIR Asynchronous therapy restores motor control by rewiring of the rat corticospinal tract after stroke	SCIENCE			English	Article							ADULT RATS; REHABILITATION; PLASTICITY; RECOVERY; PATHWAYS; CIRCUIT	The brain exhibits limited capacity for spontaneous restoration of lost motor functions after stroke. Rehabilitation is the prevailing clinical approach to augment functional recovery, but the scientific basis is poorly understood. Here, we show nearly full recovery of skilled forelimb functions in rats with large strokes when a growth-promoting immunotherapy against a neurite growth-inhibitory protein was applied to boost the sprouting of new fibers, before stabilizing the newly formed circuits by intensive training. In contrast, early high-intensity training during the growth phase destroyed the effect and led to aberrant fiber patterns. Pharmacogenetic experiments identified a subset of corticospinal fibers originating in the intact half of the forebrain, side-switching in the spinal cord to newly innervate the impaired limb and restore skilled motor function.	[Wahl, A. S.; Gullo, M.; Weinmann, O.; Schwab, M. E.] Swiss Fed Inst Technol, Dept Hlth Sci & Technol, Zurich, Switzerland; [Wahl, A. S.; Omlor, W.; Chen, J. L.; Gullo, M.; Weinmann, O.; Helmchen, F.; Schwab, M. E.] Univ Zurich, Brain Res Inst, Zurich, Switzerland; [Rubio, J. C.; Zheng, H.; Ommer, B.] Heidelberg Univ, Comp Vis Grp, Heidelberg Collaboratory Image Proc, Heidelberg, Germany; [Rubio, J. C.; Zheng, H.; Ommer, B.] Heidelberg Univ, Interdisciplinary Ctr Sci Comp IWR, Heidelberg, Germany; [Schroeter, A.] Swiss Fed Inst Technol, Inst Biomed Engn, Zurich, Switzerland; [Kobayashi, K.] Natl Inst Nat Sci Myodaiji, Natl Inst Physiol Sci, Okazaki, Aichi, Japan	Swiss Federal Institutes of Technology Domain; ETH Zurich; University of Zurich; Ruprecht Karls University Heidelberg; Ruprecht Karls University Heidelberg; Swiss Federal Institutes of Technology Domain; ETH Zurich; National Institutes of Natural Sciences (NINS) - Japan; National Institute for Physiological Sciences (NIPS)	Wahl, AS (corresponding author), Swiss Fed Inst Technol, Dept Hlth Sci & Technol, Zurich, Switzerland.	wahl@hifo.uzh.ch; schwab@hifo.uzh.ch	Omlor, Wolfgang/AAJ-8288-2021; Schwab, Martin E/B-6818-2016; Omlor, Wolfgang/AAS-3163-2020; Helmchen, Fritjof/A-6255-2008	Helmchen, Fritjof/0000-0002-8867-9569; Chen, Jerry/0000-0002-7409-7859; Omlor, Wolfgang/0000-0003-1979-7147; Wahl, Anna-Sophia/0000-0001-9498-4263	European Union [201024, 223524]; advanced European Research Council grant NOGORISE; Swiss National Science Foundation [31-138676, 3100A0_12252711, 31003A_149858]; Christopher and Dana Reeve Foundation; Dr. Wilhelm Hurka Foundation; German Excellence Initiative, Deutsche Forschungsgemeinschaft project [49/2]	European Union(European Commission); advanced European Research Council grant NOGORISE; Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Christopher and Dana Reeve Foundation; Dr. Wilhelm Hurka Foundation; German Excellence Initiative, Deutsche Forschungsgemeinschaft project	We thank T. Isa from the National Institute for Physiological Sciences, Okazaki, Japan, as well as K. Kobayashi, Fukushima Medical University, and D. Watanabe, Kyoto University, for kindly providing plasmids for viral vector production. We thank H. Kasper, C. Bleul, and N. Lindau for technical advice and fruitful discussions, as well as B. Seifert for statistical assistance. This work is supported by the European Union grants FP7 Collaborative Projects ARISE (201024) and PLASTICISE (223524), the advanced European Research Council grant NOGORISE (to M. E. S.), the Swiss National Science Foundation grants Nr. 31-138676 and 3100A0_12252711 (to M. E. S.) and Nr. 31003A_149858 (to F. H.), the Christopher and Dana Reeve Foundation (to M. E. S.), and the Dr. Wilhelm Hurka Foundation (F.H. and W.O.). The work by J.C.R and B.O. was supported by the German Excellence Initiative, Deutsche Forschungsgemeinschaft project number 49/2. A. S. W. and M. E. S. designed the study; A. S. W. and M. G. carried out experiments; A.S.W., W.O., B.O., and F.H. performed data analysis; J.C.R., H.Z., and B.O. developed computer and machine learning algorithm tools for data analysis; J. L. C. and K. K. provided virus vectors; A. S. performed magnetic resonance imaging; O.W. carried out histological analysis; and A.S.W, B.O., F.H., and M.E.S. prepared figures and wrote the manuscript. The University of Zurich holds joint patents with Novartis Pharma for antibodies against Nogo-A and their use in neurological diseases. Otherwise, we have no patents pending or financial conflicts to disclose. Materials and methods are available as supplementary materials on Science Online. Plasmids for lentiviral and AAV vectors for the TeNT experiment were obtained under material transfer agreements (MTAs) with Kyoto University, Japan (pLenti-TRE-EGFP-eTeNT-PEST-WPRE, pLenti-TRE-EGFP-WPRE, pRSV-Rev, pMDLg/pRRE, pAAV2-RC, pAAV2-CMV-rtTAV16), and Fukushima Medical University, Japan (pCAGGS-FuG-B2), respectively. Viral vectors for the DREADD experiment were obtained under a MTA with the University of Pennsylvania, Philadelphia, PA (AAV2.9-CamKII alpha.-Cre vector). The anti-Nogo-A antibody (11C7) was a gift from Novartis Pharma. The supplementary materials contain additional data.	Adkins DL, 2005, NEUROSCI LETT, V380, P214, DOI 10.1016/j.neulet.2005.01.036; Alaverdashvili M, 2008, BEHAV BRAIN RES, V188, P281, DOI 10.1016/j.bbr.2007.11.007; Alexander GM, 2009, NEURON, V63, P27, DOI 10.1016/j.neuron.2009.06.014; Asante CO, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074454; Azim E, 2014, NATURE, V508, P357, DOI 10.1038/nature13021; Carmichael ST, 2006, ANN NEUROL, V59, P735, DOI 10.1002/ana.20845; Conklin BR, 2008, NAT METHODS, V5, P673, DOI 10.1038/nmeth.1232; Dimyan MA, 2011, NAT REV NEUROL, V7, P76, DOI 10.1038/nrneurol.2010.200; Ferguson SM, 2011, NAT NEUROSCI, V14, P22, DOI 10.1038/nn.2703; Garcia-Alias G, 2009, NAT NEUROSCI, V12, P1145, DOI 10.1038/nn.2377; Kinoshita M, 2012, NATURE, V487, P235, DOI 10.1038/nature11206; Krakauer JW, 2012, NEUROREHAB NEURAL RE, V26, P923, DOI 10.1177/1545968312440745; Langhorne P, 2011, LANCET, V377, P1693, DOI 10.1016/S0140-6736(11)60325-5; Lindau NT, 2014, BRAIN, V137, P739, DOI 10.1093/brain/awt336; Maier IC, 2008, J NEUROSCI, V28, P9386, DOI 10.1523/JNEUROSCI.1697-08.2008; Murphy TH, 2009, NAT REV NEUROSCI, V10, P861, DOI 10.1038/nrn2735; Oertle T, 2003, J NEUROSCI, V23, P5393; Ommer B, 2009, INT J COMPUT VISION, V83, P57, DOI 10.1007/s11263-009-0211-7; Petruska JC, 2007, J NEUROSCI, V27, P4460, DOI 10.1523/JNEUROSCI.2302-06.2007; Starkey ML, 2011, EXP NEUROL, V232, P81, DOI 10.1016/j.expneurol.2011.08.006; Tsai SY, 2007, EXP BRAIN RES, V182, P261, DOI 10.1007/s00221-007-1067-0; Wiessner C, 2003, J CEREBR BLOOD F MET, V23, P154, DOI 10.1097/01.WCB.0000040400.30600.AF; Zeiler SR, 2013, CURR OPIN NEUROL, V26, P609, DOI 10.1097/WCO.0000000000000025	23	226	236	5	76	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 13	2014	344	6189					1250	1255		10.1126/science.1253050	http://dx.doi.org/10.1126/science.1253050			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI7ND	24926013				2022-12-28	WOS:000337077500032
J	Sacks, DB; John, WG				Sacks, David B.; John, W. Garry			Interpretation of Hemoglobin A(1c) Values	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							SYSTEM; CHAOS		[Sacks, David B.] NIH, Dept Lab Med, Bethesda, MD 20892 USA; [John, W. Garry] Norfolk & Norwich Univ Hosp, Dept Clin Biochem, Norwich, Norfolk, England; [John, W. Garry] Norwich Med Sch, Norwich, Norfolk, England	National Institutes of Health (NIH) - USA; Norfolk & Norwich University Hospitals NHS Foundation Trust; Norfolk & Norwich University Hospital; University of East Anglia	Sacks, DB (corresponding author), NIH, Bldg 10,Room 2C306,10 Ctr Dr, Bethesda, MD 20892 USA.	sacksdb@mail.nih.gov		Sacks, David/0000-0003-3100-0735				Amer Diabet Assoc, 2014, DIABETES CARE, V37, pS14, DOI 10.2337/dc14-S014; Berg AH, 2008, J CLIN PATHOL, V61, P983, DOI 10.1136/jcp.2007.049205; Bry L, 2001, CLIN CHEM, V47, P153; Hoelzel W, 2004, CLIN CHEM, V50, P166, DOI 10.1373/clinchem.2003.024802; Little RR, 2011, CLIN CHEM, V57, P205, DOI 10.1373/clinchem.2010.148841; National Glycohemoglobin Standardization Program, HARMONIZING HEMOGLOB; Sacks DB, 2011, CLIN CHEM, V57, pE1, DOI 10.1373/clinchem.2010.161596; SHAMOON H, 1993, NEW ENGL J MED, V329, P977, DOI 10.1056/nejm199309303291401; Weykamp C, 2008, CLIN CHEM, V54, P240, DOI 10.1373/clinchem.2007.097402	9	35	36	0	3	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUN 11	2014	311	22					2271	2272		10.1001/jama.2014.6342	http://dx.doi.org/10.1001/jama.2014.6342			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AI6HL	24915255				2022-12-28	WOS:000336972600015
J	Hellweg, S; Canals, LMI				Hellweg, Stefanie; Mila i Canals, Llorenc			Emerging approaches, challenges and opportunities in life cycle assessment	SCIENCE			English	Review							FRESH-WATER; IMPACT ASSESSMENT; LAND-USE; ENVIRONMENTAL IMPACTS; ANALYZING UNCERTAINTY; GLOBAL-SCALE; HUMAN HEALTH; LCA; CONSUMPTION; INVENTORY	In the modern economy, international value chains-production, use, and disposal of goods-have global environmental impacts. Life Cycle Assessment (LCA) aims to track these impacts and assess them from a systems perspective, identifying strategies for improvement without burden shifting. We review recent developments in LCA, including existing and emerging applications aimed at supporting environmentally informed decisions in policy-making, product development and procurement, and consumer choices. LCA constitutes a viable screening tool that can pinpoint environmental hotspots in complex value chains, but we also caution that completeness in scope comes at the price of simplifications and uncertainties. Future advances of LCA in enhancing regional detail and accuracy as well as broadening the assessment to economic and social aspects will make it more relevant for producers and consumers alike.	[Hellweg, Stefanie] ETH, Inst Environm Engn, CH-8093 Zurich, Switzerland; [Mila i Canals, Llorenc] UNEP, Div Technol Ind & Econ, F-75009 Paris, France	Swiss Federal Institutes of Technology Domain; ETH Zurich	Hellweg, S (corresponding author), ETH, Inst Environm Engn, HPZ E 31-2,John von Neumann Weg 9, CH-8093 Zurich, Switzerland.	hellweg@ifu.baug.ethz.ch	Hellweg, Stefanie/AAA-7756-2019	Hellweg, Stefanie/0000-0001-6376-9878				Azevedo LB, 2013, ENVIRON SCI TECHNOL, V47, P13565, DOI 10.1021/es403422a; Baitz M, 2013, INT J LIFE CYCLE ASS, V18, P5, DOI 10.1007/s11367-012-0476-x; Beno?t C., 2009, GUIDELINES SOCIAL LI; Benoit-Norris C, 2012, SUSTAINABILITY-BASEL, V4, P1946, DOI 10.3390/su4091946; Boulay AM, 2011, ENVIRON SCI TECHNOL, V45, P8948, DOI 10.1021/es1030883; Brandao M, 2013, INT J LIFE CYCLE ASS, V18, P1243, DOI 10.1007/s11367-012-0381-3; BSI, 2012, 158042012A12013 BSI; Cabeza LF, 2014, RENEW SUST ENERG REV, V29, P394, DOI 10.1016/j.rser.2013.08.037; Caduff M, 2011, ENVIRON SCI TECHNOL, V45, P751, DOI 10.1021/es103095k; Cherubini F, 2011, GCB BIOENERGY, V3, P413, DOI 10.1111/j.1757-1707.2011.01102.x; Christensen TH, 2009, WASTE MANAGE RES, V27, P871, DOI 10.1177/0734242X09350333; Cooper J, 2013, J IND ECOL, V17, P796, DOI 10.1111/jiec.12069; Cros C, 2010, INT J LIFE CYCLE ASS, V15, P537, DOI 10.1007/s11367-010-0182-5; Cucurachi S, 2012, INT J LIFE CYCLE ASS, V17, P471, DOI 10.1007/s11367-011-0377-4; Curran M., 2013, ECOL APPL; de Baan L, 2013, ENVIRON SCI TECHNOL, V47, P9281, DOI 10.1021/es400592q; De Schryver AM, 2013, INT J LIFE CYCLE ASS, V18, P698, DOI 10.1007/s11367-012-0504-x; Ekvall T, 2004, INT J LIFE CYCLE ASS, V9, P161, DOI 10.1007/BF02994190; Finnveden G, 2009, J ENVIRON MANAGE, V91, P1, DOI 10.1016/j.jenvman.2009.06.018; Fries N, 2014, INT J LIFE CYCLE ASS, V19, P546, DOI 10.1007/s11367-013-0657-2; Frischknecht R., 2012, SYSTEMBLICK INNOVATI, V16; Garnett T., 2008, COOKING STORM FOOD G; Girod B, 2011, INT J LIFE CYCLE ASS, V16, P3, DOI 10.1007/s11367-010-0240-z; Gregory JR, 2013, INT J LIFE CYCLE ASS, V18, P1605, DOI 10.1007/s11367-013-0606-0; Guinee JB, 2011, ENVIRON SCI TECHNOL, V45, P90, DOI 10.1021/es101316v; Hauschild MZ, 2013, INT J LIFE CYCLE ASS, V18, P683, DOI 10.1007/s11367-012-0489-5; Helmes RJK, 2012, INT J LIFE CYCLE ASS, V17, P646, DOI 10.1007/s11367-012-0382-2; Hertwich EG, 2005, J IND ECOL, V9, P85, DOI 10.1162/1088198054084635; Hischier R, 2012, SCI TOTAL ENVIRON, V425, P271, DOI 10.1016/j.scitotenv.2012.03.001; Huijbregts MAJ, 2003, ENVIRON SCI TECHNOL, V37, P2600, DOI 10.1021/es020971+; International Standard Organization, 1997, 14040 ISO; Jolliet O., 2014, INT J LIFE CYCLE ASS, DOI [10.1007/s11367, DOI 10.1007/S11367]; Kloverpris JH, 2010, INT J LIFE CYCLE ASS, V15, P90, DOI 10.1007/s11367-009-0132-2; Koehler A, 2009, ENVIRON SCI TECHNOL, V43, P8643, DOI 10.1021/es901236f; Levasseur A, 2012, NAT CLIM CHANGE, V2, P6, DOI 10.1038/nclimate1335; Lloyd SM, 2007, J IND ECOL, V11, P161, DOI 10.1162/jiec.2007.1136; Mattila T, 2012, J IND ECOL, V16, P51, DOI 10.1111/j.1530-9290.2011.00443.x; McKone TE, 2011, ENVIRON SCI TECHNOL, V45, P1751, DOI 10.1021/es103579c; Mila i Canals L, 2011, J IND ECOL, V15, P707, DOI 10.1111/j.1530-9290.2011.00369.x; Canals LMI, 2011, INT J LIFE CYCLE ASS, V16, P50, DOI 10.1007/s11367-010-0239-5; Motoshita M, 2011, INT J LIFE CYCLE ASS, V16, P65, DOI 10.1007/s11367-010-0236-8; Mutel CL, 2012, ENVIRON SCI TECHNOL, V46, P1096, DOI 10.1021/es203117z; Nunez M, 2013, INT J LIFE CYCLE ASS, V18, P755, DOI 10.1007/s11367-012-0525-5; Olsen S. I., 2007, NANOTECHNOLOGY LIFE; Pauliuk S, 2013, J IND ECOL, V17, P542, DOI 10.1111/j.1530-9290.2012.00571.x; Pfister S, 2011, ENVIRON SCI TECHNOL, V45, P5761, DOI 10.1021/es1041755; Pfister S, 2009, ENVIRON SCI TECHNOL, V43, P4098, DOI 10.1021/es802423e; Ramesh T, 2010, ENERG BUILDINGS, V42, P1592, DOI 10.1016/j.enbuild.2010.05.007; Riber C, 2008, WASTE MANAGE RES, V26, P96, DOI 10.1177/0734242X08088583; Rosenbaum RK, 2011, INT J LIFE CYCLE ASS, V16, P710, DOI 10.1007/s11367-011-0316-4; Saad R, 2013, INT J LIFE CYCLE ASS, V18, P1253, DOI 10.1007/s11367-013-0577-1; Saner D., 2013, THESIS ETH ZURICH SW; Saner D, 2013, ENVIRON SCI TECHNOL, V47, P5988, DOI 10.1021/es304084p; Scharlemann JPW, 2008, SCIENCE, V319, P43, DOI 10.1126/science.1153103; Steemers K, 2009, BUILD RES INF, V37, P625, DOI 10.1080/09613210903186661; Stoessel F, 2012, ENVIRON SCI TECHNOL, V46, P3253, DOI 10.1021/es2030577; Swarr TE, 2011, INT J LIFE CYCLE ASS, V16, P389, DOI 10.1007/s11367-011-0287-5; Tukker A, 2006, J IND ECOL, V10, P159, DOI 10.1162/jiec.2006.10.3.159; Tukker A, 2013, ECON SYST RES, V25, P50, DOI 10.1080/09535314.2012.761952; Verones F, 2013, ENVIRON SCI TECHNOL, V47, P12248, DOI 10.1021/es403635j; Wiedmann TO, 2015, P NATL ACAD SCI USA, V112, P6271, DOI 10.1073/pnas.1220362110; Worldwatch Institute, 2014, WAL MART SCRUTINIZES; Zamagni A, 2012, INT J LIFE CYCLE ASS, V17, P904, DOI 10.1007/s11367-012-0423-x	63	675	686	49	522	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 6	2014	344	6188					1109	1113		10.1126/science.1248361	http://dx.doi.org/10.1126/science.1248361			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI3UU	24904154				2022-12-28	WOS:000336791200036
J	Corey, GR; Kabler, H; Mehra, P; Gupta, S; Overcash, JS; Porwal, A; Giordano, P; Lucasti, C; Perez, A; Good, S; Jiang, H; Moeck, G; O'Riordan, W				Corey, G. Ralph; Kabler, Heidi; Mehra, Purvi; Gupta, Sandeep; Overcash, J. Scott; Porwal, Ashwin; Giordano, Philip; Lucasti, Christopher; Perez, Antonio; Good, Samantha; Jiang, Hai; Moeck, Greg; O'Riordan, William		SOLO I Investigators	Single-Dose Oritavancin in the Treatment of Acute Bacterial Skin Infections	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							SOFT-TISSUE INFECTIONS; STAPHYLOCOCCUS-AUREUS; COMPLICATED SKIN; CLINICAL-TRIALS; THERAPY; HOSPITALIZATION; AGENTS; BLOOD	BACKGROUND Oritavancin is a lipoglycopeptide with bactericidal activity against gram-positive bacteria. Its concentration-dependent activity and prolonged half-life allow for single-dose treatment. METHODS We conducted a randomized, double-blind trial in which adults with acute bacterial skin and skin-structure infections received either a single intravenous dose of 1200 mg of oritavancin or a regimen of intravenous vancomycin twice daily for 7 to 10 days. Three efficacy end points were tested for noninferiority. The primary composite end point was defined as cessation of spreading or reduction in lesion size, absence of fever, and no need for administration of a rescue antibiotic 48 to 72 hours after administration of oritavancin. Secondary end points were clinical cure 7 to 14 days after the end of treatment, as determined by a study investigator, and a reduction in lesion size of 20% or more 48 to 72 hours after administration of oritavancin. RESULTS The modified intention-to-treat population comprised 475 patients who received oritavancin and 479 patients who received vancomycin. All three efficacy end points met the prespecified noninferiority margin of 10 percentage points for oritavancin versus vancomycin: primary end point, 82.3% versus 78.9% (95% confidence interval [CI] for the difference, -1.6 to 8.4 percentage points); investigator-assessed clinical cure, 79.6% versus 80.0% (95% CI for the difference, -5.5 to 4.7 percentage points); and proportion of patients with a reduction in lesion area of 20% or more, 86.9% versus 82.9% (95% CI for the difference, -0.5 to 8.6 percentage points). Efficacy outcomes measured according to type of pathogen, including methicillin-resistant Staphylococcus aureus, were similar in the two treatment groups. The overall frequency of adverse events was also similar, although nausea was more common among those treated with oritavancin. CONCLUSIONS A single dose of oritavancin was noninferior to twice-daily vancomycin administered for 7 to 10 days for the treatment of acute bacterial skin and skin-structure infections caused by gram-positive pathogens. (Funded by the Medicines Company; SOLO I ClinicalTrials.gov number, NCT01252719.)	[Corey, G. Ralph] Duke Univ, Med Ctr, Durham, NC 27708 USA; [Kabler, Heidi] Sunrise Hosp & Med Ctr, Las Vegas, NV USA; [Mehra, Purvi; O'Riordan, William] Sharp Chula Vista Med Ctr, Chula Vista, CA USA; [Overcash, J. Scott] Sharp Grossmt Hosp, San Diego, CA USA; [Gupta, Sandeep] MV Hosp & Res Ctr, Lucknow, Uttar Pradesh, India; [Porwal, Ashwin] Inamdar Multispecialty Hosp, Pune, Maharashtra, India; [Giordano, Philip] Orlando Hlth, Orlando, FL USA; [Lucasti, Christopher] South Jersey Infect Dis, Somers Point, NJ USA; [Perez, Antonio; Good, Samantha; Jiang, Hai; Moeck, Greg] Medicines Co, Parsippany, NJ USA	Duke University	Corey, GR (corresponding author), Duke Univ, Med Ctr, 310 Trent Dr,Box 90519, Durham, NC 27708 USA.	g.corey@duke.edu	Mahakalkar, Chandrashekhar/ABA-8510-2020	Mahakalkar, Chandrashekhar/0000-0002-9969-9725; Moeck, Greg/0000-0001-7827-7227; Porwal, Dr Ashwin/0000-0003-4824-3215	Medicines Company	Medicines Company	Funded by the Medicines Company; SOLO I ClinicalTrials.gov number, NCT01252719.	Ambrose PG, 2012, CLIN INFECT DIS, V54, pS220, DOI 10.1093/cid/cis001; [Anonymous], 2012, TYG TIG PRESCR INF; [Anonymous], 2010, VANC PRESCR INF; [Anonymous], 2012, ZYV LIN PRESCR INF; [Anonymous], 2012, TEFL CEFT FOS PRESCR; [Anonymous], 2012, VIB TEL PRESCR INF; [Anonymous], 2013, CUB DAPT PRESCR INF; Arhin FF, 2009, ANTIMICROB AGENTS CH, V53, P4762, DOI 10.1128/AAC.00952-09; Ball AT, 2010, CLIN THER, V32, P2246, DOI 10.1016/S0149-2918(10)80027-X; Belley A, 2013, ANTIMICROB AGENTS CH, V57, P205, DOI 10.1128/AAC.01428-12; Belley A, 2010, ANTIMICROB AGENTS CH, V54, P5369, DOI 10.1128/AAC.00760-10; Belley A, 2009, ANTIMICROB AGENTS CH, V53, P918, DOI 10.1128/AAC.00766-08; Centers for Disease Control and Prevention, 2011, ACT BACT COR SURV AB; Dunbar LM, 2011, ANTIMICROB AGENTS CH, V55, P3476, DOI 10.1128/AAC.00029-11; European Centre for Disease Prevention and Control, 2012, ANT RES SURV EUR 201; FDA, 2009, GUID IND DRUG IND LI; Food and Drug Administration, 2010, GUID IND AC BACT SKI; Garau J, 2013, CLIN MICROBIOL INFEC, V19, pE377, DOI 10.1111/1469-0691.12235; Jenkins TC, 2010, CLIN INFECT DIS, V51, P895, DOI 10.1086/656431; Kumar A, 2011, INT J ARTIF ORGANS, V34, P1067, DOI 10.5301/ijao.5000008; Landrum ML, 2012, JAMA-J AM MED ASSOC, V308, P50, DOI 10.1001/jama.2012.7139; Lee BY, 2013, CLIN MICROBIOL INFEC, V19, P528, DOI 10.1111/j.1469-0691.2012.03914.x; Liu C, 2011, CLIN INFECT DIS, V53, P319, DOI [10.1093/cid/cir353, 10.1093/cid/ciq146]; Mckay GA, 2009, J ANTIMICROB CHEMOTH, V63, P1191, DOI 10.1093/jac/dkp126; Mendes RE, 2012, CLIN INFECT DIS, V54, pS203, DOI 10.1093/cid/cir923; Rehm S, 2009, J ANTIMICROB CHEMOTH, V63, P1034, DOI 10.1093/jac/dkp051; Rubino CM, 2009, ANTIMICROB AGENTS CH, V53, P4422, DOI 10.1128/AAC.00231-09; Snodgrass WR, 1937, BMJ-BRIT MED J, V1937, P101; Snodgrass WR, 1937, BMJ-BRIT MED J, V2, P1167; Spellberg B, 2009, CLIN INFECT DIS, V49, P383, DOI 10.1086/600296; Stevens DL, 2006, CLIN INFECT DIS, V42, P1219; Talbot GH, 2012, CLIN INFECT DIS, V55, P1114, DOI 10.1093/cid/cis566; Tice A, 2012, CLIN INFECT DIS, V54, pS239, DOI 10.1093/cid/cir1047; Watkins PB, 2011, DRUG SAFETY, V34, P243, DOI 10.2165/11586600-000000000-00000; Zhanel GG, 2012, CLIN INFECT DIS, V54, pS214, DOI 10.1093/cid/cir920	35	196	200	0	28	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUN 5	2014	370	23					2180	2190		10.1056/NEJMoa1310422	http://dx.doi.org/10.1056/NEJMoa1310422			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AI3AF	24897083	Bronze			2022-12-28	WOS:000336729900006
J	Maund, E; Tendal, B; Hrobjartsson, A; Lundh, A; Gotzsche, PC				Maund, Emma; Tendal, Britta; Hrobjartsson, Asbjorn; Lundh, Andreas; Gotzsche, Peter C.			Coding of adverse events of suicidality in clinical study reports of duloxetine for the treatment of major depressive disorder: descriptive study	BMJ-BRITISH MEDICAL JOURNAL			English	Article								Objective To assess the effects of coding and coding conventions on summaries and tabulations of adverse events data on suicidality within clinical study reports. Design Systematic electronic search for adverse events of suicidality in tables, narratives, and listings of adverse events in individual patients within clinical study reports. Where possible, for each event we extracted the original term reported by the investigator, the term as coded by the medical coding dictionary, medical coding dictionary used, and the patient's trial identification number. Using the patient's trial identification number, we attempted to reconcile data on the same event between the different formats for presenting data on adverse events within the clinical study report. Setting 9 randomised placebo controlled trials of duloxetine for major depressive disorder submitted to the European Medicines Agency for marketing approval. Data sources Clinical study reports obtained from the EMA in 2011. Results Six trials used the medical coding dictionary COSTART (Coding Symbols for a Thesaurus of Adverse Reaction Terms) and three used MedDRA (Medical Dictionary for Regulatory Activities). Suicides were clearly identifiable in all formats of adverse event data in clinical study reports. Suicide attempts presented in tables included both definitive and provisional diagnoses. Suicidal ideation and preparatory behaviour were obscured in some tables owing to the lack of specificity of the medical coding dictionary, especially COSTART. Furthermore, we found one event of suicidal ideation described in narrative text that was absent from tables and adverse event listings of individual patients. The reason for this is unclear, but may be due to the coding conventions used. Conclusion Data on adverse events in tables in clinical study reports may not accurately represent the underlying patient data because of the medical dictionaries and coding conventions used. In clinical study reports, the listings of adverse events for individual patients and narratives of adverse events can provide additional information, including original investigator reported adverse event terms, which can enable a more accurate estimate of harms.	[Maund, Emma; Tendal, Britta; Hrobjartsson, Asbjorn; Lundh, Andreas; Gotzsche, Peter C.] Rigshosp, Dept 7811, Nord Cochrane Ctr, DK-2100 Copenhagen, Denmark; [Lundh, Andreas] Hvidovre Univ Hosp, Dept Infect Dis, DK-2650 Hvidovre, Denmark	Rigshospitalet; University of Copenhagen; University of Copenhagen	Maund, E (corresponding author), Rigshosp, Dept 7811, Nord Cochrane Ctr, DK-2100 Copenhagen, Denmark.	em@cochrane.dk		Lundh, Andreas/0000-0002-4982-8680	Rigshospitalets Forskningsudvalg	Rigshospitalets Forskningsudvalg	This study is part of a PhD (EM) funded by Rigshospitalets Forskningsudvalg. The funding source had no role in the design and conduct of the study; data collection, management, analysis, and interpretation; preparation, review, and approval of the manuscript; or the decision to submit the paper for publication.	ABBYY, 2013, ABBYY FINEREADER 11; [Anonymous], 2014, SELECTIVE SEROTONIN; [Anonymous], 2013, SCI DISCUSSION EMA 2; [Anonymous], 1995, STRUCT CONT CLIN STU; [Anonymous], 2014, CHALLENGES WRITING 1; [Anonymous], 2013, GUID GOOD CLIN PRACT; [Anonymous], 1998, STAT PRINC CLIN TRIA; Brown DR, 1997, INT J PHARM MED, V11, P85; Brown EG, 2004, STEPHENS DETECTION N, P533; Central authorisation of medicines, 2014, CENTRAL AUTHORISATIO; Chow SC, 2004, DESIGN ANAL CLIN TRI; Committee for medicinal products for human use (CHMP), 2004, CHMPEWP299803; Doshi P, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001201; Fizames C., 1997, THER INNOV REGUL SCI, V31, P85, DOI [10.1177/009286159703100112, DOI 10.1177/009286159703100112]; Hammad TA, 2006, ARCH GEN PSYCHIAT, V63, P332, DOI 10.1001/archpsyc.63.3.332; Healy David, 2004, LET THEM EAT PROZAC; Hrobjartsson A, 2012, BMJ-BRIT MED J, V344, DOI 10.1136/bmj.e1119; ICH Secretariat, 2014, MEDDRA TERM SEL POIN; Jefferson T, 2012, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD008965.pub4, 10.1002/14651858.CD008965.pub3]; Kornai A, 2004, STUD FUZZ SOFT COMP, V140, P413; Lundh A, 2011, LANCET, V378, P1995, DOI 10.1016/S0140-6736(11)61871-0; Matsumoto C, 1991, DRUG INF J, V25, P201; MedDRA, 2013, HISTORY; Peters PH, 2001, J AM GERIATR SOC, V49, P1025, DOI 10.1046/j.1532-5415.2001.49204.x; Posner K, 2007, AM J PSYCHIAT, V164, P1035, DOI 10.1176/appi.ajp.164.7.1035; US FDA, 2010, ADV COMM M NDA 21071; White CA, 1998, DRUG INF J, V32, P347, DOI 10.1177/009286159803200204	27	6	6	0	6	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JUN 4	2014	348								g3555	10.1136/bmj.g3555	http://dx.doi.org/10.1136/bmj.g3555			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AI7CC	24899651	Green Published, hybrid			2022-12-28	WOS:000337037700002
J	Pound, P; Bracken, MB				Pound, Pandora; Bracken, Michael B.			Is animal research sufficiently evidence based to be a cornerstone of biomedical research?	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							SYSTEMATIC REVIEWS; MOUSE MODELS; TRANSLATION; ATTRITION; QUALITY		[Bracken, Michael B.] Yale Univ, Sch Publ Hlth, New Haven, CT USA; [Bracken, Michael B.] Yale Univ, Sch Med, New Haven, CT USA	Yale University; Yale University		pandorapound@gmail.com						Bailey J, 2011, ATLA-ALTERN LAB ANIM, V39, P527, DOI 10.1177/026119291103900608; Baker D, 2014, PLOS BIOL, V12, DOI 10.1371/journal.pbio.1001756; Boffelli D, 2012, DNA CELL BIOL, V31, pS11, DOI 10.1089/dna.2012.1643; Bracken M, 2013, RISK CHANCE CAUSATIO; Brown S, 2013, INDEPENDENT INVESTIG; Chalmers I, 2014, LANCET, V383, P156, DOI 10.1016/S0140-6736(13)62229-1; Chalmers I, 2009, LANCET, V374, P86, DOI 10.1016/S0140-6736(09)60329-9; Chen Z, 2012, NATURE, V483, P613, DOI 10.1038/nature10937; Collins FS, 2014, NATURE, V505, P612, DOI 10.1038/505612a; Contopoulos-Ioannidis DG, 2003, AM J MED, V114, P477, DOI 10.1016/S0002-9343(03)00013-5; Dal-Re R, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3007513; Eastwood D, 2010, BRIT J PHARMACOL, V161, P512, DOI 10.1111/j.1476-5381.2010.00922.x; Festing MF, 2013, ALTERN LAB ANIMAL, V41, P1; Geerts H, 2009, CNS DRUGS, V23, P915, DOI 10.2165/11310890-000000000-00000; Greek R, 2009, ANIMAL MODELS LIGHT; Greek R, 2013, INT J MED SCI, V10, P206, DOI 10.7150/ijms.5529; Hackam DG, 2007, BMJ-BRIT MED J, V334, P163, DOI 10.1136/bmj.39104.362951.80; Hackam DG, 2006, JAMA-J AM MED ASSOC, V296, P1731, DOI 10.1001/jama.296.14.1731; Hartung T, 2014, ALTEX, V30, P275; Hawkes N, 2014, BMJ-BRIT MED J, V348, DOI 10.1136/bmj.g2687; Henderson VC, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001489; Home Office, 2012, ANN STAT SCI PROC LI; Hooijmans CR, 2010, ATLA-ALTERN LAB ANIM, V38, P167, DOI 10.1177/026119291003800208; Ioannidis JPA, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3004631; Kilkenny C, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000412; Kilkenny C, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007824; Kimmelman J, 2012, NAT BIOTECHNOL, V30, P488, DOI 10.1038/nbt.2261; Kimmelman J, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001010; Kola I, 2004, NAT REV DRUG DISCOV, V3, P711, DOI 10.1038/nrd1470; Korevaar DA, 2011, LAB ANIM-UK, V45, P225, DOI 10.1258/la.2011.010121; Leist M, 2013, ARCH TOXICOL, V87, P563, DOI 10.1007/s00204-013-1038-0; Lin JH, 2008, CURR DRUG METAB, V9, P419, DOI 10.2174/138920008784746355; Lindner MD, 2007, PHARMACOL THERAPEUT, V115, P148, DOI 10.1016/j.pharmthera.2007.05.002; Macleod MR, 2014, LANCET, V383, P101, DOI 10.1016/S0140-6736(13)62329-6; Matthews RAJ, 2008, J ROY SOC MED, V101, P95, DOI 10.1258/jrsm.2007.070164; Morgan M, 2011, SOC SCI MED, V73, P945, DOI 10.1016/j.socscimed.2011.06.060; Muhlhausler BS, 2013, PLOS BIOL, V11, DOI 10.1371/journal.pbio.1001481; Oxford Centre for Evidence-based Medicine, 2009, LEV EV; Perel P, 2007, BMJ-BRIT MED J, V334, P197, DOI 10.1136/bmj.39048.407928.BE; Perrin S, 2014, NATURE, V507, P423, DOI 10.1038/507423a; Pound P, 2004, BMJ-BRIT MED J, V328, P514, DOI 10.1136/bmj.328.7438.514; Sandercock P, 2002, LANCET, V360, P586, DOI 10.1016/S0140-6736(02)09812-4; Sena ES, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000344; Seok J, 2013, P NATL ACAD SCI USA, V110, P3507, DOI 10.1073/pnas.1222878110; Shanks N, 2008, NAT MED, V14, P1012, DOI 10.1038/nm1008-1012a; Sutherland BA, 2012, INT J STROKE, V7, P407, DOI 10.1111/j.1747-4949.2012.00770.x; Tsilidis KK, 2013, PLOS BIOL, V11, DOI 10.1371/journal.pbio.1001609; Understanding Animal Research, EXP IND OP; *US FDA, 2004, INN STAGN CHALL OPP; van der Worp HB, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000245; Van Luijk J, 2012, ALTEX, V30, P256; Wall RJ, 2008, THERIOGENOLOGY, V69, P2, DOI 10.1016/j.theriogenology.2007.09.030; Wendler A, 2012, J TRANSL MED, V10, DOI 10.1186/1479-5876-10-39; Wooding S, 2011, PROJECT RETROSIGHT U; Wooding S., 2013, MENTAL HLTH RETROSIG	55	124	124	0	35	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	MAY 30	2014	348								g3387	10.1136/bmj.g3387	http://dx.doi.org/10.1136/bmj.g3387			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AI3EO	24879816				2022-12-28	WOS:000336742800001
J	Gilissen, C; Hehir-Kwa, JY; Thung, DT; van de Vorst, M; van Bon, BWM; Willemsen, MH; Kwint, M; Janssen, IM; Hoischen, A; Schenck, A; Leach, R; Klein, R; Tearle, R; Bo, T; Pfundt, R; Yntema, HG; de Vries, BBA; Kleefstra, T; Brunner, HG; Vissers, LELM; Veltman, JA				Gilissen, Christian; Hehir-Kwa, Jayne Y.; Thung, Djie Tjwan; van de Vorst, Maartje; van Bon, Bregje W. M.; Willemsen, Marjolein H.; Kwint, Michael; Janssen, Irene M.; Hoischen, Alexander; Schenck, Annette; Leach, Richard; Klein, Robert; Tearle, Rick; Bo, Tan; Pfundt, Rolph; Yntema, Helger G.; de Vries, Bert B. A.; Kleefstra, Tjitske; Brunner, Han G.; Vissers, Lisenka E. L. M.; Veltman, Joris A.			Genome sequencing identifies major causes of severe intellectual disability	NATURE			English	Article							DE-NOVO MUTATIONS; COPY-NUMBER VARIATION; MENTAL-RETARDATION; AUTISM; SCHIZOPHRENIA; VARIANTS; SPECTRUM; PROTEIN; PARADIGM; NETWORK	Severe intellectual disability (ID) occurs in 0.5% of newborns and is thought to be largely genetic in origin(1,2). The extensive genetic heterogeneity of this disorder requires a genome-wide detection of all types of genetic variation. Microarray studies and, more recently, exome sequencing have demonstrated the importance of de novo copy number variations (CNVs) and single-nucleotide variations (SNVs) in ID, but the majority of cases remain undiagnosed(3-6). Here we applied whole-genome sequencing to 50 patients with severe ID and their unaffected parents. All patients included had not received a molecular diagnosis after extensive genetic prescreening, including microarray-based CNV studies and exome sequencing. Notwithstanding this prescreening, 84 de novo SNVs affecting the coding region were identified, which showed a statistically significant enrichment of loss-of-function mutations as well as an enrichment for genes previously implicated in ID-related disorders. In addition, we identified eight de novo CNVs, including single-exon and intra-exonic deletions, as well as interchromosomal duplications. These CNVs affected known ID genes more frequently than expected. On the basis of diagnostic interpretation of all de novo variants, a conclusive genetic diagnosis was reached in 20 patients. Together with one compound heterozygous CNV causing disease in a recessive mode, this results in a diagnostic yield of 42% in this extensively studied cohort, and 62% as a cumulative estimate in an unselected cohort. These results suggest that de novo SNVs and CNVs affecting the coding region are a major cause of severe ID. Genome sequencing can be applied as a single genetic test to reliably identify and characterize the comprehensive spectrum of genetic variation, providing a genetic diagnosis in the majority of patients with severe ID.	[Gilissen, Christian; Hehir-Kwa, Jayne Y.; Thung, Djie Tjwan; van de Vorst, Maartje; van Bon, Bregje W. M.; Willemsen, Marjolein H.; Kwint, Michael; Janssen, Irene M.; Hoischen, Alexander; Schenck, Annette; Bo, Tan; Pfundt, Rolph; Yntema, Helger G.; de Vries, Bert B. A.; Kleefstra, Tjitske; Brunner, Han G.; Vissers, Lisenka E. L. M.; Veltman, Joris A.] Radboud Univ Nijmegen, Med Ctr, Radboud Inst Mol Life Sci, Dept Human Genet, NL-6525 GA Nijmegen, Netherlands; [Gilissen, Christian; Hehir-Kwa, Jayne Y.; Thung, Djie Tjwan; van de Vorst, Maartje; van Bon, Bregje W. M.; Willemsen, Marjolein H.; Kwint, Michael; Janssen, Irene M.; Hoischen, Alexander; Schenck, Annette; Bo, Tan; Pfundt, Rolph; Yntema, Helger G.; de Vries, Bert B. A.; Kleefstra, Tjitske; Brunner, Han G.; Vissers, Lisenka E. L. M.; Veltman, Joris A.] Radboud Univ Nijmegen, Med Ctr, Donders Ctr Neurosci, NL-6525 GA Nijmegen, Netherlands; [Leach, Richard; Klein, Robert; Tearle, Rick] Complete Genom Inc, Mountain View, CA 94043 USA; [Bo, Tan] Cent S Univ, State Key Lab Med Genet, Changsha 410078, Hunan, Peoples R China; [Gilissen, Christian; Brunner, Han G.; Veltman, Joris A.] Maastricht Univ, Med Ctr, Dept Clin Genet, NL-6229 ER Maastricht, Netherlands	Radboud University Nijmegen; Radboud University Nijmegen; Central South University; Maastricht University	Veltman, JA (corresponding author), Radboud Univ Nijmegen, Med Ctr, Radboud Inst Mol Life Sci, Dept Human Genet, Geert Grootepl 10, NL-6525 GA Nijmegen, Netherlands.	joris.veltman@radboudumc.nl	Kleefstra, Tjitske/G-2619-2012; Schenck, Annette/E-4514-2012; Veltman, Joris A/F-5128-2010; Hehir, g. J.Y./L-4358-2015; van Bon, Bregje/Q-2445-2015; Kwint, Michael/AAC-9062-2019; Willemsen, Marjolein/R-5958-2019; Gilissen, Christian/E-5246-2012; Vissers, Lisenka ELM/A-2598-2015; Hoischen, Alexander/D-1282-2013; Brunner, Han/C-9928-2013; Janssen, Irene M/V-3667-2018; Hoischen, Alexander/AGF-7293-2022; Yntema, H.G./L-4771-2015; Pfundt, Rolph/L-4576-2015; Thung, Djie Tjwan/Q-2104-2015	Schenck, Annette/0000-0002-6918-3314; Veltman, Joris A/0000-0002-3218-8250; van Bon, Bregje/0000-0003-2234-0105; Gilissen, Christian/0000-0003-1693-9699; Vissers, Lisenka ELM/0000-0001-6470-5497; Hoischen, Alexander/0000-0002-8072-4476; Hoischen, Alexander/0000-0002-8072-4476; Hehir-Kwa, Jayne/0000-0003-0837-304X; Wagner, Jennifer/0000-0001-8174-0534; Keehn, Brandon/0000-0001-8796-2250; Tager-Flusberg, Helen/0000-0002-8768-5414	Netherlands Organization for Scientific Research [912-12-109, 916-14-043, 916-12-095, 907-00-365, SH-271-13]; European Research Council (ERC) [DENOVO 281964]	Netherlands Organization for Scientific Research(Netherlands Organization for Scientific Research (NWO)); European Research Council (ERC)(European Research Council (ERC))	We thank R. Drmanac, K. Albers, J. Goeman, D. Lugtenberg and P. N. Robinson for useful discussions, and M. Steehouwer, P. de Vries and W. Nillesen for technical support. This work was in part financially supported by grants from the Netherlands Organization for Scientific Research (912-12-109 to J. A. V., A. S. and B.B.A.d.V., 916-14-043 to C. G., 916-12-095 to A. H., 907-00-365 to T. K. and SH-271-13 to C. G. and J. A. V.) and the European Research Council (ERC Starting grant DENOVO 281964 to J.A.V.).	Allen AS, 2013, NATURE, V501, P217, DOI 10.1038/nature12439; Bell J, 2007, PRACTICE GUIDELINES; Berg JS, 2011, GENET MED, V13, P499, DOI 10.1097/GIM.0b013e318220aaba; Biesecker LG, 2013, NAT REV GENET, V14, P307, DOI 10.1038/nrg3424; Carnevali P, 2012, J COMPUT BIOL, V19, P279, DOI 10.1089/cmb.2011.0201; de Ligt J, 2012, NEW ENGL J MED, V367, P1921, DOI 10.1056/NEJMoa1206524; de Vries BBA, 2005, AM J HUM GENET, V77, P606, DOI 10.1086/491719; Drmanac R, 2010, SCIENCE, V327, P78, DOI 10.1126/science.1181498; Dunham I, 2012, NATURE, V489, P57, DOI 10.1038/nature11247; Girard SL, 2011, NAT GENET, V43, P860, DOI 10.1038/ng.886; Gulsuner S, 2013, CELL, V154, P518, DOI 10.1016/j.cell.2013.06.049; Hehir-Kwa JY, 2013, CLIN GENET, V84, P415, DOI 10.1111/cge.12242; Iossifov I, 2012, NEURON, V74, P285, DOI 10.1016/j.neuron.2012.04.009; Jiang YH, 2013, AM J HUM GENET, V93, P249, DOI 10.1016/j.ajhg.2013.06.012; Kolehmainen J, 2003, AM J HUM GENET, V72, P1359, DOI 10.1086/375454; Kong A, 2012, NATURE, V488, P471, DOI 10.1038/nature11396; Lupski JR, 2010, NEW ENGL J MED, V362, P1181, DOI 10.1056/NEJMoa0908094; MacArthur DG, 2012, SCIENCE, V335, P823, DOI 10.1126/science.1215040; Mefford HC, 2012, NEW ENGL J MED, V366, P733, DOI 10.1056/NEJMra1114194; Michaelson JJ, 2012, CELL, V151, P1431, DOI 10.1016/j.cell.2012.11.019; Neale BM, 2012, NATURE, V485, P242, DOI 10.1038/nature11011; O'Roak BJ, 2012, NATURE, V485, P246, DOI 10.1038/nature10989; Petrovski S, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003709; Rauch A, 2012, LANCET, V380, P1674, DOI 10.1016/S0140-6736(12)61480-9; Rippey C, 2013, AM J HUM GENET, V93, P697, DOI 10.1016/j.ajhg.2013.09.004; Ropers HH, 2010, ANNU REV GENOM HUM G, V11, P161, DOI 10.1146/annurev-genom-082509-141640; Sanders SJ, 2012, NATURE, V485, P237, DOI 10.1038/nature10945; Vissers LELM, 2010, NAT GENET, V42, P1109, DOI 10.1038/ng.712; Vulto-van Silfhout AT, 2013, HUM MUTAT, V34, P1679, DOI 10.1002/humu.22442; Xu B, 2011, NAT GENET, V43, P864, DOI 10.1038/ng.902	30	767	794	3	160	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 17	2014	511	7509					344	+		10.1038/nature13394	http://dx.doi.org/10.1038/nature13394			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AL2YR	23964223				2022-12-28	WOS:000338992200035
